Citrus Sinensis ID: 017445

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-
Protein Sequence
MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVST
Secondary Structure (PSIPRED)
cccHHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccHHHcccccccccEEEEEEEcccccEEEEEEEEcccHHHHHHHHHHHHHHHccccccccEEEEEEEEEccccEEEEEEEccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHccccccccHHHHHHHHHcHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccccccccccccEccHcHcEEEEEEccccccEEEEEEEcccccEEEEHEHHHHcHHHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEEEcccHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccEEEEcccHHHEEEcccccEEEEccccccccccccccEccEcccHHHHHHHHHHHccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHHcccHHHHHHHccccccccccccccccccccc
Coil and Loop (DISEMBL)
MAGLEELKKKLAplfdaekgfsagstldpsdsymlsdggtvNLLSRSygvynfnelglQKCTSWladesdhsektyRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLceapcneglvefhgafympdsgqISIALeymdggslADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHlvhrdikpanllvnlkgrpkitdfgisagLENSIAMCATFVGtvtymsperirnesysypaDIWSIGLALfecgtgefpyaasegpvNLMLQIledpspspsrqnfspefcSFVDDCLKKdaearptadqllshpfitkyehAKVDLAAFVrsvfdpmqrmkdladvst
Flexible Loop (DISEMBL)
MAGLEELKKKLAPLFDAEKgfsagstldpsdsyMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHriialkkinifeKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVST
Low Complexity Region (SEG)
MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVST
Disordered region (IsUnstruct)
**********************************LSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI****************FCSFVDDCLKKD*****TADQLLSHPFITKYEHAKVDLAAFVRSVFD*************
Disordered Region (DISOPRED)
*****************************************************************************CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP*****NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD*************
Disordered Region (DISEMBL)
MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVST
Disordered Region (DISPRO)
**************************************************************************TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQR*********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVST
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	371	2.2.26 [Sep-21-2011]
Q5QN75	355	Mitogen-activated protein	yes	no	0.870	0.909	0.410	5e-67
Q9FJV0	356	Mitogen-activated protein	no	no	0.843	0.879	0.409	3e-66
Q9S7U9	363	Mitogen-activated protein	no	no	0.762	0.779	0.423	7e-65
Q94A06	354	Mitogen-activated protein	no	no	0.722	0.757	0.417	4e-57
Q24324	396	Dual specificity mitogen-	yes	no	0.760	0.712	0.396	1e-50
Q55CL6	660	Dual specificity mitogen-	yes	no	0.541	0.304	0.463	3e-48
P32491	506	MAP kinase kinase MKK2/SS	yes	no	0.727	0.533	0.366	2e-45
P06784	515	Serine/threonine-protein	no	no	0.687	0.495	0.381	4e-45
Q62862	448	Dual specificity mitogen-	yes	no	0.703	0.582	0.357	5e-45
Q13163	448	Dual specificity mitogen-	no	no	0.676	0.560	0.366	7e-45

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  255 bits (651), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 140/341 (41%), Positives = 200/341 (58%), Gaps = 18/341 (5%)

Query: 29  PSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSE---KTYRCASHEMRI 85
           P D ++ + G   +      G    N+ GLQ  +   ADE   +    +  + +  ++ +
Sbjct: 20  PVDKFLTASGTFKD------GELRLNQRGLQLISEETADEPQSTNLKVEDVQLSMDDLEM 73

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
              IG G+  +VQ   H     + ALK I +  ++  R Q++ E++ + +A  N  +V  
Sbjct: 74  IQVIGKGSGGIVQLVRHKWVGTLYALKGIQMNIQEAVRKQIVQELK-INQATQNAHIVLC 132

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           H +FY   +G I + LEYMD GSLADI++  K+I EP L+ + K++L+GL YLH  RH++
Sbjct: 133 HQSFY--HNGVIYLVLEYMDRGSLADIIKQVKTILEPYLAVLCKQVLEGLLYLHHERHVI 190

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           HRDIKP+NLLVN KG  KITDFG+SA L +S+    TFVGT  YM+PERI   SY Y +D
Sbjct: 191 HRDIKPSNLLVNRKGEVKITDFGVSAVLASSMGQRDTFVGTYNYMAPERISGSSYDYKSD 250

Query: 265 IWSIGLALFECGTGEFPYAASEGP-----VNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           IWS+GL + EC  G FPY  SEG        L+  I++ P PS     FSPEFC+F+  C
Sbjct: 251 IWSLGLVILECAIGRFPYIPSEGEGWLSFYELLEAIVDQPPPSAPADQFSPEFCAFISSC 310

Query: 320 LKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           ++KD   R +A +LL+HPFI K+E   +DL   V S+  PM
Sbjct: 311 IQKDPAERMSASELLNHPFIKKFEDKDLDLRILVESLEPPM 351

Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  252 bits (644), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 133/325 (40%), Positives = 195/325 (60%), Gaps = 12/325 (3%)

Query: 49  GVYNFNELGLQKCT-SWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHR 107
           G +  N+ GL+  +    + +SD  E  +   + ++     IG G+  VVQ   H    +
Sbjct: 35  GDFLLNQKGLRLTSDEKQSRQSDSKELDFEITAEDLETVKVIGKGSGGVVQLVRHKWVGK 94

Query: 108 IIALKKINI-FEKEKRNQLLTEIR-TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
             A+K I +  ++E R Q++ E++     + C   +V +H  ++   +G  S+ LEYMD 
Sbjct: 95  FFAMKVIQMNIQEEIRKQIVQELKINQASSQCPHVVVCYHSFYH---NGAFSLVLEYMDR 151

Query: 166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
           GSLAD++R  K+I EP L+ + K++L GL YLH  RH++HRDIKP+NLLVN KG  KI+D
Sbjct: 152 GSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNERHVIHRDIKPSNLLVNHKGEVKISD 211

Query: 226 FGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS 285
           FG+SA L +S+    TFVGT  YMSPERI   +Y Y +DIWS+G+++ EC  G FPY  S
Sbjct: 212 FGVSASLASSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGMSVLECAIGRFPYLES 271

Query: 286 EGPVN------LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           E   N      L+  I+E+P P+     FSPEFCSFV  C++KD  AR ++  LLSHPFI
Sbjct: 272 EDQQNPPSFYELLAAIVENPPPTAPSDQFSPEFCSFVSACIQKDPPARASSLDLLSHPFI 331

Query: 340 TKYEHAKVDLAAFVRSVFDPMQRMK 364
            K+E   +DL   V ++  P+  ++
Sbjct: 332 KKFEDKDIDLGILVGTLEPPVNYLR 356

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  248 bits (632), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 124/293 (42%), Positives = 183/293 (62%), Gaps = 10/293 (3%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG 140
           ++ +   IG G+S VVQ   H  T +  ALK I +  ++  R  +  E++    + C   
Sbjct: 69  DLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQELKINQSSQC-PN 127

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           LV  + +FY  D+G IS+ LEYMDGGSLAD L+  K+IP+  LS++F+++LQGL YLH  
Sbjct: 128 LVTSYQSFY--DNGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQVLQGLIYLHHD 185

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
           RH++HRD+KP+NLL+N +G  KITDFG+S  + N+  +  TFVGT  YMSPERI    Y 
Sbjct: 186 RHIIHRDLKPSNLLINHRGEVKITDFGVSTVMTNTAGLANTFVGTYNYMSPERIVGNKYG 245

Query: 261 YPADIWSIGLALFECGTGEFPYAASE------GPVNLMLQILEDPSPSPSRQNFSPEFCS 314
             +DIWS+GL + EC TG+FPYA             LM  I++ P P+    NFSPE  S
Sbjct: 246 NKSDIWSLGLVVLECATGKFPYAPPNQEETWTSVFELMEAIVDQPPPALPSGNFSPELSS 305

Query: 315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLA 367
           F+  CL+KD  +R +A +L+ HPF+ KY+++ ++LA++      P+  + +L+
Sbjct: 306 FISTCLQKDPNSRSSAKELMEHPFLNKYDYSGINLASYFTDAGSPLATLGNLS 358

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  222 bits (565), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 116/278 (41%), Positives = 172/278 (61%), Gaps = 10/278 (3%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT-EIRTLCEAPCNEG 140
           ++ +   IG G+S  VQ   H  T +  ALK I +  +E   + ++ E+R    + C   
Sbjct: 67  DLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQC-PY 125

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           LV  + +FY   +G +SI LE+MDGGSLAD+L+    +PE +LS++ K++L+GL Y+H  
Sbjct: 126 LVSCYQSFY--HNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHE 183

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
           R ++HRD+KP+NLL+N +G  KITDFG+S  L ++ ++  +FVGT  YMSPERI    YS
Sbjct: 184 RRIIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYS 243

Query: 261 YPADIWSIGLALFECGTGEFPYAASE------GPVNLMLQILEDPSPSPSRQNFSPEFCS 314
             +DIWS+GL L EC TG+FPY   E          L+  I+E+P P      FSPEFCS
Sbjct: 244 NKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCS 303

Query: 315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAF 352
           F+  C++KD   R +A +LL H F+  +E +  +L+A+
Sbjct: 304 FISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTNLSAY 341

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q24324|DSOR1_DROME Dual specificity mitogen-activated protein kinase kinase dSOR1 OS=Drosophila melanogaster GN=Dsor1 PE=2 SV=2

 Score =  200 bits (509), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 125/315 (39%), Positives = 171/315 (54%), Gaps = 33/315 (10%)

Query: 71  HSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEI 129
             EK    +  ++   G +GSG   VV +  H  TH I+A K I++  K   + Q+L E+
Sbjct: 75  QKEKIGELSDEDLEKLGELGSGNGGVVMKVRHTHTHLIMARKLIHLEVKPAIKKQILREL 134

Query: 130 RTLCEAPCN-EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           + L E  CN   +V F+GAFY    G+ISI +EYMDGGSL  IL+    IPE IL  +  
Sbjct: 135 KVLHE--CNFPHIVGFYGAFY--SDGEISICMEYMDGGSLDLILKRAGRIPESILGRITL 190

Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
            +L+GLSYL     ++HRD+KP+N+LVN  G  KI DFG+S  L +S  M  +FVGT +Y
Sbjct: 191 AVLKGLSYLRDNHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDS--MANSFVGTRSY 248

Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPY----------------AASEGPVN-- 290
           MSPER++   YS  +DIWS+GL+L E   G +P                   S  P +  
Sbjct: 249 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPNTATLESIFADNAEESGQPTDEP 308

Query: 291 -------LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
                  L+  I+ +P P    + FS EF  FVD CLKK  + R     LLSHP+I K E
Sbjct: 309 RAMAIFELLDYIVNEPPPKLEHKIFSTEFKDFVDICLKKQPDERADLKTLLSHPWIRKAE 368

Query: 344 HAKVDLAAFVRSVFD 358
             +VD++ +V    D
Sbjct: 369 LEEVDISGWVCKTMD 383

Required downstream of Raf in the sevenless (sev), torso (tor), and Drosophila EGF receptor homolog (DER) signal transduction pathways. Involved in both positive regulation (at the posterior terminus) and negative regulation (at the anterior domain) of tll, as in other terminal class gene products, maybe via the ERK-A kinase.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q55CL6|MP2K1_DICDI Dual specificity mitogen-activated protein kinase kinase 1 OS=Dictyostelium discoideum GN=mekA PE=1 SV=1

 Score =  192 bits (488), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 95/205 (46%), Positives = 139/205 (67%), Gaps = 4/205 (1%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG 140
           +++I   +G GA  VV+ A H  +   IALK I +  ++  R Q++ E++TL +      
Sbjct: 291 DLKIIRVLGRGAGGVVKLAYHETSGTYIALKVITLDIQENIRKQIILELKTLHKTSY-PY 349

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V F+ AFY    G I IALE+M+ GSL+DI++   +IPEP+L  +  ++LQGL YLH  
Sbjct: 350 IVSFYDAFYT--EGSIFIALEFMELGSLSDIMKKTSTIPEPVLGKIAFQVLQGLVYLHRK 407

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
            HL+HRDIKP+N+LVN KG  KI DFG+S  L+++++   T+VGTVTYMSPERI   SYS
Sbjct: 408 LHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQHTLSKAVTWVGTVTYMSPERISGRSYS 467

Query: 261 YPADIWSIGLALFECGTGEFPYAAS 285
           + ++IWS+GL + EC  G+FPY ++
Sbjct: 468 FDSEIWSLGLTILECAIGKFPYGSN 492

Required for cAMP-mediated activation of guanylyl cyclase activity and plays an essential role in aggregation, morphogenesis, and chemotaxis. Appears to act upstream of erk1 but not erk2.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P32491|MKK2_YEAST MAP kinase kinase MKK2/SSP33 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=MKK2 PE=1 SV=2

 Score =  183 bits (464), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 108/295 (36%), Positives = 166/295 (56%), Gaps = 25/295 (8%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNE 139
           E+   G +G GA   V +       ++ ALK IN    + E + Q+  E++   ++  ++
Sbjct: 213 EITTLGILGEGAGGSVAKCRLKNGKKVFALKTINTMNTDPEYQKQIFRELQ-FNKSFKSD 271

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSL----ADILRMQKSIPEPILSSMFKKLLQGLS 195
            +V+++G F    S  I IA+EYM G SL     ++L+    I E ++  + + +L+GLS
Sbjct: 272 YIVQYYGMFTDEQSSSIYIAMEYMGGKSLEATYKNLLKRGGRISERVIGKIAESVLRGLS 331

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           YLH  R ++HRDIKP N+L+N KG  K+ DFG+S    NS+AM  TF GT  YM+PERI+
Sbjct: 332 YLHE-RKVIHRDIKPQNILLNEKGEIKLCDFGVSGEAVNSLAM--TFTGTSFYMAPERIQ 388

Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASE-----GPVNLMLQILEDPSPSPSRQN--- 307
            + YS   D+WS+GL L E   G FP+ + +      P+ L+  IL   + SP  ++   
Sbjct: 389 GQPYSVTCDVWSLGLTLLEVAGGRFPFESDKITQNVAPIELLTMIL---TFSPQLKDEPE 445

Query: 308 ----FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD 358
               +S  F SF+D CLKKDA  RP+  Q+L HP+I      KV++  FV+  ++
Sbjct: 446 LDISWSKTFRSFIDYCLKKDARERPSPRQMLKHPWIVGQMKKKVNMERFVKKCWE 500

Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involves the kinase PKC1 that may act on the BCK1 kinase that then phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P06784|STE7_YEAST Serine/threonine-protein kinase STE7 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=STE7 PE=1 SV=1

 Score =  182 bits (462), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 106/278 (38%), Positives = 156/278 (56%), Gaps = 23/278 (8%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR--NQLLTEIRTLCEAPCNEGLVE 143
            G IG+G S  V +A+H+P  +I+A K I + +      NQL+ E+  +     +E ++ 
Sbjct: 194 LGKIGAGNSGTVVKALHVPDSKIVAKKTIPVEQNNSTIINQLVRELSIVKNVKPHENIIT 253

Query: 144 FHGAFYMPD-SGQISIALEYMDGGSLADILRMQKSI-------------PEPILSSMFKK 189
           F+GA+Y    + +I I +EY D GSL  IL + K                E  +S +   
Sbjct: 254 FYGAYYNQHINNEIIILMEYSDCGSLDKILSVYKRFVQRGTVSSKKTWFNELTISKIAYG 313

Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM 249
           +L GL +L+    ++HRDIKP+N+L+N KG+ K+ DFG+S  L NSIA   TFVGT TYM
Sbjct: 314 VLNGLDHLYRQYKIIHRDIKPSNVLINSKGQIKLCDFGVSKKLINSIA--DTFVGTSTYM 371

Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS----EGPVNLMLQILEDPSPS-PS 304
           SPERI+   YS   D+WS+GL + E  TGEFP        +G ++L+ +I+ +PSP  P 
Sbjct: 372 SPERIQGNVYSIKGDVWSLGLMIIELVTGEFPLGGHNDTPDGILDLLQRIVNEPSPRLPK 431

Query: 305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            + +S E   FV+ C  K+   R +  +LL H  I KY
Sbjct: 432 DRIYSKEMTDFVNRCCIKNERERSSIHELLHHDLIMKY 469

Serine/threonine protein kinase required for cell-type-specific transcription and signal transduction in yeast. It is thought that it is phosphorylated by the ste11 protein kinase and that it can phosphorylate the FUS3 and or KSS1 kinases.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q62862|MP2K5_RAT Dual specificity mitogen-activated protein kinase kinase 5 OS=Rattus norvegicus GN=Map2k5 PE=1 SV=1

 Score =  182 bits (461), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 100/280 (35%), Positives = 165/280 (58%), Gaps = 19/280 (6%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNE 139
            ++R    +G G    V +A H+P+ +I+A+K I +    E + Q+++E+  L +  C+ 
Sbjct: 164 QDIRYRDTLGHGNGGTVYKAYHVPSGKILAVKVILLDITLELQKQIMSELEILYK--CDS 221

Query: 140 G-LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             ++ F+GAF++ +  +ISI  E+MDGGSL D+ R    IPE +L  +   +++GL+YL 
Sbjct: 222 SYIIGFYGAFFVEN--RISICTEFMDGGSL-DVYR---KIPEHVLGRIAVAVVKGLTYLW 275

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
            ++ ++HRD+KP+N+LVN  G+ K+ DFG+S  L NSIA   T+VGT  YM+PERI  E 
Sbjct: 276 SLK-ILHRDVKPSNMLVNTSGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERISGEQ 332

Query: 259 YSYPADIWSIGLALFECGTGEFPY------AASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
           Y   +D+WS+G++  E   G FPY        S  P+ L+  I+++ SP      FS  F
Sbjct: 333 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDSPVLPLGEFSEPF 392

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAF 352
             F+  C++K  + RP  ++L+ HPFI ++      + + 
Sbjct: 393 VHFITQCMRKQPKERPAPEELMGHPFIVQFNDGNATVVSM 432

Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q13163|MP2K5_HUMAN Dual specificity mitogen-activated protein kinase kinase 5 OS=Homo sapiens GN=MAP2K5 PE=1 SV=2

 Score =  181 bits (459), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 164/270 (60%), Gaps = 19/270 (7%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNE 139
            ++R    +G G    V +A H+P+ +I+A+K I +    E + Q+++E+  L +  C+ 
Sbjct: 164 QDIRYRDTLGHGNGGTVYKAYHVPSGKILAVKVILLDITLELQKQIMSELEILYK--CDS 221

Query: 140 G-LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             ++ F+GAF++ +  +ISI  E+MDGGSL D+ R    +PE +L  +   +++GL+YL 
Sbjct: 222 SYIIGFYGAFFVEN--RISICTEFMDGGSL-DVYR---KMPEHVLGRIAVAVVKGLTYLW 275

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
            ++ ++HRD+KP+N+LVN +G+ K+ DFG+S  L NSIA   T+VGT  YM+PERI  E 
Sbjct: 276 SLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERISGEQ 332

Query: 259 YSYPADIWSIGLALFECGTGEFPY------AASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
           Y   +D+WS+G++  E   G FPY        S  P+ L+  I+++ SP      FS  F
Sbjct: 333 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDSPVLPVGEFSEPF 392

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
             F+  C++K  + RP  ++L+ HPFI ++
Sbjct: 393 VHFITQCMRKQPKERPAPEELMGHPFIVQF 422

Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	371
255560894	518	serine/threonine protein kinase, putativ	1.0	0.716	0.889	0.0
356570851	526	PREDICTED: mitogen-activated protein kin	1.0	0.705	0.876	0.0
356511672	518	PREDICTED: mitogen-activated protein kin	1.0	0.716	0.873	0.0
224055557	521	predicted protein [Populus trichocarpa]	1.0	0.712	0.870	0.0
449489475	518	PREDICTED: mitogen-activated protein kin	1.0	0.716	0.857	0.0
449446696	518	PREDICTED: mitogen-activated protein kin	1.0	0.716	0.857	0.0
297805640	520	ATMKK3 MITOGEN-ACTIVATED kinase [Arabido	1.0	0.713	0.843	0.0
99083579	552	double MYC-tagged mitogen activated prot	1.0	0.672	0.840	0.0
15242705	520	mitogen-activated protein kinase kinase	1.0	0.713	0.840	0.0
225452356	518	PREDICTED: mitogen-activated protein kin	0.994	0.712	0.853	0.0

>gi|255560894|ref|XP_002521460.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223539359|gb|EEF40950.1| serine/threonine protein kinase, putative [Ricinus communis]

 Score =  694 bits (1792), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/371 (88%), Positives = 351/371 (94%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MAGLEEL+KKL PLFDAEKGFSAGSTLDPSDSYMLS GGTVNLLSRSYGVYN NELGLQK
Sbjct: 1   MAGLEELRKKLTPLFDAEKGFSAGSTLDPSDSYMLSGGGTVNLLSRSYGVYNINELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           C+S   DE+DHSEKTYRCASHEMRIFGAIGSGASSVVQRA+HIPTHRIIALKKINIFEKE
Sbjct: 61  CSSSPVDETDHSEKTYRCASHEMRIFGAIGSGASSVVQRAIHIPTHRIIALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPCNEGLVEFHGAFY PDSGQISIALEYM+GGSLADILR+QK IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCNEGLVEFHGAFYTPDSGQISIALEYMNGGSLADILRVQKRIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LS MF+KLL GL YLHGVR+LVHRDIKPAN+LVNLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PVLSHMFQKLLHGLGYLHGVRYLVHRDIKPANMLVNLKGEPKITDFGISAGLENSVAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRNESYSYPADIWS+GLALFECGTGEFPYAA++GPVNLMLQILEDPS
Sbjct: 241 TFVGTVTYMSPERIRNESYSYPADIWSLGLALFECGTGEFPYAANDGPVNLMLQILEDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSPS+Q FSPEFCSFVD CL+KD +ARPTADQLLSHPFI+KY H  VDLAAFVR+VFDPM
Sbjct: 301 PSPSKQIFSPEFCSFVDACLQKDPDARPTADQLLSHPFISKYVHTSVDLAAFVRNVFDPM 360

Query: 361 QRMKDLADVST 371
           QR+KDLAD+ T
Sbjct: 361 QRLKDLADMLT 371

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356570851|ref|XP_003553597.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Glycine max]

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/371 (87%), Positives = 344/371 (92%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           M+GLEEL+KKLAPLFDAEKGFS+ STLDP DSY  SDGGTVNLLSRSYGVYN NELGLQK
Sbjct: 1   MSGLEELRKKLAPLFDAEKGFSSSSTLDPCDSYTFSDGGTVNLLSRSYGVYNINELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTS   DE+DHSEKTY+C SHEMRIFGAIGSGASSVVQRA+HIPTHRI+ALKKINIFEKE
Sbjct: 61  CTSRSVDETDHSEKTYKCCSHEMRIFGAIGSGASSVVQRAIHIPTHRILALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC EGLVEFHGAFY PDSGQISIALEYMDGGSLADILRM + IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCYEGLVEFHGAFYTPDSGQISIALEYMDGGSLADILRMHRRIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           PILSSMF+KLL GLSYLHGVRHLVHRDIKPANLLVNLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PILSSMFQKLLHGLSYLHGVRHLVHRDIKPANLLVNLKGEPKITDFGISAGLENSVAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRNE+YSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNENYSYPADIWSLGLALFECGTGEFPYTANEGPVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSP +  FSPEFCSFVD CL+KD + RPTA+QLLSHPFITKYE AKVDLA FVRSVFDP 
Sbjct: 301 PSPLKNKFSPEFCSFVDACLQKDPDTRPTAEQLLSHPFITKYEDAKVDLAGFVRSVFDPT 360

Query: 361 QRMKDLADVST 371
           QRMKDLAD+ T
Sbjct: 361 QRMKDLADMLT 371

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356511672|ref|XP_003524547.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Glycine max]

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/371 (87%), Positives = 344/371 (92%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           M+GLEEL+KKLAPLFDAEKGFS+ STLDP DSY  SDGGTVNLLSRSYGVYN NELGLQK
Sbjct: 1   MSGLEELRKKLAPLFDAEKGFSSSSTLDPCDSYTFSDGGTVNLLSRSYGVYNINELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTS   DE+DHSEKTYRC SHEMRIFGAIGSGASSVVQRA+HIPTHRI+ALKKINIFEKE
Sbjct: 61  CTSRSVDETDHSEKTYRCGSHEMRIFGAIGSGASSVVQRAIHIPTHRILALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC EGLVEFHGAFY PDSGQISIALEYMDGGSLADILRM + IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCYEGLVEFHGAFYTPDSGQISIALEYMDGGSLADILRMHRRIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           PILSSMF+KLL GLSYLHGVRHLVHRDIKPANLLVNLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PILSSMFQKLLHGLSYLHGVRHLVHRDIKPANLLVNLKGEPKITDFGISAGLENSVAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRNESYSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNESYSYPADIWSLGLALFECGTGEFPYTANEGPVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSP +  FSPEFCSFVD CL+KD + RPTA+QLLSHPFITK++ AKVDLA FVRSVFDP 
Sbjct: 301 PSPLKNKFSPEFCSFVDACLQKDPDTRPTAEQLLSHPFITKHDDAKVDLAGFVRSVFDPT 360

Query: 361 QRMKDLADVST 371
           QR+KDLAD+ T
Sbjct: 361 QRLKDLADMLT 371

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224055557|ref|XP_002298538.1| predicted protein [Populus trichocarpa] gi|222845796|gb|EEE83343.1| predicted protein [Populus trichocarpa]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/371 (87%), Positives = 346/371 (93%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MAGLEELKKKL PLFD+EKGFS+ STLDPSDSY+LSDGGTVNLLSRSYGVYN NELGLQK
Sbjct: 1   MAGLEELKKKLTPLFDSEKGFSSDSTLDPSDSYVLSDGGTVNLLSRSYGVYNINELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CT+   DE+DHSEKTYRCASHEMRIFGAIGSGASSVVQRA+HIP HRI+ALKKINIFEKE
Sbjct: 61  CTTSPEDETDHSEKTYRCASHEMRIFGAIGSGASSVVQRALHIPMHRILALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC EGLVEFHGAFY PDSGQISIALEYMDGGSLADILR++K IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCYEGLVEFHGAFYTPDSGQISIALEYMDGGSLADILRLRKRIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LS MF+KLL GLSYLHGVRHLVHRDIKPANLLVNLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PVLSHMFQKLLIGLSYLHGVRHLVHRDIKPANLLVNLKGEPKITDFGISAGLENSVAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRN+SYSYPADIWS+GLALFECGTGEFPY A+EG VNLMLQILEDPS
Sbjct: 241 TFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYTANEGLVNLMLQILEDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSPS+ NFSPEFCSF+D CL+KD + RPTA+QLLS+PFITKY H  VDLAAFV+SVFDP 
Sbjct: 301 PSPSKNNFSPEFCSFIDACLQKDPDTRPTAEQLLSYPFITKYAHTDVDLAAFVQSVFDPT 360

Query: 361 QRMKDLADVST 371
           QRMKDLAD+ T
Sbjct: 361 QRMKDLADMLT 371

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449489475|ref|XP_004158323.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Cucumis sativus]

 Score =  671 bits (1732), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/371 (85%), Positives = 346/371 (93%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MAGLEELKKKL PLFDAEKG S  S +DPSDSY  SD GTVNLLSRSYGVYNFNELGLQK
Sbjct: 1   MAGLEELKKKLTPLFDAEKGLSMDSPVDPSDSYTFSDNGTVNLLSRSYGVYNFNELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTSWLAD+S  SE+TYRCAS EMRIFGAIGSGASSVVQRA+HIP HRI+ALKKINIFEKE
Sbjct: 61  CTSWLADDSGSSERTYRCASREMRIFGAIGSGASSVVQRAIHIPAHRIMALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC+EGLVEFHGAFY PDSGQISIALEYMDGGSLAD+LR++K IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCSEGLVEFHGAFYTPDSGQISIALEYMDGGSLADVLRLKKCIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LS+MF+KLL+GLSYLHGVRHLVHRDIKPANLLVNLKG  KITDFGISAGLENS+AMCA
Sbjct: 181 PVLSTMFQKLLRGLSYLHGVRHLVHRDIKPANLLVNLKGEAKITDFGISAGLENSMAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRNESYSYPADIWS+GLALFECGTGEFPY+A+EG VNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNESYSYPADIWSLGLALFECGTGEFPYSATEGLVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSPS+  FS EFCSFVD CL+KDA+ARPTA+QLLSHPFI KYE+ +VDLAAFV++VFDP+
Sbjct: 301 PSPSKHKFSSEFCSFVDACLQKDADARPTAEQLLSHPFIKKYENEQVDLAAFVQNVFDPI 360

Query: 361 QRMKDLADVST 371
           QRMKDLAD+ T
Sbjct: 361 QRMKDLADMLT 371

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446696|ref|XP_004141107.1| PREDICTED: mitogen-activated protein kinase kinase 6-like [Cucumis sativus]

 Score =  671 bits (1730), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/371 (85%), Positives = 345/371 (92%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MAGLEELKKKL PLFDAEKG S  S +DPSDSY  SD GTVNLLSRSYGVYNFNELGLQK
Sbjct: 1   MAGLEELKKKLTPLFDAEKGLSMDSPVDPSDSYTFSDNGTVNLLSRSYGVYNFNELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTSWLAD+S  SE+TYRCAS EMRIFGAIGSGASSVVQRA+HIP HRI+ALKKINIFEKE
Sbjct: 61  CTSWLADDSGSSERTYRCASREMRIFGAIGSGASSVVQRAIHIPAHRIMALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC+EGLVEFHGAFY PDSGQISIALEYMDGGSLAD+LR++K IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCSEGLVEFHGAFYTPDSGQISIALEYMDGGSLADVLRLKKCIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LS+MF+KLL+GLSYLHGVRHLVHRDIKPANLLVNLKG  KITDFGISAGLENS+AMCA
Sbjct: 181 PVLSTMFQKLLRGLSYLHGVRHLVHRDIKPANLLVNLKGEAKITDFGISAGLENSMAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRNESYSYPADIWS+GLALFECGTGEFPY+A+EG VNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNESYSYPADIWSLGLALFECGTGEFPYSATEGLVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSPS+  FS EFCSFVD CL+KDA+ARPTA+QLLSHPFI KYE+ +VDLAAFV++VFDP 
Sbjct: 301 PSPSKHKFSSEFCSFVDACLQKDADARPTAEQLLSHPFIKKYENEQVDLAAFVQNVFDPT 360

Query: 361 QRMKDLADVST 371
           QRMKDLAD+ T
Sbjct: 361 QRMKDLADMLT 371

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805640|ref|XP_002870704.1| ATMKK3 MITOGEN-ACTIVATED kinase [Arabidopsis lyrata subsp. lyrata] gi|297316540|gb|EFH46963.1| ATMKK3 MITOGEN-ACTIVATED kinase [Arabidopsis lyrata subsp. lyrata]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/371 (84%), Positives = 347/371 (93%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MA LEELKKKL+PLFDAEKGFS+ S+LDP+DSY+LSDGGTVNLLSRSYGVYNFNELGLQK
Sbjct: 1   MAALEELKKKLSPLFDAEKGFSSSSSLDPNDSYLLSDGGTVNLLSRSYGVYNFNELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTS   DES+ SE TY+CASHEMR+FGAIGSGASSVVQRA+HIP HRI+ALKKINIFE+E
Sbjct: 61  CTSSHVDESESSETTYQCASHEMRVFGAIGSGASSVVQRAIHIPNHRILALKKINIFERE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC+EGLV+FHGAFY PDSGQISIALEYM+GGSLADIL++ K IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNGGSLADILKVTKKIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LSSMF KLLQGLSYLHGVRHLVHRDIKPANLL+NLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PVLSSMFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITDFGISAGLENSMAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRN+SYSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIANEGPVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           P+P +Q FSPEFCSF+D CL+KD +ARPTADQLLSHPFITK+E  +VDLA FV+S+FDP 
Sbjct: 301 PTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFITKHEKERVDLATFVQSIFDPT 360

Query: 361 QRMKDLADVST 371
           QR+KDLAD+ T
Sbjct: 361 QRLKDLADMLT 371

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|99083579|gb|ABF55663.2| double MYC-tagged mitogen activated protein kinase kinase 3 [synthetic construct]

 Score =  668 bits (1724), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/371 (84%), Positives = 347/371 (93%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MA LEELKKKL+PLFDAEKGFS+ S+LDP+DSY+LSDGGTVNLLSRSYGVYNFNELGLQK
Sbjct: 1   MAALEELKKKLSPLFDAEKGFSSSSSLDPNDSYLLSDGGTVNLLSRSYGVYNFNELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTS   DES+ SE TY+CASHEMR+FGAIGSGASSVVQRA+HIP HRI+ALKKINIFE+E
Sbjct: 61  CTSSHVDESESSETTYQCASHEMRVFGAIGSGASSVVQRAIHIPNHRILALKKINIFERE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC+EGLV+FHGAFY PDSGQISIALEYM+GGSLADIL++ K IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNGGSLADILKVTKKIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LSS+F KLLQGLSYLHGVRHLVHRDIKPANLL+NLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITDFGISAGLENSMAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRN+SYSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIANEGPVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           P+P +Q FSPEFCSF+D CL+KD +ARPTADQLLSHPFITK+E  +VDLA FV+S+FDP 
Sbjct: 301 PTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFITKHEKERVDLATFVQSIFDPT 360

Query: 361 QRMKDLADVST 371
           QR+KDLAD+ T
Sbjct: 361 QRLKDLADMLT 371

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

>gi|15242705|ref|NP_198860.1| mitogen-activated protein kinase kinase 3 [Arabidopsis thaliana] gi|3219269|dbj|BAA28829.1| MAP kinase kinase 3 [Arabidopsis thaliana] gi|10178156|dbj|BAB11601.1| MAP kinase kinase 3 [Arabidopsis thaliana] gi|26449374|dbj|BAC41814.1| putative MAP kinase kinase 3 ATMKK3 [Arabidopsis thaliana] gi|30102742|gb|AAP21289.1| At5g40440 [Arabidopsis thaliana] gi|332007165|gb|AED94548.1| mitogen-activated protein kinase kinase 3 [Arabidopsis thaliana]

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/371 (84%), Positives = 347/371 (93%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MA LEELKKKL+PLFDAEKGFS+ S+LDP+DSY+LSDGGTVNLLSRSYGVYNFNELGLQK
Sbjct: 1   MAALEELKKKLSPLFDAEKGFSSSSSLDPNDSYLLSDGGTVNLLSRSYGVYNFNELGLQK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           CTS   DES+ SE TY+CASHEMR+FGAIGSGASSVVQRA+HIP HRI+ALKKINIFE+E
Sbjct: 61  CTSSHVDESESSETTYQCASHEMRVFGAIGSGASSVVQRAIHIPNHRILALKKINIFERE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIRTLCEAPC+EGLV+FHGAFY PDSGQISIALEYM+GGSLADIL++ K IPE
Sbjct: 121 KRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNGGSLADILKVTKKIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LSS+F KLLQGLSYLHGVRHLVHRDIKPANLL+NLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITDFGISAGLENSMAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRN+SYSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIANEGPVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           P+P +Q FSPEFCSF+D CL+KD +ARPTADQLLSHPFITK+E  +VDLA FV+S+FDP 
Sbjct: 301 PTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFITKHEKERVDLATFVQSIFDPT 360

Query: 361 QRMKDLADVST 371
           QR+KDLAD+ T
Sbjct: 361 QRLKDLADMLT 371

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452356|ref|XP_002274862.1| PREDICTED: mitogen-activated protein kinase kinase 6 [Vitis vinifera] gi|296087617|emb|CBI34873.3| unnamed protein product [Vitis vinifera]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/369 (85%), Positives = 342/369 (92%)

Query: 1   MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
           MAGLEELKKKL+PLFD +KG SAGSTLDP DSYMLSDGGTVNLLS+S GVYN NELGL K
Sbjct: 1   MAGLEELKKKLSPLFDPDKGLSAGSTLDPCDSYMLSDGGTVNLLSKSCGVYNINELGLLK 60

Query: 61  CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           C+S   DE+D+ E+TYRCASHEMRIFGAIGSGASSVVQRA+HIPTHRIIALKKINIFEKE
Sbjct: 61  CSSSPVDEADYKERTYRCASHEMRIFGAIGSGASSVVQRAIHIPTHRIIALKKINIFEKE 120

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           KR QLLTEIR LCEAPC EGLVEFHGAFY PDSGQISIALEYMDGGSLAD++R+QK IPE
Sbjct: 121 KRQQLLTEIRMLCEAPCYEGLVEFHGAFYTPDSGQISIALEYMDGGSLADVIRVQKCIPE 180

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
           P+LSSM +KLL GL YLHGVRHLVHRDIKPANLLVNLKG PKITDFGISAGLENS+AMCA
Sbjct: 181 PVLSSMVRKLLHGLCYLHGVRHLVHRDIKPANLLVNLKGEPKITDFGISAGLENSVAMCA 240

Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           TFVGTVTYMSPERIRNE+YSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct: 241 TFVGTVTYMSPERIRNENYSYPADIWSLGLALFECGTGEFPYTANEGPVNLMLQILDDPS 300

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
           PSP +  FS EFCSF+D CL+KDA+ARPTA+QLLSHPFITKYEHA+VDL AFVRS+FDP 
Sbjct: 301 PSPPKHIFSAEFCSFIDACLQKDADARPTAEQLLSHPFITKYEHARVDLTAFVRSIFDPT 360

Query: 361 QRMKDLADV 369
           Q+MKDLAD+
Sbjct: 361 QKMKDLADM 369

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	371
TAIR|locus:2170578	520	MKK3 "AT5G40440" [Arabidopsis	1.0	0.713	0.840	3e-172
TAIR|locus:2164981	356	MKK6 "MAP kinase kinase 6" [Ar	0.843	0.879	0.415	3.8e-62
DICTYBASE|DDB_G0269152	660	mekA "MAP kinase kinase (MAP2K	0.584	0.328	0.443	4.8e-56
TAIR|locus:2120855	354	MEK1 "MAP kinase/ ERK kinase 1	0.722	0.757	0.417	2.6e-54
FB|FBgn0010269	396	Dsor1 "Downstream of raf1" [Dr	0.547	0.512	0.450	5.4e-51
MGI|MGI:1346867	401	Map2k2 "mitogen-activated prot	0.504	0.466	0.456	6e-46
UNIPROTKB|Q1HG70	400	MAP2K2 "Dual specificity mitog	0.504	0.467	0.451	7.6e-46
UNIPROTKB|P36507	400	MAP2K2 "Dual specificity mitog	0.504	0.467	0.446	7.6e-46
ZFIN|ZDB-GENE-080219-34	395	map2k2b "mitogen-activated pro	0.700	0.658	0.347	9.7e-46
UNIPROTKB|F1NYZ2	398	MAP2K2 "Dual-specificity mitog	0.504	0.469	0.451	1.6e-45

TAIR|locus:2170578 MKK3 "AT5G40440" [Arabidopsis thaliana (taxid:3702)]

 Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
 Identities = 312/371 (84%), Positives = 347/371 (93%)

Query:     1 MAGLEELKKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQK 60
             MA LEELKKKL+PLFDAEKGFS+ S+LDP+DSY+LSDGGTVNLLSRSYGVYNFNELGLQK
Sbjct:     1 MAALEELKKKLSPLFDAEKGFSSSSSLDPNDSYLLSDGGTVNLLSRSYGVYNFNELGLQK 60

Query:    61 CTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
             CTS   DES+ SE TY+CASHEMR+FGAIGSGASSVVQRA+HIP HRI+ALKKINIFE+E
Sbjct:    61 CTSSHVDESESSETTYQCASHEMRVFGAIGSGASSVVQRAIHIPNHRILALKKINIFERE 120

Query:   121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
             KR QLLTEIRTLCEAPC+EGLV+FHGAFY PDSGQISIALEYM+GGSLADIL++ K IPE
Sbjct:   121 KRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNGGSLADILKVTKKIPE 180

Query:   181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
             P+LSS+F KLLQGLSYLHGVRHLVHRDIKPANLL+NLKG PKITDFGISAGLENS+AMCA
Sbjct:   181 PVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITDFGISAGLENSMAMCA 240

Query:   241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
             TFVGTVTYMSPERIRN+SYSYPADIWS+GLALFECGTGEFPY A+EGPVNLMLQIL+DPS
Sbjct:   241 TFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIANEGPVNLMLQILDDPS 300

Query:   301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM 360
             P+P +Q FSPEFCSF+D CL+KD +ARPTADQLLSHPFITK+E  +VDLA FV+S+FDP 
Sbjct:   301 PTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFITKHEKERVDLATFVQSIFDPT 360

Query:   361 QRMKDLADVST 371
             QR+KDLAD+ T
Sbjct:   361 QRLKDLADMLT 371

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IEP

GO:0009866 "induced systemic resistance, ethylene mediated signaling pathway" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:0004707 "MAP kinase activity" evidence=IDA

TAIR|locus:2164981 MKK6 "MAP kinase kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 635 (228.6 bits), Expect = 3.8e-62, P = 3.8e-62
 Identities = 135/325 (41%), Positives = 195/325 (60%)

Query:    49 GVYNFNELGLQKCTSWLAD-ESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHR 107
             G +  N+ GL+  +      +SD  E  +   + ++     IG G+  VVQ   H    +
Sbjct:    35 GDFLLNQKGLRLTSDEKQSRQSDSKELDFEITAEDLETVKVIGKGSGGVVQLVRHKWVGK 94

Query:   108 IIALKKINI-FEKEKRNQLLTEIR-TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
               A+K I +  ++E R Q++ E++     + C   +V +H +FY   +G  S+ LEYMD 
Sbjct:    95 FFAMKVIQMNIQEEIRKQIVQELKINQASSQCPHVVVCYH-SFY--HNGAFSLVLEYMDR 151

Query:   166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
             GSLAD++R  K+I EP L+ + K++L GL YLH  RH++HRDIKP+NLLVN KG  KI+D
Sbjct:   152 GSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNERHVIHRDIKPSNLLVNHKGEVKISD 211

Query:   226 FGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS 285
             FG+SA L +S+    TFVGT  YMSPERI   +Y Y +DIWS+G+++ EC  G FPY  S
Sbjct:   212 FGVSASLASSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGMSVLECAIGRFPYLES 271

Query:   286 EGPVN------LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
             E   N      L+  I+E+P P+     FSPEFCSFV  C++KD  AR ++  LLSHPFI
Sbjct:   272 EDQQNPPSFYELLAAIVENPPPTAPSDQFSPEFCSFVSACIQKDPPARASSLDLLSHPFI 331

Query:   340 TKYEHAKVDLAAFVRSVFDPMQRMK 364
              K+E   +DL   V ++  P+  ++
Sbjct:   332 KKFEDKDIDLGILVGTLEPPVNYLR 356

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

DICTYBASE|DDB_G0269152 mekA "MAP kinase kinase (MAP2K)" [Dictyostelium discoideum (taxid:44689)]

 Score = 480 (174.0 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
 Identities = 98/221 (44%), Positives = 143/221 (64%)

Query:    66 ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQ 124
             A+   H +        +++I   +G GA  VV+ A H  +   IALK I +  +E  R Q
Sbjct:   275 ANNHPHYDTNLSYDLKDLKIIRVLGRGAGGVVKLAYHETSGTYIALKVITLDIQENIRKQ 334

Query:   125 LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILS 184
             ++ E++TL +      +V F+ AFY    G I IALE+M+ GSL+DI++   +IPEP+L 
Sbjct:   335 IILELKTLHKTSYPY-IVSFYDAFYT--EGSIFIALEFMELGSLSDIMKKTSTIPEPVLG 391

Query:   185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
              +  ++LQGL YLH   HL+HRDIKP+N+LVN KG  KI DFG+S  L+++++   T+VG
Sbjct:   392 KIAFQVLQGLVYLHRKLHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQHTLSKAVTWVG 451

Query:   245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS 285
             TVTYMSPERI   SYS+ ++IWS+GL + EC  G+FPY ++
Sbjct:   452 TVTYMSPERISGRSYSFDSEIWSLGLTILECAIGKFPYGSN 492

GO:0030587 "sorocarp development" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0016020 "membrane" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031152 "aggregation involved in sorocarp development" evidence=TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2120855 MEK1 "MAP kinase/ ERK kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 2.6e-54, P = 2.6e-54
 Identities = 116/278 (41%), Positives = 172/278 (61%)

Query:    82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT-EIRTLCEAPCNEG 140
             ++ +   IG G+S  VQ   H  T +  ALK I +  +E   + ++ E+R    + C   
Sbjct:    67 DLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPY- 125

Query:   141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
             LV  + +FY   +G +SI LE+MDGGSLAD+L+    +PE +LS++ K++L+GL Y+H  
Sbjct:   126 LVSCYQSFY--HNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHE 183

Query:   201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
             R ++HRD+KP+NLL+N +G  KITDFG+S  L ++ ++  +FVGT  YMSPERI    YS
Sbjct:   184 RRIIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYS 243

Query:   261 YPADIWSIGLALFECGTGEFPYAASE------GPVNLMLQILEDPSPSPSRQNFSPEFCS 314
               +DIWS+GL L EC TG+FPY   E          L+  I+E+P P      FSPEFCS
Sbjct:   244 NKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCS 303

Query:   315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAF 352
             F+  C++KD   R +A +LL H F+  +E +  +L+A+
Sbjct:   304 FISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTNLSAY 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0042542 "response to hydrogen peroxide" evidence=IEP;IDA

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA;IDA

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009814 "defense response, incompatible interaction" evidence=IGI;RCA

GO:0000023 "maltose metabolic process" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0019252 "starch biosynthetic process" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0009611 "response to wounding" evidence=IEP

FB|FBgn0010269 Dsor1 "Downstream of raf1" [Drosophila melanogaster (taxid:7227)]

 Score = 421 (153.3 bits), Expect = 5.4e-51, Sum P(2) = 5.4e-51
 Identities = 95/211 (45%), Positives = 131/211 (62%)

Query:    73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRT 131
             EK    +  ++   G +GSG   VV +  H  TH I+A K I++  K   + Q+L E++ 
Sbjct:    77 EKIGELSDEDLEKLGELGSGNGGVVMKVRHTHTHLIMARKLIHLEVKPAIKKQILRELKV 136

Query:   132 LCEAPCN-EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
             L E  CN   +V F+GAFY    G+ISI +EYMDGGSL  IL+    IPE IL  +   +
Sbjct:   137 LHE--CNFPHIVGFYGAFY--SDGEISICMEYMDGGSLDLILKRAGRIPESILGRITLAV 192

Query:   191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMS 250
             L+GLSYL     ++HRD+KP+N+LVN  G  KI DFG+S  L +S+A   +FVGT +YMS
Sbjct:   193 LKGLSYLRDNHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMAN--SFVGTRSYMS 250

Query:   251 PERIRNESYSYPADIWSIGLALFECGTGEFP 281
             PER++   YS  +DIWS+GL+L E   G +P
Sbjct:   251 PERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 281

GO:0007165 "signal transduction" evidence=IGI;IMP

GO:0004708 "MAP kinase kinase activity" evidence=ISS;NAS;TAS

GO:0008595 "anterior/posterior axis specification, embryo" evidence=TAS

GO:0008592 "regulation of Toll signaling pathway" evidence=NAS

GO:0008293 "torso signaling pathway" evidence=NAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=NAS

GO:0045500 "sevenless signaling pathway" evidence=NAS

GO:0004707 "MAP kinase activity" evidence=NAS

GO:0007362 "terminal region determination" evidence=IMP

GO:0000165 "MAPK cascade" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS;TAS

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0042386 "hemocyte differentiation" evidence=IGI

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007298 "border follicle cell migration" evidence=IGI

MGI|MGI:1346867 Map2k2 "mitogen-activated protein kinase kinase 2" [Mus musculus (taxid:10090)]

 Score = 410 (149.4 bits), Expect = 6.0e-46, Sum P(2) = 6.0e-46
 Identities = 89/195 (45%), Positives = 129/195 (66%)

Query:    89 IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
             +G+G   VV +A H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct:    78 LGAGNGGVVTKARHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHE--CNSPYIVGFYG 135

Query:   147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             AFY    G+ISI +E+MDGGSL  +L+  K IPE IL  +   +L+GL+YL     ++HR
Sbjct:   136 AFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLREKHQIMHR 193

Query:   207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
             D+KP+N+LVN +G  K+ DFG+S  L +S+A   +FVGT +YMSPER++   YS  +DIW
Sbjct:   194 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIW 251

Query:   267 SIGLALFECGTGEFP 281
             S+GL+L E   G +P
Sbjct:   252 SMGLSLVELAIGRYP 266

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005778 "peroxisomal membrane" evidence=ISO

GO:0005783 "endoplasmic reticulum" evidence=ISO

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005874 "microtubule" evidence=ISO

GO:0005911 "cell-cell junction" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0009898 "internal side of plasma membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032947 "protein complex scaffold" evidence=IDA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0097110 "scaffold protein binding" evidence=ISO

GO:2000147 "positive regulation of cell motility" evidence=IDA

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

UNIPROTKB|Q1HG70 MAP2K2 "Dual specificity mitogen-activated protein kinase kinase 2" [Canis lupus familiaris (taxid:9615)]

 Score = 407 (148.3 bits), Expect = 7.6e-46, Sum P(2) = 7.6e-46
 Identities = 88/195 (45%), Positives = 128/195 (65%)

Query:    89 IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
             +G+G   VV +  H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct:    78 LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 135

Query:   147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             AFY    G+ISI +E+MDGGSL  +L+  K IPE IL  +   +L+GL+YL     ++HR
Sbjct:   136 AFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 193

Query:   207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
             D+KP+N+LVN +G  K+ DFG+S  L +S+A   +FVGT +YMSPER++   YS  +DIW
Sbjct:   194 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIW 251

Query:   267 SIGLALFECGTGEFP 281
             S+GL+L E   G +P
Sbjct:   252 SMGLSLVELSIGRYP 266

GO:2000147 "positive regulation of cell motility" evidence=IEA

GO:0097110 "scaffold protein binding" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0009898 "internal side of plasma membrane" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005778 "peroxisomal membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P36507 MAP2K2 "Dual specificity mitogen-activated protein kinase kinase 2" [Homo sapiens (taxid:9606)]

 Score = 405 (147.6 bits), Expect = 7.6e-46, Sum P(2) = 7.6e-46
 Identities = 87/195 (44%), Positives = 128/195 (65%)

Query:    89 IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
             +G+G   VV +  H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct:    78 LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 135

Query:   147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             AFY    G+ISI +E+MDGGSL  +L+  K IPE IL  +   +L+GL+YL     ++HR
Sbjct:   136 AFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 193

Query:   207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
             D+KP+N+LVN +G  K+ DFG+S  L +S+A   +FVGT +YM+PER++   YS  +DIW
Sbjct:   194 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMAPERLQGTHYSVQSDIW 251

Query:   267 SIGLALFECGTGEFP 281
             S+GL+L E   G +P
Sbjct:   252 SMGLSLVELAVGRYP 266

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:2000147 "positive regulation of cell motility" evidence=IEA

GO:0005524 "ATP binding" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

GO:0005911 "cell-cell junction" evidence=IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IDA

GO:0005778 "peroxisomal membrane" evidence=IDA

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0030165 "PDZ domain binding" evidence=IDA

GO:0097110 "scaffold protein binding" evidence=IPI

GO:0009898 "internal side of plasma membrane" evidence=IDA

GO:0005783 "endoplasmic reticulum" evidence=IDA

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0070371 "ERK1 and ERK2 cascade" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

ZFIN|ZDB-GENE-080219-34 map2k2b "mitogen-activated protein kinase kinase 2b" [Danio rerio (taxid:7955)]

 Score = 400 (145.9 bits), Expect = 9.7e-46, Sum P(2) = 9.7e-46
 Identities = 96/276 (34%), Positives = 157/276 (56%)

Query:     8 KKKLAPLFDAEKGFSAGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLAD 67
             KK+  P+     G  A +T  P D+   +    +  L +     + +E   ++  ++L  
Sbjct:     4 KKRPDPIVITGSG-EAQTTSTPIDA---ASEANLEALQKKLDELDLDEQQKKRLEAFLTQ 59

Query:    68 ESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLL 126
             +++  E        + +    +G+G   VV +  H P+  ++A K I++  K   R+Q++
Sbjct:    60 KANLGE----LKDDDFQHICELGAGNGGVVNKVCHKPSGLVMARKLIHLEIKPAIRHQII 115

Query:   127 TEIRTLCEAPCNEG-LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSS 185
              E++ L E  CN   +V F+GAFY    G+ISI +E MDGGSL  +L+  + IPE IL  
Sbjct:   116 RELQVLHE--CNSPYIVGFYGAFY--SDGEISICMENMDGGSLDQVLKEARRIPEEILGK 171

Query:   186 MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT 245
             +   +L+GL+YL     ++HRD+KP+N+LVN +G  K+ DFG+S  L +S+A   +FVGT
Sbjct:   172 VSIAVLRGLAYLREKHQIIHRDVKPSNILVNCRGEIKLCDFGVSGQLIDSMAN--SFVGT 229

Query:   246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP 281
              +YMSPER++   YS  +D+WS+GL+L E   G +P
Sbjct:   230 RSYMSPERLQGTHYSVQSDVWSMGLSLVELAIGRYP 265

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|F1NYZ2 MAP2K2 "Dual-specificity mitogen-activated protein kinase kinase 2" [Gallus gallus (taxid:9031)]

 Score = 407 (148.3 bits), Expect = 1.6e-45, Sum P(2) = 1.6e-45
 Identities = 88/195 (45%), Positives = 128/195 (65%)

Query:    89 IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
             +G+G   VV +  H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct:    76 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 133

Query:   147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             AFY    G+ISI +E+MDGGSL  +L+  K IPE IL  +   +L+GL+YL     ++HR
Sbjct:   134 AFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 191

Query:   207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
             D+KP+N+LVN +G  K+ DFG+S  L +S+A   +FVGT +YMSPER++   YS  +DIW
Sbjct:   192 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIW 249

Query:   267 SIGLALFECGTGEFP 281
             S+GL+L E   G +P
Sbjct:   250 SMGLSLVELSIGRYP 264

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005778 "peroxisomal membrane" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0009898 "internal side of plasma membrane" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0097110 "scaffold protein binding" evidence=IEA

GO:2000147 "positive regulation of cell motility" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q5QN75	M2K1_ORYSJ	2, ., 7, ., 1, 2, ., 2	0.4105	0.8706	0.9098	yes	no
P10506	BYR1_SCHPO	2, ., 7, ., 1, 2, ., 2	0.3487	0.8247	0.9	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.824
3rd Layer	2.7.12	0.766
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_I2149 hypothetical protein (521 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	371
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-142
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-97
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-82
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-76
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-72
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-72
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-71
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-70
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-69
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-64
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-63
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-63
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-63
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-61
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-61
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-60
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-59
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-56
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-56
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-56
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-55
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-55
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-52
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-52
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-51
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-49
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-49
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-48
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-47
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-47
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-45
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-44
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-44
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-43
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-43
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-42
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-42
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-41
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-41
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-41
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-40
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-40
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-40
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-39
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-39
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-39
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-38
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-38
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-38
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-37
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-37
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-37
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-36
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-36
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-36
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-36
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-36
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-35
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-34
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-33
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-33
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-32
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-32
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-32
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-32
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-32
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-32
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-32
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-32
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-31
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-30
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-30
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-30
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-28
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-28
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-27
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-27
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-27
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-26
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-25
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-25
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-25
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-25
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-21
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-21
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-20
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-20
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-19
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-19
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-19
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-19
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-18
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-18
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-17
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-17
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-17
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-16
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-16
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-15
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-14
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-13
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-11
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-10
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-10
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.004
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  403 bits (1037), Expect = e-142
 Identities = 137/263 (52%), Positives = 176/263 (66%), Gaps = 6/263 (2%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLV 142
                +G G+S VV +  H PT +I ALKKI++   E  R QLL E++TL        +V
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVV 62

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           + +GAFY    G+ISI LEYMDGGSLAD+L+    IPEP+L+ + +++L+GL YLH  RH
Sbjct: 63  KCYGAFYKE--GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++HRDIKP+NLL+N KG  KI DFGIS  LEN++  C TFVGTVTYMSPERI+ ESYSY 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 263 ADIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
           ADIWS+GL L EC  G+FP+          LM  I + P PS   + FSPEF  F+  CL
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240

Query: 321 KKDAEARPTADQLLSHPFITKYE 343
           +KD + RP+A +LL HPFI K +
Sbjct: 241 QKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  289 bits (741), Expect = 5e-97
 Identities = 121/263 (46%), Positives = 167/263 (63%), Gaps = 11/263 (4%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLVEFH 145
           G +G+G S VV + +H PT +I+A+K I +   E  + Q+L E+  L +      +V F+
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFY 65

Query: 146 GAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           GAFY  ++G ISI +EYMDGGSL  IL  +Q  IPE IL  +   +L+GL+YLH    ++
Sbjct: 66  GAFY--NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           HRD+KP+N+LVN +G+ K+ DFG+S  L NS+A   TFVGT +YM+PERI+   YS  +D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSD 181

Query: 265 IWSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
           IWS+GL+L E  TG FPY       +G   L+  I+ +P P      FSP+F  FV+ CL
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241

Query: 321 KKDAEARPTADQLLSHPFITKYE 343
            KD   RP+  +LL HPFI KYE
Sbjct: 242 IKDPRERPSYKELLEHPFIKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  251 bits (643), Expect = 2e-82
 Identities = 82/253 (32%), Positives = 133/253 (52%), Gaps = 7/253 (2%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G G+   V  A    T +++A+K I     K+ R ++L EI+ L +   +  +V  +  
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNIVRLYDV 65

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           F   D  ++ + +EY +GG L D+L+ +  + E       +++L  L YLH  + +VHRD
Sbjct: 66  FE--DEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS-KGIVHRD 122

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWS 267
           +KP N+L++  G  K+ DFG+ A   +      TFVGT  YM+PE +  + Y    DIWS
Sbjct: 123 LKPENILLDEDGHVKLADFGL-ARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181

Query: 268 IGLALFECGTGEFPYAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
           +G+ L+E  TG+ P+   +  + L  +I +  P   P   + SPE    +   L KD E 
Sbjct: 182 LGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEK 241

Query: 327 RPTADQLLSHPFI 339
           R TA++ L HPF 
Sbjct: 242 RLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  234 bits (599), Expect = 9e-76
 Identities = 95/258 (36%), Positives = 151/258 (58%), Gaps = 10/258 (3%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLV 142
            I   IG G    V +A H  T + +A+K I +  KEK+ +++ EI+ L    C    +V
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQIL--KKCKHPNIV 60

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +++G++      ++ I +E+  GGSL D+L+   +++ E  ++ + K+LL+GL YLH   
Sbjct: 61  KYYGSYL--KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-N 117

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            ++HRDIK AN+L+   G  K+ DFG+SA L ++ A   T VGT  +M+PE I  + Y Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDY 176

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCL 320
            ADIWS+G+   E   G+ PY+    P+  + +I  +  P   + + +S EF  F+  CL
Sbjct: 177 KADIWSLGITAIELAEGKPPYSEL-PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235

Query: 321 KKDAEARPTADQLLSHPF 338
           +K+ E RPTA+QLL HPF
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  226 bits (578), Expect = 1e-72
 Identities = 87/255 (34%), Positives = 141/255 (55%), Gaps = 6/255 (2%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G+   V  A+   T  ++A+K + +    +E+   L  EIR L        +V ++G
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN-IVRYYG 66

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           +    +   ++I LEY+ GGSL+ +L+    +PEP++    +++L+GL+YLH    +VHR
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS-NGIVHR 125

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPAD 264
           DIK AN+LV+  G  K+ DFG +  L +        +  GT  +M+PE IR E Y   AD
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           IWS+G  + E  TG+ P++    P+  + +I     P    ++ S E   F+  CL++D 
Sbjct: 186 IWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDP 245

Query: 325 EARPTADQLLSHPFI 339
           + RPTAD+LL HPF+
Sbjct: 246 KKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  226 bits (579), Expect = 4e-72
 Identities = 119/307 (38%), Positives = 170/307 (55%), Gaps = 43/307 (14%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEG-LVEF 144
           G +G+G   VV + +H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F
Sbjct: 7   GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE--CNSPYIVGF 64

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           +GAFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +L+GL+YL     ++
Sbjct: 65  YGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIM 122

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           HRD+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   Y+  +D
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSD 180

Query: 265 IWSIGLALFECGTGEFP--------------YAASEG-------PVN------------- 290
           IWS+GL+L E   G +P                 SEG       PV+             
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240

Query: 291 -LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDL 349
            L+  I+ +P P      FS EF  FVD CLKK+ + R    +L  HPFI + E  +VD 
Sbjct: 241 ELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVDF 300

Query: 350 AAFVRSV 356
           A +V S 
Sbjct: 301 AGWVCST 307

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  221 bits (566), Expect = 8e-71
 Identities = 85/267 (31%), Positives = 130/267 (48%), Gaps = 19/267 (7%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTL--CEAPCNE 139
            +   +GSG+   V +A H  T +I+A+K +       +K      EIR L     P   
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN-- 59

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +V    AF   D   + + +EY +GG L D L     + E     +  ++L+GL YLH 
Sbjct: 60  -IVRLIDAFE--DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NES 258
              ++HRD+KP N+L++  G  KI DFG++  L  S +   TFVGT  YM+PE +     
Sbjct: 117 -NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL------EDPSPSPSRQNFSPEF 312
           Y    D+WS+G+ L+E  TG+ P+  S   +   LQ++            P   + S E 
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPF--SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFI 339
              +  CL KD   RPTA+++L HP+ 
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  220 bits (561), Expect = 9e-70
 Identities = 109/283 (38%), Positives = 163/283 (57%), Gaps = 17/283 (6%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG 140
           ++     +G+G    V +  HIPT  ++A K ++I  K   R Q+L E++ + E      
Sbjct: 6   DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PY 64

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V F+GAF   +   I + +E+MD GSL  I +    IP  IL  +   +++GL+YL+ V
Sbjct: 65  IVSFYGAFL--NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
             ++HRDIKP+N+LVN +G+ K+ DFG+S  L NSIA   TFVGT TYMSPERI+   Y+
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGKYT 180

Query: 261 YPADIWSIGLALFECGTGEFPYAASE----------GPVNLMLQILEDPSPSPSRQNFSP 310
             +D+WS+G+++ E   G+FP+A S           G ++L+ QI+++P P     +F  
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240

Query: 311 EFCSFVDDCLKKDAEARPTADQLL-SHPFITKYEHAKVDLAAF 352
           +   FVD CL KD   RPT  QL    PFI     + VDL A+
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW 283

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  218 bits (558), Expect = 3e-69
 Identities = 110/286 (38%), Positives = 157/286 (54%), Gaps = 22/286 (7%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTL--CEAPCNEGLVE 143
             +G GA   V +     T  I ALK I      + + Q+L E+     C++P    +V+
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP---YIVK 63

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----IPEPILSSMFKKLLQGLSYLHG 199
           ++GAF    S  I IA+EY +GGSL  I +  K     I E +L  + + +L+GLSYLH 
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            R ++HRDIKP+N+L+  KG+ K+ DFG+S  L NS+A   TF GT  YM+PERI+ + Y
Sbjct: 124 -RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKPY 180

Query: 260 SYPADIWSIGLALFECGTGEFPYAASE----GPVNLMLQILEDPSP----SPSRQ-NFSP 310
           S  +D+WS+GL L E     FP+        GP+ L+  I+  P+P     P     +S 
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSV 356
           EF  F+  CL+KD   RPT   +L HP+I      KV++A FV  V
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVAQV 286

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  205 bits (523), Expect = 8e-64
 Identities = 107/288 (37%), Positives = 163/288 (56%), Gaps = 19/288 (6%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEG 140
           ++   G IGSG    V +     T  ++A+K++     KE+  ++L ++  + ++     
Sbjct: 16  DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPY 75

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYL- 197
           +V+ +G F + DS  + I +E M   +  D L  R+Q  IPE IL  M   +++ L YL 
Sbjct: 76  IVKCYGYF-ITDS-DVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 198 --HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI- 254
             HGV   +HRD+KP+N+L++  G  K+ DFGIS  L +S A   +  G   YM+PERI 
Sbjct: 132 EKHGV---IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERID 187

Query: 255 ---RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSP 310
               N  Y   AD+WS+G++L E  TG+FPY   +    ++ +IL++  PS P  + FSP
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD 358
           +FCSFVD CL KD   RP   +LL HPFI +YE A+VD+A + + V  
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQDVMA 295

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  204 bits (520), Expect = 1e-63
 Identities = 98/280 (35%), Positives = 165/280 (58%), Gaps = 21/280 (7%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTL--CEAPC 137
            +++    +G G    V +A H+ T RI+A+K I +    E + Q+++E+  L  C++P 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              ++ F+GAF++ +  +ISI  E+MDGGSL     + + IPE +L  +   +++GL+YL
Sbjct: 61  ---IIGFYGAFFVEN--RISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYL 111

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
             ++ ++HRD+KP+N+LVN +G+ K+ DFG+S  L NSIA   T+VGT  YM+PERI  E
Sbjct: 112 WSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERISGE 168

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEG------PVNLMLQILEDPSPSPSRQNFSPE 311
            Y   +D+WS+G++  E   G FPY   +       P+ L+  I+++  P      FS +
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228

Query: 312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAA 351
           F  F+  C++K  + RP  + L+ HPFI +Y     ++ +
Sbjct: 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVS 268

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  202 bits (516), Expect = 4e-63
 Identities = 91/260 (35%), Positives = 148/260 (56%), Gaps = 11/260 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT-EIRTL--CEAPCNEGLVEFH 145
           IG G+   V +A+   T++++A+K I++ E E   + +  EI+ L  C +P    + +++
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP---YITKYY 65

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G+F      ++ I +EY  GGS  D+L+  K + E  ++ + +++L GL YLH     +H
Sbjct: 66  GSFL--KGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEG-KIH 121

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++ +G  K+ DFG+S  L ++++   TFVGT  +M+PE I+   Y   ADI
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P +    P+ ++  I ++  PS     FS  F  FV  CL KD +
Sbjct: 182 WSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPK 240

Query: 326 ARPTADQLLSHPFITKYEHA 345
            RP+A +LL H FI K +  
Sbjct: 241 ERPSAKELLKHKFIKKAKKT 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  202 bits (517), Expect = 5e-63
 Identities = 93/268 (34%), Positives = 155/268 (57%), Gaps = 11/268 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-NEGLVEFHGA 147
           IG GAS  V +A    T + +A+KK+ +  K+ +  ++ EI  + +  C +  +V+++ +
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKD--CKHPNIVDYYDS 83

Query: 148 FYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           + + D   + + +EYMDGGSL DI+      + EP ++ + +++LQGL YLH  ++++HR
Sbjct: 84  YLVGDE--LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVIHR 140

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           DIK  N+L++  G  K+ DFG +A L    +   + VGT  +M+PE I+ + Y    DIW
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200

Query: 267 SIGLALFECGTGEFPYAASEGPVNLMLQI-LEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           S+G+   E   GE PY   E P+  +  I  +   P  + + +SPEF  F++ CL KD E
Sbjct: 201 SLGIMCIEMAEGEPPY-LREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259

Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFV 353
            RP+A++LL HPF+ K    K + A  +
Sbjct: 260 KRPSAEELLQHPFLKKACP-KEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  198 bits (506), Expect = 2e-61
 Identities = 100/291 (34%), Positives = 165/291 (56%), Gaps = 22/291 (7%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG 140
           E+ +   +G G    V + +H PT   +A+K+I +  ++ K NQ++ E+  L +A     
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY- 60

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADIL---RMQKSIPEPILSSMFKKLLQGLSYL 197
           +V+F+GAF++   G + + +EYMD GSL  +       + IPE +L  +   +++GL +L
Sbjct: 61  IVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
               +++HRD+KP N+LVN  G+ K+ DFG+S  L  S+A   T +G  +YM+PERI++ 
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNIGCQSYMAPERIKSG 176

Query: 258 ------SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ---ILEDPSPS-PSRQN 307
                 +Y+  +D+WS+GL++ E   G +PY   E   N+  Q   I++   P+ PS   
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPY-PPETYANIFAQLSAIVDGDPPTLPS--G 233

Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD 358
           +S +   FV  CL K    RPT  QLL HP++ KY++A VD+A +V     
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGALK 284

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  195 bits (499), Expect = 8e-61
 Identities = 92/260 (35%), Positives = 155/260 (59%), Gaps = 13/260 (5%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGL 141
            I   +G G+   V +A+H  T +++A+K + + E  +  +++ EI  L  C++P    +
Sbjct: 6   DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ--EIIKEISILKQCDSP---YI 60

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGV 200
           V+++G+++   +  + I +EY   GS++DI+++  K++ E  ++++  + L+GL YLH  
Sbjct: 61  VKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
              +HRDIK  N+L+N +G+ K+ DFG+S  L +++A   T +GT  +M+PE I+   Y+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ-NFSPEFCSFVDDC 319
             ADIWS+G+   E   G+ PY+    P+  +  I   P P+ S    +SPEF  FV  C
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIH-PMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236

Query: 320 LKKDAEARPTADQLLSHPFI 339
           L KD E RP+A QLL HPFI
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  196 bits (500), Expect = 1e-60
 Identities = 100/287 (34%), Positives = 158/287 (55%), Gaps = 15/287 (5%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKI--NIFEKEKRNQLLTEIRTLCEAPCNE 139
           ++ +   +G GA  VV +  H+PT  I+A+K+I   +  +E++ +LL ++     +    
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCP 60

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLAD----ILRMQKSIPEPILSSMFKKLLQGLS 195
             V F+GA +    G + I +E MD  SL      +     +IPE IL  +   +++ L 
Sbjct: 61  YTVTFYGALF--REGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           YLH    ++HRD+KP+N+L+N  G+ K+ DFGIS  L +S+A      G   YM+PERI 
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-AGCKPYMAPERIN 176

Query: 256 NE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
            E     Y   +D+WS+G+ + E  TG FPY + + P   + Q++E+PSP    + FSPE
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236

Query: 312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD 358
           F  FV+ CLKK+ + RP   +LL HPF   +     D+A+FV  +  
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSLILG 283

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  191 bits (489), Expect = 4e-59
 Identities = 91/261 (34%), Positives = 142/261 (54%), Gaps = 20/261 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTL--CEAPCNEGLVE 143
           IG G+   V         ++  LK+I++    EKE+ +  L E++ L     P    +++
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERED-ALNEVKILKKLNHPN---IIK 63

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----IPEPILSSMFKKLLQGLSYLHG 199
           ++ +F   + G++ I +EY DGG L+  ++ QK      PE  +   F +L   L YLH 
Sbjct: 64  YYESFE--EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            R ++HRDIKP N+ +   G  K+ DFGIS  L +++ +  T VGT  Y+SPE  +N+ Y
Sbjct: 122 -RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-EDPSPSPSRQNFSPEFCSFVDD 318
           +Y +DIWS+G  L+E  T + P+   E  + L L+IL     P PS+  +S E  + V  
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYPPIPSQ--YSSELRNLVSS 237

Query: 319 CLKKDAEARPTADQLLSHPFI 339
            L+KD E RP+  Q+L  PFI
Sbjct: 238 LLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  188 bits (479), Expect = 1e-56
 Identities = 102/261 (39%), Positives = 146/261 (55%), Gaps = 17/261 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA   V + +H PT R+ ALK I    E   R Q+  EI  L +   +  +V+ H  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDM 140

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           F    +G+I + LE+MDGGSL +   +     E  L+ + +++L G++YLH  RH+VHRD
Sbjct: 141 F--DHNGEIQVLLEFMDGGSL-EGTHIAD---EQFLADVARQILSGIAYLHR-RHIVHRD 193

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE----SYS-YP 262
           IKP+NLL+N     KI DFG+S  L  ++  C + VGT+ YMSPERI  +    +Y  Y 
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA 253

Query: 263 ADIWSIGLALFECGTGEFPYAAS-EGP-VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
            DIWS+G+++ E   G FP+    +G   +LM  I     P       S EF  F+  CL
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA-TASREFRHFISCCL 312

Query: 321 KKDAEARPTADQLLSHPFITK 341
           +++   R +A QLL HPFI +
Sbjct: 313 QREPAKRWSAMQLLQHPFILR 333

Length = 353

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  184 bits (470), Expect = 2e-56
 Identities = 91/257 (35%), Positives = 137/257 (53%), Gaps = 14/257 (5%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKI--NIFEKEKRNQLLTEIRTLCEAPCN-EGLVEF 144
            IG GA  VV + +++ T   +A+K+I     ++E    ++ EI  L         +V++
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLL--KNLKHPNIVKY 64

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH--GVRH 202
            G+     S  + I LEY + GSL  I++     PE +++    ++LQGL+YLH  GV  
Sbjct: 65  IGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV-- 120

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
            +HRDIK AN+L    G  K+ DFG++  L +     A+ VGT  +M+PE I     S  
Sbjct: 121 -IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           +DIWS+G  + E  TG  PY     P+  + +I++D  P P  +  SPE   F+  C +K
Sbjct: 180 SDIWSLGCTVIELLTGNPPY-YDLNPMAALFRIVQDDHP-PLPEGISPELKDFLMQCFQK 237

Query: 323 DAEARPTADQLLSHPFI 339
           D   RPTA QLL HP+I
Sbjct: 238 DPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  185 bits (471), Expect = 2e-56
 Identities = 90/269 (33%), Positives = 149/269 (55%), Gaps = 28/269 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR------TLCEAPCNEGLV 142
           IG GA++VV  A+ +P +  +A+K+I++   EK    + E+R      + C  P    +V
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL---EKCQTSVDELRKEVQAMSQCNHP---NVV 62

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLHG 199
           +++ +F + D  ++ + + Y+ GGSL DI++    +  + E I++++ K++L+GL YLH 
Sbjct: 63  KYYTSFVVGD--ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIR 255
               +HRDIK  N+L+   G  KI DFG+SA L      +  +  TFVGT  +M+PE + 
Sbjct: 121 NGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS----PSRQNFSP 310
               Y + ADIWS G+   E  TG  PY+    P+ +++  L++  PS       + +S 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGADYKKYSK 238

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFI 339
            F   +  CL+KD   RPTA++LL H F 
Sbjct: 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  184 bits (470), Expect = 3e-56
 Identities = 83/265 (31%), Positives = 144/265 (54%), Gaps = 17/265 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG G    V +A H  T +++A+K ++I E E+  ++  E   L +   +  +  F+GAF
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGAF 72

Query: 149 YMPDS----GQISIALEYMDGGSLAD----ILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
              +      Q+ + +E   GGS+ D    + +  K + E  ++ + ++ L+GL+YLH  
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE- 131

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-----R 255
             ++HRDIK  N+L+      K+ DFG+SA L++++    TF+GT  +M+PE I      
Sbjct: 132 NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP 191

Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QNFSPEFCS 314
           + SY   +D+WS+G+   E   G+ P      P+  + +I  +P P+    +N+S +F  
Sbjct: 192 DASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALFKIPRNPPPTLKSPENWSKKFND 250

Query: 315 FVDDCLKKDAEARPTADQLLSHPFI 339
           F+ +CL K+ E RP  ++LL HPFI
Sbjct: 251 FISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  181 bits (461), Expect = 1e-55
 Identities = 74/253 (29%), Positives = 121/253 (47%), Gaps = 42/253 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G G    V  A    T + +A+K I          +LL EI  L +   +  +V+ +G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGV 59

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           F   D   + + +EY +GGSL D+L+  +  + E  +  +  ++L+GL YLH    ++HR
Sbjct: 60  FE--DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHR 116

Query: 207 DIKPANLLV-NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYPAD 264
           D+KP N+L+ +  G+ K+ DFG+S  L +  ++  T VGT  YM+PE +  +  YS  +D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           IWS+G+ L+E                                   PE    +   L+KD 
Sbjct: 177 IWSLGVILYEL----------------------------------PELKDLIRKMLQKDP 202

Query: 325 EARPTADQLLSHP 337
           E RP+A ++L H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  181 bits (462), Expect = 6e-55
 Identities = 103/284 (36%), Positives = 159/284 (55%), Gaps = 20/284 (7%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKI--NIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           G IG GA   V + +H P+  I+A+K+I   + EKE++ +LL ++  +  +     +V+F
Sbjct: 10  GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK-RLLMDLDVVMRSSDCPYIVKF 68

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRM-----QKSIPEPILSSMFKKLLQGLSYLHG 199
           +GA +    G   I +E MD  SL    +      +  IPE IL  +    ++ L+YL  
Sbjct: 69  YGALF--REGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI---RN 256
              ++HRD+KP+N+L++  G  K+ DFGIS  L +SIA      G   YM+PERI     
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSAR 184

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DP---SPSPSRQNFSPEF 312
           + Y   +D+WS+G+ L+E  TG+FPY       + + Q+++ DP   S S  R+ FSP F
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE-FSPSF 243

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSV 356
            +F++ CL KD   RP   +LL HPFI  YE   VD+AA+V+ +
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRI 287

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  175 bits (445), Expect = 1e-52
 Identities = 87/258 (33%), Positives = 135/258 (52%), Gaps = 14/258 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-GLVEFHGA 147
           IGSG    V +A  I T  ++A+K I +   +    +  EI  L E  C    +V + G+
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE--CRHPNIVAYFGS 68

Query: 148 FYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           +      ++ I +EY  GGSL DI ++ +  + E  ++ + ++ L+GL+YLH     +HR
Sbjct: 69  YLR--RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHR 125

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES---YSYPA 263
           DIK AN+L+   G  K+ DFG+SA L  +IA   +F+GT  +M+PE    E    Y    
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS---RQNFSPEFCSFVDDCL 320
           DIW++G+   E    + P      P+  +  I +   P P    ++ +SP F  F+  CL
Sbjct: 186 DIWALGITAIELAELQPPMFDLH-PMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCL 244

Query: 321 KKDAEARPTADQLLSHPF 338
            KD + RPTA +LL HPF
Sbjct: 245 TKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  176 bits (447), Expect = 3e-52
 Identities = 112/312 (35%), Positives = 162/312 (51%), Gaps = 51/312 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 70

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 71  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 267 SIGLALFECGTGEFPY--------------------AASEGP------------------ 288
           S+GL+L E   G +P                     A SE                    
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSR 246

Query: 289 -----VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
                  L+  I+ +P P      F  EF  FV+ CL K+   R    QL+ H FI + E
Sbjct: 247 PPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306

Query: 344 HAKVDLAAFVRS 355
             +VD A ++ S
Sbjct: 307 AEEVDFAGWLCS 318

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  174 bits (443), Expect = 1e-51
 Identities = 111/312 (35%), Positives = 165/312 (52%), Gaps = 53/312 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  I+A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 70

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+  K IPE IL  +   +L+GL+YL     ++HR
Sbjct: 71  AFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 267 SIGLALFECGTGEFPYAASEG-------------------------------PVN----- 290
           S+GL+L E   G +P    +                                PV+     
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 246

Query: 291 ---------LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
                    L+  I+ +P P      F+P+F  FV+ CL K+   R     L++H FI +
Sbjct: 247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306

Query: 342 YEHAKVDLAAFV 353
            E  +VD A ++
Sbjct: 307 SEVEEVDFAGWL 318

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  167 bits (425), Expect = 2e-49
 Identities = 94/275 (34%), Positives = 152/275 (55%), Gaps = 22/275 (8%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLV 142
           I G +G GA   V +A H  T    A K I I  +E+    + EI  L  C+ P    +V
Sbjct: 9   IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHP---NIV 65

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADI-LRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
             + A++     ++ I +E+ DGG+L  I L +++ + EP +  + +++L+ L++LH   
Sbjct: 66  GLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH--S 121

Query: 202 HLV-HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-----R 255
           H V HRD+K  N+L+ L G  K+ DFG+SA  ++++    TF+GT  +M+PE +     +
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSPEF 312
           +  Y Y ADIWS+G+ L E    E P+     P+ ++L+IL+   P+   PS+  +S  F
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELN-PMRVLLKILKSEPPTLDQPSK--WSSSF 238

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV 347
             F+  CL KD + RPTA +LL HPF++     K 
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  165 bits (420), Expect = 5e-49
 Identities = 86/257 (33%), Positives = 138/257 (53%), Gaps = 12/257 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSG+   V   +++      A+K++++ +     +E   QL  EI  L     +  +V+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALL-SKLQHPNIVQ 66

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           + G     +   + I LE + GGSLA +L+   S PEP++    +++L GL YLH  R+ 
Sbjct: 67  YLGT--EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-RNT 123

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           VHRDIK AN+LV+  G  K+ DFG++  +    +   +F G+  +M+PE I  +  Y   
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           ADIWS+G  + E  TG+ P++  EG V  + +I       P   + S E   F+  CL++
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241

Query: 323 DAEARPTADQLLSHPFI 339
           D   RPTA +LL HPF+
Sbjct: 242 DPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  163 bits (415), Expect = 6e-48
 Identities = 81/257 (31%), Positives = 146/257 (56%), Gaps = 7/257 (2%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    T R +A+KK+++ ++++R  L  E+  + +   +  +VE +
Sbjct: 24  FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMY 82

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+     + E  ++++   +L+ LS+LH  + ++H
Sbjct: 83  SSYLVGD--ELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLAVLKALSFLHA-QGVIH 138

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +    + VGT  +M+PE I    Y    DI
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M +I ++  P   +    SP   SF+D  L +D 
Sbjct: 199 WSLGIMVIEMVDGEPPY-FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257

Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL+HPF+ K
Sbjct: 258 AQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  162 bits (412), Expect = 1e-47
 Identities = 88/271 (32%), Positives = 149/271 (54%), Gaps = 19/271 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-------IFEKEKRNQLLTEIRTLCEAPCNEGL 141
           IG GA   V R  H+PT R++ALK IN       + + ++   LL+++R     P N  +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPN--I 64

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
            +++G+ Y+    ++ I +EY +GGS+  +++    I E  +S + +++L  L Y+H V 
Sbjct: 65  TKYYGS-YLKGP-RLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIHKV- 120

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYS 260
            ++HRDIK AN+LV   G  K+ DFG++A L  + +  +TFVGT  +M+PE I   + Y 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             ADIWS+G+ ++E  TG  PY+  +     M+ I +   P      +S     FV  CL
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239

Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAA 351
            ++ + R +A++LL   +I    H+K  ++ 
Sbjct: 240 DEEPKERLSAEELLKSKWIK--AHSKTPVSI 268

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  160 bits (406), Expect = 6e-47
 Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 14/261 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN--QLLTEIRTLCEAPCNEGLVEFHG 146
           IG G    V  AV++ T  ++A+K+I I + + +   ++  E++ L E   +  LV+++G
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVL-ELLKHPNLVKYYG 66

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                +  ++ I +EY  GG+L ++L   + + E ++     +LL+GL+YLH    +VHR
Sbjct: 67  VEVHRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHR 123

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMC----ATFVGTVTYMSPERIRNESYSY- 261
           DIKPAN+ ++  G  K+ DFG +  L+N+         +  GT  YM+PE I        
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 262 --PADIWSIGLALFECGTGEFPYAASEGPVNLMLQI-LEDPSPSPSRQNFSPEFCSFVDD 318
              ADIWS+G  + E  TG+ P++  +    +M  +      P P     SPE   F+D 
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDR 243

Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL+ D + RPTA +LL HPF+
Sbjct: 244 CLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  155 bits (394), Expect = 4e-45
 Identities = 78/267 (29%), Positives = 132/267 (49%), Gaps = 17/267 (6%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKI---NIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           +   IG G+   V++       +I+  K+I   N+ EKEK  QL++E+  L E   +  +
Sbjct: 4   VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELK-HPNI 61

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYL 197
           V ++       +  + I +EY +GG LA ++    + +K I E  +  +  +LL  L   
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 198 HGVRH----LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           H        ++HRD+KPAN+ ++     K+ DFG++  L +  +   T+VGT  YMSPE+
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP-SPSPSRQNFSPEF 312
           + + SY   +DIWS+G  ++E      P+ A    + L  +I E      P R  +S E 
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFRRIPYR--YSSEL 238

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFI 339
              +   L  D + RP+ ++LL  P I
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  153 bits (388), Expect = 3e-44
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 22/273 (8%)

Query: 83  MRIFGA-IGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKR---NQLLTEIRTL 132
             I GA IGSG+   V   ++  +  ++A+K++ +       +  KR   + L  EI  L
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
            E   +E +V++ G+    D+  ++I LEY+ GGS+A +L    +  E ++ +  +++L+
Sbjct: 61  KELQ-HENIVQYLGS--SLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK 117

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMC-----ATFVGTV 246
           GL+YLH  R ++HRDIK AN+LV+ KG  KI+DFGIS  LE NS++        +  G+V
Sbjct: 118 GLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 247 TYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
            +M+PE ++  SY+  ADIWS+G  + E  TG+ P+      +  + +I E+ SP     
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-QLQAIFKIGENASPEIP-S 234

Query: 307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           N S E   F++   + D   RPTA +LL HPF+
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  153 bits (388), Expect = 4e-44
 Identities = 93/279 (33%), Positives = 155/279 (55%), Gaps = 16/279 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR-NQLLTEIRTL--CEAPCNEGLVEFH 145
           IG G+   V + +   T  ++A+K I++ E E     +  EI  L  C++P    +  ++
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---ITRYY 68

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G++      ++ I +EY+ GGS  D+L+    + E  ++++ +++L+GL YLH  R  +H
Sbjct: 69  GSYL--KGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERK-IH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++ +G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y + ADI
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P +    P+ ++  I ++  P+   Q   P F  FV+ CL KD  
Sbjct: 185 WSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNSPPTLEGQYSKP-FKEFVEACLNKDPR 242

Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            RPTA +LL H FIT+Y        +F+  + D  +R K
Sbjct: 243 FRPTAKELLKHKFITRYTKK----TSFLTELIDRYKRWK 277

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 1e-43
 Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 13/259 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G GA   V     + T R +A+K++         K++ N L  EI+ L +   +E +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL-KNLQHERIVQ 68

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           ++G   + D   +SI +EYM GGS+ D L+   ++ E +     +++L+G+ YLH    +
Sbjct: 69  YYGC--LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS-NMI 125

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYS 260
           VHRDIK AN+L +  G  K+ DFG S  L+    S     +  GT  +MSPE I  E Y 
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             AD+WS+G  + E  T + P+A  E  +  + +I   P+      + SP+  +F+    
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFE-AMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244

Query: 321 KKDAEARPTADQLLSHPFI 339
            ++A+ RP+A++LL H F+
Sbjct: 245 VENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  150 bits (381), Expect = 6e-43
 Identities = 81/255 (31%), Positives = 146/255 (57%), Gaps = 7/255 (2%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A+K++N+ ++ K+  ++ EI  + E   +  +V + 
Sbjct: 24  FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYL 82

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 83  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 138

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    DI
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL+ D 
Sbjct: 199 WSLGIMAIEMVEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257

Query: 325 EARPTADQLLSHPFI 339
           E R +A +LL HPF+
Sbjct: 258 EKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  149 bits (377), Expect = 2e-42
 Identities = 95/279 (34%), Positives = 157/279 (56%), Gaps = 16/279 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR-NQLLTEIRTL--CEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E     +  EI  L  C++P    + +++
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTKYY 68

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G++      ++ I +EY+ GGS  D+LR      E  +++M K++L+GL YLH  +  +H
Sbjct: 69  GSYL--KGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK-IH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++ +G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y   ADI
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P  +   P+ ++  I ++  P+ +   FS  F  F+D CL KD  
Sbjct: 185 WSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLT-GEFSKPFKEFIDACLNKDPS 242

Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            RPTA +LL H FI K  +AK    +++  + D  +R K
Sbjct: 243 FRPTAKELLKHKFIVK--NAKK--TSYLTELIDRFKRWK 277

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  149 bits (377), Expect = 2e-42
 Identities = 92/267 (34%), Positives = 148/267 (55%), Gaps = 18/267 (6%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-LVE 143
           I G +G GA   V +A +  T  + A K I    +E+    + EI  L  A CN   +V+
Sbjct: 16  IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEIL--ATCNHPYIVK 73

Query: 144 FHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             GAFY    G++ I +E+  GG++ A +L + + + EP +  + +++L+ L YLH ++ 
Sbjct: 74  LLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK- 130

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES---- 258
           ++HRD+K  N+L+ L G  K+ DFG+SA    ++    +F+GT  +M+PE +  E+    
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 259 -YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP---SPSRQNFSPEFCS 314
            Y Y ADIWS+G+ L E    E P+     P+ ++L+I +   P    PS+  +S EF  
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPPTLSQPSK--WSMEFRD 247

Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
           F+   L K  E RP+A QLL HPF++ 
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  145 bits (367), Expect = 2e-41
 Identities = 83/260 (31%), Positives = 144/260 (55%), Gaps = 10/260 (3%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNE 139
           +  I   IG G+  VV + V     R+ A+K+I++    + +R + + E R L +   + 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SS 59

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYL 197
            ++ ++ +F   D G+++I +EY + G L  +L+MQ+   +PE  +   F ++L GL++L
Sbjct: 60  YIIRYYESFL--DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  + ++HRDIK  NL ++     KI D G++  L ++     T VGT  Y+SPE   ++
Sbjct: 118 HS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
            Y+  +D+W++G+ L+EC TG+ P+ A      L+L+I+    P P  Q +S +    +D
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFP-PVSQMYSQQLAQLID 234

Query: 318 DCLKKDAEARPTADQLLSHP 337
            CL KD   RP   QLL +P
Sbjct: 235 QCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 2e-41
 Identities = 75/258 (29%), Positives = 126/258 (48%), Gaps = 17/258 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTE--IRTLCEAPCNEGLVE 143
           +G G+   V       T ++ A+K +    I ++++    LTE  I +    P    +V+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPF---IVK 57

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            H AF   +   + + LEY  GG L   L  +    E        +++  L YLH    +
Sbjct: 58  LHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGI 114

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           ++RD+KP N+L++  G  K+TDFG++  L +  +   TF GT  Y++PE +  + Y    
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           D WS+G+ L+E  TG+ P+ A +    +  +IL+DP   P     SPE    +   L+KD
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAED-RKEIYEKILKDPLRFPE--FLSPEARDLISGLLQKD 231

Query: 324 AEARPT---ADQLLSHPF 338
              R     A+++ +HPF
Sbjct: 232 PTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  148 bits (374), Expect = 3e-41
 Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 26/306 (8%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
             RI   +G G+   V  A       +  L K    + ++  + L EI+ L        +
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLH 198
           V+ +  F   D G + + +EY+DGGSL D+L+    +  + E     +  ++L  L YLH
Sbjct: 61  VKLYDFFQ--DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 199 GVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENSI------AMCATFVGTVTYMSP 251
             + ++HRDIKP N+L++  G   K+ DFG++  L +        A+ +T VGT  YM+P
Sbjct: 119 S-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 252 ERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML---QILEDPSPSPS- 304
           E +        S  +DIWS+G+ L+E  TG  P+   +           ILE P+PS + 
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 305 ------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD 358
                  +  S      +   L KD + R ++   LSH  +   +  + DL+  ++    
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 359 PMQRMK 364
              R+ 
Sbjct: 298 APLRLS 303

Length = 384

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  143 bits (361), Expect = 3e-40
 Identities = 84/269 (31%), Positives = 135/269 (50%), Gaps = 23/269 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ----------LLTEIRTLCEAPCN 138
           IG G    V  A+++ T  ++A+K++ +                  L +EI TL +   +
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-H 67

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             +V++ G     +   +SI LEY+ GGS+   LR      E ++    +++L+GL+YLH
Sbjct: 68  LNIVQYLGFETTEEY--LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA--TFVGTVTYMSPERIRN 256
             + ++HRD+K  NLLV+  G  KI+DFGIS   ++        +  G+V +M+PE I +
Sbjct: 126 S-KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 257 ESYSYPA--DIWSIGLALFECGTGEFPYAASEGPVNLMLQILED----PSPSPSRQNFSP 310
            S  Y A  DIWS+G  + E   G  P++  E  +  M ++       P P     N SP
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-IAAMFKLGNKRSAPPIPPDVSMNLSP 243

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFI 339
               F++ C   + + RPTA +LL HPFI
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  143 bits (361), Expect = 4e-40
 Identities = 78/262 (29%), Positives = 144/262 (54%), Gaps = 14/262 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G    V +  H+ T ++ A+K +++ E E+  ++  EI  L +   +  +  ++GAF
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINMLKKYSHHRNIATYYGAF 82

Query: 149 YMP----DSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRH 202
                     Q+ + +E+   GS+ D+++  K  ++ E  ++ + +++L+GL++LH    
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-AHK 141

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-----NE 257
           ++HRDIK  N+L+      K+ DFG+SA L+ ++    TF+GT  +M+PE I      + 
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +Y Y +DIWS+G+   E   G  P      P+  +  I  +P P    + +S +F  F++
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKSKKWSKKFIDFIE 260

Query: 318 DCLKKDAEARPTADQLLSHPFI 339
            CL K+  +RP+ +QLL HPFI
Sbjct: 261 GCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  143 bits (361), Expect = 4e-40
 Identities = 85/255 (33%), Positives = 147/255 (57%), Gaps = 7/255 (2%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +  IG GAS  V  A+ + T + +A+K+IN+ ++ K+  ++ EI  + E   N  +V F 
Sbjct: 24  YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFL 82

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 83  DSFLVGD--ELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHA-NQVIH 138

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    DI
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  SP F  F++ CL+ D 
Sbjct: 199 WSLGIMAIEMVEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDV 257

Query: 325 EARPTADQLLSHPFI 339
           E R +A +LL HPF+
Sbjct: 258 EKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  142 bits (358), Expect = 1e-39
 Identities = 92/267 (34%), Positives = 150/267 (56%), Gaps = 20/267 (7%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLV 142
           I G +G GA   V +A +  T  + A K I+   +E+    + EI  L  C+ P    +V
Sbjct: 9   IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHP---NIV 65

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +   AFY  ++  + I +E+  GG++ A +L +++ + EP +  + K+ L+ L+YLH  +
Sbjct: 66  KLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES--- 258
            ++HRD+K  N+L  L G  K+ DFG+SA    +I    +F+GT  +M+PE +  E+   
Sbjct: 124 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 259 --YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSPEFC 313
             Y Y AD+WS+G+ L E    E P+     P+ ++L+I +   P+   PSR  +S EF 
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPPTLAQPSR--WSSEFK 239

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFIT 340
            F+  CL+K+ +AR T  QLL HPF+T
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVT 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  141 bits (356), Expect = 2e-39
 Identities = 84/257 (32%), Positives = 147/257 (57%), Gaps = 11/257 (4%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ I T + +A+K++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 24  FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 82

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 83  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHS-NQVIH 138

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    DI
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP---SPSRQNFSPEFCSFVDDCLKK 322
           WS+G+   E   GE PY  +E P+  +  I  + +P   +P R   S  F  F++ CL+ 
Sbjct: 199 WSLGIMAIEMVEGEPPY-LNENPLRALYLIATNGTPELQNPER--LSAVFRDFLNRCLEM 255

Query: 323 DAEARPTADQLLSHPFI 339
           D + R +A +LL HPF+
Sbjct: 256 DVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  140 bits (353), Expect = 7e-39
 Identities = 98/307 (31%), Positives = 152/307 (49%), Gaps = 33/307 (10%)

Query: 48  YGVYNFNE--LGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPT 105
           YG++ +N   LGL+     L D +D  E           I   IG G    V +  +   
Sbjct: 2   YGLFPYNSSMLGLES----LGDPTDTWE-----------IIETIGKGTYGKVYKVTNKKD 46

Query: 106 HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD---SGQISIALEY 162
             + A+K ++    +   ++  E   L   P +  +V+F+G FY  D    GQ+ + LE 
Sbjct: 47  GSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105

Query: 163 MDGGSLADI----LRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK 218
            +GGS+ ++    L   + + E ++S +    L GL +LH  R ++HRD+K  N+L+  +
Sbjct: 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTE 164

Query: 219 GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES---YSYPA--DIWSIGLALF 273
           G  K+ DFG+SA L ++     T VGT  +M+PE I  E    YSY A  D+WS+G+   
Sbjct: 165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224

Query: 274 ECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E G G+ P      PV  + +I  +P P+    + +   F  F+  CL KD EARP+   
Sbjct: 225 ELGDGDPPLFDMH-PVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283

Query: 333 LLSHPFI 339
           LL HPFI
Sbjct: 284 LLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  137 bits (346), Expect = 4e-38
 Identities = 86/256 (33%), Positives = 148/256 (57%), Gaps = 12/256 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR-NQLLTEIRTL--CEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E     +  EI  L  C++P    + +++
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTKYY 68

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G+ Y+ D+ ++ I +EY+ GGS  D+L     + E  ++++ +++L+GL YLH  +  +H
Sbjct: 69  GS-YLKDT-KLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK-IH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++  G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y   ADI
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P++    P+ ++  I ++ +P     N+S     FV+ CL K+  
Sbjct: 185 WSLGITAIELAKGEPPHSELH-PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPS 242

Query: 326 ARPTADQLLSHPFITK 341
            RPTA +LL H FI +
Sbjct: 243 FRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  136 bits (346), Expect = 4e-38
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 19/266 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           I  GA   V  A    T  I A+K I    +  K + +Q+LTE   L +A     +V+ +
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY-VVKLY 59

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F       + + +EY+ GG LA +L    S+ E +      +++  L YLH    ++H
Sbjct: 60  YSFQ--GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG-IIH 116

Query: 206 RDIKPANLLVNLKGRPKITDFGIS-AGLENSIAM-------CATFVGTVTYMSPERIRNE 257
           RD+KP N+L++  G  K+TDFG+S  GL                 VGT  Y++PE I  +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
            +S   D WS+G  L+E   G  P+   E P  +   IL      P     S E    + 
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235

Query: 318 DCLKKDAEARPTA---DQLLSHPFIT 340
             L  D E R  A   +++ +HPF  
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  136 bits (345), Expect = 6e-38
 Identities = 87/263 (33%), Positives = 132/263 (50%), Gaps = 17/263 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-----NIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G GA   V   +     ++IA+K++     N+   EK  + L E   L ++  +  +V+
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           + G     D   ISI +E++ GGS++ IL     +PEP+     K++L G++YLH    +
Sbjct: 67  YLGTCL--DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN-NCV 123

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-----AGLENSIA-MCATFVGTVTYMSPERIRNE 257
           VHRDIK  N+++   G  K+ DFG +      GL  + + M  +  GT  +M+PE I   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS-RQNFSPEFCSFV 316
            Y   +DIWSIG  +FE  TG+ P  AS   +  M  I       P    +FS     FV
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPL-ASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242

Query: 317 DDCLKKDAEARPTADQLLSHPFI 339
             CL +D   RP+A QLL H F+
Sbjct: 243 TSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  136 bits (344), Expect = 6e-38
 Identities = 77/262 (29%), Positives = 145/262 (55%), Gaps = 14/262 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G    V +  H+ T ++ A+K +++   E+  ++  EI  L +   +  +  ++GAF
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIATYYGAF 72

Query: 149 YMPD----SGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRH 202
              +      Q+ + +E+   GS+ D+++  K  ++ E  ++ + +++L+GLS+LH    
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HK 131

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-----NE 257
           ++HRDIK  N+L+      K+ DFG+SA L+ ++    TF+GT  +M+PE I      + 
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +Y + +D+WS+G+   E   G  P      P+  +  I  +P+P    + +S +F SF++
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWSKKFQSFIE 250

Query: 318 DCLKKDAEARPTADQLLSHPFI 339
            CL K+   RPT +QL+ HPFI
Sbjct: 251 SCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  135 bits (342), Expect = 1e-37
 Identities = 76/255 (29%), Positives = 132/255 (51%), Gaps = 14/255 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G+   V +   +  ++  ALK++++    +++R   + EIR L     +  ++ +  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKE 66

Query: 147 AFYMPDSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           AF   D  ++ I +EY   G L+  +      +K IPE  +  +F +LL+GL  LH  + 
Sbjct: 67  AFL--DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QK 123

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++HRD+K AN+L+      KI D GIS  L+ ++A   T +GT  YM+PE  +   YSY 
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRPYSYK 181

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           +DIWS+G  L+E  T   P+ A     +L  ++     P P    +S +  +F+   L+ 
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQV 239

Query: 323 DAEARPTADQLLSHP 337
             + RP  D++L+ P
Sbjct: 240 KPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  135 bits (340), Expect = 5e-37
 Identities = 79/257 (30%), Positives = 147/257 (57%), Gaps = 11/257 (4%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +  IG G++ +V  A    + R +A+K +++ ++++R  L  E+  + +   ++ +VE +
Sbjct: 26  YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMY 84

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + +  ++ + +E++ GG+L DI+  Q  + E  ++++ + +LQ L YLH  + ++H
Sbjct: 85  KSYLVGE--ELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHS-QGVIH 140

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+ L GR K++DFG  A +   +    + VGT  +M+PE I    Y    DI
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF---SPEFCSFVDDCLKK 322
           WS+G+ + E   GE PY  S+ PV  M ++ +  SP P  +N    SP    F++  L +
Sbjct: 201 WSLGIMVIEMVDGEPPY-FSDSPVQAMKRLRD--SPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 323 DAEARPTADQLLSHPFI 339
           + + R TA +LL HPF+
Sbjct: 258 EPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  134 bits (338), Expect = 7e-37
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 18/263 (6%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEG 140
           +I   IG G  SVV +A+ +   R++ALKK+ IFE    + R   L EI  L +   +  
Sbjct: 5   KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEI-DLLKQLDHPN 63

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----IPEPILSSMFKKLLQGLSY 196
           ++++  +F   ++ +++I LE  D G L+ +++  K     IPE  +   F +L   L +
Sbjct: 64  VIKYLASFI--ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           +H  + ++HRDIKPAN+ +   G  K+ D G+     +      + VGT  YMSPERI  
Sbjct: 122 MHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM--LQILE--DPSPSPSRQNFSPEF 312
             Y++ +DIWS+G  L+E    + P+   +  +NL    + +E  D  P P+   +S E 
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEKCDYPPLPADH-YSEEL 237

Query: 313 CSFVDDCLKKDAEARPTADQLLS 335
              V  C+  D E RP    +L 
Sbjct: 238 RDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  134 bits (338), Expect = 1e-36
 Identities = 80/255 (31%), Positives = 144/255 (56%), Gaps = 7/255 (2%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 83

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 84  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 139

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL  D 
Sbjct: 200 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258

Query: 325 EARPTADQLLSHPFI 339
           E R +A +LL H F+
Sbjct: 259 EKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  133 bits (338), Expect = 1e-36
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 37/287 (12%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPC 137
            + +    IG G+ S V  A    T++  A+K   K  + +++K   +  E   L     
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           + G+++ +  F   D   +   LEY   G L   +R   S+ E        ++L  L YL
Sbjct: 61  HPGIIKLYYTFQ--DEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM------------------- 238
           H  + ++HRD+KP N+L++     KITDFG +A + +  +                    
Sbjct: 119 HS-KGIIHRDLKPENILLDKDMHIKITDFG-TAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 239 --CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP-YAASEGPVNLMLQI 295
              A+FVGT  Y+SPE +  +     +D+W++G  +++  TG+ P   ++E       +I
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTFQKI 234

Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA----DQLLSHPF 338
           L+     P   NF P+    ++  L  D + R       D+L +HPF
Sbjct: 235 LKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  133 bits (336), Expect = 2e-36
 Identities = 80/257 (31%), Positives = 144/257 (56%), Gaps = 7/257 (2%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 25  FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 83

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +L+ LS LH  + ++H
Sbjct: 84  NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLKALSVLHA-QGVIH 139

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +    + VGT  +M+PE I    Y    DI
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 200 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258

Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 259 AQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  132 bits (334), Expect = 2e-36
 Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 17/265 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ------LLTEIRTLCEAPCNEGLV 142
           +G+GA S   +A  + T  ++A+K++         Q      L  EIR +     +  ++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHII 66

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
              GA    +    ++ +E+M GGS++ +L    +  E ++ +  ++LL+GLSYLH    
Sbjct: 67  RMLGA--TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE-NQ 123

Query: 203 LVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATF----VGTVTYMSPERIRNE 257
           ++HRD+K ANLL++  G+  +I DFG +A L         F    +GT+ +M+PE +R E
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSPSPSRQNFSPEFCSF 315
            Y    D+WS+G  + E  T + P+ A +    + L+ +I    +     ++ SP     
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 316 VDDCLKKDAEARPTADQLLSHPFIT 340
              CL+   E RP + +LL HP   
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  132 bits (333), Expect = 2e-36
 Identities = 78/239 (32%), Positives = 134/239 (56%), Gaps = 16/239 (6%)

Query: 108 IIALKKINIF---EKEKRNQL-LTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           ++  K++N+    EKE+R+ L    I +L + P    ++ ++  F   D   + I +EY 
Sbjct: 27  LVVWKEVNLTRLSEKERRDALNEIVILSLLQHP---NIIAYYNHFM--DDNTLLIEMEYA 81

Query: 164 DGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP 221
           +GG+L D +  QK     E ++     +++  +SY+H    ++HRDIK  N+ +   G  
Sbjct: 82  NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLI 140

Query: 222 KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP 281
           K+ DFGIS  L +  +M  T VGT  YMSPE  +   Y++ +DIW++G  L+E  T +  
Sbjct: 141 KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200

Query: 282 YAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           + A+  P+NL+++I++ + +P  S   +S E  S V   L++D E RPTAD++L  P +
Sbjct: 201 FDATN-PLNLVVKIVQGNYTPVVSV--YSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  130 bits (328), Expect = 2e-35
 Identities = 78/254 (30%), Positives = 130/254 (51%), Gaps = 14/254 (5%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEG 140
           RI   IG G  S V RA  +     +ALKK+ IF+    + R   + EI  L +   +  
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPN 63

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSY 196
           +++++ +F   +  +++I LE  D G L+ +++     ++ IPE  +   F +L   L +
Sbjct: 64  VIKYYASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           +H  R ++HRDIKPAN+ +   G  K+ D G+     +      + VGT  YMSPERI  
Sbjct: 122 MHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--DPSPSPSRQNFSPEFCS 314
             Y++ +DIWS+G  L+E    + P+   +  +  + + +E  D  P PS  ++S E   
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS-DHYSEELRQ 239

Query: 315 FVDDCLKKDAEARP 328
            V+ C+  D E RP
Sbjct: 240 LVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  129 bits (325), Expect = 5e-35
 Identities = 87/260 (33%), Positives = 128/260 (49%), Gaps = 16/260 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G   +V  A  + T   IA+K+I   +      L  EI  L     +  +V++ G+ 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI-ALHSYLKHRNIVQYLGSD 74

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIP----EPILSSMFKKLLQGLSYLHGVRHLV 204
              ++G   I +E + GGSL+ +LR  K  P    E  +    K++L+GL YLH    +V
Sbjct: 75  --SENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIV 130

Query: 205 HRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN--ESYSY 261
           HRDIK  N+LVN   G  KI+DFG S  L        TF GT+ YM+PE I      Y  
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQI--LEDPSPSPSRQNFSPEFCSFVDDC 319
           PADIWS+G  + E  TG+ P+     P   M ++   +     P  ++ S E  +F+  C
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP--ESLSAEAKNFILRC 248

Query: 320 LKKDAEARPTADQLLSHPFI 339
            + D + R +A  LL  PF+
Sbjct: 249 FEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 8e-34
 Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 39/286 (13%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEF 144
           G +G GA  VV +  +  T  I+A+KK    E  ++ +   L E++ L     +E +V  
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVL-RQLRHENIVNL 65

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
             AF     G++ +  EY++   L  +      +P   + S   +LLQ ++Y H   +++
Sbjct: 66  KEAFRR--KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-HNII 122

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPE-RIRNESYSYP 262
           HRDIKP N+LV+  G  K+ DFG +  L     +    +V T  Y +PE  + + +Y  P
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 263 ADIWSIGLALFECGTGE--FPYAASE-----------GPVNLMLQILED----------P 299
            D+W+IG  + E   GE  FP   S+           GP+    Q L            P
Sbjct: 183 VDVWAIGCIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241

Query: 300 SPSP--SRQNFSPEFCS-----FVDDCLKKDAEARPTADQLLSHPF 338
            PS   S +   P   S     F+  CL+ D + R T D+LL HP+
Sbjct: 242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 1e-33
 Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 38/285 (13%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVEF 144
           G IG G   VV +A    T  I+A+KKI +  + +      L EI+ L E   +  +++ 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKL 63

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRH- 202
              F     G + +  E+MD   L  +++  Q+ +PE ++ S   +LLQGL++ H   H 
Sbjct: 64  LDVF--RHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--SHG 118

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSY 261
           ++HRD+KP NLL+N +G  K+ DFG++    + +     +V T  Y +PE +  +  YS 
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 262 PADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------P 301
           P DIWS+G    E  +    FP  +    +  + + L  P                   P
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 302 SPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
             +           SP+    +   L  D   R TA+Q L+HP+ 
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  125 bits (314), Expect = 2e-33
 Identities = 76/212 (35%), Positives = 118/212 (55%), Gaps = 15/212 (7%)

Query: 141 LVEFHGAFYMPD---SGQISIALEYMDGGSLADI----LRMQKSIPEPILSSMFKKLLQG 193
           +V+F+G +Y  D     Q+ + LE  +GGS+ D+    L+  + + EPI++ +  + L G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           L +LH V   +HRD+K  N+L+  +G  K+ DFG+SA L ++     T VGT  +M+PE 
Sbjct: 137 LQHLH-VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 254 IRNE-----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QN 307
           I  E     +Y    D+WS+G+   E G G+ P A    P+  + +I  +P P+  + + 
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPRNPPPTLHQPEL 254

Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           +S EF  F+  CL KD E RPT   LL H FI
Sbjct: 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  123 bits (311), Expect = 1e-32
 Identities = 82/260 (31%), Positives = 141/260 (54%), Gaps = 17/260 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A  + T+ ++A+KK++   K   EK   ++ E+R L +   +   +E+ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYK 81

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G +    +  +   +EY  G S +DIL + +K + E  ++++    LQGL+YLH     +
Sbjct: 82  GCYLREHTAWL--VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE-RI 137

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI--RNE-SYSY 261
           HRDIK  N+L+   G  K+ DFG SA L +      +FVGT  +M+PE I   +E  Y  
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFG-SASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D+WS+G+   E    + P   +   ++ +  I ++ SP+ S  ++S  F +FVD CL+
Sbjct: 194 KVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252

Query: 322 KDAEARPTADQLLSHPFITK 341
           K  + RP++++LL H F+ +
Sbjct: 253 KIPQDRPSSEELLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  122 bits (307), Expect = 1e-32
 Identities = 90/269 (33%), Positives = 141/269 (52%), Gaps = 22/269 (8%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE------KRNQLLTEIRTLCEAPC 137
           R+   +G GA   V       T R +A+K++  F+ E      + N L  EI+ L +   
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLL-KNLL 62

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +E +V+++G    P    +SI +E+M GGS+ D L+   ++ E +     +++L+G+SYL
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVT----YMSPER 253
           H    +VHRDIK AN+L +  G  K+ DFG S  L+ +I +  T + +VT    +MSPE 
Sbjct: 123 HS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ-TICLSGTGMKSVTGTPYWMSPEV 180

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
           I  E Y   ADIWS+G  + E  T + P+A  E     M  I +  +  P+     P   
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIAT-QPTNPVLPPHVS 235

Query: 314 SFVDDCLKK---DAEARPTADQLLSHPFI 339
               D LK+   +A+ RP+AD+LL H F+
Sbjct: 236 DHCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  122 bits (307), Expect = 2e-32
 Identities = 85/260 (32%), Positives = 136/260 (52%), Gaps = 16/260 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL-CEAPC-----NEGLV 142
           +G GA   V     + T R +A K++  F+ E   +   E+  L CE        +E +V
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQ-FDPES-PETSKEVSALECEIQLLKNLQHERIV 67

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +++G         ++I +EYM GGS+ D L+   ++ E +     +++L+G+SYLH    
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS-NM 126

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVT----YMSPERIRNES 258
           +VHRDIK AN+L +  G  K+ DFG S  L+ +I M  T + +VT    +MSPE I  E 
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
           Y   AD+WS+G  + E  T + P+A  E  +  + +I   P+      + S     F+  
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAEYEA-MAAIFKIATQPTNPQLPSHISEHARDFL-G 243

Query: 319 CLKKDAEARPTADQLLSHPF 338
           C+  +A  RP+A++LL HPF
Sbjct: 244 CIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  121 bits (305), Expect = 5e-32
 Identities = 78/255 (30%), Positives = 142/255 (55%), Gaps = 7/255 (2%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    T + +A+KK+++ ++++R  L  E+  + +   +E +V+ +
Sbjct: 27  FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMY 85

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +L+ LSYLH  + ++H
Sbjct: 86  NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-ATVCLSVLRALSYLHN-QGVIH 141

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +    + VGT  +M+PE I    Y    DI
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M +I ++  P        S     F+D  L ++ 
Sbjct: 202 WSLGIMVIEMIDGEPPY-FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260

Query: 325 EARPTADQLLSHPFI 339
             R TA +LL HPF+
Sbjct: 261 SQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  120 bits (303), Expect = 5e-32
 Identities = 83/269 (30%), Positives = 141/269 (52%), Gaps = 13/269 (4%)

Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP 136
           R   H+  +   +GSG    V +A ++ T  + A+K I +   +  + +  EI  + E  
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64

Query: 137 -CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
            CN  +V + G++   +  ++ I +EY  GGSL DI  +   + E  ++ + ++ LQGL+
Sbjct: 65  HCN--IVAYFGSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI- 254
           YLH  +  +HRDIK AN+L+   G  K+ DFG++A +  +IA   +F+GT  +M+PE   
Sbjct: 121 YLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179

Query: 255 --RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNFS 309
             +N  Y+   DIW++G+   E    + P      P+    LM +    P     +  +S
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMSKSNFQPPKLKDKTKWS 238

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLSHPF 338
             F +FV   L K+ + RPTA++LL+H F
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  120 bits (303), Expect = 7e-32
 Identities = 68/247 (27%), Positives = 112/247 (45%), Gaps = 17/247 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V+       +R  ALK +    I E  ++  + +E   L E   +  +V+ +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP----ILSSMFKKLLQGLSYLHGVR 201
             F   D   I + +EY  GG L  ILR +    E      ++ +    +    YLH  R
Sbjct: 60  RTFK--DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACV----VLAFEYLHN-R 112

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +++RD+KP NLL++  G  K+ DFG +  L++      TF GT  Y++PE I N+ Y +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILNKGYDF 171

Query: 262 PADIWSIGLALFECGTGEFPYAAS-EGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             D WS+G+ L+E  TG  P+    E P+ +   IL+                  +   L
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231

Query: 321 KKDAEAR 327
           +++ E R
Sbjct: 232 RRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  120 bits (302), Expect = 8e-32
 Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 15/270 (5%)

Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CE 134
           R    +  +   IGSG    V +A ++ T  + A+K I +   E    +  EI  +  C+
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
                 +V + G++   D  ++ I +E+  GGSL DI  +   + E  ++ + ++ LQGL
Sbjct: 65  HS---NIVAYFGSYLRRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI 254
            YLH  +  +HRDIK AN+L+   G  K+ DFG+SA +  +IA   +F+GT  +M+PE  
Sbjct: 120 YYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178

Query: 255 ---RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNF 308
              R   Y+   DIW++G+   E    + P      P+    LM +    P     +  +
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMTKSNFQPPKLKDKMKW 237

Query: 309 SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
           S  F  FV   L K+ + RPTA++LL HPF
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 8e-32
 Identities = 81/287 (28%), Positives = 137/287 (47%), Gaps = 48/287 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL-----LTEIRTLCEAPCNEGLVE 143
           +G G    V  A +  T  ++A+KK+    K+K         L E+++L +   +  +V+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVR 201
               F   ++ ++    EYM+G +L  +++ +K     E ++ S+  ++LQGL+++H  +
Sbjct: 63  LKEVFR--ENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--K 117

Query: 202 H-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESY 259
           H   HRD+KP NLLV+     KI DFG++  + +       +V T  Y +PE + R+ SY
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYVSTRWYRAPEILLRSTSY 176

Query: 260 SYPADIWSIGLALFECGTGE--FPYAASE-GPVNLMLQILEDPSPSP--------SRQNF 308
           S P DIW++G  + E  T    FP  +SE   +  +  +L  P+           S+  F
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFP-GSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235

Query: 309 -----------------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                            SPE    + D L+ D + RPTA Q L HP+
Sbjct: 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 4e-31
 Identities = 79/285 (27%), Positives = 115/285 (40%), Gaps = 38/285 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G    V +A +  T  ++ALKKI   E EK    +T IR   L +   +  +V    
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
                  G I +  EYMD   L  +L   +    E  +    K+LL+GL YLH    ++H
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILH 123

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF-VGTVTYMSPERIRNE-SYSYPA 263
           RDIK +N+L+N  G  K+ DFG++       +   T  V T+ Y  PE +     Y    
Sbjct: 124 RDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEV 183

Query: 264 DIWSIGLALFECGTGE--FPYAASE-----------GPVN-------LMLQILEDPSPSP 303
           D+WS+G  L E   G+  F   ++E           G            L   E+  P  
Sbjct: 184 DMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242

Query: 304 SRQN---------FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
             +            P     +D  L  D + R +ADQ L H + 
Sbjct: 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 6e-31
 Identities = 85/288 (29%), Positives = 132/288 (45%), Gaps = 44/288 (15%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT--EIRTL-----CEAPCNEG 140
            IG GA   V +A  + T R +ALKK+ +   E+   L T  EI  L      E P    
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP---N 62

Query: 141 LVEFHGAFYMPDSG---QISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLS 195
           +V      + P +    ++++  E++D   LA  L    +  +P   +  + ++LL+G+ 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           +LH  R +VHRD+KP N+LV   G+ KI DFG++      +A+ +  V T+ Y +PE + 
Sbjct: 122 FLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-TLWYRAPEVLL 179

Query: 256 NESYSYPADIWSIGLALFE--------CGTGE------------FPYAASEGPVNLMLQI 295
             SY+ P D+WS+G    E         GT E             P +  E P N+ L  
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP-SEEEWPRNVSLPR 238

Query: 296 LE-DPSPSPSRQNFSPEFCSFVDDCLKK----DAEARPTADQLLSHPF 338
                    S ++F PE C    D LKK    +   R +A + L HP+
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 1e-30
 Identities = 78/232 (33%), Positives = 125/232 (53%), Gaps = 17/232 (7%)

Query: 112 KKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADI 171
           K++N  E E   QLL  +R       ++ +V+++G    P+  ++SI +EYM GGS+ D 
Sbjct: 46  KEVNALECEI--QLLKNLR-------HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ 96

Query: 172 LRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG 231
           L+   ++ E +     +++LQG+SYLH    +VHRDIK AN+L +  G  K+ DFG S  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155

Query: 232 LENSIAMCATFVGTVT----YMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG 287
           ++ +I M  T + +VT    +MSPE I  E Y   AD+WS+   + E  T + P+A  E 
Sbjct: 156 IQ-TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214

Query: 288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
            +  + +I   P+        S     F+     ++ + RPTA+ LL HPF+
Sbjct: 215 -MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  115 bits (290), Expect = 3e-30
 Identities = 75/262 (28%), Positives = 132/262 (50%), Gaps = 21/262 (8%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN--------QLLTEIRTLCEAPCNE 139
            +G G+   V    H    +   +KK+N+    +R         QLL++++       + 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-------HP 59

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYL 197
            +V +  ++   D G + I + + +GG L   L+ QK   +PE  +   F ++   L YL
Sbjct: 60  NIVAYRESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  +H++HRD+K  N+ +      K+ D GI+  LEN   M +T +GT  YMSPE   N+
Sbjct: 119 HE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
            Y+Y +D+W++G  ++E  T +  + A +   +L+ +I+E   P P  +++SPE    + 
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMN-SLVYRIIEGKLP-PMPKDYSPELGELIA 235

Query: 318 DCLKKDAEARPTADQLLSHPFI 339
             L K  E RP+   +L  P+I
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  115 bits (290), Expect = 4e-30
 Identities = 69/256 (26%), Positives = 131/256 (51%), Gaps = 12/256 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G GA  +V         +++ +K+I +    K++R     E + L +   +  ++E++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVL-KLLSHPNIIEYYE 66

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLV 204
            F       + I +EY  GG+LA+ ++ + +  + E  +   F ++L  L ++H  + ++
Sbjct: 67  NFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-TKLIL 123

Query: 205 HRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           HRD+K  N+L++  K   KI DFGIS  L +S +   T VGT  Y+SPE    + Y+  +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVVGTPCYISPELCEGKPYNQKS 182

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           DIW++G  L+E  + +  + A+  P  L+L+I+   + +P    +SP+    +   L  D
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDRYSPDLRQLILSMLNLD 240

Query: 324 AEARPTADQLLSHPFI 339
              RP   Q+++ P  
Sbjct: 241 PSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  115 bits (291), Expect = 6e-30
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTL--CEAPCNE 139
           +I G IG GA  +V +A    T   +ALKK+ +   E    NQ L EI+ L  C+ P   
Sbjct: 3   KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHP--- 59

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLH 198
            +V+    F  P      + +EYM    L+++LR  ++ +PE  + S  + LL+G++Y+H
Sbjct: 60  YVVKLLDVF--PHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF-VGTVTYMSPERIR-N 256
               ++HRD+KPANLL++  G  KI DFG++           +  V T  Y +PE +   
Sbjct: 117 ANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 257 ESYSYPADIWSIGLALFE 274
             Y    D+W++G    E
Sbjct: 176 RKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  114 bits (287), Expect = 9e-30
 Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 12/204 (5%)

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSY 196
           +V+FH +F   D+    I  EY +G  L   L       K++ E  +   F +LL G+ Y
Sbjct: 64  IVKFHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           +H  R ++HRD+K  N+ +      KI DFG+S  L  S  +  TF GT  YMSPE +++
Sbjct: 122 MH-QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSF 315
           + Y   +DIWS+G  L+E       +      ++++L+I+E P+PS P    +S +  S 
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRIVEGPTPSLPET--YSRQLNSI 236

Query: 316 VDDCLKKDAEARPTADQLLSHPFI 339
           +   L KD   RP+A ++L +PFI
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  114 bits (286), Expect = 2e-29
 Identities = 74/249 (29%), Positives = 128/249 (51%), Gaps = 14/249 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G  S V RA  +   + +ALKK+ IFE    + R   + EI  L +   +  ++++ 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYL 68

Query: 146 GAFYMPDSGQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
            +F   +  +++I LE  D G L+ ++    + ++ IPE  +   F +L   + ++H  R
Sbjct: 69  DSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-R 125

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            ++HRDIKPAN+ +   G  K+ D G+     +      + VGT  YMSPERI    Y++
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--DPSPSPSRQNFSPEFCSFVDDC 319
            +DIWS+G  L+E    + P+   +  +  + Q +E  D  P P+ +++S +    V  C
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT-EHYSEKLRELVSMC 244

Query: 320 LKKDAEARP 328
           +  D + RP
Sbjct: 245 IYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  111 bits (279), Expect = 2e-28
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 18/265 (6%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTL--CEAPCN 138
            +   IG GA   V       T ++ A+K +N     EK     +L E R L     P  
Sbjct: 3   ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF- 61

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             LV    +F   D   + + ++ + GG L   L  +    E  +     +++  L YLH
Sbjct: 62  --LVNLWYSF--QDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
             + ++HRDIKP N+L++ +G   ITDF I+  +     +  +  GT  YM+PE +  + 
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQG 175

Query: 259 YSYPADIWSIGLALFECGTGEFPY-AASEGPVNLMLQILEDPSP-SPSRQNFSPEFCSFV 316
           YS   D WS+G+  +EC  G+ PY   S    + +    E      P+    S E    +
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW--STEAIDAI 233

Query: 317 DDCLKKDAEAR--PTADQLLSHPFI 339
           +  L++D + R       L +HP+ 
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 3e-28
 Identities = 80/290 (27%), Positives = 121/290 (41%), Gaps = 53/290 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--------RNQLLTEIRTLCEAPCNEG 140
           +G G   VV +A    T  I+ALKKI   + E+        R     EI  L E      
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALR-----EISLLKELKH-PN 59

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHG 199
           +V+     +     ++ +  EY D   L   L +    +   ++ S+  +LL+GL+Y H 
Sbjct: 60  IVKLLDVIH--TERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVT--YMSPERIRNE 257
              ++HRD+KP N+L+N  G  K+ DFG++      I +       VT  Y +PE +   
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 258 S-YSYPADIWSIGLALFECGTGE--FPYAASE-GPVNLMLQILEDPSPS-----PSRQNF 308
             YS   DIWS+G    E  TG+  FP   SE   +  + QIL  P+           ++
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFP-GDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232

Query: 309 SPEFCSFVDDCLKK-----DAEA--------------RPTADQLLSHPFI 339
            P F  F    L+K     D E               R +A + L HP+ 
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  109 bits (275), Expect = 5e-28
 Identities = 66/233 (28%), Positives = 122/233 (52%), Gaps = 10/233 (4%)

Query: 111 LKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSL 168
           +K+INI     ++R +   E+  L     +  +V++  +F   ++G + I ++Y +GG L
Sbjct: 30  IKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESF--EENGNLYIVMDYCEGGDL 86

Query: 169 ADILRMQKSI--PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
              +  Q+ +  PE  +   F ++   L ++H  R ++HRDIK  N+ +   G  K+ DF
Sbjct: 87  YKKINAQRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDF 145

Query: 227 GISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE 286
           GI+  L +++ +  T +GT  Y+SPE   N  Y+  +DIW++G  L+E  T +  + A  
Sbjct: 146 GIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Query: 287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
              NL+L+I+    P P   ++S +  + V    K++   RP+ + +L   FI
Sbjct: 206 MK-NLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 5e-27
 Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 15/265 (5%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCN 138
           + +I   +G G    V  A    T  I+ALK++    +F+  +   +LTE R +     +
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTE-RDILTTTKS 60

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           E LV+   AF   +   + +A+EY+ GG    +L     + E        ++ + +  LH
Sbjct: 61  EWLVKLLYAFQDDEY--LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
            + + +HRD+KP N L++  G  K+TDFG+S G+   +    + VG+  YM+PE +R + 
Sbjct: 119 ELGY-IHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVVGSPDYMAPEVLRGKG 174

Query: 259 YSYPADIWSIGLALFECGTGEFPYAAS---EGPVNLML--QILEDPSPSPSRQNFSPEFC 313
           Y +  D WS+G  L+E   G  P++ S   E   NL    + L+ P     R N S E  
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234

Query: 314 SFVDDCLKKDAEARPTADQLLSHPF 338
             +   +   +    + + + +HPF
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  108 bits (271), Expect = 5e-27
 Identities = 83/285 (29%), Positives = 147/285 (51%), Gaps = 27/285 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A +  T+ ++A+KK++   K   EK   ++ E++ L +   +   +E+ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYK 87

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G +    +  +   +EY  G S +D+L + +K + E  ++++    LQGL+YLH   +++
Sbjct: 88  GCYLKEHTAWL--VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMI 143

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA-TFVGTVTYMSPERI---RNESYS 260
           HRDIK  N+L+   G+ K+ DFG +     S +  A +FVGT  +M+PE I       Y 
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
              D+WS+G+   E    + P   +   ++ +  I ++ SP+     ++  F  FVD CL
Sbjct: 199 GKVDVWSLGITCIELAERK-PPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257

Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           +K  + RP + +LL H F+ +   A+V        + D +QR KD
Sbjct: 258 QKIPQERPASAELLRHDFVRRDRPARV--------LIDLIQRTKD 294

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  108 bits (271), Expect = 5e-27
 Identities = 83/284 (29%), Positives = 146/284 (51%), Gaps = 25/284 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A  +    ++A+KK++   K   EK   ++ E+R L +   +   +++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL-QKLRHPNTIQYR 81

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G +    +  +   +EY  G S +D+L + +K + E  ++++    LQGL+YLH   +++
Sbjct: 82  GCYLREHTAWL--VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMI 137

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI---RNESYSY 261
           HRD+K  N+L++  G  K+ DFG SA +   +A    FVGT  +M+PE I       Y  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFG-SASI---MAPANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D+WS+G+   E    + P   +   ++ +  I ++ SP+    ++S  F +FVD CL+
Sbjct: 194 KVDVWSLGITCIELAERK-PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 322 KDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           K  + RPT++ LL H F+ +     V        + D +QR KD
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERPPTV--------IMDLIQRTKD 288

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  108 bits (271), Expect = 6e-27
 Identities = 84/284 (29%), Positives = 148/284 (52%), Gaps = 25/284 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A  + T+ ++A+KK++   K   EK   ++ E++ L +   +   +E+ 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL-QRIKHPNSIEYK 91

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G +    +  +   +EY  G S +D+L + +K + E  ++++    LQGL+YLH   +++
Sbjct: 92  GCYLREHTAWL--VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMI 147

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI---RNESYSY 261
           HRDIK  N+L+   G+ K+ DFG SA +    +   +FVGT  +M+PE I       Y  
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG-SASI---ASPANSFVGTPYWMAPEVILAMDEGQYDG 203

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D+WS+G+   E    + P   +   ++ +  I ++ SP+     +S  F +FVD CL+
Sbjct: 204 KVDVWSLGITCIELAERK-PPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262

Query: 322 KDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           K  + RPT+++LL H F+ +     V        + D +QR KD
Sbjct: 263 KIPQDRPTSEELLKHMFVLRERPETV--------LIDLIQRTKD 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  106 bits (267), Expect = 1e-26
 Identities = 70/259 (27%), Positives = 112/259 (43%), Gaps = 19/259 (7%)

Query: 89  IGSGASSVVQRAVHIP----THRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G GA   V +         T   +A+K +     +E+R + L E   + +      +V 
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH-PNIVR 65

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRH 202
             G         + I  EYM GG L D LR     +    L  M  ++ +G+ YL   ++
Sbjct: 66  LLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-KN 122

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYS 260
            VHRD+   N LV      KI+DFG+S  +           G   + +M+PE +++  ++
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 261 YPADIWSIGLALFE-CGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVD 317
             +D+WS G+ L+E    GE PY         +L++LED    P P  +N   E    + 
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPY--PGMSNEEVLELLEDGYRLPRP--ENCPDELYELML 238

Query: 318 DCLKKDAEARPTADQLLSH 336
            C   D E RPT  +L+  
Sbjct: 239 QCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  106 bits (265), Expect = 1e-26
 Identities = 76/262 (29%), Positives = 134/262 (51%), Gaps = 24/262 (9%)

Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKI-------NIFEKEKRNQLLTEIRTLCEA 135
           +R+ G    G + +VQ   H+ + +  A+K+I        + +  K   LL +++     
Sbjct: 5   LRVVGEGSFGRALLVQ---HVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK----- 56

Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQG 193
             +  +V F  +F     G + I +EY DGG L   +++Q+    PE  +   F ++  G
Sbjct: 57  --HPNIVAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           + ++H  R ++HRDIK  N+ +   G+ K+ DFG +  L +  A   T+VGT  Y+ PE 
Sbjct: 113 VQHIHEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
             N  Y+  +DIWS+G  L+E  T + P+ A+    NL+L++ +  S  P   ++S E  
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-NLILKVCQG-SYKPLPSHYSYELR 229

Query: 314 SFVDDCLKKDAEARPTADQLLS 335
           S +    K++  +RP+A  +LS
Sbjct: 230 SLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  104 bits (261), Expect = 6e-26
 Identities = 73/235 (31%), Positives = 121/235 (51%), Gaps = 14/235 (5%)

Query: 109 IALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I L K+ + EKE  + +++     L     +  +V F  +F   ++G++ I +EY DGG 
Sbjct: 33  IDLTKMPVKEKEASKKEVI-----LLAKMKHPNIVTFFASF--QENGRLFIVMEYCDGGD 85

Query: 168 LADILRMQKSI--PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR-PKIT 224
           L   +  Q+ +   E  + S F ++  GL ++H  R ++HRDIK  N+ ++  G   K+ 
Sbjct: 86  LMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLG 144

Query: 225 DFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA 284
           DFGI+  L +S+ +  T VGT  Y+SPE  +N  Y+   DIWS+G  L+E  T + P+  
Sbjct: 145 DFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-E 203

Query: 285 SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
                 L+L+I +    +P   NFS +  S +    K     RP+   +L  PF+
Sbjct: 204 GNNLHQLVLKICQG-YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  104 bits (260), Expect = 9e-26
 Identities = 72/258 (27%), Positives = 130/258 (50%), Gaps = 25/258 (9%)

Query: 89  IGSGA-SSVVQRAVHIPTHRIIALKKINI----FEKEKRNQ------LLTEIRTLCEAPC 137
           +GSGA   V +         ++ALK+IN+    F K+KR +      +++E+  + E   
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK----SIPEPILSSMFKKLLQG 193
           +  +V ++  F   D  ++ I ++ ++G  L +     K       E  + ++F +++  
Sbjct: 68  HPNIVRYYKTFLEND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           L YLH  + +VHRD+ P N+++    +  ITDFG+ A  +   +   + VGT+ Y  PE 
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYSCPEI 184

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSP 310
           ++NE Y   AD+W+ G  L++  T + P+  S   ++L  +I+E   +P P      +S 
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLATKIVEAVYEPLPEGM---YSE 240

Query: 311 EFCSFVDDCLKKDAEARP 328
           +    +  CL  DAEARP
Sbjct: 241 DVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 83/293 (28%), Positives = 133/293 (45%), Gaps = 44/293 (15%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNEGLVEF 144
           IGSGA  VV  AV   T R +A+KKI N+F+     KR  +L EI+ L      E ++  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR--ILREIKLLRHLRH-ENIIGL 64

Query: 145 HGAFYMPDS---GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
                 P       + I  E M+   L  +++  + + +  +     ++L+GL YLH   
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA- 122

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVT---YMSPERIRNES 258
           +++HRD+KP+N+LVN     KI DFG++ G++            V    Y +PE + + S
Sbjct: 123 NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS 182

Query: 259 -YSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS------------- 302
            Y+   DIWS+G    E  T +  FP       +NL++++L  PS               
Sbjct: 183 RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNY 242

Query: 303 ----PSRQ---------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
               P +            SPE    ++  L  D + R TAD+ L+HP++ + 
Sbjct: 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 72/237 (30%), Positives = 113/237 (47%), Gaps = 15/237 (6%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I  LKK ++  K +   +  E   +     +  + + + +F   D   + + +EY++GG 
Sbjct: 26  IKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY--LYLVMEYLNGGD 83

Query: 168 LADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG 227
            A +++    +PE        +++ G+  LH  R ++HRDIKP NLL++  G  K+TDFG
Sbjct: 84  CASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 228 IS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE 286
           +S  GLEN       FVGT  Y++PE I        +D WS+G  +FE   G  P+ A E
Sbjct: 143 LSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-E 196

Query: 287 GPVNLMLQILEDPSPSPSRQN--FSPEFCSFVDDCLKKDAEARPTAD---QLLSHPF 338
            P  +   IL      P       SPE    ++  L  D   R  A+   ++ SHPF
Sbjct: 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 55/292 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ---LLTEIRTLCEAPCNEGLVEFH 145
           IG GA   V       T ++ A+K +   +  KRNQ   +  E   L +A  +  +V+ +
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D   + + +EYM GG L ++L  +   PE        +L+  L  +H +   +H
Sbjct: 68  YSF--QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF-IH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGL-----------------------------ENSI 236
           RDIKP N+L++  G  K+ DFG+   +                             +   
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184

Query: 237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV----NLM 292
               + VGT  Y++PE +R   Y    D WS+G+ L+E   G FP   S+        ++
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG-FPPFYSDTLQETYNKII 243

Query: 293 -----LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-PTADQLLSHPF 338
                L+        P     SPE    +   L  D E R  + +++ SHPF
Sbjct: 244 NWKESLRF-------PPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  102 bits (256), Expect = 6e-25
 Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 21/218 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RN----QLLTEIRTLCEAPCNEGLV 142
           +G+G+   V    H  + +  ALK   I  K K  +      +L E R L ++  +  LV
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALK---ILSKAKIVKLKQVEHVLNEKRIL-QSIRHPFLV 64

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGV 200
             +G+F   D   + + +EY+ GG L   LR     PEP+  + F   +++  L YLH  
Sbjct: 65  NLYGSFQ--DDSNLYLVMEYVPGGELFSHLRKSGRFPEPV--ARFYAAQVVLALEYLHS- 119

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
             +V+RD+KP NLL++  G  KITDFG +  ++       T  GT  Y++PE I ++ Y 
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYG 176

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED 298
              D W++G+ ++E   G +P    + P+ +  +ILE 
Sbjct: 177 KAVDWWALGILIYEMLAG-YPPFFDDNPIQIYEKILEG 213

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 26/281 (9%)

Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRT 131
              R  + +  +   IG GA   VQ   H  + ++ A+K ++ FE  KR+      E R 
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
           +     +E +V+ H AF   D   + + +EYM GG L +++     IPE        +++
Sbjct: 96  IMAHANSEWIVQLHYAF--QDDKYLYMVMEYMPGGDLVNLMS-NYDIPEKWARFYTAEVV 152

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMS 250
             L  +H +   +HRD+KP N+L++  G  K+ DFG    ++ N +  C T VGT  Y+S
Sbjct: 153 LALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211

Query: 251 PERIRNES----YSYPADIWSIGLALFECGTGEFPYAASEGPV----NLM-----LQILE 297
           PE ++++     Y    D WS+G+ L+E   G+ P+ A +  V     +M     L   +
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPD 270

Query: 298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
           D   S   ++     C+F+ D  ++    R   D++ SHPF
Sbjct: 271 DIEISKQAKDL---ICAFLTD--REVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 65/257 (25%), Positives = 115/257 (44%), Gaps = 18/257 (7%)

Query: 89  IGSGASSVVQRAVHIP----THRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G GA   V +             +A+K +     +++  + L E R + +   +  +V+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPNVVK 65

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             G     +   + I +EYM+GG L   LR  +  +    L S   ++ +G+ YL   ++
Sbjct: 66  LLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES-KN 122

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESY 259
            +HRD+   N LV      KI+DFG+S  L +         G    + +M+PE ++   +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR--GGKLPIRWMAPESLKEGKF 180

Query: 260 SYPADIWSIGLALFE-CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
           +  +D+WS G+ L+E    GE PY         +L+ L++    P   N  PE    +  
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPY--PGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQ 238

Query: 319 CLKKDAEARPTADQLLS 335
           C  +D E RPT  +L+ 
Sbjct: 239 CWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 65/255 (25%), Positives = 113/255 (44%), Gaps = 15/255 (5%)

Query: 89  IGSGASSVVQRAVHIP----THRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G GA   V +             +A+K +     +++  + L E R + +   +  +V+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPNIVK 65

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVR 201
             G     +   + I +EYM GG L D LR  +   +    L S   ++ +G+ YL   +
Sbjct: 66  LLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-K 122

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV-GTVTYMSPERIRNESYS 260
           + +HRD+   N LV      KI+DFG+S  L +            + +M+PE ++   ++
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 261 YPADIWSIGLALFE-CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
             +D+WS G+ L+E    GE PY         +L+ L+     P   N  PE    +  C
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPY--PGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQC 240

Query: 320 LKKDAEARPTADQLL 334
             +D E RPT  +L+
Sbjct: 241 WAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 14/232 (6%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQLLTEIRTLCEA 135
           ++  + G +G GA  VV +  H  T  I+A+KK    E     KE   + L  +RTL + 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ- 59

Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
              E +VE   AF     G++ +  EY++   L  +  M   +P   + S   +L++ + 
Sbjct: 60  ---ENIVELKEAFRR--RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERI 254
           + H    +VHRDIKP NLL++     K+ DFG +  L E S A    +V T  Y SPE +
Sbjct: 115 WCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 255 RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
               Y    D+WS+G  L E   G+ P    E  ++ +  I +   P P+ Q
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ-PLFPGESEIDQLFTIQKVLGPLPAEQ 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 28/267 (10%)

Query: 89  IGSGASSVVQRAV---HIPTHRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           +G GA   V +            +A+K +     +E+R   L E R + +   +  +V  
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRL 61

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSM-FKKLLQ-------GLS 195
            G     +   + + LEYM+GG L D LR  +   P P  S++  K LL        G+ 
Sbjct: 62  LGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPE 252
           YL   +  VHRD+   N LV      KI+DFG+S  + +         G    + +M+PE
Sbjct: 120 YLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAPE 177

Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPS--PSPSRQNFS 309
            +++  ++  +D+WS G+ L+E  T G  PY         +L+ L      P P  +   
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKGYRLPKP--EYCP 233

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLSH 336
            E    +  C + D E RPT  +L+  
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 95.5 bits (237), Expect = 6e-22
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 26/266 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRTLCEAPCNEGLVEFHG 146
           IG GA   VQ   H  + ++ A+K ++ FE  KR+      E R +     +  +V+   
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF   D   + + +EYM GG L +++     +PE        +++  L  +H +  L+HR
Sbjct: 111 AF--QDDKYLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAIHSM-GLIHR 166

Query: 207 DIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIRNES----YSY 261
           D+KP N+L++  G  K+ DFG    + E  +  C T VGT  Y+SPE ++++     Y  
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL---------EDPSPSPSRQNFSPEF 312
             D WS+G+ LFE   G+ P+ A +  V    +I+         ED   S   +N     
Sbjct: 227 ECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL---I 282

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPF 338
           C+F+ D  ++    R   +++  HPF
Sbjct: 283 CAFLTD--REVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 94.0 bits (234), Expect = 6e-22
 Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 37/285 (12%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVE 143
            G +G G+  +V +  H  T +I+A+KK    E +K  +   + EIR L +   +E LV 
Sbjct: 6   LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVN 64

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
               F      ++ +  E++D   L D+ +    + E  +     ++L+G+ + H   ++
Sbjct: 65  LIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH-SHNI 121

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER-IRNESYSYP 262
           +HRDIKP N+LV+  G  K+ DFG +  L     +   +V T  Y +PE  + +  Y   
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-------------------------- 296
            DIW++G  + E  TGE P    +  ++ +  I+                          
Sbjct: 182 VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240

Query: 297 EDPSPSPSRQNF---SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
           E     P  + F   S         CL+ D + RP++ QLL H F
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)

Query: 105 THRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY 162
           T ++ A KK++    +K K  Q+    + + E   +  +V    AF   D   + + +  
Sbjct: 17  TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMTL 74

Query: 163 MDGGSLA-DILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR 220
           M+GG L   I  + +   PE        +++ GL +LH  R +V+RD+KP N+L++  G 
Sbjct: 75  MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGN 133

Query: 221 PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEF 280
            +I+D G++  L+    +     GT  YM+PE ++ E Y +  D +++G  L+E   G  
Sbjct: 134 VRISDLGLAVELKGGKKIKG-RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192

Query: 281 PYAASEGPVN---LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQ 332
           P+   +  V    L  + LE     P +  FSPE     +  L+KD E R      +AD+
Sbjct: 193 PFRQRKEKVEKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKDPEKRLGCRGGSADE 250

Query: 333 LLSHPF 338
           +  HP 
Sbjct: 251 VREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 78/260 (30%), Positives = 123/260 (47%), Gaps = 18/260 (6%)

Query: 111 LKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLA 169
           LKK  I +K K  +   TE + L        LV  H AF      ++ + L+Y++GG L 
Sbjct: 36  LKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELF 93

Query: 170 DILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS 229
             L  ++   E  +     +++  L +LH    +++RDIK  N+L++ +G   +TDFG+S
Sbjct: 94  THLYQREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLS 152

Query: 230 AG-LENSIAMCATFVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASE 286
              L        +F GT+ YM+PE IR  S  +    D WS+G+  FE  TG  P+    
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212

Query: 287 GPVN---LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR---PTADQLLSHPFIT 340
              +   +  +IL+   P P     S E   F+   L+KD + R     AD++ +HPF  
Sbjct: 213 EQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Query: 341 KYEHAKVDLAA-FVRSVFDP 359
             +    DLAA  + + F P
Sbjct: 271 GIDWD--DLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 75/259 (28%), Positives = 126/259 (48%), Gaps = 17/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A H    +  A+K   K  I +K+++  ++ E   L +   +  LV  H
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D  ++   L+Y++GG L   L+ ++S PEP       ++   L YLH +  +++
Sbjct: 63  YSFQTAD--KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN-IIY 119

Query: 206 RDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           RD+KP N+L++ +G   +TDFG+   G+E+S    +TF GT  Y++PE +R + Y    D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVD 178

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLML-QILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
            W +G  L+E   G  P+ + +     M   IL  P       N S      ++  L+KD
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRD--TAEMYDNILNKPLRLKP--NISVSARHLLEGLLQKD 234

Query: 324 AEARPTAD----QLLSHPF 338
              R  A     ++ +H F
Sbjct: 235 RTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 86/305 (28%), Positives = 132/305 (43%), Gaps = 52/305 (17%)

Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCN 138
               +    IG GA  +V  A H PT   +A+KKI+ FE +   Q  L EI+ L      
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH- 62

Query: 139 EGLVEFHGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSS-----MFKK 189
           E ++        P S +    + I  E M+   L  +++ Q       LS+        +
Sbjct: 63  ENIIGIL-DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH------LSNDHIQYFLYQ 114

Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG---ISAGLENSIAMCATFVGTV 246
           +L+GL Y+H   +++HRD+KP+NLL+N     KI DFG   I+    +       +V T 
Sbjct: 115 ILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 247 TYMSPERIRNES-YSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-- 301
            Y +PE + N   Y+   DIWS+G  L E  +    FP       +NL+L +L  PS   
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233

Query: 302 -----SPSRQNF--SPEFCSFVD-------------DCLKK----DAEARPTADQLLSHP 337
                S   +N+  S  F   V              D L K    +   R T ++ L+HP
Sbjct: 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293

Query: 338 FITKY 342
           ++ +Y
Sbjct: 294 YLEQY 298

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 73/275 (26%), Positives = 130/275 (47%), Gaps = 20/275 (7%)

Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRTLCE 134
           R  + +  +   IG GA   VQ   H  T ++ A+K ++ FE  KR+      E R +  
Sbjct: 39  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
              +  +V+   AF   D   + + +EYM GG L +++     +PE        +++  L
Sbjct: 99  FANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 155

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPER 253
             +H +   +HRD+KP N+L++  G  K+ DFG    + +  +  C T VGT  Y+SPE 
Sbjct: 156 DAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214

Query: 254 IRNES----YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQN 307
           ++++     Y    D WS+G+ L+E   G+ P+ A +  V    +I+  ++    P   +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDND 273

Query: 308 FSPE----FCSFVDDCLKKDAEARPTADQLLSHPF 338
            S E     C+F+ D  ++    R   +++  H F
Sbjct: 274 ISKEAKNLICAFLTD--REVRLGRNGVEEIKRHLF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 11/206 (5%)

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V+ H AF     G++ + L+++ GG L   L  +    E  +     +L   L +LH +
Sbjct: 60  IVKLHYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
             +++RD+KP N+L++ +G  K+TDFG+S    +      +F GTV YM+PE +    ++
Sbjct: 118 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             AD WS G+ +FE  TG  P+   +     M  IL+     P  Q  SPE  S +    
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMILKAKLGMP--QFLSPEAQSLLRALF 233

Query: 321 KKDAEARPTA-----DQLLSHPFITK 341
           K++   R  A     +++  HPF + 
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFFST 259

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 31/276 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTE--IRTLCEAPCNEGLVE 143
           I +GA   V    H  T +  A+KKIN   +  + +  Q+  E  I T  E P    +V 
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF---VVS 65

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
              +F       + + +EY++GG  A +L+   ++P  +    F + +  L YLH    +
Sbjct: 66  MFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY-GI 122

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISA-GLENSIA--------------MCATFVGTVTY 248
           VHRD+KP NLL+   G  K+TDFG+S  GL +                 +     GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP-SRQN 307
           ++PE I  + Y  P D W++G+ L+E   G  P+   + P  L  Q++ D    P   + 
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEGDEA 241

Query: 308 FSPEFCSFVDDCLKKDAEAR---PTADQLLSHPFIT 340
              +    +   L+++   R     A ++  H F  
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKK-INIFE-KEKRNQLLTEIRTLCEAPCNEGL 141
           +I G IG G  S V +A    T +  A+K     F+  E+ N L  EI+ L     +  +
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNI 60

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGV 200
           +      +   +G++++  E MD  +L ++++ +K  +PE  + S   +LL+ L ++H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR- 118

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESY 259
             + HRDIKP N+L+      K+ DFG   G+  S      ++ T  Y +PE +  +  Y
Sbjct: 119 NGIFHRDIKPENILIK-DDILKLADFGSCRGI-YSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 260 SYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS--------------- 302
               DIW++G   FE  +    FP       +  +  +L  P                  
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236

Query: 303 PSRQ---------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
           PS++         N S E    +   L  D + R TA Q L HP+
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 82/329 (24%), Positives = 141/329 (42%), Gaps = 62/329 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL---TEIRTLCEAPCNEGLVEFH 145
           +G GA   V  A  + TH + A+K +   +   RNQ+     E   L EA  NE +V+ +
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D   +   ++Y+ GG +  +L   +  PE +      +L   +  +H +   +H
Sbjct: 68  YSF--QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM-GFIH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAG-------------------------LENSIAMCA 240
           RDIKP N+L++L G  K+TDFG+  G                         L + ++ C 
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184

Query: 241 ----------------------TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG 278
                                 + VGT  Y++PE +  + Y+   D WS+G+ LFE   G
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244

Query: 279 EFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDD--CLKKDAEARPTADQLL 334
           + P+ A   P    L+++  E+    P +   SPE    +    C  ++   R  AD + 
Sbjct: 245 QPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303

Query: 335 SHPFITKYEHA---KVDLAAFVRSVFDPM 360
           +HPF ++ + +   +   A +V  +  PM
Sbjct: 304 AHPFFSEVDFSSDIRTQPAPYVPKISHPM 332

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 50/291 (17%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT---EIRTLCEAPCNEGLVEFH 145
           I  G   VV RA    T  I+ALKK+   EKEK    +T   EI  L +   +  +V   
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQ-HPNIVTVK 70

Query: 146 GAFYMPDSGQISIALEYM--DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                 +  +I + +EY+  D  SL + ++      E  +  +  +LL G+++LH    +
Sbjct: 71  EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLHD-NWI 127

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYP 262
           +HRD+K +NLL+N +G  KI DFG++    + +      V T+ Y +PE +     YS  
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187

Query: 263 ADIWSIGLALFECGTGEF----PYAASEGPVNLMLQILED-------------------- 298
            D+WS+G     C   E     P    +  ++ + +I +                     
Sbjct: 188 IDMWSVG-----CIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242

Query: 299 -----PSPSPSRQNFSPEFCSFVD-DCLKK----DAEARPTADQLLSHPFI 339
                   +  R+ F     S    D L +    D   R +A+  L HP+ 
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 36/281 (12%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G  + V +  +  T  I+ALK+I++  +E      T IR  +L +   +E +V  H 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS--TAIREISLMKELKHENIVRLHD 65

Query: 147 AFYMPDSGQISIALEYMDGG--SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
             +  +  ++ +  EYMD       D   ++ ++    + S   +LL+G+++ H  R L 
Sbjct: 66  VIHTEN--KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL- 122

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPA 263
           HRD+KP NLL+N +G  K+ DFG++      +   +  V T+ Y +P+ +  + +YS   
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182

Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS--------------------P 301
           DIWS+G  + E  TG   FP   +E  +  + +I+  P+                    P
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYP 242

Query: 302 SPSRQNFSPEF----CSFVDDCLKKDAEARPTADQLLSHPF 338
               Q   P         +   L+ + E R +A   L HP+
Sbjct: 243 PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 66/305 (21%)

Query: 88  AIGSGASS--VVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVE 143
            IG       +V  A H PT+ ++A+KKIN+    KE    L  EI T      +  ++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIIT-SRQLQHPNILP 63

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +  +F      ++ +    M  GS  D+L+    + +PE  ++ + K +L  L Y+H  +
Sbjct: 64  YVTSFI--VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-K 120

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM------CATFVGTVTY------- 248
             +HR +K +++L++  G+  ++      GL  S++M                       
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLS------GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 249 MSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML---------QILE 297
           +SPE ++   + Y+  +DI+S+G+   E   G  P+   + P   ML          +L+
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF--KDMPATQMLLEKVRGTVPCLLD 232

Query: 298 ------------------------DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQL 333
                                   D    P  + FS  F  FV+ CL++D E+RP+A QL
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292

Query: 334 LSHPF 338
           L+H F
Sbjct: 293 LNHSF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 88.5 bits (219), Expect = 8e-20
 Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 13/239 (5%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           LKK  I  K++    LTE R L  +  +  L     +F   D  ++   +EY +GG L  
Sbjct: 28  LKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHD--RLCFVMEYANGGELFF 84

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-S 229
            L  ++   E        +++  L YLH  +++V+RD+K  NL+++  G  KITDFG+  
Sbjct: 85  HLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Query: 230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV 289
            G+++   M  TF GT  Y++PE + +  Y    D W +G+ ++E   G  P+   +   
Sbjct: 145 EGIKDGATM-KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203

Query: 290 NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPFITKYE 343
              L ++E+       +  SPE  S +   LKKD + R       A +++ H F     
Sbjct: 204 LFELILMEEIRFP---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 83/298 (27%), Positives = 130/298 (43%), Gaps = 54/298 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEK---EKRNQLLTEIRTLCEAPCNEGLVEF 144
           IGSGA  VV  A+   + + +A+KKI + F+     KR   L E++ L     ++ ++  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT--LRELKILRHFK-HDNIIAI 69

Query: 145 HGAFYMPDSGQISIALEYMD--GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
                 P +    + +  MD     L  I+   + + E  +     +LL+GL Y+H   +
Sbjct: 70  RDILRPPGADFKDVYV-VMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA-N 127

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF----VGTVTYMSPERIRN-E 257
           ++HRD+KP+NLLVN     +I DFG++ GL +S      F    V T  Y +PE + +  
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP 187

Query: 258 SYSYPADIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPS-------- 302
            Y+   D+WS+G     C   E       FP       + L+L +L  PS          
Sbjct: 188 EYTTAIDMWSVG-----CIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242

Query: 303 ---------PSRQ---------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                    P +Q           SPE    +   L+ D E R T +Q L HPF+ +Y
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 67/304 (22%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQLLT-------EIRTLCEAPCNE- 139
           +G GA  +V +A+   T  ++ALKKI + F    RN   T       EI  L E   +  
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAF----RNA--TDAQRTFREIMFLQELGDHPN 68

Query: 140 --GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQ 192
              L+    A    D   I +  EYM+     D   +   I   IL  + K+     LL+
Sbjct: 69  IVKLLNVIKAENDKD---IYLVFEYME----TD---LHAVIRANILEDVHKRYIMYQLLK 118

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-----SAGLENSIAMCATFVGTVT 247
            L Y+H   +++HRD+KP+N+L+N   R K+ DFG+              +   +V T  
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 248 YMSPE-RIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS---- 300
           Y +PE  + +  Y+   D+WS+G  L E   G+  FP  ++   +  +++++  PS    
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 301 ---------------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                          PS  R+         S +    +   L  +   R TA++ L HP+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 339 ITKY 342
           + ++
Sbjct: 298 VAQF 301

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 55/294 (18%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----------QLLTEIRTLCEAP 136
            +G G  +VV +A    T RI+A+KKI + E+++             +LL E++      
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------ 60

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI---PEPILSSMFKKLLQG 193
            +  ++     F       I++  E+M+   L  +++  KSI   P  I S M    L+G
Sbjct: 61  -HPNIIGLLDVF--GHKSNINLVFEFMET-DLEKVIK-DKSIVLTPADIKSYM-LMTLRG 114

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           L YLH    ++HRD+KP NLL+   G  K+ DFG++    +        V T  Y +PE 
Sbjct: 115 LEYLH-SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 254 IRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--------------- 297
           +     Y    D+WS+G    E      P+   +  ++ + +I E               
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 298 -------DPSPSPS-RQNF---SPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
                   P P    +Q F   S +    +   L  +   R TA Q L HP+ +
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 23/222 (10%)

Query: 133 CEAPCNE-GLVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIP--EPILSSMF 187
           C A C+  G+V+    F   D  ++ + +EY  GG L   +  R+++ +P  E  +  +F
Sbjct: 118 CLAACDHFGIVKHFDDFKSDD--KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF 175

Query: 188 KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM--CATFVGT 245
            +++  L  +H  R ++HRD+K AN+ +   G  K+ DFG S    +S+++   ++F GT
Sbjct: 176 YQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LMLQIL---EDPS 300
             Y++PE    + YS  AD+WS+G+ L+E  T   P+   +GP    +M Q+L    DP 
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGKYDPF 291

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           P P     S    + +D  L K+   RPT  QLL   F+ KY
Sbjct: 292 PCP----VSSGMKALLDPLLSKNPALRPTTQQLLHTEFL-KY 328

Length = 478

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 49/301 (16%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHR--IIALKKI-NIFEKE---KRNQLLTEIRTLC---EA 135
           +   +G GA  +V  A +  T     +A+KKI N+F K+   KR   L E++ L      
Sbjct: 4   LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA--LRELKLLRHFRGH 61

Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
                L +    F    +  + +  E M+   L  I+R  + + +    S   ++L GL 
Sbjct: 62  KNITCLYDMDIVFPGNFNE-LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLK 119

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-----ENSIAMCATFVGTVTYMS 250
           Y+H   +++HRD+KP NLLVN     KI DFG++ G      EN+  M   +V T  Y +
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATRWYRA 177

Query: 251 PE-RIRNESYSYPADIWSIG--LALFECGTGEFPYAASEGPVNLMLQILEDPSP------ 301
           PE  +  +SY+   D+WS+G  LA        F        +N +LQ+L  P        
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237

Query: 302 -SPSRQNF-------------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            SP  QN+                   +P     ++  L  D   R + ++ L HP++  
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297

Query: 342 Y 342
           +
Sbjct: 298 W 298

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 37/295 (12%)

Query: 77  RCAS-HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLC 133
           RC S  E      IG G   +V RA    +  I+ALKK+   + E+    ++ +R  TL 
Sbjct: 2   RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLL 60

Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEY--MDGGSLADILRMQKSIPEPILSSMFKKLL 191
               +  +VE            I + +EY   D  SL D   M     E  +  +  +LL
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD--NMPTPFSESQVKCLMLQLL 118

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
           +GL YLH    ++HRD+K +NLL+  KG  KI DFG++             V T+ Y +P
Sbjct: 119 RGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Query: 252 ERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS------ 302
           E +    +Y+   D+W++G  L E    +   P  +    ++L++Q+L  P+ S      
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237

Query: 303 --PSRQNFS----------PEF-------CSFVDDCLKKDAEARPTADQLLSHPF 338
             P    F+           +F          ++  L  D + R TA++ L   +
Sbjct: 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 73/239 (30%), Positives = 118/239 (49%), Gaps = 17/239 (7%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +  LKK  I + +     +TE R L  A  +  L + H  F   D  ++   +EY++GG 
Sbjct: 25  VKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEYVNGGD 82

Query: 168 LADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
           L  +  +Q+S    EP       +++ GL +LH  R +++RD+K  N+L++ +G  KI D
Sbjct: 83  L--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIAD 139

Query: 226 FGISA-GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA 284
           FG+   G+       +TF GT  Y++PE +  + Y    D W++G+ L+E   G+ P+  
Sbjct: 140 FGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198

Query: 285 SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR----PTADQ-LLSHPF 338
            +    L   ILED    P  +  S E  S +   L K+ E R    PT +Q +  HPF
Sbjct: 199 -DDEDELFQSILEDEVRYP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 86.9 bits (215), Expect = 3e-19
 Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 10/219 (4%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           L+K  I +K+++N ++ E   L +   +  LV  H +F   +  ++   L+Y++GG L  
Sbjct: 28  LQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDYVNGGELFF 85

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-S 229
            L+ ++   EP       ++   + YLH + ++++RD+KP N+L++ +G   +TDFG+  
Sbjct: 86  HLQRERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Query: 230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV 289
            G+E      +TF GT  Y++PE +R E Y    D W +G  L+E   G  P+ + +  V
Sbjct: 145 EGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--V 201

Query: 290 NLMLQ-ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           + M   IL  P   P  +  +   C  +   L KD   R
Sbjct: 202 SQMYDNILHKPLQLPGGKTVAA--CDLLVGLLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 35/283 (12%)

Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVEF 144
             IG G+  VV +  +  T +I+A+KK    E +   +   L EIR L +   +  LV  
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNL 65

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              F      ++ +  EY D   L ++ +  + +PE ++  +  + LQ +++ H   + +
Sbjct: 66  IEVFRR--KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCI 122

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPA 263
           HRD+KP N+L+  +G+ K+ DFG +  L         +V T  Y +PE +  ++ Y  P 
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182

Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILED--------------------PSP 301
           D+W+IG    E  TG+  +P  +    + L+ + L D                    P P
Sbjct: 183 DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEP 242

Query: 302 SPSR------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                      N S    SF+  CL+ D   R + ++LL HP+
Sbjct: 243 ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 86.2 bits (213), Expect = 5e-19
 Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 14/234 (5%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           L+K  I  K++    +TE R L +   +  L     AF   D  ++   +EY +GG L  
Sbjct: 28  LRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTALKYAFQTHD--RLCFVMEYANGGELFF 84

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-S 229
            L  ++   E        +++  L YLH  R +V+RDIK  NL+++  G  KITDFG+  
Sbjct: 85  HLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Query: 230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV 289
            G+ +   M  TF GT  Y++PE + +  Y    D W +G+ ++E   G  P+  ++   
Sbjct: 144 EGISDGATM-KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE 201

Query: 290 NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPF 338
            L   IL +    P  +  SPE  S +   LKKD + R       A +++ H F
Sbjct: 202 RLFELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 81/316 (25%), Positives = 119/316 (37%), Gaps = 77/316 (24%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT---EIRTL------CE 134
            I G +G G    V +A  I T R++ALKKI +   EK    +T   EI+ L        
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 135 APCNEGLVEFH-------GAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSM 186
            P  +  VE         G+ YM           YMD   L+ +L      + E  +   
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYM--------VTPYMDH-DLSGLLENPSVKLTESQIKCY 120

Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG-- 244
             +LL+G++YLH   H++HRDIK AN+L++ +G  KI DFG++   +          G  
Sbjct: 121 MLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 245 -------TVT--YMSPERIRNE-SYSYPADIWSIGLALFECGTGEF----PYAASEGPVN 290
                   VT  Y  PE +  E  Y+   DIW IG     C   E     P    +  ++
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-----CVFAEMFTRRPILQGKSDID 234

Query: 291 ---LMLQILEDPSP-----------------SPSRQN--------FSPEFCSFVDDCLKK 322
              L+ ++   P+                    +             PE    +   L  
Sbjct: 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294

Query: 323 DAEARPTADQLLSHPF 338
           D   R TA   L HP+
Sbjct: 295 DPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.3 bits (211), Expect = 6e-19
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 15/188 (7%)

Query: 163 MDGGSLA----DILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK 218
           M+GG L     ++       PEP       +++ GL +LH  R +++RD+KP N+L++  
Sbjct: 75  MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDND 133

Query: 219 GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG 278
           G  +I+D G++  L++  +    + GT  +M+PE ++ E Y +  D +++G+ L+E    
Sbjct: 134 GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193

Query: 279 EFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTA 330
             P+ A    V    L  +IL D    P +  FSP   SF +  L KD E R        
Sbjct: 194 RGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNC 251

Query: 331 DQLLSHPF 338
           D L +HP 
Sbjct: 252 DGLRTHPL 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 88.3 bits (218), Expect = 7e-19
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 43/294 (14%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPC 137
           +E  +   IG+G    V    H  T      K I+   + E+EK +QL+ E+  + E   
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELK- 70

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLA----DILRMQKSIPEPILSSMFKKLLQG 193
           ++ +V +   F    + ++ I +E+ D G L+       +M   I E  +  + ++LL  
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 194 LSYLHGVR------HLVHRDIKPANLLV---------------NLKGRP--KITDFGISA 230
           L+Y H ++       ++HRD+KP N+ +               NL GRP  KI DFG+S 
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 231 --GLENSIAMCATFVGTVTYMSPERIRNESYSY--PADIWSIGLALFECGTGEFPYAASE 286
             G+E   +M  + VGT  Y SPE + +E+ SY   +D+W++G  ++E  +G+ P+  + 
Sbjct: 191 NIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Query: 287 GPVNLMLQILEDPS-PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
               L+ ++   P  P   +   S E    + + L   A+ RP+A Q L +  I
Sbjct: 248 NFSQLISELKRGPDLPIKGK---SKELNILIKNLLNLSAKERPSALQCLGYQII 298

Length = 1021

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 85.9 bits (212), Expect = 7e-19
 Identities = 68/248 (27%), Positives = 120/248 (48%), Gaps = 14/248 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+ + V         +I A+K +    + + E  + + TE     +A  N  LV  H
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F    + ++ + +EY++GG L   ++ Q+ +PE        ++   L++LH  R +++
Sbjct: 63  SCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-RGIIY 119

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  N+L++  G  K+TD+G+           +TF GT  Y++PE +R E Y +  D 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 266 WSIGLALFECGTGEFPY-AASEGP-VN----LMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           W++G+ +FE   G  P+   ++ P +N    L   ILE P   P  +  S +    +   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLKGF 237

Query: 320 LKKDAEAR 327
           L KD + R
Sbjct: 238 LNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 8/198 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+ + V       T RI A+K I    + + E  + + TE      A  +  LV  H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F      ++   +E++ GG L   ++ Q+ +PE        ++   L++LH  R +++
Sbjct: 63  SCFQTE--SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE-RGIIY 119

Query: 206 RDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           RD+K  N+L++ +G  K+TD+G+   G+       +TF GT  Y++PE +R E Y +  D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVD 178

Query: 265 IWSIGLALFECGTGEFPY 282
            W++G+ +FE   G  P+
Sbjct: 179 WWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 70/250 (28%), Positives = 120/250 (48%), Gaps = 16/250 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+ + V       T RI A+K +    + + E  + + TE     +A  +  LV  H
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F      ++   +EY++GG L   ++ Q+ +PE        ++   L+YLH  R +++
Sbjct: 63  SCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIY 119

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  N+L++ +G  K+TD+G+           +TF GT  Y++PE +R E Y +  D 
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 266 WSIGLALFECGTGEFPY---AASEGPVN-----LMLQILEDPSPSPSRQNFSPEFCSFVD 317
           W++G+ +FE   G  P+    +S+ P       L   ILE     P  ++ S +  S + 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLK 237

Query: 318 DCLKKDAEAR 327
             L KD + R
Sbjct: 238 SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 18/236 (7%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           LKK  I  K++    LTE R L +   +  L     +F   D  ++   +EY +GG L  
Sbjct: 28  LKKEVIIAKDEVAHTLTESRVL-QNTRHPFLTALKYSFQTHD--RLCFVMEYANGGELFF 84

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA 230
            L  ++   E        +++  L YLH    +V+RD+K  NL+++  G  KITDFG+  
Sbjct: 85  HLSRERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Query: 231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN 290
              +  A   TF GT  Y++PE + +  Y    D W +G+ ++E   G  P+   +    
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Query: 291 LMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPF 338
             L ++E+   P         SPE  S +   LKKD + R       A +++ H F
Sbjct: 204 FELILMEEIRFPR------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 34/269 (12%)

Query: 111 LKKINIFEKEK-------RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           LKK  I +K K         Q+L  IR   ++P    LV  H AF      ++ + L+Y+
Sbjct: 36  LKKATIVQKAKTTEHTRTERQVLEHIR---QSPF---LVTLHYAFQT--DTKLHLILDYI 87

Query: 164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI 223
           +GG L   L  ++   E  +     +++  L +LH +  +++RDIK  N+L++  G   +
Sbjct: 88  NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVL 146

Query: 224 TDFGISAG-LENSIAMCATFVGTVTYMSPERIR--NESYSYPADIWSIGLALFECGTGEF 280
           TDFG+S    E+ +    +F GT+ YM+P+ +R  +  +    D WS+G+ ++E  TG  
Sbjct: 147 TDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206

Query: 281 PYAASEGPVN----LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR----PT-AD 331
           P+   +G  N    +  +IL+   P P  Q  S      +   L KD + R    P+ AD
Sbjct: 207 PFTV-DGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDAD 263

Query: 332 QLLSHPFITKYEHAKVDLAA-FVRSVFDP 359
           ++  HPF  K      DLAA  V + F P
Sbjct: 264 EIKKHPFFQKINWD--DLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 48/296 (16%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKE---KRNQLLTEIRTLCEAPCNEGLVE 143
            +GSGA   V  A    T R +A+KK++  F+     KR     E+R L +   +E ++ 
Sbjct: 22  PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR--TYRELRLL-KHMDHENVIG 78

Query: 144 FHGAFYMPDSG-----QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
               F  P S       + +    M G  L +I++ QK   + I   +  ++L+GL Y+H
Sbjct: 79  LLDVFT-PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHI-QFLVYQILRGLKYIH 135

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE- 257
               ++HRD+KP+N+ VN     KI DFG++   ++ +     +V T  Y +PE + N  
Sbjct: 136 SA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 191

Query: 258 SYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS--------------- 300
            Y+   DIWS+G  + E  TG+  FP +     +  ++ ++  P                
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251

Query: 301 ----PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
               P   +++F       +P     ++  L  D + R TA + L+HP++ +Y   
Sbjct: 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 53/199 (26%), Positives = 99/199 (49%), Gaps = 3/199 (1%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           ++ G    G   + +R +    + +  L+K  +  ++++  ++ E   L +   +  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            H +F   +  ++   L++++GG L   L+ ++S PEP       ++   L YLH +  +
Sbjct: 61  LHYSFQTTE--KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-I 117

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           V+RD+KP N+L++ +G   +TDFG+            TF GT  Y++PE IR + Y    
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177

Query: 264 DIWSIGLALFECGTGEFPY 282
           D W +G  L+E   G  P+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 21/298 (7%)

Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNE 139
           +++ G  G G    V++     T +I A   LKK  I   +K        R + EA  + 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +V+   AF     G++ + LEY+ GG L   L  +    E        ++   L +LH 
Sbjct: 61  FIVDLIYAFQT--GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            + +++RD+KP N+L++ +G  K+TDFG+     +   +  TF GT+ YM+PE +    +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
               D WS+G  +++  TG  P+ A E     + +IL+     P     +PE    +   
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKLNLPPY--LTPEARDLLKKL 234

Query: 320 LKKDAEAR-----PTADQLLSHPFITKYEHAKVD--LAAFVRSVFDPMQRMKDLADVS 370
           LK++  +R       A ++ SHPF   + H   D  LA  V   F P+ + ++  DVS
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPF---FRHVNWDDLLARKVEPPFKPLLQSEE--DVS 287

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 90/315 (28%), Positives = 138/315 (43%), Gaps = 68/315 (21%)

Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR------ 130
           RC      I G IG G    V +A    T  ++ALKK+ + + EK    +T IR      
Sbjct: 4   RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-DNEKEGFPITAIREIKILR 61

Query: 131 --------TLCEAPCN-EGLVEFH---GAFYMPDSGQISIALEYMDGGSLADILRMQKS- 177
                    L E   + +  ++F    GAFY+          EYMD     D++ + +S 
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL--------VFEYMD----HDLMGLLESG 109

Query: 178 ---IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN 234
                E  + S  K+LL+GL+Y H  ++ +HRDIK +N+L+N KG+ K+ DFG+ A L N
Sbjct: 110 LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYN 167

Query: 235 S--IAMCATFVGTVTYMSPERIRNESYSYPA-DIWSIGLALFECGTGEFPYAASE--GPV 289
           S         V T+ Y  PE +  E    PA D+WS G  L E  T +  + A++    +
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227

Query: 290 NLMLQILEDPSPS--PS--------------------RQNFS---PEFCSFVDDCLKKDA 324
            L+ ++   P P+  P                     R+ FS         +D  L  D 
Sbjct: 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP 287

Query: 325 EARPTADQLLSHPFI 339
             R TA++ L+ P++
Sbjct: 288 SKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 26/267 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNE-GLVEFH 145
           +GSGA+  V  A  +      A+K +++    +  +N+   E+   C   C+   +V+ H
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVC--CLLNCDFFSIVKCH 97

Query: 146 GAFYMPDSGQ------ISIALEYMDGGSLADILRMQKSIPEPILSS----MFKKLLQGLS 195
             F   D         I++ L+Y + G L   ++ +              +F ++L  + 
Sbjct: 98  EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH 157

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPER 253
           ++H  +H++HRDIK AN+L+   G  K+ DFG S     +++  +  TF GT  Y++PE 
Sbjct: 158 HVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSP 310
            R + YS  AD++S+G+ L+E  T + P+   E    +M + L    DP P     + SP
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDPLPP----SISP 271

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHP 337
           E    V   L  D + RP++ +LL+ P
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 9/194 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +  +  T +I+A+KKI + E E+     T IR  +L +   +  +V    
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL-ESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 147 AFYMPDSGQISIALEY--MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                   ++ +  E+  MD     D L   + +   ++ S   ++LQG+ + H  R ++
Sbjct: 67  VLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVL 123

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPA 263
           HRD+KP NLL++ KG  K+ DFG++      + +    V T+ Y +PE +     YS P 
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183

Query: 264 DIWSIGLALFECGT 277
           DIWSIG    E  T
Sbjct: 184 DIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 83/310 (26%), Positives = 141/310 (45%), Gaps = 38/310 (12%)

Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEK-------RNQLLTEIRTL 132
           +++ G    G   +V++     T ++ A   L+K  + +K K          +L  +R  
Sbjct: 5   LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-- 62

Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
            ++P    LV  H AF      ++ + L+Y+ GG +   L  + +  E  +     +++ 
Sbjct: 63  -QSPF---LVTLHYAFQT--EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL 116

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG-LENSIAMCATFVGTVTYMSP 251
            L +LH +  +V+RDIK  N+L++ +G   +TDFG+S   L        +F GT+ YM+P
Sbjct: 117 ALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 252 ERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVN----LMLQILEDPSPSPSRQ 306
           E IR +  +    D WS+G+ +FE  TG  P+   EG  N    +  +IL+   P PS  
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL-EGERNTQSEVSRRILKCDPPFPSF- 233

Query: 307 NFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPFITKYEHAKVDLAAF-VRSVFDPM 360
              PE    +   L+KD + R       A ++  HPF    +     LA   V   F P 
Sbjct: 234 -IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW--EALALRKVNPPFRP- 289

Query: 361 QRMKDLADVS 370
             +++  DV 
Sbjct: 290 -SIRNELDVG 298

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 13/265 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V +     T RI ALK   K +I  + +    L E RT+        +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAE-RTVLAQVNCPFIVPLK 59

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F  P   ++ + L +++GG L   L+ +             +LL  L  LH   ++++
Sbjct: 60  FSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF-NVIY 116

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+KP N+L++ +G   + DFG+            TF GT  Y++PE +    Y+   D 
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           W++G+ L+E  TG  P+        +  +IL++P   P    F  +    +   L +D  
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVN-EMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPT 233

Query: 326 AR---PTADQLLSHPFITKYEHAKV 347
            R     A ++ +HPF ++    K+
Sbjct: 234 RRLGYNGAQEIKNHPFFSQLSWKKL 258

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 7/214 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A H    +  A+K   K  I +K++   +++E   L +   +  LV  H
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D  ++   L+Y++GG L   L+ ++   EP       ++   L YLH + ++V+
Sbjct: 63  FSFQTAD--KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL-NIVY 119

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+KP N+L++ +G   +TDFG+           +TF GT  Y++PE +  + Y    D 
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDP 299
           W +G  L+E   G  P+  S     +   IL  P
Sbjct: 180 WCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKP 212

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 12/212 (5%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL--LTEIRTLCEAPCNE 139
           +  I   IG GA   V         ++ A+K +N +E  KR +     E R +     N+
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLH 198
            +   H AF   D   + + ++Y  GG L  +L + +  +PE +      +++  +  +H
Sbjct: 62  WITTLHYAF--QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIR-- 255
            + H VHRDIKP N+L+++ G  ++ DFG    L E+     +  VGT  Y+SPE ++  
Sbjct: 120 QL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 256 ---NESYSYPADIWSIGLALFECGTGEFPYAA 284
                 Y    D WS+G+ ++E   GE P+ A
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 68/285 (23%), Positives = 129/285 (45%), Gaps = 28/285 (9%)

Query: 66  ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVH----IPTHRIIALKKINIFEKEK 121
           +D +   ++  +    +      +G+G+   V  A +     P   I   +K  I ++++
Sbjct: 15  SDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74

Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
            + + +E R +     +   V  +G+F   D   + + LE++ GG     LR  K  P  
Sbjct: 75  VDHVFSE-RKILNYINHPFCVNLYGSF--KDESYLYLVLEFVIGGEFFTFLRRNKRFPND 131

Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT 241
           +      +++    YL  + ++V+RD+KP NLL++  G  K+TDFG +  ++       T
Sbjct: 132 VGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY---T 187

Query: 242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP 301
             GT  Y++PE + N  +   AD W++G+ ++E   G  P+ A+E P+ +  +ILE    
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-PLLIYQKILEGII- 245

Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK 346
                 + P+F          D   +    +LLSH    +Y + K
Sbjct: 246 ------YFPKFL---------DNNCKHLMKKLLSHDLTKRYGNLK 275

Length = 340

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 87/350 (24%), Positives = 140/350 (40%), Gaps = 78/350 (22%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ---LLTEIRTLCEAPCNEGLVEFH 145
           IG GA   V     + T+ + A+K +   +   RNQ   +  E   L EA  NE +V+ +
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D   +   ++Y+ GG +  +L       E +      +L   +  +H +   +H
Sbjct: 68  YSF--QDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM-GFIH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLE-------------------------NSIAMCA 240
           RDIKP N+L++  G  K+TDFG+  G                           + I  C 
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184

Query: 241 ------------------TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
                             + VGT  Y++PE +    Y+   D WS+G+ L+E   G+ P+
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Query: 283 AASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR---PTADQLLSHP 337
            A + P    L+++  E     PS+   S E  S +   L   AE R     AD++ +HP
Sbjct: 245 LA-DTPAETQLKVINWETTLHIPSQAKLSRE-ASDLILRLCCGAEDRLGKNGADEIKAHP 302

Query: 338 FITKYEHAKVDLAAFVR----------------SVFDPMQRMKDLADVST 371
           F        +D A+ +R                S FDP+   K  +D S 
Sbjct: 303 FF-----KGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSG 347

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 49/191 (25%), Positives = 94/191 (49%), Gaps = 16/191 (8%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN- 216
           + ++Y+  G L D+L+ +  + E  +  + ++L++ L+ LH   +++H DIK  N+L + 
Sbjct: 86  LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDR 144

Query: 217 LKGRPKITDFGIS--AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
            K R  + D+G+    G        + + GT+ Y SPE+I+  +Y    D W++G+  +E
Sbjct: 145 AKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYE 198

Query: 275 CGTGEFPYAASEGP---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-PTA 330
             TG+ P+   E     +  +L+  +   P     N S     FV   LK +   R    
Sbjct: 199 LLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK--NVSKNANDFVQSMLKYNINYRLTNY 256

Query: 331 DQLLSHPFITK 341
           ++++ HPF+  
Sbjct: 257 NEIIKHPFLKI 267

Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 11/186 (5%)

Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+  + I   I  L  M  ++ +G++++   ++ +HRD++ AN+
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANI 133

Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 191

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE     P   N   E    +  C K+  E RPT
Sbjct: 192 LLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT 249

Query: 330 ADQLLS 335
            + L S
Sbjct: 250 FEYLRS 255

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 79/294 (26%), Positives = 137/294 (46%), Gaps = 24/294 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  A    + R+ A   LKK  I + +     +TE R L  A  +  L + +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHL 203
             F  PD  ++   +E+++GG L  +  +QKS    E        ++   L +LH  + +
Sbjct: 63  CCFQTPD--RLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHD-KGI 117

Query: 204 VHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+K  N+L++ +G  K+ DFG+   G+ N     +TF GT  Y++PE ++   Y   
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTPDYIAPEILQEMLYGPS 176

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ L+E   G  P+ A E   +L   IL D    P+    S +    +   + K
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTW--LSQDAVDILKAFMTK 233

Query: 323 DAEARPTA------DQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVS 370
           +   R  +      + +L HPF  + +  K++    +   F P  R+K   DVS
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQ-IEPPFRP--RIKSREDVS 284

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 20/289 (6%)

Query: 82  EMRIFGAIGSGASSVVQ-RAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCN 138
           + R+ G  G G     Q RA    T ++ A KK+     +K K   +    + + E   +
Sbjct: 4   QYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLA-DILRM-QKSIPEPILSSMFKKLLQGLSY 196
             +V    A+   D+  + + L  M+GG L   I  M +    E        ++  GL  
Sbjct: 60  RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           LH  R +V+RD+KP N+L++  G  +I+D G++  +     +    VGTV YM+PE ++N
Sbjct: 118 LHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKN 175

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSF 315
           E Y++  D W++G  L+E   G+ P+   +  +    ++ L         + FSP+  S 
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 316 VDDCLKKDAEAR-----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDP 359
               L KD + R       A ++  HP   +    +++ A  +   F P
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLE-AGMLEPPFKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.7 bits (202), Expect = 9e-17
 Identities = 70/258 (27%), Positives = 110/258 (42%), Gaps = 43/258 (16%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I   IG G    V  A      R +ALKKI   E    N LL + R L EA     L+  
Sbjct: 6   IIRLIGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSENPLLKK-RFLREAKIAADLI-- 60

Query: 145 HGAFYMP------DSGQISIALEYMDGGSLADILR---MQKSIPEPI--------LSSMF 187
           H    +P      D   +   + Y++G +L  +L+    ++S+ + +          S+F
Sbjct: 61  HPGI-VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 188 KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG--------------ISAGLE 233
            K+   + Y+H  + ++HRD+KP N+L+ L G   I D+G              I     
Sbjct: 120 HKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 234 NSIAMCAT----FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV 289
           N      T     VGT  YM+PER+     S   DI+++G+ L++  T  FPY   +G  
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 290 NLMLQILEDPSP-SPSRQ 306
                ++  P   +P R+
Sbjct: 239 ISYRDVILSPIEVAPYRE 256

Length = 932

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ---LLTEIRTLCEAPCN 138
           +  I   IG GA   V       T RI A+K +N +E  KR +      E   L    C 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC- 60

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYL 197
           + +   H AF   D   + + ++Y  GG L  +L + +  +PE +      +++  +  +
Sbjct: 61  QWITTLHYAF--QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIRN 256
           H + H VHRDIKP N+L+++ G  ++ DFG    + ++     +  VGT  Y+SPE ++ 
Sbjct: 119 HQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 257 ES-----YSYPADIWSIGLALFECGTGEFPYAA 284
                  Y    D WS+G+ ++E   GE P+ A
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 60/187 (32%), Positives = 88/187 (47%), Gaps = 13/187 (6%)

Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+    K +  P L  M  ++ +G++YL   R+ +HRD+   N+
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNI 134

Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      KI DFG++  +E+        A F   + + +PE      ++  +D+WS G+
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSDVWSFGI 192

Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
            L E  T G  PY    G  N  +L+ +E     P   N   E    +  C  KD E RP
Sbjct: 193 LLTEIVTYGRVPY---PGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERP 249

Query: 329 TADQLLS 335
           T + L S
Sbjct: 250 TFEYLQS 256

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 12/235 (5%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           LKK  I  K++    LTE R L +   +  L     +F   D  ++   +EY++GG L  
Sbjct: 28  LKKEVIIAKDEVAHTLTESRVL-KNTRHPFLTSLKYSFQTKD--RLCFVMEYVNGGELFF 84

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA 230
            L  ++   E        +++  L YLH  + +V+RD+K  NL+++  G  KITDFG+  
Sbjct: 85  HLSRERVFSEDRTRFYGAEIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCK 143

Query: 231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN 290
                 A   TF GT  Y++PE + +  Y    D W +G+ ++E   G  P+   +    
Sbjct: 144 EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Query: 291 LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPFIT 340
             L ++ED       +  S +  S +   L KD   R       A +++ H F T
Sbjct: 204 FELILMEDIKFP---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 73/263 (27%), Positives = 115/263 (43%), Gaps = 21/263 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTE----IRT-LCEAPCNEG 140
           IG G    V +     T RI A+K ++   I  K++    + E    +RT L E+P   G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           L      F       + +  +YM GG L   L+ +    E        +L+  L +LH  
Sbjct: 61  L-----KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK- 114

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-Y 259
             +V+RD+KP N+L++  G   + DFG+S           TF GT  Y++PE + +E  Y
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           +   D WS+G+ +FE   G  P+ A +     M + +        +   S E   FV   
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232

Query: 320 LKKDAEAR----PTADQLLSHPF 338
           L ++ + R      A +L  HPF
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 15/226 (6%)

Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTL 132
           ++ +  EM     +G+G+   V+ A H  T    A   LKK  I + ++   +  E   L
Sbjct: 15  WKLSDFEMG--ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL 72

Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
            E   +  +V    +F   D  ++   LE++ GG L   LR     P  +      +L+ 
Sbjct: 73  MEL-SHPFIVNMMCSFQ--DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSP 251
              YLH  + +++RD+KP NLL++ KG  K+TDFG +  + + +  +C    GT  Y++P
Sbjct: 130 AFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAP 184

Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
           E I+++ +    D W++G+ L+E   G  P+   + P  +  +IL 
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF-FDDTPFRIYEKILA 229

Length = 329

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 47/289 (16%)

Query: 89  IGSGASSVVQRAVHIPTH-RIIALKKINIFEKEKRNQLLTEIRTLC--------EAPCNE 139
           IG GA   V +A  +    R +ALK++ + +  +    L+ IR +         E P   
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP-----ILSSMFKKLLQGL 194
            L +           ++++  E++D     D+      +PEP      +  M  +LL+GL
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI 254
            +LH  R +VHRD+KP N+LV   G+ K+ DFG+ A + +      + V T+ Y +PE +
Sbjct: 124 DFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAPEVL 181

Query: 255 RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL--------ED-------- 298
              SY+ P D+WS+G    E    + P       V+ + +IL        ED        
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240

Query: 299 -----PSPSPSRQNFSPEFCSFVDD----CLKKDAEARPTADQLLSHPF 338
                   +   + F  +      D    CL  +   R +A   LSHP+
Sbjct: 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 48/287 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 147 AFYMPDSGQISIALE--------YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             +     ++ +  E        +MD   L+        IP P++ S   +LLQGL++ H
Sbjct: 67  VIH--TENKLYLVFEFLHQDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCH 117

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-E 257
             R ++HRD+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   +
Sbjct: 118 SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 258 SYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS--------------- 300
            YS   DIWS+G    E  T    FP  +    +  + + L  P                
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236

Query: 301 --PSPSRQNFS-------PEFCSFVDDCLKKDAEARPTADQLLSHPF 338
             P  +RQ+FS        +    +   L  D   R +A   L+HPF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 62/189 (32%), Positives = 92/189 (48%), Gaps = 16/189 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A    T  I+ALKKI + E E      T IR  +L +   +  +V    
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILS-SMFKK----LLQGLSYLHGVR 201
             +     ++ +  E++D     D+ +   S P   L   + K     LLQG++Y H  R
Sbjct: 66  VVH--SENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE-RIRNESYS 260
            L HRD+KP NLL++ +G  K+ DFG++      +      V T+ Y +PE  + +  YS
Sbjct: 120 VL-HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS 178

Query: 261 YPADIWSIG 269
            P DIWSIG
Sbjct: 179 TPVDIWSIG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 18/271 (6%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I  LKK  I + +  +  +TE R L  A  +  L   H  F   D  ++   +EY++GG 
Sbjct: 25  IKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEYVNGGD 82

Query: 168 LADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDF 226
           L   ++  +   EP       ++   L +LH  RH +++RD+K  N+L++ +G  K+ DF
Sbjct: 83  LMFQIQRSRKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADF 140

Query: 227 GISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE 286
           G+      +     TF GT  Y++PE ++   Y    D W++G+ ++E   G+ P+ A +
Sbjct: 141 GMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-D 199

Query: 287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-------PTADQLLSHPFI 339
              +L   IL D    P     S E  S +   + K+   R          D +  HPF 
Sbjct: 200 NEDDLFESILHDDVLYPVW--LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257

Query: 340 TKYEHAKVDLAAFVRSVFDPMQRMKDLADVS 370
            + +   ++    ++  F P  ++K   DV+
Sbjct: 258 KEIDWVLLE-QRKIKPPFKP--KIKTKRDVN 285

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 22/226 (9%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVE 143
              +G G  + V +     T  ++ALK+I +  +E      T IR  +L +   +  +V 
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVT 67

Query: 144 FHGAFYMPDSGQISIALEYMDGG------SLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
            H   +      +++  EY+D        +  +++ M       +   MF+ LL+GLSY 
Sbjct: 68  LHDIIHTERC--LTLVFEYLDSDLKQYLDNCGNLMSMHN-----VKIFMFQ-LLRGLSYC 119

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  R ++HRD+KP NLL+N KG  K+ DFG++          +  V T+ Y  P+ +   
Sbjct: 120 HK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 258 S-YSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS 300
           + YS P D+W +G  L+E  TG   FP +  +  ++L+ ++L  P+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPT 224

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 14/194 (7%)

Query: 158 IALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + L  M+GG L   +         E        ++  GL  LH  R +V+RD+KP N+L+
Sbjct: 77  LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER-IVYRDLKPENILL 135

Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC 275
           +  G  +I+D G++  +     +    VGTV YM+PE ++NE Y++  D W +G  ++E 
Sbjct: 136 DDYGHIRISDLGLAVEIPEGETIRGR-VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194

Query: 276 GTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR----- 327
             G+ P+   +  V    +  ++ ED      +  FS    S     L KD   R     
Sbjct: 195 IEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--FSEAARSICRQLLTKDPGFRLGCRG 252

Query: 328 PTADQLLSHPFITK 341
             A+++ +HPF   
Sbjct: 253 EGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 11/186 (5%)

Query: 156 ISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  +   +  P L     ++ +G++Y+   ++ +HRD++ AN+
Sbjct: 76  IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANV 134

Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   S++  +D+WS G+
Sbjct: 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 192

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L+E  T G+ PY       + ++  L+     P  +N   E    +  C K+ AE RPT
Sbjct: 193 LLYEIVTYGKIPYPGMSN--SDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250

Query: 330 ADQLLS 335
            D L S
Sbjct: 251 FDYLQS 256

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 85/334 (25%), Positives = 134/334 (40%), Gaps = 83/334 (24%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG GA   V+      T  I A   L+K  + EKE+   +  E   L EA     +V+ +
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP-WVVKLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKS----------IPEPILS--SMFKKLLQG 193
            +F   D   + + +EY+ GG +  +L M+K           I E IL+  S+ K     
Sbjct: 68  YSF--QDENYLYLIMEYLPGGDMMTLL-MKKDTFTEEETRFYIAETILAIDSIHK----- 119

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE-------------------- 233
           L Y       +HRDIKP NLL++ KG  K++DFG+  GL+                    
Sbjct: 120 LGY-------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 234 ------------------NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC 275
                             N  A+  + VGT  Y++PE      Y+   D WS+G+ ++E 
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 276 GTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPE----FCSFVDDCLKKDAEARPT 329
             G +P   S+ P     +I+  ++    P     SPE           C  +       
Sbjct: 233 LVG-YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC--CEAERRLGNNG 289

Query: 330 ADQLLSHPFI--TKYEHAKVDLAAF---VRSVFD 358
            +++ SHPF     +EH +   A     ++S+ D
Sbjct: 290 VNEIKSHPFFKGVDWEHIRERPAPIIPELKSITD 323

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 43/290 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNEGLVEF 144
           IG GA  +V  A +  T+  +A+KKI N F+     KR   L EI+ L     +E ++  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT--LREIKLLRHLD-HENVIAI 69

Query: 145 HGAFYMPDSGQIS---IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
                 P     +   I  E MD   L  I+R  +++ +        +LL+GL Y+H   
Sbjct: 70  KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA- 127

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNES-Y 259
           +++HRD+KP+NLL+N     KI DFG++    E    M   +V T  Y +PE + N S Y
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVTRWYRAPELLLNCSEY 186

Query: 260 SYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----------------- 300
           +   D+WS+G    E    +  FP       + L+ ++L  PS                 
Sbjct: 187 TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR 246

Query: 301 --PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITK 341
             P   RQ+F+  F          ++  L  D   R T ++ L+HP++  
Sbjct: 247 SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 48/290 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT--EIRTL-----CEAPCNEGL 141
           IG GA   V +A    +   +ALK + +   E    L T  E+  L      + P    L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPIL-----SSMFKKLLQGLSY 196
           ++           ++++  E++D     D+      +P P L       + ++ L+GL +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           LH    +VHRD+KP N+LV   G+ K+ DFG++      +A+    V T+ Y +PE +  
Sbjct: 124 LHANC-IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPEVLLQ 181

Query: 257 ESYSYPADIWSIGLALFE--------CGTGEFPYAASEGPVNLMLQI-LEDPSP---SPS 304
            +Y+ P D+WS+G    E        CG  E   A   G +  ++ +  ED  P   +  
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGLPPEDDWPRDVTLP 238

Query: 305 RQNFSPEFCSFVDDC---------------LKKDAEARPTADQLLSHPFI 339
           R  FSP     V                  L  +   R +A + L HPF 
Sbjct: 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 76/317 (23%), Positives = 129/317 (40%), Gaps = 69/317 (21%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL---TEIRTLCEAPCNEGLVEFH 145
           +G GA   V  A  + T  + A+K +   +   RNQ+     E   L EA  NE +V  +
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D   +   ++Y+ GG +  +L      PE +      +L   +  +H +   +H
Sbjct: 68  YSF--QDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-GFIH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAG---------------------------------- 231
           RDIKP N+L++  G  K+TDFG+  G                                  
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184

Query: 232 -------LENSIA------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG 278
                  LE   A      +  + VGT  Y++PE +    Y+   D WS+G+ L+E   G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244

Query: 279 EFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPE-------FCSFVDDCLKKDAEARPT 329
           + P+ A + P+   ++++  +     P +   SPE        C   +D L K+      
Sbjct: 245 QPPFLA-QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG----- 298

Query: 330 ADQLLSHPFITKYEHAK 346
           AD++ +HPF    + + 
Sbjct: 299 ADEIKAHPFFKTIDFSS 315

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 56/186 (30%), Positives = 93/186 (50%), Gaps = 11/186 (5%)

Query: 156 ISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E+M  GSL D L+  +    P P L     ++ +G++++   R+ +HRD++ AN+
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANI 133

Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   S++  +D+WS G+
Sbjct: 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 191

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   +++ LE     P  +N   E  + +  C K   E RPT
Sbjct: 192 LLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249

Query: 330 ADQLLS 335
            + + S
Sbjct: 250 FEYIQS 255

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 16/239 (6%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG--LVEFHGAFYMPDSGQISIALEYMDG 165
           I ALKK +I  +++   L+ E R    A       LV     F   D   +   +EY  G
Sbjct: 29  IKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH--VCFVMEYAAG 86

Query: 166 GSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKIT 224
           G L  ++ +   +  EP        ++ GL YLH    +V+RD+K  NLL++ +G  KI 
Sbjct: 87  GDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIA 143

Query: 225 DFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA 284
           DFG+           +TF GT  +++PE +   SY+   D W +G+ ++E   GE P+  
Sbjct: 144 DFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203

Query: 285 SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPF 338
            +    +   I+ D    P  +  S E  S +   L+++ E R       A+ +   PF
Sbjct: 204 DDEE-EVFDSIVNDEVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 3/175 (1%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I  LKK  I + +     + E R L        L + H  F   D  ++   +EY++GG 
Sbjct: 30  IKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYFVMEYVNGGD 87

Query: 168 LADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG 227
           L   ++      EP       ++  GL +LH  + +++RD+K  N++++ +G  KI DFG
Sbjct: 88  LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFG 146

Query: 228 ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           +            TF GT  Y++PE I  + Y    D W+ G+ L+E   G+ P+
Sbjct: 147 MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 44/291 (15%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNE--GL 141
            +GSGA   V  A+   T   +A+KK+   F+ E   KR     E+R L         GL
Sbjct: 22  QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR--AYRELRLLKHMKHENVIGL 79

Query: 142 VE-FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           ++ F     +       + + +M G  L  +++ +K + E  +  +  ++L+GL Y+H  
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKYIHAA 137

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESY 259
             ++HRD+KP NL VN     KI DFG++   ++ +     +V T  Y +PE I N   Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM---TGYVVTRWYRAPEVILNWMHY 193

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLM--LQILEDPS----------------- 300
           +   DIWS+G  + E  TG+  +   +    LM  +++   PS                 
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 301 --PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
             P   +++F       +P   + ++  L  DAE+R TA + L+HP+  ++
Sbjct: 254 KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 23/240 (9%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I ALKK  + E +     + E R L  A  +  L      F   +   +   +EY++GG 
Sbjct: 25  IKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEYLNGGD 82

Query: 168 LADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG 227
           L   ++      E        +++ GL +LH  + +++RD+K  N+L++  G  KI DFG
Sbjct: 83  LMFHIQSSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 228 ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG 287
           +     N     +TF GT  Y++PE ++ + Y+   D WS G+ L+E   G+ P+   E 
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-ED 200

Query: 288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVD----DCLKKDAEARPT-----ADQLLSHPF 338
              L   IL D           P F  ++     DCL K  E  PT        +  HPF
Sbjct: 201 EDELFDSILND----------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 34/210 (16%)

Query: 162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP 221
           ++ G  L +I++ QK + +  +  +  ++L+GL Y+H    ++HRD+KP+NL VN     
Sbjct: 102 HLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCEL 159

Query: 222 KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE- 279
           KI DFG++   ++ +     +V T  Y +PE + N   Y+   DIWS+G  + E  TG  
Sbjct: 160 KILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Query: 280 -FPYAASEGPVNLMLQILEDPSPS-----PS--------------RQNFS-------PEF 312
            FP       + L+L+++  P         S              + NF+       P  
Sbjct: 217 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 276

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
              ++  L  D++ R TA Q L+H +  +Y
Sbjct: 277 VDLLEKMLVLDSDKRITAAQALAHAYFAQY 306

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 25/205 (12%)

Query: 85  IFGAIGSGASSVVQRAVHI--PTHRIIALKKINIFEKEKRNQL---LTEIR--TLCEAPC 137
           I G IG G    V +A        +  A+KK   F+ +K        +  R   L     
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELK 60

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-----KSIPEPILSSMFKKLLQ 192
           +E +V     F       + +  +Y +   L  I++        SIP  ++ S+  ++L 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 193 GLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGISAGLENSIAMCAT---FVGT 245
           G+ YLH    ++HRD+KPAN+LV      +G  KI D G++      +   A     V T
Sbjct: 120 GVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 246 VTYMSPERIRNESYSYPA-DIWSIG 269
           + Y +PE +    +   A DIW+IG
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 42/284 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G    V +A +  TH I+ALK++ + + ++   +  L EI  L E   ++ +V  + 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYD 66

Query: 147 AFYMPDSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             +     ++++  EY D     D+ +        I   I+ S   +LL+GL++ H   +
Sbjct: 67  VLH--SDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HN 119

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSY 261
           ++HRD+KP NLL+N  G  K+ DFG++      +   +  V T+ Y  P+ +     YS 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179

Query: 262 PADIWSIGLALFE---CGTGEFPYAASEGPVNLMLQILEDPS----PSPSR--------- 305
             D+WS G    E    G   FP    +  +  + ++L  P+    P  S+         
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239

Query: 306 -----------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                         +      + + L  +   R +A++ L HP+
Sbjct: 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 11/129 (8%)

Query: 161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG- 219
           EY+ G +L ++L    ++P      +  ++L  L+  H  + +VHRD+KP N++V+  G 
Sbjct: 59  EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMVSQTGV 117

Query: 220 RP--KITDFGISA---GLENSIAMCAT----FVGTVTYMSPERIRNESYSYPADIWSIGL 270
           RP  K+ DFGI     G+ ++     T     +GT TY +PE++R E  +  +D+++ GL
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 271 ALFECGTGE 279
              EC TG+
Sbjct: 178 IFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 24/291 (8%)

Query: 82  EMRIFGAIGSGASSVVQ-RAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCN 138
           + R+ G  G G     Q RA    T ++ A K++     +K K   +    + + E   +
Sbjct: 4   QYRVLGKGGFGEVCACQVRA----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLA-DILRM-QKSIPEPILSSMFKKLLQGLSY 196
           + +V    A+   D+  + + L  M+GG L   I  M      E        ++L GL  
Sbjct: 60  QFVVNLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           LH   + V+RD+KP N+L++  G  +I+D G++  +    ++    VGTV YM+PE + N
Sbjct: 118 LHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTVGYMAPEVLNN 175

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNFSPEFC 313
           + Y+   D W +G  ++E   G+ P+   +  V    +  ++LE      ++  FS E  
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK--FSEEAK 233

Query: 314 SFVDDCLKKDAEAR-----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDP 359
           S     L KD + R       A ++  HPF       +++ A  +   F P
Sbjct: 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLE-AGMLDPPFVP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 12/209 (5%)

Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL--LTEIRTLCEAPCNEGLV 142
           I   IG GA   V       T ++ A+K +N +E  KR +     E R +        + 
Sbjct: 5   ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT 64

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
             H AF   D   + + ++Y  GG L  +L + +  +PE +      +++  +  +H + 
Sbjct: 65  NLHYAF--QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIR----- 255
           + VHRDIKP N+L++  G  ++ DFG    L  +        VGT  Y+SPE ++     
Sbjct: 123 Y-VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAA 284
              Y    D WS+G+ ++E   GE P+ A
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 11/184 (5%)

Query: 156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E M  GSL + L+     ++  P L  M  ++  G++YL   ++ +HRD+   N+
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNV 134

Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  ++  I       G    + + +PE      +S  +D+WS G+
Sbjct: 135 LVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY         +LQ ++     P       E    + DC K+D + RPT
Sbjct: 193 LLTEIVTYGRMPYPGMTNAE--VLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPT 250

Query: 330 ADQL 333
            + L
Sbjct: 251 FETL 254

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 52/300 (17%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE-------------A 135
           +G G++ +V  AV     + +A+KKI + + +     L EI+ +                
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
           P    L E  G+    +S  + I  EYM+   LA++L  Q  + E        +LL+GL 
Sbjct: 73  PSGSDLTEDVGSLTELNS--VYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLK 128

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFV-GTVT--YMSP 251
           Y+H   +++HRD+KPAN+ +N +    KI DFG++  ++   +       G VT  Y SP
Sbjct: 129 YIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 252 ERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE------------- 297
             + +  +Y+   D+W+ G    E  TG+  +A +   +  M  ILE             
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILESVPVVREEDRNEL 246

Query: 298 ---DPS---------PSPSRQ---NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
               PS           P R      +PE   F++  L  +   R TA++ L HP+++ Y
Sbjct: 247 LNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G  + V +     T  ++ALK+I +  +E      T IR  +L +   +  +V  H 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 147 AFYMPDSGQISIALEYMDGG------SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
             +   S  +++  EY+D           +I+ M        +     ++L+GL+Y H  
Sbjct: 72  IVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHN------VKIFLYQILRGLAYCHR- 122

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-Y 259
           R ++HRD+KP NLL+N +G  K+ DFG++          +  V T+ Y  P+ +   S Y
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 260 SYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS 300
           S   D+W +G   FE  +G   FP +  E  ++L+ ++L  P+
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 19/268 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    VQ      T  I A+K +    +  +E  +    E   L  +  +  + +  
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQ 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            AF   D   + + +EY  GG L  +L R +    E +      +L+  +  +H + + V
Sbjct: 68  YAF--QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY-V 124

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF-VGTVTYMSPERIR------NE 257
           HRDIKP N+L++  G  K+ DFG +A L  +  + +   VGT  Y++PE +         
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 258 SYSYPADIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF 315
           +Y    D WS+G+  +E   G   F    S    N ++         P     S +F   
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK-FPEDPKVSSDFLDL 243

Query: 316 VDDCLKKDAEARPTADQLLSHPFITKYE 343
           +   L    + R   + L  HPF +K +
Sbjct: 244 IQSLL-CGQKERLGYEGLCCHPFFSKID 270

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 14/186 (7%)

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF+ PD  ++   L+ M+GG L   L       E  +     +++ GL ++H  R +V+R
Sbjct: 65  AFHTPD--KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYR 121

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPADI 265
           D+KPAN+L++  G  +I+D G++          +  VGT  YM+PE + +  +Y   AD 
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSSADW 179

Query: 266 WSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           +S+G  LF+   G  P+       +  ++ M   +    P     +FSPE  S ++  L+
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKSLLEGLLQ 235

Query: 322 KDAEAR 327
           +D   R
Sbjct: 236 RDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 81/296 (27%), Positives = 127/296 (42%), Gaps = 51/296 (17%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSGA   V  A+   T   +A+KK++      IF K    +L     TL +   +E ++
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYREL-----TLLKHMQHENVI 77

Query: 143 EFHGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
                F    SG       + + YM    L  I  M   + E  +  +  ++L GL Y+H
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKI--MGHPLSEDKVQYLVYQMLCGLKYIH 134

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-E 257
               ++HRD+KP NL VN     KI DFG++    ++ A    +V T  Y +PE I N  
Sbjct: 135 SA-GIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWM 190

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASE-------------GPVNLMLQILEDPS---- 300
            Y+   DIWS+G  + E  TG+  +   +              P    +Q LED +    
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 301 ----PSPSRQNFS-------PEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
               P   R++FS       P+    ++  L+ D + R TA + L HP+   +  A
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 59/188 (31%), Positives = 90/188 (47%), Gaps = 17/188 (9%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I  EYM+ GSL   LR          L  M + +  G+ YL  + + VHRD+   N+LVN
Sbjct: 82  IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-VHRDLAARNILVN 140

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPERIRNESYSYPADIWSIGLALFE 274
                K++DFG+S  LE+S A   T  G   + + +PE I    ++  +D+WS G+ ++E
Sbjct: 141 SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200

Query: 275 -CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEARP 328
               GE PY   +     +++ +ED    P      P  C       + DC +KD   RP
Sbjct: 201 VMSYGERPYW--DMSNQDVIKAVEDGYRLP-----PPMDCPSALYQLMLDCWQKDRNERP 253

Query: 329 TADQLLSH 336
           T  Q++S 
Sbjct: 254 TFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 77/296 (26%), Positives = 120/296 (40%), Gaps = 61/296 (20%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEK---EKRN----QLLTEIRTLCEAPCNEG 140
           +G GA  +V  A    T + +A+KKI   F      KR     +LL  +R       +E 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-------HEN 70

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIP-EPILSSMFK-KLLQGLSYLH 198
           ++     F  P    I    E +      D+ R+  S P E      F  ++L+GL Y+H
Sbjct: 71  IISLSDIFISP-LEDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125

Query: 199 --GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
             GV   VHRD+KP+N+L+N     KI DFG++   +  +     +V T  Y +PE +  
Sbjct: 126 SAGV---VHRDLKPSNILINENCDLKICDFGLARIQDPQM---TGYVSTRYYRAPEIMLT 179

Query: 257 -ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE------------------ 297
            + Y    DIWS G    E   G+ P    +  VN    I +                  
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238

Query: 298 ----------DPSPSPSR-QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                     +P P   + +N  P     ++  L  D + R +A + L+HP++  Y
Sbjct: 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 25/191 (13%)

Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 75  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 133

Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 134 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED-------PSPSPSRQNFSPEFCSFVDDCLKK 322
            L E  T G  PY    G VN   ++L+        P P    ++     C     C +K
Sbjct: 192 LLTELTTKGRVPYP---GMVN--REVLDQVERGYRMPCPPECPESLHDLMC----QCWRK 242

Query: 323 DAEARPTADQL 333
           + E RPT + L
Sbjct: 243 EPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 37/273 (13%)

Query: 83  MRIFGAIGSGA-SSVVQRAVHIPTHRII--ALK--KINIFEKEKRNQLLTEIRTLCEAPC 137
           ++I   IG+G    V    + +P  R I  A+K  K    EK++R+        L EA  
Sbjct: 6   IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-------FLSEA-- 56

Query: 138 NEGLVEFHGAFYMPD----------SGQISIALEYMDGGSLADILRMQKSIPEPI-LSSM 186
                   G F  P+          S  + I  EYM+ GSL   LR        I L  M
Sbjct: 57  -----SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111

Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG-- 244
            + +  G+ YL  + + VHRD+   N+LVN     K++DFG+S  LE+      T  G  
Sbjct: 112 LRGIASGMKYLSDMGY-VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 245 -TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPS 302
             + + +PE I    ++  +D+WS G+ ++E  + GE PY   E     +++ +E+    
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--EMSNQDVIKAIEEGYRL 228

Query: 303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
           P+  +        + DC +KD   RP  +Q++S
Sbjct: 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 17/190 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A    T+  IALKKI + E+E      T IR  +L +   +  +V    
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPE-----PILSSMFKKLLQGLSYLHGVR 201
             +     ++ +  EY+D     D+ +   S P+      ++ +   ++L+G++Y H  R
Sbjct: 69  VVH--SEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122

Query: 202 HLVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPE-RIRNESY 259
            L HRD+KP NLL++ +    K+ DFG++      +      V T+ Y +PE  + +  Y
Sbjct: 123 VL-HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 260 SYPADIWSIG 269
           S P DIWS+G
Sbjct: 182 STPVDIWSVG 191

Length = 294

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 81/309 (26%), Positives = 117/309 (37%), Gaps = 78/309 (25%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTL------------- 132
           IG G    V +A H  T +I+ALKK+ + E EK       L EI+ L             
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 133 -CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---SIPEPILSSMFK 188
            C          + G+FY+          E+ +   LA +L  +    ++ E  +  + K
Sbjct: 79  ICRTKATPY-NRYKGSFYL--------VFEFCEH-DLAGLLSNKNVKFTLSE--IKKVMK 126

Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCAT-FVG 244
            LL GL Y+H  + L HRD+K AN+L+   G  K+ DFG++      +NS     T  V 
Sbjct: 127 MLLNGLYYIHRNKIL-HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 245 TVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEF----PY--AASE-GPVNLMLQIL 296
           T+ Y  PE +  E  Y  P D+W  G     C   E     P     +E   + L+ Q+ 
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAG-----CIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 297 EDPSPS----------------PSRQNF-----------SPEFCSFVDDCLKKDAEARPT 329
              +P                 P  Q              P     +D  L  D   R  
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300

Query: 330 ADQLLSHPF 338
           AD  L+H F
Sbjct: 301 ADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 10/217 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G  + V +     T  ++ALK+I +  +E      T IR  +L +   +  +V  H 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +   S  +++  EY+D      +     SI    +     +LL+GL+Y H  R ++HR
Sbjct: 72  IIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHR 128

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPADI 265
           D+KP NLL+N +G  K+ DFG++          +  V T+ Y  P+ +   + YS   D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188

Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS 300
           W +G   +E  TG   FP +  E  ++ + +IL  P+
Sbjct: 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 59/308 (19%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQ---------LLTEIRTLCE 134
           +G G    V++A    T +I+A+KK+ I E      + R            L E++ + E
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
              +E ++     +   +   I++ ++ M    L  ++  +  + E  +  +  ++L GL
Sbjct: 77  IK-HENIMGLVDVYV--EGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGL 132

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF------------ 242
           + LH   + +HRD+ PAN+ +N KG  KI DFG++                         
Sbjct: 133 NVLHK-WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 243 --VGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILE 297
             V T+ Y +PE +   E Y +  D+WS+G    E  TG+  FP       +  + ++L 
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251

Query: 298 DPSPSPSRQNFS-PEFCSFV---------------DDC-------LKKDAEARPTADQLL 334
            P+     Q    P +  F                DD        LK +   R +A + L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311

Query: 335 SHPFITKY 342
            H +    
Sbjct: 312 KHEYFKSD 319

Length = 335

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 35/253 (13%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-----------KEKRNQLLTEIR 130
           ++     +G+G    V       +    ALK + I E            EKR  +L E+ 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKR--VLKEVS 59

Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
                  +  ++      +  D   + + +EY+ GG L   LR               ++
Sbjct: 60  -------HPFIIRLFWTEH--DQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYM 249
           +  L YLH  + +V+RD+KP N+L++ +G  K+TDFG +  L + +  +C    GT  Y+
Sbjct: 111 VCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYL 165

Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
           +PE I+++ ++   D W++G+ ++E   G +P    + P  +  +IL      P   +  
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG-YPPFFDDNPFGIYEKILAGKLEFPRHLDL- 223

Query: 310 PEFCSFVDDCLKK 322
                +  D +KK
Sbjct: 224 -----YAKDLIKK 231

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF+ PD  ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +V+R
Sbjct: 65  AFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFVVYR 121

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPADI 265
           D+KPAN+L++  G  +I+D G++          +  VGT  YM+PE + +  +Y   AD 
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADW 179

Query: 266 WSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           +S+G  LF+   G  P+       +  ++ M   +    P     +FSPE  S ++  L+
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQ 235

Query: 322 KDAEAR-----PTADQLLSHPF 338
           +D   R       A ++  HPF
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 16/193 (8%)

Query: 153 SGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           S  + I  E+M+ G+L   LR        I L  M + +  G+ YL  + + VHRD+   
Sbjct: 77  SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY-VHRDLAAR 135

Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT------VTYMSPERIRNESYSYPADI 265
           N+LVN     K++DFG+S  LE+      T+  +      + + +PE I    ++  +D+
Sbjct: 136 NILVNSNLVCKVSDFGLSRFLEDD-TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDV 194

Query: 266 WSIGLALFECGT-GEFPY--AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           WS G+ ++E  + GE PY   +++  +N + Q    P P     +        + DC +K
Sbjct: 195 WSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP----MDCPTALHQLMLDCWQK 250

Query: 323 DAEARPTADQLLS 335
           D  ARP   Q++S
Sbjct: 251 DRNARPKFGQIVS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 52/194 (26%), Positives = 75/194 (38%), Gaps = 38/194 (19%)

Query: 161 EYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK 218
           E    GSL D LR           L     ++  G+ YL   +  +HRD+   N+L+   
Sbjct: 75  ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILLASD 133

Query: 219 GRPKITDFGISAGLENS-------------IAMCATFVGTVTYMSPERIRNESYSYPADI 265
            + KI DFG+   L  +              A CA          PE +R  ++S+ +D+
Sbjct: 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA----------PESLRTRTFSHASDV 183

Query: 266 WSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS-----FVDDC 319
           W  G+ L+E  T GE P+A   G      QIL+       R    PE C       +  C
Sbjct: 184 WMFGVTLWEMFTYGEEPWAGLSG-----SQILKKIDKEGERLE-RPEACPQDIYNVMLQC 237

Query: 320 LKKDAEARPTADQL 333
              +   RPT   L
Sbjct: 238 WAHNPADRPTFAAL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 41/125 (32%), Positives = 69/125 (55%), Gaps = 5/125 (4%)

Query: 160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG 219
           +EY++GG L   ++       P  +    +++ GL +LH  + +V+RD+K  N+L++  G
Sbjct: 75  MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG 133

Query: 220 RPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT 277
             KI DFG+    EN +  A   TF GT  Y++PE +  + Y+   D WS G+ L+E   
Sbjct: 134 HIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191

Query: 278 GEFPY 282
           G+ P+
Sbjct: 192 GQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 78/278 (28%), Positives = 118/278 (42%), Gaps = 50/278 (17%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           E+     +GSGA   V + V IP             E EK  ++   I+ L E    +  
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIP-------------EGEK-VKIPVAIKVLREETSPKAN 53

Query: 142 VEF-HGAFYMPD--------------SGQISIALEYMDGGSLADILRMQK-SIPEPILSS 185
            E    A+ M                S Q+ +  + M  G L D +R  K +I    L +
Sbjct: 54  KEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN 113

Query: 186 MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATF 242
              ++ +G+SYL   + LVHRD+   N+LV      KITDFG++  L   E         
Sbjct: 114 WCVQIAKGMSYLE-EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 243 VGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG-PVNLMLQILEDPS 300
           V  + +M+ E I +  Y++ +D+WS G+ ++E  T G  PY   EG P   +  +LE   
Sbjct: 173 V-PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY---EGIPAVEIPDLLEKGE 228

Query: 301 PSPSRQNFSPEFCSF-----VDDCLKKDAEARPTADQL 333
             P      P  C+      +  C   DAE+RPT  +L
Sbjct: 229 RLP-----QPPICTIDVYMVLVKCWMIDAESRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G    V +A    T +++ALKK  +   E+      L EI  L     +  +V    
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 147 AFYM-PDSGQISIAL--EYMDGGSLADILRMQKS----IPEPILSSMFKKLLQGLSYLHG 199
             ++   +G+ S+ L  EY+D      +    +     +P   + S   +LL+G+++ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 200 VRHLVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
              ++HRD+KP NLLV+  KG  KI D G+       +      + T+ Y +PE +   +
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187

Query: 259 -YSYPADIWSIGLALFECGTGE--FP 281
            YS P DIWS+G    E    +  FP
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFP 213

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 76/307 (24%), Positives = 124/307 (40%), Gaps = 61/307 (19%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL---TEIRTLCEAPCNEGLVEFH 145
           IG GA   V+      T +I A+K +   E  K++QL     E   L E+  +  +V  +
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            +F   D+  + + +E++ GG L  +L    +  E +      + +  +  +H +   +H
Sbjct: 68  YSF--QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL-GFIH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGL------------------------ENSIA---- 237
           RDIKP N+L++  G  K++DFG+S G                          NS+A    
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 238 -------------------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG 278
                              M  + VGT  Y++PE    + Y    D WS+G  +FEC  G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244

Query: 279 EFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDCLKKDAE---ARPTADQL 333
             P+  SE       +I+   +    P   + S E    +   L  +AE    R  A ++
Sbjct: 245 WPPF-CSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LITNAENRLGRGGAHEI 302

Query: 334 LSHPFIT 340
            SHPF  
Sbjct: 303 KSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 70.3 bits (172), Expect = 7e-14
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR      +P  L  M K + +G++Y
Sbjct: 58  HEKLVQLYGV--CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LV+ +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 116 LES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEV 172

Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
           +    +S  +D+W+ G+ ++E  + G+ PY           + +E    S   + + P  
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVE--KVSQGLRLYRPHL 225

Query: 313 CS-----FVDDCLKKDAEARPTADQLLS 335
            S      +  C  + AE RPT  QLLS
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 41/293 (13%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEK-EKRNQLLTEIRTLCEAPCNEGL 141
           +I   IG G+  VV  A+   T   +A+KKI ++FE      ++L EI  L     +  +
Sbjct: 3   KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREI-KLLRLLRHPDI 61

Query: 142 VEFHGAFYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           VE       P   +   I +  E M+   L  +++    +          +LL+ L Y+H
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGIS--AGLENSIAMCAT-FVGTVTYMSPERIR 255
              ++ HRD+KP N+L N   + KI DFG++  A  +   A+  T +V T  Y +PE   
Sbjct: 121 TA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 256 N--ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----------- 300
           +    Y+   DIWSIG    E  TG+  FP       ++L+  +L  PS           
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239

Query: 301 ------------PSPSRQNFS---PEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                       P P  Q F    P     ++  L  D + RPTA++ L+ P+
Sbjct: 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 58/193 (30%), Positives = 93/193 (48%), Gaps = 13/193 (6%)

Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+    +++  P L  M  ++  G++Y+  + + +HRD++ AN+
Sbjct: 75  IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY-IHRDLRSANI 133

Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      KI DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY         +L+ +E     P  Q+        +  C KKD E RPT
Sbjct: 192 LLTELVTKGRVPYPGMNN--REVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249

Query: 330 ADQLLSHPFITKY 342
            + L S  F+  Y
Sbjct: 250 FEYLQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.1 bits (174), Expect = 8e-14
 Identities = 49/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)

Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           + ALKK  +   +     + E R L  A  N  L   +  F   +   +   +E+++GG 
Sbjct: 25  VKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEFLNGGD 82

Query: 168 LADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
           L  +  +Q      +  + F   +++ GL +LH  + +++RD+K  N++++  G  KI D
Sbjct: 83  L--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIAD 139

Query: 226 FGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           FG+    EN       +TF GT  Y++PE ++   Y++  D WS G+ L+E   G+ P+
Sbjct: 140 FGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 75/325 (23%), Positives = 131/325 (40%), Gaps = 68/325 (20%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG GA   V+      T  I A+K   K ++ EKE+   +  E   L EA   +G     
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA---DGAWVVK 65

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             +   D   + + +E++ GG +  +L  + ++ E        + +  +  +H +   +H
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL-GFIH 124

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGL--------------------------------- 232
           RDIKP NLL++ KG  K++DFG+  GL                                 
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 233 --ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN 290
             +N   +  + VGT  Y++PE      Y+   D WS+G+ ++E   G +P   SE P  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQE 243

Query: 291 LMLQILE---------DPSPSPSRQNFSPEFCSFVDDCLKKDAEAR---PTADQLLSHPF 338
              +++          +   S   ++    FC+        D+E R      +++ SHPF
Sbjct: 244 TYRKVMNWKETLVFPPEVPISEKAKDLILRFCT--------DSENRIGSNGVEEIKSHPF 295

Query: 339 I--TKYEHAKVDLAAF---VRSVFD 358
                + H +   AA    ++S+ D
Sbjct: 296 FEGVDWGHIRERPAAIPIEIKSIDD 320

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 21/200 (10%)

Query: 89  IGSGASSVVQRAVHIP----THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G G    V+   + P    T   +A+K +N   E++ R+    EI  L     +E +V+
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL-RTLDHENIVK 70

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRH 202
           + G    P    + + +EY+  GSL D L+  +  I    L     ++ +G+ YL   + 
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QR 129

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE--------NSIAMCATFVGTVTYMSPERI 254
            +HRD+   N+LV  +   KI+DFG++  L                 F     + +PE +
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-----WYAPECL 184

Query: 255 RNESYSYPADIWSIGLALFE 274
           R   +S  +D+WS G+ L+E
Sbjct: 185 RTSKFSSASDVWSFGVTLYE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 15/194 (7%)

Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E+M  GSL D L+    K +  P L  M  ++  G++Y+  + + +HRD++ AN+
Sbjct: 75  IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY-IHRDLRAANI 133

Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      KI DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
            L E  T G  PY    G VN  +L+ +E     P  Q         +  C KKD + RP
Sbjct: 192 LLTELVTKGRVPYP---GMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERP 248

Query: 329 TADQLLSHPFITKY 342
           T + + S  F+  Y
Sbjct: 249 TFEYIQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 7/174 (4%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           LKK  + + +     + E R L        L + H  F   D  ++   +EY++GG L  
Sbjct: 33  LKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLYFVMEYVNGGDLMY 90

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA 230
            ++      EP       ++  GL +LH  R +++RD+K  N++++ +G  KI DFG+  
Sbjct: 91  HIQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Query: 231 GLENSI-AMCA-TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
             E+ +  +   TF GT  Y++PE I  + Y    D W+ G+ L+E   G+ P+
Sbjct: 150 --EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 26/240 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G+ + V + +     +++ALK I++  K +     T IR  +L +   +  +V  H 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP--ILSSMFKKLLQGLSYLHGVRHLV 204
             +  ++  ++   EYM    LA  +        P  +   MF+ LL+GL+Y+HG +H++
Sbjct: 71  IIHTKET--LTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHG-QHIL 125

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES-YS 260
           HRD+KP NLL++  G  K+ DFG++     SI    T+   V T+ Y  P+ +   + YS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA--KSIP-SQTYSSEVVTLWYRPPDVLLGATDYS 182

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI-------LEDPSPSPSR-QNFSPEF 312
              DIW  G    E   G+  +         + +I        ED  P  S+  N+ PE+
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 45/267 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTLCEAPCNEG 140
           +GSG   VV           +A+K I           E+ K   ++ ++        +  
Sbjct: 12  LGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIEEAK---VMMKLS-------HPN 60

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYL-- 197
           LV+ +G         I I  EYM  G L + LR +K       L  M   + + + YL  
Sbjct: 61  LVQLYGV--CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERI 254
           +G    +HRD+   N LV      K++DFG++  + +     +   GT   V +  PE  
Sbjct: 119 NGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKWAPPEVF 173

Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPS-----PSPSRQNF 308
               +S  +D+WS G+ ++E  + G+ PY   E   N   +++E  S       P     
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPY---ERFSN--SEVVESVSAGYRLYRPKLA-- 226

Query: 309 SPEFCSFVDDCLKKDAEARPTADQLLS 335
             E  + +  C  +  E RP   +LLS
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 40/241 (16%)

Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +VQ+      + +  L+K ++ EKE+   +  E   L EA   + L 
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA---DSLW 62

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
                +   D   + + +E++ GG +  +L  + ++ E        + +  +  +H +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL-G 121

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE----------------------------- 233
            +HRDIKP NLL++ KG  K++DFG+  GL+                             
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 234 ------NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG 287
                 N   +  + VGT  Y++PE      Y+   D WS+G+ ++E   G +P   SE 
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSET 240

Query: 288 P 288
           P
Sbjct: 241 P 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 84  RIFGAIGSGASSVVQ-RAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTLCEAPCNE 139
           R+ G  G G     Q RA    T ++ A KK+     +KR      L E R L E   + 
Sbjct: 6   RVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKRIL-EKVNSR 60

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLA-DILRMQKS-IPEPILSSMFKKLLQGLSYL 197
            +V    A+   D+  + + L  M+GG L   I  M      E        +L  GL  L
Sbjct: 61  FVVSLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
              R +V+RD+KP N+L++ +G  +I+D G++  +     +    VGTV YM+PE I NE
Sbjct: 119 QRER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-VGTVGYMAPEVINNE 176

Query: 258 SYSYPADIWSIGLALFECGTGEFPY 282
            Y++  D W +G  ++E   G+ P+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 48/133 (36%), Positives = 67/133 (50%), Gaps = 15/133 (11%)

Query: 179 PEPILSSMFK----KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN 234
           P+P+ S   K    ++L+GL YLH    ++HRDIKP NLLVN     KI DFG+ A +E 
Sbjct: 97  PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGL-ARVEE 154

Query: 235 ---SIAMCATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPV- 289
              S  M    V T  Y +PE +  +  Y+   DIWS+G    E       + A   P+ 
Sbjct: 155 PDESKHMTQEVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ-SPIQ 212

Query: 290 --NLMLQILEDPS 300
             +L+  +L  PS
Sbjct: 213 QLDLITDLLGTPS 225

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 72/288 (25%), Positives = 133/288 (46%), Gaps = 40/288 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKE-KRNQLLTEIRTLCEAPCNE--GLVE- 143
           +GSGA   V  A      + +A+KK++  F+      +   E+R L         GL++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +  ++ +    M G  L +I++ QK   E +   +  +LL+GL Y+H    +
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHV-QFLIYQLLRGLKYIHSA-GI 139

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYP 262
           +HRD+KP+N+ VN     +I DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEM---TGYVATRWYRAPEIMLNWMHYNQT 196

Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD--- 317
            DIWS+G  + E   G+  FP       +  +++++  PSP   ++  S     ++    
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Query: 318 -------------------DCLKK----DAEARPTADQLLSHPFITKY 342
                              D L+K    D++ R +A + L+HP+ ++Y
Sbjct: 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 49/295 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 206

Query: 264 DIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  P P       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266

Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFI 339
             +                          D L K    DA  R + D+ L HP+I
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 7/174 (4%)

Query: 111 LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD 170
           LKK  + + +     + E R L  +     L + H  F   D  ++   +EY++GG L  
Sbjct: 33  LKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMY 90

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA 230
            ++      EP       ++  GL +LH  + +++RD+K  N++++ +G  KI DFG+  
Sbjct: 91  QIQQVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Query: 231 GLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
             EN        TF GT  Y++PE I  + Y    D W+ G+ L+E   G+ P+
Sbjct: 150 --ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 43/138 (31%), Positives = 74/138 (53%), Gaps = 6/138 (4%)

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE 252
           G+ +LH +  +V+RD+KP N+L++ +G  +++D G++  L++   +     GT  YM+PE
Sbjct: 107 GILHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPE 164

Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFS 309
            ++ E YSYP D +++G +++E   G  P+   +  V    L  + LED       QNF+
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFT 223

Query: 310 PEFCSFVDDCLKKDAEAR 327
            E        L K  E R
Sbjct: 224 EESKDICRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 68/287 (23%), Positives = 120/287 (41%), Gaps = 46/287 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL-----VE 143
           +G G+ + V +     T +++ALK+I +  +E      T IR   EA   + L     V 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIR---EASLLKDLKHANIVT 67

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK-KLLQGLSYLHGVRH 202
            H   +   +  +++  EY+D   L   +             +F  +LL+GL+Y H  R 
Sbjct: 68  LHDIIHTKKT--LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RR 123

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSY 261
           ++HRD+KP NLL++ +G  K+ DFG++          +  V T+ Y  P+ +   + YS 
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 262 PADIWSIGLALFECGTGE--FP-YAASEGPVNLMLQILEDPSPS-----PSRQNFSPE-F 312
             D+W +G   +E  TG   FP     E  ++ + ++L  P+        S   F P  F
Sbjct: 184 SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243

Query: 313 C---------------------SFVDDCLKKDAEARPTADQLLSHPF 338
                                       L+ + + R +A + + HP+
Sbjct: 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 7/183 (3%)

Query: 155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
            + + +E    G L   L+ ++ IP   L  +  ++  G++YL    H VHRD+   N+L
Sbjct: 69  PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVL 127

Query: 215 VNLKGRPKITDFGISAGLE-NSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLA 271
           +  + + KI+DFG+S  L   S    AT  G   + + +PE I    +S  +D+WS G+ 
Sbjct: 128 LVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT 187

Query: 272 LFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA 330
           L+E  + G  PY   +G    ++ +LE     P  +    E  S +  C K   E RPT 
Sbjct: 188 LWEAFSYGAKPYGEMKGAE--VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTF 245

Query: 331 DQL 333
            +L
Sbjct: 246 SEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 13/173 (7%)

Query: 117 FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF--YMPDSGQISIALEYMDGGSLADILRM 174
           + +++R   L+E   + +   +  ++   G    + P      I  EYM+ G+L   LR 
Sbjct: 45  YTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKP----AMIITEYMENGALDKYLRD 99

Query: 175 QKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE 233
                    L  M + +  G+ YL  + + VHRD+   N+LVN     K++DFG+S  LE
Sbjct: 100 HDGEFSSYQLVGMLRGIAAGMKYLSDMNY-VHRDLAARNILVNSNLECKVSDFGLSRVLE 158

Query: 234 NSIAMCATFVG---TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           +      T  G    + + +PE I    ++  +D+WS G+ ++E  + GE PY
Sbjct: 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 48/190 (25%), Positives = 73/190 (38%), Gaps = 37/190 (19%)

Query: 188 KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGT 245
           ++LL+ L+YLHG R ++HRD+K  N+ ++      + DFG +  L+       C  + GT
Sbjct: 192 RRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--------LMLQILE 297
           +   SPE +  + Y    DIWS GL LFE           +   +          +Q+  
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310

Query: 298 DPSPSPSRQNFSPEFCSF--------------------------VDDCLKKDAEARPTAD 331
              P     N    F  +                          +   L  D E RP+A 
Sbjct: 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370

Query: 332 QLLSHPFITK 341
            +LS P  TK
Sbjct: 371 DILSLPLFTK 380

Length = 392

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 26/202 (12%)

Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILSSMFKKLL-------QGLS 195
           G + + +EY   G+L + LR ++            +P+  ++  FK L+       +G+ 
Sbjct: 94  GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT--FKDLVSCTYQVARGME 151

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPER 253
           YL   +  +HRD+   N+LV      KI DFG++  + N      T  G   V +M+PE 
Sbjct: 152 YL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEA 210

Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
           + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++        N + E 
Sbjct: 211 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTNEL 268

Query: 313 CSFVDDCLKKDAEARPTADQLL 334
              + DC       RPT  QL+
Sbjct: 269 YMMMRDCWHAIPSHRPTFKQLV 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 10/199 (5%)

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLS 195
           +  LV+  G   + + G + I  EYM  GSL D LR +    +    L      + + + 
Sbjct: 58  HSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           YL    + VHRD+   N+LV+     K++DFG++   + + +   T    V + +PE +R
Sbjct: 117 YLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALR 172

Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
            + +S  +D+WS G+ L+E  + G  PY     P+  ++  +E      +     P    
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAPDGCPPVVYD 230

Query: 315 FVDDCLKKDAEARPTADQL 333
            +  C   DA  RP+  QL
Sbjct: 231 VMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 5/131 (3%)

Query: 156 ISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I I +E + GGSL   LR +K+ +    L  M      G+ YL   ++ +HRD+   N L
Sbjct: 67  IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCL 125

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLAL 272
           V      KI+DFG+S   E  I   +  +    + + +PE +    Y+  +D+WS G+ L
Sbjct: 126 VGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILL 185

Query: 273 FECGT-GEFPY 282
           +E  + G+ PY
Sbjct: 186 WETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 17/232 (7%)

Query: 105 THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ-ISIALEYM 163
               +A+K +   +  K+     E++ L +   ++ L+       +   G+ + I  E M
Sbjct: 29  NRVRVAIKILKSDDLLKQQDFQKEVQAL-KRLRHKHLISLFA---VCSVGEPVYIITELM 84

Query: 164 DGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP 221
           + GSL   LR    + +P   L  M  ++ +G++YL   ++ +HRD+   N+LV      
Sbjct: 85  EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVC 143

Query: 222 KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEF 280
           K+ DFG++  ++  + + +       + +PE   + ++S  +D+WS G+ L+E  T G+ 
Sbjct: 144 KVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203

Query: 281 PYAASEGPVN--LMLQILEDPS-PSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
           PY    G  N  +  QI      P P++     E    + +C   + E RP+
Sbjct: 204 PY---PGMNNHEVYDQITAGYRMPCPAK--CPQEIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 66.7 bits (162), Expect = 3e-12
 Identities = 75/310 (24%), Positives = 131/310 (42%), Gaps = 60/310 (19%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 140

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 199

Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSP------SPSRQNF-- 308
           DIWS+G     C  GE       FP        N +++ L  P P       P+ +N+  
Sbjct: 200 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 309 -SPEFCS------FVDDCLKKDAE----------------------ARPTADQLLSHPFI 339
             P++        F D     D+E                       R + D+ L HP+I
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Query: 340 TK-YEHAKVD 348
              Y+ A+V+
Sbjct: 315 NVWYDPAEVE 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 22/200 (11%)

Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILS-----SMFKKLLQGLSYL 197
           G + + +EY   G+L + LR ++            +PE  LS     S   ++ +G+ YL
Sbjct: 97  GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPERIR 255
              +  +HRD+   N+LV      KI DFG++  + +      T  G   V +M+PE + 
Sbjct: 157 -ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215

Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           +  Y++ +D+WS G+ L+E  T G  PY     PV  + ++L++        N + E   
Sbjct: 216 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYM 273

Query: 315 FVDDCLKKDAEARPTADQLL 334
            + DC       RPT  QL+
Sbjct: 274 MMRDCWHAVPSQRPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 26/201 (12%)

Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILSSMFKKLL-------QGLS 195
           G + + +EY   G+L + LR ++            +PE  LS  FK L+       +G+ 
Sbjct: 91  GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS--FKDLVSCAYQVARGME 148

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPER 253
           YL   R  +HRD+   N+LV      KI DFG++ G+ +      T  G   V +M+PE 
Sbjct: 149 YLES-RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEA 207

Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
           + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L +        N + E 
Sbjct: 208 LFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEELFKLLREGHRMDKPSNCTHEL 265

Query: 313 CSFVDDCLKKDAEARPTADQL 333
              + +C       RPT  QL
Sbjct: 266 YMLMRECWHAVPTQRPTFKQL 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 41/132 (31%), Positives = 70/132 (53%), Gaps = 15/132 (11%)

Query: 158 IALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E M  G+L + LR +    +    L      + +G+ YL   + LVHRD+   N+LV
Sbjct: 75  IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILV 133

Query: 216 NLKGRPKITDFGI----SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
           +  G  K++DFG+    S G++NS          V + +PE ++++ +S  +D+WS G+ 
Sbjct: 134 SEDGVAKVSDFGLARVGSMGVDNSKL-------PVKWTAPEALKHKKFSSKSDVWSYGVL 186

Query: 272 LFECGT-GEFPY 282
           L+E  + G  PY
Sbjct: 187 LWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 39/270 (14%)

Query: 82  EMRIFGAIGSGASSVV-------QRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE 134
           E+ +   IGSG   +V       +R V I T R  A+ + +  E+ +    L+  +    
Sbjct: 5   ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK---- 60

Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQG 193
                 LV+ +G     +   I +  E+M+ G L+D LR Q+    +  L  M   + +G
Sbjct: 61  ------LVQLYGVCT--ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEG 112

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMS 250
           ++YL    +++HRD+   N LV      K++DFG++  + +     +T  GT   V + S
Sbjct: 113 MAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST--GTKFPVKWSS 169

Query: 251 PERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
           PE      YS  +D+WS G+ ++E    G+ PY   E   N   +++E    +   + + 
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY---ENRSN--SEVVET--INAGFRLYK 222

Query: 310 PEFCS-----FVDDCLKKDAEARPTADQLL 334
           P   S      +  C K+  E RP+   LL
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 32/198 (16%)

Query: 156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLL-------QGLSYLHGVRHLVHR 206
             I +E M+GG L   LR  +      P+L+   K+LL       +G  YL  + H +HR
Sbjct: 74  QYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKGCVYLEQM-HFIHR 130

Query: 207 DIKPANLLVNLKGRP-----KITDFGISAGLENSIAMCATFVG--TVTYMSPERIRNESY 259
           D+   N LV+ KG       KI DFG++  +  S        G   V +M+PE + +  +
Sbjct: 131 DLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF 190

Query: 260 SYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC----- 313
           +  +D+WS G+ ++E  T G+ PY A         ++L+  +     Q   PE C     
Sbjct: 191 TTQSDVWSFGVLMWEILTLGQQPYPALNN-----QEVLQHVTAGGRLQ--KPENCPDKIY 243

Query: 314 SFVDDCLKKDAEARPTAD 331
             + +C  +D   RPT D
Sbjct: 244 QLMTNCWAQDPSERPTFD 261

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 70/290 (24%), Positives = 114/290 (39%), Gaps = 47/290 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL---LTEIRTLCEAPCNEGLVEFH 145
           +G G    V       T ++ ALK ++  E  KRN++   LTE   L     +  L   +
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL-ATLDHPFLPTLY 67

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLH--GVR 201
            +F       + + ++Y  GG L  +L+ Q  K + E +      ++L  L YLH  G+ 
Sbjct: 68  ASFQTET--YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI- 124

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGIS-----------------------AGLENSIAM 238
             V+RD+KP N+L++  G   ++DF +S                         + +    
Sbjct: 125 --VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 239 CAT------FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM 292
                    FVGT  Y++PE I  + +    D W++G+ L+E   G  P+  S       
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242

Query: 293 LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR----PTADQLLSHPF 338
             IL+     P     S      +   L KD   R      A ++  HPF
Sbjct: 243 -NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 26/202 (12%)

Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILSSMFKKLL-------QGLS 195
           G + + +EY   G+L + LR ++            +PE  L+  FK L+       +G+ 
Sbjct: 91  GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT--FKDLVSCAYQVARGME 148

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPER 253
           YL   +  +HRD+   N+LV      KI DFG++  + N      T  G   V +M+PE 
Sbjct: 149 YL-ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEA 207

Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
           + +  Y++ +D+WS G+ L+E  T G  PY     PV  + ++L++        N + E 
Sbjct: 208 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTHEL 265

Query: 313 CSFVDDCLKKDAEARPTADQLL 334
              + +C       RPT  QL+
Sbjct: 266 YMIMRECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 20/265 (7%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALK-KINIFEKEKRNQLLTEIRTLCEAPCNEG 140
           E++    +GSGA   V + + IP    + +   I +  +    +   EI  L EA    G
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI--LDEAYVMAG 65

Query: 141 LVEFHGAFYMPD------SGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQG 193
           +    G+ Y+        +  + +  + M  G L D +R  K  I    L +   ++ +G
Sbjct: 66  V----GSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKG 121

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSP 251
           +SYL  VR LVHRD+   N+LV      KITDFG++  L+          G V   +M+ 
Sbjct: 122 MSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E I +  +++ +D+WS G+ ++E  T G  PY     P   +  +LE     P     + 
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEKGERLPQPPICTI 238

Query: 311 EFCSFVDDCLKKDAEARPTADQLLS 335
           +    +  C   D+E RP   +L+ 
Sbjct: 239 DVYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 2/97 (2%)

Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS-IAMCATFV 243
           ++ K+LL  + Y+H  + L+HRDIK  N+ +N  G+  + DFG +   E    A    +V
Sbjct: 271 AIMKQLLCAVEYIHD-KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329

Query: 244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEF 280
           GTV   SPE +  + Y    DIWS GL L +  + +F
Sbjct: 330 GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 67/266 (25%), Positives = 104/266 (39%), Gaps = 29/266 (10%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           RIF  I        +  V + T         +   + +   LL E   L        L  
Sbjct: 21  RIFYGILIDEKPGKEEEVFVKT-------VKDHASEIQVTLLLQESCLLYGLSHQNILPI 73

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI--------LSSMFKKLLQGLS 195
            H      D     +   YM+ G+L   L+  +              L  M  ++  G+S
Sbjct: 74  LHVCIE--DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-----VTYMS 250
           YLH  R ++H+DI   N +++ + + KITD  +S  L      C   +G      V +M+
Sbjct: 132 YLHK-RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC---LGDNENRPVKWMA 187

Query: 251 PERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
            E + N+ YS  +D+WS G+ L+E  T G+ PY   E     M   L+D        N  
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV--EIDPFEMAAYLKDGYRLAQPINCP 245

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLS 335
            E  + +  C   D E RP+  QL+ 
Sbjct: 246 DELFAVMACCWALDPEERPSFSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 24/265 (9%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIP---THRI-IALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E++    +GSGA   V + + +P   T +I +A+K +N     K N    +   +  +  
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           +  LV   G    P    I +  + M  G L D +   K +I   +L +   ++ +G+ Y
Sbjct: 68  HPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++  LE          G   + +M+ E I
Sbjct: 125 LEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
               +++ +D+WS G+ ++E  T G  PY     P   +  +LE     P      P  C
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERLP-----QPPIC 236

Query: 314 SF-----VDDCLKKDAEARPTADQL 333
           +      +  C   DA++RP   +L
Sbjct: 237 TIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 72/306 (23%), Positives = 132/306 (43%), Gaps = 50/306 (16%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
            IGSGA  +V  A        +A+KK+   F+ +   +       L +   ++ ++    
Sbjct: 28  PIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87

Query: 147 AFY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
            F     + +   + + +E MD  +L  ++ M+  +    +S +  ++L G+ +LH    
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME--LDHERMSYLLYQMLCGIKHLHSA-G 143

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++HRD+KP+N++V      KI DFG++     +  M   +V T  Y +PE I    Y   
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM-TPYVVTRYYRAPEVILGMGYKEN 202

Query: 263 ADIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSPS------PSRQNF---SPE 311
            DIWS+G  + E   G   +  ++     N +++ L  PS        P+ +N+    P+
Sbjct: 203 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ 262

Query: 312 F--CSFVD----------------------DCLKK----DAEARPTADQLLSHPFITK-Y 342
           +   SF +                      D L K    D + R + D+ L HP+IT  Y
Sbjct: 263 YPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322

Query: 343 EHAKVD 348
           + A+ +
Sbjct: 323 DPAEAE 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 17/188 (9%)

Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + +  + M  G L D +R  K +I    L +   ++ +G++YL   R LVHRD+   N+L
Sbjct: 83  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVL 141

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSPERIRNESYSYPADIWSIGLAL 272
           V      KITDFG++  L           G V   +M+ E I +  Y++ +D+WS G+ +
Sbjct: 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201

Query: 273 FECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS-----FVDDCLKKDAEA 326
           +E  T G  PY     P + +  ILE     P      P  C+      +  C   DA++
Sbjct: 202 WELMTFGSKPYDGI--PASEISSILEKGERLP-----QPPICTIDVYMIMVKCWMIDADS 254

Query: 327 RPTADQLL 334
           RP   +L+
Sbjct: 255 RPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 28/165 (16%)

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM----------QKSIPEPI-LSSMF 187
           E +V+F+G     +     +  EYM+ G L   LR             S    + LS + 
Sbjct: 68  ENIVKFYGV--CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 188 KKLLQ---GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF-V 243
           +  +Q   G+ YL   +H VHRD+   N LV      KI DFG+S      +     + V
Sbjct: 126 QIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGMS----RDVYTTDYYRV 180

Query: 244 G-----TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G      + +M PE I    ++  +D+WS G+ L+E  T G+ P+
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 41/271 (15%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTLC 133
           E+     +GSG   VV           +A+K IN          E+ K    L+  +   
Sbjct: 5   ELTFMKELGSGQFGVV-HLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPK--- 60

Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQ 192
                  LV+ +G         + I  E+M+ G L + LR ++  + + +L SM + + +
Sbjct: 61  -------LVQLYGV--CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCE 111

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYM 249
           G+ YL      +HRD+   N LV+  G  K++DFG++  +   E + +  A F   V + 
Sbjct: 112 GMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWS 168

Query: 250 SPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
            PE      YS  +D+WS G+ ++E  T G+ P+           +++E    S   + +
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVE--MISRGFRLY 221

Query: 309 SPEFCS-----FVDDCLKKDAEARPTADQLL 334
            P+  S      +  C  +  E RPT  +LL
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 14/138 (10%)

Query: 158 IALEYMDGGSLADILRMQKS-------IPEPILSSMFKKLLQ---GLSYLHGVRHLVHRD 207
           + +E M  G L   LR ++        +  P L    +   +   G++YL   +  VHRD
Sbjct: 86  VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRD 144

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADI 265
           +   N +V      KI DFG++  +  +        G   V +M+PE +++  ++  +D+
Sbjct: 145 LAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDV 204

Query: 266 WSIGLALFECGT-GEFPY 282
           WS G+ L+E  T  E PY
Sbjct: 205 WSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 7/175 (4%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  K + E  ++ +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 72  LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT 130

Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE +    +S  +D+WS G+ ++E
Sbjct: 131 QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Query: 275 CGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
             + G+ PY   +G  N + Q++E        Q   PE    +  C     + RP
Sbjct: 191 AFSYGQKPYKGMKG--NEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G+ + V +       +++ALK I + E+E      T IR  +L +   +  +V  H 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHD 70

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK----KLLQGLSYLHGVRH 202
             +  ++  +++  EY+      D+ +     P  +     K    +LL+GLSY+H  R+
Sbjct: 71  IIHTKET--LTLVFEYVH----TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RY 123

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSY 261
           ++HRD+KP NLL++  G  K+ DFG++          +  V T+ Y  P+ +   + YS 
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 262 PADIWSIGLALFEC--GTGEFP 281
             D+W +G    E   G   FP
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 49/225 (21%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH--GVRHLVHRDIKPANLLV 215
           + +E MD  +L  +++M   +    +S +  ++L G+ +LH  G+   +HRD+KP+N++V
Sbjct: 98  LVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVV 151

Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE- 274
                 KI DFG++     S  M   +V T  Y +PE I    Y    DIWS+G  + E 
Sbjct: 152 KSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210

Query: 275 -CGTGEFPYAASEGPVNLMLQILEDPSPS------PSRQN-------------------- 307
             GT  FP        N +++ L  PS        P+ +N                    
Sbjct: 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDV 270

Query: 308 -FSPEFCSFVD-------DCLKK----DAEARPTADQLLSHPFIT 340
            F P+  S          D L K    D E R + D  L HP+I 
Sbjct: 271 LFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 70/239 (29%)

Query: 162 YMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG 219
           +M  GS   +L+    + + E ++ ++    L+GL+YLH     +HR+IK +++L++  G
Sbjct: 80  FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG 138

Query: 220 RPKITDFGISAGLENSIAMC------------ATFVGTVT-YMSPERIRNESYSY--PAD 264
              ++      GL +  ++               F  +V  ++SPE +R + Y Y   +D
Sbjct: 139 LVSLS------GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SP--------------------- 301
           I+S+G+   E  TG  P+        ++LQ L+ P  SP                     
Sbjct: 193 IYSVGITACELATGRVPFQDML-RTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251

Query: 302 ----------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                                 +PS + FSP F + V+ CL++D E RP+A  LLSH F
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 9/135 (6%)

Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 79  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 137

Query: 216 NLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S  +          A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 138 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 195

Query: 273 FECGT-GEFPYAASE 286
           +E  T G  PY   +
Sbjct: 196 WEIATYGMSPYPGID 210

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 18/180 (10%)

Query: 105 THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD 164
           T  ++A+KK+     E       EI  L      + +V++ G  Y      + + +EY+ 
Sbjct: 32  TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLRLVMEYLP 90

Query: 165 GGSLADILRMQKSIPEPILSSMFKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNL 217
            GSL D L+  +   +       +KLL        G+ YL   R+ VHRD+   N+LV  
Sbjct: 91  YGSLRDYLQKHRERLD------HRKLLLYASQICKGMEYLGSKRY-VHRDLATRNILVES 143

Query: 218 KGRPKITDFGISAGL-ENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFE 274
           + R KI DFG++  L ++         G   + + +PE +    +S  +D+WS G+ L+E
Sbjct: 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 2/87 (2%)

Query: 188 KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVT 247
           K++L+GL YLH  R ++HRD+K  N+ +N   +  I D G +A             GTV 
Sbjct: 164 KQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVE 221

Query: 248 YMSPERIRNESYSYPADIWSIGLALFE 274
             +PE +  + Y+  ADIWS G+ LFE
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFE 248

Length = 357

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 27/253 (10%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           FG +  G   + ++ + +    I  LK  N  EK  R++++ E   + +   N  +V   
Sbjct: 8   FGCVKKGVYKMRKKQIDVA---IKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMI 61

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G   + ++  + + +E   GG L   L  +K  I    +  +  ++  G+ YL G ++ V
Sbjct: 62  G---VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-KNFV 117

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVG-TVTYMSPERIRNESYSY 261
           HRD+   N+L+  +   KI+DFG+S  L  ++S     +     + + +PE I    +S 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 262 PADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI-----LEDPSPSPSRQNFSPEFCSF 315
            +D+WS G+ ++E  + G+ PY   +GP  +M  I     L+ P+  P      PE  + 
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIEQGKRLDCPAECP------PEMYAL 230

Query: 316 VDDCLKKDAEARP 328
           + DC     E RP
Sbjct: 231 MKDCWIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 5/133 (3%)

Query: 156 ISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I I +E + GG     LR +   +    L  M +    G+ YL   +H +HRD+   N L
Sbjct: 68  IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCL 126

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLAL 272
           V  K   KI+DFG+S   E+ +      +    V + +PE +    YS  +D+WS G+ L
Sbjct: 127 VTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILL 186

Query: 273 FEC-GTGEFPYAA 284
           +E    G  PYA 
Sbjct: 187 WEAFSLGAVPYAN 199

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 13/189 (6%)

Query: 152 DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKK-LLQGLSYLHGVRHLVHRDIK 209
               + I  EYM  GSL D LR + +++        F   + +G+ YL   ++ VHRD+ 
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLA 129

Query: 210 PANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWS 267
             N+LV+     K++DFG++              G   V + +PE +R + +S  +D+WS
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 268 IGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
            G+ L+E  + G  PY     P+  ++  +E      + +   PE    + DC + D   
Sbjct: 185 FGILLWEIYSFGRVPYPRI--PLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAK 242

Query: 327 RPTADQLLS 335
           RPT  QL  
Sbjct: 243 RPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 67/237 (28%)

Query: 162 YMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG 219
           +M  GS  D++       + E  ++ + + +L+ L Y+H + + VHR +K +++L+++ G
Sbjct: 80  FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGY-VHRSVKASHILISVDG 138

Query: 220 RPKITDFGISAGLENSIAMCA-------------TFVGTVTYMSPERIRN--ESYSYPAD 264
           +  ++      GL ++++M                 V  + ++SPE ++   + Y   +D
Sbjct: 139 KVYLS------GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192

Query: 265 IWSIGLALFECGTGEFP------------------------------------------Y 282
           I+S+G+   E   G  P                                           
Sbjct: 193 IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANS 252

Query: 283 AASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
              E       +    + S  P  + FSP F  FV+ CL+++ +ARP+A  LL+H F
Sbjct: 253 GLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 10/164 (6%)

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSY 196
           +E +V++ G         I + +E++  GSL + L R +  I          ++ +G+ Y
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT---FVGTVTYMSPER 253
           L G R  VHRD+   N+LV  + + KI DFG++  +E               V + +PE 
Sbjct: 125 L-GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASE-GPVNLMLQIL 296
           +    +   +D+WS G+ L+E  T    Y  SE  P+ L L+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 52/224 (23%), Positives = 110/224 (49%), Gaps = 22/224 (9%)

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSY 196
           +E +V++ G         + + +EY+  GSL D L + + ++ + +L +  +++ +G++Y
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFA--QQICEGMAY 122

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           LH  +H +HRD+   N+L++     KI DFG++  +        +       V + + E 
Sbjct: 123 LHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 254 IRNESYSYPADIWSIGLALFE----CGTGEFPYAA-------SEGPVNL--MLQILEDPS 300
           ++   +SY +D+WS G+ L+E    C + + P           +G + +  ++++LE   
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
             P  +N   E    + +C + +A+ RPT   L+  P + +  H
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI--PILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 30/190 (15%)

Query: 166 GSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKIT 224
            SLADIL ++   + E  + ++  + L  L  LH      +  +   + L+ L G     
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILL-TWDGLLKLDG----- 54

Query: 225 DFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP 281
               S      E S            +M+PE I+ +SY+  ADI+S+G+ L+E    E P
Sbjct: 55  ----SVAFKTPEQSR-------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

Query: 282 YAASEGPVNLMLQILEDPSP---SPSRQNF-----SPEFCSFVDDCLKKDAEARPTADQL 333
           Y   E  ++ +L+IL +  P      R N      +  F  F+  C  +  + R  A+  
Sbjct: 104 Y-NEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHY 162

Query: 334 LSHPFITKYE 343
           L+H      E
Sbjct: 163 LAHCRALFAE 172

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 39/273 (14%)

Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           FG +    +  ++      T  +  LK+ N    E R+ LL+E   L +   +  +++ +
Sbjct: 13  FGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRD-LLSEFNLLKQVN-HPHVIKLY 69

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSI--------------------PEPI--- 182
           GA      G + + +EY   GSL   LR  + +                       +   
Sbjct: 70  GA--CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 183 -LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMC 239
            L S   ++ +G+ YL  ++ LVHRD+   N+LV    + KI+DFG+S  +  E+S    
Sbjct: 128 DLISFAWQISRGMQYLAEMK-LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186

Query: 240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC---GTGEFPYAASEGPVNLMLQIL 296
           +     V +M+ E + +  Y+  +D+WS G+ L+E    G   +P  A E   NL+    
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY 246

Query: 297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
               P    +N S E  + +  C K++ + RPT
Sbjct: 247 RMERP----ENCSEEMYNLMLTCWKQEPDKRPT 275

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 8/182 (4%)

Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L++ K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 81  VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR-FVHRDIAARNVL 139

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLAL 272
           V+     K+ DFG+S  LE+     A+  G   + +M+PE I    ++  +D+W  G+ +
Sbjct: 140 VSSPDCVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198

Query: 273 FEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTAD 331
           +E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   
Sbjct: 199 WEILMLGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFT 256

Query: 332 QL 333
           +L
Sbjct: 257 EL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 16/115 (13%)

Query: 167 SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           ++ DIL +++S+            L+ + YLH  R ++HRDIK  N+ +N  G   + DF
Sbjct: 180 AICDILAIERSV------------LRAIQYLHENR-IIHRDIKAENIFINHPGDVCLGDF 226

Query: 227 GISAGLENSIAMCATF--VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE 279
           G +A     I     +   GT+   +PE +  + Y    DIWS G+ LFE  T  
Sbjct: 227 G-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 26/193 (13%)

Query: 110 ALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSL 168
           A+K +  F  E  ++    E+  LC+   +  ++   GA    + G + IA+EY   G+L
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGA--CENRGYLYIAIEYAPYGNL 90

Query: 169 ADILRMQKSI-PEP----------ILSSMFKKLLQ-------GLSYLHGVRHLVHRDIKP 210
            D LR  + +  +P           L+S  ++LLQ       G+ YL   +  +HRD+  
Sbjct: 91  LDFLRKSRVLETDPAFAKEHGTASTLTS--QQLLQFASDVATGMQYLSE-KQFIHRDLAA 147

Query: 211 ANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
            N+LV      KI DFG+S G E  +      +  V +M+ E +    Y+  +D+WS G+
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGV 206

Query: 271 ALFE-CGTGEFPY 282
            L+E    G  PY
Sbjct: 207 LLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 62/247 (25%), Positives = 104/247 (42%), Gaps = 32/247 (12%)

Query: 110 ALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSL 168
           A+K++  +  K+       E+  LC+   +  ++   GA      G + +A+EY   G+L
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA--CEHRGYLYLAIEYAPHGNL 95

Query: 169 ADILRMQK--------SIPEPILSSMFKKLL--------QGLSYLHGVRHLVHRDIKPAN 212
            D LR  +        +I     S++  + L        +G+ YL   +  +HRD+   N
Sbjct: 96  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-SQKQFIHRDLAARN 154

Query: 213 LLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
           +LV      KI DFG+S G E  +      +  V +M+ E +    Y+  +D+WS G+ L
Sbjct: 155 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLL 213

Query: 273 FE-CGTGEFPYAA---SEGPVNLMLQI-LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +E    G  PY     +E    L     LE P       N   E    +  C ++    R
Sbjct: 214 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYER 267

Query: 328 PTADQLL 334
           P+  Q+L
Sbjct: 268 PSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 154 GQISIALEYMDGGSLADILRMQKSIPE----------------PILSSMFKKLLQGLSYL 197
           G + + +EY   G+L D LR ++   E                  L S   ++ +G+ +L
Sbjct: 89  GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPERIR 255
              +  +HRD+   N+LV      KI DFG++  + +      T  G   V +M+PE + 
Sbjct: 149 AS-KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207

Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           +  Y++ +D+WS G+ L+E  T G  PY     PV  + ++L++       QN + E   
Sbjct: 208 DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEGYRMEKPQNCTQELYH 265

Query: 315 FVDDCLKKDAEARPTADQLL 334
            + DC  +    RPT  QL+
Sbjct: 266 LMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 23/227 (10%)

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           +R  L++E++ +     +E +V   GA  +   G I +  EY   G L + LR ++   E
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTI--GGPILVITEYCCYGDLLNFLRRKR---E 135

Query: 181 PILSSMFKKLL-------QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL- 232
             L+   + LL       +G+++L   ++ +HRD+   N+L+      KI DFG++  + 
Sbjct: 136 SFLT--LEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192

Query: 233 --ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPV 289
              N +      +  V +M+PE I N  Y++ +D+WS G+ L+E  + G  PY     PV
Sbjct: 193 NDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--PV 249

Query: 290 NLMLQILEDPSPSPSRQNFSP-EFCSFVDDCLKKDAEARPTADQLLS 335
           +     L       ++   +P E    +  C   D   RPT  Q++ 
Sbjct: 250 DSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 58/253 (22%), Positives = 122/253 (48%), Gaps = 34/253 (13%)

Query: 66  ADESDHSEKTY-----RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE 120
           A E +  EK       R  +   ++   IG+G+  VV  A+ I T   +A+KK+ + + +
Sbjct: 46  AGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQ 104

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ-------ISIALEYMDG---GSLAD 170
            +N+ L  ++ L     N   + F   +Y  +  +       +++ +E++       +  
Sbjct: 105 YKNRELLIMKNL-----NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH 159

Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP-KITDFGIS 229
             R   ++P  ++     +L + L+Y+H  + + HRD+KP NLL++      K+ DFG +
Sbjct: 160 YARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218

Query: 230 AGL---ENSIA-MCATFVGTVTYMSPE-RIRNESYSYPADIWSIGLALFECGTGEFPYAA 284
             L   + S++ +C+ F     Y +PE  +   +Y+   D+WS+G  + E   G +P  +
Sbjct: 219 KNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFS 272

Query: 285 SEGPVNLMLQILE 297
            +  V+ +++I++
Sbjct: 273 GQSSVDQLVRIIQ 285

Length = 440

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 25/174 (14%)

Query: 128 EIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEP----- 181
           E+  LC+   +  ++   GA      G + +A+EY   G+L D LR  + +  +P     
Sbjct: 45  ELEVLCKLGHHPNIINLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 102

Query: 182 -----ILSSMFKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS 229
                 LSS  ++LL        G+ YL   +  +HRD+   N+LV      KI DFG+S
Sbjct: 103 NSTASTLSS--QQLLHFAADVARGMDYL-SQKQFIHRDLAARNILVGENYVAKIADFGLS 159

Query: 230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE-CGTGEFPY 282
            G E  +      +  V +M+ E +    Y+  +D+WS G+ L+E    G  PY
Sbjct: 160 RGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 12/189 (6%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I  EYM  G+L   LR  +  +    L  M   L  G+ YL  + + VH+ +    +LVN
Sbjct: 83  IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY-VHKGLAAHKVLVN 141

Query: 217 LKGRPKITDFGISAGLENSI-AMCATFVG--TVTYMSPERIRNESYSYPADIWSIGLALF 273
                KI+ F      E+   A+  T  G   V + +PE I+   +S  +D+WS G+ ++
Sbjct: 142 SDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199

Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E  + GE PY    G    +++ +ED    P+ +N        + DC +K+   RP   Q
Sbjct: 200 EVMSYGERPYWDMSG--QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQ 257

Query: 333 LLSHPFITK 341
           +  H  ++K
Sbjct: 258 I--HSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 26/75 (34%), Positives = 45/75 (60%), Gaps = 3/75 (4%)

Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLL 214
           + + +EY+ GG +  +L +     E +      ++   L YLH  RH ++HRD+KP N+L
Sbjct: 79  VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNML 136

Query: 215 VNLKGRPKITDFGIS 229
           ++ +G  K+TDFG+S
Sbjct: 137 ISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 29/251 (11%)

Query: 73  EKTYRCASHEMRIFGAIGSG-ASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIR 130
           EK           FG +  G A  VV+     P  R+ A+K +N      +R + L E  
Sbjct: 6   EKITMSRELGQGSFGMVYEGIAKGVVKDE---PETRV-AIKTVNEAASMRERIEFLNEAS 61

Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIA-LEYMDGGSLADILRMQKSIPE-------PI 182
            + E  C+  +V   G       GQ ++  +E M  G L   LR  +   E       P 
Sbjct: 62  VMKEFNCHH-VVRLLGVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117

Query: 183 LSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC 239
           L  M +   ++  G++YL+  +  VHRD+   N +V      KI DFG++  +  +    
Sbjct: 118 LKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176

Query: 240 ATFVG--TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ 294
               G   V +MSPE +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236

Query: 295 --ILEDPSPSP 303
             +L+ P   P
Sbjct: 237 GGLLDKPDNCP 247

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 41/111 (36%), Positives = 58/111 (52%), Gaps = 11/111 (9%)

Query: 178 IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGISAGLE 233
           +P  ++ S+  ++L G+ YLH    ++HRD+KPAN+LV      +GR KI D G  A L 
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLF 162

Query: 234 NS----IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE 279
           NS    +A     V T  Y +PE +     Y+   DIW+IG    E  T E
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 41/111 (36%), Positives = 58/111 (52%), Gaps = 11/111 (9%)

Query: 178 IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGISAGLE 233
           +P  ++ S+  ++L G+ YLH    ++HRD+KPAN+LV      +GR KI D G  A L 
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLF 162

Query: 234 NS----IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE 279
           NS    +A     V T  Y +PE +     Y+   DIW+IG    E  T E
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 31/185 (16%)

Query: 117 FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ- 175
           F++E   +LLT ++       +E +V+F+G     D   + +  EYM  G L   LR   
Sbjct: 54  FQREA--ELLTNLQ-------HEHIVKFYGV--CGDGDPLIMVFEYMKHGDLNKFLRAHG 102

Query: 176 ------------KSIPEPILSSMF---KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR 220
                       ++  E  LS M     ++  G+ YL   +H VHRD+   N LV     
Sbjct: 103 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANLL 161

Query: 221 PKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT- 277
            KI DFG+S  + ++    +    +  + +M PE I    ++  +D+WS G+ L+E  T 
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221

Query: 278 GEFPY 282
           G+ P+
Sbjct: 222 GKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 52/228 (22%)

Query: 102 HIPTHRIIALKKI------NIFEKE------KRNQLLTEIRTLCEAPCN----------- 138
           HI  H I+  +++       +F  E      +++++L  ++TL +A  N           
Sbjct: 1   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60

Query: 139 ------EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPIL--------- 183
                 E +V+F+G     D   + +  EYM  G L   LR     P+ +L         
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDP--LIMVFEYMKHGDLNKFLRAHG--PDAVLMAEGNRPAE 116

Query: 184 ---SSMF---KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS-- 235
              S M    +++  G+ YL   +H VHRD+   N LV      KI DFG+S  + ++  
Sbjct: 117 LTQSQMLHIAQQIAAGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175

Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
             +    +  + +M PE I    ++  +D+WS+G+ L+E  T G+ P+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 17/106 (16%)

Query: 178 IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL----- 232
           +       + K++  G++YL   R  VHRD+   N LV      KI DFG+S  +     
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL-SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 233 ----ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               EN           + +M PE I    Y+  +D+W+ G+ L+E
Sbjct: 186 YKASENDAI-------PIRWMPPESIFYNRYTTESDVWAYGVVLWE 224

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 57/202 (28%), Positives = 78/202 (38%), Gaps = 36/202 (17%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ-------GLSYLHGVRHLVHRDIKP 210
           I LE M GG L   LR  +  PE   S   K LL        G  YL    H +HRDI  
Sbjct: 86  ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAA 144

Query: 211 ANLLVNLKGRP----KITDFGISAGL-------ENSIAMCATFVGTVTYMSPERIRNESY 259
            N L+  KG P    KI DFG++  +       +   AM       + +M PE   +  +
Sbjct: 145 RNCLLTCKG-PGRVAKIADFGMARDIYRASYYRKGGRAMLP-----IKWMPPEAFLDGIF 198

Query: 260 SYPADIWSIGLALFEC-GTGEFPYAA-SEGPVNLMLQI---LEDPSPSPSRQNFSPEFCS 314
           +   D+WS G+ L+E    G  PY   +   V   +     L+ P   P           
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGP------VYR 252

Query: 315 FVDDCLKKDAEARPTADQLLSH 336
            + DC +   E RP    +L  
Sbjct: 253 IMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
             ++++ ++LL  + Y+HG   ++HRDIK  N+LVN      + DFG +     S +   
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 241 TF--VGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
            +   GTV   +PE +  + Y+   DIWS GL +FE
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 37/201 (18%)

Query: 158 IALEYMDGGSLADILRMQKS-----IPEPILS----SMFKKLLQGLSYLHGVRHLVHRDI 208
           + LEY D G L   LR  KS      P P+ +    ++  ++  G+ +L   R  VHRD+
Sbjct: 85  MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-FVHRDL 143

Query: 209 KPANLLVNLKGRPKITDFGISAG--------LENSIAMCATFVGTVTYMSPERIRNESYS 260
              N LV+ +   K++   +S          L N++         + +++PE ++ + +S
Sbjct: 144 AARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-------PLRWLAPEAVQEDDFS 196

Query: 261 YPADIWSIGLALFECGT-GEFPYA--ASEGPVN-LMLQILEDPSPS--PSRQNFSPEFCS 314
             +D+WS G+ ++E  T GE P+   + E  +N L    LE P P   PSR         
Sbjct: 197 TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR------LYK 250

Query: 315 FVDDCLKKDAEARPTADQLLS 335
            +  C   + + RP+  +L+S
Sbjct: 251 LMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 18/186 (9%)

Query: 158 IALEYMDGGSLADILRMQKS-------IPEPILSSMFK---KLLQGLSYLHGVRHLVHRD 207
           + +E M  G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD
Sbjct: 86  VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRD 144

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--TVTYMSPERIRNESYSYPADI 265
           +   N +V      KI DFG++  +  +        G   V +M+PE +++  ++  +D+
Sbjct: 145 LAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDM 204

Query: 266 WSIGLALFECGT-GEFPYAASEGPVN-LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           WS G+ L+E  +  E PY   +G  N  +L+ + D        N        +  C + +
Sbjct: 205 WSFGVVLWEITSLAEQPY---QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFN 261

Query: 324 AEARPT 329
            + RPT
Sbjct: 262 PKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV--GT---- 245
           QG+ +L   ++ +HRD+   N+L+      KI DFG++  + N     + +V  G     
Sbjct: 223 QGMDFL-ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND----SNYVVKGNARLP 277

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPS 304
           V +M+PE I +  Y+  +D+WS G+ L+E    G+ PY      VN     +       S
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL--VNSKFYKMVKRGYQMS 335

Query: 305 RQNFSP-EFCSFVDDCLKKDAEARPTADQL 333
           R +F+P E  S +  C   +   RPT  Q+
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 30/184 (16%)

Query: 117 FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-- 174
           F++E   +LLT ++       ++ +V F+G     +   + +  EYM  G L   LR   
Sbjct: 54  FQREA--ELLTVLQ-------HQHIVRFYGV--CTEGRPLLMVFEYMRHGDLNRFLRSHG 102

Query: 175 ---------QKSIPEPI-LSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP 221
                    +   P  + L  M     ++  G+ YL  + H VHRD+   N LV      
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVV 161

Query: 222 KITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-G 278
           KI DFG+S  + ++    +    +  + +M PE I    ++  +DIWS G+ L+E  T G
Sbjct: 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221

Query: 279 EFPY 282
           + P+
Sbjct: 222 KQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 14/164 (8%)

Query: 181 PILSSM----FK-KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--- 232
           P LS M    F  ++  G+ +L   ++ VHRD+   N+L+      KI DFG++  +   
Sbjct: 234 PALSYMDLVGFSYQVANGMEFL-ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVN- 290
            N I+  +TF+  + +M+PE I N  Y+  +D+WS G+ L+E  T G  PY   E P+N 
Sbjct: 293 SNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY--PELPMNE 349

Query: 291 LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
                ++         + S E    +  C ++  E RP   QL+
Sbjct: 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 24/168 (14%)

Query: 161 EYMDGGSLADILRM----------------QKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           EY+  G L + L                  + S+       +  ++  G+ YL    H V
Sbjct: 88  EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFV 146

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYP 262
           HRD+   N LV      KI+DFG+S  + ++    + +  +  V +M PE I    ++  
Sbjct: 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE 206

Query: 263 ADIWSIGLALFECGT-GEFPYAA-SEGPVNLML---QILEDPSPSPSR 305
           +DIWS G+ L+E  + G  PY   S   V  M+   Q+L  P   P+R
Sbjct: 207 SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPAR 254

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 25/165 (15%)

Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR-PKITDFGISAGLENSIAMCAT 241
           L S   ++ +G+S+L   ++ +HRD+   N+L+   GR  KI DFG++  + N     + 
Sbjct: 216 LLSFSYQVAKGMSFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRND----SN 269

Query: 242 FVGT------VTYMSPERIRNESYSYPADIWSIGLAL---FECGTGEFPYAASEGPVNLM 292
           +V        V +M+PE I N  Y++ +D+WS G+ L   F  G+  +P    +     M
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329

Query: 293 LQ---ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
           ++    +  P  +P       E    +  C   D   RPT  Q++
Sbjct: 330 IKEGYRMLSPECAP------SEMYDIMKSCWDADPLKRPTFKQIV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 23/199 (11%)

Query: 150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLHGVRHLVHR 206
           +P  G   + L YM  G L + +R +     P +  +    LQ   G+ YL   +  VHR
Sbjct: 66  LPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYL-ASKKFVHR 122

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYP 262
           D+   N +++     K+ DFG++  + +    S+         V +M+ E ++ + ++  
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK 182

Query: 263 ADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFV 316
           +D+WS G+ L+E  T G  PY   +   ++ + +L+       R+   PE+C       +
Sbjct: 183 SDVWSFGVLLWELMTRGAPPYPDVD-SFDITVYLLQ------GRRLLQPEYCPDPLYEVM 235

Query: 317 DDCLKKDAEARPTADQLLS 335
             C     E RPT  +L+S
Sbjct: 236 LSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 8/132 (6%)

Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLHGVRHLVHRDIKPAN 212
           I I +E + GG     LR +K   E     + K  L    G++YL   ++ +HRD+   N
Sbjct: 67  IYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARN 123

Query: 213 LLVNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLA 271
            LV      KI+DFG+S   ++ I   +      + + +PE +    YS  +D+WS G+ 
Sbjct: 124 CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183

Query: 272 LFEC-GTGEFPY 282
           L+E    G  PY
Sbjct: 184 LWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 15/151 (9%)

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT------ 245
           +G+ +L   R  +HRD+   N+L++     KI DFG    L   I     +V        
Sbjct: 185 RGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYVRKGSARLP 239

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNL-MLQILEDPSPSP 303
           + +M+PE I ++ Y+  +D+WS G+ L+E    G  PY   +  +N    Q L+D +   
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--INEEFCQRLKDGTRMR 297

Query: 304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
           + +N +PE    +  C + D + RPT   L+
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 37/247 (14%)

Query: 119 KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-- 176
           K  RN  L EI+ +     N  ++   G     D   + +  EYM+ G L   L  ++  
Sbjct: 58  KTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDP--LCMITEYMENGDLNQFLSQREIE 114

Query: 177 ----------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
                     S+    L  M  ++  G+ YL  + + VHRD+   N LV      KI DF
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGNHYTIKIADF 173

Query: 227 GISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA 284
           G+S  L +     +    V  + +M+ E I    ++  +D+W+ G+ L+E  T       
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT-----LC 228

Query: 285 SEGPVNLML--QILEDPSP---SPSRQNF--SPEFC-----SFVDDCLKKDAEARPTADQ 332
            E P +L+   Q++E+      +  RQ +      C       +  C  +D + RPT ++
Sbjct: 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288

Query: 333 LLSHPFI 339
           +  H F+
Sbjct: 289 I--HHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 48/204 (23%), Positives = 72/204 (35%), Gaps = 58/204 (28%)

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKG----------------RPKITDFGISAGLENSIA 237
           L Y H   HL+H D+KP N+L+                    R +I D G      +S  
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT 303

Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLM--- 292
                V T  Y SPE +    + Y  D+WS+G  ++E  TG+  Y   +    ++LM   
Sbjct: 304 ---AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 293 --------------------------LQILEDPS-------PSPSRQNFS-PEFCSFVDD 318
                                     L+   DP          P R+       C  +  
Sbjct: 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420

Query: 319 CLKKDAEARPTADQLLSHPFITKY 342
            L  D + R  A Q+ +HP++ KY
Sbjct: 421 LLHYDRQKRLNARQMTTHPYVLKY 444

Length = 467

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 10/160 (6%)

Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           +++   +  R      C   +V  H      DS  + + L++ +GG L   +    +IPE
Sbjct: 27  RKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDS--VFLVLQHAEGGKLWSHISKFLNIPE 84

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
             +     +++  L  LH    +V RD+ P N+L++ +G  ++T F   + +E+S   C 
Sbjct: 85  ECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CD 140

Query: 241 TFVGTVTYMSPE--RIRNESYSYPADIWSIGLALFECGTG 278
                  Y +PE   I  E+ +   D WS+G  LFE  TG
Sbjct: 141 GEAVENMYCAPEVGGISEETEA--CDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 31/194 (15%)

Query: 161 EYMDGGSLADILRMQK-----------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           EYM+ G L   L   +           +I    L  M  ++  G+ YL  + + VHRD+ 
Sbjct: 99  EYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLA 157

Query: 210 PANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWS 267
             N LV      KI DFG+S  L +     +    V  + +MS E I    ++  +D+W+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217

Query: 268 IGLALFECGT--GEFPYAASEGPVNLMLQILEDPSP---SPSRQNF--SPEFC-----SF 315
            G+ L+E  T   E PY+          Q++E+         RQ +   P  C       
Sbjct: 218 FGVTLWEILTLCKEQPYSQLSDE-----QVIENTGEFFRDQGRQVYLPKPALCPDSLYKL 272

Query: 316 VDDCLKKDAEARPT 329
           +  C +++A+ RP+
Sbjct: 273 MLSCWRRNAKERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 13/155 (8%)

Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--- 245
           ++ +G+ +L   R  +HRD+   N+L++     KI DFG    L   I     +V     
Sbjct: 187 QVAKGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYVRKGDA 241

Query: 246 ---VTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSP 301
              + +M+PE I +  Y+  +D+WS G+ L+E    G  PY   +       + L++ + 
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTR 300

Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
             +    +PE    + DC   +   RPT  +L+ H
Sbjct: 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 42/185 (22%), Positives = 80/185 (43%), Gaps = 14/185 (7%)

Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           +S+ LEY   G L ++L  +K +       M     +GL  L+   +  ++++   + LV
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 216 NLKGRPKITDFGISAGLENSIAMCA-TFVGTVTYMSPERIRN--ESYSYPADIWSIGLAL 272
               + KI    I  GLE  ++      V  + Y S + + +    Y+   DI+S+G+ L
Sbjct: 157 TENYKLKI----ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 273 FECGTGEFPY--AASEGPVNLML-QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
           +E  TG+ P+    ++   +L++ +      P         E    V+ C   D+  RP 
Sbjct: 213 WEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL----EIKCIVEACTSHDSIKRPN 268

Query: 330 ADQLL 334
             ++L
Sbjct: 269 IKEIL 273

Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 12/211 (5%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALK-KINIFEKEKRNQLLTEI--RTLCEAPCN 138
           E+R    +GSG    V + + IP    I +   I   +     Q   EI    L     +
Sbjct: 8   ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 139 EG-LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP-ILSSMFKKLLQGLSY 196
              +V   G   +     + +  +    GSL D +R  +   +P  L +   ++ +G+ Y
Sbjct: 68  HAYIVRLLG---ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERI 254
           L   R +VHR++   N+L+      +I DFG++  L  ++     +     + +M+ E I
Sbjct: 125 LEEHR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAA 284
               Y++ +D+WS G+ ++E  + G  PYA 
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 33/104 (31%), Positives = 58/104 (55%), Gaps = 6/104 (5%)

Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMC 239
           L S   ++ +G+ +L   ++ VHRD+   N+L+      KI DFG++  +    N ++  
Sbjct: 239 LLSFTYQVARGMEFL-ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPY 282
           +TF+  V +M+PE I +  Y+  +D+WS G+ L+E    G  PY
Sbjct: 298 STFL-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 26/72 (36%), Positives = 42/72 (58%), Gaps = 11/72 (15%)

Query: 161 EYMDGGSLADILRMQKSIPEP-----ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           E+M  G      ++  ++P+      ++  + +++L GL  LH +  +VHRDIKP NLLV
Sbjct: 289 EFMMAGK-----KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLV 342

Query: 216 NLKGRPKITDFG 227
            + G+ KI DFG
Sbjct: 343 TVDGQVKIIDFG 354

Length = 507

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 33/138 (23%), Positives = 61/138 (44%), Gaps = 10/138 (7%)

Query: 158 IALEYMDGGSLADILRMQK------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           + L +M  G L   L   +       +P  +L      +  G+ YL   +  +HRD+   
Sbjct: 83  VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL-SSKSFIHRDLAAR 141

Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N ++N      + DFG+S  + N        +    V +++ E + +  Y+  +D+WS G
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201

Query: 270 LALFECGT-GEFPYAASE 286
           + ++E  T G+ PY   E
Sbjct: 202 VTMWEIATRGQTPYPGVE 219

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 19/155 (12%)

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT------ 245
           +G+ +L   R  +HRD+   N+L++     KI DFG    L   I     +V        
Sbjct: 184 RGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYVRKGDARLP 238

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-VNL---MLQILEDPSP 301
           + +M+PE I ++ Y+  +D+WS G+ L+E     F   AS  P V +     + L++ + 
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI----FSLGASPYPGVQIDEEFCRRLKEGTR 294

Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
             + +  +PE  S + DC   + E RPT  +L+  
Sbjct: 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 35/135 (25%), Positives = 60/135 (44%), Gaps = 24/135 (17%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH-------GVRHL-----VH 205
           + +EYM+ G L   L  QK + E    +   K L   + L+       G+R+L     VH
Sbjct: 96  MIMEYMENGDLNQFL--QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF------VGTVTYMSPERIRNESY 259
           RD+   N LV      KI DFG+S     ++     +         + +M+ E +    +
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMS----RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF 209

Query: 260 SYPADIWSIGLALFE 274
           +  +D+W+ G+ L+E
Sbjct: 210 TTKSDVWAFGVTLWE 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 35/139 (25%), Positives = 67/139 (48%), Gaps = 12/139 (8%)

Query: 158 IALEYMDGGSLADILRMQK------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           + L +M  G L   L M +      ++P   L      +  G+ YL   ++ +HRD+   
Sbjct: 84  VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAAR 142

Query: 212 NLLVNLKGRPKITDFGISAGLENSIAM---CATFVGTVTYMSPERIRNESYSYPADIWSI 268
           N ++N      + DFG+S  + +       CA+ +  V +++ E + +  Y+  +D+W+ 
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKWLALESLADNVYTTHSDVWAF 201

Query: 269 GLALFECGT-GEFPYAASE 286
           G+ ++E  T G+ PYA  E
Sbjct: 202 GVTMWEIMTRGQTPYAGVE 220

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 8e-06
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 8/148 (5%)

Query: 164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI 223
           D GS  D   ++ ++       +  ++  G+ +L    H+VH+D+   N+LV  K   KI
Sbjct: 107 DVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFDKLNVKI 165

Query: 224 TDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEF 280
           +D G+   +   +   +    +  + +MSPE I    +S  +DIWS G+ L+E  + G  
Sbjct: 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225

Query: 281 PYAA-SEGPVNLML---QILEDPSPSPS 304
           PY   S   V  M+   Q+L  P   P+
Sbjct: 226 PYCGYSNQDVIEMIRNRQVLPCPDDCPA 253

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 42/255 (16%)

Query: 119 KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-- 176
           K  RN  L E++ L     +  ++   G     D   + +  EYM+ G L   L      
Sbjct: 60  KNARNDFLKEVKILSRLK-DPNIIRLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLD 116

Query: 177 -----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG 219
                            +I    L  +  ++  G+ YL  + + VHRD+   N LV    
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRDLATRNCLVGENL 175

Query: 220 RPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE--- 274
             KI DFG+S  L   +   +    V  + +M+ E I    ++  +D+W+ G+ L+E   
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Query: 275 -CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF--SPEFC-----SFVDDCLKKDAEA 326
            C    +     E  +    +   D      RQ +   P  C       +  C  +D   
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRD----QGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291

Query: 327 RPTADQLLSHPFITK 341
           RP+   +  H F+T+
Sbjct: 292 RPSFSDI--HAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 34/139 (24%), Positives = 65/139 (46%), Gaps = 6/139 (4%)

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMS 250
           G+ YL      VH+D+   N+L+  +   KI+D G+S  + ++    +    +  + +M 
Sbjct: 136 GMEYLSS-HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMP 194

Query: 251 PERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
           PE I    +S  +DIWS G+ L+E  + G  PY         +++++      P  ++  
Sbjct: 195 PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMVRKRQLLPCSEDCP 252

Query: 310 PEFCSFVDDCLKKDAEARP 328
           P   S + +C ++    RP
Sbjct: 253 PRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 19/64 (29%), Positives = 36/64 (56%), Gaps = 1/64 (1%)

Query: 167 SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           +  +I +  K   + ++ ++ K +L  L Y+H    + H DIKP N++V+   R  I D+
Sbjct: 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRGYIIDY 170

Query: 227 GISA 230
           GI++
Sbjct: 171 GIAS 174

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 44/201 (21%), Positives = 82/201 (40%), Gaps = 25/201 (12%)

Query: 158 IALEYMDGGSLADILR----MQKSIPEP-ILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN 212
           + LE+   G L + LR    M   + +  +L  M  ++  GL +LH     +H D+   N
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRN 130

Query: 213 LLVNLKGRPKITDFGI--SAGLENSIAMCATFVGTVTYMSPE-------RIRNESYSYPA 263
             +      KI D+G+      E+           + +++PE        +  +  +  +
Sbjct: 131 CQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS 190

Query: 264 DIWSIG---LALFECGTGEFPYAASEGPVN--LMLQILEDPSPSPSRQNFSPEFCSFVDD 318
           +IWS+G     LF      +P  + E  +   +  Q ++ P P      +S  +   +  
Sbjct: 191 NIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ-LDLKYSDRWYEVMQF 249

Query: 319 CLKKDAEARPTADQ---LLSH 336
           C   D E RPTA++   LL++
Sbjct: 250 CW-LDPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 19/52 (36%), Positives = 31/52 (59%), Gaps = 2/52 (3%)

Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LKGRPKITDFGISAGL 232
           I+ ++ +++L  L  LH    +VHRD+KP N++ +   G  KI D G +A L
Sbjct: 256 IIQTIMRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306

Length = 566

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 30/185 (16%)

Query: 161 EYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---- 215
           EY+  GSL   L+  K+ I       + K+L   L +L   + L H ++   N+L+    
Sbjct: 79  EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREE 137

Query: 216 -NLKGRP---KITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIG 269
               G P   K++D GIS   L   I      +  + ++ PE I N ++ S  AD WS G
Sbjct: 138 DRKTGNPPFIKLSDPGISITVLPKEI-----LLERIPWVPPECIENPQNLSLAADKWSFG 192

Query: 270 LALFE-CGTGEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
             L+E    G+ P +A +      LQ  ED    P+P  +      E  + ++ C+  + 
Sbjct: 193 TTLWEIFSGGDKPLSALDSQKK--LQFYEDRHQLPAPKWT------ELANLINQCMDYEP 244

Query: 325 EARPT 329
           + RP+
Sbjct: 245 DFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 2/97 (2%)

Query: 243 VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS 302
           +GT  Y++PE +  + +    D W++G+ LFE  TG  P+   E P  +   IL    P 
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF-NDETPQQVFQNILNRDIPW 599

Query: 303 PS-RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
           P   +  S    + ++  L  D   R    +L  HP 
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 17/132 (12%)

Query: 161 EYMDGGSLADILRMQKSIP--EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK 218
           E+++ G L D+   +KS     P    + K+L   LSYL   + LVH ++   N+L+  +
Sbjct: 84  EFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLARE 141

Query: 219 GRP-------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGL 270
           G         K++D GI      ++      V  + +++PE + + ++ S  AD WS G 
Sbjct: 142 GIDGECGPFIKLSDPGIPI----TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGT 197

Query: 271 ALFE-CGTGEFP 281
            L+E C  GE P
Sbjct: 198 TLWEICYNGEIP 209

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	371
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.87
smart00090	237	RIO RIO-like kinase.	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
KOG1243	690	consensus Protein kinase [General function predict	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.17
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.01
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.84
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.77
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
PRK09902	216	hypothetical protein; Provisional	98.69
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.58
PF01636	239	APH: Phosphotransferase enzyme family This family	98.58
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.4
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.38
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.31
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.15
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
PRK10593	297	hypothetical protein; Provisional	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.94
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.91
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.83
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.72
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.6
PRK05231	319	homoserine kinase; Provisional	97.57
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.52
KOG2270	520	consensus Serine/threonine protein kinase involved	97.5
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.44
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.32
PLN02236	344	choline kinase	97.3
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.18
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.17
PLN02756	418	S-methyl-5-thioribose kinase	97.12
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.91
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.9
PRK12396	409	5-methylribose kinase; Reviewed	96.58
COG2334	331	Putative homoserine kinase type II (protein kinase	96.56
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.54
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.51
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.47
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.44
PRK11768	325	serine/threonine protein kinase; Provisional	96.22
PTZ00384	383	choline kinase; Provisional	96.02
PRK06148	1013	hypothetical protein; Provisional	95.68
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.58
PTZ00296	442	choline kinase; Provisional	95.41
PRK10271	188	thiK thiamine kinase; Provisional	94.52
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.33

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-66  Score=459.16  Aligned_cols=283  Identities=48%  Similarity=0.808  Sum_probs=260.2

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ...+..++++.++.||+|+.|+||+++|+.|++.+|+|.+.. .+...++++.+|+.++.+. +|||||.+||+|+.+..
T Consensus        73 ~~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   73 DNGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             ccccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc
Confidence            355677899999999999999999999999999999999954 4667789999999999999 59999999999986554


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                       .++|+||||+||+|.+++...++++|.....|+.++++||.|||..++||||||||+|||++..|.|||||||.|+.+.
T Consensus       152 -~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  152 -EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             -eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence             7999999999999999999889999999999999999999999955899999999999999999999999999999887


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCC----CCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS----EGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      +.  ...+++||..|||||++.+..|+.++||||||++++|+++|++||...    .+...++..++.++.+......+|
T Consensus       231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS  308 (364)
T KOG0581|consen  231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS  308 (364)
T ss_pred             hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence            76  668999999999999999999999999999999999999999999874    345667777888777777666799


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcChhh
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ  361 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
                      +++++||..||++||.+|||+.|+++|||++++....++++.|+++.++|.+
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~~~~~~~  360 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRKALSPPR  360 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHHhcccCC
Confidence            9999999999999999999999999999999999999999999999997765

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-61  Score=434.52  Aligned_cols=308  Identities=29%  Similarity=0.439  Sum_probs=259.8

Q ss_pred             CCCCCCCCCceeccCCceeEeeccccccccccccccccccCCccCCCCCccccceecCcceeEeeeecccCCeEEEEEEE
Q 017445           23 AGSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVH  102 (371)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~  102 (371)
                      +...+.++.+..+.+++.+++......++-|...        ..+.+....   .-.++.|.+.+.||+|+||.|.+|..
T Consensus       125 N~e~i~k~~~r~lkN~dei~is~p~~~~~v~~~~--------s~d~~~~~p---ks~~d~yii~~~LGsGafg~Vkla~e  193 (475)
T KOG0615|consen  125 NDEMIGKGLSRILKNGDEISISIPALKIFVFEDL--------SRDSSKVPP---KSFNDYYIISKTLGSGAFGLVKLAYE  193 (475)
T ss_pred             cHhHhhccccccccCCCEEEeccchhheeeeecc--------cchhccCcc---chhcceeEeeeeecCCceeEEEEEEE
Confidence            4446677888899999999987777777666543        111111111   11456788889999999999999999


Q ss_pred             cCCCcEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhc
Q 017445          103 IPTHRIIALKKINIFE-------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ  175 (371)
Q Consensus       103 ~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~  175 (371)
                      +.||+.||||+++...       ......+.+|+++|.++. |||||+++++|.  .....||||||++||+|.+.+-.+
T Consensus       194 ~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~--~~ds~YmVlE~v~GGeLfd~vv~n  270 (475)
T KOG0615|consen  194 KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE--VPDSSYMVLEYVEGGELFDKVVAN  270 (475)
T ss_pred             cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee--cCCceEEEEEEecCccHHHHHHhc
Confidence            9999999999997521       112334679999999998 999999999884  455789999999999999999999


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCcccccccccccccCcccCCc
Q 017445          176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLENSIAMCATFVGTVTYMSPE  252 (371)
Q Consensus       176 ~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE  252 (371)
                      +.+.+.....+++|++.|+.|||+ .||+||||||+|||+..+   ..+||+|||+|+..+.. ....|.||||.|.|||
T Consensus       271 k~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~-sfm~TlCGTpsYvAPE  348 (475)
T KOG0615|consen  271 KYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG-SFMKTLCGTPSYVAPE  348 (475)
T ss_pred             cccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchhhccccc-eehhhhcCCccccChh
Confidence            999999999999999999999999 999999999999999876   67999999999988754 5668999999999999


Q ss_pred             cccCCC---CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHHHHHHHHhcccCcCCC
Q 017445          253 RIRNES---YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEFCSFVDDCLKKDAEAR  327 (371)
Q Consensus       253 ~~~~~~---~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R  327 (371)
                      ++.+..   +..++|+||+||++|-+++|.+||.....+..+..++..+.+..  +.+..++.++.+||.+||..||++|
T Consensus       349 Vl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R  428 (475)
T KOG0615|consen  349 VLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENR  428 (475)
T ss_pred             heecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccC
Confidence            997655   33478999999999999999999998888888889998887664  4567899999999999999999999


Q ss_pred             CCHHHHhcCcccccccccc
Q 017445          328 PTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       328 ps~~~il~hp~~~~~~~~~  346 (371)
                      ||++++|+||||+......
T Consensus       429 ~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  429 PSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             cCHHHHhcChhhhcccccc
Confidence            9999999999999776544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-58  Score=412.68  Aligned_cols=275  Identities=26%  Similarity=0.439  Sum_probs=243.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ...++|+++++||+|+||+|++++.++|++.+|+|++++   ......+....|..+|.+.. ||.||+++..|  ++.+
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysF--Qt~~   98 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSF--QTEE   98 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEec--ccCC
Confidence            456799999999999999999999999999999999975   23445677889999999966 99999999988  6788


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+|+||+.||.|...|++.+.|++..++.++.+|+.||.|||+ +|||||||||+|||+|.+|+++|+|||+|+....
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            999999999999999999999999999999999999999999999 9999999999999999999999999999997777


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ......++|||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+ ......++..+..+ ..+..++.++++
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-~~~~~~~I~~~k~~-~~p~~ls~~ard  255 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-VKKMYDKILKGKLP-LPPGYLSEEARD  255 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-HHHHHHHHhcCcCC-CCCccCCHHHHH
Confidence            6677788999999999999999999999999999999999999999998754 23444555555523 334568999999


Q ss_pred             HHHHhcccCcCCCC----CHHHHhcCccccccccccccHHHHHHHhcChhhh
Q 017445          315 FVDDCLKKDAEARP----TADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQR  362 (371)
Q Consensus       315 li~~~l~~dp~~Rp----s~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~~  362 (371)
                      +++++|..||++|.    ++.+|-+||||..+.++++.    .+++-||++.
T Consensus       256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~----~k~l~PpF~P  303 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL----AKKLSPPFKP  303 (357)
T ss_pred             HHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH----hcCCCCCeec
Confidence            99999999999996    68999999999999988763    5556667663

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-57  Score=426.70  Aligned_cols=261  Identities=27%  Similarity=0.479  Sum_probs=235.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+|+..+.||+|+|+.||++++..+|+.||+|++..   .....++++.+|+.+.+++. |||||+++++|  ++..++|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~F--EDs~nVY   94 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFF--EDSNNVY   94 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEe--ecCCceE
Confidence            579999999999999999999999999999999975   34556778999999999998 99999999988  7788999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||+|+|..++|..+++..++++|.+++.+++||+.||.|||+ ++|+|||||..|++++.+.++||+|||+|+.+.....
T Consensus        95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999999988999999999999999999999999 9999999999999999999999999999999987777


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ...|.||||.|+|||++.....+..+||||+||++|.||.|++||.... -.+...++.......+  ..++.++++||.
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~~Y~~P--~~ls~~A~dLI~  250 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLNEYSMP--SHLSAEAKDLIR  250 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhcCcccc--cccCHHHHHHHH
Confidence            7789999999999999999999999999999999999999999997643 3444555655555444  389999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc-ccccccccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFI-TKYEHAKVD  348 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~-~~~~~~~~~  348 (371)
                      .||+.||.+|||+++||.|+|| +++.....+
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp  282 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDHPFFKSGFTPARLP  282 (592)
T ss_pred             HHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence            9999999999999999999999 555444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-54  Score=401.10  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=231.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .....||..++.||+|+|++|++|.++.+++.||||++.+.   .+...+-+.+|-..|.++..||.|++|+-.|  ++.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecc
Confidence            44568999999999999999999999999999999998652   2333455778888888898899999999877  677


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+|+||+++|+|.++|++.+.|++..++.++.||+.||+|||+ +|||||||||+|||+|.+|+++|+|||.|+.+.
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            7999999999999999999999999999999999999999999999 999999999999999999999999999998764


Q ss_pred             ccc-------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC
Q 017445          234 NSI-------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS  300 (371)
Q Consensus       234 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  300 (371)
                      ...             ....+++||-.|++||++.....++.+|+|+|||++|+|+.|.+||.+.++ -..+.+++.-..
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~l~y  304 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQALDY  304 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHHhcc
Confidence            321             112568999999999999999999999999999999999999999988653 334455555444


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ..  +.++++.+.+||+++|..||++|+++.+|-+||||..+.++.
T Consensus       305 ~f--p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  305 EF--PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             cC--CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            33  467899999999999999999999999999999999888776

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-54  Score=374.57  Aligned_cols=269  Identities=25%  Similarity=0.453  Sum_probs=238.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH---HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE---KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ...++|++++.||.|+||.|.+++++.+|..+|+|++++...-   ..+...+|..+|.... ||+++++++.|  .+.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~--~d~~  117 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTF--KDNS  117 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEee--ccCC
Confidence            4567999999999999999999999999999999999764333   3344677888888887 99999999977  5677


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||.|++++++.++|++..++.++.||+.||+|||+ ++|++|||||+|||+|.+|++||+|||+|+....
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999999999999999999999999999999999999 9999999999999999999999999999998876


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      .   .-+.||||.|+|||.+....|+.++|+||||+++|||+.|.+||...+ +.....+++.+....+  ..+++++++
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~-~~~iY~KI~~~~v~fP--~~fs~~~kd  270 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN-PIQIYEKILEGKVKFP--SYFSSDAKD  270 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC-hHHHHHHHHhCcccCC--cccCHHHHH
Confidence            5   367899999999999999999999999999999999999999997754 5778888888876654  578999999


Q ss_pred             HHHHhcccCcCCC-----CCHHHHhcCccccccccccccHHHHHHHhcChh
Q 017445          315 FVDDCLKKDAEAR-----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM  360 (371)
Q Consensus       315 li~~~l~~dp~~R-----ps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~  360 (371)
                      |++++|+.|-.+|     ....+|..||||....+.++.    .+++-+|+
T Consensus       271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~----~r~ie~P~  317 (355)
T KOG0616|consen  271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL----QRKIEPPF  317 (355)
T ss_pred             HHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh----hccccCCC
Confidence            9999999999999     457899999999988776653    34444554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-56  Score=382.38  Aligned_cols=260  Identities=28%  Similarity=0.536  Sum_probs=229.3

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .....+|+|++.||.|.||+||++.+..+|..+|.|.+..  .+...+.....|+.+|+++. |||||++++.-+.++..
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccch
Confidence            3445689999999999999999999999999999999874  45566778999999999997 99999999955555665


Q ss_pred             eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHc--CCC-eEecCCCCCcEEEccCCceEEeccc
Q 017445          155 QISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHG--VRH-LVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~--~~~-iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                      .++||||||++|+|...++.    .+.+++..+|+++.|++.||.++|+  -+| |+||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            69999999999999998853    4569999999999999999999998  222 8999999999999999999999999


Q ss_pred             ccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          228 ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       228 ~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      +++.+........+.+|||.||+||++.+.+|+.+|||||+||++|||+.-+.||.+. +-..+..++..+..+..+...
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCCCCCcHHH
Confidence            9999988888888999999999999999999999999999999999999999999886 556677777777666555588


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +|.++..+|..|+++||..||+.     +|+++++.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence            99999999999999999999996     55555443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.3e-54  Score=398.99  Aligned_cols=268  Identities=27%  Similarity=0.441  Sum_probs=233.1

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      ...++..++|++++.||+|+||.||+|+.+.||..+|+|++++..   ....+-+..|-.+|.. ..+|+||+++.+|  
T Consensus       134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsF--  210 (550)
T KOG0605|consen  134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSF--  210 (550)
T ss_pred             ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEe--
Confidence            344778899999999999999999999999999999999998744   3444556778888887 4599999999988  


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ++..++||||||++||++..+|.+.+.+++..++.++.+++.|++.||. .|+|||||||+|+|||..|++||+|||+|+
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCCEeeccccccc
Confidence            6778999999999999999999999999999999999999999999999 999999999999999999999999999995


Q ss_pred             cCccc------------------------c-----------------------cccccccccCcccCCccccCCCCCCch
Q 017445          231 GLENS------------------------I-----------------------AMCATFVGTVTYMSPERIRNESYSYPA  263 (371)
Q Consensus       231 ~~~~~------------------------~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  263 (371)
                      -+...                        .                       ....+.+|||.|+|||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            33110                        0                       001235799999999999999999999


Q ss_pred             hHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCcc
Q 017445          264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKKDAEARPT---ADQLLSHPF  338 (371)
Q Consensus       264 Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~il~hp~  338 (371)
                      |+||||||+||||.|.+||.+ +++...+.+++.-.  ...+....+++++++||.+||+ ||.+|..   ++||-+|||
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF  447 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence            999999999999999999966 55667777776544  5566667788999999999999 9999975   999999999


Q ss_pred             ccccccccc
Q 017445          339 ITKYEHAKV  347 (371)
Q Consensus       339 ~~~~~~~~~  347 (371)
                      |+.+.+..+
T Consensus       448 F~~v~W~~l  456 (550)
T KOG0605|consen  448 FKGVDWDHL  456 (550)
T ss_pred             cccCCcchh
Confidence            999988764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-54  Score=410.62  Aligned_cols=285  Identities=25%  Similarity=0.418  Sum_probs=252.4

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..+...+|+++++||+|+||+|+++..+.+++.+|||++++   ....+.+..+.|..++....+||.+++++.+|  +.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT  440 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QT  440 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--cc
Confidence            46777899999999999999999999999999999999976   34566778889999988888999999999988  66


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ..++|+||||+.||++..+. ..+.|++..++.++..|+.||.|||+ +||||||||.+|||+|.+|++||+|||+++..
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCcEEeccccccccc
Confidence            77999999999999955544 35789999999999999999999999 99999999999999999999999999999987


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ........|+||||.|+|||++.+..|+.++|+|||||+||||+.|+.||.+++ .+.+...++......  +..++.++
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-Eee~FdsI~~d~~~y--P~~ls~ea  595 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-EEEVFDSIVNDEVRY--PRFLSKEA  595 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCCCC--CCcccHHH
Confidence            766667799999999999999999999999999999999999999999998755 355666666655443  45789999


Q ss_pred             HHHHHHhcccCcCCCCCH-----HHHhcCccccccccccccHHHHHHHhcChhh-hhhhhhhhcC
Q 017445          313 CSFVDDCLKKDAEARPTA-----DQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ-RMKDLADVST  371 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~-----~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  371 (371)
                      .++++++|..+|.+|+.+     ++|..||||..+.+.++.    .+.+-||++ +|+.-+|+|+
T Consensus       596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~----~r~i~PPf~P~i~~~~D~sn  656 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL----NRRIKPPFVPTIKGPEDVSN  656 (694)
T ss_pred             HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh----hccCCCCCCcccCChhhhcc
Confidence            999999999999999874     899999999988877653    566679999 9999999984

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-53  Score=382.53  Aligned_cols=259  Identities=30%  Similarity=0.521  Sum_probs=227.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+|.+.+.||.|+||+||+|+++.++..||||.+...  .....+....|+.+|+.+. |||||.+++++.  ..+.+||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~--~~~~i~l   86 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIE--DDDFIYL   86 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEe--cCCeEEE
Confidence            5788888999999999999999999999999999764  6677788899999999998 999999999874  4669999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC------CceEEecccccccC
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK------GRPKITDFGISAGL  232 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~------~~~kl~Dfg~s~~~  232 (371)
                      |||||+||+|.++|+..+.+++.+++.++.|++.||++||+ ++||||||||+|||++..      -.+||+|||+|+.+
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            99999999999999999999999999999999999999999 999999999999999875      46899999999988


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPE  311 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  311 (371)
                      ... ....+.||+|.|||||++....|+.|+|+||+|+++|+|++|+.||...+ ...+...+..+ ......+..+++.
T Consensus       166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t-~~eL~~~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET-PKELLLYIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhccccccCchhhhccCc
Confidence            765 45578999999999999999999999999999999999999999998754 34444443333 2333344567777


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      ..+++...+..+|..|.+..+-+.|++...-...
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~  277 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANPQD  277 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCccc
Confidence            8899999999999999999999999999766543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-54  Score=374.42  Aligned_cols=260  Identities=28%  Similarity=0.497  Sum_probs=218.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +.|+.+.++|+|+||+||++++++||+.||||++...  +....+-.++|+..|.++. |||+|.++.+|  .....++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVF--rrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVF--RRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHH--HhcceeEE
Confidence            4688899999999999999999999999999999653  2344556789999999987 99999999988  55778999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |+|||+..-|.++=.....++.+.+..+++|++.|+.|+|+ +++|||||||+|||++.+|.+||||||+|+.+......
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            99999874444443445679999999999999999999999 99999999999999999999999999999998877677


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC--------------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS--------------  300 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~--------------  300 (371)
                      .+.++.|.+|+|||.+.| .+|+..+||||+||++.||++|.+.|++.++ .+.+..+..   .-.              
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-iDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-IDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-HHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            788999999999999977 7899999999999999999999999987654 333332221   110              


Q ss_pred             ----CC-----C---CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          301 ----PS-----P---SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       301 ----~~-----~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                          +.     +   ....++.-+.+|++.||..||++|++.+++|+||||..+.+.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence                00     0   013456778899999999999999999999999999877544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=393.66  Aligned_cols=258  Identities=30%  Similarity=0.478  Sum_probs=226.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc----cH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF----EK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .....|++.+.||+|+||+|++|.+..+++.||+|+++..    .. .....+.+|+.++..+.+||||++++.++..  
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--   91 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--   91 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence            4456899999999999999999999999999999977652    11 2345667899999999889999999998854  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~  231 (371)
                      ...+|+||||+.||+|.+++...+++.+..++.++.|++.|++|||+ +||+||||||+|||++.+ +++||+|||++..
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            44699999999999999999988999999999999999999999999 999999999999999999 9999999999998


Q ss_pred             CcccccccccccccCcccCCccccCCC-CC-CchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC-
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNES-YS-YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF-  308 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  308 (371)
                      .........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||... +...+..++..+....+.  .+ 
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-~~~~l~~ki~~~~~~~p~--~~~  247 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-NVPNLYRKIRKGEFKIPS--YLL  247 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-cHHHHHHHHhcCCccCCC--CcC
Confidence            743335568899999999999998876 75 8899999999999999999999873 345556666666555543  44 


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      ++++++|+++||+.||.+|+++.+|+.||||+.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999999997

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-53  Score=396.96  Aligned_cols=258  Identities=33%  Similarity=0.618  Sum_probs=234.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ...|.....||+|+.|.||.|....+++.||||++........+-+++|+.+++... |+|||++++.|...  +.+++|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~--deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH-HPNIVNFLDSYLVG--DELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc-chHHHHHHHHhccc--ceeEEE
Confidence            356778889999999999999999999999999999888888889999999999887 99999999999764  589999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||++||+|.+.+.. ..++|.+++.|+++++.||+|||. +||+|||||.+|||++.+|.+||+|||+|..+.......
T Consensus       349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            999999999999874 459999999999999999999999 999999999999999999999999999999998877777


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  318 (371)
                      .+.+|||+|||||++....|++++||||||++++||+.|++||-. +.+...+..+... ......+..+|+++++|+.+
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence            899999999999999999999999999999999999999999976 4455555555444 45566778999999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccc
Q 017445          319 CLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ||+.|+.+|+++.++|+||||+...
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhhcC
Confidence            9999999999999999999995443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-52  Score=379.97  Aligned_cols=263  Identities=32%  Similarity=0.537  Sum_probs=224.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|...+.||+|+||.||++.+.++|+..|||.+...+....+.+.+|+.+|.++. |||||+++|.....+...++|.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEee
Confidence            346778889999999999999999999999999997654444677899999999999 9999999997433222369999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEecccccccCcc---
Q 017445          160 LEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLEN---  234 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~~---  234 (371)
                      |||+++|+|.+++...+ .+++..++.+.+|+++||+|||+ +||+||||||+|||++. ++.+||+|||.+.....   
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999998776 79999999999999999999999 99999999999999999 79999999999987663   


Q ss_pred             cccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      .........||+.|||||++.++ ....++||||+||++.||+||..||.........+..+.........+..+|.+++
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence            11223467899999999999853 34469999999999999999999997643445555666555544466778999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +|+.+|+..||.+|||++++|.|||.+.-..
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-52  Score=395.69  Aligned_cols=259  Identities=28%  Similarity=0.497  Sum_probs=229.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .-|++.+.||.|+-|.|.+|++..||+.+|||++...   .......+.+|+.+++.+. |||+++++++|  ++..++|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVw--e~~~~ly   88 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVW--ENKQHLY   88 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeee--ccCceEE
Confidence            4678889999999999999999999999999999763   2334556788888886665 99999999988  5677999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +|.||++||.|++++...+++++.++..+++||+.|+.|||. .+|+||||||+|+|+|..+++||+|||+|....+. .
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-k  166 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-K  166 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccCEeeeccceeecccCC-c
Confidence            999999999999999999999999999999999999999999 89999999999999999999999999999865554 5


Q ss_pred             ccccccccCcccCCccccCCCCC-CchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYS-YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      ...+.||+|-|.+||++.|..|. .++||||+|+|||.||+|++||.+ ++-..++.++..+.+..+  ..+++++++||
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~MP--s~Is~eaQdLL  243 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFEMP--SNISSEAQDLL  243 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcccCC--CcCCHHHHHHH
Confidence            56789999999999999998874 899999999999999999999975 444566666666655443  78999999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      ++||++||++|+|+++|++|||+.++.....
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence            9999999999999999999999999977654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-53  Score=384.70  Aligned_cols=264  Identities=25%  Similarity=0.415  Sum_probs=223.8

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ...+|.++++||.|+||.||+|+.+.+|..||||+++. ...-+.-.-++|+..|+++..||||+++.+++...+. .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence            34688999999999999999999999999999999975 2233444568999999999999999999999865443 899


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +|||||+. +|+++++.. +.|++..++.|++||++||+|+|. +|+.|||+||+|||+..+..+||+|||+|+.+... 
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-  163 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccceeEecccccccccccC-
Confidence            99999976 999999754 569999999999999999999999 99999999999999999999999999999988765 


Q ss_pred             cccccccccCcccCCccc-cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH---hhCCCCCC---------
Q 017445          237 AMCATFVGTVTYMSPERI-RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LEDPSPSP---------  303 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~---------  303 (371)
                      ...+.++.|.+|+|||++ +.+.|+.+.||||+|||++|+++-++.|++.++ .+.+.++   ++.+....         
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhHHHHHH
Confidence            455788999999999998 667799999999999999999999999987553 4444443   22221110         


Q ss_pred             ----------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          304 ----------------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       304 ----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                                      ....++.++.++|.+|+.+||++|||+.++|+||||+.-.....
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~  302 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS  302 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence                            01346789999999999999999999999999999987655433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-51  Score=369.34  Aligned_cols=287  Identities=32%  Similarity=0.574  Sum_probs=240.4

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+..+.....+|++...||.|..++||+|+...+++.||||+++... ......+.+|+..+..+. ||||++++..|..
T Consensus        17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID-HPNIVTYHCSFVV   95 (516)
T ss_pred             ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC-CCCcceEEEEEEe
Confidence            34566677789999999999999999999999999999999998632 334677889999887776 9999999999976


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                        +..+++||.||.+|++.++++..  ..++|..+..|.++++.||.|||. +|.||||||+.||||+.+|.|||+|||.
T Consensus        96 --~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   96 --DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             --cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCCcEEEcCcee
Confidence              45899999999999999999754  459999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccc---c-ccccccCcccCCcccc--CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC
Q 017445          229 SAGLENSIAM---C-ATFVGTVTYMSPERIR--NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS  302 (371)
Q Consensus       229 s~~~~~~~~~---~-~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  302 (371)
                      +..+.+....   . .+++|||+|||||++.  ...|+.|+||||||++..||.+|..||.. -.++..+...+.+.++.
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k-~pPmkvLl~tLqn~pp~  251 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK-YPPMKVLLLTLQNDPPT  251 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCCCCC
Confidence            8776543322   2 5679999999999963  35699999999999999999999999965 34566666666666553


Q ss_pred             CC--------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcChhhhh
Q 017445          303 PS--------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM  363 (371)
Q Consensus       303 ~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (371)
                      ..        ...++..+..++..||+.||++|||++++|+|+||++....++-.-..+.++-+...+.
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~l~~r~  320 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPPLGTRF  320 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCcHHHHH
Confidence            22        24567789999999999999999999999999999998887766555555554444433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-52  Score=380.76  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=222.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ....+.|+.+++||+|+||.||+|++..||+.||+|++....  ........+|+.+|+++. ||||+++.+..+....+
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCc
Confidence            444578999999999999999999999999999999997643  445566789999999997 99999999998877678


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      .+|||+|||+. +|..++...+ .|++.++..+++|++.||+|||+ +||+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            99999999987 9999987543 69999999999999999999999 999999999999999999999999999999765


Q ss_pred             ccc-cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHHHHHhhCCCCCCC-----
Q 017445          234 NSI-AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLMLQILEDPSPSPS-----  304 (371)
Q Consensus       234 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~-----  304 (371)
                      ... ...++.+-|++|+|||.+.|. .|+.++|+||+||||.||++|++.|.+..+-+  ..++++...+.....     
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            543 346778899999999999765 59999999999999999999999998866432  223444433322111     


Q ss_pred             -------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          305 -------------------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       305 -------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                         ...++....+|+..||..||++|.|+.++|.|+||
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence                               12457888899999999999999999999999999

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-51  Score=361.60  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=225.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|+.+.+|++|+||.||+|+++.|++.||+|+++....  .---..++|+.+|.+.. |||||.+..+....+-+.+|
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence            4789999999999999999999999999999999976321  12234689999999998 99999999998887778899


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||||||+. +|..+++.-+ +|...++..++.|++.|++|||. +.|+||||||+|+|+++.|.+||+|||+|+.++.+.
T Consensus       154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999987 9999997654 89999999999999999999999 999999999999999999999999999999999988


Q ss_pred             cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhCCCCCCCC--------
Q 017445          237 AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSR--------  305 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~--------  305 (371)
                      ...+..+-|++|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+..+.  .+.+++.+..+.....+        
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            88888899999999999866 45999999999999999999999999876543  23344444443321110        


Q ss_pred             -------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          306 -------------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       306 -------------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                                         ..+++...+|+..+|..||.+|.|+++.|+|+||....
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                               11458889999999999999999999999999998853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.6e-51  Score=346.15  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=218.5

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+|...++||+|+||.||+|++..||+.||||+++..+  .......++|+..|..+. |+||+.++++|  +..+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F--~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVF--PHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-Ccchhhhhhhc--cCCCceEE
Confidence            46778889999999999999999999999999997632  223456789999999887 99999999998  55668999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |+||++- +|...++.. ..++...+..++.+++.||+|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9999975 999988643 568999999999999999999999 9999999999999999999999999999999887765


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhCCCCCCCC---------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSR---------  305 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~---------  305 (371)
                      .....+-|.+|+|||.+.| ..|+..+|+||.||++.||+.|.+-|.+.++-  ...++..+.++.+...+         
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            5555689999999999876 46999999999999999999999888775532  22334444444332221         


Q ss_pred             --------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          306 --------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       306 --------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                    ...++++.+|+.+|+..||.+|+++.|+|+|+||+....
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence                          234678899999999999999999999999999986433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-50  Score=373.89  Aligned_cols=254  Identities=30%  Similarity=0.500  Sum_probs=217.4

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcE-EEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRI-IALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +.+...++.+.+.||+|+||+||+|.+..+  . ||+|++....  ......+.+|+.++.++. |||||+++|++..+.
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSPP  112 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence            445556667777899999999999988544  5 9999997532  222668999999999987 999999999885322


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCC-eEecCCCCCcEEEccCC-ceEEecccc
Q 017445          153 SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLLVNLKG-RPKITDFGI  228 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~-iiH~Dlkp~NIl~~~~~-~~kl~Dfg~  228 (371)
                       ..++|||||+++|+|.++++.  .+.+++..+..++.||+.|+.|||+ ++ ||||||||+|||++.++ ++||+|||+
T Consensus       113 -~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  113 -GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             -CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence             269999999999999999987  5789999999999999999999999 88 99999999999999998 999999999


Q ss_pred             cccCcccccccccccccCcccCCcccc--CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIR--NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ++.............||+.|||||++.  ...|+.++||||||+++|||+||+.||..... ......+.........+.
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCc
Confidence            987765433334478999999999999  56899999999999999999999999987665 666666666666666666


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+..++.+||..||++||++.+|+.
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            79999999999999999999999998873

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-51  Score=380.44  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=230.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.+.  .+...+.+.+|++++++++ ||||+.+++.|  +...++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esf--Et~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESF--ETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhh--cccceEEE
Confidence            4788889999999999999999999999999999763  4456677999999999998 99999999977  67889999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |+||+.| +|..++...+.++|+.+..++.+++.||.|||+ ++|+|||+||.|||++..|++|+||||+|+........
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            9999987 999999999999999999999999999999999 99999999999999999999999999999988887777


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      .+...|||.|||||...+..|+..+|+||+||++||++.|++||.... -..++..++..+...+  ...+..+..|++.
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i~~Lv~~I~~d~v~~p--~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-ITQLVKSILKDPVKPP--STASSSFVNFLQG  233 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-HHHHHHHHhcCCCCCc--ccccHHHHHHHHH
Confidence            788899999999999999999999999999999999999999997533 3455566666655544  4899999999999


Q ss_pred             hcccCcCCCCCHHHHhcCcccccc
Q 017445          319 CLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      +|.+||.+|.+-.+++.|||.++-
T Consensus       234 LL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HhhcChhhcccHHHHhcChHHhhh
Confidence            999999999999999999998654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=359.67  Aligned_cols=263  Identities=28%  Similarity=0.450  Sum_probs=220.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEec--cccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe---cCCCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM---PDSGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~---~~~~~~  156 (371)
                      .|..++.||.|+||.|..|.++.+|+.||||++.  .......++..+|+..|+.+. |+||+.+.+.+..   .+-..+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccccccee
Confidence            4455789999999999999999999999999997  356677888999999999998 9999999999865   233569


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc-
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS-  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~-  235 (371)
                      |+|+|+|+ .+|...++.+..+++..+..+++|++.||+|+|| .+|+||||||+|++++.+..+||||||+|+..... 
T Consensus       102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999994 5999999988889999999999999999999999 99999999999999999999999999999887542 


Q ss_pred             -ccccccccccCcccCCccc-cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHHHHHhhCCC-----------
Q 017445          236 -IAMCATFVGTVTYMSPERI-RNESYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLMLQILEDPS-----------  300 (371)
Q Consensus       236 -~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~-----------  300 (371)
                       ....+..+.|.+|+|||.+ ....|+.+.||||+|||+.||++|++.|.+.+.-.  .++...+..+.           
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             2334677899999999998 45679999999999999999999999998754211  11111111111           


Q ss_pred             ---------C-C-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          301 ---------P-S-----PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       301 ---------~-~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                               . .     ...++.++.+.+|+++||..||.+|+|++|+|.|||+..|....-
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d  321 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED  321 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence                     0 0     111467899999999999999999999999999999999865443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-52  Score=349.52  Aligned_cols=259  Identities=31%  Similarity=0.479  Sum_probs=225.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+.|.+.+.||+|.|+.||++.+..||+.+|+|+++.  ......+.+.+|+.+-..++ ||||+++.+.+  .+.+..|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti--~~~~~~y   86 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSI--QEESFHY   86 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhh--cccceeE
Confidence            4577888899999999999999999999999999864  23335566778888776666 99999999966  6678999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~  234 (371)
                      ||+|+++|++|..-|-...-+++..+...+.||++||.|+|. +||||||+||.|+++...   .-+||+|||+|..+..
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999999999776655668999999999999999999999 999999999999999543   4699999999998884


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--CCCCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  312 (371)
                       ......++|||.|||||+++...|+..+|||++|++||-|+.|.+||.+. ....+..+++.+..  +.+.+..+++++
T Consensus       166 -g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  166 -GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             -ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhccccCCCCcccCcCCHHH
Confidence             45567889999999999999999999999999999999999999999763 34667777877765  445678999999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ++|+++||..||.+|+|+.|+|+|||+.+-+.
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~  275 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRER  275 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence            99999999999999999999999999986543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7e-49  Score=367.61  Aligned_cols=275  Identities=39%  Similarity=0.698  Sum_probs=231.1

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..++|++.+.||+|+||.||++.+..++..+|+|.+... .......+.+|+.++.++. ||||+++++++.  +.+.++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~   79 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGEIS   79 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECCEEE
Confidence            457899999999999999999999999999999998753 3344567889999999886 999999999875  356899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+..+|+||||||+||+++.++.++|+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999999999888889999999999999999999998346999999999999999999999999998766433  


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH---------------------------
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---------------------------  290 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~---------------------------  290 (371)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........                           
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            22455799999999999988899999999999999999999999965332110                           


Q ss_pred             ------------------HHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHH
Q 017445          291 ------------------LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAF  352 (371)
Q Consensus       291 ------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~  352 (371)
                                        ....+.....+......+++++.+|+.+||+.||++|||+.+++.||||+.......+...|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~  317 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEVDFAGW  317 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccccHHHH
Confidence                              00111111122222335788999999999999999999999999999999999999998888


Q ss_pred             HHHhcC
Q 017445          353 VRSVFD  358 (371)
Q Consensus       353 ~~~~~~  358 (371)
                      +...++
T Consensus       318 ~~~~~~  323 (331)
T cd06649         318 LCKTLR  323 (331)
T ss_pred             HHHhhc
Confidence            877664

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=372.28  Aligned_cols=257  Identities=33%  Similarity=0.616  Sum_probs=227.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..|..++.||+|+||.||+|.+..+++.||+|+++.. .+.....+..|+..+..+. ++||.++|+.|..  +..++|+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~--g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLK--GTKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheee--cccHHHH
Confidence            4566778999999999999999999999999999873 3445577888999998887 8999999999976  4479999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||||.||++.+.++..+.+++..+..++++++.||.|||+ .+.+|||||+.|||+..+|.+||+|||++.++.......
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            9999999999999987777999999999999999999999 999999999999999999999999999999988877777


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      .+++|||.|||||++.+..|+.++||||||++.+||++|.+|+..- .++..+..+-...+|.. ...+++.+++|+..|
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~-hPmrvlflIpk~~PP~L-~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL-HPMRVLFLIPKSAPPRL-DGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc-CcceEEEeccCCCCCcc-ccccCHHHHHHHHHH
Confidence            9999999999999999989999999999999999999999999653 34444444444444433 348999999999999


Q ss_pred             cccCcCCCCCHHHHhcCccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      |+.||+.||++.++|+|+|++...
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHhcC
Confidence            999999999999999999999844

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-49  Score=356.80  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=231.4

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      -.+..++|++++.||.|.-|+||+|....++..+|+|++.+..   .....+...|-++|..+. ||.++.+|..|  +.
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~f--et  148 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASF--ET  148 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhhee--ec
Confidence            3455678999999999999999999999999999999997633   334455677888887776 99999999988  56


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +...|+|||||+||+|..+.+++  +.|++..++.++.+++.||+|||- .|||+|||||+||||.++|++.|+||.++.
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccc
Confidence            77999999999999999998765  469999999999999999999999 999999999999999999999999999874


Q ss_pred             cCcc-----------------------------------c---------------------ccccccccccCcccCCccc
Q 017445          231 GLEN-----------------------------------S---------------------IAMCATFVGTVTYMSPERI  254 (371)
Q Consensus       231 ~~~~-----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~  254 (371)
                      ....                                   .                     .....+++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                   0                     0112456899999999999


Q ss_pred             cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC----H
Q 017445          255 RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT----A  330 (371)
Q Consensus       255 ~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~  330 (371)
                      .|...+.++|+|+||+++|||+.|.-||.+.++ ...+.+++..+...+....++..+++||+++|.+||++|..    +
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA  386 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA  386 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence            999999999999999999999999999998665 45677888887777776788999999999999999999999    9


Q ss_pred             HHHhcCccccccccc
Q 017445          331 DQLLSHPFITKYEHA  345 (371)
Q Consensus       331 ~~il~hp~~~~~~~~  345 (371)
                      .||-+||||.+.+|.
T Consensus       387 ~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  387 AEIKRHPFFEGVNWA  401 (459)
T ss_pred             HHhhcCccccCCChh
Confidence            999999999999876

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-50  Score=365.39  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=226.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--------------HHHHHHHHHHHHHHhCCCCCCee
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--------------EKRNQLLTEIRTLCEAPCNEGLV  142 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~~~~h~~iv  142 (371)
                      +...++|++.+.||+|.||.|.+|.+..+++.||||++.+...              ...+++.+|+.++.++. |||||
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV  171 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVV  171 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCee
Confidence            4456799999999999999999999999999999999864221              12347889999999997 99999


Q ss_pred             EeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCce
Q 017445          143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP  221 (371)
Q Consensus       143 ~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~  221 (371)
                      +++.+.-.+....+|||+|||..|.+...=. .++ +++.+++.++.+++.||+|||. +|||||||||+|+|++.+|++
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcCCCcE
Confidence            9999988888899999999999988765322 334 8999999999999999999999 999999999999999999999


Q ss_pred             EEecccccccCc-----ccccccccccccCcccCCccccCCC----CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 017445          222 KITDFGISAGLE-----NSIAMCATFVGTVTYMSPERIRNES----YSYPADIWSIGLALFECGTGEFPYAASEGPVNLM  292 (371)
Q Consensus       222 kl~Dfg~s~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~  292 (371)
                      ||+|||.+....     .........+|||.|+|||...++.    -+.+.||||+|++||.|+.|+.||-+. ....+.
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~~~~l~  328 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-FELELF  328 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-hHHHHH
Confidence            999999997652     2222234478999999999986632    356789999999999999999999764 346778


Q ss_pred             HHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          293 LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .++++.+...+....+..++++||.+||++||.+|.++.+|..|||..+.
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            88999988888877899999999999999999999999999999999876

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.8e-49  Score=369.06  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=220.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..+. ||||+++++.+.  +.+.
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~   92 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQ--DENR   92 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--cCCE
Confidence            4578999999999999999999999999999999986532   233456788999998886 999999999874  4668


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999999999888889999999999999999999999 99999999999999999999999999999766443


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      .   .+..||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+......  .+..++..+.+|
T Consensus       172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~--~p~~~~~~~~~l  245 (329)
T PTZ00263        172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGRLK--FPNWFDGRARDL  245 (329)
T ss_pred             c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCcC--CCCCCCHHHHHH
Confidence            2   34679999999999999999999999999999999999999997543 33444455444332  335688999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCcccccccc
Q 017445          316 VDDCLKKDAEARPT-----ADQLLSHPFITKYEH  344 (371)
Q Consensus       316 i~~~l~~dp~~Rps-----~~~il~hp~~~~~~~  344 (371)
                      +++||+.||.+||+     +.+++.||||....+
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence            99999999999997     799999999987543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-49  Score=362.79  Aligned_cols=255  Identities=24%  Similarity=0.384  Sum_probs=219.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.++.++. ||||+++++.+  .+...+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--~~~~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTE--HDQRFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhh--ccCCeEE
Confidence            37889999999999999999999999999999986522   233456778999998886 99999999876  4567899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            999999999999999888889999999999999999999999 99999999999999999999999999998766433  


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                       ..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+......  .+..++..+.+|++
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~--~~~~~~~~~~~li~  230 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-PFGIYEKILAGKLE--FPRHLDLYAKDLIK  230 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCcC--CCccCCHHHHHHHH
Confidence             234579999999999998889999999999999999999999997644 33344444444332  23457899999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCccccccccc
Q 017445          318 DCLKKDAEARPT-----ADQLLSHPFITKYEHA  345 (371)
Q Consensus       318 ~~l~~dp~~Rps-----~~~il~hp~~~~~~~~  345 (371)
                      +||+.||.+||+     ++++++||||....+.
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            999999999995     9999999999876654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-49  Score=368.76  Aligned_cols=251  Identities=27%  Similarity=0.418  Sum_probs=214.4

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|.+..+|+.||+|+++..   .......+.+|+.++.++. ||||+++++.+.  +...+||||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~e~~~   78 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQ--THDRLCFVMEYAN   78 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence            699999999999999999999999998752   2234456778899988886 999999999774  5668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.............+|
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence            99999999888899999999999999999999999 99999999999999999999999999998754333333455679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++||||+||++|+|++|..||...+ .......+.....  ..+..+++++.+|+++||+.||
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05571         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCCH
Confidence            999999999999999999999999999999999999997643 2333333333322  2345789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccccccc
Q 017445          325 EARP-----TADQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rp-----s~~~il~hp~~~~~~~~  345 (371)
                      ++||     ++.++++||||....+.
T Consensus       235 ~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         235 KQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             HHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999     89999999999886544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-50  Score=342.54  Aligned_cols=281  Identities=34%  Similarity=0.633  Sum_probs=245.5

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..+....++.++++.||.|+.|+|+++..+.+|...|||.+.. .+++..++++..+.++++...+|+||+.+|+|..  
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--  162 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--  162 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--
Confidence            3455556788889999999999999999999999999999976 5667788899999999888789999999999975  


Q ss_pred             CCeEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +..++|.||.|.- -+..++. ..++++|..+-++...++.||.||...+||+|||+||+|||+|..|++||||||.+.+
T Consensus       163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            3468899999853 5555554 3578999999999999999999999877999999999999999999999999999998


Q ss_pred             CcccccccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCC-CC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QN  307 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~  307 (371)
                      +.+.... +...|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.+.+.+...+.++++..++.... ..
T Consensus       242 lvdSkAh-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  242 LVDSKAH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG  320 (391)
T ss_pred             eeccccc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence            8776433 55679999999999954   4689999999999999999999999999887788888888766554433 44


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcC
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD  358 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~  358 (371)
                      +++.+++|+..||+.|+.+||...++|+|||+..++..++++++|...+..
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~  371 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMA  371 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHh
Confidence            999999999999999999999999999999999999999999999999873

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4e-49  Score=367.49  Aligned_cols=252  Identities=23%  Similarity=0.384  Sum_probs=215.6

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.++.+++.||+|++...   .......+..|..++....+||||+++++++.  +...+|+||||++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~~   79 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFVN   79 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCCC
Confidence            699999999999999999999999998642   22344567788888888778999999999874  5668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............|
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            99999999888899999999999999999999999 99999999999999999999999999998754333333355679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++||||+||++|+|++|..||...+ .......+......  .+..++.++.+|+++||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEVV--YPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHcccCH
Confidence            999999999999899999999999999999999999997644 33444444443332  334689999999999999999


Q ss_pred             CCCCCH------HHHhcCccccccccc
Q 017445          325 EARPTA------DQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps~------~~il~hp~~~~~~~~  345 (371)
                      .+||++      ++++.||||..+.+.
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999998      999999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-48  Score=369.08  Aligned_cols=260  Identities=23%  Similarity=0.410  Sum_probs=215.3

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++...   ......+..|+.++..+. ||||+++++.+  .+...+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~--~~~~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSF--QDKLNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEE--ecCCeEE
Confidence            47899999999999999999999999999999996522   233455777888888876 99999999987  4566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      |||||++||+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++....... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999999999888899999999999999999999999 999999999999999999999999999987543210 


Q ss_pred             ----------------------------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCC
Q 017445          237 ----------------------------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY  282 (371)
Q Consensus       237 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf  282 (371)
                                                        ....+.+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0012457999999999999999999999999999999999999999


Q ss_pred             CCCCCcHHHHHHHhhC--CCCCCCCCCCCHHHHHHHHHhcccCcC---CCCCHHHHhcCcccccccccc
Q 017445          283 AASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDDCLKKDAE---ARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~---~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .... ......++...  ....+....+++++.+++.+|+. +|.   .||++++|++||||....+..
T Consensus       237 ~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         237 CSET-PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCC-HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            7643 33444444432  22233334578999999999775 444   458999999999999876544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-48  Score=357.42  Aligned_cols=260  Identities=24%  Similarity=0.380  Sum_probs=216.6

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      |++.+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+.++.++. |++|+++++.+.  +.+..++|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~--~~~~~~lv   78 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYE--TKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEc--cCCeEEEE
Confidence            678889999999999999999999999999986422   223345778999998886 999999999774  45689999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++|+|||++....... 
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999999999887542  368999999999999999999999 999999999999999999999999999987654332 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......  ..+...+.. .....+..++.++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~l  235 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-DQEEYSEKFSEDAKSI  235 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-ccccCCccCCHHHHHH
Confidence            2245579999999999999999999999999999999999999997654321  122222222 2223445689999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCcccccccccccc
Q 017445          316 VDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       316 i~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~~  348 (371)
                      +++||+.||.+||+     ++++++||||.....++++
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE  273 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence            99999999999997     8999999999988776654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-48  Score=363.97  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=219.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +|++++.||+|+||.||+|.+..+++.||+|++...   .......+..|..++..+.+|++|+++++++.  +.+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence            588999999999999999999999999999998752   23345567788888888876778999988774  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            99999999999999888889999999999999999999999 99999999999999999999999999998654332233


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.....  ..+..++.++.+++++
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~li~~  234 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-EDELFQSIMEHNV--SYPKSLSKEAVSICKG  234 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence            345679999999999999999999999999999999999999997643 3344444444332  2345689999999999


Q ss_pred             hcccCcCCCCCH-----HHHhcCcccccccccc
Q 017445          319 CLKKDAEARPTA-----DQLLSHPFITKYEHAK  346 (371)
Q Consensus       319 ~l~~dp~~Rps~-----~~il~hp~~~~~~~~~  346 (371)
                      ||..||.+|++.     .++++||||....+.+
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~  267 (324)
T cd05587         235 LLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK  267 (324)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            999999999986     8999999998875543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-48  Score=365.86  Aligned_cols=264  Identities=23%  Similarity=0.388  Sum_probs=223.2

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCC-cEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTH-RIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ......+..++|.+.+.||+|+||.||+|.+..++ ..||+|++...   .......+.+|+.++..+. ||||++++++
T Consensus        21 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~   99 (340)
T PTZ00426         21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGS   99 (340)
T ss_pred             cccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEE
Confidence            34455667789999999999999999999876654 68999998642   2234456778999888886 9999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                      +.  +.+.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus       100 ~~--~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        100 FK--DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EE--eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCC
Confidence            74  456899999999999999999888899999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          228 ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       228 ~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ++......   ..+.+||+.|+|||++.+..++.++||||+||++|+|++|..||...+ .......+.....  ..+..
T Consensus       177 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~i~~~~~--~~p~~  250 (340)
T PTZ00426        177 FAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-PLLIYQKILEGII--YFPKF  250 (340)
T ss_pred             CCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-HHHHHHHHhcCCC--CCCCC
Confidence            99765432   245679999999999998889999999999999999999999997643 3333444444332  23456


Q ss_pred             CCHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHA  345 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~  345 (371)
                      +++.+.+++++||+.||.+|+     +++++++||||..+.+.
T Consensus       251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            889999999999999999995     89999999999876543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-48  Score=365.06  Aligned_cols=257  Identities=27%  Similarity=0.452  Sum_probs=218.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.++..+. ||||+++++.+.  +....|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~--~~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQ--DDEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEE--cCCEEE
Confidence            36899999999999999999999999999999997532   234456788999998887 999999999774  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....   
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999999999888889999999999999999999999 9999999999999999999999999999876544   


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC------CCCCCCCCCCHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP------SPSPSRQNFSPE  311 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~  311 (371)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+....      ........++++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-PNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-HHHHHHHHHhccccccCCCCCccccccCHH
Confidence            2345679999999999998899999999999999999999999997644 233333332211      111111356899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +.+|+.+||..+|.+||++.++++||||......
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence            9999999999999999999999999999976543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-48  Score=361.80  Aligned_cols=276  Identities=38%  Similarity=0.672  Sum_probs=229.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|.+... .......+.+|+.++..+. ||||+++++++..  .+.++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS--DGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEE--CCEEE
Confidence            457899999999999999999999999999999998753 3344567889999999887 9999999998854  56899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+..+++||||||+||+++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999999999888889999999999999999999997347999999999999999999999999998765432  


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--------------------------
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--------------------------  291 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--------------------------  291 (371)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.........                          
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            223457899999999999888999999999999999999999999753321100                          


Q ss_pred             -----------------HHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHH
Q 017445          292 -----------------MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVR  354 (371)
Q Consensus       292 -----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~  354 (371)
                                       ...+.....+......++.++.+|+.+||+.||++|||+.+++.||||+....+..+...|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~  317 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWLC  317 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccccccHHHHHH
Confidence                             011111111222223467899999999999999999999999999999998888888889986


Q ss_pred             HhcCh
Q 017445          355 SVFDP  359 (371)
Q Consensus       355 ~~~~~  359 (371)
                      ....|
T Consensus       318 ~~~~~  322 (333)
T cd06650         318 STIGL  322 (333)
T ss_pred             HHHhh
Confidence            65544

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.6e-50  Score=341.52  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=224.9

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .|.-.+.||.|..++|.++.++.+|..+|+|++....        ..-.+....|+.+|+++..||+|+++.+.|  +..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~   95 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESD   95 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCc
Confidence            4455568999999999999999999999999986411        123455678999999999999999999977  567


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+|+|.|+.|.|+|+|...-.++++..+.|++|+++|++|||. ++|+||||||+|||++++.++||+|||+|+.+.
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            7899999999999999999888889999999999999999999999 999999999999999999999999999999998


Q ss_pred             ccccccccccccCcccCCccccC------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSR  305 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~  305 (371)
                      ..... ...||||+|.|||.+..      ..|+..+|+||+|+++|.|+.|.+||-... ++-.+..+.++...  .+.+
T Consensus       175 ~GekL-relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-QmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  175 PGEKL-RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-QMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             CchhH-HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-HHHHHHHHHhcccccCCcch
Confidence            77544 67899999999999853      468889999999999999999999997532 34556666776654  4556


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .+++.+.++||.+||+.||.+|.|++++|.||||.++-.
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            789999999999999999999999999999999976633

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.7e-48  Score=358.24  Aligned_cols=260  Identities=21%  Similarity=0.359  Sum_probs=210.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+|+.++..+. ||||+++++++.  +....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIH--TKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEe--cCCeEEE
Confidence            3689999999999999999999999999999999875322 23345678999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+. ++|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            999996 5888877643 568999999999999999999999 9999999999999999999999999999875543333


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh---hCCCCC-----------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL---EDPSPS-----------  302 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~-----------  302 (371)
                      ......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.........+..+.   ..+...           
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            3345678999999999865 4588999999999999999999999986544333222221   111000           


Q ss_pred             -------C---------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          303 -------P---------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       303 -------~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                             .         ....+++++.+|+.+||+.||++|||+.++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                   0         00124578999999999999999999999999999987654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-48  Score=361.89  Aligned_cols=253  Identities=28%  Similarity=0.421  Sum_probs=214.7

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      +.||+|+||.||++.+..+|+.||+|++...   .......+.+|+.++..+. ||||++++++|.  ..+.+||||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~--~~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCEEEEEEeCC
Confidence            3699999999999999999999999998752   2234456678888888886 999999999874  456899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++|+|..++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..............
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence            999999999888889999999999999999999999 9999999999999999999999999999875433333334567


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD  323 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  323 (371)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+.....  ..+..+++++.+++.+||+.|
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCC
Confidence            9999999999999999999999999999999999999997643 2333344433332  234578999999999999999


Q ss_pred             cCCCC-----CHHHHhcCcccccccccc
Q 017445          324 AEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       324 p~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      |++||     ++.++++||||.+..+..
T Consensus       234 P~~R~~~~~~~~~~~l~h~~~~~~~~~~  261 (323)
T cd05595         234 PKQRLGGGPSDAKEVMEHRFFLSINWQD  261 (323)
T ss_pred             HHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            99998     899999999998876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-48  Score=362.32  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=227.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ...|.+.+.||.|.||.||+++++.||+.+|+|.+....   ......+.+|+.+|.++..|||||.++++|  ++...+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~~~  111 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF--EDPDSV  111 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCCeE
Confidence            357888899999999999999999999999999997532   234578999999999999999999999988  456689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC----CceEEecccccccC
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK----GRPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~----~~~kl~Dfg~s~~~  232 (371)
                      ++|||++.||.|.+.+... .+++..+..++.|++.|+.|||+ .||+||||||+|+|+...    +.+|++|||+|...
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            9999999999999998765 49999999999999999999999 999999999999999643    47999999999988


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--CCCCCCCCCH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSP  310 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  310 (371)
                      .. .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.... ....++..+..  ....+..++.
T Consensus       190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-EIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-HHHHHHHcCCCCCCCCCccccCH
Confidence            77 45667889999999999999999999999999999999999999999876543 33345555543  4566788899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+.+||++|+..||.+|+|+.++|+|||+....
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            999999999999999999999999999999863

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-48  Score=362.61  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=216.7

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|++...   .......+..|..++..+.+||||+++++++.  +.+.+|+||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~   79 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYVN   79 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCCC
Confidence            699999999999999999999999998752   22344556788888887778999999999884  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|..++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............|
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            99999999888889999999999999999999999 99999999999999999999999999998764433333455679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+......  .+..++.++.+++.+||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-EDDLFESILHDDVL--YPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhccCH
Confidence            999999999998899999999999999999999999997644 34444555444332  234688999999999999999


Q ss_pred             CCCC-------CHHHHhcCcccccccccc
Q 017445          325 EARP-------TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       325 ~~Rp-------s~~~il~hp~~~~~~~~~  346 (371)
                      ++||       ++.++++||||..+.+..
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~~~~~  264 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEIDWVL  264 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence            9999       999999999998776544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-48  Score=367.61  Aligned_cols=259  Identities=26%  Similarity=0.451  Sum_probs=220.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|.+..+++.||||+++...   ......+..|+.++..+. ||||+++++.+  .+...+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~--~~~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSF--QDEEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhhe--ecCCeEE
Confidence            37899999999999999999999999999999997522   234456778888888876 99999999987  4566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999999888889999999999999999999999 999999999999999999999999999997665432 


Q ss_pred             ----------------------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc
Q 017445          237 ----------------------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP  288 (371)
Q Consensus       237 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~  288 (371)
                                                  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~  235 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-L  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-H
Confidence                                        12345579999999999999999999999999999999999999997654 3


Q ss_pred             HHHHHHHhh--CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCccccccccc
Q 017445          289 VNLMLQILE--DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT-ADQLLSHPFITKYEHA  345 (371)
Q Consensus       289 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~il~hp~~~~~~~~  345 (371)
                      .....++..  .....+....+++++.+||.+||. ||.+||+ +.++++||||......
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence            334444444  233333334579999999999997 9999999 9999999999876554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.2e-48  Score=368.46  Aligned_cols=259  Identities=27%  Similarity=0.492  Sum_probs=214.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +.|++++.||+|+||+||+|.+..+++.||+|++...   .......+.+|+.++..+. ||||+++++.+.  +...+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~--~~~~~~   77 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNLY   77 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEe--cCCEEE
Confidence            3688999999999999999999999999999999652   2334456788999888876 999999999874  466899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      +||||++||+|.+++...+.+++..+..++.|++.||.|||+ .||+||||||+|||++.++++||+|||++....... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999999999888889999999999999999999999 999999999999999999999999999875321000 


Q ss_pred             ----------------------------------------------cccccccccCcccCCccccCCCCCCchhHHHHHH
Q 017445          237 ----------------------------------------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGL  270 (371)
Q Consensus       237 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  270 (371)
                                                                    ....+.+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0112457999999999999888999999999999


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHhh--CCCCCCCCCCCCHHHHHHHHHhcc--cCcCCCCCHHHHhcCcccccccc
Q 017445          271 ALFECGTGEFPYAASEGPVNLMLQILE--DPSPSPSRQNFSPEFCSFVDDCLK--KDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       271 il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~--~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ++|||++|..||..... ......++.  .....+....+++++.+|+.+|+.  .+|..|+++.+++.||||....+
T Consensus       237 il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         237 ILFEMLVGQPPFLAPTP-TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHHHhCCCCCcCCCH-HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            99999999999976543 333333432  223333345689999999999654  45556999999999999987654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6e-48  Score=354.30  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++.+.||.|+||+||+|.+..+++.||+|+++... ......+.+|+.++.++. ||||+++++++.  .....++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~l   80 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIH--TERCLTL   80 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEc--CCCeEEE
Confidence            457999999999999999999999999999999986532 223445678999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+++ +|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9999975 9999886544 57999999999999999999999 9999999999999999999999999999876544333


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCCC-------------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSP-------------  301 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~-------------  301 (371)
                      ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.......  +.+....+..             
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            3345678999999999865 56899999999999999999999999765432221  1111111100             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          302 ------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       302 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                  ......+++++.+|+++||+.||.+|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                        00113467899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-48  Score=360.44  Aligned_cols=258  Identities=23%  Similarity=0.380  Sum_probs=219.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...   ..........|..++....+|++|+++++++.  +.+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEE
Confidence            578899999999999999999999999999998752   22334456778888877777999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            99999999999999888889999999999999999999999 99999999999999999999999999998754433333


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+......  .+..++.++.+++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~~li~~  234 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVA--YPKSMSKEAVAICKG  234 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC--CCCcCCHHHHHHHHH
Confidence            355679999999999999999999999999999999999999997644 34444555444332  345689999999999


Q ss_pred             hcccCcCCCCC-----HHHHhcCccccccccc
Q 017445          319 CLKKDAEARPT-----ADQLLSHPFITKYEHA  345 (371)
Q Consensus       319 ~l~~dp~~Rps-----~~~il~hp~~~~~~~~  345 (371)
                      ||+.||++|++     ..++++||||....+.
T Consensus       235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         235 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             HcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999998     4899999999876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.3e-48  Score=361.75  Aligned_cols=251  Identities=26%  Similarity=0.414  Sum_probs=213.6

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||++.+..+++.||+|++...   .......+.+|+.++..+. ||||+++++.+  .+...+|+||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--~~~~~~~lv~Ey~~   78 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSF--QTKDRLCFVMEYVN   78 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEE--EcCCEEEEEEeCCC
Confidence            699999999999999999999999999742   2334456788888888776 99999999877  45668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.............+|
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999998764333333345679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.....  ..+..++.++.+|+++||+.||
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP  234 (328)
T cd05593         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEDI--KFPRTLSADAKSLLSGLLIKDP  234 (328)
T ss_pred             CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-HHHHHHHhccCCc--cCCCCCCHHHHHHHHHHcCCCH
Confidence            999999999998899999999999999999999999997643 2333333333322  2345789999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccccccc
Q 017445          325 EARP-----TADQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rp-----s~~~il~hp~~~~~~~~  345 (371)
                      ++|+     ++.++++||||....+.
T Consensus       235 ~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         235 NKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9997     89999999999876544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-48  Score=359.39  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=213.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||+|+||.||+|.+..+++.||+|+++..   .......+..|+.++.++. ||||+++++.+.  +....|+||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQ--SPEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEe--cCCeEEEEEcCCCC
Confidence            79999999999999999999999998642   2334556778999998886 999999999774  46689999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccccc
Q 017445          166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT  245 (371)
Q Consensus       166 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt  245 (371)
                      |+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++.............+||
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence            9999999888889999999999999999999999 999999999999999999999999999987654333334556799


Q ss_pred             CcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcC
Q 017445          246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE  325 (371)
Q Consensus       246 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  325 (371)
                      +.|+|||++.+..++.++||||+||++|+|++|..||.... .......+.....  ..+..+++++.+|+.+||..||+
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCCHH
Confidence            99999999999999999999999999999999999997643 3334444444332  33457899999999999999999


Q ss_pred             CCC---CHHHHhcCcccccccc
Q 017445          326 ARP---TADQLLSHPFITKYEH  344 (371)
Q Consensus       326 ~Rp---s~~~il~hp~~~~~~~  344 (371)
                      +||   ++.+++.||||.+...
T Consensus       234 ~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         234 RRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             HcCCCCCHHHHHcCCCcCCCCH
Confidence            997   5899999999987643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-49  Score=331.97  Aligned_cols=259  Identities=27%  Similarity=0.376  Sum_probs=227.9

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..+...++|++.+.||.|-||.||+|+.+.++-.||+|++.+..   ....+++.+|+++-..+. ||||+++|++|.  
T Consensus        16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fh--   92 (281)
T KOG0580|consen   16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFH--   92 (281)
T ss_pred             ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhhee--
Confidence            44566789999999999999999999999999999999986522   234567788888887776 999999999885  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          152 DSGQISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      +...+||++||..+|+|...|.  ....+++..++.+++|++.||.|+|. ++||||||||+|+|++.++.+||+|||.+
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            5668999999999999999998  55679999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ....  .....+.|||..|.|||...+..++..+|+|++|++.||++.|.+||.... .......+.......+  ..++
T Consensus       172 V~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p--~~is  246 (281)
T KOG0580|consen  172 VHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFP--STIS  246 (281)
T ss_pred             eecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCC--cccC
Confidence            7654  345578999999999999999999999999999999999999999998755 4455555655544443  6899


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .++.++|.+|+..+|.+|.+..|++.|||+...
T Consensus       247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  247 GGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             hhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999999999754

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-49  Score=353.09  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=213.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC---eEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG---QISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~---~~~l  158 (371)
                      .|+..+++|.|+||.||+|....+++.||||++.....    ---+|+.+|..+. |||||++.-+|....+.   +..+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHHH
Confidence            46677899999999999999999999999999865332    2235788888665 99999999998765544   5679


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccccccCc
Q 017445          159 ALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLE  233 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~~~  233 (371)
                      ||||++. +|.+.++.    +..++.-.++-+.+||++||.|||+ .||+||||||+|+|+|.+ |.+||||||.|+.+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            9999986 99998874    5678999999999999999999999 999999999999999987 999999999999887


Q ss_pred             ccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCCCC--------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPS--------  302 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~--------  302 (371)
                      .... ..+...|..|+|||.+.|. .|+.+.||||.||++.||+.|++.|.+.+.-..+  +.++++.+...        
T Consensus       178 ~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            7643 3788899999999999764 5999999999999999999999999886543322  22333322200        


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          303 ----------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       303 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                      ......++++.+|+.++|+.+|.+|.++.+++.||||.......
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence                            12245689999999999999999999999999999998877663

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-48  Score=361.27  Aligned_cols=253  Identities=22%  Similarity=0.347  Sum_probs=212.4

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      +.||+|+||.||+|.++.+|+.||+|.++...   .........|..++....+||||+++++.+.  +.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence            36999999999999999999999999997521   2334556778888877767999999999874  566899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++|+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++.............+
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence            999999999888889999999999999999999999 9999999999999999999999999999875433223335667


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD  323 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  323 (371)
                      ||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+.....  ..+..++.++.+|+++||+.|
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~d  234 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-EDELFESIRVDTP--HYPRWITKESKDILEKLFERD  234 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHccCC
Confidence            9999999999999999999999999999999999999997543 2333333333222  223468899999999999999


Q ss_pred             cCCCCCH-HHHhcCccccccccc
Q 017445          324 AEARPTA-DQLLSHPFITKYEHA  345 (371)
Q Consensus       324 p~~Rps~-~~il~hp~~~~~~~~  345 (371)
                      |++||++ +++++||||......
T Consensus       235 P~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         235 PTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             HHHcCCChHHHHcCCCcCCCCHH
Confidence            9999997 589999999886543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.6e-48  Score=361.71  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=212.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|.+..+++.||+|+++..   .......+..|..++..+.+||||+++++++.  +...+|+||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~~   79 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFVS   79 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence            699999999999999999999999999752   22334557788888888878999999999874  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...........+.+|
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999999888899999999999999999999999 99999999999999999999999999998754333333356689


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC-------CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-------GPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      |+.|+|||++.+..++.++|+|||||++|+|++|+.||....       .......+.+.... ...+..++.++.++++
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~  237 (329)
T cd05588         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKASSVLK  237 (329)
T ss_pred             CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence            999999999999999999999999999999999999996321       11122233222222 2234568999999999


Q ss_pred             HhcccCcCCCCC------HHHHhcCcccccccc
Q 017445          318 DCLKKDAEARPT------ADQLLSHPFITKYEH  344 (371)
Q Consensus       318 ~~l~~dp~~Rps------~~~il~hp~~~~~~~  344 (371)
                      +||+.||.+|++      +.++++||||....+
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            999999999987      799999999976544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-48  Score=367.36  Aligned_cols=259  Identities=28%  Similarity=0.457  Sum_probs=217.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|.+..+++.||||++....   ......+.+|+.++..+. ||||+++++.+.  +...+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQ--DENYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE--cCCeEE
Confidence            47899999999999999999999999999999997522   233455678899888886 999999999874  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||||+++|+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++.++|+|||++........
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999999999888889999999999999999999999 9999999999999999999999999999865422110


Q ss_pred             --------------------------------------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCC
Q 017445          238 --------------------------------------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE  279 (371)
Q Consensus       238 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~  279 (371)
                                                            ...+.+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  112346999999999999989999999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHhhCC--CCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccccc
Q 017445          280 FPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKKDAEARPT---ADQLLSHPFITKYEHA  345 (371)
Q Consensus       280 ~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~il~hp~~~~~~~~  345 (371)
                      .||.... .......+....  ...+....+++++.+||++|+. +|.+|++   +.+++.||||....+.
T Consensus       237 ~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         237 PPFCSDN-PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCCCCCC-HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9997644 333444444322  2223334678999999999996 9999998   9999999999887543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.8e-48  Score=359.42  Aligned_cols=252  Identities=27%  Similarity=0.425  Sum_probs=214.4

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|+++..   .......+..|..++..+.+||||+++++++.  +.+.+|+||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~   79 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYVN   79 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCCC
Confidence            699999999999999999999999999752   22344556788888888878999999999874  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.............+|
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            99999999888889999999999999999999999 99999999999999999999999999998654333233345679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      ++.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.....  ..+..++.++.+|+++||+.||
T Consensus       159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHccCCH
Confidence            999999999999999999999999999999999999997543 3333344433332  2335689999999999999999


Q ss_pred             CCCCCH-----HHHhcCccccccccc
Q 017445          325 EARPTA-----DQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps~-----~~il~hp~~~~~~~~  345 (371)
                      ++||++     .+++.||||....+.
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            999999     999999999886543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8e-48  Score=358.12  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=212.4

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|.++..   ..........|..++.....||||+++++.+.  ....+|+||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~   79 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYLN   79 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCCC
Confidence            699999999999999999999999998752   22334455677777777777999999999774  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      ||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.............+|
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999999765433334456679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+....  ...+..++.++.+|+.+||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-EDELFDSILNDR--PHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCH
Confidence            999999999999899999999999999999999999997644 233333433322  22345688999999999999999


Q ss_pred             CCCCCH-HHHhcCccccccccc
Q 017445          325 EARPTA-DQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps~-~~il~hp~~~~~~~~  345 (371)
                      ++||++ .+++.||||....+.
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             HHcCCChHHHHcCcccCCCCHH
Confidence            999986 588899999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-47  Score=351.71  Aligned_cols=254  Identities=28%  Similarity=0.474  Sum_probs=209.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.++..+. ||||+++++++  .+.+.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAF--RRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhE--ecCCEEEE
Confidence            36899999999999999999999999999999986532  234456788999988886 99999999987  45668999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      ||||++++.+..+......+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++........ 
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99999987777666555679999999999999999999999 9999999999999999999999999999987643322 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh--CCC---------------
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--DPS---------------  300 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~---------------  300 (371)
                      ......|++.|+|||++.+..++.++||||+||++|+|++|+.||........ ...+..  .+.               
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhc
Confidence            22345789999999999988899999999999999999999999976543221 111110  000               


Q ss_pred             ----CC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          301 ----PS---------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       301 ----~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                          +.         .....++.++.+|+++||+.||++|||++++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                00         0012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-49  Score=351.14  Aligned_cols=252  Identities=25%  Similarity=0.450  Sum_probs=227.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+|++.+.||+|+||.|.+|.....|+.||||.++.   .++++.-.+.+|++++..+. ||||+.+|.+|  ++...+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVF--ENkdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVF--ENKDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhh--cCCceE
Confidence            4689999999999999999999999999999999865   45566677889999999887 99999999988  677899


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      .|||||..+|.|+|++...+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||+|.++++||+|||++..+... 
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-  206 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-  206 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence            9999999999999999999999999999999999999999999 99999999999999999999999999999877665 


Q ss_pred             cccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ....++||+|.|.+||++.|..| ++.+|-||||++||.|+.|..||.+.+ ...++.++-.+.+..+.   -|..+.-|
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-hk~lvrQIs~GaYrEP~---~PSdA~gL  282 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-HKRLVRQISRGAYREPE---TPSDASGL  282 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-HHHHHHHhhcccccCCC---CCchHHHH
Confidence            44589999999999999999887 489999999999999999999998744 46677888777666543   56789999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      |++||.+||++|.|+.+|-.|=|..
T Consensus       283 IRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhheee
Confidence            9999999999999999999998873

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-47  Score=357.32  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=219.4

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +|+..+.||+|+||+||+|.++.+|+.||+|++...   .......+..|..++..+.+|++|+++++++.  +...+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEE
Confidence            467788999999999999999999999999998752   22334557788888888887889999998774  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            99999999999999888889999999999999999999999 99999999999999999999999999998765433333


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+......  .+..++.++.+++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~--~p~~~~~~~~~li~~  234 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-EDELFQSIMEHNVS--YPKSLSKEAVSICKG  234 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC--CCccCCHHHHHHHHH
Confidence            345679999999999998889999999999999999999999997643 34444555444332  345688999999999


Q ss_pred             hcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          319 CLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       319 ~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      ||+.+|.+|++     ..++++||||....+..
T Consensus       235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~  267 (323)
T cd05615         235 LMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK  267 (323)
T ss_pred             HcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence            99999999997     57999999999875543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-47  Score=359.39  Aligned_cols=252  Identities=28%  Similarity=0.459  Sum_probs=212.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|+++..   .......+..|+.++.++.+||||+++++++.  ....+|+||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~~   79 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVN   79 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCCC
Confidence            699999999999999999999999999752   23344567788888888878999999999874  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|..++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............|
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999998754333333345679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC-------CcHHHHHH-HhhCCCCCCCCCCCCHHHHHHH
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-------GPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~-------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||....       .......+ +.....  ..+..++.++.+++
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Confidence            999999999999999999999999999999999999995311       11122222 223222  23457889999999


Q ss_pred             HHhcccCcCCCCC------HHHHhcCcccccccc
Q 017445          317 DDCLKKDAEARPT------ADQLLSHPFITKYEH  344 (371)
Q Consensus       317 ~~~l~~dp~~Rps------~~~il~hp~~~~~~~  344 (371)
                      ++||+.||++||+      +.++++||||..+.+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            9999999999998      589999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-48  Score=344.18  Aligned_cols=263  Identities=25%  Similarity=0.456  Sum_probs=219.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCC-eeEeceeEEecC----
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEG-LVEFHGAFYMPD----  152 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~-iv~l~~~~~~~~----  152 (371)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|+++....  ......++|+.++..+. |+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            3456777899999999999999999999999999986433  23455689999999988 888 999999886533    


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK----SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      .+.+++|+||++- +|.+++....    .++...++.+++|++.||+|||+ ++|+||||||+||||++.|.+||+|||+
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccch
Confidence            2479999999975 9999997654    57888999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHH---HHhhCCCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML---QILEDPSPSPS  304 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~~  304 (371)
                      |+...-......+.++|.+|+|||++.+. .|+...||||+||+++||++++..|.+..+ .+.+.   ..+..+.....
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCC
Confidence            99777555556778899999999999776 699999999999999999999999988665 33333   33333321111


Q ss_pred             C-------------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          305 R-------------------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       305 ~-------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +                         ...+++..+++.+||+.+|.+|.|+..+|.||||.....+.
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            1                         12235889999999999999999999999999999886554

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-47  Score=365.98  Aligned_cols=257  Identities=26%  Similarity=0.477  Sum_probs=214.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +|++++.||+|+||+||+|++..+++.||+|++....   ......+.+|+.++..+. ||||+++++.+.  +...+|+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~--~~~~~~l   78 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQ--DKDNLYF   78 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEE--eCCEEEE
Confidence            6889999999999999999999999999999986532   234456778999888886 999999999884  4668999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc---
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS---  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~---  235 (371)
                      ||||+++|+|.+++...+.+++..+..++.|++.||+|||+ .||+||||||+|||++.+|.+||+|||++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999999999888889999999999999999999999 99999999999999999999999999997532100   


Q ss_pred             --------------------------------------------ccccccccccCcccCCccccCCCCCCchhHHHHHHH
Q 017445          236 --------------------------------------------IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA  271 (371)
Q Consensus       236 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~i  271 (371)
                                                                  .....+.+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        001123579999999999999899999999999999


Q ss_pred             HHHHhcCCCCCCCCCCcHHHHHHHhhC--CCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCcccccccc
Q 017445          272 LFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDDCLKKDAEARPT---ADQLLSHPFITKYEH  344 (371)
Q Consensus       272 l~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~il~hp~~~~~~~  344 (371)
                      +|||++|+.||.... +.....++...  ....+....+++++.++|.+|+ .+|.+|++   ++++++||||.....
T Consensus       238 l~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         238 LYEMLVGQPPFLAQT-PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHhCCCCCCCCC-HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            999999999997644 33333444332  2233334568999999999986 59999997   999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.5e-48  Score=359.74  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=212.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|.+..+++.||+|++...   .......+..|+.++..+. ||||+++++.+.  ....+||||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~--~~~~~~lv~E~~~   78 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--THDRLCFVMEYAN   78 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEE--cCCEEEEEEeCCC
Confidence            699999999999999999999999999752   2233455677888887775 999999999774  4668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||.|||+.+||+||||||+|||++.++.+||+|||++..............|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            99999999888889999999999999999999996469999999999999999999999999998754333333345679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.....  ..+..+++++.+|+++||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI--RFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999999998999999999999999999999999976442 233333333222  2345689999999999999999


Q ss_pred             CCCC-----CHHHHhcCccccccccc
Q 017445          325 EARP-----TADQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rp-----s~~~il~hp~~~~~~~~  345 (371)
                      ++|+     ++.++++||||....+.
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9997     89999999999876544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-47  Score=364.33  Aligned_cols=263  Identities=27%  Similarity=0.486  Sum_probs=217.9

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|+++..   .......+.+|+.++..+. ||||+++++++  .+
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~--~~  114 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAF--QD  114 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEE--ec
Confidence            345567999999999999999999999999999999999642   2233344667888887775 99999999877  45


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            6689999999999999999864 468999999999999999999999 99999999999999999999999999998766


Q ss_pred             ccccc-ccccccccCcccCCccccCC----CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--CCCCC
Q 017445          233 ENSIA-MCATFVGTVTYMSPERIRNE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSR  305 (371)
Q Consensus       233 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~  305 (371)
                      ..... ...+.+||+.|+|||++.+.    .++.++|||||||++|+|++|..||.... ......++.....  ..+..
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~  271 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNSLTFPDD  271 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCCcCCCCCc
Confidence            43322 23456799999999998643    47899999999999999999999997644 3344455544332  22333


Q ss_pred             CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCcccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYEH  344 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~~  344 (371)
                      ..++.++.+|+++||+.+|.+  |+++++++.||||+...+
T Consensus       272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence            468999999999999999998  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-47  Score=355.81  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=212.8

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHh--CCCCCCeeEeceeEEecCCCeEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCE--APCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~--~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      |++++.||+|+||.||+|.+..+++.||||+++...   ......+.+|..++..  ..+||||+++++++.  .....|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence            678899999999999999999999999999997522   2234456666665532  235999999999874  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +||||+++++|..++. .+.+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++........
T Consensus        79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            9999999999998886 4579999999999999999999999 9999999999999999999999999999875443333


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ...+.+|++.|+|||.+.+..++.++|||||||++|+|++|..||.... .......+......  .+..+++++.++++
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-~~~~~~~i~~~~~~--~p~~~~~~~~~li~  233 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-EEEVFDSIVNDEVR--YPRFLSREAISIMR  233 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC--CCCCCCHHHHHHHH
Confidence            3456779999999999999999999999999999999999999997644 23334444443332  34568999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCcccccccc
Q 017445          318 DCLKKDAEARP-----TADQLLSHPFITKYEH  344 (371)
Q Consensus       318 ~~l~~dp~~Rp-----s~~~il~hp~~~~~~~  344 (371)
                      +||+.||++||     ++.++++||||.....
T Consensus       234 ~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         234 RLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            99999999999     6999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-47  Score=356.75  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=210.9

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---CeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---GQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---~~~  156 (371)
                      +|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++...+.   ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceE
Confidence            588999999999999999999999999999998642  2234456889999998886 9999999998764332   358


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+. ++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            99999995 6999999888889999999999999999999999 999999999999999999999999999987543221


Q ss_pred             c---ccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHH--------------
Q 017445          237 A---MCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQI--------------  295 (371)
Q Consensus       237 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~--------------  295 (371)
                      .   .....+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.........  +...              
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1   1234579999999999865  67899999999999999999999999764421110  0000              


Q ss_pred             ---------hhCCCCC---CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          296 ---------LEDPSPS---PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       296 ---------~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                               +....+.   .....+++++.+++.+||+.||++|||++++++||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                     0001111   111356788999999999999999999999999999987655

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-47  Score=365.68  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=214.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.++..+. ||||+++++.+.  +.+.+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQ--DKDNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCEEE
Confidence            47899999999999999999999999999999986422   223455778999988886 999999999874  567899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc--
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~--  235 (371)
                      |||||+++|+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|......  
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999999999888889999999999999999999999 99999999999999999999999999997532100  


Q ss_pred             -----------------------------------------ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHH
Q 017445          236 -----------------------------------------IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE  274 (371)
Q Consensus       236 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e  274 (371)
                                                               .....+.+||+.|+|||++.+..++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000123579999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCCcHHHHHHHhhC--CCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCccccccc
Q 017445          275 CGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDDCLKKDAEARP---TADQLLSHPFITKYE  343 (371)
Q Consensus       275 ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~il~hp~~~~~~  343 (371)
                      |++|+.||..... ......+...  ....+....+++++.++|.+|+ .+|.+|+   ++.++++||||..+.
T Consensus       237 ll~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         237 MLVGQPPFLADTP-AETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             hhhCCCCCCCCCH-HHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            9999999976543 2333333322  2222334568999999999977 5999999   999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-47  Score=357.34  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=211.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|+++...   .........|..++....+||||+++++++.  +.+.+|+||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~~   79 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYLN   79 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCCC
Confidence            6999999999999999999999999987521   2334456677888877777999999999874  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..............|
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            99999999887889999999999999999999999 99999999999999999999999999998754332233345679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+.....  ..+..++.++.+|+.+||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-EEELFQSIRMDNP--CYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCC--CCCccCCHHHHHHHHHHhccCH
Confidence            999999999998899999999999999999999999997644 2333333332222  2334688999999999999999


Q ss_pred             CCCCCHH-HHhcCccccccccc
Q 017445          325 EARPTAD-QLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps~~-~il~hp~~~~~~~~  345 (371)
                      ++||++. +++.||||....+.
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             hhcCCChHHHHcCcccCCCCHH
Confidence            9999996 89999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-47  Score=364.59  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|.+..+++.||||++...   .......+.+|+.++..+. ||||+++++.+.  +...+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQ--DAQYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--cCCeeE
Confidence            3788999999999999999999999999999998642   2233456778999888775 999999999874  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      |||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999999999888889999999999999999999999 999999999999999999999999999986321100 


Q ss_pred             -----------c-----------------------------------ccccccccCcccCCccccCCCCCCchhHHHHHH
Q 017445          237 -----------A-----------------------------------MCATFVGTVTYMSPERIRNESYSYPADIWSIGL  270 (371)
Q Consensus       237 -----------~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  270 (371)
                                 .                                   ...+.+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                       0                                   001356999999999999889999999999999


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCcccccccc
Q 017445          271 ALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKKDAEAR---PTADQLLSHPFITKYEH  344 (371)
Q Consensus       271 il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~il~hp~~~~~~~  344 (371)
                      ++|||++|..||.... .......+....  ...+....++.++.+||.+||. +|.+|   +++.+++.||||....+
T Consensus       237 il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         237 IMFECLIGWPPFCSEN-SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhhhhhcCCCCCCCCC-HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999997644 233344443322  2223334678999999999998 67665   59999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.8e-48  Score=358.64  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=211.5

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+|+.||+|++....   ......+..|...+.+..+||||+++++.+.  +....|+||||++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~   79 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYVN   79 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCCC
Confidence            6999999999999999999999999986422   2233456666666655556999999999774  4668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.............+|
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999998754433333455679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+......  ....++..+.+++++||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCH
Confidence            999999999999999999999999999999999999997643 33344444444322  234679999999999999999


Q ss_pred             CCCCCH----HHHhcCccccccccc
Q 017445          325 EARPTA----DQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps~----~~il~hp~~~~~~~~  345 (371)
                      .+||++    .++++||||..+.+.
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999987    699999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-48  Score=360.91  Aligned_cols=259  Identities=31%  Similarity=0.529  Sum_probs=230.3

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|..++.+|+|+||.+++++++.++..+++|++...  ....+.....|+..+.++. |||||.+.+.|. .++..++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~-~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFE-EDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchh-cCCceEEE
Confidence            5788899999999999999999999999999999753  3344456788999999976 999999999985 33334999


Q ss_pred             EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          159 ALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||+||+||+|.+.+.+.+  -|+++.+..|+.|++.|+.|||+ ++|+|||||+.||+++.++.|+|+|||+|+.+....
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999997654  49999999999999999999998 999999999999999999999999999999998887


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      ....+.+|||.|++||.+.+..|+.++|||||||++|||++-+++|.+.+ ...++.++.... ..+.+..++.++..++
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-m~~Li~ki~~~~-~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-MSELILKINRGL-YSPLPSMYSSELRSLV  238 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-hHHHHHHHhhcc-CCCCCccccHHHHHHH
Confidence            67788999999999999999999999999999999999999999998754 445666666555 4555678999999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +.||..+|..||++.++|.+|.+..+..
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~~  266 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRRPHLLRYLV  266 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhChhhhhHHH
Confidence            9999999999999999999999987763

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-47  Score=356.97  Aligned_cols=259  Identities=26%  Similarity=0.416  Sum_probs=214.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +|++++.||+|+||+||+|.+.   .+++.||+|++....    ......+..|+.++..+.+||+|+++++.+  .+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence            5889999999999999998763   578999999986421    223455778899999988899999999877  4566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+++||||+++|+|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            899999999999999999888889999999999999999999999 9999999999999999999999999999876533


Q ss_pred             cc-cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCC---cHHHHHHHhhCCCCCCCCCCCC
Q 017445          235 SI-AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       235 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....   .......+....  ...+..++
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIG  235 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCC
Confidence            22 222356799999999999765 478999999999999999999999965322   122222233222  23345689


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccccc
Q 017445          310 PEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHA  345 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~  345 (371)
                      +.+.+++.+||+.||++||     +++++++||||+.....
T Consensus       236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999999999999     88999999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-49  Score=342.48  Aligned_cols=281  Identities=25%  Similarity=0.413  Sum_probs=243.5

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ...+..++|..+++||+|.||.|-+++.+.+++.+|+|++++   ..+....-.+.|-++|.... ||.+..+...|  +
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsF--Q  238 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSF--Q  238 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhh--c
Confidence            445667899999999999999999999999999999999875   23444445567777887776 99999998877  5


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ...++|+||||..||.|+-.|...+.|++..++.+-..|+.||.|||+ ++||+||||.+|+++|++|++||+|||+++.
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchh
Confidence            567999999999999999999988999999999999999999999999 9999999999999999999999999999987


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      --.......++||||.|.|||++....|+.++|+|.+|+++|||++|++||.+.+. ..+...++.+...  .+..++++
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~ed~k--FPr~ls~e  394 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILMEDLK--FPRTLSPE  394 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHhhhcc--CCccCCHH
Confidence            66666677899999999999999999999999999999999999999999987543 3444444444433  34579999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCccccccccccccHHHHHHHhcChhhhhhhh
Q 017445          312 FCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDL  366 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (371)
                      ++.|+..+|..||.+|..     +.+|.+|+||..+.++..    +.+.+.||++-.++.
T Consensus       395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~----~~Kki~PPfKPqVtS  450 (516)
T KOG0690|consen  395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT----YRKKIEPPFKPQVTS  450 (516)
T ss_pred             HHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH----HHhccCCCCCCCccc
Confidence            999999999999999964     899999999999888764    577888999866554

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-47  Score=355.42  Aligned_cols=254  Identities=26%  Similarity=0.440  Sum_probs=213.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|++...   .......+..|..++.++.+||+|+++++++.  +...+|+||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~   79 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYVN   79 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCCC
Confidence            699999999999999999999999999752   22344567788888888888999999999874  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...........+.+|
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999998754333333356779


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC-----CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-----GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      |+.|+|||++.+..++.++||||||+++|+|++|..||....     .......+.+... +...+..++..+.+++++|
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999996421     1222333333222 2224456889999999999


Q ss_pred             cccCcCCCCC------HHHHhcCccccccccc
Q 017445          320 LKKDAEARPT------ADQLLSHPFITKYEHA  345 (371)
Q Consensus       320 l~~dp~~Rps------~~~il~hp~~~~~~~~  345 (371)
                      |+.||++|++      +.+++.||||....+.
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            9999999998      5799999999877543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-47  Score=361.25  Aligned_cols=260  Identities=25%  Similarity=0.435  Sum_probs=215.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++..   .......+..|+.++..+. ||+|+++++.+  .+.+.+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~--~~~~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSF--QDKRNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEE--EcCCEEE
Confidence            3788999999999999999999999999999999642   2233456777888888775 99999999977  4567899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      |||||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++|+|||++....... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999999999888889999999999999999999999 999999999999999999999999999986543210 


Q ss_pred             ----------------------------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCC
Q 017445          237 ----------------------------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY  282 (371)
Q Consensus       237 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf  282 (371)
                                                        ....+.+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                              0112457999999999999999999999999999999999999999


Q ss_pred             CCCCCcHHHHHHHhhCC--CCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCcccccccccc
Q 017445          283 AASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKKDAEARP---TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~il~hp~~~~~~~~~  346 (371)
                      .... ......++....  ...+....+++++.+||.+|+ .||.+|+   ++.+++.||||....+..
T Consensus       237 ~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         237 CSET-PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCC-HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence            7644 333444444322  222233457899999999987 4999998   489999999999876544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-46  Score=347.37  Aligned_cols=268  Identities=41%  Similarity=0.743  Sum_probs=226.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+... ......++.+|+.++.++. ||||+++++.+.  +.+.+++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAFY--SDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--eCCEEEEE
Confidence            3689999999999999999999999999999998753 3344566889999999986 999999999885  46689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--cc
Confidence            9999999999999888889999999999999999999997358999999999999999999999999998765432  22


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh-----------------------
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-----------------------  296 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~-----------------------  296 (371)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .. ....+                       
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCccccccccCCcccccCCCCCc
Confidence            456789999999999888899999999999999999999999964331 11 11111                       


Q ss_pred             --------------hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHH
Q 017445          297 --------------EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRS  355 (371)
Q Consensus       297 --------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~  355 (371)
                                    ....+......++.++.+|+.+||..+|++||++.++++||||.++..+.++..+|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~  306 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVDFAGWVCS  306 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccchhhhhhhc
Confidence                          11111111224788999999999999999999999999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.8e-47  Score=367.53  Aligned_cols=260  Identities=20%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec------
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP------  151 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~------  151 (371)
                      ....+|++.+.||+|+||+||+|.+..+++.||||++....    ....+|+.++..+. ||||++++++|...      
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcC-CCCCcceeeeEeecccccCC
Confidence            34568999999999999999999999999999999885422    12346888888886 99999999887532      


Q ss_pred             CCCeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecc
Q 017445          152 DSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDF  226 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Df  226 (371)
                      ....+++||||+++ +|.+++.    ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeecc
Confidence            12357799999975 7877664    34679999999999999999999999 9999999999999999764 7999999


Q ss_pred             cccccCcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC--
Q 017445          227 GISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS--  300 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~--  300 (371)
                      |+|....... ...+..||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+...... +.+++.   .+.  
T Consensus       216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~p~~~  293 (440)
T PTZ00036        216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVLGTPTED  293 (440)
T ss_pred             ccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence            9998665432 22456789999999998654 689999999999999999999999977543322 222211   100  


Q ss_pred             --------------CC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 --------------PS--------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 --------------~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                    +.        ..+...++++.+||.+||+.||.+|||+.++|.||||.......
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~  361 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPC  361 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhccc
Confidence                          00        11234678999999999999999999999999999998776543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-47  Score=353.42  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=212.3

Q ss_pred             eeecccCCeEEEEEEEc---CCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           87 GAIGSGASSVVQRAVHI---PTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +.||+|+||.||+|.+.   .+++.||+|+++...    ......+..|+.++..+. ||||+++++.+.  ..+.+|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~--~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQ--TGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEe--cCCeEEEE
Confidence            57999999999999863   578999999986421    223345678888888886 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence            9999999999999888889999999999999999999999 999999999999999999999999999987544333334


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.....  ..+..+++++.+|+++|
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  234 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-KKTIDKILKGKL--NLPPYLTPEARDLLKKL  234 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            456799999999999988899999999999999999999999976442 334444444432  23456889999999999


Q ss_pred             cccCcCCCC-----CHHHHhcCcccccccc
Q 017445          320 LKKDAEARP-----TADQLLSHPFITKYEH  344 (371)
Q Consensus       320 l~~dp~~Rp-----s~~~il~hp~~~~~~~  344 (371)
                      |+.||++||     ++.+++.||||....+
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.5e-47  Score=345.29  Aligned_cols=253  Identities=27%  Similarity=0.467  Sum_probs=209.9

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||+|+||+||++.+..+++.||+|++.....   .....+..|+.++..+. ||||+++.+++.  ....+|+||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQ--TKTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEc--CCCeEEEEEeCCCC
Confidence            7999999999999999999999999864222   23345678888888885 999999998774  45689999999999


Q ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          166 GSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       166 g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |+|.+++..    ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||.+............
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            999987742    3468999999999999999999999 99999999999999999999999999998766544333445


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH---HHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ..||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.......   .....+...  +...+..++.++.+++.+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  234 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEA  234 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHH
Confidence            679999999999999999999999999999999999999997644321   112222222  223345689999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCccccccccccc
Q 017445          319 CLKKDAEARP-----TADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       319 ~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~~  347 (371)
                      ||+.||++||     +++++++||||+...+..+
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence            9999999999     8899999999998765553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.6e-47  Score=355.88  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=215.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|+++...   ......+.+|+.++.... ||||+++++.+.  +...+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~--~~~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQ--DKDNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCeEE
Confidence            36889999999999999999999999999999997532   223445667777776654 999999999774  466899


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999999999765 679999999999999999999999 999999999999999999999999999997664432


Q ss_pred             c-ccccccccCcccCCcccc------CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCCCCC
Q 017445          237 A-MCATFVGTVTYMSPERIR------NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQN  307 (371)
Q Consensus       237 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~  307 (371)
                      . ......||+.|+|||++.      +..++.++|||||||++|+|++|..||..... .....++....  ...+....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  235 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-AKTYNNIMNFQRFLKFPEDPK  235 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-HHHHHHHHcCCCccCCCCCCC
Confidence            2 223457999999999986      45678999999999999999999999976442 33344444332  22233346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +++++.+|++.||. +|++||++.+++.||||....+..
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence            89999999999998 999999999999999998766544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.4e-46  Score=342.28  Aligned_cols=272  Identities=36%  Similarity=0.670  Sum_probs=226.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .......+..|+..+.+..+||||+++++.+.  ..+.+|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEE
Confidence            4789999999999999999999999999999998753 22344566677777667777999999999875  45679999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          160 LEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      |||++ |+|.+++..    ...+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||.+.....
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99997 588887753    3468999999999999999999998 6 999999999999999999999999999876543


Q ss_pred             cccccccccccCcccCCccccC----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          235 SIAMCATFVGTVTYMSPERIRN----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .. ......++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||.........+........+......+|.
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd06617         157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP  235 (283)
T ss_pred             cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence            32 2233568899999999865    456889999999999999999999997644444445555554444444456899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF  357 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~  357 (371)
                      ++.+++.+||..+|++||++.++++||||.+......+..+|++.++
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~  282 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSLIL  282 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHHHHHHHHhcC
Confidence            99999999999999999999999999999999999899999998765

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-46  Score=353.04  Aligned_cols=257  Identities=23%  Similarity=0.400  Sum_probs=210.3

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      |++..++|++.+.||+|+||.||+|.+     ..+++.||+|++... .......+.+|+.++.++.+||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            567778999999999999999999975     234578999998653 23445678899999999977999999999875


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ------------------------------------------------------  175 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~------------------------------------------------------  175 (371)
                      . ..+.++++|||+++|+|.+++...                                                      
T Consensus        82 ~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          82 K-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             C-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            3 345689999999999999998642                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--cccccccc
Q 017445          176 --------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGT  245 (371)
Q Consensus       176 --------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt  245 (371)
                              .++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........  ...+..++
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                    247788889999999999999999 9999999999999999999999999999976533211  12233467


Q ss_pred             CcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          246 VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       246 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      +.|+|||++.+..++.++||||||+++|||++ |..||.......... +.+........+..+++.+.+++.+||..||
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-QRLKDGTRMRAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            88999999998899999999999999999997 999997654433333 3333333334456789999999999999999


Q ss_pred             CCCCCHHHHhc
Q 017445          325 EARPTADQLLS  335 (371)
Q Consensus       325 ~~Rps~~~il~  335 (371)
                      ++|||+.++++
T Consensus       319 ~~RPs~~el~~  329 (338)
T cd05102         319 KERPTFSALVE  329 (338)
T ss_pred             hhCcCHHHHHH
Confidence            99999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-46  Score=357.79  Aligned_cols=262  Identities=26%  Similarity=0.460  Sum_probs=214.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ......+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.++..+. ||||+++++++.  +
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~--~  114 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQ--D  114 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE--c
Confidence            345567899999999999999999999999999999998642   1223344667777776665 999999999874  5


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            6689999999999999999964 468999999999999999999999 99999999999999999999999999999876


Q ss_pred             ccccc-ccccccccCcccCCccccCC----CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCCC
Q 017445          233 ENSIA-MCATFVGTVTYMSPERIRNE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSR  305 (371)
Q Consensus       233 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  305 (371)
                      ..... ...+.+||+.|+|||++.+.    .++.++||||+||++|+|++|..||.... ......++....  ...+..
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~  271 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFPED  271 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCcccCCCCc
Confidence            43322 23466799999999999653    37889999999999999999999997644 334445554433  222333


Q ss_pred             CCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYE  343 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~  343 (371)
                      ..++..+.+++.+||+.++.+  |+++.++++||||+...
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            467999999999999866654  89999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.4e-47  Score=357.01  Aligned_cols=258  Identities=38%  Similarity=0.642  Sum_probs=211.0

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ...++|+.++.||+|+||+||+|.+..+++.||||++... .......+.+|+.++..+. |+||+++++++  .+.+.+
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~~~  147 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMF--DHNGEI  147 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEe--ccCCeE
Confidence            3456788899999999999999999999999999998653 3344567889999998886 99999999977  456789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ++||||+++++|.+.    ...++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999999999998653    345778889999999999999999 999999999999999999999999999998765443


Q ss_pred             cccccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCC-cHHHHHHHhhCCCCCCCCCCCCH
Q 017445          237 AMCATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEG-PVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .......||..|+|||++..     ...+.++|||||||++|||++|+.||..... ........+...........++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence            33455679999999998843     2345689999999999999999999974322 11112222222222333457889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ++.+||.+||..||++||++.++++||||.+..
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            999999999999999999999999999998763

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-46  Score=344.39  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=204.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcC-CCcEEEEEEecccc--HHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEe---cC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIP-THRIIALKKINIFE--KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYM---PD  152 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~---~~  152 (371)
                      .+|++.+.||+|+||+||+|.+.. +++.||+|.++...  ........+|+..+..+.  .||||+++++++..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368899999999999999999854 46889999986522  222344566777666553  59999999998753   23


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ...+++||||++ ++|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            456999999997 5999988653  458999999999999999999999 999999999999999999999999999987


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC---CCC-----
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP---SPS-----  302 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~-----  302 (371)
                      ..... .......||+.|+|||.+.+..++.++||||+||++|+|++|..||..... ...+..++...   .+.     
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhchhh
Confidence            65443 233456789999999999888899999999999999999999999976543 33333332211   000     


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          303 -----------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       303 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                       .....++..+.+|+.+||+.||++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.2e-47  Score=354.04  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=210.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+|+.||+|++...   .......+..|...+.+..+||||+++++.+.  ..+..|+||||++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~~   79 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFVN   79 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCCC
Confidence            699999999999999999999999998642   22334556667666655556999999998774  4668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +|+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.............+|
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            99999999888899999999999999999999999 99999999999999999999999999998754333333355679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+......  .....+..+.+++++||+.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMYDNILHKPLV--LRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-HHHHHHHHHcCCcc--CCCCCCHHHHHHHHHHhccCH
Confidence            999999999999999999999999999999999999997643 33344444443322  234688999999999999999


Q ss_pred             CCCCCH----HHHhcCcccccccc
Q 017445          325 EARPTA----DQLLSHPFITKYEH  344 (371)
Q Consensus       325 ~~Rps~----~~il~hp~~~~~~~  344 (371)
                      .+||++    .+++.||||....+
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCCCH
Confidence            999976    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=364.78  Aligned_cols=261  Identities=31%  Similarity=0.594  Sum_probs=234.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .+-|+|++.||.|+||.||+|.++.++...|.|++.....+....++-|+.+|..+. ||+||+++++|+.++  .++|+
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~en--kLwil  107 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFEN--KLWIL  107 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccC--ceEEE
Confidence            346788899999999999999999999999999998888888899999999999887 999999999998744  79999


Q ss_pred             EeccCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      .|||.||...-++ .-...+++.++..+++|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+.........
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999999998866 446779999999999999999999999 99999999999999999999999999999887777677


Q ss_pred             cccccccCcccCCccc-----cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHHH
Q 017445          239 CATFVGTVTYMSPERI-----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEF  312 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  312 (371)
                      ..++.|||+|||||+.     ...+|++++||||||++|.||..+.+|-.. -+++..+.++... ++....+..++..+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            7899999999999987     456799999999999999999999998854 5567777777544 44456678899999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      .+|+.+||.+||..||++.++|+||||+....+
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            999999999999999999999999999977655

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-47  Score=354.54  Aligned_cols=251  Identities=27%  Similarity=0.405  Sum_probs=207.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      ||+|+||+||+|.+..+++.||+|++....   .........|..++....  .||+|+++++.+  .+...+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~--~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF--QTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE--ecCCeEEEEEcCC
Confidence            799999999999999999999999986422   122334455666665544  799999999977  4466899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++|+|||++.............+
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            999999999888889999999999999999999999 9999999999999999999999999999876544333445677


Q ss_pred             ccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhccc
Q 017445          244 GTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK  322 (371)
Q Consensus       244 gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  322 (371)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+...... .....+++++.+|+++||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVR-FPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-HHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCC
Confidence            99999999998654 48999999999999999999999997643 23333444333322 22345789999999999999


Q ss_pred             CcCCCC----CHHHHhcCcccccccc
Q 017445          323 DAEARP----TADQLLSHPFITKYEH  344 (371)
Q Consensus       323 dp~~Rp----s~~~il~hp~~~~~~~  344 (371)
                      ||.+||    ++.++++||||....+
T Consensus       236 ~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         236 NPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             CHHHCCCCCCCHHHHhcCccccCCCH
Confidence            999998    7999999999987543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-46  Score=357.40  Aligned_cols=256  Identities=22%  Similarity=0.337  Sum_probs=208.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +...+|++++.||+|+||.||+|.+..+++.||+|...      ...+.+|+.++.++. ||||++++++|..  ....+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAIN-HPSIIQLKGTFTY--NKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCC-CCCCCCEeEEEEE--CCeeE
Confidence            45578999999999999999999999999999999753      234678999998886 9999999998854  55899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc-c
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS-I  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~-~  236 (371)
                      +|+|++. ++|..++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...... .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            9999995 6999998877889999999999999999999999 99999999999999999999999999998654322 1


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC------cHHHHHHHhh-------------
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG------PVNLMLQILE-------------  297 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~------~~~~~~~~~~-------------  297 (371)
                      ......+||+.|+|||++.+..++.++||||+||++|+|++|..||.....      ....+..++.             
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223456799999999999988999999999999999999999988753211      0111111110             


Q ss_pred             -------------CCCCCC-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          298 -------------DPSPSP-------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       298 -------------~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                   .....+       ....++.++.+||.+||+.||.+|||+.++|+||||+.+..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                         000000       00134678999999999999999999999999999987543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.9e-46  Score=364.92  Aligned_cols=266  Identities=27%  Similarity=0.433  Sum_probs=221.0

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +.+....+|++.+.||+|+||+||+|.+..+++.||||++...  .......+.+|+..+..+. |+|++++++.+...+
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKD  104 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceeccc
Confidence            3344557999999999999999999999999999999998652  3445566788998888776 999999988765332


Q ss_pred             C------CeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceE
Q 017445          153 S------GQISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK  222 (371)
Q Consensus       153 ~------~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~k  222 (371)
                      .      ..+++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+|
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEE
Confidence            2      147899999999999999864    2468999999999999999999999 9999999999999999999999


Q ss_pred             EecccccccCccc--ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC
Q 017445          223 ITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS  300 (371)
Q Consensus       223 l~Dfg~s~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  300 (371)
                      |+|||+++.....  .....+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..++....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-~~~~~~~~~~~~~  262 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRY  262 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhcCCC
Confidence            9999998765432  122345679999999999999999999999999999999999999997643 2333444443332


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       301 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                       .+.+..+++++.+++.+||..||.+||++.+++.|||++.+..
T Consensus       263 -~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~  305 (496)
T PTZ00283        263 -DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS  305 (496)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence             3345678999999999999999999999999999999876543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-46  Score=351.42  Aligned_cols=252  Identities=26%  Similarity=0.436  Sum_probs=210.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|++....   ......+..|...+.+..+||||+++++.+.  +.+.+|+||||++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~~   79 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYIN   79 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCCC
Confidence            6999999999999999999999999986422   2233445566655545456999999999774  4568999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.............+|
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999998765433333456679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.....  .....+++.+.+++.+||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-HHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHcccCH
Confidence            999999999999999999999999999999999999997643 2333344443332  2335789999999999999999


Q ss_pred             CCCCCHH----HHhcCccccccccc
Q 017445          325 EARPTAD----QLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps~~----~il~hp~~~~~~~~  345 (371)
                      .+||++.    ++++|+||..+.+.
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCCCCHH
Confidence            9999865    89999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-47  Score=352.14  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=213.2

Q ss_pred             eeecccCCeEEEEEEE---cCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           87 GAIGSGASSVVQRAVH---IPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      +.||+|+||.||++.+   ..+|+.||+|++....  .........|+.++.++. ||||+++++.+.  +.+.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQ--TEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEE--cCCEEEEEEc
Confidence            4799999999999976   3578999999997532  223445678888888886 999999999874  4668999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++............
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            99999999999888889999999999999999999999 99999999999999999999999999998766544333455


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcc
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK  321 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  321 (371)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... .......+.....  ..+..+++++.+|+++||+
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~  234 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-RKETMTMILKAKL--GMPQFLSPEAQSLLRALFK  234 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-HHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhh
Confidence            679999999999998889999999999999999999999997643 3344444444332  2345688999999999999


Q ss_pred             cCcCCCCC-----HHHHhcCccccccccc
Q 017445          322 KDAEARPT-----ADQLLSHPFITKYEHA  345 (371)
Q Consensus       322 ~dp~~Rps-----~~~il~hp~~~~~~~~  345 (371)
                      .||++||+     +.+++.||||....+.
T Consensus       235 ~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         235 RNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             cCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            99999999     7889999999876543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-46  Score=349.63  Aligned_cols=251  Identities=26%  Similarity=0.419  Sum_probs=209.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|.+..+++.||+|++....   ......+..|...+.+..+||||+++++.+  .+.+..|+||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~--~~~~~~~lv~e~~~   79 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF--QTAEKLYFVLDYVN   79 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCEEEEEEcCCC
Confidence            6999999999999999999999999986422   233445666666555555699999999877  45668999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      +++|...+.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.............+|
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            99999999888889999999999999999999999 99999999999999999999999999998754333333355679


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+.....  ..+...+.++.+++.+||+.||
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPL--QLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCCH
Confidence            999999999998889999999999999999999999997643 2333344443332  2335678999999999999999


Q ss_pred             CCCCCH----HHHhcCcccccccc
Q 017445          325 EARPTA----DQLLSHPFITKYEH  344 (371)
Q Consensus       325 ~~Rps~----~~il~hp~~~~~~~  344 (371)
                      .+||++    .++++||||..+..
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCCCCH
Confidence            999875    59999999986554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.3e-46  Score=351.46  Aligned_cols=258  Identities=23%  Similarity=0.368  Sum_probs=208.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++..  ........+.+|+.++..+. ||||+++++++....    .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcccc
Confidence            3689999999999999999999999999999999864  23344566788999888886 999999999875432    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            358999999975 6777664  358899999999999999999999 999999999999999999999999999987654


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH------------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI------------------  295 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~------------------  295 (371)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+...                  
T Consensus       175 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         175 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             cC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHHHHHHH
Confidence            32 2234567899999999999999999999999999999999999999765421 111111                  


Q ss_pred             ----hhCCCCC------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          296 ----LEDPSPS------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       296 ----~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                          .......                  ......++++.+|+.+||+.||++|||+.|+|.||||..|..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence                1110000                  011234678999999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-46  Score=340.40  Aligned_cols=260  Identities=24%  Similarity=0.387  Sum_probs=215.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .|++.+.||+|+||+||++.+..+++.||+|++....   ......+.+|+.++..+. ||||+++++.+.  +...+++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--TKDALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeec--CCCeEEE
Confidence            3788899999999999999999999999999986422   223345678999998886 999999999774  4568999


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          159 ALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999999888543  458999999999999999999999 999999999999999999999999999987654332


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH--HHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                       ......|++.|+|||++.+..++.++||||+|+++|+|++|..||........  .+...+.. .....+..++..+.+
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE-DQEEYSEKFSEAARS  234 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh-cccccCcccCHHHHH
Confidence             22345789999999999988899999999999999999999999976443221  12222222 122234568999999


Q ss_pred             HHHHhcccCcCCCC-----CHHHHhcCccccccccccc
Q 017445          315 FVDDCLKKDAEARP-----TADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       315 li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~~  347 (371)
                      |+.+||..||++||     +++++++||||.....++.
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05605         235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL  272 (285)
T ss_pred             HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence            99999999999999     8999999999987665543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.5e-46  Score=339.39  Aligned_cols=271  Identities=35%  Similarity=0.668  Sum_probs=226.5

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++++.||+|+||.||+|.+..++..||+|.+... .......+.+|+.++.++. ||||+++++.+.  ..+..|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFF--IEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhhee--cCCeEEEE
Confidence            3688899999999999999999999999999988653 3444567889999998875 999999999875  45689999


Q ss_pred             EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQ---KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+..|++||||+|+||+++.++.++|+|||.+...... 
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999999998753   379999999999999999999996359999999999999999999999999998765432 


Q ss_pred             cccccccccCcccCCccccCC------CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHHHHHhhCCCCCCCCCCC
Q 017445          237 AMCATFVGTVTYMSPERIRNE------SYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  308 (371)
                       ......+++.|+|||.+.+.      .++.++|+||+||++|+|++|..||.......  ..+..+... .+...+..+
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPSGY  234 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCccc
Confidence             22345688899999998544      35789999999999999999999996543211  112222222 223334558


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF  357 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~  357 (371)
                      +.++.+|+.+||+.+|++||++.+++.||||..+...+.++.+|+...+
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  283 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGAL  283 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccchHHHHHHHH
Confidence            9999999999999999999999999999999999999999999998776

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.7e-46  Score=352.86  Aligned_cols=263  Identities=26%  Similarity=0.449  Sum_probs=214.7

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..++..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|..++..+. ||||+++++.+.  
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~--  113 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ--  113 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--
Confidence            34556689999999999999999999999999999999986422   223344667777776665 999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +...+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            56689999999999999999864 468999999999999999999999 9999999999999999999999999999976


Q ss_pred             Cccccc-ccccccccCcccCCccccCC----CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCC
Q 017445          232 LENSIA-MCATFVGTVTYMSPERIRNE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPS  304 (371)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~  304 (371)
                      ...... ...+.+||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+ ......++....  ...+.
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~  270 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPD  270 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCcccCCC
Confidence            643322 23456799999999999653    37899999999999999999999997643 334445554432  22333


Q ss_pred             CCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccc
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYE  343 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~  343 (371)
                      ...++.++.++|..||..++.+  |+++.++++||||....
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            4578999999999999854443  78999999999997743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.3e-45  Score=335.90  Aligned_cols=262  Identities=32%  Similarity=0.586  Sum_probs=220.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .+.|++++.||.|+||.||+|.+..+++.+|+|.+..........+.+|+..+..+. ||||+++++.+.  ..+..|+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFY--WDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEE--eCCeEEEE
Confidence            357899999999999999999999999999999998766666777888999988887 999999999875  35689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++++|..++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            999999999988754 4568999999999999999999999 99999999999999999999999999998765443333


Q ss_pred             cccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCCCCCCCCHHH
Q 017445          239 CATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-PSPSRQNFSPEF  312 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  312 (371)
                      .....+++.|+|||.+.     ...++.++|+|||||++|+|++|..||.... ......+...... ....+..++.++
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCcccCHHH
Confidence            34567899999999984     3446889999999999999999999996543 3333334333322 223345678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .+++++||..+|++||++.++++||||......+
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            9999999999999999999999999998877665

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=345.56  Aligned_cols=261  Identities=25%  Similarity=0.417  Sum_probs=210.5

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||++.+..+++.||+|++...   .......+.+|..++..+ +|+||+++++++.  +.+.+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~--~~~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQ--DENNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEe--cCCeEE
Confidence            4789999999999999999999999999999998642   223344567777777766 4999999999874  566899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||++||+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999999999975 4579999999999999999999999 999999999999999999999999999987654432


Q ss_pred             cc-cccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC---CCCCCCC
Q 017445          237 AM-CATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSPSRQN  307 (371)
Q Consensus       237 ~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  307 (371)
                      .. ....+||+.|+|||++.+     ..++.++||||+||++|+|++|+.||.... .......+.....   .......
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCcccCCCccCC
Confidence            22 223469999999999863     457889999999999999999999997643 2333333433221   1122245


Q ss_pred             CCHHHHHHHHHhcccCcCC--CCCHHHHhcCcccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~~~~  346 (371)
                      ++..+.+|+++||..++++  |+++.+++.||||....+..
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence            7999999999998765544  78999999999998765443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=379.52  Aligned_cols=267  Identities=28%  Similarity=0.462  Sum_probs=229.6

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      ...+...+||+++++||+|+||.|.+++++.|++.||+|++++.   .......|..|-.++... +.+.|++++.+|  
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF--  144 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF--  144 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh--
Confidence            45678889999999999999999999999999999999999862   334455566666666544 489999999988  


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ++..++|+||||++||+|-.++.+..++|++.++.++..|+.||.-||+ -|+|||||||+|||+|..|++||+|||.+.
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhHH
Confidence            6788999999999999999999988899999999999999999999999 999999999999999999999999999998


Q ss_pred             cCc-ccccccccccccCcccCCcccc----C-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC--CCCC
Q 017445          231 GLE-NSIAMCATFVGTVTYMSPERIR----N-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPS  302 (371)
Q Consensus       231 ~~~-~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~  302 (371)
                      .+. ++...+...+|||.|++||++.    + +.|+..+|+||+|+++|||+.|..||.... -.....+|+..  ....
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-lveTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-LVETYGKIMNHKESLSF  302 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-HHHHHHHHhchhhhcCC
Confidence            877 4445567889999999999984    3 569999999999999999999999997643 34555566554  2333


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCcccccccccc
Q 017445          303 PSRQNFSPEFCSFVDDCLKKDAEARPT---ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       303 ~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~il~hp~~~~~~~~~  346 (371)
                      +....+|.++++||++.+ .+|+.|..   ++++-.||||.+..|..
T Consensus       303 P~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  303 PDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             CcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhh
Confidence            334569999999999888 58889988   99999999999998854

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.5e-46  Score=354.18  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=210.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC-----CCeeEeceeEEecCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-----EGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h-----~~iv~l~~~~~~~~~~~  155 (371)
                      .+|++++.||+|+||+|.+|.+..|++.||||+++. ......+...|+.+|..+.+|     -|+|+++++|..  .++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccc
Confidence            489999999999999999999999999999999974 455566778899988877743     489999999976  559


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC--CceEEeccccccc
Q 017445          156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK--GRPKITDFGISAG  231 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~--~~~kl~Dfg~s~~  231 (371)
                      +|||+|.+. -+|+++++.+  .+++...++.++.||+.||.+||. .||||+||||+|||+...  ..+||+|||.|+.
T Consensus       263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999996 5999999865  358999999999999999999999 999999999999999765  4699999999987


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CC--------
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PS--------  300 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~--------  300 (371)
                      .....   .+.+.+..|+|||++.|..|+.+.||||||||++||++|.+.|.+.++.+ .+..+++.   +.        
T Consensus       341 ~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D-Ql~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  341 ESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD-QLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH-HHHHHHHHhCCCCHHHHHhcc
Confidence            76543   37889999999999999999999999999999999999988888765432 22222110   00        


Q ss_pred             --------------------------------------CC-CCC----------C-CCCHHHHHHHHHhcccCcCCCCCH
Q 017445          301 --------------------------------------PS-PSR----------Q-NFSPEFCSFVDDCLKKDAEARPTA  330 (371)
Q Consensus       301 --------------------------------------~~-~~~----------~-~~~~~~~~li~~~l~~dp~~Rps~  330 (371)
                                                            .. ..+          . .-...+.+|+++||+.||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                                                  00 000          0 112568899999999999999999


Q ss_pred             HHHhcCccccccc
Q 017445          331 DQLLSHPFITKYE  343 (371)
Q Consensus       331 ~~il~hp~~~~~~  343 (371)
                      .++|+||||+...
T Consensus       497 ~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  497 AQALNHPFLTGTS  509 (586)
T ss_pred             HHHhcCccccccc
Confidence            9999999998443

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-45  Score=338.16  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=203.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEec---CCC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYMP---DSG  154 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~~---~~~  154 (371)
                      +|++.+.||+|+||+||+|.++.+++.||+|.++...  ........+|+..+..+.  +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999999999999999999986522  112234556666665543  599999999987532   234


Q ss_pred             eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          155 QISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      .++++|||+.+ +|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            68999999975 899988653  348999999999999999999999 99999999999999999999999999998766


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCC--------
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSP--------  301 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~--------  301 (371)
                      .... ......+|+.|+|||++.+..++.++||||+||++|+|++|..||...... ..+.++..   ....        
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCccccc
Confidence            5432 224456899999999999888999999999999999999999999764432 22222211   0000        


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          302 --------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       302 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                    ......++..+.+++.+||+.||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          00113567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-45  Score=335.52  Aligned_cols=257  Identities=29%  Similarity=0.611  Sum_probs=213.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~~  155 (371)
                      ...|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+..+.++.+||||+++++.+...+    ...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            346778889999999999999999999999999986533 334567788888888877999999999886432    246


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +|++|||+++++|.+++...  ..+++..+..++.|++.||.|||+ ++|+|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            89999999999999998753  458999999999999999999999 999999999999999999999999999987665


Q ss_pred             ccccccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ..........|++.|+|||++.     +..++.++||||+||++|+|++|..||.... ....................+
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCCCCCCCCc
Confidence            4433345567999999999986     3457889999999999999999999996533 222233333333333444568


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.++.+|+.+||..+|.+|||+.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-45  Score=360.13  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=217.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCC-CcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPT-HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ...|.+.+.||+|++|.||+|.+..+ ++.||+|.+..........+.+|+..+..+. ||||+++++.+.  ..+.+||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~--~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDFK--SDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE--ECCEEEE
Confidence            34589999999999999999998877 7889999886655555566778999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          159 ALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ||||++||+|.+++..    ..++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999999999988753    3468999999999999999999999 9999999999999999999999999999987654


Q ss_pred             ccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ...  ...+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+..+... +.+..+++++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~~-~~~~~~s~~~  299 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-QREIMQQVLYGKYD-PFPCPVSSGM  299 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC-CCCccCCHHH
Confidence            322  2345679999999999999999999999999999999999999997643 33444444444332 3345788999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .++|.+||..||++||++.+++.|||+...
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999999654

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-45  Score=330.28  Aligned_cols=254  Identities=33%  Similarity=0.522  Sum_probs=215.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|.+....     ......+.+|+.++.++. ||||+++++.+.  +...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLR--DDET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEc--cCCe
Confidence            46788899999999999999999999999999986421     123356788999888886 999999999874  4568


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +++|+||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999999999888889999999999999999999999 99999999999999999999999999998765432


Q ss_pred             cccc---ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          236 IAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       236 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ....   ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .....+..........+..++..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-MAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-HHHHHHHhccCCCCCCCccCCHHH
Confidence            2111   234678899999999988899999999999999999999999976443 333344444444444556789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .+++++||..+|.+||++.++++||||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-45  Score=341.97  Aligned_cols=259  Identities=22%  Similarity=0.424  Sum_probs=209.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|.++... ........+|+.++.++. ||||+++++++.  ..+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVH--TDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEe--eCCeEEEE
Confidence            57999999999999999999999999999999987532 223345678999988886 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++ +|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.........
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            999975 888887654 458999999999999999999999 99999999999999999999999999998765443333


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCC---------------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPS---------------  300 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~---------------  300 (371)
                      .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.....  +...+..+.               
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            345568999999999865 45889999999999999999999999765432211  111111000               


Q ss_pred             ---CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          301 ---PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       301 ---~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                         +.       .....++.++.+|+++||+.||.+|||+.++++||||..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence               00       011356889999999999999999999999999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-45  Score=338.36  Aligned_cols=260  Identities=30%  Similarity=0.552  Sum_probs=218.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|++.+.||+|++|.||+|.+..+++.||+|.+..........+.+|+.++..+. |||++++++.+..  ....|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~--~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC-CCCEeeEEEEEEe--CCEEEEe
Confidence            458899999999999999999999999999999997655455567788998888775 9999999998754  5589999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||.+..........
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence            999999999999864 568999999999999999999999 999999999999999999999999999987654433333


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||......................+..++..+.+++.+|
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence            44578999999999998889999999999999999999999997654322222222222222233456889999999999


Q ss_pred             cccCcCCCCCHHHHhcCcccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      |..+|.+||++.+++.||||.....
T Consensus       254 l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         254 LDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             CcCCcccCcCHHHHhhChhhhccCC
Confidence            9999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-45  Score=360.79  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=203.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-----PCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~-----~~h~~iv~l~~~~~~~  151 (371)
                      .....+|++++.||+|+||+||+|.+..+++.||||+++.... .......|+.++..+     ..|+++++++++|. .
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~-~  202 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ-N  202 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE-c
Confidence            3456789999999999999999999999999999999964221 222233454444333     23667889888774 3


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC------------
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG------------  219 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~------------  219 (371)
                      +.+.+|||||++ |++|.+++...+.+++..+..++.||+.||.|||+..||+||||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            456899999998 6799999988888999999999999999999999724999999999999998765            


Q ss_pred             ----ceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HH
Q 017445          220 ----RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--ML  293 (371)
Q Consensus       220 ----~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~  293 (371)
                          .+||+|||.+.....   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +.
T Consensus       282 ~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence                499999998764332   224568999999999999999999999999999999999999999765432111  11


Q ss_pred             HHhhCCC-----------------------CCCC--------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          294 QILEDPS-----------------------PSPS--------------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       294 ~~~~~~~-----------------------~~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ..+....                       +...              .....+.+.+||.+||+.||.+|||+.|+|+|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            1111000                       0000              00113567899999999999999999999999


Q ss_pred             ccccccccc
Q 017445          337 PFITKYEHA  345 (371)
Q Consensus       337 p~~~~~~~~  345 (371)
                      |||.++...
T Consensus       439 p~~~~~~~~  447 (467)
T PTZ00284        439 PYVLKYYPE  447 (467)
T ss_pred             ccccccCCc
Confidence            999987543

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.8e-45  Score=335.33  Aligned_cols=260  Identities=32%  Similarity=0.578  Sum_probs=217.9

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+..........+.+|+.++..+. |||++++++.+..  ....++|||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~--~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYY--ENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEee--CCEEEEEEE
Confidence            3577889999999999999999999999999997656566677888999988886 9999999998753  568999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          162 YMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       162 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      |+++++|..++.. ..++++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++...........
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            9999999998764 4679999999999999999999999 9999999999999999999999999999876544333334


Q ss_pred             cccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCCCCCCCCHHHHH
Q 017445          241 TFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-PSPSRQNFSPEFCS  314 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  314 (371)
                      ...+++.|+|||++.     +..++.++||||+||++|+|++|..||.... ......++..... ....+..++.++.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            567899999999983     4457889999999999999999999997644 3333334333322 22334568899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      |+.+||..||.+||++.++++||||.......
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  272 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP  272 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEeccCCCC
Confidence            99999999999999999999999998765543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-45  Score=335.88  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=207.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||+|+||+||++.+..+|+.||+|.+....   .........|+.++.++. ||||+++++.+  .+...+|+||||++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~--~~~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAF--ESKTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEE--ecCCeEEEEEecCCC
Confidence            799999999999999999999999986421   223344567888998885 99999999977  456689999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          166 GSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       166 g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++|.+++...  ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++....... ......
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            9999888543  358899999999999999999999 999999999999999999999999999987665432 223456


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH---HHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      |++.|+|||++.+..++.++||||+||++|+|++|..||.......   ............ .....+++++.+|+.+||
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHh
Confidence            8999999999988889999999999999999999999997543321   222222222222 223468999999999999


Q ss_pred             ccCcCCCCCH----HHHhcCccccccccccc
Q 017445          321 KKDAEARPTA----DQLLSHPFITKYEHAKV  347 (371)
Q Consensus       321 ~~dp~~Rps~----~~il~hp~~~~~~~~~~  347 (371)
                      +.||.+||++    ++++.||||+.+..++.
T Consensus       235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~  265 (277)
T cd05607         235 AKKPEDRLGSREKNDDPRKHEFFKTINFPRL  265 (277)
T ss_pred             ccCHhhCCCCccchhhhhcChhhcCCCHHHH
Confidence            9999999999    77889999988765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-45  Score=339.76  Aligned_cols=263  Identities=30%  Similarity=0.552  Sum_probs=220.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|.+++.||+|+||.||+|.+..+++.||+|.+..........+.+|+.++..+. ||||+++++.+.  .....|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYL--VGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCEEEEe
Confidence            468899999999999999999999999999999997655555566788888887775 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+..........
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            999999999999864 568999999999999999999999 999999999999999999999999999987654433333


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+..................+..++..+.+|+.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC  252 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence            44578999999999998889999999999999999999999997644322211111122222234456889999999999


Q ss_pred             cccCcCCCCCHHHHhcCccccccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      |..+|++||++.++++||||........
T Consensus       253 l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         253 LEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             ccCChhhCcCHHHHhcCchhcccccccc
Confidence            9999999999999999999987765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-45  Score=347.87  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=209.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~  153 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++...    +.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccccccccc
Confidence            35899999999999999999999999999999998642  3344566788988888776 99999999987532    22


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            468999999975 7888775  358899999999999999999999 999999999999999999999999999997654


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---------------  298 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  298 (371)
                      .. .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+. ...+.+++..               
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            43 223456799999999999999999999999999999999999999976442 2222222110               


Q ss_pred             -------CCC------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          299 -------PSP------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       299 -------~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                             ...                  .......++.+.+||.+||+.||++|||+.++|+||||..+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence                   000                  00011235678999999999999999999999999999876443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=336.79  Aligned_cols=259  Identities=34%  Similarity=0.628  Sum_probs=220.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++++.||.|+||+||+|.+..++..+|+|.+..........+..|+.++.++. ||||+++++.+.  +....|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYF--YENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEe--cCCeEEEE
Confidence            357889999999999999999998899999999998766666677889999999987 999999999874  46689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            9999999999998753 569999999999999999999999 99999999999999999999999999998766544344


Q ss_pred             cccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCCHHH
Q 017445          239 CATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPEF  312 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  312 (371)
                      .....+++.|+|||.+.     ...++.++|+||||+++|+|++|..||.... ......++.....+ ...+..++.++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-PMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-HHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            45567899999999974     3446789999999999999999999997643 33334444433322 22345688999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+++.+||+.+|++||++.++++||||....
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            9999999999999999999999999998774

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-45  Score=348.52  Aligned_cols=257  Identities=23%  Similarity=0.370  Sum_probs=208.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .........+|+.++..+. ||||+++++++....    .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccccc
Confidence            46899999999999999999999999999999998652  3344566778988888776 999999999875332    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            468999999975 7777775  358999999999999999999999 999999999999999999999999999997654


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh-----------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-----------------  296 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~-----------------  296 (371)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+...+                 
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhcHH
Confidence            43 2234567999999999999989999999999999999999999999764321 1111110                 


Q ss_pred             -----hCCCC------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          297 -----EDPSP------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       297 -----~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                           .....                  .......+.++.+||.+||+.||++|||+.++|+||||..+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                 00000                  001122456789999999999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-45  Score=344.50  Aligned_cols=261  Identities=25%  Similarity=0.438  Sum_probs=211.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|+||+||++.+..+++.+|+|++....   ......+.+|..++... +|++|+++++.+.  +...+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~--~~~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQ--DENNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEe--cCCEEE
Confidence            37899999999999999999999999999999986421   22233456677777666 4999999999774  566899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999999999999976 4678999999999999999999999 999999999999999999999999999987654322


Q ss_pred             c-ccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC---CCCCC
Q 017445          237 A-MCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQN  307 (371)
Q Consensus       237 ~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~  307 (371)
                      . .....+||+.|+|||++.     ...++.++|||||||++|+|++|+.||...+ ......++.......   .....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCccccCCCcccc
Confidence            2 223457999999999986     3458899999999999999999999997643 334444444332211   22246


Q ss_pred             CCHHHHHHHHHhcccCcCC--CCCHHHHhcCcccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~~~~  346 (371)
                      +++++.+|+++|++.++++  |+++.++++||||....+..
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~  276 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN  276 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence            7999999999999765555  68999999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-49  Score=339.46  Aligned_cols=255  Identities=33%  Similarity=0.630  Sum_probs=225.7

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      |.++++||+|+||.||+|+++.+|+.+|||++..  ..+...++.|+.++.++. .|++|++||.|+.  ...++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK--~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFK--HSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcC-Cchhhhhhhhhcc--CCceEeehhh
Confidence            4577799999999999999999999999999975  456678999999998887 9999999999875  3479999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          163 MDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       163 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |..|+..+++.. ++++++.++..+++..+.||+|||. -.-||||||..|||++.+|+.||+|||.|.++.+.....++
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999999864 5679999999999999999999999 66899999999999999999999999999999888888899


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCCHHHHHHHHHhc
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l  320 (371)
                      ..|||.|||||++....|+.++||||||++..||..|++||.+ -.++..++.+-..+++ ...+..+++++.+|++.||
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD-IHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD-IHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc-ccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            9999999999999999999999999999999999999999965 3445444444333333 3445678999999999999


Q ss_pred             ccCcCCCCCHHHHhcCcccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .++|++|.|+.++++|||++....
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCCCc
Confidence            999999999999999999986643

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-46  Score=336.64  Aligned_cols=253  Identities=34%  Similarity=0.602  Sum_probs=211.3

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHH--HHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN--QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      |++++.||+|+||+||++++..+++.||+|.+.........  ...+|+..+.++ +||||+++++.+..  ....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence            78899999999999999999999999999999875443332  345688999888 59999999998854  66899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      ||+++++|.+++...+.+++..+..++.|++.||.+||+ +|++|+||||+||+++.++.++|+|||.+...........
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999878889999999999999999999999 9999999999999999999999999999875433333445


Q ss_pred             cccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHhhCCCCCCC--CCCCCHHHHHH
Q 017445          241 TFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSPSPS--RQNFSPEFCSF  315 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  315 (371)
                      ...+++.|+|||++. +..++.++||||+|+++++|++|..||....  .......+..........  ....+.++.++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            677899999999998 8889999999999999999999999998652  112222222222111111  11224899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.+||+.||++||++.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-45  Score=334.08  Aligned_cols=254  Identities=30%  Similarity=0.519  Sum_probs=212.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+..+..+. ||||+++++.+.  +.+..|+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~--~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYL--RRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCeeeEEEEEE--eCCEEEEE
Confidence            357888899999999999999999999999999997655555566778888888775 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+..........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            9999999999999888899999999999999999999999 999999999999999999999999999987665443333


Q ss_pred             ccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-C--CCCCCCCHHHH
Q 017445          240 ATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-S--PSRQNFSPEFC  313 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~  313 (371)
                      ....|++.|+|||++.   ...++.++|+||+||++|+|++|..||........ .......... .  .....++..+.
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCCCcccccCCCCHHHH
Confidence            4567999999999974   45688999999999999999999999965432222 2222222111 1  11235788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      +++.+||..+|++||+++++++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=347.43  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=217.9

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...+.+..+.+..++.||+|-||+|++|.+..+ ..||+|.++.. ....+.+.+|+.++.++. |++||+++|++..  
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~--  272 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLR-HEKLVKLYGVCTK--  272 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCc-ccCeEEEEEEEec--
Confidence            456777788888999999999999999997544 36999999753 333456779999999998 9999999998853  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+.+|||||||+.|+|.++|..  .+.+...+...++.||++|++||++ +++|||||...||||+++..+||+|||+|+
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCceEEEccccccc
Confidence            3479999999999999999986  4568999999999999999999999 999999999999999999999999999999


Q ss_pred             cCcccccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          231 GLENSIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ...+.... .....-...|.|||++....++.+|||||||++||||+| |+.||....+  ..+...++.+...+.+..+
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--~ev~~~le~GyRlp~P~~C  429 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--EEVLELLERGYRLPRPEGC  429 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--HHHHHHHhccCcCCCCCCC
Confidence            66554332 223334557999999999999999999999999999999 9999987653  3455667777888888999


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      |+++.+++..||..+|++|||++.+.
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            99999999999999999999998553

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-45  Score=335.97  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      |++.+.||+|+||+||++.+..+++.||+|.+....   ......+..|+.++..+. |++++.+++.+.  +...+++|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~lv   78 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYE--TKDALCLV   78 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEe--cCCEEEEE
Confidence            677889999999999999999999999999986422   223355678999988886 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....... 
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999999999988543  358999999999999999999999 999999999999999999999999999987654332 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ......|++.|+|||.+.+..++.++||||+|+++|+|++|..||.......  ......... .....+..+++++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSL  235 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHH
Confidence            2234579999999999998889999999999999999999999997643221  112222111 1223345688999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          316 VDDCLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       316 i~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      +++||+.||++|||     +.++++||||.+....+
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR  271 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence            99999999999999     99999999998765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-47  Score=352.20  Aligned_cols=259  Identities=30%  Similarity=0.547  Sum_probs=230.1

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      ++.||.|+||.||.|.+..+.+.||||++...   ..+....++.|+..|.++. |||++.+.|+|..  ....+|||||
T Consensus        31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLr--e~TaWLVMEY  107 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLR--EHTAWLVMEY  107 (948)
T ss_pred             HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeec--cchHHHHHHH
Confidence            44799999999999999999999999999764   3456678999999999998 9999999999974  3478999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          163 MDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       163 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |- |+-.|++.. .+++.+..+..|..+.+.||.|||| .+.||||||..|||+++.|.|||+|||.|....+.    ++
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----ns  181 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----NS  181 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCCeeeeccccchhhcCch----hc
Confidence            96 488998864 4679999999999999999999999 99999999999999999999999999998766554    78


Q ss_pred             ccccCcccCCccc---cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          242 FVGTVTYMSPERI---RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       242 ~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ++|||+|||||++   ..+.|+-++||||||++..||...++|+.+.+ -+..++.+..+..|......+++.|+.|+..
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSALYHIAQNesPtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence            9999999999998   56789999999999999999999999987755 4778888988888888889999999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccccccccHHHHHHH
Q 017445          319 CLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRS  355 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~  355 (371)
                      ||++-|.+|||.+++|+|+|..+-+..++ ++++..+
T Consensus       261 CLqKipqeRptse~ll~H~fv~R~Rp~tv-i~dLIqR  296 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLKHRFVLRERPPTV-IMDLIQR  296 (948)
T ss_pred             HHhhCcccCCcHHHHhhcchhccCCCchH-HHHHHHH
Confidence            99999999999999999999998877665 3455444

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-45  Score=346.68  Aligned_cols=258  Identities=24%  Similarity=0.441  Sum_probs=209.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      .++|.+++.||+|+||+||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++....    .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccccc
Confidence            35788999999999999999999999999999998652  2234456778999998887 999999999874321    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...|++++++ +++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            3579999998 679998875 4679999999999999999999999 999999999999999999999999999998654


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC----------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP----------  299 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~----------  299 (371)
                      ..   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+..+..   ..          
T Consensus       170 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             CC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhcch
Confidence            43   245679999999999976 5689999999999999999999999976432 111111111   00          


Q ss_pred             ---------CCCC-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          300 ---------SPSP-------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       300 ---------~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                               .+..       .....++.+.+|+.+||+.||.+|||+.+++.||||.++..+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                     0000       012456778999999999999999999999999999987554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.6e-45  Score=335.44  Aligned_cols=257  Identities=28%  Similarity=0.489  Sum_probs=221.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+....   ......+.+|+.++.++. ||||+++++.+.  +...+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQ--DDSNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEE--cCCeEE
Confidence            37889999999999999999999999999999986422   234466788999998887 999999999874  456899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||++......  
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999999999888889999999999999999999999 99999999999999999999999999998876544  


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                       .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||.... ......++.....  ..+..++..+.++++
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~--~~~~~~~~~l~~li~  230 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILEGKV--RFPSFFSPDAKDLIR  230 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCc--cCCccCCHHHHHHHH
Confidence             244568999999999988888999999999999999999999997644 3333444443332  234567899999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCccccccccccc
Q 017445          318 DCLKKDAEARP-----TADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       318 ~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~~  347 (371)
                      +||+.||.+|+     +++++++||||....+...
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  265 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL  265 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence            99999999999     8999999999988775544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.1e-45  Score=335.67  Aligned_cols=258  Identities=31%  Similarity=0.579  Sum_probs=218.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|.+.+.||.|++|.||+|.+..+++.||+|.+..........+.+|+..+..+. |||++++++.+.  +...+|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSFL--VGDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC-CCceeeeeeeEe--cCceEEEE
Confidence            357899999999999999999999999999999997655455567788999888876 999999999875  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      +||+++++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            999999999998864 468999999999999999999999 999999999999999999999999999987655433333


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh-CCCCCCCCCCCCHHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.. .......+..+++.+.+++++
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            4456899999999999888999999999999999999999999765432 22233322 222333456788999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccc
Q 017445          319 CLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ||..||.+||++.+++.||||....
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-44  Score=325.33  Aligned_cols=253  Identities=28%  Similarity=0.552  Sum_probs=213.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .|++.+.||.|++|.||++.+..+++.||+|++...  .......+.+|+..+.++. |+|++++.+.+. .....+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWE-GEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeec-CCCCEEEEE
Confidence            488999999999999999999999999999998652  2334456788888888886 999999998763 234578999


Q ss_pred             EeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++..  ...+++.++..++.|++.|+.+||+ .|++||||+|+||+++.++.++|+|||.+........
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999999875  3458999999999999999999999 9999999999999999999999999999876654434


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+. ......+.....+ ..+..+++++.+++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVYRIIEGKLP-PMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCC-CCccccCHHHHHHHH
Confidence            44556789999999999998899999999999999999999999975442 3333344343332 234568899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +||+.+|.+||++.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.8e-45  Score=343.20  Aligned_cols=261  Identities=24%  Similarity=0.426  Sum_probs=211.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|+||+||++.+..+++.||+|.+...   .......+.+|..++.... |++|+++++++  .+.+..|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~--~~~~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAF--QDENYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--EcCCEEE
Confidence            4789999999999999999999999999999998642   1223334566677766664 99999999987  4566899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||++||+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999999976 4679999999999999999999999 999999999999999999999999999987654432


Q ss_pred             cc-cccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC---CCCCC
Q 017445          237 AM-CATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQN  307 (371)
Q Consensus       237 ~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~  307 (371)
                      .. .....||+.|+|||++.+     ..++.++||||+|+++|+|++|+.||.... .......+.......   .....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-HHHHHHHHHcCCCcccCCCcccc
Confidence            21 233579999999999865     467889999999999999999999997643 233344443332211   12245


Q ss_pred             CCHHHHHHHHHhcccCcCC--CCCHHHHhcCcccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~~~~  346 (371)
                      ++.++.+++.+||+..+++  |++++++++||||....+..
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence            7899999999999876655  57899999999998765443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-44  Score=330.98  Aligned_cols=258  Identities=36%  Similarity=0.729  Sum_probs=215.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +|++++.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.++.++. ||||+++++.+..  ....++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFV--ENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEE--CCEEEEEE
Confidence            678888999999999999999999999999998653 3344566889999988886 9999999998854  55899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++......  ...
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~  151 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAK  151 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--ccc
Confidence            99999999764    357899999999999999999999 99999999999999999999999999998765443  224


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc------HHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP------VNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||......      ......+.....+.......++++.+
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            467999999999999888999999999999999999999999653211      11122222222233333457889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccccccccH
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDL  349 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~  349 (371)
                      ++.+||+.+|.+||++++++.||||.....+..+.
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~  266 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV  266 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccccCccHHH
Confidence            99999999999999999999999999988777654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.2e-45  Score=347.46  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=209.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---CeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---GQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---~~~  156 (371)
                      +|++.+.||+|+||+||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++...+.   ...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            467888999999999999999999999999998642  3344567889999998886 9999999998753321   268


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+. ++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++.......
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            99999996 5899988877889999999999999999999999 999999999999999999999999999987654322


Q ss_pred             -cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh------------------
Q 017445          237 -AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL------------------  296 (371)
Q Consensus       237 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~------------------  296 (371)
                       .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+... ...+..+.                  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-IQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence             122345689999999999764 478999999999999999999999976542 22111111                  


Q ss_pred             -----hCCCCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          297 -----EDPSPS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       297 -----~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                           ......       ......++++.+||.+||+.||.+|||+.+++.||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                 111100       1123467899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-44  Score=330.40  Aligned_cols=273  Identities=39%  Similarity=0.684  Sum_probs=225.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+... .......+.+|+..+..+. ||||+++++.+...+.+.+|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEEE
Confidence            3688999999999999999999999999999998753 2345567889999998886 9999999998876666789999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            999999999988653    3458999999999999999999999 99999999999999999999999999998765433


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC----CcHHHHHHHhhCCCCCC-----CCC
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE----GPVNLMLQILEDPSPSP-----SRQ  306 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~-----~~~  306 (371)
                      ..  ....++..|+|||.+.+..++.++||||+|+++|+|++|..||....    ..............+..     ...
T Consensus       159 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 LA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             cc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            21  23457889999999998889999999999999999999999997652    22222222222111111     112


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF  357 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~  357 (371)
                      .+++.+.+|+.+||..+|++|||+.+++.||||+....++.++..++..+|
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~~~~~  287 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVAQVW  287 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhHHHHHHhhC
Confidence            456789999999999999999999999999999999888888777766543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.7e-45  Score=335.45  Aligned_cols=272  Identities=35%  Similarity=0.669  Sum_probs=221.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|...+.||+|+||.||++.+..+++.||+|.+... .......+.+|+..+.++..||||+++++.+.  ..+..+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEEE
Confidence            4566777999999999999999999999999998753 23455678889999988877999999999875  35578999


Q ss_pred             EeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          160 LEYMDGGSLADILR-----MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       160 ~E~~~~g~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      |||+.. ++.++..     ....+++..+..++.|++.||+|||+..+++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999864 6655432     2367999999999999999999999735999999999999999999999999999876544


Q ss_pred             cccccccccccCcccCCccccCC---CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC---CCCCC
Q 017445          235 SIAMCATFVGTVTYMSPERIRNE---SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP---SRQNF  308 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~  308 (371)
                      .. ......|++.|+|||.+.+.   .++.++||||+|+++|+|++|+.||.........+.+......+..   ....+
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            32 22344688999999999766   6899999999999999999999999765432233333333222221   12358


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHh
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSV  356 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~  356 (371)
                      +.++.+|+.+||+.+|++|||+++++.||||.++...+.....+++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~~~~~~~~  287 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRI  287 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhHHHHHHHh
Confidence            899999999999999999999999999999999999999888877654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-47  Score=326.56  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=216.4

Q ss_pred             ceeEe-eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE--ecCCCeEEE
Q 017445           82 EMRIF-GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY--MPDSGQISI  158 (371)
Q Consensus        82 ~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~--~~~~~~~~l  158 (371)
                      +|.+. ++||-|-.|.|..+.++.|++.+|+|++...     ....+|++.......|||||.++++|-  .....++.+
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            44443 5899999999999999999999999998642     233467777667778999999999883  234567889


Q ss_pred             EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEecccccccCc
Q 017445          159 ALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISAGLE  233 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~~~~  233 (371)
                      |||.++||.|++.+...+.  |+|.++..|++||..|+.|||+ .+|.||||||+|+|...   +..+||+|||+|+...
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            9999999999999987665  9999999999999999999999 89999999999999965   4579999999998766


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc---HHHHHHHhhCC--CCCCCCCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP---VNLMLQILEDP--SPSPSRQNF  308 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~--~~~~~~~~~  308 (371)
                      .. ....+.+.||+|.|||++....|+..+|+||+|+++|-|++|.+||....+.   ...-.++..+.  .+.+.+..+
T Consensus       216 ~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  216 EP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             CC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence            53 3446789999999999999999999999999999999999999999764431   23334444443  455667889


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      |..++++|+.+|..+|++|.|+.+++.|||+.++..
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            999999999999999999999999999999988754

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-44  Score=331.80  Aligned_cols=258  Identities=32%  Similarity=0.567  Sum_probs=212.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC---CCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD---SGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~---~~~~  156 (371)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.++.++.+|||++++++.+...+   .+..
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            568999999999999999999999999999999986532 233556788888888877999999999886433   2468


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          157 SIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ++||||+++++|.++++.    ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||.+...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            999999999999998853    4568999999999999999999999 99999999999999999999999999998766


Q ss_pred             cccccccccccccCcccCCccccCC-----CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCCCCC
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNE-----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-PSPSRQ  306 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~  306 (371)
                      ...........++..|+|||.+...     .++.++||||||+++|+|++|+.||..... ...+..+..... ....+.
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHhcCCCCCCCccc
Confidence            5433333445689999999998543     368899999999999999999999976432 233333333322 222344


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      .++..+.+++.+||+.+|++||++.+++.||||+
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            5778999999999999999999999999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.9e-44  Score=324.64  Aligned_cols=252  Identities=33%  Similarity=0.657  Sum_probs=216.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+..  ........+.+|+.++..+. ||||+++++.+.  +.+..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFL--DKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeec--cCCEEEEE
Confidence            47788899999999999999999999999999864  23455667888999988886 999999999774  45689999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++...  ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999999999764  568999999999999999999999 9999999999999999999999999999887655443


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ......+++.|+|||++.+..++.++|+||||+++++|++|..||.... .......+.....+. ....++..+.++++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  234 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKIIRGVFPP-VSQMYSQQLAQLID  234 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCC-CccccCHHHHHHHH
Confidence            3445678999999999998889999999999999999999999997654 334444444443332 33478899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +||+.+|++||++.++++|||+
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-45  Score=331.30  Aligned_cols=258  Identities=34%  Similarity=0.618  Sum_probs=219.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.++..+. |+||+++++.+.  +...+|+|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v~   78 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFL--KGSKLWIIM   78 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEE--ECCeEEEEE
Confidence            6788889999999999999999999999999987533 344556788999988887 999999999875  346899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      ||+++++|.+++... ++++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            999999999999754 89999999999999999999999 9999999999999999999999999999987765433334


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||.... +......+.....+......++.++.+++.+||
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  235 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL  235 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence            5678899999999988889999999999999999999999997544 233333333333322222238899999999999


Q ss_pred             ccCcCCCCCHHHHhcCccccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      ..+|++||+++++++||||++....
T Consensus       236 ~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         236 NKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             hCChhhCcCHHHHhhChhhcCCCcc
Confidence            9999999999999999999887665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-44  Score=325.33  Aligned_cols=254  Identities=27%  Similarity=0.524  Sum_probs=218.5

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++++.||.|+||.||+|.+..+++.||+|.+..  .......++..|+..+..+. ||||+++++.+........+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEE
Confidence            57888999999999999999999999999999864  23445567888999998887 9999999998876666789999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----cCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          160 LEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLH-----GVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      |||+++++|.+++..    ..++++..++.++.|++.||.|||     + .+++|+||+|+||+++.++.++|+|||.+.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEecccccc
Confidence            999999999999865    357899999999999999999999     7 889999999999999999999999999998


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .............+++.|+|||.+.+..++.++|+||||+++++|++|..||.... .. .+.+.+........+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~-~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QL-QLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HH-HHHHHHhcCCCCCCccccCH
Confidence            77655433445678999999999988889999999999999999999999997654 22 23333344444444567889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .+.+++.+||..+|++||++.+|++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.3e-45  Score=335.47  Aligned_cols=260  Identities=24%  Similarity=0.433  Sum_probs=210.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++++.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+..+..+. ||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~--~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEe--cCCeEEE
Confidence            468999999999999999999999999999999986532 223345678999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||++ ++|.+++... ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+........
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            999997 5999888653 568999999999999999999999 9999999999999999999999999999876544333


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCC--------------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPS--------------  300 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~--------------  300 (371)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.....  +...+..+.              
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            3344567899999999865 45788999999999999999999999765432111  111111100              


Q ss_pred             ----CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          301 ----PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       301 ----~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                          +.       .....+++++.+||.+||+.||.+|||+.++++||||+...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                00       012357889999999999999999999999999999987763

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.1e-45  Score=331.87  Aligned_cols=257  Identities=30%  Similarity=0.612  Sum_probs=213.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~~~  155 (371)
                      ...|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+..|+.++.++.+||||+++++.+...    ....
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            357888889999999999999999999999999986533 33456788888888887899999999987532    2457


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +|++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            89999999999999998653  458899999999999999999999 999999999999999999999999999987654


Q ss_pred             ccccccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ..........|++.|+|||.+.     +..++.++|+||||+++|+|++|..||.... +...................+
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  251 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKSKKW  251 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhhCCCCCCccccc
Confidence            4333334567899999999985     3457889999999999999999999996543 222233333333333444568


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.++.+|+++||..||.+||++.++++||||
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=340.15  Aligned_cols=256  Identities=25%  Similarity=0.444  Sum_probs=222.2

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      |.+-+.||+|.|+.|.+|++.-||..||||++++  .+......++.|++.+...+ |||||++|.+.  .....+|||+
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEVi--DTQTKlyLiL   96 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVI--DTQTKLYLIL   96 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehh--cccceEEEEE
Confidence            3445589999999999999999999999999976  34445567899999997776 99999999977  4456899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE-ccCCceEEecccccccCcccccc
Q 017445          161 EYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV-NLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       161 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~-~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |+-++|+|++||-+ ...+.++.+.+++.||+.|+.|+|. -.+|||||||+||++ .+-|-+||+|||++..+.+.. .
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-k  174 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-K  174 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-h
Confidence            99999999998854 4579999999999999999999999 779999999999877 556999999999998887764 4


Q ss_pred             cccccccCcccCCccccCCCCC-CchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYS-YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ..+.||++.|-|||++.|..|+ +++||||||+|||-|++|++||...++ ...+..++...+..  +..++.+.++||.
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-SETLTmImDCKYtv--PshvS~eCrdLI~  251 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-SETLTMIMDCKYTV--PSHVSKECRDLIQ  251 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-hhhhhhhhcccccC--chhhhHHHHHHHH
Confidence            4789999999999999998887 789999999999999999999976544 34556677766544  4578999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .||+.||++|.+.++|..|+|++......
T Consensus       252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             HHHhcCchhhccHHHHhccccccCCCCCc
Confidence            99999999999999999999999886643

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=329.58  Aligned_cols=258  Identities=32%  Similarity=0.616  Sum_probs=215.7

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SG  154 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~  154 (371)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|.+..... ....+.+|+.++.++..|+||+++++.+....    ..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            35789999999999999999999998999999999876443 34668899999999877999999999886533    45


Q ss_pred             eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          155 QISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            68999999999999998864    3579999999999999999999999 999999999999999999999999999987


Q ss_pred             cCcccccccccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC-C
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP-S  304 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~  304 (371)
                      .............+++.|+|||.+..     ..++.++||||||+++|+|++|..||.... ......++.....+.. .
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHHHHhhccCCCCCCc
Confidence            66544344455678999999998853     346789999999999999999999997543 3334444444433222 2


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ...+++++.+|+.+||..||++|||+.++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            23478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-44  Score=331.36  Aligned_cols=259  Identities=31%  Similarity=0.529  Sum_probs=211.7

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe---cCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM---PDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~---~~~~  154 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.++.++.+||||+++++.+..   +++.
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            35578999999999999999999999999999999886422 2235567888888888679999999998753   2345


Q ss_pred             eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          155 QISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+.
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            79999999999999998752    3468899999999999999999999 999999999999999999999999999987


Q ss_pred             cCcccccccccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC-CCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP-SPSPS  304 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~  304 (371)
                      .............|++.|+|||++..     ..++.++||||+||++|+|++|+.||..... .....+..... .....
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhccccCCCcccC
Confidence            66543333345579999999999853     4478899999999999999999999976432 22222222221 12223


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +..++.++.+++.+||+.||++|||+.++++|+||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            34568899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-44  Score=333.10  Aligned_cols=279  Identities=36%  Similarity=0.669  Sum_probs=229.7

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+.+..++|++.+.||+|++|+||+|.+..+++.||||.++... ......+..|+..+.+...||||+++++.+.  +.
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~   86 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TD   86 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cC
Confidence            44566678999999999999999999999889999999997532 3345566778877777777999999999874  46


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...|++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+..||+||||+|+||+++.++.++|+|||.+...
T Consensus        87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            68999999985 478877654 4578999999999999999999997358999999999999999999999999998765


Q ss_pred             cccccccccccccCcccCCccccCCC----CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC-CCCCC
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNES----YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQN  307 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  307 (371)
                      ...... ....+++.|+|||.+.+..    ++.++|+||||+++|+|++|+.||.........+........+. .....
T Consensus       166 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06618         166 VDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG  244 (296)
T ss_pred             cCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence            443222 3345788999999986543    78899999999999999999999976433333444444443322 22235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF  357 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~  357 (371)
                      ++.++.+|+.+||..||.+||++++++.||||..++..+.++..|++.++
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~  294 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQDVM  294 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHHHHHHHHHHh
Confidence            78999999999999999999999999999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-44  Score=367.98  Aligned_cols=263  Identities=25%  Similarity=0.444  Sum_probs=217.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ....+|++++.||.|+||+||+|.+..++..||+|.+..  ........+..|+.++..+. ||||++++++|.......
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCE
Confidence            345689999999999999999999999999999999865  23445667889999999887 999999999987766778


Q ss_pred             EEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC------CCeEecCCCCCcEEEcc--------
Q 017445          156 ISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGV------RHLVHRDIKPANLLVNL--------  217 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~------~~iiH~Dlkp~NIl~~~--------  217 (371)
                      +||||||+++|+|.++|..    ...+++..++.|+.||+.||.|||+.      ++|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            9999999999999999864    25699999999999999999999982      24999999999999964        


Q ss_pred             ---------CCceEEecccccccCcccccccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCC
Q 017445          218 ---------KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASE  286 (371)
Q Consensus       218 ---------~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~  286 (371)
                               .+.+||+|||++....... ......||+.|+|||++.+  ..++.++|||||||++|+|++|..||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                     2358999999997664432 2245579999999999854  458899999999999999999999997655


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .....+..+ .... ......++.++.+||..||..+|.+||++.++|.|||+.....
T Consensus       248 ~~~qli~~l-k~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 NFSQLISEL-KRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cHHHHHHHH-hcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            433333333 3222 2223457899999999999999999999999999999986644

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-45  Score=330.50  Aligned_cols=254  Identities=30%  Similarity=0.518  Sum_probs=211.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+..+.++. ||||+++++.+.  ....+++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~--~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGSYL--SREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC-CCCeeeeeEEEE--eCCEEEEE
Confidence            457899999999999999999999999999999997654445556778998888876 999999999875  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++..........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            9999999999999888889999999999999999999999 999999999999999999999999999998765443333


Q ss_pred             ccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC---CCCCCCCCHHHH
Q 017445          240 ATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP---SPSRQNFSPEFC  313 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  313 (371)
                      ....+++.|+|||.+.   ...++.++|+||+|+++|+|++|..||..... ......+......   ......++..+.
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hhhheeeecCCCCCCCCccccccCHHHH
Confidence            4567899999999884   34578899999999999999999999964332 1111111111111   112245789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      +|+++||..+|++||+++++++|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=358.60  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=226.1

Q ss_pred             CCCCccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           68 ESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      +.......+.+...+++|.+.|.+|||+.||+|.+...|..||+|++-..++...+.+.+|+.+++++..|+|||.+++.
T Consensus        24 ~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   24 ENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             ccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            33445567788889999999999999999999999888899999998777888899999999999999999999999994


Q ss_pred             E-Eec--C--CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEccC
Q 017445          148 F-YMP--D--SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNLK  218 (371)
Q Consensus       148 ~-~~~--~--~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~~  218 (371)
                      . ...  +  .-.++|+||||.||.|-|++.+  +..|++.++++|++|+++|+.+||. ..  |||||||-+||||+.+
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~  182 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSAD  182 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCC
Confidence            3 221  1  1357899999999999999973  4569999999999999999999999 65  9999999999999999


Q ss_pred             CceEEecccccccCccccccc---------ccccccCcccCCccc---cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC
Q 017445          219 GRPKITDFGISAGLENSIAMC---------ATFVGTVTYMSPERI---RNESYSYPADIWSIGLALFECGTGEFPYAASE  286 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~  286 (371)
                      |+.||||||.++..-......         -....|+.|+|||.+   .+...+.|+|||||||+||-|+....||+...
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            999999999986543221110         123479999999998   57789999999999999999999999998653


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                           ...|+.+.+..+....+++.+.+||+.||+.||++||++-+++.+-+
T Consensus       263 -----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  263 -----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             -----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                 25667777777777889999999999999999999999999986543

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.7e-45  Score=329.87  Aligned_cols=257  Identities=46%  Similarity=0.841  Sum_probs=218.6

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+... .......+.+|+..+..+. ||||+++++.+..  ....++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYN--NGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeec--CCEEEEEE
Confidence            677888999999999999999999999999998763 3455677889999998887 9999999998753  56899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+..|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            999999999999765 78999999999999999999999856899999999999999999999999999876543322  


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC----CcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE----GPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|..||....    ..............+......++.++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence            22678999999999988899999999999999999999999996542    22333334444443333333388999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      |.+||..||++|||+.+++.||||++|+
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            9999999999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=326.18  Aligned_cols=254  Identities=33%  Similarity=0.574  Sum_probs=215.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+..........+.+|+..+.++. ||||+++++.+.  +...+|++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGSYL--RRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC-CCChhceEEEEE--eCCEEEEE
Confidence            368999999999999999999999999999999998765556678889999998886 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            9999999999998766 789999999999999999999999 99999999999999999999999999998776554333


Q ss_pred             cccccccCcccCCccccCC---CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC---CCCCCCCCHHH
Q 017445          239 CATFVGTVTYMSPERIRNE---SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP---SPSRQNFSPEF  312 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  312 (371)
                      .....++..|+|||.+.+.   .++.++|+||||+++|+|++|..||...... ............   ......++.++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-RALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCccccchhhhhHHH
Confidence            3456788999999999776   7899999999999999999999999764422 222222222111   11233567889


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      .+|+++||..+|.+||++.+++.|||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-44  Score=326.54  Aligned_cols=255  Identities=32%  Similarity=0.503  Sum_probs=212.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      +|++.+.||+|+||.||+|.+..++..||+|++...     .......+.+|+.++..+. ||||+++++.+.......+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            678888999999999999999999999999988642     1233456788999998886 9999999998765455688


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ++++||+++++|.+++...+.+++...+.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999999999887889999999999999999999999 999999999999999999999999999987553321


Q ss_pred             ---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          237 ---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       237 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                         .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ....+..........+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAIFKIATQPTNPQLPSHISEHAR  239 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHHHHHhcCCCCCCCchhcCHHHH
Confidence               1112345889999999999888999999999999999999999999765433 233333333333333456788899


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      +++ .||..+|++||+++++++||||+
T Consensus       240 ~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         240 DFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-44  Score=331.80  Aligned_cols=242  Identities=19%  Similarity=0.291  Sum_probs=204.6

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEe--cCCCeEEEEEe
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM--PDSGQISIALE  161 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~--~~~~~~~lv~E  161 (371)
                      ..||+|++|.||+|..  +|+.||||.++....   .....+.+|+.++.++. ||||++++|++..  .+...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            4799999999999987  788999999975322   22466779999999987 9999999998865  34557899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |+++|+|.+++...+.+++.....++.|++.||.|||+..+++||||||+||+++.++.+||+|||++.......   ..
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence            999999999998888899999999999999999999984489999999999999999999999999987654321   34


Q ss_pred             ccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          242 FVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ..+++.|+|||.+.+  ..++.++|||||||++|||++|..||.... .......+.........+..+++++.+|+.+|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c  258 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC  258 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence            568999999999976  679999999999999999999999997644 33444444444444444457899999999999


Q ss_pred             cccCcCCCCCHHHHhc
Q 017445          320 LKKDAEARPTADQLLS  335 (371)
Q Consensus       320 l~~dp~~Rps~~~il~  335 (371)
                      |+.||++|||+.++++
T Consensus       259 l~~dp~~Rps~~ell~  274 (283)
T PHA02988        259 TSHDSIKRPNIKEILY  274 (283)
T ss_pred             hcCCcccCcCHHHHHH
Confidence            9999999999999974

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-44  Score=325.59  Aligned_cols=250  Identities=33%  Similarity=0.521  Sum_probs=207.4

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ...||+|+||.||+|.+..+++.||+|.+..........+.+|+..+..+. |+||+++++++.  .....++|+||+++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~~   89 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGSDS--ENGFFKIFMEQVPG   89 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC-CCCeeeeeeeec--cCCEEEEEEecCCC
Confidence            348999999999999999999999999988766666677889999998886 999999999774  45689999999999


Q ss_pred             CCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEecccccccCccccccccc
Q 017445          166 GSLADILRMQ-KSI--PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       166 g~L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      ++|.+++... ..+  ++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||.+............
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence            9999999754 455  888899999999999999999 99999999999999986 679999999998765443333344


Q ss_pred             ccccCcccCCccccCCC--CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          242 FVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ..+++.|+|||.+.+..  ++.++|+||+|+++|+|++|..||......................+..+++++.+|+++|
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  248 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC  248 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence            56899999999986543  7889999999999999999999997644333222222211222233456889999999999


Q ss_pred             cccCcCCCCCHHHHhcCccc
Q 017445          320 LKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~  339 (371)
                      |+.+|++|||+.+++.||||
T Consensus       249 l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         249 FEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             cCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-44  Score=330.97  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|++|+||+|.+..++..||+|++....  ......+.+|+.++..+. ||||+++++.+.  +...+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLM--QESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEe--eCCeEEEE
Confidence            5788999999999999999999999999999986532  223456778999998887 999999999875  45689999


Q ss_pred             EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQ---KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||++ ++|.+++...   ..+++..++.++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            99997 5898888642   468999999999999999999999 999999999999999999999999999987655433


Q ss_pred             cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH--hhC---------------
Q 017445          237 AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI--LED---------------  298 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~--~~~---------------  298 (371)
                      .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.............  ...               
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            333445678999999988654 47899999999999999999999997644322111110  000               


Q ss_pred             ---------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          299 ---------PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       299 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                               .........+++++.++|++||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                     00011123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.1e-44  Score=323.49  Aligned_cols=256  Identities=32%  Similarity=0.483  Sum_probs=213.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ++|++.+.||+|+||.||.|.+..+++.||+|.+...     .......+.+|+..+.++. ||||+++++++.......
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            5789999999999999999999999999999988532     1233456788999998886 999999999875444567


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++++|||+++++|.+++.....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            89999999999999999877789999999999999999999999 99999999999999999999999999998755321


Q ss_pred             c---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          236 I---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       236 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      .   .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....+..........+..++..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPVLPPHVSDHC  238 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHHHhcCCCCCCCchhhCHHH
Confidence            1   1123346889999999998888999999999999999999999999764332 23333333333333455678899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      .+++++|+. +|++||+++++++|||+.
T Consensus       239 ~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         239 RDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            999999995 999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.9e-44  Score=324.67  Aligned_cols=252  Identities=35%  Similarity=0.653  Sum_probs=213.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+.....  ...+.+|+..+.++ +||||+++++.+.  +....|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~--~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQC-DSPYIVKYYGSYF--KNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhC-CCCcEeeeeeeee--cCCcEEEEE
Confidence            578889999999999999999998899999999875332  66788999999888 5999999999875  456899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence            99999999999965 4568999999999999999999999 999999999999999999999999999998766543333


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  318 (371)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ....+... .........++.++.+++.+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AIFMIPNKPPPTLSDPEKWSPEFNDFVKK  235 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-hhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence            44568899999999988889999999999999999999999997644322 22222111 11122234578899999999


Q ss_pred             hcccCcCCCCCHHHHhcCccc
Q 017445          319 CLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ||+.||++|||+.+++.||||
T Consensus       236 ~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         236 CLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=343.40  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=207.7

Q ss_pred             ccccccccccccccCCccCCCCCccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHH
Q 017445           49 GVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTE  128 (371)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E  128 (371)
                      ....|+..++.++|+.|..+.                  .||+|+||.||+|.. .+++.||||++.........++.+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~------------------~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~E  121 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESN------------------LIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNE  121 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhc------------------ceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHH
Confidence            345677777888887777665                  899999999999984 4558999998876433214459999


Q ss_pred             HHHHHhCCCCCCeeEeceeEEecCCC-eEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCC--Ce
Q 017445          129 IRTLCEAPCNEGLVEFHGAFYMPDSG-QISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVR--HL  203 (371)
Q Consensus       129 ~~~l~~~~~h~~iv~l~~~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--~i  203 (371)
                      +.++.++. |||+|+++|+|.  +.+ ..+||+||+++|+|.++|....  +++|..+.+|+.+++.||+|||...  .|
T Consensus       122 i~~ls~l~-H~Nlv~LlGyC~--e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i  198 (361)
T KOG1187|consen  122 VEILSRLR-HPNLVKLLGYCL--EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPI  198 (361)
T ss_pred             HHHHhcCC-CcCcccEEEEEe--cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence            99999998 999999999875  344 5999999999999999997654  8999999999999999999999944  39


Q ss_pred             EecCCCCCcEEEccCCceEEecccccccCcccccccccc-cccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCC
Q 017445          204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF-VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY  282 (371)
Q Consensus       204 iH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf  282 (371)
                      |||||||+|||+|++.++||+|||+|...........+. .||.+|+|||++..+..+.++||||||++++|+++|+.+.
T Consensus       199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~  278 (361)
T KOG1187|consen  199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAV  278 (361)
T ss_pred             ecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCccc
Confidence            999999999999999999999999996655411222222 7999999999999899999999999999999999999888


Q ss_pred             CCCC--CcHHHH---HHHhhCC-C----CCCCC-CCCC-----HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          283 AASE--GPVNLM---LQILEDP-S----PSPSR-QNFS-----PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       283 ~~~~--~~~~~~---~~~~~~~-~----~~~~~-~~~~-----~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ....  ....+.   ...+... .    ..... ..++     ..+..+..+|++.+|.+||++.+|++
T Consensus       279 d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  279 DQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            7532  111111   1111111 1    11111 2233     23667888999999999999999743

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.7e-45  Score=337.42  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=194.5

Q ss_pred             eeecccCCeEEEEEEEc--CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           87 GAIGSGASSVVQRAVHI--PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .+||+|+||+||+|.++  .+++.||+|.+....  ......+|+.++.++. ||||+++++.+.......+|++|||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEeccC
Confidence            47999999999999865  467899999986432  2234678999998886 999999999987666778999999996


Q ss_pred             CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE----ccCCceEEeccccccc
Q 017445          165 GGSLADILRMQ---------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGISAG  231 (371)
Q Consensus       165 ~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~----~~~~~~kl~Dfg~s~~  231 (371)
                      + +|.+++...         ..+++..++.++.|++.||.|||+ +||+||||||+|||+    +.++.+||+|||++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            4 898887532         248999999999999999999999 999999999999999    4557899999999976


Q ss_pred             Cccccc---ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--------HHHHHHH---h
Q 017445          232 LENSIA---MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGP--------VNLMLQI---L  296 (371)
Q Consensus       232 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--------~~~~~~~---~  296 (371)
                      ......   ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||......        ...+..+   +
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            543321   2235678999999999976 45899999999999999999999999653321        0111111   1


Q ss_pred             hCCCC---------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          297 EDPSP---------------------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       297 ~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ..+..                                 .......+.++.+|+++||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000                                 00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.9e-44  Score=329.42  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+.++..+. |++|+.+.+.+.  .....+++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~--~~~~~~lv   78 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYE--TKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEe--cCCEEEEE
Confidence            677789999999999999999999999999986422   223445678999998885 999999998774  45689999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999999888643  369999999999999999999999 999999999999999999999999999986654322 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH--HHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........  .+...... ........++.++.+|
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  235 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE-TEEVYSAKFSEEAKSI  235 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc-cccccCccCCHHHHHH
Confidence            22345789999999999888899999999999999999999999976443211  11111111 1223345688999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccccccc
Q 017445          316 VDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       316 i~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~  347 (371)
                      +.+||+.||++||+     +.+++.||||.....+++
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL  272 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence            99999999999999     899999999998866554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-44  Score=331.70  Aligned_cols=260  Identities=38%  Similarity=0.693  Sum_probs=217.8

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..++|++++.||+|+||+||++.+..+++.||+|++.... ......+.+|+.++..+. ||||+++++.+.  ....++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~   79 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFL--NENNIC   79 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEe--cCCEEE
Confidence            4568899999999999999999999999999999886532 344567889999998886 999999999875  356899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+..+++||||+|+||+++.++.++|+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999999999998878899999999999999999999974589999999999999999999999999986553321 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc----------HHHHHHHhhCCCCCCCCCC
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP----------VNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~~~  307 (371)
                       .....|+..|+|||++.+..++.++|+|||||++|++++|..||......          ......+.....+......
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD  237 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence             23457899999999998888999999999999999999999999754431          1222333333333322334


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ++.++.+|+.+||+.||++||++.++++||||.+..
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            788999999999999999999999999999886653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-44  Score=330.35  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=202.9

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHH--HhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l--~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      .||+|+||.||++.+..+++.+|+|.+....   ........+|...+  ....+||+|+.+++.+.  ..+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEec
Confidence            4899999999999999999999999886421   12222233443332  23346999999998774  35589999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccc
Q 017445          163 MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF  242 (371)
Q Consensus       163 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~  242 (371)
                      +++++|.+++...+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......  ....
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS  155 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence            9999999999888889999999999999999999999 999999999999999999999999999987554332  2345


Q ss_pred             cccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcc
Q 017445          243 VGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK  321 (371)
Q Consensus       243 ~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  321 (371)
                      .|++.|+|||.+. +..++.++|+||+|+++|+|++|..||......................+..++.++.+++++||.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            6899999999986 456899999999999999999999999754322211111111222233445689999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCcccccccccc
Q 017445          322 KDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       322 ~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      .||++||     ++.++++||||+.+...+
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            9999999     699999999999877544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=347.04  Aligned_cols=255  Identities=29%  Similarity=0.496  Sum_probs=218.6

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ....|++.++...-++-||+|+.|.||+|+.  .++.||||+++...       ..++..|+++. ||||+.|.|+|.  
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLk-H~NII~FkGVCt--  182 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLK-HPNIITFKGVCT--  182 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhcc-CcceeeEeeeec--
Confidence            3456777778888899999999999999986  56789999987432       24566788887 999999999885  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..-.+|||||||..|.|...|+....++......|.++|+.|+.|||. +.|||||||.-||||+.+..|||+|||.++.
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e  261 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDFGTSKE  261 (904)
T ss_pred             CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccceEEeccccchHh
Confidence            455899999999999999999999999999999999999999999999 8899999999999999999999999999988


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ..+. ....+++||..|||||++++.+.+.|+|||||||+|||||||..||.+-+. ...+.-+-.+..-.+.+..+|+.
T Consensus       262 ~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  262 LSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             hhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchH
Confidence            7765 445678999999999999999999999999999999999999999976332 22222222233445567789999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      ++-|++.||+-.|..||++.+||.|-=+..
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            999999999999999999999999864443

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-44  Score=333.50  Aligned_cols=264  Identities=26%  Similarity=0.395  Sum_probs=221.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+|++.+.||+|++|+||+|.+..+++.||+|.+.....   .....+..|+..+..+. ||||+++++.+  .+....|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--~~~~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASF--QTETYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeee--ecCCEEE
Confidence            368899999999999999999999999999999975322   34556788899888887 99999999977  4566899


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +||||+.+++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999999998754  568999999999999999999999 99999999999999999999999999998654321


Q ss_pred             cc-----------------------------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC
Q 017445          236 IA-----------------------------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE  286 (371)
Q Consensus       236 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~  286 (371)
                      ..                             ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            10                             1123468899999999998889999999999999999999999997654


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHhcCccccccccccccH
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT----ADQLLSHPFITKYEHAKVDL  349 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~il~hp~~~~~~~~~~~~  349 (371)
                      . ......+............++.++.+++.+||+.||++||+    +++++.||||+...+..+.+
T Consensus       237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         237 R-DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             h-HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence            3 33344444444444444457999999999999999999999    99999999999877666543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-44  Score=331.57  Aligned_cols=253  Identities=25%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.++...  ......+.+|+..+.++. ||||+++++.+.  +....+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLH--SDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhc--cCCceEEE
Confidence            4788899999999999999999999999999986532  222345678999998886 999999999874  56689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      +||+++ +|.+++.. .+.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+.........
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            999975 88887754 5679999999999999999999999 99999999999999999999999999998766543333


Q ss_pred             cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---C---------------
Q 017445          239 CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---P---------------  299 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~---------------  299 (371)
                      .....+++.|+|||++.+. .++.++||||||+++|+|++|..|+.........+..+...   .               
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            3445678999999998664 47899999999999999999998865444332222221110   0               


Q ss_pred             CC---------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          300 SP---------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       300 ~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ..         ......+++++.+|+++||+.||.+|||+++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00         01123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.4e-44  Score=342.39  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=210.9

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+     ..++..||||+++.. .......+.+|+.++..+.+||||++++++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            35566677999999999999999999974     356778999998653 234456788999999988679999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcC---------------------------------------------------
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQK---------------------------------------------------  176 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------  176 (371)
                      +  .+.+..++||||+++|+|.+++....                                                   
T Consensus       108 ~--~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         108 C--TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             e--ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            7  45668999999999999999986422                                                   


Q ss_pred             ------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          177 ------------------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       177 ------------------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                                              .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceec
Confidence                                    46788899999999999999999 99999999999999999999999999999765


Q ss_pred             cccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          233 ENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       233 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ......  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...+.+........+...+
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  343 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRMLSPECAP  343 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccCCCCCCCC
Confidence            443211  122335678999999999999999999999999999998 899997644332 3334444433333445678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .++.+|+.+||+.||++||++.++++.
T Consensus       344 ~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         344 SEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.8e-44  Score=323.52  Aligned_cols=252  Identities=33%  Similarity=0.532  Sum_probs=209.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      +|++.+.||+|+||+||+|.+ .+++.+|+|.+....      ......+.+|+..+..+. |+||+++++++.  +...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCL--DDNT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEee--cCCe
Confidence            477888999999999999985 578899999886421      223456788999988886 999999999874  4578


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      .+++|||+++++|.+++....++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999999999887889999999999999999999999 99999999999999999999999999998754221


Q ss_pred             ------ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCC
Q 017445          236 ------IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNF  308 (371)
Q Consensus       236 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  308 (371)
                            ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....+... ......+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHRGLMPRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhccCCCCCCCCCC
Confidence                  111234568999999999998889999999999999999999999997644322 22222222 2223345678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.++.+++++||..+|++||++.+++.||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-44  Score=342.60  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=210.6

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+.+..++|++.+.||+|+||.||+|.+..+     +..||+|+++.. .......+.+|+.++..+..|+||++++++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            35566778999999999999999999986443     357999999753 334456688999999988679999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhc----------------------------------------------------
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQ----------------------------------------------------  175 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------------------------------------------------  175 (371)
                      +.  +.+.+++||||+++|+|.+++...                                                    
T Consensus       111 ~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         111 CT--HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             ec--CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            74  456899999999999999998542                                                    


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          176 ------------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       176 ------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                                        .++++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                              247888899999999999999999 9999999999999999999999999999876543321


Q ss_pred             --ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          238 --MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       238 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                        ...+..+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ..............+..+++++.+
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~  346 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPPEIYS  346 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCHHHHH
Confidence              1122335678999999988889999999999999999997 999997654332 333444444444445567899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhc
Q 017445          315 FVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+||+.||++|||+.++++
T Consensus       347 li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         347 IMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999964

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.6e-44  Score=322.43  Aligned_cols=260  Identities=53%  Similarity=0.906  Sum_probs=223.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|+..+.++. |+|++++++.+.  ....+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFY--KEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc--cCCeEEEE
Confidence            368889999999999999999999999999999876433 45677889999999887 999999999874  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++.....+++..+..++.|++.|+.|||+..|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            99999999999998778899999999999999999999974689999999999999999999999999998776554443


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....  ........+.....+......++..+.++++
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence            45678999999999988889999999999999999999999997654  4444555555443333332338999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +||..+|++||++.++++||||+.+.
T Consensus       238 ~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHccCChhhCCCHHHHHhCHHHHhcc
Confidence            99999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=350.88  Aligned_cols=252  Identities=33%  Similarity=0.539  Sum_probs=220.5

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS  167 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~  167 (371)
                      +||+|+||+||-|++..|...+|||.+...+.....-...|+...+.+. |.|||+++|.+  .+++++-|.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~--senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGSV--SENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhcc--CCCCeEEEEeecCCCCc
Confidence            7999999999999999999999999997655555555566666655555 99999999976  67789999999999999


Q ss_pred             HHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEecccccccCccccccccccc
Q 017445          168 LADILRM-QKSI--PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       168 L~~~l~~-~~~l--~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      |.+++.. .+++  .+.++..+.+||++||.|||. +.|||||||-+||||+. .|.+||+|||.++++..-+....++.
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            9999964 5777  889999999999999999999 88999999999999976 59999999999999887777778899


Q ss_pred             ccCcccCCccccCC--CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcc
Q 017445          244 GTVTYMSPERIRNE--SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK  321 (371)
Q Consensus       244 gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  321 (371)
                      ||+.|||||++..+  .|+.++|||||||++.||.||++||..-.++...+++.-.-..-.+.+..++.+++.||.+|+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            99999999999765  4899999999999999999999999887777777777644444445567788999999999999


Q ss_pred             cCcCCCCCHHHHhcCccccccc
Q 017445          322 KDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       322 ~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +||..||++.++|..||++.-.
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             CCcccCccHHHhccCcccccCC
Confidence            9999999999999999998773

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-46  Score=332.14  Aligned_cols=283  Identities=24%  Similarity=0.413  Sum_probs=242.4

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ....++...+|..+.+||.|+||.|.+|..+.|.+.+|||+++.   ....+.+..+.|-++|....+-|.+++++.+| 
T Consensus       341 ~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-  419 (683)
T KOG0696|consen  341 SKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-  419 (683)
T ss_pred             CcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-
Confidence            34457778899999999999999999999999999999999875   23344555677777777777789999999988 


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                       +.-+.+|.||||+.||+|--.+++-+.+.+..+..++.+|+-||-+||+ +|||+||||.+||+++.+|++||+|||++
T Consensus       420 -QTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  420 -QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             -hhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCceEeeecccc
Confidence             4556899999999999999999999999999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      +.-.-......+++|||.|+|||++...+|+.++|+||+|++||||+.|++||.+.+ ...+...+.+....  .+..+|
T Consensus       498 KEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-E~elF~aI~ehnvs--yPKslS  574 (683)
T KOG0696|consen  498 KENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-EDELFQAIMEHNVS--YPKSLS  574 (683)
T ss_pred             cccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHccCc--Cccccc
Confidence            876555566789999999999999999999999999999999999999999998754 34455555555433  346799


Q ss_pred             HHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccccccccHHHHHHHhcChhh-hhhh
Q 017445          310 PEFCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ-RMKD  365 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  365 (371)
                      .++.++.+..|.+.|.+|..     -.+|-.||||..+.+.+++    .+.+-||++ +++.
T Consensus       575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E----~~eiqPPfkPk~k~  632 (683)
T KOG0696|consen  575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE----RREIQPPFKPKIKC  632 (683)
T ss_pred             HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh----hccCCCCCCCcccc
Confidence            99999999999999999976     3789999999999998876    344556666 4433

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=321.60  Aligned_cols=255  Identities=27%  Similarity=0.469  Sum_probs=218.1

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      +.||+|+|+.|--++...+|..||||++.+.....+.++.+|++++.....|+||++++++|  +++...|||||-|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF--Edd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF--EDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh--cccceEEEEEecccCc
Confidence            47999999999999999999999999998876677889999999999999999999999987  6777999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---ceEEecccccccCccc-------c
Q 017445          167 SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---RPKITDFGISAGLENS-------I  236 (371)
Q Consensus       167 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~~kl~Dfg~s~~~~~~-------~  236 (371)
                      +|...|.+.+.|++.++..+.++|+.||.|||. +||.||||||+|||..+..   -+|||||.+...+...       .
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            999999999999999999999999999999999 9999999999999997664   4899999887544221       1


Q ss_pred             cccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC--------------cHHHHHHHhh
Q 017445          237 AMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEG--------------PVNLMLQILE  297 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~--------------~~~~~~~~~~  297 (371)
                      ....+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||.+.-+              +..++..+-+
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            1235678999999999873     23589999999999999999999999976321              1122333333


Q ss_pred             CC--CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          298 DP--SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       298 ~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +.  .+...+..+|.++++++..+|..|+.+|.++.+++.|||+++...
T Consensus       321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            33  344556788999999999999999999999999999999988754

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=336.50  Aligned_cols=267  Identities=27%  Similarity=0.431  Sum_probs=228.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..+.|+..++||+|+||.||-++-..||+.+|+|++.+   .........++|-.+|.+.. .+.||.+-.+|  +..
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAf--eTk  257 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAF--ETK  257 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeee--cCC
Confidence            4455778888999999999999999999999999998854   23344556788888888887 88999998887  556


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..+|+||..|.||+|.-+|.+.+  .|++..+..++.+|+.||++||+ .+||+|||||+|||+|+.|+++|+|+|+|..
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEEe
Confidence            68999999999999998886555  79999999999999999999999 9999999999999999999999999999998


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc---HHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP---VNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  308 (371)
                      +... ......+||.+|||||++.++.|+.+.|+|||||+||||+.|+.||..-.+.   +..-..+++.+.  ..+..+
T Consensus       337 i~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~--ey~~kF  413 (591)
T KOG0986|consen  337 IPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE--EYSDKF  413 (591)
T ss_pred             cCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh--hccccc
Confidence            8776 3445669999999999999999999999999999999999999999764322   122233333332  334789


Q ss_pred             CHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccccccccHH
Q 017445          309 SPEFCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKVDLA  350 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~~~~  350 (371)
                      |++++++.+.+|+.||++|..     +.++-+||||+...++++++.
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleag  460 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAG  460 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhcc
Confidence            999999999999999999976     679999999999999998743

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-44  Score=326.65  Aligned_cols=267  Identities=32%  Similarity=0.586  Sum_probs=221.5

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..|..++.||.|+||.||+|.+..++..||+|.+.... ......+.+|+..+..+. ||||+++++.+.  +....++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCEEEEE
Confidence            35667789999999999999999999999999987532 345567888999988886 999999999875  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++.. .++++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            999999999999874 578999999999999999999999 999999999999999999999999999997665443333


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... +....+......++..+.+++.+|
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-MRVLFL-IPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-HhHhhh-hhcCCCCCCchhhhHHHHHHHHHH
Confidence            445688899999999888899999999999999999999999975432 222222 222223333456788999999999


Q ss_pred             cccCcCCCCCHHHHhcCccccccccccccHHHHHH
Q 017445          320 LKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVR  354 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~  354 (371)
                      |..+|++||++.+++.||||.....+..-+...++
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~  271 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELID  271 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhhcchhhhHHHHHHH
Confidence            99999999999999999999888776544444443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-44  Score=332.10  Aligned_cols=259  Identities=29%  Similarity=0.535  Sum_probs=216.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      .|.....||+|+||.||++.+..++..||||.+..........+.+|+..+..+. ||||+++++.+.  ..+..|+|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~--~~~~~~lv~e   99 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYL--VGDELWVVME   99 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC-CCcHHHHHHhee--cCCeEEEEEe
Confidence            3444568999999999999999999999999987655566677889999888876 999999999875  4568999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |+++++|.+++. .+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++............
T Consensus       100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            999999999886 4568999999999999999999999 99999999999999999999999999998765444333345


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHHHHHHHHHhc
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      ..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+... .........++..+.+++.+||
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            6789999999999888899999999999999999999999975432 2222222221 1122223457889999999999


Q ss_pred             ccCcCCCCCHHHHhcCcccccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ..||.+|||+.++++||||.....+.
T Consensus       257 ~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         257 VREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             cCChhHCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999998776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.6e-44  Score=329.03  Aligned_cols=260  Identities=28%  Similarity=0.453  Sum_probs=214.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....   ......+.+|+.++..+. ||||+++++.+.  +...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFE--TKRHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEe--cCCEEE
Confidence            36889999999999999999999999999999987533   233456778888888775 999999999774  466899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      +||||++|++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++....... 
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999999999888889999999999999999999999 999999999999999999999999999876321100 


Q ss_pred             --------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC
Q 017445          237 --------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS  302 (371)
Q Consensus       237 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  302 (371)
                                    .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.. ...............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~~~~  235 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDIEW  235 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccCC
Confidence                          01122457889999999988889999999999999999999999997543 333344444333222


Q ss_pred             C-CCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccccc
Q 017445          303 P-SRQNFSPEFCSFVDDCLKKDAEARPT---ADQLLSHPFITKYEHA  345 (371)
Q Consensus       303 ~-~~~~~~~~~~~li~~~l~~dp~~Rps---~~~il~hp~~~~~~~~  345 (371)
                      + ....++.++.+++.+||+.||++||+   +.+++.||||......
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            2 22368899999999999999999998   7999999999775443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-44  Score=323.70  Aligned_cols=251  Identities=34%  Similarity=0.579  Sum_probs=210.2

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---------HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---------EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      |.+.+.||+|++|.||+|.+..+++.+|+|.+.....         .....+.+|+.++.++. ||||+++++.+.  +.
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   78 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL--DA   78 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--eC
Confidence            5667799999999999999988999999998864211         12245778888898886 999999999774  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...+++|||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            6899999999999999999888889999999999999999999999 999999999999999999999999999987665


Q ss_pred             cccc------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          234 NSIA------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       234 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ....      ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..... .....+.... .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~  235 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIGEN-ASPEIPSN  235 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-HHHHHHHhcc-CCCcCCcc
Confidence            2211      11234588999999999988899999999999999999999999976443 2233333332 22233456


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ++..+.+++++||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            88999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-45  Score=337.05  Aligned_cols=275  Identities=28%  Similarity=0.449  Sum_probs=219.9

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..+.+..+.|++++.||+|+.+.||++.. .+.+.||+|++..  .+.....-+.+|+..|.++..|.+|++++++-.  
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv--  430 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV--  430 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--
Confidence            45678889999999999999999999985 4456788887753  455667779999999999999999999999654  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l-~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .++++|+||||-+ .+|.++|.+.... +.-.++.+++||+.|+.++|. .||||.||||.|+|+- .|.+||+|||.|.
T Consensus       431 ~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  431 TDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             cCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE-eeeEEeeeechhc
Confidence            4779999999875 5999999876553 334788899999999999999 9999999999999998 7899999999998


Q ss_pred             cCccccc--ccccccccCcccCCccccCCC-----------CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh
Q 017445          231 GLENSIA--MCATFVGTVTYMSPERIRNES-----------YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  297 (371)
                      .+.....  ...+.+||+.||+||.+....           .+.+|||||||||||+|+.|+.||....+....+..+.+
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            8765532  346678999999999985432           457899999999999999999999764444444444444


Q ss_pred             CCCCCCCCCCC-CHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHH
Q 017445          298 DPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVR  354 (371)
Q Consensus       298 ~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~  354 (371)
                      .......+..- ..++.++++.||..||++||++.++|+|||++....+-..+.+..+
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~  645 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTT  645 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHH
Confidence            33322222211 2349999999999999999999999999999986665544444333

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.4e-44  Score=321.96  Aligned_cols=254  Identities=33%  Similarity=0.643  Sum_probs=211.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++.+.||.|+||+||+|....++..+|+|++.... ......+.+|+..+..+. |+|++++++.+.  .....++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFV--VGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEe--eCCEEEEE
Confidence            37889999999999999999998899999999986532 235567888999888875 999999999774  45689999


Q ss_pred             EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQ---KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||++++++|.+++...   ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999999764   458999999999999999999999 999999999999999999999999999987665432


Q ss_pred             cc----cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCC---CCC
Q 017445          237 AM----CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPS---RQN  307 (371)
Q Consensus       237 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~---~~~  307 (371)
                      ..    .....++..|+|||.+... .++.++|+||||+++|+|++|+.||...... ....+....... ...   ...
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCcCCcccccc
Confidence            22    2344689999999998766 7899999999999999999999999765432 233333333221 111   136


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +++.+.+++.+||..||++||++.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.8e-44  Score=326.42  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=209.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....  ......+.+|+.++..+. |||++++++.+.  .....++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFR--RKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEe--eCCEEEE
Confidence            36889999999999999999999999999999886422  223345678999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++++|..++.....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            99999999998888777789999999999999999999999 99999999999999999999999999999876554333


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC---------------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP---------------  299 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~---------------  299 (371)
                      .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......... ..+..   ..               
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChHHhhhcccccccc
Confidence            344568899999999876 45789999999999999999999999765432222 11110   00               


Q ss_pred             ---CCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          300 ---SPSP--------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       300 ---~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                         .+..        ....++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               0000        013567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-43  Score=318.95  Aligned_cols=252  Identities=27%  Similarity=0.526  Sum_probs=214.9

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...  .......+.+|+.++.++. ||||+++++.+  .+.+..++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESF--EENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeee--cCCCeEEEE
Confidence            578899999999999999999999999999998642  3344567888999998886 99999999977  456789999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999999987543  57899999999999999999999 9999999999999999999999999999876654433


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ......|++.|+|||++.+..++.++|+||||+++++|++|..||.... .......++.+..+ ..+..++.++.+++.
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~  234 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-MKNLVLKIIRGSYP-PVSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-HHHHHHHHhcCCCC-CCcccCCHHHHHHHH
Confidence            3334568899999999988889999999999999999999999997643 33444444444332 334578999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +||+.+|++||++.++++||||
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-44  Score=329.00  Aligned_cols=258  Identities=32%  Similarity=0.623  Sum_probs=216.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      .|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+..+.++. ||||+++++.+.  .....|+||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYL--KGTKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhcccc--cCCceEEEE
Confidence            4566778999999999999999999999999987532 344567888999998886 999999999874  456899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      ||+++++|.+++. ...+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            9999999999886 4578999999999999999999999 9999999999999999999999999999877655433334


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .... ..+...........++.++.+++.+||
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-MRVL-FLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-hhHH-hhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            45688999999999988899999999999999999999999965432 2222 222222233334567889999999999


Q ss_pred             ccCcCCCCCHHHHhcCcccccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ..+|++||++.++++||||..+....
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYTKKT  263 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHhhhH
Confidence            99999999999999999998877544

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.2e-44  Score=334.11  Aligned_cols=255  Identities=24%  Similarity=0.477  Sum_probs=201.0

Q ss_pred             Eeeeeccc--CCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           85 IFGAIGSG--ASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        85 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++++||+|  +||+||++.+..+|+.||+|.++..  .......+.+|+.++..+. ||||+++++++..  ....++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIA--DNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEE--CCEEEEEE
Confidence            45689999  6789999999999999999999753  2334455667888877775 9999999998854  55899999


Q ss_pred             eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          161 EYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       161 E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      ||+++|+|.+++..  ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.++++||+.+........ 
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999999864  3458999999999999999999999 9999999999999999999999999986543321111 


Q ss_pred             ------ccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--------
Q 017445          238 ------MCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--------  301 (371)
Q Consensus       238 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------  301 (371)
                            ......++..|+|||++.+  ..++.++||||+||++|+|++|..||............ .....+        
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccch
Confidence                  0122356788999999975  45899999999999999999999999754322211111 111100        


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          302 ------------------------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       302 ------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                                          ......+++.+.+|+++||+.||++|||++++++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence                                                0111235678999999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-43  Score=325.43  Aligned_cols=257  Identities=31%  Similarity=0.575  Sum_probs=216.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      +|...+.||+|++|.||++.+..+++.+|+|++..........+.+|+.++..+. ||||+++++.+.  .....++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~--~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYL--VGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC-CCChheEEEEEE--cCCeEEEEEe
Confidence            4455669999999999999998999999999987655556667888999888886 999999999875  4568999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |+++++|.+++.. +++++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||.+............
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            9999999999876 678999999999999999999999 99999999999999999999999999988765443333344


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC-CCCCCCCHHHHHHHHHhc
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l  320 (371)
                      ..|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... +......+.....+. .....++..+.+|+++||
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence            568999999999988889999999999999999999999996533 333333333332222 222347899999999999


Q ss_pred             ccCcCCCCCHHHHhcCcccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ..+|++||++.++++||||.+...
T Consensus       254 ~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         254 VRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ccChhhCcCHHHHccCcccccCCC
Confidence            999999999999999999988765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.7e-44  Score=329.27  Aligned_cols=258  Identities=30%  Similarity=0.569  Sum_probs=216.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      .+|++.+.||+|+||.||++.+..++..||+|.+..........+.+|+..+.++. ||||+++++.+..  ....|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYLDSYLV--GDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC-CCCeeehhheeee--CCcEEEEE
Confidence            58889999999999999999988899999999987654455567888998888886 9999999998753  55799999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            99999999999864 468899999999999999999999 9999999999999999999999999998876554433334


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|..||......................+..++..+.+++++||
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence            45688999999999888899999999999999999999999976443222111111222222334457889999999999


Q ss_pred             ccCcCCCCCHHHHhcCccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ..+|.+||++.+++.||||+...
T Consensus       254 ~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         254 EMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             cCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999997655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-43  Score=321.34  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=214.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||.|++|.||+|.+..+++.+|+|.+...   .......+.+|+.++..+. ||||+++++.+.  +....|++|||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFK--DKKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEE--cCCccEEEEecCCC
Confidence            69999999999999999999999998652   2234567888999888885 999999999774  45689999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccccc
Q 017445          166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT  245 (371)
Q Consensus       166 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt  245 (371)
                      ++|.+++.....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~  155 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGT  155 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCC
Confidence            9999999887789999999999999999999999 999999999999999999999999999998765542 22345689


Q ss_pred             CcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC-cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG-PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       246 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      +.|+|||.+.+..++.++|+||+|+++|+|++|..||..... .......+.........+...++++.+++.+||..+|
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            999999999888899999999999999999999999976553 2333444443333334445568999999999999999


Q ss_pred             CCCCC-----HHHHhcCccccccccc
Q 017445          325 EARPT-----ADQLLSHPFITKYEHA  345 (371)
Q Consensus       325 ~~Rps-----~~~il~hp~~~~~~~~  345 (371)
                      ++||+     +.++++||||+.+.+.
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCCCCC
Confidence            99999     9999999999987653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-43  Score=321.58  Aligned_cols=255  Identities=30%  Similarity=0.548  Sum_probs=212.5

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      +|+..+.||+|++|.||+|.+..+++.||+|.+....      ......+.+|+..+..+. |+||+++++.+  .+.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~--~~~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGAT--CEDSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhcee--ccCCe
Confidence            3667789999999999999999999999999986422      123467888999998886 99999999987  45668


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~  234 (371)
                      .++|+||+++++|.+++...+++++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999999999888889999999999999999999999 9999999999999998776 599999999876643


Q ss_pred             ccc----ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHhhCCCCCCCCCCC
Q 017445          235 SIA----MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       235 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ...    ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....  ......+..........+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL  236 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence            311    11234688999999999888899999999999999999999999965432  122222332233333444568


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      ++++.+++.+||..+|++||++.++++||||+
T Consensus       237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         237 SPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            89999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-43  Score=319.24  Aligned_cols=252  Identities=34%  Similarity=0.592  Sum_probs=213.5

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      +|+..+.||+|++|+||+|.+..+++.||+|.+....     ......+.+|+..+..+. |+||+++++.+  .+...+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~--~~~~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTE--REEDNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeE--ecCCeE
Confidence            3566779999999999999998899999999986532     335567888999888885 99999999976  455689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ++++||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||.+.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999999999887789999999999999999999999 999999999999999999999999999987654432


Q ss_pred             cccccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                       ......+++.|+|||.+.... ++.++|+||||+++|+|++|..||.... .................+..+++.+.++
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence             234566899999999997766 8999999999999999999999997654 3333333333233333456788999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +++||+.+|++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-43  Score=324.41  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHH--HhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l--~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      .||+|+||.||+|.+..+++.||+|.+....   .........|...+  .+...||+|+.+++.+.  +....|+||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEEec
Confidence            4899999999999999999999999986421   11122233333322  23346999999999774  45689999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccc
Q 017445          163 MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF  242 (371)
Q Consensus       163 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~  242 (371)
                      +.|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+.......  ....
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  155 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS  155 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCc
Confidence            9999999999888889999999999999999999999 999999999999999999999999999987654322  2345


Q ss_pred             cccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH-HHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          243 VGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPV-NLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       243 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      .|+..|+|||.+.++ .++.++||||+|+++|+|++|..||....... ........ ......+..++.++.+++.+||
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-ccCCCCCCcCCHHHHHHHHHHh
Confidence            799999999999754 68999999999999999999999997653211 11122111 1222334457899999999999


Q ss_pred             ccCcCCCC-----CHHHHhcCccccccccccc
Q 017445          321 KKDAEARP-----TADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       321 ~~dp~~Rp-----s~~~il~hp~~~~~~~~~~  347 (371)
                      ..+|.+||     ++.++++||||....+...
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~  266 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV  266 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence            99999999     9999999999998775544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=319.50  Aligned_cols=277  Identities=32%  Similarity=0.583  Sum_probs=234.5

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      +..+.+..++++-++.||.|+||+|++-.++.+|+..|||+++... .....+++.|.....+..+.||||++||+.+. 
T Consensus        56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-  134 (361)
T KOG1006|consen   56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-  134 (361)
T ss_pred             ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-
Confidence            4466777788888889999999999999999999999999998744 46677899999999999999999999999874 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          152 DSGQISIALEYMDGGSLADILR-----MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                       ++..+|.||+|+ .+|..+.+     ++..++|..+..|....+.||.||.....|||||+||+|||++..|.+|||||
T Consensus       135 -EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  135 -EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             -CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence             457899999996 48877653     34569999999999999999999998678999999999999999999999999


Q ss_pred             cccccCcccccccccccccCcccCCcccc--CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          227 GISAGLENSIAMCATFVGTVTYMSPERIR--NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      |.+..+.++... +...|...|||||.+.  +..|+.+|||||||++|||+.||..||...++-.+.+.++..+.++...
T Consensus       213 GIcGqLv~SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  213 GICGQLVDSIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             cchHhHHHHHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            999888776433 4567999999999994  3458999999999999999999999998877666666676666554332


Q ss_pred             -C---CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc--cccHHHHH
Q 017445          305 -R---QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA--KVDLAAFV  353 (371)
Q Consensus       305 -~---~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~--~~~~~~~~  353 (371)
                       .   .+++..++.||.-||.+|-+.||+..+++++||+..+...  ++..++.+
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~v~vak~i  346 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPDVEVAKRI  346 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCceehhhhh
Confidence             2   3478999999999999999999999999999999988654  44444444

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-43  Score=337.83  Aligned_cols=260  Identities=22%  Similarity=0.350  Sum_probs=209.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc--CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI--PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .+...+|++++.||+|+||.||+|...  .+++.||+|.+...     ....+|+.++..+. ||||+++++.+.  ...
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~-h~~iv~~~~~~~--~~~  159 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTIS-HRAIINLIHAYR--WKS  159 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcC-CCCccceeeeEe--eCC
Confidence            344568999999999999999999754  45688999988642     23457889998886 999999999874  456


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+|||++. ++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++|+|||++.....
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            8999999996 5899999777889999999999999999999999 9999999999999999999999999999876554


Q ss_pred             ccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhC---C--------
Q 017445          235 SIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILED---P--------  299 (371)
Q Consensus       235 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~---~--------  299 (371)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....  ...+..++..   .        
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322  123457999999999999989999999999999999999999999654321  1111111110   0        


Q ss_pred             ----------------CCCC-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          300 ----------------SPSP-----SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       300 ----------------~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                      .+..     ....++.++.+||++||..||.+||++.++|.||||.+...+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence                            0000     0124567899999999999999999999999999998766554

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.1e-44  Score=334.39  Aligned_cols=258  Identities=24%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      |.+..++|++.+.||+|+||.||+|.+..     +++.||+|+++.. .......+..|+..+.++.+|+||+++++++.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            55667799999999999999999997433     4578999998753 23345667889999999877999999999775


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ------------------------------------------------------  175 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~------------------------------------------------------  175 (371)
                      . ....++++|||+++++|.+++...                                                      
T Consensus        82 ~-~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          82 K-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             c-CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            3 445789999999999999988532                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--ccccccccC
Q 017445          176 -------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTV  246 (371)
Q Consensus       176 -------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~  246 (371)
                             .++++..+..++.||+.||.|||+ +||+||||||+||+++.++.++|+|||++..+.....  ......++.
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                   257899999999999999999999 9999999999999999999999999999987543221  122344677


Q ss_pred             cccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcC
Q 017445          247 TYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE  325 (371)
Q Consensus       247 ~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  325 (371)
                      .|+|||++.+..++.++|||||||++|+|++ |..||........ ....+........+...++++.+++.+||+.+|+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence            8999999999999999999999999999997 9999976443332 3333333333344457889999999999999999


Q ss_pred             CCCCHHHHhcC
Q 017445          326 ARPTADQLLSH  336 (371)
Q Consensus       326 ~Rps~~~il~h  336 (371)
                      +||++.++++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-43  Score=328.51  Aligned_cols=262  Identities=25%  Similarity=0.355  Sum_probs=211.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+.....  .......+|+.++.++. |+||+++++.+.......++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEE
Confidence            4689999999999999999999999999999999864321  22234567999998886 99999999988655556799


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999975 89888865 3668999999999999999999999 999999999999999999999999999998765443


Q ss_pred             cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CCC-----------
Q 017445          237 AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PSP-----------  301 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~-----------  301 (371)
                      .......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||...+. ...+..+...   +..           
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhhcccc
Confidence            33334456888999999865 5578999999999999999999999976543 2222222210   000           


Q ss_pred             -----C--C-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          302 -----S--P-------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       302 -----~--~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                           .  .       .....++++.+||.+||+.||++|||+.+++.||||++....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                 0  0       012357889999999999999999999999999999866543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-44  Score=337.28  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ....+|++++.||+|+||.||+|.+..+++.||+|+....      ....|+.++.++. ||||+++++++.  .....+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVN-HPSVIRMKDTLV--SGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCC-CCCCcChhheEE--eCCeeE
Confidence            3345799999999999999999999999999999985432      2345788888876 999999999875  355899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +|||++. ++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||.+...... 
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            9999996 588888754 4579999999999999999999999 99999999999999999999999999998754332 


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCC-CCCCCc--------HHHHHHHhhC---C---CC
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY-AASEGP--------VNLMLQILED---P---SP  301 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf-~~~~~~--------~~~~~~~~~~---~---~~  301 (371)
                      .......||+.|+|||++.+..++.++|||||||++|||+++..|+ ......        ...+..++..   .   .+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            2224567999999999999989999999999999999999855444 332111        0111111110   0   00


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          302 --------------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       302 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                                                ......++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                      0011245677888999999999999999999999999985

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=319.46  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=206.9

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      +.||+|+||.||+|.+..+++.||+|.+....   ......+..|...+....+|+|++++++.+.  +...+|+|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence            47999999999999999999999999986532   2223344556666656667999999999874  456899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+.....    .....
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~  154 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV  154 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence            999999999888889999999999999999999999 9999999999999999999999999998875443    23456


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--CCCCCCCCCHHHHHHHHHhcc
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSFVDDCLK  321 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~  321 (371)
                      +++.|+|||.+.+..++.++||||+|+++|+|++|..||..... ......+.....  +......+++++.+++.+||+
T Consensus       155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-DAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            88999999999888889999999999999999999999976442 333333332222  222334689999999999999


Q ss_pred             cCcCCCC---CHHHHhcCcccccccc
Q 017445          322 KDAEARP---TADQLLSHPFITKYEH  344 (371)
Q Consensus       322 ~dp~~Rp---s~~~il~hp~~~~~~~  344 (371)
                      .+|++||   ++.+++.||||....+
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhcCCC
Confidence            9999999   5589999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-43  Score=320.70  Aligned_cols=252  Identities=27%  Similarity=0.454  Sum_probs=215.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +|++.+.||.|+||.||+|.+..++..||+|.+...   .....+.+.+|+..+.++. ||||+++++.+  .+....++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSF--QDEENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhh--cCCCeEEE
Confidence            478899999999999999999999999999999642   2234567888999998886 99999999977  45668999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |+||++|++|.+++....++++..+..++.|+++||.|||+ .|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~  155 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-L  155 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-c
Confidence            99999999999999877789999999999999999999999 999999999999999999999999999987665432 2


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-HHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-VNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...+.+.... .....+..++..+.+++.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHH
Confidence            24566889999999998888999999999999999999999999765431 1222222221 333444578899999999


Q ss_pred             HhcccCcCCCCCH--HHHhcCccc
Q 017445          318 DCLKKDAEARPTA--DQLLSHPFI  339 (371)
Q Consensus       318 ~~l~~dp~~Rps~--~~il~hp~~  339 (371)
                      +||..||.+||++  .+++.||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-43  Score=319.99  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      +...+|++.+.||+|+||.||+|.+.   ..+..||+|.++.. .......+.+|+..+.++. ||||+++++.+.  ..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~   78 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVIT--RG   78 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEe--cC
Confidence            34568999999999999999999764   45678999998753 2344567889999998875 999999999874  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.++++|||.+...
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            6899999999999999999764 568999999999999999999999 99999999999999999999999999987654


Q ss_pred             cccccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          233 ENSIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       233 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ...... .....++..|+|||.+.+..++.++|||||||++||+++ |..||..... ...... +......+.+..++.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~  235 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKA-VEDGFRLPAPRNCPN  235 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHH-HHCCCCCCCCCCCCH
Confidence            322111 112335678999999999999999999999999999775 9999976443 223333 333333445667899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+.+++.+||+.+|++||++.+|++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-45  Score=343.34  Aligned_cols=252  Identities=26%  Similarity=0.488  Sum_probs=225.8

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEecc----ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINI----FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ...+||+|+|-+||+|.|..+|..||--.++.    .......++..|+..|..++ ||||++++..|.......+.+|+
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeee
Confidence            34589999999999999999999998655543    23455688999999998887 99999999999888888899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--CeEecCCCCCcEEEccC-CceEEecccccccCccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR--HLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSIA  237 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |.+..|+|..|+++.+.++.+.+..|++||+.||.|||+ +  .|||||||-+||+|+.+ |.|||+|+|+|+.......
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            999999999999999999999999999999999999999 5  59999999999999875 9999999999988776543


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                        ...+|||.|||||.+. ..|+..+||||||++++||+|+..||..-.++.....++..+..|.....--.+++++||.
T Consensus       202 --ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe  278 (632)
T KOG0584|consen  202 --KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE  278 (632)
T ss_pred             --ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence              4478999999999997 7799999999999999999999999998888888888888887777666666899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCcccccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      +||.. .++|||+.|+|.||||..-
T Consensus       279 kCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  279 KCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHhcC-chhccCHHHHhhChhhccc
Confidence            99999 9999999999999999874

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.9e-43  Score=315.69  Aligned_cols=252  Identities=30%  Similarity=0.525  Sum_probs=216.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|+.++.||.|+||.||.+.+..+++.+++|.+...  .......+.+|+.++.++. |+||+++++++.  +...++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFM--DDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEe--cCCeEEEE
Confidence            578899999999999999999999999999998653  3455567889999998885 999999999885  45689999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999999999764  458999999999999999999999 9999999999999999999999999999876655443


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... .......+...... .....++.++.+++.
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  234 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-PLNLVVKIVQGNYT-PVVSVYSSELISLVH  234 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCC-CCccccCHHHHHHHH
Confidence            3455678999999999988889999999999999999999999997643 33334444433332 333678899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +||..+|++||++.++++|||+
T Consensus       235 ~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.8e-44  Score=329.32  Aligned_cols=255  Identities=29%  Similarity=0.568  Sum_probs=213.1

Q ss_pred             eEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .....||+|+||.||+|.+..+++.||+|.+..........+.+|+..+..+. |||++++++.+..  ....|++|||+
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~~~~iv~e~~  100 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLV--GEELWVLMEFL  100 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC-CCchhhhhhheee--CCeEEEEEecC
Confidence            34447999999999999998899999999987644455567888998888886 9999999998753  56899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++++|.+++.. ..+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++..............
T Consensus       101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            99999998754 568999999999999999999999 9999999999999999999999999999876554433334567


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCCCCCCCCHHHHHHHHHhccc
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-PSPSRQNFSPEFCSFVDDCLKK  322 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~  322 (371)
                      +++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......+..... .......++..+.+++++||+.
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-VQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            89999999999888899999999999999999999999975432 222333222221 1223346788999999999999


Q ss_pred             CcCCCCCHHHHhcCcccccccc
Q 017445          323 DAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       323 dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +|.+||++.+++.||||.+..-
T Consensus       258 ~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         258 EPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             CcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.7e-43  Score=320.60  Aligned_cols=257  Identities=31%  Similarity=0.613  Sum_probs=215.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      -|++++.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+..+.++. ||||+++++.+.  +....++||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL--KDTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEE--eCCeEEEEE
Confidence            4667789999999999999998999999999986532 334456778889888876 999999999874  456899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      ||+++++|.+++. ...+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            9999999999986 4578999999999999999999999 9999999999999999999999999999876554333334


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... ....... +...........++.++.+++.+||
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFL-IPKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-hHHHHHH-HhcCCCCCCCcccCHHHHHHHHHHc
Confidence            4568899999999988888999999999999999999999996543 2222222 2333333344568899999999999


Q ss_pred             ccCcCCCCCHHHHhcCccccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      ..+|++||++.++++||||.+...+
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhhhhc
Confidence            9999999999999999999886554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=339.13  Aligned_cols=255  Identities=27%  Similarity=0.464  Sum_probs=215.3

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      .+..|.+..+++.+..+||+|.||+||+|.+..+   ||||+++.  ...+..+.|.+|+..+++.+ |.||+-+.|++.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~  458 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACM  458 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhc
Confidence            3467788888999999999999999999998664   99999975  34567788999999999998 999999999886


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      .+   .+.||+.+|+|-+|+.+|+.. ..|+..+...|+.|+++|+.|||. ++|||||||..||++.+++.|||+|||+
T Consensus       459 ~p---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  459 NP---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             CC---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccc
Confidence            33   349999999999999999754 469999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCc--ccccccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CC
Q 017445          229 SAGLE--NSIAMCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PS  300 (371)
Q Consensus       229 s~~~~--~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~  300 (371)
                      +....  ..........|...|||||+++.   .+|++.+||||||+|+|||++|.+||. .+..+..+.++-.+   +-
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCcc
Confidence            85432  12223345568899999999954   468999999999999999999999998 55555555555444   22


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       301 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ......+++.++++|+..||..++++||.+.+||.
T Consensus       614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            33344678899999999999999999999999986

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=321.45  Aligned_cols=261  Identities=31%  Similarity=0.573  Sum_probs=214.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .|++++.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.++..+.  .|||++++++.+.  +....|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEE
Confidence            467778999999999999999999999999998653 3334456778888887775  5999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++++|.+++.. +.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            9999999999999865 579999999999999999999999 99999999999999999999999999999876654443


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+.....+......++.++.+++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            445678999999999865 4478999999999999999999999976432 22222222222222223348899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      +||+.||++||++.+++.||||++......
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~~~~~  266 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHSKTPV  266 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhccccCch
Confidence            999999999999999999999987665443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-43  Score=322.91  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=205.6

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++++.||.|++|.||+|.+..+++.||||++....  ......+.+|+..+.++. ||||+++++++  .+....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVI--HTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhc--ccCCcEEEE
Confidence            4788899999999999999999999999999986532  223356788999999886 99999999987  456689999


Q ss_pred             EeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+. ++|.+++..  ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            99996 589998864  3568999999999999999999999 9999999999999999999999999999876654333


Q ss_pred             ccccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCC--------------
Q 017445          238 MCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSP--------------  301 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~--------------  301 (371)
                      ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ...+.... ..+              
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            334456788999999886644 6889999999999999999999997654322 22222111 000              


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          302 ------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       302 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                  ......++.++.++|.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        00113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-43  Score=322.66  Aligned_cols=252  Identities=21%  Similarity=0.360  Sum_probs=208.6

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCC-----cEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTH-----RIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...+|++++.||+|+||.||+|.+...+     ..||+|.+... .......+.+|+..+..+. ||||+++++++.  +
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~--~   79 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCT--K   79 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEc--C
Confidence            4468899999999999999999876554     67999998653 3344566888999998886 999999999774  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN  216 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~  216 (371)
                      .+..+++|||+++++|.+++...                ..+++..+..++.|++.||.|||+ +|++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence            56799999999999999999754                457889999999999999999999 9999999999999999


Q ss_pred             cCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 017445          217 LKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLML  293 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~  293 (371)
                      .++.++|+|||++.......  .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~  237 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIE  237 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH
Confidence            99999999999987653321  12233456889999999988889999999999999999998 9999976443 33333


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+ ........+..+++++.+|+.+||+.||.+||++.+|+++
T Consensus       238 ~i-~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MI-RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HH-HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33 3333444557899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.7e-43  Score=324.66  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=210.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-----EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+.....     .....+..|+..+..+. |+||+++++++.  +....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFG--HKSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheee--cCCEE
Confidence            47788899999999999999999999999999975322     23345677888888887 999999999885  36689


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          157 SIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++||||+ +++|.+++.... .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999999 889999998765 79999999999999999999999 99999999999999999999999999999876554


Q ss_pred             ccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CCC----------
Q 017445          236 IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PSP----------  301 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~----------  301 (371)
                      ........+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||..... .....+....   +..          
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccccc
Confidence            333344567889999999854 4578999999999999999999888865443 2222222211   000          


Q ss_pred             -------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          302 -------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       302 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                   .......+.++.+++.+||..||++|||+.+++.||||.+.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                         001134578899999999999999999999999999998865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-43  Score=323.63  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=206.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---Ce
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---GQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---~~  155 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++..+.+||||+++++++...+.   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36889999999999999999999999999999986532  22335678899999999878999999998754332   23


Q ss_pred             EEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEeccccc
Q 017445          156 ISIALEYMDGGSLADILRMQ-----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGIS  229 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s  229 (371)
                      .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||+ +|++||||+|+||+++. ++.+||+|||.+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            8999999986 898887542     357999999999999999999999 99999999999999998 889999999998


Q ss_pred             ccCcccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCC----
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSP----  301 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~----  301 (371)
                      ..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ....+..   .+..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence            765443333334457889999998865 457899999999999999999999997654322 2222111   0000    


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          302 -------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       302 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                                         ......++.++.+||.+||..||.+||++.+++.||||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                               001135788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-43  Score=327.92  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=193.5

Q ss_pred             eeecccCCeEEEEEEEcC--CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           87 GAIGSGASSVVQRAVHIP--THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .+||+|+||+||+|.+..  ++..||+|.+....  ....+.+|+.++..+. ||||+++++++.......+++||||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            479999999999998654  66889999986532  2234678999998886 999999999987666778999999997


Q ss_pred             CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE----ccCCceEEeccccccc
Q 017445          165 GGSLADILRMQ---------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGISAG  231 (371)
Q Consensus       165 ~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~----~~~~~~kl~Dfg~s~~  231 (371)
                      + +|.+++...         ..+++..++.++.|++.||.|||+ .||+||||||+||++    +.++.+||+|||++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5 888877421         248899999999999999999999 999999999999999    4567999999999976


Q ss_pred             Cccccc---ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--------HHHHHHh---
Q 017445          232 LENSIA---MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPV--------NLMLQIL---  296 (371)
Q Consensus       232 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--------~~~~~~~---  296 (371)
                      ......   ......+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||.......        ..+..+.   
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            644321   2234578999999999976 458999999999999999999999997533210        0111100   


Q ss_pred             hCCC---------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          297 EDPS---------------------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       297 ~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ....                                 ........+..+.+|+.+||+.||.+|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000                                 000011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.8e-43  Score=319.87  Aligned_cols=245  Identities=24%  Similarity=0.400  Sum_probs=200.0

Q ss_pred             ceeEeeee--cccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAI--GSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.+  |+|+||.||++.++.+++.+|+|.+.......     .|+.......+||||+++++.|..  .+..|+|
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv   87 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT--LKGHVLI   87 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec--CCeeEEE
Confidence            45555555  99999999999999999999999986422111     122222223369999999998854  4589999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||.+......   
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            9999999999999887789999999999999999999999 9999999999999999998 9999999998765433   


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH---HHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                       ....++..|+|||++.+..++.++||||+|+++|+|++|..||........   .+....  .........+++.+.+|
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  240 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDF  240 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHH
Confidence             345689999999999988899999999999999999999999975433221   112222  22223345789999999


Q ss_pred             HHHhcccCcCCCCC-HHHHhcCcccc
Q 017445          316 VDDCLKKDAEARPT-ADQLLSHPFIT  340 (371)
Q Consensus       316 i~~~l~~dp~~Rps-~~~il~hp~~~  340 (371)
                      |.+||+.+|.+||+ ++++|+||||.
T Consensus       241 i~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        241 VQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999996 69999999996

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.2e-43  Score=322.44  Aligned_cols=255  Identities=24%  Similarity=0.405  Sum_probs=203.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ..+|++++.||+|+||.||+|.+..++..||+|.+..... .....+.+|+..+..+. |+||+++++++.  +....|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIH--TKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEe--cCCeEEE
Confidence            4689999999999999999999999999999999865322 22345678898888886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+. ++|.+++.. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+........
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            999996 577776643 3568889999999999999999999 9999999999999999999999999999876544333


Q ss_pred             ccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CC-------------
Q 017445          238 MCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PS-------------  300 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~-------------  300 (371)
                      ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.........+.+....   +.             
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            33445679999999998754 57889999999999999999999997654332222222110   00             


Q ss_pred             -CC------C-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          301 -PS------P-------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       301 -~~------~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                       ..      .       .....+.++.+++.+|++.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             00      0       001235789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.6e-43  Score=313.83  Aligned_cols=256  Identities=34%  Similarity=0.593  Sum_probs=221.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|++|.||+|.+..+++.|++|++....  ......+.+|+..+.++. ||||+++++.+.......++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEE
Confidence            4678889999999999999999899999999987643  245677889999999887 9999999998754323689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--  237 (371)
                      +||+++++|.+++.....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            9999999999999877789999999999999999999999 9999999999999999999999999999987665432  


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ......++..|+|||.+.+...+.++||||||+++++|++|..||......................+..++..+.+++.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            13456789999999999888899999999999999999999999987664444445544433444455677999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +||+.+|++||++.+++.||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-43  Score=323.43  Aligned_cols=254  Identities=28%  Similarity=0.500  Sum_probs=208.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++..+. ||||+++++++  .+....|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVF--RRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhc--ccCCeEEE
Confidence            36889999999999999999999899999999876422  223456778999888886 99999999987  45668999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++++|.++......+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            99999999999888766779999999999999999999999 99999999999999999999999999998776554333


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---C----------------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---D----------------  298 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~----------------  298 (371)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+..   .                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            345668899999999865 4478899999999999999999999975432 222111110   0                


Q ss_pred             -C-CCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          299 -P-SPS--------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       299 -~-~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                       . .+.        .....++..+.+|+.+||+.+|++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             0 000        0123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.6e-43  Score=316.05  Aligned_cols=254  Identities=33%  Similarity=0.593  Sum_probs=213.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.++....  .....+..|+.++..+. |+||+++++.+  .+...+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~--~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVE--VHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeE--ecCCEEEEE
Confidence            47888999999999999999988999999999876433  36677889999998886 99999999976  456689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||.+..........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999999877779999999999999999999999 999999999999999999999999999987765432221


Q ss_pred             ----ccccccCcccCCccccCCC---CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHH
Q 017445          240 ----ATFVGTVTYMSPERIRNES---YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPE  311 (371)
Q Consensus       240 ----~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  311 (371)
                          ....+++.|+|||++.+..   ++.++||||||++++++++|..||............+... ....+....++..
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence                1346788999999998766   8899999999999999999999997654333333333222 2222333456899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.+++.+||+.+|.+||++.+++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=322.12  Aligned_cols=255  Identities=22%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++.+.||+|++|.||+|.++.+++.||+|.+.... ......+.+|+.++..+. ||||+++++++.  +....++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIH--TKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEe--cCCeEEE
Confidence            368899999999999999999999899999999986532 222344678999998886 999999999874  5668999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+.+ +|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+........
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9999985 999988654 468999999999999999999999 9999999999999999999999999999875433222


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCC-----------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPS-----------  302 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~-----------  302 (371)
                      ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.........+..+..   .+...           
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            2233457889999999865 45889999999999999999999999765433222222111   10000           


Q ss_pred             --------------CCCCCCC--HHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          303 --------------PSRQNFS--PEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       303 --------------~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                    .....++  .++.+++.+||+.+|++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                          0001233  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-43  Score=332.34  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=209.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+..  ........+.+|+.++..+. ||||++++++|....    .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcccc
Confidence            3679999999999999999999999999999999864  23344556778999888876 999999999875332    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||.+....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            358999999965 899888643  8999999999999999999999 999999999999999999999999999997665


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---C------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---D------------  298 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~------------  298 (371)
                      ... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. .....+..   .            
T Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         170 TSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhhhh
Confidence            432 224456889999999999999999999999999999999999999764321 11111110   0            


Q ss_pred             -------CCCC-------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          299 -------PSPS-------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       299 -------~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                             ....                   ......++.+.+++.+||+.||++|||+.++|.||||..|-.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence                   0000                   0012346678999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=314.54  Aligned_cols=255  Identities=32%  Similarity=0.502  Sum_probs=217.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+...     .......+.+|+..+.++. ||||+++++.+...+.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            4789999999999999999999999999999987531     2234457788999998886 999999999886555667


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +++++||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            99999999999999999877789999999999999999999999 99999999999999999999999999999765321


Q ss_pred             c---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          236 I---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       236 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      .   .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .....++...+.....+..+++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~  238 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-MAAIFKIATQPTKPMLPDGVSDAC  238 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-HHHHHHHHcCCCCCCCCcccCHHH
Confidence            1   111245689999999999988899999999999999999999999976543 334445554545555567889999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .+++++||+ +|.+||++.+++.|||.
T Consensus       239 ~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         239 RDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=314.71  Aligned_cols=284  Identities=24%  Similarity=0.414  Sum_probs=245.0

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      ....+.+.-.+|.++.+||+|+|+.|.++++++|.+.+|+|++++   .+.++..-+..|-.+.....+||.+|-++.+|
T Consensus       241 ~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  241 IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            335566777899999999999999999999999999999999975   34455566777888888889999999999988


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                        +....+|+|.||++||+|--.+..++.++++.++.+...|..||.|||+ +|||+||||.+|||+|..|++||+|+|+
T Consensus       321 --qtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  321 --QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             --cccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCceeecccch
Confidence              5566899999999999999999989999999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCC------CCCcHHHHHHHhhCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA------SEGPVNLMLQILEDPSPS  302 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~------~~~~~~~~~~~~~~~~~~  302 (371)
                      ++.--......++++|||.|.|||++++..|+.++|+|+||++++||+.|+.||.-      ..+.++.+++++-.....
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            98776666777899999999999999999999999999999999999999999962      224456677765544332


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCC------HHHHhcCccccccccccccHHHHHHHhcChhhhh
Q 017445          303 PSRQNFSPEFCSFVDDCLKKDAEARPT------ADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM  363 (371)
Q Consensus       303 ~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (371)
                       .+..++-.+..+++.-|++||.+|..      ..++..|+||..+.+...+    .+.+.||++-.
T Consensus       478 -iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le----qk~v~ppf~p~  539 (593)
T KOG0695|consen  478 -IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE----QKQVLPPFQPQ  539 (593)
T ss_pred             -ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh----hcccCCCCCCc
Confidence             23467788899999999999999964      7899999999977665443    67788898843

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.5e-43  Score=316.85  Aligned_cols=252  Identities=28%  Similarity=0.519  Sum_probs=210.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||||.++.   ........+.+|+.++..+. ||||+++++.+..  .+..+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIE--DNELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEE--CCeEE
Confidence            478999999999999999999999999999998764   23344566788999998886 9999999998754  45899


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          158 IALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +++||+++++|.+++..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999999998852    3458999999999999999999999 999999999999999999999999999987765


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEF  312 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  312 (371)
                      ..........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.........+.+.+.. ..+......++..+
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            44333345578999999999988889999999999999999999999997654333333333333 33333345678899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+++.+||+.+|++||++.++++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.7e-43  Score=321.98  Aligned_cols=258  Identities=33%  Similarity=0.628  Sum_probs=217.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ..|++.+.||+|++|.||+|.+..++..||+|++..... ....+.+|+..+..+. |+|++++++.+..  ....|+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCK-HPNIVDYYDSYLV--GDELWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCC-CCCeeEEEEEEEE--CCEEEEEE
Confidence            457777899999999999999988899999999976444 5567888999888886 9999999998854  46899999


Q ss_pred             eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence            9999999999998766 89999999999999999999999 999999999999999999999999999987655433333


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCCCCCCCCHHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-PSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  318 (371)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+..... .......++.++.+++.+
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-LRALFLITTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence            445688999999999888899999999999999999999999975432 333333333222 222333488999999999


Q ss_pred             hcccCcCCCCCHHHHhcCcccccccc
Q 017445          319 CLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ||+.+|.+||++.+++.||||.+...
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.7e-43  Score=335.10  Aligned_cols=259  Identities=22%  Similarity=0.344  Sum_probs=212.1

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      ...+.+..++|++++.||+|+||.||+|.+...     +..||||++... .......+.+|+.++.++..||||+++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            356778888999999999999999999986433     346999999753 33445678999999999977999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhc---------------------------------------------------
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQ---------------------------------------------------  175 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------------------------------------------  175 (371)
                      ++  .+.+.+||||||+++|+|.+++..+                                                   
T Consensus       109 ~~--~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         109 AC--TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EE--ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            87  4566899999999999999988642                                                   


Q ss_pred             ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          176 ---------------------------------------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       176 ---------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                                                                   ..+++..+..++.|++.||.|||+ .+|+||||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp  265 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAA  265 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCh
Confidence                                                         236778889999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG  287 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~  287 (371)
                      +||+++.++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            999999999999999999876543221  1233456788999999988889999999999999999997 9999976443


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ... ....+........+..++.++.+++.+||+.||++||++.++.+
T Consensus       346 ~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         346 DST-FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hHH-HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            222 33333333334445678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9e-43  Score=315.54  Aligned_cols=252  Identities=21%  Similarity=0.366  Sum_probs=210.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+...+|.+.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+..+..+. ||||+++++.+.  ....+
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   77 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--REPPF   77 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCC-CCChhheEEEEc--CCCCc
Confidence            45567899999999999999999999999999999998753 334566888999998886 999999999774  45689


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      +++|||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999999999998653  358999999999999999999999 9999999999999999999999999999876654


Q ss_pred             ccccc-ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIAMC-ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ..... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ... ....+........+..++.++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ-VYELLEKGYRMERPEGCPPKV  234 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHH-HHHHHHCCCCCCCCCCCCHHH
Confidence            32211 12234568999999998899999999999999999998 999997643 223 333334433444556789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+||+.+|++||++.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-43  Score=321.23  Aligned_cols=253  Identities=29%  Similarity=0.504  Sum_probs=210.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|++|.||+|.+..+++.||+|.++..  .......+.+|+.++.++. |+||+++++.+..  .+..+++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~iv   78 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRR--KGRLYLV   78 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEE--CCEEEEE
Confidence            689999999999999999999999999999998642  2334567889999999887 9999999998854  5689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-c
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-M  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-~  238 (371)
                      |||++++.+..+......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            9999987777777666779999999999999999999999 9999999999999999999999999999887665433 3


Q ss_pred             cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC---------------
Q 017445          239 CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP---------------  299 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~---------------  299 (371)
                      .....++..|+|||++.+. .++.++|+||+|+++|+|++|..||....... .+.....   ..               
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            3456788999999999877 78999999999999999999999997644322 2211110   00               


Q ss_pred             ---CC---------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          300 ---SP---------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       300 ---~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                         .+         ...+..++.++.+|+++||..+|++||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               00         01122358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-42  Score=311.16  Aligned_cols=252  Identities=37%  Similarity=0.656  Sum_probs=214.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      +|.+.+.||+|++|.||++.+..+++.+++|++..........+.+|+..+..+. |+|++++++.+.  .....++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYL--KKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEe--cCCeEEEEEe
Confidence            4778889999999999999998899999999997755556678889999998887 999999999874  3468999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          162 YMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       162 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      |+++++|.+++... ..+++..+..++.|++.||.+||+ .|++||||+|+||+++.++.++|+|||.+........ ..
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~  155 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN  155 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence            99999999999765 579999999999999999999999 9999999999999999999999999999887665432 34


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhc
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  320 (371)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.........................++..+.+++.+||
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL  235 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence            56789999999999888899999999999999999999999976533222222222222222233345899999999999


Q ss_pred             ccCcCCCCCHHHHhcCcc
Q 017445          321 KKDAEARPTADQLLSHPF  338 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~  338 (371)
                      +.||++|||+.++++|||
T Consensus       236 ~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         236 QKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cCChhhCCCHHHHhcCCC
Confidence            999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.4e-43  Score=319.57  Aligned_cols=253  Identities=29%  Similarity=0.510  Sum_probs=207.4

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|++|.||+|.+..+|+.||+|++....  ......+.+|+.++.++. ||||+++++.+.  .....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFP--HGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEe--cCCeeEEE
Confidence            5789999999999999999999999999999987533  334567888999998887 999999999874  46689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      |||+ +++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9999 9999999864 4569999999999999999999999 9999999999999999999999999999876654321 


Q ss_pred             ccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CC-------------
Q 017445          238 MCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PS-------------  300 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~-------------  300 (371)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|++|..||..... ...+......   ..             
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchh
Confidence            22345689999999998654 468999999999999999999888865442 2222222110   00             


Q ss_pred             -----CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          301 -----PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       301 -----~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                           +.       ......+.++.+++++||..+|.+||++++++.||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                 00       01134578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-43  Score=341.17  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....      ....+|+.++.++. |+||+++++++.  ..+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~-HpnIv~l~~~~~--~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLS-HPAVLALLDVRV--VGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCC-CCCCCcEEEEEE--ECCEEEEE
Confidence            4579999999999999999999999999999996432      23567899998886 999999999875  35689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      ||++. ++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........ 
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            99995 6898888653 469999999999999999999999 9999999999999999999999999999876543211 


Q ss_pred             -ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC-C-----cHHHHHHHhhCCC------CC--
Q 017445          238 -MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-G-----PVNLMLQILEDPS------PS--  302 (371)
Q Consensus       238 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~-~-----~~~~~~~~~~~~~------~~--  302 (371)
                       ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... .     ....+.+++....      +.  
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence             1234579999999999999999999999999999999999876553211 1     1112222221100      00  


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          303 -------------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       303 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                                               .....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                     000134568999999999999999999999999999964

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.2e-43  Score=318.00  Aligned_cols=253  Identities=33%  Similarity=0.539  Sum_probs=206.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH----------HHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK----------EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.++....          ...+.+..|+..+..+. |||++++++.+.  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFET--   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEec--
Confidence            46778899999999999999988999999998853211          11235677888888886 999999999764  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .....++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+..
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          79 TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             cCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            456899999999999999999888889999999999999999999999 9999999999999999999999999999876


Q ss_pred             Cccccc--ccccccccCcccCCccccCCC--CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC----CCCC
Q 017445          232 LENSIA--MCATFVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP----SPSP  303 (371)
Q Consensus       232 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~~~  303 (371)
                      ......  ......++..|+|||.+.+..  ++.++|+||||+++|++++|..||...... ..........    .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccccCCcCCcc
Confidence            543211  123446889999999987654  889999999999999999999999654332 2222222111    1222


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ....++.++.+++.+||..+|++||+++++++||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            234578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-43  Score=320.12  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=208.6

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||+|+||+||+|.+..+|+.||+|.+....   ......+..|+.++..+. ||||+++++.+.  ..+..|+||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFE--TKDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEe--cCCeEEEEEecCCC
Confidence            689999999999999999999999986422   223445678999998886 999999999874  45689999999999


Q ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccc
Q 017445          166 GSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV  243 (371)
Q Consensus       166 g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~  243 (371)
                      ++|.+++....  .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+...... .......
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA  155 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence            99999997655  69999999999999999999999 99999999999999999999999999998765432 2223456


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcc
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK  321 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  321 (371)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  ...+..... ......+..+++++.+++++||+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHHcc
Confidence            888999999998888999999999999999999999999765431  111111111 12223345679999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCccccccccccc
Q 017445          322 KDAEARP-----TADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       322 ~dp~~Rp-----s~~~il~hp~~~~~~~~~~  347 (371)
                      .||++||     ++.+++.||||....+.+.
T Consensus       235 ~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         235 KDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             CChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence            9999999     8999999999987765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=303.36  Aligned_cols=262  Identities=26%  Similarity=0.373  Sum_probs=218.2

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..+..+..++|++.+.||+|+|+-||++++..+++.||+|++.....+..+..++|+...+++. |||++++++....+.
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREE   91 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhh
Confidence            4466788899999999999999999999999999999999998878888899999999999987 899999988764432


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEccCCceEE
Q 017445          153 ---SGQISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNLKGRPKI  223 (371)
Q Consensus       153 ---~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~~~~~kl  223 (371)
                         ....||+++|...|+|.+.+..    +.-+++.+...|+.++++||++||+ ..  ++||||||.|||++..+.++|
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEE
Confidence               2469999999999999998853    2358999999999999999999999 77  999999999999999999999


Q ss_pred             ecccccccCcccccc---------cccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-HH
Q 017445          224 TDFGISAGLENSIAM---------CATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGP-VN  290 (371)
Q Consensus       224 ~Dfg~s~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-~~  290 (371)
                      .|||.++...-.-..         ......|..|+|||.+.   +...+.++|||||||++|+|+.|..||...... ..
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            999999765432111         12234789999999984   445789999999999999999999999653221 12


Q ss_pred             HHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          291 LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +...+..+....+....+|..+.++|+.||++||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2233334445555556699999999999999999999999999864

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.4e-43  Score=313.80  Aligned_cols=249  Identities=29%  Similarity=0.511  Sum_probs=210.5

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +|++.+.||.|+||.||++.+..+++.+|+|.++.. .....+.+..|+.++..+. ||||+++++.+.  +.+.+|++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFE--ADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--ECCEEEEEE
Confidence            578899999999999999999999999999998642 3344566778888888876 999999999874  466899999


Q ss_pred             eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          161 EYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       161 E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99999999998864  3458999999999999999999999 99999999999999999999999999998766554333


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      .....+++.|+|||++.+..++.++|+||+|+++|+|++|..||.... .......+..+ .....+..++..+.+|+.+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQG-SYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-HHHHHHHHhcC-CCCCCCcccCHHHHHHHHH
Confidence            445678999999999998889999999999999999999999997543 23333333333 3333445788999999999


Q ss_pred             hcccCcCCCCCHHHHhcC
Q 017445          319 CLKKDAEARPTADQLLSH  336 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~h  336 (371)
                      ||+.||++||++.+++.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-42  Score=312.14  Aligned_cols=251  Identities=27%  Similarity=0.490  Sum_probs=211.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...  .......+.+|+.++..+. |||++++++.+.  .....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFL--EDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEe--cCCEEEEE
Confidence            478899999999999999999999999999998653  3344567888999998886 999999999774  45689999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999999753  358999999999999999999999 999999999999999865 468999999998765432


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                       ......++..|+|||.+.+..++.++||||+|+++|+|++|..||...+.. .....+.... ....+..++.++.+++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~l~~li  233 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVLKIMSGT-FAPISDRYSPDLRQLI  233 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-HHHHHHHhcC-CCCCCCCcCHHHHHHH
Confidence             223456899999999998888999999999999999999999999765432 3333333332 2233456899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .+||..+|++|||+.+++.||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.4e-43  Score=322.62  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=208.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.++....  .....+.+|+.++.++. ||||+++++++...+....|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEEE
Confidence            478888999999999999999999999999999975332  22335678999998887 999999999887655578999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+.+ +|.+++.... .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999975 9999887543 58999999999999999999999 9999999999999999999999999999887665433


Q ss_pred             ccccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---C--------------
Q 017445          238 MCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---P--------------  299 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~--------------  299 (371)
                      ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||..... .....++...   +              
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            334556889999999986544 68899999999999999999999976443 2222211110   0              


Q ss_pred             ------------CCCCCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          300 ------------SPSPSRQN-FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       300 ------------~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                  .....+.. +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                        00011111 57889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.9e-43  Score=318.37  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=203.1

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      |++.+.||+|+||.||+|.+..+++.||+|+++.. .........+|+..+.++..|+|++++++++.....+.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            57788999999999999999999999999998652 22223345678888888888999999999886554478999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          162 YMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       162 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      |+++ +|.+.+.. ...+++..+..++.|++.||.|||+ +|++||||+|+||+++. +.+||+|||.+....... ...
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcC
Confidence            9975 88888765 3568999999999999999999999 99999999999999999 999999999997664432 223


Q ss_pred             cccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC---------------C
Q 017445          241 TFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS---------------P  301 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~---------------~  301 (371)
                      ...+++.|+|||++. +..++.++||||+||++|+|++|..||...+. ...+..+..   ...               .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN  235 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence            456889999999764 45578899999999999999999999976442 221111110   000               0


Q ss_pred             C---------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          302 S---------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       302 ~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .         .....++.++.+++.+||..+|++||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0         0013568999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.5e-43  Score=322.05  Aligned_cols=255  Identities=30%  Similarity=0.558  Sum_probs=212.5

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ...||+|+||.||++....+++.||+|++..........+.+|+..+..+. |+|++++++.+.  .....++||||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYL--VGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC-CcchhheeeEEE--eCCEEEEEEecCCC
Confidence            347999999999999999999999999987655556677888999888876 999999999875  45689999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccccc
Q 017445          166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT  245 (371)
Q Consensus       166 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt  245 (371)
                      ++|.+++. .+.+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||.+..............++
T Consensus       102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            99999875 4568999999999999999999999 999999999999999999999999999987654433233445689


Q ss_pred             CcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       246 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      +.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+... +........++..+.+++.+||+.+|
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P  258 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP  258 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence            999999999888889999999999999999999999975432 2222222111 12222334678999999999999999


Q ss_pred             CCCCCHHHHhcCcccccccccc
Q 017445          325 EARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       325 ~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .+||++.+++.||||.+...+.
T Consensus       259 ~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         259 AQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             ccCcCHHHHhcChHHhccCCCc
Confidence            9999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-42  Score=321.65  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=199.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcC----------------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIP----------------THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGL  141 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i  141 (371)
                      ...+|++.+.||+|+||.||+|.+..                ++..||+|.+... .......+.+|+.++.++. ||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCCe
Confidence            45688999999999999999997532                3457999998753 3445667889999998886 9999


Q ss_pred             eEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHcCCC
Q 017445          142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-------------------SIPEPILSSMFKKLLQGLSYLHGVRH  202 (371)
Q Consensus       142 v~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~~~  202 (371)
                      +++++++.  +....++||||+++|+|.+++....                   .+++..+..++.|++.||.|||+ .|
T Consensus        82 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~  158 (304)
T cd05096          82 IRLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN  158 (304)
T ss_pred             eEEEEEEe--cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence            99999875  4557999999999999999986431                   36778899999999999999999 99


Q ss_pred             eEecCCCCCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc--C
Q 017445          203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT--G  278 (371)
Q Consensus       203 iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~--g  278 (371)
                      |+||||||+|||++.++.+||+|||++........  ......++..|+|||++.+..++.++||||||+++|+|++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999999876543221  1223446788999999988889999999999999999986  6


Q ss_pred             CCCCCCCCCcHHHHHHH---hhC---CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          279 EFPYAASEGPVNLMLQI---LED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       279 ~~pf~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      ..||..... ...+...   ...   ......+..++..+.+|+.+||+.||++|||+.+|.
T Consensus       239 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         239 EQPYGELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCcCCH-HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            678865432 2222211   111   111223356789999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.4e-43  Score=315.40  Aligned_cols=250  Identities=30%  Similarity=0.452  Sum_probs=210.9

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||.|+||.||+|.+..+++.+|+|.+.....   .....+.+|+..+.++. ||||+++++.+.  .....|++|||+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQ--GKKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhee--cCcEEEEEEecCCC
Confidence            6899999999999998999999999865332   45567888899998887 999999999774  46689999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--------
Q 017445          166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--------  237 (371)
Q Consensus       166 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--------  237 (371)
                      ++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........        
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9999999887789999999999999999999999 9999999999999999999999999999875443311        


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      ......++..|+|||.+.+...+.++||||||+++|++++|..||.... ...............+....++..+.++++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCcCCCccccCCHHHHHHHH
Confidence            2234568889999999988889999999999999999999999996543 333444444433333333345899999999


Q ss_pred             HhcccCcCCCCCH---HHHhcCccccccc
Q 017445          318 DCLKKDAEARPTA---DQLLSHPFITKYE  343 (371)
Q Consensus       318 ~~l~~dp~~Rps~---~~il~hp~~~~~~  343 (371)
                      +||+.+|++||++   .++++||||..+.
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            9999999999999   9999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-42  Score=323.88  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcE----EEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRI----IALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +...+|++.+.||+|+||+||+|.+..++..    ||+|.++.. .......+.+|+.++..+. ||||++++|++..  
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~--   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcC--
Confidence            3456899999999999999999998766654    899998653 3345567888998888886 9999999998753  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                       ...++++||+++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus        81 -~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          81 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             -CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEcccccccc
Confidence             3578999999999999999764 458999999999999999999999 9999999999999999999999999999987


Q ss_pred             Ccccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....  ...+..++......+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLPQPPIC  236 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhCCCCCCCCCCC
Confidence            6543221  122234678999999999999999999999999999997 999997543  22344555554444455678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.++.+++.+||..+|.+||++.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.2e-42  Score=317.33  Aligned_cols=261  Identities=20%  Similarity=0.355  Sum_probs=208.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+...+|++.+.||+|+||.||+|..+.     .+..||+|.++... ......+.+|+..+..+. ||||+++++.+. 
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVS-   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc-
Confidence            4556789999999999999999997542     35589999886432 233445778888888886 999999999774 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQ----------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR  220 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~  220 (371)
                       +....|+||||+++|+|.+++...          ..++...+..++.|++.||.|||+ ++|+||||||+||+++.++.
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCCc
Confidence             456799999999999999999642          224667888999999999999999 99999999999999999999


Q ss_pred             eEEecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhh
Q 017445          221 PKITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~  297 (371)
                      ++|+|||++.........  .....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... ......+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFVMD  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc
Confidence            999999998755432211  122345678999999998889999999999999999998 7889965432 333333333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------Cccccccc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS------HPFITKYE  343 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~------hp~~~~~~  343 (371)
                      .. ....+..+++.+.+++.+||+.||++|||+.++++      ||||....
T Consensus       237 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         237 GG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            32 22334567899999999999999999999999987      99998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.8e-44  Score=334.46  Aligned_cols=259  Identities=25%  Similarity=0.417  Sum_probs=224.4

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ....|.+.+.||+|.|++|.+|.+..|+..||||.++.  .+........+|+.++..+. |||||+++.+.  .....+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~--~t~~~l  130 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVI--ETEATL  130 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeee--eeccee
Confidence            34578999999999999999999999999999999976  33445556899999998887 99999999977  445689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+.+|.+++++.+.+.+.+..+..++.|++.|++|||+ ++|+|||||.+|||++.+.++||+|||++..+... 
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-  208 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-  208 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccccccceeeeccccceeeccc-
Confidence            9999999999999999999999999999999999999999999 99999999999999999999999999999988754 


Q ss_pred             cccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ....+++|++.|.|||++.+..| ++.+|+||+|+++|.|++|.+||++..-. .+-...+.+...  .+..++.+..++
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-~Lr~rvl~gk~r--Ip~~ms~dce~l  285 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-ELRPRVLRGKYR--IPFYMSCDCEDL  285 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-cccchheeeeec--ccceeechhHHH
Confidence            55588999999999999988776 58999999999999999999999875421 111222222222  234578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      |+++|.++|.+|++.+++.+|+|.....+.
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999877665

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=333.08  Aligned_cols=250  Identities=28%  Similarity=0.516  Sum_probs=217.7

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      ++||+|-||+||-|++.++|+.||||++++  .......+..+|+.+|.++. ||.||.+...|  +..+.+|+|||-+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~--ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMF--ETPERVFVVMEKLH  646 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEee--cCCceEEEEehhhc
Confidence            589999999999999999999999999975  23344577888999998887 99999998866  56679999999996


Q ss_pred             CCCHHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCccccccc
Q 017445          165 GGSLADIL-R-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       165 ~g~L~~~l-~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      | +..+.| . ..+++++.....++.||+.||.|||- ++|+|+||||+|||+...   -++||||||+|+.+++. ...
T Consensus       647 G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFR  723 (888)
T KOG4236|consen  647 G-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFR  723 (888)
T ss_pred             c-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh-hhh
Confidence            6 555544 3 45789999999999999999999999 999999999999999765   47999999999998876 445


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      .+.+|||.|.|||++.+..|+.+-|+||.|+++|--++|.+||..+ ++.+...+.....++...+..++.++.+||..+
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-EdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-EDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-cchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            7889999999999999999999999999999999999999999543 334444455555667777889999999999999


Q ss_pred             cccCcCCCCCHHHHhcCccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      |+..-.+|.|+++.|.|||++.++
T Consensus       803 LqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHhcchHhhccchhhhcch
Confidence            999999999999999999999885

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.9e-42  Score=315.75  Aligned_cols=254  Identities=22%  Similarity=0.366  Sum_probs=205.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+..++|++.+.||+|+||.||+|.+.     .++..||+|++... .......+.+|+.++..+. ||||+++++.+  
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~--   78 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVV--   78 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE--
Confidence            456678999999999999999999864     24577999998642 2334556888999888875 99999999976  


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQK----------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR  220 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~  220 (371)
                      .+....++||||+++++|.+++....          .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCCC
Confidence            45668999999999999999986532          35778889999999999999999 99999999999999999999


Q ss_pred             eEEecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhh
Q 017445          221 PKITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~  297 (371)
                      ++|+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .........
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc
Confidence            999999998755432211  122345788999999998889999999999999999999 7899976442 333333333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ... ...+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332 23345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-42  Score=317.35  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=214.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|..++.++..||||+++++.+  .+....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCceEE
Confidence            4788999999999999999999999999999998642   2334466788888888887799999999977  4566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            999999999999999888889999999999999999999999 999999999999999999999999999987654432 


Q ss_pred             -------------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh
Q 017445          237 -------------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       237 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  297 (371)
                                         .......++..|+|||.+.+..++.++|+||||++++++++|..||..... .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~  236 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKILK  236 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHh
Confidence                               122344678999999999888899999999999999999999999976542 222333332


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCccc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA----DQLLSHPFI  339 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~il~hp~~  339 (371)
                      .  ....+..+++.+.+|+++||+.+|++||++    .++++||||
T Consensus       237 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 L--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             c--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            2  223345678999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.2e-43  Score=327.03  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=211.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---Ce
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---GQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---~~  155 (371)
                      .+|.+.+.||+|+||+||+|.+..+++.||||.+...  .........+|+.++..+. ||||+++++++.....   ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccccccCc
Confidence            4789999999999999999999999999999998642  2333456778999888876 9999999998754322   35


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            899999996 6999999888889999999999999999999999 99999999999999999999999999999766544


Q ss_pred             ccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH---hhC-------------
Q 017445          236 IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LED-------------  298 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~~-------------  298 (371)
                      ........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.. .....+   ...             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcCchh
Confidence            333345568999999998864 46889999999999999999999999754321 111100   000             


Q ss_pred             -------CC--C----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          299 -------PS--P----SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       299 -------~~--~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                             ..  .    ......+++++.+++++||+.+|++|||+.++++||||..+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                   00  0    01124578999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-42  Score=318.74  Aligned_cols=258  Identities=24%  Similarity=0.417  Sum_probs=207.3

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++.+.||+|++|+||+|.+..+|+.||+|.+....  ......+.+|+..+.++. ||||+++++++.  +....|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVH--SEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEe--cCCeEEE
Confidence            47899999999999999999999999999999986532  223456778999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEecccccccCccc
Q 017445          159 ALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENS  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~~~  235 (371)
                      ||||++ ++|.+++.....  +++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||.+......
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            999996 588888765433  5788899999999999999999 99999999999999985 467999999999765443


Q ss_pred             ccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCC---------
Q 017445          236 IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPS---------  302 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~---------  302 (371)
                      ........+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||..... .....+...   .+...         
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccccccch
Confidence            333344567899999999866 4578999999999999999999999976443 233332221   11000         


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          303 ---------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       303 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                     .....+++++.+++.+||+.+|++||++.+++.||||..+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                           011356889999999999999999999999999999987653

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-42  Score=316.73  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=208.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +..++|.+.+.||+|+||+||++..     ..++..+|+|.+..........+.+|+.++.++. ||||+++++++.  .
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--E   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--c
Confidence            3456889999999999999999975     2355679999987666666777899999999886 999999999774  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          153 SGQISIALEYMDGGSLADILRMQK-------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                      ...+++||||+++++|.+++...+             .+++..+..++.|++.||+|||+ +|++||||||+||+++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            568999999999999999997543             38999999999999999999999 9999999999999999999


Q ss_pred             ceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHh
Q 017445          220 RPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQIL  296 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~  296 (371)
                      .++|+|||.+........  ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.... .......+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH
Confidence            999999999876543221  1223345778999999998889999999999999999998 999996543 333444444


Q ss_pred             hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      .+.. ......++.++.+|+.+||+.||.+|||+.+++
T Consensus       237 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         237 QGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             cCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            4332 233456889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-42  Score=309.61  Aligned_cols=252  Identities=34%  Similarity=0.623  Sum_probs=217.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||.|+||.||++.+..++..||+|++...  .......+.+|+..+..+. |||++++.+.+..  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~--~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEE--KGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEec--CCEEEEE
Confidence            578889999999999999999989999999999753  2356667888999998887 9999999998754  4689999


Q ss_pred             EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +||+++++|.+++...    ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            9999999999999763    679999999999999999999999 99999999999999999999999999999876555


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ........+++.|+|||.+.+..++.++|+||+|+++++|++|..||.... ........... .....+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKG-QYPPIPSQYSSELRNL  234 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcC-CCCCCCCCCCHHHHHH
Confidence            434445678999999999988889999999999999999999999997654 23333333333 2333445788999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +++||..+|++||++.++|.||||
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=308.94  Aligned_cols=252  Identities=35%  Similarity=0.590  Sum_probs=217.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.....  .....+.+|+..+.++. |||++++++++.  +....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIE--TSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEE--eCCEEEEE
Confidence            47888999999999999999999999999999976433  45567889999998886 999999999774  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+..........
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            9999999999999887889999999999999999999999 999999999999999999999999999998776554433


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ....++..|+|||...+..++.++||||+|+++|+|++|..||..... .....+.... .....+..++..+.+++.+|
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIVQD-DHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHhcc-CCCCCCCCCCHHHHHHHHHH
Confidence            456789999999999888889999999999999999999999975442 2223333222 22334567889999999999


Q ss_pred             cccCcCCCCCHHHHhcCccc
Q 017445          320 LKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~  339 (371)
                      |..+|++||++.++++||||
T Consensus       235 l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         235 FQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-42  Score=317.05  Aligned_cols=252  Identities=26%  Similarity=0.462  Sum_probs=205.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.++.... .....+.+|+..+.++. ||||+++++.+.  +.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIH--TENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEe--eCCcEEEEE
Confidence            57889999999999999999999999999999876332 23456678999888885 999999999875  456899999


Q ss_pred             eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          161 EYMDGGSLADILRMQ---KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       161 E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+........
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            99985 899888643   358999999999999999999999 9999999999999999999999999999876544333


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CC-------------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PS-------------  300 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~-------------  300 (371)
                      ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||....... ....+...   +.             
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCchh
Confidence            3344567899999999865 457889999999999999999999997654322 22221110   00             


Q ss_pred             ----CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          301 ----PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       301 ----~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                          +.       .....++..+.+++.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                00       0012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-42  Score=321.14  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=205.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcE--EEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRI--IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++.+.||+|+||.||+|.+..++..  +|+|.++. ........+.+|+.++.++.+||||+++++++  ...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CCCC
Confidence            3456889999999999999999998777754  57777654 23445567888999999997799999999977  4566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          155 QISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      .+|+||||+++++|.+++...+                .+++..+..++.|++.||+|||+ +|++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence            8999999999999999997543                47899999999999999999999 999999999999999999


Q ss_pred             CceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhh
Q 017445          219 GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~  297 (371)
                      +.+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .... ....
T Consensus       161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~-~~~~  237 (303)
T cd05088         161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELY-EKLP  237 (303)
T ss_pred             CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHH-HHHh
Confidence            99999999998643221 11122234667999999988889999999999999999998 9999975442 2222 2233


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      .......+..+++++.+|+.+||+.+|++||++++++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            3323333456789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-42  Score=326.62  Aligned_cols=258  Identities=23%  Similarity=0.394  Sum_probs=208.8

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      |.+..++|++.+.||+|+||+||+|.+     ..+++.||||+++.. .......+.+|+.++.++.+||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            556678999999999999999999984     356789999999753 23345668899999999988999999999775


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ------------------------------------------------------  175 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~------------------------------------------------------  175 (371)
                      . ....++++|||+++|+|.+++...                                                      
T Consensus        82 ~-~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          82 K-PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             c-CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            3 345789999999999999998642                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--ccc
Q 017445          176 -------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCA  240 (371)
Q Consensus       176 -------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~  240 (371)
                                   ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........  ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                         236778889999999999999999 9999999999999999999999999999876533211  112


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||............ +........+..+++++.+++.+|
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~c  318 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-HhccCCCCCCCCCCHHHHHHHHHH
Confidence            2345678999999988889999999999999999996 99999765433333333 323223333455788999999999


Q ss_pred             cccCcCCCCCHHHHhcC
Q 017445          320 LKKDAEARPTADQLLSH  336 (371)
Q Consensus       320 l~~dp~~Rps~~~il~h  336 (371)
                      |+.||++|||+.++++|
T Consensus       319 l~~~p~~Rps~~eil~~  335 (343)
T cd05103         319 WHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-43  Score=327.74  Aligned_cols=262  Identities=29%  Similarity=0.450  Sum_probs=215.9

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC---CCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD---SGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~---~~~~  156 (371)
                      +|++.+.||+|++|.||+|.+..+++.||+|++....  ....+.+.+|+..+..+. ||||+++.+++...+   ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccce
Confidence            5788899999999999999999999999999987533  445567888999998886 999999999875432   2368


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |++|||+. ++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||.+.......
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            99999997 4899999877789999999999999999999999 999999999999999999999999999998765543


Q ss_pred             ---cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC---CC--------
Q 017445          237 ---AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP---SP--------  301 (371)
Q Consensus       237 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~--------  301 (371)
                         .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ......+....   ..        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhhccc
Confidence               123445689999999999877 789999999999999999999999976542 22222221110   00        


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          302 ------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       302 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                                        ......++.++.+++++||+.+|++||++.+++.||||.++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence                              0011346789999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.3e-42  Score=319.09  Aligned_cols=254  Identities=30%  Similarity=0.542  Sum_probs=210.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..|.+.+.||+|+||+||+|.+..+++.||+|.+...   .......+.+|+.++..+. ||||+++.+++..  ....|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~--~~~~~   91 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLR--EHTAW   91 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEe--CCeEE
Confidence            4578888999999999999999999999999998642   2344466888999988886 9999999998853  55799


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||+. |+|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++...... 
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9999997 477777653 4579999999999999999999999 99999999999999999999999999998655432 


Q ss_pred             cccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          237 AMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                         ....+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+ .......+.....+......++..+.
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCHHHH
Confidence               3456889999999884   4568899999999999999999999997543 23333333333333333456788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +++.+||..+|++||++.+++.||||..-..
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence            9999999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-42  Score=311.32  Aligned_cols=252  Identities=30%  Similarity=0.533  Sum_probs=211.4

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+...  .......+.+|+.++..+. |+||+++++.+  .+....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~--~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASF--QENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhhee--ccCCeEEEE
Confidence            478899999999999999999999999999998652  1234456778999988886 99999999977  456689999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~~~  236 (371)
                      +||+++++|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999999986543  47999999999999999999999 9999999999999999886 46999999987765543


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||.... ............. ......++.++.+++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~i  234 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQGYF-APISPNFSRDLRSLI  234 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcccC-CCCCCCCCHHHHHHH
Confidence            33344568999999999988889999999999999999999999997543 2333334433332 233456789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .+||..+|++|||+.++++||||
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=317.35  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=204.9

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      |++.+.||.|++|+||+|.+..+|..||+|++....  ......+.+|+..+..+. |||++++++++.  +....|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~--~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVH--SENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheec--cCCeEEEEE
Confidence            567789999999999999999999999999986532  223356778999998887 999999999874  457899999


Q ss_pred             eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          161 EYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||++ ++|.+++....  .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||.+.........
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            9995 69999987665  68999999999999999999999 99999999999999999999999999998765443333


Q ss_pred             cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-------------------
Q 017445          239 CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-------------------  298 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------------------  298 (371)
                      .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.. ....++...                   
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            3344578999999988654 5788999999999999999999999765422 222221110                   


Q ss_pred             --------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          299 --------PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       299 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                              .........++..+.+++.+||+.+|.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                    00011124577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-42  Score=319.54  Aligned_cols=258  Identities=23%  Similarity=0.392  Sum_probs=210.4

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcC-------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIP-------THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      ..+.+..++|.+.+.||+|+||.||+|.+..       +...+|+|.++.. .......+..|+..+..+.+||||++++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            3567778899999999999999999998643       2357999999753 2344566888999999887799999999


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCC
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK  209 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlk  209 (371)
                      +.+.  ..+..|+||||+++|+|.+++...+                .+++..+..++.|++.||+|||+ +|++|||||
T Consensus        91 ~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlk  167 (307)
T cd05098          91 GACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLA  167 (307)
T ss_pred             EEEe--cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCccccccc
Confidence            9874  4568999999999999999997532                47889999999999999999999 999999999


Q ss_pred             CCcEEEccCCceEEecccccccCccccccc--ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCC
Q 017445          210 PANLLVNLKGRPKITDFGISAGLENSIAMC--ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASE  286 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~  286 (371)
                      |+||+++.++.++|+|||.+..........  ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            999999999999999999987654322111  12234568999999988889999999999999999998 889986533


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                        ...+...+........+..++.++.+|+.+||..+|++||++.+++++
T Consensus       248 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         248 --VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             --HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence              233333444444444456788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.6e-42  Score=314.09  Aligned_cols=252  Identities=23%  Similarity=0.403  Sum_probs=206.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..++|.+.+.||+|++|.||+|.+..     ++..||+|.+... .......+.+|+.++..+. |+||+++++++.  +
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~   80 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSF--E   80 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--c
Confidence            45678999999999999999999877     7789999998653 3344566888999998886 999999999774  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---ceE
Q 017445          153 SGQISIALEYMDGGSLADILRMQK-------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---RPK  222 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~~k  222 (371)
                      ....++||||+++++|.+++...+       .+++..+..++.|++.||.|||+ ++++||||||+||+++.++   .+|
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceE
Confidence            557899999999999999997653       48899999999999999999999 9999999999999998765   599


Q ss_pred             EecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCC
Q 017445          223 ITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDP  299 (371)
Q Consensus       223 l~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  299 (371)
                      |+|||++.........  ......+..|+|||++.+..++.++|||||||++|+|++ |..||...... .. ...+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~-~~~~~~~  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EV-MEFVTGG  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HH-HHHHHcC
Confidence            9999999866332111  112234568999999988889999999999999999997 99999764432 22 2333333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .....+..++..+.+++.+||+.+|++||++.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3334456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.6e-43  Score=315.58  Aligned_cols=246  Identities=25%  Similarity=0.505  Sum_probs=200.2

Q ss_pred             eEeeeecccCCeEEEEEEEc----CCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           84 RIFGAIGSGASSVVQRAVHI----PTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++.+.||.|+||.||+|...    ..+..|+||.++. ........+.+|+..+.++ +||||++++|++.  ..+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~--~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCI--ENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEE--SSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccc--ccccccc
Confidence            45679999999999999987    4568899999965 3444578899999999998 5999999999886  4456999


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc-
Q 017445          159 ALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS-  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~-  235 (371)
                      ||||+++|+|.+++...  ..+++..+..|+.|++.||.|||+ ++++|++|+++||+++.++.+||+|||++...... 
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            99999999999999876  679999999999999999999999 89999999999999999999999999999776221 


Q ss_pred             -ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          236 -IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       236 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                       ............|+|||.+.+..++.++||||||+++||+++ |+.||... .......++ ........+..++..+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQRLPIPDNCPKDIY  235 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEETTSBTTSBHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-cccccceeccchhHHHH
Confidence             122234457789999999988889999999999999999999 78999765 334444444 44344445567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017445          314 SFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++..||..||++|||+.++++
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.2e-42  Score=314.48  Aligned_cols=252  Identities=20%  Similarity=0.397  Sum_probs=206.1

Q ss_pred             cCcceeEeeeecccCCeEEEEEEE----cCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVH----IPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..++|++.+.||+|+||+||+|.+    ..++..+|+|.+.. ........+.+|+..+..+. ||||+++++.+.  ..
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~   79 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVT--QE   79 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe--cC
Confidence            346889999999999999999985    34568899999975 33444567888999998886 999999999774  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc
Q 017445          154 GQISIALEYMDGGSLADILRMQ-----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN  216 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~  216 (371)
                      ...|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||+ +|++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence            5799999999999999998532                 237888899999999999999999 9999999999999999


Q ss_pred             cCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 017445          217 LKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLML  293 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~  293 (371)
                      .++.+||+|||++.......  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ... +.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~-~~  236 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQE-VI  236 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHH-HH
Confidence            99999999999997653321  11233446778999999988889999999999999999998 999996543 222 33


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ..+........+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3333333344556789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-42  Score=313.73  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=210.6

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ...+|.+.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+..+..+. ||||+++++.+.  +....++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVCS--VGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC-CcchhheeeeEe--cCCCeEE
Confidence            44678899999999999999999877 8899999998765556677888999998886 999999999774  4568999


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          159 ALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999999753  468999999999999999999999 999999999999999999999999999997765443


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+. .......+..++..+.++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQIT-AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence            33334456778999999988889999999999999999998 899996543 233333333 333334456789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhc
Q 017445          316 VDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+||+.||++|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.3e-43  Score=326.98  Aligned_cols=276  Identities=24%  Similarity=0.396  Sum_probs=217.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+|++.+.||+|+||.||+|.+..+++.+|+|++..  ........+.+|+..+.++.+||||+++++++...+....|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            578888999999999999999998999999998853  233444567789999999956999999999886555667999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      ||||++ ++|..++... .+++..+..++.|++.||.|||+ +||+||||+|+||+++.++.+||+|||.+........ 
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            999997 4999998754 78999999999999999999999 9999999999999999999999999999876543321 


Q ss_pred             ----ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC--------------
Q 017445          238 ----MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--------------  298 (371)
Q Consensus       238 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------------  298 (371)
                          ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ....+...              
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHHh
Confidence                2234568999999998854 557889999999999999999999997543221 11111000              


Q ss_pred             ------------C---CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcChhh
Q 017445          299 ------------P---SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ  361 (371)
Q Consensus       299 ------------~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
                                  .   ........++.++.+++.+||+.||++|||+.++++||||+++.....+. .....+-+|.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~-~~~~~~~~~~~  319 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP-VLPYPITIPLD  319 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC-CCCCCccCCcc
Confidence                        0   00111234788999999999999999999999999999999886654443 22344445555

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.4e-42  Score=349.46  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=204.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...   ......++.+|+.++.++. ||||+++++++.  +.+..|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~--d~~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICS--DGDPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEe--eCCEEE
Confidence            5799999999999999999999999999999998642   2334567889999998887 999999999774  466899


Q ss_pred             EEEeccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          158 IALEYMDGGSLADILRMQ-----------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      +||||++||+|.+++...           ..++...+..++.|++.||+|||+ +||+||||||+||+++.++.++|+||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCCCEEEEec
Confidence            999999999999988631           235567788999999999999999 99999999999999999999999999


Q ss_pred             cccccCcccc------------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc
Q 017445          227 GISAGLENSI------------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP  288 (371)
Q Consensus       227 g~s~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~  288 (371)
                      |++.......                  ......+||+.|+|||++.+..++.++||||+||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                  0112356999999999999999999999999999999999999999764433


Q ss_pred             HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ..........+........+++.+.+++.+||..||++||+..+.+.+
T Consensus       238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222222222222222335788999999999999999999886665543

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-42  Score=313.55  Aligned_cols=251  Identities=30%  Similarity=0.538  Sum_probs=209.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|++|.||+|.+..+++.+|||.+...   .......+.+|+.++..+. ||||+++++.+.  +.+..+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~--~~~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFI--EDNELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeE--eCCeEE
Confidence            4678888999999999999999999999999988642   3334567888999988886 999999999875  356899


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          158 IALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999998863    3468999999999999999999999 999999999999999999999999999987665


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH-HHHhhCCCCCCCCCCCCHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM-LQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ..........++..|+|||++.+..++.++|+||||+++|+|++|..||.......... ..+.....+......++.++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            44333345678999999999988889999999999999999999999997544332222 22223333333445688999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+||..||++|||+.+|++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999997763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=284.79  Aligned_cols=256  Identities=25%  Similarity=0.455  Sum_probs=211.5

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|...++||+|.||+||+|++..+++.||+|.++..  ++......++|+.++..+. |.|||++++..  ..+..+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvl--hsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVL--HSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhh--ccCceeEEe
Confidence            455567899999999999999999999999999763  3334566789999998887 99999999976  456789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      +|||.. +|..+... ++.++.+.++.++.|+++||.|+|+ +++.|||+||.|.||+.+|.+||+|||+++.++-....
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            999965 89888754 5679999999999999999999999 99999999999999999999999999999988776555


Q ss_pred             cccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHH---hhCCCCCCCC--------
Q 017445          239 CATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI---LEDPSPSPSR--------  305 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~---~~~~~~~~~~--------  305 (371)
                      .+..+-|.+|++|.++.+.. |+.+.|+||.||++.|+.. |++.|++.+-. +.+..+   +..+.....+        
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCCCC
Confidence            56678899999999997754 8999999999999999997 77777765432 333333   3333222111        


Q ss_pred             ----------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          306 ----------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       306 ----------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                                      +.++..-+++++++|.-+|.+|.+++++++||||...+
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                            12345577999999999999999999999999998765

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.1e-42  Score=309.43  Aligned_cols=251  Identities=30%  Similarity=0.562  Sum_probs=209.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.++.   ........+.+|+.++.++. |++++++++.+.  +.+..+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~--~~~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFI--ENNELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeee--cCCeEE
Confidence            478899999999999999999998999999998864   22344667889999999886 999999999885  356899


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          158 IALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999998853    3458999999999999999999999 999999999999999999999999999987665


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH-HHHhhCCCCCCCCCCCCHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM-LQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......... ........+......++..+
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            44333345678999999999998889999999999999999999999996654332222 22222222222333688899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+||..+|++||++.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-42  Score=315.29  Aligned_cols=250  Identities=23%  Similarity=0.375  Sum_probs=206.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||+|.++..... ....+.+|+.++..+. ||||+++++.+.  ..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCT--EG   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEe--cC
Confidence            4578888999999999999998643     4688999998764333 5577889999998886 999999999875  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          154 GQISIALEYMDGGSLADILRMQK--------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                      ...++||||+++++|.+++...+              .+++..+..++.|++.||.|||+ +|++||||||+||+++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCCC
Confidence            68999999999999999997542              37889999999999999999999 9999999999999999999


Q ss_pred             ceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHh
Q 017445          220 RPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQIL  296 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~  296 (371)
                      .++|+|||.+.......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH
Confidence            99999999987543221  11223346788999999999999999999999999999998 9999976443 33333333


Q ss_pred             hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+ .....+..++..+.+++++||+.||++||++.++++
T Consensus       239 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33 333334578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.6e-42  Score=313.02  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=205.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCc----EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHR----IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..++|++++.||+|+||+||+|.+..+++    .||+|.+... .......+.+|+..+..+. ||||+++++.+.   .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~---~   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICL---T   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEc---C
Confidence            45689999999999999999999877766    4899998653 3344566788888887776 999999999774   2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...++++||+++|+|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            3578999999999999999763 568999999999999999999999 99999999999999999999999999998766


Q ss_pred             cccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          233 ENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       233 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ......  .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....  .......+........+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEKGERLPQPPICT  237 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCcCCCCccCC
Confidence            433221  122335678999999988889999999999999999998 999996533  222333444443334456789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .++.+++.+||..||++||++.+++.
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=310.32  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=206.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      .++|++.+.||+|+||+||+|.+..+   ...||+|.++.. .......+.+|+..+..+. ||||+++++.+.  +.+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVT--KSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEe--cCCc
Confidence            45788999999999999999987644   467999998753 3445567888999998886 999999999774  4567


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+++|||+++++|.+++... +.+++..+..++.|++.||.|||+ ++|+|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999999998754 468999999999999999999999 9999999999999999999999999999987652


Q ss_pred             cccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          235 SIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       235 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ....  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .... ..+......+.+..++..
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~  236 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVI-KAVEDGYRLPPPMDCPSA  236 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHHH-HHHHcCCCCCCCCCCCHH
Confidence            2111  122235678999999998889999999999999999998 9999965432 2233 333333333445678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.+++.+||+.+|++||++.+++++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=312.18  Aligned_cols=254  Identities=21%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      |++..++|.+.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+..+..+. ||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc
Confidence            345677999999999999999999987643     4789999986532 344556788999888876 999999999874


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ----------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                        .....++||||+++++|.+++...          ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++
T Consensus        80 --~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 --TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             --CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC
Confidence              456899999999999999998643          236788999999999999999999 9999999999999999999


Q ss_pred             ceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHh
Q 017445          220 RPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQIL  296 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~  296 (371)
                      .+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|++++ |..||.... .........
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~  235 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI  235 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh
Confidence            999999999876543321  1233456789999999988889999999999999999998 999997543 233333333


Q ss_pred             hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                       .......+..++.++.+++.+||+.+|++|||+.+++.
T Consensus       236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         236 -DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             33333445667999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.5e-42  Score=316.48  Aligned_cols=257  Identities=23%  Similarity=0.405  Sum_probs=210.8

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      .+.+..++|++.+.||+|+||.||++.+...     ...+|+|.+... .......+.+|+.++.++.+||||+++++.+
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4567778999999999999999999987643     378999998752 3344566888999998886799999999977


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCc
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN  212 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~N  212 (371)
                        ...+.++++|||+++|+|.+++...                +.+++..+..++.|++.||.|||+ +||+||||||+|
T Consensus        86 --~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~N  162 (293)
T cd05053          86 --TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARN  162 (293)
T ss_pred             --cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceee
Confidence              4566899999999999999998642                358899999999999999999999 999999999999


Q ss_pred             EEEccCCceEEecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcH
Q 017445          213 LLVNLKGRPKITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPV  289 (371)
Q Consensus       213 Il~~~~~~~kl~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~  289 (371)
                      |+++.++.+||+|||.+.........  .....++..|+|||.+.+..++.++|||||||++|++++ |..||..... .
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-E  241 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-H
Confidence            99999999999999999866543211  122235678999999988889999999999999999997 9999975432 2


Q ss_pred             HHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          290 NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                       ...+.+........+..++.++.+|+.+||..||++|||+.+++++
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         242 -ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence             2333333433334456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-42  Score=312.84  Aligned_cols=253  Identities=23%  Similarity=0.420  Sum_probs=206.4

Q ss_pred             cceeEeeeecccCCeEEEEEE----EcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAV----HIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+|++.+.||+|+||.||+|.    +..+++.||+|++..........+.+|+.++..+. ||||+++++++...+...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCCce
Confidence            478899999999999999997    34578899999997766666677889999999886 9999999998766666679


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          157 SIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999999999999754 468999999999999999999999 99999999999999999999999999999866433


Q ss_pred             ccc---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--------------HHHHHHhhC
Q 017445          236 IAM---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV--------------NLMLQILED  298 (371)
Q Consensus       236 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--------------~~~~~~~~~  298 (371)
                      ...   .....++..|+|||++.+..++.++||||||+++|||++|..|+.......              ..+...+..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            211   111223456999999988889999999999999999999877764322110              011122333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ....+....++.++.+|+.+||..+|++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3333445678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.9e-42  Score=314.46  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +...+|.+.+.||+|+||.||+|.+.     .++..+++|.+..........+.+|+..+.++. ||||+++++.+  .+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVKFYGVC--GD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-CCCcceEEEEE--cc
Confidence            34568899999999999999999853     345679999987655566677889999998886 99999999977  45


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN  216 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~  216 (371)
                      ....++||||+++++|.+++....                .+++..++.++.|++.||.|||+ +|++||||||+||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~  157 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVG  157 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc
Confidence            668999999999999999996532                37899999999999999999999 9999999999999999


Q ss_pred             cCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 017445          217 LKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLML  293 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~  293 (371)
                      .++.++|+|||++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+.
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~  236 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIE  236 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH
Confidence            99999999999987654322  11233456889999999999899999999999999999998 9999965432 23333


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+ ...........++..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            33 333333334567899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=322.99  Aligned_cols=261  Identities=28%  Similarity=0.466  Sum_probs=207.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec---CCCeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP---DSGQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~---~~~~~  156 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.++.++. ||||+++++.+...   ....+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccceE
Confidence            5899999999999999999999999999999998653 2334456778999998887 99999999976432   22468


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+|+||+.+ +|.+++. ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            999999975 8888875 4679999999999999999999999 999999999999999999999999999987654322


Q ss_pred             c---ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCC----------
Q 017445          237 A---MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPS----------  300 (371)
Q Consensus       237 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~----------  300 (371)
                      .   ......|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.........  +...+..+.          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1   1133568999999998754 56889999999999999999999999654311100  000000000          


Q ss_pred             ---------CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          301 ---------PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       301 ---------~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                               +.       ......++++.+++.+||+.+|++|||+.+++.||||..+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                     00       0013467889999999999999999999999999999988644

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-42  Score=325.06  Aligned_cols=263  Identities=29%  Similarity=0.489  Sum_probs=212.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CCCeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~~~~  156 (371)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++...  .......+.+|+.++.++. ||||+++++.+...  ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCceE
Confidence            6889999999999999999999999999999998653  2234456778999998887 99999999977432  33578


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+. ++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+.......
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            99999996 5999999877889999999999999999999999 999999999999999999999999999987654322


Q ss_pred             c----ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH--HHHhhCC----------
Q 017445          237 A----MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM--LQILEDP----------  299 (371)
Q Consensus       237 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~----------  299 (371)
                      .    ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+......  ......+          
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            1    1134578999999999865 458899999999999999999999997643221110  0000000          


Q ss_pred             ---------CC--CC-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          300 ---------SP--SP-----SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       300 ---------~~--~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                               .+  ..     .....+.++.++|++||+.+|++||++.+++.||||.++..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                     00  00     0134688999999999999999999999999999998876554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.8e-42  Score=309.26  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=206.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+..++|+++++||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.++..+. |+||+++++.+  .+....
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~   76 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQ-HDKLVRLYAVV--TKEEPI   76 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCC-CCCeeeEEEEE--cCCCCc
Confidence            456789999999999999999999854 55679999886533 33567888999998886 99999999977  455679


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      +++|||+++++|.+++..  ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999999999999865  3468899999999999999999999 9999999999999999999999999999977654


Q ss_pred             cccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      .... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.... .......+. .....+....++.++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~  233 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-NSDVMSALQ-RGYRMPRMENCPDEL  233 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCCHHH
Confidence            3221 123345678999999988889999999999999999998 999997643 233333333 333334445789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+||..+|++||+++++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999854

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=333.15  Aligned_cols=266  Identities=21%  Similarity=0.380  Sum_probs=236.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      +...++++++..||-|+||.|-++........+|+|.+++   .+....+-+..|-+++.... .|.||++|..|  .+.
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTf--rd~  492 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTF--RDS  492 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHh--ccc
Confidence            3445788889999999999999998766666689888865   33344555788999998887 99999999977  678


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      .++|++||-|-||.|...|...+.|++.+++.++..+++|++|||+ +|||+|||||+|.+++.+|.+||.|||+|+.+.
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            8999999999999999999999999999999999999999999999 999999999999999999999999999999988


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      ... ..-++||||.|.|||++.+...+.++|.||||+++|||++|.+||.+. +++.....++.+--....+..++..+.
T Consensus       572 ~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-dpmktYn~ILkGid~i~~Pr~I~k~a~  649 (732)
T KOG0614|consen  572 SGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-DPMKTYNLILKGIDKIEFPRRITKTAT  649 (732)
T ss_pred             cCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-chHHHHHHHHhhhhhhhcccccchhHH
Confidence            764 447899999999999999999999999999999999999999999874 467677777777766677788999999


Q ss_pred             HHHHHhcccCcCCCCC-----HHHHhcCcccccccccccc
Q 017445          314 SFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~~  348 (371)
                      +||++++..+|.+|..     +.+|-+|.||..+.+.-.-
T Consensus       650 ~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  650 DLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             HHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence            9999999999999987     8999999999999887653

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.6e-42  Score=307.35  Aligned_cols=242  Identities=25%  Similarity=0.400  Sum_probs=198.7

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      .||+|+||.||+|.+..+++.||+|.+... .......+.+|+.++..+. ||||+++++++.  .....++||||++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCT--QKQPIYIVMELVQGG   78 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc--CCCCeEEEEeeccCC
Confidence            699999999999999999999999987642 3445567889999988885 999999999774  456899999999999


Q ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc--cccc
Q 017445          167 SLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC--ATFV  243 (371)
Q Consensus       167 ~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~--~~~~  243 (371)
                      +|.+++...+ .+++..++.++.|++.||.|||+ +|++||||+|+||+++.++.+||+|||.+..........  ....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999997543 58999999999999999999999 999999999999999999999999999987554321111  1112


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhccc
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK  322 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  322 (371)
                      .+..|+|||.+.+..++.++||||||+++|+|++ |..||..... .. ....+........+..++..+.+|+.+||+.
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQ-TREAIEQGVRLPCPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HH-HHHHHHcCCCCCCcccCCHHHHHHHHHHcCC
Confidence            3456999999988889999999999999999997 8899965432 22 2223333333344567889999999999999


Q ss_pred             CcCCCCCHHHHhc
Q 017445          323 DAEARPTADQLLS  335 (371)
Q Consensus       323 dp~~Rps~~~il~  335 (371)
                      +|++|||+.++++
T Consensus       236 ~p~~Rps~~~~~~  248 (252)
T cd05084         236 DPGQRPSFSTVHQ  248 (252)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999964

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.8e-42  Score=308.09  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=203.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|+..+.++. ||||+++++++  .+....++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLS-HPKLVQLYGVC--TQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCC-CCCceeEEEEE--ccCCCEEEE
Confidence            357889999999999999999865 45679999886432 23456788999998886 99999999977  445689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++|+|.+++.. .+.+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||.+.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999999999999874 3468999999999999999999999 99999999999999999999999999998765432221


Q ss_pred             -cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          239 -CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       239 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... ......+..+.. ...+...+..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~~-~~~~~~~~~~~~~li  234 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGFR-LYRPKLASMTVYEVM  234 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCC-CCCCCCCCHHHHHHH
Confidence             122235568999999988889999999999999999999 9999976443 333444433332 233455788999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 017445          317 DDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~  335 (371)
                      .+||+.+|++||++.++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.5e-42  Score=315.19  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=203.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCc--EEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++. ........+.+|+.++.++.+||||+++++.+  .+.+.++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE--ccCCcce
Confidence            578899999999999999999877764  468888864 23444567888999999997799999999976  4566899


Q ss_pred             EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCce
Q 017445          158 IALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP  221 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~  221 (371)
                      ++|||+++++|.+++....                .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCCeE
Confidence            9999999999999996532                47889999999999999999999 999999999999999999999


Q ss_pred             EEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCC
Q 017445          222 KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPS  300 (371)
Q Consensus       222 kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  300 (371)
                      ||+|||++....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||.... .......+.. ..
T Consensus       159 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-~~~~~~~~~~-~~  235 (297)
T cd05089         159 KIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLPQ-GY  235 (297)
T ss_pred             EECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhc-CC
Confidence            999999986432211 1112223557999999988889999999999999999997 999997643 2333333333 22


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       301 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ....+..++..+.+|+.+||..+|.+||+++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333445689999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=319.44  Aligned_cols=255  Identities=27%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcC--CCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIP--THRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .|++.+.||+|++|.||+|.+..  +++.||+|.+....   ........+|+.++..+. ||||+++++.+...+...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            47888999999999999999988  89999999987622   333456778898888886 9999999999876555789


Q ss_pred             EEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc----CCceEEeccc
Q 017445          157 SIALEYMDGGSLADILRMQ-----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL----KGRPKITDFG  227 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~----~~~~kl~Dfg  227 (371)
                      ++||||+++ +|.+++...     ..+++..++.++.|++.||.|||+ .+++||||||+||+++.    ++.+||+|||
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999999975 777766422     268999999999999999999999 99999999999999999    8999999999


Q ss_pred             ccccCccccc---ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--------HHHHHH
Q 017445          228 ISAGLENSIA---MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPV--------NLMLQI  295 (371)
Q Consensus       228 ~s~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--------~~~~~~  295 (371)
                      ++........   ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......        ..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9886644322   2234567899999998866 457899999999999999999999997544321        001110


Q ss_pred             hh------------------------CCCCCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          296 LE------------------------DPSPSPSR-----------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       296 ~~------------------------~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.                        ........           ...+.++.+++.+||+.||++|||+.+++.||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                        00000000           1466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-41  Score=307.64  Aligned_cols=241  Identities=23%  Similarity=0.397  Sum_probs=199.2

Q ss_pred             eecccCCeEEEEEEE--cCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           88 AIGSGASSVVQRAVH--IPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .||+|+||.||+|.+  ..++..+|+|+++..  .......+..|+.++..+. ||||+++++.+.   ....++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE---AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc---CCCcEEEEecC
Confidence            699999999999964  567889999998643  2344567888999888886 999999999762   34679999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc---cc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM---CA  240 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~---~~  240 (371)
                      ++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||.||+++.++.+||+|||.+.........   ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999999877889999999999999999999999 99999999999999999999999999999766443221   12


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ...+++.|+|||.+.+..++.++|+||||+++|||++ |..||..... ... .+.+........+..+++++.++|.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~  234 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEV-TQMIESGERMECPQRCPPEMYDLMKLC  234 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH-HHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            2234578999999988889999999999999999998 9999976432 233 333333333344567899999999999


Q ss_pred             cccCcCCCCCHHHHhc
Q 017445          320 LKKDAEARPTADQLLS  335 (371)
Q Consensus       320 l~~dp~~Rps~~~il~  335 (371)
                      |+.||++||++++|..
T Consensus       235 ~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         235 WTYGVDERPGFAVVEL  250 (257)
T ss_pred             hccCchhCcCHHHHHH
Confidence            9999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=314.54  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=211.0

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      .+.+..++|++.+.||+|+||.||+|.+     ..++..||+|.++.. .......+.+|+.++.++.+||||+++++.+
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            4556678999999999999999999975     334568999998753 2344566889999999986799999999977


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      .  ..+..++||||+++|+|.+++....  .+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.++|+||
T Consensus       109 ~--~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         109 T--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             e--cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCC
Confidence            4  4567999999999999999997543  38999999999999999999999 99999999999999999999999999


Q ss_pred             cccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCC
Q 017445          227 GISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSP  303 (371)
Q Consensus       227 g~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      |.+........  ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..............
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~  264 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGYRMA  264 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHHcCCcCC
Confidence            99876543321  1123346788999999998889999999999999999998 99999764432 33334444433334


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+...++++.+++.+||..+|++|||+.+++.
T Consensus       265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            44567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-42  Score=321.41  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=206.3

Q ss_pred             cee-EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHH--------------HHHHHHHHHHHHhCCCCCCeeEece
Q 017445           82 EMR-IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--------------RNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        82 ~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      +|. +.+.||+|+||+||+|.+..+++.||+|++.......              ...+.+|+.++..+. ||||+++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~   87 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLVD   87 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-CcceeeeeE
Confidence            444 4467999999999999999999999999986432211              124678999998886 999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      .+.  .....++||||+. ++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+||
T Consensus        88 ~~~--~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         88 VYV--EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EEe--cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCCEEECCc
Confidence            874  4568999999997 5999999877889999999999999999999999 99999999999999999999999999


Q ss_pred             cccccCcc--------------cccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH
Q 017445          227 GISAGLEN--------------SIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNL  291 (371)
Q Consensus       227 g~s~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~  291 (371)
                      |.+.....              .........+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.. ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~  242 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-DQ  242 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            99876541              11112234578899999998764 4689999999999999999999999765432 22


Q ss_pred             HHHHh---hCCCCC-----------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          292 MLQIL---EDPSPS-----------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       292 ~~~~~---~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +..+.   ..+...                       ......+.++.+++.+||+.+|++||++++++.||||..+...
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            22221   111110                       0012457889999999999999999999999999999877543

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8e-42  Score=326.52  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=211.1

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+.+..++|.+.+.||+|+||.||+|.+.     .+++.||+|+++.. .......+.+|+.++.++..||||++++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            457888889999999999999999999853     34578999999753 233345688999999988779999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcC---------------------------------------------------
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQK---------------------------------------------------  176 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------  176 (371)
                      +.  ..+.+++||||+++|+|.++++..+                                                   
T Consensus       110 ~~--~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         110 CT--KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             Ec--cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            74  4568999999999999999996432                                                   


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCC
Q 017445          177 -----------------------------------------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK  209 (371)
Q Consensus       177 -----------------------------------------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlk  209 (371)
                                                                     .+++..+..++.|++.||.|||+ ++++|||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlk  266 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLA  266 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCC
Confidence                                                           25667788899999999999999 999999999


Q ss_pred             CCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCC
Q 017445          210 PANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASE  286 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~  286 (371)
                      |+|||++.++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999876432211  1223457889999999998889999999999999999998 899997544


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .. ......+........+..++.++.+|+.+||..+|.+||++++|++.
T Consensus       347 ~~-~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MN-EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             ch-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            32 23333333333333455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-41  Score=310.68  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCc----EEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHR----IIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ...+|++++.||+|+||+||+|.+..+++    .+++|.+.... ......+..|+..+.++. ||||+++++++.   .
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~---~   80 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP---G   80 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC---C
Confidence            34688999999999999999999887776    46777765322 233455667777777665 999999999763   3


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...++++||+++|+|.+++.. .+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            457899999999999999975 4568999999999999999999999 99999999999999999999999999999765


Q ss_pred             ccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          233 ENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       233 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .....  ......++..|+|||.+.+..++.++||||||+++||+++ |..||....  .....+++........+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVPDLLEKGERLAQPQICT  237 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCcCCCCCCCC
Confidence            43221  1233456778999999988889999999999999999998 999997543  223344444444444445678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..+.+++.+||..||++|||+.++++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            89999999999999999999999864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-41  Score=313.79  Aligned_cols=255  Identities=29%  Similarity=0.541  Sum_probs=210.2

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      |...+.||+|+||+||+|.+..+++.||+|++...   .......+.+|+..+..+. |||++++++++.  +....|+|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv   99 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYL--KEHTAWLV   99 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEE--eCCEEEEE
Confidence            44556899999999999999999999999998642   2334456788999998886 999999999875  35689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+. ++|.+++.. ..++++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.....    
T Consensus       100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            99996 488887754 4568999999999999999999999 9999999999999999999999999998864332    


Q ss_pred             cccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          239 CATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      .....|+..|+|||++.   +..++.++||||||+++|+|++|..||.... .......+.....+......++..+.+|
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLQSNEWTDSFRGF  252 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            23557899999999984   4568889999999999999999999997643 2333444444444444445678899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      +.+||+.+|.+||++.+++.||||......++
T Consensus       253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         253 VDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             HHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            99999999999999999999999997654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-41  Score=311.66  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +..++++..++||+|+||.||+|..     ..++..+|+|.+..........+.+|+..+..+. |+||+++++.+.  +
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVRFYGVCT--E   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC-CCCCceEEEEEe--c
Confidence            3456888999999999999999964     2356789999987766666778899999998885 999999999774  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK---------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL  217 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~  217 (371)
                      ....+++|||+++++|.+++...+               .+++..+..++.|++.||.|||+ +|++||||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~  157 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ  157 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC
Confidence            567999999999999999987543               47899999999999999999999 99999999999999999


Q ss_pred             CCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHH
Q 017445          218 KGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQ  294 (371)
Q Consensus       218 ~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~  294 (371)
                      ++.++|+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... ......
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~  236 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIEC  236 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHHH
Confidence            99999999999865433211  1123345788999999998889999999999999999998 9999965432 333333


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .... .....+..+++.+.+++.+||+.||.+||++.++++
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3333 223344578999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-41  Score=306.56  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+.. +..+|+|.+.... .....+.+|+..+.++. ||||+++++++.  +....+++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLS-HEKLVQLYGVCT--KQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCC-CCCeeeEEEEEc--cCCCcEEE
Confidence            4688999999999999999998654 4469999887432 23456888999998886 999999999774  45578999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+.+++|.+++... ..+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||.+.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            9999999999999754 468999999999999999999999 99999999999999999999999999998765433211


Q ss_pred             -cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          239 -CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       239 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+.... ........+..+.+++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~li  234 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGL-RLYRPHLASEKVYAIM  234 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHhcCC-CCCCCCCCCHHHHHHH
Confidence             112235678999999988889999999999999999998 9999965442 23333443332 2233456789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017445          317 DDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+||..+|.+||++.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-41  Score=314.96  Aligned_cols=256  Identities=23%  Similarity=0.395  Sum_probs=207.4

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcC-------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIP-------THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .+.+...+|.+.+.||+|+||.||+|.+..       ....+|+|.++.. .......+..|+.++.++..||||+++++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            456667899999999999999999997632       3457999998753 33445668889999988877999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      ++.  +.+.++++|||+++|+|.+++...                ..+++..+..++.|++.||.|||+ +|++||||||
T Consensus        86 ~~~--~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp  162 (314)
T cd05099          86 VCT--QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAA  162 (314)
T ss_pred             EEc--cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence            774  456899999999999999999653                247889999999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCccccccc--ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIAMC--ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG  287 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~  287 (371)
                      +||+++.++.+||+|||.+..........  ....++..|+|||++.+..++.++||||||+++|+|++ |..||.... 
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-  241 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-  241 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-
Confidence            99999999999999999997664322111  12234467999999988889999999999999999999 899996543 


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .... ...+........+..++.++.+++.+||..+|++||++.++++
T Consensus       242 ~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         242 VEEL-FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2233 3333333333345678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-41  Score=307.53  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=206.2

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      |++..++|+++++||+|+||.||+|.. .+++.||+|.+.... .....+.+|+..+.++. |+||+++++.+.   ...
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~   74 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQ-HPRLVRLYAVVT---QEP   74 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC-CcHHHHHHHHHHHHhcC-CcCeeeEEEEEc---cCC
Confidence            356678999999999999999999985 456789999987533 23456888999988886 999999998752   346


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      .+++|||+++++|.+++...  ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            89999999999999998653  358999999999999999999999 999999999999999999999999999987665


Q ss_pred             cccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          234 NSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       234 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      .... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||..... ...... +........+..++.+
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~  231 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQN-LERGYRMPRPDNCPEE  231 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHH-HHcCCCCCCCCCCCHH
Confidence            3221 1223345678999999988889999999999999999998 9999976543 222222 3333333445678899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+++.+||..+|++||+++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         232 LYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-41  Score=312.36  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=211.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +|++.+.||+|+||.||+|.+.   .+|+.||+|.++...    ......+.+|+.++..+.+|+||+++++.+  ..+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe--ecCC
Confidence            4788899999999999999874   478999999986522    123455678999999998899999999877  4456


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..|+||||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            899999999999999999888889999999999999999999999 9999999999999999999999999999876543


Q ss_pred             ccc-ccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhCCCCCCCCCCCC
Q 017445          235 SIA-MCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       235 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ... ......|+..|+|||.+.+  ..++.++||||+|+++|+|++|..||......  ...+...+.... .+.+..++
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMS  236 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-CCCCccCC
Confidence            221 1234568999999999865  34678999999999999999999999643221  111222222211 12345688


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHhcCcccccccc
Q 017445          310 PEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEH  344 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~  344 (371)
                      +.+.+++++||+.||++||     ++.+++.||||++..+
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            9999999999999999997     8999999999998875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=326.87  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=220.1

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCC----cEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEe
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTH----RIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEF  144 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l  144 (371)
                      ....|.+.-++..+.++||+|+||+||+|..+..+    ..||+|..+.   ........+++|+++++++. |||||++
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~  226 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRF  226 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEE
Confidence            44568888888899999999999999999875542    2389999874   45777888999999999976 9999999


Q ss_pred             ceeEEecCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEE
Q 017445          145 HGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI  223 (371)
Q Consensus       145 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl  223 (371)
                      +|+..  ....++||||+|.||+|.++|.+.+ .++..+...++.+.+.||+|||+ +++|||||..+|+|++.++.+||
T Consensus       227 yGVa~--~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  227 YGVAV--LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EEEEc--CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEe
Confidence            99775  4558999999999999999998876 49999999999999999999999 99999999999999999999999


Q ss_pred             ecccccccCcccccccc-cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCC
Q 017445          224 TDFGISAGLENSIAMCA-TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP  301 (371)
Q Consensus       224 ~Dfg~s~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  301 (371)
                      +|||++..... ..... ...-...|+|||.+....|++++||||||+++||+++ |..||.+... .....++.....+
T Consensus       304 SDFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  304 SDFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-YEVKAKIVKNGYR  381 (474)
T ss_pred             CccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-HHHHHHHHhcCcc
Confidence            99999876542 22222 2235578999999999999999999999999999998 8899987553 3444555577777


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      .+.+...|.++..++..||..+|++||++.++.
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence            777788999999999999999999999999885

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=306.16  Aligned_cols=244  Identities=26%  Similarity=0.416  Sum_probs=206.9

Q ss_pred             eeecccCCeEEEEEEEcCC---CcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           87 GAIGSGASSVVQRAVHIPT---HRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      +.||+|+||.||+|.+...   +..||+|.+...... ....+.+|+..+..+. |+|++++++.+.  +...+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCT--EEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeec--CCCceEEEEEe
Confidence            3699999999999998765   889999999764333 3677889999999988 999999999774  46789999999


Q ss_pred             cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          163 MDGGSLADILRMQ---------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       163 ~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +++++|.+++...         ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999999875         679999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          234 NSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       234 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ...  .......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.... .......+. .......+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLR-KGYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHH-cCCCCCCCccCCh
Confidence            432  22234567889999999988889999999999999999999 699997653 233333333 3334444567799


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ++.+++.+||..+|++|||+.+++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=306.34  Aligned_cols=251  Identities=23%  Similarity=0.373  Sum_probs=205.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ++..++|++.+.||+|++|.||+|.+. +++.||+|.++... .....+.+|+..+.++. ||||+++++.+.  ..+..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   76 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLR-HPKLIQLYAVCT--LEEPI   76 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCC-CCCccceeEEEe--cCCCe
Confidence            456678999999999999999999864 45679999987533 23456888999998887 999999999764  45679


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      +++|||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999999997544  68999999999999999999999 9999999999999999999999999999877653


Q ss_pred             cccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      .... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.... .......+ ........+..++..+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~  233 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-NAEVLQQV-DQGYRMPCPPGCPKEL  233 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH-HcCCCCCCCCcCCHHH
Confidence            3211 111223457999999998889999999999999999999 999997543 23333333 3333333456788999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+||+.+|++||++.++++
T Consensus       234 ~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         234 YDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.6e-42  Score=321.44  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=207.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC--------
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD--------  152 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~--------  152 (371)
                      .+|++.+.||.|+||.||+|.+..+++.||+|++........+.+.+|+.++.++. ||||+++++.+....        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC-CCcchhhHhhhcccccccccccc
Confidence            68999999999999999999999999999999997655555677888999998885 999999998764322        


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEeccc
Q 017445          153 ----SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFG  227 (371)
Q Consensus       153 ----~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg  227 (371)
                          ....|+||||++ ++|.+++. .+.+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                135799999997 59998886 4579999999999999999999999 99999999999999975 5678999999


Q ss_pred             ccccCccccc---ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC----
Q 017445          228 ISAGLENSIA---MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP----  299 (371)
Q Consensus       228 ~s~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----  299 (371)
                      .+........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ......+...    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~  239 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILESVPVVR  239 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            9876533211   1122357889999998754 56888999999999999999999999754321 1111111110    


Q ss_pred             --------------------CCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          300 --------------------SPS----PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       300 --------------------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                          ...    .....++.++.+|+++||+.||.+|||+.+++.||||+.+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence                                000    0113577899999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-41  Score=313.93  Aligned_cols=257  Identities=27%  Similarity=0.381  Sum_probs=201.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC-----
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD-----  152 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~-----  152 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....  ........+|+.++.++. ||||+++++++...+     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccccC
Confidence            357999999999999999999999999999999886422  222344567888888886 999999999875432     


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 -SGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 -~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       ....++||||+.+ +|.+++.... .+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||.+.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             2467999999965 8888876543 68999999999999999999999 999999999999999999999999999997


Q ss_pred             cCccccc----ccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH--HHHHHhhCCCCC-
Q 017445          231 GLENSIA----MCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LMLQILEDPSPS-  302 (371)
Q Consensus       231 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-  302 (371)
                      .......    ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........  .+..+.....+. 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            6543321    11234578899999998664 478899999999999999999999976442211  111111100000 


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          303 --------------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       303 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                                ......++.+.+||.+||..||.+|||++++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                                      0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-41  Score=312.94  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEc-------CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHI-------PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .+.+...+|.+.+.||+|+||.||+|.+.       .++..||+|.+... .......+.+|+..+..+..||||+++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            35667789999999999999999999753       23457999998642 33445678899999988867999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      .+.  .....+++|||+++++|.+++...                ..+++..+..++.|++.||.|||+ +|++||||||
T Consensus        89 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp  165 (304)
T cd05101          89 ACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAA  165 (304)
T ss_pred             EEe--cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence            874  456899999999999999999753                246788899999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG  287 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~  287 (371)
                      +||+++.++.+||+|||.+.........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.... 
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-  244 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-  244 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-
Confidence            9999999999999999999766443221  122345678999999988889999999999999999998 788886543 


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                       ...+...+........+..++.++.+|+.+||..+|++|||+.++++.
T Consensus       245 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 -VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             -HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence             233333344444444456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-41  Score=317.91  Aligned_cols=261  Identities=25%  Similarity=0.413  Sum_probs=209.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCC--CcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CCCe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPT--HRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQ  155 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~~~  155 (371)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+...  .......+.+|+.++.++..||||+++++.+...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478889999999999999999888  899999998642  2233556788999999887899999999875422  2346


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +|+++||+. ++|.+++.....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            889999996 5999999878889999999999999999999999 99999999999999999999999999999765432


Q ss_pred             cc----ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh-------------
Q 017445          236 IA----MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-------------  297 (371)
Q Consensus       236 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------  297 (371)
                      ..    ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+. ...+.+++.             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHHHHhh
Confidence            21    1233568999999998865 4689999999999999999999999975432 111111110             


Q ss_pred             -------------CCC---CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          298 -------------DPS---PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       298 -------------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                   ...   ........+..+.+|+.+||+.||++|||+.+++.||||.+|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                         000   001123457899999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2e-41  Score=305.35  Aligned_cols=246  Identities=25%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +...+|++.+.||+|+||.||++..  .+..||+|.++...  ....+.+|+..+.++. |+|++++++++. .+....+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-~~~~~~~   76 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR-HSNLVQLLGVIV-EEKGGLY   76 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCC-CCCeeeEEEEEE-cCCCceE
Confidence            3456889999999999999999976  47789999986432  3456788999988886 999999999765 3445789


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++|||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            9999999999999997543  38899999999999999999999 99999999999999999999999999998754432


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      .   ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.... .... ...+...........+++.+.+
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDV-VPRVEKGYKMDAPDGCPPVVYD  230 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHH-HHHHhcCCCCCCCCCCCHHHHH
Confidence            2   23345678999999998889999999999999999997 999997543 2222 2323333333445678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhc
Q 017445          315 FVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+||..+|++|||+.++++
T Consensus       231 li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         231 VMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-41  Score=303.81  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=206.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +...+|++.+.||.|+||.||+|..  .|+.||+|.++.... ...++.+|+.++..+. |+||+++++.+.  +....+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLR-HPNLVQLLGVVL--QGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcC-CcceeeeEEEEc--CCCCeE
Confidence            3456888999999999999999986  478999999976443 5667889999998886 999999999874  366899


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            9999999999999997655  69999999999999999999999 99999999999999999999999999999776432


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ..   ....+..|+|||.+.+..++.++|+||||+++|++++ |..||.... .... ...+........+..+++.+.+
T Consensus       156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDV-VPHVEKGYRMEAPEGCPPEVYK  230 (256)
T ss_pred             cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHH-HHHHhcCCCCCCccCCCHHHHH
Confidence            21   2335667999999988889999999999999999997 999996543 2232 3333333333344568899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhc
Q 017445          315 FVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+||..+|++||++.+++.
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-41  Score=309.61  Aligned_cols=250  Identities=23%  Similarity=0.385  Sum_probs=201.6

Q ss_pred             eeEeeeecccCCeEEEEEE----EcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           83 MRIFGAIGSGASSVVQRAV----HIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      |++++.||+|+||+||++.    ...++..||+|.++... ......+.+|+..+.++. ||||+++++++...+...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCceEE
Confidence            4888999999999998764    34578899999987532 344567788999998886 99999999987655556799


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ++|||+++++|.+++.. ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++........
T Consensus        85 lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999999975 469999999999999999999999 9999999999999999999999999999876654322


Q ss_pred             c---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH-------------HHHHHhhCCCC
Q 017445          238 M---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN-------------LMLQILEDPSP  301 (371)
Q Consensus       238 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~-------------~~~~~~~~~~~  301 (371)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++|..||........             ...........
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR  242 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence            1   1223456779999999888899999999999999999999999865322110             11111111222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+.+..++.++.+++.+||+.+|++|||+++++.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2234567899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=329.74  Aligned_cols=245  Identities=28%  Similarity=0.422  Sum_probs=211.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ...|.+...+|.|+|+.|..+.+..+++..++|++...    .....+|+.++....+||||+++.+.+  .+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee--cCCceeeee
Confidence            45677777899999999999999999999999999753    233456777788888899999999977  567799999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE-ccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV-NLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~-~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||++.|+.|.+.+...+.+. ..+..|+.+|+.|+.|||+ +||+||||||+|||+ +..|+++|+|||.++.....   
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            99999999998887655555 7888899999999999999 999999999999999 58899999999999877665   


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||....+......++....    ....+|+++++|+++
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQ  545 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHH
Confidence            4567789999999999999999999999999999999999999987555433333332221    227899999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccc
Q 017445          319 CLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ||+.||.+||++++++.||||
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-41  Score=311.47  Aligned_cols=251  Identities=20%  Similarity=0.330  Sum_probs=203.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+|++.+.||+|+||.||+|.+..+     +..||+|+++... ......+.+|+.++..+. ||||+++++.+.  ..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~--~~   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVT--KE   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CC
Confidence            45688889999999999999987543     5789999997533 233456778888887776 999999999774  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc
Q 017445          154 GQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL  217 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~  217 (371)
                      ...++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+ +||+||||||+||+++.
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecC
Confidence            5799999999999999998532                347888899999999999999999 99999999999999999


Q ss_pred             CCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHH
Q 017445          218 KGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQ  294 (371)
Q Consensus       218 ~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~  294 (371)
                      ++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... .......
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Confidence            99999999999876543221  1233446789999999988889999999999999999998 888886543 2333344


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.. ......+..++.++.+|+.+||+.+|++||++.+|+..
T Consensus       239 i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            333 33334456799999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.2e-41  Score=303.48  Aligned_cols=250  Identities=30%  Similarity=0.561  Sum_probs=212.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...  .......+.+|+..+..+. |+||+++++.+.  +....++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFL--DGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhc--cCCEEEEE
Confidence            478889999999999999999999999999998752  3344566788999998887 999999999875  35689999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.+||+|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999999865    3568999999999999999999999 99999999999999999999999999998766554


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                        ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+. ......+... ........++.++.++
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~l  232 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKVQRG-KYPPIPPIYSQDLQNF  232 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcC-CCCCCchhhCHHHHHH
Confidence              22345689999999999988899999999999999999999999976542 2233333333 3333334788999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +.+||..+|++||++.+++.||++
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-41  Score=316.49  Aligned_cols=260  Identities=27%  Similarity=0.484  Sum_probs=202.3

Q ss_pred             eeccc--CCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           88 AIGSG--ASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        88 ~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .||+|  ++|.||.+++..+++.||+|++...  .......+..|+..+..+. ||||+++++++.  +....+++|||+
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~--~~~~~~~~~e~~   81 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFI--VDSELYVVSPLM   81 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhheee--cCCeEEEEEecc
Confidence            34444  4456666666779999999998753  3455677889999998886 999999999874  456899999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc----
Q 017445          164 DGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----  237 (371)
Q Consensus       164 ~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~----  237 (371)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||.+........    
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999999999753  458999999999999999999999 9999999999999999999999999998865432211    


Q ss_pred             ---ccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC------------
Q 017445          238 ---MCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS------------  300 (371)
Q Consensus       238 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  300 (371)
                         ......++..|+|||++.+  ..++.++|+||+|+++|+|++|..||...........+......            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence               1233457788999999865  35889999999999999999999999764433322222211100            


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHH
Q 017445          301 -------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAA  351 (371)
Q Consensus       301 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~  351 (371)
                                         .......++.++.+|+++||+.||++|||+.++|+||||++..+.+.++-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~~~~  310 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLD  310 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchhHHH
Confidence                               001112234678899999999999999999999999999988766554433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=305.80  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=202.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|+.++..+. ||||+++++.+  .+.+..|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLS-HPNLVQLYGVC--TKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCC-CCCEEEEEEEE--cCCCceEEE
Confidence            357888999999999999999875 46679999986422 22345778999988886 99999999976  455689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999999999998753 468999999999999999999999 99999999999999999999999999998765433211


Q ss_pred             -cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          239 -CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       239 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ......+. .......+..++.++.+++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVS-AGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHHHHHH-cCCcCCCCCCCCHHHHHHH
Confidence             112223457999999998889999999999999999999 8999965432 33333333 3333334456899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017445          317 DDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+||..+|++|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-41  Score=317.70  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=209.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC----
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS----  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~----  153 (371)
                      ..+|.+++.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++.....    
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcccccc
Confidence            45799999999999999999999999999999998542  2334456788999998886 9999999998753221    


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...++||||+ +++|.+++. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            2568999999 679998886 4679999999999999999999999 999999999999999999999999999987654


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS------------  300 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  300 (371)
                      ...   ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...... .....+.....            
T Consensus       170 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         170 SEM---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cCc---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhcc
Confidence            321   34567899999999876 45889999999999999999999999754321 12221111000            


Q ss_pred             ----------C-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          301 ----------P-------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       301 ----------~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                +       ......+++.+.+++.+||+.||++|||+.+++.||||..+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                      0       01124578889999999999999999999999999999988554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-41  Score=318.66  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=209.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~  153 (371)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.++.++. ||||+++++++...    ..
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccccccc
Confidence            46899999999999999999999999999999998652  2233456778999998886 99999999987432    22


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...|++++++ +++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence            3578899987 6799988764 569999999999999999999999 999999999999999999999999999987654


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---------------  297 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------  297 (371)
                      ..   .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... .....+..               
T Consensus       172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         172 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             cc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhhccc
Confidence            32   234568899999999866 56889999999999999999999999754322 11111111               


Q ss_pred             -----------CCCC---CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          298 -----------DPSP---SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       298 -----------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                                 ....   .......++++.+||.+||+.||.+||++.+++.||||+++..+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence                       0000   0011246788999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3e-41  Score=306.78  Aligned_cols=249  Identities=19%  Similarity=0.354  Sum_probs=200.6

Q ss_pred             eEeeeecccCCeEEEEEEEcCCCc--EEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CCe
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTHR--IIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SGQ  155 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~~  155 (371)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++..  .......+.+|+..+..+. ||||+++++.+....    ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCCC
Confidence            456789999999999999877765  6899988652  3455667888999998885 999999999764321    225


Q ss_pred             EEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          156 ISIALEYMDGGSLADILRM------QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      .+++|||+++|+|.+++..      ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||.+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            7899999999999998742      2348899999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          230 AGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       230 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+... .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~  237 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-NSEIYDYLRQG-NRLKQPP  237 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcC-CCCCCCC
Confidence            876443211  122346778999999999899999999999999999999 899997643 23333333333 2233345


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .++..+.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-41  Score=309.53  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=204.2

Q ss_pred             cceeEeeeecccCCeEEEEEEE----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVH----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      .-|++++.||+|+||.||+|..    ..++..||+|.++.. .......+.+|+.++..+. |||++++++++...+...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCc
Confidence            3467888999999999999974    457889999998753 2344567889999998886 999999999876544567


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++||||++|++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||.+.....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            89999999999999999654 358999999999999999999999 9999999999999999999999999999976644


Q ss_pred             ccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC-------------cHHHHHHHhhC
Q 017445          235 SIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG-------------PVNLMLQILED  298 (371)
Q Consensus       235 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~-------------~~~~~~~~~~~  298 (371)
                      ...   ......++..|+|||.+.+..++.++||||||+++|+|+++..|+.....             ........+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            321   12244567789999999888899999999999999999998766532110             11111222223


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ......+..++..+.+|+.+||+.+|++||++.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            33333456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-41  Score=305.61  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=202.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +...+|++.+.||+|+||.||+|.+..++ .||+|+++... .....+.+|+.++..+. ||||+++++.+  . ....+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~-~~~~~~~~E~~~l~~l~-~~~i~~~~~~~--~-~~~~~   76 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT-MSPEAFLQEAQVMKKLR-HEKLVQLYAVV--S-EEPIY   76 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCc-cCHHHHHHHHHHHHhCC-CCCcceEEEEE--C-CCCcE
Confidence            34568999999999999999999876654 59999987522 23356788999998886 99999999865  2 34689


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||.+......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999999999753  358999999999999999999999 99999999999999999999999999999765443


Q ss_pred             ccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          236 IAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       236 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      ... .....++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+. ..........++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~l~  233 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVE-RGYRMPCPPECPESLH  233 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-HHHHHHHh-cCCCCCCccccCHHHH
Confidence            221 123346678999999988889999999999999999999 8889976543 23333332 2233333457889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017445          314 SFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++.+||+.+|++||++.+++.
T Consensus       234 ~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         234 DLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.9e-41  Score=311.65  Aligned_cols=256  Identities=30%  Similarity=0.537  Sum_probs=212.6

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .|...+.||+|+||.||+|.+..++..||+|.+...   .......+.+|+..+.++. |||++++++++.  +....++
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~l  102 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYL--REHTAWL  102 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--eCCeEEE
Confidence            466777999999999999999999999999998642   2334456888999998886 999999999875  3557899


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+.| +|.+++.. ..++++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||.+......  
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9999975 78877753 5668999999999999999999999 99999999999999999999999999988654432  


Q ss_pred             ccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          238 MCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                        ....+++.|+|||.+.   +..++.++||||+|+++|+|++|..||.... .......+.....+......+++.+.+
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCCCCCccccHHHHH
Confidence              3456899999999973   4568899999999999999999999997643 334444554444444445678899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      ++.+||+.+|.+||++.++++|+|+.......+
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            999999999999999999999999976655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=302.70  Aligned_cols=242  Identities=25%  Similarity=0.434  Sum_probs=199.9

Q ss_pred             eeecccCCeEEEEEEEcCCC---cEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           87 GAIGSGASSVVQRAVHIPTH---RIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      +.||+|+||.||+|....++   ..+|+|.+..... .....+.+|+..+..+. ||||+++++.+.   ....++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVCK---GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc---CCceEEEEEe
Confidence            37999999999999876554   7899999875332 35567888999998886 999999999653   3468999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc--
Q 017445          163 MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA--  240 (371)
Q Consensus       163 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~--  240 (371)
                      +++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+...........  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999999999887789999999999999999999999 9999999999999999999999999999876644322211  


Q ss_pred             -cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          241 -TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       241 -~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                       ...++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ... ...+........+..++..+.+++.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEV-IAMLESGERLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHH-HHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence             1123467999999998889999999999999999998 9999976442 233 33333333444556788999999999


Q ss_pred             hcccCcCCCCCHHHHhc
Q 017445          319 CLKKDAEARPTADQLLS  335 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~  335 (371)
                      ||..+|++||++.++++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=306.00  Aligned_cols=250  Identities=19%  Similarity=0.370  Sum_probs=201.6

Q ss_pred             eeEeeeecccCCeEEEEEEEcC---CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC----
Q 017445           83 MRIFGAIGSGASSVVQRAVHIP---THRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS----  153 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~----  153 (371)
                      |.+++.||+|+||.||+|....   ++..||+|.++..  .......+.+|+..+..+. ||||+++++.+...+.    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccC
Confidence            4577899999999999998754   3478999998742  3344567889999888876 9999999998754322    


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          154 GQISIALEYMDGGSLADILRMQ------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                      ...+++|||+++++|.+++...      ..+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCcc
Confidence            2479999999999999988432      358999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          228 ISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       228 ~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .+.........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .... +.+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~-~~~~~~~~~~~  236 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIY-DYLRHGNRLKQ  236 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHH-HHHHcCCCCCC
Confidence            98765433211  112234678999999988889999999999999999999 8999966443 2333 33333333344


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +..++.++.+++.+||+.||++||++.+++++
T Consensus       237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            56789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-42  Score=336.76  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=216.7

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .....+..++.+..+.||+|+||+||+|+-.     .+...||||.++.... +.+..|.+|++.+..+. |||||+++|
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlG  556 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLG  556 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEE
Confidence            3456778889999999999999999999742     3457899999987544 47888999999999998 999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCc
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQK--------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN  212 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~N  212 (371)
                      ++  .+++.+|+|+|||..|+|.++|....              +++..+...|+.||+.|++||-+ +.+|||||..+|
T Consensus       557 VC--~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRN  633 (774)
T KOG1026|consen  557 VC--REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRN  633 (774)
T ss_pred             EE--ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhh
Confidence            77  56778999999999999999995421              27888999999999999999999 889999999999


Q ss_pred             EEEccCCceEEecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcH
Q 017445          213 LLVNLKGRPKITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPV  289 (371)
Q Consensus       213 Il~~~~~~~kl~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~  289 (371)
                      .||.++-.|||+|||+++.+......  .....-..+|||||.|..+.|+.+|||||+||+|||+++ |..||.+-.+ .
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~  712 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-Q  712 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-H
Confidence            99999999999999999876543221  112334678999999999999999999999999999998 9999987654 3


Q ss_pred             HHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 017445          290 NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQL  333 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~i  333 (371)
                      +.+..+ ..+.....+..+|.++.+|+..||+.+|++||++.||
T Consensus       713 EVIe~i-~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  713 EVIECI-RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHHH-HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            334444 4444477789999999999999999999999999998

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-41  Score=315.66  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=209.0

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCC-------CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPT-------HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .+.+...+|.+.+.||+|+||.||+|.+...       +..||+|.++.. .......+.+|+.++.++..||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            4566667899999999999999999986432       246899988753 33445678899999999867999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      .+.  ..+.++++|||+++|+|.+++....                .+++..+..++.|++.||.|||+ +|++||||||
T Consensus        86 ~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp  162 (334)
T cd05100          86 ACT--QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAA  162 (334)
T ss_pred             EEc--cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeecccccc
Confidence            874  4568999999999999999987532                37788899999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCcccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG  287 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~  287 (371)
                      +||+++.++.+||+|||.+.........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||.... 
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-  241 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-  241 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-
Confidence            9999999999999999998765443211  122234567999999999889999999999999999998 889996543 


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      ... ....+........+..++.++.+++.+||..+|.+||++.+++.+-
T Consensus       242 ~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         242 VEE-LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            233 3333333333334457889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-41  Score=310.12  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=211.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +|++.+.||+|++|.||++.+.   .+++.||+|.++...    ......+.+|+.++.++.+||||+++++.+  ....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCC
Confidence            4788899999999999999853   467899999986422    223455778999999998899999999977  4456


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            899999999999999999877789999999999999999999999 9999999999999999999999999999876543


Q ss_pred             ccc-ccccccccCcccCCccccCCC--CCCchhHHHHHHHHHHHhcCCCCCCCCCCc---HHHHHHHhhCCCCCCCCCCC
Q 017445          235 SIA-MCATFVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGP---VNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       235 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ... ......++..|+|||.+.+..  .+.++|+||+|+++|+|++|..||......   ...........  ...+..+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  235 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTM  235 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCccc
Confidence            322 122346899999999987654  788999999999999999999999643221   12222222222  2334568


Q ss_pred             CHHHHHHHHHhcccCcCCCCC---HHHHhcCcccccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPT---ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps---~~~il~hp~~~~~~~~~  346 (371)
                      +..+.+++.+||+.||++|||   +.++|+||||+.+.+..
T Consensus       236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~  276 (288)
T cd05583         236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD  276 (288)
T ss_pred             CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence            899999999999999999998   56779999999887543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-41  Score=310.68  Aligned_cols=252  Identities=22%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCC----------------cEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTH----------------RIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGL  141 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i  141 (371)
                      ...+|++++.||+|+||.||+|.+..++                ..||+|.+... .......+.+|+.++.++. ||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCE
Confidence            3568899999999999999999876543                56899998753 3445667889999999986 9999


Q ss_pred             eEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       142 v~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      +++++++.  ..+..+++|||+++++|.+++....           .+++..++.++.|++.||.|||+ +|++||||||
T Consensus        82 ~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence            99999874  4568999999999999999997655           68999999999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc--CCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT--GEFPYAASE  286 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~--g~~pf~~~~  286 (371)
                      +||+++.++.++|+|||.+.......  .......+++.|+|||.+.+..++.++||||||+++|+|++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999987654322  12234456788999999988889999999999999999998  778886533


Q ss_pred             CcHHHHHHHhhC------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          287 GPVNLMLQILED------PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       287 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      . ...+......      ......+..++.++.+++.+||+.||++|||+.+++.
T Consensus       239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 D-QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             h-HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            2 2222222211      1122233467899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-41  Score=304.21  Aligned_cols=250  Identities=25%  Similarity=0.413  Sum_probs=204.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCC---cEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTH---RIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.++.. .......+.+|+..+..+. ||||+++++++.  +.+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT--KSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe--cCCc
Confidence            457889999999999999999876444   37999998653 2344567888999988886 999999999874  4568


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .|+||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999999999754 468999999999999999999999 9999999999999999999999999999976654


Q ss_pred             ccccc---ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          235 SIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       235 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .....   ....++..|+|||.+.+..++.++|+||||+++|++++ |..||..... ......+. .....+....+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~  236 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIE-EGYRLPAPMDCPA  236 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHHHHHh-CCCcCCCCCCCCH
Confidence            32211   11223568999999998889999999999999999886 9999975442 23333333 3233344457889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-41  Score=318.95  Aligned_cols=259  Identities=25%  Similarity=0.441  Sum_probs=210.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC----
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS----  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~----  153 (371)
                      .++|.+.+.||+|++|.||+|.+..+++.||+|++...  .......+.+|+.++.++. |||++++.+++...+.    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccccccc
Confidence            45799999999999999999999999999999998642  2334456778999998885 9999999987743221    


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||.+....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            3489999999 5699999874 579999999999999999999999 999999999999999999999999999987664


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS------------  300 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  300 (371)
                      ..   .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ...+..+.....            
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccc
Confidence            43   244568899999999865 3678999999999999999999999976543 222222211100            


Q ss_pred             -----------CC------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 -----------PS------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 -----------~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                 ..      .....++.++.+|+.+||+.+|++|||+.+|+.||||.++....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                       00      00124588999999999999999999999999999999987664

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=332.78  Aligned_cols=258  Identities=31%  Similarity=0.605  Sum_probs=229.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec---CCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP---DSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~---~~~~~  156 (371)
                      ..-|++.+.||.|.+|.||+++++++++..|+|+.... ....+.+..|.+++...++|||++.++|+|...   ..+.+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            35688999999999999999999999999999998763 344566778889999999999999999999653   34689


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      +||||||.||+.-|+++.  ..++.|+.+..|++.++.||.|||. +.++|||||-.|||++.++.|||+|||+++++..
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            999999999999999874  4568999999999999999999999 8899999999999999999999999999999988


Q ss_pred             cccccccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC-CCCCC
Q 017445          235 SIAMCATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP-SRQNF  308 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  308 (371)
                      ......+.+|||.|||||++..     ..|+.++|+||||++..||.-|.+|+-+ -.++-.++++..++++.. .+..+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D-mHPmraLF~IpRNPPPkLkrp~kW  254 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKRPKKW  254 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC-cchhhhhccCCCCCCccccchhhH
Confidence            8888899999999999999954     3478899999999999999999999965 345666777766666544 47789


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      +.++.+||..||.+|-.+||++.++|+|||++
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            99999999999999999999999999999998

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.7e-42  Score=319.20  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=198.8

Q ss_pred             eeccc--CCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           88 AIGSG--ASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        88 ~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .||.|  +||+||+|.+..+|+.||+|++...  .....+.+.+|+.++..+. ||||++++++|.  .....++|+||+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~--~~~~~~~v~e~~   81 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFT--TGSWLWVISPFM   81 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEe--cCCceEEEEecc
Confidence            56666  9999999999999999999998652  2334456777777766665 999999999885  456899999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc---
Q 017445          164 DGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM---  238 (371)
Q Consensus       164 ~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~---  238 (371)
                      .+++|.+++...  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++||+.+.........   
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999998754  358999999999999999999999 99999999999999999999999999865332211111   


Q ss_pred             ----cccccccCcccCCccccCC--CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC------------
Q 017445          239 ----CATFVGTVTYMSPERIRNE--SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS------------  300 (371)
Q Consensus       239 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  300 (371)
                          .....++..|+|||++.+.  .++.++||||+||++|+|++|..||..................            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                0112356679999999763  4789999999999999999999999765433322222111000            


Q ss_pred             --------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 --------------------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 --------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                                      .......+++.+.+|+++||+.||++|||+.++++||||....++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~  318 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT  318 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence                                            0011234567899999999999999999999999999998877653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=309.03  Aligned_cols=251  Identities=31%  Similarity=0.548  Sum_probs=206.4

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      |++.+.||+|++|.||+|.+..+++.+|+|.++....  .....+.+|+.++.++. |+||+++++.+.  ....+++|+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFR--HKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhc--cCCCEEEEE
Confidence            4567799999999999999999999999999875322  34567788999998887 999999999874  456899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||+++ +|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            99975 88888765 3579999999999999999999999 999999999999999999999999999987765543233


Q ss_pred             ccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CCC--------------
Q 017445          240 ATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PSP--------------  301 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~--------------  301 (371)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+. ...+..+...   ..+              
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            445688899999999776 789999999999999999999999976543 2222222111   000              


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          302 -----------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       302 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                 ......++.++.+||.+||..||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                       00113467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.8e-41  Score=303.66  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.++.++. |+|++++++.+  . ....
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~-~~~i~~~~~~~--~-~~~~   75 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLR-HDKLVQLYAVV--S-EEPI   75 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcC-CCceEEEEeEE--C-CCCc
Confidence            345678999999999999999999765 556799999875322 3456889999999886 99999999865  2 3468


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      +++|||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999999999998753  458999999999999999999999 9999999999999999999999999999976543


Q ss_pred             cccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ......+. .......+...+..+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~  232 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVE-RGYRMPCPQDCPISL  232 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH-cCCCCCCCCcCCHHH
Confidence            3211 122335668999999988889999999999999999999 8999976442 33333333 333334456788999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHh
Q 017445          313 CSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il  334 (371)
                      .+|+.+||..+|++|||+.+++
T Consensus       233 ~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         233 HELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             HHHHHHHcccCcccCcCHHHHH
Confidence            9999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-40  Score=302.70  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCc---EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHR---IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ..++|...+.||+|+||.||+|.+..++.   .+|+|.++.. .......+..|+..+..+. |||++++.+.+  .+.+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~   79 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVV--TKFK   79 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEE--ccCC
Confidence            34578888999999999999999876554   7999998753 3444567888999888886 99999999977  4556


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..++||||+++++|.+++... +.+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            899999999999999999753 568999999999999999999999 999999999999999999999999999987654


Q ss_pred             ccccccc---cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          234 NSIAMCA---TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       234 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .......   ....++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+ ......+....++
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i-~~~~~~~~~~~~~  236 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI-NDGFRLPAPMDCP  236 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHH-hcCCCCCCCCCCC
Confidence            3322111   1123457999999988889999999999999999997 9999965432 3333333 3333444455789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .++.+++.+||..+|++||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-41  Score=311.36  Aligned_cols=257  Identities=28%  Similarity=0.419  Sum_probs=205.3

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----  152 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|+.++..+. ||||+++++.+...+    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhh
Confidence            4568899999999999999999999999999999987532  223345678889988886 999999999875432    


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          153 ----SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       153 ----~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                          .+.+++|+||+++ +|.+.+... ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCccc
Confidence                3479999999986 777777643 468999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCccccc-ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH---hhCCCCC
Q 017445          228 ISAGLENSIA-MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LEDPSPS  302 (371)
Q Consensus       228 ~s~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~  302 (371)
                      .+........ ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...+. ...+..+   .....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPCPA  240 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChh
Confidence            9876644321 1223356788999998864 4578999999999999999999999976442 2222211   1111100


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          303 -------------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       303 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                               .....++..+.+++.+||..||++||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     0123468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.8e-41  Score=312.81  Aligned_cols=256  Identities=29%  Similarity=0.446  Sum_probs=201.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC-----
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD-----  152 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~-----  152 (371)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.....  .......+|+..+..+. ||||+++++.+....     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccccc
Confidence            4689999999999999999999999999999999864221  12335678899888886 999999999875432     


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 -SGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 -~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       ...+++||||+.+ +|...+.. ...+++..+..++.|+++||.|||+ .|++|+||||+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence             2368999999975 77777654 3579999999999999999999999 999999999999999999999999999987


Q ss_pred             cCcccccc-----------cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh-
Q 017445          231 GLENSIAM-----------CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-  297 (371)
Q Consensus       231 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~-  297 (371)
                      ........           .....+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ......+.. 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~~~  242 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIFKL  242 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence            65432111           1233578889999988654 588999999999999999999999976443 222222211 


Q ss_pred             --CCCCC-------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          298 --DPSPS-------------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       298 --~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                        ...+.                         .....+++.+.+|+.+||+.||++|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence              00000                         0012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-41  Score=304.09  Aligned_cols=242  Identities=25%  Similarity=0.431  Sum_probs=196.2

Q ss_pred             eecccCCeEEEEEEEcCCCc--EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHR--IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|.+..++.  .+|+|.++.. .......+..|+..+.++.+||||+++++.+.  ..+..++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEeCC
Confidence            69999999999999888775  4688888642 34455678889999999977999999999874  4567999999999


Q ss_pred             CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          165 GGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       165 ~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      +|+|.+++....                .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCC
Confidence            999999997543                37889999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      +....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+ ........+..
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~-~~~~~~~~~~~  235 (270)
T cd05047         159 SRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKL-PQGYRLEKPLN  235 (270)
T ss_pred             ccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHH-hCCCCCCCCCc
Confidence            85332211 1112234567999999988889999999999999999997 9999965432 2233333 22222233456


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.++.+++.+||..+|.+|||+.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         236 CDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            7899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-41  Score=306.69  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      |++.+.||+|++|.||+|.+..+++.+|+|.+....  ......+.+|+.++..+. |||++++++.+.....+..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEe
Confidence            568889999999999999999999999999997642  334456788999998887 99999999988644337899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-c
Q 017445          161 EYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-M  238 (371)
Q Consensus       161 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-~  238 (371)
                      ||+++ +|.+++... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            99975 899988654 579999999999999999999999 9999999999999999999999999999976654421 1


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CCCC------------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PSPS------------  302 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~------------  302 (371)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ......+...   ....            
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchhhh
Confidence            233457889999998765 4578999999999999999999999976543 2222222211   0000            


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          303 --------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       303 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                                    .....++..+.+++++||..+|.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          0011138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-40  Score=300.93  Aligned_cols=241  Identities=24%  Similarity=0.431  Sum_probs=196.1

Q ss_pred             eecccCCeEEEEEEEc--CCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHI--PTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|.+.  .++..||+|++.... ......+.+|+.++.++. ||||+++++.+.   ....++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~---~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE---AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc---CCCeEEEEEeCC
Confidence            4899999999999764  445679999987543 344566889999998885 999999999762   346899999999


Q ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc---c
Q 017445          165 GGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC---A  240 (371)
Q Consensus       165 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~---~  240 (371)
                      +++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+..........   .
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            9999999874 4568999999999999999999999 999999999999999999999999999987654332211   1


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ...+++.|+|||.+.+..++.++||||||+++|++++ |..||..... .... ..+........+..+++++.+++.+|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVM-SFIEQGKRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHH-HHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            1223578999999988889999999999999999996 9999976432 2333 33333333344567899999999999


Q ss_pred             cccCcCCCCCHHHHhc
Q 017445          320 LKKDAEARPTADQLLS  335 (371)
Q Consensus       320 l~~dp~~Rps~~~il~  335 (371)
                      |..+|++||++.+|.+
T Consensus       235 ~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         235 WIYKWEDRPNFAKVEE  250 (257)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.6e-41  Score=304.35  Aligned_cols=251  Identities=29%  Similarity=0.497  Sum_probs=206.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      +|.+.+.||+|+||+||++.+..++..+++|.++..     ..........|+..+..+. ||||+++++.+.  +....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFL--ERDAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHh--cCCce
Confidence            478889999999999999998887777777766431     2233445667888888775 999999999874  45579


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          157 SIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. +.++|+|||.+...
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-CCEeecccCceeec
Confidence            999999999999998853    3568999999999999999999999 99999999999999974 67999999998766


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ...........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... ............ ....+..++.++
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~  233 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-FLSVVLRIVEGP-TPSLPETYSRQL  233 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcCC-CCCCcchhcHHH
Confidence            544344445668999999999988888999999999999999999999996543 233333433332 333346788999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .+++.+||..+|++||++.++++||||
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-41  Score=300.68  Aligned_cols=244  Identities=29%  Similarity=0.481  Sum_probs=208.6

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      ||+|+||.||++.+..+++.+|+|.+....   ......+..|+.++.++. ||||+++++.+  .+...+|++|||+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAF--QTEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHe--ecCCeeEEEEecCCC
Confidence            699999999999998889999999986532   224456788888888887 99999999977  456789999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccccccc
Q 017445          166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT  245 (371)
Q Consensus       166 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt  245 (371)
                      ++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..............++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            9999999887789999999999999999999999 999999999999999999999999999987765543333456789


Q ss_pred             CcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcC
Q 017445          246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE  325 (371)
Q Consensus       246 ~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  325 (371)
                      ..|+|||.+.+...+.++|+||||+++|++++|..||..... ......+..  .....+..++..+.+++++||..||+
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence            999999999888889999999999999999999999965432 333334333  22334456789999999999999999


Q ss_pred             CCCCH---HHHhcCccc
Q 017445          326 ARPTA---DQLLSHPFI  339 (371)
Q Consensus       326 ~Rps~---~~il~hp~~  339 (371)
                      +||++   .+++.||||
T Consensus       234 ~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         234 KRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hCCCcccHHHHHhCCCC
Confidence            99999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-40  Score=311.74  Aligned_cols=262  Identities=24%  Similarity=0.416  Sum_probs=210.6

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..++|.+.+.||.|+||.||+|.+..+++.||+|++..  ........+..|+.++..+. ||||+++.++|.. .....
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFIS-PLEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEec-CCCcE
Confidence            34679999999999999999999999999999998854  22234456778999998886 9999999998753 34578


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+++||+ +++|.+++. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+...... 
T Consensus        86 ~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          86 YFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             EEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            9999999 569998886 4568899999999999999999999 99999999999999999999999999998754332 


Q ss_pred             cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH--HHHHHhh----------------
Q 017445          237 AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LMLQILE----------------  297 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~----------------  297 (371)
                        .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........  .+...+.                
T Consensus       162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence              234567889999999865 5689999999999999999999999975432100  0011100                


Q ss_pred             -------CCCCCC---CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccccc
Q 017445          298 -------DPSPSP---SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       298 -------~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~  348 (371)
                             .....+   ....++.++.+++++||+.+|++||++++++.||||..++.+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence                   000000   113567899999999999999999999999999999988776544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-40  Score=304.39  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=207.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcC----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +..++|.+.+.||+|+||.||+|.+..    ++..||+|.+... .......+.+|+..+.++. ||||+++++++.. +
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~-~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILHVCIE-D   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec-C
Confidence            456789999999999999999999866    3588999988653 3445667888999998885 9999999998753 3


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEe
Q 017445          153 SGQISIALEYMDGGSLADILRMQ--------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKIT  224 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~  224 (371)
                      ....++++||+++++|.+++...        ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCCcEEEC
Confidence            45789999999999999998653        358999999999999999999999 999999999999999999999999


Q ss_pred             cccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCC
Q 017445          225 DFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP  301 (371)
Q Consensus       225 Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  301 (371)
                      |||+++.+.....  ......++..|+|||++.+..++.++||||||+++|++++ |+.||.... .... ...+.....
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~-~~~~~~~~~  237 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEM-AAYLKDGYR  237 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHHH-HHHHHcCCC
Confidence            9999976543221  1123345678999999988889999999999999999998 999997543 3333 333333333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ......+++++.+++.+||..||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3344568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.5e-41  Score=306.69  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=201.4

Q ss_pred             ceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+... .......+.+|+..+..+. ||||+++++.+.  ..+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACS--QDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEe--cCCC
Confidence            46778899999999999998643     2356889988653 2344567889999998886 999999999774  4567


Q ss_pred             EEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCC
Q 017445          156 ISIALEYMDGGSLADILRMQ------------------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA  211 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~  211 (371)
                      .++++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+ .|++||||||+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp~  156 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAAR  156 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhhh
Confidence            99999999999999998642                        247889999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCc
Q 017445          212 NLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGP  288 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~  288 (371)
                      ||+++.++.+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... +
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-P  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-H
Confidence            99999999999999999876533221  1122345678999999988889999999999999999998 999996543 2


Q ss_pred             HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      . .+.+..........+..++.++.+++.+||+.+|++||++.++++
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 E-RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             H-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2 333444444444445678999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-40  Score=301.27  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=202.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +...+|++.+.||+|++|.||+|.+..++ .+|+|.+.... .....+.+|+.++..+. |||++++++.+.   ....+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~   76 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS---EEPIY   76 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc---CCCcE
Confidence            34567899999999999999999876554 59999876432 23456788999998886 999999998762   34689


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999999999999999753  347899999999999999999999 99999999999999999999999999999765433


Q ss_pred             ccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          236 IAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       236 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      ... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .....++.. ......+...+..+.
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~  233 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVER-GYRMPCPQGCPESLH  233 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCCCCCcccCHHHH
Confidence            211 122346678999999988889999999999999999999 9999976443 333333333 333333457889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017445          314 SFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++++||..||++||+++++++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         234 ELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=301.31  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=205.3

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ++..++|++.+.||+|+||+||+|.+. +++.||+|.+.... .....+.+|+..+.++. ||||+++++.+  ......
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~   76 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLR-HDKLVQLYAVC--SEEEPI   76 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCC-CCCEeeeeeee--ecCCce
Confidence            456689999999999999999999865 45789999987532 33456888999998887 99999999976  345679


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ++||||+++++|.+++...  ..+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999999999999754  368999999999999999999999 9999999999999999999999999999876653


Q ss_pred             ccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ... ......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||..... ......+ ........+...+.++
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~  233 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQV-ERGYRMPRPPNCPEEL  233 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-HcCCCCCCCCCCCHHH
Confidence            211 1122234578999999998889999999999999999998 9999975432 3333333 3333333445678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHh
Q 017445          313 CSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il  334 (371)
                      .+++.+||+.+|++||++++++
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         234 YDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             HHHHHHHcccCcccCCCHHHHH
Confidence            9999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.5e-42  Score=301.69  Aligned_cols=269  Identities=27%  Similarity=0.407  Sum_probs=212.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCc----EEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHR----IIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ..|++.+.||+|+||.||+|..+.++.    .+|||+++...  ........+|+..++.+. |||++.+..+|... +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~-d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSH-DK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhcc-Cc
Confidence            368888999999999999997665543    78999997532  223345678888888887 99999999998743 67


Q ss_pred             eEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC----CceEEec
Q 017445          155 QISIALEYMDGGSLADILRM-----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK----GRPKITD  225 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~----~~~kl~D  225 (371)
                      .+++++||.+. +|.++|+-     .+.++......|++||+.|+.|||+ +-|+||||||.|||+..+    |.|||+|
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEeec
Confidence            89999999986 99999853     2458999999999999999999999 889999999999999887    8999999


Q ss_pred             ccccccCcccccc---cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCC-----------cHH
Q 017445          226 FGISAGLENSIAM---CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEG-----------PVN  290 (371)
Q Consensus       226 fg~s~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~-----------~~~  290 (371)
                      ||+++.+.+....   ....+-|.+|+|||.+.|. -||.+.||||.|||+.||++-++.|.+.+.           +..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999887665433   3456789999999999765 499999999999999999999988865331           122


Q ss_pred             HHHHHhhCCCCCCCC--------------------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          291 LMLQILEDPSPSPSR--------------------------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      .+..++..+.....+                                ..-++...+|+.+||+.||.+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            334444433221111                                112355889999999999999999999999999


Q ss_pred             ccccccccccHHHHH
Q 017445          339 ITKYEHAKVDLAAFV  353 (371)
Q Consensus       339 ~~~~~~~~~~~~~~~  353 (371)
                      |+.-.-+..+.++.+
T Consensus       340 F~~d~lpp~pt~~~v  354 (438)
T KOG0666|consen  340 FTEDPLPPLPTSDNV  354 (438)
T ss_pred             cccCCCCCCccccee
Confidence            987755544444433

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-41  Score=316.02  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~  154 (371)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.++..+. ||||+++++++....    ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCCCCc
Confidence            5789999999999999999999999999999998642  2223345778999988885 999999999875332    23


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..|+|+||+.. +|..++  ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            57999999964 787765  3468999999999999999999999 9999999999999999999999999999876533


Q ss_pred             cccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--------------
Q 017445          235 SIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--------------  299 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------------  299 (371)
                      .   .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+. ...+..++...              
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         170 E---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             C---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhccc
Confidence            2   234567899999999866 4588999999999999999999999976432 22222221100              


Q ss_pred             --------CCCC-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          300 --------SPSP-------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       300 --------~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                              .+..       .....+.++.+|+++||+.||++||++++++.||||..+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                    0000       01246788999999999999999999999999999988864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=308.41  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCC--------------CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPT--------------HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVE  143 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~  143 (371)
                      ..++|++.+.||+|+||.||+|.+..+              ...||+|.++.. .......+.+|+..+.++. |||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            456899999999999999999986543              235899998753 3445567889999998886 999999


Q ss_pred             eceeEEecCCCeEEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCC
Q 017445          144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQK------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA  211 (371)
Q Consensus       144 l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~  211 (371)
                      +++++.  .....++||||+++++|.+++....            .+++..+..++.|++.||.|||+ +|++||||||+
T Consensus        82 ~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR  158 (295)
T ss_pred             EEEEEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence            999874  4568999999999999999986432            36888999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc--CCCCCCCCCC
Q 017445          212 NLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT--GEFPYAASEG  287 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~--g~~pf~~~~~  287 (371)
                      ||+++.++.+||+|||++........  ......+++.|+|||.+.+..++.++|+||||+++|+|++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999876533211  1122345678999999988889999999999999999988  6678865432


Q ss_pred             cHHHHHHHh------hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          288 PVNLMLQIL------EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       288 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                       ...+....      ........+..+++.+.+|+.+||+.||++|||+++|++
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 -EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             -HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             22222211      111122234567899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-41  Score=305.17  Aligned_cols=251  Identities=29%  Similarity=0.480  Sum_probs=203.1

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      |++.+.||+|++|+||+|....+++.||||++.... ........+|+..+.++..|||++++++.+.  +.+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEEe
Confidence            567789999999999999998899999999986522 2233345678888888877999999999874  4668999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          162 YMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |+ +|+|.+++....  .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  155 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY  155 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence            99 779999887654  78999999999999999999999 999999999999999999999999999997665432 22


Q ss_pred             ccccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC---------------
Q 017445          240 ATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS---------------  300 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~---------------  300 (371)
                      ....++..|+|||++. +..++.++|+||||+++++|++|..||........ ..+...   ...               
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            3456889999999884 45578999999999999999999999976543222 211111   000               


Q ss_pred             ---CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          301 ---PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       301 ---~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                         +.       ......+.++.+++++||+.+|++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence               00       0011236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-40  Score=301.61  Aligned_cols=250  Identities=25%  Similarity=0.440  Sum_probs=204.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCc---EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHR---IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..+|++.+.||+|+||.||+|.+..++.   .||+|.+... .......+..|+..+..+. ||||+++++.+  .+...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~--~~~~~   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVV--TKSRP   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEE--CCCCc
Confidence            3578899999999999999999876654   6999998753 3445667889999988876 99999999976  45668


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999999999875 3568999999999999999999999 9999999999999999999999999999875543


Q ss_pred             cccc--ccc-c--cccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          235 SIAM--CAT-F--VGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       235 ~~~~--~~~-~--~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ....  ... .  ..+..|+|||.+.+..++.++||||+|+++||+++ |..||..... ...... +......+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~-i~~~~~~~~~~~~  236 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINA-IEQDYRLPPPMDC  236 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHH-HHcCCcCCCcccC
Confidence            2211  011 1  12457999999998889999999999999999886 9999975432 223333 3333344445678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +..+.+++.+||..+|++||++.+++.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.9e-40  Score=301.45  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ++...+|.+.+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+..+..+. ||||+++++.+.   
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~---   77 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVIT---   77 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEc---
Confidence            45667889999999999999999987544   4578999887543 455667889999998886 999999999763   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ....++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+..
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          78 ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             CCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeee
Confidence            345789999999999999997643 58999999999999999999999 9999999999999999999999999999876


Q ss_pred             Ccccccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          232 LENSIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       232 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ....... .....+++.|+|||.+.+..++.++||||||+++|++++ |..||...... .....+.. ......+..++
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~  234 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIEN-GERLPMPPNCP  234 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHc-CCcCCCCCCCC
Confidence            5443211 122234568999999988889999999999999999986 99999765432 33333332 22333456789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .++.+++.+|+..+|++|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.1e-41  Score=309.94  Aligned_cols=257  Identities=29%  Similarity=0.511  Sum_probs=212.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .|...+.||+|+||.||+|++..++..+|+|.+..   ........+.+|+.++..+. |+|++++.+++..  ....++
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l   92 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHTAWL   92 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEc--CCeeEE
Confidence            46667789999999999999999999999999864   22334456788999998886 9999999998754  557999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+. |+|.+++.. ..++++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||.+......  
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            999997 588877653 4568999999999999999999999 99999999999999999999999999998655432  


Q ss_pred             ccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          238 MCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                        ....+++.|+|||.+.   ...++.++||||||+++|+|++|..||..... ......+.....+......++..+.+
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhcCCCCcCcccccHHHHH
Confidence              3456889999999974   35678899999999999999999999966432 33334444444444445578899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~  348 (371)
                      ||++||..+|.+||++.++++|||+.........
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~  279 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI  279 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCccccccCChhHH
Confidence            9999999999999999999999999886554433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-41  Score=334.26  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=195.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCC-cEEEEEE--------------ec---cccHHHHHHHHHHHHHHHhCCCCCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTH-RIIALKK--------------IN---IFEKEKRNQLLTEIRTLCEAPCNEGL  141 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~~~~h~~i  141 (371)
                      ..+|++++.||+|+||+||+|..+... ...++|.              +.   .........+.+|+.++.++. ||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCCc
Confidence            468999999999999999998754322 2222221              10   012223456788999998886 9999


Q ss_pred             eEeceeEEecCCCeEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc
Q 017445          142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN  216 (371)
Q Consensus       142 v~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~  216 (371)
                      +++++++.  .....|+|++++. ++|.+++...     .......+..++.|++.||.|||+ +||+||||||+|||++
T Consensus       226 v~l~~~~~--~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILR--SEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEE--ECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC
Confidence            99999875  4557899999995 5888776432     223456778899999999999999 9999999999999999


Q ss_pred             cCCceEEecccccccCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCC-CCCCC-CcHHHHH
Q 017445          217 LKGRPKITDFGISAGLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP-YAASE-GPVNLML  293 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~p-f~~~~-~~~~~~~  293 (371)
                      .++.+||+|||++..+..... .....+||+.|+|||++.+..++.++|||||||++|||++|..+ |.... .....+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987654322 22346799999999999999999999999999999999998754 43322 1122222


Q ss_pred             HHhhCC------CCC------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          294 QILEDP------SPS------------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       294 ~~~~~~------~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +++...      .+.                        .....++.++.+++.+||+.||.+|||+.|+|.||||....
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            221100      000                        01123567788899999999999999999999999998765


Q ss_pred             ccc
Q 017445          344 HAK  346 (371)
Q Consensus       344 ~~~  346 (371)
                      .+.
T Consensus       462 ~~~  464 (501)
T PHA03210        462 EEE  464 (501)
T ss_pred             chH
Confidence            443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=304.42  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=201.6

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEecCC---Ce
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYMPDS---GQ  155 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~~~~---~~  155 (371)
                      |++.+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|+..+.++.  .|||++++++.+...+.   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            577889999999999999998889999999997422  222344556777665553  59999999998865332   23


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ++++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            8999999975 8999887643  48999999999999999999999 999999999999999999999999999987664


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-------------  300 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  300 (371)
                      ... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+.....             
T Consensus       159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCccc
Confidence            432 22344578899999999988899999999999999999999999976443 222332222100             


Q ss_pred             -----CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          301 -----PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       301 -----~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                           +.       .....++..+.+++++||+.||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 00       0012346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-40  Score=302.99  Aligned_cols=253  Identities=19%  Similarity=0.355  Sum_probs=208.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..++|++++.||+|+||+||+|..+.     +.+.||+|.+...... ....+.+|+.++.++. ||||+++++.+  .+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~   79 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLC--RE   79 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEE--CC
Confidence            34688999999999999999999654     3467999988653333 4567889999999986 99999999976  45


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEE
Q 017445          153 SGQISIALEYMDGGSLADILRMQK---------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI  223 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl  223 (371)
                      ....++||||+++++|.+++....         .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCCcEEE
Confidence            668999999999999999997655         68999999999999999999999 99999999999999999999999


Q ss_pred             ecccccccCcccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCC
Q 017445          224 TDFGISAGLENSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP  301 (371)
Q Consensus       224 ~Dfg~s~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  301 (371)
                      +|||++....... .......++..|+|||.+.+..++.++||||||+++|++++ |..||.... ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-~~~~~~~~~~~~~~  237 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-DEEVLNRLQAGKLE  237 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-hHHHHHHHHcCCcC
Confidence            9999986543221 12233456778999999988888999999999999999998 888996533 23344444444444


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ......++..+.+++.+||+.+|++||++.+++..
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            44556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=353.65  Aligned_cols=258  Identities=33%  Similarity=0.513  Sum_probs=220.9

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +|.-...||.|.||.||-|.+..+|+..|+|.++..  .......+.+|+.++..+. |||+|+++|+=.+  ...++|.
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH--Rekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH--REKVYIF 1312 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeec--HHHHHHH
Confidence            445566899999999999999999999999988753  2334456778888888776 9999999997654  4579999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--  237 (371)
                      ||||++|+|.+.+...+..++.....+..|++.|+.|||+ .|||||||||.||+++.+|.+|++|||.|..+.....  
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            9999999999999988888999999999999999999999 9999999999999999999999999999987765531  


Q ss_pred             --ccccccccCcccCCccccCC---CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          238 --MCATFVGTVTYMSPERIRNE---SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       238 --~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                        .....+||+.|||||++.+.   +-.-+.||||+|||+.||+||+.||..-++....+++...+..|.. +..++++.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-P~~ls~~g 1470 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-PERLSSEG 1470 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC-chhhhHhH
Confidence              12456899999999999653   4567899999999999999999999988877777777765555444 34599999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .+||..||+-||++|.++.|++.|-|-+--..
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence            99999999999999999999999998865443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=306.47  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=205.7

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      |++.+.||+|++|.||+|++..+++.||+|.+....  ......+..|+..+.++. |+|++++++++.  +....++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIH--TERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhh--cCCceEEEe
Confidence            456778999999999999999999999999997642  333456778899988886 999999999874  456899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||++ ++|.+++... ..+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||.+..........
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            9997 5999999865 579999999999999999999999 999999999999999999999999999987765543333


Q ss_pred             ccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh--------------------C
Q 017445          240 ATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--------------------D  298 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~--------------------~  298 (371)
                      ....++..|+|||.+.+. .++.++||||||+++|++++|..||...... ..+.++..                    .
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            445567889999998766 7899999999999999999999999764422 22221111                    0


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          299 PSPS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       299 ~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      ..+.       .....++..+.+++++||..+|++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000       0112347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.3e-40  Score=300.63  Aligned_cols=251  Identities=25%  Similarity=0.497  Sum_probs=206.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcC-CCcEEEEEEeccc----------cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIP-THRIIALKKINIF----------EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      +|.+.+.||+|+||.||+|.+.. +++.+|+|.+...          .......+..|+..+.+..+||||+++++.+. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            36778899999999999999877 6789999987532          22334557788888887667999999999874 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          151 PDSGQISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                       +.+..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+.++++|+||+|.||+++.++.++|+||
T Consensus        80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence             56789999999999999998742    3468999999999999999999996468999999999999999999999999


Q ss_pred             cccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          227 GISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      |.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+...........
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-MLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-HHHHHHHHhhccCCcCCcc
Confidence            9987655442 3345568999999999998889999999999999999999999996543 2333334434333333334


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .++.++.+++++||+.||++||++.++..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            678999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.8e-41  Score=299.24  Aligned_cols=229  Identities=23%  Similarity=0.284  Sum_probs=189.7

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHH
Q 017445           92 GASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADI  171 (371)
Q Consensus        92 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~  171 (371)
                      |.+|.||+|.+..+++.||+|++.....     ...|...+.... ||||+++++.+.  +....+++|||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~-~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHC-VPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcC-CCceeehhhhee--cCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999975322     223333333443 999999999874  45689999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCC
Q 017445          172 LRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP  251 (371)
Q Consensus       172 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aP  251 (371)
                      +.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++++|||.+.......   ....++..|+||
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aP  151 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAP  151 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCC
Confidence            9877789999999999999999999999 999999999999999999999999999876554431   334567889999


Q ss_pred             ccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH-
Q 017445          252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA-  330 (371)
Q Consensus       252 E~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-  330 (371)
                      |.+.+..++.++|+||+|+++|+|++|..|+......       .........+..+++.+.+++.+||+.||++||++ 
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            9998888999999999999999999999887543211       01111112335678999999999999999999985 


Q ss_pred             ----HHHhcCccc
Q 017445          331 ----DQLLSHPFI  339 (371)
Q Consensus       331 ----~~il~hp~~  339 (371)
                          ++++.||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.6e-40  Score=297.73  Aligned_cols=246  Identities=26%  Similarity=0.439  Sum_probs=204.0

Q ss_pred             eEeeeecccCCeEEEEEEEcCCC----cEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTH----RIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+.+.||.|+||.||++.+..++    ..||+|.+...... ....+..|+..+..+ +|+||+++++.+.  +.+..++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~--~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCT--EEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEc--CCCeeEE
Confidence            45678999999999999988766    89999999764332 567788999999888 5999999999774  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          159 ALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +|||+++++|.+++.....  +++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999999976544  9999999999999999999999 999999999999999999999999999987665432


Q ss_pred             cccc-cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          237 AMCA-TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      .... ...+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.... .......+ ........+..++.++.+
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~  235 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-NEEVLEYL-KKGYRLPKPENCPPEIYK  235 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH-hcCCCCCCCCcCCHHHHH
Confidence            2111 2236789999999988889999999999999999998 888886533 23333333 333333344568999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhc
Q 017445          315 FVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+||..||++|||+.++++
T Consensus       236 ~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      236 LMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-40  Score=300.78  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCc----EEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHR----IIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ...+|++.+.||+|+||+||+|.+..+|.    .+|+|...... ......+.+|+..+.++. ||||+++++.+..   
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS---   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec---
Confidence            34688999999999999999999877664    58999886533 345567888999998886 9999999998753   


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.+||+|||.+...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            5799999999999999999764 468999999999999999999999 99999999999999999999999999999766


Q ss_pred             ccccccc--ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          233 ENSIAMC--ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       233 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .......  ....++..|+|||.+.+..++.++|+||||+++||+++ |..||.... ... +.+.+........+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~-~~~~~~~~~~~~~~~~~~  237 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVE-IPDLLEKGERLPQPPICT  237 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHH-HHHHHhCCCCCCCCCCCC
Confidence            5332211  11223567999999988889999999999999999998 999997643 222 333333433344455678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      .++.+++.+||..+|.+||++.+++
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHH
Confidence            9999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-40  Score=298.53  Aligned_cols=242  Identities=22%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             eecccCCeEEEEEEEcC-CC--cEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           88 AIGSGASSVVQRAVHIP-TH--RIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .||+|++|.||+|.+.. .+  ..||+|.+..... .....+.+|+..+.++. ||||+++++.+..   ...++||||+
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e~~   77 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT---HPLMMVTELA   77 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC---CeEEEEEEec
Confidence            68999999999998755 33  3699999976544 56677889999999886 9999999998753   6899999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc---
Q 017445          164 DGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM---  238 (371)
Q Consensus       164 ~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~---  238 (371)
                      ++++|.+++....  .+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||.+.........   
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999997654  68999999999999999999999 99999999999999999999999999999776442211   


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+.........+..++..+.+++.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence            123456789999999998889999999999999999998 999996543 233334443333333344568899999999


Q ss_pred             HhcccCcCCCCCHHHHhc
Q 017445          318 DCLKKDAEARPTADQLLS  335 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~  335 (371)
                      +||..+|++||++.+++.
T Consensus       236 ~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         236 QCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHCCCCcccCCCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.4e-40  Score=306.02  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=204.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCc----EEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHR----IIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +...+|++.+.||+|+||.||+|.+..++.    .||+|.+.... ......+.+|+.++..+. ||||+++++.+..  
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLS--   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcC--
Confidence            345688899999999999999999877775    46888876532 233446788888888875 9999999997742  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                       ...++++||+++|+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+..
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEcccccccc
Confidence             34679999999999999987643 58999999999999999999999 9999999999999999999999999999976


Q ss_pred             Ccccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....  .......+........+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGERLPQPPIC  236 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCC
Confidence            5433221  122345678999999998889999999999999999997 999996543  22233444443333444567


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +..+.+++.+||..+|++||++.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2e-40  Score=335.77  Aligned_cols=147  Identities=25%  Similarity=0.407  Sum_probs=131.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+|.+++.||.|+||+||+|.+..+++.||||+++..   .......+..|+..+..+. ||||+++++.+.  ....+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQ--SANNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEE--ECCEE
Confidence            35899999999999999999999999999999998642   2334466778888887765 999999998764  45689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ||||||+.|++|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999887889999999999999999999999 899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3e-40  Score=303.03  Aligned_cols=251  Identities=22%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+.... ......+.+|+..+.++. ||||+++++++  .+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~--~~   79 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVC--AV   79 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEE--cC
Confidence            34688999999999999999998743     67889999987532 344566888999998886 99999999976  44


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          153 SGQISIALEYMDGGSLADILRMQK----------------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~----------------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      ....+++|||+++++|.+++....                      .+++..++.++.|++.||.|||+ ++++||||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p  158 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT  158 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence            567999999999999999986432                      36788899999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG  287 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~  287 (371)
                      +||+++.++.++|+|||.+........  .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.... 
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-  237 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-  237 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            999999999999999999875433211  1122334667999999988889999999999999999997 888986543 


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .......+..... ...+..++.++.+|+.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            2333444433332 2334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-40  Score=303.21  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=207.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEc----CCCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHI----PTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ..+|++.+.||+|+||.||+|...    .++..+|+|.+...... ....+.+|+..+..+. ||||+++++++......
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCC
Confidence            356778889999999999999864    34789999999764433 5667889999998885 99999999987655566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            8999999999999999997654 58999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccccc---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-------------HHHHHHHhh
Q 017445          234 NSIAM---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-------------VNLMLQILE  297 (371)
Q Consensus       234 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-------------~~~~~~~~~  297 (371)
                      .....   .....++..|+|||.+.+..++.++||||||+++++|++|..|+......             ...+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            32211   11234556799999998888999999999999999999999998653321             112223333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .......+..++.++.+++.+||..+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33333444567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.8e-40  Score=304.49  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=199.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcC----------------CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIP----------------THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGL  141 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i  141 (371)
                      ..++|++.+.||+|+||.||++.+..                ++..+|+|++... .......+.+|+..+..+. |+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCc
Confidence            45689999999999999999986432                3457999998753 3445567889999998886 9999


Q ss_pred             eEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       142 v~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      +++++++.  .....++||||+++++|.+++....           .+++..+..++.|++.||.|||+ +|++||||||
T Consensus        82 ~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCI--TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             ceEEEEEe--cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            99999874  4557999999999999999987532           36678899999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc--CCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT--GEFPYAASE  286 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~--g~~pf~~~~  286 (371)
                      +||+++.++.++|+|||.+........  ......+++.|++||...++.++.++|+|||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999999876543221  1122334678999999888889999999999999999998  778886543


Q ss_pred             CcHHHHHHH---h---hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          287 GPVNLMLQI---L---EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       287 ~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .. ..+...   .   ......+.+..+++.+.+|+.+||+.||++||++.+|++
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         239 DE-QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hH-HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            22 211111   1   111122334567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-41  Score=336.88  Aligned_cols=252  Identities=24%  Similarity=0.427  Sum_probs=214.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCC-----cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTH-----RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      +........+.||+|+||.||.|....-.     ..||+|.++. .+.+....|++|..++.++. |||||+++|++.. 
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~-  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLD-  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecC-
Confidence            55678888999999999999999865432     3499999976 46677888999999999997 9999999998864 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEe
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKIT  224 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~  224 (371)
                       .+..+|++|||+||+|..+|++.       ..++...+..++.||+.|+.||++ +++|||||..+|+|++....+||+
T Consensus       767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccCcEEEc
Confidence             66899999999999999999865       248899999999999999999999 999999999999999999999999


Q ss_pred             cccccccCccccccc-ccc-cccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCC
Q 017445          225 DFGISAGLENSIAMC-ATF-VGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP  301 (371)
Q Consensus       225 Dfg~s~~~~~~~~~~-~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  301 (371)
                      |||+|+.+....... ... .-...|||||.+..+.++.++||||||+++||++| |..||.+..+ .+.+....++. .
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~~~gg-R  922 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDVLEGG-R  922 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHHHhCC-c
Confidence            999998554332221 111 23468999999999999999999999999999998 9999987654 34444455555 6


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ...+..+|+.+.+++..||..+|++||++..|++
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            6677899999999999999999999999999987

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.5e-40  Score=296.30  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      |.+...+|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.++..+. |+||+++++.+.  + ..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~-~~   74 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT--K-EP   74 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcC-CCCcceEEEEEc--C-CC
Confidence            3456678999999999999999999754 4556999988653 334566888999988886 999999998764  3 57


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      .+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            89999999999999999753  357888999999999999999999 999999999999999999999999999987654


Q ss_pred             ccccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          234 NSIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       234 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ..... .....++..|+|||++.+..++.++|+||||+++|++++ |..||..... .... ..+............+.+
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~  231 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVI-RALERGYRMPRPENCPEE  231 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHH-HHHhCCCCCCCcccCCHH
Confidence            32211 122345677999999988889999999999999999998 9999976442 2223 333343444445678899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+++.+||+.+|++||++.+++.
T Consensus       232 ~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         232 LYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.8e-40  Score=295.67  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=202.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|++.+.||+|+||.||+|.+. .++.+|+|.+.... .....+.+|+..+..+. |||++++++.+  ......++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLS-HPKLVQLYGVC--TERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCC-CCCeeeEEEEE--ccCCceEEE
Confidence            357889999999999999999875 46789999886422 22346788999998886 99999999976  445689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      |||+++++|.+++... +.++++.+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            9999999999998754 468999999999999999999999 9999999999999999999999999999875543211 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+ ........+...+..+.+|+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETI-NAGFRLYKPRLASQSVYELM  234 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH-hCCCCCCCCCCCCHHHHHHH
Confidence            1122335678999999998889999999999999999998 9999965432 2333333 22222223445789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017445          317 DDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+||+.+|++||++.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-40  Score=293.50  Aligned_cols=241  Identities=24%  Similarity=0.376  Sum_probs=196.7

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      .||+|+||.||+|.. .++..+|+|.+... .......+.+|+..+..+. ||||+++++.+.  .....++||||++++
T Consensus         2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~~   77 (250)
T cd05085           2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCT--QRQPIYIVMELVPGG   77 (250)
T ss_pred             ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEe--cCCccEEEEECCCCC
Confidence            699999999999985 46889999998653 2334456888999988875 999999999774  456899999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc-ccccc
Q 017445          167 SLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC-ATFVG  244 (371)
Q Consensus       167 ~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~-~~~~g  244 (371)
                      +|.+++... ..+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++.......... ....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            999998653 458999999999999999999999 999999999999999999999999999987544332211 12234


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD  323 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  323 (371)
                      ++.|+|||++.+..++.++||||||+++|++++ |..||..... ......+ ........+..++..+.+++.+||..+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            567999999988889999999999999999998 9999976432 2222232 333333344568899999999999999


Q ss_pred             cCCCCCHHHHhc
Q 017445          324 AEARPTADQLLS  335 (371)
Q Consensus       324 p~~Rps~~~il~  335 (371)
                      |++||++.++++
T Consensus       235 p~~Rp~~~~l~~  246 (250)
T cd05085         235 PENRPKFSELQK  246 (250)
T ss_pred             cccCCCHHHHHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-40  Score=294.45  Aligned_cols=241  Identities=25%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      .||+|+||.||+|.+.. ++.||+|.+..... .....+..|+.++.++. ||||+++++.+.  +....++||||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--~~~~~~~v~e~~~~~   77 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCV--QKQPIYIVMELVPGG   77 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEe--cCCCeEEEEEcCCCC
Confidence            69999999999999877 89999999875332 35567888999888886 999999999774  556899999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc--cccc
Q 017445          167 SLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC--ATFV  243 (371)
Q Consensus       167 ~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~--~~~~  243 (371)
                      +|.+++.. ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||.+..........  ....
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            99999865 3468999999999999999999999 999999999999999999999999999987654321111  1223


Q ss_pred             ccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhccc
Q 017445          244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK  322 (371)
Q Consensus       244 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  322 (371)
                      .+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....  ......+........+..++.++.+++.+||..
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            4567999999988889999999999999999998 8899966442  222333333333334567889999999999999


Q ss_pred             CcCCCCCHHHHhc
Q 017445          323 DAEARPTADQLLS  335 (371)
Q Consensus       323 dp~~Rps~~~il~  335 (371)
                      +|++||++.+++.
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.5e-40  Score=297.80  Aligned_cols=243  Identities=19%  Similarity=0.286  Sum_probs=189.6

Q ss_pred             eecccCCeEEEEEEEc--CCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHI--PTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|...  .++..+|+|.++... ......+.+|+..+..+. ||||+++++.+  .+....++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQC--TEVTPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--cCCCCcEEEEECCC
Confidence            6999999999999754  355779999987533 334456888999988886 99999999977  44567899999999


Q ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--
Q 017445          165 GGSLADILRMQK-----SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--  237 (371)
Q Consensus       165 ~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--  237 (371)
                      +|+|.+++....     ..++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||.+........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999999986432     35677888999999999999999 9999999999999999999999999999865433221  


Q ss_pred             ccccccccCcccCCccccCC-------CCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCC---CCCC
Q 017445          238 MCATFVGTVTYMSPERIRNE-------SYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPS---PSRQ  306 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  306 (371)
                      ......+++.|+|||++.+.       .++.++|+||||+++|+|++ |..||............+.......   ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence            11234578889999998642       35789999999999999996 9999976544332222222222211   1123


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..++.+.++++.|+ .+|++|||+++|+.
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            56788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7e-40  Score=296.15  Aligned_cols=243  Identities=22%  Similarity=0.358  Sum_probs=193.2

Q ss_pred             eecccCCeEEEEEEEcC---CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           88 AIGSGASSVVQRAVHIP---THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .||+|+||.||+|.+..   .+..||+|.+.. ........+.+|+..+..+. ||||+++++.+.. ..+..+++|||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLP-SEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEeec-CCCCcEEEEecC
Confidence            68999999999998653   346799999854 33445667888888887775 9999999997653 345688999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc----cc
Q 017445          164 DGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI----AM  238 (371)
Q Consensus       164 ~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~----~~  238 (371)
                      .+++|.+++... ...++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......    ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            999999999754 346778888999999999999999 999999999999999999999999999987554321    11


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG-EFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      .....+++.|+|||.+.+..++.++||||||+++|||++| .+||.... ........... .....+..+++.+.+++.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  236 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-SFDITVYLLQG-RRLLQPEYCPDPLYEVML  236 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhcC-CCCCCCCcCCHHHHHHHH
Confidence            1233457789999999888899999999999999999995 56665433 33333333332 233334567899999999


Q ss_pred             HhcccCcCCCCCHHHHhc
Q 017445          318 DCLKKDAEARPTADQLLS  335 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~  335 (371)
                      +||..+|++||++.+++.
T Consensus       237 ~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         237 SCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHcCCChhhCCCHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.3e-41  Score=337.84  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=208.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec-------
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP-------  151 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~-------  151 (371)
                      .++|+.++.||+||||.||+++++-+|+.||||++... ......++.+|+..+.++. |||||+++.+|...       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCccccc
Confidence            36888999999999999999999999999999999764 3445567899999999997 99999998887000       


Q ss_pred             ---------------------------------------------------------C----------------------
Q 017445          152 ---------------------------------------------------------D----------------------  152 (371)
Q Consensus       152 ---------------------------------------------------------~----------------------  152 (371)
                                                                               +                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                     0                      


Q ss_pred             -----------------------C--------CeEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHcC
Q 017445          153 -----------------------S--------GQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHGV  200 (371)
Q Consensus       153 -----------------------~--------~~~~lv~E~~~~g~L~~~l~~~~~l-~~~~~~~i~~qi~~aL~~LH~~  200 (371)
                                             .        ..+||-||||+..+|.++++.+... ....+|.++++|++||.|+|+ 
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-  715 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-  715 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh-
Confidence                                   0        2478999999998888888765544 578899999999999999999 


Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccccCc------------------ccccccccccccCcccCCccccCCC---C
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLE------------------NSIAMCATFVGTVTYMSPERIRNES---Y  259 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~---~  259 (371)
                      .|||||||||.||+++.++.|||+|||+|+...                  ......++.+||..|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999997621                  0111335678999999999997655   9


Q ss_pred             CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       260 ~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      +.|+|+||||+||+||+.   ||...-+....+.++..+..+.+  ....--+.-..+|++|++.||++|||+.|+|.+.
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~  872 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE  872 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence            999999999999999986   57554444444444444444443  1222335667899999999999999999999999


Q ss_pred             cccc
Q 017445          338 FITK  341 (371)
Q Consensus       338 ~~~~  341 (371)
                      ||..
T Consensus       873 llpp  876 (1351)
T KOG1035|consen  873 LLPP  876 (1351)
T ss_pred             CCCc
Confidence            9985

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-40  Score=300.02  Aligned_cols=237  Identities=21%  Similarity=0.340  Sum_probs=187.0

Q ss_pred             eecccCCeEEEEEEEcCC------------------------CcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeE
Q 017445           88 AIGSGASSVVQRAVHIPT------------------------HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE  143 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~  143 (371)
                      .||+|+||.||+|....+                        ...||+|++..........+.+|+..+..+. ||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~-h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS-HIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC-CCCeee
Confidence            699999999999974321                        2458899887644444556777887777665 999999


Q ss_pred             eceeEEecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---
Q 017445          144 FHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---  219 (371)
Q Consensus       144 l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---  219 (371)
                      +++++.  +....++||||+++|+|..++.. .+.+++..+..++.|++.||+|||+ +||+||||||+||+++..+   
T Consensus        81 ~~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCV--RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEE--eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEeccCccc
Confidence            999875  45588999999999999999865 4568999999999999999999999 9999999999999998654   


Q ss_pred             ----ceEEecccccccCcccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHh-cCCCCCCCCCCcHHHHH
Q 017445          220 ----RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECG-TGEFPYAASEGPVNLML  293 (371)
Q Consensus       220 ----~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell-~g~~pf~~~~~~~~~~~  293 (371)
                          .++++|||.+......    ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||........  .
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--E  231 (274)
T ss_pred             CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--H
Confidence                4899999987544322    23457888999998865 56899999999999999985 79999976443221  1


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ........  .+...++++.+++.+||+.+|++|||+.+++++
T Consensus       232 ~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22222211  123356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-40  Score=300.18  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=189.6

Q ss_pred             eecccCCeEEEEEEEcCCCc-------EEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           88 AIGSGASSVVQRAVHIPTHR-------IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      .||+|+||.||+|.+..++.       .+|+|.+..........+..|+..+..+. ||||+++++.+..  ....++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~--~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS-HKHLVLNYGVCVC--GDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC-CCChhheeeEEEe--CCCcEEEE
Confidence            69999999999998765544       38888876544445566777888887775 9999999998864  45789999


Q ss_pred             eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc--------eEEeccccccc
Q 017445          161 EYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR--------PKITDFGISAG  231 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~--------~kl~Dfg~s~~  231 (371)
                      ||+++|+|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.        ++++|||.+..
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999997644 58999999999999999999999 99999999999999987764        69999999865


Q ss_pred             CcccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE-FPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ....    ....+++.|+|||++.+ ..++.++||||||+++|+|++|. .||.... ... .........  ..+...+
T Consensus       158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~-~~~~~~~~~--~~~~~~~  229 (258)
T cd05078         158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQK-KLQFYEDRH--QLPAPKW  229 (258)
T ss_pred             cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHH-HHHHHHccc--cCCCCCc
Confidence            5432    34568899999999976 45799999999999999999985 6664433 222 122222222  2233466


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .++.+++.+||+.||++|||++++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         230 TELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.7e-40  Score=302.28  Aligned_cols=256  Identities=19%  Similarity=0.249  Sum_probs=192.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEeccccHHH--H---------HHHHHHHHHHHhCCCCCCee
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINIFEKEK--R---------NQLLTEIRTLCEAPCNEGLV  142 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~~~~h~~iv  142 (371)
                      ++...+|++.+.||+|+||+||+|.+..+   +..+|+|+........  .         .....+...+..+ .|++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~   86 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP   86 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence            34557899999999999999999998777   6677787654322111  0         1112222233333 599999


Q ss_pred             EeceeEEecCCC--eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc
Q 017445          143 EFHGAFYMPDSG--QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR  220 (371)
Q Consensus       143 ~l~~~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~  220 (371)
                      ++++++......  ..++++|++. .++.+.+......++..+..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCc
Confidence            999876543322  4578899885 4788877766667899999999999999999999 99999999999999999999


Q ss_pred             eEEecccccccCcccc-------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 017445          221 PKITDFGISAGLENSI-------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML  293 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~  293 (371)
                      ++|+|||+|+......       .......||+.|+|||++.+..++.++|||||||++|||++|..||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999997653221       112334699999999999999999999999999999999999999987533222211


Q ss_pred             H----HhhC-CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          294 Q----ILED-PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       294 ~----~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .    .+.. .........+++++.++++.|+..+|++||++.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1    1111 1111123456899999999999999999999999875

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.1e-40  Score=295.38  Aligned_cols=242  Identities=23%  Similarity=0.400  Sum_probs=199.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||.||++..  +++.||+|.++...  ....+.+|+..+..+. |||++++++.+..   ...+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~~~~~v   76 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLH-HKNLVRLLGVILH---NGLYIV   76 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---CCcEEE
Confidence            46789999999999999999864  77889999986532  2356788999888886 9999999998742   347999


Q ss_pred             EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          160 LEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||.+....... 
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            99999999999997543  47999999999999999999999 999999999999999999999999999987543321 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                        .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .... ..+...........++..+.+++
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVK-ECVEKGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-HHHH-HHHhCCCCCCCCCcCCHHHHHHH
Confidence              22334678999999988889999999999999999997 9999976543 2222 33333333334567899999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 017445          317 DDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~  335 (371)
                      ++||+.+|.+||++++++.
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.5e-40  Score=296.49  Aligned_cols=237  Identities=19%  Similarity=0.323  Sum_probs=188.1

Q ss_pred             eecccCCeEEEEEEEcC------------CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           88 AIGSGASSVVQRAVHIP------------THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      .||+|+||.||+|....            ....||+|.+..........+.+|+..+..+. ||||+++++++.  ....
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~--~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS-HKHIVLLYGVCV--RDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCC
Confidence            69999999999997432            22358899886655555556777888887776 999999999875  4457


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc-------eEEeccc
Q 017445          156 ISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR-------PKITDFG  227 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~-------~kl~Dfg  227 (371)
                      .++||||+++++|..++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.       ++++|||
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            8999999999999998875 3568999999999999999999999 99999999999999987664       8999999


Q ss_pred             ccccCcccccccccccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHh-cCCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          228 ISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECG-TGEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       228 ~s~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .+......    ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......  ...........  ..
T Consensus       158 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~~~--~~  229 (262)
T cd05077         158 IPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKERFYEGQCM--LV  229 (262)
T ss_pred             CCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHHHHHhcCcc--CC
Confidence            98655332    3345788999999986 566899999999999999998 588888653321  11222222211  12


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ...++++.+|+.+||+.||.+||++.+|+++
T Consensus       230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            2346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.1e-40  Score=295.34  Aligned_cols=234  Identities=24%  Similarity=0.357  Sum_probs=190.1

Q ss_pred             eecccCCeEEEEEEEcCCC----------cEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           88 AIGSGASSVVQRAVHIPTH----------RIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .||+|+||.||+|.+..++          ..+++|.+...... ...+.+|+.++.++. ||||+++++.+..   ...+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLS-HKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCC-CcchhheeeEEec---CCcE
Confidence            6999999999999988776          45888877653333 567788888888886 9999999998754   4679


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-------ceEEeccccc
Q 017445          158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-------RPKITDFGIS  229 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-------~~kl~Dfg~s  229 (371)
                      +||||+++|+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+||+++.++       .+||+|||.+
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999997655 78999999999999999999999 9999999999999999887       7999999998


Q ss_pred             ccCcccccccccccccCcccCCccccCC--CCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNE--SYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ......    ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||..... ..... ........+  .
T Consensus       156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~-~~~~~~~~~--~  227 (259)
T cd05037         156 ITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKER-FYQDQHRLP--M  227 (259)
T ss_pred             cccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHH-HHhcCCCCC--C
Confidence            765442    344577889999999776  78999999999999999999 6788865432 22111 111111111  1


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .....+.+++.+||..+|++||++.++++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-39  Score=296.14  Aligned_cols=242  Identities=20%  Similarity=0.331  Sum_probs=187.8

Q ss_pred             eecccCCeEEEEEEEcC--CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIP--THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||+||+|....  ....+|+|.+... .......+.+|+..+..+. ||||+++++.+.  .....++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~--~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCI--ESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEEC--CCCceEEEEEeCC
Confidence            69999999999996432  3457888887543 3344566788998888775 999999999774  4568999999999


Q ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc--
Q 017445          165 GGSLADILRMQK-----SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--  237 (371)
Q Consensus       165 ~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--  237 (371)
                      +|+|.+++....     ..++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999997543     24678889999999999999999 9999999999999999999999999999865432211  


Q ss_pred             ccccccccCcccCCccccC-------CCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCC-CC---CCCC
Q 017445          238 MCATFVGTVTYMSPERIRN-------ESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDP-SP---SPSR  305 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~-~~---~~~~  305 (371)
                      ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||...... ....+.+... ..   ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhccCccCCCCccc
Confidence            1123345678999998743       356789999999999999999 88898765433 3333333222 11   1223


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..++..+.+++..|+ .||++||++++|++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            467889999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=302.37  Aligned_cols=260  Identities=30%  Similarity=0.401  Sum_probs=207.8

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCC-----CeeEeceeEE
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-----GLVEFHGAFY  149 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~-----~iv~l~~~~~  149 (371)
                      .-.....+|.+++.+|+|+||.|-++.+..++..||||+++... ..++....|+.++.++..+.     .+|++.++|-
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            33455789999999999999999999999999999999997533 33445667888888774332     3677777663


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc----------
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL----------  217 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~----------  217 (371)
                        -.++.|||+|.+ |.+++++|..++  +++...++.+++|++++++|||+ .+++|.||||+|||+..          
T Consensus       162 --yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  162 --YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             --ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccC
Confidence              367999999998 669999997653  68999999999999999999999 89999999999999942          


Q ss_pred             ----------CCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC
Q 017445          218 ----------KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG  287 (371)
Q Consensus       218 ----------~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~  287 (371)
                                +..++|+|||.|+.....   ..+.+.|.-|+|||++.+-+++..+||||+||||+|+++|...|...++
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                      235899999999765443   2677899999999999999999999999999999999999999987664


Q ss_pred             cHHH--HHHHhhCCCCCCC---------------------CC---------------------CCCHHHHHHHHHhcccC
Q 017445          288 PVNL--MLQILEDPSPSPS---------------------RQ---------------------NFSPEFCSFVDDCLKKD  323 (371)
Q Consensus       288 ~~~~--~~~~~~~~~~~~~---------------------~~---------------------~~~~~~~~li~~~l~~d  323 (371)
                      .+.+  +..+++ +.|...                     ..                     .-..++.+|+++||..|
T Consensus       315 ~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  315 LEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             HHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            4432  223332 221100                     00                     00135889999999999


Q ss_pred             cCCCCCHHHHhcCccccccc
Q 017445          324 AEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       324 p~~Rps~~~il~hp~~~~~~  343 (371)
                      |.+|+|+.|+|.||||+...
T Consensus       394 P~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  394 PARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccccHHHHhcCHHhhcCC
Confidence            99999999999999998764

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-39  Score=295.90  Aligned_cols=242  Identities=24%  Similarity=0.396  Sum_probs=196.4

Q ss_pred             eecccCCeEEEEEEEcCCC------cEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           88 AIGSGASSVVQRAVHIPTH------RIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      .||+|+||.||+|.+....      +.+|+|.+.... ......+.+|+..+..+. ||||+++++.+.  .....++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCL--LNEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeec--CCCCeEEEE
Confidence            6999999999999876543      689999886432 344567888999988886 999999999874  455799999


Q ss_pred             eccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-----ceEEecccc
Q 017445          161 EYMDGGSLADILRMQ-------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-----RPKITDFGI  228 (371)
Q Consensus       161 E~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-----~~kl~Dfg~  228 (371)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++     .++|+|||+
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999998642       347889999999999999999999 9999999999999999887     899999999


Q ss_pred             cccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          229 SAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       229 s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      +........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...... +........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~~~~~~-~~~~~~~~~~  235 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQH-VTAGGRLQKP  235 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-HHHHHH-HhcCCccCCc
Confidence            876543211  1123346788999999998899999999999999999998 9999975442 233222 2333333344


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..++..+.+++.+||..+|.+||+++++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            678899999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-40  Score=311.13  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=215.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      -....+-|..++.||-|+||+|.++...+|...||+|.+.+.+.   ....-+..|..+|.... .+.||+||..|  ++
T Consensus       624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySF--QD  700 (1034)
T KOG0608|consen  624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSF--QD  700 (1034)
T ss_pred             hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEe--cc
Confidence            34556788999999999999999999999999999999876443   33334567888888776 89999999887  67


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...+|+||+|++||++-.+|-+-+-|+|+.++.++.++..|+++.|. -|+|||||||+|||||.+|++||+|||+++-+
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeeccccccc
Confidence            88999999999999999999888999999999999999999999999 99999999999999999999999999999533


Q ss_pred             c---------cc---------------------------------ccccccccccCcccCCccccCCCCCCchhHHHHHH
Q 017445          233 E---------NS---------------------------------IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL  270 (371)
Q Consensus       233 ~---------~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  270 (371)
                      .         +.                                 .......+||+.|+|||++....|+..+|+||.|+
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1         00                                 00112357999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCCCcHHHHHHH--hhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccc
Q 017445          271 ALFECGTGEFPYAASEGPVNLMLQI--LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT---ADQLLSHPFITKYE  343 (371)
Q Consensus       271 il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~il~hp~~~~~~  343 (371)
                      |||||+.|+.||-+..-. ....++  .+.........+++.++.++|.+++ -+++.|+.   +++|-.||||+.+.
T Consensus       860 il~em~~g~~pf~~~tp~-~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPG-ETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             HHHHHhhCCCCccCCCCC-cceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence            999999999999765422 112222  2333444555789999999999765 47888865   78899999998654

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.4e-39  Score=293.40  Aligned_cols=250  Identities=19%  Similarity=0.350  Sum_probs=199.2

Q ss_pred             eeEeeeecccCCeEEEEEEEc---CCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC---
Q 017445           83 MRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG---  154 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~---  154 (371)
                      |++.+.||+|+||.||+|.+.   .+++.||||.+...  ......++.+|+..+..+. ||||+++++.+...+..   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcc
Confidence            466779999999999999864   35789999998642  3445667889999988886 99999999987543221   


Q ss_pred             -eEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          155 -QISIALEYMDGGSLADILRMQ------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       155 -~~~lv~E~~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                       ..++++||+.+|+|.+++...      ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECccc
Confidence             357899999999999887432      247889999999999999999999 999999999999999999999999999


Q ss_pred             ccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          228 ISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       228 ~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .+........  ......+++.|++||.+.+..++.++||||||+++|+|++ |..||..... ......+... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~-~~~~~  236 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKG-NRLKQ  236 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHHcC-CcCCC
Confidence            9876543221  1123345678999999988889999999999999999999 8899965432 3333333332 22233


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ...+++.+.+++.+||..+|++|||+.+++.+
T Consensus       237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            35678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-41  Score=287.71  Aligned_cols=279  Identities=24%  Similarity=0.325  Sum_probs=218.6

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-c-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe--
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-E-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM--  150 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~--  150 (371)
                      .+-...+.|+.+.+||+|.||+||+|+.+.+|+.||+|++-.. + ..--...++|+.+|..+. |+|++.++..+..  
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~   89 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKA   89 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhcc
Confidence            3444456777888999999999999999999999999976431 1 122344678999998887 9999999887632  


Q ss_pred             ----cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEec
Q 017445          151 ----PDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD  225 (371)
Q Consensus       151 ----~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~D  225 (371)
                          .+...+|+|+.+|+. +|..++... -+++..++..++.+++.||.|+|+ ..|+|||+|+.|+||+.+|.+||+|
T Consensus        90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeec
Confidence                233469999999986 999999754 469999999999999999999999 8899999999999999999999999


Q ss_pred             ccccccCcccc----cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhC
Q 017445          226 FGISAGLENSI----AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILED  298 (371)
Q Consensus       226 fg~s~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~  298 (371)
                      ||+++.+....    ...+..+-|++|++||.+.| ..|+++.|||+.||++.||.++.+.+.+..+...+  +.+....
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            99996553321    12345577999999999866 45999999999999999999999999876544322  2222222


Q ss_pred             CCCCCCC------------------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccccc
Q 017445          299 PSPSPSR------------------------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       299 ~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~  348 (371)
                      -.++..+                              -.-.+++.+|+..++..||.+|++++++|.|.||..-.-+..+
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqan  327 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQAN  327 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhh
Confidence            2111110                              0113688999999999999999999999999999776666667


Q ss_pred             HHHHHHHh
Q 017445          349 LAAFVRSV  356 (371)
Q Consensus       349 ~~~~~~~~  356 (371)
                      +.+++...
T Consensus       328 l~~ml~t~  335 (376)
T KOG0669|consen  328 LQDMLSTH  335 (376)
T ss_pred             HHHHHHHh
Confidence            76666653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.1e-39  Score=319.00  Aligned_cols=261  Identities=20%  Similarity=0.298  Sum_probs=182.0

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCC----CcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE--
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPT----HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY--  149 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~--  149 (371)
                      ..+..++|++.+.||+|+||.||+|.+..+    +..||+|++......  +....+.  +... ++.+++.+...+.  
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~--l~~~-~~~~~~~~~~~~~~~  201 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNER--VRRA-CPNSCADFVYGFLEP  201 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHH--HHhh-chhhHHHHHHhhhcc
Confidence            345678999999999999999999999888    899999998642211  1111111  1111 1222322222211  


Q ss_pred             --ecCCCeEEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHcCCCeEecC
Q 017445          150 --MPDSGQISIALEYMDGGSLADILRMQKS--------------------IPEPILSSMFKKLLQGLSYLHGVRHLVHRD  207 (371)
Q Consensus       150 --~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~aL~~LH~~~~iiH~D  207 (371)
                        ..+....+|||||+.+++|.+++.....                    ..+..+..++.|++.||.|||+ ++|+|||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRD  280 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRD  280 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCc
Confidence              1345679999999999999999864321                    1234466899999999999999 9999999


Q ss_pred             CCCCcEEEcc-CCceEEecccccccCcccc-cccccccccCcccCCccccCC----------------------CCCCch
Q 017445          208 IKPANLLVNL-KGRPKITDFGISAGLENSI-AMCATFVGTVTYMSPERIRNE----------------------SYSYPA  263 (371)
Q Consensus       208 lkp~NIl~~~-~~~~kl~Dfg~s~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  263 (371)
                      |||+|||++. ++.+||+|||+|+...... .......+++.|+|||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5899999999997654321 223566899999999976322                      234467


Q ss_pred             hHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC-CC---------CCCC----------CCCCCHHHHHHHHHhcccC
Q 017445          264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILED-PS---------PSPS----------RQNFSPEFCSFVDDCLKKD  323 (371)
Q Consensus       264 Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~---------~~~~----------~~~~~~~~~~li~~~l~~d  323 (371)
                      ||||+||++|||+++..++...   ...+...+.. ..         ....          .........+||.+||+.|
T Consensus       361 DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999999987665321   1111111111 00         0000          0112334668999999999


Q ss_pred             cCCCCCHHHHhcCccccccccc
Q 017445          324 AEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       324 p~~Rps~~~il~hp~~~~~~~~  345 (371)
                      |++|||+.++|+||||++....
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCcc
Confidence            9999999999999999876654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=270.83  Aligned_cols=230  Identities=34%  Similarity=0.614  Sum_probs=197.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      +..+++.-+..||+|+||.|-+.++..+|...|+|.+.. .+.+..++.++|+.+..+...+|++|+++|+++  +++.+
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccE
Confidence            334455566689999999999999999999999999975 456677889999999999888999999999886  46689


Q ss_pred             EEEEeccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          157 SIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      +|.||.|+- +|+.+.    ++.+.++|..+-+|+..++.||.|||+.-.+||||+||+|||++.+|++|+||||.+..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999964 888764    456789999999999999999999999558999999999999999999999999999888


Q ss_pred             cccccccccccccCcccCCccccC----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRN----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .++... +-..|...|||||.+..    ..|+-+|||||||+++.||.+++.||.....+...+.++++++.+......+
T Consensus       200 ~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~~~F  278 (282)
T KOG0984|consen  200 VDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPADTF  278 (282)
T ss_pred             hhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCccccc
Confidence            765332 23568999999999843    4689999999999999999999999999999999999999998877665555


Q ss_pred             CHH
Q 017445          309 SPE  311 (371)
Q Consensus       309 ~~~  311 (371)
                      |.+
T Consensus       279 S~e  281 (282)
T KOG0984|consen  279 SPE  281 (282)
T ss_pred             CCC
Confidence            543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.1e-38  Score=285.97  Aligned_cols=242  Identities=17%  Similarity=0.297  Sum_probs=186.6

Q ss_pred             eecccCCeEEEEEEEcCC--CcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPT--HRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      .||+|+||.||+|....+  ...+++|.+.... ......+.+|+..+..+. ||||+++++.+.  +....|+||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~--~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCV--EAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEec--CCCccEEEEecCC
Confidence            699999999999975433  3456777766432 345567888988888775 999999999874  4567999999999


Q ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc--cc
Q 017445          165 GGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI--AM  238 (371)
Q Consensus       165 ~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~  238 (371)
                      +|+|.+++...    ...++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+.......  ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999999753    235677788999999999999999 999999999999999999999999999876432211  12


Q ss_pred             cccccccCcccCCccccC-------CCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCC----CCCCCC
Q 017445          239 CATFVGTVTYMSPERIRN-------ESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPS----PSPSRQ  306 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~  306 (371)
                      .....+++.|+|||++.+       ..++.++||||||+++|||++ |..||.... ........+....    ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhcccccCCCccCC
Confidence            234568899999999843       235789999999999999996 577886543 2333333332221    122234


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+.++++.|| .+|++||++++|++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            57889999999999 68999999999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=311.54  Aligned_cols=243  Identities=28%  Similarity=0.501  Sum_probs=195.2

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CCeEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SGQIS  157 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~~~~  157 (371)
                      |..-+.||+|+||.||+++++.+|+.||||.++. .....++...+|+++++++. |||||++++.=-...    .....
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccce
Confidence            4455589999999999999999999999999976 33455677889999999998 999999988532111    23467


Q ss_pred             EEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc--cCC--ceEEecccccc
Q 017445          158 IALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN--LKG--RPKITDFGISA  230 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~--~~~--~~kl~Dfg~s~  230 (371)
                      +|||||.||+|...+..   ...+++.+...++.+++.||.|||. +||+||||||.||++-  .+|  .-||+|||.|+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            99999999999999964   3569999999999999999999998 9999999999999983  334  46999999999


Q ss_pred             cCcccccccccccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH---HHHHHhhCCC------
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPS------  300 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~------  300 (371)
                      .+.++. ...+.+||+.|.+||.+. +..|+..+|.|||||++|+++||..||.+...+..   ...+++....      
T Consensus       173 el~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  173 ELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             cCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            988874 668899999999999998 58899999999999999999999999987655532   2222222111      


Q ss_pred             -------------CCCCCCCCCH----HHHHHHHHhcccCcCCCC
Q 017445          301 -------------PSPSRQNFSP----EFCSFVDDCLKKDAEARP  328 (371)
Q Consensus       301 -------------~~~~~~~~~~----~~~~li~~~l~~dp~~Rp  328 (371)
                                   ..+.+..+++    .+...+..+|..+|.+|-
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                         1122233333    344677788899999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.4e-38  Score=303.61  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=191.5

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc----------------CCCcEEEEEEeccccHHHHHHH--------------H
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI----------------PTHRIIALKKINIFEKEKRNQL--------------L  126 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~  126 (371)
                      ++..++|++.++||+|+||+||+|...                ..++.||||++..........+              .
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            456889999999999999999999642                3456899999875433322222              3


Q ss_pred             HHHHHHHhCCCCC----CeeEeceeEEec------CCCeEEEEEeccCCCCHHHHHHhcC--------------------
Q 017445          127 TEIRTLCEAPCNE----GLVEFHGAFYMP------DSGQISIALEYMDGGSLADILRMQK--------------------  176 (371)
Q Consensus       127 ~E~~~l~~~~~h~----~iv~l~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~--------------------  176 (371)
                      .|+..+.++.+++    ++++++++|...      +.+..+|||||+++++|.++++...                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            4555666665332    346677765431      2356899999999999999886321                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc-cccccccCcccCC
Q 017445          177 ----SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM-CATFVGTVTYMSP  251 (371)
Q Consensus       177 ----~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~-~~~~~gt~~y~aP  251 (371)
                          .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......... .....+|+.|+||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                23567788999999999999999 99999999999999999999999999998755432211 1122358899999


Q ss_pred             ccccCCC--------------------C--CCchhHHHHHHHHHHHhcCCC-CCCCCCC----------cHHHHHHHhhC
Q 017445          252 ERIRNES--------------------Y--SYPADIWSIGLALFECGTGEF-PYAASEG----------PVNLMLQILED  298 (371)
Q Consensus       252 E~~~~~~--------------------~--~~~~Dv~slG~il~ell~g~~-pf~~~~~----------~~~~~~~~~~~  298 (371)
                      |.+....                    +  ..+.|+||+||++|+|++|.. ||.....          ....+......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9985432                    1  134799999999999999885 6653211          11111222223


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCc---CCCCCHHHHhcCccccc
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDA---EARPTADQLLSHPFITK  341 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~~il~hp~~~~  341 (371)
                      ..........++..++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            33333445678999999999999766   78999999999999963

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.3e-39  Score=270.89  Aligned_cols=259  Identities=22%  Similarity=0.399  Sum_probs=213.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ..++|++.+++|+|-|++||.|.+..+++.++||++++   -..+.+.+|+.+|..+..||||+++++....+.+....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35789999999999999999999999999999999975   445678899999999999999999999998888889999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ++||+++.+...+.   ..++...++.++.+++.||.|||| .||+|||+||.|++||.. -.++|+|||+|...-.. .
T Consensus       113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-~  187 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  187 (338)
T ss_pred             HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC-c
Confidence            99999997777654   357888899999999999999999 999999999999999976 56999999999876544 3


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH---hh----------------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LE----------------  297 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~----------------  297 (371)
                      ..+-.+.+..|-.||.+-. ..|+.+-|+|||||++..|+..+.||....+.-+.+.++   +.                
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            4456678999999999854 568999999999999999999999986543322222111   11                


Q ss_pred             --------CCC--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          298 --------DPS--------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       298 --------~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                              ...        ......-.++++.+|+.++|..|..+|+|+.|++.||||....+.
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence                    000        001112346999999999999999999999999999999766543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=295.24  Aligned_cols=266  Identities=25%  Similarity=0.435  Sum_probs=216.0

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-------HHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-------EKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      +......++|-++..||+|+|+.||+|.+....+.||+|+-.....       ...+-..+|..+...+. ||.||++|+
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYD  534 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYD  534 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeee
Confidence            3445567888999999999999999999999999999998643211       11223456777776665 999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEcc---CCceE
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNL---KGRPK  222 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~---~~~~k  222 (371)
                      +|.. +...+|-|+|||+|-+|.-+|+..+.+++.+++.|+.||+.||.||...+ .|||-||||.|||+-.   -|.+|
T Consensus       535 yfsl-DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  535 YFSL-DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeee-ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            9864 45578999999999999999999999999999999999999999998732 5999999999999954   37899


Q ss_pred             EecccccccCcccccc-------cccccccCcccCCccccC----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH
Q 017445          223 ITDFGISAGLENSIAM-------CATFVGTVTYMSPERIRN----ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL  291 (371)
Q Consensus       223 l~Dfg~s~~~~~~~~~-------~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~  291 (371)
                      |+|||+++.+++....       ..-..||.+|++||++.-    ...+.++||||.|+++|+++.|+.||.......+.
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            9999999887654322       234579999999999842    34788999999999999999999999876544333


Q ss_pred             HHH--HhhC-CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          292 MLQ--ILED-PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       292 ~~~--~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      +..  ++.. ....+..+-+++++++||++||++--+.|.++.++..||||..
T Consensus       694 LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  694 LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            322  2222 2234455678999999999999999999999999999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=277.14  Aligned_cols=241  Identities=32%  Similarity=0.561  Sum_probs=203.9

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeccccHHH-HHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHH
Q 017445           93 ASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADI  171 (371)
Q Consensus        93 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~  171 (371)
                      +||.||+|.+..+++.+|+|++....... ...+.+|+..+.++ +|+|++++++.+..  ....++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999997644333 67788999998888 59999999998753  4689999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCC
Q 017445          172 LRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP  251 (371)
Q Consensus       172 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aP  251 (371)
                      +.....+++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|++|
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p  155 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP  155 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence            9876669999999999999999999999 999999999999999999999999999998765542 33456688999999


Q ss_pred             ccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCC--CCHHHHHHHHHhcccCcCCCCC
Q 017445          252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQN--FSPEFCSFVDDCLKKDAEARPT  329 (371)
Q Consensus       252 E~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps  329 (371)
                      |.+.+..++.++|+||+|++++++++|..||......... .+.+...........  ++.++.+++.+||..+|++||+
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL-FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            9998888999999999999999999999999764333333 333333332222222  8899999999999999999999


Q ss_pred             HHHHhcCccc
Q 017445          330 ADQLLSHPFI  339 (371)
Q Consensus       330 ~~~il~hp~~  339 (371)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=285.42  Aligned_cols=274  Identities=25%  Similarity=0.408  Sum_probs=214.0

Q ss_pred             cCCCCCccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC-------C
Q 017445           66 ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-------N  138 (371)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-------h  138 (371)
                      ....+.......+...+|.+.++||=|-|+|||+|-+..+.+.||+|+++. .....+..+.|+.+|.+...       .
T Consensus        63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~  141 (590)
T KOG1290|consen   63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGK  141 (590)
T ss_pred             cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence            333344444455666899999999999999999999999999999999975 23334556788888876543       3


Q ss_pred             CCeeEeceeEEe--cCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEE
Q 017445          139 EGLVEFHGAFYM--PDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL  214 (371)
Q Consensus       139 ~~iv~l~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl  214 (371)
                      ..||++++.|..  +++.++|+|+|++ |.+|..+|...  +.++...+..|++||+.||.|||+..||||.||||+|||
T Consensus       142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL  220 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL  220 (590)
T ss_pred             ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence            479999999864  5677999999999 67999998754  569999999999999999999999889999999999999


Q ss_pred             Ec------------------------------------------------------------------------------
Q 017445          215 VN------------------------------------------------------------------------------  216 (371)
Q Consensus       215 ~~------------------------------------------------------------------------------  216 (371)
                      +.                                                                              
T Consensus       221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~  300 (590)
T KOG1290|consen  221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ  300 (590)
T ss_pred             eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence            95                                                                              


Q ss_pred             ------------------------------------cC------------------------------------------
Q 017445          217 ------------------------------------LK------------------------------------------  218 (371)
Q Consensus       217 ------------------------------------~~------------------------------------------  218 (371)
                                                          ..                                          
T Consensus       301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v  380 (590)
T KOG1290|consen  301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV  380 (590)
T ss_pred             cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence                                                00                                          


Q ss_pred             ----------CceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC--
Q 017445          219 ----------GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE--  286 (371)
Q Consensus       219 ----------~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~--  286 (371)
                                -.|||+|||.|+......   +....|..|+|||++.+..|++.+||||++|+++||+||...|....  
T Consensus       381 ~p~~~~~~~di~vKIaDlGNACW~~khF---T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~  457 (590)
T KOG1290|consen  381 NPDIPLPECDIRVKIADLGNACWVHKHF---TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGE  457 (590)
T ss_pred             CCCCCCCccceeEEEeeccchhhhhhhh---chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence                      026888888887766543   44568999999999999999999999999999999999999997533  


Q ss_pred             ---CcHHHHHHHhhC--CCCC-------------------------CCC---------CCC----CHHHHHHHHHhcccC
Q 017445          287 ---GPVNLMLQILED--PSPS-------------------------PSR---------QNF----SPEFCSFVDDCLKKD  323 (371)
Q Consensus       287 ---~~~~~~~~~~~~--~~~~-------------------------~~~---------~~~----~~~~~~li~~~l~~d  323 (371)
                         .+++.+.++++-  ..|.                         ..+         -.+    ..++.+|+.-||+.+
T Consensus       458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~  537 (590)
T KOG1290|consen  458 NYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD  537 (590)
T ss_pred             CCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence               223333333221  0000                         000         011    256889999999999


Q ss_pred             cCCCCCHHHHhcCcccccccc
Q 017445          324 AEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       324 p~~Rps~~~il~hp~~~~~~~  344 (371)
                      |.+|||+.++|+|||+...-.
T Consensus       538 PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  538 PEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             ccccccHHHHhcCccccCCCC
Confidence            999999999999999986543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=313.59  Aligned_cols=244  Identities=27%  Similarity=0.385  Sum_probs=195.0

Q ss_pred             eeecccCCeE-EEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           87 GAIGSGASSV-VQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        87 ~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      +++|.|+.|+ ||+|..  .|+.||||.+-   .+......+|+..|+....||||+++++  ...+.+.+||+.|.|..
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalELC~~  587 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALELCAC  587 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehHhhh
Confidence            5789999986 799987  77899999874   3444567789999999999999999988  55778899999999976


Q ss_pred             CCHHHHHHhcCC-C---CHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---C--CceEEecccccccCcccc
Q 017445          166 GSLADILRMQKS-I---PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---K--GRPKITDFGISAGLENSI  236 (371)
Q Consensus       166 g~L~~~l~~~~~-l---~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~--~~~kl~Dfg~s~~~~~~~  236 (371)
                       +|.++++..+. .   .....+.+..|++.||+|||+ -+||||||||.||||+.   +  ..++|+|||+++.+....
T Consensus       588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence             99999986411 1   113457789999999999999 89999999999999976   3  368999999999886543


Q ss_pred             ---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcC-CCCCCCCCCcHHHHHHHhhCCCCCCCC-CCCCHH
Q 017445          237 ---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG-EFPYAASEGPVNLMLQILEDPSPSPSR-QNFSPE  311 (371)
Q Consensus       237 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  311 (371)
                         ....+..||-+|+|||++....-+.++||||+||++|+.++| ..||......   ..+++.+....... ..-..+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---~~NIl~~~~~L~~L~~~~d~e  742 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---QANILTGNYTLVHLEPLPDCE  742 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---hhhhhcCccceeeeccCchHH
Confidence               234566799999999999988888999999999999999995 8999654322   23344333322111 111128


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      +.+||.+|+.++|..||++.+||.||+|=.+
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            9999999999999999999999999999433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=296.79  Aligned_cols=254  Identities=22%  Similarity=0.383  Sum_probs=223.1

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...|++.+.+..+..+||-|-||.||.|.|++-.-.||||.++. +.-..+.|+.|+.++..+. |||+|+++|+|..  
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~--  334 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTH--  334 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhc-CccHHHHhhhhcc--
Confidence            45677788888899999999999999999999999999999875 3445678999999998887 9999999998854  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ....|||+|||..|+|.++|....+  ++.-.+..++.||..|++||.. +++|||||...|.|+.++..+|++|||+++
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhh
Confidence            4479999999999999999976543  6777888999999999999999 999999999999999999999999999999


Q ss_pred             cCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .+..... ......-..-|.|||-+.-..++.++|||+||++|||+.| |..||.+.+  ...+..+++..+....+..|
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--lSqVY~LLEkgyRM~~PeGC  491 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYGLLEKGYRMDGPEGC  491 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHhccccccCCCCC
Confidence            8765432 2223334567999999998999999999999999999998 889998754  56678888999988889999


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHH
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQL  333 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~i  333 (371)
                      |+.+..|++.||+++|+.||++.++
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHH
Confidence            9999999999999999999999887

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=297.78  Aligned_cols=255  Identities=22%  Similarity=0.385  Sum_probs=215.5

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcC----CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIP----THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ...|++.+......+.||.|-||.||+|....    ..-.||||.-+. .+....+.|+.|..+++++. ||||++++|+
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikLIGv  459 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKLIGV  459 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhheeee
Confidence            34567777777778899999999999998532    234588998876 45566888999999999997 9999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      +.   ....+||||+++-|.|..+|+.+ ..++...+..+++|++.||.|||| +++|||||...|||+.....+||+||
T Consensus       460 ~~---e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  460 CV---EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             ee---ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcceeeeccc
Confidence            84   44699999999999999999765 469999999999999999999999 99999999999999999999999999


Q ss_pred             cccccCcccccccccc-cccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          227 GISAGLENSIAMCATF-VGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      |+++.+.++.....+. .-..-|||||-+.-..++.+||||-||+++||+++ |..||.+-.+.+  +.-.++.+...+.
T Consensus       536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--VI~~iEnGeRlP~  613 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--VIGHIENGERLPC  613 (974)
T ss_pred             chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--eEEEecCCCCCCC
Confidence            9999988764443332 23446999999988899999999999999999997 999998754321  2333566666777


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      +.++|+.+..|+.+||.+||.+||.+.++.
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            889999999999999999999999988775

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=279.04  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~  154 (371)
                      .+|..++.+|.|+- .|.-|.+..++++||+|+...  .+....++..+|...+..+. |+||++++.+|....    -.
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHHHHH
Confidence            47788889999998 788888999999999998753  34556677788888887776 999999999986432    23


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+|||+|.. +|...+.  -.++-+++..+++|++.|++|||+ .||+||||||+||++..++.+||.|||+|.....
T Consensus        95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchhheeeccchhhcccCc
Confidence            68999999965 9999886  457889999999999999999999 9999999999999999999999999999987665


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CC-----------
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PS-----------  300 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~-----------  300 (371)
                      . ...+..+.|..|+|||++-+.+|...+||||+||++.||++|...|.+.. ..+.+.++.+.   +-           
T Consensus       171 ~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  171 D-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             c-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            5 45577899999999999998889999999999999999999999997643 22222222110   00           


Q ss_pred             -------------------CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          301 -------------------PS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       301 -------------------~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                                         +.       .....-...+.+++.+||..||++|.|++++|+|||++
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                               00       00011235688999999999999999999999999997

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=307.54  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=220.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCC---cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTH---RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ++..+...|.++||.|.||+|++|..+..|   ..||||.++. .....+..|+.|+.++.+.. ||||+++.|+..  .
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVT--k  701 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVT--K  701 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEe--c
Confidence            455677889999999999999999876554   6799999986 45667788999999999998 999999999774  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ...+.||+|||++|+|+.+|..+ +.|+..++..+++.|+.|++||-+ .|+|||||...|||++.+-.+|++|||+++.
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccceEEEeccccceee
Confidence            66899999999999999999765 569999999999999999999999 9999999999999999999999999999998


Q ss_pred             Cccccccccccc---ccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          232 LENSIAMCATFV---GTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       232 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      +.+......+..   -...|.|||.+.-..++.+|||||+|+++||.++ |..||-+..+  +.+.+.++..+..+.+.+
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVIkaIe~gyRLPpPmD  858 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEQGYRLPPPMD  858 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHHHHHHhccCCCCCCC
Confidence            866543222222   2368999999999999999999999999999997 9999976654  446677788888888999


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +|..+.+|+..||++|-.+||.+.||+.
T Consensus       859 CP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  859 CPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            9999999999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=293.37  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=208.7

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .-++.++.+.+.++||+|-||.|.++. ...+..||+|+++.. ....+..+..|+.+|.+++ ||||++++|+|..  +
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~--D  607 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQ--D  607 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeec--C
Confidence            346778889999999999999999997 445789999999874 4455688999999999995 9999999998864  4


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +.+++++||+++|+|.+++.++..  ..-+....|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||+++.
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecCcccccc
Confidence            479999999999999999976632  3455667799999999999999 8899999999999999999999999999986


Q ss_pred             Ccccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc--CCCCCCCCCCcHHHHHHH---hhCCC---C
Q 017445          232 LENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT--GEFPYAASEGPVNLMLQI---LEDPS---P  301 (371)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~--g~~pf~~~~~~~~~~~~~---~~~~~---~  301 (371)
                      +..+...  ....+-...|||||.+..+.++.+||+|+||+++||+++  .+.||....+ ++.+.+.   +..+.   .
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCccee
Confidence            6443222  233456789999999999999999999999999999875  7889965432 2222221   22221   2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      ...+.-++.++.+++.+||..|-++||+++++-
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            344567899999999999999999999999983

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.8e-38  Score=292.48  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=208.6

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC-----CCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-----NEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-----h~~iv~l~~~~~~~~  152 (371)
                      ..-++|.+....|+|-|++|..|.+..-|..||||+|.. +..-.+.=+.|+.+|.++..     .-++++++..|..  
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--  505 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--  505 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence            445899999999999999999999999999999999975 34444556789999988763     2468888888865  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGI  228 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~  228 (371)
                      ..++|||+|-+. -+|.++|++.+   .+....+..++.|+..||.+|.. .||+|.||||+||||++. ..+||||||.
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcc
Confidence            559999999995 49999998755   48889999999999999999999 999999999999999976 5689999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-HHHHHHHhhCCCCCCC---
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-VNLMLQILEDPSPSPS---  304 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~---  304 (371)
                      |........  +.+.-+..|+|||++.|..|++..|+||.||+||||+||+..|++..+. +-.+..-+.+..+...   
T Consensus       584 A~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  584 ASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             ccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            987765432  4455678999999999999999999999999999999999999886543 2222222222221100   


Q ss_pred             -----------------------------------C-----------CCCC-------HHHHHHHHHhcccCcCCCCCHH
Q 017445          305 -----------------------------------R-----------QNFS-------PEFCSFVDDCLKKDAEARPTAD  331 (371)
Q Consensus       305 -----------------------------------~-----------~~~~-------~~~~~li~~~l~~dp~~Rps~~  331 (371)
                                                         +           +.++       ..+.+|+.+||..||.+|.|+.
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence                                               0           0122       4588999999999999999999


Q ss_pred             HHhcCccccc
Q 017445          332 QLLSHPFITK  341 (371)
Q Consensus       332 ~il~hp~~~~  341 (371)
                      ++|.||||+.
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999974

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=297.96  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=219.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      -|...+..+.+.||+|.||.|++|.|+.-   ...||||.++.... .....|++|+.++.++. |||++++||+...  
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~--  182 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD--  182 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc--
Confidence            34556777888999999999999998643   35689999976433 36788999999999998 9999999998753  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       ..+.+|+|++++|+|.+.|++  ...|.-..+..++.||+.|+.||.+ +++|||||...|+|+-....|||+|||+.+
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccceeeeeccccee
Confidence             468899999999999999976  3458889999999999999999999 999999999999999999999999999999


Q ss_pred             cCccccccc---ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          231 GLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       231 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .++.....+   ....-...|+|||.++...++.+||||++|++||||++ |+.||.+-.  ...+.+.++.......+.
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~~iD~~erLpRPk  338 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILKNIDAGERLPRPK  338 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHHhccccccCCCCC
Confidence            887654443   11223457999999999999999999999999999998 899998754  345666667777778889


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      .++.++.+++++||..+|.+||++..|...-+..+
T Consensus       339 ~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            99999999999999999999999999875554443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=304.29  Aligned_cols=256  Identities=25%  Similarity=0.436  Sum_probs=218.2

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEc----C---CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHI----P---THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~---~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .+.+..++..+.+.||+|+||+|++|.-.    .   ....||||..+. ....+...+..|+.+++.+..||||+.+.|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            67888888888899999999999999732    1   256799999875 334667889999999999999999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      ++..  .+.+++|+||+..|+|.+++...+                .++......+++||+.|++||++ .+++||||..
T Consensus       370 ~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAA  446 (609)
T ss_pred             eecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhh
Confidence            8854  778999999999999999998665                38889999999999999999999 8999999999


Q ss_pred             CcEEEccCCceEEecccccccCccccccc-ccccc--cCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIAMC-ATFVG--TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASE  286 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~  286 (371)
                      +|||+..+..+||+|||+|+......... ....+  ...|||||.+....|+.+|||||+|+++||+++ |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999998655432222 22222  335999999999999999999999999999998 999998744


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      ..... .+.+..+.....+..+++++.++++.||..+|++||++.++.
T Consensus       527 ~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  527 PTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             cHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            34444 456777777777888999999999999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=299.10  Aligned_cols=276  Identities=29%  Similarity=0.534  Sum_probs=231.5

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ...+|+.+.++|+|+||.||+|+++.+++..|+|+++........-+..|+.+++... ||||+.++|.|..  ...++|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsylr--~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLR--RDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC-CcChHHHHhhhhh--hcCcEE
Confidence            3568999999999999999999999999999999998755556666777887777766 9999999998854  557999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      +||||.||+|.+..+..+++++.++..+.+..+.||+|||+ .|-+|||||-.||++++.|.+|++|||.+..+......
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999999999999888999999999999999999999999 99999999999999999999999999999998887777


Q ss_pred             cccccccCcccCCccc---cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCCCCCCCCCHHH
Q 017445          239 CATFVGTVTYMSPERI---RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEF  312 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  312 (371)
                      ..++.|||+|||||+-   +.+.|+..+|||++|+...|+-.-+.|-.. ..++..++..-.   .+........+++-+
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd-lhpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-LHPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc-cchHHHHHHhhccCCCCCcccCCccchHHH
Confidence            7899999999999986   567899999999999999999887777643 233333332211   222233345678899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcChh
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPM  360 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~  360 (371)
                      -+|++.+|..+|++||+++.+|.|||..+-..-+.. -+++.++.+|-
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~-~eLLdK~n~P~  294 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLA-IELLDKVNNPN  294 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccchhhHHH-HHHHHHccCCC
Confidence            999999999999999999999999999877433322 45666666554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.1e-36  Score=318.39  Aligned_cols=239  Identities=20%  Similarity=0.317  Sum_probs=184.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      .+...+.||+|+||.||+|.+..++..||+|++.......    ..|+..+.++. ||||++++|++.  +....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~-HpnIv~~~~~~~--~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQ-HPNIVKLIGLCR--SEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCC-CCCcceEEEEEE--cCCCCEEEEe
Confidence            4556678999999999999998999999999986532211    23466777775 999999999885  4557899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---cCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH---GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |+++|+|.++++   .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++..++. ||........   
T Consensus       764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            999999999996   3899999999999999999999   5 689999999999999998888776 6654433221   


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHH---H-hh---------CCCCCC--
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ---I-LE---------DPSPSP--  303 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~---~-~~---------~~~~~~--  303 (371)
                       ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.........+..   . ..         ......  
T Consensus       836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence             2346889999999999999999999999999999999999999543221111111   1 00         000000  


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .......++.+++.+||+.||++||++.++++.
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            001112357789999999999999999999754

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=267.45  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=203.5

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---CeEEEEEe
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---GQISIALE  161 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---~~~~lv~E  161 (371)
                      +.||-|+||.||.+.+..+|+.||+|++..  .+-..-+.+.+|+..|+..+ |.|++..++..-.+.-   ..+|+++|
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            389999999999999999999999999864  23455678999999999998 9999998886532221   24788999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc-cc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM-CA  240 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~-~~  240 (371)
                      .+.. +|..+|-....++.+.+..+.+||++||+|||+ .+|.||||||.|.|++.+..+||||||+++..+..... .+
T Consensus       138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT  215 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT  215 (449)
T ss_pred             HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccchhhhhhhH
Confidence            9964 999988888889999999999999999999999 99999999999999999999999999999876654333 33


Q ss_pred             cccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHhhCCC-----------------
Q 017445          241 TFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLMLQILEDPS-----------------  300 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~-----------------  300 (371)
                      ..+-|.+|+|||.+.|. .|+.+.||||.||++.||+..+..|...+.  ..+++...+..+.                 
T Consensus       216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR  295 (449)
T KOG0664|consen  216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR  295 (449)
T ss_pred             HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence            44679999999999765 499999999999999999999999976432  1122222222221                 


Q ss_pred             ---CCCC---------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          301 ---PSPS---------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       301 ---~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                         ..+.         +..-..+...++..++..||++|.+..+++.|+|..+-
T Consensus       296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence               1111         12234578899999999999999999999999998653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-35  Score=281.14  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=210.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCC----cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTH----RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      .+.+..++||+|+||+||+|.+...|    -+||+|++.. ........++.|+..+.++. |||+++++|++...   .
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s---~  771 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLS---T  771 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccc---h
Confidence            45566789999999999999986655    4578887754 33445677899999999997 99999999988533   3


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      +-||++|+++|+|.++++.+ .++-......|.+||++|+.|||. ++++||||..+||||..-.++|+.|||+++....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            88999999999999999754 468899999999999999999999 9999999999999999999999999999988766


Q ss_pred             cccccccc--cccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          235 SIAMCATF--VGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       235 ~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ........  .-.+-|||-|.+....|+.++||||||+++||++| |..|+.+..  ...+.+.++.+.....++.++-+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGERLSQPPICTID  928 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhccccCCCCCCccHH
Confidence            54433322  23567999999999999999999999999999998 999997654  45567777777778888899999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHh
Q 017445          312 FCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      +..++.+||..|+..||+++++.
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHH
Confidence            99999999999999999988775

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.3e-35  Score=265.01  Aligned_cols=263  Identities=26%  Similarity=0.468  Sum_probs=206.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcC---CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIP---THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .......|+..++||+|+|++||++.+..   ..+.||+|.+....  ...++.+|++.|..+..+.||+++.+++  ..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~--rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF--RN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh--cc
Confidence            34456788899999999999999998776   78899999987533  3345889999999999999999999988  45


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~  231 (371)
                      .+.+.+|+||++..+..+++.   .++-..+..+++.++.||.++|. +|||||||||+|+|.+.. +.-.|+|||+|..
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHH
Confidence            668999999999988888775   47788999999999999999999 999999999999999865 7889999999862


Q ss_pred             Cccc--------------------------------------------ccccccccccCcccCCccccC-CCCCCchhHH
Q 017445          232 LENS--------------------------------------------IAMCATFVGTVTYMSPERIRN-ESYSYPADIW  266 (371)
Q Consensus       232 ~~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~  266 (371)
                      ....                                            ........||++|+|||++.. ...++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            1100                                            000112469999999999954 5578999999


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCcHHHHHHHh--------------hCC---------------------------------
Q 017445          267 SIGLALFECGTGEFPYAASEGPVNLMLQIL--------------EDP---------------------------------  299 (371)
Q Consensus       267 slG~il~ell~g~~pf~~~~~~~~~~~~~~--------------~~~---------------------------------  299 (371)
                      |.|++++.++++..||....++.+.+..+.              .+.                                 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999999965443222111110              000                                 


Q ss_pred             --CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          300 --SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       300 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                        ........++..+.+|+.+|++.||.+|.|++++|+||||......+
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~  391 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE  391 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence              00011123455789999999999999999999999999998554433

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=264.30  Aligned_cols=246  Identities=25%  Similarity=0.360  Sum_probs=183.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHh-CCCCCCeeEeceeEEecC--CCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE-APCNEGLVEFHGAFYMPD--SGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-~~~h~~iv~l~~~~~~~~--~~~~  156 (371)
                      ......++.||+|.||.||+|..  +++.||||++..   +....+.+|-++... ...|+||++++++-...+  ...+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            34566778999999999999976  568999999964   445556666666543 235999999998642211  3368


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeEecCCCCCcEEEccCCceEEecccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR--------HLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      .||+||.+.|+|.++|+ ...++|....+++..+++||+|||+..        .|+|||||..||||..|+++-|+|||+
T Consensus       284 wLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999999997 467999999999999999999999732        499999999999999999999999999


Q ss_pred             cccCcccccc--cccccccCcccCCccccCCC-CC-----CchhHHHHHHHHHHHhcCCC------------CCCCCC--
Q 017445          229 SAGLENSIAM--CATFVGTVTYMSPERIRNES-YS-----YPADIWSIGLALFECGTGEF------------PYAASE--  286 (371)
Q Consensus       229 s~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slG~il~ell~g~~------------pf~~~~--  286 (371)
                      |..+......  ....+||.+|||||++.+.. +.     .+.||||+|.++|||++.-.            ||...-  
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9877644322  23468999999999997653 22     36799999999999998542            232110  


Q ss_pred             --CcHHHHHHHhhCCCCCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHH
Q 017445          287 --GPVNLMLQILEDPSPSPSR-----QNFSPEFCSFVDDCLKKDAEARPTAD  331 (371)
Q Consensus       287 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~  331 (371)
                        .-+++....+........+     .....-+++.+..||+.||+-|+|+.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence              0112222222222111111     12245688999999999999999974

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=257.09  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=185.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHH-hCCCCCCeeEeceeEEecC--CCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLC-EAPCNEGLVEFHGAFYMPD--SGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~~~~h~~iv~l~~~~~~~~--~~~~  156 (371)
                      ..+..+++.||+|.||+|++|.+  .|+.||||++...   +.....+|.++.. .+.+|+||+.++++=...+  ...+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            35778899999999999999987  6779999999643   3344556666542 3446999999988632221  2369


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----C---CeEecCCCCCcEEEccCCceEEeccccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV----R---HLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~---~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      +||++|.+.|||+|+|.. ..++.+...+++..++.||+|||-.    +   .|.|||||..||||.++|.+-|+|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999985 6799999999999999999999951    2   4999999999999999999999999999


Q ss_pred             ccCcccc----cccccccccCcccCCccccCCCC------CCchhHHHHHHHHHHHhcC----------CCCCCCC---C
Q 017445          230 AGLENSI----AMCATFVGTVTYMSPERIRNESY------SYPADIWSIGLALFECGTG----------EFPYAAS---E  286 (371)
Q Consensus       230 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~slG~il~ell~g----------~~pf~~~---~  286 (371)
                      .......    ...+..+||..|||||++.....      -..+||||||.++||++..          ++||.+-   +
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            7665442    22366789999999999975431      1468999999999999862          2777542   2


Q ss_pred             CcHHHHHHHhhC-CCC---CCCCCC--CCHHHHHHHHHhcccCcCCCCCHHHH
Q 017445          287 GPVNLMLQILED-PSP---SPSRQN--FSPEFCSFVDDCLKKDAEARPTADQL  333 (371)
Q Consensus       287 ~~~~~~~~~~~~-~~~---~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~i  333 (371)
                      .....+.+.+-. ...   ...+..  .-..+..+++.||..||.-|.|+-.|
T Consensus       444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            222333333211 111   111111  12457789999999999999998665

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=268.59  Aligned_cols=201  Identities=29%  Similarity=0.483  Sum_probs=174.6

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCC--CCCCeeEeceeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAF  148 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~  148 (371)
                      +..+|..++.+|+|+||.|++|.++.....|+||.+.+..        ......+-.|+.+|..+.  .|+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4578999999999999999999999999999999986411        111223556777775543  499999999988


Q ss_pred             EecCCCeEEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          149 YMPDSGQISIALEYM-DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~-~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                        ++++++||+||-- +|.+|+++|+....++|.++..|++|++.|+++||+ .||||||||-+||+++.+|-+||+|||
T Consensus       639 --Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  639 --EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             --ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCeEEEeecc
Confidence              7788999999965 567999999999999999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCcccccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCC
Q 017445          228 ISAGLENSIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAA  284 (371)
Q Consensus       228 ~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~  284 (371)
                      .|......  +...++||..|.|||++.|..| +...|||++|++||.++....||.+
T Consensus       716 saa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99877654  3368899999999999998876 5778999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5e-32  Score=234.89  Aligned_cols=211  Identities=35%  Similarity=0.630  Sum_probs=185.7

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCC
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS  167 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~  167 (371)
                      ||+|.+|.||++....+++.+++|++...... ....+.+|+..+..+. |++++++++.+.  .....++++|++++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~--~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFE--DENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeee--cCCeEEEEEecCCCCc
Confidence            68999999999999888999999999764332 4567889999998887 899999999874  3468999999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEecccccccCccccccccccccc
Q 017445          168 LADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGT  245 (371)
Q Consensus       168 L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~~~~~~~~~~~gt  245 (371)
                      |.+++... ..+++..+..++.+++.++.+||+ .|++|+||+|.||+++. ++.++|+|||.+..............+.
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            99999765 478999999999999999999999 89999999999999999 8999999999987665543223445688


Q ss_pred             CcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017445          246 VTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       246 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  324 (371)
                      ..|++||.+... .++.++|+|++|++++++                                  ..+.+++.+|+..+|
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhCCc
Confidence            999999999877 788999999999999998                                  689999999999999


Q ss_pred             CCCCCHHHHhcCc
Q 017445          325 EARPTADQLLSHP  337 (371)
Q Consensus       325 ~~Rps~~~il~hp  337 (371)
                      ++||++.++++|+
T Consensus       203 ~~R~~~~~l~~~~  215 (215)
T cd00180         203 EKRPSAKEILEHL  215 (215)
T ss_pred             ccCcCHHHHhhCC
Confidence            9999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=1.1e-30  Score=229.85  Aligned_cols=212  Identities=30%  Similarity=0.523  Sum_probs=178.0

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      |++.+.||+|++|+||++.+..+++.+|+|.+...... ....+.+|+..+.++. |+|++++++.+.  .....++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~--~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVFE--DPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeeee--cCCceEEEEe
Confidence            45677999999999999999888999999999764433 5677888999988885 999999999774  4568999999


Q ss_pred             ccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-ccc
Q 017445          162 YMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-AMC  239 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-~~~  239 (371)
                      ++++++|.+++..... +++..+..++.+++.++.+||+ .+++|+|++|.||+++.++.++|+|||.+....... ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999987666 8999999999999999999999 899999999999999999999999999987765432 122


Q ss_pred             ccccccCcccCCccc-cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC
Q 017445          240 ATFVGTVTYMSPERI-RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED  298 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  298 (371)
                      ....++..|++||.+ ....++.++|+|+||+++++|++|+.||....++...+.+.+..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF  216 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence            445688899999998 66778889999999999999999999996623334333443333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=238.09  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=211.2

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCC-----cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTH-----RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .....+...+++....+-+|.||.||.|++.+..     +.|-+|.++. ....+...++.|...+..+. |||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeE
Confidence            3455667788888999999999999999876543     3355665543 34445666788888887777 999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQ--------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      +.. ++....+.++.++.-|+|..++...        ..++..+...++.|++.|++|||+ +||||.||...|.+|++.
T Consensus       355 V~i-e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSI-EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEe-eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhh
Confidence            875 4566789999999999999999732        236677788899999999999999 999999999999999999


Q ss_pred             CceEEecccccccCccccccc--ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHH
Q 017445          219 GRPKITDFGISAGLENSIAMC--ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI  295 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~  295 (371)
                      -++||+|=.+++.+-+....+  ..--....||+||.+.+..|+.++|+||||+++|||+| |+.|+...+ + ..+...
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-P-fEm~~y  510 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-P-FEMEHY  510 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-H-HHHHHH
Confidence            999999999998764432221  22234568999999999999999999999999999998 999996543 3 345666


Q ss_pred             hhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +..+.....+.++|+++..++..||...|++||+++|+..
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            6777788888999999999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=227.71  Aligned_cols=240  Identities=23%  Similarity=0.366  Sum_probs=189.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +.|.|.+.||+|.||.+-++.|+.+++.+++|.+.. .......+.+|...-..+..|.||+.-|+.-+ +..+.+++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence            467788899999999999999999999999999965 44556778999988777888999998887655 4566888999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc-cC-CceEEecccccccCcccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LK-GRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~-~~-~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||++-|+|.+-+.. ..+-|.....++.|++.|+.|+|+ +++||||||.+||||- .+ ..+||||||.+...+..-. 
T Consensus       102 E~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-  178 (378)
T ss_pred             ccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceeh-
Confidence            99999999998764 568899999999999999999999 9999999999999993 33 5799999999876654321 


Q ss_pred             cccccccCcccCCcccc---CC--CCCCchhHHHHHHHHHHHhcCCCCCCCCCC---cHHHHHHHhhCCCC--CCCCCCC
Q 017445          239 CATFVGTVTYMSPERIR---NE--SYSYPADIWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSP--SPSRQNF  308 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~---~~--~~~~~~Dv~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~  308 (371)
                        ..--+..|.+||...   ++  ..++.+|+|.||++++.+++|.+||.....   +--.+.+......+  ...-..+
T Consensus       179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence              122466789999763   22  246889999999999999999999974321   11123333333222  1122457


Q ss_pred             CHHHHHHHHHhcccCcCCC
Q 017445          309 SPEFCSFVDDCLKKDAEAR  327 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~R  327 (371)
                      ++.+..+.++-|..+|++|
T Consensus       257 s~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             CHHHHHHHHHhcCCccccc
Confidence            8899999999999999999

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.8e-31  Score=276.48  Aligned_cols=198  Identities=20%  Similarity=0.211  Sum_probs=145.3

Q ss_pred             CCeeEeceeEEe-----cCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCc
Q 017445          139 EGLVEFHGAFYM-----PDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN  212 (371)
Q Consensus       139 ~~iv~l~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~N  212 (371)
                      +||.++++.|..     .+...++.++|++ +++|.++|.. ...+++..+..+++||+.||.|||+ +||+||||||+|
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHrDlKP~N  110 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVHNVRPSC  110 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh-CCeeeccCCchh
Confidence            466666665411     1123577889988 5699999975 3469999999999999999999999 999999999999


Q ss_pred             EEEccC-------------------CceEEecccccccCcccc----------------cccccccccCcccCCccccCC
Q 017445          213 LLVNLK-------------------GRPKITDFGISAGLENSI----------------AMCATFVGTVTYMSPERIRNE  257 (371)
Q Consensus       213 Il~~~~-------------------~~~kl~Dfg~s~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~  257 (371)
                      ||++..                   +.+|++|||+++......                ......+||+.|+|||++.+.
T Consensus       111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  190 (793)
T PLN00181        111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS  190 (793)
T ss_pred             EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence            999653                   456666666664321100                001124689999999999999


Q ss_pred             CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       258 ~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      .++.++|||||||++|||++|..|+.....   .+..+.....+... ....+...+++.+||..+|.+||++.++++||
T Consensus       191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        191 SSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            999999999999999999999888754221   11222111111111 12245677899999999999999999999999


Q ss_pred             ccccc
Q 017445          338 FITKY  342 (371)
Q Consensus       338 ~~~~~  342 (371)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=9.5e-31  Score=222.39  Aligned_cols=162  Identities=27%  Similarity=0.373  Sum_probs=132.0

Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          166 GSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       166 g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      |+|.+++.. .+++++..++.++.|++.||.|||+ ++      ||+||+++.++.+++  ||.+......     ...|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence            689999976 4569999999999999999999999 76      999999999999999  9998765442     2368


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC-----CCCCCCCH--HHHHHHH
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-----PSRQNFSP--EFCSFVD  317 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~li~  317 (371)
                      |+.|+|||++.+..++.++||||+||++|||++|+.||............+.......     .....++.  ++.+++.
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            9999999999999999999999999999999999999976543333333333322221     11122333  6999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccc
Q 017445          318 DCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      +||..+|.+||++.+++.|+|+..
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHHH
Confidence            999999999999999999999863

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-27  Score=219.68  Aligned_cols=252  Identities=20%  Similarity=0.178  Sum_probs=193.7

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCC-cEEEEEEeccccHHHHHHHHHHHHHHHhCC---CCCCeeEeceeEEecCCCeEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTH-RIIALKKINIFEKEKRNQLLTEIRTLCEAP---CNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~~~---~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|............+..|..++..+.   ..+++..+++.+. .....-|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            7999999999999999999987774 678888876533332225666777766665   2457888888663 3456889


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-----CceEEecccccc
Q 017445          158 IALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-----GRPKITDFGISA  230 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-----~~~kl~Dfg~s~  230 (371)
                      |||+.+ |.+|.++....  +.++..++..|+.|++.+|++||+ .|++||||||+|+.+...     ..+.|.|||+++
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            999998 77999988543  579999999999999999999999 999999999999999865     359999999998


Q ss_pred             --cCcccc------c-c-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhC
Q 017445          231 --GLENSI------A-M-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILED  298 (371)
Q Consensus       231 --~~~~~~------~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~  298 (371)
                        ......      . . ...+.||..|.++.+..+...+.+.|+||++.++.+++.|.+||......  .....+....
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              321111      0 1 23456999999999999999999999999999999999999999765432  2222222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ..........+.++.++...+-..+...+|....+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111234566788888888888999999998877655

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-27  Score=207.77  Aligned_cols=245  Identities=21%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      -.|++.++||+|+||+.++|.+.-++++||||.-...  ....++..|.+....+...++|...+.  +.+++.+-.||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~NiLVi  103 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKYNILVI  103 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceee--eccccchhhhhh
Confidence            4789999999999999999999999999999986542  233455566666666777899998876  447777888999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-----ceEEecccccccCcc
Q 017445          161 EYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-----RPKITDFGISAGLEN  234 (371)
Q Consensus       161 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-----~~kl~Dfg~s~~~~~  234 (371)
                      |++ |.+|.|+..-+ +.|+.++...++.|++.-++|+|+ +.+|+|||||+|+||...+     .+.++|||+|+...+
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            999 78999998754 569999999999999999999999 9999999999999997543     589999999988755


Q ss_pred             ccc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHHHHHhhCC---CCC
Q 017445          235 SIA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLMLQILEDP---SPS  302 (371)
Q Consensus       235 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~---~~~  302 (371)
                      ...       ...+..||..||+-....|...+.+.|+-|||-++++.|.|.+||.+-..+.  ....++-+..   ...
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            421       2355679999999999999999999999999999999999999998755432  2233332222   222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHH
Q 017445          303 PSRQNFSPEFCSFVDDCLKKDAEARPTAD  331 (371)
Q Consensus       303 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~  331 (371)
                      ....++|.++...++-.-..+-.+-|+.+
T Consensus       262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  262 VLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            23356788888888877777888878754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.6e-28  Score=243.06  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEec----c-ccHHH-HHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKIN----I-FEKEK-RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      -...+|.|++|.|+.+........++.|.+.    . ..... ...+..|..+-..+. |||++.....+..  ....+-
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~--~~~~~~  398 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE--IDGILQ  398 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh--cccchh
Confidence            4568999999988888776666666666553    1 11111 122445555555555 9999887776532  223334


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc--
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI--  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--  236 (371)
                      .||||++ +|+.++...+.+....+..+++|++.|++|+|+ .||.|||+||+|+++..+|.+||+|||.+....-..  
T Consensus       399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            4999999 999999877789999999999999999999999 999999999999999999999999999986543221  


Q ss_pred             --cccccccccCcccCCccccCCCCCCc-hhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh------CCCCCCCCCC
Q 017445          237 --AMCATFVGTVTYMSPERIRNESYSYP-ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE------DPSPSPSRQN  307 (371)
Q Consensus       237 --~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~  307 (371)
                        ......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||.......+.......      ...+......
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL  556 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence              33467789999999999999999865 79999999999999999999765433332111111      1122233356


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      ++.+.+.++.+||++||.+|.|+++|++.+||+....-.+
T Consensus       557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             chhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence            7889999999999999999999999999999998876544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-27  Score=199.56  Aligned_cols=247  Identities=21%  Similarity=0.324  Sum_probs=199.8

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      -...|+++++||+|+||.+|+|....+|+.||||+-..  .....+...|..+...+.....|+.+..++  .+..+-.+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvl   88 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVL   88 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhc--ccccccee
Confidence            34689999999999999999999999999999998653  334455677777777777677788777654  56678889


Q ss_pred             EEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCcc
Q 017445          159 ALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLEN  234 (371)
Q Consensus       159 v~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~  234 (371)
                      ||+.+ |.+|.++.. ..+.++..+..-++-|++.-++|+|. +++|||||||+|+|+.-+   ..+.|+|||+|+...+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            99999 789999886 35679999999999999999999999 999999999999999754   5689999999987654


Q ss_pred             ccc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHhhC---CCCC
Q 017445          235 SIA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLMLQILED---PSPS  302 (371)
Q Consensus       235 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~~---~~~~  302 (371)
                      ...       ......||..|.+-....+...+.+.|+-|+|.++.++..|.+||.+-..  ......++.+.   .++.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            321       12445799999999988888889999999999999999999999987442  23333444333   2334


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHH
Q 017445          303 PSRQNFSPEFCSFVDDCLKKDAEARPTAD  331 (371)
Q Consensus       303 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~  331 (371)
                      .....+|.++.-.+.-|-..--.+-|+..
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            44578899999999999888888888854

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.4e-25  Score=207.04  Aligned_cols=257  Identities=30%  Similarity=0.494  Sum_probs=206.0

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....   .....+.+|+..+..+..|++++++.+.+.  .....+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEE
Confidence            677889999999999999976   6799999865322   246778889998888885558999999883  34458999


Q ss_pred             EeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~~  235 (371)
                      ++++.++++.+++....   .++......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+......
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            99999999998887664   79999999999999999999999 9999999999999999988 7999999998755443


Q ss_pred             cc------ccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCC---cHHHHHHHhhCCCC-C
Q 017445          236 IA------MCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSP-S  302 (371)
Q Consensus       236 ~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~-~  302 (371)
                      ..      ......|+..|++||.+.+   ..+....|+||+|++++++++|..||.....   .......+.....+ .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            22      2366789999999999987   5788999999999999999999999876553   22333333333322 1


Q ss_pred             C--CCCCC----CHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          303 P--SRQNF----SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       303 ~--~~~~~----~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      .  .....    ...+.+++..|+..+|..|.+..+...++|.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            1  11111    2578999999999999999999999998777655443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=214.95  Aligned_cols=169  Identities=18%  Similarity=0.232  Sum_probs=133.0

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcC-CCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhCCCCCCeeE-ece
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIP-THRIIALKKINIF-----EKEKRNQLLTEIRTLCEAPCNEGLVE-FHG  146 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~~~~h~~iv~-l~~  146 (371)
                      ...+....+|.+.+.||+|+||+||+|.+.. +++.||||++...     .......+.+|+.++.++. |+|++. +++
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE
Confidence            3455667789999999999999999998876 6788899986532     2334566889999999997 888874 443


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCC-CCCcEEEccCCceEEec
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI-KPANLLVNLKGRPKITD  225 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dl-kp~NIl~~~~~~~kl~D  225 (371)
                            .+..||||||++|++|... .   ...   ...++.|++.||.|||+ +||+|||| ||+|||++.++.+||+|
T Consensus        90 ------~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 ------TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             ------cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence                  2358999999999999732 1   111   14678999999999999 99999999 99999999999999999


Q ss_pred             ccccccCcccccc--------cccccccCcccCCccccCC
Q 017445          226 FGISAGLENSIAM--------CATFVGTVTYMSPERIRNE  257 (371)
Q Consensus       226 fg~s~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~  257 (371)
                      ||+|.........        ..+..+++.|+|||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999866543211        1355788899999998543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.9e-28  Score=227.69  Aligned_cols=244  Identities=27%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             eecccCCeEEEEEEE---cCCCcEEEEEEeccccHH--HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           88 AIGSGASSVVQRAVH---IPTHRIIALKKINIFEKE--KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      ++|+|+||.|+++..   .+.|..+|+|+.+.....  .......|..++....+||.++++..+|  +.++.+++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence            379999999988752   356788999987652211  1113344566666677799999999988  557789999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccc
Q 017445          163 MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF  242 (371)
Q Consensus       163 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~  242 (371)
                      ..||.|...+.....+++.....+...++.|++++|+ .+++|||+|++||+++.+|++++.|||.++...+....    
T Consensus        79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            9999999999888889999999999999999999999 99999999999999999999999999999876654332    


Q ss_pred             cccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhccc
Q 017445          243 VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK  322 (371)
Q Consensus       243 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  322 (371)
                      |||..|||||++.  ....++|.||+|++++||++|..||..     +....+......  .+..++.++.+++..++..
T Consensus       154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~--~p~~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE--MPRELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC--CchhhhHHHHHHHHHHHhh
Confidence            8999999999998  568899999999999999999999976     344444443332  3456788999999999999


Q ss_pred             CcCCCCC-----HHHHhcCccccccccccc
Q 017445          323 DAEARPT-----ADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       323 dp~~Rps-----~~~il~hp~~~~~~~~~~  347 (371)
                      +|..|.-     ..++++|+||+...+.+.
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~~l  254 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSIDWNEL  254 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheeeeHhhH
Confidence            9999965     589999999998887753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1.4e-24  Score=194.30  Aligned_cols=234  Identities=19%  Similarity=0.279  Sum_probs=149.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCC---------CCCeeEeceeEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPC---------NEGLVEFHGAFY  149 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~---------h~~iv~l~~~~~  149 (371)
                      .+...+.||.|+++.||.+.+..||+.+|+|++....   ....+++.+|......+..         |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566789999999999999999999999999985422   2234455555543333221         112222222221


Q ss_pred             ec----------CCC-----eEEEEEeccCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHcCCCeEecC
Q 017445          150 MP----------DSG-----QISIALEYMDGGSLADILRM---QKS----IPEPILSSMFKKLLQGLSYLHGVRHLVHRD  207 (371)
Q Consensus       150 ~~----------~~~-----~~~lv~E~~~~g~L~~~l~~---~~~----l~~~~~~~i~~qi~~aL~~LH~~~~iiH~D  207 (371)
                      .+          +..     ..+++|+-+. ++|.+++..   ...    +.......+..|++..+++||+ .|++|+|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgd  170 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGD  170 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecc
Confidence            11          111     2467888885 599887642   111    2233445666999999999999 9999999


Q ss_pred             CCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccccC--------CCCCCchhHHHHHHHHHHHhcCC
Q 017445          208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN--------ESYSYPADIWSIGLALFECGTGE  279 (371)
Q Consensus       208 lkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ell~g~  279 (371)
                      |+|+|++++.+|.++|+||+.....+.....   ...+..|.|||....        ..++.+.|.|+||+++|.|.||.
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999999987766554221   345688999997743        24788999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 017445          280 FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR  327 (371)
Q Consensus       280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  327 (371)
                      .||.........       ........++|+.++.||+.+|+.||.+|
T Consensus       248 lPf~~~~~~~~~-------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADP-------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTS-------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccc-------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999754311100       00122223789999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=1.2e-24  Score=216.38  Aligned_cols=226  Identities=28%  Similarity=0.476  Sum_probs=173.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      -..++|..++.|..|+||.||.++|+.+.+++|+ ++++.+.     ++            .||..+-+        ..+
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----il------------Rnilt~a~--------npf  133 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----IL------------RNILTFAG--------NPF  133 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hh------------hccccccC--------Ccc
Confidence            3457899999999999999999999999999999 4443221     11            12333222        233


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc-
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI-  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~-  236 (371)
                      .|      |+=...++.-++++-..        +.|++|||+ .||+|||+||+|.+|+.-|++|++|||+++...... 
T Consensus       134 vv------gDc~tllk~~g~lPvdm--------vla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIGPLPVDM--------VLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ee------chhhhhcccCCCCcchh--------hHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence            33      34444555445555433        789999999 999999999999999999999999999986432110 


Q ss_pred             --------------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC
Q 017445          237 --------------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS  302 (371)
Q Consensus       237 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  302 (371)
                                    ......+|||.|+|||++....|+..+|+|++|+++|+.+-|..||.++ .++.++.+.+......
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEW  277 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhccc
Confidence                          1113358999999999999999999999999999999999999999774 4667777766554332


Q ss_pred             C-CCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCccccccccc
Q 017445          303 P-SRQNFSPEFCSFVDDCLKKDAEAR---PTADQLLSHPFITKYEHA  345 (371)
Q Consensus       303 ~-~~~~~~~~~~~li~~~l~~dp~~R---ps~~~il~hp~~~~~~~~  345 (371)
                      + ....+++++++++.++|+.+|..|   +.+-++.+|+||+...+.
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            2 245688999999999999999999   457888899999877665

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=3.9e-24  Score=186.01  Aligned_cols=176  Identities=18%  Similarity=0.179  Sum_probs=133.5

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHH------HHHHHHHHHhCCCCCCeeEece
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQ------LLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      -.+...+|++.+.||.|+||.||++..  ++..+|+|.+.....   .....      +.+|+..+.++. ||+|..+.+
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d  102 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLND  102 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceE
Confidence            355678999999999999999999754  567899999964221   11122      467888888885 999999988


Q ss_pred             eEEecC------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc
Q 017445          147 AFYMPD------SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR  220 (371)
Q Consensus       147 ~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~  220 (371)
                      .+...+      .+..+|+|||++|.+|.++..    +++    ....+++.++..+|+ .|++|||++|+||+++.+| 
T Consensus       103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             eeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC-
Confidence            765433      246899999999999988742    333    245699999999999 9999999999999999988 


Q ss_pred             eEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHh
Q 017445          221 PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECG  276 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell  276 (371)
                      ++|+|||.+......... ..           ......++.++|+||||+++....
T Consensus       173 i~liDfg~~~~~~e~~a~-d~-----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-DR-----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-HH-----------HHHHhHhcccccccceeEeehHHH
Confidence            999999987655332111 10           223344667999999999887643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=7.9e-24  Score=181.64  Aligned_cols=140  Identities=20%  Similarity=0.232  Sum_probs=106.6

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccHH--H------------------------HHHHHHHHHHHHhCCCCCC
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE--K------------------------RNQLLTEIRTLCEAPCNEG  140 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~~~~h~~  140 (371)
                      +.||+|++|.||+|.+. +|+.||||+++.....  .                        ......|...+.++. +++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   80 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TAG   80 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HCC
Confidence            47999999999999976 8999999998652110  0                        112234777777764 555


Q ss_pred             eeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCeEecCCCCCcEEEccCC
Q 017445          141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL-HGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       141 iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                      +........  .  ..+|||||++|+++........++++..+..++.|++.+|.++ |+ .||+||||||+||+++ ++
T Consensus        81 v~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          81 IPCPEPILL--K--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCCcEEEe--c--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEE-CC
Confidence            432222111  1  2389999999988776544457899999999999999999999 68 8999999999999998 58


Q ss_pred             ceEEecccccccCcc
Q 017445          220 RPKITDFGISAGLEN  234 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~  234 (371)
                      .++|+|||+|.....
T Consensus       155 ~v~LiDFG~a~~~~~  169 (190)
T cd05147         155 KLYIIDVSQSVEHDH  169 (190)
T ss_pred             cEEEEEccccccCCC
Confidence            899999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-23  Score=187.78  Aligned_cols=192  Identities=19%  Similarity=0.268  Sum_probs=145.3

Q ss_pred             CCCCCCeeEeceeEEec-------------------------CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHH
Q 017445          135 APCNEGLVEFHGAFYMP-------------------------DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK  189 (371)
Q Consensus       135 ~~~h~~iv~l~~~~~~~-------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~q  189 (371)
                      +..|||||++.++|..+                         +...+|+||..++. +|.+++.. ...+.....-++.|
T Consensus       272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQ  349 (598)
T ss_pred             cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHH
Confidence            34699999999988331                         23478999999976 99999974 44677778889999


Q ss_pred             HHHHHHHHHcCCCeEecCCCCCcEEEc--cCC--ceEEecccccccCccc------ccccccccccCcccCCccccCCC-
Q 017445          190 LLQGLSYLHGVRHLVHRDIKPANLLVN--LKG--RPKITDFGISAGLENS------IAMCATFVGTVTYMSPERIRNES-  258 (371)
Q Consensus       190 i~~aL~~LH~~~~iiH~Dlkp~NIl~~--~~~--~~kl~Dfg~s~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-  258 (371)
                      +++|+.|||. +||.|||+|.+|||+.  +|+  .+.|+|||++-.-+..      .+.....-|.-..||||+....+ 
T Consensus       350 lLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  350 LLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            9999999999 9999999999999994  343  5789999987432221      11122334778899999985322 


Q ss_pred             ----C-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017445          259 ----Y-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA  330 (371)
Q Consensus       259 ----~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  330 (371)
                          . -.++|.|+.|.+.||++....||.... .+.+-.....+..-...+..+++.+++++..+|+.||++|+++
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence                1 258999999999999999999997633 2222222233333445567899999999999999999999995

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=174.73  Aligned_cols=142  Identities=18%  Similarity=0.202  Sum_probs=109.1

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH--------------------------HHHHHHHHHHHHHhCCCCC
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE--------------------------KRNQLLTEIRTLCEAPCNE  139 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~~~~h~  139 (371)
                      .+.||+|++|+||+|.+. +|+.||||+++.....                          .......|...+.++. |+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            458999999999999976 8999999998753110                          0112346777777775 67


Q ss_pred             CeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       140 ~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                      ++.........    ..+|||||++|+++.........++...+..++.|++.++.++|+..||+||||||+||+++ ++
T Consensus        80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence            66433332221    24899999998865544333567888999999999999999999867999999999999999 89


Q ss_pred             ceEEecccccccCcc
Q 017445          220 RPKITDFGISAGLEN  234 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~  234 (371)
                      .++|+|||++.....
T Consensus       155 ~~~liDFG~a~~~~~  169 (190)
T cd05145         155 KPYIIDVSQAVELDH  169 (190)
T ss_pred             CEEEEEcccceecCC
Confidence            999999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1e-23  Score=210.10  Aligned_cols=242  Identities=20%  Similarity=0.180  Sum_probs=176.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++...+.||++.|=.|.+|++. .| .|+||++-...    -....+.+.|+.  ..+.+|||.+.+.-.-  ......|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~--~t~kAAy   97 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVL--VTDKAAY   97 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHH--HhhHHHH
Confidence            5667779999999999999853 34 48899874322    233444555555  3345699999987643  3455688


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc--cc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE--NS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~--~~  235 (371)
                      ||-+|+.. +|+|.+....-+..-+.+.|+.|++.||.-+|. .||+|||||.+||||+.=+-+.|+||..-+..-  ..
T Consensus        98 lvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen   98 LVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            99999976 999999876667888899999999999999999 999999999999999999999999997654321  11


Q ss_pred             c-cc----cccccccCcccCCccccCC-----------CCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhC
Q 017445          236 I-AM----CATFVGTVTYMSPERIRNE-----------SYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED  298 (371)
Q Consensus       236 ~-~~----~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  298 (371)
                      . ..    ..+.....+|.|||++...           ..+++-||||+||+++||++ |++||..+     .+.....+
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~  250 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG  250 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc
Confidence            1 11    1222345589999998431           15688999999999999998 78998532     11111111


Q ss_pred             CCCC--C-CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          299 PSPS--P-SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       299 ~~~~--~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ....  . ...--+..++.+|..|++.||++|.++++.|+.
T Consensus       251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1000  0 001113468899999999999999999999865

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.9e-23  Score=178.60  Aligned_cols=243  Identities=20%  Similarity=0.312  Sum_probs=189.5

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+++.+.-+|.+...|+.|+|++..+  .+++|+++..+  ......+..|.-.|+-.. ||||+.++|++-.  ...+
T Consensus       188 d~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacns--ppnl  262 (448)
T KOG0195|consen  188 DVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACNS--PPNL  262 (448)
T ss_pred             chhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhccC--CCCc
Confidence            334555666899999999999998554  56677765422  223344666766776666 9999999998844  4578


Q ss_pred             EEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEec-CCCCCcEEEccCCceEEe--ccccccc
Q 017445          157 SIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHR-DIKPANLLVNLKGRPKIT--DFGISAG  231 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~-Dlkp~NIl~~~~~~~kl~--Dfg~s~~  231 (371)
                      .++..||+.|+|+..++....  .+..++.+++.++++|+.|||+...++-| -|....|++|++-+.+|+  |--++. 
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-  341 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-  341 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence            999999999999999987654  67889999999999999999996666655 689999999999776664  322221 


Q ss_pred             CcccccccccccccCcccCCccccCCCCC---CchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYS---YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                            ......-.|.||+||.+...+.+   .++|+|||++++|||.|...||..- .++..-.++.-++.....++.+
T Consensus       342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl-spmecgmkialeglrv~ippgi  414 (448)
T KOG0195|consen  342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL-SPMECGMKIALEGLRVHIPPGI  414 (448)
T ss_pred             ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC-CchhhhhhhhhccccccCCCCc
Confidence                  12344568999999999765533   5789999999999999999999764 3455556666666667777899


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      +..+..|+.-|+..||.+||.++.|+
T Consensus       415 s~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  415 SRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            99999999999999999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.1e-22  Score=169.34  Aligned_cols=186  Identities=14%  Similarity=0.068  Sum_probs=140.3

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH----HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK----EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +...|++|+||+||++..  .+.+++.+.+.....    .....+.+|+.++.++.+|+++++++++      ...+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence            445899999999998864  667888777754322    2233578899999999878999999874      2479999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCC-CCCcEEEccCCceEEecccccccCcccccc-
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI-KPANLLVNLKGRPKITDFGISAGLENSIAM-  238 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dl-kp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~-  238 (371)
                      ||+.|.+|.+.+..      . ...++.|++.+|.++|+ +||+|||| ||+|||++.++.++|+|||+|......... 
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            99999999765421      1 13578899999999999 99999999 799999999999999999999855443210 


Q ss_pred             ---c---------ccccccCcccCCccccCC-CCC-CchhHHHHHHHHHHHhcCCCCCCCCC
Q 017445          239 ---C---------ATFVGTVTYMSPERIRNE-SYS-YPADIWSIGLALFECGTGEFPYAASE  286 (371)
Q Consensus       239 ---~---------~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~il~ell~g~~pf~~~~  286 (371)
                         .         .-...++.|++|+...-- ..+ .+.++++.|+-+|.++|+..+.-.+.
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence               0         011257777777765322 223 56789999999999999998775543

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.7e-21  Score=168.88  Aligned_cols=137  Identities=16%  Similarity=0.237  Sum_probs=108.1

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC----CCCCeeEeceeEEecC-CCeEE-EEE
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP----CNEGLVEFHGAFYMPD-SGQIS-IAL  160 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----~h~~iv~l~~~~~~~~-~~~~~-lv~  160 (371)
                      +.||+|+||.||.  +..++.. +||++..........+.+|+.++..+.    .||||++++|++.... .+.++ +|+
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            4899999999995  6777766 699987654445677899999998884    4899999999885432 24545 789


Q ss_pred             ec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHcCCCeEecCCCCCcEEEccC----CceEEecccccc
Q 017445          161 EY--MDGGSLADILRMQKSIPEPILSSMFKKLLQGL-SYLHGVRHLVHRDIKPANLLVNLK----GRPKITDFGISA  230 (371)
Q Consensus       161 E~--~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~iiH~Dlkp~NIl~~~~----~~~kl~Dfg~s~  230 (371)
                      ||  +.+++|.+++.. +.+++.  ..++.|++.++ +|||+ ++|+||||||+|||++..    +.++|+||+.+.
T Consensus        85 e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         85 DFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             cCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            99  557999999975 456666  35678888777 99999 999999999999999743    479999955443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.87  E-value=5.8e-23  Score=191.88  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=169.7

Q ss_pred             eeEeeeecccCCeEEEEEEEcCC---CcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEec------eeEEe---
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH------GAFYM---  150 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~------~~~~~---  150 (371)
                      ..+.+..+..++|.+...+....   ..-++-+..+......-....+++..+.....|+..+..-      ..+..   
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            34445566666666555443222   1222223222222233344455555555555455444332      00100   


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                      ....++||.|++|...+|.+||....   ..++.....++.|++.|++|    +|.+|+|+||.||+...+..+||.|||
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhh
Confidence            11336899999999999999996443   36778889999999999999    789999999999999999999999999


Q ss_pred             ccccCcccc------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC
Q 017445          228 ISAGLENSI------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP  301 (371)
Q Consensus       228 ~s~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  301 (371)
                      +........      ...+..+||+.||+||.+.+..|+.++||||||++|+|++.   +|...-........+-.+..+
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIP  478 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCC
Confidence            998776554      23456689999999999999999999999999999999997   332222222223333334444


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      .....++| +-..|+.+|+.+.|.+||++.+.--|+|.
T Consensus       479 ~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 PEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            33334443 44589999999999999988877777775

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=5.1e-21  Score=169.75  Aligned_cols=145  Identities=21%  Similarity=0.181  Sum_probs=112.8

Q ss_pred             ceeEeeeecccCCeEEEEEE-EcCCCcEEEEEEeccccHH------------------------HHHHHHHHHHHHHhCC
Q 017445           82 EMRIFGAIGSGASSVVQRAV-HIPTHRIIALKKINIFEKE------------------------KRNQLLTEIRTLCEAP  136 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~~~  136 (371)
                      -|++.+.||+|++|.||+|. +..+|+.||+|+++.....                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788899999999999998 7789999999998642210                        1123457888887775


Q ss_pred             C-CCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC-eEecCCCCCcEE
Q 017445          137 C-NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLL  214 (371)
Q Consensus       137 ~-h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-iiH~Dlkp~NIl  214 (371)
                      . ...++++++.      ...+|||||++|++|.........+....+..++.|++.++.+||+ .| ++||||||+||+
T Consensus       109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhhEE
Confidence            2 2333444431      1358999999998887765444566777788999999999999999 88 999999999999


Q ss_pred             EccCCceEEecccccccCcc
Q 017445          215 VNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       215 ~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ++ ++.++|+|||.+.....
T Consensus       182 i~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EE-CCCEEEEEChhhhccCC
Confidence            99 88999999999875544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=8.5e-21  Score=192.28  Aligned_cols=199  Identities=19%  Similarity=0.241  Sum_probs=158.6

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ...+.+....|.|-+.||+|+||.||+|.+.. |+.||+|+-+....   ..-.+++..+. +..   -+.|.++..++.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~  764 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHV  764 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHc
Confidence            34566778899999999999999999999766 99999998764221   11122222222 111   235666666665


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-------CCceE
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-------KGRPK  222 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-------~~~~k  222 (371)
                      ..+  .-+||+||.+.|+|.+++...+.+++.....++.|++.-+++||. .+|||+||||+|+++..       .-.++
T Consensus       765 ~~~--~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  765 FQN--ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cCC--cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceE
Confidence            544  578999999999999999988889999999999999999999999 99999999999999953       23589


Q ss_pred             EecccccccCccc--ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCC
Q 017445          223 ITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE  279 (371)
Q Consensus       223 l~Dfg~s~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~  279 (371)
                      |+|||.|..+.--  .......++|-.+-.+|...|..+++..|.|.++.+++.||.|+
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            9999999654321  12335667899999999999999999999999999999999986

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=7.4e-22  Score=195.75  Aligned_cols=259  Identities=23%  Similarity=0.333  Sum_probs=206.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEc-CCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHI-PTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ...|++.+.||+|+|+.|-.+... .....+|.|.+....  ......+..|..+-..+.+|.|++++++..  .+....
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCccc
Confidence            446677778999999999988763 344567777765532  233344445666656666699999999976  455688


Q ss_pred             EEEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-cCCCeEecCCCCCcEEEccCC-ceEEecccccccC
Q 017445          157 SIALEYMDGGSLADIL-RMQK-SIPEPILSSMFKKLLQGLSYLH-GVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l-~~~~-~l~~~~~~~i~~qi~~aL~~LH-~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~  232 (371)
                      ++.++|..|+++.+.+ +... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++..+ .++++|||+|...
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999999999988 5544 6788889999999999999999 7 9999999999999999999 9999999999876


Q ss_pred             cc-c--ccccccccc-cCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCCC
Q 017445          233 EN-S--IAMCATFVG-TVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSR  305 (371)
Q Consensus       233 ~~-~--~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  305 (371)
                      .. .  .......+| ++.|.|||...+. ...+..|+||+|+++..+++|..||.................  .....+
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            55 2  223345578 9999999999884 567889999999999999999999987554333333333332  234456


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      ..++....+++.+++..+|+.|.+.+++-.+||+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            778899999999999999999999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.1e-19  Score=153.15  Aligned_cols=134  Identities=19%  Similarity=0.251  Sum_probs=107.3

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +.||+|++|.||+|.+  +|..+++|+.....        ........+|+..+..+. |+++.....++..  ....++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~--~~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVD--PENFII   76 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEe--CCCCEE
Confidence            4799999999999987  67789999764311        112345677888887775 7776655554433  346789


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +|||++|++|.+++.....    ....++.+++.+|.++|+ .|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999999864322    788999999999999999 9999999999999999 88999999998764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=4.4e-19  Score=168.80  Aligned_cols=195  Identities=26%  Similarity=0.408  Sum_probs=152.5

Q ss_pred             CCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCe-EecCCCCCcEE
Q 017445          137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHL-VHRDIKPANLL  214 (371)
Q Consensus       137 ~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~i-iH~Dlkp~NIl  214 (371)
                      .|.|+.+++|.+...  ...++|.+||..|+|.|.+.. .-.+++.-...++++++.||.|||+ ..| .|+.+++.|.+
T Consensus         5 ~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~-s~i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    5 DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN-SPIGYHGALKSSNCL   81 (484)
T ss_pred             chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc-Ccceeeeeeccccce
Confidence            499999999998754  689999999999999999976 3458888888999999999999999 544 99999999999


Q ss_pred             EccCCceEEecccccccCcc--cccccccccccCcccCCccccCCC-------CCCchhHHHHHHHHHHHhcCCCCCCCC
Q 017445          215 VNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNES-------YSYPADIWSIGLALFECGTGEFPYAAS  285 (371)
Q Consensus       215 ~~~~~~~kl~Dfg~s~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~il~ell~g~~pf~~~  285 (371)
                      ++....+||+|||+......  ............-|.|||.+++..       .+.+.|+||+|++++|+++...||...
T Consensus        82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~  161 (484)
T KOG1023|consen   82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR  161 (484)
T ss_pred             eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence            99999999999999876642  111122233566799999997642       467799999999999999999999763


Q ss_pred             CC---cHHHHHHHhhCCCCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          286 EG---PVNLMLQILEDPSPSPS-----RQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       286 ~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      ..   +...+..+.........     ....++++..++++||..+|.+||++++|-
T Consensus       162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  162 NLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             cccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            32   22344444331221111     124566899999999999999999998875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=6.5e-19  Score=152.64  Aligned_cols=137  Identities=20%  Similarity=0.211  Sum_probs=104.6

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH----------------------HHHHHHHHHHHHHHhCCCCC-
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK----------------------EKRNQLLTEIRTLCEAPCNE-  139 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~~~~h~-  139 (371)
                      |.+.+.||+|+||.||++.+ .+|+.||||+++....                      ........|...+..+. |+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            56677999999999999986 4799999998754210                      01122456777776664 44 


Q ss_pred             -CeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          140 -GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       140 -~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                       .++..++      ....++||||++|++|......      .....++.+++.++.++|+ .|++||||+|+||+++.+
T Consensus        95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          95 FPVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEcCC
Confidence             3444433      2346899999999999875421      3456788999999999999 999999999999999999


Q ss_pred             CceEEecccccccCcc
Q 017445          219 GRPKITDFGISAGLEN  234 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~  234 (371)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.2e-18  Score=149.35  Aligned_cols=129  Identities=20%  Similarity=0.323  Sum_probs=100.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCe--eEeceeEEecCCCeEE
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGL--VEFHGAFYMPDSGQIS  157 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~i--v~l~~~~~~~~~~~~~  157 (371)
                      .||+|++|.||+|..  ++..+++|......        .....++.+|+..+..+. |+++  +.++.  ..  ....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~--~~--~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYD--VD--PDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEE--EE--CCCCE
Confidence            389999999999984  67789999864311        112355678888887776 4443  34433  22  33568


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      +||||++|++|.+++.....       .++.+++.+|.+||+ .|++|+|++|.||+++ ++.++++|||.+...
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999999998754321       789999999999999 9999999999999999 899999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=2.2e-17  Score=164.05  Aligned_cols=135  Identities=23%  Similarity=0.281  Sum_probs=105.1

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEe--ccc------cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKI--NIF------EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~--~~~------~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      |...+.||+|+||+||++.+...  .+++|+.  +..      .......+.+|+..+..+. |++++....++..  ..
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~--~~  409 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVD--PE  409 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEe--CC
Confidence            34567899999999999986443  3444432  111      1122355788999998887 8888776654443  34


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ..++||||++|++|.+++.        ....++.|++.+|.+||+ .|++||||||+||++ .++.++|+|||+++..
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            5789999999999999885        356789999999999999 999999999999999 5789999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.2e-17  Score=143.24  Aligned_cols=139  Identities=20%  Similarity=0.242  Sum_probs=96.0

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH--HHHH----------------------HHHHHHHHHhCCCC-CC
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE--KRNQ----------------------LLTEIRTLCEAPCN-EG  140 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~~~~h-~~  140 (371)
                      .+.||+|+||+||+|.+. +++.||||++......  ....                      ...|...+..+..+ ..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357999999999999875 7899999998642111  1111                      12344444433211 22


Q ss_pred             eeEeceeEEecCCCeEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          141 LVEFHGAFYMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       141 iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                      +.+.++.      ...++||||++++++.. .+... ... ..+..++.+++.++.++|+..||+|+||||+||+++ ++
T Consensus        81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CCceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence            3444332      24689999999854321 11111 111 667889999999999999867899999999999999 99


Q ss_pred             ceEEecccccccCcc
Q 017445          220 RPKITDFGISAGLEN  234 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~  234 (371)
                      .++|+|||.+.....
T Consensus       152 ~~~liDfg~a~~~~~  166 (187)
T cd05119         152 KVYIIDVPQAVEIDH  166 (187)
T ss_pred             cEEEEECcccccccC
Confidence            999999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.4e-18  Score=163.89  Aligned_cols=259  Identities=23%  Similarity=0.268  Sum_probs=205.2

Q ss_pred             eecCcceeEeeeecc--cCCeEEEEEEE--cCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           77 RCASHEMRIFGAIGS--GASSVVQRAVH--IPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+....+-+.+.+|.  |.+|.||.+..  ..++..+|+|+-+.  ........-.+|+....+...|++.++.+..+  
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--  187 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--  187 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--
Confidence            444456667789999  99999999987  78899999998543  33345556678888888888899999988876  


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHcCCCeEecCCCCCcEEEccC-CceEEe
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQ----GLSYLHGVRHLVHRDIKPANLLVNLK-GRPKIT  224 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~----aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~  224 (371)
                      .+.+..|+-+|++. .+|..+.+.... ++...++..+.+...    ||.++|+ .+++|-|+||.||+...+ ..++++
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecC
Confidence            56779999999995 688888876555 899999999999999    9999999 999999999999999999 889999


Q ss_pred             cccccccCcccccccccc-----cccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC
Q 017445          225 DFGISAGLENSIAMCATF-----VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP  299 (371)
Q Consensus       225 Dfg~s~~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  299 (371)
                      |||....+..........     .|...|++||... ..++..+|+|++|.++.+..++..+.....  ...+.++-...
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--~~~W~~~r~~~  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK--NSSWSQLRQGY  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC--CCCcccccccc
Confidence            999998887664332222     6888999999875 458899999999999999999886664431  11122222222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .+.......+..+...+..|++.+|-.|++...++.|+++..-
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            2333334556777789999999999999999999999999743

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.1e-16  Score=131.65  Aligned_cols=134  Identities=19%  Similarity=0.170  Sum_probs=107.8

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC-CCeeEeceeEEecCCCeEEEEEecc
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      +++.||+|.++.||++....  ..+++|.+.....  ...+..|+..+..+.++ .+++++++.+  ...+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEEEEec
Confidence            34689999999999998743  6899999865433  45677788887777644 6788887755  3346799999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--CCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV--RHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +|+++..+       +......++.+++.++.++|..  .+++|+|++|.||+++..+.++++|||.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98777654       5566778899999999999983  2699999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=3.2e-16  Score=139.29  Aligned_cols=135  Identities=17%  Similarity=0.216  Sum_probs=102.1

Q ss_pred             eec-ccCCeEEEEEEEcCCCcEEEEEEecccc-------------HHHHHHHHHHHHHHHhCCCCCC--eeEeceeEEec
Q 017445           88 AIG-SGASSVVQRAVHIPTHRIIALKKINIFE-------------KEKRNQLLTEIRTLCEAPCNEG--LVEFHGAFYMP  151 (371)
Q Consensus        88 ~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~~~~h~~--iv~l~~~~~~~  151 (371)
                      .|| .|+.|+||.+..  .+..++||.+....             .....+..+|+..+..+. |++  ++..++.....
T Consensus        38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVR  114 (239)
T ss_pred             eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeee
Confidence            687 899999999875  36789999874311             123456778988888776 555  46666654322


Q ss_pred             CCC--eEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          152 DSG--QISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       152 ~~~--~~~lv~E~~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      ...  ..++|||+++| .+|.+++.. .++++..    +.|++.+|.+||+ +||+||||||.|||++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            221  23599999997 699998864 4556543    6789999999999 9999999999999999999999999998


Q ss_pred             ccc
Q 017445          229 SAG  231 (371)
Q Consensus       229 s~~  231 (371)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=2.2e-16  Score=158.10  Aligned_cols=267  Identities=25%  Similarity=0.350  Sum_probs=204.4

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHH---HHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      |+...+.+.+.+.+-+|+++.++.+.-..+|...++|.........   ......+-.++ ....+|-++.....+.  .
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~-i~p~~P~v~~~~~s~~--~  875 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNIL-ITPRSPAVVRSFPSFP--C  875 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcc-ccCCCCceecccCCCC--C
Confidence            7778889999999999999999999877778767776654322111   11111111111 1233576776655443  3


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ....+|+++|+.+++|...++..+..+.+.++.....+..++++||+ ..+.|+|++|.|+++..+|+.+++|||.....
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccCCcccCcccccccc
Confidence            45799999999999999999988888999999999999999999999 77999999999999999999999999843221


Q ss_pred             ccc---------------------c----------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCC
Q 017445          233 ENS---------------------I----------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP  281 (371)
Q Consensus       233 ~~~---------------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~p  281 (371)
                      +.-                     .          .......+|+.|.+||...+......+|+|+.|+++++.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                     0          011234689999999999999999999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHhhCCCCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCccccccccccc
Q 017445          282 YAASEGPVNLMLQILEDPSPSP-SRQNFSPEFCSFVDDCLKKDAEARPTAD---QLLSHPFITKYEHAKV  347 (371)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~---~il~hp~~~~~~~~~~  347 (371)
                      |.... +......+.....+.+ .+...+.++++++...+..+|.+|..+.   ++-.||||+...+..+
T Consensus      1035 ~na~t-pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1035 FNAET-PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             CCCcc-hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence            97643 4445555555544443 2356789999999999999999999887   9999999988776554

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.58  E-value=7e-14  Score=134.98  Aligned_cols=170  Identities=15%  Similarity=0.217  Sum_probs=130.1

Q ss_pred             EEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCC
Q 017445           99 RAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI  178 (371)
Q Consensus        99 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l  178 (371)
                      .|..+.++.+|.|...+...........+-+..+..++ ||||+++++.+  +.++.+|||+|.+.  .|..++++.   
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~--e~~~~~ylvTErV~--Pl~~~lk~l---  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR-HPNILSYLDTT--EEEGTLYLVTERVR--PLETVLKEL---  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc-Cchhhhhhhhh--cccCceEEEeeccc--cHHHHHHHh---
Confidence            45567788999999988755544445555566666665 99999999977  56779999999985  788888754   


Q ss_pred             CHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccccCCC
Q 017445          179 PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES  258 (371)
Q Consensus       179 ~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  258 (371)
                      ........+.||+.||.|||...+++|++|+.+.|+|+..|..||++|..+...............-..|..|+.+....
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            36777888999999999998758899999999999999999999999998765443322222222333456666553322


Q ss_pred             CCCchhHHHHHHHHHHHhcC
Q 017445          259 YSYPADIWSIGLALFECGTG  278 (371)
Q Consensus       259 ~~~~~Dv~slG~il~ell~g  278 (371)
                        ...|.|.|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              457999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=3.3e-15  Score=132.44  Aligned_cols=206  Identities=22%  Similarity=0.302  Sum_probs=145.9

Q ss_pred             CCCeeEeceeEEe---cCCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCC
Q 017445          138 NEGLVEFHGAFYM---PDSGQISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIK  209 (371)
Q Consensus       138 h~~iv~l~~~~~~---~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlk  209 (371)
                      |-|+|+++.+|..   .+.....++.||+.-|+|.++|++    +..+....+.+|..||+.||.|||+.. .|+|+++.
T Consensus       126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlT  205 (458)
T KOG1266|consen  126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLT  205 (458)
T ss_pred             HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcc
Confidence            8899999988753   234467889999999999999964    345888999999999999999999933 49999999


Q ss_pred             CCcEEEccCCceEEecccccccCccc----ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCC
Q 017445          210 PANLLVNLKGRPKITDFGISAGLENS----IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS  285 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~  285 (371)
                      .+.|++..+|-+|+..-........-    ........+-++|.+||.=.-...+..+|||++|++.++|..+..--..+
T Consensus       206 c~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tns  285 (458)
T KOG1266|consen  206 CDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNS  285 (458)
T ss_pred             hhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCC
Confidence            99999999998888633222111000    01112234678999999776666778999999999999999887543333


Q ss_pred             CCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccccc
Q 017445          286 EGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~  348 (371)
                      .........+.....  ..   -...-+.++.+|++.+|..||++.+++.||..-.....+..
T Consensus       286 eS~~~~ee~ia~~i~--~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll  343 (458)
T KOG1266|consen  286 ESKVEVEENIANVII--GL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLL  343 (458)
T ss_pred             cceeehhhhhhhhee--ec---cCccccCcCcccccCCCCCCcchhhhhcCceeeecchHHHH
Confidence            221111111111100  00   01223468899999999999999999999988766554443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3.4e-14  Score=137.01  Aligned_cols=142  Identities=20%  Similarity=0.308  Sum_probs=96.9

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHH----------------------------------H------HHH
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR----------------------------------N------QLL  126 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------~------~~~  126 (371)
                      +.||+|++|+||+|+. .+|+.||||+.++......                                  .      .+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4799999999999984 5789999999865211100                                  0      122


Q ss_pred             HHHHHHHh----CCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHcC
Q 017445          127 TEIRTLCE----APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQ-GLSYLHGV  200 (371)
Q Consensus       127 ~E~~~l~~----~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~-aL~~LH~~  200 (371)
                      +|+..+.+    ..++++ +.+-..+. .-.+..+|||||++|++|.++.... ...+   ...++.+++. .+..+|. 
T Consensus       202 ~Ea~n~~~~~~~~~~~~~-v~vP~v~~-~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       202 REAANASELGENFKNDPG-VYVPEVYW-DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCC-EEeCCEeh-hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh-
Confidence            33333322    222333 33333332 2234578999999999999876432 1222   3445666665 4778898 


Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      .|++|+|++|.||+++.++.++|+|||++..+...
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            99999999999999999999999999999877643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.54  E-value=1.1e-14  Score=142.19  Aligned_cols=145  Identities=19%  Similarity=0.278  Sum_probs=96.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH----------------------------------HHHH--
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE----------------------------------KRNQ--  124 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~~--  124 (371)
                      .+|.. +.||+|++|+||+|+.+.+|+.||||+.++.-..                                  ..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45565 6899999999999998888999999998642110                                  0111  


Q ss_pred             ----HHHHHHHHHhCC---CCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHH--HHhcC----CCCHHHHHHHHHHHH
Q 017445          125 ----LLTEIRTLCEAP---CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADI--LRMQK----SIPEPILSSMFKKLL  191 (371)
Q Consensus       125 ----~~~E~~~l~~~~---~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~--l~~~~----~l~~~~~~~i~~qi~  191 (371)
                          +.+|+..+.++.   .+...+.+-..|. +-.+..+|||||++|+.+.++  +...+    .+.+..+..++.|++
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~-d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW-DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeec-ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                223333222221   1222333333332 113467899999999999874  33332    234444445555554


Q ss_pred             HHHHHHHcCCCeEecCCCCCcEEEccCC----ceEEecccccccCccc
Q 017445          192 QGLSYLHGVRHLVHRDIKPANLLVNLKG----RPKITDFGISAGLENS  235 (371)
Q Consensus       192 ~aL~~LH~~~~iiH~Dlkp~NIl~~~~~----~~kl~Dfg~s~~~~~~  235 (371)
                             . .|++|+|+||.||+++.+|    .+++.|||++..+...
T Consensus       278 -------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   4 7899999999999999888    9999999999877554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.8e-14  Score=137.67  Aligned_cols=256  Identities=21%  Similarity=0.194  Sum_probs=189.6

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEc-CCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHI-PTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..+...+|..+..||.|.|+.|+.+... .++..|++|....  ........-+.|+.....+..|.+++.++..|..  
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--  337 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--  337 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--
Confidence            4556678999999999999999987644 5778899998754  2222333345566666666668889998887753  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~  231 (371)
                      ....||-.|||+++++...+...-.+++...+.+..|++.++.++|+ ..++|+|++|+||++..+ +..++.|||..+.
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccccc
Confidence            33567999999999998877555568889999999999999999999 999999999999999886 7889999999875


Q ss_pred             CcccccccccccccCcc-cCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          232 LENSIAMCATFVGTVTY-MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      +.-..  ......+..| .+|.......+..+.|++|||..+.+.+++...-.. .   .....+..+..+..  .....
T Consensus       417 ~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~---~~~~~i~~~~~p~~--~~~~~  488 (524)
T KOG0601|consen  417 LAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-G---VQSLTIRSGDTPNL--PGLKL  488 (524)
T ss_pred             cceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcc-c---ccceeeecccccCC--CchHH
Confidence            33221  1112234444 356666777889999999999999999987632221 1   11222333333322  33448


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ++..+.+.++..++..||.+.++..|+-|.+.
T Consensus       489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  489 QLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            89999999999999999999999999876544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=1.1e-13  Score=116.60  Aligned_cols=127  Identities=16%  Similarity=0.116  Sum_probs=92.0

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      +.|+.|.++.||++..  .+..|++|....... .......|+..+..+.....+++++...  .  ...++||||++|.
T Consensus         4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCC
Confidence            4789999999999986  367899998764321 1223456777776654333344555432  2  2357999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eEecCCCCCcEEEccCCceEEecccccc
Q 017445          167 SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH-----LVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       167 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-----iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ++.+.        ......++.+++.+|..||+ .+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE--------DFSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc--------cccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87643        01123457899999999999 66     49999999999999 7789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=2e-13  Score=116.52  Aligned_cols=140  Identities=18%  Similarity=0.206  Sum_probs=100.4

Q ss_pred             eeecccCCeEEEEEEEcC------CCcEEEEEEecccc----------------------HHHHHHHH----HHHHHHHh
Q 017445           87 GAIGSGASSVVQRAVHIP------THRIIALKKINIFE----------------------KEKRNQLL----TEIRTLCE  134 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~  134 (371)
                      ..||.|-=+.||.|....      .+..+|||+.+...                      ...+..+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            479999999999998543      35789999864210                      01122233    68887776


Q ss_pred             CCCC-CCeeEeceeEEecCCCeEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCeEecCCCCC
Q 017445          135 APCN-EGLVEFHGAFYMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYL-HGVRHLVHRDIKPA  211 (371)
Q Consensus       135 ~~~h-~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~iiH~Dlkp~  211 (371)
                      +... .++++.++.      ..-+|||||+.+..+.. .++ ...++.+....+..+++.+|..| |. .|++|+||++.
T Consensus        83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHH
Confidence            6533 456666652      24679999997654432 222 23456667788899999999999 88 89999999999


Q ss_pred             cEEEccCCceEEecccccccCccc
Q 017445          212 NLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ||+++ ++.+.|+|||.+.....+
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCCCC
Confidence            99997 578999999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=7.9e-13  Score=128.26  Aligned_cols=158  Identities=23%  Similarity=0.397  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc---------cccccccccCcccCCccccCCCC
Q 017445          189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI---------AMCATFVGTVTYMSPERIRNESY  259 (371)
Q Consensus       189 qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~  259 (371)
                      +++.|+.|+|...++||++|.|++|.++..+..||+.|+++.......         ...........|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            344899999997789999999999999999999999999886543311         11112245678999999999888


Q ss_pred             CCchhHHHHHHHHHHHh-cCCCCCCCCCCcHHH-HHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          260 SYPADIWSIGLALFECG-TGEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       260 ~~~~Dv~slG~il~ell-~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      +.++|+||+|+++|.+. .|+..+...+..... ......+.........+|+++.+=+.+++..++.-||++..++..|
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence            99999999999999999 466555554332222 1222223333344478999999999999999999999999999999


Q ss_pred             ccccccccc
Q 017445          338 FITKYEHAK  346 (371)
Q Consensus       338 ~~~~~~~~~  346 (371)
                      ||....-..
T Consensus       267 ff~D~~~~a  275 (700)
T KOG2137|consen  267 FFSDPGLKA  275 (700)
T ss_pred             ccCCchhhh
Confidence            998765444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.31  E-value=7.5e-11  Score=111.04  Aligned_cols=222  Identities=19%  Similarity=0.222  Sum_probs=159.0

Q ss_pred             CeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CCCeEEEEEeccCC-CCHHH
Q 017445           94 SSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQISIALEYMDG-GSLAD  170 (371)
Q Consensus        94 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~~~~~lv~E~~~~-g~L~~  170 (371)
                      -.+.|++....+|..|++|++.............-++.+.++. |+|+|++..+|.+.  .+..+++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4578999999999999999995433333333344456666765 99999999988632  23468999999987 67777


Q ss_pred             HHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          171 ILR---------------MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       171 ~l~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +--               .+...+|+.+|.++.|+..||.++|+ .|+..+-|.|.+||++.+.+++|+.-|....+...
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            541               12347889999999999999999999 99999999999999999889999877765444332


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      .       +       +.+.   ...+-|.-.||.+++.|.||..---..+.........        ....++.+++++
T Consensus       447 ~-------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------I~~~yS~D~rn~  501 (655)
T KOG3741|consen  447 P-------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------ITTTYSTDLRNV  501 (655)
T ss_pred             C-------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------hhhhhhHHHHHH
Confidence            1       0       1111   1236799999999999999964321112222221111        123578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCc---cccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHP---FITKYE  343 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp---~~~~~~  343 (371)
                      |.-....++++ -++.+++.|-   ||...+
T Consensus       502 v~yl~s~~~~~-ksI~~llp~~~~~ff~vme  531 (655)
T KOG3741|consen  502 VEYLESLNFRE-KSIQDLLPMIGSRFFTVME  531 (655)
T ss_pred             HHHHHhcCccc-ccHHHHHHHHHHHHHHHHH
Confidence            99999999987 7888887654   555443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=9.2e-11  Score=97.11  Aligned_cols=129  Identities=22%  Similarity=0.246  Sum_probs=93.7

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEe-cc-------ccHHHHHHHHHHHHHHHhCCCC-CCeeEeceeEEecCCCeEEE
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKI-NI-------FEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~-------~~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+++|+=+.+|.+.+  -|..+++|.- ++       ..+-...+..+|+.++.++..- -+.+.+++  +  +.....|
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--v--D~~~~~I   76 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--V--DPDNGLI   76 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--E--cCCCCEE
Confidence            688999999999966  3345666642 11       1233455677888888765421 22333333  2  2335779


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +|||++|..|.+.+...       ...++..+-..+.-||. .||+|+||.++||++..++ +.++|||++..
T Consensus        77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999999888754       25677788888899999 9999999999999999554 99999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=7e-11  Score=103.72  Aligned_cols=143  Identities=19%  Similarity=0.175  Sum_probs=102.4

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCC-CCCeeEeceeEEecC-CCeEEEEEecc
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPC-NEGLVEFHGAFYMPD-SGQISIALEYM  163 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~-h~~iv~l~~~~~~~~-~~~~~lv~E~~  163 (371)
                      +.|+.|..+.||++... +|+.+++|....... .....+..|..++..+.. +.++++++....... .+..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            47899999999999853 357899999764221 134456778888777653 234566655432111 13578999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV-------------------------------------------  200 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------------------------------------------  200 (371)
                      +|.++.+.+.. ..+++.....++.+++.+|..||+.                                           
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888775431 4567777777888888888888741                                           


Q ss_pred             ------------CCeEecCCCCCcEEEcc--CCceEEeccccccc
Q 017445          201 ------------RHLVHRDIKPANLLVNL--KGRPKITDFGISAG  231 (371)
Q Consensus       201 ------------~~iiH~Dlkp~NIl~~~--~~~~kl~Dfg~s~~  231 (371)
                                  ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        23699999999999998  56789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.17  E-value=3.6e-10  Score=93.25  Aligned_cols=137  Identities=23%  Similarity=0.338  Sum_probs=97.2

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEecc--------ccHHHHHHHHHHHHHHHhCC----CCCCeeEeceeEEecC
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINI--------FEKEKRNQLLTEIRTLCEAP----CNEGLVEFHGAFYMPD  152 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~~~----~h~~iv~l~~~~~~~~  152 (371)
                      .+..|-+|+-+.|+++.+  .|+..+||.-..        ..+-...+..+|+..+.++.    +.|.+..     .  +
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-----~--D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-----I--D   81 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-----E--e
Confidence            345899999999999976  778888885321        22334566778888776643    1222221     1  2


Q ss_pred             CCeEEEEEeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---ceEEecc
Q 017445          153 SGQISIALEYMDG-GSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---RPKITDF  226 (371)
Q Consensus       153 ~~~~~lv~E~~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~~kl~Df  226 (371)
                      ...-.|+|||++| .++.+++...  ..........++.++-+.+.-||. ++|+|+||..+||++..++   .+.+.||
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence            2245688999987 4777877543  223333347889999999999999 9999999999999997765   3589999


Q ss_pred             ccccc
Q 017445          227 GISAG  231 (371)
Q Consensus       227 g~s~~  231 (371)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=3.6e-10  Score=96.14  Aligned_cols=128  Identities=21%  Similarity=0.231  Sum_probs=83.1

Q ss_pred             EEEEEEEcCCCcEEEEEEeccc--------------------------cHHHHHHHHHHHHHHHhCCCC-CCeeEeceeE
Q 017445           96 VVQRAVHIPTHRIIALKKINIF--------------------------EKEKRNQLLTEIRTLCEAPCN-EGLVEFHGAF  148 (371)
Q Consensus        96 ~Vy~~~~~~~~~~vavK~~~~~--------------------------~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~~  148 (371)
                      .||.|.. .+|..+|+|+.+..                          .........+|...|.++... -++++.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888974 56779999986421                          011233467788999888744 3567776532


Q ss_pred             EecCCCeEEEEEeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHcCCCeEecCCCCCcEEEccCCceEEec
Q 017445          149 YMPDSGQISIALEYMD--GGSLADILRMQKSIPEPILSSMFKKLLQGLSY-LHGVRHLVHRDIKPANLLVNLKGRPKITD  225 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~iiH~Dlkp~NIl~~~~~~~kl~D  225 (371)
                            .-+|||||++  |..+..+...  .++.+....++.+++..+.. +|+ .||+|+||++.||+++.+ .+.++|
T Consensus        80 ------~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ------RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ------TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE--
T ss_pred             ------CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEEe
Confidence                  2469999998  6566554432  22245567788888886555 578 999999999999999976 999999


Q ss_pred             ccccccCcc
Q 017445          226 FGISAGLEN  234 (371)
Q Consensus       226 fg~s~~~~~  234 (371)
                      ||.+.....
T Consensus       150 f~qav~~~~  158 (188)
T PF01163_consen  150 FGQAVDSSH  158 (188)
T ss_dssp             GTTEEETTS
T ss_pred             cCcceecCC
Confidence            998865543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=2.3e-09  Score=96.62  Aligned_cols=133  Identities=14%  Similarity=-0.005  Sum_probs=90.5

Q ss_pred             eEEEEEEEcCCCcEEEEEEeccccHHH-HH----------HHHHHHHHHHhCCC-CCCeeEeceeEEecC---CCeEEEE
Q 017445           95 SVVQRAVHIPTHRIIALKKINIFEKEK-RN----------QLLTEIRTLCEAPC-NEGLVEFHGAFYMPD---SGQISIA  159 (371)
Q Consensus        95 g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~----------~~~~E~~~l~~~~~-h~~iv~l~~~~~~~~---~~~~~lv  159 (371)
                      ..|+++..  .|+.|.||......... .+          ...+|...+.++.. .-..+...+++....   ...-+||
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34556543  56788999764322111 11          35677776655421 111223333222111   2357899


Q ss_pred             EeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-------CCceEEeccccc
Q 017445          160 LEYMDGG-SLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-------KGRPKITDFGIS  229 (371)
Q Consensus       160 ~E~~~~g-~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-------~~~~kl~Dfg~s  229 (371)
                      ||++++. +|.+++..  ..+.+......++.+++..+.-||. .||+|+|+++.|||++.       ++.+.|+||+.+
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            9999885 89998853  3456677888999999999999999 99999999999999985       467999999987


Q ss_pred             c
Q 017445          230 A  230 (371)
Q Consensus       230 ~  230 (371)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=3.9e-09  Score=97.42  Aligned_cols=238  Identities=17%  Similarity=0.186  Sum_probs=154.6

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeE----eceeEEecCCCe-EEEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE----FHGAFYMPDSGQ-ISIAL  160 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~----l~~~~~~~~~~~-~~lv~  160 (371)
                      ...||+|+-+.+|-.-...+   .+.|++.........+...   .|.+...||-+-.    -....+..+.+. +-++|
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            34799999999996542222   3457665433333333222   3344555553322    111112234444 77889


Q ss_pred             eccCCC-CHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          161 EYMDGG-SLADILR------MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       161 E~~~~g-~L~~~l~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..++|- .+..++.      ......|.-+.+.++.++.|...||. .|.+-+|++++|+|+++++.+.|.|-..-.. .
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi-~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI-N  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEcccceee-c
Confidence            988773 2222221      11237889999999999999999999 9999999999999999999999987543222 2


Q ss_pred             ccccccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcC-CCCCCCCC----CcHHHHHHHh-------
Q 017445          234 NSIAMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTG-EFPYAASE----GPVNLMLQIL-------  296 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g-~~pf~~~~----~~~~~~~~~~-------  296 (371)
                      .........+|.+.|.+||.-.     +..-+..+|.|.||+++++++.| +.||.+..    .+......+.       
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya  247 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA  247 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence            3334456778999999999864     34456789999999999999986 99997631    1111110110       


Q ss_pred             -------hCCCCCCCCCCCCHHHHHHHHHhccc--CcCCCCCHH
Q 017445          297 -------EDPSPSPSRQNFSPEFCSFVDDCLKK--DAEARPTAD  331 (371)
Q Consensus       297 -------~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rps~~  331 (371)
                             ..........-+++.+..+..+|+..  ++.-|||++
T Consensus       248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence                   01112233356789999999999864  366899964

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.01  E-value=4.3e-09  Score=92.38  Aligned_cols=139  Identities=21%  Similarity=0.231  Sum_probs=100.3

Q ss_pred             eEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--------------------c--HHHHHHHHHHHHHHHhCCCC-CC
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--------------------E--KEKRNQLLTEIRTLCEAPCN-EG  140 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~~~~h-~~  140 (371)
                      .+...||.|-=+.||.|.+ ..|.++|||.=+.-                    +  ...+....+|..+|.++..+ -.
T Consensus        94 ~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3556899999999999985 46889999963210                    0  11233456788888877544 34


Q ss_pred             eeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc
Q 017445          141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR  220 (371)
Q Consensus       141 iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~  220 (371)
                      +++.++      .+.-.+|||+++|-.|...     +++.+....++..|++-+..+-. .|+||+|+++-||+++++|.
T Consensus       173 VP~P~~------~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIA------WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCccc------cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEecCCC
Confidence            555544      3467899999999777643     12355556666777777666666 89999999999999999999


Q ss_pred             eEEecccccccCccc
Q 017445          221 PKITDFGISAGLENS  235 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~  235 (371)
                      +.++||-.+.....+
T Consensus       241 ~~vIDwPQ~v~~~hp  255 (304)
T COG0478         241 IVVIDWPQAVPISHP  255 (304)
T ss_pred             EEEEeCcccccCCCC
Confidence            999999877655443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=4.1e-08  Score=85.40  Aligned_cols=108  Identities=19%  Similarity=0.162  Sum_probs=80.1

Q ss_pred             HHHHHHHHHHHhCCC-CCCeeEeceeEEecCC--CeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 017445          123 NQLLTEIRTLCEAPC-NEGLVEFHGAFYMPDS--GQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLH  198 (371)
Q Consensus       123 ~~~~~E~~~l~~~~~-h~~iv~l~~~~~~~~~--~~~~lv~E~~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH  198 (371)
                      ....+|...+..+.. .-..++.+++......  ...+||+|++++ .+|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            345666665544321 1223444443332211  246899999998 489999876555778888999999999999999


Q ss_pred             cCCCeEecCCCCCcEEEccCC---ceEEeccccccc
Q 017445          199 GVRHLVHRDIKPANLLVNLKG---RPKITDFGISAG  231 (371)
Q Consensus       199 ~~~~iiH~Dlkp~NIl~~~~~---~~kl~Dfg~s~~  231 (371)
                      . .||+|+|+++.|||++.++   .+.|+||+.+..
T Consensus       136 ~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 D-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             H-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9 9999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.77  E-value=6.9e-08  Score=84.03  Aligned_cols=141  Identities=21%  Similarity=0.259  Sum_probs=94.5

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHH-------------------H-----HHHHHHHHHHHhCC-CCCC
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------------------R-----NQLLTEIRTLCEAP-CNEG  140 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~-----~~~~~E~~~l~~~~-~h~~  140 (371)
                      ...|++|--+.||+|. ..++..+|+|+++......                   .     .-...|...|.++. .+-.
T Consensus        53 ~g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            3467888888999997 4678899999986422111                   0     01234555555442 2344


Q ss_pred             eeEeceeEEecCCCeEEEEEeccCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          141 LVEFHGAFYMPDSGQISIALEYMDGGSLA-DILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       141 iv~l~~~~~~~~~~~~~lv~E~~~~g~L~-~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                      +++-+++.      .-.|||||+....+. -.|+ .-++..+.+..+..++++.+.-|-...++||+||+.-|||+. ++
T Consensus       132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         132 VPEPIAFR------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCCceeec------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence            55555433      356999999653110 0111 112334467888899999998887657899999999999999 99


Q ss_pred             ceEEecccccccCccc
Q 017445          220 RPKITDFGISAGLENS  235 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~~  235 (371)
                      .+.++|||.|....++
T Consensus       204 ~p~iID~~QaV~~~hp  219 (268)
T COG1718         204 EPYIIDVSQAVTIDHP  219 (268)
T ss_pred             eEEEEECccccccCCC
Confidence            9999999998766644

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.73  E-value=1.8e-07  Score=80.66  Aligned_cols=141  Identities=18%  Similarity=0.216  Sum_probs=88.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHH------------HHHHHHHHHhCCCCCCeeEe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ------------LLTEIRTLCEAPCNEGLVEF  144 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~------------~~~E~~~l~~~~~h~~iv~l  144 (371)
                      .+...+|++.+++-.....-|.+..  .+|..+++|..+.......+.            .+.....+.... .-....+
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g-~~~~~~~  103 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG-FTEPADP  103 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC-ccccccc
Confidence            3456678888888887777666664  366789999876432222121            112222222211 1112222


Q ss_pred             ceeEEe---cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCce
Q 017445          145 HGAFYM---PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP  221 (371)
Q Consensus       145 ~~~~~~---~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~  221 (371)
                      +.+..-   .-....+++|||++|..|.+...    +++    .++..+++++.-||+ .|+.|+|.+|.|++++.++ +
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc-E
Confidence            111110   11234568999999988877542    333    245667788999999 9999999999999999554 9


Q ss_pred             EEecccccc
Q 017445          222 KITDFGISA  230 (371)
Q Consensus       222 kl~Dfg~s~  230 (371)
                      ++.||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=5.9e-08  Score=94.70  Aligned_cols=141  Identities=23%  Similarity=0.331  Sum_probs=89.6

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHH----------------------------------HHH------HHH
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK----------------------------------RNQ------LLT  127 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~~------~~~  127 (371)
                      .|+.++-|+||+|+ ..+|+.||||+.++.-...                                  .+.      +.+
T Consensus       132 PiAsASIaQVH~A~-L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         132 PIASASIAQVHRAV-LKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             chhhhhHhhheeEE-ecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            79999999999998 4559999999875421110                                  011      122


Q ss_pred             HHHHHHh----CCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 017445          128 EIRTLCE----APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVR  201 (371)
Q Consensus       128 E~~~l~~----~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  201 (371)
                      |...+.+    ..+.+++ .+-..|+ +-.+.-.|+|||++|..+.+..  +. ..++.+.+.....++.  +..+-. .
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~w-e~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~-d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYW-EYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLR-D  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-Eeceeeh-hccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHh-c
Confidence            2222221    2223332 2222222 2245678999999999999874  43 4556444333222222  222223 6


Q ss_pred             CeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |++|.|.+|.||+++.+|.+.+.|||+...+.+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            7999999999999999999999999999877654

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=1.1e-06  Score=75.57  Aligned_cols=140  Identities=15%  Similarity=0.124  Sum_probs=97.6

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEec-ccc-----HHHHHHHHHHHHHHHhCCCC-CCeeEecee--EEecCCCeEEEE
Q 017445           89 IGSGASSVVQRAVHIPTHRIIALKKIN-IFE-----KEKRNQLLTEIRTLCEAPCN-EGLVEFHGA--FYMPDSGQISIA  159 (371)
Q Consensus        89 lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~-----~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~--~~~~~~~~~~lv  159 (371)
                      -|.|+-+.|+....  .|..+-+|.-. ...     ......+.+|...+..+... ..+++....  -.....-..+||
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            45688888888764  33367788754 100     22456788888877665321 113333311  111122247899


Q ss_pred             EeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc--eEEeccccccc
Q 017445          160 LEYMDG-GSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR--PKITDFGISAG  231 (371)
Q Consensus       160 ~E~~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~--~kl~Dfg~s~~  231 (371)
                      +|-++| .+|.+++...  .+.+......++.+++.++.-||+ .|+.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998764 5898888643  345778888999999999999999 99999999999999987777  99999987653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.58  E-value=6.2e-09  Score=100.67  Aligned_cols=251  Identities=18%  Similarity=0.190  Sum_probs=166.9

Q ss_pred             eEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCC-eeEeceeEEecCCCeEEEEEec
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-LVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~-iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      ....-+++|+++.+++.+...+...+ .+.+...     ....-+++.|.+.. ||| .+..++.+  +.+.+..+++++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n-~P~~~v~~~~d~--~~E~~~~i~~~i  315 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVN-NPNPVVRYLEDY--DGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHcc-CCCCcccccccC--Ccccccchhhhh
Confidence            34456899999999999876665544 6666432     22334556677776 999 56655543  445678999999


Q ss_pred             cCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          163 MDGG-SLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       163 ~~~g-~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      +.++ +-...+ ...-.+..-+...+.+.-+++++++|+ ---+|+|    ||+.. .+..+..||+....+.... ..+
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~-~~~  388 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM-KPR  388 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccc-ccccccccccCCcccCccc-ccc
Confidence            9876 221111 111123334445566667788999998 4358888    77766 4788999999988776654 346


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCC--CCCCHHHH-HHHH
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR--QNFSPEFC-SFVD  317 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~li~  317 (371)
                      +..+++.++|||+..+..+....|+|++|.-..++.-|.+|-...-   .....+-.++......  ...+.... ++..
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~---~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~  465 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP---AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPA  465 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc---cccCCCCCCCCccccchhhhcCcccccCCcc
Confidence            7889999999999999999999999999987777777777654311   1111110111000000  11111222 4788


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccccccccHHHHH
Q 017445          318 DCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFV  353 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~  353 (371)
                      .|+...|..|+....++.|.+|.+..-.--.++.|.
T Consensus       466 ~~~~g~P~~pkv~mgacfsKvfngCpl~i~~aaswI  501 (829)
T KOG0576|consen  466 PCLNGLPPTPKVHMGACFSKVFNGCPLRIHCAASWI  501 (829)
T ss_pred             cccCCCCCCCcchhhHHHHHHhccCcccceeccccc
Confidence            899999999999999999999988765554445554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.58  E-value=8.9e-07  Score=78.09  Aligned_cols=141  Identities=23%  Similarity=0.228  Sum_probs=79.3

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC-CCeeEeceeEEe-cCCCeEEEEEecc
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGAFYM-PDSGQISIALEYM  163 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~~~~-~~~~~~~lv~E~~  163 (371)
                      ++.|+.|..+.||++....  ..+++|.....  .....+..|...+..+..+ ..+++++..... ......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3579999999999998644  48999998653  3445556666665544323 235555553222 2234579999999


Q ss_pred             CCCCHHH----------------HH---Hhc----CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 017445          164 DGGSLAD----------------IL---RMQ----KSIPEPI---------LSSM------------FKKLLQ-GLSYLH  198 (371)
Q Consensus       164 ~~g~L~~----------------~l---~~~----~~l~~~~---------~~~i------------~~qi~~-aL~~LH  198 (371)
                      +|.++..                .+   +..    .++....         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988777                11   111    1111000         0000            011222 233333


Q ss_pred             c------CCCeEecCCCCCcEEEc-cCCceEEecccccc
Q 017445          199 G------VRHLVHRDIKPANLLVN-LKGRPKITDFGISA  230 (371)
Q Consensus       199 ~------~~~iiH~Dlkp~NIl~~-~~~~~kl~Dfg~s~  230 (371)
                      +      ...++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1      24599999999999999 66767899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.56  E-value=3.4e-07  Score=94.32  Aligned_cols=208  Identities=25%  Similarity=0.332  Sum_probs=146.1

Q ss_pred             HHHHHHHHHHhCCCCCCeeEeceeEEecCC-C-eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 017445          124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDS-G-QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR  201 (371)
Q Consensus       124 ~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~-~-~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  201 (371)
                      ....|...+.+.. |+|++.++.+...... + ...+..+++...++.+.+......+.++.+.+..+.++||.|+|+ .
T Consensus       228 ~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~-~  305 (1351)
T KOG1035|consen  228 TTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS-L  305 (1351)
T ss_pred             HHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH-h
Confidence            3445666677776 9999999886643221 2 233556899999999999888899999999999999999999999 5


Q ss_pred             CeEecCCCCC---cEEEccCCceEEe--cccccccCcccccccccccccCcccCCccccCCCCCCc--hhHHHHHHHHHH
Q 017445          202 HLVHRDIKPA---NLLVNLKGRPKIT--DFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP--ADIWSIGLALFE  274 (371)
Q Consensus       202 ~iiH~Dlkp~---NIl~~~~~~~kl~--Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Dv~slG~il~e  274 (371)
                      ...|.-+..+   +.-.+..+.+..+  ||+.+........ .........+.+||......+..+  .|+|++|.....
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            4444433333   3333445566666  8888877655432 234456677888888876665544  799999999999


Q ss_pred             HhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          275 CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       275 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +..|..+-......    ...+        ......+..+++.+|+.-++++|+++.+++.|||........
T Consensus       385 ~~~~~~i~~~~~~~----~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~  444 (1351)
T KOG1035|consen  385 LSQGEDISEKSAVP----VSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNE  444 (1351)
T ss_pred             hhhcCcccccccch----hhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccc
Confidence            98876543222111    1111        111222778899999999999999999999999997665443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.5e-06  Score=76.60  Aligned_cols=135  Identities=16%  Similarity=0.139  Sum_probs=77.0

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCC-CeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-GLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~-~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      .||+|..+.||+.    .+..+++|......  ....+.+|...+..+.... .+++.+++.  ++.+...+|||+++|.
T Consensus         8 ~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         8 QTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVGK   79 (226)
T ss_pred             eecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCCc
Confidence            7999999999984    24467889876522  2233567777765543221 134444433  3455678899999986


Q ss_pred             C-HHHH---------------------HHhc--CCCCHHHHH-HHHH----------HHHH-HHHHHHc---CCCeEecC
Q 017445          167 S-LADI---------------------LRMQ--KSIPEPILS-SMFK----------KLLQ-GLSYLHG---VRHLVHRD  207 (371)
Q Consensus       167 ~-L~~~---------------------l~~~--~~l~~~~~~-~i~~----------qi~~-aL~~LH~---~~~iiH~D  207 (371)
                      + +...                     ++.-  ...+..... .+..          .+.. ...+|.+   ...++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 2111                     1111  011111100 0100          0111 1222221   13478999


Q ss_pred             CCCCcEEEccCCceEEeccccccc
Q 017445          208 IKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       208 lkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +.|.||++++++ +.|+||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.51  E-value=1.4e-06  Score=77.90  Aligned_cols=136  Identities=15%  Similarity=0.032  Sum_probs=81.2

Q ss_pred             eecccCC-eEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           88 AIGSGAS-SVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        88 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      .|..|.. ..||++..  .+..+.+|......   .....+|+.++..+..+.-+++++++.  ...+..++|||+++|.
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYG--SDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEE--ecCCccEEEEEeeCCc
Confidence            4555666 78899964  23678888876432   334566777776665454566777654  3345688999999998


Q ss_pred             CHHHHH-------------------HhcC----CCCHH--HHHHHHH--------------------HHHHHHHHHHc--
Q 017445          167 SLADIL-------------------RMQK----SIPEP--ILSSMFK--------------------KLLQGLSYLHG--  199 (371)
Q Consensus       167 ~L~~~l-------------------~~~~----~l~~~--~~~~i~~--------------------qi~~aL~~LH~--  199 (371)
                      +|....                   +.-.    ++...  .......                    .+...+..|-.  
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            776431                   1100    11100  0000000                    01111222211  


Q ss_pred             ----CCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          200 ----VRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       200 ----~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                          ...++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                1348999999999999988778999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.40  E-value=2.4e-06  Score=83.31  Aligned_cols=140  Identities=17%  Similarity=0.185  Sum_probs=87.1

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccH-------------------------------HHHHH------HHHHH
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-------------------------------EKRNQ------LLTEI  129 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------------------------~~~~~------~~~E~  129 (371)
                      +.||.-+.|+||+|+.+ +|+.||||+-++.-+                               +-.+.      +.+|+
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            37999999999999854 499999998643110                               01111      22232


Q ss_pred             HHHHhCC---CCCC------eeEeceeEEecCCCeEEEEEeccCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 017445          130 RTLCEAP---CNEG------LVEFHGAFYMPDSGQISIALEYMDGGSLADI--LRMQKSIPEPILSSMFKKLLQGLSYLH  198 (371)
Q Consensus       130 ~~l~~~~---~h~~------iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~--l~~~~~l~~~~~~~i~~qi~~aL~~LH  198 (371)
                      +...+..   .|-+      |++++-.+    .....|+||||+|..+.|.  |.+ ..++...+..-+.++..-.  +-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~q--If  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQ--IF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHH--HH
Confidence            2211110   1333      44444322    4468899999999877764  443 3455554333333322212  12


Q ss_pred             cCCCeEecCCCCCcEEEcc----CCceEEecccccccCccc
Q 017445          199 GVRHLVHRDIKPANLLVNL----KGRPKITDFGISAGLENS  235 (371)
Q Consensus       199 ~~~~iiH~Dlkp~NIl~~~----~~~~kl~Dfg~s~~~~~~  235 (371)
                      . .|++|.|-+|.||+++.    ++.+.+-|||+...+...
T Consensus       319 ~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 K-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             h-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            2 67999999999999984    578999999998876654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=2e-06  Score=71.09  Aligned_cols=131  Identities=20%  Similarity=0.125  Sum_probs=90.2

Q ss_pred             eEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      ++.+.|++|..|.||++.+  .|..+|+|+-+.  ...+..+..|+.+|..+..-.--.+++.+.      ..++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhhhhh
Confidence            3456899999999999987  566899998763  345566788888887766443444555422      355679999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCC-CCcEEEccCCceEEecccccccC
Q 017445          164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK-PANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       164 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlk-p~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      .|..|.++-...   +.++    ...++++-.-|-. .||-|+.|+ |...++-.++.+.|+||..|+..
T Consensus        95 ~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG---DRKH----LLRVLEKAYKLDR-LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc---cHHH----HHHHHHHHHHHHH-hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            998888765321   3333    3445555444444 789999886 55556655669999999988743

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.31  E-value=1.7e-07  Score=98.55  Aligned_cols=213  Identities=14%  Similarity=0.025  Sum_probs=150.8

Q ss_pred             HHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcC
Q 017445          125 LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGV  200 (371)
Q Consensus       125 ~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~  200 (371)
                      .+.|...++... |+++...+.-....+....+++++|+.+|.+++.|-++    ..+.+.-......+.+.+..-+|+.
T Consensus      1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            334444333444 88888877655545566789999999999999988543    2344444444455547777777763


Q ss_pred             CC----eEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHh
Q 017445          201 RH----LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECG  276 (371)
Q Consensus       201 ~~----iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell  276 (371)
                      .+    .+|+++|+-|.+|..+..+|+.++|+.+...+.........+++.|+.|+....-.++.++|+|..|+.+|++.
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            33    68999999999999999999999999985555545556778899999999988888898899999999999998


Q ss_pred             cCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 017445          277 TGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       277 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      .|..+|....  ...+..++.+......+.-.|.+.-.....+|-..-..||.-..++.-+.|.
T Consensus      1435 ~~n~~fi~fl--q~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIFFL--QPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccHHHHHHH--HHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            8887774311  1112222333333333344456666666677777778888888888777764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=4.3e-05  Score=65.22  Aligned_cols=128  Identities=25%  Similarity=0.374  Sum_probs=89.8

Q ss_pred             cceeEeeeecccCC-eEEEEEEEcCCCcEEEEEEecc---ccH------------------HHHHHHHHHHHHHHhCCC-
Q 017445           81 HEMRIFGAIGSGAS-SVVQRAVHIPTHRIIALKKINI---FEK------------------EKRNQLLTEIRTLCEAPC-  137 (371)
Q Consensus        81 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~~~~-  137 (371)
                      .+++.++.||.|.- |.|+++..  .|+.+|+|.+..   ...                  ....-+..|.+...++.. 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68899999999999 99999976  777999999421   000                  111235667776655542 


Q ss_pred             -CCCe--eEeceeEEecC----------------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 017445          138 -NEGL--VEFHGAFYMPD----------------SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH  198 (371)
Q Consensus       138 -h~~i--v~l~~~~~~~~----------------~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH  198 (371)
                       +..+  |+++|+.....                .....||.||++...         .+.    ..-+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             3345  89999875431                112468888887633         122    233567888889999


Q ss_pred             cCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          199 GVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       199 ~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      . .||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k-~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 K-LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H-CCeeeccCcccccc-----CCEEEecccC
Confidence            9 99999999999986     2489999864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=3e-05  Score=81.25  Aligned_cols=82  Identities=13%  Similarity=0.039  Sum_probs=53.6

Q ss_pred             eeeecccCCeEEEEEEEcCCC--cEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCe--eEeceeEEec-CCCeEEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTH--RIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGL--VEFHGAFYMP-DSGQISIA  159 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i--v~l~~~~~~~-~~~~~~lv  159 (371)
                      ++.++.|.++.+|+......+  ..+++|+..... ......+.+|..++..+..|.++  ++++..+... ..+..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            457899999999998754432  467788765422 12234677888888777545443  6666544221 12468999


Q ss_pred             EeccCCCC
Q 017445          160 LEYMDGGS  167 (371)
Q Consensus       160 ~E~~~~g~  167 (371)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=2.9e-05  Score=68.98  Aligned_cols=31  Identities=32%  Similarity=0.422  Sum_probs=26.1

Q ss_pred             CCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .+++|+|+.|.||+++.++..-|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999999766668999998653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=1.7e-05  Score=67.72  Aligned_cols=100  Identities=24%  Similarity=0.162  Sum_probs=77.6

Q ss_pred             HHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--C
Q 017445          127 TEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD---ILRMQKSIPEPILSSMFKKLLQGLSYLHGV--R  201 (371)
Q Consensus       127 ~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~---~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~  201 (371)
                      .|..++..+...+++++++|.+      -.++|.||...+++..   .+..-...+|..+.+|+.++++.+.+|+..  .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            4666677777667999999976      2356889998766542   111223468999999999999999999861  2


Q ss_pred             CeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      .+.-.|++|+|+-++.+|.+|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            3778899999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00018  Score=66.29  Aligned_cols=80  Identities=11%  Similarity=-0.014  Sum_probs=54.2

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC--CCeeEeceeEEe-cCCCeEEEEEe
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN--EGLVEFHGAFYM-PDSGQISIALE  161 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h--~~iv~l~~~~~~-~~~~~~~lv~E  161 (371)
                      -.+.||.|..+.||.... .++ .+.+|..+.  ......+..|...+..+..+  ..++++++.+.. ...+..+||||
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            345799999999999863 333 466777532  11234677888888776543  467788776532 22456899999


Q ss_pred             ccCCCCH
Q 017445          162 YMDGGSL  168 (371)
Q Consensus       162 ~~~~g~L  168 (371)
                      +++|+++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.94  E-value=0.00011  Score=65.21  Aligned_cols=75  Identities=9%  Similarity=0.093  Sum_probs=46.0

Q ss_pred             eeecccCCeEEEEEEEcC-CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           87 GAIGSGASSVVQRAVHIP-THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      +.|..|-...+|++.... .+..|++|+...... ......+|+.++..+..+.-.+++++.+  . .   .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-~---~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF--Q-N---GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe--C-C---cEEEEeeCC
Confidence            468888899999997432 356788997754221 1122335666666554343445555432  2 2   379999999


Q ss_pred             CCH
Q 017445          166 GSL  168 (371)
Q Consensus       166 g~L  168 (371)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00028  Score=67.16  Aligned_cols=77  Identities=14%  Similarity=0.102  Sum_probs=50.9

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccc-----c--HHHHHHHHHHHHHHHhCCC--CCCeeEeceeEEecCCCeEE
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIF-----E--KEKRNQLLTEIRTLCEAPC--NEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~~~~--h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +.||.|.+..||++...+.++.++||.....     .  .....+...|...|..+..  ...+++++.+    +....+
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~----D~~~~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY----DEELAV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE----CCCCCE
Confidence            4799999999999987544458999985421     1  1133455666666665432  2456777663    234578


Q ss_pred             EEEeccCCCC
Q 017445          158 IALEYMDGGS  167 (371)
Q Consensus       158 lv~E~~~~g~  167 (371)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998744

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.91  E-value=4e-05  Score=68.99  Aligned_cols=136  Identities=13%  Similarity=0.099  Sum_probs=74.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS  167 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~  167 (371)
                      .+..|-.+.+|+..  .++..+++|..........-...+|..++..+..+.-.++++...  +    -++||||++|..
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCcc
Confidence            45678888999886  356678888764322111012355666666554332223333321  1    258999999866


Q ss_pred             HHH--------------H---HHhcC----CCCHH-HHHHHHHHH---------HHHHHHHHc-------CCCeEecCCC
Q 017445          168 LAD--------------I---LRMQK----SIPEP-ILSSMFKKL---------LQGLSYLHG-------VRHLVHRDIK  209 (371)
Q Consensus       168 L~~--------------~---l~~~~----~l~~~-~~~~i~~qi---------~~aL~~LH~-------~~~iiH~Dlk  209 (371)
                      +..              .   ++...    +++.. .+..+..++         ...+..+-.       ...++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            532              1   11111    11211 111221111         111222221       0248999999


Q ss_pred             CCcEEEccCCceEEecccccccC
Q 017445          210 PANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      |.||+++.++ +.|.||..+...
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCcC
Confidence            9999999877 789999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.83  E-value=0.00066  Score=58.36  Aligned_cols=127  Identities=20%  Similarity=0.266  Sum_probs=84.6

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEecccc----------------HHHHHHHHHHHHHHHh-----CCCCCCeeEece
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFE----------------KEKRNQLLTEIRTLCE-----APCNEGLVEFHG  146 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~-----~~~h~~iv~l~~  146 (371)
                      .||+|+.-.||.--   .+....||+.....                .....+..+|+.....     ...+..|.+++|
T Consensus         8 ~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    8 LIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             ccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            79999999999543   33346789886544                1224455556554332     224778999999


Q ss_pred             eEEecCCCeEEEEEeccCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-
Q 017445          147 AFYMPDSGQISIALEYMDG------GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-  219 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-  219 (371)
                      ..  +.+.-+-+|+|.+.+      .+|.+++. .+.+++ .   +...+-+-..||-+ .+|+.+|++|.||++...+ 
T Consensus        85 ~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~---~~~~L~~f~~~l~~-~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   85 FV--ETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-E---LRQALDEFKRYLLD-HHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             EE--ecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-H---HHHHHHHHHHHHHH-cCCeecCCCcccEEEEecCC
Confidence            65  455567888887653      47888885 445665 3   33334445567777 7899999999999996542 


Q ss_pred             ---ceEEec
Q 017445          220 ---RPKITD  225 (371)
Q Consensus       220 ---~~kl~D  225 (371)
                         .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence               466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.72  E-value=0.00034  Score=64.27  Aligned_cols=140  Identities=15%  Similarity=0.125  Sum_probs=77.8

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC-CCeeEecee----EEecCCCeEEEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGA----FYMPDSGQISIAL  160 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~----~~~~~~~~~~lv~  160 (371)
                      .+.|..|....+|+...  ++..+++|+.....   ...+..|+..+..+..+ -.+++++..    +.....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            34788888889999863  33468899876422   23344455444433211 123443321    1112234678999


Q ss_pred             eccCCCCHHH----H----------HHhc-CCC----------CHHHH----------HHHHHHHHHHHHHHHc------
Q 017445          161 EYMDGGSLAD----I----------LRMQ-KSI----------PEPIL----------SSMFKKLLQGLSYLHG------  199 (371)
Q Consensus       161 E~~~~g~L~~----~----------l~~~-~~l----------~~~~~----------~~i~~qi~~aL~~LH~------  199 (371)
                      +|++|..+..    .          ++.. ..+          .+...          ......+..++.++..      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999866421    1          1110 000          10000          0011112333444432      


Q ss_pred             CCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          200 VRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       200 ~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ..+++|+|+.|.||+++.++.+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            1469999999999999988778999999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.60  E-value=0.00038  Score=64.22  Aligned_cols=76  Identities=16%  Similarity=0.145  Sum_probs=45.2

Q ss_pred             eeecccCCeEEEEEEEcC------CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           87 GAIGSGASSVVQRAVHIP------THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +.|..|-...+|++....      +++.+++|+..... .......+|..++..+..+.-.+++++.+  ++    .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF--PN----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe--CC----Cchh
Confidence            356778888999887432      25789999875432 22234456666555544333334555533  22    2589


Q ss_pred             eccCCCCHH
Q 017445          161 EYMDGGSLA  169 (371)
Q Consensus       161 E~~~~g~L~  169 (371)
                      ||++|.++.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999987664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.57  E-value=0.0029  Score=58.86  Aligned_cols=30  Identities=23%  Similarity=0.336  Sum_probs=26.1

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .++||+|++|.||+++.+...-|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999966666899999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.52  E-value=0.0014  Score=60.65  Aligned_cols=141  Identities=16%  Similarity=0.155  Sum_probs=76.6

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCCeeEecee----EEecCCCeEEEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-NEGLVEFHGA----FYMPDSGQISIAL  160 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-h~~iv~l~~~----~~~~~~~~~~lv~  160 (371)
                      .+.++.|....+|++.. .+| .+++|+......  ...+..|...+..+.. .-.+++++..    ......+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45688888889999863 344 577898754211  1222333443333211 1113333321    1222345789999


Q ss_pred             eccCCCCHH-----H------H---HHhc-CCC--------CHHHHH---------------HHHHHHHHHHHHHHc---
Q 017445          161 EYMDGGSLA-----D------I---LRMQ-KSI--------PEPILS---------------SMFKKLLQGLSYLHG---  199 (371)
Q Consensus       161 E~~~~g~L~-----~------~---l~~~-~~l--------~~~~~~---------------~i~~qi~~aL~~LH~---  199 (371)
                      +|++|..+.     +      .   ++.. ..+        ......               .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999985432     1      1   1110 111        001000               001122334555532   


Q ss_pred             ---CCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          200 ---VRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       200 ---~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                         ..+++|+|+++.||+++.++.+.|.||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               2579999999999999988877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.50  E-value=0.001  Score=61.58  Aligned_cols=144  Identities=20%  Similarity=0.236  Sum_probs=93.6

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----c-----------------HHHHHH----HHHHHHHHHhCCCC
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----E-----------------KEKRNQ----LLTEIRTLCEAPCN  138 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~-----------------~~~~~~----~~~E~~~l~~~~~h  138 (371)
                      +-..|..|--+-||.|. ..+|..+|||+++-.     +                 ...++.    ...|++-|.++. .
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N  225 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence            34567788888999997 677888999987410     0                 001111    233555555443 1


Q ss_pred             CCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       139 ~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      ..|...--...    ..-.|||+++.......-.-+...++...+..+..|++.-+.-|....++||.||+--|+|+. +
T Consensus       226 aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  226 AGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             cCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence            11111111000    124589999954222221122445788889999999999998887767899999999999998 8


Q ss_pred             CceEEecccccccCccc
Q 017445          219 GRPKITDFGISAGLENS  235 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~  235 (371)
                      |.+.++|.+.|.....+
T Consensus       301 G~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             CEEEEEEccccccCCCh
Confidence            89999999988766554

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.44  E-value=0.00018  Score=65.35  Aligned_cols=138  Identities=16%  Similarity=0.156  Sum_probs=92.7

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--------cH--------------HHHHHHHHHHHHHHhCCCCCC
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--------EK--------------EKRNQLLTEIRTLCEAPCNEG  140 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~--------------~~~~~~~~E~~~l~~~~~h~~  140 (371)
                      +.+...||-|--+.+|.+.+ ..|.+.++|.-+..        .+              -.+-...+|...+..+..|..
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            34667899999999999974 45778888853210        00              011123556666666654433


Q ss_pred             -eeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC
Q 017445          141 -LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       141 -iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~  219 (371)
                       +++.++      ...-++|||++.|-.|...-+-   -+   ...+...+..-+.-|-. +|+||+|..--||++++++
T Consensus       173 pVPkpiD------~~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  173 PVPKPID------HNRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCCccc------ccceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHH-cCceecccchheeEEecCC
Confidence             334433      3467899999999888764321   12   23344555555666777 9999999999999999999


Q ss_pred             ceEEecccccccCcc
Q 017445          220 RPKITDFGISAGLEN  234 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~  234 (371)
                      .++++||-.+.....
T Consensus       240 ~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  240 KIVVIDFPQMVSTSH  254 (465)
T ss_pred             CEEEeechHhhccCC
Confidence            999999987654443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.32  E-value=0.0029  Score=59.15  Aligned_cols=74  Identities=12%  Similarity=0.105  Sum_probs=45.6

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc------c-HHHHHHHHHHHHHHHhCCC-CC-CeeEeceeEEecCCCeEEE
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF------E-KEKRNQLLTEIRTLCEAPC-NE-GLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~~~~-h~-~iv~l~~~~~~~~~~~~~l  158 (371)
                      .||.|....||++.+...++.|+||.....      + .-...+...|...|..... .| .+++++.  +  +.....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~--D~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F--DTEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E--cccccee
Confidence            589999999999997544468999975321      1 1223344456666654332 23 4555554  2  3445679


Q ss_pred             EEeccCC
Q 017445          159 ALEYMDG  165 (371)
Q Consensus       159 v~E~~~~  165 (371)
                      |||+++.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            9999965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.30  E-value=0.0025  Score=59.96  Aligned_cols=138  Identities=15%  Similarity=0.141  Sum_probs=76.7

Q ss_pred             eeecccCCeEEEEEEEcC----CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           87 GAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      ..|..|-...+|++....    .++.|++|......... -...+|..++..+..+.--+++++.+  ++ +   .|++|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRF--PN-G---RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEE--CC-c---eEEEe
Confidence            356568888999986432    34678899875432211 11245666655554343344555544  22 2   47999


Q ss_pred             cCCCCHHHH-----------------HHhcC------CCCHHHHHHHHHHH-----------------HHHHHHH----H
Q 017445          163 MDGGSLADI-----------------LRMQK------SIPEPILSSMFKKL-----------------LQGLSYL----H  198 (371)
Q Consensus       163 ~~~g~L~~~-----------------l~~~~------~l~~~~~~~i~~qi-----------------~~aL~~L----H  198 (371)
                      +++.+|...                 ++...      ...++.+..+..++                 ...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            988776421                 11111      01122222332111                 1111111    1


Q ss_pred             c---CCCeEecCCCCCcEEEcc-CCceEEeccccccc
Q 017445          199 G---VRHLVHRDIKPANLLVNL-KGRPKITDFGISAG  231 (371)
Q Consensus       199 ~---~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~  231 (371)
                      +   ...++|+|+++.||++++ ++.+.|+||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1   125899999999999986 47899999998753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.18  E-value=0.0056  Score=55.69  Aligned_cols=31  Identities=26%  Similarity=0.447  Sum_probs=25.7

Q ss_pred             CeEecCCCCCcEEEccCCc-eEEecccccccC
Q 017445          202 HLVHRDIKPANLLVNLKGR-PKITDFGISAGL  232 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~-~kl~Dfg~s~~~  232 (371)
                      .++|+|++|.||+++.++. .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 579999987543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.17  E-value=0.0074  Score=55.64  Aligned_cols=33  Identities=24%  Similarity=0.421  Sum_probs=28.9

Q ss_pred             CeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++|+|+++.|++++..+-+-|.||+.+..-+.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            389999999999999988899999999875544

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.12  E-value=0.013  Score=55.89  Aligned_cols=74  Identities=15%  Similarity=0.160  Sum_probs=46.4

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccc----cH---HHHHHHHHHHHHHHhCCC--CCCeeEeceeEEecCCCeE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIF----EK---EKRNQLLTEIRTLCEAPC--NEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~~~~--h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+.||.|....||++.+  .+..++||.-...    ..   -...+...|...|..+..  ...+++++.+.  +  ..-
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMA  110 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCC
Confidence            45799999999999986  3456889986521    11   123333444555544321  24677777643  3  356


Q ss_pred             EEEEeccCC
Q 017445          157 SIALEYMDG  165 (371)
Q Consensus       157 ~lv~E~~~~  165 (371)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            788999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.91  E-value=0.0066  Score=56.78  Aligned_cols=30  Identities=27%  Similarity=0.448  Sum_probs=26.0

Q ss_pred             eEecCCCCCcEEEcc-CCceEEecccccccC
Q 017445          203 LVHRDIKPANLLVNL-KGRPKITDFGISAGL  232 (371)
Q Consensus       203 iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~  232 (371)
                      ++|+|+.+.||++++ ++.++++||..|...
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            799999999999975 478999999988643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.90  E-value=0.0019  Score=62.18  Aligned_cols=165  Identities=20%  Similarity=0.230  Sum_probs=97.5

Q ss_pred             HHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 017445          123 NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH  202 (371)
Q Consensus       123 ~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~  202 (371)
                      .+++-...++..+. |+|...++++... ......+|||++. -+|.+++.... +.....       +       . ++
T Consensus        27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~-~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~-------~-------~-~~   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQ-HDNLCQYLDFSRG-KHERVIVVMEHYT-MSLEDILKTGN-LKDESL-------L-------A-HG   87 (725)
T ss_pred             HHHhhhhHHHHhhc-CccceeeEeeecC-ccceEEEEehhhc-cchHHHHHhcc-cchhhh-------c-------c-cc
Confidence            34455566666666 9999999886532 2335889999995 59999886543 211110       0       1 22


Q ss_pred             eEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCC
Q 017445          203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY  282 (371)
Q Consensus       203 iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf  282 (371)
                      +.|-     |+       ++.+| -++...       .+.                ..+++||||+|.++.++..|...+
T Consensus        88 ~~~~-----~~-------~~~td-~~~t~~-------~~~----------------~~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   88 VLHL-----NI-------IYITD-HFLTKY-------PSP----------------IGPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             ccee-----hh-------hhccc-cccccC-------CCC----------------CCcchhhhhHHHHHHHHHHhhHHH
Confidence            3221     22       23333 011000       011                114999999999999999998776


Q ss_pred             CCCCCcHHH--HHHHhhCCCCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          283 AASEGPVNL--MLQILEDPSPS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       283 ~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ..-...+..  +.+....+...       .....++..+.++...|+...|..||...++.+++-|...
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            543221111  11110000000       0012356778899999999999999999999999998765

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.58  E-value=0.025  Score=53.66  Aligned_cols=76  Identities=18%  Similarity=0.089  Sum_probs=46.9

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----c-HHHHHHHHHHHHHHHhCCC-CC-CeeEeceeEEecCCCeEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----E-KEKRNQLLTEIRTLCEAPC-NE-GLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~~~~-h~-~iv~l~~~~~~~~~~~~~  157 (371)
                      .+.||.|....||++.+...++.|+||.....     + .-...+...|...|..... .| .+++++.  +  +.....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~--D~e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--F--DSVMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--E--CcHHhh
Confidence            45799999999999987443567999975321     1 1223444555555544321 23 4566654  2  344567


Q ss_pred             EEEeccCC
Q 017445          158 IALEYMDG  165 (371)
Q Consensus       158 lv~E~~~~  165 (371)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            89999864

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.56  E-value=0.019  Score=53.38  Aligned_cols=137  Identities=20%  Similarity=0.237  Sum_probs=77.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC------CCCeeEeceeEEecCCC--eEEEE
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC------NEGLVEFHGAFYMPDSG--QISIA  159 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~------h~~iv~l~~~~~~~~~~--~~~lv  159 (371)
                      .|.+ .-..+|+... .+|+ +++|+....  ....++..|+..+..+..      -| +..+-|.....-.+  +.+-+
T Consensus        33 ~l~s-~eN~~f~~~~-~~g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQT-EDGR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEe-cCCC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEE
Confidence            3444 4456888864 3444 489988764  233344445444433221      12 44444444333344  78899


Q ss_pred             EeccCCCCHHH-----H----------HHhc-C-----------CCCHH----H---------HHHHHHHHHHHHHHHHc
Q 017445          160 LEYMDGGSLAD-----I----------LRMQ-K-----------SIPEP----I---------LSSMFKKLLQGLSYLHG  199 (371)
Q Consensus       160 ~E~~~~g~L~~-----~----------l~~~-~-----------~l~~~----~---------~~~i~~qi~~aL~~LH~  199 (371)
                      .+|++|..+..     .          |+.. +           ...|.    .         ......++...++.+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999987772     1          1110 0           01121    0         00122333344444433


Q ss_pred             -------CCC--eEecCCCCCcEEEccCCc-eEEecccccc
Q 017445          200 -------VRH--LVHRDIKPANLLVNLKGR-PKITDFGISA  230 (371)
Q Consensus       200 -------~~~--iiH~Dlkp~NIl~~~~~~-~kl~Dfg~s~  230 (371)
                             ..+  +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                   134  999999999999998874 8999999764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.54  E-value=0.014  Score=50.45  Aligned_cols=151  Identities=17%  Similarity=0.166  Sum_probs=86.9

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHH
Q 017445           92 GASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD  170 (371)
Q Consensus        92 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~  170 (371)
                      |+.++.-.+.-+. | +..+|++....-. ....+..+..++.+..   .|+++..    .+.-.+-++.|+|-....  
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh---GilrL~N----Dn~~~yGvIlE~Cy~~~i--  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH---GILRLKN----DNNYKYGVILERCYKIKI--  141 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh---heeEeec----CCCceeEEEEeeccCccc--
Confidence            3444444443222 3 3556766532222 3344566666766553   5777753    233456789999854211  


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCccc
Q 017445          171 ILRMQKSIPEPILSSMFKKLLQGLSYLHG-VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM  249 (371)
Q Consensus       171 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~  249 (371)
                             .+    ..++..=+.+|.-.|+ ..+.+|+|..|+||+-|+.|.+||.|-+.--  ..+          ..|.
T Consensus       142 -------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~~----------V~~v  198 (308)
T PF07387_consen  142 -------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--ENQ----------VNMV  198 (308)
T ss_pred             -------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--hhe----------eeEE
Confidence                   11    1122222567888895 3579999999999999999999999987531  111          1111


Q ss_pred             CCccccCCCCCCchhHHHHHHHHHHHhcCC
Q 017445          250 SPERIRNESYSYPADIWSIGLALFECGTGE  279 (371)
Q Consensus       250 aPE~~~~~~~~~~~Dv~slG~il~ell~g~  279 (371)
                      --   .-...+.++.+-+|-.-++++....
T Consensus       199 N~---~Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  199 NI---EYESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             ee---eccccChHHHHHHHHHHHHHHHHHH
Confidence            11   1123567777777766666666543

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.51  E-value=0.01  Score=55.87  Aligned_cols=63  Identities=25%  Similarity=0.422  Sum_probs=47.1

Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      ...|+-+|..|.++..+++. ...+++....++.-.+.|+--+--..+++|.|++|.||++.-+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            45677789999999999874 4456667777777777775544333679999999999999543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.47  E-value=0.008  Score=55.77  Aligned_cols=104  Identities=17%  Similarity=0.212  Sum_probs=72.0

Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ..+.|++|++- |++|..+    ..-.++++..++.+++.-+.-+......-|||+...||||+ +|++.|+||-+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            44678888876 5565532    23567888999999999998888755789999999999999 999999999999844


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSI  268 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  268 (371)
                      ..+......     ..--|-.+. +.-+..-+||-+
T Consensus       372 ~~q~~isy~-----rldhp~lF~-G~dd~QFeIYrl  401 (488)
T COG5072         372 YSQGIISYN-----RLDHPDLFN-GVDDYQFEIYRL  401 (488)
T ss_pred             cCCceeecc-----ccCchhhhc-CccceeeeHHHH
Confidence            333222111     122233333 223666777753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.44  E-value=0.06  Score=49.80  Aligned_cols=30  Identities=17%  Similarity=0.237  Sum_probs=27.2

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+++|+|+.+.||+++.++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            379999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.22  E-value=0.1  Score=48.66  Aligned_cols=28  Identities=25%  Similarity=0.398  Sum_probs=23.9

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 57899999764

>PTZ00384 choline kinase; Provisional

Probab=96.02  E-value=0.061  Score=51.26  Aligned_cols=77  Identities=13%  Similarity=0.067  Sum_probs=44.6

Q ss_pred             eeeecccCCeEEEEEEEcCC-CcE-----EEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPT-HRI-----IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++.|..|-...+|++..... +..     |.++.... .....-...+|..++..+..+..-.++++.+  +    -+++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f--~----~g~l  127 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF--G----DFTI  127 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEec--C----CEEE
Confidence            34666688899999964332 122     44443221 1111112345667776666566667777765  2    2589


Q ss_pred             EeccCCCCHH
Q 017445          160 LEYMDGGSLA  169 (371)
Q Consensus       160 ~E~~~~g~L~  169 (371)
                      .||++|.+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999997664

>PRK06148 hypothetical protein; Provisional

Probab=95.68  E-value=0.096  Score=56.40  Aligned_cols=31  Identities=29%  Similarity=0.503  Sum_probs=26.0

Q ss_pred             CCeEecCCCCCcEEEccCC--ce-EEeccccccc
Q 017445          201 RHLVHRDIKPANLLVNLKG--RP-KITDFGISAG  231 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~--~~-kl~Dfg~s~~  231 (371)
                      .++||+|+.+.|||++.++  .+ -|+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4699999999999999875  44 4999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.58  E-value=0.067  Score=48.88  Aligned_cols=74  Identities=12%  Similarity=0.031  Sum_probs=42.5

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEecCCCeEEEEEecc
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .+.++.|....+|+..  .+++.+.||.-..   .....+..|..-|..+.  ..-.+++.++....  .+..||||||+
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEEEee
Confidence            4578999999999986  5677899998752   23344566666555542  24557788776643  33459999999


Q ss_pred             CCC
Q 017445          164 DGG  166 (371)
Q Consensus       164 ~~g  166 (371)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00296 choline kinase; Provisional

Probab=95.41  E-value=0.18  Score=49.10  Aligned_cols=28  Identities=25%  Similarity=0.426  Sum_probs=23.9

Q ss_pred             CeEecCCCCCcEEEccCCceEEecccccc
Q 017445          202 HLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .++|+|+.+.|||.+.+ .++|+||..|.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            48999999999988744 49999998875

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.52  E-value=0.033  Score=47.27  Aligned_cols=32  Identities=19%  Similarity=0.343  Sum_probs=27.0

Q ss_pred             CeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..+|+|+.|.||+++.++ ++|+||+.+...+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp  109 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDI  109 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCCCH
Confidence            369999999999998777 89999999865443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.33  E-value=0.094  Score=48.37  Aligned_cols=29  Identities=24%  Similarity=0.379  Sum_probs=25.4

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999997 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	371
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-49
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-47
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-47
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-44
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-44
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-44
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-44
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-43
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-43
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-43
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-43
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-43
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-42
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-40
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-40
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-38
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-35
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-34
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-34
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-34
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-33
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-33
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-33
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-33
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-33
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-33
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-33
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-33
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-32
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-32
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-32
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-32
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-32
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-31
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-31
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-31
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-31
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-31
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-31
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-30
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-27
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-24
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-24
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-23
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-23
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-23
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-23
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-23
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-23
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-23
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-22
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-22
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-21
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-21
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-21
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-21
3soa_A	444	Full-Length Human Camkii Length = 444		2e-21
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-21
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-21
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-20
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-20
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-19
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-19
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-19
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-19
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-18
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-18
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-18
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-18
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-18
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-17
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-17
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-17
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-17
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-17
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-17
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-17
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-17
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-17
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-17
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-17
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-17
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-17
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-17
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-17
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-17
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-17
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-17
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-17
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-17
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-17
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-16
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-16
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-16
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-16
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-15
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-15
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-15
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-15
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-14
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-14
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-14
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-14
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-14
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-14
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-14
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-14
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-14
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-14
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-14
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-14
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-14
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-14
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-14
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-14
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-14
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-14
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-14
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-13
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-11
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-09
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-07

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  192 bits (487), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 163/274 (59%), Gaps = 11/274 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 90
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 91  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 148
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 149 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 206
Query: 267 SIGLALFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           S+GL+L E   G +P  +  G +    L+  I+ +P P      FS EF  FV+ CL K+
Sbjct: 207 SMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 266
Query: 324 AEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
              R    QL+ H FI + +  +VD A ++ S  
Sbjct: 267 PAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTI 300

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  184 bits (467), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 109/280 (38%), Positives = 163/280 (58%), Gaps = 17/280 (6%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 72  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 267 SIGLALFECGTGEFPYAA------SEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           S+GL+L E   G +P         S  P+    L+  I+ +P P      FS EF  FV+
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 247
Query: 318 DCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
            CL K+   R    QL+ H FI + +  +VD A ++ S  
Sbjct: 248 KCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTI 287

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  184 bits (466), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 106/271 (39%), Positives = 158/271 (58%), Gaps = 9/271 (3%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 74
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 75  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 132
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +   M   FVGT +YMSPER++   YS  +DIW
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVSGQLIDE--MANEFVGTRSYMSPERLQGTHYSVQSDIW 190
Query: 267 SIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
           S+GL+L E   G +P         L+  I+ +P P      FS EF  FV+ CL K+   
Sbjct: 191 SMGLSLVEMAVGRYPRPPM-AIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAE 249
Query: 327 RPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
           R    QL+ H FI + +  +VD A ++ S  
Sbjct: 250 RADLKQLMVHAFIKRSDAEEVDFAGWLCSTI 280

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 163/312 (52%), Gaps = 53/312 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  I+A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 81
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+  K IPE IL  +   +L+GL+YL     ++HR
Sbjct: 82  AFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 139
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YM+PER++   YS  +DIW
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMAPERLQGTHYSVQSDIW 197
Query: 267 SIGLALFECGTGEFPYAASEG---------PV---------------------------- 289
           S+GL+L E   G +P    +          PV                            
Sbjct: 198 SMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 257
Query: 290 --------NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
                    L+  I+ +P P      F+P+F  FV+ CL K+   R     L +H FI +
Sbjct: 258 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKR 317
Query: 342 YEHAKVDLAAFV 353
            E  +VD A ++
Sbjct: 318 SEVEEVDFAGWL 329

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 110/312 (35%), Positives = 162/312 (51%), Gaps = 49/312 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  K   RNQ++ E++ L E  CN   +V F+G
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 133
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 134 AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 191
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 192 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 249
Query: 267 SIGLALFECGTGEFP-------------------------------------YAASEGP- 288
           S+GL+L E   G +P                                     Y     P 
Sbjct: 250 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 309
Query: 289 ---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  
Sbjct: 310 MAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 369
Query: 346 KVDLAAFVRSVF 357
           +VD A ++ S  
Sbjct: 370 EVDFAGWLCSTI 381

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 162/312 (51%), Gaps = 49/312 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 72  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 267 SIGLALFECGTGEFP-------------------------------------YAASEGP- 288
           S+GL+L E   G +P                                     Y     P 
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 289 ---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  
Sbjct: 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307
Query: 346 KVDLAAFVRSVF 357
           +VD A ++ S  
Sbjct: 308 EVDFAGWLCSTI 319

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 162/312 (51%), Gaps = 49/312 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 72  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 267 SIGLALFECGTGEFP-------------------------------------YAASEGP- 288
           S+GL+L E   G +P                                     Y     P 
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 289 ---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  
Sbjct: 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307
Query: 346 KVDLAAFVRSVF 357
           +VD A ++ S  
Sbjct: 308 EVDFAGWLCSTI 319

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 162/312 (51%), Gaps = 49/312 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 72  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 267 SIGLALFECGTGEFP-------------------------------------YAASEGP- 288
           S+GL+L E   G +P                                     Y     P 
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 289 ---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  
Sbjct: 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307
Query: 346 KVDLAAFVRSVF 357
           +VD A ++ S  
Sbjct: 308 EVDFAGWLCSTI 319

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 95/292 (32%), Positives = 158/292 (54%), Gaps = 11/292 (3%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTL 132
           + +   + ++     +G GA  VV++  H+P+ +I+A+K+I      +++ +LL ++   
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG---SLADILRMQKSIPEPILSSMFKK 189
                    V F+GA +    G + I +E MD         ++   ++IPE IL  +   
Sbjct: 104 MRTVDCPFTVTFYGALFR--EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM 249
           +++ L +LH    ++HRD+KP+N+L+N  G+ K+ DFGIS  L +S+A      G   YM
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID-AGCKPYM 220
Query: 250 SPERIRNE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
           +PERI  E     YS  +DIWS+G+ + E     FPY +   P   + Q++E+PSP    
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 280
Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
             FS EF  F   CLKK+++ RPT  +L+ HPF T +E    D+A+FV+ + 
Sbjct: 281 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLIL 332

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 162/312 (51%), Gaps = 49/312 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 72  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 267 SIGLALFECGTGEFP-------------------------------------YAASEGP- 288
           S+GL+L E   G +P                                     Y     P 
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 289 ---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  
Sbjct: 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307
Query: 346 KVDLAAFVRSVF 357
           +VD A ++ S  
Sbjct: 308 EVDFAGWLCSTI 319

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 161/312 (51%), Gaps = 49/312 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEG-LVEFHG 146
           +G+G   VV +  H P+  ++A K I++  +   RNQ++ E++ L E  CN   +V F+G
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--CNSPYIVGFYG 98
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AFY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HR
Sbjct: 99  AFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KP+N+LVN +G  K+ DFG+S  L +S  M  +FVGT +YMSPER++   YS  +DIW
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 267 SIGLALFECGTGEFPYAASEGP-------------------------------------- 288
           S+GL+L E   G +P    +                                        
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274
Query: 289 ---VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  
Sbjct: 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334
Query: 346 KVDLAAFVRSVF 357
           +VD A ++ S  
Sbjct: 335 EVDFAGWLCSTI 346

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 152/277 (54%), Gaps = 11/277 (3%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G GA  VV++  H+P+ +I+A+K+I      +++ +LL ++            V F+GA
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 148 FYMPDSGQISIALEYMDGG---SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            +    G + I +E MD         ++   ++IPE IL  +   +++ L +LH    ++
Sbjct: 75  LFR--EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE----SYS 260
           HRD+KP+N+L+N  G+ K+ DFGIS  L + +A      G   YM+PERI  E     YS
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAPERINPELNQKGYS 191
Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             +DIWS+G+ + E     FPY +   P   + Q++E+PSP      FS EF  F   CL
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 251
Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
           KK+++ RPT  +L+ HPF T +E    D+A+FV+ + 
Sbjct: 252 KKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLIL 288

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 102/302 (33%), Positives = 161/302 (53%), Gaps = 19/302 (6%)
Query: 73  EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKI--NIFEKEKRNQLLTEIR 130
           E+ +   + +++  G IG GA   V + VH P+ +I+A+K+I   + EKE++ QLL ++ 
Sbjct: 14  EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK-QLLMDLD 72
Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-----MQKSIPEPILSS 185
            +  +     +V+F+GA +    G   I +E M   S     +     +   IPE IL  
Sbjct: 73  VVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 186 MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT 245
           +    ++ L++L     ++HRDIKP+N+L++  G  K+ DFGIS  L +SIA      G 
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGC 188
Query: 246 VTYMSPERI----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP 301
             YM+PERI      + Y   +D+WS+G+ L+E  TG FPY       + + Q+++   P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248
Query: 302 SPS---RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD 358
             S    + FSP F +FV+ CL KD   RP   +LL HPFI  YE   V++A +V  + D
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 308
Query: 359 PM 360
            M
Sbjct: 309 QM 310

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 161/293 (54%), Gaps = 14/293 (4%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTL 132
           + Y+   +++   G +GSG    V +     T  +IA+K++     KE+  ++L ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKL 190
            ++     +V+  G F    +  + IA+E M  G+ A+ L  RMQ  IPE IL  M   +
Sbjct: 78  LKSHDCPYIVQCFGTFIT--NTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMS 250
           ++ L YL     ++HRD+KP+N+L++ +G+ K+ DFGIS  L +  A   +  G   YM+
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-AGCAAYMA 192
Query: 251 PERI-----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-EDPSPSPS 304
           PERI         Y   AD+WS+G++L E  TG+FPY   +    ++ ++L E+P   P 
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
              FS +F SFV DCL KD   RP  ++LL H FI +YE  +VD+A++ + V 
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM 305

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 150/292 (51%), Gaps = 11/292 (3%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTL 132
           + +   + ++     +G GA  VV++  H+P+ +I A+K+I      +++ +LL ++   
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDIS 86
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG---SLADILRMQKSIPEPILSSMFKK 189
                    V F+GA +    G + I  E  D         ++   ++IPE IL  +   
Sbjct: 87  XRTVDCPFTVTFYGALFR--EGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVS 144
Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM 249
           +++ L +LH    ++HRD+KP+N+L+N  G+ K  DFGIS  L + +A      G   Y 
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGCKPYX 203
Query: 250 SPERIRNE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
           +PERI  E     YS  +DIWS+G+   E     FPY +   P   + Q++E+PSP    
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 263
Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
             FS EF  F   CLKK+++ RPT  +L  HPF T +E    D+A+FV+ + 
Sbjct: 264 DKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFTLHESKGTDVASFVKLIL 315

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 153/259 (59%), Gaps = 13/259 (5%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLV 142
           +   +G G+   V +A+H  T +I+A+K++ +  +    +++ EI  +  C++P    +V
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSP---HVV 87
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVR 201
           +++G+++   +  + I +EY   GS++DI+R++ K++ E  ++++ +  L+GL YLH +R
Sbjct: 88  KYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
             +HRDIK  N+L+N +G  K+ DFG++  L + +A     +GT  +M+PE I+   Y+ 
Sbjct: 146 K-IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QNFSPEFCSFVDDCL 320
            ADIWS+G+   E   G+ PYA    P+  +  I  +P P+  + + +S  F  FV  CL
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263
Query: 321 KKDAEARPTADQLLSHPFI 339
            K  E R TA QLL HPF+
Sbjct: 264 VKSPEQRATATQLLQHPFV 282

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 154/279 (55%), Gaps = 16/279 (5%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V + +   T  ++A+K I++ E E      Q    + + C++P    +  + 
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---ITRYF 83
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G++    S ++ I +EY+ GGS  D+L+    + E  ++++ +++L+GL YLH  R  +H
Sbjct: 84  GSYL--KSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERK-IH 139
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++ +G  K+ DFG++  L ++      FVGT  +M+PE I+  +Y + ADI
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P  +   P+ ++  I ++  P+   Q+  P F  FV+ CL KD  
Sbjct: 200 WSLGITAIELAKGE-PPNSDLHPMRVLFLIPKNSPPTLEGQHSKP-FKEFVEACLNKDPR 257
Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            RPTA +LL H FIT+Y        +F+  + D  +R K
Sbjct: 258 FRPTAKELLKHKFITRYTKK----TSFLTELIDRYKRWK 292

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 152/277 (54%), Gaps = 12/277 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT-EIRTLCEAPCNEGLVEFHGA 147
           IG G+   V + +   T +++A+K I++ E E   + +  EI  L +  C+   V  +  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ--CDSSYVTKYYG 88
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
            Y+  S ++ I +EY+ GGS  D+LR      E  +++M K++L+GL YLH  +  +HRD
Sbjct: 89  SYLKGS-KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKK-IHRD 145
Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWS 267
           IK AN+L++ +G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y   ADIWS
Sbjct: 146 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWS 205
Query: 268 IGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +G+   E   GE P  +   P+ ++  I ++  P+    +F+  F  F+D CL KD   R
Sbjct: 206 LGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLV-GDFTKSFKEFIDACLNKDPSFR 263
Query: 328 PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
           PTA +LL H FI K         +++  + D  +R K
Sbjct: 264 PTAKELLKHKFIVKNSKK----TSYLTELIDRFKRWK 296

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 149/265 (56%), Gaps = 16/265 (6%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLV 142
           I G +G GA   V +A +  T  + A K I    +E+    + EI  L  C+ P    +V
Sbjct: 23  IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY---IV 79
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +  GA+Y    G++ I +E+  GG++ A +L + + + EP +  + +++L+ L++LH  R
Sbjct: 80  KLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES--- 258
            ++HRD+K  N+L+ L+G  ++ DFG+SA    ++    +F+GT  +M+PE +  E+   
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 259 --YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSF 315
             Y Y ADIWS+G+ L E    E P+     P+ ++L+I + DP    +   +S EF  F
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 316 VDDCLKKDAEARPTADQLLSHPFIT 340
           +   L K+ E RP+A QLL HPF++
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVS 280

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 149/265 (56%), Gaps = 16/265 (6%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLV 142
           I G +G GA   V +A +  T  + A K I    +E+    + EI  L  C+ P    +V
Sbjct: 15  IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY---IV 71
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +  GA+Y    G++ I +E+  GG++ A +L + + + EP +  + +++L+ L++LH  R
Sbjct: 72  KLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 129
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES--- 258
            ++HRD+K  N+L+ L+G  ++ DFG+SA    ++    +F+GT  +M+PE +  E+   
Sbjct: 130 -IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 259 --YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSF 315
             Y Y ADIWS+G+ L E    E P+     P+ ++L+I + DP    +   +S EF  F
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 247
Query: 316 VDDCLKKDAEARPTADQLLSHPFIT 340
           +   L K+ E RP+A QLL HPF++
Sbjct: 248 LKIALDKNPETRPSAAQLLEHPFVS 272

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 147/268 (54%), Gaps = 20/268 (7%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGL 141
            I G +G GA   V +A +  T  + A K I+   +E+    + EI  L  C+ P    +
Sbjct: 40  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP---NI 96
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           V+   AFY  ++  + I +E+  GG++ A +L +++ + E  +  + K+ L  L+YLH  
Sbjct: 97  VKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-----R 255
           + ++HRD+K  N+L  L G  K+ DFG+SA    +I    +F+GT  +M+PE +     +
Sbjct: 155 K-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSPEF 312
           +  Y Y AD+WS+G+ L E    E P+     P+ ++L+I +   P+   PSR  +S  F
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSR--WSSNF 270
Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFIT 340
             F+  CL+K+ +AR T  QLL HPF+T
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 146/268 (54%), Gaps = 20/268 (7%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGL 141
            I G +G GA   V +A +  T  + A K I+   +E+    + EI  L  C+ P    +
Sbjct: 40  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP---NI 96
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           V+   AFY  ++  + I +E+  GG++ A +L +++ + E  +  + K+ L  L+YLH  
Sbjct: 97  VKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-----R 255
           + ++HRD+K  N+L  L G  K+ DFG+SA     I    +F+GT  +M+PE +     +
Sbjct: 155 K-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSPEF 312
           +  Y Y AD+WS+G+ L E    E P+     P+ ++L+I +   P+   PSR  +S  F
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSR--WSSNF 270
Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFIT 340
             F+  CL+K+ +AR T  QLL HPF+T
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 144/255 (56%), Gaps = 7/255 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 83
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 84  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 139
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL  D 
Sbjct: 200 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 325 EARPTADQLLSHPFI 339
           E R +A +LL H F+
Sbjct: 259 EKRGSAKELLQHQFL 273

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 145/262 (55%), Gaps = 14/262 (5%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G    V +  H+ T ++ A+K +++   E+  ++  EI  L +   +  +  ++GAF
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 149 YMPD----SGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRH 202
              +      Q+ + +E+   GS+ D+++  K  ++ E  ++ + +++L+GLS+LH  + 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-----NE 257
           ++HRDIK  N+L+      K+ DFG+SA L+ ++    TF+GT  +M+PE I      + 
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 209
Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +Y + +D+WS+G+   E   G  P      P+  +  I  +P+P    + +S +F SF++
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWSKKFQSFIE 268
Query: 318 DCLKKDAEARPTADQLLSHPFI 339
            CL K+   RP  +QL+ HPFI
Sbjct: 269 SCLVKNHSQRPATEQLMKHPFI 290

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 145/268 (54%), Gaps = 20/268 (7%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGL 141
            I G +G GA   V +A +  T  + A K I+   +E+    + EI  L  C+ P    +
Sbjct: 40  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP---NI 96
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSL-ADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           V+   AFY  ++  + I +E+  GG++ A +L +++ + E  +  + K+ L  L+YLH  
Sbjct: 97  VKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-----R 255
           + ++HRD+K  N+L  L G  K+ DFG+SA     I     F+GT  +M+PE +     +
Sbjct: 155 K-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSPEF 312
           +  Y Y AD+WS+G+ L E    E P+     P+ ++L+I +   P+   PSR  +S  F
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSR--WSSNF 270
Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFIT 340
             F+  CL+K+ +AR T  QLL HPF+T
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 146/279 (52%), Gaps = 32/279 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTL--CEAPCNEGLVEF 144
            IGSGA++VVQ A   P    +A+K+IN+ + +   ++LL EI+ +  C  P    +V +
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP---NIVSY 78
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRM------QKS--IPEPILSSMFKKLLQGLSY 196
           + +F + D  ++ + ++ + GGS+ DI++        KS  + E  ++++ +++L+GL Y
Sbjct: 79  YTSFVVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC-----ATFVGTVTYMSP 251
           LH     +HRD+K  N+L+   G  +I DFG+SA L     +       TFVGT  +M+P
Sbjct: 137 LHK-NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 252 ERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR----- 305
           E +     Y + ADIWS G+   E  TG  PY        LML +  DP PS        
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-PSLETGVQDK 254
Query: 306 ---QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
              + +   F   +  CL+KD E RPTA +LL H F  K
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 146/279 (52%), Gaps = 32/279 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTL--CEAPCNEGLVEF 144
            IGSGA++VVQ A   P    +A+K+IN+ + +   ++LL EI+ +  C  P    +V +
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP---NIVSY 73
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRM------QKS--IPEPILSSMFKKLLQGLSY 196
           + +F + D  ++ + ++ + GGS+ DI++        KS  + E  ++++ +++L+GL Y
Sbjct: 74  YTSFVVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC-----ATFVGTVTYMSP 251
           LH     +HRD+K  N+L+   G  +I DFG+SA L     +       TFVGT  +M+P
Sbjct: 132 LHK-NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190
Query: 252 ERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR----- 305
           E +     Y + ADIWS G+   E  TG  PY        LML +  DP PS        
Sbjct: 191 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-PSLETGVQDK 249
Query: 306 ---QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
              + +   F   +  CL+KD E RPTA +LL H F  K
Sbjct: 250 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 144/255 (56%), Gaps = 7/255 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 83
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 84  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 139
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +  VGT  +M+PE +  ++Y    DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL+ D 
Sbjct: 200 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 258
Query: 325 EARPTADQLLSHPFI 339
           E R +A +LL H F+
Sbjct: 259 EKRGSAKELLQHQFL 273

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 158/279 (56%), Gaps = 16/279 (5%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E      Q    + + C++P    + +++
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTKYY 71
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G+ Y+ D+ ++ I +EY+ GGS  D+L     + E  ++++ +++L+GL YLH  +  +H
Sbjct: 72  GS-YLKDT-KLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK-IH 127
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++  G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y   ADI
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P++    P+ ++  I ++ +P     N+S     FV+ CL K+  
Sbjct: 188 WSLGITAIELARGEPPHSELH-PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPS 245
Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            RPTA +LL H FI +  +AK    +++  + D  +R K
Sbjct: 246 FRPTAKELLKHKFILR--NAKK--TSYLTELIDRYKRWK 280

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 145/255 (56%), Gaps = 7/255 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 26  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 84
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 85  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 140
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           R+IK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    DI
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL+ D 
Sbjct: 201 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 259
Query: 325 EARPTADQLLSHPFI 339
           E R +A +L+ H F+
Sbjct: 260 EKRGSAKELIQHQFL 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 143/255 (56%), Gaps = 7/255 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 83
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 84  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 139
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +  VGT  +M+PE +  ++Y    DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL  D 
Sbjct: 200 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 325 EARPTADQLLSHPFI 339
           E R +A +LL H F+
Sbjct: 259 EKRGSAKELLQHQFL 273

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 147/256 (57%), Gaps = 12/256 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E      Q    + + C++P    + +++
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTKYY 91
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G+ Y+ D+ ++ I +EY+ GGS  D+L     + E  ++++ +++L+GL YLH  +  +H
Sbjct: 92  GS-YLKDT-KLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK-IH 147
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++  G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y   ADI
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P++    P+ ++  I ++ +P     N+S     FV+ CL K+  
Sbjct: 208 WSLGITAIELARGEPPHSELH-PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPS 265
Query: 326 ARPTADQLLSHPFITK 341
            RPTA +LL H FI +
Sbjct: 266 FRPTAKELLKHKFILR 281

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 144/255 (56%), Gaps = 7/255 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V + 
Sbjct: 26  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYL 84
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    ++H
Sbjct: 85  DSYLVGD--ELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQVIH 140
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  N+L+ + G  K+TDFG  A +    +  +  VGT  +M+PE +  ++Y    DI
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL+ D 
Sbjct: 201 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 259
Query: 325 EARPTADQLLSHPFI 339
           E R +A +L+ H F+
Sbjct: 260 EKRGSAKELIQHQFL 274

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 146/257 (56%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +  IG G++ +V  A    + R +A+K +++ ++++R  L  E+  + +   +  +VE +
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMY 108
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + +  ++ + +E++ GG+L DI+  Q  + E  ++++ + +LQ L+YLH  + ++H
Sbjct: 109 KSYLVGE--ELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHA-QGVIH 164
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+ L GR K++DFG  A +   +      VGT  +M+PE I    Y+   DI
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  S+ PV  M ++ + P P   +    SP    F++  L +D 
Sbjct: 225 WSLGIMVIEMVDGEPPY-FSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 325 EARPTADQLLSHPFITK 341
           + R TA +LL HPF+ +
Sbjct: 284 QERATAQELLDHPFLLQ 300

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 157/279 (56%), Gaps = 16/279 (5%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E      Q    + + C++P    + +++
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTKYY 86
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G+ Y+ D+ ++ I +EY+ GGS  D+L     + E  ++++ +++L+GL YLH  +  +H
Sbjct: 87  GS-YLKDT-KLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK-IH 142
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++  G  K+ DFG++  L ++      FVGT  +M+PE I+  +Y   ADI
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P++    P+ ++  I ++ +P     N+S     FV+ CL K+  
Sbjct: 203 WSLGITAIELARGEPPHSELH-PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPS 260
Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            RPTA +LL H FI +  +AK    +++  + D  +R K
Sbjct: 261 FRPTAKELLKHKFILR--NAKK--TSYLTELIDRYKRWK 295

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 157/279 (56%), Gaps = 16/279 (5%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E      Q    + + C++P    + +++
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---VTKYY 71
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G+ Y+ D+ ++ I +EY+ GGS  D+L     + E  ++++ +++L+GL YLH  +  +H
Sbjct: 72  GS-YLKDT-KLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK-IH 127
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++  G  K+ DFG++  L ++      FVGT  +M+PE I+  +Y   ADI
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P++    P+ ++  I ++ +P     N+S     FV+ CL K+  
Sbjct: 188 WSLGITAIELARGEPPHSELH-PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPS 245
Query: 326 ARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            RPTA +LL H FI +  +AK    +++  + D  +R K
Sbjct: 246 FRPTAKELLKHKFILR--NAKK--TSYLTELIDRYKRWK 280

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 143/257 (55%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 29  FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 87
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +LQ LS LH  + ++H
Sbjct: 88  NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLHA-QGVIH 143
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 203
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 204 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 262
Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 263 AQRATAAELLKHPFLAK 279

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 143/257 (55%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 25  FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMY 83
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +LQ LS LH  + ++H
Sbjct: 84  NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLHA-QGVIH 139
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 199
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 200 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 259 AQRATAAELLKHPFLAK 275

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 143/257 (55%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 36  FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMY 94
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +LQ LS LH  + ++H
Sbjct: 95  NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLHA-QGVIH 150
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 210
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 211 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 269
Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 270 AQRATAAELLKHPFLAK 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 143/257 (55%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 34  FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMY 92
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +LQ LS LH  + ++H
Sbjct: 93  NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLHA-QGVIH 148
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 208
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 209 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 267
Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 268 AQRATAAELLKHPFLAK 284

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 143/257 (55%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 79  FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMY 137
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +LQ LS LH  + ++H
Sbjct: 138 NSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLHA-QGVIH 193
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 253
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 254 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 312
Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 313 AQRATAAELLKHPFLAK 329

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 143/257 (55%), Gaps = 7/257 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    + +++A+KK+++ ++++R  L  E+  + +   +E +VE +
Sbjct: 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMY 214
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+     + E  ++++   +LQ LS LH  + ++H
Sbjct: 215 NSYLVGD--ELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLQALSVLHA-QGVIH 270
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDI 330
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M  I ++  P   +    SP    F+D  L +D 
Sbjct: 331 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 389
Query: 325 EARPTADQLLSHPFITK 341
             R TA +LL HPF+ K
Sbjct: 390 AQRATAAELLKHPFLAK 406

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 139/255 (54%), Gaps = 7/255 (2%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           F  IG G++ +V  A    T + +A+KK+++ ++++R  L  E+  +     ++ +V+ +
Sbjct: 50  FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV-VIMRDYHHDNVVDMY 108
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            ++ + D  ++ + +E+++GG+L DI+   +   E I +++   +L+ LSYLH  + ++H
Sbjct: 109 SSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQI-ATVCLSVLRALSYLHN-QGVIH 164
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  ++L+   GR K++DFG  A +   +      VGT  +M+PE I    Y    DI
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDI 224
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILED-PSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS+G+ + E   GE PY  +E P+  M +I +  P         S     F+D  L ++ 
Sbjct: 225 WSLGIMVIEMIDGEPPY-FNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREP 283
Query: 325 EARPTADQLLSHPFI 339
             R TA +LL HPF+
Sbjct: 284 SQRATAQELLGHPFL 298

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 130/254 (51%), Gaps = 14/254 (5%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEG 140
           RI   IG G  S V RA  +     +ALKK+ IF+    + R   + EI  L +   +  
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPN 93
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSY 196
           +++++ +F   +  +++I LE  D G L+ +++     ++ IPE  +   F +L   L +
Sbjct: 94  VIKYYASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           +H  R ++HRDIKPAN+ +   G  K+ D G+     +      + VGT  YMSPERI  
Sbjct: 152 MHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--DPSPSPSRQNFSPEFCS 314
             Y++ +DIWS+G  L+E    + P+   +  +  + + +E  D  P PS  ++S E   
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS-DHYSEELRQ 269
Query: 315 FVDDCLKKDAEARP 328
            V+ C+  D E RP
Sbjct: 270 LVNMCINPDPEKRP 283

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 138/280 (49%), Gaps = 16/280 (5%)
Query: 68  ESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR-NQLL 126
           ESD  E  Y    +  R+   +G G   +V     +     IA+K+I   E++ R +Q L
Sbjct: 11  ESDLLEYDYEYDENGDRV--VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPL 66
Query: 127 TEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIP----EPI 182
            E   L +   ++ +V++ G+F   ++G I I +E + GGSL+ +LR  K  P    E  
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSF--SENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQT 123
Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCAT 241
           +    K++L+GL YLH    +VHRDIK  N+L+N   G  KI+DFG S  L        T
Sbjct: 124 IGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 242 FVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP 299
           F GT+ YM+PE I      Y   ADIWS+G  + E  TG+ P+     P   M ++    
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
                 ++ S E  +F+  C + D + R  A+ LL   F+
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 10/266 (3%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEG 140
           E ++F  +G GA SVV+R + IPT +  A K IN  +   R+ Q L     +C    +  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V  H +  + + G   +  + + GG L + +  ++   E   S   +++L+ +++ H +
Sbjct: 65  IVRLHDS--ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH-L 121
Query: 201 RHLVHRDIKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
             +VHRD+KP NLL+  K +    K+ DFG++  ++        F GT  Y+SPE +R +
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSF 315
            Y  P D+W+ G+ L+    G +P    E    L  QI       PSP     +PE    
Sbjct: 182 PYGKPVDMWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 316 VDDCLKKDAEARPTADQLLSHPFITK 341
           ++  L  +   R TA + L HP+I +
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQ 266

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 10/266 (3%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEG 140
           E ++F  +G GA SVV+R + IPT +  A K IN  +   R+ Q L     +C    +  
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V  H +  + + G   +  + + GG L + +  ++   E   S   +++L+ +++ H +
Sbjct: 65  IVRLHDS--ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH-L 121
Query: 201 RHLVHRDIKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
             +VHRD+KP NLL+  K +    K+ DFG++  ++        F GT  Y+SPE +R +
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD 181
Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSF 315
            Y  P D+W+ G+ L+    G +P    E    L  QI       PSP     +PE    
Sbjct: 182 PYGKPVDMWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 316 VDDCLKKDAEARPTADQLLSHPFITK 341
           ++  L  +   R TA + L HP+I +
Sbjct: 241 INKMLTINPAKRITASEALKHPWICQ 266

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 130/260 (50%), Gaps = 14/260 (5%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHG 146
            +G G   +V     +     IA+K+I   E++ R +Q L E   L +   ++ +V++ G
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIP----EPILSSMFKKLLQGLSYLHGVRH 202
           +F   ++G I I +E + GGSL+ +LR  K  P    E  +    K++L+GL YLH    
Sbjct: 73  SF--SENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQ 128
Query: 203 LVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN--ESY 259
           +VHRDIK  N+L+N   G  KI+DFG S  L        TF GT+ YM+PE I      Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
              ADIWS+G  + E  TG+ P+     P   M ++          ++ S E  +F+  C
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 248
Query: 320 LKKDAEARPTADQLLSHPFI 339
            + D + R  A+ LL   F+
Sbjct: 249 FEPDPDKRACANDLLVDEFL 268

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 11/261 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEGLVEFHGA 147
           +G GA SVV+R VH  T    A K IN  +   R+ Q L     +C    +  +V  H +
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
             + +     +  + + GG L + +  ++   E   S   +++L+ ++Y H    +VHR+
Sbjct: 73  --IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRN 129
Query: 208 IKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL+  K +    K+ DFG++  + +S A    F GT  Y+SPE ++ + YS P D
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVD 188
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKK 322
           IW+ G+ L+    G +P    E    L  QI       PSP     +PE  S +D  L  
Sbjct: 189 IWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 247
Query: 323 DAEARPTADQLLSHPFITKYE 343
           + + R TADQ L  P+I   E
Sbjct: 248 NPKKRITADQALKVPWICNRE 268

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 11/261 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEGLVEFHGA 147
           +G GA SVV+R VH  T    A K IN  +   R+ Q L     +C    +  +V  H +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
             + +     +  + + GG L + +  ++   E   S   +++L+ ++Y H    +VHR+
Sbjct: 74  --IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRN 130
Query: 208 IKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL+  K +    K+ DFG++  + +S A    F GT  Y+SPE ++ + YS P D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVD 189
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKK 322
           IW+ G+ L+    G +P    E    L  QI       PSP     +PE  S +D  L  
Sbjct: 190 IWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248
Query: 323 DAEARPTADQLLSHPFITKYE 343
           + + R TADQ L  P+I   E
Sbjct: 249 NPKKRITADQALKVPWICNRE 269

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 145/284 (51%), Gaps = 25/284 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A  +    ++A+KK++   K   EK   ++ E+R L +   +   +++ 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL-QKLRHPNTIQYR 120
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G +    +  +   +EY   GS +D+L + K  + E  ++++    LQGL+YLH   +++
Sbjct: 121 GCYLREHTAWL--VMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMI 176
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI---RNESYSY 261
           HRD+K  N+L++  G  K+ DFG SA +   +A    FVGT  +M+PE I       Y  
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFG-SASI---MAPANXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D+WS+G+   E    + P   +   ++ +  I ++ SP+    ++S  F +FVD CL+
Sbjct: 233 KVDVWSLGITCIELAERK-PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291
Query: 322 KDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           K  + RPT++ LL H F+ +     V        + D +QR KD
Sbjct: 292 KIPQDRPTSEVLLKHRFVLRERPPTV--------IMDLIQRTKD 327

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 11/261 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEGLVEFHGA 147
           +G GA SVV+R VH  T    A K IN  +   R+ Q L     +C    +  +V  H +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
             + +     +  + + GG L + +  ++   E   S   +++L+ ++Y H    +VHR+
Sbjct: 74  --IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRN 130
Query: 208 IKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL+  K +    K+ DFG++  + +S A    F GT  Y+SPE ++ + YS P D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVD 189
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKK 322
           IW+ G+ L+    G +P    E    L  QI       PSP     +PE  S +D  L  
Sbjct: 190 IWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248
Query: 323 DAEARPTADQLLSHPFITKYE 343
           + + R TADQ L  P+I   E
Sbjct: 249 NPKKRITADQALKVPWICNRE 269

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 145/284 (51%), Gaps = 25/284 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A  +    ++A+KK++   K   EK   ++ E+R L +   +   +++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL-QKLRHPNTIQYR 81
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G +    +  +   +EY   GS +D+L + K  + E  ++++    LQGL+YLH   +++
Sbjct: 82  GCYLREHTAWL--VMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMI 137
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI---RNESYSY 261
           HRD+K  N+L++  G  K+ DFG SA +   +A    FVGT  +M+PE I       Y  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFG-SASI---MAPANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D+WS+G+   E    + P   +   ++ +  I ++ SP+    ++S  F +FVD CL+
Sbjct: 194 KVDVWSLGITCIELAERK-PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252
Query: 322 KDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           K  + RPT++ LL H F+ +     V        + D +QR KD
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERPPTV--------IMDLIQRTKD 288

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 10/266 (3%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEG 140
           E +++  IG GA SVV+R V + T    A K IN  +   R+ Q L     +C    +  
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSN 64
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V  H +  + + G   +  + + GG L + +  ++   E   S   +++L+ + + H +
Sbjct: 65  IVRLHDS--ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 201 RHLVHRDIKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
             +VHRD+KP NLL+  K +    K+ DFG++  ++        F GT  Y+SPE +R E
Sbjct: 123 G-VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSF 315
           +Y  P DIW+ G+ L+    G +P    E    L  QI       PSP     +PE  + 
Sbjct: 182 AYGKPVDIWACGVILYILLVG-YPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 316 VDDCLKKDAEARPTADQLLSHPFITK 341
           ++  L  +   R TA + L HP++ +
Sbjct: 241 INQMLTINPAKRITAHEALKHPWVCQ 266

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 11/261 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEGLVEFHGA 147
           +G GA SVV+R VH  T    A K IN  +   R+ Q L     +C    +  +V  H +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
             + +     +  + + GG L + +  ++   E   S   +++L+ ++Y H    +VHR+
Sbjct: 97  --IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRN 153
Query: 208 IKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL+  K +    K+ DFG++  + +S A    F GT  Y+SPE ++ + YS P D
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVD 212
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKK 322
           IW+ G+ L+    G +P    E    L  QI       PSP     +PE  S +D  L  
Sbjct: 213 IWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 271
Query: 323 DAEARPTADQLLSHPFITKYE 343
           + + R TADQ L  P+I   E
Sbjct: 272 NPKKRITADQALKVPWICNRE 292

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 10/266 (3%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEG 140
           + ++F  +G GA SVV+R V     +  A K IN  +   R+ Q L     +C    +  
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 91
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +V  H +  + + G   +  + + GG L + +  ++   E   S    ++L+ ++++H  
Sbjct: 92  IVRLHDS--ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ- 148
Query: 201 RHLVHRDIKPANLLVNLKGR---PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
             +VHRD+KP NLL+  K +    K+ DFG++  ++        F GT  Y+SPE +R +
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSF 315
            Y  P DIW+ G+ L+    G +P    E    L  QI       PSP     +PE  + 
Sbjct: 209 PYGKPVDIWACGVILYILLVG-YPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 316 VDDCLKKDAEARPTADQLLSHPFITK 341
           ++  L  +   R TADQ L HP++ +
Sbjct: 268 INQMLTINPAKRITADQALKHPWVCQ 293

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 10/263 (3%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCNEGLV 142
           ++F  +G GA SVV+R V +   +  A K IN  +   R+ Q L     +C    +  +V
Sbjct: 25  QLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIV 84
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             H +  + + G   +  + + GG L + +  ++   E   S   +++L+ + + H +  
Sbjct: 85  RLHDS--ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG- 141
Query: 203 LVHRDIKPANLLV--NLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
           +VHRD+KP NLL+   LKG   K+ DFG++  +E        F GT  Y+SPE +R + Y
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSFVD 317
             P D+W+ G+ L+    G +P    E    L  QI       PSP     +PE    ++
Sbjct: 202 GKPVDLWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 260
Query: 318 DCLKKDAEARPTADQLLSHPFIT 340
             L  +   R TA + L HP+I+
Sbjct: 261 KMLTINPSKRITAAEALKHPWIS 283

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 123/239 (51%), Gaps = 10/239 (4%)
Query: 107 RIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD 164
           R   +K+INI     ++R +   E+  L     +  +V++  +F   ++G + I ++Y +
Sbjct: 50  RQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESF--EENGSLYIVMDYCE 106
Query: 165 GGSLADILRMQKSI--PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
           GG L   +  QK +   E  +   F ++   L ++H  R ++HRDIK  N+ +   G  +
Sbjct: 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQ 165
Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           + DFGI+  L +++ +    +GT  Y+SPE   N+ Y+  +DIW++G  L+E  T +  +
Sbjct: 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            A     NL+L+I+    P P   ++S +  S V    K++   RP+ + +L   FI K
Sbjct: 226 EAGSMK-NLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 96/175 (54%), Gaps = 7/175 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN+L++ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANILISA 151
Query: 218 KGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 275 CGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEAR 327
             TGE P+   + PV++  Q + EDP P  +R +  S +  + V   L K+ E R
Sbjct: 212 VLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 7/175 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN++++ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA 151
Query: 218 KGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 275 CGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEAR 327
             TGE P+   + PV++  Q + EDP P  +R +  S +  + V   L K+ E R
Sbjct: 212 VLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 7/175 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN++++ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA 151
Query: 218 KGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 275 CGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEAR 327
             TGE P+   + PV++  Q + EDP P  +R +  S +  + V   L K+ E R
Sbjct: 212 VLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 7/175 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN++++ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA 151
Query: 218 KGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 275 CGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEAR 327
             TGE P+   + PV++  Q + EDP P  +R +  S +  + V   L K+ E R
Sbjct: 212 VLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 7/175 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN++++ 
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA 168
Query: 218 KGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 228
Query: 275 CGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEAR 327
             TGE P+   + PV++  Q + EDP P  +R +  S +  + V   L K+ E R
Sbjct: 229 VLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 10/267 (3%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-QLLTEIRTLCEAPCN 138
           + E ++F  +G GA SVV+R V +   +  A   IN  +   R+ Q L     +C    +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             +V  H +  + + G   +  + + GG L + +  ++   E   S   +++L+ + + H
Sbjct: 70  PNIVRLHDS--ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 199 GVRHLVHRDIKPANLLV--NLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
            +  +VHR++KP NLL+   LKG   K+ DFG++  +E        F GT  Y+SPE +R
Sbjct: 128 QMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFC 313
            + Y  P D+W+ G+ L+    G +P    E    L  QI       PSP     +PE  
Sbjct: 187 KDPYGKPVDLWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 314 SFVDDCLKKDAEARPTADQLLSHPFIT 340
             ++  L  +   R TA + L HP+I+
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 8/202 (3%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           +   +G GA+  VQ AV+  T   +A+K +++       + + +   + +   +E +V+F
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 145 HGAFYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           +G       G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  +
Sbjct: 70  YGHRR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GI 125
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYS 260
            HRDIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 261 YPADIWSIGLALFECGTGEFPY 282
            P D+WS G+ L     GE P+
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPW 207

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 26/276 (9%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRTLCEAPC 137
           + +  +   IG GA   VQ   H  + ++ A+K ++ FE  KR+      E R +     
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +  +V+   AF   D   + + +EYM GG L +++     +PE        +++  L  +
Sbjct: 134 SPWVVQLFCAF--QDDKYLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAI 190
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIRN 256
           H +  L+HRD+KP N+L++  G  K+ DFG    + E  +  C T VGT  Y+SPE +++
Sbjct: 191 HSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 257 ES----YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL---------EDPSPSP 303
           +     Y    D WS+G+ LFE   G+ P+ A +  V    +I+         ED   S 
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLCFPEDAEISK 308
Query: 304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
             +N     C+F+ D  ++    R   +++  HPF 
Sbjct: 309 HAKNL---ICAFLTD--REVRLGRNGVEEIKQHPFF 339

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 72  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 188 DVWSCGIVLTAMLAGELPW 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   + +   +E +V+F+G 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 73  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 8/199 (4%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA   VQ AV+  T   +A+K +++       + + +   +     +E +V+F+G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 148 FYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                 G I  + LEY  GG L D +     +PEP     F +L+ G+ YLHG+  + HR
Sbjct: 74  RR---EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERI-RNESYSYPA 263
           DIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE + R E ++ P 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L     GE P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 11/216 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRTLCE 134
           R  + +  +   IG GA   VQ   H  T ++ A+K ++ FE  KR+      E R +  
Sbjct: 65  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
              +  +V+   AF   D   + + +EYM GG L +++     +PE        +++  L
Sbjct: 125 FANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 181
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPER 253
             +H +   +HRD+KP N+L++  G  K+ DFG    + +  +  C T VGT  Y+SPE 
Sbjct: 182 DAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 254 IRNES----YSYPADIWSIGLALFECGTGEFPYAAS 285
           ++++     Y    D WS+G+ L+E   G+ P+ A 
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 11/215 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRTLCE 134
           R  + +  +   IG GA   VQ   H  T ++ A+K ++ FE  KR+      E R +  
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
              +  +V+   AF   D   + + +EYM GG L +++     +PE        +++  L
Sbjct: 130 FANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 186
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPER 253
             +H +   +HRD+KP N+L++  G  K+ DFG    + +  +  C T VGT  Y+SPE 
Sbjct: 187 DAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 254 IRNES----YSYPADIWSIGLALFECGTGEFPYAA 284
           ++++     Y    D WS+G+ L+E   G+ P+ A
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 11/216 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRTLCE 134
           R  + +  +   IG GA   VQ   H  T ++ A+K ++ FE  KR+      E R +  
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
              +  +V+   AF   D   + + +EYM GG L +++     +PE        +++  L
Sbjct: 130 FANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLAL 186
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPER 253
             +H +   +HRD+KP N+L++  G  K+ DFG    + +  +  C T VGT  Y+SPE 
Sbjct: 187 DAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 254 IRNES----YSYPADIWSIGLALFECGTGEFPYAAS 285
           ++++     Y    D WS+G+ L+E   G+ P+ A 
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 281

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 95/175 (54%), Gaps = 7/175 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN++++ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA 151
Query: 218 KGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 275 CGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSR-QNFSPEFCSFVDDCLKKDAEAR 327
             TGE P+   + P ++  Q + EDP P  +R +  S +  + V   L K+ E R
Sbjct: 212 VLTGEPPFTG-DSPDSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 127/259 (49%), Gaps = 18/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           E+ +   +G GA  VV +A      + +A+K+I    + +R   + E+R L     +  +
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRVN-HPNI 64
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLH 198
           V+ +GA   P    + + +EY +GGSL ++L   + +P    +      LQ   G++YLH
Sbjct: 65  VKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 199 GV--RHLVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
            +  + L+HRD+KP NLL+   G   KI DFG +  ++  +       G+  +M+PE   
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVFE 177
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF 315
             +YS   D++S G+ L+E  T   P+    GP   ++  + + +  P  +N      S 
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 237
Query: 316 VDDCLKKDAEARPTADQLL 334
           +  C  KD   RP+ ++++
Sbjct: 238 MTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 127/259 (49%), Gaps = 18/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           E+ +   +G GA  VV +A      + +A+K+I    + +R   + E+R L     +  +
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRVN-HPNI 63
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLH 198
           V+ +GA   P    + + +EY +GGSL ++L   + +P    +      LQ   G++YLH
Sbjct: 64  VKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 199 GV--RHLVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
            +  + L+HRD+KP NLL+   G   KI DFG +  ++  +       G+  +M+PE   
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVFE 176
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF 315
             +YS   D++S G+ L+E  T   P+    GP   ++  + + +  P  +N      S 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 316 VDDCLKKDAEARPTADQLL 334
           +  C  KD   RP+ ++++
Sbjct: 237 MTRCWSKDPSQRPSMEEIV 255

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTH-----RIIALKKINIFEKEKRNQLL---TEIRTL--CEAPC 137
            +GSGA   V+ A    T      RII+ +K  I    + +  L   TEI  L     PC
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 202 ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 256 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 313
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 367
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 19/269 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFH 145
            IG G SSVV+R VH  T    A+K + +  +    + L E+R  T  E      +    
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 146 GAFYMPDSGQIS----IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
               + DS + S    +  + M  G L D L  + ++ E    S+ + LL+ +S+LH   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-N 219
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR------ 255
           ++VHRD+KP N+L++   + +++DFG S  LE    +     GT  Y++PE ++      
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL-RELCGTPGYLAPEILKCSMDET 278
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSPSRQNFSPEF 312
           +  Y    D+W+ G+ LF    G  P+        LML+++ +      SP   + S   
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMIMEGQYQFSSPEWDDRSSTV 336
Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITK 341
              +   L+ D EAR TA+Q L HPF  +
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTH-----RIIALKKINIFEKEKRNQLL---TEIRTL--CEAPC 137
            +GSGA   V+ A    T      RII+ +K  I    + +  L   TEI  L     PC
Sbjct: 156 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 215
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 216 ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 269
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 270 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 327
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 381
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 382 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 115/225 (51%), Gaps = 7/225 (3%)
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
           + +  +R ++  EI ++  +  ++ +V FHG F   D+  + + LE     SL ++ + +
Sbjct: 55  LLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRR 111
Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           K++ EP      ++++ G  YLH  R ++HRD+K  NL +N     KI DFG++  +E  
Sbjct: 112 KALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 170
Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
                T  GT  Y++PE +  + +S+  D+WSIG  ++    G+ P+  S       L+I
Sbjct: 171 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRI 229
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
            ++    P   N  P   S +   L+ D  ARPT ++LL+  F T
Sbjct: 230 KKNEYSIPKHIN--PVAASLIQKMLQTDPTARPTINELLNDEFFT 272

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 115/225 (51%), Gaps = 7/225 (3%)
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
           + +  +R ++  EI ++  +  ++ +V FHG F   D+  + + LE     SL ++ + +
Sbjct: 55  LLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRR 111
Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           K++ EP      ++++ G  YLH  R ++HRD+K  NL +N     KI DFG++  +E  
Sbjct: 112 KALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 170
Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
                T  GT  Y++PE +  + +S+  D+WSIG  ++    G+ P+  S       L+I
Sbjct: 171 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRI 229
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
            ++    P   N  P   S +   L+ D  ARPT ++LL+  F T
Sbjct: 230 KKNEYSIPKHIN--PVAASLIQKMLQTDPTARPTINELLNDEFFT 272

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPC 137
            +GSGA   V+ A    T + +A+K I+          E +    + TEI  L     PC
Sbjct: 16  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 76  ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 129
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 130 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 187
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 241
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 242 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 117/225 (52%), Gaps = 7/225 (3%)
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
           + +  +R ++  EI ++  +  ++ +V FHG F   D+  + + LE     SL ++ + +
Sbjct: 59  LLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFE--DNDFVFVVLELCRRRSLLELHKRR 115
Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           K++ EP      ++++ G  YLH  R ++HRD+K  NL +N     KI DFG++  +E  
Sbjct: 116 KALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 174
Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
                T  GT  Y++PE +  + +S+  D+WSIG  ++    G+ P+  S       L+I
Sbjct: 175 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRI 233
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
            ++    P  ++ +P   S +   L+ D  ARPT ++LL+  F T
Sbjct: 234 KKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 276

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPC 137
            +GSGA   V+ A    T + +A+K I+          E +    + TEI  L     PC
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 77  ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 131 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 188
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 242
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPC 137
            +GSGA   V+ A    T + +A+K I+          E +    + TEI  L     PC
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 77  ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 131 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 188
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 242
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPC 137
            +GSGA   V+ A    T + +A+K I+          E +    + TEI  L     PC
Sbjct: 23  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 82
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 83  ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 136
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 137 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 194
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 248
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 249 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPC 137
            +GSGA   V+ A    T + +A+K I+          E +    + TEI  L     PC
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
              +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YL
Sbjct: 77  ---IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE-- 252
           H    ++HRD+KP N+L++ +      KITDFG S  L    ++  T  GT TY++PE  
Sbjct: 131 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVL 188
Query: 253 -RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
             +    Y+   D WS+G+ LF C +G  P++     V+L  QI      +  + NF PE
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------TSGKYNFIPE 242
Query: 312 FCSFVD----DCLKK----DAEARPTADQLLSHPFI 339
             + V     D +KK    D +AR T ++ L HP++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 23/268 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG G+ SV +R +H  T+   A+K   I +K KR+    EI  L     +  ++     +
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHPNIITLKDVY 85
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
              D   + +  E M GG L D +  QK   E   S++   + + + YLH  + +VHRD+
Sbjct: 86  --DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDL 142
Query: 209 KPANLL-VNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           KP+N+L V+  G P   +I DFG +  L     +  T   T  +++PE +  + Y    D
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACD 202
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK-- 322
           IWS+G+ L+   TG  P+A   GP +   +IL        + + S  + + V D  K   
Sbjct: 203 IWSLGVLLYTMLTGYTPFA--NGPDDTPEEIL--ARIGSGKFSLSGGYWNSVSDTAKDLV 258
Query: 323 ------DAEARPTADQLLSHPFITKYEH 344
                 D   R TA  +L HP+I  ++ 
Sbjct: 259 SKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 7/246 (2%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-L 141
           +++ G    G   +V++     +  + A+K +     + R+++ T++     A  N   +
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFV 92
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ H AF     G++ + L+++ GG L   L  +    E  +     +L  GL +LH + 
Sbjct: 93  VKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLG 150
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +++RD+KP N+L++ +G  K+TDFG+S    +      +F GTV YM+PE +  + +S+
Sbjct: 151 -IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSH 209
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            AD WS G+ +FE  TG  P+   +    + L IL+     P  Q  S E  S +    K
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTL-ILKAKLGMP--QFLSTEAQSLLRALFK 266
Query: 322 KDAEAR 327
           ++   R
Sbjct: 267 RNPANR 272

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 114/225 (50%), Gaps = 7/225 (3%)
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
           + +  +R ++  EI ++  +  ++ +V FHG F   D+  + + LE     SL ++ + +
Sbjct: 53  LLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRR 109
Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           K++ EP      ++++ G  YLH  R ++HRD+K  NL +N     KI DFG++  +E  
Sbjct: 110 KALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
                   GT  Y++PE +  + +S+  D+WSIG  ++    G+ P+  S       L+I
Sbjct: 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRI 227
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
            ++    P   N  P   S +   L+ D  ARPT ++LL+  F T
Sbjct: 228 KKNEYSIPKHIN--PVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 122/261 (46%), Gaps = 20/261 (7%)
Query: 89  IGSGASSVVQRAVHIPTH--RIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEF 144
           +GSGA   V       TH  R I + +         ++LL E+  L   + P    L +F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                  D     + +E   GG L D +  +    E   + + K++L G++YLH   ++V
Sbjct: 105 -----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-HNIV 158
Query: 205 HRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+KP NLL+  K +    KI DFG+SA  EN   M    +GT  Y++PE +R + Y  
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-LGTAYYIAPEVLR-KKYDE 216
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSPSRQNFSPEFCSFVDD 318
             D+WSIG+ LF    G  P+         +L+ +E       SP  +N S      +  
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 319 CLKKDAEARPTADQLLSHPFI 339
            L+ D++ R +A Q L HP+I
Sbjct: 275 MLQFDSQRRISAQQALEHPWI 295

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 15/262 (5%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG G+ S  +R VH  T+   A+K   + +K KR+    EI  L     +  ++     
Sbjct: 34  TIGVGSYSECKRCVHKATNMEYAVK---VIDKSKRDPS-EEIEILLRYGQHPNIITLKDV 89
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           +   D   + +  E M GG L D +  QK   E   S +   + + + YLH  + +VHRD
Sbjct: 90  Y--DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS-QGVVHRD 146
Query: 208 IKPANLL-VNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +KP+N+L V+  G P   +I DFG +  L     +  T   T  +++PE ++ + Y    
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGC 206
Query: 264 DIWSIGLALFECGTGEFPYA--ASEGPVNLMLQILEDP-SPSPSRQNFSPEFCS-FVDDC 319
           DIWS+G+ L+    G  P+A   S+ P  ++ +I     + S    N   E     V   
Sbjct: 207 DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKM 266
Query: 320 LKKDAEARPTADQLLSHPFITK 341
           L  D   R TA Q+L HP++T+
Sbjct: 267 LHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 116/225 (51%), Gaps = 7/225 (3%)
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
           + +  +R ++  EI ++  +  ++ +V FHG F   D+  + + LE     SL ++ + +
Sbjct: 77  LLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRR 133
Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           K++ EP      ++++ G  YLH  R ++HRD+K  NL +N     KI DFG++  +E  
Sbjct: 134 KALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 192
Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
                   GT  Y++PE +  + +S+  D+WSIG  ++    G+ P+  S       L+I
Sbjct: 193 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRI 251
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
            ++    P  ++ +P   S +   L+ D  ARPT ++LL+  F T
Sbjct: 252 KKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 294

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 15/262 (5%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG G+ S  +R VH  T+   A+K   + +K KR+    EI  L     +  ++     
Sbjct: 34  TIGVGSYSECKRCVHKATNMEYAVK---VIDKSKRDPS-EEIEILLRYGQHPNIITLKDV 89
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           +   D   + +  E M GG L D +  QK   E   S +   + + + YLH  + +VHRD
Sbjct: 90  Y--DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS-QGVVHRD 146
Query: 208 IKPANLL-VNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +KP+N+L V+  G P   +I DFG +  L     +  T   T  +++PE ++ + Y    
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGC 206
Query: 264 DIWSIGLALFECGTGEFPYA--ASEGPVNLMLQILEDP-SPSPSRQNFSPEFCS-FVDDC 319
           DIWS+G+ L+    G  P+A   S+ P  ++ +I     + S    N   E     V   
Sbjct: 207 DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKM 266
Query: 320 LKKDAEARPTADQLLSHPFITK 341
           L  D   R TA Q+L HP++T+
Sbjct: 267 LHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 116/225 (51%), Gaps = 7/225 (3%)
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
           + +  +R ++  EI ++  +  ++ +V FHG F   D+  + + LE     SL ++ + +
Sbjct: 79  LLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFE--DNDFVFVVLELCRRRSLLELHKRR 135
Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           K++ EP      ++++ G  YLH  R ++HRD+K  NL +N     KI DFG++  +E  
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
                   GT  Y++PE +  + +S+  D+WSIG  ++    G+ P+  S       L+I
Sbjct: 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRI 253
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
            ++    P  ++ +P   S +   L+ D  ARPT ++LL+  F T
Sbjct: 254 KKNEYSIP--KHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 132/272 (48%), Gaps = 17/272 (6%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAP 136
           + +  +   IG+G+    Q+       +I+  K+++   + E EK+  L++E+  L E  
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELK 63
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQ 192
            +  +V ++       +  + I +EY +GG LA ++    + ++ + E  +  +  +L  
Sbjct: 64  -HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 193 GLSYLH----GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
            L   H    G   ++HRD+KPAN+ ++ K   K+ DFG++  L +  +   TFVGT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP-SPSPSRQN 307
           MSPE++   SY+  +DIWS+G  L+E      P+ A      L  +I E      P R  
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPYR-- 239
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           +S E    +   L      RP+ +++L +P I
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG G+ SV +R +H  T+   A+K   I +K KR+    EI  L     +  ++     +
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVK---IIDKSKRDPT-EEIEILLRYGQHPNIITLKDVY 85
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
              D   + +  E   GG L D +  QK   E   S++   + + + YLH  + +VHRD+
Sbjct: 86  --DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDL 142
Query: 209 KPANLL-VNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           KP+N+L V+  G P   +I DFG +  L     +  T   T  +++PE +  + Y    D
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACD 202
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK-- 322
           IWS+G+ L+   TG  P+A   GP +   +IL        + + S  + + V D  K   
Sbjct: 203 IWSLGVLLYTXLTGYTPFA--NGPDDTPEEIL--ARIGSGKFSLSGGYWNSVSDTAKDLV 258
Query: 323 ------DAEARPTADQLLSHPFITKYEH 344
                 D   R TA  +L HP+I  ++ 
Sbjct: 259 SKXLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 124/255 (48%), Gaps = 10/255 (3%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G  +       + T  + A K   K  + +  ++ ++ TEI  + ++  N  +V FH
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI-AIHKSLDNPHVVGFH 108
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G F   D   + + LE     SL ++ + +K++ EP      ++ +QG+ YLH  R ++H
Sbjct: 109 GFFE--DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIH 165
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  NL +N     KI DFG++  +E       T  GT  Y++PE +  + +S+  DI
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G  L+    G+ P+  S       ++I ++    P  ++ +P   + +   L  D  
Sbjct: 226 WSLGCILYTLLVGKPPFETS-CLKETYIRIKKNEYSVP--RHINPVASALIRRMLHADPT 282
Query: 326 ARPTADQLLSHPFIT 340
            RP+  +LL+  F T
Sbjct: 283 LRPSVAELLTDEFFT 297

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 131/272 (48%), Gaps = 24/272 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQL----LTEIRTLCEAPCNE 139
           +G G SSVV+R +H PT +  A+K I++     F  E+  +L    L E+  L +   + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +++    +    +    +  + M  G L D L  + ++ E     + + LL+ +  LH 
Sbjct: 85  NIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR---- 255
           + ++VHRD+KP N+L++     K+TDFG S  L+    +  +  GT +Y++PE I     
Sbjct: 143 L-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-RSVCGTPSYLAPEIIECSMN 200
Query: 256 --NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSPSRQNFSP 310
             +  Y    D+WS G+ ++    G  P+   +    LML+++   +    SP   ++S 
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSD 258
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                V   L    + R TA++ L+HPF  +Y
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 131/272 (48%), Gaps = 17/272 (6%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAP 136
           + +  +   IG+G+    Q+       +I+  K+++   + E EK+  L++E+  L E  
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELK 63
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQ 192
            +  +V ++       +  + I +EY +GG LA ++    + ++ + E  +  +  +L  
Sbjct: 64  -HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 193 GLSYLH----GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
            L   H    G   ++HRD+KPAN+ ++ K   K+ DFG++  L +  +    FVGT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP-SPSPSRQN 307
           MSPE++   SY+  +DIWS+G  L+E      P+ A      L  +I E      P R  
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPYR-- 239
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           +S E    +   L      RP+ +++L +P I
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 24/272 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQL----LTEIRTLCEAPCNE 139
           +G G SSVV+R +H PT +  A+K I++     F  E+  +L    L E+  L +   + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +++    +    +    +  + M  G L D L  + ++ E     + + LL+ +  LH 
Sbjct: 85  NIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR---- 255
           + ++VHRD+KP N+L++     K+TDFG S  L+    +     GT +Y++PE I     
Sbjct: 143 L-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLAPEIIECSMN 200
Query: 256 --NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSPSRQNFSP 310
             +  Y    D+WS G+ ++    G  P+   +    LML+++   +    SP   ++S 
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSD 258
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                V   L    + R TA++ L+HPF  +Y
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 24/272 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQL----LTEIRTLCEAPCNE 139
           +G G SSVV+R +H PT +  A+K I++     F  E+  +L    L E+  L +   + 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +++    +    +    +  + M  G L D L  + ++ E     + + LL+ +  LH 
Sbjct: 72  NIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR---- 255
           + ++VHRD+KP N+L++     K+TDFG S  L+    +     GT +Y++PE I     
Sbjct: 130 L-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLAPEIIECSMN 187
Query: 256 --NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSPSRQNFSP 310
             +  Y    D+WS G+ ++    G  P+   +    LML+++   +    SP   ++S 
Sbjct: 188 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSD 245
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                V   L    + R TA++ L+HPF  +Y
Sbjct: 246 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 66  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDY 177
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 228
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWIT 266

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 66  ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---R 122
           + + +   K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    
Sbjct: 10  SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 69
Query: 123 NQLL--TEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           +QL    EI++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E
Sbjct: 70  HQLRREVEIQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDE 124
Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
              ++   +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     
Sbjct: 125 QRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRT 181
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           T  GT+ Y+ PE I    +    D+WS+G+  +E   G+ P+ A+           ++  
Sbjct: 182 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETY 232
Query: 301 PSPSRQNFS-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
              SR  F+ P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 233 KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 278

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTL 132
           +R   +E      +G G    V       T R  A   LKK  I  K++    LTE R L
Sbjct: 146 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
            +   +  L     +F   D  ++   +EY +GG L   L  ++   E        +++ 
Sbjct: 206 -QNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 262
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSP 251
            L YLH  +++V+RD+K  NL+++  G  KITDFG+   G+++   M  TF GT  Y++P
Sbjct: 263 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KTFCGTPEYLAP 321
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
           E + +  Y    D W +G+ ++E   G  P+   +      L ++E+       +   PE
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP---RTLGPE 378
Query: 312 FCSFVDDCLKKDAEAR-----PTADQLLSHPFI 339
             S +   LKKD + R       A +++ H F 
Sbjct: 379 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 18/267 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEI----RTLCEAPCNEGLVE 143
            IG GA SVV+R ++  T +  A+K +++ +      L TE      ++C    +  +VE
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLA-DILRMQKS---IPEPILSSMFKKLLQGLSYLHG 199
               +     G + +  E+MDG  L  +I++   +     E + S   +++L+ L Y H 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 200 VRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
             +++HRD+KP N+L+  K      K+ DFG++  L  S  +    VGT  +M+PE ++ 
Sbjct: 149 -NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ--NFSPEFCS 314
           E Y  P D+W  G+ LF   +G  P+  ++    L   I++       RQ  + S     
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            V   L  D   R T  + L+HP++ +
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTL 132
           +R   +E      +G G    V       T R  A   LKK  I  K++    LTE R L
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
            +   +  L     +F   D  ++   +EY +GG L   L  ++   E        +++ 
Sbjct: 203 -QNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSP 251
            L YLH  +++V+RD+K  NL+++  G  KITDFG+   G+++   M  TF GT  Y++P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KTFCGTPEYLAP 318
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
           E + +  Y    D W +G+ ++E   G  P+   +      L ++E+       +   PE
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP---RTLGPE 375
Query: 312 FCSFVDDCLKKDAEAR-----PTADQLLSHPFI 339
             S +   LKKD + R       A +++ H F 
Sbjct: 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 123/255 (48%), Gaps = 10/255 (3%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G  +       + T  + A K   K  + +  ++ ++ TEI  + ++  N  +V FH
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI-AIHKSLDNPHVVGFH 92
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G F   D   + + LE     SL ++ + +K++ EP      ++ +QG+ YLH  R ++H
Sbjct: 93  GFF--EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIH 149
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  NL +N     KI DFG++  +E          GT  Y++PE +  + +S+  DI
Sbjct: 150 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDI 209
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G  L+    G+ P+  S       ++I ++    P  ++ +P   + +   L  D  
Sbjct: 210 WSLGCILYTLLVGKPPFETS-CLKETYIRIKKNEYSVP--RHINPVASALIRRMLHADPT 266
Query: 326 ARPTADQLLSHPFIT 340
            RP+  +LL+  F T
Sbjct: 267 LRPSVAELLTDEFFT 281

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 95  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 151
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 260 SYPADIWSIGLALFECGTGEFPY-AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A +EG +   +  LE   P    + F P+    V+ 
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLVEK 267
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 28/286 (9%)
Query: 66  ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---R 122
           + + +   K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    
Sbjct: 19  SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 78
Query: 123 NQLL--TEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           +QL    EI++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E
Sbjct: 79  HQLRREVEIQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDE 133
Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
              ++   +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     
Sbjct: 134 QRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRT 190
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
           T  GT+ Y+ PE I    +    D+WS+G+  +E   G+ P+ A+           ++  
Sbjct: 191 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETY 241
Query: 301 PSPSRQNFS-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
              SR  F+ P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 242 KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 14/259 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP 136
           +  +   +I   +G G  S V  A     +  +A+K I I  +EK   L    +      
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL----KRFEREV 62
Query: 137 CNEGLVEFHGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
            N   +       M D  +      + +EY++G +L++ +     +      +   ++L 
Sbjct: 63  HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSP 251
           G+ + H +R +VHRDIKP N+L++     KI DFGI+  L E S+      +GTV Y SP
Sbjct: 123 GIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS---RQNF 308
           E+ + E+     DI+SIG+ L+E   GE P+   E  V++ ++ ++D  P+ +   R++ 
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSVPNVTTDVRKDI 240
Query: 309 SPEFCSFVDDCLKKDAEAR 327
                + +    +KD   R
Sbjct: 241 PQSLSNVILRATEKDKANR 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 64  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDY 175
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 226
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G +   L+      E   ++   
Sbjct: 66  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDY 177
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 228
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 123/257 (47%), Gaps = 18/257 (7%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           ++ I   IG+G+   V RA    +   + +     F  E+ N+ L E+  + +   +  +
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREV-AIMKRLRHPNI 96
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILR---MQKSIPEPILSSMFKKLLQGLSYLH 198
           V F GA   P +  +SI  EY+  GSL  +L     ++ + E    SM   + +G++YLH
Sbjct: 97  VLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 199 GVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
                +VHRD+K  NLLV+ K   K+ DFG+S    +         GT  +M+PE +R+E
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 258 SYSYPADIWSIGLALFECGTGEFPY-----AASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
             +  +D++S G+ L+E  T + P+     A     V    + LE P      +N +P+ 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------RNLNPQV 268
Query: 313 CSFVDDCLKKDAEARPT 329
            + ++ C   +   RP+
Sbjct: 269 AAIIEGCWTNEPWKRPS 285

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  DS ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  + ++HRDIKP NLL+   G  KI DFG S    +S    A   GT+ Y+ P
Sbjct: 119 NALSYCHS-KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLDYLPP 175
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           +D     SR  F+ P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQDTYKRISRVEFTFP 226
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 14/258 (5%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL-TEIRTLCEAPCNEGLVEFHGA 147
           +G GA+S+V R     T +  ALK   + +K    +++ TEI  L     +  +++    
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEI 116
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           F  P   +IS+ LE + GG L D +  +    E   +   K++L+ ++YLH    +VHRD
Sbjct: 117 FETPT--EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-NGIVHRD 173
Query: 208 IKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL          KI DFG+S  +E+ + M  T  GT  Y +PE +R  +Y    D
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-KTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDCLKK 322
           +WS+G+  +    G  P+    G   +  +IL  E    SP     S      V   +  
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 323 DAEARPTADQLLSHPFIT 340
           D + R T  Q L HP++T
Sbjct: 293 DPKKRLTTFQALQHPWVT 310

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 123/255 (48%), Gaps = 10/255 (3%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G  +       + T  + A K   K  + +  ++ ++ TEI  + ++  N  +V FH
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI-AIHKSLDNPHVVGFH 108
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G F   D   + + LE     SL ++ + +K++ EP      ++ +QG+ YLH  R ++H
Sbjct: 109 GFFE--DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIH 165
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  NL +N     KI DFG++  +E          GT  Y++PE +  + +S+  DI
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G  L+    G+ P+  S       ++I ++    P  ++ +P   + +   L  D  
Sbjct: 226 WSLGCILYTLLVGKPPFETS-CLKETYIRIKKNEYSVP--RHINPVASALIRRMLHADPT 282
Query: 326 ARPTADQLLSHPFIT 340
            RP+  +LL+  F T
Sbjct: 283 LRPSVAELLTDEFFT 297

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 130/271 (47%), Gaps = 12/271 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEI-RTLCEAPCNEGL 141
           +++ G    G   +V++       ++ A+K +     + R+++ T++ R +     +  +
Sbjct: 30  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 89
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ H AF     G++ + L+++ GG L   L  +    E  +     +L   L +LH + 
Sbjct: 90  VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL- 146
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +++RD+KP N+L++ +G  K+TDFG+S    +      +F GTV YM+PE +    ++ 
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 206
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            AD WS G+ +FE  TG  P+   +     M  IL+     P  Q  SPE  S +    K
Sbjct: 207 SADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAKLGMP--QFLSPEAQSLLRMLFK 263
Query: 322 KDAEARPTA-----DQLLSHPFITKYEHAKV 347
           ++   R  A     +++  H F +  +  K+
Sbjct: 264 RNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 294

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 95  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 151
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 260 SYPADIWSIGLALFECGTGEFPY-AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A +EG +   +  LE   P    + F P+    V+ 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLVEK 267
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 130/271 (47%), Gaps = 12/271 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEI-RTLCEAPCNEGL 141
           +++ G    G   +V++       ++ A+K +     + R+++ T++ R +     +  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ H AF     G++ + L+++ GG L   L  +    E  +     +L   L +LH + 
Sbjct: 89  VKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL- 145
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +++RD+KP N+L++ +G  K+TDFG+S    +      +F GTV YM+PE +    ++ 
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            AD WS G+ +FE  TG  P+   +     M  IL+     P  Q  SPE  S +    K
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAKLGMP--QFLSPEAQSLLRMLFK 262
Query: 322 KDAEARPTA-----DQLLSHPFITKYEHAKV 347
           ++   R  A     +++  H F +  +  K+
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 64  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDY 175
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 226
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 123/255 (48%), Gaps = 10/255 (3%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G  +       + T  + A K   K  + +  ++ ++ TEI  + ++  N  +V FH
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEI-AIHKSLDNPHVVGFH 108
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G F   D   + + LE     SL ++ + +K++ EP      ++ +QG+ YLH  R ++H
Sbjct: 109 GFF--EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIH 165
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  NL +N     KI DFG++  +E          GT  Y++PE +  + +S+  DI
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G  L+    G+ P+  S       ++I ++    P  ++ +P   + +   L  D  
Sbjct: 226 WSLGCILYTLLVGKPPFETS-CLKETYIRIKKNEYSVP--RHINPVASALIRRMLHADPT 282
Query: 326 ARPTADQLLSHPFIT 340
            RP+  +LL+  F T
Sbjct: 283 LRPSVAELLTDEFFT 297

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 66  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDY 177
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 228
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 28/281 (9%)
Query: 71  HSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL- 126
           H  K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL  
Sbjct: 3   HMSKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 127 -TEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSS 185
             EI++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++
Sbjct: 63  EVEIQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 186 MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT 245
              +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S        GT
Sbjct: 118 YITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGT 174
Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
           + Y+ PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISR 225
Query: 306 QNFS-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
             F+ P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 226 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 130/271 (47%), Gaps = 12/271 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEI-RTLCEAPCNEGL 141
           +++ G    G   +V++       ++ A+K +     + R+++ T++ R +     +  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ H AF     G++ + L+++ GG L   L  +    E  +     +L   L +LH + 
Sbjct: 89  VKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL- 145
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +++RD+KP N+L++ +G  K+TDFG+S    +      +F GTV YM+PE +    ++ 
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            AD WS G+ +FE  TG  P+   +     M  IL+     P  Q  SPE  S +    K
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAKLGMP--QFLSPEAQSLLRMLFK 262
Query: 322 KDAEARPTA-----DQLLSHPFITKYEHAKV 347
           ++   R  A     +++  H F +  +  K+
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           ++ I   IG+G+   V RA    +   + +     F  E+ N+ L E+  + +   +  +
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREV-AIMKRLRHPNI 96
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILR---MQKSIPEPILSSMFKKLLQGLSYLH 198
           V F GA   P +  +SI  EY+  GSL  +L     ++ + E    SM   + +G++YLH
Sbjct: 97  VLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 199 GVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
                +VHR++K  NLLV+ K   K+ DFG+S    ++     +  GT  +M+PE +R+E
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 258 SYSYPADIWSIGLALFECGTGEFPY-----AASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
             +  +D++S G+ L+E  T + P+     A     V    + LE P      +N +P+ 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------RNLNPQV 268
Query: 313 CSFVDDCLKKDAEARPT 329
            + ++ C   +   RP+
Sbjct: 269 AAIIEGCWTNEPWKRPS 285

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 63  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 117
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ P
Sbjct: 118 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPP 174
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 225
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 226 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 62  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSCHAPSS--RRTTLSGTLDY 173
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 224
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 62  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDTLCGTLDY 173
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 224
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 68  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 122
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ P
Sbjct: 123 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPP 179
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 230
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 231 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 265

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 141/288 (48%), Gaps = 20/288 (6%)
Query: 65  LADESDHSEKTYRCASHEMR-IFG---AIGSGASSVVQRAVHIPTHRIIALKKI-NIFEK 119
           +A E+  S  +++  + +++ IF     +G+GA S V  A    T ++ A+K I     K
Sbjct: 2   MARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALK 61
Query: 120 EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIP 179
            K + +  EI  L +   +E +V     +  P+   + + ++ + GG L D +  +    
Sbjct: 62  GKESSIENEIAVLRKIK-HENIVALEDIYESPN--HLYLVMQLVSGGELFDRIVEKGFYT 118
Query: 180 EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGLENSI 236
           E   S++ +++L  + YLH +  +VHRD+KP NLL    + + +  I+DFG+S  +E   
Sbjct: 119 EKDASTLIRQVLDAVYYLHRM-GIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKG 176
Query: 237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA--LFECGTGEFPYAASEGPVNLMLQ 294
            + +T  GT  Y++PE +  + YS   D WSIG+   +  CG   +P    E    L  Q
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG---YPPFYDENDSKLFEQ 233
Query: 295 IL--EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
           IL  E    SP   + S     F+ + ++KD   R T +Q   HP+I 
Sbjct: 234 ILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 107/212 (50%), Gaps = 10/212 (4%)
Query: 77  RCASHEMRIFGAIGSGASSVVQ--RAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE 134
           + +  + +I   +G+G+   V   R+ H   +  + + K  I  + K+ +   + R +  
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
              +  ++   G F   D+ QI + ++Y++GG L  +LR  +  P P+      ++   L
Sbjct: 62  IVTHPFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN-SIAMCATFVGTVTYMSPER 253
            YLH  + +++RD+KP N+L++  G  KITDFG +  + + +  +C    GT  Y++PE 
Sbjct: 120 EYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC----GTPDYIAPEV 174
Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAAS 285
           +  + Y+   D WS G+ ++E   G  P+  S
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ P
Sbjct: 119 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPP 175
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 226
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 17/272 (6%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAP 136
           + +  +   IG+G+    Q+       +I+  K+++   + E EK+  L++E+  L E  
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELK 63
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQ 192
            +  +V ++       +  + I +EY +GG LA ++    + ++ + E  +  +  +L  
Sbjct: 64  -HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 193 GLSYLH----GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
            L   H    G   ++HRD+KPAN+ ++ K   K+ DFG++  L +       FVGT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP-SPSPSRQN 307
           MSPE++   SY+  +DIWS+G  L+E      P+ A      L  +I E      P R  
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPYR-- 239
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           +S E    +   L      RP+ +++L +P I
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            IG+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EYM GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  K+ DFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 127/267 (47%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 95  VKLY--FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 151
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A   +FVGT  Y+SPE +  +S 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
           S  +D+W++G  +++   G  P+ A  G   L+ Q I++     P  + F P+    V+ 
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 267
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            IG+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EYM GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  K+ DFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHG 146
            +G+GA S V  A    T +++A+K I     E K   +  EI  L +   +  +V    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK-HPNIVALDD 83
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            +     G + + ++ + GG L D +  +    E   S +  ++L  + YLH +  +VHR
Sbjct: 84  IY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-GIVHR 140
Query: 207 DIKPANLL---VNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP NLL   ++   +  I+DFG+S  +E+  ++ +T  GT  Y++PE +  + YS   
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 199
Query: 264 DIWSIGLA--LFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDC 319
           D WSIG+   +  CG   +P    E    L  QIL  E    SP   + S     F+   
Sbjct: 200 DCWSIGVIAYILLCG---YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 320 LKKDAEARPTADQLLSHPFIT 340
           ++KD E R T +Q L HP+I 
Sbjct: 257 MEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHG 146
            +G+GA S V  A    T +++A+K I     E K   +  EI  L +   +  +V    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK-HPNIVALDD 83
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            +     G + + ++ + GG L D +  +    E   S +  ++L  + YLH +  +VHR
Sbjct: 84  IY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG-IVHR 140
Query: 207 DIKPANLL---VNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP NLL   ++   +  I+DFG+S  +E+  ++ +T  GT  Y++PE +  + YS   
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 199
Query: 264 DIWSIGLA--LFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDC 319
           D WSIG+   +  CG   +P    E    L  QIL  E    SP   + S     F+   
Sbjct: 200 DCWSIGVIAYILLCG---YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 320 LKKDAEARPTADQLLSHPFIT 340
           ++KD E R T +Q L HP+I 
Sbjct: 257 MEKDPEKRFTCEQALQHPWIA 277

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 67  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    A   GT+ Y+ P
Sbjct: 122 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLDYLPP 178
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 229
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    A   GT+ Y+ P
Sbjct: 119 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLDYLPP 175
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 226
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHG 146
            +G+GA S V  A    T +++A+K I     E K   +  EI  L +   +  +V    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK-HPNIVALDD 83
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            +     G + + ++ + GG L D +  +    E   S +  ++L  + YLH +  +VHR
Sbjct: 84  IY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG-IVHR 140
Query: 207 DIKPANLL---VNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP NLL   ++   +  I+DFG+S  +E+  ++ +T  GT  Y++PE +  + YS   
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 199
Query: 264 DIWSIGLA--LFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDC 319
           D WSIG+   +  CG   +P    E    L  QIL  E    SP   + S     F+   
Sbjct: 200 DCWSIGVIAYILLCG---YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 320 LKKDAEARPTADQLLSHPFIT 340
           ++KD E R T +Q L HP+I 
Sbjct: 257 MEKDPEKRFTCEQALQHPWIA 277

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHG 146
            +G+GA S V  A    T +++A+K I     E K   +  EI  L +   +  +V    
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDD 83
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            +     G + + ++ + GG L D +  +    E   S +  ++L  + YLH +  +VHR
Sbjct: 84  IY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG-IVHR 140
Query: 207 DIKPANLL---VNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP NLL   ++   +  I+DFG+S  +E+  ++ +T  GT  Y++PE +  + YS   
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 199
Query: 264 DIWSIGLA--LFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDDC 319
           D WSIG+   +  CG   +P    E    L  QIL  E    SP   + S     F+   
Sbjct: 200 DCWSIGVIAYILLCG---YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 320 LKKDAEARPTADQLLSHPFIT 340
           ++KD E R T +Q L HP+I 
Sbjct: 257 MEKDPEKRFTCEQALQHPWIA 277

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A       I+ALK +   + EK    +QL    EI++
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 61  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 115
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ P
Sbjct: 116 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPP 172
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 223
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 224 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 258

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 63  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI +FG S    +S     T  GT+ Y
Sbjct: 118 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDY 174
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 225
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 64  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI +FG S    +S     T  GT+ Y
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDY 175
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 226
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 16/272 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLC 133
           R   +E      +G G    V       T R  A   LKK  I  K++    LTE R L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL- 62
Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG 193
           +   +  L     +F   D  ++   +EY +GG L   L  ++   E        +++  
Sbjct: 63  QNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 120
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPE 252
           L YLH  +++V+RD+K  NL+++  G  KITDFG+   G+++   M   F GT  Y++PE
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KXFCGTPEYLAPE 179
Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
            + +  Y    D W +G+ ++E   G  P+   +      L ++E+       +   PE 
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP---RTLGPEA 236
Query: 313 CSFVDDCLKKDAEAR-----PTADQLLSHPFI 339
            S +   LKKD + R       A +++ H F 
Sbjct: 237 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 9/214 (4%)
Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPC 137
            +  +   IG G+ + V       T RI A++ +    + + E  + + TE     +A  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +  LV  H  F      ++   +EY++GG L   ++ Q+ +PE        ++   L+YL
Sbjct: 112 HPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  R +++RD+K  N+L++ +G  K+TD+G+           +TF GT  Y++PE +R E
Sbjct: 170 HE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 258 SYSYPADIWSIGLALFECGTGEFPY---AASEGP 288
            Y +  D W++G+ +FE   G  P+    +S+ P
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 16/272 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLC 133
           R   +E      +G G    V       T R  A   LKK  I  K++    LTE R L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL- 63
Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG 193
           +   +  L     +F   D  ++   +EY +GG L   L  ++   E        +++  
Sbjct: 64  QNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 121
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPE 252
           L YLH  +++V+RD+K  NL+++  G  KITDFG+   G+++   M   F GT  Y++PE
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KXFCGTPEYLAPE 180
Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
            + +  Y    D W +G+ ++E   G  P+   +      L ++E+       +   PE 
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP---RTLGPEA 237
Query: 313 CSFVDDCLKKDAEAR-----PTADQLLSHPFI 339
            S +   LKKD + R       A +++ H F 
Sbjct: 238 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G +   L+      E   ++   
Sbjct: 66  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S        GT+ Y
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLXGTLDY 177
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 228
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 64  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTV 246
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    +C    GT+
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 173
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
            Y+ PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR 
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRV 224
Query: 307 NFS-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
            F+ P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 141/304 (46%), Gaps = 42/304 (13%)
Query: 79  ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           +S + +    +G+G  + V + ++  T   +ALK++ +  +E          +L +   +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFK----KLLQ 192
           E +V  +   +  +  ++++  E+MD   L   +  R   + P  +  ++ K    +LLQ
Sbjct: 63  ENIVRLYDVIHTEN--KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE 252
           GL++ H  + ++HRD+KP NLL+N +G+ K+ DFG++      +   ++ V T+ Y +P+
Sbjct: 120 GLAFCHENK-ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 253 RIR-NESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS--PS--- 304
            +  + +YS   DIWS G  L E  TG+  FP    E  + L+  I+  P+ S  PS   
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 305 ----------------RQNFSPE--------FCSFVDDCLKKDAEARPTADQLLSHPFIT 340
                           RQ   P            F+   L+ + + R +A Q L HP+  
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
Query: 341 KYEH 344
           +Y H
Sbjct: 299 EYYH 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 91
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 92  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 148
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A   +FVGT  Y+SPE +  +S 
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 264
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 90
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 91  KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 147
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           L++RD+KP NLL++ +G  ++TDFG +  ++       T  GT  Y++PE I ++ Y+  
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEYLAPEIILSKGYNKA 204
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 261
Query: 323 DAEAR 327
           D   R
Sbjct: 262 DLTKR 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 61  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 115
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S        GT+ Y
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDY 172
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 223
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 16/272 (5%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLC 133
           R   +E      +G G    V       T R  A   LKK  I  K++    LTE R L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL- 64
Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG 193
           +   +  L     +F   D  ++   +EY +GG L   L  ++   E        +++  
Sbjct: 65  QNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 122
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPE 252
           L YLH  +++V+RD+K  NL+++  G  KITDFG+   G+++   M   F GT  Y++PE
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KXFCGTPEYLAPE 181
Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
            + +  Y    D W +G+ ++E   G  P+   +      L ++E+       +   PE 
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP---RTLGPEA 238
Query: 313 CSFVDDCLKKDAEAR-----PTADQLLSHPFI 339
            S +   LKKD + R       A +++ H F 
Sbjct: 239 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 63  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTV 246
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    +C    GT+
Sbjct: 118 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 172
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
            Y+ PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR 
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRV 223
Query: 307 NFS-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
            F+ P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 224 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           L++RD+KP NLL++ +G  ++TDFG +  ++       T  GT  Y++PE I ++ Y+  
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEYLAPEIILSKGYNKA 219
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 276
Query: 323 DAEAR 327
           D   R
Sbjct: 277 DLTKR 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 9/214 (4%)
Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPC 137
            +  +   IG G+ + V       T RI A+K +    + + E  + + TE     +A  
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +  LV  H  F      ++   +EY++GG L   ++ Q+ +PE        ++   L+YL
Sbjct: 80  HPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  R +++RD+K  N+L++ +G  K+TD+G+           + F GT  Y++PE +R E
Sbjct: 138 HE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 258 SYSYPADIWSIGLALFECGTGEFPY---AASEGP 288
            Y +  D W++G+ +FE   G  P+    +S+ P
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 230

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TE 128
           K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           I++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   
Sbjct: 62  IQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S        GT+ Y
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDY 173
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           + PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEF 224
Query: 309 S-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           + P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 9/214 (4%)
Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPC 137
            +  +   IG G+ + V       T RI A+K +    + + E  + + TE     +A  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +  LV  H  F      ++   +EY++GG L   ++ Q+ +PE        ++   L+YL
Sbjct: 69  HPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  R +++RD+K  N+L++ +G  K+TD+G+           + F GT  Y++PE +R E
Sbjct: 127 HE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 258 SYSYPADIWSIGLALFECGTGEFPY---AASEGP 288
            Y +  D W++G+ +FE   G  P+    +S+ P
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH--GVRHLVHRDIKPAN 212
            + + +E+  GG L  +L   K IP  IL +   ++ +G++YLH   +  ++HRD+K +N
Sbjct: 80  NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138
Query: 213 LLVNLKGRP--------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +L+  K           KITDFG++     +  M A   G   +M+PE IR   +S  +D
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA--GAYAWMAPEVIRASMFSKGSD 196
Query: 265 IWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSPSPSRQNFSPE-FCSFVDDCL 320
           +WS G+ L+E  TGE P+   +G      + +  L  P PS       PE F   ++DC 
Sbjct: 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST-----CPEPFAKLMEDCW 251
Query: 321 KKDAEARPTADQLLSH 336
             D  +RP+   +L  
Sbjct: 252 NPDPHSRPSFTNILDQ 267

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 9/214 (4%)
Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPC 137
            +  +   IG G+ + V       T RI A+K +    + + E  + + TE     +A  
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +  LV  H  F      ++   +EY++GG L   ++ Q+ +PE        ++   L+YL
Sbjct: 65  HPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H  R +++RD+K  N+L++ +G  K+TD+G+           + F GT  Y++PE +R E
Sbjct: 123 HE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 258 SYSYPADIWSIGLALFECGTGEFPY---AASEGP 288
            Y +  D W++G+ +FE   G  P+    +S+ P
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 215

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 91
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 92  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 148
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 264
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 66  ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---R 122
           + + +   K  + A  +  I   +G G    V  A    +  I+ALK +   + EK    
Sbjct: 19  SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 78
Query: 123 NQLL--TEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPE 180
           +QL    EI++    P    ++  +G F+  D+ ++ + LEY   G++   L+      E
Sbjct: 79  HQLRREVEIQSHLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDE 133
Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
              ++   +L   LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S     
Sbjct: 134 QRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRD 190
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
              GT+ Y+ PE I    +    D+WS+G+  +E   G+ P+ A+           ++  
Sbjct: 191 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETY 241
Query: 301 PSPSRQNFS-PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
              SR  F+ P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 242 KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 32/277 (11%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYM 249
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    +C    GT+ Y+
Sbjct: 119 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYL 173
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
            PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFT 224
Query: 310 -PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
            P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 134/300 (44%), Gaps = 25/300 (8%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNE 139
           +R+ G  G G    V++     T +I A   LKK  I    K        R + E   + 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +V+   AF     G++ + LEY+ GG L   L  +    E        ++   L +LH 
Sbjct: 82  FIVDLIYAFQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            + +++RD+KP N+++N +G  K+TDFG+     +   +  TF GT+ YM+PE +    +
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           +   D WS+G  +++  TG  P+   E     + +IL+       + N  P       D 
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILK------CKLNLPPYLTQEARDL 251
Query: 320 LKK----DAEAR-----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVS 370
           LKK    +A +R       A ++ +HPF       ++ LA  V   F P+  ++   DVS
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL-LARKVEPPFKPL--LQSEEDVS 308

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 95
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 96  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 152
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A   +FVGT  Y+SPE +  +S 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P  + F P+    V+ 
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 268
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 32/277 (11%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYM 249
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    +C    GT+ Y+
Sbjct: 119 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYL 173
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
            PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFT 224
Query: 310 -PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
            P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 18  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 76
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 77  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 133
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 249
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 250 LLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 28/275 (10%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S        GT+ Y+ P
Sbjct: 119 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPP 175
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-P 310
           E I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+ P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFTFP 226
Query: 311 EFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
           +F +      +   LK +   RP   ++L HP+IT
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 92
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 93  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 149
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 265
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 32/277 (11%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 64  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYM 249
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    +C    GT+ Y+
Sbjct: 119 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYL 173
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
            PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFT 224
Query: 310 -PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
            P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 95  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 151
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 267
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 92
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 93  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 149
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 265
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            IG+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  K+ DFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 70
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 71  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 127
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P  + F P+    V+ 
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 243
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 92
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 93  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 149
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 265
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 11  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 69
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 70  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 126
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P  + F P+    V+ 
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 242
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 243 LLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 95  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 151
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 267
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 100/194 (51%), Gaps = 6/194 (3%)
Query: 151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP 210
           P+   + +  E ++ G + ++  + K + E      F+ L++G+ YLH  + ++HRDIKP
Sbjct: 108 PNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLH-YQKIIHRDIKP 165
Query: 211 ANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA---DIWS 267
           +NLLV   G  KI DFG+S   + S A+ +  VGT  +M+PE +      +     D+W+
Sbjct: 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWA 225
Query: 268 IGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +G+ L+    G+ P+   E  + L  +I       P + + + +    +   L K+ E+R
Sbjct: 226 MGVTLYCFVFGQCPF-MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284
Query: 328 PTADQLLSHPFITK 341
               ++  HP++T+
Sbjct: 285 IVVPEIKLHPWVTR 298

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 95  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 151
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 267
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 95
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 96  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 152
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 268
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY  GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  K+TDFG++  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 13  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 71
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 72  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 128
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P  + F P+    V+ 
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 244
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 245 LLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
           R ++  E+  L +   +  ++  H  +   +   + + LE + GG L D L  ++S+ E 
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE 115
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIA 237
             +S  K++L G++YLH  + + H D+KP N+++  K  P    K+ DFG++  +E+ + 
Sbjct: 116 EATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
               F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L      
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ 227
Query: 298 DPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFIT 340
             + +    +F  EF S        F+   L K+   R T  + L HP+IT
Sbjct: 228 -ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
           R ++  E+  L +   +  ++  H  +   +   + + LE + GG L D L  ++S+ E 
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE 115
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIA 237
             +S  K++L G++YLH  + + H D+KP N+++  K  P    K+ DFG++  +E+ + 
Sbjct: 116 EATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
               F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L      
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ 227
Query: 298 DPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFIT 340
             + +    +F  EF S        F+   L K+   R T  + L HP+IT
Sbjct: 228 -ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 89  IGSGASSVV----------QRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAP 136
           +GSGA   V          +RA+ I       +KK ++        LL E+  L   + P
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKI-------IKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L EF       D     + +E   GG L D + +++   E   + + K++L G +Y
Sbjct: 82  NIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 136
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           LH   ++VHRD+KP NLL+  K R    KI DFG+SA  E    M    +GT  Y++PE 
Sbjct: 137 LHK-HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-KERLGTAYYIAPEV 194
Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSP 310
           +R + Y    D+WS G+ L+    G  P+         +L+ +E    S   P     S 
Sbjct: 195 LRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTD--QEILKRVEKGKFSFDPPDWTQVSD 251
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           E    V   L  +   R +A++ L+HP+I K+
Sbjct: 252 EAKQLVKLMLTYEPSKRISAEEALNHPWIVKF 283

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
           R ++  E+  L +   +  ++  H  +   +   + + LE + GG L D L  ++S+ E 
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE 115
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIA 237
             +S  K++L G++YLH  + + H D+KP N+++  K  P    K+ DFG++  +E+ + 
Sbjct: 116 EATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
               F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L      
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ 227
Query: 298 DPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFIT 340
             + +    +F  EF S        F+   L K+   R T  + L HP+IT
Sbjct: 228 -ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
           R ++  E+  L +   +  ++  H  +   +   + + LE + GG L D L  ++S+ E 
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE 115
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIA 237
             +S  K++L G++YLH  + + H D+KP N+++  K  P    K+ DFG++  +E+ + 
Sbjct: 116 EATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
               F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L      
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ 227
Query: 298 DPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFIT 340
             + +    +F  EF S        F+   L K+   R T  + L HP+IT
Sbjct: 228 -ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           + DS    I  E   GG L D +  +K   E   + + K++  G++Y+H   ++VHRD+K
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLK 148
Query: 210 PANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           P N+L+  K +    KI DFG+S   + +  M    +GT  Y++PE +R  +Y    D+W
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLRG-TYDEKCDVW 206
Query: 267 SIGLALFECGTGEFP-YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           S G+ L+   +G  P Y  +E  +   ++  +     P  +  S +    +   L     
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 326 ARPTADQLLSHPFITKY 342
            R TA Q L HP+I KY
Sbjct: 267 LRITATQCLEHPWIQKY 283

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 41  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 99
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 100 VKLY--FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 156
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 272
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 273 LLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 89  IGSGASSVV----------QRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAP 136
           +GSGA   V          +RA+ I       +KK ++        LL E+  L   + P
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKI-------IKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L EF       D     + +E   GG L D + +++   E   + + K++L G +Y
Sbjct: 65  NIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 119
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           LH   ++VHRD+KP NLL+  K R    KI DFG+SA  E    M    +GT  Y++PE 
Sbjct: 120 LHK-HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-KERLGTAYYIAPEV 177
Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSP 310
           +R + Y    D+WS G+ L+    G  P+         +L+ +E    S   P     S 
Sbjct: 178 LRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQE--ILKRVEKGKFSFDPPDWTQVSD 234
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           E    V   L  +   R +A++ L+HP+I K+
Sbjct: 235 EAKQLVKLMLTYEPSKRISAEEALNHPWIVKF 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
           R ++  E+  L +   +  ++  H  +   +   + + LE + GG L D L  ++S+ E 
Sbjct: 59  REEIEREVSILRQV-LHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEE 115
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIA 237
             +S  K++L G++YLH  + + H D+KP N+++  K  P    K+ DFG++  +E+ + 
Sbjct: 116 EATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
               F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L      
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ 227
Query: 298 DPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFIT 340
             + +    +F  EF S        F+   L K+   R T  + L HP+IT
Sbjct: 228 -ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 32/277 (11%)
Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRT 131
           + A  +  I   +G G    V  A    +  I+ALK +   + EK    +QL    EI++
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLL 191
               P    ++  +G F+  D+ ++ + LEY   G++   L+      E   ++   +L 
Sbjct: 67  HLRHP---NILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYM 249
             LSY H  R ++HRDIKP NLL+   G  KI DFG S    +S    +C    GT+ Y+
Sbjct: 122 NALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYL 176
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
            PE I    +    D+WS+G+  +E   G+ P+ A+           ++     SR  F+
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------TYQETYKRISRVEFT 227
Query: 310 -PEFCS-----FVDDCLKKDAEARPTADQLLSHPFIT 340
            P+F +      +   LK +   RP   ++L HP+IT
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 19/264 (7%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I   +GSGA  VV R V   T R+   K IN      +  +  EI  + +   +  L+  
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINL 113
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHL 203
           H AF   D  ++ + LE++ GG L D +  +   + E  + +  ++  +GL ++H    +
Sbjct: 114 HDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSI 170
Query: 204 VHRDIKPANLLVNLK--GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           VH DIKP N++   K     KI DFG++  L N   +      T  + +PE +  E   +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLM------LQILEDPSPSPSRQNFSPEFCSF 315
             D+W+IG+  +   +G  P+A  +    L        +  ED   S      SPE   F
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-----VSPEAKDF 284
Query: 316 VDDCLKKDAEARPTADQLLSHPFI 339
           + + L+K+   R T    L HP++
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           + DS    I  E   GG L D +  +K   E   + + K++  G++Y+H   ++VHRD+K
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLK 148
Query: 210 PANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           P N+L+  K +    KI DFG+S   + +  M    +GT  Y++PE +R  +Y    D+W
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLRG-TYDEKCDVW 206
Query: 267 SIGLALFECGTGEFP-YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           S G+ L+   +G  P Y  +E  +   ++  +     P  +  S +    +   L     
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 326 ARPTADQLLSHPFITKY 342
            R TA Q L HP+I KY
Sbjct: 267 LRITATQCLEHPWIQKY 283

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 14  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 72
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 73  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 129
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P  + F P+    V+ 
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFP--EKFFPKARDLVEK 245
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 246 LLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G+ S+ ++ VH  +++  A+K I+   +    + +T ++ LCE   N  +V+ H  F
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALK-LCEGHPN--IVKLHEVF 75
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
           +  D     + +E ++GG L + ++ +K   E   S + +KL+  +S++H V  +VHRD+
Sbjct: 76  H--DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG-VVHRDL 132
Query: 209 KPANLLV---NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           KP NLL    N     KI DFG +           T   T+ Y +PE +    Y    D+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192
Query: 266 WSIGLALFECGTGEFPYAASE 286
           WS+G+ L+   +G+ P+ + +
Sbjct: 193 WSLGVILYTMLSGQVPFQSHD 213

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY  GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  K+TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY  GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  K+TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 71
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 72  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 128
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A   TF GT  Y++PE + +  Y   
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 188
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 189 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 245
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 246 DPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 69  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 125
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A   TF GT  Y++PE + +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 242
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 120/262 (45%), Gaps = 28/262 (10%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRTLCEAPCNEGLVE 143
           +G G    V  A    +  I+ALK +   + EK    +QL    EI++    P    ++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP---NILR 76
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            +G F+  D+ ++ + LEY   G++   L+      E   ++   +L   LSY H  R +
Sbjct: 77  LYGYFH--DATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR-V 133
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ PE I    +    
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-PEFCS-----FVD 317
           D+WS+G+  +E   G  P+ A            ++     SR  F+ P+F +      + 
Sbjct: 192 DLWSLGVLCYEFLVGMPPFEA---------HTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 318 DCLKKDAEARPTADQLLSHPFI 339
             LK +A  R T  ++L HP+I
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWI 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 69  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 125
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A   TF GT  Y++PE + +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 242
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 3/202 (1%)
Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG 140
           H +++ G    G   + +       + +  L+K  I +K++   +++E   L +   +  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           LV  H +F   D  ++   L+Y++GG L   L+ ++   EP       ++   L YLH +
Sbjct: 101 LVGLHFSFQTAD--KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
            ++V+RD+KP N+L++ +G   +TDFG+        +  +TF GT  Y++PE +  + Y 
Sbjct: 159 -NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 261 YPADIWSIGLALFECGTGEFPY 282
              D W +G  L+E   G  P+
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + LEY  GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  K+ DFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 14/221 (6%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ---LLTEIR 130
           K  +    +  I   IG GA   V       T RI A+K +N +E  KR +      E  
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKK 189
            L    C + +   H AF   D   + + ++Y  GG L  +L + +  +PE +      +
Sbjct: 127 VLVNGDC-QWITALHYAF--QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGE 183
Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTY 248
           ++  +  +H + H VHRDIKP N+L+++ G  ++ DFG    + ++     +  VGT  Y
Sbjct: 184 MVLAIDSIHQL-HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 249 MSPERIRNE-----SYSYPADIWSIGLALFECGTGEFPYAA 284
           +SPE ++        Y    D WS+G+ ++E   GE P+ A
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           + DS    I  E   GG L D +  +K   E   + + K++  G++Y+H   ++VHRD+K
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLK 148
Query: 210 PANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           P N+L+  K +    KI DFG+S   + +  M    +GT  Y++PE +R  +Y    D+W
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLRG-TYDEKCDVW 206
Query: 267 SIGLALFECGTGEFP-YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           S G+ L+   +G  P Y  +E  +   ++  +     P  +  S +    +   L     
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 326 ARPTADQLLSHPFITKY 342
            R TA Q L HP+I KY
Sbjct: 267 LRITATQCLEHPWIQKY 283

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEYSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S V  A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 39  FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 97
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 98  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 154
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P+   F P+    V+ 
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPA--AFFPKARDLVEK 270
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 271 LLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 14/221 (6%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ---LLTEIR 130
           K  +    +  I   IG GA   V       T RI A+K +N +E  KR +      E  
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKK 189
            L    C + +   H AF   D   + + ++Y  GG L  +L + +  +PE +      +
Sbjct: 143 VLVNGDC-QWITALHYAF--QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGE 199
Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTY 248
           ++  +  +H + H VHRDIKP N+L+++ G  ++ DFG    + ++     +  VGT  Y
Sbjct: 200 MVLAIDSIHQL-HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 249 MSPERIRNES-----YSYPADIWSIGLALFECGTGEFPYAA 284
           +SPE ++        Y    D WS+G+ ++E   GE P+ A
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 299

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            ++  H  +   +   + + LE + GG L D L  ++S+ E   +S  K++L G++YLH 
Sbjct: 76  NIITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 200 VRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
            + + H D+KP N+++  K  P    K+ DFG++  +E+ +     F GT  +++PE + 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
            E     AD+WSIG+  +   +G  P+        L        + +    +F  EF S 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITAVSYDFDEEFFSQ 244
Query: 315 -------FVDDCLKKDAEARPTADQLLSHPFIT 340
                  F+   L K+   R T  + L HP+IT
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 126 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 182
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           L++RD+KP NLL++ +G  ++TDFG +  ++ +     T  GT  Y++PE I ++ Y+  
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA---TWTLCGTPEYLAPEIILSKGYNKA 239
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 296
Query: 323 DAEAR 327
           D   R
Sbjct: 297 DLTKR 301

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEYSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEYSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 118/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF--- 144
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +  V F   
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQA-VNFPFL 104
Query: 145 -HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
               F   D+  + + +EY  GG +   LR      EP       +++    YLH +  L
Sbjct: 105 TKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-DL 163
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+KP NL+++ +G  K+TDFG +  ++  +  +C    GT  Y++PE I ++ Y+  
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNKA 219
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 276
Query: 323 DAEAR 327
           D   R
Sbjct: 277 DLTKR 281

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 124/267 (46%), Gaps = 21/267 (7%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           FG I G G+ S    A  + T R  A+K   K +I  KE +   +T  R +     +   
Sbjct: 34  FGKILGEGSFSTTVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFF 92
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +  F   D  ++   L Y   G L   +R   S  E        +++  L YLHG +
Sbjct: 93  VKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K 149
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +  L  E+  A    FVGT  Y+SPE +  +S 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDD 318
              +D+W++G  +++   G  P+ A  G   L+ Q I++     P +  F P+    V+ 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEK--FFPKARDLVEK 265
Query: 319 CLKKDAEARPTADQ------LLSHPFI 339
            L  DA  R   ++      L +HPF 
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 118/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF--- 144
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +  V F   
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQA-VNFPFL 104
Query: 145 -HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
               F   D+  + + +EY  GG +   LR      EP       +++    YLH +  L
Sbjct: 105 TKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-DL 163
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+KP NL+++ +G  K+TDFG +  ++  +  +C    GT  Y++PE I ++ Y+  
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNKA 219
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 276
Query: 323 DAEAR 327
           D   R
Sbjct: 277 DLTKR 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 121/246 (49%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY  GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  ++TDFG++  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 118/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF--- 144
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +  V F   
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQA-VNFPFL 104
Query: 145 -HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
               F   D+  + + +EY  GG +   LR      EP       +++    YLH +  L
Sbjct: 105 TKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-DL 163
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+KP NL+++ +G  K+TDFG +  ++  +  +C    GT  Y++PE I ++ Y+  
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNKA 219
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 276
Query: 323 DAEAR 327
           D   R
Sbjct: 277 DLTKR 281

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 120/262 (45%), Gaps = 28/262 (10%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLL--TEIRTLCEAPCNEGLVE 143
           +G G    V  A    +  I+ALK +   + EK    +QL    EI++    P    ++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP---NILR 76
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            +G F+  D+ ++ + LEY   G++   L+      E   ++   +L   LSY H  R +
Sbjct: 77  LYGYFH--DATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR-V 133
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ PE I    +    
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-PEFCS-----FVD 317
           D+WS+G+  +E   G  P+ A            ++     SR  F+ P+F +      + 
Sbjct: 192 DLWSLGVLCYEFLVGMPPFEA---------HTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 318 DCLKKDAEARPTADQLLSHPFI 339
             LK +A  R T  ++L HP+I
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWI 264

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 35/284 (12%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVE 143
            G IG G+  VV +  +  T +I+A+KK    E +   +   L EIR L +   +  LV 
Sbjct: 8   IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVN 66
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
               F      ++ +  EY D   L ++ R Q+ +PE ++ S+  + LQ +++ H   + 
Sbjct: 67  LLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNC 123
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYP 262
           +HRD+KP N+L+      K+ DFG +  L          V T  Y SPE +  ++ Y  P
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS----------------PS 304
            D+W+IG    E  +G   +P  +    + L+ + L D  P                 P 
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243
Query: 305 RQNFSPEFCSF----------VDDCLKKDAEARPTADQLLSHPF 338
            ++  P    F          +  CL  D   R T +QLL HP+
Sbjct: 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 25/300 (8%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNE 139
           +R+ G  G G    V++     T +I A   LKK  I    K        R + E   + 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +V+   AF     G++ + LEY+ GG L   L  +    E        ++   L +LH 
Sbjct: 82  FIVDLIYAFQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            + +++RD+KP N+++N +G  K+TDFG+     +   +   F GT+ YM+PE +    +
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           +   D WS+G  +++  TG  P+   E     + +IL+       + N  P       D 
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILK------CKLNLPPYLTQEARDL 251
Query: 320 LKK----DAEAR-----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVS 370
           LKK    +A +R       A ++ +HPF       ++ LA  V   F P+  ++   DVS
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL-LARKVEPPFKPL--LQSEEDVS 308

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ--LLTEIRT 131
           K  R    +  I   IG GA   V         ++ A+K +N +E  KR +     E R 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKL 190
           +     ++ +   H AF   D   + + ++Y  GG L  +L + +  +PE +      ++
Sbjct: 127 VLVNGDSKWITTLHYAF--QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYM 249
           +  +  +H + H VHRDIKP N+L+++ G  ++ DFG    L E+     +  VGT  Y+
Sbjct: 185 VIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 250 SPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAA 284
           SPE ++        Y    D WS+G+ ++E   GE P+ A
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 97
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 98  KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 154
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 210
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 267
Query: 322 KDAEAR 327
            D   R
Sbjct: 268 VDLTKR 273

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A E P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADE-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 126 KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 182
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 238
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 295
Query: 322 KDAEAR 327
            D   R
Sbjct: 296 VDLTKR 301

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 97
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 98  KLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 154
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 210
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 267
Query: 322 KDAEAR 327
            D   R
Sbjct: 268 VDLTKR 273

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H+ T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY  GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  T    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY  GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  K+TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 118/245 (48%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           L++RD+KP NLL++ +G  ++TDFG +  ++      A   GT  Y++PE I ++ Y+  
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---GTPEYLAPEIILSKGYNKA 218
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 275
Query: 323 DAEAR 327
           D   R
Sbjct: 276 DLTKR 280

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 69  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 125
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A    F GT  Y++PE + +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 242
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 69  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 125
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A    F GT  Y++PE + +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 242
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 73
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 74  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 130
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A    F GT  Y++PE + +  Y   
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 247
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 248 DPKQRLGGGPSDAKEVMEHRFF 269

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 34/282 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G GA + VQ AV +   +  A+K I       R+++  E+ TL +   N+ ++E     
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL--IE 78
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
           +  D  +  +  E + GGS+   ++ QK   E   S + + +   L +LH  + + HRD+
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH-TKGIAHRDL 137
Query: 209 KPANLLVNL--KGRP-KITDFGISAG--LENSIA-----MCATFVGTVTYMSPERI---- 254
           KP N+L     K  P KI DF + +G  L NS          T  G+  YM+PE +    
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 255 -RNESYSYPADIWSIGLALFECGTGEFPYAASEGP-------------VNLMLQILEDPS 300
            +   Y    D+WS+G+ L+   +G  P+    G               N + + +++  
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 301 ---PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
              P     + S E    +   L +DA+ R +A Q+L HP++
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 12/262 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +++ G    G   +V+       + +  L+K  I  K++    +TE R L +   +  L 
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               AF   D  ++   +EY +GG L   L  ++   E        +++  L YLH  R 
Sbjct: 69  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD 125
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +V+RDIK  NL+++  G  KITDFG+     +  A    F GT  Y++PE + +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+   +      L ++E+       +  SPE  S +   LKK
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKK 242
Query: 323 DAEAR-----PTADQLLSHPFI 339
           D + R       A +++ H F 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 150/323 (46%), Gaps = 27/323 (8%)
Query: 66  ADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKR 122
           A+ + H+EK        +++ G    G   +V++     T ++ A   LKK  I +K K 
Sbjct: 42  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 101
Query: 123 NQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
            +   TE + L     +  LV  H AF      ++ + L+Y++GG L   L  ++   E 
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEH 159
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG-LENSIAMCA 240
            +     +++  L +LH +  +++RDIK  N+L++  G   +TDFG+S   + +      
Sbjct: 160 EVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 241 TFVGTVTYMSPERIR--NESYSYPADIWSIGLALFECGTGEFPYAASEGPVN----LMLQ 294
            F GT+ YM+P+ +R  +  +    D WS+G+ ++E  TG  P+   +G  N    +  +
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRR 277
Query: 295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR-----PTADQLLSHPFITKYEHAKVDL 349
           IL+   P P  Q  S      +   L KD + R       AD++  H F  K      DL
Sbjct: 278 ILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD--DL 333
Query: 350 AA-FVRSVFDPMQRMKDLADVST 371
           AA  V + F P+  ++D  DVS 
Sbjct: 334 AAKKVPAPFKPV--IRDELDVSN 354

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 99
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 100 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 156
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 212
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 213 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 269
Query: 322 KDAEAR 327
            D   R
Sbjct: 270 VDLTKR 275

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 106 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 162
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 218
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 275
Query: 322 KDAEAR 327
            D   R
Sbjct: 276 VDLTKR 281

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGLS+ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLSFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 152 DSGQISIALEYMDGGSLAD-ILRMQ---KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           D   + I +E  +GG L + I+  Q   K++ E  ++ + K+++  L+Y H  +H+VH+D
Sbjct: 91  DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKD 149
Query: 208 IKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +KP N+L      P    KI DFG+ A L  S        GT  YM+PE  + +  ++  
Sbjct: 150 LKPENILFQ-DTSPHSPIKIIDFGL-AELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKC 206
Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           DIWS G+ ++   TG  P+  +           ++P+ +   +  +P+    +   L KD
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKD 266
Query: 324 AEARPTADQLLSHPFITK 341
            E RP+A Q+L H +  +
Sbjct: 267 PERRPSAAQVLHHEWFKQ 284

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 91
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 92  KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 148
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 204
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 205 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 261
Query: 322 KDAEAR 327
            D   R
Sbjct: 262 VDLTKR 267

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 126 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL-D 182
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 238
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 295
Query: 322 KDAEAR 327
            D   R
Sbjct: 296 VDLTKR 301

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKK----INIFEKEKRNQLLTEIRTLCEAPC-NEGLVE 143
           +G G   VV +      +  +A+KK    ++I  +E + Q   EI+ +  A C +E LVE
Sbjct: 39  MGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM--AKCQHENLVE 94
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG----LSYLHG 199
             G  +  D   + +   YM  GSL D L      P P+   M  K+ QG    +++LH 
Sbjct: 95  LLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHE 151
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNE 257
             H +HRDIK AN+L++     KI+DFG++   E      M +  VGT  YM+PE +R E
Sbjct: 152 NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE 210
Query: 258 SYSYPADIWSIGLALFECGTG 278
             +  +DI+S G+ L E  TG
Sbjct: 211 -ITPKSDIYSFGVVLLEIITG 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 117/245 (47%), Gaps = 17/245 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           L++RD+KP NLL++ +G  ++TDFG +  ++          GT  Y++PE I ++ Y+  
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLXGTPEYLAPEIILSKGYNKA 218
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ 
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 275
Query: 323 DAEAR 327
           D   R
Sbjct: 276 DLTKR 280

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +      MD     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 190 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 250 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +      MD     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 129 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 189 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 249 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 119/259 (45%), Gaps = 16/259 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +GSGA S V       T ++ ALK I      + + L  EI  L +   +E +V     
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLEDI 74
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           +    +    + ++ + GG L D +  +    E   S + +++L  + YLH    +VHRD
Sbjct: 75  Y--ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRD 131
Query: 208 IKPANLLV---NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL        +  ITDFG+S   +N I   +T  GT  Y++PE +  + YS   D
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKPYSKAVD 189
Query: 265 IWSIGLA--LFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDDCL 320
            WSIG+   +  CG   +P    E    L  +I E      SP   + S     F+   L
Sbjct: 190 CWSIGVITYILLCG---YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246
Query: 321 KKDAEARPTADQLLSHPFI 339
           +KD   R T ++ LSHP+I
Sbjct: 247 EKDPNERYTCEKALSHPWI 265

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKK----INIFEKEKRNQLLTEIRTLCEAPC-NEGLVE 143
           +G G   VV +      +  +A+KK    ++I  +E + Q   EI+ +  A C +E LVE
Sbjct: 39  MGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM--AKCQHENLVE 94
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG----LSYLHG 199
             G  +  D   + +   YM  GSL D L      P P+   M  K+ QG    +++LH 
Sbjct: 95  LLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHE 151
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNE 257
             H +HRDIK AN+L++     KI+DFG++   E      M    VGT  YM+PE +R E
Sbjct: 152 NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE 210
Query: 258 SYSYPADIWSIGLALFECGTG 278
             +  +DI+S G+ L E  TG
Sbjct: 211 -ITPKSDIYSFGVVLLEIITG 230

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +      MD     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 130
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 131 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 191 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 251 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 119/242 (49%), Gaps = 19/242 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KD 323
            D
Sbjct: 275 VD 276

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D  +  D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 130
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 191 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 251 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 126
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +      MD     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 130
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 191 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 251 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ +++   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYQMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKK----INIFEKEKRNQLLTEIRTLCEAPC-NEGLVE 143
           +G G   VV +      +  +A+KK    ++I  +E + Q   EI+ +  A C +E LVE
Sbjct: 33  MGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM--AKCQHENLVE 88
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG----LSYLHG 199
             G  +  D   + +   YM  GSL D L      P P+   M  K+ QG    +++LH 
Sbjct: 89  LLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHE 145
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNE 257
             H +HRDIK AN+L++     KI+DFG++   E      M    VGT  YM+PE +R E
Sbjct: 146 NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE 204
Query: 258 SYSYPADIWSIGLALFECGTG 278
             +  +DI+S G+ L E  TG
Sbjct: 205 -ITPKSDIYSFGVVLLEIITG 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 19/271 (7%)
Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLC 133
           +   + E+ +   IGSG+   V +      H  +A+K + + +   E+      E+  L 
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQ 192
           +   +  ++ F G  YM     ++I  ++ +G SL   L +Q++  +   L  + ++  Q
Sbjct: 88  KTR-HVNILLFMG--YMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMS 250
           G+ YLH  ++++HRD+K  N+ ++     KI DFG++      +         G+V +M+
Sbjct: 144 GMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 251 PERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LEDPSPSPS 304
           PE IR   N  +S+ +D++S G+ L+E  TGE PY+       ++  +      P  S  
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262
Query: 305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            +N        V DC+KK  E RP   Q+LS
Sbjct: 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 126
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 131/267 (49%), Gaps = 20/267 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-----LLTEIRTLCEAPCNEGLVE 143
           +G G  +VV++ +   T +  A K     +K +R Q     +L EI  L  A     ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
            H  +   ++ +I + LEY  GG +  +    + + + E  +  + K++L+G+ YLH   
Sbjct: 94  LHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-N 150
Query: 202 HLVHRDIKPANLLVNL---KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           ++VH D+KP N+L++     G  KI DFG+S  + ++  +    +GT  Y++PE +  + 
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL-REIMGTPEYLAPEILNYDP 209
Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLM--LQILEDPSPSPSRQNFSPEFCSFV 316
            +   D+W+IG+  +   T   P+   +     +   Q+  D S   +  + S     F+
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS-EETFSSVSQLATDFI 268
Query: 317 DDCLKKDAEARPTADQLLSHPFITKYE 343
              L K+ E RPTA+  LSH ++ +++
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWLQQWD 295

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEI----RTLCEAPCNEGLVE 143
            IG G  SVV+R ++  T +  A+K +++ +      L TE      ++C    +  +VE
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLA-DILRMQKS---IPEPILSSMFKKLLQGLSYLHG 199
               +     G + +  E+MDG  L  +I++   +     E + S   +++L+ L Y H 
Sbjct: 93  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 200 VRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
             +++HRD+KP  +L+  K      K+  FG++  L  S  +    VGT  +M+PE ++ 
Sbjct: 151 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 209
Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ--NFSPEFCS 314
           E Y  P D+W  G+ LF   +G  P+  ++    L   I++       RQ  + S     
Sbjct: 210 EPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISESAKD 267
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            V   L  D   R T  + L+HP++ +
Sbjct: 268 LVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NL+++ +G  ++TDFG +  ++  +  +C    GT  Y++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPEIIISKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 129 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 189 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 249 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEI----RTLCEAPCNEGLVE 143
            IG G  SVV+R ++  T +  A+K +++ +      L TE      ++C    +  +VE
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLA-DILRMQKS---IPEPILSSMFKKLLQGLSYLHG 199
               +     G + +  E+MDG  L  +I++   +     E + S   +++L+ L Y H 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 200 VRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
             +++HRD+KP  +L+  K      K+  FG++  L  S  +    VGT  +M+PE ++ 
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ--NFSPEFCS 314
           E Y  P D+W  G+ LF   +G  P+  ++    L   I++       RQ  + S     
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            V   L  D   R T  + L+HP++ +
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 126
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 129 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 189 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 249 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 129 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 189 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 249 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 128
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 129 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 189 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 248
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 249 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 190 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 250 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 126
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 134
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 135 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 194
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 195 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 254
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 255 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 130
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 191 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 251 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 131
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 132 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 191
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 192 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 251
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 252 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 134
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 135 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDI 194
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 195 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 254
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 255 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 130
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 191 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 250
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 251 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 190 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 250 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 14/226 (6%)
Query: 156 ISIALEYMDGGSLA-DILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           + + L  M+GG L   I  M Q   PE        ++  GL  LH  R +V+RD+KP N+
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENI 317
Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALF 273
           L++  G  +I+D G++  +     +    VGTV YM+PE ++NE Y++  D W++G  L+
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376
Query: 274 ECGTGEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR----- 327
           E   G+ P+   +  +    ++ L    P    + FSP+  S     L KD   R     
Sbjct: 377 EMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG 436
Query: 328 PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQR---MKDLADVS 370
            +A ++  HP   K    ++  A  +   F P  +    KD+ D+ 
Sbjct: 437 GSAREVKEHPLFKKLNFKRLG-AGMLEPPFKPDPQAIYCKDVLDIE 481

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 129
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 130 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 190 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 249
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 250 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D  +  D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 126
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 14/225 (6%)
Query: 156 ISIALEYMDGGSLA-DILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           + + L  M+GG L   I  M Q   PE        ++  GL  LH  R +V+RD+KP N+
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENI 317
Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALF 273
           L++  G  +I+D G++  +     +    VGTV YM+PE ++NE Y++  D W++G  L+
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376
Query: 274 ECGTGEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR----- 327
           E   G+ P+   +  +    ++ L    P    + FSP+  S     L KD   R     
Sbjct: 377 EMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG 436
Query: 328 PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQR---MKDLADV 369
            +A ++  HP   K    ++  A  +   F P  +    KD+ D+
Sbjct: 437 GSAREVKEHPLFKKLNFKRLG-AGMLEPPFKPDPQAIYCKDVLDI 480

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 131
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 132 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 191
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 192 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 251
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 252 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/317 (26%), Positives = 138/317 (43%), Gaps = 48/317 (15%)
Query: 73  EKTYRC-ASHEMRIFGAIGSGASSVVQRAVHIPTH-RIIALKKINIFEKEKRNQLLTEIR 130
           EK   C A  +      IG GA   V +A  +    R +ALK++ +   E+    L+ IR
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIR 60
Query: 131 TLC--------EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP- 181
            +         E P    L +           ++++  E++D     D+      +PEP 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPG 116
Query: 182 ----ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA 237
                +  M  +LL+GL +LH  R +VHRD+KP N+LV   G+ K+ DFG++      +A
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL- 296
           + +  V T+ Y +PE +   SY+ P D+WS+G    E    + P       V+ + +IL 
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILD 233
Query: 297 ------EDPSP---SPSRQNFSP-------EFCSFVDD--------CLKKDAEARPTADQ 332
                 E+  P   +  RQ F         +F + +D+        CL  +   R +A  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 333 LLSHPFITKYEHAKVDL 349
            LSHP+    E  K +L
Sbjct: 294 ALSHPYFQDLERCKENL 310

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 42/268 (15%)
Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADI----LRMQKS-- 177
           Q++T+I+      C EG++         +  ++ I  EYM+  S+         + K+  
Sbjct: 95  QIITDIKNEYCLTC-EGII--------TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 178 --IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
             IP  ++  + K +L   SY+H  +++ HRD+KP+N+L++  GR K++DFG S  + + 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 236 IAMCATFVGTVTYMSPERIRNESYSY---PADIWSIGLALFECGTGEFPYAASEGPVNLM 292
               +   GT  +M PE   NES SY     DIWS+G+ L+       P++     V L 
Sbjct: 206 KIKGSR--GTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 293 LQI-----------------LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
             I                 L +   + S    S E   F+   L+K+   R T++  L 
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 336 HPFITKYEHAKVDLAAFVRSVFDPMQRM 363
           H ++   +    DL  F + ++   +++
Sbjct: 323 HEWLA--DTNIEDLREFSKELYKKRKKL 348

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 75  TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLC 133
           T  C   EM+    +G+G    V R +H  T   +A+K+       + R +   EI+ + 
Sbjct: 10  TQTCGPWEMK--ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM- 66
Query: 134 EAPCNEGLVEFHGAFYMPDSGQIS-------IALEYMDGGSLADILRMQKS---IPEPIL 183
               N   V    A  +PD  Q         +A+EY +GG L   L   ++   + E  +
Sbjct: 67  -KKLNHPNVV--SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 184 SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP-----KITDFGISAGLENSIAM 238
            ++   +   L YLH  R ++HRD+KP N++  L+  P     KI D G +  L+    +
Sbjct: 124 RTLLSDISSALRYLHENR-IIHRDLKPENIV--LQPGPQRLIHKIIDLGYAKELDQG-EL 179
Query: 239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN 290
           C  FVGT+ Y++PE +  + Y+   D WS G   FEC TG  P+  +  PV 
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 75  TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLC 133
           T  C   EM+    +G+G    V R +H  T   +A+K+       + R +   EI+ + 
Sbjct: 11  TQTCGPWEMK--ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM- 67
Query: 134 EAPCNEGLVEFHGAFYMPDSGQIS-------IALEYMDGGSLADILRMQKS---IPEPIL 183
               N   V    A  +PD  Q         +A+EY +GG L   L   ++   + E  +
Sbjct: 68  -KKLNHPNVV--SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 124
Query: 184 SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP-----KITDFGISAGLENSIAM 238
            ++   +   L YLH  R ++HRD+KP N++  L+  P     KI D G +  L+    +
Sbjct: 125 RTLLSDISSALRYLHENR-IIHRDLKPENIV--LQPGPQRLIHKIIDLGYAKELDQG-EL 180
Query: 239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN 290
           C  FVGT+ Y++PE +  + Y+   D WS G   FEC TG  P+  +  PV 
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T R +A+K   I +K + N     +L  E+R +     P
Sbjct: 15  RLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    S F++++  + Y
Sbjct: 72  NIVKLFEV-----IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 126
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  R +VHRD+K  NLL++     KI DFG S           TF G+  Y +PE  + 
Sbjct: 127 CHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDTFCGSPPYAAPELFQG 184
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT  Y++P  I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPAIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 136/314 (43%), Gaps = 48/314 (15%)
Query: 73  EKTYRC-ASHEMRIFGAIGSGASSVVQRAVHIPTH-RIIALKKINIFEKEKRNQLLTEIR 130
           EK   C A  +      IG GA   V +A  +    R +ALK++ +   E+    L+ IR
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIR 60
Query: 131 TLC--------EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP- 181
            +         E P    L +           ++++  E++D     D+      +PEP 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPG 116
Query: 182 ----ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA 237
                +  M  +LL+GL +LH  R +VHRD+KP N+LV   G+ K+ DFG++      +A
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL- 296
           + +  V T+ Y +PE +   SY+ P D+WS+G    E    + P       V+ + +IL 
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILD 233
Query: 297 ------EDPSP---SPSRQNFSP-------EFCSFVDD--------CLKKDAEARPTADQ 332
                 E+  P   +  RQ F         +F + +D+        CL  +   R +A  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 333 LLSHPFITKYEHAK 346
            LSHP+    E  K
Sbjct: 294 ALSHPYFQDLERCK 307

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 42/284 (14%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI + + E      T IR  +L +   +  +V+   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS-----IPEPILSSMFKKLLQGLSYLHGVR 201
             +     ++ +  E++D     D+ +   +     IP P++ S   +LLQGL++ H  R
Sbjct: 73  VIHT--ENKLYLVFEHVD----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYS 260
            ++HRD+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS
Sbjct: 127 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------P 301
              DIWS+G    E  T    FP  +    +  + + L  P                  P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 302 SPSRQNFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
             +RQ+FS        +  S +   L  D   R +A   L+HPF
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++AL KI + + E      T IR  +L +   +  +V+   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 127
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 188 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 247
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 248 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++AL KI + + E      T IR  +L +   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +  +   +     + D     D   +   IP P++ S   +LLQGL++ H  R ++HR
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR-VLHR 126
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADI 265
           D+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +   + YS   DI
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 266 WSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS-----------------PSPSRQ 306
           WS+G    E  T    FP  +    +  + + L  P                  P  +RQ
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 307 NFSP-------EFCSFVDDCLKKDAEARPTADQLLSHPF 338
           +FS        +  S +   L  D   R +A   L+HPF
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 19/246 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-----LV 142
            +G+G+   V    H  +    A+K   I +K+K  +L     TL E    +      LV
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +   +F   D+  + + +EY+ GG +   LR      EP       +++    YLH +  
Sbjct: 105 KLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-D 161
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSY 261
           L++RD+KP NLL++ +G  ++TDFG +  ++  +  +C    GT   ++PE I ++ Y+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEALAPEIILSKGYNK 217
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274
Query: 322 KDAEAR 327
            D   R
Sbjct: 275 VDLTKR 280

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 139/295 (47%), Gaps = 15/295 (5%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +R+ G    G   + +       + +  LKK  I + +     +TE R L  A  +  L 
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +    F  PD  ++   +E+++GG L   ++  +   E        +++  L +LH  + 
Sbjct: 88  QLFCCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-KG 144
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           +++RD+K  N+L++ +G  K+ DFG+   G+ N +   ATF GT  Y++PE ++   Y  
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFCGTPDYIAPEILQEMLYGP 203
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS--RQNFSPEFCSFV--D 317
             D W++G+ L+E   G  P+ A E   +L   IL D    P+   ++ +    SF+  +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKN 262
Query: 318 DCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ-RMKDLADVST 371
             ++  +  +     +L HPF  + + A+++     R +  P + R+K   DVS 
Sbjct: 263 PTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH----RQIEPPFRPRIKSREDVSN 313

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 30/234 (12%)
Query: 118 EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS 177
           E E+   +L EIR       +  ++  H  F   +   + + LE + GG L D L  ++S
Sbjct: 54  EIEREVNILREIR-------HPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKES 104
Query: 178 IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLE 233
           + E   +   K++L G+ YLH  R + H D+KP N+++  K  P    K+ DFGI+  +E
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML 293
                   F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L  
Sbjct: 164 AGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-- 220
Query: 294 QILEDPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFI 339
                 + S    +F  E+ S        F+   L KD + R T  Q L H +I
Sbjct: 221 -----TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 76
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 77  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 132
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 252 AECLKKKRDERPLFPQILA 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G    V +     T   +A K I     + + ++  EI  + +   +  L++ + AF
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAF 155
Query: 149 YMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
                  I + +EY+DGG L D I+    ++ E       K++ +G+ ++H + +++H D
Sbjct: 156 --ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM-YILHLD 212
Query: 208 IKPANLL-VNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +KP N+L VN   +  KI DFG++   +    +   F GT  +++PE +  +  S+P D+
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDM 271
Query: 266 WSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           WS+G+  +   +G  P+        +N +L    D       Q+ S E   F+   L K+
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE-DEEFQDISEEAKEFISKLLIKE 330
Query: 324 AEARPTADQLLSHPFITKYE-HAKV 347
              R +A + L HP+++ ++ H+++
Sbjct: 331 KSWRISASEALKHPWLSDHKLHSRL 355

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T R +A+K   I +K + N     +L  E+R +     P
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    S F++++  + Y
Sbjct: 75  NIVKLFEV-----IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  R +VHRD+K  NLL++     KI DFG S        + A F G   Y +PE  + 
Sbjct: 130 CHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQG 187
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 73
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 74  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 129
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 248
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 249 AECLKKKRDERPLFPQILA 267

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 76
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 77  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 132
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 252 AECLKKKRDERPLFPQILA 270

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 31/300 (10%)
Query: 67  DESDHSEKTYRCASHEMRIFG---AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN 123
           D+   S     C S + RI+     IGSG SS V + ++    +I A+K +N+  +E  N
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADN 95
Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIP 179
           Q L   R   E      L +           +I+    YM  + G+  L   L+ +KSI 
Sbjct: 96  QTLDSYRN--EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSID 153
Query: 180 EPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSI 236
                S +K +L+ +  +H  +H +VH D+KPAN L+ + G  K+ DFGI+  ++   + 
Sbjct: 154 PWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTS 210
Query: 237 AMCATFVGTVTYMSPERIRNESYS-----------YPADIWSIGLALFECGTGEFPYAAS 285
            +  + VGTV YM PE I++ S S             +D+WS+G  L+    G+ P+   
Sbjct: 211 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 286 EGPVNLMLQILEDPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              ++ +  I+ DP+      +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 271 INQISKLHAII-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 98
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 99  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 154
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 273
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 274 AECLKKKRDERPLFPQILA 292

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 99
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 100 YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 155
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 274
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 275 AECLKKKRDERPLFPQILA 293

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 72  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 127
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 247 AECLKKKRDERPLFPQILA 265

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 21/259 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 72  YSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 127
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 317 DDCLKKDAEARPTADQLLS 335
            +CLKK  + RP   Q+L+
Sbjct: 247 AECLKKKRDERPLFPQILA 265

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 31/300 (10%)
Query: 67  DESDHSEKTYRCASHEMRIFG---AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN 123
           D+   S     C S + RI+     IGSG SS V + ++    +I A+K +N+  +E  N
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADN 95
Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIP 179
           Q L   R   E      L +           +I+    YM  + G+  L   L+ +KSI 
Sbjct: 96  QTLDSYRN--EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSID 153
Query: 180 EPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSI 236
                S +K +L+ +  +H  +H +VH D+KPAN L+ + G  K+ DFGI+  ++   + 
Sbjct: 154 PWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTS 210
Query: 237 AMCATFVGTVTYMSPERIRNESYS-----------YPADIWSIGLALFECGTGEFPYAAS 285
            +  + VGTV YM PE I++ S S             +D+WS+G  L+    G+ P+   
Sbjct: 211 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 286 EGPVNLMLQILEDPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              ++ +  I+ DP+      +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 271 INQISKLHAII-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 73  EKTYRC-ASHEMRIFGAIGSGASSVVQRAVHIPTH-RIIALKKINIFEKEKRNQLLTEIR 130
           EK   C A  +      IG GA   V +A  +    R +ALK++ +   E+    L+ IR
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIR 60
Query: 131 TLC--------EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP- 181
            +         E P    L +           ++++  E++D     D+      +PEP 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPG 116
Query: 182 ----ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA 237
                +  M  +LL+GL +LH  R +VHRD+KP N+LV   G+ K+ DFG++      +A
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           + +  V T+ Y +PE +   SY+ P D+WS+G    E
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 16/262 (6%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           +  + K  + +K  +  LL E++ L   + P    L EF       D G   +  E   G
Sbjct: 79  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTG 133
Query: 166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP---K 222
           G L D +  +K   E   + + +++L G++Y+H  + +VHRD+KP NLL+  K +    +
Sbjct: 134 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 192
Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           I DFG+S   E S  M    +GT  Y++PE + + +Y    D+WS G+ L+   +G  P+
Sbjct: 193 IIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 250
Query: 283 -AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
             A+E  +   ++  +     P  +  S      +   L      R +A   L H +I  
Sbjct: 251 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 310
Query: 342 Y--EHAKVDLAAFVRSVFDPMQ 361
           Y  E   VD+ +   ++ +  Q
Sbjct: 311 YTKEQISVDVPSLDNAILNIRQ 332

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 16/262 (6%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           +  + K  + +K  +  LL E++ L   + P    L EF       D G   +  E   G
Sbjct: 80  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTG 134
Query: 166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP---K 222
           G L D +  +K   E   + + +++L G++Y+H  + +VHRD+KP NLL+  K +    +
Sbjct: 135 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 193
Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           I DFG+S   E S  M    +GT  Y++PE + + +Y    D+WS G+ L+   +G  P+
Sbjct: 194 IIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 251
Query: 283 -AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
             A+E  +   ++  +     P  +  S      +   L      R +A   L H +I  
Sbjct: 252 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 311
Query: 342 Y--EHAKVDLAAFVRSVFDPMQ 361
           Y  E   VD+ +   ++ +  Q
Sbjct: 312 YTKEQISVDVPSLDNAILNIRQ 333

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 91/188 (48%), Gaps = 8/188 (4%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV-HRDIKPANLL 214
           I + +EY+ GG L D +     + E     +F+++L G+ Y H  RH+V HRD+KP N+L
Sbjct: 91  IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVL 148
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP-ADIWSIGLALF 273
           ++     KI DFG+S  + +   +  +  G+  Y +PE I    Y+ P  DIWS G+ L+
Sbjct: 149 LDAHMNAKIADFGLSNMMSDGEFLRXS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 274 ECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQL 333
               G  P+     P  L  +I +    +P  Q  +P   S +   L+ D   R T   +
Sbjct: 208 ALLCGTLPFDDDHVP-TLFKKICDGIFYTP--QYLNPSVISLLKHMLQVDPMKRATIKDI 264
Query: 334 LSHPFITK 341
             H +  +
Sbjct: 265 REHEWFKQ 272

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 123/258 (47%), Gaps = 19/258 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 99
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 100 YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 155
Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNES---YS 260
           RD+K  N+ ++     KI DFG++      +         G++ +M+PE IR +    YS
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFVD 317
           + +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        + 
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 275
Query: 318 DCLKKDAEARPTADQLLS 335
           +CLKK  + RP   Q+L+
Sbjct: 276 ECLKKKRDERPLFPQILA 293

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 16/262 (6%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           +  + K  + +K  +  LL E++ L   + P    L EF       D G   +  E   G
Sbjct: 56  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTG 110
Query: 166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP---K 222
           G L D +  +K   E   + + +++L G++Y+H  + +VHRD+KP NLL+  K +    +
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 169
Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           I DFG+S   E S  M    +GT  Y++PE + + +Y    D+WS G+ L+   +G  P+
Sbjct: 170 IIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 227
Query: 283 -AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
             A+E  +   ++  +     P  +  S      +   L      R +A   L H +I  
Sbjct: 228 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 342 Y--EHAKVDLAAFVRSVFDPMQ 361
           Y  E   VD+ +   ++ +  Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 129/263 (49%), Gaps = 29/263 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 75
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L   ++  E   L  + ++  +G+ YLH  + ++H
Sbjct: 76  YSTKP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIH 131
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG+ A +++  +    F    G++ +M+PE IR +    Y
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-------DPSPSPSRQNFSPEF 312
           S+ +D+++ G+ L+E  TG+ PY+     +N   QI+E        P  S  R N     
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 246
Query: 313 CSFVDDCLKKDAEARPTADQLLS 335
              + +CLKK  + RP+  ++L+
Sbjct: 247 KRLMAECLKKKRDERPSFPRILA 269

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 123/258 (47%), Gaps = 19/258 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 91
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 92  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 147
Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNES---YS 260
           RD+K  N+ ++     KI DFG++      +         G++ +M+PE IR +    YS
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFVD 317
           + +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        + 
Sbjct: 208 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 267
Query: 318 DCLKKDAEARPTADQLLS 335
           +CLKK  + RP   Q+L+
Sbjct: 268 ECLKKKRDERPLFPQILA 285

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T + +A+K   I +K + N     +L  E+R +     P
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 74  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        +  TF G+  Y +PE  + 
Sbjct: 129 CHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTFCGSPPYAAPELFQG 186
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T + +A+K   I +K + N     +L  E+R +     P
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 74  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        +  TF G+  Y +PE  + 
Sbjct: 129 CHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTFCGSPPYAAPELFQG 186
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 11/264 (4%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCN 138
           + ++   +G G+ + V RA  I T   +A+K I+   +++     ++  E++  C+   +
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-H 70
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYL 197
             ++E +   Y  DS  + + LE    G +   L+ + K   E        +++ G+ YL
Sbjct: 71  PSILELYN--YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H    ++HRD+  +NLL+      KI DFG++  L+       T  GT  Y+SPE     
Sbjct: 129 HS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           ++   +D+WS+G   +    G  P+        L   +L D    PS    S E    + 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSF--LSIEAKDLIH 244
Query: 318 DCLKKDAEARPTADQLLSHPFITK 341
             L+++   R +   +L HPF+++
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 31/289 (10%)
Query: 78  CASHEMRIFG---AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE 134
           C S + RI+     IGSG SS V + ++    +I A+K +N+  +E  NQ L   R   E
Sbjct: 3   CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRN--E 57
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIPEPILSSMFKKL 190
                 L +           +I+    YM  + G+  L   L+ +KSI      S +K +
Sbjct: 58  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 117
Query: 191 LQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVT 247
           L+ +  +H  +H +VH D+KPAN L+ + G  K+ DFGI+  ++   +  +  + VGTV 
Sbjct: 118 LEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 248 YMSPERIRNESYS-----------YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL 296
           YM PE I++ S S             +D+WS+G  L+    G+ P+      ++ +  I+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 297 EDPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
            DP+      +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 235 -DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 42/275 (15%)
Query: 89  IGSGASSVVQR-----------AVHIPTHRIIALKK-INIFEKEKRNQLLTEIRTLCEAP 136
           +GSG  ++V++           A  I   R+ + ++ ++  E E+   +L EIR      
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR------ 87
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
            +  ++  H  F   +   + + LE + GG L D L  ++S+ E   +   K++L G+ Y
Sbjct: 88  -HPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPE 252
           LH  R + H D+KP N+++  K  P    K+ DFGI+  +E        F GT  +++PE
Sbjct: 145 LHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPE 202
Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
            +  E     AD+WSIG+  +   +G  P+        L        + S    +F  E+
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------TNISAVNYDFDEEY 255
Query: 313 CS--------FVDDCLKKDAEARPTADQLLSHPFI 339
            S        F+   L KD + R    Q L H +I
Sbjct: 256 FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 123/258 (47%), Gaps = 19/258 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 71
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L + ++  E I L  + ++  QG+ YLH  + ++H
Sbjct: 72  YSTKP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIH 127
Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNES---YS 260
           RD+K  N+ ++     KI DFG++      +         G++ +M+PE IR +    YS
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPSRQNFSPEFCSFVD 317
           + +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        + 
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247
Query: 318 DCLKKDAEARPTADQLLS 335
           +CLKK  + RP   Q+L+
Sbjct: 248 ECLKKKRDERPLFPQILA 265

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A H+ T R +A+K   I +K + N     +L  E+R +     P
Sbjct: 18  RLQKTIGKGNFAKVKLARHVLTGREVAVK---IIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 75  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 129
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  +++VHRD+K  NLL++     KI DFG S        +  TF G+  Y +PE  + 
Sbjct: 130 CHQ-KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKL-DTFCGSPPYAAPELFQG 187
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 21/258 (8%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRII--ALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLV 142
           FG + SG        + +P+ + I  A+K + + + +++R   L E   + +   +  ++
Sbjct: 29  FGEVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 80
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVR 201
              G   +  S  + I  EYM+ GSL   LR   +    I L  M + +  G+ YL  + 
Sbjct: 81  RLEGV--VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNES 258
           + VHRD+   N+L+N     K++DFG+S  LE+      T  G    + + SPE I    
Sbjct: 139 Y-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           ++  +D+WS G+ L+E  + GE PY   E     +++ +++    P   +        + 
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLML 255
Query: 318 DCLKKDAEARPTADQLLS 335
           DC +KD   RP  +Q++S
Sbjct: 256 DCWQKDRNNRPKFEQIVS 273

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 31/289 (10%)
Query: 78  CASHEMRIFG---AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE 134
           C S + RI+     IGSG SS V + ++    +I A+K +N+  +E  NQ L   R   E
Sbjct: 2   CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRN--E 56
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIPEPILSSMFKKL 190
                 L +           +I+    YM  + G+  L   L+ +KSI      S +K +
Sbjct: 57  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 116
Query: 191 LQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVT 247
           L+ +  +H  +H +VH D+KPAN L+ + G  K+ DFGI+  ++   +  +  + VGTV 
Sbjct: 117 LEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 173
Query: 248 YMSPERIRNESYS-----------YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL 296
           YM PE I++ S S             +D+WS+G  L+    G+ P+      ++ +  I+
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 233
Query: 297 EDPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
            DP+      +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 234 -DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 281

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 31/290 (10%)
Query: 77  RCASHEMRIFG---AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLC 133
            C S + RI+     IGSG SS V + ++    +I A+K +N+  +E  NQ L   R   
Sbjct: 5   ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRN-- 59
Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIPEPILSSMFKK 189
           E      L +           +I+    YM  + G+  L   L+ +KSI      S +K 
Sbjct: 60  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 119
Query: 190 LLQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTV 246
           +L+ +  +H  +H +VH D+KPAN L+ + G  K+ DFGI+  ++   +  +  + VGTV
Sbjct: 120 MLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 247 TYMSPERIRNESYS-----------YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
            YM PE I++ S S             +D+WS+G  L+    G+ P+      ++ +  I
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 236
Query: 296 LEDPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
           + DP+      +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 237 I-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 285

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +   A FV T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---AGFVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 130
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 131 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 189
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 190 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 250 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 300

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 30/234 (12%)
Query: 118 EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS 177
           E E+   +L EIR       +  ++  H  F   +   + + LE + GG L D L  ++S
Sbjct: 61  EIEREVNILREIR-------HPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKES 111
Query: 178 IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLE 233
           + E   +   K++L G+ YLH  R + H D+KP N+++  K  P    K+ DFGI+  +E
Sbjct: 112 LTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML 293
                   F GT  +++PE +  E     AD+WSIG+  +   +G  P+        L  
Sbjct: 171 AGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-- 227
Query: 294 QILEDPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARPTADQLLSHPFI 339
                 + S    +F  E+ S        F+   L KD + R    Q L H +I
Sbjct: 228 -----TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE M+    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 76  IRLLDWFERPDS--FVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 134 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 190
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 241
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 242 CLALRPSDRPTFEEIQNHPWM 262

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +   A FV T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---AGFVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T + +A+K   I +K + N     +L  E+R +     P
Sbjct: 10  RLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 67  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY 121
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        +  TF G+  Y +PE  + 
Sbjct: 122 CHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTFCGSPPYAAPELFQG 179
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 142
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +   A FV T  Y +PE + N   Y+  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---AGFVATRWYRAPEIMLNWMHYNQT 199
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 259
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 120
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 121 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 179
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 180 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 239
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 240 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 290

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 27/262 (10%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 87
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L   ++  E   L  + ++  +G+ YLH  + ++H
Sbjct: 88  YSTKP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIH 143
Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNES---YS 260
           RD+K  N+ ++     KI DFG++      +         G++ +M+PE IR +    YS
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-------DPSPSPSRQNFSPEFC 313
           + +D+++ G+ L+E  TG+ PY+     +N   QI+E        P  S  R N      
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 314 SFVDDCLKKDAEARPTADQLLS 335
             + +CLKK  + RP+  ++L+
Sbjct: 260 RLMAECLKKKRDERPSFPRILA 281

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 5/201 (2%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I  AIG G+   V       T ++ A+K +N  +  +RN++    + L      E     
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           +  +   D   + + ++ + GG L   L+      E  +     +L+  L YL   R ++
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR-II 137
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI---RNESYSY 261
           HRD+KP N+L++  G   ITDF I+A L     +  T  GT  YM+PE     +   YS+
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 262 PADIWSIGLALFECGTGEFPY 282
             D WS+G+  +E   G  PY
Sbjct: 197 AVDWWSLGVTAYELLRGRRPY 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 66/312 (21%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKI----NIFEKEKRNQLLTEIRTLCEAPC 137
           E  I   IG+GA  VV  A    T + +A+KKI    ++    KR   L E++ L     
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT--LRELKILKHFK- 111
Query: 138 NEGLVEF---------HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           ++ ++           +G F       + + L+ M+   L  I+   + +    +     
Sbjct: 112 HDNIIAIKDILRPTVPYGEF-----KSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLY 165
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----MCATFVG 244
           +LL+GL Y+H  + ++HRD+KP+NLLVN     KI DFG++ GL  S A        +V 
Sbjct: 166 QLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 245 TVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE-------FPYAASEGPVNLMLQIL 296
           T  Y +PE + +   Y+   D+WS+G     C  GE       FP       + L++ +L
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVG-----CIFGEMLARRQLFPGKNYVHQLQLIMMVL 279
Query: 297 EDPSPS-----------------PSRQNFSPEFC---------SFVDDCLKKDAEARPTA 330
             PSP+                 P RQ    E           S +   L+ +  AR +A
Sbjct: 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA 339
Query: 331 DQLLSHPFITKY 342
              L HPF+ KY
Sbjct: 340 AAALRHPFLAKY 351

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 156 ISIALEYMDGGSLA-DILRMQKSIP---EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           + + +  M+GG +   I  + +  P   EP       +++ GL +LH  R++++RD+KP 
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPE 318
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
           N+L++  G  +I+D G++  L+        + GT  +M+PE +  E Y +  D +++G+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 272 LFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR- 327
           L+E      P+ A    V    L  ++LE     P +  FSP    F +  L+KD E R 
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRL 436
Query: 328 ----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM---KDLADVST 371
                + D L +HP        +++ A  +   F P  R    K++ DV  
Sbjct: 437 GFRDGSCDGLRTHPLFRDISWRQLE-AGMLTPPFVPDSRTVYAKNIQDVGA 486

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 156 ISIALEYMDGGSLA-DILRMQKSIP---EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           + + +  M+GG +   I  + +  P   EP       +++ GL +LH  R++++RD+KP 
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPE 318
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
           N+L++  G  +I+D G++  L+        + GT  +M+PE +  E Y +  D +++G+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 272 LFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR- 327
           L+E      P+ A    V    L  ++LE     P +  FSP    F +  L+KD E R 
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRL 436
Query: 328 ----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM---KDLADVST 371
                + D L +HP        +++ A  +   F P  R    K++ DV  
Sbjct: 437 GFRDGSCDGLRTHPLFRDISWRQLE-AGMLTPPFVPDSRTVYAKNIQDVGA 486

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 111/233 (47%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  +   VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-GFVHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 77  RCASHEMR---IFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQ-LLTEIRT 131
           R   H +R   +   +G GA  +V +++   T  ++A+KKI + F+     Q    EI  
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI 61
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSS-MFKKL 190
           L E   +E +V         +   + +  +YM+    A I   + +I EP+    +  +L
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI---RANILEPVHKQYVVYQL 118
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN----------SIA--- 237
           ++ + YLH    L+HRD+KP+N+L+N +   K+ DFG+S    N          SI    
Sbjct: 119 IKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 238 --------MCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFE--CGTGEFPYAASE 286
                   +   +V T  Y +PE +   + Y+   D+WS+G  L E  CG   FP +++ 
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
             +  ++ +++ PS        SP F   + + LK+  E R +
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSP-FAKTMIESLKEKVEIRQS 279

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 156 ISIALEYMDGGSLA-DILRMQKSIP---EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           + + +  M+GG +   I  + +  P   EP       +++ GL +LH  R++++RD+KP 
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPE 318
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
           N+L++  G  +I+D G++  L+        + GT  +M+PE +  E Y +  D +++G+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 272 LFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR- 327
           L+E      P+ A    V    L  ++LE     P +  FSP    F +  L+KD E R 
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRL 436
Query: 328 ----PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM---KDLADVST 371
                + D L +HP        +++ A  +   F P  R    K++ DV  
Sbjct: 437 GFRDGSCDGLRTHPLFRDISWRQLE-AGMLTPPFVPDSRTVYAKNIQDVGA 486

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T + +A++   I +K + N     +L  E+R +     P
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVR---IIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 74  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        +  TF G+  Y +PE  + 
Sbjct: 129 CHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DTFCGSPPYAAPELFQG 186
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 28/279 (10%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I   IGSG SS V + ++    +I A+K +N+  +E  NQ L   R   E      L + 
Sbjct: 32  ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 145 HGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
                     +I+    YM  + G+  L   L+ +KSI      S +K +L+ +  +H  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-- 144
Query: 201 RH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERIRNE 257
           +H +VH D+KPAN L+ + G  K+ DFGI+  ++   +  +  + VGTV YM PE I++ 
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 258 SYS-----------YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
           S S             +D+WS+G  L+    G+ P+      ++ +  I+ DP+      
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-DPNHEIEFP 262
Query: 307 NF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
           +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 27/262 (10%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG 87
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L   ++  E   L  + ++  +G+ YLH  + ++H
Sbjct: 88  YSTAP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIH 143
Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNES---YS 260
           RD+K  N+ ++     KI DFG++      +         G++ +M+PE IR +    YS
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-------DPSPSPSRQNFSPEFC 313
           + +D+++ G+ L+E  TG+ PY+     +N   QI+E        P  S  R N      
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 314 SFVDDCLKKDAEARPTADQLLS 335
             + +CLKK  + RP+  ++L+
Sbjct: 260 RLMAECLKKKRDERPSFPRILA 281

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 140
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 199 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 330 ADQLLS 335
            D L S
Sbjct: 257 FDYLRS 262

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 141
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 142 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 199
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 200 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 257
Query: 330 ADQLLS 335
            D L S
Sbjct: 258 FDYLRS 263

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T + +A+K   I +K + N     +L  E+R +     P
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 74  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        + A F G   Y +PE  + 
Sbjct: 129 CHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA-FCGAPPYAAPELFQG 186
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 156 ISIALEYMDGGSLA-DILRMQKSIP---EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA 211
           + + +  M+GG +   I  + +  P   EP       +++ GL +LH  R++++RD+KP 
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPE 318
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
           N+L++  G  +I+D G++  L+        + GT  +M+PE +  E Y +  D +++G+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 272 LFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR- 327
           L+E      P+ A    V    L  ++LE     P +  FSP    F +  L+KD E R 
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRL 436
Query: 328 ----PTADQLLSHPFI 339
                + D L +HP  
Sbjct: 437 GFRDGSCDGLRTHPLF 452

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 140/300 (46%), Gaps = 31/300 (10%)
Query: 67  DESDHSEKTYRCASHEMRIFG---AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN 123
           D+   S     C S + RI+     IGSG SS V + ++    +I A+K +N+  +E  N
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADN 95
Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIP 179
           Q L   R   E      L +           +I+    YM  + G+  L   L+ +KSI 
Sbjct: 96  QTLDSYRN--EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSID 153
Query: 180 EPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLE--NSI 236
                S +K +L+ +  +H  +H +VH D+KPAN L+ + G  K+ DFGI+  ++   + 
Sbjct: 154 PWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTS 210
Query: 237 AMCATFVGTVTYMSPERIRNESYS-----------YPADIWSIGLALFECGTGEFPYAAS 285
            +  + VG V YM PE I++ S S             +D+WS+G  L+    G+ P+   
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 286 EGPVNLMLQILEDPSPSPSRQNF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              ++ +  I+ DP+      +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 271 INQISKLHAII-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 140
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 199 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 330 ADQLLS 335
            D L S
Sbjct: 257 FDYLRS 262

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 142
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 143 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 200
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 201 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 258
Query: 330 ADQLLS 335
            D L S
Sbjct: 259 FDYLRS 264

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 135
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 136 LVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 193
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 194 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 251
Query: 330 ADQLLS 335
            D L S
Sbjct: 252 FDYLRS 257

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 7/203 (3%)
Query: 140 GLVEFHGAFYMPDSGQISIAL--EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
            +V F+ ++     G+  I L  E    G+L   L+  K     +L S  +++L+GL +L
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 198 HG-VRHLVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           H     ++HRD+K  N+ +    G  KI D G++     S A     +GT  + +PE   
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV--IGTPEFXAPEXY- 202
Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF 315
            E Y    D+++ G    E  T E+PY+  +    +  ++     P+   +   PE    
Sbjct: 203 EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 316 VDDCLKKDAEARPTADQLLSHPF 338
           ++ C++++ + R +   LL+H F
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAF 285

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 140
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 141 LVSDTLSCKIADFGLARLIEDAEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 199 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 330 ADQLLS 335
            D L S
Sbjct: 257 FDYLRS 262

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 28/279 (10%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I   IGSG SS V + ++    +I A+K +N+  +E  NQ L   R   E      L + 
Sbjct: 32  ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL--EEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 145 HGAFYMPDSGQISIALEYM--DGGS--LADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
                     +I+    YM  + G+  L   L+ +KSI      S +K +L+ +  +H  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-- 144
Query: 201 RH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA--TFVGTVTYMSPERIRNE 257
           +H +VH D+KPAN L+ + G  K+ DFGI+  ++         + VGTV YM PE I++ 
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 258 SYS-----------YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
           S S             +D+WS+G  L+    G+ P+      ++ +  I+ DP+      
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-DPNHEIEFP 262
Query: 307 NF-SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
           +    +    +  CLK+D + R +  +LL+HP++    H
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 140
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 199 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 330 ADQLLS 335
            D L S
Sbjct: 257 FDYLRS 262

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 148
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 149 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 206
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 207 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 264
Query: 330 ADQLLS 335
            D L S
Sbjct: 265 FDYLRS 270

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G++  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 149
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 150 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 207
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 208 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 265
Query: 330 ADQLLS 335
            D L S
Sbjct: 266 FDYLRS 271

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 146
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 204
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 205 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262
Query: 330 ADQLLS 335
            D L S
Sbjct: 263 FDYLRS 268

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 146 LVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 204 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 261
Query: 330 ADQLLS 335
            D L S
Sbjct: 262 FDYLRS 267

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 66/312 (21%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKI----NIFEKEKRNQLLTEIRTLCEAPC 137
           E  I   IG+GA  VV  A    T + +A+KKI    ++    KR   L E++ L     
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT--LRELKILKHFK- 112
Query: 138 NEGLVEF---------HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           ++ ++           +G F       + + L+ M+   L  I+   + +    +     
Sbjct: 113 HDNIIAIKDILRPTVPYGEF-----KSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLY 166
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----MCATFVG 244
           +LL+GL Y+H  + ++HRD+KP+NLLVN     KI DFG++ GL  S A        +V 
Sbjct: 167 QLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 245 TVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE-------FPYAASEGPVNLMLQIL 296
           T  Y +PE + +   Y+   D+WS+G     C  GE       FP       + L++ +L
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVG-----CIFGEMLARRQLFPGKNYVHQLQLIMMVL 280
Query: 297 EDPSPS-----------------PSRQNFSPEFC---------SFVDDCLKKDAEARPTA 330
             PSP+                 P RQ    E           S +   L+ +  AR +A
Sbjct: 281 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA 340
Query: 331 DQLLSHPFITKY 342
              L HPF+ KY
Sbjct: 341 AAALRHPFLAKY 352

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 146
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 204
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 205 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262
Query: 330 ADQLLS 335
            D L S
Sbjct: 263 FDYLRS 268

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 52/305 (17%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLT 127
           KTY   +H       +GSGA   V  A+   +   +A+KK++      IF K    +LL 
Sbjct: 42  KTYVSPTH-------VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 94
Query: 128 EIRTLCEAPCNEGLVE-FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSM 186
                 E     GL++ F  A  + +     + + +M    L  I+ M+ S  E  +  +
Sbjct: 95  LKHMQHENVI--GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGMEFS--EEKIQYL 149
Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV 246
             ++L+GL Y+H    +VHRD+KP NL VN     KI DFG++    ++ A    +V T 
Sbjct: 150 VYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTR 205
Query: 247 TYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEG-------------PVNLM 292
            Y +PE I +   Y+   DIWS+G  + E  TG+  +   +              P    
Sbjct: 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265
Query: 293 LQILEDPS--------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHP 337
           +Q L D +        P   R++F       SP+    ++  L+ D + R TA Q L+HP
Sbjct: 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325
Query: 338 FITKY 342
           F   +
Sbjct: 326 FFEPF 330

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 14/241 (5%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           +  + K  + +K  +  LL E++ L   + P    L EF       D G   +  E   G
Sbjct: 62  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTG 116
Query: 166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP---K 222
           G L D +  +K   E   + + +++L G++Y+H  + +VHRD+KP NLL+  K +    +
Sbjct: 117 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIR 175
Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           I DFG+S   E S  M    +GT  Y++PE + + +Y    D+WS G+ L+   +G  P+
Sbjct: 176 IIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 233
Query: 283 -AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
             A+E  +   ++  +     P  +  S      +   L      R +A   L H +I  
Sbjct: 234 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293
Query: 342 Y 342
           Y
Sbjct: 294 Y 294

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 150
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 151 LVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 208
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 209 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 266
Query: 330 ADQLLS 335
            D L S
Sbjct: 267 FDYLRS 272

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  EYM+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEYMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+   LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 38/289 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 109
Query: 148 FYMPDSGQIS--IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
              P   Q+     + ++ G  L  +L+ Q    + I   +++ +L+GL Y+H   +++H
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVLH 167
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYSY 261
           RD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+ 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 262 PADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------- 300
             DIWS+G  L E  +    FP       +N +L IL  PS                   
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 287
Query: 301 PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 288 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E+M  GSL D L+  +   +P+  L     ++ +G++++   R+ +HRD++ AN+
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANI 315
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   S++  +D+WS G+
Sbjct: 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   +++ LE     P  +N   E  + +  C K   E RPT
Sbjct: 374 LLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 431
Query: 330 ADQLLS 335
            + + S
Sbjct: 432 FEYIQS 437

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E+M  GSL D L+  +   +P+  L     ++ +G++++   R+ +HRD++ AN+
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANI 142
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   S++  +D+WS G+
Sbjct: 143 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 200
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   +++ LE     P  +N   E  + +  C K   E RPT
Sbjct: 201 LLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 258
Query: 330 ADQLLS 335
            + + S
Sbjct: 259 FEYIQS 264

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 16/262 (6%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           +  + K  + +K  +  LL E++ L   + P    L EF       D G   +  E   G
Sbjct: 56  VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEF-----FEDKGYFYLVGEVYTG 110
Query: 166 GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP---K 222
           G L D +  +K   E   + + +++L G++Y H  + +VHRD+KP NLL+  K +    +
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK-IVHRDLKPENLLLESKSKDANIR 169
Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
           I DFG+S   E S       +GT  Y++PE + + +Y    D+WS G+ L+   +G  P+
Sbjct: 170 IIDFGLSTHFEAS-KKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 227
Query: 283 -AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
             A+E  +   ++  +     P  +  S      +   L      R +A   L H +I  
Sbjct: 228 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQT 287
Query: 342 Y--EHAKVDLAAFVRSVFDPMQ 361
           Y  E   VD+ +   ++ +  Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 34/284 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G    V +A +  TH I+ALK++ + + ++   +  L EI  L E   ++ +V  H 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +     ++++  E+ D             +   I+ S   +LL+GL + H  R+++HR
Sbjct: 69  VLH--SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHR 125
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPADI 265
           D+KP NLL+N  G  K+ DFG++      +   +  V T+ Y  P+ +     YS   D+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 266 WSIGLALFECGTGE---FPYAASEGPVNLMLQILEDPS--------------PSP----- 303
           WS G    E        FP    +  +  + ++L  P+              P P     
Sbjct: 186 WSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 304 -SRQNFSPEFCS----FVDDCLKKDAEARPTADQLLSHPFITKY 342
            S  N  P+  +     + + LK +   R +A++ L HP+ + +
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 14/261 (5%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
             IG G+   V+ AV   T    A KKI  +  E  ++   EI  + ++  +  ++  + 
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM-KSLDHPNIIRLYE 90
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            F   D+  I + +E   GG L + +  ++   E   + + K +L  ++Y H + ++ HR
Sbjct: 91  TF--EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL-NVAHR 147
Query: 207 DIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           D+KP N L  L   P    K+ DFG++A  +    M  T VGT  Y+SP+ +    Y   
Sbjct: 148 DLKPENFLF-LTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEG-LYGPE 204
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ--NFSPEFCSFVDDCL 320
            D WS G+ ++    G  P++A      +ML+I E     P +   N SP+  S +   L
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 263
Query: 321 KKDAEARPTADQLLSHPFITK 341
            K  + R T+ Q L H +  K
Sbjct: 264 TKSPKQRITSLQALEHEWFEK 284

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 134/304 (44%), Gaps = 42/304 (13%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTE 128
           KT        +    +GSGA   V  +  + +   IA+KK++     I   ++  + L  
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 129 IRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
           ++ +        L  F  A  + +   + +    M G  L +I++ QK + +  +  +  
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIY 161
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           ++L+GL Y+H    ++HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y
Sbjct: 162 QILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWY 217
Query: 249 MSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---------- 297
            +PE + N   Y+   DIWS+G  + E  TG   +  ++  +N + QI+           
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDH-INQLQQIMRLTGTPPASVI 276
Query: 298 ------------DPSPSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPF 338
                       +  P   ++NF+  F          ++  L  D + R TA + L+HP+
Sbjct: 277 SRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPY 336
Query: 339 ITKY 342
            ++Y
Sbjct: 337 FSQY 340

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 14/261 (5%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
             IG G+   V+ AV   T    A KKI  +  E  ++   EI  + ++  +  ++  + 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM-KSLDHPNIIRLYE 73
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            F   D+  I + +E   GG L + +  ++   E   + + K +L  ++Y H + ++ HR
Sbjct: 74  TF--EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL-NVAHR 130
Query: 207 DIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           D+KP N L  L   P    K+ DFG++A  +    M  T VGT  Y+SP+ +    Y   
Sbjct: 131 DLKPENFLF-LTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEG-LYGPE 187
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ--NFSPEFCSFVDDCL 320
            D WS G+ ++    G  P++A      +ML+I E     P +   N SP+  S +   L
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246
Query: 321 KKDAEARPTADQLLSHPFITK 341
            K  + R T+ Q L H +  K
Sbjct: 247 TKSPKQRITSLQALEHEWFEK 267

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L+ +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G+ + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  +   +  P L     ++ +G++Y+   ++ +HRD++ AN+
Sbjct: 83  IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANV 141
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I    ++  +D+WS G+
Sbjct: 142 LVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGCFTIKSDVWSFGI 199
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
            L+E  T G+ PY    G  N  ++  L      P  +N   E    +  C K+ AE RP
Sbjct: 200 LLYEIVTYGKIPYP---GRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKAEERP 256
Query: 329 TADQLLS 335
           T D L S
Sbjct: 257 TFDYLQS 263

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 39  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 96
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 97  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 152
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 153 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 210
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 211 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 270
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 271 LIRNLLKTEPTQRMTITEFMNHPWIMQ 297

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 40/291 (13%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEG 140
              +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        
Sbjct: 37  LAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           L  F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H  
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA 154
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SY 259
             ++HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y
Sbjct: 155 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHY 210
Query: 260 SYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF-- 308
           +   DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+  
Sbjct: 211 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 270
Query: 309 -----------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                            +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 271 SLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIR--TLCEAP 136
           R+   IG G  + V+ A HI T + +A+K   I +K + N     +L  E+R   +   P
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVK---IIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + +  EY  GG + D L       E    + F++++  + Y
Sbjct: 74  NIVKLFEV-----IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQY 128
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        + A F G   Y +PE  + 
Sbjct: 129 CHQ-KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA-FCGAPPYAAPELFQG 186
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           IGSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 151
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 208
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 96  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD-I 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 209
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 269
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 30  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 87
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 88  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 143
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 144 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 201
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 202 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 261
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 262 LIRNLLKTEPTQRMTITEFMNHPWIMQ 288

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 82
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 83  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 138
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 139 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 196
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 256
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 82
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 83  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 138
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 139 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 196
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 256
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAP 136
           R+   IG G  + V+ A HI T + +A++   I +K + N     +L  E+R +     P
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVR---IIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
               L E      +     + + +EY  GG + D L     + E    + F++++  + Y
Sbjct: 74  NIVKLFEV-----IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY 128
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
            H  + +VHRD+K  NLL++     KI DFG S        +   F G+  Y +PE  + 
Sbjct: 129 CHQ-KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL-DEFCGSPPYAAPELFQG 186
Query: 257 ESYSYP-ADIWSIGLALFECGTGEFPY 282
           + Y  P  D+WS+G+ L+   +G  P+
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 126
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 127 LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 182
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 183 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 240
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQ 327

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 80
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 81  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 136
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 137 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 194
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 254
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 75  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 132
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 133 LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 188
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 189 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 246
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 247 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 306
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 307 LIRNLLKTEPTQRMTITEFMNHPWIMQ 333

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 29  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 86
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 87  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 142
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 143 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 200
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 201 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 260
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 261 LIRNLLKTEPTQRMTITEFMNHPWIMQ 287

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 127/266 (47%), Gaps = 38/266 (14%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IGSG    V +A H    +   +K++  +  EK  +   E++ L +   +  +V ++G +
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAER---EVKALAKLD-HVNIVHYNGCW 73
Query: 149 ----YMPDSGQ----------ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQ 192
               Y P++            + I +E+ D G+L   +  R  + + + +   +F+++ +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE 252
           G+ Y+H  + L++RD+KP+N+ +    + KI DFG+   L+N      +  GT+ YMSPE
Sbjct: 134 GVDYIHS-KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS-KGTLRYMSPE 191
Query: 253 RIRNESYSYPADIWSIGLALFE----CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           +I ++ Y    D++++GL L E    C T    +  S+   +L   I+ D         F
Sbjct: 192 QISSQDYGKEVDLYALGLILAELLHVCDTA---FETSKFFTDLRDGIISDI--------F 240
Query: 309 SPEFCSFVDDCLKKDAEARPTADQLL 334
             +  + +   L K  E RP   ++L
Sbjct: 241 DKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 96  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 209
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 24  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 81
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 82  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 137
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 138 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 195
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 196 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 255
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 256 LIRNLLKTEPTQRMTITEFMNHPWIMQ 282

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HR+++ AN+
Sbjct: 78  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRNLRAANI 136
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I   +++  +D+WS G+
Sbjct: 137 LVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGI 194
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY     P   ++Q LE         N   E    +  C K+  E RPT
Sbjct: 195 LLTEIVTHGRIPYPGMTNPE--VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 252
Query: 330 ADQLLS 335
            D L S
Sbjct: 253 FDYLRS 258

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 31  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 88
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 89  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 144
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 145 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 202
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 203 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 262
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 263 LIRNLLKTEPTQRMTITEFMNHPWIMQ 289

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 205
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH +  + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 123/268 (45%), Gaps = 27/268 (10%)
Query: 83  MRIFGAIGSGA-SSVVQRAVHIPTHRIIALK----KINIFEKEKRNQLLTEIRTLCEAPC 137
           ++I   IG+G    V    + +P  R +A+     K+   EK++R+        LCEA  
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD-------FLCEASI 97
Query: 138 -----NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLL 191
                +  +V   G   +     + I +E+M+ G+L   LR        I L  M + + 
Sbjct: 98  MGQFDHPNVVHLEGV--VTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIA 155
Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTY 248
            G+ YL  + + VHRD+   N+LVN     K++DFG+S  +E+      T  G    V +
Sbjct: 156 AGMRYLADMGY-VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW 214
Query: 249 MSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN 307
            +PE I+   ++  +D+WS G+ ++E  + GE PY         +++ +E+    P+  +
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEEGYRLPAPMD 272
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   + DC +K+   RP  +Q++ 
Sbjct: 273 CPAGLHQLMLDCWQKERAERPKFEQIVG 300

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 142
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 199
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 259
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 114/260 (43%), Gaps = 9/260 (3%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I   +G+GA  VV R     T    A K +    +  +  +  EI+T+     +  LV  
Sbjct: 55  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS-VLRHPTLVNL 113
Query: 145 HGAFYMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           H AF   D  ++ +  E+M GG L + +      + E       +++ +GL ++H   + 
Sbjct: 114 HDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNY 170
Query: 204 VHRDIKPANLLVNLK--GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           VH D+KP N++   K     K+ DFG++A L+   ++  T  GT  + +PE    +   Y
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGY 229
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLM-LQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             D+WS+G+  +   +G  P+        L  ++  +      +    S +   F+   L
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 289
Query: 321 KKDAEARPTADQLLSHPFIT 340
             D   R T  Q L HP++T
Sbjct: 290 LADPNTRMTIHQALEHPWLT 309

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 110 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 166
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 223
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 283
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 109 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 165
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 222
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 282
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L+ +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G+ + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLT 127
           KTY   +H       +GSGA   V  A+   +   +A+KK++      IF K    +LL 
Sbjct: 24  KTYVSPTH-------VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 76
Query: 128 EIRTLCEAPCNEGLVE-FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSM 186
                 E     GL++ F  A  + +     + + +M    L  I+ ++ S  E  +  +
Sbjct: 77  LKHMQHENVI--GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQYL 131
Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV 246
             ++L+GL Y+H    +VHRD+KP NL VN     KI DFG++    ++ A    +V T 
Sbjct: 132 VYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTR 187
Query: 247 TYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEG-------------PVNLM 292
            Y +PE I +   Y+   DIWS+G  + E  TG+  +   +              P    
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 293 LQILEDPS--------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHP 337
           +Q L D +        P   R++F       SP+    ++  L+ D + R TA Q L+HP
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 338 FI 339
           F 
Sbjct: 308 FF 309

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 88  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 146
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 147 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 205
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 206 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 259 PKKRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 88  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 146
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 147 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 205
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 206 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 259 PKKRMTIQDSLQHPWI 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH +  + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           + + LE + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIML 147
Query: 216 ---NL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
              N+ K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+ 
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKD 323
            +   +G  P+        L        + S     F  E+ S        F+   L KD
Sbjct: 207 TYILLSGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 324 AEARPTADQLLSHPFI 339
            + R T    L HP+I
Sbjct: 260 PKKRMTIQDSLQHPWI 275

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 101 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 157
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 214
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 158 IALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E+ D G+L   +  R  + + + +   +F+++ +G+ Y+H  + L+HRD+KP+N+ +
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS-KKLIHRDLKPSNIFL 169
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE- 274
               + KI DFG+   L+N      +  GT+ YMSPE+I ++ Y    D++++GL L E 
Sbjct: 170 VDTKQVKIGDFGLVTSLKNDGKRTRS-KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 275 ---CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTAD 331
              C T    +  S+   +L   I+ D         F  +  + +   L K  E RP   
Sbjct: 229 LHVCDTA---FETSKFFTDLRDGIISDI--------FDKKEKTLLQKLLSKKPEDRPNTS 277
Query: 332 QLL 334
           ++L
Sbjct: 278 EIL 280

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 151
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 208
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 21/258 (8%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRII--ALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLV 142
           FG + SG        + +P+ + I  A+K + + + +++R   L E   + +   +  ++
Sbjct: 29  FGEVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 80
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVR 201
              G   +  S  + I  E M+ GSL   LR   +    I L  M + +  G+ YL  + 
Sbjct: 81  RLEGV--VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNES 258
           + VHRD+   N+L+N     K++DFG+S  LE+      T  G    + + SPE I    
Sbjct: 139 Y-VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           ++  +D+WS G+ L+E  + GE PY   E     +++ +++    P   +        + 
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLML 255
Query: 318 DCLKKDAEARPTADQLLS 335
           DC +KD   RP  +Q++S
Sbjct: 256 DCWQKDRNNRPKFEQIVS 273

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNAMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 77  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 135 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 191
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 242
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 243 CLALRPSDRPTFEEIQNHPWM 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  E M+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEXMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  + + VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 76  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 134 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 190
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 241
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 242 CLALRPSDRPTFEEIQNHPWM 262

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 101 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 157
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 214
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 114/260 (43%), Gaps = 9/260 (3%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           I   +G+GA  VV R     T    A K +    +  +  +  EI+T+     +  LV  
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS-VLRHPTLVNL 219
Query: 145 HGAFYMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           H AF   D  ++ +  E+M GG L + +      + E       +++ +GL ++H   + 
Sbjct: 220 HDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNY 276
Query: 204 VHRDIKPANLLVNLK--GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           VH D+KP N++   K     K+ DFG++A L+   ++  T  GT  + +PE    +   Y
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGY 335
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLM-LQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             D+WS+G+  +   +G  P+        L  ++  +      +    S +   F+   L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 321 KKDAEARPTADQLLSHPFIT 340
             D   R T  Q L HP++T
Sbjct: 396 LADPNTRMTIHQALEHPWLT 415

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           G++     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H
Sbjct: 73  GVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 199 GVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
               ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR  
Sbjct: 131 NC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYH 187
Query: 258 SY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
            Y    A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLI 238
Query: 317 DDCLKKDAEARPTADQLLSHPFI 339
             CL      RPT +++ +HP++
Sbjct: 239 RWCLALRPSDRPTFEEIQNHPWM 261

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           G++     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H
Sbjct: 117 GVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 199 GVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
               ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR  
Sbjct: 175 NC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYH 231
Query: 258 SY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
            Y    A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLI 282
Query: 317 DDCLKKDAEARPTADQLLSHPFI 339
             CL      RPT +++ +HP++
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 20/263 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG   V +      ++ ++A+K I   EK  E   + +   R+L     +  +V F  
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR----HPNIVRFKE 81
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
               P    ++I +EY  GG L + +       E      F++L+ G+SY H ++ + HR
Sbjct: 82  VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHR 138
Query: 207 DIKPANLLVNLKGRP--KITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYS-Y 261
           D+K  N L++    P  KI DFG S   ++S+  +   + VGT  Y++PE +  + Y   
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNL---MLQILEDPSPSPSRQNFSPEFCSFVDD 318
            AD+WS G+ L+    G +P+   E P N    + +IL      P   + SPE    +  
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 319 CLKKDAEARPTADQLLSHPFITK 341
               D   R +  ++ +H +  K
Sbjct: 256 IFVADPAKRISIPEIRNHEWFLK 278

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 92  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 150 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 206
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 257
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 258 CLALRPSDRPTFEEIQNHPWM 278

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 77  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 135 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 191
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 242
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 243 CLALRPSDRPTFEEIQNHPWM 263

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 72  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 130 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 186
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSSECQHLIRW 237
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWM 258

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 102 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 158
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 215
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 102 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 158
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 215
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 102 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 158
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 215
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 34/284 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G    V +A +  TH I+ALK++ + + ++   +  L EI  L E   ++ +V  H 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHD 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
             +     ++++  E+ D             +   I+ S   +LL+GL + H  R+++HR
Sbjct: 69  VLH--SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHR 125
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPADI 265
           D+KP NLL+N  G  K+ +FG++      +   +  V T+ Y  P+ +     YS   D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 266 WSIGLALFE---CGTGEFPYAASEGPVNLMLQILEDPS--------------PSP----- 303
           WS G    E    G   FP    +  +  + ++L  P+              P P     
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 304 -SRQNFSPEFCS----FVDDCLKKDAEARPTADQLLSHPFITKY 342
            S  N  P+  +     + + LK +   R +A++ L HP+ + +
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 111 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 169 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 225
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 276
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 277 CLALRPSDRPTFEEIQNHPWM 297

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 97  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 153
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 210
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L  A  +E ++  +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL-AFRHENIIGINDI 91
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 148
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLS 268
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQY 318

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 96  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD-I 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 209
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 14/156 (8%)
Query: 186 MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCATFVG 244
            F +++  + + H  R +VHRDIK  N+L++L+ G  K+ DFG  A L +       F G
Sbjct: 144 FFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDG 200
Query: 245 TVTYMSPERI-RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP 303
           T  Y  PE I R++ ++ PA +WS+G+ L++   G+ P+   +       +ILE     P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAELHFP 253
Query: 304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           +  + SP+ C+ +  CL     +RP+ +++L  P++
Sbjct: 254 A--HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 50/295 (16%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKI------NIFEKEKRNQLLTEIRTLCEAPC 137
           R    +GSGA   V  AV   T   +A+KK+       +F K    +L      L +   
Sbjct: 28  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL-----RLLKHMR 82
Query: 138 NEGLVEFHGAFY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG 193
           +E ++     F     + D     + + +M G  L  +++ +K + E  +  +  ++L+G
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKG 140
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           L Y+H    ++HRD+KP NL VN     KI DFG++   ++ +      V T  Y +PE 
Sbjct: 141 LRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---XGXVVTRWYRAPEV 196
Query: 254 IRNE-SYSYPADIWSIGLALFECGTGEFPYAASEG--------------PVNLMLQILED 298
           I N   Y+   DIWS+G  + E  TG+  +  S+               P   + ++  D
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 299 PS-------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
            +       P   +++F       SP   + ++  L  DAE R TA + L+HP+ 
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 91  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 149 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 205
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 256
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 257 CLALRPSDRPTFEEIQNHPWM 277

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           G++     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H
Sbjct: 70  GVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 199 GVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
               ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR  
Sbjct: 128 NC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYH 184
Query: 258 SY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
            Y    A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLI 235
Query: 317 DDCLKKDAEARPTADQLLSHPFI 339
             CL      RPT +++ +HP++
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 151
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 208
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 95  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 151
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 208
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 105 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 163 G-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 219
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSSECQHLIRW 270
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 271 CLALRPSDRPTFEEIQNHPWM 291

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 89  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 145
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 202
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 203 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 262
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 263 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 87  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 143
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 200
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 260
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 92  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 150 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 206
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 257
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 258 CLALRPSDRPTFEEIQNHPWM 278

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 205
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 77  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 135 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 191
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 242
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 243 CLALRPSDRPTFEEIQNHPWM 263

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 113 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 169
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 226
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 205
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           G++     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H
Sbjct: 102 GVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 199 GVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
               ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR  
Sbjct: 160 NC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYH 216
Query: 258 SY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
            Y    A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLI 267
Query: 317 DDCLKKDAEARPTADQLLSHPFI 339
             CL      RPT +++ +HP++
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWM 290

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 96  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 209
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 113 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 169
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGYVATRWYRAPEIMLNWMHYNQT 226
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 105 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 163 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 219
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSSECQHLIRW 270
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 271 CLALRPSDRPTFEEIQNHPWM 291

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN----IFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IGSG   V +      T  ++A+K I     I E  +R   +   R+L     +  +V F
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE--IINHRSLR----HPNIVRF 81
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                 P    ++I +EY  GG L + +       E      F++LL G+SY H ++ + 
Sbjct: 82  KEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ-IC 138
Query: 205 HRDIKPANLLVNLKGRP--KITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYS 260
           HRD+K  N L++    P  KI DFG S   ++S+  +   + VGT  Y++PE +  + Y 
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 261 YP-ADIWSIGLALFECGTGEFPYAASEGPVNL---MLQILEDPSPSPSRQNFSPEFCSFV 316
              AD+WS G+ L+    G +P+   E P +    + +IL      P     SPE C  +
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255
Query: 317 DDCLKKDAEARPTADQLLSHPFITK 341
                 D   R +  ++ +H +  K
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFLK 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 119 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 177 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 233
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 284
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 285 CLALRPSDRPTFEEIQNHPWM 305

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKSQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG+    ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 109 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 165
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 222
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 282
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 104 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 162 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 218
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSSECQHLIRW 269
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 270 CLALRPSDRPTFEEIQNHPWM 290

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 91  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 149 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 205
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 256
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 257 CLALRPSDRPTFEEIQNHPWM 277

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 92  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 205
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 99  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 157 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 213
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 214 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 264
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 265 CLALRPSDRPTFEEIQNHPWM 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 105 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 163 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 219
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSXECQHLIRW 270
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 271 CLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 104 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 162 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 218
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSXECQHLIRW 269
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 270 CLALRPSDRPTFEEIQNHPWM 290

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 110 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 166
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 223
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 283
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 87  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 143
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 200
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 260
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 142
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 199
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 88  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 144
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 201
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 202 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 261
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 262 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 104 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 162 G-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 218
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSSECQHLIRW 269
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 270 CLALRPSDRPTFEEIQNHPWM 290

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 72  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 130 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 186
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 237
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWM 258

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 36/280 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +       ALKKI + EKE      T IR  ++ +   +  +V+ + 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK-KLLQGLSYLHGVRHLVH 205
             +     ++ +  E++D   L  +L + +   E + +  F  +LL G++Y H  R ++H
Sbjct: 68  VIHT--KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLH 123
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPAD 264
           RD+KP NLL+N +G  KI DFG++      +      V T+ Y +P+ +  ++ YS   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 265 IWSIGLALFEC--GTGEFPYAASEGPVNLMLQIL------------EDPSPSPSRQNFSP 310
           IWS+G    E   GT  FP  +    +  + +IL            E P   P+   + P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 311 ----EFCSFVDDC--------LKKDAEARPTADQLLSHPF 338
                F   +D+         LK D   R TA Q L H +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 92  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 150 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 206
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 257
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 258 CLALRPXDRPTFEEIQNHPWM 278

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 105 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 163 G-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 219
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFF---------RQRVSXECQHLIRW 270
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 271 CLALRPSDRPTFEEIQNHPWM 291

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 119 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 177 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 233
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 284
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 285 CLALRPSDRPTFEEIQNHPWM 305

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 24/272 (8%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRT 131
           S +      +GSGA   V  AV    ++ + +K I           E  K  ++  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALE-YMDGGSLADILRMQKSIPEPILSSMFKKL 190
           L     +  +++    F   + G   + +E +  G  L   +     + EP+ S +F++L
Sbjct: 83  LSRVE-HANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMS 250
           +  + YL  ++ ++HRDIK  N+++      K+ DFG +A LE    +  TF GT+ Y +
Sbjct: 140 VSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCA 197
Query: 251 PERIRNESYSYPA-DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
           PE +    Y  P  ++WS+G+ L+     E P+   E  V   +               S
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH---------PPYLVS 248
Query: 310 PEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            E  S V   L+   E R T ++L++ P++T+
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L+ +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E+M  GSL D L+  +   +P+  L     ++ +G++++   R+ +HRD++ AN+
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANI 309
Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALF 273
           LV+     KI DFG++        + A F   + + +PE I   S++  +D+WS G+ L 
Sbjct: 310 LVSASLVCKIADFGLA-------RVGAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLM 360
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E  T G  PY     P   +++ LE     P  +N   E  + +  C K   E RPT + 
Sbjct: 361 EIVTYGRIPYPGMSNPE--VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 418
Query: 333 LLS 335
           + S
Sbjct: 419 IQS 421

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 24/261 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-------GL 141
           +GSG    V   + +  +  +A+K +         +L    R   E    +       G+
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 142 VEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 124 IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L++++     F GT  Y  PE IR   Y
Sbjct: 182 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRY 238
Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 239 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSXECQHLIRW 289
Query: 319 CLKKDAEARPTADQLLSHPFI 339
           CL      RPT +++ +HP++
Sbjct: 290 CLALRPSDRPTFEEIQNHPWM 310

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 18/262 (6%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG+G   V +       + ++A+K I   EK  E   + +   R+L     +  +V F  
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR----HPNIVRFKE 82
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
               P    ++I +EY  GG L + +       E      F++L+ G+SY H ++ + HR
Sbjct: 83  VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ-VAHR 139
Query: 207 DIKPANLLVNLKGRP--KITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYS-YP 262
           D+K  N L++    P  KI DFG S A + +S    A  VGT  Y++PE +  + Y    
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTPAYIAPEVLLKKEYDGKV 197
Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNL---MLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           AD+WS G+ L+    G +P+   E P N    + +IL      P   + SPE    +   
Sbjct: 198 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRI 257
Query: 320 LKKDAEARPTADQLLSHPFITK 341
              D   R +  ++ +H +  K
Sbjct: 258 FVADPAKRISIPEIRNHEWFLK 279

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 122/257 (47%), Gaps = 15/257 (5%)
Query: 88  AIGSGA-SSVVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVE 143
            IG+G    V    + +P  R   +A+K + + + +++R   L E   + +   +  ++ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIH 87
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRH 202
             G   +  S  + I  EYM+ GSL   L+        I L  M + +  G+ YL  + +
Sbjct: 88  LEGV--VTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY 145
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG---TVTYMSPERIRNESY 259
            VHRD+   N+L+N     K++DFG+S  LE+      T  G    + + +PE I    +
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 260 SYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
           +  +D+WS G+ ++E  + GE PY   E     +++ +E+    PS  +        + D
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERPYW--EMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLD 262
Query: 319 CLKKDAEARPTADQLLS 335
           C +K+  +RP  D++++
Sbjct: 263 CWQKERNSRPKFDEIVN 279

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
            +G G+   V+ A H  T + +ALK I+  + +K   +  +    +  +   +  +++ +
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH-LV 204
                P    I + +EY  GG L D +  +K + E      F++++  + Y H  RH +V
Sbjct: 76  DVITTPTD--IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH--RHKIV 130
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP-A 263
           HRD+KP NLL++     KI DFG+S  + +      T  G+  Y +PE I  + Y+ P  
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 264 DIWSIGLALFECGTGEFPY 282
           D+WS G+ L+    G  P+
Sbjct: 190 DVWSCGIVLYVMLVGRLPF 208

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L  A  +E ++  +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL-AFRHENIIGINDI 91
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 148
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 268
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQY 318

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF+ PD  ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +V+R
Sbjct: 259 AFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYR 315
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPADI 265
           D+KPAN+L++  G  +I+D G++          +  VGT  YM+PE + +  +Y   AD 
Sbjct: 316 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADW 373
Query: 266 WSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           +S+G  LF+   G  P+       +  ++ M   +    P     +FSPE  S ++  L+
Sbjct: 374 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQ 429
Query: 322 KDAEAR 327
           +D   R
Sbjct: 430 RDVNRR 435

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 21/267 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 80
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 81  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 136
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++      T  Y++PE +  E Y
Sbjct: 137 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSLTEPCY-TPYYVAPEVLGPEKY 194
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 254
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF+ PD  ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +V+R
Sbjct: 260 AFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYR 316
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPADI 265
           D+KPAN+L++  G  +I+D G++          +  VGT  YM+PE + +  +Y   AD 
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADW 374
Query: 266 WSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           +S+G  LF+   G  P+       +  ++ M   +    P     +FSPE  S ++  L+
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQ 430
Query: 322 KDAEAR 327
           +D   R
Sbjct: 431 RDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF+ PD  ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +V+R
Sbjct: 260 AFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYR 316
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPADI 265
           D+KPAN+L++  G  +I+D G++          +  VGT  YM+PE + +  +Y   AD 
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADW 374
Query: 266 WSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           +S+G  LF+   G  P+       +  ++ M   +    P     +FSPE  S ++  L+
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQ 430
Query: 322 KDAEAR 327
           +D   R
Sbjct: 431 RDVNRR 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           AF+ PD  ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +V+R
Sbjct: 260 AFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYR 316
Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPADI 265
           D+KPAN+L++  G  +I+D G++          +  VGT  YM+PE + +  +Y   AD 
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADW 374
Query: 266 WSIGLALFECGTGEFPY----AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           +S+G  LF+   G  P+       +  ++ M   +    P     +FSPE  S ++  L+
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQ 430
Query: 322 KDAEAR 327
           +D   R
Sbjct: 431 RDVNRR 436

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 20/263 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN--QLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG   V +      ++ ++A+K I   EK   N  + +   R+L     +  +V F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLR----HPNIVRFKE 82
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
               P    ++I +EY  GG L + +       E      F++L+ G+SY H ++ + HR
Sbjct: 83  VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHR 139
Query: 207 DIKPANLLVNLKGRP--KITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYS-Y 261
           D+K  N L++    P  KI DFG S   ++S+  +   + VGT  Y++PE +  + Y   
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNL---MLQILEDPSPSPSRQNFSPEFCSFVDD 318
            AD+WS G+ L+    G +P+   E P N    + +IL      P   + SPE    +  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 319 CLKKDAEARPTADQLLSHPFITK 341
               D   R +  ++ +H +  K
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLK 279

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 36/280 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +       ALKKI + EKE      T IR  ++ +   +  +V+ + 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK-KLLQGLSYLHGVRHLVH 205
             +     ++ +  E++D   L  +L + +   E + +  F  +LL G++Y H  R ++H
Sbjct: 68  VIHT--KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLH 123
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPAD 264
           RD+KP NLL+N +G  KI DFG++      +      + T+ Y +P+ +  ++ YS   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 265 IWSIGLALFEC--GTGEFPYAASEGPVNLMLQIL------------EDPSPSPSRQNFSP 310
           IWS+G    E   GT  FP  +    +  + +IL            E P   P+   + P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 311 ----EFCSFVDDC--------LKKDAEARPTADQLLSHPF 338
                F   +D+         LK D   R TA Q L H +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 143/320 (44%), Gaps = 46/320 (14%)
Query: 89  IGSGASSVVQRAV-HIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNE--GLVEF 144
           IG GA  +V  A  H+   R+ A+KKI+ FE +   Q  L EI+ L         G+ + 
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRV-AIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
             A  +     + I  + M+   L  +L+ Q+   + I   +++ +L+GL Y+H   +++
Sbjct: 110 LRASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHICYFLYQ-ILRGLKYIHSA-NVL 166
Query: 205 HRDIKPANLLVNLKGRPKITDFG---ISAGLENSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG   I+    +        V T  Y +PE + N + Y+
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQS 286
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY-----EHAKV 347
            PS ++  ++  F          +D  L  +   R T ++ L+HP++ +Y     E    
Sbjct: 287 LPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAE 346
Query: 348 DLAAFVRSVFD-PMQRMKDL 366
           +   F   + D P +R+K+L
Sbjct: 347 EPFTFAMELDDLPKERLKEL 366

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 109 IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K + + + +++R   L E   + +   +  ++   G   +  S  + I  E M+ GS
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV--VTKSKPVMIVTEXMENGS 132
Query: 168 LADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF 226
           L   LR   +    I L  M + +  G+ YL  +   VHRD+   N+L+N     K++DF
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-GAVHRDLAARNILINSNLVCKVSDF 191
Query: 227 GISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           G+S  LE+      T  G    + + SPE I    ++  +D+WS G+ L+E  + GE PY
Sbjct: 192 GLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              E     +++ +++    P   +        + DC +KD   RP  +Q++S
Sbjct: 252 W--EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 97  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 153
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++    + +     +V T  Y +PE + N   Y+  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGYVATRWYRAPEIMLNWMHYNQT 210
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFR-HENIIGINDI 93
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 150
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L+ +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 97  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 153
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++    + +     +V T  Y +PE + N   Y+  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGYVATRWYRAPEIMLNWMHYNQT 210
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI D+G++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 124/274 (45%), Gaps = 32/274 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G G   VV  A +       A+K+I +  +E  R +++ E++ L +   + G+V +  A
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNA 71
Query: 148 FYMPDSGQ----------ISIALEYMDGGSLADILRMQKSIPE---PILSSMFKKLLQGL 194
           +   ++ +          + I ++     +L D +  + +I E    +   +F ++ + +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN------------SIAMCATF 242
            +LH  + L+HRD+KP+N+   +    K+ DFG+   ++             + A     
Sbjct: 132 EFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 243 VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS 302
           VGT  YMSPE+I   SYS+  DI+S+GL LFE     +P++     V  +  +     P 
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPP 247
Query: 303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              Q +  E+   V D L      RP A  ++ +
Sbjct: 248 LFTQKYPCEYV-MVQDMLSPSPMERPEAINIIEN 280

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 97  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 153
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++    + +     +V T  Y +PE + N   Y+  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGYVATRWYRAPEIMLNWMHYNQT 210
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G  + V +     T  ++ALK+I +  +E      T IR  +L +   +  +V  H 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 147 AFYMPDSGQISIALEYMDGG------SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
             +   S  +++  EY+D           +I+ M        +     +LL+GL+Y H  
Sbjct: 68  IIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLFQLLRGLAYCHRQ 119
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-Y 259
           + ++HRD+KP NLL+N +G  K+ DFG++             V T+ Y  P+ +   + Y
Sbjct: 120 K-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 260 SYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS 300
           S   D+W +G   +E  TG   FP +  E  ++ + +IL  P+
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDI 89
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 146
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLS 266
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 89
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 146
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 266
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 110 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 166
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +      V T  Y +PE + N   Y+  
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVATRWYRAPEIMLNWMHYNQT 223
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 283
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 89
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 146
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLS 266
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 68/133 (51%), Gaps = 5/133 (3%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV-HRDIKPANLLVN 216
           + +EY+ GG L D +     + E     +F+++L  + Y H  RH+V HRD+KP N+L++
Sbjct: 88  MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLD 145
Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP-ADIWSIGLALFEC 275
                KI DFG+S  + +      T  G+  Y +PE I    Y+ P  DIWS G+ L+  
Sbjct: 146 AHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 276 GTGEFPYAASEGP 288
             G  P+     P
Sbjct: 205 LCGTLPFDDEHVP 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L+ +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 36/280 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           IG G   VV +A +       ALKKI + EKE      T IR  ++ +   +  +V+ + 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK-KLLQGLSYLHGVRHLVH 205
             +     ++ +  E++D   L  +L + +   E + +  F  +LL G++Y H  R ++H
Sbjct: 68  VIHT--KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLH 123
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPAD 264
           RD+KP NLL+N +G  KI DFG++      +      V T+ Y +P+ +  ++ YS   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 265 IWSIGLALFECGTGE--FPYAASEGPVNLMLQIL------------EDPSPSPSRQNFSP 310
           IWS+G    E   G   FP  +    +  + +IL            E P   P+   + P
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 311 ----EFCSFVDDC--------LKKDAEARPTADQLLSHPF 338
                F   +D+         LK D   R TA Q L H +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 91
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 148
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 268
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 269 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 318

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
             D     +  E+ +GG L + +  +    E   +++ K++L G+ YLH   ++VHRDIK
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-HNIVHRDIK 173
Query: 210 PANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           P N+L+  K      KI DFG+S+       +    +GT  Y++PE ++ + Y+   D+W
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKL-RDRLGTAYYIAPEVLK-KKYNEKCDVW 231
Query: 267 SIGLALF--ECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSFVDDCLKK 322
           S G+ ++   CG   +P    +   +++ ++ +          +N S E    +   L  
Sbjct: 232 SCGVIMYILLCG---YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTY 288
Query: 323 DAEARPTADQLLSHPFITKY 342
           D   R TA++ L+  +I KY
Sbjct: 289 DYNKRCTAEEALNSRWIKKY 308

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 21/191 (10%)
Query: 161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NL 217
           E + GG L D L  ++S+ E   +   K++L G+ YLH ++ + H D+KP N+++   N+
Sbjct: 94  ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNV 152
Query: 218 -KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECG 276
            K R KI DFG++  ++        F GT  +++PE +  E     AD+WSIG+  +   
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 277 TGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS--------FVDDCLKKDAEARP 328
           +G  P+        L        + S     F  E+ S        F+   L KD + R 
Sbjct: 212 SGASPFLGDTKQETL-------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264
Query: 329 TADQLLSHPFI 339
           T    L HP+I
Sbjct: 265 TIQDSLQHPWI 275

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 93
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 150
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 97
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 98  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 154
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 215 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 274
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 275 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 324

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 89
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 146
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 266
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 89
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 146
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 266
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 267 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++  K + +  +  +  ++L+GL Y+H    +
Sbjct: 86  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSA-DI 142
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 199
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 259
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 109
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 110 IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 166
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 286
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 287 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  E+M  GSL D L+  +   +  P L     ++ +G++Y+   ++ +HRD++ AN+
Sbjct: 82  IYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANV 140
Query: 214 LVNLKGRPKITDFGISAGLENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++       A F   + + +PE I    ++  +++WS G+
Sbjct: 141 LVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGCFTIKSNVWSFGI 198
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
            L+E  T G+ PY    G  N  ++  L      P  +N   E    +  C K+ AE RP
Sbjct: 199 LLYEIVTYGKIPYP---GRTNADVMSALSQGYRMPRMENCPDELYDIMKMCWKEKAEERP 255
Query: 329 TADQLLS 335
           T D L S
Sbjct: 256 TFDYLQS 262

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DFG++   ++ +      V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 94
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 95  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 151
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 211
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 271
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 272 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 321

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 95
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 96  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 152
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 212
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 213 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 272
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 273 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 322

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 86
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 87  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 143
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 203
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 204 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 263
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 264 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 93
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 150
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 87
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 88  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 144
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 264
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 265 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 314

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 75
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 73
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 76
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 69
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 101
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 93
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKCQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 150
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 70
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 77
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 68
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 74
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 70
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 70
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I +EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 204 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 257 EERPTFEYL 265

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 124/266 (46%), Gaps = 21/266 (7%)
Query: 83  MRIFGAIGSGA-SSVVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCN 138
           ++I   IG+G    V    + +P  R   +A+K +   + +++R   L+E   + +   +
Sbjct: 35  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-H 93
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
             ++   G   +  S  + I  E+M+ GSL   LR        I L  M + +  G+ YL
Sbjct: 94  PNVIHLEGV--VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 151
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA---MCATFVGT--VTYMSPE 252
             + + VHRD+   N+LVN     K++DFG+S  LE+  +     +   G   + + +PE
Sbjct: 152 ADMNY-VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPY--AASEGPVNLMLQILEDPSPSPSRQNFS 309
            I+   ++  +D+WS G+ ++E  + GE PY    ++  +N + Q    P P     +  
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP----MDCP 266
Query: 310 PEFCSFVDDCLKKDAEARPTADQLLS 335
                 + DC +KD   RP   Q+++
Sbjct: 267 SALHQLMLDCWQKDRNHRPKFGQIVN 292

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 25/191 (13%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I +EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED-------PSPSPSRQNFSPEFCSFVDDCLKK 322
            L E  T G  PY    G VN   ++L+        P P    ++     C     C +K
Sbjct: 204 LLTELTTKGRVPYP---GMVN--REVLDQVERGYRMPCPPECPESLHDLMCQ----CWRK 254
Query: 323 DAEARPTADQL 333
           D E RPT + L
Sbjct: 255 DPEERPTFEYL 265

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L+ +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 88
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI DF ++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 88
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A++KI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 93
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 150
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 126/299 (42%), Gaps = 37/299 (12%)
Query: 72  SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEI 129
           +E  Y  +  +    G +G G+  +V +  +  T RI+A+KK    + +K  +   + EI
Sbjct: 16  TENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI 75
Query: 130 RTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK 189
           + L +   +E LV            +  +  E++D   L D+      +   ++     +
Sbjct: 76  KLLKQLR-HENLVNLLEV--CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM 249
           ++ G+ + H   +++HRDIKP N+LV+  G  K+ DFG +  L     +    V T  Y 
Sbjct: 133 IINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 250 SPERIRNE-SYSYPADIWSIGLALFECGTGE--FPYAA---------------------- 284
           +PE +  +  Y    D+W+IG  + E   GE  FP  +                      
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 285 -SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD----CLKKDAEARPTADQLLSHPF 338
            ++ PV   +++ E     P  + + P+    V D    CL  D + RP   +LL H F
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 118/257 (45%), Gaps = 18/257 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V  A    +H I+ALK   K  I ++   +QL  EI        +  ++  +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL-HHPNILRLY 89
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             FY  D  +I + LEY   G L   L+   +  E   +++ ++L   L Y HG + ++H
Sbjct: 90  NYFY--DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG-KKVIH 146
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIKP NLL+ LKG  KI DFG S    +      T  GT+ Y+ PE I    ++   D+
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWSVHAPS--LRRKTMCGTLDYLPPEMIEGRMHNEKVDL 204
Query: 266 WSIGLALFECGTGEFPYAAS---EGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           W IG+  +E   G  P+ ++   E    ++   L+ P+  P+           +   L+ 
Sbjct: 205 WCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQ------DLISKLLRH 258
Query: 323 DAEARPTADQLLSHPFI 339
           +   R    Q+ +HP++
Sbjct: 259 NPSERLPLAQVSAHPWV 275

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 2/175 (1%)
Query: 154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           GQ+ +    ++G  LA  LR Q  +  P   ++ +++              HRD+KP N+
Sbjct: 107 GQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI-GSALDAAHAAGATHRDVKPENI 165
Query: 214 LVNLKGRPKITDFGI-SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
           LV+      + DFGI SA  +  +      VGT+ Y +PER      +Y ADI+++   L
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVL 225
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +EC TG  PY   +  V         P PS  R      F + +     K+ E R
Sbjct: 226 YECLTGSPPYQGDQLSVXGAHINQAIPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI  FG++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  PSP       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 119/263 (45%), Gaps = 20/263 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG   V +      ++ ++A+K I   EK  E   + +   R+L     +  +V F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR----HPNIVRFKE 82
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
               P    ++I +EY  GG L + +       E      F++L+ G+SY H ++ + HR
Sbjct: 83  VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHR 139
Query: 207 DIKPANLLVNLKGRP--KITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYS-Y 261
           D+K  N L++    P  KI  FG S   ++S+  +   + VGT  Y++PE +  + Y   
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYS---KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNL---MLQILEDPSPSPSRQNFSPEFCSFVDD 318
            AD+WS G+ L+    G +P+   E P N    + +IL      P   + SPE    +  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 319 CLKKDAEARPTADQLLSHPFITK 341
               D   R +  ++ +H +  K
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLK 279

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 127/283 (44%), Gaps = 34/283 (12%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA + VQ  +++ T +  A+K I       R+++  E+  L +   +  ++E    
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           F   D  +  +  E M GGS+   +  ++   E   S + + +   L +LH  + + HRD
Sbjct: 80  FEEED--RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRD 136
Query: 208 IKPANLLV---NLKGRPKITDFGISAGLE-------NSIAMCATFVGTVTYMSPERIRNE 257
           +KP N+L    N     KI DFG+ +G++        S     T  G+  YM+PE +   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 258 S-----YSYPADIWSIGLALFECGTGEFPYAASEGP-------------VNLMLQILEDP 299
           S     Y    D+WS+G+ L+   +G  P+    G               N++ + +++ 
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 300 SPSPSRQNFSPEFCS---FVDDCLKKDAEARPTADQLLSHPFI 339
                 ++++   C+    +   L +DA+ R +A Q+L HP++
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 90  GSGASSVVQRAVHIPTHRIIALKK----INIFEKEKRNQLLTEIRTLCEAPC-NEGLVEF 144
           G G   VV +      +  +A+KK    ++I  +E + Q   EI+    A C +E LVE 
Sbjct: 31  GEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKV--XAKCQHENLVEL 86
Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG----LSYLHGV 200
            G  +  D   + +   Y   GSL D L      P P+      K+ QG    +++LH  
Sbjct: 87  LG--FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP-PLSWHXRCKIAQGAANGINFLHEN 143
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNES 258
            H +HRDIK AN+L++     KI+DFG++   E        +  VGT  Y +PE +R E 
Sbjct: 144 HH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE- 201
Query: 259 YSYPADIWSIGLALFECGTG 278
            +  +DI+S G+ L E  TG
Sbjct: 202 ITPKSDIYSFGVVLLEIITG 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 79  ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           A+H++R+    G G+   V R     T    A+KK+ + E  +  +L+      C    +
Sbjct: 95  ATHQLRL----GRGSFGEVHRMEDKQTGFQCAVKKVRL-EVFRAEELMA-----CAGLTS 144
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             +V  +GA    +   ++I +E ++GGSL  +++ Q  +PE        + L+GL YLH
Sbjct: 145 PRIVPLYGAVR--EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLH 202
Query: 199 GVRHLVHRDIKPANLLVNLKG-RPKITDFGISA-----GLENSIAMCATFVGTVTYMSPE 252
             R ++H D+K  N+L++  G    + DFG +      GL  S+       GT T+M+PE
Sbjct: 203 S-RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAA-SEGPVNLMLQILEDPSP----SPSRQN 307
            +   S     D+WS    +     G  P+     GP  L L+I  +P P     PS   
Sbjct: 262 VVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP--LCLKIASEPPPVREIPPS--- 316
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQL 333
            +P     + + L+K+   R +A +L
Sbjct: 317 CAPLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 89  IGSGASS-VVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IGSG S  V    + +P  R   +A+K +   + + +R   L+E   + +   +  ++  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRL 115
Query: 145 HGAFYMPDSGQIS-IALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLHGV 200
            G       G+++ I  EYM+ GSL   LR    Q +I +  L  M + +  G+ YL  +
Sbjct: 116 EGVV---TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDL 170
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNE 257
            + VHRD+   N+LV+     K++DFG+S  LE+      T  G    + + +PE I   
Sbjct: 171 GY-VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 258 SYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           ++S  +D+WS G+ ++E    GE PY         ++  +E+    P+           +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRLPAPMGCPHALHQLM 287
Query: 317 DDCLKKDAEARPTADQLLS 335
            DC  KD   RP   Q++S
Sbjct: 288 LDCWHKDRAQRPRFSQIVS 306

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI D G++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 6/223 (2%)
Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRN 123
           D    S    R    +      +G G+   V  A    T  + A   LKK  + + +   
Sbjct: 5   DRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVE 64
Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPIL 183
             + E R L        L + H  F   D  ++   +EY++GG L   ++      EP  
Sbjct: 65  CTMVEKRVLALLDKPPFLTQLHSCFQTVD--RLYFVMEYVNGGDLMYHIQQVGKFKEPQA 122
Query: 184 SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV 243
                ++  GL +LH  R +++RD+K  N++++ +G  KI DFG+             F 
Sbjct: 123 VFYAAEISIGLFFLHK-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC 181
Query: 244 GTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE 286
           GT  Y++PE I  + Y    D W+ G+ L+E   G+ P+   +
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 224

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 30/287 (10%)
Query: 74  KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL--LTEIRT 131
           K  R    +  I   IG GA S V       T ++ A+K +N ++  KR ++    E R 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKL 190
           +        + + H AF   D   + + +EY  GG L  +L +  + IP  +      ++
Sbjct: 114 VLVNGDRRWITQLHFAF--QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYM 249
           +  +  +H + + VHRDIKP N+L++  G  ++ DFG    L  +        VGT  Y+
Sbjct: 172 VMAIDSVHRLGY-VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 250 SPERIRNESYSY-------PADIWSIGLALFECGTGEFPY-----AASEGPV-----NLM 292
           SPE ++               D W++G+  +E   G+ P+     A + G +     +L 
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290
Query: 293 LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           L ++++  P  +R       C        +    R  A    +HPF 
Sbjct: 291 LPLVDEGVPEEARDFIQRLLCP------PETRLGRGGAGDFRTHPFF 331

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+    +++  P L  M  ++  G++Y+  + + +HRD++ AN+
Sbjct: 78  IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY-IHRDLRSANI 136
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      KI DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 137 LVGNGLICKIADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 194
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L E  T G  PY         +L+ +E     P  Q+        +  C KKD E RPT
Sbjct: 195 LLTELVTKGRVPYPGMNN--REVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPT 252
Query: 330 ADQLLSHPFITKY 342
            + L S  F+  Y
Sbjct: 253 FEYLQS--FLEDY 263

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 204 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 257 EERPTFEYL 265

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI D G++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 87
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 88  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 144
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +       +V T  Y +PE + N + Y+
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  P                   
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLS 264
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 265 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 314

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 204 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 257 EERPTFEYL 265

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 204 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 257 EERPTFEYL 265

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 78  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 136
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 137 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 194
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 195 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 247
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 248 EERPTFEYL 256

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 29/266 (10%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFH 145
            +G G      +  H  T  ++ +K++  F++E +   L E++ +   E P    +++F 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP---NVLKFI 73
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G  Y     +++   EY+ GG+L  I++ M    P     S  K +  G++YLH + +++
Sbjct: 74  GVLY--KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM-NII 130
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA--------------TFVGTVTYMS 250
           HRD+   N LV       + DFG++  + +                    T VG   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 251 PERIRNESYSYPADIWSIGLALFEC---GTGEFPYAASEGPVNLMLQILEDPSPSPSRQN 307
           PE I   SY    D++S G+ L E       +  Y        L ++   D    P   N
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP---N 247
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQL 333
             P F      C   D E RP+  +L
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKL 273

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 25/191 (13%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 76  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 134
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 135 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 192
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED-------PSPSPSRQNFSPEFCSFVDDCLKK 322
            L E  T G  PY    G VN   ++L+        P P    ++     C     C +K
Sbjct: 193 LLTELTTKGRVPYP---GMVN--REVLDQVERGYRMPCPPECPESLHDLMCQ----CWRK 243
Query: 323 DAEARPTADQL 333
           D E RPT + L
Sbjct: 244 DPEERPTFEYL 254

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+K++     +++     EI+ L +A  +
Sbjct: 9   LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHS 67
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYL 197
           + +V++ G  Y P   ++ + +EY+  G L D L R +  +    L     ++ +G+ YL
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 127
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G R  VHRD+   N+LV  +   KI DFG++  L   ++   +       + + +PE +
Sbjct: 128 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 255 RNESYSYPADIWSIGLALFECGT 277
            +  +S  +D+WS G+ L+E  T
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 94  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 149
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   FV T  Y +PE I    Y    
Sbjct: 150 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-VPFVVTRYYRAPEVILGMGYKENV 208
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  P P       P+ + +    P++
Sbjct: 209 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 268
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 269 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 326

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A    T   +A+KK++     I   ++  + L  ++ +        L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + +   + +    M G  L +I++ QK + +  +  +  ++L+GL Y+H    +
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-DI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+NL VN     KI D G++   ++ +     +V T  Y +PE + N   Y+  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQT 203
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP-------SPSRQNF----- 308
            DIWS+G  + E  TG   FP       + L+L+++  P         S S +N+     
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 309 --------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 66/136 (48%), Gaps = 7/136 (5%)
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
           Y  D  +I + LE+   G L   L+      E   ++  ++L   L Y H  R ++HRDI
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHRDI 140
Query: 209 KPANLLVNLKGRPKITDFG--ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           KP NLL+  KG  KI DFG  + A       MC    GT+ Y+ PE I  +++    D+W
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVDLW 196
Query: 267 SIGLALFECGTGEFPY 282
             G+  +E   G  P+
Sbjct: 197 CAGVLCYEFLVGMPPF 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 89  IGSGASS-VVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IGSG S  V    + +P  R   +A+K +   + + +R   L+E   + +   +  ++  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRL 115
Query: 145 HGAFYMPDSGQIS-IALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLHGV 200
            G       G+++ I  EYM+ GSL   LR    Q +I +  L  M + +  G+ YL  +
Sbjct: 116 EGVV---TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDL 170
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNE 257
            + VHRD+   N+LV+     K++DFG+S  LE+      T  G    + + +PE I   
Sbjct: 171 GY-VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 258 SYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           ++S  +D+WS G+ ++E    GE PY         ++  +E+    P+           +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRLPAPMGCPHALHQLM 287
Query: 317 DDCLKKDAEARPTADQLLS 335
            DC  KD   RP   Q++S
Sbjct: 288 LDCWHKDRAQRPRFSQIVS 306

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 254 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 312
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG+   +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 313 LVGENLVCKVADFGLGRLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 370
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 371 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 423
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 424 EERPTFEYL 432

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 5/133 (3%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV-HRDIKPANLLVN 216
           + +EY+ GG L D +     + E     +F+++L  + Y H  RH+V HRD+KP N+L++
Sbjct: 88  MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLD 145
Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP-ADIWSIGLALFEC 275
                KI DFG+S  + +         G+  Y +PE I    Y+ P  DIWS G+ L+  
Sbjct: 146 AHMNAKIADFGLSNMMSDG-EFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 276 GTGEFPYAASEGP 288
             G  P+     P
Sbjct: 205 LCGTLPFDDEHVP 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 66/136 (48%), Gaps = 7/136 (5%)
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
           Y  D  +I + LE+   G L   L+      E   ++  ++L   L Y H  R ++HRDI
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHRDI 141
Query: 209 KPANLLVNLKGRPKITDFG--ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           KP NLL+  KG  KI DFG  + A       MC    GT+ Y+ PE I  +++    D+W
Sbjct: 142 KPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVDLW 197
Query: 267 SIGLALFECGTGEFPY 282
             G+  +E   G  P+
Sbjct: 198 CAGVLCYEFLVGMPPF 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 20/263 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEK--EKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG   V +      ++ ++A+K I   EK  E   + +   R+L     +  +V F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR----HPNIVRFKE 82
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
               P    ++I +EY  GG L + +       E      F++L+ G+SY H ++ + HR
Sbjct: 83  VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHR 139
Query: 207 DIKPANLLVNLKGRP--KITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYS-Y 261
           D+K  N L++    P  KI  FG S   ++S+  +     VGT  Y++PE +  + Y   
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYS---KSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNL---MLQILEDPSPSPSRQNFSPEFCSFVDD 318
            AD+WS G+ L+    G +P+   E P N    + +IL      P   + SPE    +  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 319 CLKKDAEARPTADQLLSHPFITK 341
               D   R +  ++ +H +  K
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLK 279

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 73
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+   + I    L     ++ +G+ YL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 25/191 (13%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I +EYM  G L D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED-------PSPSPSRQNFSPEFCSFVDDCLKK 322
            L E  T G  PY    G VN   ++L+        P P    ++     C     C +K
Sbjct: 204 LLTELTTKGRVPYP---GMVN--REVLDQVERGYRMPCPPECPESLHDLMCQ----CWRK 254
Query: 323 DAEARPTADQL 333
           D E RPT + L
Sbjct: 255 DPEERPTFEYL 265

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 93
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 150
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +        V T  Y +PE + N + Y+
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGA 147
           IG GA  +V  A        +A+KKI+ FE +   Q  L EI+ L     +E ++  +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDI 94
Query: 148 FYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
              P   Q   + I  + M+   L  +L+ Q    + I   +++ +L+GL Y+H   +++
Sbjct: 95  IRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-ILRGLKYIHSA-NVL 151
Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLE---NSIAMCATFVGTVTYMSPERIRN-ESYS 260
           HRD+KP+NLL+N     KI DFG++   +   +        V T  Y +PE + N + Y+
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  L E  +    FP       +N +L IL  PS                  
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 271
Query: 301 -PSPSRQNFSPEF-------CSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P  ++  ++  F          +D  L  +   R   +Q L+HP++ +Y
Sbjct: 272 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M    V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV-TRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPSPS------PSRQNF---SPEF 312
           DIWS+G  + E  C    FP        N +++ L  P P+      P+ +N+    P++
Sbjct: 207 DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 71
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +EY+  GSL D L+  K   + I L     ++ +G+ YL
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HR++   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEG 140
           +I   +G G+   V+ A H  T + +ALK IN   + + + + ++  EI  L     +  
Sbjct: 17  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPH 75
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +++ +      D  +I + +EY  G  L D +  +  + E      F++++  + Y H  
Sbjct: 76  IIKLYDVIKSKD--EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 130
Query: 201 RH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
           RH +VHRD+KP NLL++     KI DFG+S  + +      T  G+  Y +PE I  + Y
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLY 189
Query: 260 SYP-ADIWSIGLALFECGTGEFPYAASEGPV 289
           + P  D+WS G+ L+       P+     PV
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPV 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+K++     +++     EI+ L +A  +
Sbjct: 12  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHS 70
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYL 197
           + +V++ G  Y P    + + +EY+  G L D L R +  +    L     ++ +G+ YL
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 130
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G R  VHRD+   N+LV  +   KI DFG++  L   ++   +       + + +PE +
Sbjct: 131 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 255 RNESYSYPADIWSIGLALFECGT 277
            +  +S  +D+WS G+ L+E  T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEG 140
           +I   +G G+   V+ A H  T + +ALK IN   + + + + ++  EI  L     +  
Sbjct: 7   QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPH 65
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +++ +      D  +I + +EY  G  L D +  +  + E      F++++  + Y H  
Sbjct: 66  IIKLYDVIKSKD--EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 120
Query: 201 RH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
           RH +VHRD+KP NLL++     KI DFG+S  + +      T  G+  Y +PE I  + Y
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLY 179
Query: 260 SYP-ADIWSIGLALFECGTGEFPYAASEGPV 289
           + P  D+WS G+ L+       P+     PV
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPV 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEG 140
           +I   +G G+   V+ A H  T + +ALK IN   + + + + ++  EI  L     +  
Sbjct: 16  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPH 74
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +++ +      D  +I + +EY  G  L D +  +  + E      F++++  + Y H  
Sbjct: 75  IIKLYDVIKSKD--EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 129
Query: 201 RH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
           RH +VHRD+KP NLL++     KI DFG+S  + +      T  G+  Y +PE I  + Y
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLY 188
Query: 260 SYP-ADIWSIGLALFECGTGEFPYAASEGPV 289
           + P  D+WS G+ L+       P+     PV
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 131/312 (41%), Gaps = 58/312 (18%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-- 137
           S + ++   +G GA  VV  A H PT  I+A+KKI  F+K      L  +RTL E     
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILK 64
Query: 138 ---NEGLVEFHGAFYMPDS----GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
              +E ++        PDS     ++ I  E M    L  ++  Q    + I   +++ L
Sbjct: 65  HFKHENIITIFN-IQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTL 122
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----------MCA 240
            + +  LHG  +++HRD+KP+NLL+N     K+ DFG++  ++ S A             
Sbjct: 123 -RAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 241 TFVGTVTYMSPE-RIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILE 297
            FV T  Y +PE  + +  YS   D+WS G  L E       FP       + L+  I+ 
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 298 DP----------SP--------------SPSRQNF---SPEFCSFVDDCLKKDAEARPTA 330
            P          SP              +P  + F   +P+    +   L  D   R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 331 DQLLSHPFITKY 342
            + L HP++  Y
Sbjct: 301 KEALEHPYLQTY 312

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+K++     +++     EI+ L +A  +
Sbjct: 13  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHS 71
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYL 197
           + +V++ G  Y P    + + +EY+  G L D L R +  +    L     ++ +G+ YL
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 131
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G R  VHRD+   N+LV  +   KI DFG++  L   ++   +       + + +PE +
Sbjct: 132 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 255 RNESYSYPADIWSIGLALFECGT 277
            +  +S  +D+WS G+ L+E  T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEG 140
           +I   +G G+   V+ A H  T + +ALK IN   + + + + ++  EI  L     +  
Sbjct: 11  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL-RLLRHPH 69
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +++ +      D  +I + +EY  G  L D +  +  + E      F++++  + Y H  
Sbjct: 70  IIKLYDVIKSKD--EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 124
Query: 201 RH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
           RH +VHRD+KP NLL++     KI DFG+S  + +      T  G+  Y +PE I  + Y
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLY 183
Query: 260 SYP-ADIWSIGLALFECGTGEFPYAASEGPV 289
           + P  D+WS G+ L+       P+     PV
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPV 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+K++     +++     EI+ L +A  +
Sbjct: 25  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHS 83
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYL 197
           + +V++ G  Y P    + + +EY+  G L D L R +  +    L     ++ +G+ YL
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G R  VHRD+   N+LV  +   KI DFG++  L   ++   +       + + +PE +
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 255 RNESYSYPADIWSIGLALFECGT 277
            +  +S  +D+WS G+ L+E  T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + +EY   G+L + LR ++            +PE  ++     
Sbjct: 103 IINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + +EY   G+L + LR ++            +PE  ++     
Sbjct: 103 IINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + +EY   G+L + LR ++            +PE  ++     
Sbjct: 103 IIHLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 21/297 (7%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 126
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I  E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 127 LY---AGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI-NI 182
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +    +  ++  T   T  Y++PE +  E Y
Sbjct: 183 AHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKY 240
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D WS+G+  +    G  P+ ++ G          ++  +   P+P     S E   
Sbjct: 241 DKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKX 300
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLADVST 371
            + + LK +   R T  +  +HP+I +            R + +  +R +D+ +  T
Sbjct: 301 LIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKERWEDVKEEXT 357

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 24/236 (10%)
Query: 119 KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-- 176
           +E  + L++E+  +     ++ ++   GA      G + + +EY   G+L + LR ++  
Sbjct: 81  EEDLSDLVSEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 177 ---------SIPEPILS-----SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
                     +PE  ++     S   +L +G+ YL   +  +HRD+   N+LV      K
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMK 197
Query: 223 ITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GE 279
           I DFG++  + N      T  G   V +M+PE + +  Y++ +D+WS G+ ++E  T G 
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 280 FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            PY     PV  + ++L++        N + E    + DC       RPT  QL+ 
Sbjct: 258 SPYPGI--PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 207
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  P P       P+ + +    P++
Sbjct: 208 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 267
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 268 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  P P       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 79  ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           A+H++R+    G G+   V R     T    A+KK+ + E  +  +L+      C    +
Sbjct: 76  ATHQLRL----GRGSFGEVHRMEDKQTGFQCAVKKVRL-EVFRAEELMA-----CAGLTS 125
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             +V  +GA    +   ++I +E ++GGSL  +++ Q  +PE        + L+GL YLH
Sbjct: 126 PRIVPLYGAVR--EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLH 183
Query: 199 GVRHLVHRDIKPANLLVNLKG-RPKITDFGISA-----GLENSIAMCATFVGTVTYMSPE 252
             R ++H D+K  N+L++  G    + DFG +      GL   +       GT T+M+PE
Sbjct: 184 S-RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAA-SEGPVNLMLQILEDPSP----SPSRQN 307
            +   S     D+WS    +     G  P+     GP  L L+I  +P P     PS   
Sbjct: 243 VVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP--LCLKIASEPPPVREIPPS--- 297
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQL 333
            +P     + + L+K+   R +A +L
Sbjct: 298 CAPLTAQAIQEGLRKEPIHRVSAAEL 323

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + +EY   G+L + LR ++            +PE  ++     
Sbjct: 103 IITLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + +EY   G+L + LR ++            +PE  ++     
Sbjct: 103 IINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+  M K +  P L  M  ++  G++Y+  + + VHRD+  AN+
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLAAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED-------PSPSPSRQNFSPEFCSFVDDCLKK 322
            L E  T G  PY    G VN   ++L+        P P    ++     C     C +K
Sbjct: 204 LLTELTTKGRVPYP---GMVN--REVLDQVERGYRMPCPPECPESLHDLMCQ----CWRK 254
Query: 323 DAEARPTADQL 333
           D E RPT + L
Sbjct: 255 DPEERPTFEYL 265

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILS-----SMFKKLLQGLSYL 197
           G + + +EY   G+L + LR ++            +PE  ++     S   +L +G+ YL
Sbjct: 106 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 165
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIR 255
              +  +HRD+   N+LV      KI DFG++  + N      T  G   V +M+PE + 
Sbjct: 166 -ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 224
Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++        N + E   
Sbjct: 225 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTNELYM 282
Query: 315 FVDDCLKKDAEARPTADQLLS 335
            + DC       RPT  QL+ 
Sbjct: 283 MMRDCWHAVPSQRPTFKQLVE 303

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 110/228 (48%), Gaps = 17/228 (7%)
Query: 117 FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK 176
           + + +R + L+E   + +   +  ++   G   + +S  + I  E+M+ G+L   LR+  
Sbjct: 54  YTERQRREFLSEASIMGQFE-HPNIIRLEGV--VTNSMPVMILTEFMENGALDSFLRLND 110
Query: 177 SIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
                I L  M + +  G+ YL  + + VHRD+   N+LVN     K++DFG+S  LE +
Sbjct: 111 GQFTVIQLVGMLRGIASGMRYLAEMSY-VHRDLAARNILVNSNLVCKVSDFGLSRFLEEN 169
Query: 236 IA---MCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY--AASEG 287
            +     ++  G   + + +PE I    ++  +D WS G+ ++E  + GE PY   +++ 
Sbjct: 170 SSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 229
Query: 288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            +N + Q    P P     +        + DC +KD  ARP   Q++S
Sbjct: 230 VINAIEQDYRLPPPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVS 273

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILS-----SMFKKLLQGLSYL 197
           G + + +EY   G+L + LR ++            +PE  ++     S   +L +G+ YL
Sbjct: 101 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 160
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIR 255
              +  +HRD+   N+LV      KI DFG++  + N      T  G   V +M+PE + 
Sbjct: 161 -ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 219
Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++        N + E   
Sbjct: 220 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTNELYM 277
Query: 315 FVDDCLKKDAEARPTADQLLS 335
            + DC       RPT  QL+ 
Sbjct: 278 MMRDCWHAVPSQRPTFKQLVE 298

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILS-----SMFKKLLQGLSYL 197
           G + + +EY   G+L + LR ++            +PE  ++     S   +L +G+ YL
Sbjct: 103 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 162
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIR 255
              +  +HRD+   N+LV      KI DFG++  + N      T  G   V +M+PE + 
Sbjct: 163 -ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 221
Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++        N + E   
Sbjct: 222 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTNELYM 279
Query: 315 FVDDCLKKDAEARPTADQLL 334
            + DC       RPT  QL+
Sbjct: 280 MMRDCWHAVPSQRPTFKQLV 299

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  G L D L+  M K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 87  IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 145
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +KD 
Sbjct: 204 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKDP 256
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 257 EERPTFEYL 265

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G   VV +A      RI+ALK+I + + E      T IR  +L +   +  +V    
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRL-DAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             +      +++  E+M+   L  +L   K+ + +  +     +LL+G+++ H  R ++H
Sbjct: 87  VIHSERC--LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILH 142
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPAD 264
           RD+KP NLL+N  G  K+ DFG++      +      V T+ Y +P+ +  ++ YS   D
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 265 IWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS--PSRQNFS----------- 309
           IWSIG    E  TG+  FP    +  +  +  IL  P+P   P  Q              
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 310 --------PEFCS----FVDDCLKKDAEARPTADQLLSHPF 338
                   P FC      + + L  D   R +A   ++HP+
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 123/266 (46%), Gaps = 21/266 (7%)
Query: 83  MRIFGAIGSGA-SSVVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCN 138
           ++I   IG+G    V    + +P  R   +A+K +   + +++R   L+E   + +   +
Sbjct: 9   VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-H 67
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
             ++   G   +  S  + I  E+M+ GSL   LR        I L  M + +  G+ YL
Sbjct: 68  PNVIHLEGV--VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA---MCATFVGT--VTYMSPE 252
             + + VHR +   N+LVN     K++DFG+S  LE+  +     +   G   + + +PE
Sbjct: 126 ADMNY-VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPY--AASEGPVNLMLQILEDPSPSPSRQNFS 309
            I+   ++  +D+WS G+ ++E  + GE PY    ++  +N + Q    P P     +  
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP----MDCP 240
Query: 310 PEFCSFVDDCLKKDAEARPTADQLLS 335
                 + DC +KD   RP   Q+++
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVN 266

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + +EY   G+L + LR ++            +PE  ++     
Sbjct: 103 IINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      +I DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 83  MRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN 138
           ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L ++  +
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL-KSLQH 73
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
           + +V++ G  Y      + + +E++  GSL + L+  K   + I L     ++ +G+ YL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
            G +  +HRD+   N+LV  + R KI DFG++  L   +    +       + + +PE +
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 255 RNESYSYPADIWSIGLALFECGT 277
               +S  +D+WS G+ L+E  T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHG 146
           +G G   VV +A      RI+ALK+I + + E      T IR  +L +   +  +V    
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRL-DAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             +      +++  E+M+   L  +L   K+ + +  +     +LL+G+++ H  R ++H
Sbjct: 87  VIHSERC--LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILH 142
Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR-NESYSYPAD 264
           RD+KP NLL+N  G  K+ DFG++      +      V T+ Y +P+ +  ++ YS   D
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 265 IWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPS--PSRQNFS----------- 309
           IWSIG    E  TG+  FP    +  +  +  IL  P+P   P  Q              
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 310 --------PEFCS----FVDDCLKKDAEARPTADQLLSHPF 338
                   P FC      + + L  D   R +A   ++HP+
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 154 GQISIALEYMDGGSLADILRMQK-----------SIPEPILS-----SMFKKLLQGLSYL 197
           G + + +EY   G+L + LR ++            +PE  ++     S   +L +G+ YL
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIR 255
              +  +HRD+   N+LV      KI DFG++  + N      T  G   V +M+PE + 
Sbjct: 220 -ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 278
Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++        N + E   
Sbjct: 279 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHRMDKPANCTNELYM 336
Query: 315 FVDDCLKKDAEARPTADQLL 334
            + DC       RPT  QL+
Sbjct: 337 MMRDCWHAVPSQRPTFKQLV 356

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLH 198
           LV+  G   + + G + I  EYM  GSL D LR +    +    L      + + + YL 
Sbjct: 248 LVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           G  + VHRD+   N+LV+     K++DFG++   + + +   T    V + +PE +R + 
Sbjct: 307 G-NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKK 362
Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +S  +D+WS G+ L+E  + G  PY     P+  ++  +E      +     P     + 
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAPDGCPPAVYDVMK 420
Query: 318 DCLKKDAEARPTADQL 333
           +C   DA  RPT  QL
Sbjct: 421 NCWHLDAATRPTFLQL 436

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 131/312 (41%), Gaps = 58/312 (18%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-- 137
           S + ++   +G GA  VV  A H PT  I+A+KKI  F+K      L  +RTL E     
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILK 64
Query: 138 ---NEGLVEFHGAFYMPDS----GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
              +E ++        PDS     ++ I  E M    L  ++  Q    + I   +++ L
Sbjct: 65  HFKHENIITIFN-IQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTL 122
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----------MCA 240
            + +  LHG  +++HRD+KP+NLL+N     K+ DFG++  ++ S A             
Sbjct: 123 -RAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 241 TFVGTVTYMSPE-RIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILE 297
            +V T  Y +PE  + +  YS   D+WS G  L E       FP       + L+  I+ 
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 298 DP----------SP--------------SPSRQNF---SPEFCSFVDDCLKKDAEARPTA 330
            P          SP              +P  + F   +P+    +   L  D   R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 331 DQLLSHPFITKY 342
            + L HP++  Y
Sbjct: 301 KEALEHPYLQTY 312

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 110/228 (48%), Gaps = 17/228 (7%)
Query: 117 FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK 176
           + + +R + L+E   + +   +  ++   G   + +S  + I  E+M+ G+L   LR+  
Sbjct: 56  YTERQRREFLSEASIMGQFE-HPNIIRLEGV--VTNSMPVMILTEFMENGALDSFLRLND 112
Query: 177 SIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
                I L  M + +  G+ YL  + + VHRD+   N+LVN     K++DFG+S  LE +
Sbjct: 113 GQFTVIQLVGMLRGIASGMRYLAEMSY-VHRDLAARNILVNSNLVCKVSDFGLSRFLEEN 171
Query: 236 IA---MCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY--AASEG 287
            +     ++  G   + + +PE I    ++  +D WS G+ ++E  + GE PY   +++ 
Sbjct: 172 SSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD 231
Query: 288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            +N + Q    P P     +        + DC +KD  ARP   Q++S
Sbjct: 232 VINAIEQDYRLPPPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVS 275

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 77  NPHVCRLLGICL---TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 134 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 250
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 251 MIMVKCWMIDADSRPKFRELI 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 78  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 251
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 252 MIMVKCWMIDADSRPKFRELI 272

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 77  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 134 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 250
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 251 MIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 79  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 136 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 252
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 253 MIMVKCWMIDADSRPKFRELI 273

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 76  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 86  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 141
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 200
Query: 264 DIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           D+WS+G  + E  C    FP        N +++ L  P P       P+ + +    P++
Sbjct: 201 DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 260
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 261 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 318

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 97  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 153 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 211
Query: 264 DIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           D+WS+G  + E  C    FP        N +++ L  P P       P+ + +    P++
Sbjct: 212 DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 271
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 272 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 329

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 114/237 (48%), Gaps = 33/237 (13%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
              +G GA   V +A +    R  A+KKI   E EK + +L+E+  L  +  ++ +V ++
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEV-MLLASLNHQYVVRYY 68
Query: 146 GAFY-----------MPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQG 193
            A+            +     + I +EY + G+L D++  +  +        +F+++L+ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM--------------C 239
           LSY+H  + ++HRD+KP N+ ++     KI DFG++  +  S+ +               
Sbjct: 129 LSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 240 ATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
            + +GT  Y++ E +     Y+   D++S+G+  FE     +P++     VN++ ++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL 241

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 80  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 137 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 253
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 254 MIMVKCWMIDADSRPKFRELI 274

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 126/283 (44%), Gaps = 34/283 (12%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G GA + VQ  +++ T +  A+K I       R+++  E+  L +   +  ++E    
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           F   D  +  +  E M GGS+   +  ++   E   S + + +   L +LH  + + HRD
Sbjct: 80  FEEED--RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRD 136
Query: 208 IKPANLLV---NLKGRPKITDFGISAGLE-------NSIAMCATFVGTVTYMSPERIRNE 257
           +KP N+L    N     KI DF + +G++        S     T  G+  YM+PE +   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 258 S-----YSYPADIWSIGLALFECGTGEFPYAASEGP-------------VNLMLQILEDP 299
           S     Y    D+WS+G+ L+   +G  P+    G               N++ + +++ 
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 300 SPSPSRQNFSPEFCS---FVDDCLKKDAEARPTADQLLSHPFI 339
                 ++++   C+    +   L +DA+ R +A Q+L HP++
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------RNQLLTEIRTLCEAPCNEGL 141
           IG GA   V +A    +   +ALK + +   E+       R   L       E P    L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSS-----MFKKLLQGLSY 196
           ++           ++++  E++D     D+       P P L +     + ++ L+GL +
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           LH    +VHRD+KP N+LV   G  K+ DFG++      +A+ A  V T+ Y +PE +  
Sbjct: 128 LHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-APVVVTLWYRAPEVLLQ 185
Query: 257 ESYSYPADIWSIGLALFE--------CGTGE 279
            +Y+ P D+WS+G    E        CG  E
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 8/185 (4%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I  EYM+ GSL   LR        I L  M + +  G+ YL  + + VHRD+   N+L
Sbjct: 90  VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY-VHRDLAARNIL 148
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLA 271
           VN     K++DFG+S  LE+      T  G    + + +PE I    ++  +D+WS G+ 
Sbjct: 149 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 208
Query: 272 LFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA 330
           ++E  + GE PY         +++ +E+    P   +        + DC +K+   RP  
Sbjct: 209 MWEVMSYGERPYWDMSN--QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 266
Query: 331 DQLLS 335
            Q+++
Sbjct: 267 GQIVN 271

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 118/262 (45%), Gaps = 15/262 (5%)
Query: 83  MRIFGAIGSGA-SSVVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCN 138
           ++I   IG G    V    + +P  R   +A+K +   +  ++R   L+E   + +   +
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-H 68
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYL 197
             ++   G   +     + I  EYM+ GSL   LR        I L  M + +  G+ YL
Sbjct: 69  PNIIHLEGV--VTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERI 254
             + + VHRD+   N+LVN     K++DFG+S  LE+      T  G    + + +PE I
Sbjct: 127 SDMSY-VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
               ++  +D+WS G+ ++E  + GE PY         +++ +E+    P   +      
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEEGYRLPPPMDCPIALH 243
Query: 314 SFVDDCLKKDAEARPTADQLLS 335
             + DC +K+   RP   Q+++
Sbjct: 244 QLMLDCWQKERSDRPKFGQIVN 265

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M    V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV-TRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   FP        N +++ L  P P       P+ + +    P++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 158 IALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E M+GG L   +  R  ++  E   + + + +   + +LH   ++ HRD+KP NLL 
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLY 161
Query: 216 NLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
             K +    K+TDFG +   E +     T   T  Y++PE +  E Y    D+WS+G+ +
Sbjct: 162 TSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 273 FECGTGEFPYAASEGP-----VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +    G  P+ ++ G      +   +++ +   P+P     S +    +   LK D   R
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
Query: 328 PTADQLLSHPFITK 341
            T  Q ++HP+I +
Sbjct: 280 LTITQFMNHPWINQ 293

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 23/198 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 84  IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY-VHRDLRAANI 142
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 143 LVGENLVCKVADFGLARLIEDNEWTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 200
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 201 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKEP 253
Query: 325 EARPTADQLLSHPFITKY 342
           E RPT + L    F+  Y
Sbjct: 254 EERPTFEYL--QAFLEDY 269

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 158 IALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E M+GG L   +  R  ++  E   + + + +   + +LH   ++ HRD+KP NLL 
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLY 142
Query: 216 NLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
             K +    K+TDFG +   E +     T   T  Y++PE +  E Y    D+WS+G+ +
Sbjct: 143 TSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 273 FECGTGEFPYAASEGP-----VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +    G  P+ ++ G      +   +++ +   P+P     S +    +   LK D   R
Sbjct: 201 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 260
Query: 328 PTADQLLSHPFITK 341
            T  Q ++HP+I +
Sbjct: 261 LTITQFMNHPWINQ 274

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 93/189 (49%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 84  IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY-VHRDLRAANI 142
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 143 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 200
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 201 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKEP 253
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 254 EERPTFEYL 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 311
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 370 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMC----QCWRKEP 422
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 423 EERPTFEYL 431

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 79  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 136 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 252
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 253 MIMRKCWMIDADSRPKFRELI 273

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 311
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 370 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMC----QCWRKEP 422
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 423 EERPTFEYL 431

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 76  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 250 MIMRKCWMIDADSRPKFRELI 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 23/198 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 77  IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 135
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 136 LVGENLVCKVADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 193
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 194 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKEP 246
Query: 325 EARPTADQLLSHPFITKY 342
           E RPT + L    F+  Y
Sbjct: 247 EERPTFEYL--QAFLEDY 262

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQME--LDHERMSYLLYQMLXGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 207 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 252
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 253 QPTVRNYVENRP 264

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQME--LDHERMSYLLYQMLXGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 207 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 252
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 253 QPTVRNYVENRP 264

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 86  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 143 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 259
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 260 MIMRKCWMIDADSRPKFRELI 280

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQME--LDHERMSYLLYQMLXGIKHLHSA-GI 140
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 141 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 199
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 200 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 245
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 246 QPTVRNYVENRP 257

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +E ++++ G      +  + + +EY+  GSL D L  + SI    L    +++ +G++YL
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYL 150
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
           H  +H +HRD+   N+L++     KI DFG++  +        +       V + +PE +
Sbjct: 151 HA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 255 RNESYSYPADIWSIGLALFE----CGTGEFP---------YAASEGPVNLMLQILEDPSP 301
           +   + Y +D+WS G+ L+E    C + + P          A  +  V  + ++LE    
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            P       E    + +C + +A  RPT + L+
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 89  IGSGASSVVQRAVHIPTHR---IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  A    T++   I ALKK  +   +     + E R L  A  +  L    
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F   ++  +   +EY++GG L  +  +Q      +  + F   +++ GL +LH  + +
Sbjct: 86  CTFQTKEN--LFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGI 140
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT--FVGTVTYMSPERIRNESYSY 261
           V+RD+K  N+L++  G  KI DFG+    EN +    T  F GT  Y++PE +  + Y++
Sbjct: 141 VYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLGQKYNH 198
Query: 262 PADIWSIGLALFECGTGEFPYAASE 286
             D WS G+ L+E   G+ P+   +
Sbjct: 199 SVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + + Y   G+L + LR ++            +PE  ++     
Sbjct: 103 IINLLGA--CTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------RNQLLTEIRTLCEAPCNEGL 141
           IG GA   V +A    +   +ALK + +   E+       R   L       E P    L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSS-----MFKKLLQGLSY 196
           ++           ++++  E++D     D+       P P L +     + ++ L+GL +
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           LH    +VHRD+KP N+LV   G  K+ DFG++      +A+    V T+ Y +PE +  
Sbjct: 128 LHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAPEVLLQ 185
Query: 257 ESYSYPADIWSIGLALFE--------CGTGE 279
            +Y+ P D+WS+G    E        CG  E
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 89  IGSGASSVVQRAVHIPTHR---IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  A    T++   I ALKK  +   +     + E R L  A  +  L    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F   ++  +   +EY++GG L  +  +Q      +  + F   +++ GL +LH  + +
Sbjct: 85  CTFQTKEN--LFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGI 139
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT--FVGTVTYMSPERIRNESYSY 261
           V+RD+K  N+L++  G  KI DFG+    EN +    T  F GT  Y++PE +  + Y++
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQKYNH 197
Query: 262 PADIWSIGLALFECGTGEFPYAASE 286
             D WS G+ L+E   G+ P+   +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 78  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 251
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 252 MIMVKCWMIDADSRPKFRELI 272

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 101 NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 158 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 274
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 275 MIMVKCWMIDADSRPKFRELI 295

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 79  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 136 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 252
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 253 MIMVKCWMIDADSRPKFRELI 273

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 78  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG +   G E            + +M+ E I
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 251
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 252 MIMRKCWMIDADSRPKFRELI 272

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 79  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 136 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 252
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 253 MIMVKCWMIDADSRPKFRELI 273

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 73  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 130 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 246
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 247 MIMVKCWMIDADSRPKFRELI 267

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 23/173 (13%)
Query: 120 EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIP 179
           +K  QLL  +R       ++ +++     Y  +  ++ + +EY     +  +  M  S+P
Sbjct: 54  KKEIQLLRRLR-------HKNVIQLVDVLYNEEKQKMYMVMEY----CVCGMQEMLDSVP 102
Query: 180 E---PILSS--MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN 234
           E   P+  +   F +L+ GL YLH  + +VH+DIKP NLL+   G  KI+  G++  L  
Sbjct: 103 EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 235 SIA--MCATFVGTVTYMSPERIRN--ESYS-YPADIWSIGLALFECGTGEFPY 282
             A   C T  G+  +  PE I N  +++S +  DIWS G+ L+   TG +P+
Sbjct: 162 FAADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 76  NPHVCRLLGICL---TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 70  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 243
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 244 MIMVKCWMIDADSRPKFRELI 264

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 76  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 25/191 (13%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 80  IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 138
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 139 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 196
Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED-------PSPSPSRQNFSPEFCSFVDDCLKK 322
            L E  T G  PY    G VN   ++L+        P P    ++     C     C +K
Sbjct: 197 LLTELTTKGRVPYP---GMVN--REVLDQVERGYRMPCPPECPESLHDLMCQ----CWRK 247
Query: 323 DAEARPTADQL 333
           + E RPT + L
Sbjct: 248 EPEERPTFEYL 258

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 82  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 139 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 255
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 256 MIMVKCWMIDADSRPKFRELI 276

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 207 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 252
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 253 QPTVRNYVENRP 264

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 83  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 140 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 256
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 32/274 (11%)
Query: 89  IGSGA--SSVVQRAVHIPTHR-----IIALKKINIFEKEKR-NQLLTEIRTLCEAPCNEG 140
           +G GA    V+  AV I   +      +A+K +     EK  + L++E+  +     ++ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILS----- 184
           ++   GA      G + + + Y   G+L + LR ++            +PE  ++     
Sbjct: 103 IINLLGA--CTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
           S   +L +G+ YL   +  +HRD+   N+LV      KI DFG++  + N      T  G
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 245 T--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY     PV  + ++L++   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKEGHR 277
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
                N + E    + DC       RPT  QL+ 
Sbjct: 278 MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 10/110 (9%)
Query: 178 IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA 237
           +P   +  + ++ L+GL +LH    +VHRD+KP N+LV   G  K+ DFG++      +A
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE--------CGTGE 279
           +    V T+ Y +PE +   +Y+ P D+WS+G    E        CG  E
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 16/225 (7%)
Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA 135
           YR   H M     +G G+   V R     T    A+KK+ +           E    C  
Sbjct: 69  YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAG 122
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
             +  +V  +GA    +   ++I +E ++GGSL  +++    +PE        + L+GL 
Sbjct: 123 LSSPRIVPLYGAVR--EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 180
Query: 196 YLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISA-----GLENSIAMCATFVGTVTYM 249
           YLH  R ++H D+K  N+L++  G R  + DFG +      GL  S+       GT T+M
Sbjct: 181 YLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 239
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS-EGPVNLML 293
           +PE +  +      DIWS    +     G  P+     GP+ L +
Sbjct: 240 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 284

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 21/247 (8%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 185
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 244
Query: 264 DIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
           DIWS+G  + E    +  FP        N +++ L  P          PEF   +   ++
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKLQPTVR 295
Query: 322 KDAEARP 328
              E RP
Sbjct: 296 NYVENRP 302

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLH 198
           LV+  G   + + G + I  EYM  GSL D LR +    +    L      + + + YL 
Sbjct: 61  LVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           G  + VHRD+   N+LV+     K++DFG++   + + +   T    V + +PE +R + 
Sbjct: 120 G-NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKK 175
Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +S  +D+WS G+ L+E  + G  PY     P+  ++  +E      +     P     + 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 233
Query: 318 DCLKKDAEARPTADQL 333
           +C   DA  RP+  QL
Sbjct: 234 NCWHLDAAMRPSFLQL 249

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 207 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 252
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 253 QPTVRNYVENRP 264

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------RNQLLTEIRTLCEAPCNEGL 141
           IG GA   V +A    +   +ALK + +   E+       R   L       E P    L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP-----ILSSMFKKLLQGLSY 196
           ++           ++++  E++D     D+       P P      +  + ++ L+GL +
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           LH    +VHRD+KP N+LV   G  K+ DFG++      +A+    V T+ Y +PE +  
Sbjct: 128 LHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV-TLWYRAPEVLLQ 185
Query: 257 ESYSYPADIWSIGLALFE--------CGTGE 279
            +Y+ P D+WS+G    E        CG  E
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 16/225 (7%)
Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA 135
           YR   H M     +G G+   V R     T    A+KK+ +           E    C  
Sbjct: 53  YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAG 106
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
             +  +V  +GA    +   ++I +E ++GGSL  +++    +PE        + L+GL 
Sbjct: 107 LSSPRIVPLYGAVR--EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 196 YLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISA-----GLENSIAMCATFVGTVTYM 249
           YLH  R ++H D+K  N+L++  G R  + DFG +      GL  S+       GT T+M
Sbjct: 165 YLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS-EGPVNLML 293
           +PE +  +      DIWS    +     G  P+     GP+ L +
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 8/185 (4%)
Query: 156 ISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I  EYM+ GSL   LR        I L  M + +  G+ YL  +   VHRD+   N+L
Sbjct: 105 VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM-SAVHRDLAARNIL 163
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVG---TVTYMSPERIRNESYSYPADIWSIGLA 271
           VN     K++DFG+S  LE+      T  G    + + +PE I    ++  +D+WS G+ 
Sbjct: 164 VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 223
Query: 272 LFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA 330
           ++E  + GE PY         +++ +E+    P   +        + DC +K+   RP  
Sbjct: 224 MWEVMSYGERPYWDMSN--QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 281
Query: 331 DQLLS 335
            Q+++
Sbjct: 282 GQIVN 286

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 8/183 (4%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I  EYM+ G+L   LR +      + L  M + +  G+ YL  + + VHRD+   N+LVN
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY-VHRDLAARNILVN 181
Query: 217 LKGRPKITDFGISAGLENSIAMCATFVG---TVTYMSPERIRNESYSYPADIWSIGLALF 273
                K++DFG+S  LE+      T  G    + + +PE I    ++  +D+WS G+ ++
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E  T GE PY   E   + +++ + D    P+  +        +  C +++   RP    
Sbjct: 242 EVMTYGERPYW--ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 299
Query: 333 LLS 335
           ++S
Sbjct: 300 IVS 302

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 253 IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 311
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 370 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMC----QCWRKEP 422
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 423 EERPTFEYL 431

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLH 198
           LV+  G   + + G + I  EYM  GSL D LR +    +    L      + + + YL 
Sbjct: 76  LVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           G  + VHRD+   N+LV+     K++DFG++   + + +   T    V + +PE +R + 
Sbjct: 135 G-NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKK 190
Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +S  +D+WS G+ L+E  + G  PY     P+  ++  +E      +     P     + 
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 248
Query: 318 DCLKKDAEARPTADQL 333
           +C   DA  RP+  QL
Sbjct: 249 NCWHLDAAMRPSFLQL 264

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+  + + VHRD++ AN+
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANI 394
Query: 214 LVNLKGRPKITDFGISAGLEN---SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           LV      K+ DFG++  +E+   +    A F   + + +PE      ++  +D+WS G+
Sbjct: 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 452
Query: 271 ALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G VN  +L  +E     P P    ++     C     C +K+ 
Sbjct: 453 LLTELTTKGRVPYP---GMVNREVLDQVERGYRMPCPPECPESLHDLMC----QCWRKEP 505
Query: 325 EARPTADQL 333
           E RPT + L
Sbjct: 506 EERPTFEYL 514

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 19/238 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-----RNQLLTEIRTLCEA--PCNEGL 141
           +G G  + V +A    T++I+A+KKI +  + +         L EI+ L E   P   GL
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGV 200
           ++  G         IS+  ++M+   L  I++    +  P  + +     LQGL YLH  
Sbjct: 78  LDAFG-----HKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 130
Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESY 259
             ++HRD+KP NLL++  G  K+ DFG++    +        V T  Y +PE +     Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
               D+W++G  L E      P+   +  ++ + +I E    +P+ + + P+ CS  D
Sbjct: 191 GVGVDMWAVGCILAEL-LLRVPFLPGDSDLDQLTRIFETLG-TPTEEQW-PDMCSLPD 245

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 130/312 (41%), Gaps = 58/312 (18%)
Query: 80  SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-- 137
           S + ++   +G GA  VV  A H PT  I+A+KKI  F+K      L  +RTL E     
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILK 64
Query: 138 ---NEGLVEFHGAFYMPDS----GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
              +E ++        PDS     ++ I  E M    L  ++  Q    + I   +++ L
Sbjct: 65  HFKHENIITIFN-IQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTL 122
Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----------MCA 240
            + +  LHG  +++HRD+KP+NLL+N     K+ DFG++  ++ S A             
Sbjct: 123 -RAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 241 TFVGTVTYMSPE-RIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILE 297
             V T  Y +PE  + +  YS   D+WS G  L E       FP       + L+  I+ 
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 298 DP----------SP--------------SPSRQNF---SPEFCSFVDDCLKKDAEARPTA 330
            P          SP              +P  + F   +P+    +   L  D   R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 331 DQLLSHPFITKY 342
            + L HP++  Y
Sbjct: 301 KEALEHPYLQTY 312

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA 135
           YR   H M     +G G+   V R     T    A+KK+ +           E    C  
Sbjct: 67  YREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAG 120
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
             +  +V  +GA  + +   ++I +E ++GGSL  +++    +PE        + L+GL 
Sbjct: 121 LSSPRIVPLYGA--VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 178
Query: 196 YLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISA-----GLENSIAMCATFVGTVTYM 249
           YLH  R ++H D+K  N+L++  G R  + DFG +      GL  S+       GT T+M
Sbjct: 179 YLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 237
Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAAS-EGPVNLML 293
           +PE +  +      DIWS    +     G  P+     GP+ L +
Sbjct: 238 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 282

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 207
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 208 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 253
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 254 QPTVRNYVENRP 265

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 78  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG +   G E            + +M+ E I
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 251
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 252 MIMVKCWMIDADSRPKFRELI 272

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 146
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 147 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 205
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 206 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 251
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 252 QPTVRNYVENRP 263

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 207 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 252
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 253 QPTVRNYVENRP 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLH 198
           LV+  G   + + G + I  EYM  GSL D LR +    +    L      + + + YL 
Sbjct: 67  LVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 125
Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           G  + VHRD+   N+LV+     K++DFG++   + + +   T    V + +PE +R  +
Sbjct: 126 G-NNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREAA 181
Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +S  +D+WS G+ L+E  + G  PY     P+  ++  +E      +     P     + 
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 239
Query: 318 DCLKKDAEARPTADQL 333
           +C   DA  RP+  QL
Sbjct: 240 NCWHLDAAMRPSFLQL 255

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 185
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 244
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 245 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 290
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 291 QPTVRNYVENRP 302

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 140
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 199
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 200 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 245
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 246 QPTVRNYVENRP 257

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 80  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG +   G E            + +M+ E I
Sbjct: 137 LED-RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 253
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 254 MIMVKCWMIDADSRPKFRELI 274

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 141
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 200
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 201 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 246
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 247 QPTVRNYVENRP 258

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 207 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 252
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 253 QPTVRNYVENRP 264

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 141
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 200
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 201 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 246
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 247 QPTVRNYVENRP 258

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 31/252 (12%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 148
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y    
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKENV 207
Query: 264 DIWSIGLALFECGTGE-------FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           DIWS+G     C  GE       FP        N +++ L  P          PEF   +
Sbjct: 208 DIWSVG-----CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP---------CPEFMKKL 253
Query: 317 DDCLKKDAEARP 328
              ++   E RP
Sbjct: 254 QPTVRNYVENRP 265

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHG 199
           LV+ +G     +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL  
Sbjct: 64  LVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRN 256
              ++HRD+   N LV      K++DFG++  + +     +T  GT   V + SPE    
Sbjct: 122 A-SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 178
Query: 257 ESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
             YS  +D+WS G+ ++E    G+ PY           +++ED   S   + + P   S 
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED--ISTGFRLYKPRLAST 231
Query: 315 ----FVDDCLKKDAEARPTADQLL 334
                ++ C K+  E RP   +LL
Sbjct: 232 HVYQIMNHCWKERPEDRPAFSRLL 255

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A      R +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + I +E MD  +L  +++M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     S  M    V T  Y +PE I    Y    
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV-TRYYRAPEVILGMGYKENV 206
Query: 264 DIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           D+WS+G  + E  C    FP        N +++ L  P P       P+ + +    P++
Sbjct: 207 DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266
Query: 313 CSF------------------------VDDCLKK----DAEARPTADQLLSHPFITKY 342
             +                          D L K    DA  R + D+ L HP+I  +
Sbjct: 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 129/313 (41%), Gaps = 64/313 (20%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAPCNE 139
           GAIG G+  VV+ A+   T  I A+K +N  +  + N     ++ TE+R +     P   
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM------------------------- 174
            L E +      D   I + +E   GG L D L +                         
Sbjct: 92  RLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 175 QKSIP---------------EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL--VNL 217
           +++I                E ++S++ +++   L YLH  + + HRDIKP N L   N 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNK 205
Query: 218 KGRPKITDFGISA---GLEN-SIAMCATFVGTVTYMSPERIR--NESYSYPADIWSIGLA 271
               K+ DFG+S     L N       T  GT  +++PE +   NESY    D WS G+ 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 272 LFECGTGEFPYAASEGPVNLMLQILEDP--SPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
           L     G  P+       + + Q+L       +P+    SP     + + L ++ + R  
Sbjct: 266 LHLLLMGAVPFPGV-NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 330 ADQLLSHPFITKY 342
           A + L HP+I+++
Sbjct: 325 AMRALQHPWISQF 337

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 14/260 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIP---THRI-IALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E++    +GSGA   V + + +P   T +I +A+K +N     K N    +   +  +  
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           +  LV   G    P    I +  + M  G L + +   K +I   +L +   ++ +G+ Y
Sbjct: 76  HPHLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++  LE          G   + +M+ E I
Sbjct: 133 LEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
               +++ +D+WS G+ ++E  T G  PY     P   +  +LE     P     + +  
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQL 333
             +  C   DA++RP   +L
Sbjct: 250 MVMVKCWMIDADSRPKFKEL 269

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 3/204 (1%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           + + G    G   + +R      + +  LKK  + + +     + E R L        L 
Sbjct: 25  LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           + H  F   D  ++   +EY++GG L   ++      EP       ++  GL +L   + 
Sbjct: 85  QLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KG 141
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +++RD+K  N++++ +G  KI DFG+             F GT  Y++PE I  + Y   
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 263 ADIWSIGLALFECGTGEFPYAASE 286
            D W+ G+ L+E   G+ P+   +
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGED 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 177 SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI 236
           S+PE  +    +  L  L++LH  + LVH D+KPAN+ +  +GR K+ DFG+   L  + 
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTA 210
Query: 237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG-EFPYAASEGPVNLMLQI 295
                  G   YM+PE ++  SY   AD++S+GL + E     E P+   EG      Q+
Sbjct: 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-EG----WQQL 264
Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            +   P       S E  S +   L+ D + R TA+ LL+ P + +
Sbjct: 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 78  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG +   G E            + +M+ E I
Sbjct: 135 LED-RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 251
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 252 MIMRKCWMIDADSRPKFRELI 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    + SGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + + ++ M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 83  NPHVCRLLGICL---TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 140 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 256
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHG 199
           LV+ +G     +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL  
Sbjct: 62  LVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRN 256
              ++HRD+   N LV      K++DFG++  + +     +T  GT   V + SPE    
Sbjct: 120 A-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 176
Query: 257 ESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
             YS  +D+WS G+ ++E    G+ PY           +++ED   S   + + P   S 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED--ISTGFRLYKPRLAST 229
Query: 315 ----FVDDCLKKDAEARPTADQLL 334
                ++ C K+  E RP   +LL
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLL 253

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 3/204 (1%)
Query: 83  MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           + + G    G   + +R      + +  LKK  + + +     + E R L        L 
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           + H  F   D  ++   +EY++GG L   ++      EP       ++  GL +L   + 
Sbjct: 406 QLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KG 462
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +++RD+K  N++++ +G  KI DFG+             F GT  Y++PE I  + Y   
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 263 ADIWSIGLALFECGTGEFPYAASE 286
            D W+ G+ L+E   G+ P+   +
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGED 546

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHG 199
           LV+ +G     +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL  
Sbjct: 64  LVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRN 256
              ++HRD+   N LV      K++DFG++  + +     +T  GT   V + SPE    
Sbjct: 122 A-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 178
Query: 257 ESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
             YS  +D+WS G+ ++E    G+ PY           +++ED   S   + + P   S 
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED--ISTGFRLYKPRLAST 231
Query: 315 ----FVDDCLKKDAEARPTADQLL 334
                ++ C K+  E RP   +LL
Sbjct: 232 HVYQIMNHCWKERPEDRPAFSRLL 255

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/325 (21%), Positives = 141/325 (43%), Gaps = 82/325 (25%)
Query: 85  IFGAIGSGASSV--VQRAVHIPTHRIIALKKINIFEKEKRNQLLT------EIRTLCEAP 136
           +   IG G   +  V  A + PT   + +++IN+  +   N+++T       +  L   P
Sbjct: 29  LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFNHP 86
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGL 194
               +V +   F   +  ++ +   +M  GS  D++       + E  ++ + + +L+ L
Sbjct: 87  ---NIVPYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA-------------T 241
            Y+H + + VHR +K +++L+++ G+  ++      GL ++++M +              
Sbjct: 142 DYIHHMGY-VHRSVKASHILISVDGKVYLS------GLRSNLSMISHGQRQRVVHDFPKY 194
Query: 242 FVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYA---ASE-------GPV 289
            V  + ++SPE ++   + Y   +DI+S+G+   E   G  P+    A++       G V
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 290 NLMLQI--------------------LED------PSPS-------PSRQNFSPEFCSFV 316
             +L                      L D      P PS       P  + FSP F  FV
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 317 DDCLKKDAEARPTADQLLSHPFITK 341
           + CL+++ +ARP+A  LL+H F  +
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQ 339

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 14/260 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIP---THRI-IALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E++    +GSGA   V + + +P   T +I +A+K +N     K N    +   +  +  
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           +  LV   G    P    I +  + M  G L + +   K +I   +L +   ++ +G+ Y
Sbjct: 99  HPHLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++  LE          G   + +M+ E I
Sbjct: 156 LEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
               +++ +D+WS G+ ++E  T G  PY     P   +  +LE     P     + +  
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEKGERLPQPPICTIDVY 272
Query: 314 SFVDDCLKKDAEARPTADQL 333
             +  C   DA++RP   +L
Sbjct: 273 MVMVKCWMIDADSRPKFKEL 292

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/325 (21%), Positives = 141/325 (43%), Gaps = 82/325 (25%)
Query: 85  IFGAIGSGASSV--VQRAVHIPTHRIIALKKINIFEKEKRNQLLT------EIRTLCEAP 136
           +   IG G   +  V  A + PT   + +++IN+  +   N+++T       +  L   P
Sbjct: 13  LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL--EACSNEMVTFLQGELHVSKLFNHP 70
Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGL 194
               +V +   F   +  ++ +   +M  GS  D++       + E  ++ + + +L+ L
Sbjct: 71  ---NIVPYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 125
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT------------- 241
            Y+H + + VHR +K +++L+++ G+  +      +GL ++++M +              
Sbjct: 126 DYIHHMGY-VHRSVKASHILISVDGKVYL------SGLRSNLSMISHGQRQRVVHDFPKY 178
Query: 242 FVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYA---ASE-------GPV 289
            V  + ++SPE ++   + Y   +DI+S+G+   E   G  P+    A++       G V
Sbjct: 179 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 238
Query: 290 NLMLQI--------------------LED------PSPS-------PSRQNFSPEFCSFV 316
             +L                      L D      P PS       P  + FSP F  FV
Sbjct: 239 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 298
Query: 317 DDCLKKDAEARPTADQLLSHPFITK 341
           + CL+++ +ARP+A  LL+H F  +
Sbjct: 299 EQCLQRNPDARPSASTLLNHSFFKQ 323

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A      + +A+KK++     +    +  + L  ++ L        L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + D  ++ +    M G  L +I++ Q ++ +  +  +  +LL+GL Y+H    +
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIVKCQ-ALSDEHVQFLVYQLLRGLKYIHSA-GI 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+N+ VN     +I DFG++   +  +     +V T  Y +PE + N   Y+  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMHYNQT 209
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP 301
            DIWS+G  + E   G+  FP +     +  +++++  PSP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 250

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHG 199
           LV+ +G     +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL  
Sbjct: 84  LVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 141
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRN 256
              ++HRD+   N LV      K++DFG++  + +     +T  GT   V + SPE    
Sbjct: 142 A-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 198
Query: 257 ESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
             YS  +D+WS G+ ++E    G+ PY           +++ED   S   + + P   S 
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED--ISTGFRLYKPRLAST 251
Query: 315 ----FVDDCLKKDAEARPTADQLL 334
                ++ C K+  E RP   +LL
Sbjct: 252 HVYQIMNHCWKERPEDRPAFSRLL 275

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 113/237 (47%), Gaps = 33/237 (13%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
              +G GA   V +A +    R  A+KKI   E EK + +L+E+  L  +  ++ +V ++
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEV-MLLASLNHQYVVRYY 68
Query: 146 GAFY-----------MPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQG 193
            A+            +     + I +EY +  +L D++  +  +        +F+++L+ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM--------------C 239
           LSY+H  + ++HRD+KP N+ ++     KI DFG++  +  S+ +               
Sbjct: 129 LSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 240 ATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
            + +GT  Y++ E +     Y+   D++S+G+  FE     +P++     VN++ ++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL 241

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A      + +A+KK++     +    +  + L  ++ L        L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + D  ++ +    M G  L +I++ Q ++ +  +  +  +LL+GL Y+H    +
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIVKSQ-ALSDEHVQFLVYQLLRGLKYIHSA-GI 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+N+ VN     +I DFG++   +  +     +V T  Y +PE + N   Y+  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMHYNQT 209
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP 301
            DIWS+G  + E   G+  FP +     +  +++++  PSP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 250

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 76  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG +   G E            + +M+ E I
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    +GSGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 83  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG +   G E            + +M+ E I
Sbjct: 140 LED-RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 256
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V  A      + +A+KK++     +    +  + L  ++ L        L  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F  A  + D  ++ +    M G  L +I++ Q ++ +  +  +  +LL+GL Y+H    +
Sbjct: 88  FTPATSIEDFSEVYLVTTLM-GADLNNIVKCQ-ALSDEHVQFLVYQLLRGLKYIHSA-GI 144
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYP 262
           +HRD+KP+N+ VN     +I DFG++   +  +     +V T  Y +PE + N   Y+  
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMHYNQT 201
Query: 263 ADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSP 301
            DIWS+G  + E   G+  FP +     +  +++++  PSP
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSP 242

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 120
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 179
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 240 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 329 TADQLL 334
           T  QL+
Sbjct: 298 TFKQLV 303

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 113
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 172
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 173 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 232
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 233 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 290
Query: 329 TADQLL 334
           T  QL+
Sbjct: 291 TFKQLV 296

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 112
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 171
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 172 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 231
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 232 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 289
Query: 329 TADQLL 334
           T  QL+
Sbjct: 290 TFKQLV 295

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHG 199
           LV+ +G     +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL  
Sbjct: 67  LVQLYGV--CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 124
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRN 256
              ++HRD+   N LV      K++DFG++  + +     +T  GT   V + SPE    
Sbjct: 125 A-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 181
Query: 257 ESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
             YS  +D+WS G+ ++E    G+ PY           +++ED   S   + + P   S 
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED--ISTGFRLYKPRLAST 234
Query: 315 ----FVDDCLKKDAEARPTADQLL 334
                ++ C ++  E RP   +LL
Sbjct: 235 HVYQIMNHCWRERPEDRPAFSRLL 258

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 120
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 179
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 240 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 329 TADQLL 334
           T  QL+
Sbjct: 298 TFKQLV 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 109
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 168
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 229 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 286
Query: 329 TADQLL 334
           T  QL+
Sbjct: 287 TFKQLV 292

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 105
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 164
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 225 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 329 TADQLL 334
           T  QL+
Sbjct: 283 TFKQLV 288

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 120
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 179
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 240 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 329 TADQLL 334
           T  QL+
Sbjct: 298 TFKQLV 303

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    + SGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 83  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 140 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 256
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 257 MIMVKCWMIDADSRPKFRELI 277

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 20/266 (7%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALK-KINIFEKEKRNQLLTEIRTLCEAPCNEG 140
           E+R    +GSGA   V + + IP    + +   I +  +    +   EI  L EA    G
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI--LDEAYVMAG 75
Query: 141 LVEFHGAFYMPD------SGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQG 193
           +    G+ Y+        +  + +  + M  G L D +R  +  +    L +   ++ +G
Sbjct: 76  V----GSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKG 131
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSP 251
           +SYL  VR LVHRD+   N+LV      KITDFG++  L+          G V   +M+ 
Sbjct: 132 MSYLEDVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E I    +++ +D+WS G+ ++E  T G  PY     P   +  +LE     P     + 
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEKGERLPQPPICTI 248
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +    +  C   D+E RP   +L+S 
Sbjct: 249 DVYMIMVKCWMIDSECRPRFRELVSE 274

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIFEKEKRNQLLTEIRTLCEAPC 137
           E +    + SGA   V + + IP    +    A+K++      K N+ + +   +  +  
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSY 196
           N  +    G      +  + +  + M  G L D +R  K +I    L +   ++ +G++Y
Sbjct: 76  NPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERI 254
           L   R LVHRD+   N+LV      KITDFG++   G E            + +M+ E I
Sbjct: 133 LED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 255 RNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
            +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVY 249
Query: 314 SFVDDCLKKDAEARPTADQLL 334
             +  C   DA++RP   +L+
Sbjct: 250 MIMVKCWMIDADSRPKFRELI 270

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 161
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 220
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 281 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 338
Query: 329 TADQLL 334
           T  QL+
Sbjct: 339 TFKQLV 344

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 58  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 116 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEV 172
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 228
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSN 254

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 63  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 121 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEV 177
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 233
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 234 KVYTIMYSCWHEKADERPTFKILLSN 259

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 127/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A        +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  ++ M+  +    +S +  ++L G+ +LH    +
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHME--LDHERMSYLLYQMLCGIKHLHSAG-I 145
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     +  M   +V T  Y +PE I    Y    
Sbjct: 146 IHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM-TPYVVTRYYRAPEVILGMGYKENV 204
Query: 264 DIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSP------SPSRQNFS------ 309
           DIWS+G  + E   G   +  ++     N +++ L  PS        P+ +N+       
Sbjct: 205 DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAY 264
Query: 310 ---------PEF------------CSFVDDCLKK----DAEARPTADQLLSHPFITKY 342
                    P++             S   D L K    D + R + D+ L HP+IT +
Sbjct: 265 PGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 322

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 62  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 120 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEV 176
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 232
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 233 KVYTIMYSCWHEKADERPTFKILLSN 258

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHG 199
           LV+ +G     +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL  
Sbjct: 65  LVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRN 256
              ++HRD+   N LV      K++DFG++  + +     +T  GT   V + SPE    
Sbjct: 123 A-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 179
Query: 257 ESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS- 314
             YS  +D+WS G+ ++E    G+ PY           +++ED   S   + + P   S 
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED--ISTGFRLYKPRLAST 232
Query: 315 ----FVDDCLKKDAEARPTADQLL 334
                ++ C ++  E RP   +LL
Sbjct: 233 HVYQIMNHCWRERPEDRPAFSRLL 256

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 25/246 (10%)
Query: 109 IALKKINIFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           +A+K +     EK  + L++E+  +     ++ ++   GA      G + + +EY   G+
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGN 120
Query: 168 LADILRMQK-----------SIPEPILSSM-----FKKLLQGLSYLHGVRHLVHRDIKPA 211
           L + L+ ++             PE  LSS        ++ +G+ YL   +  +HRD+   
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAAR 179
Query: 212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIG 269
           N+LV      KI DFG++  + +      T  G   V +M+PE + +  Y++ +D+WS G
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 270 LALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           + L+E  T G  PY     PV  + ++L++        N + E    + DC       RP
Sbjct: 240 VLLWEIFTLGGSPYPGV--PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 329 TADQLL 334
           T  QL+
Sbjct: 298 TFKQLV 303

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +E ++++ G         + + +EY+  GSL D L  + SI    L    +++ +G++YL
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYL 133
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
           H  +H +HR++   N+L++     KI DFG++  +        +       V + +PE +
Sbjct: 134 HA-QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 255 RNESYSYPADIWSIGLALFE----CGTGEFP---------YAASEGPVNLMLQILEDPSP 301
           +   + Y +D+WS G+ L+E    C + + P          A  +  V  + ++LE    
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 252
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            P       E    + +C + +A  RPT + L+
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 34/271 (12%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           E +    +GSGA   V + + IP             EK K    + E+R       N+ +
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEG-----------EKVKIPVAIMELREATSPKANKEI 98
Query: 142 VEFHGAFYMPD--------------SGQISIALEYMDGGSLADILRMQK-SIPEPILSSM 186
           ++   A+ M                +  + +  + M  G L D +R  K +I    L + 
Sbjct: 99  LD--EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 156
Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVG 244
             ++ +G++YL   R LVHRD+   N+LV      KITDFG++   G E           
Sbjct: 157 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 245 TVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSP 303
            + +M+ E I +  Y++ +D+WS G+ ++E  T G  PY     P + +  ILE     P
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLP 273
Query: 304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
                + +    +  C   DA++RP   +L+
Sbjct: 274 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 78  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 136 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEV 192
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 248
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 249 KVYTIMYSCWHEKADERPTFKILLSN 274

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 69  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 127 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEV 183
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 239
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 240 KVYTIMYSCWHEKADERPTFKILLSN 265

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +E ++++ G         + + +EY+  GSL D L  + SI    L    +++ +G++YL
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYL 133
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERI 254
           H  +H +HR++   N+L++     KI DFG++  +        +       V + +PE +
Sbjct: 134 HS-QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 255 RNESYSYPADIWSIGLALFE----CGTGEFP---------YAASEGPVNLMLQILEDPSP 301
           +   + Y +D+WS G+ L+E    C + + P          A  +  V  + ++LE    
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 252
Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            P       E    + +C + +A  RPT + L+
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLI 285

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A  + +  + A+KK+ + +K  +N+ L +I  + + P    +V+    
Sbjct: 47  VIGNGSFGVVFQAKLVESDEV-AIKKV-LQDKRFKNREL-QIMRIVKHP---NVVDLKAF 100
Query: 148 FY----MPDSGQISIALEYMDGG---SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ LEY+      +     ++++++P  ++     +LL+ L+Y+H +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 201 RHLVHRDIKPANLLVN-LKGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++   G  K+ DFG    + AG  N   +C+ +     Y +PE I 
Sbjct: 161 -GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPELIF 214
Query: 256 NES-YSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------ 300
             + Y+   DIWS G  + E   G+  FP  +    +  ++++L  PS            
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274
Query: 301 --------PSPSRQNFS----PEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                   P P  + F     P+    +   L+    AR TA + L HPF
Sbjct: 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 42/267 (15%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            +G G +  V +  +  T    ALK +    K +R   L    + C  P    +V+ +  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIVRIVDVYEN 82
Query: 148 FYMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            Y   +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH + ++
Sbjct: 83  LY---AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NI 138
Query: 204 VHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            HRD+KP NLL   K RP    K+TDFG +                      +    E Y
Sbjct: 139 AHRDVKPENLLYTSK-RPNAILKLTDFGFA----------------------KETTGEKY 175
Query: 260 SYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCS 314
               D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E   
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235
Query: 315 FVDDCLKKDAEARPTADQLLSHPFITK 341
            + + LK +   R T  + ++HP+I +
Sbjct: 236 LIRNLLKTEPTQRMTITEFMNHPWIMQ 262

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 78  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + ++ + F   V +  PE 
Sbjct: 136 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEV 192
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 248
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 249 KVYTIMYSCWHEKADERPTFKILLSN 274

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 67
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 68  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 125 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 242
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 243 DIYNVMVQCWAHKPEDRPT 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSY 196
           +E LV+ +G         I I  EYM  G L + LR M+       L  M K + + + Y
Sbjct: 63  HEKLVQLYGV--CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   N LVN +G  K++DFG+S  +   E + +  + F   V +  PE 
Sbjct: 121 LES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKF--PVRWSPPEV 177
Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQILEDPSPSPSRQNFSP 310
           +    +S  +DIW+ G+ ++E  + G+ PY    +      + Q L    P  +    S 
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA----SE 233
Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
           +  + +  C  + A+ RPT   LLS+
Sbjct: 234 KVYTIMYSCWHEKADERPTFKILLSN 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 67
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 68  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 125 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 242
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 243 DIYNVMVQCWAHKPEDRPT 261

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 186 MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN----------- 234
           +F ++ + + +LH  + L+HRD+KP+N+   +    K+ DFG+   ++            
Sbjct: 169 IFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 235 -SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML 293
            + A     VGT  YMSPE+I   +YS+  DI+S+GL LFE     + ++     V ++ 
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIIT 284
Query: 294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
            +     P    Q + P+    V D L      RP A  ++ +
Sbjct: 285 DVRNLKFPLLFTQKY-PQEHMMVQDMLSPSPTERPEATDIIEN 326

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 71
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 72  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 128
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 129 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 246
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 247 DIYNVMVQCWAHKPEDRPT 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 77
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 78  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 135 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 252
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 253 DIYNVMVQCWAHKPEDRPT 271

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/339 (23%), Positives = 129/339 (38%), Gaps = 71/339 (20%)
Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
           D+  + +  +   ++   +   IG G+   V +A     H+ +ALK +   EK    Q  
Sbjct: 83  DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAA 141
Query: 127 TEIRTL---CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK--SIPEP 181
            EIR L    +   +  +   H          I +  E +   +L ++++  K      P
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP 200
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP--KITDFGISAGLENSIAMC 239
           ++      +LQ L  LH  R ++H D+KP N+L+  +GR   K+ DFG S      +   
Sbjct: 201 LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-- 257
Query: 240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE---GPVNLMLQIL 296
            T + +  Y +PE I    Y  P D+WS+G  L E  TG +P    E     +  M+++L
Sbjct: 258 -TXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELL 315
Query: 297 EDPS-----PSPSRQNFS-----PEFCS-------------------------------- 314
             PS      S   +NF      P +C+                                
Sbjct: 316 GMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN 375
Query: 315 ------------FVDDCLKKDAEARPTADQLLSHPFITK 341
                       F+  CL+ D   R T  Q L HP++ +
Sbjct: 376 ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 77
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 78  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 135 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 252
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 253 DIYNVMVQCWAHKPEDRPT 271

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 71
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 72  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 128
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 129 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 246
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 247 DIYNVMVQCWAHKPEDRPT 265

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 115/259 (44%), Gaps = 17/259 (6%)
Query: 82  EMRIFGAIGSGASSVVQRA-VHIPTHRIIA-----LKKINIFEKEKRNQLLTEIRTLCEA 135
           ++R+   +G G+  VV+R     P+ + ++     LK   + + E  +  + E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM-HS 67
Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +  L+  +G    P    + +  E    GSL D LR  Q       LS    ++ +G+
Sbjct: 68  LDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSP 251
            YL   R  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +P
Sbjct: 125 GYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           E ++  ++S+ +D W  G+ L+E  T G+ P+    G   ++ +I ++    P  ++   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQ 242
Query: 311 EFCSFVDDCLKKDAEARPT 329
           +  + +  C     E RPT
Sbjct: 243 DIYNVMVQCWAHKPEDRPT 261

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 128/298 (42%), Gaps = 49/298 (16%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IGSGA  +V  A        +A+KK++  F+ +   +       L +   ++ ++     
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 148 FY----MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           F     + +   + + +E MD  +L  ++ M+  +    +S +  ++L G+ +LH    +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDA-NLCQVIHME--LDHERMSYLLYQMLCGIKHLHSA-GI 147
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+KP+N++V      KI DFG++     +  M   +V T  Y +PE I    Y+   
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM-TPYVVTRYYRAPEVILGMGYAANV 206
Query: 264 DIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSP------SPSRQNF---SPEF 312
           DIWS+G  + E   G   +  ++     N +++ L  PS        P+ +N+    P++
Sbjct: 207 DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKY 266
Query: 313 ------------------------CSFVDDCLKK----DAEARPTADQLLSHPFITKY 342
                                    S   D L K    D + R + D+ L HP+IT +
Sbjct: 267 PGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 324

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 32/227 (14%)
Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
           + C  P    L+ F       +  ++ +  +YM+ G+L    R       P +S  +++ 
Sbjct: 90  SFCRHPHLVSLIGF-----CDERNEMILIYKYMENGNLK---RHLYGSDLPTMSMSWEQR 141
Query: 191 LQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS-AGLE-NSIAMCAT 241
           L+       GL YLH  R ++HRD+K  N+L++    PKITDFGIS  G E +   +   
Sbjct: 142 LEICIGAARGLHYLH-TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDP 299
             GT+ Y+ PE       +  +D++S G+ LFE  C       +     VNL    +E  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 300 SPSPSRQNFSP------------EFCSFVDDCLKKDAEARPTADQLL 334
           +     Q   P            +F      CL   +E RP+   +L
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/339 (23%), Positives = 129/339 (38%), Gaps = 71/339 (20%)
Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
           D+  + +  +   ++   +   IG G+   V +A     H+ +ALK +   EK    Q  
Sbjct: 83  DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAA 141
Query: 127 TEIRTL---CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK--SIPEP 181
            EIR L    +   +  +   H          I +  E +   +L ++++  K      P
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP 200
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP--KITDFGISAGLENSIAMC 239
           ++      +LQ L  LH  R ++H D+KP N+L+  +GR   K+ DFG S      +   
Sbjct: 201 LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-- 257
Query: 240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE---GPVNLMLQIL 296
            T + +  Y +PE I    Y  P D+WS+G  L E  TG +P    E     +  M+++L
Sbjct: 258 -TXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELL 315
Query: 297 EDPS-----PSPSRQNFS-----PEFCS-------------------------------- 314
             PS      S   +NF      P +C+                                
Sbjct: 316 GMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN 375
Query: 315 ------------FVDDCLKKDAEARPTADQLLSHPFITK 341
                       F+  CL+ D   R T  Q L HP++ +
Sbjct: 376 ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSY 196
           +E +V++ G         + + +EY+  GSL D L R    + + +L +  +++ +G++Y
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFA--QQICEGMAY 127
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           LH  +H +HR +   N+L++     KI DFG++  +        +       V + +PE 
Sbjct: 128 LHA-QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 254 IRNESYSYPADIWSIGLALFE----CGTGEFPYAA-------SEGPVNL--MLQILEDPS 300
           ++   + Y +D+WS G+ L+E    C + + P+         ++G + +  + ++LE   
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 246
Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
             P       E    + +C + +A  RPT   L+
Sbjct: 247 RLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 112/237 (47%), Gaps = 33/237 (13%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
              +G GA   V +A +    R  A+KKI   E EK + +L+E+  L  +  ++ +V ++
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLA-SLNHQYVVRYY 68
Query: 146 GA------FYMPDSG-----QISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQG 193
            A      F  P +       + I  EY +  +L D++  +  +        +F+++L+ 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM--------------C 239
           LSY+H  + ++HR++KP N+ ++     KI DFG++  +  S+ +               
Sbjct: 129 LSYIHS-QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 240 ATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI 295
            + +GT  Y++ E +     Y+   D +S+G+  FE     +P++     VN++ ++
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKL 241

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSY 196
           +E +V++ G         + + +EY+  GSL D L R    + + +L +  +++ +G++Y
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFA--QQICEGMAY 126
Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           LH  +H +HR +   N+L++     KI DFG++  +        +       V + +PE 
Sbjct: 127 LHA-QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 254 IRNESYSYPADIWSIGLALFE----CGTGEFPYAA-------SEGPVNL--MLQILEDPS 300
           ++   + Y +D+WS G+ L+E    C + + P+         ++G + +  + ++LE   
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGE 245
Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
             P       E    + +C + +A  RPT   L+
Sbjct: 246 RLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 112/251 (44%), Gaps = 22/251 (8%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 57  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 115
Query: 164 DGGSLADILRMQKS--IPEPILSSMFKKLL-------------QGLSYLHGVRHLVHRDI 208
             G+L+  LR +++  +P      ++K  L             +G+ +L   R  +HRD+
Sbjct: 116 KFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDL 174
Query: 209 KPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSPERIRNESYSYPADIW 266
              N+L++ K   KI DFG++  +             +   +M+PE I +  Y+  +D+W
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 267 SIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           S G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   +  
Sbjct: 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293
Query: 326 ARPTADQLLSH 336
            RPT  +L+ H
Sbjct: 294 QRPTFSELVEH 304

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 131 TLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
           + C  P    L+ F       +  ++ +  +YM+ G+L    R       P +S  +++ 
Sbjct: 90  SFCRHPHLVSLIGF-----CDERNEMILIYKYMENGNLK---RHLYGSDLPTMSMSWEQR 141
Query: 191 LQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS-AGLE-NSIAMCAT 241
           L+       GL YLH  R ++HRD+K  N+L++    PKITDFGIS  G E     +   
Sbjct: 142 LEICIGAARGLHYLH-TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDP 299
             GT+ Y+ PE       +  +D++S G+ LFE  C       +     VNL    +E  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 300 SPSPSRQNFSP------------EFCSFVDDCLKKDAEARPTADQLL 334
           +     Q   P            +F      CL   +E RP+   +L
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 10/144 (6%)
Query: 151 PDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           P+   + +  E +    LA I + + + IP   +  + K+LL GL Y+H    ++H DIK
Sbjct: 100 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159
Query: 210 PANLLVNLKGRP------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           P N+L+ +   P      KI D G +   +         + T  Y SPE +    +   A
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGA 216
Query: 264 DIWSIGLALFECGTGEFPYAASEG 287
           DIWS    +FE  TG+F +   EG
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEG 240

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 17/247 (6%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 114
Query: 164 DGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGV---------RHLVHRDIKPAN 212
             G+L+  LR +++  +P   L   F  L   + Y   V         R  +HRD+   N
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARN 174
Query: 213 LLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           +L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+WS G+
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 234
Query: 271 ALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L+E    G  PY   +       + L++ +   +    +PE    + DC   +   RPT
Sbjct: 235 LLWEIFSLGASPYPGVKIDEEFXRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 293
Query: 330 ADQLLSH 336
             +L+ H
Sbjct: 294 FSELVEH 300

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 156 ISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + + +E   GG L   L  ++  IP   ++ +  ++  G+ YL   ++ VHRD+   N+L
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVL 142
Query: 215 VNLKGRPKITDFGISAGL-ENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLA 271
           +  +   KI+DFG+S  L  +     A   G   + + +PE I    +S  +D+WS G+ 
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 272 LFEC-GTGEFPYAASEGPVNLML----QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
           ++E    G+ PY   +GP  +      + +E P   P      PE  + + DC     E 
Sbjct: 203 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP------PELYALMSDCWIYKWED 256
Query: 327 RP 328
           RP
Sbjct: 257 RP 258

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 46/297 (15%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH--- 145
           +G G + +V  AV     + +A+KKI + + +     L EI+ +     +  +  F    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 146 --GAFYMPDSGQIS------IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
             G+    D G ++      I  EYM+   LA++L     + E     M++ LL+GL Y+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQ-LLRGLKYI 136
Query: 198 HGVRHLVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFV-GTVT--YMSPER 253
           H   +++HRD+KPANL +N +    KI DFG++  ++   +       G VT  Y SP  
Sbjct: 137 HSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 254 IRN-ESYSYPADIWSIGLALFECGTGEFPYAASEG------------------------- 287
           + +  +Y+   D+W+ G    E  TG+  +A +                           
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV 255
Query: 288 -PVNLMLQILEDPSP-SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            PV +   + E   P +      S E   F++  L      R TA++ LSHP+++ Y
Sbjct: 256 IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 10/144 (6%)
Query: 151 PDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           P+   + +  E +    LA I + + + IP   +  + K+LL GL Y+H    ++H DIK
Sbjct: 100 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159
Query: 210 PANLLVNLKGRP------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           P N+L+ +   P      KI D G +   +         + T  Y SPE +    +   A
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGA 216
Query: 264 DIWSIGLALFECGTGEFPYAASEG 287
           DIWS    +FE  TG+F +   EG
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEG 240

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/250 (30%), Positives = 109/250 (43%), Gaps = 40/250 (16%)
Query: 85  IFGAIGSGA-SSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA----PCNE 139
           I   +G G    VVQ   H      +ALK I   EK K    L EI  L +     P N+
Sbjct: 37  IVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARL-EINVLEKINEKDPDNK 95
Query: 140 GL-VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSY 196
            L V+    F     G + I+ E + G S  D L+    +P PI  +  M  +L Q + +
Sbjct: 96  NLCVQMFDWF--DYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKF 152
Query: 197 LHGVRHLVHRDIKPANLLV---------NLKGRP----------KITDFGISAGLENSIA 237
           LH  + L H D+KP N+L          NL+ +           ++ DFG SA  ++   
Sbjct: 153 LHDNK-LTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG-SATFDHE-- 208
Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE--CGTGEFPYAASEGPVNLMLQI 295
             +T V T  Y +PE I    +S P D+WSIG  +FE   G   F    +   + +M +I
Sbjct: 209 HHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERI 268
Query: 296 LEDPSPSPSR 305
           L    P PSR
Sbjct: 269 L---GPIPSR 275

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 17/247 (6%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 114
Query: 164 DGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGV---------RHLVHRDIKPAN 212
             G+L+  LR +++  +P   L   F  L   + Y   V         R  +HRD+   N
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARN 174
Query: 213 LLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGL 270
           +L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+WS G+
Sbjct: 175 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 234
Query: 271 ALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
            L+E    G  PY   +       + L++ +   +    +PE    + DC   +   RPT
Sbjct: 235 LLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 293
Query: 330 ADQLLSH 336
             +L+ H
Sbjct: 294 FSELVEH 300

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 111/250 (44%), Gaps = 21/250 (8%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 58  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 116
Query: 164 DGGSLADILRMQKS-----IPEPILSSMFK---------KLLQGLSYLHGVRHLVHRDIK 209
             G+L+  LR +++      PE +               ++ +G+ +L   R  +HRD+ 
Sbjct: 117 KFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL-ASRKXIHRDLA 175
Query: 210 PANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSPERIRNESYSYPADIWS 267
             N+L++ K   KI DFG++  +             +   +M+PE I +  Y+  +D+WS
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 268 IGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
            G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   +   
Sbjct: 236 FGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 294
Query: 327 RPTADQLLSH 336
           RPT  +L+ H
Sbjct: 295 RPTFSELVEH 304

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G GA++ V R  H  T  + A+K  N     +   +      + +   ++ +V+     
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHGVRHLVH 205
               +    + +E+   GSL  +L    +   +PE     + + ++ G+++L     +VH
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVH 135
Query: 206 RDIKPANLL--VNLKGRP--KITDFGISAGLENSIAMCATFVGTVTYMSPE--------R 253
           R+IKP N++  +   G+   K+TDFG +  LE+     + + GT  Y+ P+        +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYERAVLRK 194
Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGP 288
              + Y    D+WSIG+  +   TG  P+   EGP
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G GA++ V R  H  T  + A+K  N     +   +      + +   ++ +V+     
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHGVRHLVH 205
               +    + +E+   GSL  +L    +   +PE     + + ++ G+++L     +VH
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVH 135
Query: 206 RDIKPANLL--VNLKGRP--KITDFGISAGLENSIAMCATFVGTVTYMSPE--------R 253
           R+IKP N++  +   G+   K+TDFG +  LE+       + GT  Y+ P+        +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY-GTEEYLHPDMYERAVLRK 194
Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGP 288
              + Y    D+WSIG+  +   TG  P+   EGP
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE---KRNQLLTEIRTLCEAPCN 138
           E+ +   +GSG   VV+       + + A+K I    KE     ++   E +T+ +   +
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI----KEGSMSEDEFFQEAQTMMKLS-H 62
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP-ILSSMFKKLLQGLSYL 197
             LV+F+G         I I  EY+  G L + LR      EP  L  M   + +G+++L
Sbjct: 63  PKLVKFYGV--CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERI 254
                 +HRD+   N LV+     K++DFG++  + +   + +  VGT   V + +PE  
Sbjct: 121 ES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAPEVF 177
Query: 255 RNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
               YS  +D+W+ G+ ++E    G+ PY        ++L++      S   + + P   
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKV------SQGHRLYRPHLA 230
Query: 314 S-----FVDDCLKKDAEARPTADQLLS 335
           S      +  C  +  E RPT  QLLS
Sbjct: 231 SDTIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 70  DHSEKTYRCASH-----EMRIFGAIGSGASSVVQRAVHIPTHRIIALKK-INIFEKEKRN 123
           D SEK  +  +      E+R    +GSG    V + V IP    I +   I + E +   
Sbjct: 15  DPSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR 74
Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP-I 182
           Q    +     A  +           +     + +  +Y+  GSL D +R  +    P +
Sbjct: 75  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 134
Query: 183 LSSMFKKLLQGLSYL--HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAM 238
           L +   ++ +G+ YL  HG   +VHR++   N+L+    + ++ DFG++  L  ++   +
Sbjct: 135 LLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE 297
            +     + +M+ E I    Y++ +D+WS G+ ++E  T G  PYA         L++ E
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG--------LRLAE 243
Query: 298 DPSPSPSRQNFS-PEFCSF-----VDDCLKKDAEARPTADQL 333
            P      +  + P+ C+      +  C   D   RPT  +L
Sbjct: 244 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 24/265 (9%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKK-INIFEKEKRNQLLTEIRTLCEAPCNEG 140
           E+R    +GSG    V + V IP    I +   I + E +   Q    +     A  +  
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP-ILSSMFKKLLQGLSYL-- 197
                    +     + +  +Y+  GSL D +R  +    P +L +   ++ +G+ YL  
Sbjct: 74  HAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIR 255
           HG   +VHR++   N+L+    + ++ DFG++  L  ++   + +     + +M+ E I 
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 256 NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS-PEFC 313
              Y++ +D+WS G+ ++E  T G  PYA         L++ E P      +  + P+ C
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAG--------LRLAEVPDLLEKGERLAQPQIC 242
Query: 314 SF-----VDDCLKKDAEARPTADQL 333
           +      +  C   D   RPT  +L
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 146
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 147 QHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206
Query: 275 C-GTGEFPYAASEGP-VNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 207 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 259

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 105
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 106 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 164
Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +             +   +M+PE I +  Y+  +D+
Sbjct: 165 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 225 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 283
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 284 SQRPTFSELVEH 295

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 82  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 140
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 141 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 201 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 253

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 142
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 143 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 255

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 88  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 146
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 147 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 207 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 259

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 114
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 173
Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +             +   +M+PE I +  Y+  +D+
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 293 SQRPTFSELVEH 304

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/299 (19%), Positives = 130/299 (43%), Gaps = 53/299 (17%)
Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           + ++   +G G  S V  A++I  +  + +K   I +  K+N++  EI+ L        +
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKNKIKREIKILENLRGGPNI 94
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +        P S   ++  E+++     D  ++ +++ +  +     ++L+ L Y H + 
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG 151
Query: 202 HLVHRDIKPANLLVNLKGRP-KITDFGISA----GLENSIAMCATFVGTVTYMSPERIRN 256
            ++HRD+KP N++++ + R  ++ D+G++     G E ++ + + +     +  PE + +
Sbjct: 152 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVD 205
Query: 257 -ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE------------------ 297
            + Y Y  D+WS+G  L      + P+       + +++I +                  
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 298 DPS-----------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
           DP                   S ++   SPE   F+D  L+ D ++R TA + + HP+ 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 152
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 153 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 213 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 265

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 110 ALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSL 168
           A+K++  +  K+       E+  LC+   +  ++   GA      G + +A+EY   G+L
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA--CEHRGYLYLAIEYAPHGNL 113
Query: 169 ADILRMQK--------SIPEPILSSMFKKLL--------QGLSYLHGVRHLVHRDIKPAN 212
            D LR  +        +I     S++  + L        +G+ YL   +  +HRD+   N
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-SQKQFIHRDLAARN 172
Query: 213 LLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
           +LV      KI DFG+S G E  +      +  V +M+ E +    Y+  +D+WS G+ L
Sbjct: 173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 273 FE-CGTGEFPYAASEGPVNLMLQILEDPSPSPSR----QNFSPEFCSFVDDCLKKDAEAR 327
           +E    G  PY        +    L +  P   R     N   E    +  C ++    R
Sbjct: 232 WEIVSLGGTPYCG------MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285
Query: 328 PTADQLL 334
           P+  Q+L
Sbjct: 286 PSFAQIL 292

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 111/252 (44%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 58  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 116
Query: 164 DGGSLADILRMQ-------KSIPEPILSSMFK---------KLLQGLSYLHGVRHLVHRD 207
             G+L+  LR +       K  PE +               ++ +G+ +L   R  +HRD
Sbjct: 117 KFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 175
Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+
Sbjct: 176 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 235
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 236 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 294
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 295 SQRPTFSELVEH 306

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 110 ALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSL 168
           A+K++  +  K+       E+  LC+   +  ++   GA      G + +A+EY   G+L
Sbjct: 46  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA--CEHRGYLYLAIEYAPHGNL 103
Query: 169 ADILRMQK--------SIPEPILSSMFKKLL--------QGLSYLHGVRHLVHRDIKPAN 212
            D LR  +        +I     S++  + L        +G+ YL   +  +HRD+   N
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-SQKQFIHRDLAARN 162
Query: 213 LLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
           +LV      KI DFG+S G E  +      +  V +M+ E +    Y+  +D+WS G+ L
Sbjct: 163 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLL 221
Query: 273 FE-CGTGEFPYAASEGPVNLMLQILEDPSPSPSR----QNFSPEFCSFVDDCLKKDAEAR 327
           +E    G  PY        +    L +  P   R     N   E    +  C ++    R
Sbjct: 222 WEIVSLGGTPYCG------MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 275
Query: 328 PTADQLL 334
           P+  Q+L
Sbjct: 276 PSFAQIL 282

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 102 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 160
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 161 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 221 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 273

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 114/252 (45%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 114
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 173
Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 293 SQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 114/252 (45%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 114
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 173
Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 293 SQRPTFSELVEH 304

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 89/179 (49%), Gaps = 21/179 (11%)
Query: 180 EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-----KGRPKITDFGISAGL-- 232
           EPI  ++ ++   GL++LH + ++VHRD+KP N+L+++     K +  I+DFG+   L  
Sbjct: 119 EPI--TLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 233 -ENSIAMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFEC-GTGEFPYAAS-E 286
             +S +  +   GT  +++PE +     E+ +Y  DI+S G   +     G  P+  S +
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235
Query: 287 GPVNLMLQI--LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
              N++L    L+   P       + E    ++  +  D + RP+A  +L HPF    E
Sbjct: 236 RQANILLGACSLDCLHPEKHEDVIARE---LIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 104 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 162
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 163 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 223 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 275

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 104 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT 162
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 163 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222
Query: 275 C-GTGEFPYAASEG-PVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 223 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 275

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 114/252 (45%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + + +E+ 
Sbjct: 93  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC 151
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 152 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 210
Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+
Sbjct: 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 329
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 330 SQRPTFSELVEH 341

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 504
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 505 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564
Query: 275 C-GTGEFPYAASEGP-VNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 565 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 617

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + VHRD+   N+L+  
Sbjct: 447 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVT 505
Query: 218 KGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
           +   KI+DFG+S  L   EN           V + +PE I    +S  +D+WS G+ ++E
Sbjct: 506 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565
Query: 275 C-GTGEFPYAASEGP-VNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
               G+ PY   +G  V  ML+  E    P+  P       E    ++ C   D E RP
Sbjct: 566 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------EMYDLMNLCWTYDVENRP 618

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 120/269 (44%), Gaps = 29/269 (10%)
Query: 79  ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRT------L 132
           A +E+     IG G   +V +   +    ++A+K + + + E   +++ + +       +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
                +  +V+ +G  + P      + +E++  G L   L + K+   PI  S+  +L+ 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRL-LDKA--HPIKWSVKLRLML 129
Query: 193 ----GLSYLHGVRH-LVHRDIKPANLLV-----NLKGRPKITDFGISAGLENSIAMCATF 242
               G+ Y+      +VHRD++  N+ +     N     K+ DFG+S   + S+   +  
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGL 186
Query: 243 VGTVTYMSPERI--RNESYSYPADIWSIGLALFECGTGEFPY-AASEGPVNLMLQILEDP 299
           +G   +M+PE I    ESY+  AD +S  + L+   TGE P+   S G +  +  I E+ 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
                 ++  P   + ++ C   D + RP
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCA 240
           L S   ++ QG+ YL  ++ LVHRD+   N+LV    + KI+DFG+S  +  E+S    +
Sbjct: 152 LISFAWQISQGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDP 299
                V +M+ E + +  Y+  +D+WS G+ L+E  T G  PY     P   +  +L+  
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTG 268
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
                  N S E    +  C K++ + RP 
Sbjct: 269 HRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCA 240
           L S   ++ QG+ YL  ++ LVHRD+   N+LV    + KI+DFG+S  +  E+S    +
Sbjct: 152 LISFAWQISQGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDP 299
                V +M+ E + +  Y+  +D+WS G+ L+E  T G  PY     P   +  +L+  
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTG 268
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
                  N S E    +  C K++ + RP 
Sbjct: 269 HRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 112/252 (44%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + +  E+ 
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVITEFC 105
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 106 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 164
Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTV--TYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +             +   +M+PE I +  Y+  +D+
Sbjct: 165 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 225 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 283
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 284 SQRPTFSELVEH 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + +  E+ 
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVITEFC 105
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 106 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 164
Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+
Sbjct: 165 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 225 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 283
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 284 SQRPTFSELVEH 295

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 156 ISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + + +E   GG L   L  ++  IP   ++ +  ++  G+ YL   ++ VHR++   N+L
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVL 468
Query: 215 VNLKGRPKITDFGISAGL-ENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLA 271
           +  +   KI+DFG+S  L  +     A   G   + + +PE I    +S  +D+WS G+ 
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 272 LFEC-GTGEFPYAASEGPVNLML----QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
           ++E    G+ PY   +GP  +      + +E P   P      PE  + + DC     E 
Sbjct: 529 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP------PELYALMSDCWIYKWED 582
Query: 327 RP 328
           RP
Sbjct: 583 RP 584

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 105 THRIIALKKINIFEKEKRNQ-LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYM 163
           T R +A+K +        ++ L++E++ L     +  +V   GA   P  G + +  E+ 
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVITEFC 105
Query: 164 DGGSLADILRMQKS--IPEPIL-SSMFKKLL-------------QGLSYLHGVRHLVHRD 207
             G+L+  LR +++  +P  +    ++K  L             +G+ +L   R  +HRD
Sbjct: 106 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRD 164
Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +   N+L++ K   KI DFG++  +  +            + +M+PE I +  Y+  +D+
Sbjct: 165 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 266 WSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           WS G+ L+E    G  PY   +       + L++ +   +    +PE    + DC   + 
Sbjct: 225 WSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEP 283
Query: 325 EARPTADQLLSH 336
             RPT  +L+ H
Sbjct: 284 SQRPTFSELVEH 295

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVE 143
              IG G    V +A H  T + +ALKK+ + E EK    +T +R   + +   +E +V 
Sbjct: 23  LAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 144 F------HGAFYMPDSGQISIALEYMD---GGSLADILRMQKSIPEPILSSMFKKLLQGL 194
                    + Y    G I +  ++ +    G L+++L ++ ++ E  +  + + LL GL
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSE--IKRVMQMLLNGL 138
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA------TFVGTVTY 248
            Y+H  + ++HRD+K AN+L+   G  K+ DFG++     S+A  +        V T+ Y
Sbjct: 139 YYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYXNRVVTLWY 195
Query: 249 MSPERIRNE-SYSYPADIWSIGLALFECGT 277
             PE +  E  Y  P D+W  G  + E  T
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 107 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 165
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 166 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 225
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 226 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 279
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 280 PSFSELVS 287

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 128/334 (38%), Gaps = 70/334 (20%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-------PC 137
           +   +G G  S V  +  I   + +A+K +   E      L  EIR L          P 
Sbjct: 25  VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-DEIRLLKSVRNSDPNDPN 83
Query: 138 NEGLVEFHGAFYMP--DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGL 194
            E +V+    F +   +   I +  E +    L  I++   + +P P +  + +++LQGL
Sbjct: 84  REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 143
Query: 195 SYLHGVRHLVHRDIKPANLLVNLK-----------------GRPKITDFGIS-------- 229
            YLH    ++H DIKP N+L+++                  G P  +   +S        
Sbjct: 144 DYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 203
Query: 230 ------------------AGLENSIAMCATF---VGTVTYMSPERIRNESYSYPADIWSI 268
                             A L N+  +   F   + T  Y S E +    Y+ PADIWS 
Sbjct: 204 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWST 263
Query: 269 GLALFECGTGEF--------PYAASEGPVNLMLQIL-EDPSPSPSRQNFSPEFCSFVDDC 319
               FE  TG++         Y   E  + L++++L + P        +S EF +   D 
Sbjct: 264 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD- 322
Query: 320 LKKDAEARPTADQLLSHPFITKYEHAKVDLAAFV 353
           LK   + +P     L    + KYE ++ + A F 
Sbjct: 323 LKHITKLKPWG---LFEVLVEKYEWSQEEAAGFT 353

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVE 143
              IG G    V +A H  T + +ALKK+ + E EK    +T +R   + +   +E +V 
Sbjct: 22  LAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 144 F------HGAFYMPDSGQISIALEYMD---GGSLADILRMQKSIPEPILSSMFKKLLQGL 194
                    + Y    G I +  ++ +    G L+++L ++ ++ E  +  + + LL GL
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSE--IKRVMQMLLNGL 137
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIA-MCATFVGTVTYMS 250
            Y+H  + ++HRD+K AN+L+   G  K+ DFG++      +NS        V T+ Y  
Sbjct: 138 YYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 251 PERIRNE-SYSYPADIWSIGLALFECGT 277
           PE +  E  Y  P D+W  G  + E  T
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 108 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 166
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 167 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 226
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 227 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 280
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 281 PSFSELVS 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 17/192 (8%)
Query: 154 GQISIALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN 212
           G   + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N
Sbjct: 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARN 158
Query: 213 LLVNLKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSI 268
            +++ K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS 
Sbjct: 159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218
Query: 269 GLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKD 323
           G+ L+E  T   P        ++ + +L+       R+   PE+C       +  C    
Sbjct: 219 GVLLWELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPK 272
Query: 324 AEARPTADQLLS 335
           AE RP+  +L+S
Sbjct: 273 AEMRPSFSELVS 284

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 109 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 167
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 168 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 228 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 281
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 282 PSFSELVS 289

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/339 (22%), Positives = 126/339 (37%), Gaps = 71/339 (20%)
Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
           D+  + +  +   ++   +   IG G    V +A     H+ +ALK +   EK    Q  
Sbjct: 83  DQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAA 141
Query: 127 TEIRTL---CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK--SIPEP 181
            EIR L    +   +  +   H          I +  E +   +L ++++  K      P
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP 200
Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP--KITDFGISAGLENSIAMC 239
           ++      +LQ L  LH  R ++H D+KP N+L+  +GR   K+ DFG S      +   
Sbjct: 201 LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-- 257
Query: 240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE---GPVNLMLQIL 296
              + +  Y +PE I    Y  P D+WS+G  L E  TG +P    E     +  M+++L
Sbjct: 258 -XXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELL 315
Query: 297 EDP-----SPSPSRQNFS-----PEFCS-------------------------------- 314
             P       S   +NF      P +C+                                
Sbjct: 316 GMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN 375
Query: 315 ------------FVDDCLKKDAEARPTADQLLSHPFITK 341
                       F+  CL+ D   R T  Q L HP++ +
Sbjct: 376 ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 90  GSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY 149
           G G    VQ      T   +A+KK+ I +   RN+ L  ++ L     +  +V+    FY
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLA-VLHHPNIVQLQSYFY 89
Query: 150 M---PDSGQI--SIALEYMDGGSLADILR---MQKSIPEPILSSMFK-KLLQGLSYLH-G 199
                D   I  ++ +EY+   +L    R    ++  P PIL  +F  +L++ +  LH  
Sbjct: 90  TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 200 VRHLVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNE 257
             ++ HRDIKP N+LVN   G  K+ DFG +  L  S    A ++ +  Y +PE I  N+
Sbjct: 149 SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-YICSRYYRAPELIFGNQ 207
Query: 258 SYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS 300
            Y+   DIWS+G    E   GE  F    S G ++ ++++L  PS
Sbjct: 208 HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 32/277 (11%)
Query: 86  FG-AIGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKRNQLLTEIRTLCEAPCN 138
           FG  +G+GA   V  A      +  A+ K+ +         +++  L++E++ +     +
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-----------SIPEPILSS-- 185
           E +V   GA      G + +  EY   G L + LR ++             PE  LSS  
Sbjct: 110 ENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 186 ---MFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCA 240
                 ++ QG+++L   ++ +HRD+   N+L+      KI DFG++  + N  +  +  
Sbjct: 168 LLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDP 299
                V +M+PE I +  Y+  +D+WS G+ L+E    G  PY      VN     L   
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--VNSKFYKLVKD 284
Query: 300 SPSPSRQNFSPE-FCSFVDDCLKKDAEARPTADQLLS 335
               ++  F+P+   S +  C   +   RPT  Q+ S
Sbjct: 285 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 321

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 109 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 167
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 168 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 228 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 281
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 282 PSFSELVS 289

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 128/334 (38%), Gaps = 70/334 (20%)
Query: 85  IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-------PC 137
           +   +G G  S V  +  I   + +A+K +   E      L  EIR L          P 
Sbjct: 41  VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-DEIRLLKSVRNSDPNDPN 99
Query: 138 NEGLVEFHGAFYMP--DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGL 194
            E +V+    F +   +   I +  E +    L  I++   + +P P +  + +++LQGL
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 195 SYLHGVRHLVHRDIKPANLLVNLK-----------------GRPKITDFGIS-------- 229
            YLH    ++H DIKP N+L+++                  G P  +   +S        
Sbjct: 160 DYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 230 ------------------AGLENSIAMCATF---VGTVTYMSPERIRNESYSYPADIWSI 268
                             A L N+  +   F   + T  Y S E +    Y+ PADIWS 
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWST 279
Query: 269 GLALFECGTGEF--------PYAASEGPVNLMLQIL-EDPSPSPSRQNFSPEFCSFVDDC 319
               FE  TG++         Y   E  + L++++L + P        +S EF +   D 
Sbjct: 280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD- 338
Query: 320 LKKDAEARPTADQLLSHPFITKYEHAKVDLAAFV 353
           LK   + +P     L    + KYE ++ + A F 
Sbjct: 339 LKHITKLKPWG---LFEVLVEKYEWSQEEAAGFT 369

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 108 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 166
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 167 EKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 226
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 227 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 280
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 281 PSFSELVS 288

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVE 143
              IG G    V +A H  T + +ALKK+ + E EK    +T +R   + +   +E +V 
Sbjct: 23  LAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 144 F------HGAFYMPDSGQISIALEYMD---GGSLADILRMQKSIPEPILSSMFKKLLQGL 194
                    + Y    G I +  ++ +    G L+++L ++ ++ E  +  + + LL GL
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSE--IKRVMQMLLNGL 138
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA------TFVGTVTY 248
            Y+H  + ++HRD+K AN+L+   G  K+ DFG++     S+A  +        V T+ Y
Sbjct: 139 YYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYXNRVVTLWY 195
Query: 249 MSPERIRNE-SYSYPADIWSIGLALFECGT 277
             PE +  E  Y  P D+W  G  + E  T
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 17/192 (8%)
Query: 154 GQISIALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN 212
           G   + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N
Sbjct: 97  GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARN 155
Query: 213 LLVNLKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSI 268
            +++ K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS 
Sbjct: 156 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 215
Query: 269 GLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKD 323
           G+ L+E  T   P        ++ + +L+       R+   PE+C       +  C    
Sbjct: 216 GVLLWELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPK 269
Query: 324 AEARPTADQLLS 335
           AE RP+  +L+S
Sbjct: 270 AEMRPSFSELVS 281

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 79  ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRT------L 132
           A +E+     IG G   +V +   +    ++A+K + + + E   +++ + +       +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
                +  +V+ +G  + P      + +E++  G L   L + K+   PI  S+  +L+ 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRL-LDKA--HPIKWSVKLRLML 129
Query: 193 ----GLSYLHGVRH-LVHRDIKPANLLV-----NLKGRPKITDFGISAGLENSIAMCATF 242
               G+ Y+      +VHRD++  N+ +     N     K+ DFG S   + S+   +  
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGL 186
Query: 243 VGTVTYMSPERI--RNESYSYPADIWSIGLALFECGTGEFPY-AASEGPVNLMLQILEDP 299
           +G   +M+PE I    ESY+  AD +S  + L+   TGE P+   S G +  +  I E+ 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
                 ++  P   + ++ C   D + RP
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 127 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 185
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 186 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 245
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 246 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 299
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 300 PSFSELVS 307

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 164
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 165 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 279 PSFSELVS 286

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ YL   +  VHRD+   N +++
Sbjct: 128 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD 186
Query: 217 LKGRPKITDFGISAGLEN----SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  + +    S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 187 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 246
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 247 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 300
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 301 PSFSELVS 308

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 110 ALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSL 168
           A+K++  +  K+       E+  LC+   +  ++   GA      G + +A+EY   G+L
Sbjct: 53  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA--CEHRGYLYLAIEYAPHGNL 110
Query: 169 ADILRMQK--------SIPEPILSSMFKKLL--------QGLSYLHGVRHLVHRDIKPAN 212
            D LR  +        +I     S++  + L        +G+ YL   +  +HR++   N
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-SQKQFIHRNLAARN 169
Query: 213 LLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
           +LV      KI DFG+S G E  +      +  V +M+ E +    Y+  +D+WS G+ L
Sbjct: 170 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLL 228
Query: 273 FE-CGTGEFPYAASEGPVNLMLQILEDPSPSPSR----QNFSPEFCSFVDDCLKKDAEAR 327
           +E    G  PY        +    L +  P   R     N   E    +  C ++    R
Sbjct: 229 WEIVSLGGTPYCG------MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 282
Query: 328 PTADQLL 334
           P+  Q+L
Sbjct: 283 PSFAQIL 289

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 26/271 (9%)
Query: 86  FG-AIGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKRNQLLTEIRTLCEAPCN 138
           FG  +G+GA   V  A      +  A+ K+ +         +++  L++E++ +     +
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR------MQKSIPEPI----LSSMFK 188
           E +V   GA      G + +  EY   G L + LR      + K    P+    L     
Sbjct: 110 ENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTV 246
           ++ QG+++L   ++ +HRD+   N+L+      KI DFG++  + N  +  +       V
Sbjct: 168 QVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
            +M+PE I +  Y+  +D+WS G+ L+E    G  PY      VN     L       ++
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI--LVNSKFYKLVKDGYQMAQ 284
Query: 306 QNFSPE-FCSFVDDCLKKDAEARPTADQLLS 335
             F+P+   S +  C   +   RPT  Q+ S
Sbjct: 285 PAFAPKNIYSIMQACWALEPTHRPTFQQICS 315

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCA 240
           L S   ++ QG+ YL  +  LVHRD+   N+LV    + KI+DFG+S  +  E+S    +
Sbjct: 152 LISFAWQISQGMQYLAEM-SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDP 299
                V +M+ E + +  Y+  +D+WS G+ L+E  T G  PY     P   +  +L+  
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTG 268
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
                  N S E    +  C K++ + RP 
Sbjct: 269 HRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 21  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 79
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 80  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 137 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 195
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 196 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 253
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 254 ----LLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 26/271 (9%)
Query: 86  FG-AIGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKRNQLLTEIRTLCEAPCN 138
           FG  +G+GA   V  A      +  A+ K+ +         +++  L++E++ +     +
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR------MQKSIPEPI----LSSMFK 188
           E +V   GA      G + +  EY   G L + LR      + K    P+    L     
Sbjct: 102 ENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTV 246
           ++ QG+++L   ++ +HRD+   N+L+      KI DFG++  + N  +  +       V
Sbjct: 160 QVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
            +M+PE I +  Y+  +D+WS G+ L+E    G  PY      VN     L       ++
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI--LVNSKFYKLVKDGYQMAQ 276
Query: 306 QNFSPE-FCSFVDDCLKKDAEARPTADQLLS 335
             F+P+   S +  C   +   RPT  Q+ S
Sbjct: 277 PAFAPKNIYSIMQACWALEPTHRPTFQQICS 307

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 88/171 (51%), Gaps = 18/171 (10%)
Query: 138 NEGLVEFHGAFYMPDSGQ--ISIALEYMDG---GSLADILRMQKSIPEPILSSMFKKLLQ 192
           N G+   H +  +  S    +++ +EY+       L   +R  +SIP  ++S    +L +
Sbjct: 93  NNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152
Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRP-KITDFGISAGL---ENSIA-MCATFVGTVT 247
            + ++H +  + HRDIKP NLLVN K    K+ DFG +  L   E S+A +C+ F     
Sbjct: 153 AVGFIHSLG-ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF----- 206
Query: 248 YMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
           Y +PE +   + Y+   D+WSIG    E   G+ P  + E  ++ +++I++
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQ 256

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 126/275 (45%), Gaps = 30/275 (10%)
Query: 56  LGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKIN 115
           + L K T+ +A      ++    +  + ++   IG+G+  VV +A    +  ++A+KK+ 
Sbjct: 3   MSLSKVTTVVATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV- 58
Query: 116 IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY----MPDSGQISIALEYMDGGSLA-- 169
           + +K  +N+ L  +R L    CN  +V     FY      D   +++ L+Y+        
Sbjct: 59  LQDKRFKNRELQIMRKLDH--CN--IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 114
Query: 170 -DILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFG 227
               R ++++P   +     +L + L+Y+H    + HRDIKP NLL++      K+ DFG
Sbjct: 115 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFG 173
Query: 228 ----ISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPY 282
               +  G  N   +C+ +     Y +PE I   + Y+   D+WS G  L E   G+  +
Sbjct: 174 SAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228
Query: 283 AASEGPVNL--MLQILEDPSPSPSRQNFSPEFCSF 315
               G   L  ++++L  P+    R+  +P +  F
Sbjct: 229 PGDSGVDQLVEIIKVLGTPTREQIRE-MNPNYTEF 262

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGL 141
           R    +G G    V +A+   T+  +A+K+I + E E+     T IR  +L +   +  +
Sbjct: 37  RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +E     +   + ++ +  EY +   L   +     +   ++ S   +L+ G+++ H  R
Sbjct: 96  IELKSVIH--HNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 202 HLVHRDIKPANLLVNLKGRP-----KITDFGISAGLENSIAMCATFVGTVTYMSPE-RIR 255
             +HRD+KP NLL+++         KI DFG++      I      + T+ Y  PE  + 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 256 NESYSYPADIWSIG 269
           +  YS   DIWSI 
Sbjct: 212 SRHYSTSVDIWSIA 225

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 30  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 88
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 89  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 146 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 204
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 262
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 263 ----LFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 110 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 168
Query: 217 LKGRPKITDFGISAG-LENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++   L+          G    V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 169 EKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 228
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 229 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 282
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 283 PSFSELVS 290

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 23/234 (9%)
Query: 120 EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIP 179
           +++  L++E++ +     +E +V   GA      G + +  EY   G L + LR +  + 
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 180 E-----PILSSMFK---------KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
           E      I +S            ++ QG+++L   ++ +HRD+   N+L+      KI D
Sbjct: 149 ETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 226 FGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPY 282
           FG++  + N  +  +       V +M+PE I +  Y+  +D+WS G+ L+E    G  PY
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPE-FCSFVDDCLKKDAEARPTADQLLS 335
                 VN     L       ++  F+P+   S +  C   +   RPT  Q+ S
Sbjct: 268 PGI--LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 125/273 (45%), Gaps = 30/273 (10%)
Query: 58  LQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF 117
           L K T+ +A      ++    +  + ++   IG+G+  VV +A    +  ++A+KK+ + 
Sbjct: 1   LSKVTTVVATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV-LQ 56
Query: 118 EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY----MPDSGQISIALEYMDGGSLA---D 170
           +K  +N+ L  +R L    CN  +V     FY      D   +++ L+Y+          
Sbjct: 57  DKRFKNRELQIMRKLDH--CN--IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 112
Query: 171 ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFG-- 227
             R ++++P   +     +L + L+Y+H    + HRDIKP NLL++      K+ DFG  
Sbjct: 113 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSA 171
Query: 228 --ISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAA 284
             +  G  N   +C+ +     Y +PE I   + Y+   D+WS G  L E   G+  +  
Sbjct: 172 KQLVRGEPNVSXICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 226
Query: 285 SEGPVNL--MLQILEDPSPSPSRQNFSPEFCSF 315
             G   L  ++++L  P+    R+  +P +  F
Sbjct: 227 DSGVDQLVEIIKVLGTPTREQIRE-MNPNYTEF 258

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 114 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 172
Query: 217 LKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  +     +S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 173 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 232
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 233 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 286
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 287 PSFSELVS 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 107 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 165
Query: 217 LKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  +     +S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 166 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 225
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 226 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 279
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 280 PSFSELVS 287

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 110 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 168
Query: 217 LKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  +     +S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 169 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 228
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 229 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 282
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 283 PSFSELVS 290

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 109 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 167
Query: 217 LKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  +     +S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 168 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 228 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 281
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 282 PSFSELVS 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 109 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 167
Query: 217 LKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  +     +S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 168 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 227
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 228 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 281
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 282 PSFSELVS 289

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---- 176
           +R  L++E++ L     +  +V   GA  +   G   +  EY   G L + LR ++    
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 177 -SIPEPIL-------------SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
            S   P +              S   ++ +G+++L   ++ +HRD+   N+L+      K
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITK 185
Query: 223 ITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGE 279
           I DFG++  ++N  +  +       V +M+PE I N  Y++ +D+WS G+ L+E    G 
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 280 FPYAASEGPVN-LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            PY     PV+    +++++     S ++   E    +  C   D   RPT  Q++
Sbjct: 246 SPYPGM--PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---- 176
           +R  L++E++ L     +  +V   GA  +   G   +  EY   G L + LR ++    
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 177 -SIPEPIL-------------SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
            S   P +              S   ++ +G+++L   ++ +HRD+   N+L+      K
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITK 208
Query: 223 ITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGE 279
           I DFG++  ++N  +  +       V +M+PE I N  Y++ +D+WS G+ L+E    G 
Sbjct: 209 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 280 FPYAASEGPVN-LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            PY     PV+    +++++     S ++   E    +  C   D   RPT  Q++
Sbjct: 269 SPYPGM--PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 11/178 (6%)
Query: 158 IALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  EYM  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 105 IVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 163
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +   ++S  +D+W+ G+ L
Sbjct: 164 GENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNTFSIKSDVWAFGVLL 221
Query: 273 FECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
           +E  T G  PY   +  ++ +  +LE        +   P+    +  C K     RP+
Sbjct: 222 WEIATYGMSPYPGID--LSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPS 277

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 85  VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 143
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 144 VSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 204 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 261
Query: 333 L 333
           L
Sbjct: 262 L 262

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---- 176
           +R  L++E++ L     +  +V   GA  +   G   +  EY   G L + LR ++    
Sbjct: 85  EREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFI 142
Query: 177 -SIPEPIL-------------SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
            S   P +              S   ++ +G+++L   ++ +HRD+   N+L+      K
Sbjct: 143 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITK 201
Query: 223 ITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGE 279
           I DFG++  ++N  +  +       V +M+PE I N  Y++ +D+WS G+ L+E    G 
Sbjct: 202 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 261
Query: 280 FPYAASEGPVN-LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            PY     PV+    +++++     S ++   E    +  C   D   RPT  Q++
Sbjct: 262 SPYPGM--PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 85  VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 143
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 144 VSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 204 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 261
Query: 333 L 333
           L
Sbjct: 262 L 262

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 45/234 (19%)
Query: 138 NEGLVEFHGAFYMPDSGQISIAL--EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
           +E +++F GA     S  + + L   + + GSL+D L+    +    L  + + + +GL+
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLA 135
Query: 196 YLH----GVRH-----LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF--VG 244
           YLH    G++      + HRDIK  N+L+       I DFG++   E   +   T   VG
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 245 TVTYMSPERIRNE-SYSYPA----DIWSIGLALFECGTGEFPYAASEGPVN-LMLQILED 298
           T  YM+PE +    ++   A    D++++GL L+E  +      A++GPV+  ML   E+
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS---RCTAADGPVDEYMLPFEEE 252
Query: 299 PSPSPSRQNFS----------------------PEFCSFVDDCLKKDAEARPTA 330
               PS ++                           C  +++C   DAEAR +A
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---- 176
           +R  L++E++ L     +  +V   GA  +   G   +  EY   G L + LR ++    
Sbjct: 87  EREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFI 144
Query: 177 -SIPEPIL-------------SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
            S   P +              S   ++ +G+++L   ++ +HRD+   N+L+      K
Sbjct: 145 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITK 203
Query: 223 ITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGE 279
           I DFG++  ++N  +  +       V +M+PE I N  Y++ +D+WS G+ L+E    G 
Sbjct: 204 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 263
Query: 280 FPYAASEGPVN-LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            PY     PV+    +++++     S ++   E    +  C   D   RPT  Q++
Sbjct: 264 SPYPGM--PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 23/234 (9%)
Query: 120 EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIP 179
           +++  L++E++ +     +E +V   GA      G + +  EY   G L + LR +  + 
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 180 EPI--------------LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
           E                L     ++ QG+++L   ++ +HRD+   N+L+      KI D
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 226 FGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPY 282
           FG++  + N  +  +       V +M+PE I +  Y+  +D+WS G+ L+E    G  PY
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPE-FCSFVDDCLKKDAEARPTADQLLS 335
                 VN     L       ++  F+P+   S +  C   +   RPT  Q+ S
Sbjct: 268 PGI--LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 158 IALEYMDGGSLADILRMQKSIPE-PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L + +R +   P    L     ++ +G+ +L   +  VHRD+   N +++
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD 226
Query: 217 LKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
            K   K+ DFG++  +     +S+         V +M+ E ++ + ++  +D+WS G+ L
Sbjct: 227 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
Query: 273 FECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC-----SFVDDCLKKDAEAR 327
           +E  T   P        ++ + +L+       R+   PE+C       +  C    AE R
Sbjct: 287 WELMTRGAPPYPDVNTFDITVYLLQ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
Query: 328 PTADQLLS 335
           P+  +L+S
Sbjct: 341 PSFSELVS 348

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 29  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 87
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 88  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 145 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 261
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 262 ----LFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 93
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 154 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 207
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 266
Query: 313 CSF 315
             F
Sbjct: 267 TEF 269

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 30  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 88
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 89  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 146 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 204
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 262
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 263 ----LFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 35  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 89
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 149
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 150 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 203
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 262
Query: 313 CSF 315
             F
Sbjct: 263 TEF 265

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 116
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 117 GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 174 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 232
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 290
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 291 ----LFELMRMCWQYNPKMRPSFLEIIS 314

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/269 (21%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 79  ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRT------L 132
           A +E+     IG G   +V +   +    ++A+K + + + E   +++ + +       +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 133 CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ 192
                +  +V+ +G  + P      + +E++  G L   L + K+   PI  S+  +L+ 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRL-LDKA--HPIKWSVKLRLML 129
Query: 193 ----GLSYLHGVRH-LVHRDIKPANLLV-----NLKGRPKITDFGISAGLENSIAMCATF 242
               G+ Y+      +VHRD++  N+ +     N     K+ DF +S   + S+   +  
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGL 186
Query: 243 VGTVTYMSPERI--RNESYSYPADIWSIGLALFECGTGEFPY-AASEGPVNLMLQILEDP 299
           +G   +M+PE I    ESY+  AD +S  + L+   TGE P+   S G +  +  I E+ 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
                 ++  P   + ++ C   D + RP
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 46  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 100
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 160
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 161 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 214
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 273
Query: 313 CSF 315
             F
Sbjct: 274 TEF 276

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 523
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 524 VSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 584 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641
Query: 333 L 333
           L
Sbjct: 642 L 642

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 29  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 87
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 88  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 145 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 261
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 262 ----LFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 121 KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---- 176
           +R  L++E++ L     +  +V   GA  +   G   +  EY   G L + LR ++    
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 177 -SIPEPIL-------------SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK 222
            S   P +              S   ++ +G+++L   ++ +HRD+   N+L+      K
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITK 208
Query: 223 ITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGE 279
           I DFG++  ++N  +  +       V +M+PE I N  Y++ +D+WS G+ L+E    G 
Sbjct: 209 ICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 280 FPYAASEGPVN-LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            PY     PV+    +++++     S ++   E    +  C   D   RPT  Q++
Sbjct: 269 SPYPGM--PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 23  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 81
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 82  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 139 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 255
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 256 ----LFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 93
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 154 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 207
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 266
Query: 313 CSF 315
             F
Sbjct: 267 TEF 269

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 31  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 85
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 145
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 146 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 199
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 258
Query: 313 CSF 315
             F
Sbjct: 259 TEF 261

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 94
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 95  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 152 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 268
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 269 ----LFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 85  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 143
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 144 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 204 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 261
Query: 333 L 333
           L
Sbjct: 262 L 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 82  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 140
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 141 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 201 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 258
Query: 333 L 333
           L
Sbjct: 259 L 259

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 27  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 85
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 86  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 143 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 201
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 202 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 259
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 260 ----LFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 26  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 84
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILRMQKS-------IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR  +        +  P LS M +   ++  G+
Sbjct: 85  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 142 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 200
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 201 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 258
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 259 ----LFELMRMCWQYNPKMRPSFLEIIS 282

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 85  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 143
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 144 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 204 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 261
Query: 333 L 333
           L
Sbjct: 262 L 262

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 94
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILRMQKS-------IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR  +        +  P LS M +   ++  G+
Sbjct: 95  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N +V      KI DFG++  +  +        G   V +MSPE
Sbjct: 152 AYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 268
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 269 ----LFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 90  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 148
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 149 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 209 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 266
Query: 333 L 333
           L
Sbjct: 267 L 267

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 86  FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVE 143
              IG G    V +A H  T + +ALKK+ + E EK    +T +R   + +   +E +V 
Sbjct: 23  LAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 144 F------HGAFYMPDSGQISIALEYMD---GGSLADILRMQKSIPEPILSSMFKKLLQGL 194
                    + Y      I +  ++ +    G L+++L ++ ++ E  +  + + LL GL
Sbjct: 82  LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL-VKFTLSE--IKRVMQMLLNGL 138
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA------TFVGTVTY 248
            Y+H  + ++HRD+K AN+L+   G  K+ DFG++     S+A  +        V T+ Y
Sbjct: 139 YYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYXNRVVTLWY 195
Query: 249 MSPERIRNE-SYSYPADIWSIGLALFECGT 277
             PE +  E  Y  P D+W  G  + E  T
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 115
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 229
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 288
Query: 313 CSF 315
             F
Sbjct: 289 TEF 291

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 88  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 146
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 147 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 206
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 207 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 264
Query: 333 L 333
           L
Sbjct: 265 L 265

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 40  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 94
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 154
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 155 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 208
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 267
Query: 313 CSF 315
             F
Sbjct: 268 TEF 270

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 87  VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 145
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 146 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 205
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 206 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 263
Query: 333 L 333
           L
Sbjct: 264 L 264

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 109
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 169
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 170 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 223
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 282
Query: 313 CSF 315
             F
Sbjct: 283 TEF 285

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 523
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 584 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641
Query: 333 L 333
           L
Sbjct: 642 L 642

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + I +E    G L   L+++K S+    L     +L   L+YL   R  VHRDI   N+L
Sbjct: 113 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVL 171
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT-VTYMSPERIRNESYSYPADIWSIGLALF 273
           V+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  +D+W  G+ ++
Sbjct: 172 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 231
Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQ 332
           E    G  P+   +   N ++  +E+    P   N  P   S +  C   D   RP   +
Sbjct: 232 EILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 289
Query: 333 L 333
           L
Sbjct: 290 L 290

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK---KLLQGL 194
           +E +V++ G         I + +E++  GSL + L   K+  +  L    K   ++ +G+
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGM 139
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT---FVGTVTYMSP 251
            YL G R  VHRD+   N+LV  + + KI DFG++  +E               V + +P
Sbjct: 140 DYL-GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-GPVNLMLQIL 296
           E +    +   +D+WS G+ L E  T    Y  S+  P+ L L+++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMI 240

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK---KLLQGL 194
           +E +V++ G         I + +E++  GSL + L   K+  +  L    K   ++ +G+
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGM 127
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT---FVGTVTYMSP 251
            YL G R  VHRD+   N+LV  + + KI DFG++  +E               V + +P
Sbjct: 128 DYL-GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-GPVNLMLQIL 296
           E +    +   +D+WS G+ L E  T    Y  S+  P+ L L+++
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMI 228

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 115
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 229
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 288
Query: 313 CSF 315
             F
Sbjct: 289 TEF 291

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 117
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 177
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 178 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 231
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 290
Query: 313 CSF 315
             F
Sbjct: 291 TEF 293

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 58/112 (51%), Gaps = 11/112 (9%)
Query: 177 SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGISAGL 232
            +P  ++ S+  ++L G+ YLH    ++HRD+KPAN+LV      +GR KI D G  A L
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARL 181
Query: 233 ENS----IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE 279
            NS    +A     V T  Y +PE +     Y+   DIW+IG    E  T E
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYF 160
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 220
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 221 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 274
Query: 256 NES-YSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  FP  +    +  ++++L  P+    R+  +P +
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 333
Query: 313 CSF 315
             F
Sbjct: 334 TEF 336

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 27/242 (11%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG+G+  VV +A    +  ++A+KK+ + +K  +N+ L  +R L    CN  +V     F
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMRKLDH--CN--IVRLRYFF 120
Query: 149 Y----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           Y      D   +++ L+Y+            R ++++P   +     +L + L+Y+H   
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 179
Query: 202 HLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIRN 256
            + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I  
Sbjct: 180 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFG 234
Query: 257 ES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEFC 313
            + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P + 
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNYT 293
Query: 314 SF 315
            F
Sbjct: 294 EF 295

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ +  K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 118/268 (44%), Gaps = 30/268 (11%)
Query: 87  GAIGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           G+ G     V +  V       +A+K +N      +R + L E   + E  C+  +V   
Sbjct: 23  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLL 81
Query: 146 GAFYMPDSGQIS-IALEYMDGGSLADILR-----MQKS--IPEPILSSMFK---KLLQGL 194
           G       GQ + + +E M  G L   LR     M+ +  +  P LS M +   ++  G+
Sbjct: 82  GVV---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPE 252
           +YL+     VHRD+   N  V      KI DFG++  +  +        G   V +MSPE
Sbjct: 139 AYLNA-NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQN 307
            +++  ++  +D+WS G+ L+E  T  E PY   ++E  +  +++  +L+ P   P    
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-- 255
Query: 308 FSPEFCSFVDDCLKKDAEARPTADQLLS 335
                   +  C + + + RP+  +++S
Sbjct: 256 ----LLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 108 IIALKKINIFEKEKRN--QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           ++A+K +    +  R   Q   E+ T+ +   ++ +V F G     +   + +  EYM  
Sbjct: 44  LVAVKALKEASESARQDFQREAELLTMLQ---HQHIVRFFGV--CTEGRPLLMVFEYMRH 98
Query: 166 GSLADILRM-----------QKSIPEPI----LSSMFKKLLQGLSYLHGVRHLVHRDIKP 210
           G L   LR            +   P P+    L ++  ++  G+ YL G+ H VHRD+  
Sbjct: 99  GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLAT 157
Query: 211 ANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSI 268
            N LV      KI DFG+S  + ++    +    +  + +M PE I    ++  +D+WS 
Sbjct: 158 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 217
Query: 269 GLALFECGT-GEFPY--AASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           G+ L+E  T G+ P+   ++   ++ + Q   LE P   P      PE  + +  C +++
Sbjct: 218 GVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP------PEVYAIMRGCWQRE 271
Query: 324 AEAR 327
            + R
Sbjct: 272 PQQR 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 84  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 142
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 143 GENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 200
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 201 WEIATYGMSPY 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 29/192 (15%)
Query: 158 IALEYMDGGSLADILRM-----------QKSIPEPI----LSSMFKKLLQGLSYLHGVRH 202
           +  EYM  G L   LR            +   P P+    L ++  ++  G+ YL G+ H
Sbjct: 97  MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-H 155
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYS 260
            VHRD+   N LV      KI DFG+S  + ++    +    +  + +M PE I    ++
Sbjct: 156 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 215
Query: 261 YPADIWSIGLALFECGT-GEFPY--AASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSF 315
             +D+WS G+ L+E  T G+ P+   ++   ++ + Q   LE P   P      PE  + 
Sbjct: 216 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP------PEVYAI 269
Query: 316 VDDCLKKDAEAR 327
           +  C +++ + R
Sbjct: 270 MRGCWQREPQQR 281

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 144
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 203 WEIATYGMSPY 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 123/289 (42%), Gaps = 49/289 (16%)
Query: 86  FGAI-GSGASSVVQRAVHIPTHRI-----IALKKINIFEKEK-----RNQLLTEIRTLCE 134
           FG + GSGA   V  A      +      +A+K +    KEK     R  L++E++ + +
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSEREALMSELKMMTQ 104
Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM--------------QKSIPE 180
              +E +V   GA  +  SG I +  EY   G L + LR               QK + E
Sbjct: 105 LGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 181 P----ILSSMFKKLL-------QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS 229
                +L+  F+ LL       +G+ +L   +  VHRD+   N+LV      KI DFG++
Sbjct: 163 EEDLNVLT--FEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 230 AGL--ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASE 286
             +  +++  +       V +M+PE +    Y+  +D+WS G+ L+E  + G  PY    
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              N   +++++          + E    +  C   D+  RP+   L S
Sbjct: 280 VDANF-YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 36/244 (14%)
Query: 108 IIALKKINIFEKEKRN--QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG 165
           ++A+K +    +  R   Q   E+ T+ +   ++ +V F G     +   + +  EYM  
Sbjct: 73  LVAVKALKEASESARQDFQREAELLTMLQ---HQHIVRFFGV--CTEGRPLLMVFEYMRH 127
Query: 166 GSLADILRM-----------QKSIPEPI----LSSMFKKLLQGLSYLHGVRHLVHRDIKP 210
           G L   LR            +   P P+    L ++  ++  G+ YL G+ H VHRD+  
Sbjct: 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLAT 186
Query: 211 ANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSI 268
            N LV      KI DFG+S  + ++    +    +  + +M PE I    ++  +D+WS 
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246
Query: 269 GLALFECGT-GEFPY--AASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           G+ L+E  T G+ P+   ++   ++ + Q   LE P   P      PE  + +  C +++
Sbjct: 247 GVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACP------PEVYAIMRGCWQRE 300
Query: 324 AEAR 327
            + R
Sbjct: 301 PQQR 304

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 47  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 101
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD+   N +V
Sbjct: 102 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV 160
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 161 AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 220
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + + + RP
Sbjct: 221 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPKMRP 274
Query: 329 T 329
           T
Sbjct: 275 T 275

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 144
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 203 WEIATYGMSPY 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT--EIRTLCEAPCNEGLVEFHG 146
           +G G   +V R V   + +    K + +   +  +Q+L   EI  L  A  +  ++  H 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIAR-HRNILHLHE 68
Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHGVRHL 203
           +F      ++ +  E++ G  + +  R+  S   + E  + S   ++ + L +LH   ++
Sbjct: 69  SF--ESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHS-HNI 123
Query: 204 VHRDIKPANLLVNLK--GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            H DI+P N++   +     KI +FG +  L+        F     Y +PE  +++  S 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP-EYYAPEVHQHDVVST 182
Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP------SRQNFSPEFCSF 315
             D+WS+G  ++   +G  P+ A         QI+E+   +       + +  S E   F
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 316 VDDCLKKDAEARPTADQLLSHPFITK 341
           VD  L K+ ++R TA + L HP++ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 23/163 (14%)
Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPIL------------SS 185
           +E +V+F+G     D   + +  EYM  G L   LR     P+ +L            S 
Sbjct: 74  HEHIVKFYGVCVEGDP--LIMVFEYMKHGDLNKFLRAHG--PDAVLMAEGNPPTELTQSQ 129
Query: 186 MF---KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--IAMCA 240
           M    +++  G+ YL   +H VHRD+   N LV      KI DFG+S  + ++    +  
Sbjct: 130 MLHIAQQIAAGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
             +  + +M PE I    ++  +D+WS+G+ L+E  T G+ P+
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ +  K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 78/345 (22%), Positives = 134/345 (38%), Gaps = 89/345 (25%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G+   V  A    T + +A+KK+N +FE      ++L EI T+     ++ ++  + 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREI-TILNRLKSDYIIRLYD 92
Query: 147 AFYMPDS----GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
              +PD      ++ I LE  D   L  + +    + E  + ++   LL G +++H    
Sbjct: 93  LI-IPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE-SG 149
Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGL----------------------ENSIAMCA 240
           ++HRD+KPAN L+N     K+ DFG++  +                      +N      
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209
Query: 241 TFVGTVTYMSPERI-RNESYSYPADIWSIGLALFEC-------------------GTGEF 280
           + V T  Y +PE I   E+Y+   DIWS G    E                    G+  F
Sbjct: 210 SHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCF 269
Query: 281 PYA-----------ASEGPVNLMLQILEDPSPS-----------------PSRQ--NFSP 310
           P +           ++   +N++  I+  P+                   P R+  N   
Sbjct: 270 PLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329
Query: 311 EFCSFVDD-------CLKKDAEARPTADQLLSHPFITKYEHAKVD 348
           ++ S  DD        LK +   R T DQ L HP++      K++
Sbjct: 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 87  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 145
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 146 GENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 203
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 204 WEIATYGMSPY 214

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 27/243 (11%)
Query: 88  AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
            IG+G+  VV +A    +  ++A+KK+ +  K  +N+ L  +R L    CN  +V     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMRKLDH--CN--IVRLRYF 81
Query: 148 FY----MPDSGQISIALEYMDGGSLA---DILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           FY      D   +++ L+Y+            R ++++P   +     +L + L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPERIR 255
             + HRDIKP NLL++      K+ DFG    +  G  N   +C+ +     Y +PE I 
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 195
Query: 256 NES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPSPSRQNFSPEF 312
             + Y+   D+WS G  L E   G+  +    G   L  ++++L  P+    R+  +P +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE-MNPNY 254
Query: 313 CSF 315
             F
Sbjct: 255 TEF 257

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 50  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD+   N +V
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV 163
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 164 AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + + + RP
Sbjct: 224 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPKMRP 277
Query: 329 T 329
           T
Sbjct: 278 T 278

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 29/182 (15%)
Query: 120 EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM----- 174
           ++  +LLT ++       +E +V+F+G     D   + +  EYM  G L   LR      
Sbjct: 65  QREAELLTNLQ-------HEHIVKFYGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 175 --------QKSIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI 223
                   +++  E  LS M     ++  G+ YL   +H VHRD+   N LV      KI
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKI 174
Query: 224 TDFGISAGLENS--IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEF 280
            DFG+S  + ++    +    +  + +M PE I    ++  +D+WS G+ L+E  T G+ 
Sbjct: 175 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 281 PY 282
           P+
Sbjct: 235 PW 236

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 113/285 (39%), Gaps = 54/285 (18%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I  LKKI   EK+K N+ L  + +            FHG         + IA E + G +
Sbjct: 99  INVLKKIK--EKDKENKFLCVLMS--------DWFNFHG--------HMCIAFELL-GKN 139
Query: 168 LADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL-VNLKGRP--- 221
             + L+     P P+  +  M  +L   L +LH    L H D+KP N+L VN +      
Sbjct: 140 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYN 198
Query: 222 ---------------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
                          ++ DFG SA  ++      T V T  Y  PE I    ++ P D+W
Sbjct: 199 EHKSCEEKSVKNTSIRVADFG-SATFDHEHH--TTIVATRHYRPPEVILELGWAQPCDVW 255
Query: 267 SIGLALFECGTGEFPYAASEGPVNL-MLQILEDPSPS-----PSRQNFSPEFCSFVDDCL 320
           SIG  LFE   G   +   E   +L M++ +  P PS       +Q +  +     D+  
Sbjct: 256 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 315
Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSV--FDPMQRM 363
                 +     L S+      EH  V L   +R +  FDP QR+
Sbjct: 316 SDGRYVKENCKPLKSYMLQDSLEH--VQLFDLMRRMLEFDPAQRI 358

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 45/217 (20%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I  LKKI   EK+K N+ L  + +            FHG         + IA E + G +
Sbjct: 67  INVLKKIK--EKDKENKFLCVLMS--------DWFNFHG--------HMCIAFELL-GKN 107
Query: 168 LADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL-VNLKGRP--- 221
             + L+     P P+  +  M  +L   L +LH    L H D+KP N+L VN +      
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYN 166
Query: 222 ---------------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
                          ++ DFG SA  ++      T V T  Y  PE I    ++ P D+W
Sbjct: 167 EHKSCEEKSVKNTSIRVADFG-SATFDHEHH--TTIVATRHYRPPEVILELGWAQPCDVW 223
Query: 267 SIGLALFECGTGEFPYAASEGPVNL-MLQILEDPSPS 302
           SIG  LFE   G   +   E   +L M++ +  P PS
Sbjct: 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS 260

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I +E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 149
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 207
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 208 WEIATYGMSPY 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 50  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD+   N +V
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV 163
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 164 AHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + + + RP
Sbjct: 224 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPKMRP 277
Query: 329 T 329
           T
Sbjct: 278 T 278

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 45/217 (20%)
Query: 108 IIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS 167
           I  LKKI   EK+K N+ L  + +            FHG         + IA E + G +
Sbjct: 76  INVLKKIK--EKDKENKFLCVLMS--------DWFNFHG--------HMCIAFELL-GKN 116
Query: 168 LADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL-VNLKGRP--- 221
             + L+     P P+  +  M  +L   L +LH    L H D+KP N+L VN +      
Sbjct: 117 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYN 175
Query: 222 ---------------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
                          ++ DFG SA  ++      T V T  Y  PE I    ++ P D+W
Sbjct: 176 EHKSCEEKSVKNTSIRVADFG-SATFDHEHH--TTIVATRHYRPPEVILELGWAQPCDVW 232
Query: 267 SIGLALFECGTGEFPYAASEGPVNL-MLQILEDPSPS 302
           SIG  LFE   G   +   E   +L M++ +  P PS
Sbjct: 233 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS 269

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 50  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD+   N +V
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV 163
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 164 AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + +   RP
Sbjct: 224 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPNMRP 277
Query: 329 T 329
           T
Sbjct: 278 T 278

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 142
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 143 GENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 200
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 201 WEIATYGMSPY 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 5/129 (3%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 142
Query: 216 NLKGRPKITDFGISAGLE-NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
                 K+ DFG+S  +  ++    A     + + +PE +    +S  +D+W+ G+ L+E
Sbjct: 143 GENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 275 CGT-GEFPY 282
             T G  PY
Sbjct: 203 IATYGMSPY 211

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 5/151 (3%)
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTV 246
           ++ +G+ +L   R  +HRD+   N+L++ K   KI DFG++  +  +            +
Sbjct: 199 QVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
            +M+PE I +  Y+  +D+WS G+ L+E    G  PY   +       + L++ +   + 
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAP 316
Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              +PE    + DC   +   RPT  +L+ H
Sbjct: 317 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 5/151 (3%)
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTV 246
           ++ +G+ +L   R  +HRD+   N+L++ K   KI DFG++  +  +            +
Sbjct: 206 QVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
            +M+PE I +  Y+  +D+WS G+ L+E    G  PY   +       + L++ +   + 
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAP 323
Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              +PE    + DC   +   RPT  +L+ H
Sbjct: 324 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 5/151 (3%)
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTV 246
           ++ +G+ +L   R  +HRD+   N+L++ K   KI DFG++  +  +            +
Sbjct: 201 QVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
            +M+PE I +  Y+  +D+WS G+ L+E    G  PY   +       + L++ +   + 
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAP 318
Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              +PE    + DC   +   RPT  +L+ H
Sbjct: 319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 50  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD+   N +V
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV 163
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 164 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + + + RP
Sbjct: 224 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPKMRP 277
Query: 329 T 329
           T
Sbjct: 278 T 278

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 144
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 203 WEIATYGMSPY 213

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 5/151 (3%)
Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTV 246
           ++ +G+ +L   R  +HRD+   N+L++ K   KI DFG++  +  +            +
Sbjct: 208 QVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 247 TYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLMLQILEDPSPSPSR 305
            +M+PE I +  Y+  +D+WS G+ L+E    G  PY   +       + L++ +   + 
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRMRAP 325
Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              +PE    + DC   +   RPT  +L+ H
Sbjct: 326 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 149
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 150 GENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 207
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 208 WEIATYGMSPY 218

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 144
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 203 WEIATYGMSPY 213

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 149
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 207
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 208 WEIATYGMSPY 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 156 ISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I I +E + GG     LR + + +    L  M      G+ YL   +  +HRD+   N L
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCL 245
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLAL 272
           V  K   KI+DFG+S    + +   +  +    V + +PE +    YS  +D+WS G+ L
Sbjct: 246 VTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 273 FEC-GTGEFPY 282
           +E    G  PY
Sbjct: 306 WETFSLGASPY 316

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 39/284 (13%)
Query: 86  FG-AIGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKRNQLLTEIRTLCEAPCN 138
           FG  +G+GA   V  A      +  A+ K+ +         +++  L++E++ +     +
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-------------------MQKSIP 179
           E +V   GA      G + +  EY   G L + LR                   + K   
Sbjct: 95  ENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 180 EPI----LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN- 234
            P+    L     ++ QG+++L   ++ +HRD+   N+L+      KI DFG++  + N 
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 235 -SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFEC-GTGEFPYAASEGPVNLM 292
            +  +       V +M+PE I +  Y+  +D+WS G+ L+E    G  PY      VN  
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--VNSK 269
Query: 293 LQILEDPSPSPSRQNFSPE-FCSFVDDCLKKDAEARPTADQLLS 335
              L       ++  F+P+   S +  C   +   RPT  Q+ S
Sbjct: 270 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 313

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 157
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 158 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 215
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 216 WEIATYGMSPY 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 146
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 204
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 205 WEIATYGMSPY 215

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 149
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 207
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 208 WEIATYGMSPY 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 144
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 203 WEIATYGMSPY 213

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 146
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 204
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 205 WEIATYGMSPY 215

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 49  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 103
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHRD+   N +V
Sbjct: 104 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMV 162
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 163 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 222
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + + + RP
Sbjct: 223 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPKMRP 276
Query: 329 T 329
           T
Sbjct: 277 T 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 145
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 146 GENHLVKVADFGLSRLMTGDTYTAPAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 203
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 204 WEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 146
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAPAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 204
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 205 WEIATYGMSPY 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 62/133 (46%), Gaps = 9/133 (6%)
Query: 156 ISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I I +E + GG     LR + + +    L  M      G+ YL   +  +HRD+   N L
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCL 245
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT----VTYMSPERIRNESYSYPADIWSIGL 270
           V  K   KI+DFG+S   E +  + A   G     V + +PE +    YS  +D+WS G+
Sbjct: 246 VTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGI 303
Query: 271 ALFEC-GTGEFPY 282
            L+E    G  PY
Sbjct: 304 LLWETFSLGASPY 316

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 149
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 207
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 208 WEIATYGMSPY 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 148
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 149 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 206
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 207 WEIATYGMSPY 217

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HRD+   N LV
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLV 144
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 203 WEIATYGMSPY 213

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 32/205 (15%)
Query: 158 IALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I  EY +GGSLAD +    R+     E  L  +  ++ +GL Y+H +  LVH DIKP+N+
Sbjct: 86  IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNI 144
Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATF-----VGTVTYMSPERIR------------N 256
            ++   R  I +     G E+  A          +G VT +S  ++              
Sbjct: 145 FIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 201
Query: 257 ESYSY--PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           E+Y++   ADI+++ L +  C  G  P   +    + + Q      P    Q  S EF  
Sbjct: 202 ENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQWHEIRQGRLPRIP----QVLSQEFTE 256
Query: 315 FVDDCLKKDAEARPTADQLLSHPFI 339
            +   +  D E RP+A  L+ H  +
Sbjct: 257 LLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 32/205 (15%)
Query: 158 IALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I  EY +GGSLAD +    R+     E  L  +  ++ +GL Y+H +  LVH DIKP+N+
Sbjct: 88  IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNI 146
Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATF-----VGTVTYMSPERIR------------N 256
            ++   R  I +     G E+  A          +G VT +S  ++              
Sbjct: 147 FIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 203
Query: 257 ESYSY--PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           E+Y++   ADI+++ L +  C  G  P   +    + + Q      P    Q  S EF  
Sbjct: 204 ENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQWHEIRQGRLPRIP----QVLSQEFTE 258
Query: 315 FVDDCLKKDAEARPTADQLLSHPFI 339
            +   +  D E RP+A  L+ H  +
Sbjct: 259 LLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 23/189 (12%)
Query: 108 IIALKKINIFEKEKRNQ-----LLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY 162
           ++A+K++    KE+R Q       TE+  +  A  +  L+   G F M  + ++ +   Y
Sbjct: 64  LVAVKRL----KEERXQGGELQFQTEVEMISMA-VHRNLLRLRG-FCMTPTERL-LVYPY 116
Query: 163 MDGGSLADILRMQKSIPEPILSSMFKKLL----QGLSYLHGVRH----LVHRDIKPANLL 214
           M  GS+A  LR +     P+     +++     +GL+YLH   H    ++HRD+K AN+L
Sbjct: 117 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDVKAANIL 174
Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFV-GTVTYMSPERIRNESYSYPADIWSIGLALF 273
           ++ +    + DFG++  ++         V GT+ +++PE +     S   D++  G+ L 
Sbjct: 175 LDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 234
Query: 274 ECGTGEFPY 282
           E  TG+  +
Sbjct: 235 ELITGQRAF 243

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 32/205 (15%)
Query: 158 IALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I  EY +GGSLAD +    R+     E  L  +  ++ +GL Y+H +  LVH DIKP+N+
Sbjct: 86  IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNI 144
Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATF-----VGTVTYMSPERIR------------N 256
            ++   R  I +     G E+  A          +G VT +S  ++              
Sbjct: 145 FIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 201
Query: 257 ESYSY--PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS 314
           E+Y++   ADI+++ L +  C  G  P   +    + + Q      P    Q  S EF  
Sbjct: 202 ENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQWHEIRQGRLPRIP----QVLSQEFTE 256
Query: 315 FVDDCLKKDAEARPTADQLLSHPFI 339
            +   +  D E RP+A  L+ H  +
Sbjct: 257 LLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 162 YMDGGSLADILRMQKS---IPEPI----LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + +  SL+D+   + S     EPI    L S   ++ +G+ +L   R  +HRD+   N+L
Sbjct: 173 FQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSS-RKCIHRDLAARNIL 231
Query: 215 VNLKGRPKITDFGISAGLENS---IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLA 271
           ++     KI DFG++  +  +   +    T +  + +M+PE I ++ YS  +D+WS G+ 
Sbjct: 232 LSENNVVKICDFGLARDIYKNPDYVRKGDTRL-PLKWMAPESIFDKIYSTKSDVWSYGVL 290
Query: 272 LFEC-GTGEFPYAASEGPVNLMLQILED---PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           L+E    G  PY   +   +   ++ E     +P  S    +PE    + DC  +D + R
Sbjct: 291 LWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEYS----TPEIYQIMLDCWHRDPKER 346
Query: 328 PTADQLL 334
           P   +L+
Sbjct: 347 PRFAELV 353

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
           D+SD   +T       +R+   +  G  + V  A  + + R  ALK++   E+EK   ++
Sbjct: 14  DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73
Query: 127 TEIRTLCEAPCNEGLVEFHGAFYM----PDSGQIS-IALEYMDGGSLADILRMQKS---I 178
            E+  + +   +  +V+F  A  +     D+GQ   + L  +  G L + L+  +S   +
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
Query: 179 PEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRPKITDFG---------- 227
               +  +F +  + + ++H  +  ++HRD+K  NLL++ +G  K+ DFG          
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 228 --ISAGLENSIAMCATFVGTVTYMSPERI---RNESYSYPADIWSIGLALF 273
              SA     +    T   T  Y +PE I    N       DIW++G  L+
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 93/241 (38%), Gaps = 47/241 (19%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IG+G+   V  A      R++A+KKI  +FE      L+   R L E      L   H  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-----DLIDCKRILREIAILNRLNHDHVV 115
Query: 148 ----FYMPDS----GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
                 +P       ++ + LE  D      + R    + E  + ++   LL G+ Y+H 
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174
Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE-------------------------- 233
              ++HRD+KPAN LVN     K+ DFG++  ++                          
Sbjct: 175 A-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 234 -NSIAMCATFVGTVTYMSPERI-RNESYSYPADIWSIGL---ALFECGTGEFPYAASEGP 288
            N        V T  Y +PE I   E+Y+   D+WSIG     L         Y A  GP
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 289 V 289
           +
Sbjct: 294 L 294

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 158 IALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV 215
           I  E+M  G+L D LR   ++ +   +L  M  ++   + YL   ++ +HR++   N LV
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLV 351
Query: 216 NLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLAL 272
                 K+ DFG+S    G   +    A F   + + +PE +    +S  +D+W+ G+ L
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 273 FECGT-GEFPY 282
           +E  T G  PY
Sbjct: 410 WEIATYGMSPY 420

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI 223
           D GS  D   ++ ++  P    +  ++  G+ YL    H+VH+D+   N+LV  K   KI
Sbjct: 128 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYDKLNVKI 186
Query: 224 TDFGI--SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEF 280
           +D G+       +   +    +  + +M+PE I    +S  +DIWS G+ L+E  + G  
Sbjct: 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246
Query: 281 PYAA-SEGPVNLML---QILEDPSPSPS 304
           PY   S   V  M+   Q+L  P   P+
Sbjct: 247 PYCGYSNQDVVEMIRNRQVLPCPDDCPA 274

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 164 DGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI 223
           D GS  D   ++ ++  P    +  ++  G+ YL    H+VH+D+   N+LV  K   KI
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYDKLNVKI 169
Query: 224 TDFGI--SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEF 280
           +D G+       +   +    +  + +M+PE I    +S  +DIWS G+ L+E  + G  
Sbjct: 170 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 281 PYAA-SEGPVNLML---QILEDPSPSPS 304
           PY   S   V  M+   Q+L  P   P+
Sbjct: 230 PYCGYSNQDVVEMIRNRQVLPCPDDCPA 257

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 138 NEGLVEFHGAFYMPDSGQISIAL--EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
           +E L++F  A     + ++ + L   + D GSL D L+    I    L  + + + +GLS
Sbjct: 68  HENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK-GNIITWNELCHVAETMSRGLS 126
Query: 196 YLH-------GVRH---LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF--V 243
           YLH       G  H   + HRD K  N+L+       + DFG++   E       T   V
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV 186
Query: 244 GTVTYMSPERIRNE-SYSYPA----DIWSIGLALFECGTGEFPYAASEGPVN-LMLQILE 297
           GT  YM+PE +    ++   A    D++++GL L+E  +      A++GPV+  ML   E
Sbjct: 187 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS---RCKAADGPVDEYMLPFEE 243
Query: 298 DPSPSPSRQNFS----------------------PEFCSFVDDCLKKDAEARPTA 330
           +    PS +                          + C  +++C   DAEAR +A
Sbjct: 244 EIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSA 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 109 IALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQIS-IALEYMDG 165
           +A+K +N     +   L   I  L EA   +G    H    +     GQ + + +E M  
Sbjct: 50  VAVKTVN-----ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 166 GSLADILRMQK-------SIPEPILSSMFK---KLLQGLSYLHGVRHLVHRDIKPANLLV 215
           G L   LR  +         P P L  M +   ++  G++YL+  +  VHR++   N +V
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRNLAARNCMV 163
Query: 216 NLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALF 273
                 KI DFG++  +  +        G   V +M+PE +++  ++  +D+WS G+ L+
Sbjct: 164 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 274 ECGT-GEFPYA--ASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E  +  E PY   ++E  +  ++    L+ P   P R          +  C + +   RP
Sbjct: 224 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER------VTDLMRMCWQFNPNMRP 277
Query: 329 T 329
           T
Sbjct: 278 T 278

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 74/338 (21%), Positives = 129/338 (38%), Gaps = 90/338 (26%)
Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKR-NQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G+   V  A     ++ +A+KK+N +FE      ++L EI T+     ++ ++  H 
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREI-TILNRLKSDYIIRLHD 94
Query: 147 AFYMPD---SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                D     ++ I LE  D   L  + +    + E  + ++   LL G  ++H    +
Sbjct: 95  LIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHE-SGI 152
Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGL-------------------------ENSIAM 238
           +HRD+KPAN L+N     KI DFG++  +                         +N    
Sbjct: 153 IHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQ 212
Query: 239 CATFVGTVTYMSPERI-RNESYSYPADIWSIGLALFEC-------------------GTG 278
             + V T  Y +PE I   E+Y+   DIWS G    E                    G+ 
Sbjct: 213 LTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSS 272
Query: 279 EFPYA-----------ASEGPVNLMLQILEDPSPS-----------------PSRQ---- 306
            FP +           ++   +N++  ++  P                    P+R     
Sbjct: 273 CFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDL 332
Query: 307 -----NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
                + S E    ++  L+ +A+ R T D+ LSHP++
Sbjct: 333 SKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYL 370
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	371
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-121
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-121
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-120
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-117
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-114
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-73
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-72
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-72
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-71
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-71
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-70
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-70
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-70
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-70
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-70
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-69
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-68
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-66
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-64
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-64
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-64
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-64
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-64
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-62
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-61
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-59
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-49
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-48
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-47
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-47
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-47
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-47
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-45
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-45
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-45
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-45
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-44
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-44
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-44
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-44
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-44
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-44
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-44
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-43
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-43
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-43
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-43
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-42
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-42
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-42
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-42
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-42
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-42
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-42
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-42
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-42
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-42
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-42
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-41
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-41
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-41
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-41
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-40
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-40
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-40
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-38
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-37
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-35
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-35
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-34
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-33
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-33
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-33
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-31
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-31
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-30
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-30
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-29
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-29
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-29
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-29
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-29
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-29
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-29
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-29
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-28
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-28
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-28
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-28
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-28
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-27
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-27
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-27
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-27
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-27
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-26
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-26
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-26
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-26
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-26
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-26
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-26
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-25
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-23
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-22
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-21
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-15
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-11
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-11
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-10
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  352 bits (905), Expect = e-121
 Identities = 94/291 (32%), Positives = 156/291 (53%), Gaps = 11/291 (3%)

Query: 75  TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLC 133
           +    + ++     +G GA  VV++  H+P+ +I+A+K+I      +++ +LL ++    
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGS---LADILRMQKSIPEPILSSMFKKL 190
                   V F+GA +    G + I +E MD         ++   ++IPE IL  +   +
Sbjct: 61  RTVDCPFTVTFYGALF--REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMS 250
           ++ L +LH    ++HRD+KP+N+L+N  G+ K+ DFGIS  L + +A      G   YM+
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-IDAGCKPYMA 177

Query: 251 PERIRNE----SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
           PERI  E     YS  +DIWS+G+ + E     FPY +   P   + Q++E+PSP     
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237

Query: 307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
            FS EF  F   CLKK+++ RPT  +L+ HPF T +E    D+A+FV+ + 
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLIL 288

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  352 bits (905), Expect = e-121
 Identities = 95/307 (30%), Positives = 158/307 (51%), Gaps = 10/307 (3%)

Query: 65  LADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRN 123
                    + Y+   +++   G +GSG    V +     T  +IA+K++     KE+  
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68

Query: 124 QLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPIL 183
           ++L ++  + ++     +V+  G F    +  + IA+E M   +     RMQ  IPE IL
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELMGTCAEKLKKRMQGPIPERIL 126

Query: 184 SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV 243
             M   +++ L YL     ++HRD+KP+N+L++ +G+ K+ DFGIS  L +  A      
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSA 185

Query: 244 GTVTYMSPERI-----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED 298
           G   YM+PERI         Y   AD+WS+G++L E  TG+FPY   +    ++ ++L++
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245

Query: 299 PSPS-PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
             P  P    FS +F SFV DCL KD   RP  ++LL H FI +YE  +VD+A++ + V 
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM 305

Query: 358 DPMQRMK 364
              +  +
Sbjct: 306 AKTESPR 312

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  343 bits (881), Expect = e-117
 Identities = 99/307 (32%), Positives = 158/307 (51%), Gaps = 17/307 (5%)

Query: 71  HSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEI 129
             E+ +   + +++  G IG GA   V + VH P+ +I+A+K+I     E ++ QLL ++
Sbjct: 12  SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71

Query: 130 RTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR-----MQKSIPEPILS 184
             +  +     +V+F+GA +    G   I +E M   S     +     +   IPE IL 
Sbjct: 72  DVVMRSSDCPYIVQFYGALF--REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILG 128

Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
            +    ++ L++L     ++HRDIKP+N+L++  G  K+ DFGIS  L +SIA      G
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT-RDAG 187

Query: 245 TVTYMSPERI----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS 300
              YM+PERI      + Y   +D+WS+G+ L+E  TG FPY       + + Q+++   
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247

Query: 301 P---SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF 357
           P   +   + FSP F +FV+ CL KD   RP   +LL HPFI  YE   V++A +V  + 
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKIL 307

Query: 358 DPMQRMK 364
           D M    
Sbjct: 308 DQMPATP 314

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  336 bits (862), Expect = e-114
 Identities = 110/341 (32%), Positives = 166/341 (48%), Gaps = 51/341 (14%)

Query: 65  LADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRN 123
           L       +K       +      +G+G   VV +  H P+  ++A K I++  K   RN
Sbjct: 17  LEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN 76

Query: 124 QLLTEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
           Q++ E++ L  C +P    +V F+GAFY    G+ISI +E+MDGGSL  +L+    IPE 
Sbjct: 77  QIIRELQVLHECNSPY---IVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQ 131

Query: 182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT 241
           IL  +   +++GL+YL     ++HRD+KP+N+LVN +G  K+ DFG+S  L +S  M  +
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 189

Query: 242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE--------------- 286
           FVGT +YMSPER++   YS  +DIWS+GL+L E   G +P    +               
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

Query: 287 --------------------------GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
                                         L+  I+ +P P      FS EF  FV+ CL
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309

Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ 361
            K+   R    QL+ H FI + +  +VD A ++ S     Q
Sbjct: 310 IKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ 350

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  229 bits (586), Expect = 1e-73
 Identities = 79/260 (30%), Positives = 144/260 (55%), Gaps = 9/260 (3%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLV 142
             F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E       +V
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE--NKNPNIV 80

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
            +  ++ + D  ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    
Sbjct: 81  NYLDSYLVGD--ELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHS-NQ 136

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++HRDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLK 321
            DIWS+G+   E   GE PY  +E P+  +  I  + +P   + +  S  F  F++ CL+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 322 KDAEARPTADQLLSHPFITK 341
            D E R +A +LL H F+  
Sbjct: 256 MDVEKRGSAKELLQHQFLKI 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  228 bits (583), Expect = 1e-72
 Identities = 78/260 (30%), Positives = 146/260 (56%), Gaps = 9/260 (3%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLV 142
             +  IG G++ +V  A    + R +A+K +++ ++++R  L  E+  + +       +V
Sbjct: 48  DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD--YQHFNVV 105

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           E + ++ + +  ++ + +E++ GG+L DI+  Q  + E  ++++ + +LQ L+YLH  + 
Sbjct: 106 EMYKSYLVGE--ELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHA-QG 161

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++HRDIK  ++L+ L GR K++DFG  A +   +    + VGT  +M+PE I    Y+  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLK 321
            DIWS+G+ + E   GE PY  S+ PV  M ++ + P P   +    SP    F++  L 
Sbjct: 222 VDIWSLGIMVIEMVDGEPPY-FSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 322 KDAEARPTADQLLSHPFITK 341
           +D + R TA +LL HPF+ +
Sbjct: 281 RDPQERATAQELLDHPFLLQ 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  227 bits (580), Expect = 4e-72
 Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 19/287 (6%)

Query: 65  LADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ 124
           L ++    +  YR   H M     +G G+   V R     T    A+KK+ +        
Sbjct: 42  LTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-- 99

Query: 125 LLTEIRTLCEAPCN-EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPIL 183
              E+     A  +   +V  +GA        ++I +E ++GGSL  +++    +PE   
Sbjct: 100 ---ELVAC--AGLSSPRIVPLYGAVREGPW--VNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 184 SSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP-KITDFGISA-----GLENSIA 237
                + L+GL YLH  R ++H D+K  N+L++  G    + DFG +      GL  S+ 
Sbjct: 153 LYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211

Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
                 GT T+M+PE +  +      DIWS    +     G  P+        L L+I  
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCLKIAS 270

Query: 298 DPSPSP-SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
           +P P      + +P     + + L+K+   R +A +L         E
Sbjct: 271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  222 bits (569), Expect = 7e-71
 Identities = 84/257 (32%), Positives = 146/257 (56%), Gaps = 12/257 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT-EIRTL--CEAPCNEGLVEFH 145
           IG G+   V + +   T +++A+K I++ E E   + +  EI  L  C++P    + +++
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP-Y--VTKYY 86

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G++      ++ I +EY+ GGS  D+L     + E  ++++ +++L+GL YLH  + + H
Sbjct: 87  GSYL--KDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKI-H 142

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK AN+L++  G  K+ DFG++  L ++     TFVGT  +M+PE I+  +Y   ADI
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 202

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+   E   GE P+ +   P+ ++  I ++  P+    N+S     FV+ CL K+  
Sbjct: 203 WSLGITAIELARGEPPH-SELHPMKVLFLIPKNNPPT-LEGNYSKPLKEFVEACLNKEPS 260

Query: 326 ARPTADQLLSHPFITKY 342
            RPTA +LL H FI + 
Sbjct: 261 FRPTAKELLKHKFILRN 277

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  222 bits (568), Expect = 7e-71
 Identities = 87/288 (30%), Positives = 131/288 (45%), Gaps = 14/288 (4%)

Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
            ESD  E  Y    +  R+   +G G   +V     +     IA+K+I   +      L 
Sbjct: 10  CESDLLEYDYEYDENGDRVV--LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH 67

Query: 127 TEIRTLCEAPCN-EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---SIPEPI 182
            EI          + +V++ G+F   ++G I I +E + GGSL+ +LR +       E  
Sbjct: 68  EEIALHKH--LKHKNIVQYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123

Query: 183 LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCAT 241
           +    K++L+GL YLH    +VHRDIK  N+L+N   G  KI+DFG S  L        T
Sbjct: 124 IGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182

Query: 242 FVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP 299
           F GT+ YM+PE I      Y   ADIWS+G  + E  TG+ P+     P   M ++    
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242

Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV 347
                 ++ S E  +F+  C + D + R  A+ LL   F+      K 
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  224 bits (572), Expect = 1e-70
 Identities = 70/260 (26%), Positives = 123/260 (47%), Gaps = 14/260 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+             R   +K+INI     KE+      E+  L     +  +V++ 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANM-KHPNIVQYR 89

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHL 203
            +F   ++G + I ++Y +GG L   +  QK     E  +   F ++   L ++H  R +
Sbjct: 90  ESFE--ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKI 146

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRDIK  N+ +   G  ++ DFGI+  L +++ +    +GT  Y+SPE   N+ Y+  +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSFVDDCLKK 322
           DIW++G  L+E  T +  + A     NL+L+I+     P      +S +  S V    K+
Sbjct: 207 DIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPPVSLH--YSYDLRSLVSQLFKR 263

Query: 323 DAEARPTADQLLSHPFITKY 342
           +   RP+ + +L   FI K 
Sbjct: 264 NPRDRPSVNSILEKGFIAKR 283

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  222 bits (567), Expect = 1e-70
 Identities = 84/272 (30%), Positives = 147/272 (54%), Gaps = 14/272 (5%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLV 142
            I G +G GA   V +A +  T  + A K I    +E+    + EI  L    C+   +V
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT--CDHPYIV 79

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           +  GA+Y     ++ I +E+  GG++  I+  + + + EP +  + +++L+ L++LH  +
Sbjct: 80  KLLGAYYHDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS-K 136

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES--- 258
            ++HRD+K  N+L+ L+G  ++ DFG+SA    ++    +F+GT  +M+PE +  E+   
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 259 --YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSF 315
             Y Y ADIWS+G+ L E    E P+     P+ ++L+I +   P+  +   +S EF  F
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255

Query: 316 VDDCLKKDAEARPTADQLLSHPFITKYEHAKV 347
           +   L K+ E RP+A QLL HPF++     K 
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  223 bits (569), Expect = 2e-70
 Identities = 74/269 (27%), Positives = 144/269 (53%), Gaps = 14/269 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G    V +  H+ T ++ A+K +++   ++  ++  EI  L +   +  +  ++GAF
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90

Query: 149 Y----MPDSGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRH 202
                     Q+ + +E+   GS+ D+++     ++ E  ++ + +++L+GLS+LH    
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HK 149

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE----- 257
           ++HRDIK  N+L+      K+ DFG+SA L+ ++    TF+GT  +M+PE I  +     
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 209

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           +Y + +D+WS+G+   E   G  P      P+  +  I  +P+P    + +S +F SF++
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE 268

Query: 318 DCLKKDAEARPTADQLLSHPFITKYEHAK 346
            CL K+   RP  +QL+ HPFI    + +
Sbjct: 269 SCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  221 bits (566), Expect = 2e-70
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 14/260 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLLTEIRTLCEAPCN-EGLVEF 144
           IG G  S V RA  +     +ALKK+ IF+      R   + EI  L     N   ++++
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL--KQLNHPNVIKY 97

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKS----IPEPILSSMFKKLLQGLSYLHGV 200
           + +F   +  +++I LE  D G L+ +++  K     IPE  +   F +L   L ++H  
Sbjct: 98  YASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS- 154

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
           R ++HRDIKPAN+ +   G  K+ D G+     +      + VGT  YMSPERI    Y+
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214

Query: 261 YPADIWSIGLALFECGTGEFPYAA-SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           + +DIWS+G  L+E    + P+        +L  +I +   P     ++S E    V+ C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274

Query: 320 LKKDAEARPTADQLLSHPFI 339
           +  D E RP    +      
Sbjct: 275 INPDPEKRPDVTYVYDVAKR 294

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  221 bits (566), Expect = 3e-70
 Identities = 85/256 (33%), Positives = 148/256 (57%), Gaps = 11/256 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGA 147
           +G G+   V +A+H  T +I+A+K++ +    +  +++ EI  + +  C+   +V+++G+
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ--EIIKEISIMQQ--CDSPHVVKYYGS 92

Query: 148 FYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           ++      + I +EY   GS++DI+R+  K++ E  ++++ +  L+GL YLH     +HR
Sbjct: 93  YFKNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHR 149

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           DIK  N+L+N +G  K+ DFG++  L +++A   T +GT  +M+PE I+   Y+  ADIW
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209

Query: 267 SIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVDDCLKKDAE 325
           S+G+   E   G+ PY A   P+  +  I  +P P+    + +S  F  FV  CL K  E
Sbjct: 210 SLGITAIEMAEGKPPY-ADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268

Query: 326 ARPTADQLLSHPFITK 341
            R TA QLL HPF+  
Sbjct: 269 QRATATQLLQHPFVRS 284

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  219 bits (560), Expect = 2e-69
 Identities = 90/299 (30%), Positives = 151/299 (50%), Gaps = 32/299 (10%)

Query: 68  ESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLL 126
             D S   +     +  +   IGSGA++VVQ A   P    +A+K+IN+ + +   ++LL
Sbjct: 2   SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL 61

Query: 127 TEIRTL--CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILR--------MQK 176
            EI+ +  C  P N  +V ++ +F      ++ + ++ + GGS+ DI++           
Sbjct: 62  KEIQAMSQCHHP-N--IVSYYTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 177 SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI 236
            + E  ++++ +++L+GL YLH     +HRD+K  N+L+   G  +I DFG+SA L    
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175

Query: 237 AMCA-----TFVGTVTYMSPERI-RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN 290
            +       TFVGT  +M+PE + +   Y + ADIWS G+   E  TG  PY     P+ 
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMK 234

Query: 291 LMLQILEDPSPS--------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
           +++  L++  PS           + +   F   +  CL+KD E RPTA +LL H F  K
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  215 bits (550), Expect = 2e-68
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 15/272 (5%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGL 141
            +   IG+G+    Q+       +I+  K+++     + ++  L++E+  L E   +  +
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNI 67

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----IPEPILSSMFKKLLQGLSYL 197
           V ++       +  + I +EY +GG LA ++         + E  +  +  +L   L   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 198 H----GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           H    G   ++HRD+KPAN+ ++ K   K+ DFG++  L +  +   TFVGT  YMSPE+
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPSPSPSRQNFSPEF 312
           +   SY+  +DIWS+G  L+E      P+ A      L  +I E      P R  +S E 
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPYR--YSDEL 244

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              +   L      RP+ +++L +P I ++ H
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  211 bits (538), Expect = 2e-66
 Identities = 60/259 (23%), Positives = 119/259 (45%), Gaps = 10/259 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G+   V + +   T   +A  ++   +  K +R +   E   L     +  +V F+ 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYD 92

Query: 147 AFYMPDSGQ--ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG-VRHL 203
           ++     G+  I +  E M  G+L   L+  K +   +L S  +++L+GL +LH     +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 204 VHRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +HRD+K  N+ +    G  KI D G++     S       +GT  +M+PE    + Y   
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDES 209

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D+++ G+ + E  T E+PY+  +    +  ++     P+   +   PE    ++ C+++
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269

Query: 323 DAEARPTADQLLSHPFITK 341
           + + R +   LL+H F  +
Sbjct: 270 NKDERYSIKDLLNHAFFQE 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  209 bits (535), Expect = 7e-66
 Identities = 62/279 (22%), Positives = 104/279 (37%), Gaps = 38/279 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG    V + V      I A+K+              L E+        +  +V +  
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQK----SIPEPILSSMFKKLLQGLSYLHGVRH 202
           A+   +   + I  EY +GGSLAD +           E  L  +  ++ +GL Y+H    
Sbjct: 79  AWA--EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MS 135

Query: 203 LVHRDIKPANLLVNLKGRP-------------------KITDFGISAGLENSIAMCATFV 243
           LVH DIKP+N+ ++    P                   KI D G    + +         
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEE 191

Query: 244 GTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS 302
           G   +++ E ++ N ++   ADI+++ L +      E          +   +I +   P 
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQGRLPR 247

Query: 303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
              Q  S EF   +   +  D E RP+A  L+ H  +  
Sbjct: 248 IP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  207 bits (528), Expect = 1e-64
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 22/272 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCE-APCNEGLVEFH 145
           IGSG SS V + ++    +I A+K +N+   + +  +    EI  L +    ++ ++  +
Sbjct: 36  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
                     I + +E      L   L+ +KSI      S +K +L+ +  +H    +VH
Sbjct: 95  DYEI--TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVH 150

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNES----- 258
            D+KPAN L+   G  K+ DFGI+  ++   +  +  + VGTV YM PE I++ S     
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209

Query: 259 ------YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
                  S  +D+WS+G  L+    G+ P+      ++ +  I++             + 
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 269

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              +  CLK+D + R +  +LL+HP++    H
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  206 bits (527), Expect = 2e-64
 Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 11/255 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEK-RNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G+   V +       R+ A+K+    F   K R + L E+ +  +   +   V    
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           A+   + G + +  E               S+PE  +    +  L  L++LH  + LVH 
Sbjct: 125 AWE--EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHL 181

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           D+KPAN+ +  +GR K+ DFG+   L  +        G   YM+PE +   SY   AD++
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVF 239

Query: 267 SIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
           S+GL + E           EG   L    L            S E  S +   L+ D + 
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT----AGLSSELRSVLVMMLEPDPKL 295

Query: 327 RPTADQLLSHPFITK 341
           R TA+ LL+ P + +
Sbjct: 296 RATAEALLALPVLRQ 310

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  207 bits (529), Expect = 2e-64
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 22/272 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCE-APCNEGLVEFH 145
           IGSG SS V + ++    +I A+K +N+   + +  +    EI  L +    ++ ++  +
Sbjct: 17  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
                     I + +E      L   L+ +KSI      S +K +L+ +  +H    +VH
Sbjct: 76  DYEI--TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVH 131

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNES----- 258
            D+KPAN L+   G  K+ DFGI+  ++   +  +  + VGTV YM PE I++ S     
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190

Query: 259 ------YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
                  S  +D+WS+G  L+    G+ P+      ++ +  I++             + 
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 250

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              +  CLK+D + R +  +LL+HP++    H
Sbjct: 251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  205 bits (523), Expect = 3e-64
 Identities = 59/270 (21%), Positives = 116/270 (42%), Gaps = 32/270 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGA 147
           IGSG    V +A H    +   +K++         +   E++ L  A  +   +V ++G 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKAL--AKLDHVNIVHYNGC 72

Query: 148 F--------------YMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLL 191
           +                  +  + I +E+ D G+L   +  ++   + + +   +F+++ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSP 251
           +G+ Y+H  + L++RD+KP+N+ +    + KI DFG+   L+N         GT+ YMSP
Sbjct: 133 KGVDYIHS-KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTLRYMSP 190

Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE 311
           E+I ++ Y    D++++GL L E         A E        + +          F  +
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDT--AFETS-KFFTDLRDGIISD----IFDKK 243

Query: 312 FCSFVDDCLKKDAEARPTADQLLSHPFITK 341
             + +   L K  E RP   ++L    + K
Sbjct: 244 EKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  206 bits (527), Expect = 4e-64
 Identities = 72/261 (27%), Positives = 135/261 (51%), Gaps = 19/261 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKR---NQLLTEIRTLCEAPCN-EGLVEF 144
           IG G+   V  A  +    ++A+KK++   K+       ++ E+R L +        +++
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK--LRHPNTIQY 119

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            G +         + +EY   GS +D+L + +K + E  ++++    LQGL+YLH   ++
Sbjct: 120 RGCYLREH--TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNM 175

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE---SYS 260
           +HRD+K  N+L++  G  K+ DFG ++ +  +     +FVGT  +M+PE I       Y 
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYD 231

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
              D+WS+G+   E    + P   +   ++ +  I ++ SP+    ++S  F +FVD CL
Sbjct: 232 GKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 290

Query: 321 KKDAEARPTADQLLSHPFITK 341
           +K  + RPT++ LL H F+ +
Sbjct: 291 QKIPQDRPTSEVLLKHRFVLR 311

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  204 bits (521), Expect = 1e-62
 Identities = 67/272 (24%), Positives = 124/272 (45%), Gaps = 22/272 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCE-APCNEGLVEFH 145
           IGSG SS V + ++    +I A+K +N+   + +  +    EI  L +    ++ ++  +
Sbjct: 64  IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
                     I + +E      L   L+ +KSI      S +K +L+ +  +H    +VH
Sbjct: 123 DYEI--TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVH 178

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATFVGTVTYMSPERIRNES----- 258
            D+KPAN L+   G  K+ DFGI+  ++   +  +  + VG V YM PE I++ S     
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 259 ------YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF 312
                  S  +D+WS+G  L+    G+ P+      ++ +  I++             + 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH 344
              +  CLK+D + R +  +LL+HP++    H
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  197 bits (502), Expect = 6e-61
 Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 34/282 (12%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCN-EGLVEFHG 146
           +G G   VV  A +       A+K+I +  +E  R +++ E++ L  A     G+V +  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL--AKLEHPGIVRYFN 70

Query: 147 AF----------YMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQG 193
           A+                 + I ++     +L D +  + +       +   +F ++ + 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF----------- 242
           + +LH  + L+HRD+KP+N+   +    K+ DFG+   ++                    
Sbjct: 131 VEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189

Query: 243 -VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP 301
            VGT  YMSPE+I   SYS+  DI+S+GL LFE           E      L  + +   
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP--FSTQME--RVRTLTDVRNLKF 245

Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
            P      P     V D L      RP A  ++ +      +
Sbjct: 246 PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  194 bits (495), Expect = 6e-59
 Identities = 65/338 (19%), Positives = 133/338 (39%), Gaps = 71/338 (21%)

Query: 89  IGSGASS--VVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTL--CEAPCNEGLV 142
           IG G      V  A + PT   + +++IN+     E    L  E+        P N  +V
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP-N--IV 89

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGV 200
            +   F   +  ++ +   +M  GS  D++       + E  ++ + + +L+ L Y+H +
Sbjct: 90  PYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-------MCATFVGTVTYMSPER 253
            + VHR +K +++L+++ G+  ++    +  + +               V  + ++SPE 
Sbjct: 148 GY-VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 254 IR--NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--------- 302
           ++   + Y   +DI+S+G+   E   G  P+        ++L+ L    P          
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPF-KDMPATQMLLEKLNGTVPCLLDTSTIPA 265

Query: 303 -----------------------------------PSRQNFSPEFCSFVDDCLKKDAEAR 327
                                              P  + FSP F  FV+ CL+++ +AR
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325

Query: 328 PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           P+A  LL+H F  +    K   +  +  +  P+  + +
Sbjct: 326 PSASTLLNHSFFKQ---IKRRASEALPELLRPVTPITN 360

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  187 bits (478), Expect = 3e-57
 Identities = 63/285 (22%), Positives = 118/285 (41%), Gaps = 39/285 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHG 146
           +G GA   V +A +    R  A+KKI    +EK + +L+E+  L          +V ++ 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY---VVRYYA 69

Query: 147 AFYMPDSGQIS-----------IALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGL 194
           A+    +               I +EY + G+L D I     +        +F+++L+ L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA-------------- 240
           SY+H  + ++HRD+KP N+ ++     KI DFG++  +  S+ +                
Sbjct: 130 SYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188

Query: 241 TFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL--E 297
           + +GT  Y++ E +     Y+   D++S+G+  FE           E  VN++ ++    
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST--GME-RVNILKKLRSVS 245

Query: 298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
              P     N        +   +  D   RP A  LL+  ++   
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  186 bits (474), Expect = 1e-56
 Identities = 53/293 (18%), Positives = 101/293 (34%), Gaps = 20/293 (6%)

Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
           +            +        +G G  S V     +      ALK+I   E++ R +  
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 127 TEIRTLCEAPCNEGLVEFHGAFYMPDSG--QISIALEYMDGGSLADILRMQKS----IPE 180
            E         +  ++              +  + L +   G+L + +   K     + E
Sbjct: 75  READMH-RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM-- 238
             +  +   + +GL  +H  +   HRD+KP N+L+  +G+P + D G        +    
Sbjct: 134 DQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 239 -------CATFVGTVTYMSPERIRNESY---SYPADIWSIGLALFECGTGEFPYAASEGP 288
                   A    T++Y +PE    +S+       D+WS+G  L+    GE PY      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            + +   +++    P     S      ++  +  D   RP    LLS     +
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  177 bits (451), Expect = 5e-52
 Identities = 63/301 (20%), Positives = 125/301 (41%), Gaps = 25/301 (8%)

Query: 58  LQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGA-SSVVQRAVHIPTHRIIALKKINI 116
           +    S   D+ D                  +G GA  ++V R +    +R +A+K+I  
Sbjct: 1   MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRIL- 57

Query: 117 FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLAD-ILRMQ 175
              E  +    E++ L E+  +  ++ +       D     IA+E     +L + + +  
Sbjct: 58  --PECFSFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIAIELC-AATLQEYVEQKD 112

Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-----RPKITDFGISA 230
            +       ++ ++   GL++LH   ++VHRD+KP N+L+++       +  I+DFG+  
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171

Query: 231 GLEN---SIAMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFEC-GTGEFPYA 283
            L     S +  +   GT  +++PE +     E+ +Y  DI+S G   +     G  P+ 
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

Query: 284 A-SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
              +   N++L         P  ++        ++  +  D + RP+A  +L HPF    
Sbjct: 232 KSLQRQANILLGACSLDCLHPE-KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

Query: 343 E 343
           E
Sbjct: 291 E 291

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  166 bits (422), Expect = 3e-49
 Identities = 68/259 (26%), Positives = 111/259 (42%), Gaps = 16/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G    V  A    +  I+ALK +    + +    +QL  E+        P    ++ 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP---NILR 73

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            +G F+  D+ ++ + LEY   G++   L+      E   ++   +L   LSY H  + +
Sbjct: 74  LYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRV 130

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRDIKP NLL+   G  KI DFG S    +S        GT+ Y+ PE I    +    
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DLCGTLDYLPPEMIEGRMHDEKV 188

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           D+WS+G+  +E   G+ P+ A         +I       P     +      +   LK +
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHN 245

Query: 324 AEARPTADQLLSHPFITKY 342
              RP   ++L HP+IT  
Sbjct: 246 PSQRPMLREVLEHPWITAN 264

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  163 bits (415), Expect = 5e-48
 Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 16/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G  +         T  + A K +    + +  +R ++  EI             +V 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH---VVG 79

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           FHG F   D+  + + LE     SL ++ + +K++ EP      ++++ G  YLH    +
Sbjct: 80  FHGFFE--DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRV 136

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+K  NL +N     KI DFG++  +E          GT  Y++PE +  + +S+  
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           D+WSIG  ++    G+ P+  S   +      I ++    P   + +P   S +   L+ 
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQT 252

Query: 323 DAEARPTADQLLSHPFITK 341
           D  ARPT ++LL+  F T 
Sbjct: 253 DPTARPTINELLNDEFFTS 271

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  164 bits (416), Expect = 9e-48
 Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 16/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G  +         T  + A K   K  + +  +R ++  EI             +V 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH---VVG 105

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           FHG F   D+  + + LE     SL ++ + +K++ EP      ++++ G  YLH    +
Sbjct: 106 FHGFFE--DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRV 162

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRD+K  NL +N     KI DFG++  +E          GT  Y++PE +  + +S+  
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           D+WSIG  ++    G+ P+  S   +      I ++    P   + +P   S +   L+ 
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQT 278

Query: 323 DAEARPTADQLLSHPFITK 341
           D  ARPT ++LL+  F T 
Sbjct: 279 DPTARPTINELLNDEFFTS 297

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  163 bits (414), Expect = 2e-47
 Identities = 58/296 (19%), Positives = 115/296 (38%), Gaps = 29/296 (9%)

Query: 67  DESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLL 126
           D+SD   +T       +R+   +  G  + V  A  + + R  ALK++   E+EK   ++
Sbjct: 14  DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73

Query: 127 TEIRTLCEAPCNEGLVEFHGAFY-----MPDSGQISIALEYMDGGSLADIL---RMQKSI 178
            E+  + +   +  +V+F  A               + L  +  G L + L     +  +
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133

Query: 179 PEPILSSMFKKLLQGLSYLHGVRH-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA 237
               +  +F +  + + ++H  +  ++HRD+K  NLL++ +G  K+ DFG +  + +   
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193

Query: 238 MC------------ATFVGTVTYMSPERI---RNESYSYPADIWSIGLALFECGTGEFPY 282
                          T   T  Y +PE I    N       DIW++G  L+     + P+
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

Query: 283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                     L+I+      P        F S +   L+ + E R +  +++    
Sbjct: 254 EDG-----AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  165 bits (419), Expect = 2e-47
 Identities = 87/330 (26%), Positives = 141/330 (42%), Gaps = 37/330 (11%)

Query: 32  SYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGS 91
              L++   + L      V+ F +L +   + +     D     Y        +   +GS
Sbjct: 97  RRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDE----YI-------MSKTLGS 145

Query: 92  GASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPCNEGL 141
           GA   V+ A    T + +A++ I+          E +    + TEI  L     PC   +
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC---I 202

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           ++    F   D+    I LE M+GG L D +   K + E      F ++L  + YLH   
Sbjct: 203 IKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-N 258

Query: 202 HLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE---RIR 255
            ++HRD+KP N+L++ +      KITDFG S  L  +  M  T  GT TY++PE    + 
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPTYLAPEVLVSVG 317

Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFC 313
              Y+   D WS+G+ LF C +G  P++     V+L  QI     +         S +  
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFITKYE 343
             V   L  D +AR T ++ L HP++   +
Sbjct: 378 DLVKKLLVVDPKARFTTEEALRHPWLQDED 407

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  160 bits (407), Expect = 5e-47
 Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 15/264 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G+ + V RA  I T   +A+K   K  +++     ++  E++  C+   P +  ++E
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP-S--ILE 75

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRH 202
            +   Y  DS  + + LE    G +   L+ + K   E        +++ G+ YLH    
Sbjct: 76  LYN--YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HG 132

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++HRD+  +NLL+      KI DFG++  L+       T  GT  Y+SPE     ++   
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           +D+WS+G   +    G  P+       N + +++      PS    S E    +   L++
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVVLADYEMPS--FLSIEAKDLIHQLLRR 249

Query: 323 DAEARPTADQLLSHPFITKYEHAK 346
           +   R +   +L HPF+++    K
Sbjct: 250 NPADRLSLSSVLDHPFMSRNSSTK 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 6e-47
 Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 55/300 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGL-----V 142
           +G GA++ V R  H  T  + A+K  N I      +  + E   L      + L     V
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL------KKLNHKNIV 70

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHG 199
           +         +    + +E+   GSL  +L    +   +PE     + + ++ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 200 VRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
              +VHR+IKP N++  +        K+TDFG +  LE+      +  GT  Y+ P+   
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYE 188

Query: 256 --------NESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQIL-------- 296
                    + Y    D+WSIG+  +   TG  P+   EGP     +M +I+        
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 297 ---------------EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
                          + P      +         + + L+ D E     DQ  +      
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  157 bits (400), Expect = 1e-45
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 21/270 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G+ S+ ++ VH  +++  A+K I+   K        EI  L     +  +V+ H  F
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH--GVRHLVHR 206
              D     + +E ++GG L + ++ +K   E   S + +KL+  +S++H  GV   VHR
Sbjct: 76  --HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV---VHR 130

Query: 207 DIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP NLL   +      KI DFG +           T   T+ Y +PE +    Y    
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190

Query: 264 DIWSIGLALFE--CGT----GEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSF 315
           D+WS+G+ L+    G                V +M +I + D S    + +N S E    
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250

Query: 316 VDDCLKKDAEARPTADQLLSHPFITKYEHA 345
           +   L  D   R     L  + ++      
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  156 bits (397), Expect = 2e-45
 Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 16/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G    V  A       I+ALK +    + ++   +QL  EI        P    ++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN---ILR 78

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            +  F+  D  +I + LE+   G L   L+      E   ++  ++L   L Y H  R +
Sbjct: 79  MYNYFH--DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKV 135

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRDIKP NLL+  KG  KI DFG S    +      T  GT+ Y+ PE I  +++    
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TMCGTLDYLPPEMIEGKTHDEKV 193

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           D+W  G+  +E   G  P+ +         +I+      P     S      +   L+  
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDLKFPP--FLSDGSKDLISKLLRYH 250

Query: 324 AEARPTADQLLSHPFITKY 342
              R     ++ HP++   
Sbjct: 251 PPQRLPLKGVMEHPWVKAN 269

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  157 bits (400), Expect = 3e-45
 Identities = 82/294 (27%), Positives = 132/294 (44%), Gaps = 25/294 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G GA SVV+R VH  T    A K IN          +L  E R +C    +  +V  H 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHD 95

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           +    +     +  + + GG L + +  ++   E   S   +++L+ ++Y H    +VHR
Sbjct: 96  SI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHR 152

Query: 207 DIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           ++KP NLL+  K +    K+ DFG++  + +S A    F GT  Y+SPE ++ + YS P 
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFAGTPGYLSPEVLKKDPYSKPV 211

Query: 264 DIWSIGLALFE--CGTGEFP--YAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVD 317
           DIW+ G+ L+    G   +P  +   +    L  QI       PSP     +PE  S +D
Sbjct: 212 DIWACGVILYILLVG---YPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266

Query: 318 DCLKKDAEARPTADQLLSHPFITKYEHA-KVDLAAFVRSV---FDPMQRMKDLA 367
             L  + + R TADQ L  P+I   E                 F+  +++K   
Sbjct: 267 SMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAI 320

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  158 bits (400), Expect = 4e-45
 Identities = 36/295 (12%), Positives = 76/295 (25%), Gaps = 44/295 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN---QLLTEIRTL------------- 132
           +  G  SVV     +      ALK   +  +  R+   +L                    
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 133 ----------CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDG------GSLADILRMQK 176
                               +              + +            +L  +   + 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 177 SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI 236
                 L  +  +L++  + L   + LVH    P NL +   GR  + D      +    
Sbjct: 190 DEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR- 247

Query: 237 AMCATFVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVN---- 290
                    VTY   E +   +  +++  + W +GL+++       P+      +     
Sbjct: 248 --GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 291 --LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
              +     D     S         + +   L  D   R    + +  P   + +
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  155 bits (395), Expect = 6e-45
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 20/255 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G GA  VV +A      + +A+K+I    + +R   + E+R L     +  +V+ +GA 
Sbjct: 16  VGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRV-NHPNIVKLYGAC 70

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLHG--VRHL 203
             P    + + +EY +GGSL ++L   + +P    +      LQ   G++YLH    + L
Sbjct: 71  LNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 204 VHRDIKPANLLVNLKGR-PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +HRD+KP NLL+   G   KI DFG +  ++          G+  +M+PE     +YS  
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 263 ADIWSIGLALFECGTGEFPYA-ASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            D++S G+ L+E  T   P+         +M  +     P P  +N      S +  C  
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLMTRCWS 242

Query: 322 KDAEARPTADQLLSH 336
           KD   RP+ ++++  
Sbjct: 243 KDPSQRPSMEEIVKI 257

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  156 bits (396), Expect = 9e-45
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 14/286 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G GA+S+V R     T +  ALK +   +   +  + TEI  L     +  +++    F
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLS-HPNIIKLKEIF 117

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
                 +IS+ LE + GG L D +  +    E   +   K++L+ ++YLH    +VHRD+
Sbjct: 118 --ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDL 174

Query: 209 KPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           KP NLL          KI DFG+S  +E+ + M  T  GT  Y +PE +R  +Y    D+
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-KTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLKKD 323
           WS+G+  +    G  P+    G   +  +IL  +    SP     S      V   +  D
Sbjct: 234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293

Query: 324 AEARPTADQLLSHPFITKYEHAKVDLAAFVRSV--FDPMQRMKDLA 367
            + R T  Q L HP++T      V +    + +  F+  +++K   
Sbjct: 294 PKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAV 339

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  154 bits (392), Expect = 1e-44
 Identities = 70/276 (25%), Positives = 126/276 (45%), Gaps = 22/276 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI---------FEKEKRNQLLTEIRTLCEAPCNE 139
           +G G SSVV+R +H PT +  A+K I++           +E R   L E+  L +   + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +++    +    +    +  + M  G L D L  + ++ E     + + LL+ +  LH 
Sbjct: 85  NIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE------R 253
             ++VHRD+KP N+L++     K+TDFG S  L+    +     GT +Y++PE       
Sbjct: 143 -LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLAPEIIECSMN 200

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPE 311
             +  Y    D+WS G+ ++    G  P+      + ++  I+  +    SP   ++S  
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDT 259

Query: 312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV 347
               V   L    + R TA++ L+HPF  +Y   +V
Sbjct: 260 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  156 bits (396), Expect = 2e-44
 Identities = 38/299 (12%), Positives = 83/299 (27%), Gaps = 56/299 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN------------QLLTEIRTLCEAP 136
           +G         A    T     +      E+   N            +LL  I+   +A 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMD---------------------GGSLADILRMQ 175
            +   +        P   ++                             G  L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS 235
           KS+       +  ++++ L+ LH    LVH  ++P +++++ +G   +T F         
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----R 255

Query: 236 IAMCATFVGTVTYMSPERIRNES-----------YSYPADIWSIGLALFECGTGEFPYAA 284
                    +  +  PE     +            ++  D W++GL ++     + P   
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 285 SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
            +  +     I          +N      + ++  L+   E R    Q +  P   +  
Sbjct: 316 -DAALGGSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  155 bits (392), Expect = 2e-44
 Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 22/213 (10%)

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP---ILSSMFKKLLQGLSYLHGVR 201
                      + I ++     +L D +  + S+ +    +   +F ++ + + +LH  +
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-K 183

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF------------VGTVTYM 249
            L+HRD+KP+N+   +    K+ DFG+   ++                     VGT  YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 250 SPERIRNESYSYPADIWSIGLALFE-CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF 308
           SPE+I   +YS+  DI+S+GL LFE      + ++     V ++  +     P    Q  
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL----YSFSTQMERVRIITDVRNLKFPLLFTQ-K 298

Query: 309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            P+    V D L      RP A  ++ +     
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  153 bits (389), Expect = 2e-44
 Identities = 81/264 (30%), Positives = 125/264 (47%), Gaps = 13/264 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G GA SVV+R VH  T    A K IN          +L  E R +C    +  +V  H 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHD 72

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           +    +     +  + + GG L + +  ++   E   S   +++L+ ++Y H    +VHR
Sbjct: 73  SI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHR 129

Query: 207 DIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           ++KP NLL+  K +    K+ DFG++  + +S A    F GT  Y+SPE ++ + YS P 
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFAGTPGYLSPEVLKKDPYSKPV 188

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLK 321
           DIW+ G+ L+    G  P+   E    L  QI       PSP     +PE  S +D  L 
Sbjct: 189 DIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 247

Query: 322 KDAEARPTADQLLSHPFITKYEHA 345
            + + R TADQ L  P+I   E  
Sbjct: 248 VNPKKRITADQALKVPWICNRERV 271

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  154 bits (392), Expect = 2e-44
 Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 28/297 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPCN 138
           +GSGA   V+ A    T + +A+K I+          E +    + TEI  L     PC 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC- 76

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
             +++    F   D+    I LE M+GG L D +   K + E      F ++L  + YLH
Sbjct: 77  --IIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 199 GVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPE--- 252
               ++HRD+KP N+L++ +      KITDFG S  L  +  M  T  GT TY++PE   
Sbjct: 132 E-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGTPTYLAPEVLV 189

Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSP 310
            +    Y+   D WS+G+ LF C +G  P++     V+L  QI               S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLA 367
           +    V   L  D +AR T ++ L HP++   +  +      + S  +    +  + 
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD--LLSEENESTALPQVL 304

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  154 bits (392), Expect = 3e-44
 Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 25/297 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG G+ SV +R +H  T+   A+K I+    + +     EI  L     +  ++     +
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVY 85

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
              D   + +  E M GG L D +  QK   E   S++   + + + YLH  + +VHRD+
Sbjct: 86  --DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDL 142

Query: 209 KPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           KP+N+L   +       +I DFG +  L     +  T   T  +++PE +  + Y    D
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACD 202

Query: 265 IWSIGLALFE--CGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCSFVDDCL 320
           IWS+G+ L+    G   F     + P  ++ +I             + S      V   L
Sbjct: 203 IWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKML 262

Query: 321 KKDAEARPTADQLLSHPFITKYEHA----------KVDLAAFVRSVFDPMQRMKDLA 367
             D   R TA  +L HP+I  ++               +   + + +  + R +   
Sbjct: 263 HVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPV 319

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  160 bits (405), Expect = 6e-44
 Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 42/295 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIR-----------TLCEAP 136
           +G+G    V R +H  T   +A+K+       + R +   EI+           +  E P
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQG 193
                +  +    +        A+EY +GG L   L   ++   + E  + ++   +   
Sbjct: 82  DGLQKLAPNDLPLL--------AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMS 250
           L YLH    ++HRD+KP N+++    +    KI D G +  L+    +C  FVGT+ Y++
Sbjct: 134 LRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLA 191

Query: 251 PERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           PE +  + Y+   D WS G   FEC TG  P+  +  PV    ++ E  +      +   
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
               F                      ++                ++   QR  D
Sbjct: 252 GAVKFSSVL--PTPNHLSGILAGKLERWLQC------------MLMWHQRQRGTD 292

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  153 bits (389), Expect = 1e-43
 Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 32/301 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           IG G  SVV+R ++  T +  A+K +++             L  E   +C    +  +VE
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS-ICHMLKHPHIVE 90

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLAD-ILRMQKSIP---EPILSSMFKKLLQGLSYLHG 199
               +     G + +  E+MDG  L   I++   +     E + S   +++L+ L Y H 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 200 VRHLVHRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
             +++HRD+KP  +L+  K      K+  FG++  L  S  +    VGT  +M+PE ++ 
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207

Query: 257 ESYSYPADIWSIGLALFE--CGTGEFP--YAASEGPVNLMLQILE-DPS-PSPSRQNFSP 310
           E Y  P D+W  G+ LF    G       Y   E    L   I++           + S 
Sbjct: 208 EPYGKPVDVWGCGVILFILLSG---CLPFYGTKER---LFEGIIKGKYKMNPRQWSHISE 261

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA--KVDLAAFVRSV--FDPMQRMKDL 366
                V   L  D   R T  + L+HP++ + +    K+ L   V  +  F+  +++K  
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321

Query: 367 A 367
            
Sbjct: 322 V 322

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  155 bits (393), Expect = 1e-43
 Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 42/289 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G+S  V         R +A+K++     +  +  L EI+ L E+  +  ++ ++ + 
Sbjct: 23  LGYGSSGTV-VFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYYCSE 78

Query: 149 YMPDSGQISIALEYMDGGSLADIL-------RMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
                  + IALE     +L D++          K   E    S+ +++  G+++LH   
Sbjct: 79  T--TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-L 134

Query: 202 HLVHRDIKPANLLVNLKG-------------RPKITDFGISAGLENS----IAMCATFVG 244
            ++HRD+KP N+LV+                R  I+DFG+   L++             G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 245 TVTYMSPERIRNES-------YSYPADIWSIGLALFEC-GTGEFP-YAASEGPVNLMLQI 295
           T  + +PE +   +        +   DI+S+G   +     G+ P         N++  I
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 254

Query: 296 LE-DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE 343
              D       ++   E    +   +  D   RPTA ++L HP      
Sbjct: 255 FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  154 bits (392), Expect = 3e-43
 Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 24/294 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G GA SVV+R V +   +  A   IN          +L  E R +C    +  +V  H 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR-ICRLLKHPNIVRLHD 77

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
           +    + G   +  + + GG L + +  ++   E   S   +++L+ + + H    +VHR
Sbjct: 78  SI--SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHR 134

Query: 207 DIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           ++KP NLL+  K +    K+ DFG++  +E        F GT  Y+SPE +R + Y  P 
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194

Query: 264 DIWSIGLALFE--CGTGEFP--YAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVD 317
           D+W+ G+ L+    G   +P  +   +    L  QI       PSP     +PE    ++
Sbjct: 195 DLWACGVILYILLVG---YPPFWDEDQH--RLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 318 DCLKKDAEARPTADQLLSHPFITKYEHA-KVDLAAFVRSV---FDPMQRMKDLA 367
             L  +   R TA + L HP+I+                    F+  +++K   
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAI 303

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  151 bits (384), Expect = 4e-43
 Identities = 67/269 (24%), Positives = 130/269 (48%), Gaps = 14/269 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G  +VV++ +   T +  A K +      ++ R ++L EI  L  A     ++  H 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 147 AFYMPDSGQISIALEYMDGGSLAD--ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            +   ++ +I + LEY  GG +    +  + + + E  +  + K++L+G+ YLH   ++V
Sbjct: 97  VY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIV 153

Query: 205 HRDIKPANLLV---NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           H D+KP N+L+      G  KI DFG+S  + ++  +    +GT  Y++PE +  +  + 
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-EIMGTPEYLAPEILNYDPITT 212

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDC 319
             D+W+IG+  +   T   P+   E      L I + +      +  + S     F+   
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271

Query: 320 LKKDAEARPTADQLLSHPFITKYEHAKVD 348
           L K+ E RPTA+  LSH ++ +++   + 
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  153 bits (388), Expect = 5e-43
 Identities = 38/289 (13%), Positives = 86/289 (29%), Gaps = 47/289 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN------------QLLTEIRTLCEAP 136
           +G         A    T     +      E+   N            +LL  I+   +A 
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 137 CNEGLVEFHGAFYMP----------DSGQISIALEYMD-----------GGSLADILRMQ 175
            +   +        P          D   + +   +             G  L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-EN 234
           KS+       +  ++++ L+ LH    LVH  ++P +++++ +G   +T F        +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264

Query: 235 SIAMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPV 289
           +++            +   +          ++  D W++GLA++     + P    +  +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAAL 323

Query: 290 NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                I          +N      + ++  L+   E R    Q +  P 
Sbjct: 324 GGSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  151 bits (383), Expect = 7e-43
 Identities = 65/318 (20%), Positives = 115/318 (36%), Gaps = 51/318 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG-------- 140
           +  G  + +        ++  ALKK      EK+                          
Sbjct: 39  LNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 141 --------LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--------KSIPEPILS 184
                    +   G     +  ++ I  EYM+  S+                 IP  ++ 
Sbjct: 97  ITDIKNEYCLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG 244
            + K +L   SY+H  +++ HRD+KP+N+L++  GR K++DFG S  + +         G
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRG 212

Query: 245 TVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL------ 296
           T  +M PE   NES       DIWS+G+ L+       P++     V L   I       
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272

Query: 297 -----------EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
                       +   + S    S E   F+   L+K+   R T++  L H ++      
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332

Query: 346 KVDLAAFVRSVFDPMQRM 363
             DL  F + ++   +++
Sbjct: 333 --DLREFSKELYKKRKKL 348

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  152 bits (385), Expect = 1e-42
 Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 55/295 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGL-----V 142
           +G GA++ V R  H  T  + A+K  N I      +  + E   L      + L     V
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL------KKLNHKNIV 70

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHG 199
           +         +    + +E+   GSL  +L    +   +PE     + + ++ G+++L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 200 VRHLVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPE--- 252
              +VHR+IKP N++  +        K+TDFG +  LE+      +  GT  Y+ P+   
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYE 188

Query: 253 -----RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQIL-------- 296
                +   + Y    D+WSIG+  +   TG  P+   EGP     +M +I+        
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 297 ---------------EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                          + P      +         + + L+ D E     DQ  + 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  153 bits (389), Expect = 2e-42
 Identities = 80/283 (28%), Positives = 135/283 (47%), Gaps = 15/283 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +GSGA   V       TH   A+K I          ++LL E+  L     +  +++ + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYD 103

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            F   D     + +E   GG L D +  +    E   + + K++L G++YLH   ++VHR
Sbjct: 104 FF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHR 160

Query: 207 DIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP NLL+  K      KI DFG+SA  EN   M    +GT  Y++PE +R + Y    
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-KERLGTAYYIAPEVLR-KKYDEKC 218

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLK 321
           D+WSIG+ LF    G  P+   +    ++ ++ +   +  SP  +N S      +   L+
Sbjct: 219 DVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQ 277

Query: 322 KDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
            D++ R +A Q L HP+I +    K +    + S+ + ++ M+
Sbjct: 278 FDSQRRISAQQALEHPWIKEMCSKK-ESGIELPSLANAIENMR 319

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  150 bits (380), Expect = 2e-42
 Identities = 69/309 (22%), Positives = 118/309 (38%), Gaps = 60/309 (19%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-----IFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           IG G+  VV+ A+   T  I A+K +N         +   ++ TE+R L +   +  +  
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR-LMKKLHHPNIAR 92

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLAD--------------------------------- 170
            +  +   D   I + +E   GG L D                                 
Sbjct: 93  LYEVYE--DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 171 -------ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG--RP 221
                     +     E ++S++ +++   L YLH  + + HRDIKP N L +       
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEI 209

Query: 222 KITDFGIS----AGLENSIAMCATFVGTVTYMSPE--RIRNESYSYPADIWSIGLALFEC 275
           K+ DFG+S               T  GT  +++PE     NESY    D WS G+ L   
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 276 GTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQL 333
             G  P+       + + Q+L       +P+    SP     + + L ++ + R  A + 
Sbjct: 270 LMGAVPFPG-VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328

Query: 334 LSHPFITKY 342
           L HP+I+++
Sbjct: 329 LQHPWISQF 337

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  148 bits (376), Expect = 2e-42
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 18/263 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTL--CEAPCNEGLVEF 144
           +G G+   V +     T +  A+K IN    + +  + +L E+  L   + P    +++ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN---IMKL 86

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                  DS    I  E   GG L D +  +K   E   + + K++  G++Y+H   ++V
Sbjct: 87  FEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIV 143

Query: 205 HRDIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+KP N+L+  K      KI DFG+S   + +  M    +GT  Y++PE +   +Y  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPE-VLRGTYDE 201

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDC 319
             D+WS G+ L+   +G  P+   +   +++ ++     +   P  +  S +    +   
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260

Query: 320 LKKDAEARPTADQLLSHPFITKY 342
           L      R TA Q L HP+I KY
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKY 283

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  149 bits (378), Expect = 3e-42
 Identities = 57/285 (20%), Positives = 119/285 (41%), Gaps = 14/285 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G   +V R V   + +    K + + +   +  +  EI  L  A  +  ++  H +F
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR-HRNILHLHESF 70

Query: 149 YMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
                 ++ +  E++ G  + + I      + E  + S   ++ + L +LH   ++ H D
Sbjct: 71  --ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFD 127

Query: 208 IKPANLL-VNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           I+P N++    +    KI +FG +  L+              Y +PE  +++  S   D+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPEVHQHDVVSTATDM 186

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLKKD 323
           WS+G  ++   +G  P+ A E    ++  I+  + +    + +  S E   FVD  L K+
Sbjct: 187 WSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245

Query: 324 AEARPTADQLLSHPFITKYEHAKVDLAAFVRS-VFDPMQRMKDLA 367
            ++R TA + L HP++ + +  +V                +    
Sbjct: 246 RKSRMTASEALQHPWLKQ-KIERVSTKVIRTLKHRRYYHTLIKKD 289

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  148 bits (376), Expect = 4e-42
 Identities = 65/287 (22%), Positives = 125/287 (43%), Gaps = 18/287 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSG  ++V++     T    A K I             R ++  E+  L +   +  ++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVI 78

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             H  +   +   + + LE + GG L D L  ++S+ E   +S  K++L G++YLH  + 
Sbjct: 79  TLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KK 135

Query: 203 LVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           + H D+KP N+++  K  P    K+ DFG++  +E+ +       GT  +++PE +  E 
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-KNIFGTPEFVAPEIVNYEP 194

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFV 316
               AD+WSIG+  +   +G  P+   +     +  I             + S     F+
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKDFI 253

Query: 317 DDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM 363
              L K+   R T  + L HP+IT  ++ +  +        +  ++ 
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQ 300

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  149 bits (377), Expect = 4e-42
 Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 29/297 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G +  V    H  T +  ALK +         +   E+    +A     +V     +
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDVY 91

Query: 149 YMPDSGQISIAL--EYMDGGSLAD--ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                G+  + +  E M+GG L      R  ++  E   + + + +   + +LH   ++ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIA 150

Query: 205 HRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+KP NLL   K +    K+TDFG +     +     T   T  Y++PE +  E Y  
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ--TPCYTPYYVAPEVLGPEKYDK 208

Query: 262 PADIWSIGLALFE--CGTGEFP--YAASE--GPVNLMLQILE-DPS-PSPSRQNFSPEFC 313
             D+WS+G+ ++   CG   FP  Y+ +       +  +I       P+P     S +  
Sbjct: 209 SCDMWSLGVIMYILLCG---FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFITKYEHAK---VDLAAFVRSVFDPMQRMKDLA 367
             +   LK D   R T  Q ++HP+I +        +  A  ++   D    +K+  
Sbjct: 266 QLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEM 322

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (375), Expect = 5e-42
 Identities = 70/272 (25%), Positives = 112/272 (41%), Gaps = 39/272 (14%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-----------FEKEKRNQLLTEIRTL 132
           R+   +G G    V  A      RI+ALK ++             ++E R          
Sbjct: 37  RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA-------- 88

Query: 133 CEAPCNE-GLVEFHGAFYMPDSGQIS----IALEYMDGGSLADILRMQKSIPEPILSSMF 187
                 E  +V  H      D G+I     + +  ++G  LA +LR Q  +  P   ++ 
Sbjct: 89  --GRLQEPHVVPIH------DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIV 140

Query: 188 KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI-SAGLENSIAMCATFVGTV 246
           +++   L   H      HRD+KP N+LV+      + DFGI SA  +  +      VGT+
Sbjct: 141 RQIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTL 199

Query: 247 TYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ 306
            YM+PER      +Y ADI+++   L+EC TG  PY      +++M   +    P PS  
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIPRPSTV 257

Query: 307 N--FSPEFCSFVDDCLKKDAEAR-PTADQLLS 335
                  F + +   + K+ E R  T   L +
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  151 bits (384), Expect = 7e-42
 Identities = 66/284 (23%), Positives = 125/284 (44%), Gaps = 17/284 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V       T +  A+K I+   + +K  +  LL E++ L +   +  +++ +
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLY 92

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F   D G   +  E   GG L D +  +K   E   + + +++L G++Y+H    +VH
Sbjct: 93  EFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK-NKIVH 149

Query: 206 RDIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           RD+KP NLL+  K      +I DFG+S   E S  M    +GT  Y++PE +   +Y   
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-KDKIGTAYYIAPEVLH-GTYDEK 207

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCL 320
            D+WS G+ L+   +G  P+       +++ ++ +   +   P  +  S      +   L
Sbjct: 208 CDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266

Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
                 R +A   L H +I  Y   ++ +          +  ++
Sbjct: 267 TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA--ILNIR 308

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  149 bits (377), Expect = 7e-42
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 21/269 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--------FEKEKRNQLLTEIRTLCEAPCNEG 140
           IG G SSVV+R VH  T    A+K + +          +E R     E   L +   +  
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           ++    ++    S  + +  + M  G L D L  + ++ E    S+ + LL+ +S+LH  
Sbjct: 162 IITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA- 218

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE------RI 254
            ++VHRD+KP N+L++   + +++DFG S  LE    +     GT  Y++PE        
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL-RELCGTPGYLAPEILKCSMDE 277

Query: 255 RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEF 312
            +  Y    D+W+ G+ LF    G  P+      + ++  I+E      SP   + S   
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSSTV 336

Query: 313 CSFVDDCLKKDAEARPTADQLLSHPFITK 341
              +   L+ D EAR TA+Q L HPF  +
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFFER 365

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  149 bits (377), Expect = 8e-42
 Identities = 65/287 (22%), Positives = 123/287 (42%), Gaps = 18/287 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSG  ++V++     T    A K I             R ++  E+  L +   +  ++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNII 78

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             H  +   +   + + LE + GG L D L  ++S+ E   +S  K++L G++YLH  + 
Sbjct: 79  TLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KK 135

Query: 203 LVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           + H D+KP N+++  K  P    K+ DFG++  +E+ +       GT  +++PE +  E 
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-KNIFGTPEFVAPEIVNYEP 194

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFV 316
               AD+WSIG+  +   +G  P+   +     +  I               S     F+
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKDFI 253

Query: 317 DDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRM 363
              L K+   R T  + L HP+IT  +  +  +        +  ++ 
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQ 300

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (373), Expect = 9e-42
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 28/282 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEA--PCNEGLVEF 144
           IG+G+   V RA        +A+K +    F  E+ N+ L E+  +     P    +V F
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN---IVLF 99

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQ---KSIPEPILSSMFKKLLQGLSYLHGVR 201
            GA  +     +SI  EY+  GSL  +L      + + E    SM   + +G++YLH   
Sbjct: 100 MGA--VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 202 H-LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
             +VHR++K  NLLV+ K   K+ DFG+S    ++     +  GT  +M+PE +R+E  +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
             +D++S G+ L+E  T + P+     P  ++  +          +N +P+  + ++ C 
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276

Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQR 362
             +   RP+   ++              L   ++S   P  R
Sbjct: 277 TNEPWKRPSFATIMDL------------LRPLIKSAVPPPNR 306

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  145 bits (369), Expect = 2e-41
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 20/266 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL--CEAPCNEGLVEFHG 146
           IG G+   V+ AV   T    A KKI  +  E  ++   EI  +   + P N  ++  + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP-N--IIRLYE 73

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
            F   D+  I + +E   GG L + +  ++   E   + + K +L  ++Y H   ++ HR
Sbjct: 74  TFE--DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAHR 130

Query: 207 DIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP N L          K+ DFG++A  +    M  T VGT  Y+SP+ +    Y    
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKVGTPYYVSPQVLEG-LYGPEC 188

Query: 264 DIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDC 319
           D WS G+ ++   CG   F  A ++    +ML+I E   + P     N SP+  S +   
Sbjct: 189 DEWSAGVMMYVLLCGYPPF-SAPTDS--EVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 245

Query: 320 LKKDAEARPTADQLLSHPFITKYEHA 345
           L K  + R T+ Q L H +  K   +
Sbjct: 246 LTKSPKQRITSLQALEHEWFEKQLSS 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (369), Expect = 3e-41
 Identities = 63/260 (24%), Positives = 121/260 (46%), Gaps = 21/260 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 32  IGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMG 87

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
               P   Q++I  ++ +G SL   L   +       L  + ++  +G+ YLH  + ++H
Sbjct: 88  YSTAP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIH 143

Query: 206 RDIKPANLLVNLKGRPKITDFGIS---AGLENSIAMCATFVGTVTYMSPERIRNES---Y 259
           RD+K  N+ ++     KI DFG++   +    S        G++ +M+PE IR +    Y
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQDSNPY 202

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PSPSPSRQNFSPEFCSFV 316
           S+ +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262

Query: 317 DDCLKKDAEARPTADQLLSH 336
            +CLKK  + RP+  ++L+ 
Sbjct: 263 AECLKKKRDERPSFPRILAE 282

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  147 bits (374), Expect = 3e-41
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 11/265 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +GSGA  VV R V   T R+   K IN      +  +  EI  + +   +  L+  H AF
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAF 117

Query: 149 YMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
              D  ++ + LE++ GG L D I      + E  + +  ++  +GL ++H    +VH D
Sbjct: 118 --EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLD 174

Query: 208 IKPANLLVNLKGRP--KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           IKP N++   K     KI DFG++  L     +      T  + +PE +  E   +  D+
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIV-KVTTATAEFAAPEIVDREPVGFYTDM 233

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLKKD 323
           W+IG+  +   +G  P+A  E  +  +  +   D      +  + SPE   F+ + L+K+
Sbjct: 234 WAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 292

Query: 324 AEARPTADQLLSHPFITKYEHAKVD 348
              R T    L HP++         
Sbjct: 293 PRKRLTVHDALEHPWLKGDHSNLTS 317

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  148 bits (375), Expect = 3e-41
 Identities = 65/272 (23%), Positives = 111/272 (40%), Gaps = 25/272 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G +  V +  +  T    ALK +     +   +   E+     A     +V     +
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 124

Query: 149 --YMPDSGQISIALEYMDGGSLAD--ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                    + I +E +DGG L      R  ++  E   S + K + + + YLH   ++ 
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIA 183

Query: 205 HRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+KP NLL   K      K+TDFG +    +  ++  T   T  Y++PE +  E Y  
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEVLGPEKYDK 242

Query: 262 PADIWSIGLALFE--CG----TGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFC 313
             D+WS+G+ ++   CG          A S G   +  +I       P+P     S E  
Sbjct: 243 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFPNPEWSEVSEEVK 299

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
             + + LK +   R T  + ++HP+I +    
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  149 bits (378), Expect = 5e-41
 Identities = 72/284 (25%), Positives = 131/284 (46%), Gaps = 17/284 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G+   V +     T +  A+K IN    + +  + +L E+  L +   +  +++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFE 88

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                DS    I  E   GG L D +  +K   E   + + K++  G++Y+H   ++VHR
Sbjct: 89  IL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHR 145

Query: 207 DIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           D+KP N+L+  K      KI DFG+S   + +  M    +GT  Y++PE +R  +Y    
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRIGTAYYIAPEVLR-GTYDEKC 203

Query: 264 DIWSIGLALFECGTGEFP-YAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCL 320
           D+WS G+ L+   +G  P Y  +E   +++ ++     +   P  +  S +    +   L
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261

Query: 321 KKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMK 364
                 R TA Q L HP+I KY  ++    + + S+   M  ++
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYS-SETPTISDLPSLESAMTNIR 304

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  145 bits (367), Expect = 6e-41
 Identities = 60/265 (22%), Positives = 104/265 (39%), Gaps = 25/265 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA--PCNEGLVEFHG 146
           +G G      +  H  T  ++ +K++  F++E +   L E++ +     P    +++F G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN---VLKFIG 74

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             Y     +++   EY+ GG+L  I++   S  P     S  K +  G++YLH   +++H
Sbjct: 75  VLYKD--KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIH 131

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA--------------TFVGTVTYMSP 251
           RD+   N LV       + DFG++  + +                    T VG   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 252 ERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QNFSP 310
           E I   SY    D++S G+ L E             P  +   +            N  P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNAD-PDYLPRTMDFGLNVRGFLDRYCPPNCPP 250

Query: 311 EFCSFVDDCLKKDAEARPTADQLLS 335
            F      C   D E RP+  +L  
Sbjct: 251 SFFPITVRCCDLDPEKRPSFVKLEH 275

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  150 bits (380), Expect = 9e-41
 Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 15/267 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+GA  VV R     T    A K +    +  +  +  EI+T+     +  LV  H AF
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAF 223

Query: 149 YMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
              +   + +  E+M GG L + +      + E       +++ +GL ++H   + VH D
Sbjct: 224 EDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLD 280

Query: 208 IKPANLLVNLKGRP--KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +KP N++   K     K+ DFG++A L+   ++     GT  + +PE    +   Y  D+
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEVAEGKPVGYYTDM 339

Query: 266 WSIGLALFE--CGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLK 321
           WS+G+  +    G   F    ++     +  +   D +    +    S +   F+   L 
Sbjct: 340 WSVGVLSYILLSGLSPF-GGEND--DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

Query: 322 KDAEARPTADQLLSHPFITKYEHAKVD 348
            D   R T  Q L HP++T       D
Sbjct: 397 ADPNTRMTIHQALEHPWLTPGNAPGRD 423

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (367), Expect = 1e-40
 Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 25/293 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSG  +VV++     T    A K I             R  +  E+  L E   +  ++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             H  +   +   + + LE + GG L D L  ++S+ E   +   K++L G+ YLH    
Sbjct: 78  TLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQ 134

Query: 203 LVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           + H D+KP N+++  +  P    KI DFG++  ++          GT  +++PE +  E 
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-KNIFGTPEFVAPEIVNYEP 193

Query: 259 YSYPADIWSIGLALFE--CGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCS 314
               AD+WSIG+  +    G   F    ++     +  +   +         N S     
Sbjct: 194 LGLEADMWSIGVITYILLSGASPF-LGDTKQ--ETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLA 367
           F+   L KD + R T    L HP+I   +  +       ++    M++ K  A
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSR---KASAVNMEKFKKFA 300

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (363), Expect = 1e-40
 Identities = 68/266 (25%), Positives = 115/266 (43%), Gaps = 31/266 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA--------PCNEG 140
           IG G    V RA        +A+K       E  +Q +  +R   EA        P    
Sbjct: 15  IGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQ--EAKLFAMLKHPN--- 67

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH-- 198
           ++   G         + + +E+  GG L  +L   K IP  IL +   ++ +G++YLH  
Sbjct: 68  IIALRGVCLKEP--NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDE 124

Query: 199 GVRHLVHRDIKPANLLVNLKGRP--------KITDFGISAGLENSIAMCATFVGTVTYMS 250
            +  ++HRD+K +N+L+  K           KITDFG++     +  M  +  G   +M+
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMA 182

Query: 251 PERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           PE IR   +S  +D+WS G+ L+E  TGE P+   +  + +   +  +    P       
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLALPIPSTCPE 241

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
            F   ++DC   D  +RP+   +L  
Sbjct: 242 PFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  144 bits (365), Expect = 2e-40
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 34/285 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G GA + VQ  +++ T +  A+K I       R+++  E+  L +   +  ++E    F
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
              +  +  +  E M GGS+   +  ++   E   S + + +   L +LH  + + HRD+
Sbjct: 81  --EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDL 137

Query: 209 KPANLLVNLKGRP---KITDFGISAGLENSIAMC-------ATFVGTVTYMSPE-----R 253
           KP N+L     +    KI DF + +G++ +            T  G+  YM+PE      
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197

Query: 254 IRNESYSYPADIWSIGLALF-----------ECGTGEFPYAASEGPVN---LMLQILE-D 298
                Y    D+WS+G+ L+            CG+          P     L   I E  
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257

Query: 299 PS-PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
              P     + S      +   L +DA+ R +A Q+L HP++   
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (363), Expect = 2e-40
 Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 7/183 (3%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           + +EY++G +L++ +     +      +   ++L G+ + H    +VHRDIKP N+L++ 
Sbjct: 88  LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS 146

Query: 218 KGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECG 276
               KI DFGI+ A  E S+      +GTV Y SPE+ + E+     DI+SIG+ L+E  
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206

Query: 277 TGEFPYAASEGPVNLMLQILEDPSPSPSRQ---NFSPEFCSFVDDCLKKDAEARP-TADQ 332
            GE P+   E  V++ ++ ++D  P+ +     +      + +    +KD   R  T  +
Sbjct: 207 VGEPPFNG-ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQE 265

Query: 333 LLS 335
           +  
Sbjct: 266 MKD 268

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  143 bits (362), Expect = 3e-40
 Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 37/284 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG G+  VV+ A +   +   A+K   +  K+K  +     R                  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMK---VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 149 YM----------------------------PDSGQISIALEYMDGGSLADILRMQKSIPE 180
                                         P+   + +  E ++ G + ++  ++  + E
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSE 136

Query: 181 PILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA 240
                 F+ L++G+ YLH  + ++HRDIKP+NLLV   G  KI DFG+S   + S A+ +
Sbjct: 137 DQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195

Query: 241 TFVGTVTYMSPERIRNESYSY---PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
             VGT  +M+PE +      +     D+W++G+ L+    G+ P+   E  + L  +I  
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKS 254

Query: 298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
                P + + + +    +   L K+ E+R    ++  HP++T+
Sbjct: 255 QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  142 bits (361), Expect = 3e-40
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 18/271 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSG  ++V++     T +  A K I             R ++  E+  L E   +  ++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNII 71

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             H  F   +   + + LE + GG L D L  ++S+ E   +   K++L G+ YLH  + 
Sbjct: 72  TLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS-KR 128

Query: 203 LVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           + H D+KP N+++  K  P    K+ DFGI+  +E          GT  +++PE +  E 
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-KNIFGTPEFVAPEIVNYEP 187

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFV 316
               AD+WSIG+  +   +G  P+   E     +  I   +         N S     F+
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246

Query: 317 DDCLKKDAEARPTADQLLSHPFITKYEHAKV 347
              L KD + R T  Q L H +I       V
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  147 bits (372), Expect = 6e-40
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 34/305 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-------------IFEKEKRNQLLTEIRTLCEA 135
           +GSGA   V        H   A+K I                 ++   ++  EI  L   
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 136 PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
             +  +++    F   D     +  E+ +GG L + +  +    E   +++ K++L G+ 
Sbjct: 104 D-HPNIIKLFDVFE--DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160

Query: 196 YLHGVRHLVHRDIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPE 252
           YLH   ++VHRDIKP N+L+  K      KI DFG+S+       +    +GT  Y++PE
Sbjct: 161 YLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-RDRLGTAYYIAPE 218

Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFP-YAASEGPVNLMLQILE-DPS-PSPSRQNFS 309
            ++ + Y+   D+WS G+ ++    G  P    ++   +++ ++ +          +N S
Sbjct: 219 VLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKGKYYFDFNDWKNIS 275

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE------HAKVDLAAFVR-SVFDPMQR 362
            E    +   L  D   R TA++ L+  +I KY         K    A      F+  Q+
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQK 335

Query: 363 MKDLA 367
           +   A
Sbjct: 336 LAQAA 340

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  143 bits (363), Expect = 1e-39
 Identities = 62/266 (23%), Positives = 123/266 (46%), Gaps = 12/266 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G    V +     T   +A K I     + + ++  EI  + +   +  L++ + AF
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAF 155

Query: 149 YMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
                  I + +EY+DGG L D I+    ++ E       K++ +G+ ++H   +++H D
Sbjct: 156 --ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-MYILHLD 212

Query: 208 IKPANLLVNLKGRP--KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           +KP N+L   +     KI DFG++   +    +     GT  +++PE +  +  S+P D+
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKL-KVNFGTPEFLAPEVVNYDFVSFPTDM 271

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFCSFVDDCLKKD 323
           WS+G+  +   +G  P+   +     +  IL           Q+ S E   F+   L K+
Sbjct: 272 WSVGVIAYMLLSGLSPFLG-DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKE 330

Query: 324 AEARPTADQLLSHPFITKY-EHAKVD 348
              R +A + L HP+++ +  H+++ 
Sbjct: 331 KSWRISASEALKHPWLSDHKLHSRLS 356

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  141 bits (357), Expect = 1e-39
 Identities = 56/271 (20%), Positives = 105/271 (38%), Gaps = 37/271 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-------NIFEKEKRNQLLTEIRTLCEA--PCNE 139
           IG G   +V +   +    ++A+K +            EK  +   E+  +     P   
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN-- 84

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLH 198
            +V+ +G  + P      + +E++  G L   L  +   I   +   +   +  G+ Y+ 
Sbjct: 85  -IVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 199 GVRH-LVHRDIKPANLLVNLKGR-----PKITDFGISAGLENSIAMCATFVGTVTYMSPE 252
                +VHRD++  N+ +           K+ DFG+S             +G   +M+PE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVS--GLLGNFQWMAPE 196

Query: 253 RI--RNESYSYPADIWSIGLALFECGTGEFPYA-ASEGPVNLMLQILED----PSPSPSR 305
            I    ESY+  AD +S  + L+   TGE P+   S G +  +  I E+      P    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE--- 253

Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
            +  P   + ++ C   D + RP    ++  
Sbjct: 254 -DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  141 bits (357), Expect = 2e-39
 Identities = 54/267 (20%), Positives = 108/267 (40%), Gaps = 30/267 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEA--PCNEGLVEF 144
           IG G    V        H  +A++ I+I    +++      E+    +        +V F
Sbjct: 41  IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN---VVLF 94

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHL 203
            GA   P    ++I      G +L  ++R  K  +       + +++++G+ YLH  + +
Sbjct: 95  MGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGI 151

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-----AGLENSIAMCATFVGTVTYMSPERIRN-- 256
           +H+D+K  N+  +  G+  ITDFG+                    G + +++PE IR   
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 257 -------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
                    +S  +D++++G   +E    E+P+        ++ Q+     P+ S+    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-AEAIIWQMGTGMKPNLSQIGMG 269

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLSH 336
            E    +  C   + E RPT  +L+  
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKLMDM 296

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  139 bits (352), Expect = 1e-38
 Identities = 55/184 (29%), Positives = 100/184 (54%), Gaps = 8/184 (4%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL 217
           I +EY+DG +L DI+  +  +       +     Q L++ H    ++HRD+KPAN++++ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA 151

Query: 218 KGRPKITDFGIS-AGLENSIAMCAT--FVGTVTYMSPERIRNESYSYPADIWSIGLALFE 274
               K+ DFGI+ A  ++  ++  T   +GT  Y+SPE+ R +S    +D++S+G  L+E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

Query: 275 CGTGEFPYAASEGPVNLMLQILEDPSPSPSRQN--FSPEFCSFVDDCLKKDAEARP-TAD 331
             TGE P+   + PV++  Q + +    PS ++   S +  + V   L K+ E R  TA 
Sbjct: 212 VLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270

Query: 332 QLLS 335
           ++ +
Sbjct: 271 EMRA 274

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  137 bits (348), Expect = 2e-38
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 22/265 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTL--CEAPCNEGLVEFH 145
           +GSGA   V       +     +K IN    +    Q+  EI  L   + P    +++  
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN---IIKIF 86

Query: 146 GAFYMPDSGQISIALEYMDGGSLAD----ILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
             F   D   + I +E  +GG L +         K++ E  ++ + K+++  L+Y H  +
Sbjct: 87  EVFE--DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-Q 143

Query: 202 HLVHRDIKPANLLVNLK---GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           H+VH+D+KP N+L          KI DFG++   ++         GT  YM+PE +    
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPE-VFKRD 201

Query: 259 YSYPADIWSIGLALFECGTGEFP-YAASEGPVNLMLQILE-DPSPSPSRQNFSPEFCSFV 316
            ++  DIWS G+ ++   TG  P    S     +  +    +P+ +   +  +P+    +
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVECRPLTPQAVDLL 259

Query: 317 DDCLKKDAEARPTADQLLSHPFITK 341
              L KD E RP+A Q+L H +  +
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFKQ 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  135 bits (342), Expect = 1e-37
 Identities = 43/259 (16%), Positives = 96/259 (37%), Gaps = 23/259 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEA--PCNEGLVEF 144
           +    S  + +         I +K + +  +   K      E   L     P    ++  
Sbjct: 18  LNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN---VLPV 72

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGV-R 201
            GA   P +   ++   +M  GSL ++L    +  + +         + +G+++LH +  
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +    +   +++++     +I+   +    ++        +    +++PE ++ +    
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQKKPEDT 187

Query: 262 P---ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSRQNFSPEFCSFVD 317
               AD+WS  + L+E  T E P+A        M   LE   P+ P     SP     + 
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP--GISPHVSKLMK 245

Query: 318 DCLKKDAEARPTADQLLSH 336
            C+ +D   RP  D ++  
Sbjct: 246 ICMNEDPAKRPKFDMIVPI 264

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  132 bits (334), Expect = 2e-36
 Identities = 69/262 (26%), Positives = 113/262 (43%), Gaps = 18/262 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT----EIRT--LCEAPCNEGLV 142
           +G GA   VQ AV+  T   +A+K   I + ++          EI    +     N  +V
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE-N--VV 68

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +F+G  +  +     + LEY  GG L D +     +PEP     F +L+ G+ YLHG   
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IG 125

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNESYS 260
           + HRDIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE ++   + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 261 -YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
             P D+WS G+ L     GE P+              E  +     +       + +   
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 320 LKKDAEARPTADQLLSHPFITK 341
           L ++  AR T   +    +  K
Sbjct: 246 LVENPSARITIPDIKKDRWYNK 267

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  133 bits (337), Expect = 4e-36
 Identities = 43/276 (15%), Positives = 90/276 (32%), Gaps = 40/276 (14%)

Query: 89  IGSGASSVVQRAVH-----IPTHRIIALKKI---NIFEKEKRNQLLTEIRTLCEAPCNEG 140
           +G GA + V  A           +   LK     N +E     QL+  ++          
Sbjct: 73  LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM----QHM 128

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS-----IPEPILSSMFKKLLQGLS 195
            ++F+ A    +     +  E    G+L + + + K+     +P+ ++ S   ++L  + 
Sbjct: 129 FMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRP-----------KITDFGISAGLEN--SIAMCATF 242
            +H    ++H DIKP N ++                  + D G S  ++      +    
Sbjct: 187 QVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 243 VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS 302
             T  +   E + N+ ++Y  D + +   ++    G +    +EG       +       
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF------ 299

Query: 303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
             R      +  F    L         +  LL    
Sbjct: 300 -RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  130 bits (330), Expect = 2e-35
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 26/265 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLT---EI---RTLCEAPCNE 139
           +G G    V     +     +A+K I    +      +  +T   E+     +     + 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 140 GLVEFHGAFYMPDSGQISIALEY-MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           G++     F   +     + LE  +    L D +  +  + E      F +++  + + H
Sbjct: 99  GVIRLLDWFETQEG--FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156

Query: 199 GVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
             R +VHRDIK  N+L++L+ G  K+ DFG  A L +       F GT  Y  PE I   
Sbjct: 157 S-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRH 213

Query: 258 SYS-YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
            Y   PA +WS+G+ L++   G+ P+   +       +ILE     P+    SP+ C+ +
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAELHFPAH--VSPDCCALI 264

Query: 317 DDCLKKDAEARPTADQLLSHPFITK 341
             CL     +RP+ +++L  P++  
Sbjct: 265 RRCLAPKPSSRPSLEEILLDPWMQT 289

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  129 bits (327), Expect = 5e-35
 Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 30/267 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G+ S V  A  + T R  A+K   K +I ++ K   +  E   +     P     V+
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP---FFVK 94

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVR 201
            +  F   D  ++   L Y   G L   +R   S  E    + F   +++  L YLHG +
Sbjct: 95  LYFTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETC--TRFYTAEIVSALEYLHG-K 149

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGIS--AGLENSIAMCATFVGTVTYMSPERIRNESY 259
            ++HRD+KP N+L+N     +ITDFG +     E+  A   +FVGT  Y+SPE +  +S 
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209

Query: 260 SYPADIWSIGLALFECGTGEFP-YAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVD 317
              +D+W++G  +++   G  P  A +E    L+ Q I++     P    F P+    V+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKIIKLEYDFPE--KFFPKARDLVE 264

Query: 318 DCLKKDAEARPT------ADQLLSHPF 338
             L  DA  R           L +HPF
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  130 bits (328), Expect = 5e-35
 Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 28/265 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN--------IFEKEKRNQLLTEIRTL--CEAPCN 138
           +GSGA   V  AV    ++ + +K I           E  K  ++  EI  L   E    
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 139 EGLVEFHGAFYMPDSGQISIALE-YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
             +++        + G   + +E +  G  L   +     + EP+ S +F++L+  + YL
Sbjct: 92  IKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
              + ++HRDIK  N+++      K+ DFG +A LE    +  TF GT+ Y +PE +   
Sbjct: 147 RL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGN 204

Query: 258 SYSYP-ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
            Y  P  ++WS+G+ L+     E P+         +   +  P         S E  S V
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPF---CELEETVEAAIHPPYL------VSKELMSLV 255

Query: 317 DDCLKKDAEARPTADQLLSHPFITK 341
              L+   E R T ++L++ P++T+
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQ 280

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  128 bits (324), Expect = 2e-34
 Identities = 69/262 (26%), Positives = 113/262 (43%), Gaps = 18/262 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLT----EIRT--LCEAPCNEGLV 142
           +G GA   VQ AV+  T   +A+K   I + ++          EI    +     N  +V
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHE-N--VV 68

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
           +F+G  +  +     + LEY  GG L D +     +PEP     F +L+ G+ YLHG   
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IG 125

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNESYS 260
           + HRDIKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE ++   + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 261 -YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
             P D+WS G+ L     GE P+              E  +     +       + +   
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 320 LKKDAEARPTADQLLSHPFITK 341
           L ++  AR T   +    +  K
Sbjct: 246 LVENPSARITIPDIKKDRWYNK 267

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  125 bits (315), Expect = 3e-33
 Identities = 66/267 (24%), Positives = 117/267 (43%), Gaps = 30/267 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN------IFEKEKRNQLLTEIRTL----CEAPCN 138
           +GSG    V   + +  +  +A+K +         E     ++  E+  L          
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 108

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
            G++     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + 
Sbjct: 109 -GVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165

Query: 198 HGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN 256
           H    ++HRDIK  N+L++L +G  K+ DFG  A L+++  +   F GT  Y  PE IR 
Sbjct: 166 HN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY 222

Query: 257 ESYS-YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF 315
             Y    A +WS+G+ L++   G+ P+   E       +I+        R   S E    
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVFFRQR--VSSECQHL 273

Query: 316 VDDCLKKDAEARPTADQLLSHPFITKY 342
           +  CL      RPT +++ +HP++   
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPWMQDV 300

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  123 bits (311), Expect = 8e-33
 Identities = 61/272 (22%), Positives = 101/272 (37%), Gaps = 46/272 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G +  V +  +  T    ALK +     +   +   E+     A     +V     +
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 149 --YMPDSGQISIALEYMDGGSLAD--ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                    + I +E +DGG L      R  ++  E   S + K + + + YLH   ++ 
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIA 139

Query: 205 HRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+KP NLL   K      K+TDFG +                      E    E Y  
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFA---------------------KE-TTGEKYDK 177

Query: 262 PADIWSIGLALFE--CG----TGEFPYAASEGPVNLMLQILE-DPS-PSPSRQNFSPEFC 313
             D+WS+G+ ++   CG          A S G   +  +I       P+P     S E  
Sbjct: 178 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFPNPEWSEVSEEVK 234

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFITKYEHA 345
             + + LK +   R T  + ++HP+I +    
Sbjct: 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  123 bits (310), Expect = 8e-33
 Identities = 59/304 (19%), Positives = 101/304 (33%), Gaps = 57/304 (18%)

Query: 77  RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQLLTEIRT 131
           R  + ++ +   +G G    V R         +A+K  +      + +E        +R 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLR- 60

Query: 132 LCEAPCNEGLVEFHGA--FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK 189
                 +E ++ F  +       S Q+ +   Y + GSL D L+   ++       +   
Sbjct: 61  ------HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLS 113

Query: 190 LLQGLSYLHGVRHL-------VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM---- 238
           +  GL++LH             HRD+K  N+LV   G+  I D G++     S       
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173

Query: 239 CATFVGTVTYMSPERIRNE------SYSYPADIWSIGLALFECGTGEFPYAASEG---PV 289
               VGT  YM+PE +               DIW+ GL L+E           E    P 
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 290 NLMLQILEDPS------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTAD 331
             ++    DPS                                 + +C  ++  AR TA 
Sbjct: 234 YDVVP--NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291

Query: 332 QLLS 335
           ++  
Sbjct: 292 RIKK 295

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  123 bits (312), Expect = 1e-32
 Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 21/263 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN-----QLLTEIRTL--CEAPCNEGL 141
           IG G  + V+ A HI T R +A+K   I +K + N     +L  E+R +     P    L
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
            E      +     + + +EY  GG + D L     + E    S F++++  + Y H  +
Sbjct: 80  FEV-----IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-K 133

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +VHRD+K  NLL++     KI DFG S            F G   Y +PE  + + Y  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 262 P-ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
           P  D+WS+G+ L+   +G  P+        L  ++L      P     S +  + +   L
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRERVLRGKYRIPF--YMSTDCENLLKRFL 249

Query: 321 KKDAEARPTADQLLSHPFITKYE 343
             +   R T +Q++   +I    
Sbjct: 250 VLNPIKRGTLEQIMKDRWINAGH 272

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (319), Expect = 3e-32
 Identities = 49/265 (18%), Positives = 95/265 (35%), Gaps = 41/265 (15%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTH-RIIALKK---------INIFEKEKRNQLLTEIRTLC 133
            + G I  G    +  A+    + R + LK            +   E++   L E+    
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF--LAEVV--- 137

Query: 134 EAPCNEGLVEFH--GAFYMPDSGQIS-IALEYMDGGSLADILRMQKSIPEPILSSMFKKL 190
               +  +V+              +  I +EY+ G SL      +  + E I  +   ++
Sbjct: 138 ----HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI--AYLLEI 191

Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMS 250
           L  LSYLH    LV+ D+KP N+++  + + K+ D G  + + +         GT  + +
Sbjct: 192 LPALSYLHS-IGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSF----GYLYGTPGFQA 245

Query: 251 PERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           PE +R    +   DI+++G  L                    +  L +  P         
Sbjct: 246 PEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR------YVDGLPEDDPVLKT---YD 295

Query: 311 EFCSFVDDCLKKDAEARP-TADQLL 334
            +   +   +  D   R  TA+++ 
Sbjct: 296 SYGRLLRRAIDPDPRQRFTTAEEMS 320

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  122 bits (307), Expect = 1e-31
 Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 20/262 (7%)

Query: 88  AIGSGASSVVQRAVHIPTHRIIALK---KINIFEKEKRNQLLTEIRTLCEA--PCNEGLV 142
           AIG G+   V       T ++ A+K   K    E+ +   +  E++ +     P    LV
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF---LV 78

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
               +F   D   + + ++ + GG L   L+      E  +     +L+  L YL   + 
Sbjct: 79  NLWYSF--QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QR 135

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPE---RIRNESY 259
           ++HRD+KP N+L++  G   ITDF I+A L        T  GT  YM+PE     +   Y
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 260 SYPADIWSIGLALFECGTGEFPY--AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
           S+  D WS+G+  +E   G  PY   +S     ++          PS   +S E  S + 
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQEMVSLLK 252

Query: 318 DCLKKDAEAR-PTADQLLSHPF 338
             L+ + + R      + + P+
Sbjct: 253 KLLEPNPDQRFSQLSDVQNFPY 274

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  120 bits (303), Expect = 2e-31
 Identities = 62/326 (19%), Positives = 108/326 (33%), Gaps = 67/326 (20%)

Query: 65  LADESDHSEKT----------YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKI 114
           L D  + S+ +           R  + ++++   IG G    V           +A+K  
Sbjct: 11  LRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVF 68

Query: 115 NI-----FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG--QISIALEYMDGGS 167
                  + +E        +R       +E ++ F  A         Q+ +  +Y + GS
Sbjct: 69  FTTEEASWFRETEIYQTVLMR-------HENILGFIAADIKGTGSWTQLYLITDYHENGS 121

Query: 168 LADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL-------VHRDIKPANLLVNLKGR 220
           L D L+   ++    +  +    + GL +LH             HRD+K  N+LV   G 
Sbjct: 122 LYDYLK-STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180

Query: 221 PKITDFGIS----AGLENSIAMCATFVGTVTYMSPE------RIRNESYSYPADIWSIGL 270
             I D G++    +          T VGT  YM PE         +      AD++S GL
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

Query: 271 ALFECGTGEFPYAASEG---PVNLMLQILEDPS------------------PSPSRQNFS 309
            L+E           E    P + ++    DPS                     S     
Sbjct: 241 ILWEVARRCVSGGIVEEYQLPYHDLVP--SDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLS 335
            +    + +C   +  +R TA ++  
Sbjct: 299 RQMGKLMTECWAHNPASRLTALRVKK 324

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  118 bits (299), Expect = 3e-31
 Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 16/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRT--LCEAPCNEGLVE 143
           +G G    V+   H  T   +A+K +N   I   +   ++  EI+   L   P    L +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                 +       + +EY+ GG L D +     + E     +F+++L  + Y H    +
Sbjct: 79  V-----ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMV 132

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP- 262
           VHRD+KP N+L++     KI DFG+S  + +      T  G+  Y +PE I    Y+ P 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            DIWS G+ L+    G  P+     P  L  +I       P     +    + +   L+ 
Sbjct: 192 VDIWSCGVILYALLCGTLPFDDEHVP-TLFKKIRGGVFYIPE--YLNRSVATLLMHMLQV 248

Query: 323 DAEARPTADQLLSHPFITK 341
           D   R T   +  H +  +
Sbjct: 249 DPLKRATIKDIREHEWFKQ 267

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  120 bits (302), Expect = 4e-31
 Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 20/263 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN--QLLTEIRT--LCEAPCNEGLVEF 144
           IGSG   V +      T  ++A+K     E+       +  EI        P N  +V F
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIINHRSLRHP-N--IVRF 81

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                 P    ++I +EY  GG L + +       E      F++LL G+SY H    + 
Sbjct: 82  KEVILTPT--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQIC 138

Query: 205 HRDIKPANLLV--NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           HRD+K  N L+  +   R KI DFG S       +   + VGT  Y++PE +  + Y   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

Query: 263 -ADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNFSPEFCSFVDD 318
            AD+WS G+ L+    G +P+   E P +    + +IL      P     SPE C  +  
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257

Query: 319 CLKKDAEARPTADQLLSHPFITK 341
               D   R +  ++ +H +  K
Sbjct: 258 IFVADPATRISIPEIKTHSWFLK 280

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  117 bits (295), Expect = 2e-30
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 30/271 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------RNQLLTEIRTL--CEAPCNE 139
           +G G+   V+  +   T    A+K   I +K+K          +  EI+ L       N 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRRLRHK-N- 67

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGS--LADILRMQKSIPEPILSSMFKKLLQGLSYL 197
            +++     Y  +  ++ + +EY   G   + D +  +K  P       F +L+ GL YL
Sbjct: 68  -VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIR 255
           H  + +VH+DIKP NLL+   G  KI+  G++  L    A   C T  G+  +  PE   
Sbjct: 126 HS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 256 N-ESYSYP-ADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSRQNFSPE 311
             +++S    DIWS G+ L+   TG +P+   EG     L   I +     P   +  P 
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPF---EGDNIYKLFENIGKGSYAIPG--DCGPP 239

Query: 312 FCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
               +   L+ +   R +  Q+  H +  K 
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (295), Expect = 3e-30
 Identities = 61/303 (20%), Positives = 105/303 (34%), Gaps = 55/303 (18%)

Query: 76  YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQLLTEIR 130
            R  +  + +  +IG G    V R         +A+K  +      + +E        +R
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLR 94

Query: 131 TLCEAPCNEGLVEFHGA--FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFK 188
                  +E ++ F  A         Q+ +  +Y + GSL D L  + ++    +  +  
Sbjct: 95  -------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLAL 146

Query: 189 KLLQGLSYLH-------GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM--- 238
               GL++LH       G   + HRD+K  N+LV   G   I D G++   +++      
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206

Query: 239 -CATFVGTVTYMSPERIRNES------YSYPADIWSIGLALFECGTGEFPYAASEGPVNL 291
                VGT  YM+PE + +            ADI+++GL  +E           E    L
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQL 265

Query: 292 MLQILEDPSPS-----------------PSRQNFSPEFCSFVD---DCLKKDAEARPTAD 331
               L    PS                 P+R               +C   +  AR TA 
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325

Query: 332 QLL 334
           ++ 
Sbjct: 326 RIK 328

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  117 bits (296), Expect = 4e-30
 Identities = 74/318 (23%), Positives = 126/318 (39%), Gaps = 56/318 (17%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNEGLVEF 144
           IGSGA  +V  A      R +A+KK+   F+ +   KR     E+  +     ++ ++  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR--AYRELVLMKCV-NHKNIIGL 89

Query: 145 HGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
              F    S +    + I +E MD  +L  +++M+       +S +  ++L G+ +LH  
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD--HERMSYLLYQMLCGIKHLHS- 145

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
             ++HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y 
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYK 204

Query: 261 YPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------ 300
              DIWS+G  + E   G   FP        N +++ L  P                   
Sbjct: 205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264

Query: 301 PSPSRQNFS-------------------PEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
           P  +  +F                     +    +   L  DA  R + D+ L HP+I  
Sbjct: 265 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324

Query: 342 YEHAKVDLAAFVRSVFDP 359
           + +   +  A    + D 
Sbjct: 325 W-YDPSEAEAPPPKIPDK 341

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  118 bits (296), Expect = 1e-29
 Identities = 71/324 (21%), Positives = 124/324 (38%), Gaps = 54/324 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEA--PCNEGLV 142
           IGSGA  +V  A      R +A+KK+   F+ +   KR     E+  +          L+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR--AYRELVLMKCVNHKNIISLL 127

Query: 143 EFHGAFYMPDSGQ-ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
                    +  Q + + +E MD  +L  +++M+       +S +  ++L G+ +LH   
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELD--HERMSYLLYQMLCGIKHLHS-A 183

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            ++HRD+KP+N++V      KI DFG++     S  M   +V T  Y +PE I    Y  
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKE 242

Query: 262 PADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------------P 301
             DIWS+G  + E    +  FP        N +++ L  P                   P
Sbjct: 243 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302

Query: 302 SPSRQNFS-------------------PEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
             +   F                     +    +   L  D   R + D  L HP+I  +
Sbjct: 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362

Query: 343 EHAKVDLAAFVRSVFDPMQRMKDL 366
            +   ++ A    ++D     ++ 
Sbjct: 363 -YDPAEVEAPPPQIYDKQLDEREH 385

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  116 bits (292), Expect = 1e-29
 Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 46/296 (15%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNE 139
           R    +GSGA   V  AV   T   +A+KK+   F+ E   KR     E+R L     +E
Sbjct: 28  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR--AYRELRLLKHM-RHE 84

Query: 140 GLVEFHGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
            ++     F   ++        + + +M    L  +++ +K   + I   +++ +L+GL 
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQ-MLKGLR 142

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           Y+H    ++HRD+KP NL VN     KI DFG++   ++ +     +V T  Y +PE I 
Sbjct: 143 YIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 198

Query: 256 N-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------ 300
           N   Y+   DIWS+G  + E  TG+  F  +     +  ++++   P             
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258

Query: 301 -------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                  P   +++F       SP   + ++  L  DAE R TA + L+HP+    
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  116 bits (292), Expect = 1e-29
 Identities = 75/304 (24%), Positives = 115/304 (37%), Gaps = 60/304 (19%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKE---KRNQLLTEIRTLCEA--PCNEGLVE 143
           +G GA  VV  A H PT  I+A+KKI  F+K     R   L EI+ L          +  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR--TLREIKILKHFKHENIITIFN 76

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQGLSYLH 198
                   +  ++ I  E M    L  ++  Q      +LS    +      L+ +  LH
Sbjct: 77  IQRPDSFENFNEVYIIQELMQT-DLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLH 129

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM--------- 249
           G  +++HRD+KP+NLL+N     K+ DFG++  ++ S A  +   G  + M         
Sbjct: 130 GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 250 -SPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----- 300
            +PE +     YS   D+WS G  L E       FP       + L+  I+  P      
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248

Query: 301 ---------------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                          P              +P+    +   L  D   R TA + L HP+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

Query: 339 ITKY 342
           +  Y
Sbjct: 309 LQTY 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  115 bits (289), Expect = 1e-29
 Identities = 59/289 (20%), Positives = 100/289 (34%), Gaps = 53/289 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQLLTEIRTLCEAPCNEGLVE 143
              G    V +A     +  +A+K   I     ++ E     L  ++       +E +++
Sbjct: 32  KARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMK-------HENILQ 82

Query: 144 FHGAFYMPDSG--QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           F GA     S    + +   + + GSL+D L+    +    L  + + + +GL+YLH   
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHEDI 141

Query: 202 HL---------VHRDIKPANLLVNLKGRPKITDFGISAGLE--NSIAMCATFVGTVTYMS 250
                       HRDIK  N+L+       I DFG++   E   S       VGT  YM+
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201

Query: 251 PERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--- 302
           PE +              D++++GL L+E  +             L  +      PS   
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261

Query: 303 --------------PSRQNFSPEFCSFVD---DCLKKDAEARPTADQLL 334
                                       +   +C   DAEAR +A  + 
Sbjct: 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  115 bits (289), Expect = 2e-29
 Identities = 61/296 (20%), Positives = 102/296 (34%), Gaps = 64/296 (21%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-----FEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           IG G    V +       R +A+K  +      F  EK    +  +        ++ +  
Sbjct: 21  IGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLME-------HDNIAR 71

Query: 144 FHGAFYMPDSG---QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH-- 198
           F        +    +  + +EY   GSL   L    +        +   + +GL+YLH  
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 199 ------GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA--------TFVG 244
                     + HRD+   N+LV   G   I+DFG+S  L  +  +          + VG
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 245 TVTYMSPERIRN-------ESYSYPADIWSIGLALFECGTG-------------EFPYAA 284
           T+ YM+PE +         ES     D++++GL  +E                 +  +  
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250

Query: 285 SEGP----------VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTA 330
             G           V+   Q  + P                ++DC  +DAEAR TA
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  115 bits (291), Expect = 3e-29
 Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 22/267 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL---LTEIRTLCEAPCNEGLVEFH 145
           IG GA S V       T ++ A+K +N ++  KR ++     E   L        + + H
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLH 127

Query: 146 GAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            AF   D   + + +EY  GG L  +L +  + IP  +      +++  +  +H     V
Sbjct: 128 FAF--QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYV 184

Query: 205 HRDIKPANLLVNLKGRPKITDFGISA-GLENSIAMCATFVGTVTYMSPERIRNES----- 258
           HRDIKP N+L++  G  ++ DFG       +        VGT  Y+SPE ++        
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 259 --YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP---SRQNFSPEFC 313
             Y    D W++G+  +E   G+ P+ A +       +I+            +    E  
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303

Query: 314 SFVDDCLKKDAE--ARPTADQLLSHPF 338
            F+   L        R  A    +HPF
Sbjct: 304 DFIQRLLCPPETRLGRGGAGDFRTHPF 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  115 bits (291), Expect = 3e-29
 Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 20/263 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL---LTEIRTLCEAPCNEGLVEFH 145
           IG GA   VQ   H  T ++ A+K ++ FE  KR+       E   +  A  +  +V+  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLF 135

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
            AF   D   + + +EYM GG L +++     +PE        +++  L  +H     +H
Sbjct: 136 YAFQ--DDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS-MGFIH 191

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIRNE----SYS 260
           RD+KP N+L++  G  K+ DFG    + +  +  C T VGT  Y+SPE ++++     Y 
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL--EDPSPSPSRQNFSPEFCSFVDD 318
              D WS+G+ L+E   G+ P+ A +  V    +I+  ++    P   + S E  + +  
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310

Query: 319 CLKKDAEAR---PTADQLLSHPF 338
               D E R      +++  H F
Sbjct: 311 -FLTDREVRLGRNGVEEIKRHLF 332

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  114 bits (288), Expect = 4e-29
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 47/296 (15%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNE 139
                +GSGA   V  A+   +   +A+KK+   F+ E   KR     E+  L     +E
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR--AYRELLLLKHM-QHE 83

Query: 140 GLVEFHGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
            ++     F    S +      + + +M    L  I+ ++ S  E  +  +  ++L+GL 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQYLVYQMLKGLK 140

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           Y+H    +VHRD+KP NL VN     KI DFG++   +  +     +V T  Y +PE I 
Sbjct: 141 YIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVIL 196

Query: 256 N-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------ 300
           +   Y+   DIWS+G  + E  TG+  F        +  +L++   P             
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256

Query: 301 -------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                  P   R++F       SP+    ++  L+ D + R TA Q L+HPF   +
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  116 bits (292), Expect = 4e-29
 Identities = 75/261 (28%), Positives = 119/261 (45%), Gaps = 20/261 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G    V       T R  A   LKK  I  K++    LTE R L  +  P    L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF---LTA 212

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
              +F   D  ++   +EY +GG L   L  ++   E        +++  L YLH  +++
Sbjct: 213 LKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           V+RD+K  NL+++  G  KITDFG+   G+++  A   TF GT  Y++PE + +  Y   
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRA 329

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W +G+ ++E   G  P+  ++    L   IL +    P  +   PE  S +   LKK
Sbjct: 330 VDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFP--RTLGPEAKSLLSGLLKK 386

Query: 323 DAEAR----PT-ADQLLSHPF 338
           D + R       A +++ H F
Sbjct: 387 DPKQRLGGGSEDAKEIMQHRF 407

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  117 bits (295), Expect = 4e-29
 Identities = 72/263 (27%), Positives = 116/263 (44%), Gaps = 20/263 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEG--LVE 143
           IG G    V       T ++ A   L K  I  K+     L E   L      +   +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
              AF+ PD  ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +
Sbjct: 257 MSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFV 313

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYP 262
           V+RD+KPAN+L++  G  +I+D G++   + S       VGT  YM+PE + +  +Y   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371

Query: 263 ADIWSIGLALFECGTGEFP-YAASEGPVNLMLQ-ILEDPSPSPSRQNFSPEFCSFVDDCL 320
           AD +S+G  LF+   G  P         + + +  L      P   +FSPE  S ++  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEGLL 429

Query: 321 KKDAEAR-----PTADQLLSHPF 338
           ++D   R       A ++   PF
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPF 452

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  115 bits (290), Expect = 5e-29
 Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 20/265 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG GA   V         ++ A   L K  + ++ +      E R +     ++ +   H
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE-RDVLVNGDSKWITTLH 140

Query: 146 GAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            AF   D   + + ++Y  GG L  +L + +  +PE +      +++  +  +H   H V
Sbjct: 141 YAF--QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYV 197

Query: 205 HRDIKPANLLVNLKGRPKITDFGISA-GLENSIAMCATFVGTVTYMSPERIRNES----- 258
           HRDIKP N+L+++ G  ++ DFG     +E+     +  VGT  Y+SPE ++        
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP---SRQNFSPEFCSF 315
           Y    D WS+G+ ++E   GE P+ A E  V    +I+             + S      
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316

Query: 316 VDDCLKKDAE--ARPTADQLLSHPF 338
           +   +        +   +    HPF
Sbjct: 317 IRRLICSREHRLGQNGIEDFKKHPF 341

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  114 bits (287), Expect = 6e-29
 Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 56/303 (18%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE---KRNQLLTEIRTLCEA--PCN 138
                IG GA  +V  A        +A+KKI+ FE +   +R   L EI+ L        
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENI 87

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQG 193
            G+ +   A  +     + I  + M+   L  +L+ Q       LS+         +L+G
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQILRG 140

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG----ISAGLENSIAMCAT-FVGTVTY 248
           L Y+H   +++HRD+KP+NLL+N     KI DFG         +++  +  T +V T  Y
Sbjct: 141 LKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWY 197

Query: 249 MSPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----- 300
            +PE + N + Y+   DIWS+G  L E  +    FP       +N +L IL  PS     
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 301 --------------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
                         P  ++  +         +    +D  L  +   R   +Q L+HP++
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

Query: 340 TKY 342
            +Y
Sbjct: 318 EQY 320

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  112 bits (282), Expect = 2e-28
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 47/287 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+  +V +  +  T RI+A+KK      +    +   + EI+ L +   +E LV   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLE-SDDDKMVKKIAMREIKLLKQLR-HENLVNLL 90

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK----LLQGLSYLHGVR 201
                    +  +  E++D      IL   +  P  +   + +K    ++ G+ + H   
Sbjct: 91  EVCK--KKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-H 143

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYS 260
           +++HRDIKP N+LV+  G  K+ DFG +  L     +    V T  Y +PE +  +  Y 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203

Query: 261 YPADIWSIGLALFECGTGE--FPYAASE-GPVNLMLQILEDPSPS--------------- 302
              D+W+IG  + E   GE  FP   S+   +  ++  L +  P                
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 303 -PSRQ----------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
            P  +            S         CL  D + RP   +LL H F
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  112 bits (283), Expect = 2e-28
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 23/283 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRT--LCEAPCNEGLVE 143
           +G G+   V+ A H  T + +ALK I+   + + +   ++  EI    L   P    L +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                 +     I + +EY  GG L D +  +K + E      F++++  + Y H    +
Sbjct: 77  V-----ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKI 129

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP- 262
           VHRD+KP NLL++     KI DFG+S  +        T  G+  Y +PE I  + Y+ P 
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D+WS G+ L+    G  P+     P NL  ++       P     SP   S +   +  
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKKVNSCVYVMPD--FLSPGAQSLIRRMIVA 245

Query: 323 DAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKD 365
           D   R T  ++   P+         +L  ++R + +      D
Sbjct: 246 DPMQRITIQEIRRDPWFNV------NLPDYLRPMEEVQGSYAD 282

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  112 bits (283), Expect = 2e-28
 Identities = 65/324 (20%), Positives = 115/324 (35%), Gaps = 74/324 (22%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTL-------CE 134
            +   +G G  S V  A  +  +  +A+K   I   +K        EI+ L         
Sbjct: 22  ILVRKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 135 APCNEG---LVEFHGAFYM--PDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMF 187
              + G   +++    F    P+   + +  E + G +L  +++  +   IP   +  + 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137

Query: 188 KKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP------KITDFGISAGLENSIAMCAT 241
           K+LL GL Y+H    ++H DIKP N+L+ +   P      KI D G +   +        
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 194

Query: 242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVN------LML 293
            + T  Y SPE +    +   ADIWS    +FE  TG+  F                 ++
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 294 QILEDPSPS---------------------------------PSRQNFSPE----FCSFV 316
           ++L +                                       +  FS +       F+
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 317 DDCLKKDAEARPTADQLLSHPFIT 340
              L+ D   R  A  L++HP++ 
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLK 338

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  113 bits (285), Expect = 3e-28
 Identities = 68/260 (26%), Positives = 112/260 (43%), Gaps = 16/260 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRT--LCEAPCNEGLVE 143
           +G G    V+   H  T   +A+K +N   I   +   ++  EI+   L   P    L +
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                 +     I + +EY+ GG L D +     + E     +F+++L G+ Y H    +
Sbjct: 84  -----VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMV 137

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP- 262
           VHRD+KP N+L++     KI DFG+S  + +      T  G+  Y +PE I    Y+ P 
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 196

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            DIWS G+ L+    G  P+     P  L  +I +    +P     +P   S +   L+ 
Sbjct: 197 VDIWSSGVILYALLCGTLPFDDDHVP-TLFKKICDGIFYTPQ--YLNPSVISLLKHMLQV 253

Query: 323 DAEARPTADQLLSHPFITKY 342
           D   R T   +  H +  + 
Sbjct: 254 DPMKRATIKDIREHEWFKQD 273

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  110 bits (278), Expect = 4e-28
 Identities = 61/288 (21%), Positives = 110/288 (38%), Gaps = 43/288 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQL----LTEIRTLCEAPCNE---- 139
           IG GA   V +A    +   +ALK + +         L    + E+  L      E    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 140 -GLVE-FHGAFYMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLS 195
             L++    +       ++++  E++D   L   L       +P   +  + ++ L+GL 
Sbjct: 77  VRLMDVCATS-RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           +LH    +VHRD+KP N+LV   G  K+ DFG++      +A+    V T+ Y +PE + 
Sbjct: 135 FLHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWYRAPEVLL 192

Query: 256 NESYSYPADIWSIGLALFECGTGE--FPYAASEGP-VNLMLQILEDPS------------ 300
             +Y+ P D+WS+G    E    +  F    SE   +  +  ++  P             
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251

Query: 301 ---PSPSRQNFSPEFCSFVDD-------CLKKDAEARPTADQLLSHPF 338
              P    +          +         L  +   R +A + L H +
Sbjct: 252 GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  112 bits (281), Expect = 4e-28
 Identities = 76/296 (25%), Positives = 124/296 (41%), Gaps = 56/296 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNEGLVEF 144
           +GSGA   V  A    T   +A+KK+   F+     KR     E+R L     +E ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR--TYRELRLLKHM-KHENVIGL 93

Query: 145 HGAFYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQGLS 195
              F    S +    + +    M    L +I++ QK      L+    +     +L+GL 
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK------LTDDHVQFLIYQILRGLK 146

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR 255
           Y+H    ++HRD+KP+NL VN     KI DFG++    + +     +V T  Y +PE + 
Sbjct: 147 YIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGYVATRWYRAPEIML 202

Query: 256 N-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------------ 300
           N   Y+   DIWS+G  + E  TG   FP       + L+L+++  P             
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262

Query: 301 -------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                      + NF       +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  111 bits (280), Expect = 5e-28
 Identities = 65/260 (25%), Positives = 122/260 (46%), Gaps = 22/260 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL---LTEIRTLCEAPCNEGLVEFH 145
           +G+G+   V    H  +    A+K ++  +  K  Q+   L E R L        LV+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP-FLVKLE 107

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
            +F   D+  + + +EY+ GG +   LR      EP   + F   +++    YLH    L
Sbjct: 108 FSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHS-LDL 162

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           ++RD+KP NLL++ +G  ++TDFG +  ++       T  GT   ++PE I ++ Y+   
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           D W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ D
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVD 276

Query: 324 AEAR-----PTADQLLSHPF 338
              R        + + +H +
Sbjct: 277 LTKRFGNLKNGVNDIKNHKW 296

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  110 bits (278), Expect = 5e-28
 Identities = 72/283 (25%), Positives = 116/283 (40%), Gaps = 39/283 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+  VV +  +  T +I+A+KK     ++    +   L EIR L +   +  LV   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLE-SEDDPVIKKIALREIRMLKQLK-HPNLVNLL 68

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F      ++ +  EY D   L ++ R Q+ +PE ++ S+  + LQ +++ H   + +H
Sbjct: 69  EVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIH 125

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYPAD 264
           RD+KP N+L+      K+ DFG +  L          V T  Y SPE +  +  Y  P D
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVD 185

Query: 265 IWSIGLALFECGTGE--FPYAASE--------------------GPVNLML-QILEDPSP 301
           +W+IG    E  +G   +P   S+                              ++ P P
Sbjct: 186 VWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244

Query: 302 SPSR------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                      N S      +  CL  D   R T +QLL HP+
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  110 bits (278), Expect = 8e-28
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 28/270 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+ + V       T RI A   +KK  + + E  + + TE     +A  +  LV  H
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F      ++   +EY++GG L   ++ Q+ +PE    + F   ++   L+YLH  R +
Sbjct: 77  SCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEE--HARFYSAEISLALNYLHE-RGI 131

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+K  N+L++ +G  K+TD+G+   GL       +TF GT  Y++PE +R E Y + 
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFS 190

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNL-------MLQ-ILEDPSPSPSRQNFSPEFCS 314
            D W++G+ +FE   G  P+       N        + Q ILE     P  ++ S +  S
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAAS 248

Query: 315 FVDDCLKKDAEAR------PTADQLLSHPF 338
            +   L KD + R           +  HPF
Sbjct: 249 VLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  110 bits (278), Expect = 1e-27
 Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 31/266 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A H       A   L+K  I +K++   +++E   L +   +  LV  H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP--------ILSSMFKKLLQGLSYL 197
            +F   D  ++   L+Y++GG L   L+ ++   EP        I S         L YL
Sbjct: 106 FSFQTAD--KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS--------ALGYL 155

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRN 256
           H   ++V+RD+KP N+L++ +G   +TDFG+    +E++ +  +TF GT  Y++PE +  
Sbjct: 156 HS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHK 213

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
           + Y    D W +G  L+E   G  P+  S     +   IL  P       N +      +
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLK--PNITNSARHLL 270

Query: 317 DDCLKKDAEAR----PTADQLLSHPF 338
           +  L+KD   R        ++ SH F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  112 bits (282), Expect = 2e-27
 Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 20/263 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V       T ++ A   L+K  I +++     L E + L E   +  +V   
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVVSLA 250

Query: 146 GAFYMPDSGQISIALEYMDGGSL-ADILRMQKSI-PEPILSSMFKKLLQGLSYLHGVRHL 203
            A+   D   + + L  M+GG L   I  M ++  PE        ++  GL  LH    +
Sbjct: 251 YAYETKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-ERI 307

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           V+RD+KP N+L++  G  +I+D G++  +          VGTV YM+PE ++NE Y++  
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSP 366

Query: 264 DIWSIGLALFECGTGEFPYAASEGPV---NLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
           D W++G  L+E   G+ P+   +  +    +   + E P      + FSP+  S     L
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQLL 424

Query: 321 KKDAEAR-----PTADQLLSHPF 338
            KD   R      +A ++  HP 
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPL 447

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  112 bits (282), Expect = 2e-27
 Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 25/267 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V       T ++ A   L K  + +++     + E + L     +  +V   
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVSLA 251

Query: 146 GAFYMPDSGQISIALEYMDGGSL----ADILRMQKSIPEPILSSMF--KKLLQGLSYLHG 199
            AF       + + +  M+GG +     ++        EP   ++F   +++ GL +LH 
Sbjct: 252 YAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--RAIFYTAQIVSGLEHLHQ 307

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
            R++++RD+KP N+L++  G  +I+D G++  L+        + GT  +M+PE +  E Y
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366

Query: 260 SYPADIWSIGLALFECGTGEFP-YAASEGPVNLMLQ--ILEDPSPSPSRQNFSPEFCSFV 316
            +  D +++G+ L+E      P  A  E   N  L+  +LE     P    FSP    F 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFC 424

Query: 317 DDCLKKDAEAR-----PTADQLLSHPF 338
           +  L+KD E R      + D L +HP 
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPL 451

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  109 bits (274), Expect = 2e-27
 Identities = 67/313 (21%), Positives = 119/313 (38%), Gaps = 68/313 (21%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE---KRNQLLTEIRTLCE------ 134
                +G G + +V  AV     + +A+KKI +       K    L EI+ +        
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKH--ALREIKIIRRLDHDNI 70

Query: 135 --------APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSM 186
                      ++   +      +     + I  EYM+   LA++L          L   
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNS---VYIVQEYMET-DLANVLEQGP------LLEE 120

Query: 187 FKK-----LLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENSIAMCA 240
             +     LL+GL Y+H   +++HRD+KPANL +N +    KI DFG++  ++   +   
Sbjct: 121 HARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 241 TFVGTVT---YMSPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQ 294
                +    Y SP  + +  +Y+   D+W+ G    E  TG+  F  A     + L+L+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

Query: 295 ILEDPS------------------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPT 329
            +                       +   +         S E   F++  L      R T
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299

Query: 330 ADQLLSHPFITKY 342
           A++ LSHP+++ Y
Sbjct: 300 AEEALSHPYMSIY 312

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  109 bits (275), Expect = 2e-27
 Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 36/265 (13%)

Query: 97  VQRAVHIPTHRIIA---LKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD 152
           V++     T ++ A   LKK  I +K K      TE + L     +  LV  H AF    
Sbjct: 73  VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QT 130

Query: 153 SGQISIALEYMDGGSLADILRMQKSIPEP--------ILSSMFKKLLQGLSYLHGVRHLV 204
             ++ + L+Y++GG L   L  ++   E         I+          L +LH    ++
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL--------ALEHLHK-LGII 181

Query: 205 HRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSY-- 261
           +RDIK  N+L++  G   +TDFG+S   + +       F GT+ YM+P+ +R     +  
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 241

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVN---LMLQILEDPSPSPSRQNFSPEFCSFVDD 318
             D WS+G+ ++E  TG  P+       +   +  +IL+   P P  Q  S      +  
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQR 299

Query: 319 CLKKDAEAR----PT-ADQLLSHPF 338
            L KD + R    P  AD++  H F
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLF 324

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  109 bits (274), Expect = 5e-27
 Identities = 71/334 (21%), Positives = 128/334 (38%), Gaps = 95/334 (28%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCNEGLVEF 144
           +G GA  +V +++   T  ++A+KKI + F+     +R     EI  L E   +E +V  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR--TFREIMILTELSGHENIVNL 74

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQGLSYLHG 199
                  +   + +  +YM+   L  ++R        IL  + K+     L++ + YLH 
Sbjct: 75  LNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS 127

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-------------- 245
              L+HRD+KP+N+L+N +   K+ DFG+S    N   +      +              
Sbjct: 128 -GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 246 -----VT--YMSPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGP-----VN 290
                 T  Y +PE +     Y+   D+WS+G  L E   G+  FP     G      + 
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP-----GSSTMNQLE 241

Query: 291 LMLQILEDPSP-------SPSRQNF----------------------------------- 308
            ++ +++ PS        SP  +                                     
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           + E    +D  L+ +   R +A+  L HPF++ +
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  108 bits (273), Expect = 5e-27
 Identities = 63/257 (24%), Positives = 108/257 (42%), Gaps = 16/257 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  A    T++  A   LKK  +   +     + E R L  A  +  L    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F   +   +   +EY++GG L   ++           + F   +++ GL +LH  + +
Sbjct: 85  CTFQTKE--NLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGLQFLHS-KGI 139

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           V+RD+K  N+L++  G  KI DFG+    +    A   TF GT  Y++PE +  + Y++ 
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHS 198

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D WS G+ L+E   G+ P+   +    L   I  D    P  +    E    +     +
Sbjct: 199 VDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYP--RWLEKEAKDLLVKLFVR 255

Query: 323 DAEAR-PTADQLLSHPF 338
           + E R      +  HP 
Sbjct: 256 EPEKRLGVRGDIRQHPL 272

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  109 bits (274), Expect = 5e-27
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 28/270 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+ + V       T RI A   +KK  + + E  + + TE     +A  +  LV  H
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F      ++   +EY++GG L   ++ Q+ +PE    + F   ++   L+YLH  R +
Sbjct: 120 SCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEE--HARFYSAEISLALNYLHE-RGI 174

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+K  N+L++ +G  K+TD+G+   GL       +TF GT  Y++PE +R E Y + 
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFS 233

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVN--------LMLQILEDPSPSPSRQNFSPEFCS 314
            D W++G+ +FE   G  P+       N        L   ILE     P  ++ S +  S
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAAS 291

Query: 315 FVDDCLKKDAEAR------PTADQLLSHPF 338
            +   L KD + R           +  HPF
Sbjct: 292 VLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (271), Expect = 1e-26
 Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 54/297 (18%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK---RNQLLTEIRTLCEAPCN------- 138
           IG G    V +A H  T + +ALKK+ + E EK       L EI+ L             
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQL--LKHENVVNL 81

Query: 139 EGLVEFHGAFYMPDSGQISIALEYMDG--GSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
             +     + Y    G I +  ++ +     L     +        +  + + LL GL Y
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYY 139

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFG----ISAGLENSIAMCATFVGTVTYMSPE 252
           +H    ++HRD+K AN+L+   G  K+ DFG     S    +        V T+ Y  PE
Sbjct: 140 IHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198

Query: 253 RIRNE-SYSYPADIWSIGLALFECGTGE--FPYAASE-GPVNLMLQILEDPS-------- 300
            +  E  Y  P D+W  G  + E  T         +E   + L+ Q+    +        
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ-GNTEQHQLALISQLCGSITPEVWPNVD 257

Query: 301 ----------PSPSRQNFSPEFCSFVDD---------CLKKDAEARPTADQLLSHPF 338
                         ++       ++V D          L  D   R  +D  L+H F
Sbjct: 258 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  107 bits (270), Expect = 1e-26
 Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 21/262 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  A    T  + A   LKK  I + +     +TE R L  A  +  L +  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F  PD  ++   +E+++GG L   ++  +   E    + F   +++  L +LH  + +
Sbjct: 91  CCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFDEA--RARFYAAEIISALMFLHD-KGI 145

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+K  N+L++ +G  K+ DFG+   G+ N     ATF GT  Y++PE ++   Y   
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPA 204

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D W++G+ L+E   G  P+  +E   +L   IL D    P       +    +   + K
Sbjct: 205 VDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYP--TWLHEDATGILKSFMTK 261

Query: 323 DAEAR------PTADQLLSHPF 338
           +   R           +L HPF
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPF 283

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  106 bits (268), Expect = 2e-26
 Identities = 57/287 (19%), Positives = 122/287 (42%), Gaps = 45/287 (15%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G  S V  A++I  +  + +K +   +K+K   +  EI+ L        ++      
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPNIITLADIV 100

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI 208
             P S   ++  E+++     D  ++ +++ +  +     ++L+ L Y H +  ++HRD+
Sbjct: 101 KDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG-IMHRDV 156

Query: 209 KPANLLVNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIW 266
           KP N++++ + R  ++ D+G++             V +  +  PE + + + Y Y  D+W
Sbjct: 157 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRYFKGPELLVDYQMYDYSLDMW 215

Query: 267 SIGLALFECGTGEFPYAASEGPVNLMLQILE------------------DPS-----PSP 303
           S+G  L      + P+       + +++I +                  DP         
Sbjct: 216 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 275

Query: 304 SRQNF------------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
           SR+ +            SPE   F+D  L+ D ++R TA + + HP+
Sbjct: 276 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  106 bits (267), Expect = 2e-26
 Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 38/262 (14%)

Query: 97  VQRAVHIPTHRIIA---LKKINIFEKEK-RNQLLTEIRTLCEA--PCNEGLVEFHGAFYM 150
           V++     T +I A   LKK  I    K       E   L E   P    +V+   AF  
Sbjct: 36  VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF---IVDLIYAFQT 92

Query: 151 PDSGQISIALEYMDGGSLADILRMQKSIPEP--------ILSSMFKKLLQGLSYLHGVRH 202
               ++ + LEY+ GG L   L  +    E         I           L +LH  + 
Sbjct: 93  GG--KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM--------ALGHLHQ-KG 141

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           +++RD+KP N+++N +G  K+TDFG+    + +   +  TF GT+ YM+PE +    ++ 
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNR 200

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D WS+G  +++  TG  P+   E     + +IL+     P     + E    +   LK
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLP--PYLTQEARDLLKKLLK 257

Query: 322 KDAEAR----PT-ADQLLSHPF 338
           ++A +R    P  A ++ +HPF
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPF 279

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  109 bits (274), Expect = 2e-26
 Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 16/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  +    T  + A   LKK  + + +     + E R L        L + H
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F   D   +   +EY++GG L   ++      EP       ++  GL +L   + +++
Sbjct: 409 SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIY 465

Query: 206 RDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           RD+K  N++++ +G  KI DFG+    + +      TF GT  Y++PE I  + Y    D
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVD 524

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
            W+ G+ L+E   G+ P+   E    L   I+E     P  ++ S E  +     + K  
Sbjct: 525 WWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYP--KSMSKEAVAICKGLMTKHP 581

Query: 325 EAR-----PTADQLLSHPF 338
             R          +  H F
Sbjct: 582 GKRLGCGPEGERDIKEHAF 600

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  106 bits (266), Expect = 3e-26
 Identities = 63/262 (24%), Positives = 116/262 (44%), Gaps = 26/262 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQL---LTEIRTLCEA--PCNEGLVE 143
           +G+G+   V         R  A+K +      +  Q+     E   L     P    ++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF---IIR 70

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVR 201
             G F   D+ QI + ++Y++GG L  +LR  +  P P+  + F   ++   L YLH  +
Sbjct: 71  MWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV--AKFYAAEVCLALEYLHS-K 125

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
            +++RD+KP N+L++  G  KITDFG +  + +   +  T  GT  Y++PE +  + Y+ 
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
             D WS G+ ++E   G  P+      +    +IL      P    F+ +    +   + 
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLIT 239

Query: 322 KDAEAR-----PTADQLLSHPF 338
           +D   R        + + +HP+
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPW 261

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  106 bits (266), Expect = 3e-26
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 38/261 (14%)

Query: 97  VQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEA--PCNEGLVEFHGAFYMP 151
           V++       ++ A   LKK  +  +++  +   E   L E   P    +V+ H AF   
Sbjct: 43  VKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNHPF---IVKLHYAFQTE 98

Query: 152 DSGQISIALEYMDGGSLADILRMQKSIPEP--------ILSSMFKKLLQGLSYLHGVRHL 203
              ++ + L+++ GG L   L  +    E         +           L +LH    +
Sbjct: 99  G--KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL--------ALDHLHS-LGI 147

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+KP N+L++ +G  K+TDFG+S   +++      +F GTV YM+PE +    ++  
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQS 206

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           AD WS G+ +FE  TG  P+   +     M  IL+     P  Q  SPE  S +    K+
Sbjct: 207 ADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMP--QFLSPEAQSLLRMLFKR 263

Query: 323 DAEAR-----PTADQLLSHPF 338
           +   R        +++  H F
Sbjct: 264 NPANRLGAGPDGVEEIKRHSF 284

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  105 bits (265), Expect = 5e-26
 Identities = 78/262 (29%), Positives = 118/262 (45%), Gaps = 23/262 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V       T R  A   L+K  I  K++    +TE R L +   +  L    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTALK 71

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
            AF   D  ++   +EY +GG L   L  ++   E    + F   +++  L YLH  R +
Sbjct: 72  YAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEE--RARFYGAEIVSALEYLHS-RDV 126

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           V+RDIK  NL+++  G  KITDFG+   G+ +   M  TF GT  Y++PE + +  Y   
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYGRA 185

Query: 263 ADIWSIGLALFECGTGEFP-YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            D W +G+ ++E   G  P Y        L   IL +    P  +  SPE  S +   LK
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEEIRFP--RTLSPEAKSLLAGLLK 241

Query: 322 KDAEAR-----PTADQLLSHPF 338
           KD + R       A +++ H F
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRF 263

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  106 bits (266), Expect = 9e-26
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 46/287 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP-CNEGLVEFHGA 147
           IG+G+  VV +A    +  ++A+KK+   ++ K      E++ + +   CN  +V     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK----NRELQIMRKLDHCN--IVRLRYF 115

Query: 148 FYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKK----LLQGLSYLHG 199
           FY     +    +++ L+Y+   ++  + R      + +     K     L + L+Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174

Query: 200 VRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNE 257
              + HRDIKP NLL++      K+ DFG +  L        +++ +  Y +PE I    
Sbjct: 175 FG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGAT 232

Query: 258 SYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS--------------- 300
            Y+   D+WS G  L E   G+  FP  +    +  ++++L  P+               
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292

Query: 301 -PSPSRQNF--------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
            P      +         PE  +     L+    AR T  +  +H F
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  105 bits (263), Expect = 1e-25
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 22/262 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIA---LKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  +    T  + A   LKK  + + +     + E R L        L + H
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMF--KKLLQGLSYLHGVRHL 203
             F   D  ++   +EY++GG L   ++      EP   ++F   ++  GL +L   + +
Sbjct: 88  SCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEP--HAVFYAAEIAIGLFFLQS-KGI 142

Query: 204 VHRDIKPANLLVNLKGRPKITDFGIS-AGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           ++RD+K  N++++ +G  KI DFG+    + +      TF GT  Y++PE I  + Y   
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKS 201

Query: 263 ADIWSIGLALFECGTGEFP-YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLK 321
            D W+ G+ L+E   G+ P     E    L   I+E     P  ++ S E  +     + 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEHNVAYP--KSMSKEAVAICKGLMT 257

Query: 322 KDAEAR----PT-ADQLLSHPF 338
           K    R    P     +  H F
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAF 279

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  105 bits (263), Expect = 1e-25
 Identities = 61/304 (20%), Positives = 110/304 (36%), Gaps = 60/304 (19%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI----------NIFEKE---KRNQLLTEIRTLCEA 135
           I SG+   V   V       +A+K++          NI       KR  +L EIR L   
Sbjct: 30  ISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR--VLREIRLLNHF 86

Query: 136 --PCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK---- 189
             P   GL +    F  P   ++ +  E M    LA ++  Q+ +    +S    +    
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV----ISPQHIQYFMY 141

Query: 190 -LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
            +L GL  LH    +VHRD+ P N+L+       I DF ++            +V    Y
Sbjct: 142 HILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHRWY 199

Query: 249 MSPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----- 300
            +PE +   + ++   D+WS G  + E    +  F  +     +N +++++  P      
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259

Query: 301 ---------------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                           +   + +        P     +   L+ + + R + +Q L HP+
Sbjct: 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319

Query: 339 ITKY 342
               
Sbjct: 320 FESL 323

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 5e-25
 Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 59/295 (20%)

Query: 89  IGSGASSVVQRAVHI-PTHRIIALKKINIFEKEK--------RNQLLTEIRTLCEAPCNE 139
           IG GA   V +A  +    R +ALK++ + +  +        R     E+  L      E
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIR-----EVAVLRHLETFE 72

Query: 140 -----GLVE-FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILS-----SMFK 188
                 L +    +       ++++  E++D     D+      +PEP +       M  
Sbjct: 73  HPNVVRLFDVCTVS-RTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 189 KLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
           +LL+GL +LH    +VHRD+KP N+LV   G+ K+ DFG++      +A+ +  V T+ Y
Sbjct: 128 QLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWY 185

Query: 249 MSPERIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGP-VNLMLQILEDPS----- 300
            +PE +   SY+ P D+WS+G    E    +  F   +S+   +  +L ++  P      
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEEDWP 244

Query: 301 ----------PSPSRQNFSPEFCSFVDD-------CLKKDAEARPTADQLLSHPF 338
                      S S Q          +        CL  +   R +A   LSHP+
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  101 bits (254), Expect = 2e-24
 Identities = 71/294 (24%), Positives = 111/294 (37%), Gaps = 51/294 (17%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAP-CNEGLVEFHG 146
            G G    VQ      T   +A+KK+   +    RN+ L  ++ L      N  +V+   
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKV--IQDPRFRNRELQIMQDLAVLHHPN--IVQLQS 86

Query: 147 AFYMPDSGQ-----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQGLSY 196
            FY           +++ +EY+   +L    R            +  K     L++ +  
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVA-PPPILIKVFLFQLIRSIGC 144

Query: 197 LHGVRHLV-HRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI 254
           LH     V HRDIKP N+LVN   G  K+ DFG +  L  S    A ++ +  Y +PE I
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-YICSRYYRAPELI 203

Query: 255 RN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----------- 300
              + Y+   DIWS+G    E   GE  F    S G ++ ++++L  PS           
Sbjct: 204 FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263

Query: 301 ---------PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                      P    F       + E    +   L+   E R    + L HP+
Sbjct: 264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 99.8 bits (249), Expect = 3e-24
 Identities = 32/260 (12%), Positives = 75/260 (28%), Gaps = 52/260 (20%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNE- 139
           R+    G        +A+     R +AL  ++   +   +   + L+    L  +  ++ 
Sbjct: 34  RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL--SRIDKP 91

Query: 140 GLVEFHGAFYMPDSGQIS----IALEYMDGGSLADILRMQKSIPEPILS-SMFKKLLQGL 194
           G+          D         +  E++ GGSL ++     + P P+ +    + L    
Sbjct: 92  GVARVL------DVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAA 142

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI 254
              H    +      P+ + V++ G   +                         M     
Sbjct: 143 DAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA-- 179

Query: 255 RNESYSYPADIWSIGLALFECGTGEFPYAAS--EGPVNLMLQILEDPSPSPSRQN--FSP 310
                +   DI  IG +L+      +P   +     +    +        P+  +     
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 311 EFCSFVDDCLKKDAEARPTA 330
           +  +     ++ D   R  +
Sbjct: 235 QISAVAARSVQGDGGIRSAS 254

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  100 bits (251), Expect = 4e-24
 Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 74/302 (24%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--------RNQLLTEIRTLCEAPCNEG 140
           +G G    V +A+   T+  +A+K+I + E E+        R     E+  L E   +  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIR-----EVSLLKELQ-HRN 94

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           ++E     +   + ++ +  EY +   L   +     +   ++ S   +L+ G+++ H  
Sbjct: 95  IIELKSVIH--HNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS- 150

Query: 201 RHLVHRDIKPANLLVNL-----KGRPKITDFGISAGLENSIAMCATFVGT---------V 246
           R  +HRD+KP NLL+++         KI DFG+           A   G          +
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-----------ARAFGIPIRQFTHEII 199

Query: 247 T--YMSPERI-RNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS- 300
           T  Y  PE +  +  YS   DIWSI     E       FP  +    +  + ++L  P  
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259

Query: 301 ----------------PSPSRQNFSPEFCSFVDD--------CLKKDAEARPTADQLLSH 336
                           P    +       + +DD         L+ D   R +A   L H
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319

Query: 337 PF 338
           P+
Sbjct: 320 PY 321

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 66/296 (22%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--------RNQLLTEIRTLCEAPCNEG 140
           IG G    V +A +  TH I+ALK++ + + +         R     EI  L E   ++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALR-----EICLLKELK-HKN 62

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKK----LLQGLSY 196
           +V  H   +     ++++  E+ D     D+ +   S    +   + K     LL+GL +
Sbjct: 63  IVRLHDVLH--SDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGI--SAGLENSIAMCATF---VGTVTYMSP 251
            H  R+++HRD+KP NLL+N  G  K+ +FG+  + G+         +   V T+ Y  P
Sbjct: 117 CHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-----CYSAEVVTLWYRPP 170

Query: 252 ERI-RNESYSYPADIWSIG--LA-LFECGTGEFPYAASE-GPVNLMLQIL----ED---- 298
           + +   + YS   D+WS G   A L   G   FP        +  + ++L    E+    
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 299 -------------PSPSPSRQNF---SPEFCSFVDDCLKKDAEARPTADQLLSHPF 338
                        P+ +         +      + + LK +   R +A++ L HP+
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 69/297 (23%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------RNQLLTEIRTLCEAPCNEGL 141
           +G G  + V +     T  ++ALK+I + E E+       R     E+  L +   +  +
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-----EVSLLKDLK-HANI 62

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGV 200
           V  H   +      +++  EY+D   L   L      I    +     +LL+GL+Y H  
Sbjct: 63  VTLHDIIH--TEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR- 118

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---------VT--YM 249
           + ++HRD+KP NLL+N +G  K+ DFG+           A              VT  Y 
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGL-----------ARAKSIPTKTYDNEVVTLWYR 167

Query: 250 SPERI-RNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS------ 300
            P+ +  +  YS   D+W +G   +E  TG   FP +  E  ++ + +IL  P+      
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227

Query: 301 ------------PSPSRQNFSPEFCSFVDD-------CLKKDAEARPTADQLLSHPF 338
                       P    +           D        L+ +   R +A+  + HPF
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.5 bits (241), Expect = 6e-23
 Identities = 70/299 (23%), Positives = 119/299 (39%), Gaps = 73/299 (24%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--------RNQLLTEIRTLCEAPCNEG 140
           +G G   VV +A      RI+ALK+I + + E         R     EI  L E   +  
Sbjct: 29  VGEGTYGVVYKAKDS-QGRIVALKRIRL-DAEDEGIPSTAIR-----EISLLKELH-HPN 80

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHG 199
           +V      +      +++  E+M+   L  +L   +  + +  +     +LL+G+++ H 
Sbjct: 81  IVSLIDVIH--SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---------VT--Y 248
              ++HRD+KP NLL+N  G  K+ DFG+           A   G          VT  Y
Sbjct: 138 -HRILHRDLKPQNLLINSDGALKLADFGL-----------ARAFGIPVRSYTHEVVTLWY 185

Query: 249 MSPERI-RNESYSYPADIWSIGLALFECGTGE--FPYAASE-GPVNLMLQILEDPS---- 300
            +P+ +  ++ YS   DIWSIG    E  TG+  FP   ++   +  +  IL  P+    
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP-GVTDDDQLPKIFSILGTPNPREW 244

Query: 301 --------------PSPSRQNFSPEFCSFVDD-------CLKKDAEARPTADQLLSHPF 338
                             ++ +S     F  +        L  D   R +A   ++HP+
Sbjct: 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.8 bits (244), Expect = 7e-23
 Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 47/287 (16%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP-CNEGLVEFHGA 147
           IG+G+  VV +A  + +  + A+KK+   ++ K      E++ +      N  +V+    
Sbjct: 48  IGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFK----NRELQIMRIVKHPN--VVDLKAF 100

Query: 148 FYMPDSGQ----ISIALEYMDGGSLADILRMQKSIPEPILSSMFKK----LLQGLSYLHG 199
           FY     +    +++ LEY+   ++    R    + + +   + K     LL+ L+Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159

Query: 200 VRHLVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           +  + HRDIKP NLL++   G  K+ DFG +  L       + ++ +  Y +PE I   +
Sbjct: 160 IG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS-YICSRYYRAPELIFGAT 217

Query: 259 -YSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS--------------- 300
            Y+   DIWS G  + E   G+  FP  +    +  ++++L  PS               
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277

Query: 301 -PSPSRQNFS--------PEFCSFVDDCLKKDAEARPTADQLLSHPF 338
            P      FS        P+    +   L+    AR TA + L HPF
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 97.7 bits (243), Expect = 7e-23
 Identities = 69/361 (19%), Positives = 114/361 (31%), Gaps = 110/361 (30%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE----APCNE 139
            +   +G G  S V  +  I   + +A+K +    +      L EIR L       P + 
Sbjct: 40  HVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 140 G---LVEFHGAFYM--PDSGQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQ 192
               +V+    F +   +   I +  E + G  L   +       +P P +  + +++LQ
Sbjct: 99  NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNL----------------------------------- 217
           GL YLH    ++H DIKP N+L+++                                   
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 218 --------------KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
                         K + KI D G +  +            T  Y S E +    Y+ PA
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVLIGSGYNTPA 274

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVN--------LMLQIL------------------- 296
           DIWS     FE  TG++ +    G           L++++L                   
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334

Query: 297 -------EDPSPSPSRQNFSPE-----------FCSFVDDCLKKDAEARPTADQLLSHPF 338
                                E           F  F+   L+   E R TA + L HP+
Sbjct: 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394

Query: 339 I 339
           +
Sbjct: 395 L 395

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 97.9 bits (244), Expect = 8e-23
 Identities = 77/349 (22%), Positives = 121/349 (34%), Gaps = 109/349 (31%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCN-EGLVE 143
           IG G+   V  A    T + +A+KK+  +FE     KR  +L EI  L       + ++ 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR--ILREITILNR--LKSDYIIR 89

Query: 144 FHGAFYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKK-----LLQGLS 195
            +      D  +   + I LE  D   L  + +         L+    K     LL G +
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF-----LTEEHIKTILYNLLLGEN 143

Query: 196 YLH--GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-------- 245
           ++H  G+   +HRD+KPAN L+N     K+ DFG++  + +                   
Sbjct: 144 FIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 246 ------------VT--YMSPERIRN-ESYSYPADIWSIG--LA----------------- 271
                       VT  Y +PE I   E+Y+   DIWS G   A                 
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 272 -LFECGTGEFPYAASEGPV-----------NLMLQILEDPS------------------- 300
            LF  G+  FP +                 N++  I+  P+                   
Sbjct: 261 PLFP-GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319

Query: 301 PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           P     N        S +  + ++  LK +   R T DQ L HP++   
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 77/343 (22%), Positives = 124/343 (36%), Gaps = 80/343 (23%)

Query: 70  DHSEKTYRCASHEM-----RIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKEKRN 123
           D  + +Y    H+       +   IG G+   V +A     H+ +ALK + N   K    
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHR 138

Query: 124 QLLTEIRTL-----CEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSI 178
           Q   EIR L      +      ++     F       I +  E +   +L ++++  K  
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFT--FRNHICMTFELL-SMNLYELIKKNKFQ 195

Query: 179 PEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP--KITDFGISAGLEN 234
              +  +      +LQ L  LH  R ++H D+KP N+L+  +GR   K+ DFG S     
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254

Query: 235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLM 292
            +    T++ +  Y +PE I    Y  P D+WS+G  L E  TG    P       +  M
Sbjct: 255 RVY---TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

Query: 293 LQILEDPSP-----SPSRQNF--------------------------------------- 308
           +++L  PS      S   +NF                                       
Sbjct: 312 IELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR 371

Query: 309 -------SPEFCSFVD---DCLKKDAEARPTADQLLSHPFITK 341
                    +   F+D    CL+ D   R T  Q L HP++ +
Sbjct: 372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 70/298 (23%), Positives = 113/298 (37%), Gaps = 69/298 (23%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-----LLTEIRTLCEAPCNEGLVE 143
           +G G  + V +A    T++I+A+KKI +  + +         L EI+ L E   +  ++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 76

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
              AF       IS+  ++M+   L  I++     +    + +     LQGL YLH    
Sbjct: 77  LLDAF--GHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HW 132

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---------VT--YMSP 251
           ++HRD+KP NLL++  G  K+ DFG+           A   G+         VT  Y +P
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGL-----------AKSFGSPNRAYTHQVVTRWYRAP 181

Query: 252 E-----RIRNESYSYPADIWSIGLALFECGTGE--FPYAASE-GPVNLMLQILEDPS--- 300
           E     R     Y    D+W++G  L E        P   S+   +  + + L  P+   
Sbjct: 182 ELLFGAR----MYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETLGTPTEEQ 236

Query: 301 -------------PSPSRQNFSPEFCSFVDD-------CLKKDAEARPTADQLLSHPF 338
                         S         F +  DD           +  AR TA Q L   +
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 75/297 (25%), Positives = 113/297 (38%), Gaps = 70/297 (23%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--------RNQLLTEIRTLCEAPCNEG 140
           IG G   VV +A +       ALKKI + EKE         R     EI  L E   +  
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIR-----EISILKELK-HSN 61

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHG 199
           +V+ +   +      + +  E++D   L  +L   +  +      S   +LL G++Y H 
Sbjct: 62  IVKLYDVIHTKKR--LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---------VT--Y 248
            R ++HRD+KP NLL+N +G  KI DFG+           A   G          VT  Y
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGL-----------ARAFGIPVRKYTHEIVTLWY 166

Query: 249 MSPERI-RNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS----- 300
            +P+ +  ++ YS   DIWS+G    E   G   FP  +    +  + +IL  P+     
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 301 ------------PSPSRQNFSPEFCSFVDD-------CLKKDAEARPTADQLLSHPF 338
                              +        +         LK D   R TA Q L H +
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 78/306 (25%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-------RNQLLTEIRTLCEAPCNEGL 141
           +G+G  + V + ++  T   +ALK++ + + E+       R     EI  + E   +E +
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIR-----EISLMKELK-HENI 65

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADIL------RMQKSIPEPILSSMFKKLLQGLS 195
           V  +   +     ++++  E+MD   L   +         + +   ++     +LLQGL+
Sbjct: 66  VRLYDVIH--TENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---------V 246
           + H    ++HRD+KP NLL+N +G+ K+ DFG+           A   G          V
Sbjct: 123 FCHE-NKILHRDLKPQNLLINKRGQLKLGDFGL-----------ARAFGIPVNTFSSEVV 170

Query: 247 T--YMSPERI-RNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPS- 300
           T  Y +P+ +  + +YS   DIWS G  L E  TG+  FP    E  + L+  I+  P+ 
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230

Query: 301 --------------------PSPSRQNFSPEFCSFVDD--------CLKKDAEARPTADQ 332
                               P   RQ   P     +D          L+ + + R +A Q
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290

Query: 333 LLSHPF 338
            L HP+
Sbjct: 291 ALHHPW 296

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 78/350 (22%), Positives = 125/350 (35%), Gaps = 103/350 (29%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE---KRNQLLTEIRTLCEAPCN-EGLVE 143
           IG+G+   V  A      R++A+KKI  +FE     KR  +L EI  L     N + +V+
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR--ILREIAILNR--LNHDHVVK 116

Query: 144 FHGAFYMPDSGQ---ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
                   D  +   + + LE  D      + R    + E  + ++   LL G+ Y+H  
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--------------- 245
             ++HRD+KPAN LVN     K+ DFG++  ++      +    +               
Sbjct: 176 G-ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

Query: 246 ----------VT--YMSPERIRN-ESYSYPADIWSIG--LA------------------L 272
                     VT  Y +PE I   E+Y+   D+WSIG   A                  L
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294

Query: 273 FECGTGEFPYAASEGPV--------------NLMLQILEDPS------------------ 300
           F  G+  FP +  +                 N++  IL  PS                  
Sbjct: 295 FP-GSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353

Query: 301 -PSPSRQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
            P     +        S +    +   L  +   R T ++ L+HPF  + 
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 95.2 bits (237), Expect = 5e-22
 Identities = 58/313 (18%), Positives = 110/313 (35%), Gaps = 66/313 (21%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKI--------------------------NIFEKEKR 122
           +G+G+  +V     I + +  ALKK+                          + F     
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGD 74

Query: 123 NQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ-----ISIALEYMDGGSLADILRMQKS 177
            +                    +               +++ +EY+   +L  +L+    
Sbjct: 75  EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR 133

Query: 178 IPEPILSSMFKK----LLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGL 232
               I  ++       L + + ++H +  + HRDIKP NLLVN K    K+ DFG +  L
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIHSLG-ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192

Query: 233 ENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGE--FPYAASEGPV 289
             S    A ++ +  Y +PE +     Y+   D+WSIG    E   G+  F    S   +
Sbjct: 193 IPSEPSVA-YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL 251

Query: 290 NLMLQILEDPS----------------PSPSRQNFSPEFCSFVD----DCLKK----DAE 325
             ++QI+  P+                P+   +++             D L++    + +
Sbjct: 252 VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311

Query: 326 ARPTADQLLSHPF 338
            R    + ++HPF
Sbjct: 312 LRINPYEAMAHPF 324

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 79/346 (22%), Positives = 115/346 (33%), Gaps = 83/346 (23%)

Query: 70  DHSEKTYRCASHEM-----RIFGAIGSGA-SSVVQRAVHIPTHRIIALKKI-NIFEKEKR 122
           D  E    C   +       I G +G G    VV+   H      +ALK I N+   + R
Sbjct: 3   DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYR 60

Query: 123 NQLLTEIR---TLCEA-PCNE-GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS 177
                EI     + E    N+   V     F     G + IA E + G +  + L+    
Sbjct: 61  EAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--HGHMCIAFELL-GKNTFEFLKENNF 117

Query: 178 IPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPAN-LLVNLKGRP------------- 221
            P P+  +  M  +L   L +LH  + L H D+KP N L VN +                
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 222 -----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECG 276
                ++ DFG SA  ++      T V T  Y  PE I    ++ P D+WSIG  LFE  
Sbjct: 177 KNTSIRVADFG-SATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 277 TGE--FPYAASEGPVNLMLQILEDPSPS-------------------------------- 302
            G   F    +   + +M +IL                                      
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293

Query: 303 -PSRQNFSPE------FCSFVDDCLKKDAEARPTADQLLSHPFITK 341
            P +     +          +   L+ D   R T  + L HPF   
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 62/325 (19%), Positives = 108/325 (33%), Gaps = 68/325 (20%)

Query: 77  RCASHEMRIFGAIGSGASSVVQRAV--HIPTHRIIALKKINIFEKEKRNQLLTEIRTLCE 134
           R           +G G    V +A        +  ALK+I             EI  L E
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRE 74

Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEY--------MDGGSLADILRMQKSIPEPILSSM 186
              +  ++     F      ++ +  +Y        +     +   +    +P  ++ S+
Sbjct: 75  LK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFG---ISAGLENSIAMC 239
             ++L G+ YLH    ++HRD+KPAN+LV      +GR KI D G   +       +A  
Sbjct: 134 LYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 240 ATFVGTVTYMSPERI-RNESYSYPADIWSIG--LA-------LFECGTGEFPYAASEGPV 289
              V T  Y +PE +     Y+   DIW+IG   A       +F     E    ++    
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIKTSNPYHH 251

Query: 290 NLMLQILE--------------------------------DPSPSPSRQNFSPEFCSFVD 317
           + + +I                                  + S     +    +  S   
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311

Query: 318 DCLKK----DAEARPTADQLLSHPF 338
             L+K    D   R T++Q +  P+
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPY 336

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 68/353 (19%), Positives = 115/353 (32%), Gaps = 89/353 (25%)

Query: 67  DESDHSEKTYRCASHEM-----RIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE 120
            + D     +      +      +   +G G    V    HI   +  A+K + NI  K+
Sbjct: 16  FQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KK 73

Query: 121 KRNQLLTEIR---TLCEAPCNE-GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK 176
                  E      +     N   +V++HG F       + +  E + G SL +I+    
Sbjct: 74  YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDHMCLIFEPL-GPSLYEIITRNN 130

Query: 177 SIPEPI--LSSMFKKLLQGLSYLHGVRHLVHRDIKPAN-LLVNLKGRP------------ 221
                I  +     ++L+ L+YL  +  L H D+KP N LL +                 
Sbjct: 131 YNGFHIEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189

Query: 222 ------------KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIG 269
                       K+ DFG  A  ++      + + T  Y +PE I N  +   +D+WS G
Sbjct: 190 KIQIYRTKSTGIKLIDFG-CATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246

Query: 270 LALFECGTGE--FPYAASEGPVNLMLQILEDP-------SPSPSRQNF------------ 308
             L E  TG   F        + +M  I++         +   +   +            
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306

Query: 309 ----------------------SPEFCSFVDDCLKKDAEARPTADQLLSHPFI 339
                                    FC F+   L+ D   RP+  +LL H F+
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 69/340 (20%), Positives = 112/340 (32%), Gaps = 50/340 (14%)

Query: 67  DESDHSEKTYRCASHEM-----RIFGAIGSGASSVVQRAVHIPTHRIIALKKI-NIFEKE 120
           D  D     Y   + E       I   IG G+   V +A        +A+K I N   K 
Sbjct: 35  DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KA 92

Query: 121 KRNQLLTEIRTL----CEAPCNEG-LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ 175
             NQ   E+R L          +  +V     F       + +  E +   +L D+LR  
Sbjct: 93  FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--FRNHLCLVFEML-SYNLYDLLRNT 149

Query: 176 KSIPEPI--LSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRP--KITDFGISA 230
                 +       +++   L +L      ++H D+KP N+L+    R   KI DFG S+
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SS 208

Query: 231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGP 288
                      ++ +  Y SPE +    Y    D+WS+G  L E  TGE  F  A     
Sbjct: 209 CQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266

Query: 289 VNLMLQILEDPSPS------------PSRQNFSPEFCSFVDD-------CLKKDAEARPT 329
           +N ++++L  P                   + +       D          +K       
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326

Query: 330 ADQLLSHPFITKYEHAKVDLAAFVRSV-----FDPMQRMK 364
                      +  H   D   F   +     +DP  R++
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 8/31 (25%), Positives = 11/31 (35%)

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
           +F   +   L  D + R      L H F  K
Sbjct: 348 KFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 77/340 (22%), Positives = 119/340 (35%), Gaps = 83/340 (24%)

Query: 76  YRCASHEM-----RIFGAIGSGA-SSVVQRAVHIPTHRIIALKKI-NIFEKEKRNQLLTE 128
             C S ++      I   +G GA   VV+   H    R +A+K + N+          +E
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSE 61

Query: 129 IR---TLCEA-PCNE-GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI- 182
           I+    L    P +    V+    F     G I I  E + G S  D ++    +P  + 
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFE--HHGHICIVFELL-GLSTYDFIKENGFLPFRLD 118

Query: 183 -LSSMFKKLLQGLSYLHGVRHLVHRDIKPAN-LLVNLKGRP------------------K 222
            +  M  ++ + +++LH  + L H D+KP N L V                        K
Sbjct: 119 HIRKMAYQICKSVNFLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

Query: 223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE--F 280
           + DFG SA  ++     +T V T  Y +PE I    +S P D+WSIG  L E   G   F
Sbjct: 178 VVDFG-SATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

Query: 281 PYAASEGPVNLMLQILEDPSP-----SPSRQNF--------------------------- 308
           P   S+  + +M +IL          +  R+ F                           
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294

Query: 309 -------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
                         +   L+ D   R T  + L HPF   
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 89.4 bits (222), Expect = 8e-20
 Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 27/260 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G    V   V       +A+K  K +  E E+    L E   + E   +  LV+  G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEI-KHPNLVQLLG 283

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                      I  E+M  G+L D LR    + +   +L  M  ++   + YL   ++ +
Sbjct: 284 V--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFI 340

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY--MSPERIRNESYSYP 262
           HR++   N LV      K+ DFG+S  +       A           +PE +    +S  
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 263 ADIWSIGLALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFV 316
           +D+W+ G+ L+E  T G  PY    G     + ++LE       P    +    +    +
Sbjct: 400 SDVWAFGVLLWEIATYGMSPY---PGIDLSQVYELLEKDYRMERP----EGCPEKVYELM 452

Query: 317 DDCLKKDAEARPTADQLLSH 336
             C + +   RP+  ++   
Sbjct: 453 RACWQWNPSDRPSFAEIHQA 472

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 56/259 (21%), Positives = 107/259 (41%), Gaps = 23/259 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRII--ALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           +GSG    V++  +     +   A+K  K    +   +++LL E   + +   N  +V  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRM 83

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            G   + ++    + +E  + G L   L+  + + +  +  +  ++  G+ YL    + V
Sbjct: 84  IG---ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFV 139

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSY 261
           HRD+   N+L+  +   KI+DFG+S  L                V + +PE I    +S 
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199

Query: 262 PADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFV 316
            +D+WS G+ ++E  + G+ PY   +G    +  +LE       P         E    +
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCP----AGCPREMYDLM 253

Query: 317 DDCLKKDAEARPTADQLLS 335
           + C   D E RP    +  
Sbjct: 254 NLCWTYDVENRPGFAAVEL 272

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 58/257 (22%), Positives = 97/257 (37%), Gaps = 21/257 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           IG G    V        + ++A+K        + + + L E R L +      +V   G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIG- 179

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                   I I +E + GG     LR +   +    L  M      G+ YL   +  +HR
Sbjct: 180 -VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHR 237

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPAD 264
           D+   N LV  K   KI+DFG+S    + +   +  +    V + +PE +    YS  +D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297

Query: 265 IWSIGLALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDD 318
           +WS G+ L+E  + G  PY       N    + +E     P P    +         ++ 
Sbjct: 298 VWSFGILLWETFSLGASPY---PNLSNQQTREFVEKGGRLPCP----ELCPDAVFRLMEQ 350

Query: 319 CLKKDAEARPTADQLLS 335
           C   +   RP+   +  
Sbjct: 351 CWAYEPGQRPSFSTIYQ 367

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 17/191 (8%)

Query: 155 QISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
            + +  + M  G L D +R  K +I    L +   ++ +G++YL   R LVHRD+   N+
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNV 148

Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGL 270
           LV      KITDFG++  L           G    + +M+ E I +  Y++ +D+WS G+
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAE 325
            ++E  T G  PY         +  ILE     P P       + +    +  C   DA+
Sbjct: 208 TVWELMTFGSKPYDGIPASE--ISSILEKGERLPQP----PICTIDVYMIMRKCWMIDAD 261

Query: 326 ARPTADQLLSH 336
           +RP   +L+  
Sbjct: 262 SRPKFRELIIE 272

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 18/187 (9%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I +E    G L   L+++K S+    L     +L   L+YL   +  VHRDI   N+LV+
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS 525

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
                K+ DFG+S  +E+S    A+       + +M+PE I    ++  +D+W  G+ ++
Sbjct: 526 SNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583

Query: 274 ECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEARP 328
           E    G  P+   +     ++  +E+    P P     N  P   S +  C   D   RP
Sbjct: 584 EILMHGVKPFQGVKNND--VIGRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSRRP 637

Query: 329 TADQLLS 335
              +L +
Sbjct: 638 RFTELKA 644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I +E    G L   L+++K S+    L     +L   L+YL   +  VHRDI   N+LV+
Sbjct: 92  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS 150

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
                K+ DFG+S  +E+S    A+       + +M+PE I    ++  +D+W  G+ ++
Sbjct: 151 SNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208

Query: 274 ECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           E    G  P+   +G  N  ++  +E+    P P     N  P   S +  C   D   R
Sbjct: 209 EILMHGVKPF---QGVKNNDVIGRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSRR 261

Query: 328 PTADQLLS 335
           P   +L +
Sbjct: 262 PRFTELKA 269

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 66/256 (25%), Positives = 108/256 (42%), Gaps = 23/256 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G    V       T R+ A+K +           L E + + +    + LV+ +   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEK-LVQLYAVV 248

Query: 149 YMPDSGQISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                  I I  EYM  GSL D L+    K +  P L  M  ++  G++Y+    + VHR
Sbjct: 249 ---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHR 304

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSI-AMCATFVGTVTYMSPERIRNESYSYPADI 265
           D++ AN+LV      K+ DFG++  +E++           + + +PE      ++  +D+
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 266 WSIGLALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDC 319
           WS G+ L E  T G  PY    G VN  +L  +E     P P              +  C
Sbjct: 365 WSFGILLTELTTKGRVPY---PGMVNREVLDQVERGYRMPCP----PECPESLHDLMCQC 417

Query: 320 LKKDAEARPTADQLLS 335
            +K+ E RPT + L +
Sbjct: 418 WRKEPEERPTFEYLQA 433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 18/190 (9%)

Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           + + +E   GG L   L  ++  IP   ++ +  ++  G+ YL   ++ VHRD+   N+L
Sbjct: 84  LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVL 142

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLA 271
           +  +   KI+DFG+S  L    +           + + +PE I    +S  +D+WS G+ 
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202

Query: 272 LFECGT-GEFPYAASEGP-VNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           ++E  + G+ PY   +GP V   +  +E       P        PE  + + DC     E
Sbjct: 203 MWEALSYGQKPYKKMKGPEV---MAFIEQGKRMECP----PECPPELYALMSDCWIYKWE 255

Query: 326 ARPTADQLLS 335
            RP    +  
Sbjct: 256 DRPDFLTVEQ 265

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 58/278 (20%), Positives = 113/278 (40%), Gaps = 27/278 (9%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAP 136
             ++    +G G    V+   + P    T  ++A+K++     +++     EI+ L    
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL- 81

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLS 195
            ++ +V++ G  Y P    + + +EY+  G L D L+  +  +    L     ++ +G+ 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPE 252
           YL   R  VHRD+   N+LV  +   KI DFG++  L                + + +PE
Sbjct: 142 YLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 253 RIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPS----------- 300
            + +  +S  +D+WS G+ L+E  T  +   + S   + +M    + P+           
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260

Query: 301 ---PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
              P+P       E    +  C     + RP+   L  
Sbjct: 261 QRLPAP--PACPAEVHELMKLCWAPSPQDRPSFSALGP 296

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.7 bits (199), Expect = 8e-17
 Identities = 66/256 (25%), Positives = 108/256 (42%), Gaps = 23/256 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G    V       T R+ A+K +           L E + + +    + LV+ +   
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEK-LVQLYAVV 331

Query: 149 YMPDSGQISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                  I I  EYM  GSL D L+    K +  P L  M  ++  G++Y+    + VHR
Sbjct: 332 ---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHR 387

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSI-AMCATFVGTVTYMSPERIRNESYSYPADI 265
           D++ AN+LV      K+ DFG++  +E++           + + +PE      ++  +D+
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 266 WSIGLALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDC 319
           WS G+ L E  T G  PY    G VN  +L  +E     P P              +  C
Sbjct: 448 WSFGILLTELTTKGRVPY---PGMVNREVLDQVERGYRMPCP----PECPESLHDLMCQC 500

Query: 320 LKKDAEARPTADQLLS 335
            +K+ E RPT + L +
Sbjct: 501 WRKEPEERPTFEYLQA 516

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 20/188 (10%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I +E    G L   L   K S+    L     ++ + ++YL    + VHRDI   N+LV 
Sbjct: 89  IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVA 147

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
                K+ DFG+S  +E+     A+   T   + +MSPE I    ++  +D+W   + ++
Sbjct: 148 SPECVKLGDFGLSRYIEDEDYYKAS--VTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205

Query: 274 ECGT-GEFPYAASEGP-VNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           E  + G+ P+   E   V   + +LE     P P        P   + +  C   D   R
Sbjct: 206 EILSFGKQPFFWLENKDV---IGVLEKGDRLPKP----DLCPPVLYTLMTRCWDYDPSDR 258

Query: 328 PTADQLLS 335
           P   +L+ 
Sbjct: 259 PRFTELVC 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 29/259 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G    V  A +    ++ A+K +           L E   +     ++ LV+ H   
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSMS-VEAFLAEANVMKTL-QHDKLVKLHAVV 252

Query: 149 YMPDSGQ-ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
               + + I I  E+M  GSL D L+  +    P P L     ++ +G++++   R+ +H
Sbjct: 253 ----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRNYIH 307

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYP 262
           RD++ AN+LV+     KI DFG++  +E++        G    + + +PE I   S++  
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAINFGSFTIK 365

Query: 263 ADIWSIGLALFECGT-GEFPYAASEG-PVNLMLQILED----PSPSPSRQNFSPEFCSFV 316
           +D+WS G+ L E  T G  PY    G     +++ LE     P P    +N   E  + +
Sbjct: 366 SDVWSFGILLMEIVTYGRIPY---PGMSNPEVIRALERGYRMPRP----ENCPEELYNIM 418

Query: 317 DDCLKKDAEARPTADQLLS 335
             C K   E RPT + + S
Sbjct: 419 MRCWKNRPEERPTFEYIQS 437

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 20/221 (9%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I  EYM+ GSL   LR          L  M + +  G+ YL      VHRD+   N+L+N
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILIN 181

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
                K++DFG+   LE+      T  G    + + SPE I    ++  +D+WS G+ L+
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241

Query: 274 ECGT-GEFPYAASEGP-VNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           E  + GE PY       V   ++ +++    P P     +        + DC +KD   R
Sbjct: 242 EVMSYGERPYWEMSNQDV---IKAVDEGYRLPPP----MDCPAALYQLMLDCWQKDRNNR 294

Query: 328 PTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLAD 368
           P  +Q++S   + K       L     +   P   + D ++
Sbjct: 295 PKFEQIVS--ILDKLIRNPGSLKIITSAAARPSNLLLDQSN 333

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 59/262 (22%), Positives = 113/262 (43%), Gaps = 29/262 (11%)

Query: 89  IGSGASSVVQRAVHIPTHRII--ALKKI-NIFEKEKRNQLLTEIRTLCEA--PCNEGLVE 143
           +G G    V++ V+    + I  A+K +    EK    +++ E + + +   P    +V 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY---IVR 400

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRH 202
             G   +  +  + + +E   GG L   L  ++  IP   ++ +  ++  G+ YL   ++
Sbjct: 401 LIG---VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KN 456

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESY 259
            VHR++   N+L+  +   KI+DFG+S  L    +           + + +PE I    +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 260 SYPADIWSIGLALFECGT-GEFPYAASEGP-VNLMLQILED----PSPSPSRQNFSPEFC 313
           S  +D+WS G+ ++E  + G+ PY   +GP V   +  +E       P        PE  
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQGKRMECP----PECPPELY 569

Query: 314 SFVDDCLKKDAEARPTADQLLS 335
           + + DC     E RP    +  
Sbjct: 570 ALMSDCWIYKWEDRPDFLTVEQ 591

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 18/188 (9%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I  EYM+ G+L   LR +        L  M + +  G+ YL    + VHRD+   N+LVN
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVN 181

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
                K++DFG+S  LE+      T  G    + + +PE I    ++  +D+WS G+ ++
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241

Query: 274 ECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           E  T GE PY       N  +++ + D    P+P     +        +  C +++   R
Sbjct: 242 EVMTYGERPY---WELSNHEVMKAINDGFRLPTP----MDCPSAIYQLMMQCWQQERARR 294

Query: 328 PTADQLLS 335
           P    ++S
Sbjct: 295 PKFADIVS 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 13/186 (6%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           +  E    GSL D LR  +       LS    ++ +G+ YL   +  +HRD+   NLL+ 
Sbjct: 97  MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLA 155

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
            +   KI DFG+   L  +               + +PE ++  ++S+ +D W  G+ L+
Sbjct: 156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215

Query: 274 ECGT-GEFPYAASEGPVNLMLQILEDPS---PSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
           E  T G+ P+    G    +L  ++      P P  ++   +  + +  C     E RPT
Sbjct: 216 EMFTYGQEPWIGLNGS--QILHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRPT 271

Query: 330 ADQLLS 335
              L  
Sbjct: 272 FVALRD 277

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 18/188 (9%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           I  EYM+ GSL   LR          L  M + +  G+ YL      VHRD+   N+LV+
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVD 185

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLALF 273
                K++DFG+S  LE+      T  G    + + +PE I   ++S  +D+WS G+ ++
Sbjct: 186 SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245

Query: 274 ECGT-GEFPYAASEGP-VNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           E    GE PY       V   +  +E+    P+P              + DC  KD   R
Sbjct: 246 EVLAYGERPYWNMTNRDV---ISSVEEGYRLPAP----MGCPHALHQLMLDCWHKDRAQR 298

Query: 328 PTADQLLS 335
           P   Q++S
Sbjct: 299 PRFSQIVS 306

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 15/187 (8%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           +  +Y+  GSL D +R  + ++   +L +   ++ +G+ YL     +VHR++   N+L+ 
Sbjct: 91  LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLK 149

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFE 274
              + ++ DFG++  L               + +M+ E I    Y++ +D+WS G+ ++E
Sbjct: 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWE 209

Query: 275 CGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEARPT 329
             T G  PYA        +  +LE       P    Q  + +    +  C   D   RPT
Sbjct: 210 LMTFGAEPYAGLRLAE--VPDLLEKGERLAQP----QICTIDVYMVMVKCWMIDENIRPT 263

Query: 330 ADQLLSH 336
             +L + 
Sbjct: 264 FKELANE 270

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.1 bits (188), Expect = 5e-16
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 20/190 (10%)

Query: 156 ISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I I  EY+  G L + LR   K +    L  M   + +G+++L      +HRD+   N L
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCL 136

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLA 271
           V+     K++DFG++  + +   + +   GT   V + +PE      YS  +D+W+ G+ 
Sbjct: 137 VDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKYSSKSDVWAFGIL 194

Query: 272 LFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           ++E  + G+ PY   +   N  ++  +        P       S      +  C  +  E
Sbjct: 195 MWEVFSLGKMPY---DLYTNSEVVLKVSQGHRLYRP----HLASDTIYQIMYSCWHELPE 247

Query: 326 ARPTADQLLS 335
            RPT  QLLS
Sbjct: 248 KRPTFQQLLS 257

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 77.0 bits (190), Expect = 5e-16
 Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 34/291 (11%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAP 136
             ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L    
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL- 99

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLS 195
            ++ +V++ G  Y      + + +EY+  GSL D L+  K  I    L     ++ +G+ 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPE 252
           YL   +  +HRD+   N+LV  + R KI DFG++  L                + + +PE
Sbjct: 160 YLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218

Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF---- 308
            +    +S  +D+WS G+ L+E     F Y             +           F    
Sbjct: 219 SLTESKFSVASDVWSFGVVLYEL----FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 309 ---------SPEFCS-----FVDDCLKKDAEARPTADQLLSH--PFITKYE 343
                     P+ C       + +C   +   RP+   L         +  
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 21/192 (10%)

Query: 156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
           I I  EYM+ GSL D L+      +    L  M  ++ +G++++   R+ +HRD++ AN+
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANI 140

Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGL 270
           LV+     KI DFG++  +E++        G    + + +PE I   +++  +D+WS G+
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198

Query: 271 ALFECGT-GEFPYAASEG-PVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDA 324
            L E  T G  PY    G     ++Q LE       P     N   E    +  C K+  
Sbjct: 199 LLTEIVTHGRIPY---PGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMRLCWKERP 251

Query: 325 EARPTADQLLSH 336
           E RPT D L S 
Sbjct: 252 EDRPTFDYLRSV 263

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 76.1 bits (188), Expect = 6e-16
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 20/190 (10%)

Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I +  E+M+ G L+D LR Q+       L  M   + +G++YL     ++HRD+   N L
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCL 136

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLA 271
           V      K++DFG++  + +     +T  GT   V + SPE      YS  +D+WS G+ 
Sbjct: 137 VGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194

Query: 272 LFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           ++E  + G+ PY   E   N  +++ +        P    +  S      ++ C ++  E
Sbjct: 195 MWEVFSEGKIPY---ENRSNSEVVEDISTGFRLYKP----RLASTHVYQIMNHCWRERPE 247

Query: 326 ARPTADQLLS 335
            RP   +LL 
Sbjct: 248 DRPAFSRLLR 257

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 17/191 (8%)

Query: 155 QISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL 213
            + +  + M  G L D +R  K +I    L +   ++ +G++YL   R LVHRD+   N+
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNV 148

Query: 214 LVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGL 270
           LV      KITDFG++  L           G    + +M+ E I +  Y++ +D+WS G+
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207

Query: 271 ALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAE 325
            ++E  T G  PY         +  ILE     P P       + +    +  C   DA+
Sbjct: 208 TVWELMTFGSKPYDGIPASE--ISSILEKGERLPQP----PICTIDVYMIMVKCWMIDAD 261

Query: 326 ARPTADQLLSH 336
           +RP   +L+  
Sbjct: 262 SRPKFRELIIE 272

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 32/282 (11%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIP----THRIIALKKINIFEKEKRNQLLTEIRTLCEAP 136
             ++    +G G    V+   + P    T  ++A+KK+    +E       EI  L    
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL- 68

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLS 195
            ++ +V++ G  Y      + + +EY+  GSL D L+  K  I    L     ++ +G+ 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPE 252
           YL   +  +HRD+   N+LV  + R KI DFG++  L                + + +PE
Sbjct: 129 YLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF---- 308
            +    +S  +D+WS G+ L+E     F Y             +           F    
Sbjct: 188 SLTESKFSVASDVWSFGVVLYEL----FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 309 ---------SPEFCS-----FVDDCLKKDAEARPTADQLLSH 336
                     P+ C       + +C   +   RP+   L   
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 40/287 (13%)

Query: 81  HEMRIFGAIGSGASSVVQRA-----VHIPTHRIIALK--KINIFEKEKRNQLLTEIRTLC 133
             +++   +G GA   V  A         T R +A+K  K      E R  L++E++ L 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILI 85

Query: 134 EAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSM------- 186
               +  +V   GA   P  G + + +E+   G+L+  LR +++   P   +        
Sbjct: 86  HIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 187 --FKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA 237
              + L+        G+ +L   R  +HRD+   N+L++ K   KI DFG++  +     
Sbjct: 145 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 238 MCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQ 294
                     + +M+PE I +  Y+  +D+WS G+ L+E  + G  PY   +       +
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263

Query: 295 I-----LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
           +     +  P         +PE    + DC   +   RPT  +L+ H
Sbjct: 264 LKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 57/260 (21%), Positives = 102/260 (39%), Gaps = 27/260 (10%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           +G G    V   V       +A+K  K +  E E+    L E   + E      LV+  G
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKH-PNLVQLLG 76

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
                      I  E+M  G+L D LR    + +   +L  M  ++   + YL   ++ +
Sbjct: 77  V--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFI 133

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSY 261
           HRD+   N LV      K+ DFG+S  +           G    + + +PE +    +S 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESLAYNKFSI 191

Query: 262 PADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFV 316
            +D+W+ G+ L+E  T G  PY      ++ + ++LE       P    +    +    +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP----EGCPEKVYELM 245

Query: 317 DDCLKKDAEARPTADQLLSH 336
             C + +   RP+  ++   
Sbjct: 246 RACWQWNPSDRPSFAEIHQA 265

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 34/281 (12%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIP----THRIIALK--KINIFEKEKRNQLLTEIRTLCE 134
             ++    +G G    V    + P    T  ++A+K  K +   + +      EI  L  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRT 89

Query: 135 APCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGL 194
               E ++++ G      +  + + +EY+  GSL D L  + SI    L    +++ +G+
Sbjct: 90  LYH-EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGM 147

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGT--VTYMSP 251
           +YLH  +H +HRD+   N+L++     KI DFG++  + E          G   V + +P
Sbjct: 148 AYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLM------------LQILED 298
           E ++   + Y +D+WS G+ L+E  T  +   +     + L+             ++LE 
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 299 ----PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
               P P         E    + +C + +A  RPT + L+ 
Sbjct: 267 GERLPRP----DKCPAEVYHLMKNCWETEASFRPTFENLIP 303

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 58/275 (21%), Positives = 103/275 (37%), Gaps = 34/275 (12%)

Query: 89  IGSGASSVVQRAVHIP----THRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +G G    V+   + P    T   +A+K  K         + L  EI  L     +E +V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNL-YHENIV 86

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVR 201
           ++ G         I + +E++  GSL + L   K  I          ++ +G+ YL   R
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-R 145

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNES 258
             VHRD+   N+LV  + + KI DFG++  +E               V + +PE +    
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGPVNLM------------LQILED----PSP 301
           +   +D+WS G+ L E  T  +   +     + ++            +  L++    P P
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265

Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                N   E    +  C +     R +   L+  
Sbjct: 266 ----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 63/281 (22%), Positives = 110/281 (39%), Gaps = 43/281 (15%)

Query: 89  IGSGASSVVQRA-----VHIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           +G+GA   V  A     +       +A+K  K +    E+   L++E++ L     +  +
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 89

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILR-----------MQKSIPEPILSSMFKKL 190
           V   GA      G   +  EY   G L + LR               + +  L+   + L
Sbjct: 90  VNLLGA--CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 191 LQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV 243
           L        G+++L   ++ +HRD+   N+L+      KI DFG++  ++N         
Sbjct: 148 LSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 244 GT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI----- 295
               V +M+PE I N  Y++ +D+WS G+ L+E  + G  PY            I     
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266

Query: 296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
           +  P      ++   E    +  C   D   RPT  Q++  
Sbjct: 267 MLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 51/271 (18%), Positives = 95/271 (35%), Gaps = 32/271 (11%)

Query: 89  IGSGASSVVQRAV---HIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           +G G    V+ A       +   +A+K  K +I       + L E   + E      + +
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAK 89

Query: 144 FHGA----FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ------- 192
             G               + L +M  G L   L   +    P    + + L++       
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL-QTLVRFMVDIAC 148

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMS 250
           G+ YL   R+ +HRD+   N ++       + DFG+S  + +             V +++
Sbjct: 149 GMEYLSS-RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207

Query: 251 PERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSR 305
            E + +  Y+  +D+W+ G+ ++E  T G+ PYA        +   L        P    
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI--ENAEIYNYLIGGNRLKQP---- 261

Query: 306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                E    +  C   D + RP+   L   
Sbjct: 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 19/192 (9%)

Query: 152 DSGQISIALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           + G + I  EYM  GSL D LR   +  +    L      + + + YL G  + VHRD+ 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLA 316

Query: 210 PANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIG 269
             N+LV+     K++DFG+     +S          V + +PE +R + +S  +D+WS G
Sbjct: 317 ARNVLVSEDNVAKVSDFGL-TKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFG 373

Query: 270 LALFECGT-GEFPYAASEG-PVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKD 323
           + L+E  + G  PY      P+  ++  +E      +P        P     + +C   D
Sbjct: 374 ILLWEIYSFGRVPY---PRIPLKDVVPRVEKGYKMDAP----DGCPPAVYDVMKNCWHLD 426

Query: 324 AEARPTADQLLS 335
           A  RPT  QL  
Sbjct: 427 AATRPTFLQLRE 438

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 20/191 (10%)

Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
           I I  EYM  G L + LR  +       L  M K + + + YL   +  +HRD+   N L
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCL 152

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIWSIGLA 271
           VN +G  K++DFG+S  + +     +   G+   V +  PE +    +S  +DIW+ G+ 
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210

Query: 272 LFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           ++E  + G+ PY   E   N    + +        P       S +  + +  C  + A+
Sbjct: 211 MWEIYSLGKMPY---ERFTNSETAEHIAQGLRLYRP----HLASEKVYTIMYSCWHEKAD 263

Query: 326 ARPTADQLLSH 336
            RPT   LLS+
Sbjct: 264 ERPTFKILLSN 274

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 23/195 (11%)

Query: 152 DSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK 209
           + G + I  EYM  GSL D LR +    +    L      + + + YL G  + VHRD+ 
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLA 144

Query: 210 PANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT---VTYMSPERIRNESYSYPADIW 266
             N+LV+     K++DFG++    ++             V + +PE +R + +S  +D+W
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVW 198

Query: 267 SIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLK 321
           S G+ L+E  + G  PY     P+  ++  +E      +P        P     + +C  
Sbjct: 199 SFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAP----DGCPPAVYEVMKNCWH 252

Query: 322 KDAEARPTADQLLSH 336
            DA  RP+  QL   
Sbjct: 253 LDAAMRPSFLQLREQ 267

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 39/277 (14%)

Query: 89  IGSGASSVVQRA-----VHIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           +G+GA   V  A             +A+K  K      EK   L++E++ +     +E +
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 112

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSM-------FKKLLQ-- 192
           V   GA      G + +  EY   G L + LR +  + E   +          + LL   
Sbjct: 113 VNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 193 -----GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG--T 245
                G+++L   ++ +HRD+   N+L+      KI DFG++  + N             
Sbjct: 171 SQVAQGMAFLAS-KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI-----LEDP 299
           V +M+PE I +  Y+  +D+WS G+ L+E  + G  PY            +     +  P
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289

Query: 300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                         S +  C   +   RPT  Q+ S 
Sbjct: 290 ------AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 50/202 (24%), Positives = 72/202 (35%), Gaps = 24/202 (11%)

Query: 152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ-------GLSYLHGVRHLV 204
            S    I +E M GG L   LR  +  P    S     LL        G  YL    H +
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFI 162

Query: 205 HRDIKPANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESY 259
           HRDI   N L+   G     KI DFG++  +  +            V +M PE      +
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222

Query: 260 SYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCS 314
           +   D WS G+ L+E  + G  PY +       +L+ +        P    +N       
Sbjct: 223 TSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGRMDPP----KNCPGPVYR 276

Query: 315 FVDDCLKKDAEARPTADQLLSH 336
            +  C +   E RP    +L  
Sbjct: 277 IMTQCWQHQPEDRPNFAIILER 298

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 21/198 (10%)

Query: 151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLHGVRHLVHRD 207
              G   + L YM  G L + +R       P +  +    LQ   G+ YL   +  VHRD
Sbjct: 97  RSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRD 153

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENS--IAMCATFVGT--VTYMSPERIRNESYSYPA 263
           +   N +++ K   K+ DFG++  + +    ++         V +M+ E ++ + ++  +
Sbjct: 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 213

Query: 264 DIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDD 318
           D+WS G+ L+E  T G  PY         +   L        P    +         +  
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLLQP----EYCPDPLYEVMLK 267

Query: 319 CLKKDAEARPTADQLLSH 336
           C    AE RP+  +L+S 
Sbjct: 268 CWHPKAEMRPSFSELVSR 285

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 41/193 (21%), Positives = 75/193 (38%), Gaps = 22/193 (11%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ-------GLSYLHGVRHLVHRDIKP 210
           + L +M  G L   L   +    P    + + LL+       G+ YL   R+ +HRD+  
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPL-QTLLKFMVDIALGMEYLSN-RNFLHRDLAA 175

Query: 211 ANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSI 268
            N ++       + DFG+S  + +        +    V +++ E + +  Y+  +D+W+ 
Sbjct: 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235

Query: 269 GLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKD 323
           G+ ++E  T G  PY       + M   L        P    ++   E    +  C + D
Sbjct: 236 GVTMWEIATRGMTPYPGV--QNHEMYDYLLHGHRLKQP----EDCLDELYEIMYSCWRTD 289

Query: 324 AEARPTADQLLSH 336
              RPT   L   
Sbjct: 290 PLDRPTFSVLRLQ 302

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 50/196 (25%), Positives = 71/196 (36%), Gaps = 24/196 (12%)

Query: 158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ-------GLSYLHGVRHLVHRDIKP 210
           I LE M GG L   LR  +  P    S     LL        G  YL    H +HRDI  
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAA 209

Query: 211 ANLLVNLKGRP---KITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADI 265
            N L+   G     KI DFG++  +  +            V +M PE      ++   D 
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269

Query: 266 WSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCL 320
           WS G+ L+E  + G  PY +       +L+ +        P    +N        +  C 
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCW 323

Query: 321 KKDAEARPTADQLLSH 336
           +   E RP    +L  
Sbjct: 324 QHQPEDRPNFAIILER 339

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 17/189 (8%)

Query: 158 IALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN 216
           + L YM  G L   +R  + +     L S   ++ +G+ YL   +  VHRD+   N +++
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLD 158

Query: 217 LKGRPKITDFGISAGLENSIAMCATFVGT----VTYMSPERIRNESYSYPADIWSIGLAL 272
                K+ DFG++  + +               V + + E ++   ++  +D+WS G+ L
Sbjct: 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218

Query: 273 FECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEAR 327
           +E  T G  PY         +   L      P P    +         +  C + D   R
Sbjct: 219 WELLTRGAPPYRHI--DPFDLTHFLAQGRRLPQP----EYCPDSLYQVMQQCWEADPAVR 272

Query: 328 PTADQLLSH 336
           PT   L+  
Sbjct: 273 PTFRVLVGE 281

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 42/203 (20%), Positives = 79/203 (38%), Gaps = 44/203 (21%)

Query: 156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL 214
             +  E++  GSL   L+  K  I       + K+L   + +L     L+H ++   N+L
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNIL 145

Query: 215 VNLKGRP--------KITDFGISAGLENSIAMCATFVGTVTY-------MSPERIRN-ES 258
           +  +           K++D GIS  +                       + PE I N ++
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKN 194

Query: 259 YSYPADIWSIGLALFECGT-GEFPYAASEGP-VNLMLQILED----PSPSPSRQNFSPEF 312
            +   D WS G  L+E  + G+ P +A +       LQ  ED    P+P         E 
Sbjct: 195 LNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQFYEDRHQLPAPKA------AEL 245

Query: 313 CSFVDDCLKKDAEARPTADQLLS 335
            + +++C+  + + RP+   ++ 
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIR 268

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 23/199 (11%)

Query: 151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQ---GLSYLHGVRHLVHRD 207
              G   + L YM  G L + +R +     P +  +    LQ   G+ +L   +  VHRD
Sbjct: 161 RSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRD 217

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-----VTYMSPERIRNESYSYP 262
           +   N +++ K   K+ DFG++  + +     +    T     V +M+ E ++ + ++  
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQTQKFTTK 276

Query: 263 ADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVD 317
           +D+WS G+ L+E  T G  PY         +   L        P    +         + 
Sbjct: 277 SDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLLQP----EYCPDPLYEVML 330

Query: 318 DCLKKDAEARPTADQLLSH 336
            C    AE RP+  +L+S 
Sbjct: 331 KCWHPKAEMRPSFSELVSR 349

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 32/238 (13%)

Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
            + L++E+  +     ++ ++   GA      G + + +EY   G+L + LR ++     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGME 141

Query: 182 ILSSM---------FKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
               +         FK L+        G+ YL   +  +HRD+   N+LV      KI D
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIAD 200

Query: 226 FGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           FG++  + N      T  G   V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

Query: 283 AASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                PV  + ++L++      P     N + E    + DC       RPT  QL+  
Sbjct: 261 PGI--PVEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 36/273 (13%)

Query: 89  IGSGASSVVQRAV--HIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IG G    V +A           A+K  K    + + R+    E+  LC+   +  ++  
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINL 91

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSM---------FKKLLQ--- 192
            GA      G + +A+EY   G+L D LR  + +      ++          ++LL    
Sbjct: 92  LGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 193 ----GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTY 248
               G+ YL   +  +HRD+   N+LV      KI DFG+S G E  +      +  V +
Sbjct: 150 DVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRW 207

Query: 249 MSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSP 303
           M+ E +    Y+  +D+WS G+ L+E  + G  PY         + + L        P  
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGYRLEKP-- 263

Query: 304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              N   E    +  C ++    RP+  Q+L  
Sbjct: 264 --LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 32/238 (13%)

Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
            + L++E+  +     ++ ++   GA      G + + +EY   G+L + LR ++     
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGME 187

Query: 182 ILSSM---------FKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
               +         FK L+        G+ YL   +  +HRD+   N+LV      KI D
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIAD 246

Query: 226 FGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           FG++  + N      T  G   V +M+PE + +  Y++ +D+WS G+ ++E  T G  PY
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 283 AASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                PV  + ++L++      P     N + E    + DC       RPT  QL+  
Sbjct: 307 PGI--PVEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)

Query: 122 RNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEP 181
            + L++E+  +     ++ ++   GA      G + + +EY   G+L + L+ ++     
Sbjct: 118 LSDLISEMEMMKMIGKHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175

Query: 182 ILSSM---------FKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD 225
              +           K L+        G+ YL   +  +HRD+   N+LV      KI D
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIAD 234

Query: 226 FGISAGLENSIAMCATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY 282
           FG++  + +      T  G   V +M+PE + +  Y++ +D+WS G+ L+E  T G  PY
Sbjct: 235 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

Query: 283 AASEGPVNLMLQILED----PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                PV  + ++L++      P     N + E    + DC       RPT  QL+  
Sbjct: 295 PGV--PVEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 58/195 (29%), Positives = 87/195 (44%), Gaps = 33/195 (16%)

Query: 161 EYMDGGSLADILRMQKSIPEPILSSMFKKLL-------QGLSYLHGVRHLVHRDIKPANL 213
           +YM+ G+L   L     +P   +S  +++ L       +GL YLH  R ++HRD+K  N+
Sbjct: 115 KYMENGNLKRHLY-GSDLPTMSMS--WEQRLEICIGAARGLHYLHT-RAIIHRDVKSINI 170

Query: 214 LVNLKGRPKITDFGIS-AGLENSIAMCATFV-GTVTYMSPERIRNESYSYPADIWSIGLA 271
           L++    PKITDFGIS  G E      +T V GT+ Y+ PE       +  +D++S G+ 
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230

Query: 272 LFECGTGEFP--YAASEGPVNL-----------MLQILEDPSPSPSRQNFSPE----FCS 314
           LFE          +     VNL            L+ + DP+         PE    F  
Sbjct: 231 LFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN---LADKIRPESLRKFGD 287

Query: 315 FVDDCLKKDAEARPT 329
               CL   +E RP+
Sbjct: 288 TAVKCLALSSEDRPS 302

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 67/286 (23%), Positives = 108/286 (37%), Gaps = 48/286 (16%)

Query: 89  IGSGASSVVQRA-----VHIPTHRIIALK--KINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           +GSGA   V  A             +A+K  K      E+   L++E++ + +   +E +
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHENI 111

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILR----------------MQKSIPEPILSS 185
           V   GA     SG I +  EY   G L + LR                 +    E +   
Sbjct: 112 VNLLGA--CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 186 MFKKLLQ-------GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM 238
            F+ LL        G+ +L   +  VHRD+   N+LV      KI DFG++  + +    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228

Query: 239 CATFVGT--VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI 295
                    V +M+PE +    Y+  +D+WS G+ L+E  + G  PY       N    I
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288

Query: 296 -----LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                ++ P         + E    +  C   D+  RP+   L S 
Sbjct: 289 QNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 47/202 (23%), Positives = 83/202 (41%), Gaps = 24/202 (11%)

Query: 152 DSGQISIALEYMDGGSLADILRM-------QKSIPEPILSSMFKKLLQ---GLSYLHGVR 201
                 + +E M  G L   LR           +  P LS M +   +   G++YL+   
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-N 157

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPERIRNESY 259
             VHRD+   N +V      KI DFG++  +  +        G   V +MSPE +++  +
Sbjct: 158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217

Query: 260 SYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNFSPEFCS 314
           +  +D+WS G+ L+E  T  E PY         +L+ + +      P     N       
Sbjct: 218 TTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEGGLLDKP----DNCPDMLFE 271

Query: 315 FVDDCLKKDAEARPTADQLLSH 336
            +  C + + + RP+  +++S 
Sbjct: 272 LMRMCWQYNPKMRPSFLEIISS 293

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 55/188 (29%), Positives = 82/188 (43%), Gaps = 23/188 (12%)

Query: 161 EYMDGGSLADILRMQKSIPEPILS-SMFKKLL----QGLSYLHGVRHLVHRDIKPANLLV 215
            YM  GSL D L        P LS  M  K+      G+++LH   H +HRDIK AN+L+
Sbjct: 110 VYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILL 166

Query: 216 NLKGRPKITDFGIS-AGLENSIAMCAT-FVGTVTYMSPERIRNESYSYPADIWSIGLALF 273
           +     KI+DFG++ A  + +  +  +  VGT  YM+PE +R E  +  +DI+S G+ L 
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLL 225

Query: 274 ECGTGEFPYAASEGPVNLM---LQILEDPSP-----SPSRQNFSPE----FCSFVDDCLK 321
           E  TG         P  L+    +I ++             +          S    CL 
Sbjct: 226 EIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLH 285

Query: 322 KDAEARPT 329
           +    RP 
Sbjct: 286 EKKNKRPD 293

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.4 bits (165), Expect = 8e-13
 Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 34/268 (12%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK--RNQLLTEIRTLCEAPCNEGL 141
           ++   IG G+  V+    ++  ++ +A+K    FE  +    QL  E RT        G+
Sbjct: 13  KVGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---SIPEPILSSMF-KKLLQGLSYL 197
              +  ++  +     + ++ + G SL D+L +     S+ + +   M  K++L  +  +
Sbjct: 69  PNVY--YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV-KTVA--MAAKQMLARVQSI 122

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPK-----ITDFGISAGLENS-----IAMC--ATFVGT 245
           H  + LV+RDIKP N L+            + DFG+     +      I         GT
Sbjct: 123 HE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML--QILEDPSPSP 303
             YMS         S   D+ ++G        G  P+   +   N     +I E    +P
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241

Query: 304 SR---QNFSPEFCSFVDDCLKKDAEARP 328
            R     F  EF  ++        +A P
Sbjct: 242 LRELCAGFPEEFYKYMHYARNLAFDATP 269

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.4 bits (165), Expect = 9e-13
 Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 29/216 (13%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE--KRNQLLTEIRTLCEAPCNEGL 141
           R+   IG G    ++   ++ T+  +A+K     E    +  QL  E R   +    +G+
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGI 67

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK---SIPEPILSSMF-KKLLQGLSYL 197
            + +  ++ P     ++ LE + G SL D+  +     S+ + +L  M   +L+  + Y+
Sbjct: 68  PQVY--YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL-KTVL--MIAIQLISRMEYV 121

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPK-----ITDFGIS-----AGLENSIAMC--ATFVGT 245
           H  ++L++RD+KP N L+   G        I DF ++        +  I      +  GT
Sbjct: 122 HS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP 281
             YMS      +  S   D+ ++G        G  P
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 15/153 (9%)

Query: 192 QGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYM 249
           +G+ +L   R  +HRD+   N+L++ K   KI DFG++  +               + +M
Sbjct: 204 KGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 250 SPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI-----LEDPSPSP 303
           +PE I +  Y+  +D+WS G+ L+E  + G  PY   +       ++     +  P    
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---- 318

Query: 304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                +PE    + DC   +   RPT  +L+ H
Sbjct: 319 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 42/208 (20%), Positives = 78/208 (37%), Gaps = 30/208 (14%)

Query: 152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSM---------FKKLLQ-------GLS 195
               +S+   Y   G L + L M+    +   +               +        G+ 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT--VTYMSPER 253
           YL    H+VH+D+   N+LV  K   KI+D G+   +  +            + +M+PE 
Sbjct: 143 YLSS-HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEA 201

Query: 254 IRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQNF 308
           I    +S  +DIWS G+ L+E  + G  PY         +++++ +    P P     + 
Sbjct: 202 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVEMIRNRQVLPCP----DDC 255

Query: 309 SPEFCSFVDDCLKKDAEARPTADQLLSH 336
                + + +C  +    RP    + S 
Sbjct: 256 PAWVYALMIECWNEFPSRRPRFKDIHSR 283

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 35/210 (16%)

Query: 152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSM--------FKKLLQ-------GLSY 196
           +   + +  EYM  G L   LR      + +              +LL        G+ Y
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-----VTYMSP 251
           L G  H VHRD+   N LV      KI DFG+S  + ++       VG      + +M P
Sbjct: 174 LAG-LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPP 229

Query: 252 ERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PSPSPSRQ 306
           E I    ++  +D+WS G+ L+E  T G+ P+   +      +  +        P    +
Sbjct: 230 ESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSNTEAIDCITQGRELERP----R 283

Query: 307 NFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
              PE  + +  C +++ + R +   + + 
Sbjct: 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 38/211 (18%)

Query: 152 DSGQISIALEYMDGGSLADILRM---------QKSIPEPILSSMFKKLLQ-------GLS 195
           D   + +  EYM  G L   LR               +        ++L        G+ 
Sbjct: 88  DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 147

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-----VTYMS 250
           YL   +H VHRD+   N LV      KI DFG+S  + ++       VG      + +M 
Sbjct: 148 YLAS-QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYRVGGHTMLPIRWMP 203

Query: 251 PERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNL-MLQILED----PSPSPS 304
           PE I    ++  +D+WS G+ L+E  T G+ P+       N  +++ +        P   
Sbjct: 204 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPW---FQLSNTEVIECITQGRVLERP--- 257

Query: 305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            +    E    +  C +++ + R    ++  
Sbjct: 258 -RVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 38/216 (17%)

Query: 152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSM-----------------FKKLLQ-- 192
             G + + +EY   GSL   LR  + +    L S                     L+   
Sbjct: 97  QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156

Query: 193 -----GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-- 245
                G+ YL     LVHRD+   N+LV    + KI+DFG+S  +    +      G   
Sbjct: 157 WQISQGMQYLAE-MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PS 300
           V +M+ E + +  Y+  +D+WS G+ L+E  T G  PY     P   +  +L+       
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLFNLLKTGHRMER 273

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
           P     N S E    +  C K++ + RP    +   
Sbjct: 274 P----DNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 7/144 (4%)

Query: 161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQG----LSYLH-GVR-HLVHRDIKPANLL 214
            YM  GS+A  LR +     P+     +++  G    L+YLH      ++HRD+K AN+L
Sbjct: 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166

Query: 215 VNLKGRPKITDFGISAGLENSIAMCATFV-GTVTYMSPERIRNESYSYPADIWSIGLALF 273
           ++ +    + DFG++  ++       T V GT+ +++PE +     S   D++  G+ L 
Sbjct: 167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 226

Query: 274 ECGTGEFPYAASEGPVNLMLQILE 297
           E  TG+  +  +    +  + +L+
Sbjct: 227 ELITGQRAFDLARLANDDDVMLLD 250

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 46/215 (21%), Positives = 83/215 (38%), Gaps = 28/215 (13%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR---TLCEAPCNEGLVEFH 145
           IGSG   ++  A         A   + + E ++   L +E++    + +  C +  +E  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKV-EYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 146 GAFY--MP---DSGQISIA-LEY----MD--GGSLADILRMQKSIPEPILSSMFKKLLQG 193
              Y  +P    SG        Y    M+  G  L  I     +  +  +  +  ++L  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 194 LSYLHGVRHLVHRDIKPANLLVNLKGRPKIT--DFGIS-----AGLENSIAMC--ATFVG 244
           L Y+H     VH DIK ANLL+  K   ++   D+G+S      G              G
Sbjct: 164 LEYIHE-NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222

Query: 245 TVTYMSPERIRNESYSYPADIWSIG--LALFECGT 277
           T+ + S +  +  + S  +D+  +G  +  + CG 
Sbjct: 223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 17/209 (8%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           R+   IGSG+   +    +I T+  +A+K  N+  K K  QLL E +         G+  
Sbjct: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPN 67

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRH 202
               ++  +     + ++ + G SL D+     + +    +  +  +++  + ++H  + 
Sbjct: 68  VR--WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KS 123

Query: 203 LVHRDIKPANLLVNLKGRPK---ITDFGISAGLENSIAM-------CATFVGTVTYMSPE 252
            +HRDIKP N L+ L  R     I DFG++    ++               GT  Y S  
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183

Query: 253 RIRNESYSYPADIWSIGLALFECGTGEFP 281
                  S   D+ S+G  L     G  P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.8 bits (149), Expect = 2e-10
 Identities = 59/373 (15%), Positives = 112/373 (30%), Gaps = 98/373 (26%)

Query: 43  LLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVH 102
           L  +   V  F E  L+    +L      +E   R  S   R++          +     
Sbjct: 72  LSKQEEMVQKFVEEVLRINYKFLM-SPIKTE--QRQPSMMTRMY----IEQRDRLYNDNQ 124

Query: 103 IPTHRIIALKKINIFEKEKRNQLLTEIRT-LCEAPCNEGLVEFHGAFYMPDSGQISIALE 161
           +         K N+     R Q   ++R  L E    + ++   G   +  SG+  +AL+
Sbjct: 125 V-------FAKYNV----SRLQPYLKLRQALLELRPAKNVL-IDG---VLGSGKTWVALD 169

Query: 162 ---------YMDGG----------SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV-- 200
                     MD            S   +L M + +   I  +   +     +    +  
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 201 -----RHLVHRDIKPANLLV--NLKGRPKITD-FGISAGLENSIAMCATFVGT----VT- 247
                R L+        LLV  N++   K  + F +S         C   + T    VT 
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQ-NAKAWNAFNLS---------CKILLTTRFKQVTD 279

Query: 248 YMSPERIRNESYSYPADIWSI--GLALF----ECGTGEFPYAASEG-PVNLMLQILEDPS 300
           ++S     + S  + +   +     +L     +C   + P       P  L + I E   
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIR 338

Query: 301 PSPSR-QNF----SPEFCSFVDDCLK--KDAEARPTADQLLSHPFITKYEHAKVDLAAFV 353
              +   N+      +  + ++  L   + AE R              ++     L+ F 
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK------------MFD----RLSVFP 382

Query: 354 RSVFDPMQRMKDL 366
            S   P   +  +
Sbjct: 383 PSAHIPTILLSLI 395

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 21/211 (9%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE--KRNQLLTEIRTLCEAPCNEGL 141
           R+   IGSG+   +     I     +A+K     E    K  QL  E +         G+
Sbjct: 12  RLGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGV 200
                 +   +     + +E + G SL D+     +      +  +  +++  + Y+H  
Sbjct: 68  PTIR--WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS- 123

Query: 201 RHLVHRDIKPANLLVNLKGRPK---ITDFGISAGLENS-----IAMCAT--FVGTVTYMS 250
           ++ +HRD+KP N L+ L  +     I DFG++    ++     I         GT  Y S
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 251 PERIRNESYSYPADIWSIGLALFECGTGEFP 281
                    S   D+ S+G  L     G  P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 7e-10
 Identities = 44/238 (18%), Positives = 73/238 (30%), Gaps = 52/238 (21%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRN--------------QLLTEIRTLCE 134
           IG G    V + +    H  +A+K I I   +  N               +  E+  L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 135 APCN--EGLVEFHGAF----------------------------YMPDSGQISIALEYMD 164
             CN  EG +  +                                     Q+ I LE+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKIT 224
           GG   + +   K        S+  +L   L+         HRD+   N+L+      K+ 
Sbjct: 146 GGIDLEQM-RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204

Query: 225 DFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY 282
                 G  ++I  C   V  + Y      R+    +  D  S+   LF  G G++ +
Sbjct: 205 YTL--NGKSSTIPSCGLQVSIIDYTLSRLERDGIVVF-CD-VSMDEDLFT-GDGDYQF 257

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 49/216 (22%), Positives = 77/216 (35%), Gaps = 38/216 (17%)

Query: 152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSM-----------------FKKLLQ-- 192
               + +  EYM  G L + LR         LS                     + L   
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 193 -----GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGT-- 245
                G++YL   R  VHRD+   N LV      KI DFG+S  + ++    A       
Sbjct: 181 RQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 239

Query: 246 VTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILED----PS 300
           + +M PE I    Y+  +D+W+ G+ L+E  + G  PY         ++  + D      
Sbjct: 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--AHEEVIYYVRDGNILAC 297

Query: 301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
           P    +N   E  + +  C  K    RP+   +   
Sbjct: 298 P----ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 31/218 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G    +     + +   +      +   E      L TE++    A   E + ++  
Sbjct: 43  IGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 147 AFYMPDSG---------QISIALEY----MD--GGSLADILRMQ-KSIPEPILSSMFKKL 190
              +   G                Y    MD  G  L  I     K      +  +  ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKIT--DFGIS-----AGLENSIAMC--AT 241
           L  L Y+H     VH DIK +NLL+N K   ++   D+G++      G+  + A      
Sbjct: 162 LDILEYIHE-HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220

Query: 242 FVGTVTYMSPERIRNESYSYPADIWSIG--LALFECGT 277
             GT+ + S +     + S   D+  +G  +  +  G 
Sbjct: 221 HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 20/104 (19%)

Query: 163 MD--GGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK 218
           +   G SL   L +     + E  +  +  +LL  L +LH     VH ++   N+ V+ +
Sbjct: 137 LPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDPE 195

Query: 219 GRPKIT--DFGIS----------AGLENSIAMCATFVGTVTYMS 250
            + ++T   +G +          A +E S    +   G + ++S
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGS---RSPHEGDLEFIS 236

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	371
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.97
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.74
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.44
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.36
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.21
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.07
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.91
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.61
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.46
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.41
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.14
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.97
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.73
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.99
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.8
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.31

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-65  Score=474.74  Aligned_cols=259  Identities=30%  Similarity=0.557  Sum_probs=229.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ..|++++.||+|+||+||+|.++.+|+.||||+++.......+.+.+|+.++.++. |||||+++++|..  .+.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEE
Confidence            57999999999999999999999999999999997655455567889999999986 9999999998854  56899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      |||+||+|.+++.. +++++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+.+........
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99999999999975 679999999999999999999999 9999999999999999999999999999998776655667


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCCHHHHHHHHHh
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  319 (371)
                      +.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+. +....+..+.....+ ...+..+++++.+||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence            889999999999999999999999999999999999999999764 344555555554332 334467899999999999


Q ss_pred             cccCcCCCCCHHHHhcCccccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      |+.||++|||+.|+|+||||++...+
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             cCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            99999999999999999999876543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-65  Score=467.02  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=231.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++..   .......+.+|+.++.++. |||||+++++|  ++.+.+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~--~~~~~~  107 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTF--QDDEKL  107 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEE--ECSSEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE--EeCCEE
Confidence            36899999999999999999999999999999999752   2234567899999999886 99999999988  456799


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc-
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS-  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~-  235 (371)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+.+... 
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999999999988999999999999999999999999 99999999999999999999999999999876533 


Q ss_pred             -ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          236 -IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       236 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                       .....+.+||+.|||||++.+..|+.++||||+||++|+|++|+.||.+. +....+.++.......  +..+++++++
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~--p~~~s~~~~d  263 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDF--PEKFFPKARD  263 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCC--CTTCCHHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC--CcccCHHHHH
Confidence             23446789999999999999999999999999999999999999999764 3455666776665443  4579999999


Q ss_pred             HHHHhcccCcCCCCCHHH------HhcCccccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQ------LLSHPFITKYEHAKV  347 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~------il~hp~~~~~~~~~~  347 (371)
                      ||++||+.||++|||++|      |++||||+.+.++++
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            999999999999999987      689999999887765

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-64  Score=470.11  Aligned_cols=259  Identities=27%  Similarity=0.496  Sum_probs=224.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++.  ........+.+|+.++.++. |||||+++++|.  +.+.+|
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~--~~~~~y   99 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFE--ENGSLY   99 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEE--ECCEEE
Confidence            3689999999999999999999999999999999975  34456678999999999997 999999999885  466899


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ||||||+||+|.++|...  ..+++..++.|+.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999999999754  357999999999999999999999 99999999999999999999999999999987765


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      .....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+. +....+.++..+..+ +.+..+|+++.+|
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~-~~~~~~s~~~~~l  256 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIISGSFP-PVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCC-CCCccCCHHHHHH
Confidence            44556778999999999999999999999999999999999999999764 445666677766554 3456799999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      |.+||+.||++|||+.|+|+||||++.-+
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~~  285 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIAKRIE  285 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence            99999999999999999999999976443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-63  Score=454.68  Aligned_cols=254  Identities=24%  Similarity=0.459  Sum_probs=221.3

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CCCeEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQISI  158 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~~~~~l  158 (371)
                      |++.+.||+|+||+||+|.+..+++.||+|++..  ........+.+|+.++.++. |||||+++++|...  ....+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEE
Confidence            3677789999999999999999999999999964  34556678999999999997 99999999988542  3456899


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEcc-CCceEEecccccccCccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNL-KGRPKITDFGISAGLENS  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||||+||+|.+++...+.+++..+..|+.||+.||+|||+ +|  |+||||||+|||++. +|.+||+|||+|+.....
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            99999999999999988999999999999999999999999 88  999999999999985 799999999999754432


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                        ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+...+..+++++.+|
T Consensus       186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  262 (290)
T 3fpq_A          186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence              3457789999999999875 5999999999999999999999999876655555555555555555566788999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      |.+||+.||++|||+.|+|+||||++
T Consensus       263 i~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          263 IEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.3e-64  Score=476.44  Aligned_cols=260  Identities=30%  Similarity=0.544  Sum_probs=230.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .+.|++++.||+|+||+||+|.++.+|+.||||+++.......+.+.+|+.++..+. |||||+++++|..  .+.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCCCceEEEEEE--CCEEEEE
Confidence            357999999999999999999999999999999997655555667889999999996 9999999999854  5689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||||+||+|.+++.. +.+++..++.++.||+.||+|||+ +|||||||||+|||++.+|.+||+|||+|+.+.......
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            999999999999974 579999999999999999999999 999999999999999999999999999999877665566


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCCCCCCCCHHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS-PSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  318 (371)
                      .+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+. .....+..+..... ....+..+++++.+||.+
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            7889999999999999999999999999999999999999999764 34455555555433 334456799999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccccc
Q 017445          319 CLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      ||+.||++|||+.|+|+||||++...+
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            999999999999999999999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-64  Score=462.52  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=220.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .++|++++.||+|+||+||+|++.   .+++.||||+++..  .......+.+|+.++.++. |||||+++++|.  +.+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQ--TEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEE--ETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECC
Confidence            468999999999999999999874   46889999999652  2223345778999888876 999999999885  466


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|||||||+||+|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            899999999999999999988999999999999999999999999 9999999999999999999999999999987766


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ......+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. +....+.++......  .+..+|+++.+
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~~  255 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLG--MPQFLSPEAQS  255 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCCC--CCCcCCHHHHH
Confidence            555567789999999999999999999999999999999999999999764 345566666666544  34679999999


Q ss_pred             HHHHhcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          315 FVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       315 li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      ||++||+.||++|||     ++|+++||||+.+.+.+
T Consensus       256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence            999999999999998     58999999998876544

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.6e-63  Score=446.38  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+|++++.||+|+||+||+|.++.+|+.||||+++..   .......+.+|+.++.++. |||||+++++|.  +.+.+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIK--SKDEII   89 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEE--ECCEEE
Confidence            5899999999999999999999999999999999652   2334567899999999996 999999999884  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||||+ +|+|.+++...+++++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+..... .
T Consensus        90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  166 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-N  166 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-C
Confidence            999999 67999999988999999999999999999999999 99999999999999999999999999999876554 3


Q ss_pred             ccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+ ......++......  .+..+|+++.+||
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~~li  243 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-IPVLFKNISNGVYT--LPKFLSPGAAGLI  243 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCC--CCTTSCHHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence            3456889999999999988876 579999999999999999999997643 34455555555443  3457899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      ++||+.||++|||++|+++||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999963

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-62  Score=454.86  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=222.6

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      +...+.|++.++||+|+||+||+|+++.+|+.||||+++...     ...+|+.++.++. |||||+++++|.  +.+.+
T Consensus        54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~-HpnIV~l~~~~~--~~~~~  125 (336)
T 4g3f_A           54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLS-SPRIVPLYGAVR--EGPWV  125 (336)
T ss_dssp             CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCC-CTTBCCEEEEEE--ETTEE
T ss_pred             hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEE
Confidence            334568999999999999999999999999999999997522     1246888888876 999999999885  46689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENS  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~~  235 (371)
                      |||||||+||+|.++|+..+++++..+..++.||+.||+|||+ +|||||||||+|||++.+| ++||+|||+|+.....
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999999999988999999999999999999999999 9999999999999999987 6999999999876543


Q ss_pred             cc-----ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCC
Q 017445          236 IA-----MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFS  309 (371)
Q Consensus       236 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  309 (371)
                      ..     ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .....++.....+ ...+..++
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-GPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-SCCHHHHHHSCCGGGGSCTTSC
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHHcCCCCchhcCccCC
Confidence            21     22346899999999999999999999999999999999999999976543 3445555555443 23457899


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHH-------------hcCccccccccccc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQL-------------LSHPFITKYEHAKV  347 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~i-------------l~hp~~~~~~~~~~  347 (371)
                      +++.+||.+||+.||++|||+.|+             |+|||+.++.+++-
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence            999999999999999999999997             67999999887763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-60  Score=435.80  Aligned_cols=259  Identities=24%  Similarity=0.413  Sum_probs=203.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC------
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS------  153 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~------  153 (371)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++.++. |||||+++++|...+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccccc
Confidence            4799999999999999999999999999999999753 3445677899999999886 9999999999865432      


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          154 ----GQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       154 ----~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                          .++|||||||+||+|.+++.....   .++..++.++.|++.||+|||+ +||+||||||+|||++.+|.+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccC
Confidence                257999999999999999987654   3456788999999999999999 99999999999999999999999999


Q ss_pred             cccccCccccc------------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 017445          227 GISAGLENSIA------------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ  294 (371)
Q Consensus       227 g~s~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~  294 (371)
                      |+|+.......            ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||....+....+..
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD  239 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence            99987654321            1245689999999999999999999999999999999996   77543222223333


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +.....+ +.....++.+.+||++||+.||++|||+.|+|+||||+....+
T Consensus       240 ~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          240 VRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            3333222 2223456778899999999999999999999999999877543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-59  Score=443.92  Aligned_cols=260  Identities=28%  Similarity=0.434  Sum_probs=218.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CCC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DSG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~~  154 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++.  ........+.+|+.+|..+. |||||++++++...    +.+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccccCC
Confidence            579999999999999999999999999999999965  23455677899999999986 99999999987432    346


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|||||||+ |+|.+++...+++++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            8999999996 6899999988999999999999999999999999 9999999999999999999999999999987643


Q ss_pred             c----ccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCC-----
Q 017445          235 S----IAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSP-----  301 (371)
Q Consensus       235 ~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~-----  301 (371)
                      .    .....+.+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+. ...+..+..   .+..     
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-VHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCGGGTC-
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCChHHhhh
Confidence            2    2234567999999999998775 569999999999999999999999987543 333333322   1110     


Q ss_pred             --------------CC-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          302 --------------SP-------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       302 --------------~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                    ..       ....+++++.+||.+||+.||++|||+.|+|+||||+++..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                          00       01357899999999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-59  Score=426.92  Aligned_cols=258  Identities=22%  Similarity=0.390  Sum_probs=218.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      .+..++|.+.+.||+|+||+||+|.+.     .+++.||||+++.......+.+.+|+.++.++. |||||+++|++.  
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~--   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC-CCCCccEEEEEe--
Confidence            456679999999999999999999864     468899999998777777788999999999986 999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      +.+.+|||||||++|+|.++|+..             ..+++..+..|+.|++.||.|||+ ++|+||||||+|||++.+
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCC
Confidence            566899999999999999999754             369999999999999999999999 999999999999999999


Q ss_pred             CceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHH
Q 017445          219 GRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQI  295 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~  295 (371)
                      +.+||+|||+|+.......  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+ ....+..+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~~~i  243 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECI  243 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH
Confidence            9999999999976544322  2234569999999999999999999999999999999998 999997654 34555555


Q ss_pred             hhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          296 LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ..+.. ...+..+|+++.+|+.+||+.||++|||+.+|  |+|+++.
T Consensus       244 ~~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          244 TQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            55443 34457899999999999999999999999999  4566543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-58  Score=434.38  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=210.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .++|++.+.||+|+||+||+|.++   .+++.||+|++....  ...++.+|+.++..+.+||||++++++|.  +.+++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~--~~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR--KNDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE--ETTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE--ECCEE
Confidence            357999999999999999999874   467899999986532  33567889999999988999999999885  46689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccccccCccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISAGLENS  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~~~~~~  235 (371)
                      ||||||++||+|.+++.   .+++..++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            99999999999999984   59999999999999999999999 999999999999999877 89999999999754322


Q ss_pred             c----------------------------cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCC
Q 017445          236 I----------------------------AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASE  286 (371)
Q Consensus       236 ~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~  286 (371)
                      .                            ....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            1                            112456899999999999775 58999999999999999999999997665


Q ss_pred             CcHHHHHHHhhC----------------------------------------------------CCCCCCCCCCCHHHHH
Q 017445          287 GPVNLMLQILED----------------------------------------------------PSPSPSRQNFSPEFCS  314 (371)
Q Consensus       287 ~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~~  314 (371)
                      +....+.++...                                                    .........+|+++.+
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            544443333210                                                    0011123567899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ||++||+.||++|||++|+|+||||+..
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3e-58  Score=427.17  Aligned_cols=255  Identities=22%  Similarity=0.363  Sum_probs=212.0

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      ..+..++|.+.+.||+|+||+||+|.+.     .+++.||||+++.......+.+.+|+.++.++. |||||+++|++. 
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~-  113 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCT-  113 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE-
Confidence            3456678999999999999999999864     468899999998777777888999999999986 999999999874 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQ---------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV  215 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~  215 (371)
                       +...+|||||||++|+|.++++..               +++++..+..|+.|++.||.|||+ ++|+||||||+|||+
T Consensus       114 -~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          114 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLV  191 (329)
T ss_dssp             -SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEE
Confidence             566899999999999999999753               358999999999999999999999 999999999999999


Q ss_pred             ccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHH
Q 017445          216 NLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLM  292 (371)
Q Consensus       216 ~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~  292 (371)
                      +.++.+||+|||+|+......  ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ....+
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~  270 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-NTEAI  270 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-HHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-HHHHH
Confidence            999999999999998664432  22345679999999999999999999999999999999999 999997654 34445


Q ss_pred             HHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          293 LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ..+..+. ....+..+|+++.+|+.+||+.||++|||+.+|+++
T Consensus       271 ~~i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          271 DCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5554443 334457899999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-58  Score=423.61  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=208.7

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .|++..+++++.+.||+|+||+||+|++..   .||||+++.  ......+.+.+|+.++.++. |||||+++|++.   
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~---  102 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMT---  102 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE---
Confidence            467788899999999999999999998543   599999875  34556678999999999986 999999999763   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .+.+|||||||+||+|.++|... .++++..+..|+.|++.||.|||+ ++||||||||+|||++.++++||+|||+|+.
T Consensus       103 ~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            34689999999999999999754 579999999999999999999999 9999999999999999999999999999986


Q ss_pred             Cccc--ccccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC---CCC
Q 017445          232 LENS--IAMCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS---PSP  303 (371)
Q Consensus       232 ~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~  303 (371)
                      ....  .....+.+||+.|||||++.+   ..|+.++|||||||++|||+||+.||...+........+.....   ...
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence            6432  223356789999999999964   35899999999999999999999999875544433333333221   123


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+..+|+++.+|+.+||+.||++|||+.+|+++
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            446789999999999999999999999988654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.7e-59  Score=461.72  Aligned_cols=265  Identities=25%  Similarity=0.382  Sum_probs=221.9

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHH--HhCCCCCCeeEeceeEEe
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTL--CEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l--~~~~~h~~iv~l~~~~~~  150 (371)
                      ..+..++|++++.||+|+||+||+|+++.+|+.||||+++...   ........+|..++  .+..+|||||+++++|  
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--  261 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--  261 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--
Confidence            3456689999999999999999999999999999999996421   11222334443322  2333599999999988  


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+...+|||||||+||+|.++|...+.+++..++.++.||+.||+|||+ +|||||||||+|||++.+|++||+|||+|+
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCCCEEecccceee
Confidence            4567999999999999999999988999999999999999999999999 999999999999999999999999999998


Q ss_pred             cCcccccccccccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHhhCCCCCCCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .....  ...+.+||+.|||||++. +..|+.++|||||||++|||++|..||.+...  .......+......  .+..
T Consensus       341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~--~p~~  416 (689)
T 3v5w_A          341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDS  416 (689)
T ss_dssp             ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC--CCTT
T ss_pred             ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC--CCcc
Confidence            76553  235789999999999996 46799999999999999999999999976432  22333444444433  3467


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~~  347 (371)
                      +|+++++||.+||+.||.+|++     +++|++||||+.+.+.++
T Consensus       417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence            9999999999999999999998     799999999998877664

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-58  Score=421.60  Aligned_cols=254  Identities=21%  Similarity=0.350  Sum_probs=214.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      ++..+++++.+.||+|+||+||+|...     .+++.||||+++.. .....+.+.+|+.++.++. |||||+++|++. 
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~-   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVT-   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEE-
Confidence            355678899999999999999999853     46789999999753 3344577999999999996 999999999874 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEE
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLL  214 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl  214 (371)
                       +.+.++||||||++|+|.++|...                ..+++..+..|+.||+.||.|||+ ++||||||||+|||
T Consensus       100 -~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NIL  177 (308)
T 4gt4_A          100 -KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVL  177 (308)
T ss_dssp             -SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             -ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceE
Confidence             456899999999999999999643                358999999999999999999999 99999999999999


Q ss_pred             EccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHH
Q 017445          215 VNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNL  291 (371)
Q Consensus       215 ~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~  291 (371)
                      ++.++++||+|||+|+......  ....+.+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.. ....
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-~~~~  256 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDV  256 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-HHHH
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-HHHH
Confidence            9999999999999998764432  22345689999999999999999999999999999999998 899997654 3444


Q ss_pred             HHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          292 MLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +..+.. ....+.+..+|+++.+|+.+||+.||++|||+.+|+++
T Consensus       257 ~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444443 44445567899999999999999999999999999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-58  Score=430.35  Aligned_cols=260  Identities=22%  Similarity=0.383  Sum_probs=222.4

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..|++..++|++.+.||+|+||+||+|.+..+     ++.||||+++.. .....+.+.+|+.++.++.+|||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            45788899999999999999999999987654     468999999753 345567799999999999878999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCC
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA  211 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~  211 (371)
                      |.. +.+.+|||||||++|+|.++|+..                ..+++..+..++.||+.||+|||+ ++||||||||+
T Consensus       137 ~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~  214 (353)
T 4ase_A          137 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAAR  214 (353)
T ss_dssp             ECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             EEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcc
Confidence            753 345789999999999999999753                348999999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCc
Q 017445          212 NLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGP  288 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~  288 (371)
                      |||++.++.+||+|||+|+......  ....+.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998764432  23345679999999999999999999999999999999998 99999876554


Q ss_pred             HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ......+ ........+..+++++.+|+.+||+.||++|||+.+|++|
T Consensus       295 ~~~~~~i-~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          295 EEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4444444 3334445567899999999999999999999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-56  Score=446.08  Aligned_cols=259  Identities=24%  Similarity=0.402  Sum_probs=228.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++..........+.+|+.+|..+. |||||+++++|  .+.+.+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~--~~~~~~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAF--EDDNEMVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEE--ECSSEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC-CCCCCeEEEEE--EECCEEEEEE
Confidence            58999999999999999999999999999999998766667778899999999986 99999999988  4567999999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC--CceEEecccccccCccccc
Q 017445          161 EYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK--GRPKITDFGISAGLENSIA  237 (371)
Q Consensus       161 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~--~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+||+|.++|.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||++.+  +.+||+|||+|+.+... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~  311 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  311 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence            99999999999864 4679999999999999999999999 999999999999999864  89999999999887654 3


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCCCCCCHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSRQNFSPEFCSF  315 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  315 (371)
                      ...+.+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+ ....+.++......  ......+++++.+|
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDETLRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            3356789999999999999999999999999999999999999997644 45555666555433  33446799999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      |++||+.||.+|||+.|+|+||||+....+
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            999999999999999999999999976543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.5e-55  Score=411.31  Aligned_cols=264  Identities=23%  Similarity=0.379  Sum_probs=224.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++++.||+|+||+||+|.++.+++.||||+++..   .......+.+|..++..+.+||||+++++++.  +.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~   96 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TP   96 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eC
Confidence            45567999999999999999999999999999999999752   23345667889999988878999999999884  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+...
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            6899999999999999999988899999999999999999999999 999999999999999999999999999998655


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      .......+.+||+.|+|||++.+..++.++|||||||++|||++|..||...+ .......+.......  +..+++++.
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~~--p~~~~~~~~  252 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEVVY--PTWLHEDAT  252 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCC--CCCCCHHHH
Confidence            54455567789999999999998889999999999999999999999997643 455566666655443  356899999


Q ss_pred             HHHHHhcccCcCCCCCH------HHHhcCcccccccccc
Q 017445          314 SFVDDCLKKDAEARPTA------DQLLSHPFITKYEHAK  346 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~------~~il~hp~~~~~~~~~  346 (371)
                      +||++||+.||.+||++      .++++||||+...+.+
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence            99999999999999998      8999999999876554

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.8e-54  Score=400.79  Aligned_cols=262  Identities=27%  Similarity=0.414  Sum_probs=228.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++++.||+|+||+||+|.++.+|+.||+|+++..   .......+.+|+.++..+. ||||+++++++.  +.+
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~--~~~   78 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THD   78 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSS
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEE--eCC
Confidence            3457999999999999999999999999999999999652   2234556788999998876 999999999884  566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||++.....
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            899999999999999999888899999999999999999999999 9999999999999999999999999999986554


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ......+.+||+.|+|||++.+..++.++|||||||++|||++|..||...+ .......+......  .+..+++++.+
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~~  234 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR--FPRTLSPEAKS  234 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence            4444567789999999999999999999999999999999999999997643 34445555554433  34578999999


Q ss_pred             HHHHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          315 FVDDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       315 li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      ||.+||+.||++||     ++.++++||||....+.+
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~  271 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence            99999999999999     899999999998876554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.5e-54  Score=410.33  Aligned_cols=266  Identities=26%  Similarity=0.439  Sum_probs=226.3

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++++.||+|+||+||+|+++.+++.||+|+++..   .......+.+|..++.++.+||||++++++|.  +.
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~  125 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TE  125 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--EC
Confidence            45567999999999999999999999999999999999753   23334457788999888877999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+...
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            6899999999999999999988899999999999999999999999 999999999999999999999999999998654


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC-------cHH-HHHHHhhCCCCCCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG-------PVN-LMLQILEDPSPSPSR  305 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~-------~~~-~~~~~~~~~~~~~~~  305 (371)
                      .......+.+||+.|+|||++.+..++.++|||||||++|||++|..||.....       ... ....+......  .+
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p  282 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IP  282 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--CC
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--CC
Confidence            444455778999999999999999999999999999999999999999964321       122 33344444333  34


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCccccccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTA------DQLLSHPFITKYEHAKV  347 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~------~~il~hp~~~~~~~~~~  347 (371)
                      ..+++++.+||++||+.||.+||++      .+|++||||+.+.+..+
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l  330 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM  330 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence            5689999999999999999999984      89999999998766543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-53  Score=392.86  Aligned_cols=260  Identities=30%  Similarity=0.553  Sum_probs=226.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|++++.||+|+||+||+|.+..+++.||+|++..........+.+|+.++..+. ||||+++++++..  .+.+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEE--CCEEEEE
Confidence            458899999999999999999999999999999997655555677889999998886 9999999998854  5589999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+++|+|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..........
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            999999999999975 469999999999999999999999 999999999999999999999999999998776655555


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHh
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|..||......................+..+++.+.+|+.+|
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence            67789999999999999999999999999999999999999997654333333333334444445567899999999999


Q ss_pred             cccCcCCCCCHHHHhcCcccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      |+.||++|||+.++++||||+....
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.9e-54  Score=401.51  Aligned_cols=264  Identities=22%  Similarity=0.340  Sum_probs=227.6

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++.+.||+|+||+||+|.++.+|+.||||+++...   .........|..++..+.+||||+++++++.  +.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~~   90 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TK   90 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--eC
Confidence            456689999999999999999999999999999999997522   2234567788888887767999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||++....
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            6899999999999999999888899999999999999999999999 999999999999999999999999999998654


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      .......+.+||+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+......  .+..+++++.
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~  246 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPF--YPRWLEKEAK  246 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHhCCCC--CCcccCHHHH
Confidence            44444567789999999999999999999999999999999999999997643 34455555554433  3456899999


Q ss_pred             HHHHHhcccCcCCCCCHH-HHhcCcccccccccc
Q 017445          314 SFVDDCLKKDAEARPTAD-QLLSHPFITKYEHAK  346 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~-~il~hp~~~~~~~~~  346 (371)
                      +||.+||+.||++||++. ++++||||+.+.+.+
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~  280 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  280 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence            999999999999999998 999999999876543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.5e-53  Score=396.66  Aligned_cols=264  Identities=27%  Similarity=0.432  Sum_probs=226.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++++.||+|+||.||+|+++.+++.||+|+++..   .......+.+|..++.++.+||||+++++++.  +..
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~   83 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TES   83 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSS
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCC
Confidence            3457899999999999999999999999999999999752   34456678889999988877999999999874  566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||++.....
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            899999999999999999888899999999999999999999999 9999999999999999999999999999986544


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC--------CcHHHHHHHhhCCCCCCCCC
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE--------GPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ......+.+||+.|+|||++.+..++.++|||||||++|||++|..||....        ........+......  .+.
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~  240 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPR  240 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--CCT
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--CCC
Confidence            4444567789999999999999999999999999999999999999996522        112223334444332  345


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCH------HHHhcCcccccccccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTA------DQLLSHPFITKYEHAK  346 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~------~~il~hp~~~~~~~~~  346 (371)
                      .++.++.+||++||+.||.+||++      .++++||||..+.+..
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~  286 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  286 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence            789999999999999999999995      8999999998776543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.7e-53  Score=391.71  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=225.0

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ...+|++++.||+|+||+||+|.+..+|+.||||++...  .......+.+|+.++..+. ||||+++++++.  +.+.+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~~~~~   89 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIE--TEKTL   89 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE--ECCEE
Confidence            346899999999999999999999999999999999652  4455677889999999887 999999999874  56689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999999999888899999999999999999999999 99999999999999999999999999999766543 


Q ss_pred             cccccccccCcccCCccccCCCCC-CchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYS-YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ....+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+ .......+..+....  +..+++++.+|
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~--p~~~s~~~~~l  244 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLRGKYRI--PFYMSTDCENL  244 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCC--CCCCCHHHHHH
Confidence            233567899999999999887765 78999999999999999999997644 344555555554433  35689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +++||+.||.+|||+.++++||||....
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.4e-54  Score=393.99  Aligned_cols=250  Identities=23%  Similarity=0.268  Sum_probs=191.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC--CeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS--GQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~--~~~~l  158 (371)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++..... ......|+..+.++. |||||+++|++..++.  ..+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceEEEE
Confidence            4688899999999999999987  6889999999753322 222234454445554 9999999999875443  36899


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeEecCCCCCcEEEccCCceEEecccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR--------HLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      |||||++|+|.++++. .+++++.+..++.|++.||.|||+ +        +|+||||||+|||++.++++||+|||+|+
T Consensus        79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999975 579999999999999999999998 5        89999999999999999999999999997


Q ss_pred             cCccccc----ccccccccCcccCCccccCC------CCCCchhHHHHHHHHHHHhcCCCCCCCCCC-------------
Q 017445          231 GLENSIA----MCATFVGTVTYMSPERIRNE------SYSYPADIWSIGLALFECGTGEFPYAASEG-------------  287 (371)
Q Consensus       231 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~ell~g~~pf~~~~~-------------  287 (371)
                      .......    ...+.+||+.|||||++.+.      .++.++|||||||++|||+||..||.....             
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            6644322    12345799999999999764      367799999999999999999876643211             


Q ss_pred             cHHHHHH-HhhCCCCCCCCC-----CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          288 PVNLMLQ-ILEDPSPSPSRQ-----NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       288 ~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ....+.+ +.........+.     ..++.+.+|+.+||+.||++|||+.+|++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            1122222 233322222111     233578899999999999999999999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-53  Score=397.64  Aligned_cols=266  Identities=22%  Similarity=0.351  Sum_probs=228.3

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ...+..++|++++.||+|+||+||+|.++.+++.||||+++...   ......+..|..++..+.+||+|+++++++.  
T Consensus        14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--   91 (353)
T 2i0e_A           14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--   91 (353)
T ss_dssp             -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--
T ss_pred             cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--
Confidence            34556789999999999999999999999999999999997532   2334567888999988877999999999884  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +.+.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||++..
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            566899999999999999999888899999999999999999999999 9999999999999999999999999999986


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      .........+.+||+.|+|||++.+..++.++|||||||++|||++|..||... .......++......  .+..++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~  247 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIMEHNVA--YPKSMSKE  247 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC--CCTTSCHH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-CHHHHHHHHHhCCCC--CCCCCCHH
Confidence            544444456778999999999999999999999999999999999999999764 344555666665443  34578999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      +.+||++||+.||.+||+     +.++++||||+...+.+
T Consensus       248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence            999999999999999994     79999999998776544

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.7e-52  Score=380.68  Aligned_cols=259  Identities=24%  Similarity=0.438  Sum_probs=215.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++++.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.++.++. ||||+++++++.  +.+.+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEE--eCCEEEE
Confidence            5799999999999999999999999999999999752  3344567889999998886 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+++ +|.+.+ ...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9999986 555555 446789999999999999999999999 9999999999999999999999999999987765545


Q ss_pred             ccccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCC------------
Q 017445          238 MCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSP------------  301 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~------------  301 (371)
                      ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.........+..+..   ....            
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            556678999999999997765 899999999999999999998887555544444444322   1110            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          302 ------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       302 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                  ......+++++.+|+++||+.||++|||++|+|+||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                        0112357899999999999999999999999999999997753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-52  Score=385.61  Aligned_cols=258  Identities=24%  Similarity=0.439  Sum_probs=225.0

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|+++....   .....+.+|..++..+. ||||+++++++.  +...
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~--~~~~   80 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQQ   80 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSSE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEE--eCCE
Confidence            45789999999999999999999999999999999975221   23455678888888775 999999999874  5668


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999999999988899999999999999999999999 99999999999999999999999999999865543


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                         ..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||...+ ......++......  .+..+++++.+|
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~--~p~~~~~~~~~l  233 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAELR--FPPFFNEDVKDL  233 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC--CCCCCCHHHHHH
Confidence               246789999999999999999999999999999999999999997643 44555666665433  345789999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          316 VDDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       316 i~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      |++||+.||++||     +++++++||||+...+.+
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence            9999999999999     899999999998776544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.6e-52  Score=392.59  Aligned_cols=259  Identities=25%  Similarity=0.407  Sum_probs=223.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|+++....      .....+.+|+.++..+. ||||+++++++  .+.
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~--~~~   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVY--ENR   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE--ECS
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEE--EeC
Confidence            3579999999999999999999999999999999975322      13467889999998887 99999999987  456


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC----ceEEeccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG----RPKITDFGIS  229 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~----~~kl~Dfg~s  229 (371)
                      ..+|+||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+||+++.++    .+||+|||++
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            7899999999999999999888889999999999999999999999 9999999999999998876    7999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQN  307 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  307 (371)
                      ...... ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ....+..+........  .+..
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          167 HEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             EECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCchhccC
Confidence            876554 23356789999999999999999999999999999999999999997643 3444555544433322  2357


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +++++.+||++||..||.+|||+.++++||||+....
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            8999999999999999999999999999999986643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-52  Score=402.01  Aligned_cols=277  Identities=26%  Similarity=0.437  Sum_probs=230.3

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..++..++|++++.||+|+||+||+|.++.+++.||+|+++....   .....+.+|+.++..+. ||||++++++|.  
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--  139 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ--  139 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--
Confidence            456677899999999999999999999999999999999964221   12234678888888875 999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +...+||||||++||+|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+|..
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            56789999999999999999975 579999999999999999999999 9999999999999999999999999999977


Q ss_pred             Cccccc-ccccccccCcccCCccccCCC----CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--CCCCC
Q 017445          232 LENSIA-MCATFVGTVTYMSPERIRNES----YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--SPSPS  304 (371)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~  304 (371)
                      ...... ...+.+||+.|+|||++.+..    ++.++|||||||++|||++|..||...+ ......+++...  ...+.
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~p~  296 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPD  296 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHCCCCT
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-hhhHHHHHHhccccccCCC
Confidence            654322 335778999999999997655    7899999999999999999999997643 344555554432  33334


Q ss_pred             CCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccccccccHHHHHHHhcChhh
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ  361 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
                      ...+++++.+||++||+.+|.+  ||++++|++||||+...+....    .+.+-+|+.
T Consensus       297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~----~~~~~~p~~  351 (410)
T 3v8s_A          297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET----LRDTVAPVV  351 (410)
T ss_dssp             TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTT----GGGSCCSCC
T ss_pred             cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHh----hcccCCCCC
Confidence            4579999999999999999999  9999999999999988766554    234445544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-52  Score=394.45  Aligned_cols=264  Identities=24%  Similarity=0.419  Sum_probs=224.9

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++++.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..+. ||||++++++|.  +.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~   87 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQ--DE   87 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eC
Confidence            345679999999999999999999999999999999986422   233467889999998886 999999999884  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||+.||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||++....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            6899999999999999999988899999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccccccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHhhCCCCCCCCCCC
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .. ....+.+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.....  .......+.....  ..+..+
T Consensus       167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~p~~~  243 (384)
T 4fr4_A          167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TYPSAW  243 (384)
T ss_dssp             TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--CCCTTS
T ss_pred             CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--CCCCcC
Confidence            43 33467789999999999963   4589999999999999999999999975432  2222333333322  234578


Q ss_pred             CHHHHHHHHHhcccCcCCCCC-HHHHhcCccccccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPT-ADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps-~~~il~hp~~~~~~~~~~  347 (371)
                      ++++.+||.+||+.||.+||+ ++++++||||..+.+.++
T Consensus       244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~  283 (384)
T 4fr4_A          244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV  283 (384)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred             CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence            999999999999999999998 999999999998776543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-52  Score=396.36  Aligned_cols=263  Identities=25%  Similarity=0.418  Sum_probs=219.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ...++|++++.||+|+||+||+|+++.+++.||||+++...   ......+..|..++.+..+||||+++++++.  +.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eCC
Confidence            34578999999999999999999999999999999996532   3344556777777655566999999999874  566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++....
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            899999999999999999988899999999999999999999999 9999999999999999999999999999986544


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ......+.+||+.|+|||++.+..++.++|||||||++|||++|..||...+ .......++.....  .+..++.++.+
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~--~~~~~~~~~~~  268 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPLQ--LKPNITNSARH  268 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHHHHHHSCCC--CCSSSCHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcccC--CCCCCCHHHHH
Confidence            4445567889999999999999999999999999999999999999997643 34555566655433  34578999999


Q ss_pred             HHHHhcccCcCCCCCH----HHHhcCcccccccccc
Q 017445          315 FVDDCLKKDAEARPTA----DQLLSHPFITKYEHAK  346 (371)
Q Consensus       315 li~~~l~~dp~~Rps~----~~il~hp~~~~~~~~~  346 (371)
                      ||++||+.||.+||++    .++++||||....+.+
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence            9999999999999986    6999999998876544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=399.08  Aligned_cols=258  Identities=27%  Similarity=0.447  Sum_probs=224.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...  .......+.+|+.++..+. ||||+++++++  .+.+..|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~--~~~~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSI--SEEGHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEE--ECSSEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEE--EECCEEE
Confidence            46899999999999999999999999999999999653  3445567889999999986 99999999987  4567899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc---cCCceEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN---LKGRPKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~---~~~~~kl~Dfg~s~~~~~  234 (371)
                      +||||++||+|.+.+...+.+++..+..++.|++.||.|||+ +||+||||||+|||++   .++.+||+|||++.....
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            999999999999999988899999999999999999999999 9999999999999998   457899999999987766


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  312 (371)
                      ........+||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+..+...  .+....+++++
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-QHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhCCCCCCccccccCCHHH
Confidence            5555566789999999999999899999999999999999999999997643 44455555555433  33446789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .+||.+||+.||++|||+.++|+||||+..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999765

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-52  Score=382.09  Aligned_cols=260  Identities=25%  Similarity=0.451  Sum_probs=219.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH--------------------------HHHHHHHHHHHH
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK--------------------------EKRNQLLTEIRT  131 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~  131 (371)
                      +..++|++.+.||+|+||+||+|.+..+++.||||++.....                          .....+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            345689999999999999999999999999999999865321                          123457889999


Q ss_pred             HHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCC
Q 017445          132 LCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA  211 (371)
Q Consensus       132 l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~  211 (371)
                      +.++. ||||+++++++.......+|+||||+++++|.+++. .+.+++..+..++.|++.||.|||+ +||+||||||+
T Consensus        90 l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~  166 (298)
T 2zv2_A           90 LKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPS  166 (298)
T ss_dssp             HHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGG
T ss_pred             HHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHH
Confidence            99886 999999999987656778999999999999988654 4679999999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEecccccccCcccccccccccccCcccCCccccCCC---CCCchhHHHHHHHHHHHhcCCCCCCCCCCc
Q 017445          212 NLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES---YSYPADIWSIGLALFECGTGEFPYAASEGP  288 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~ell~g~~pf~~~~~~  288 (371)
                      ||+++.++.+||+|||++..............||+.|+|||++.+..   ++.++||||||+++|+|++|..||.... .
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-I  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-H
T ss_pred             HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-H
Confidence            99999999999999999987665544445678999999999997665   3778999999999999999999997643 3


Q ss_pred             HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      ......+.......+....+++++.+|+.+||+.||++|||+.++++||||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            34444555555555555679999999999999999999999999999999964

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-52  Score=402.91  Aligned_cols=268  Identities=24%  Similarity=0.422  Sum_probs=225.0

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH---HHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE---KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..++..++|++++.||+|+||+||+|.++.+++.||+|+++.....   ....+.+|..++..+. ||||++++++|  .
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~--~  144 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAF--Q  144 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEE--E
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE--e
Confidence            3456678999999999999999999999999999999999752221   1223778888888875 99999999987  4


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +.+.+||||||++||+|.+++.. .+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|.
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            56789999999999999999986 4789999999999999999999999 999999999999999999999999999997


Q ss_pred             cCccccc-ccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC---CC
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP---SP  301 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~  301 (371)
                      ....... .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+ ......+++...   ..
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~  302 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKERFQF  302 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHCCC
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhhccccccC
Confidence            6654322 234568999999999996     5668999999999999999999999997644 344444444321   11


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccccccc
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEA--RPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~il~hp~~~~~~~~~~  347 (371)
                      ......+++++.+||++||+.+|++  |++++++++||||+.+.+..+
T Consensus       303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            2223568999999999999999988  999999999999999887764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.5e-52  Score=385.03  Aligned_cols=263  Identities=24%  Similarity=0.390  Sum_probs=216.0

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      ..+..++|++.+.||+|+||+||+|.+.   .+++.||+|+++...    ......+.+|+.++..+. ||||+++++++
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   90 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAF   90 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEE
Confidence            3455679999999999999999999975   689999999997532    233455778999999887 99999999987


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      .  +.+.+|+||||++|++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus        91 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           91 Q--TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             E--CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             E--cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            4  466899999999999999999888889999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      +.............+||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+......  .+..+
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~--~p~~~  244 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKILKCKLN--LPPYL  244 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTCCC--CCTTS
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCC--CCCCC
Confidence            9765544444456789999999999999999999999999999999999999997644 34445555555433  33578


Q ss_pred             CHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHA  345 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~  345 (371)
                      ++++.+|+.+||..||.+||     ++.++++||||+.+.+.
T Consensus       245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            99999999999999999999     89999999999877544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.6e-52  Score=386.52  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=222.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++++.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++..+. ||||+++++++  .+.+..|+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~--~~~~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHR--REGNIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEE--ECSSEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEE--ecCCeEEE
Confidence            4689999999999999999999999999999999865332 33456788999998886 99999999977  45678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc--c
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--I  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~--~  236 (371)
                      ||||+++|+|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......  .
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999999999877889999999999999999999999 99999999999999999999999999999765422  2


Q ss_pred             cccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........................+++++.+|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            22346689999999999987765 77899999999999999999999876654444555555544444456789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +.+||+.||++|||+.|+++||||.+..
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999998654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-51  Score=376.97  Aligned_cols=278  Identities=34%  Similarity=0.625  Sum_probs=227.0

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +++..++|++.+.||+|+||+||+|.+..+|+.||+|++... ..........|...+.+...||||+++++++.  +.+
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~   79 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF--REG   79 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSS
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccC
Confidence            346678999999999999999999999999999999999753 33344455566666556666999999999875  456


Q ss_pred             eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEccCCceEEeccccc
Q 017445          155 QISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      ..++||||+++ +|.+++..    ...+++..++.++.|++.||.|||+ + ||+||||||+||+++.++.+||+|||.+
T Consensus        80 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           80 DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            89999999975 88877653    5679999999999999999999999 8 9999999999999999999999999999


Q ss_pred             ccCcccccccccccccCcccCCccc----cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERI----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ....... ......||+.|+|||++    .+..++.++||||+|+++|+|++|..||.........+........+....
T Consensus       158 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (290)
T 3fme_A          158 GYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA  236 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred             ccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence            7765542 22445799999999996    556788999999999999999999999987666667777777777666666


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcC
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD  358 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~  358 (371)
                      ..+++++.+|+.+||+.||++|||+.++++||||+.......+..++++..++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~l~  289 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLILG  289 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHHC
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccccCHHHHHHHhhc
Confidence            78999999999999999999999999999999999998888888998887764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-51  Score=386.98  Aligned_cols=259  Identities=23%  Similarity=0.401  Sum_probs=226.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.++..+. ||||+++++++.  +..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~  114 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNS  114 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--cCC
Confidence            34579999999999999999999999999999999996532   123456788999998885 999999999874  566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||++.....
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            899999999999999999988899999999999999999999999 9999999999999999999999999999987654


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      .   ..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||... .......++......  .+..+++++.+
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~~~~~~~  267 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSGKVR--FPSHFSSDLKD  267 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC--CCTTCCHHHHH
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-CHHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence            3   24568999999999999999999999999999999999999999764 344555566655433  34578999999


Q ss_pred             HHHHhcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          315 FVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       315 li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      ||++||+.||.+||+     +++|++||||....+..
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~  304 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence            999999999999998     99999999998766543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-51  Score=389.55  Aligned_cols=261  Identities=26%  Similarity=0.407  Sum_probs=212.2

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ...++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+..+..+. ||||+++++++.  +.+.+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLR-HPNIVRFKEVIL--TPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCC-CCCCCcEEEEEe--eCCEEE
Confidence            34578999999999999999999999999999999997532 22355778999998887 999999999885  456899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc--eEEecccccccCccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR--PKITDFGISAGLENS  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~--~kl~Dfg~s~~~~~~  235 (371)
                      +||||+++|+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.  +||+|||++......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999999888899999999999999999999999 99999999999999987765  999999998754332


Q ss_pred             ccccccccccCcccCCccccCCCCCCc-hhHHHHHHHHHHHhcCCCCCCCCCCc---HHHHHHHhhCCCCCCCCCCCCHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYP-ADIWSIGLALFECGTGEFPYAASEGP---VNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                       ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......   ...+..+.......+....++++
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence             22345679999999999988877655 89999999999999999999764432   23344455555555555678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +.+||++||+.||.+|||+.++++||||.+...
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            999999999999999999999999999976543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-51  Score=390.79  Aligned_cols=261  Identities=25%  Similarity=0.431  Sum_probs=210.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++++.||+|+||+||+|.+..+|+.||||++..  ..........+|+.++..+..||||+++++++...+...+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            4689999999999999999999999999999999854  34556677889999999998899999999998766666899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc--
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--  235 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~--  235 (371)
                      +||||++ ++|.+++.. +.+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9999997 599999875 579999999999999999999999 99999999999999999999999999999765321  


Q ss_pred             -------------------ccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH
Q 017445          236 -------------------IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI  295 (371)
Q Consensus       236 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~  295 (371)
                                         .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+. ...+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i  243 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-MNQLERI  243 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence                               112245689999999999976 6789999999999999999999999987543 3333332


Q ss_pred             hh---CCCC------------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017445          296 LE---DPSP------------------------------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTA  330 (371)
Q Consensus       296 ~~---~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~  330 (371)
                      +.   .+..                                          ......+++++.+|+++||+.||++|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            21   1100                                          00123678999999999999999999999


Q ss_pred             HHHhcCcccccccc
Q 017445          331 DQLLSHPFITKYEH  344 (371)
Q Consensus       331 ~~il~hp~~~~~~~  344 (371)
                      .++|+||||+.+..
T Consensus       324 ~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          324 NDALKHPFVSIFHN  337 (388)
T ss_dssp             HHHTTSTTTTTTCC
T ss_pred             HHHhCCHHHHHhcC
Confidence            99999999987754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=383.93  Aligned_cols=264  Identities=28%  Similarity=0.405  Sum_probs=213.5

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...  ...+.+.+|+.++.++. ||||+++++++.  +....++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLS-HPNIIKLKEIFE--TPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCC-CCCCcceeeeEe--cCCeEEE
Confidence            456899999999999999999999999999999999753  23456778999999987 999999999884  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEecccccccCccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISAGLENS  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~~~~~~  235 (371)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||++......
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999999999888889999999999999999999999 99999999999999975   789999999999866543


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEFC  313 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  313 (371)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||............+.......  +....++.++.
T Consensus       205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  283 (349)
T 2w4o_A          205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK  283 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence             223456799999999999999999999999999999999999999987665554555555544332  33467899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccccccccH
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDL  349 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~  349 (371)
                      +||++||+.||++|||+.++|+||||.....+...+
T Consensus       284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  319 (349)
T 2w4o_A          284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHM  319 (349)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCccchhhh
Confidence            999999999999999999999999999887665544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.8e-52  Score=403.03  Aligned_cols=265  Identities=26%  Similarity=0.409  Sum_probs=218.2

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .++..++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+|+.++..+. ||||+++++++.  +
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~--~  219 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ--T  219 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEE--E
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEe--e
Confidence            445668999999999999999999999999999999999742   2334456678888887776 999999999885  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      .+.+||||||+++|+|.+++...+.+++..+..++.|++.||.|||+.+||+||||||+|||++.++.+||+|||++...
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            56899999999999999999888899999999999999999999996368999999999999999999999999999875


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ........+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+......  .+..+++++
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~~~~~  376 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILMEEIR--FPRTLGPEA  376 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCC--CCccCCHHH
Confidence            554445567889999999999999999999999999999999999999997644 34444555554433  345689999


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          313 CSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      .+||.+||+.||.+||     ++.++++||||....++.
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~  415 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH  415 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence            9999999999999999     999999999999876554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-51  Score=417.96  Aligned_cols=267  Identities=22%  Similarity=0.362  Sum_probs=231.1

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ...+..++|++++.||+|+||+||+|.++.+++.||||+++..   ..........|..++..+.+||+|+++++++  .
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~  412 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--Q  412 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--B
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--E
Confidence            3455678999999999999999999999999999999999742   2233456788999998888899999999977  5


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +...+||||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+.
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            567899999999999999999988899999999999999999999999 9999999999999999999999999999986


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      .........+.+||+.|+|||++.+..++.++||||||+++|||++|..||...+ .......++......  +..++++
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~--p~~~s~~  568 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVAY--PKSMSKE  568 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHSSCCCC--CTTSCHH
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCCC--CccCCHH
Confidence            5444445567889999999999999999999999999999999999999997643 455566666654433  4579999


Q ss_pred             HHHHHHHhcccCcCCCCCH-----HHHhcCccccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTA-----DQLLSHPFITKYEHAKV  347 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~-----~~il~hp~~~~~~~~~~  347 (371)
                      +.+||++||+.||++||++     ++|++||||..+.+.++
T Consensus       569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  609 (674)
T ss_dssp             HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred             HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence            9999999999999999997     99999999998776554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-52  Score=396.70  Aligned_cols=267  Identities=25%  Similarity=0.389  Sum_probs=222.3

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..++..++|++++.||+|+||+||+|+++.+|+.||||+++....   .....+.+|..++..+. ||||++++++|.  
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~--  131 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQ--  131 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEE--
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEe--
Confidence            345667899999999999999999999999999999999975221   22334678888888875 999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +.+.+||||||++||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||++.
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            566899999999999999999765 479999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc-ccccccccCcccCCcccc-------CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC---
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIR-------NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP---  299 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---  299 (371)
                      ....... .....+||+.|+|||++.       +..++.++|||||||++|||++|+.||...+ ......+++...   
T Consensus       211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~  289 (412)
T 2vd5_A          211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKIVHYKEHL  289 (412)
T ss_dssp             ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHC
T ss_pred             eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccCc
Confidence            7654332 234568999999999997       4568999999999999999999999997644 334444444321   


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCccccccccccc
Q 017445          300 SPSPSRQNFSPEFCSFVDDCLKKDAEAR---PTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~il~hp~~~~~~~~~~  347 (371)
                      ........+++++.+||++||+ +|.+|   |+++++++||||+.+.+.++
T Consensus       290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            1112235789999999999999 99998   59999999999999887765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-51  Score=379.67  Aligned_cols=258  Identities=30%  Similarity=0.581  Sum_probs=223.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      .|...+.||+|+||+||+|.+..+|+.||||++..........+.+|+.++.++. ||||+++++++..  .+..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLV--GEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEE--CCEEEEEEe
Confidence            4677789999999999999999999999999997655555677889999998886 9999999998854  558999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccccc
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      |+++++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++............
T Consensus       123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            999999999986 4579999999999999999999999 99999999999999999999999999999876655444456


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCCHHHHHHHHHhc
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPEFCSFVDDCL  320 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l  320 (371)
                      ..||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.....+ ......+++++.+|+.+||
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  279 (321)
T 2c30_A          201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML  279 (321)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred             ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence            789999999999999999999999999999999999999997643 34444444444332 2233568899999999999


Q ss_pred             ccCcCCCCCHHHHhcCccccccccc
Q 017445          321 KKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       321 ~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +.||++|||+.++++||||.+...+
T Consensus       280 ~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          280 VRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             CSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             cCChhhCcCHHHHhcChhhccCCCc
Confidence            9999999999999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.1e-52  Score=388.09  Aligned_cols=257  Identities=27%  Similarity=0.421  Sum_probs=220.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.++.+|+.||||+++....    ...+|+.++.++..||||+++++++  .+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~--~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY--DDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE--ECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE--EcCCEEEEE
Confidence            4689999999999999999999999999999999975322    2346777888887799999999987  456789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC----CceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK----GRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~----~~~kl~Dfg~s~~~~~~  235 (371)
                      |||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||+..+    +.+||+|||++......
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            9999999999999888889999999999999999999999 999999999999998543    35999999999877655


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC--CcHHHHHHHhhCCCCC--CCCCCCCHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE--GPVNLMLQILEDPSPS--PSRQNFSPE  311 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~  311 (371)
                      .....+.+||+.|+|||++.+..++.++|||||||++|+|++|..||....  ........+..+....  ..+..++++
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence            445567789999999999988889999999999999999999999997632  3334444554444332  234678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +.+||++||..||++|||+.++++||||..+.
T Consensus       254 ~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            99999999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.8e-51  Score=384.84  Aligned_cols=257  Identities=30%  Similarity=0.456  Sum_probs=222.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...  .......+.+|+.++..+. ||||+++++++.  +.+..|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCEEE
Confidence            35899999999999999999999999999999999652  3455667889999999986 999999999874  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~  234 (371)
                      +||||++||+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++.+   +.+||+|||++.....
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999999999999888889999999999999999999999 999999999999999865   4599999999987664


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  312 (371)
                      .. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+..+....  .....+++++
T Consensus       184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             CC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             Cc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            42 3345789999999999999899999999999999999999999997643 344455555554332  2335689999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .+||.+||+.||++||++.++|+||||...
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8e-51  Score=376.12  Aligned_cols=262  Identities=25%  Similarity=0.423  Sum_probs=214.0

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +...++|++++.||+|+||+||+|.+. +++.||+|++....  ......+.+|+.++.++. ||||+++++++  .+..
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--~~~~   92 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVI--HSER   92 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE--CCSS
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEE--ccCC
Confidence            445679999999999999999999974 58999999996532  233467889999999996 99999999987  4566


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      .+++||||+++ +|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            89999999985 888887654 459999999999999999999999 999999999999999999999999999998766


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH--HHHHHhhCCCCCC-------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LMLQILEDPSPSP-------  303 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~-------  303 (371)
                      ..........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........  .+...+....+..       
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            54444456679999999999976 5689999999999999999999999976543322  2222222222110       


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          304 ------------------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       304 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                        ....+++++.+||++||+.||++|||+.++|+||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                              01346789999999999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-51  Score=381.21  Aligned_cols=257  Identities=21%  Similarity=0.360  Sum_probs=222.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+... ......+.+|+.++..+. ||||+++++++.  +...+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR-HRNILHLHESFE--SMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSC-CTTBCCEEEEEE--ETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCC-CCCCCeEeEEEe--cCCEEEEE
Confidence            46899999999999999999999999999999999753 344566889999999886 999999999885  45689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc--CCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL--KGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~--~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||++||+|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.  ++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999999999999755 369999999999999999999999 99999999999999987  7899999999998765442


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCCCCHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  314 (371)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+........  ....+++++.+
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence             2345679999999999998889999999999999999999999997644 3445555555544332  23578999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      |+.+||..||.+|||+.++|+||||++..
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            99999999999999999999999998654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.3e-51  Score=387.46  Aligned_cols=271  Identities=23%  Similarity=0.438  Sum_probs=219.5

Q ss_pred             ccceecCcceeEeeeeccc--CCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           74 KTYRCASHEMRIFGAIGSG--ASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ..+.....+|++++.||+|  +||+||+|.+..+++.||||++...  .......+.+|+.++..+. ||||+++++++.
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~   96 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFI   96 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEE
Confidence            3445566799999999999  9999999999999999999999753  3455667888999999887 999999999885


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                        +.+.+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus        97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B           97 --ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             --ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             --ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccc
Confidence              456899999999999999999765  679999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCcccc-------cccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC
Q 017445          228 ISAGLENSI-------AMCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED  298 (371)
Q Consensus       228 ~s~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  298 (371)
                      .+.......       ......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||......... ...+..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~  252 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNG  252 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC---
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcC
Confidence            886543221       11233478999999999987  57999999999999999999999999765433222 221111


Q ss_pred             CC--------------------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          299 PS--------------------------------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       299 ~~--------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      ..                                            .......+++++.+||++||+.||++|||+.++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            10                                            1122356789999999999999999999999999


Q ss_pred             cCccccccccccccH
Q 017445          335 SHPFITKYEHAKVDL  349 (371)
Q Consensus       335 ~hp~~~~~~~~~~~~  349 (371)
                      +||||+++.....+.
T Consensus       333 ~hp~f~~~~~~~~~~  347 (389)
T 3gni_B          333 NHSFFKQIKRRASEA  347 (389)
T ss_dssp             TSGGGGGC---CCSS
T ss_pred             cCHHHHHHhhcchhh
Confidence            999999887655443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-51  Score=379.57  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=222.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.....      .....+.+|+.++..+. ||||+++++++.  +.
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--NK   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eC
Confidence            3579999999999999999999999999999999865321      13567889999999987 999999999874  46


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC----ceEEeccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG----RPKITDFGIS  229 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~----~~kl~Dfg~s  229 (371)
                      ...++||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++    .+||+|||++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            6899999999999999999888889999999999999999999999 9999999999999999887    7999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQN  307 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~  307 (371)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.......  .....
T Consensus       166 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          166 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             EECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHhcCCCcCcccccc
Confidence            8765432 2345679999999999999999999999999999999999999997644 333344443333222  22357


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ++..+.+|+++||+.||++|||+.++|+||||+....
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            8899999999999999999999999999999987653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-51  Score=387.92  Aligned_cols=258  Identities=25%  Similarity=0.421  Sum_probs=219.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-----EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.....     .....+.+|+.++..+. ||||+++++++.  +.+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS--SDG   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETT
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE--eCC
Confidence            4589999999999999999999999999999999864221     13567889999999886 999999999875  456


Q ss_pred             eEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc---eEEeccc
Q 017445          155 QISIALEYMDGGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR---PKITDFG  227 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~---~kl~Dfg  227 (371)
                      .+|+||||++|++|.+++...    ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.   +||+|||
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            899999999999999887532    358999999999999999999999 99999999999999987654   9999999


Q ss_pred             ccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CC
Q 017445          228 ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SR  305 (371)
Q Consensus       228 ~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  305 (371)
                      ++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...  .......+........  ..
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHHH
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCcccc
Confidence            9987766544455678999999999999989999999999999999999999999764  2344455555443322  22


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ..+++++.+||++||+.||++|||+.++|+||||+...
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            57899999999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-51  Score=386.56  Aligned_cols=275  Identities=38%  Similarity=0.690  Sum_probs=235.0

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      .+..++|++++.||+|+||+||+|.+..+++.||+|++... .......+.+|+.++..+. ||||+++++++..  .+.
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS--DGE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE--TTE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEE--CCE
Confidence            45567999999999999999999999999999999999763 4455677889999998886 9999999998854  568


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+ + ||+||||||+||+++.++.+||+|||++.....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999999988899999999999999999999998 6 899999999999999999999999999865543


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH-------------------------
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV-------------------------  289 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~-------------------------  289 (371)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......                         
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            2  2345679999999999999999999999999999999999999997643211                         


Q ss_pred             ----------------HHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHH
Q 017445          290 ----------------NLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFV  353 (371)
Q Consensus       290 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~  353 (371)
                                      .....+.....+......++.++.+||++||+.||++|||+.++|+||||+......++...|+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~  342 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL  342 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhhHHHHH
Confidence                            1122223333344444568999999999999999999999999999999999999999999988


Q ss_pred             HHhc
Q 017445          354 RSVF  357 (371)
Q Consensus       354 ~~~~  357 (371)
                      .+.+
T Consensus       343 ~~~~  346 (360)
T 3eqc_A          343 CSTI  346 (360)
T ss_dssp             HHHH
T ss_pred             hhhh
Confidence            7654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6e-51  Score=377.93  Aligned_cols=262  Identities=25%  Similarity=0.468  Sum_probs=203.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++++.||+|+||+||+|.+..+|+.||+|+++... ......+.+|+.++.++. ||||+++++++  .+.+.+|+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVI--HTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEE--CCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEE--EECCeEEE
Confidence            468999999999999999999999999999999997533 223456788999998886 99999999987  45678999


Q ss_pred             EEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          159 ALEYMDGGSLADILRMQ------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ||||++ ++|.+++...      ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            999998 5999998653      358999999999999999999999 99999999999999999999999999999876


Q ss_pred             cccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCC------
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPS------  302 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~------  302 (371)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+..+..   .....      
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhhh
Confidence            554444456689999999999976 4689999999999999999999999976543 222222221   11000      


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          303 -----------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       303 -----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                                             .....++.++.+||.+||+.||++|||+.++|+||||+++.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence                                   011357889999999999999999999999999999999877653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.2e-51  Score=379.71  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=198.5

Q ss_pred             ceeEe---eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRIF---GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~~---~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      +|.+.   +.||+|+||+||+|.+..+++.||||++...   ......+|+..+..+..||||+++++++.  +....|+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~~l   83 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH--DQLHTFL   83 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEEEE
Confidence            45553   6899999999999999999999999999642   34556789999999888999999999874  5678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---ceEEecccccccCccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---RPKITDFGISAGLENS  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~~kl~Dfg~s~~~~~~  235 (371)
                      ||||+++|+|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++   .+||+|||++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999999999988899999999999999999999999 9999999999999998765   8999999999876655


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC------cHHHHHHHhhCCCCCCC--CCC
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG------PVNLMLQILEDPSPSPS--RQN  307 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~--~~~  307 (371)
                      .....+.+||+.|+|||++.+..++.++||||||+++|+|++|..||.....      .......+..+......  ...
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN  242 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence            5555677899999999999999999999999999999999999999976432      12334444444332221  246


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +++++.+||++||+.||.+|||+.++++||||+....
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            8999999999999999999999999999999987644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.9e-51  Score=394.32  Aligned_cols=303  Identities=27%  Similarity=0.390  Sum_probs=228.8

Q ss_pred             CCCCCCCCceeccCCceeEeeccccccccccccccccccCCccCCCCCccccceecCcceeEeeeecccCCeEEEEEEEc
Q 017445           24 GSTLDPSDSYMLSDGGTVNLLSRSYGVYNFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHI  103 (371)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~  103 (371)
                      +..+.+.....+.+++.+.+......++.|.+......           ...-....++|.+.+.||+|+||+||+|.+.
T Consensus        89 ~~~~~~~~~~~l~~~d~i~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~  157 (419)
T 3i6u_A           89 TELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQ-----------SVYPKALRDEYIMSKTLGSGACGEVKLAFER  157 (419)
T ss_dssp             TEECCTTCEEECCTTEEEEESSTTCEEEEEEESCSSCG-----------GGSCHHHHTTEEEEEEEEECSSSEEEEEEET
T ss_pred             cccccCCCcccCCCCCEeeeeccccceEEEeccccccc-----------cccchhhhccEEEEeEEeeCCCeEEEEEEEC
Confidence            33455555666677776666544444444433211100           0011223578999999999999999999999


Q ss_pred             CCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhc
Q 017445          104 PTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ  175 (371)
Q Consensus       104 ~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~  175 (371)
                      .+++.||||++....        ......+.+|+.++.++. ||||+++++++.   ....|+||||+++|+|.+++...
T Consensus       158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~  233 (419)
T 3i6u_A          158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGN  233 (419)
T ss_dssp             TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE---SSEEEEEEECCTTCBGGGGTSSS
T ss_pred             CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cCceEEEEEcCCCCcHHHHHhcc
Confidence            999999999986421        112234788999999996 999999999863   34689999999999999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---ceEEecccccccCcccccccccccccCcccCCc
Q 017445          176 KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---RPKITDFGISAGLENSIAMCATFVGTVTYMSPE  252 (371)
Q Consensus       176 ~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE  252 (371)
                      +.+++..++.++.|++.||.|||+ +||+||||||+|||++.++   .+||+|||++...... ....+.+||+.|+|||
T Consensus       234 ~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE  311 (419)
T 3i6u_A          234 KRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE  311 (419)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCce
Confidence            889999999999999999999999 9999999999999997544   5999999999876654 3335678999999999


Q ss_pred             cccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCCCCHHHHHHHHHhcccCcCCC
Q 017445          253 RIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQNFSPEFCSFVDDCLKKDAEAR  327 (371)
Q Consensus       253 ~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R  327 (371)
                      ++.+   ..++.++|||||||++|+|++|..||............+........  ....+++++.+|+++||+.||++|
T Consensus       312 ~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  391 (419)
T 3i6u_A          312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR  391 (419)
T ss_dssp             TTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred             eeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHC
Confidence            9853   56788999999999999999999999865544444444444433222  225689999999999999999999


Q ss_pred             CCHHHHhcCccccccc
Q 017445          328 PTADQLLSHPFITKYE  343 (371)
Q Consensus       328 ps~~~il~hp~~~~~~  343 (371)
                      ||+.++|+||||+...
T Consensus       392 ps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          392 FTTEEALRHPWLQDED  407 (419)
T ss_dssp             CCHHHHHHSGGGCCHH
T ss_pred             cCHHHHhCCcccCChh
Confidence            9999999999997543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.3e-50  Score=366.07  Aligned_cols=259  Identities=23%  Similarity=0.447  Sum_probs=223.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DS  153 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~  153 (371)
                      .....|++.+.||+|+||+||+|.+..++..||+|++..  ........+.+|+.++.++. ||||+++++++...  +.
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCC
Confidence            344568999999999999999999999999999999864  34556677889999998886 99999999987542  34


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEc-cCCceEEecccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVN-LKGRPKITDFGISA  230 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~-~~~~~kl~Dfg~s~  230 (371)
                      ..+++||||+++++|.+++...+.+++..++.++.|++.||.|||+ +|  |+||||||+||+++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            5689999999999999999888889999999999999999999999 88  99999999999998 78999999999997


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .....  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..................+.......++
T Consensus       181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence            55443  2245679999999998875 58999999999999999999999998766655555555555555555667889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      ++.+|+.+||+.||.+|||+.++++||||+.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            9999999999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=374.21  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=211.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++...  .......+.+|+.++.++. ||||+++++++.  +.+..++
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   79 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFR--RKRRLHL   79 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheee--cCCeEEE
Confidence            5899999999999999999999999999999998653  3344567889999999997 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.........
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999999999888889999999999999999999999 99999999999999999999999999999877655444


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH---hhC----------------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LED----------------  298 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~~----------------  298 (371)
                      .....||+.|+|||++.+ ..++.++||||+|+++|+|++|..||....... ....+   ...                
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhcccccccccccccccccc
Confidence            456789999999999976 668999999999999999999999997654322 22111   111                


Q ss_pred             --CCCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          299 --PSPSP--------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       299 --~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                        ..+..        ....+++++.+|+++||+.||++|||+.++++||||+...+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence              00000        0146788999999999999999999999999999999886543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=372.64  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=212.5

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .+..++|++.+.||+|+||+||+|.+..+++.||||++..  ...........|+..+.+...||||+++++++.  +.+
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~  130 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGG  130 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETT
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCC
Confidence            3445789999999999999999999999999999999864  334555667778888877767999999999874  467


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      .+|+||||+ +++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            899999999 56999888654 469999999999999999999999 999999999999999999999999999987665


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      ... ......||+.|+|||++.+ .++.++||||||+++|+|++|..|+...    .....+.....+......+++++.
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~  282 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELR  282 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHH
T ss_pred             cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHH
Confidence            432 3345679999999999986 6899999999999999999997666442    223344444333334467899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      +|+.+||+.||++|||+.++|+||||++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.7e-51  Score=382.01  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=215.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++.....   .....+.+|+.++..+. ||||+++++++.  +.+.+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--~~~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVIT--TPTDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCEE
Confidence            4689999999999999999999999999999999864221   12346788999998886 999999999874  45689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ++||||+ +|+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...... 
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            9999999 67999999888899999999999999999999999 99999999999999999999999999999876554 


Q ss_pred             cccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ....+.+||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ....+ . ......+..+++++.+|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i-~-~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-LFKKV-N-SCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-CBCCC-C-SSCCCCCTTSCHHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-HHHHH-H-cCCCCCcccCCHHHHHH
Confidence            23356789999999999988776 689999999999999999999997643211 11111 1 11223345689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      +++||+.||.+|||+.++++||||+..
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=377.90  Aligned_cols=263  Identities=26%  Similarity=0.420  Sum_probs=220.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCC-CCeeEeceeEEecC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGAFYMPD  152 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~~~~~~  152 (371)
                      ..+...+|++++.||+|+||+||+|.+ .+++.||||++..  ........+.+|+.++.++.+| |||+++++++.  +
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~   80 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--T   80 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--C
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--e
Confidence            456678899999999999999999986 5688999999865  3445567788999999888743 99999999874  5


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...+|||||+ .+++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||++...
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            6689999995 578999999988899999999999999999999999 9999999999999997 788999999999876


Q ss_pred             ccccc--ccccccccCcccCCccccC-----------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC
Q 017445          233 ENSIA--MCATFVGTVTYMSPERIRN-----------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP  299 (371)
Q Consensus       233 ~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  299 (371)
                      .....  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.........+...+...
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  237 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  237 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence            54322  2345679999999999864           6688999999999999999999999987666666666666666


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .....+...+.++.+|+.+||+.||.+|||+.++|+||||+....
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            666666778899999999999999999999999999999986544

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-50  Score=382.69  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=222.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++++.||+|+||+||+|.+..+++.||+|++..........+.+|+.++..+. ||||+++++++.  +...+++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC-CcCCCeEEEEEE--eCCEEEEE
Confidence            368999999999999999999999999999999998765566677889999998886 999999999874  56789999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc--CCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL--KGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~--~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||++||+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.  ++.+||+|||++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999999998754 369999999999999999999999 99999999999999974  4789999999998765442


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--CCCCCCCCCHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  314 (371)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+.....  +......+++++.+
T Consensus       206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWEFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence             2345579999999999999999999999999999999999999997643 3444444444432  23334578999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ||.+||+.||.+|||+.++|+||||+...
T Consensus       284 li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999999999999999999999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-50  Score=393.57  Aligned_cols=264  Identities=27%  Similarity=0.379  Sum_probs=202.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC---CC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD---SG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~---~~  154 (371)
                      .++|++++.||+|+||+||+|.+..+++.||||++..  ........+.+|+.++..+. ||||+++++++...+   ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcccCc
Confidence            3689999999999999999999999999999999864  34456678899999999996 999999999885432   35


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||+. ++|.+++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            7999999985 6999999888889999999999999999999999 9999999999999999999999999999987642


Q ss_pred             cc---------------------------cccccccccCcccCCccc-cCCCCCCchhHHHHHHHHHHHhc---------
Q 017445          235 SI---------------------------AMCATFVGTVTYMSPERI-RNESYSYPADIWSIGLALFECGT---------  277 (371)
Q Consensus       235 ~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~ell~---------  277 (371)
                      ..                           ......+||+.|+|||++ .+..++.++|||||||++|||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            21                           123456789999999986 56679999999999999999999         


Q ss_pred             --CCCCCCCCCCc-------------------HH---HHHHHhhCCC-------------------C-------CCCCCC
Q 017445          278 --GEFPYAASEGP-------------------VN---LMLQILEDPS-------------------P-------SPSRQN  307 (371)
Q Consensus       278 --g~~pf~~~~~~-------------------~~---~~~~~~~~~~-------------------~-------~~~~~~  307 (371)
                        |+++|.+....                   .+   .+..++..+.                   +       ......
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              66777553210                   01   1111111111                   0       011245


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +++++.+||++||+.||++|||++|+|+||||+.+....
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            689999999999999999999999999999999886544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-50  Score=375.62  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             cceeEe-eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIF-GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +.|++. +.||+|+||+||+|.+..+++.||||++..........+.+|+.++.++.+||||+++++++.  +.+.+|+|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE--EEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe--eCCEEEEE
Confidence            567775 689999999999999999999999999976555556778899999999777999999999885  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc---eEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR---PKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~---~kl~Dfg~s~~~~~~~  236 (371)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.   +||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9999999999999888889999999999999999999999 99999999999999998765   9999999987653221


Q ss_pred             -------cccccccccCcccCCccccC-----CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--------------HH
Q 017445          237 -------AMCATFVGTVTYMSPERIRN-----ESYSYPADIWSIGLALFECGTGEFPYAASEGP--------------VN  290 (371)
Q Consensus       237 -------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--------------~~  290 (371)
                             ......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||......              ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                   11234569999999999965     55889999999999999999999999764321              12


Q ss_pred             HHHHHhhCCCCCCC--CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          291 LMLQILEDPSPSPS--RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       291 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ....+.......+.  ...+++++.+|+++||+.||++|||+.++++||||+....
T Consensus       249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            23333333332221  2468899999999999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-49  Score=363.12  Aligned_cols=260  Identities=30%  Similarity=0.485  Sum_probs=224.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..  ........+.+|+.++.++. ||||+++++++  .+....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~~~~~~   81 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSI--QEESFHY   81 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE--ECSSEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEE--EcCCEEE
Confidence            4689999999999999999999999999999999865  23455677889999999996 99999999987  4566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc---eEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR---PKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~---~kl~Dfg~s~~~~~  234 (371)
                      +||||+++++|.+.+.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.   +||+|||.+.....
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999999888889999999999999999999999 99999999999999987655   99999999976654


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--CCCCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--PSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  312 (371)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.....  +......+++++
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             SC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             Cc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-hhHHHHHHHhccccCCchhhcccCHHH
Confidence            42 2345679999999999999999999999999999999999999997644 3344444444433  333345789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      .+|+.+||+.||++|||+.++++||||+.....
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            999999999999999999999999999876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-50  Score=369.82  Aligned_cols=255  Identities=25%  Similarity=0.423  Sum_probs=207.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++....  ......+.+|+.++.++. ||||+++++++.  +.+..++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEc--cCCeEEE
Confidence            5799999999999999999997 678999999996532  223466788999998886 999999999874  4568999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+++ +|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            9999986 999998754 679999999999999999999999 9999999999999999999999999999976654433


Q ss_pred             ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCC-----------
Q 017445          238 MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPS-----------  302 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~-----------  302 (371)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+..+..   .....           
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhccccc
Confidence            3455678999999999976 4589999999999999999999999976543 222222221   11000           


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          303 -------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       303 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                                   .....+++++.+|+++||+.||++|||+.++++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         0124578999999999999999999999999999999853

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-49  Score=384.32  Aligned_cols=266  Identities=26%  Similarity=0.388  Sum_probs=213.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---G  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---~  154 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..  ........+.+|+.++..+. ||||+++++++...+.   .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCcCC
Confidence            4689999999999999999999999999999999965  34456678899999999997 9999999998854322   5


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            7999999996 5999999888889999999999999999999999 9999999999999999999999999999987644


Q ss_pred             ccc----------------------ccccccccCcccCCccc-cCCCCCCchhHHHHHHHHHHHhcCCCC----------
Q 017445          235 SIA----------------------MCATFVGTVTYMSPERI-RNESYSYPADIWSIGLALFECGTGEFP----------  281 (371)
Q Consensus       235 ~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~ell~g~~p----------  281 (371)
                      ...                      ...+.+||+.|+|||++ .+..++.++||||+||++|||++|..|          
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            321                      23567899999999986 566799999999999999999985444          


Q ss_pred             -CCCCCC----------------cHHH---HHHHhhCCC--------------------C-CC-----CCCCCCHHHHHH
Q 017445          282 -YAASEG----------------PVNL---MLQILEDPS--------------------P-SP-----SRQNFSPEFCSF  315 (371)
Q Consensus       282 -f~~~~~----------------~~~~---~~~~~~~~~--------------------~-~~-----~~~~~~~~~~~l  315 (371)
                       |.+...                ..+.   +...+..+.                    . ..     ....+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence             333210                0111   111111111                    0 00     014589999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEHAKVD  348 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~  348 (371)
                      |++||+.||++|||++++|+||||+.+..++.+
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e  374 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRKKKLE  374 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence            999999999999999999999999998766543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-50  Score=377.45  Aligned_cols=260  Identities=22%  Similarity=0.388  Sum_probs=206.8

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..++|++++.||+|+||+||+|.+..+++.||||+++...  ......+.+|+.++.++. ||||+++++++.  +...+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIH--HNHRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEE--ETTEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEe--cCCEE
Confidence            3468999999999999999999999999999999997533  233456778999999886 999999999875  45689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc-----cCCceEEeccccccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-----LKGRPKITDFGISAG  231 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~-----~~~~~kl~Dfg~s~~  231 (371)
                      ||||||+++ +|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++     .++.+||+|||++..
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            999999985 999999988899999999999999999999999 9999999999999994     445699999999987


Q ss_pred             CcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC---CCCCCC---
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED---PSPSPS---  304 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~~~---  304 (371)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+.++...   +.....   
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HHHHHHHHHHhCCCchhhhhhh
Confidence            65544444566789999999999774 489999999999999999999999976543 3333333221   111000   


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          305 ----------------------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       305 ----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                            ...+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                  0116789999999999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-50  Score=383.99  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=208.6

Q ss_pred             CcceeEe-eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe--cCCCeE
Q 017445           80 SHEMRIF-GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM--PDSGQI  156 (371)
Q Consensus        80 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~--~~~~~~  156 (371)
                      .++|.+. +.||+|+||+||+|.+..+++.||||++...     ....+|+.++.+..+||||++++++|..  .+...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567776 6899999999999999999999999999642     2456788887777779999999998743  335579


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEeccccccc
Q 017445          157 SIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISAG  231 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~~  231 (371)
                      ||||||++||+|.+++...+  .+++..++.++.|++.||.|||+ +||+||||||+|||++.   ++.+||+|||++..
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            99999999999999997643  59999999999999999999999 99999999999999998   78999999999986


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH---HHHHHHhhCCC--CCCCCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV---NLMLQILEDPS--PSPSRQ  306 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~--~~~~~~  306 (371)
                      .... ....+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....+.....  +.....
T Consensus       214 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  292 (400)
T 1nxk_A          214 TTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  292 (400)
T ss_dssp             CC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred             cCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence            6543 22356789999999999999999999999999999999999999997644221   12333333332  233346


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+++++.+||++||+.||++|||+.++++||||.+..
T Consensus       293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            7899999999999999999999999999999997643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-50  Score=395.91  Aligned_cols=264  Identities=24%  Similarity=0.394  Sum_probs=226.0

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++++.||+|+||+||+|.++.+|+.||+|++.....   .....+.+|+.++.++. ||||+++++++.  +.
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~~  257 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFE--TK  257 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEe--eC
Confidence            3456799999999999999999999999999999999965221   23456788999998886 999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      ..+|+||||++||+|.+++...    ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||++
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            6899999999999999999753    369999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC---cHHHHHHHhhCCCCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  306 (371)
                      ...........+.+||+.|+|||++.+..++.++|||||||++|||++|..||.....   .......+......  .+.
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~--~p~  414 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT--YPD  414 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC--CCT
T ss_pred             eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC--CCc
Confidence            8776554444566899999999999999999999999999999999999999976532   23344444444333  346


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      .+++++.+||++||+.||.+||+     ++++++||||+.+.+.+
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~  459 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ  459 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence            78999999999999999999996     58999999999876544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.8e-50  Score=364.95  Aligned_cols=257  Identities=28%  Similarity=0.397  Sum_probs=222.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+..++..||+|++..........+.+|+.++.++. ||||+++++++.  +....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFE--DNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC-CCCEeeEEEEEe--cCCeEEEE
Confidence            357999999999999999999999999999999997654455677889999999886 999999999874  56689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||.+.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999999999999888889999999999999999999999 999999999999999   778999999999997765442


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCC--CCCCCHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS--RQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  314 (371)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.... .......+.......+.  ...+++++.+
T Consensus       164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-DSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence             33556799999999998765 8999999999999999999999997644 34444555554433322  2368999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      |+.+||+.||.+|||+.++++||||++..
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999997653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-50  Score=397.92  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=223.9

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.++..+. ||||+++++++.  +.
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~--~~  256 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE--TK  256 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEe--eC
Confidence            356789999999999999999999999999999999996522   223456788999999886 999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||++..
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCCCeEEEeccccee
Confidence            68999999999999999997654  39999999999999999999999 9999999999999999999999999999987


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC---cHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ..... ...+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .......+.....  ..+..+
T Consensus       336 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~  412 (576)
T 2acx_A          336 VPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERF  412 (576)
T ss_dssp             CCTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTS
T ss_pred             cccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccC
Confidence            65432 23456899999999999998999999999999999999999999976532   2223333333322  234678


Q ss_pred             CHHHHHHHHHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      ++++.+||++||+.||.+||     ++.++++||||+...+.+
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~  455 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR  455 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence            99999999999999999999     899999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=367.83  Aligned_cols=262  Identities=22%  Similarity=0.367  Sum_probs=208.2

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-----HHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEe
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-----KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYM  150 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~  150 (371)
                      +..++|++.+.||+|+||+||+|.+..+++.||||++....     ........+|+..+..+.  .||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34578999999999999999999999999999999986421     111234455666555443  49999999998865


Q ss_pred             cCCC---eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEec
Q 017445          151 PDSG---QISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD  225 (371)
Q Consensus       151 ~~~~---~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~D  225 (371)
                      ....   .+++||||+. ++|.+++.....  +++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEEee
Confidence            4322   5899999997 599999986654  9999999999999999999999 9999999999999999999999999


Q ss_pred             ccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCC
Q 017445          226 FGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPS  302 (371)
Q Consensus       226 fg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~  302 (371)
                      ||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....++..   .....
T Consensus       164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChh
Confidence            9999876543 233567899999999999999999999999999999999999999976543 333333322   11111


Q ss_pred             C----------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          303 P----------------------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       303 ~----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .                      ....+++++.+||.+||+.||++|||+.++|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            0                      0135789999999999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.8e-50  Score=381.23  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=221.4

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCC-CCCeeEeceeEEec
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPC-NEGLVEFHGAFYMP  151 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~-h~~iv~l~~~~~~~  151 (371)
                      ...+...+|++.+.||+|+||+||+|.+.. ++.||||++..  ........+.+|+.++.++.. ||||+++++++.  
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~--  126 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--  126 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe--
Confidence            345556789999999999999999998755 89999999865  345566778999999998874 799999999875  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ....+||||| +.+++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++..
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            4558999999 5678999999988899999999999999999999999 9999999999999996 68999999999987


Q ss_pred             Cccccc--ccccccccCcccCCccccC-----------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC
Q 017445          232 LENSIA--MCATFVGTVTYMSPERIRN-----------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED  298 (371)
Q Consensus       232 ~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  298 (371)
                      ......  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.........+..++..
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence            654322  2345679999999999865           368899999999999999999999998766555566666666


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ......+...+.++.+||.+||+.||++|||+.++|+||||+....
T Consensus       284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            5555556677899999999999999999999999999999986543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-50  Score=365.33  Aligned_cols=254  Identities=25%  Similarity=0.449  Sum_probs=208.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|.+.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.++.++. ||||+++++++.  +....++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~~~lv   98 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFE--DYHNMYIV   98 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHhee--cCCeEEEE
Confidence            68999999999999999999999999999999987532 234567889999999886 999999999874  56689999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccC
Q 017445          160 LEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGL  232 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~  232 (371)
                      |||+++|+|.+++..    ...+++..++.++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999998853    3679999999999999999999999 999999999999999   44578999999999766


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh-hCCCCCCCCCCCCHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-EDPSPSPSRQNFSPE  311 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  311 (371)
                      ... .......||+.|+|||++. ..++.++||||||+++|+|++|..||..... ........ ...........++++
T Consensus       178 ~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          178 KSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             CCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-HHHHhhhccCCcccccccCcCCHH
Confidence            543 2235567999999999986 4688999999999999999999999976543 22223322 222233333458999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      +.+|+.+||+.||++|||+.++|+||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.7e-50  Score=371.43  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=222.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....      .....+.+|+.++.++. ||||+++++++.  +.
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE--NR   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe--cC
Confidence            4679999999999999999999999999999999865321      13567889999999987 999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC----ceEEeccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG----RPKITDFGIS  229 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~----~~kl~Dfg~s  229 (371)
                      ...++||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++    .+||+|||++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            6899999999999999999888889999999999999999999999 9999999999999999887    7999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQN  307 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  307 (371)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+........  ....
T Consensus       167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          167 HEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             EECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcccccChhhhcc
Confidence            8765542 2345679999999999999999999999999999999999999997644 3334444443332221  1256


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      ++..+.+||.+||..||++|||+.++++||||+....+
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            88999999999999999999999999999999877544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-50  Score=375.54  Aligned_cols=255  Identities=24%  Similarity=0.384  Sum_probs=209.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC------
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS------  153 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~------  153 (371)
                      ++|++.+.||+|+||+||+|.+..+|+.||||+++.. .......+.+|+.++.++. ||||++++++|.....      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhhhh
Confidence            5899999999999999999999999999999999753 3345677899999999886 9999999998854322      


Q ss_pred             -------------------------------------------------CeEEEEEeccCCCCHHHHHHhcCC---CCHH
Q 017445          154 -------------------------------------------------GQISIALEYMDGGSLADILRMQKS---IPEP  181 (371)
Q Consensus       154 -------------------------------------------------~~~~lv~E~~~~g~L~~~l~~~~~---l~~~  181 (371)
                                                                       ..+++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             248999999999999999986543   5666


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc------------cccccccccCccc
Q 017445          182 ILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI------------AMCATFVGTVTYM  249 (371)
Q Consensus       182 ~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~------------~~~~~~~gt~~y~  249 (371)
                      .++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.......            .......||+.|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            789999999999999999 999999999999999999999999999998765432            1224457999999


Q ss_pred             CCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC
Q 017445          250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT  329 (371)
Q Consensus       250 aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  329 (371)
                      |||++.+..++.++||||||+++|+|++|..|+..   ........... .........++++.+|+.+||+.||++|||
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  319 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERPE  319 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhcc-CCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence            99999999999999999999999999998776522   12222222222 222222345688999999999999999999


Q ss_pred             HHHHhcCccccc
Q 017445          330 ADQLLSHPFITK  341 (371)
Q Consensus       330 ~~~il~hp~~~~  341 (371)
                      +.++++||||++
T Consensus       320 ~~~~l~~~~f~~  331 (332)
T 3qd2_B          320 ATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHSTTCCC
T ss_pred             HHHHhhchhhhc
Confidence            999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.4e-50  Score=364.06  Aligned_cols=262  Identities=26%  Similarity=0.422  Sum_probs=222.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++... .......+.+|+.++..+. ||||+++++++.  +.+..|+|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   83 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQYLF   83 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEE--cCCEEEEE
Confidence            5899999999999999999999999999999998653 2344567888999988886 999999999875  45689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc--c
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI--A  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~  237 (371)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+.......  .
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999999877789999999999999999999999 999999999999999999999999999997654321  2


Q ss_pred             ccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.........................+++.+.+|+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            2345679999999999987665 778999999999999999999998765444444444444443344467899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .+||+.||++|||+.++++||||++...+.
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence            999999999999999999999998775543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.9e-50  Score=362.74  Aligned_cols=260  Identities=26%  Similarity=0.385  Sum_probs=219.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.++..+. ||||+++++++.  +.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   81 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DA   81 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CS
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEe--cC
Confidence            345679999999999999999999999999999999986422   223456788999988887 999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +..++||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++....
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            6899999999999999999888889999999999999999999999 999999999999999999999999999986554


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      ..  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+......  .+..+++++.
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~  235 (279)
T 3fdn_A          161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISRVEFT--FPDFVTEGAR  235 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCC--CCTTSCHHHH
T ss_pred             cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-HHHHHHHHHhCCCC--CCCcCCHHHH
Confidence            43  2245679999999999999999999999999999999999999997643 33333344333322  3456899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +|+.+||+.||.+|||+.++++||||+....+
T Consensus       236 ~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          236 DLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             HHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence            99999999999999999999999999876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-49  Score=363.24  Aligned_cols=264  Identities=26%  Similarity=0.440  Sum_probs=223.4

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||+++...         ......+.+|+.++.++..||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            3568999999999999999999999999999999996532         233566789999999997899999999987 


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                       .+.+..++||||+++++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+
T Consensus        94 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           94 -ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             -ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             -ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCCcEEEecccch
Confidence             4567899999999999999999888889999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccccccccccccCcccCCcccc------CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIR------NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP  303 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....... ......|++.|+|||++.      ...++.++||||||+++|+|++|..||.... .......+........
T Consensus       172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          172 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQFG  249 (298)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCC
T ss_pred             hhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-HHHHHHHHhcCCcccC
Confidence            7765432 234567999999999985      4568899999999999999999999997643 3344444444433322


Q ss_pred             --CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          304 --SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       304 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                        ....+++++.+|+.+||+.||.+|||+.++++||||+++..+++
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence              23568999999999999999999999999999999998876553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.8e-50  Score=372.92  Aligned_cols=264  Identities=25%  Similarity=0.438  Sum_probs=220.9

Q ss_pred             cCcceeEe-eeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           79 ASHEMRIF-GAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        79 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..++|.+. +.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.++..+.+||||+++++++  .+.+.
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~--~~~~~  103 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY--ENTSE  103 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSSE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE--EeCCe
Confidence            34577777 8999999999999999999999999998752  2234567889999999998899999999987  45668


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEecccccc
Q 017445          156 ISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISA  230 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~  230 (371)
                      .++||||+++|+|.+++...  +.+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||++.
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            99999999999999988543  679999999999999999999999 99999999999999987   7899999999998


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC--CCCCCCCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~  308 (371)
                      ...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+...  ..+......+
T Consensus       183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  260 (327)
T 3lm5_A          183 KIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-QETYLNISQVNVDYSEETFSSV  260 (327)
T ss_dssp             EC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCCTTTTTTS
T ss_pred             ccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhcccccCchhhccc
Confidence            765442 23456799999999999999999999999999999999999999976543 3333333332  3334444678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                      ++.+.+||.+||+.||.+|||++++|+||||+.+.....
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            999999999999999999999999999999998876554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=370.43  Aligned_cols=267  Identities=28%  Similarity=0.590  Sum_probs=219.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----  152 (371)
                      .....+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+..+.++..||||+++++++....    
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            345678999999999999999999999999999999987532 234567889999998877999999999987543    


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ...+++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            56899999999999999999764  569999999999999999999999 999999999999999999999999999998


Q ss_pred             cCcccccccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .............||+.|+|||++.     +..++.++||||||+++|+|++|..||.... .......+.....+....
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSC
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCccccCCc
Confidence            7655444445667999999999986     5668999999999999999999999997644 344445555555555556


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ..+++.+.+||.+||..||.+||++.++++||||.......
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence            78899999999999999999999999999999998765433

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-50  Score=389.53  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=222.4

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +...+|.+.+.||+|+||+||+|.+..+|+.||||++.....   .....+.+|+.++..+. ||||+++++++.  +.+
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~--~~~   89 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVIS--TPS   89 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSS
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECC
Confidence            345789999999999999999999999999999999965321   23456889999998876 999999999874  456


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            899999999999999999888889999999999999999999999 9999999999999999999999999999987654


Q ss_pred             cccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                      . ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ......++..+...  .+..+++++.
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~  244 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDGIFY--TPQYLNPSVI  244 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-SHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCcC--CCccCCHHHH
Confidence            3 23356789999999999988765 689999999999999999999997654 34445555554432  3456899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      +||++||+.||.+|||+.++++||||++.
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-50  Score=380.65  Aligned_cols=253  Identities=24%  Similarity=0.382  Sum_probs=213.8

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      ..+.||+|+||.||+|.+..+|+.||+|+++.........+.+|+.++.++. ||||+++++++.  +.+.++|||||++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--~~~~~~lv~E~~~  169 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFE--SKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEEEEEECCT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCEEEEEEeCCC
Confidence            3678999999999999999999999999998766666778899999999886 999999999874  4668999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE--ccCCceEEecccccccCccccccccc
Q 017445          165 GGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV--NLKGRPKITDFGISAGLENSIAMCAT  241 (371)
Q Consensus       165 ~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~--~~~~~~kl~Dfg~s~~~~~~~~~~~~  241 (371)
                      +++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||+  +.++.+||+|||++....... ....
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~  247 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKV  247 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccc
Confidence            99999988654 469999999999999999999999 999999999999999  556899999999998765442 2345


Q ss_pred             ccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHHHHHHHHh
Q 017445          242 FVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  319 (371)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+.......  .....+++++.+||.+|
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  326 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-DAETLNNILACRWDLEDEEFQDISEEAKEFISKL  326 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence            679999999999998899999999999999999999999997654 344555555554332  22357899999999999


Q ss_pred             cccCcCCCCCHHHHhcCccccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      |+.||.+|||+.++|+||||....
T Consensus       327 L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          327 LIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             cCCChhhCCCHHHHhcCcCcCCCc
Confidence            999999999999999999998664

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4e-50  Score=390.86  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=207.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      .++|++++.||+|+||+||+|.+..+++.||||++...  ......++.+|+.++..+. ||||+++++++....    .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccccC
Confidence            46899999999999999999999999999999999753  4456677889999999886 999999999885432    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+||||||+++ +|.+.+.  ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            578999999976 6777764  459999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC----------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS----------  300 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~----------  300 (371)
                      .. ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+. .+.+.+++.   .+.          
T Consensus       216 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          216 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             -C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHcchh
Confidence            43 233567899999999999999999999999999999999999999976542 233333221   110          


Q ss_pred             --------CCCCCC-------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          301 --------PSPSRQ-------------------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       301 --------~~~~~~-------------------~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                              +.....                   ..++++.+||++||+.||++|||++|+|+||||..+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                    000000                   0146789999999999999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=374.74  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=206.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ++|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.++..+. ||||+++++++.  +.+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIH--TEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEE--CSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEe--eCCEEEEE
Confidence            5799999999999999999999999999999999753322 1223557888888886 999999999874  46689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++ +|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.........
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            999975 999988764 459999999999999999999999 99999999999999999999999999999876655444


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH---hhCCCCCCC----------
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LEDPSPSPS----------  304 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~----------  304 (371)
                      .....||+.|+|||++.+ ..++.++||||+|+++|+|++|..||...... .....+   ...+.....          
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            456678999999999876 56899999999999999999999999775432 222222   222211111          


Q ss_pred             ---------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          305 ---------------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       305 ---------------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                     ...+++++.+||.+||+.||++|||+.|+|+||||....+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                           135788999999999999999999999999999999886643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=362.32  Aligned_cols=259  Identities=23%  Similarity=0.402  Sum_probs=193.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.....   .....+.+|+.++.++. ||||+++++++.  +.+..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFE--DSNYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEE--CSSEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEc--cCCeE
Confidence            3589999999999999999999999999999999964221   22366788999998886 999999999874  56689


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          157 SIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999999865 579999999999999999999999 99999999999999999999999999999876544


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ........||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ..........  ...+..++.++.+|
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~l  242 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVVLAD--YEMPSFLSIEAKDL  242 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSC--CCCCTTSCHHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHhhcc--cCCccccCHHHHHH
Confidence            33445567999999999999888999999999999999999999999765432 2222222222  22345689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +.+||+.||++|||+.++++||||.+....
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  272 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSRNSST  272 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence            999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.1e-50  Score=368.52  Aligned_cols=262  Identities=31%  Similarity=0.599  Sum_probs=218.0

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++..........+.+|+.++..+. ||||+++++++.  +.+..++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYY--HDGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CC-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC-CCCEeeeeeeee--eCCeEEE
Confidence            3468999999999999999999999999999999997655556677889999999886 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            9999999999998865 4679999999999999999999999 9999999999999999999999999998765433333


Q ss_pred             ccccccccCcccCCccc-----cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCCHH
Q 017445          238 MCATFVGTVTYMSPERI-----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPE  311 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  311 (371)
                      ......||+.|+|||++     .+..++.++||||||+++|+|++|..||.... .......+.....+ ...+..++.+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHHHHhccCCcccCCccccCHH
Confidence            33456799999999998     46678999999999999999999999997644 33344444443332 3345678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      +.+++.+||..||.+|||+.++++||||......
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            9999999999999999999999999999987754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-49  Score=368.59  Aligned_cols=258  Identities=19%  Similarity=0.369  Sum_probs=216.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...   ...+.+|+.++..+..||||+++++++..+.....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            468999999999999999999999999999999997533   35678899999999889999999999876667789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCcccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENSIAM  238 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |||+++++|.+++.   .+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++....... .
T Consensus       112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~  186 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-E  186 (330)
T ss_dssp             EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-C
T ss_pred             EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-c
Confidence            99999999999875   48999999999999999999999 9999999999999999776 89999999997665432 2


Q ss_pred             cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh-------------CC-----
Q 017445          239 CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE-------------DP-----  299 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------~~-----  299 (371)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+..+..             ..     
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  266 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP  266 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred             cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence            355679999999999977 67899999999999999999999999665443332222111             00     


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          300 -----------------SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       300 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                       ........+++++.+||.+||+.||.+|||++++|+||||+...++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence                             0011122378999999999999999999999999999999987653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-49  Score=361.26  Aligned_cols=252  Identities=24%  Similarity=0.332  Sum_probs=211.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..  ........+.+|+..+..+.+||||+++++++.  +.+..+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~--~~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA--EDDHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE--ETTEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEE
Confidence            3689999999999999999999999999999999875  234456778899999999977999999999885  456899


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---------------
Q 017445          158 IALEYMDGGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---------------  218 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---------------  218 (371)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+ +||+||||||+||+++.+               
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999999754    679999999999999999999999 999999999999999844               


Q ss_pred             ----CceEEecccccccCcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 017445          219 ----GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML  293 (371)
Q Consensus       219 ----~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~  293 (371)
                          ..+||+|||.+......    ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...    ....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~  238 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWH  238 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHH
T ss_pred             cCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHH
Confidence                47999999998876543    334699999999999765 5668999999999999999998777432    2233


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+.... ....+..+++++.+|+.+||+.||++|||+.++++||||+...
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          239 EIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HHHTTC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HHHcCC-CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            333333 3334567899999999999999999999999999999998654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-49  Score=375.15  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=210.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      ..+|++++.||+|+||+||+|.+..+|+.||||++..  ........+.+|+.++..+. ||||+++++++...+    .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccC
Confidence            3689999999999999999999999999999999854  34455677889999999997 999999999885432    1


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            4579999999 7899999875 679999999999999999999999 999999999999999999999999999998755


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC---------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS---------  300 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~---------  300 (371)
                      ..   ....++|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+. ...+..+..   .+.         
T Consensus       180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhhh
Confidence            43   245679999999999977 6799999999999999999999999976542 222222211   100         


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          301 -----------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       301 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                       .......+++++.+|+.+||+.||.+|||+.++|+||||..+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                             00112467899999999999999999999999999999988754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.6e-49  Score=371.58  Aligned_cols=256  Identities=29%  Similarity=0.517  Sum_probs=221.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..|++++.||+|+||+||+|.+..+++.||||++...   .......+.+|+.++.++. ||||+++++++..  .+..+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~  130 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHTAW  130 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCeEE
Confidence            4689999999999999999999999999999999642   3344567889999999986 9999999998854  56899


Q ss_pred             EEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||+. |+|.+++. ...++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...... 
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9999997 58888775 45679999999999999999999999 99999999999999999999999999999766543 


Q ss_pred             cccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHH
Q 017445          237 AMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC  313 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (371)
                         ....||+.|+|||++.   +..++.++|||||||++|+|++|..||.... ....+..+.....+......+++.+.
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence               4567999999999984   5678999999999999999999999997644 34445556666555555678899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +|+.+||+.||++|||+.++++||||.+...+.
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            999999999999999999999999998776544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.6e-49  Score=363.60  Aligned_cols=258  Identities=29%  Similarity=0.410  Sum_probs=220.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++..........+.+|+.++.++. ||||+++++++.  +.+..|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLEDIYE--STTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC-CTTBCCEEEEEE--CSSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC-CCCeeehhhhcc--cCCEEEEE
Confidence            358999999999999999999999999999999998655455567889999999986 999999999874  56689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||.+...... 
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            9999999999999888889999999999999999999999 999999999999999   77899999999998765432 


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCCCCCCHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSRQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  314 (371)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+......  ......+++++.+
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-ESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence             2244579999999999999999999999999999999999999997643 33444455444332  2334678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      |+.+||..||++|||+.++++||||.....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             HHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.6e-49  Score=364.26  Aligned_cols=270  Identities=30%  Similarity=0.581  Sum_probs=230.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+.|++++.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++..+. ||||+++++++..  ....++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK--DTKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec--CCeEEE
Confidence            357899999999999999999999999999999997532 344567889999998886 9999999998854  568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      ||||+++++|.+++. .+++++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.........
T Consensus        98 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           98 IMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred             EEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence            999999999999986 4679999999999999999999999 99999999999999999999999999999876655444


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+... ........++..+.+|+.+
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHS-CCCCCCSSCCHHHHHHHHH
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-HHHHHHHhhcC-CCCCCccccCHHHHHHHHH
Confidence            456789999999999999999999999999999999999999997643 33333333333 3334456789999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccccccccHHHHHHHh
Q 017445          319 CLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSV  356 (371)
Q Consensus       319 ~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~  356 (371)
                      ||..||.+|||+.++++||||.........+.+++++.
T Consensus       254 ~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~  291 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRY  291 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTCHHHHHHCCCGGGGHHHHHHH
T ss_pred             HcCCChhhCcCHHHHhhChhhhcCCCccHHHHHHHHHH
Confidence            99999999999999999999988777666555555553

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.6e-49  Score=373.07  Aligned_cols=257  Identities=28%  Similarity=0.459  Sum_probs=219.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++....        ......+.+|+.++..+.+||||+++++++.  
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  170 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--  170 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe--
Confidence            468999999999999999999999999999999986522        1224567889999998867999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..+..|+||||++|++|.+++.....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++..
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            466899999999999999999888889999999999999999999999 9999999999999999999999999999987


Q ss_pred             CcccccccccccccCcccCCccccC------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRN------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--  303 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  303 (371)
                      ..... .....+||+.|+|||++.+      ..++.++|||||||++|+|++|..||.... .......+........  
T Consensus       250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~  327 (365)
T 2y7j_A          250 LEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-QILMLRMIMEGQYQFSSP  327 (365)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCHH
T ss_pred             cCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCCc
Confidence            65542 2356789999999999853      358899999999999999999999997643 3344444444433322  


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      .+..++.++.+|+.+||+.||++|||+.++++||||++
T Consensus       328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            22568899999999999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-49  Score=390.22  Aligned_cols=260  Identities=26%  Similarity=0.443  Sum_probs=221.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++++.||+|+||+||+|.+..+++.||||++...  .......+.+|+.++.++. ||||+++++++  .+...+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~--~~~~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEIL--EDSSSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEE--ECSSEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEE--EcCCEEE
Confidence            36899999999999999999999999999999998642  2234567889999999996 99999999987  4567899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc---cCCceEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN---LKGRPKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~---~~~~~kl~Dfg~s~~~~~  234 (371)
                      +||||+.+|+|.+.+...+.+++..++.++.|++.||.|||+ +||+||||||+|||++   .++.+||+|||++.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            999999999999999888899999999999999999999999 9999999999999995   456799999999987654


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  312 (371)
                      .. .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ....+..+.......  +.+..+++++
T Consensus       177 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          177 NT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             C-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             CC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            42 3355679999999999976 48999999999999999999999997644 344455555544332  3345789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .+||++||+.||.+|||+.++|+||||+++....
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            9999999999999999999999999999876543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.2e-49  Score=358.91  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=222.3

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..+. ||||+++++++.  +.+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   87 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFH--DRK   87 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSS
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEE--cCC
Confidence            44578999999999999999999999999999999986422   122456788999998886 999999999874  466


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            899999999999999999888889999999999999999999999 9999999999999999999999999999865543


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      .  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.....  ..+..++.++.+
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~  241 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-HTETHRRIVNVDL--KFPPFLSDGSKD  241 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCC--CCCTTSCHHHHH
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-HhHHHHHHhcccc--CCCCcCCHHHHH
Confidence            2  2245679999999999999999999999999999999999999997644 2333444444332  234578999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      |+.+||..||.+|||+.++++||||+....+
T Consensus       242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~  272 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRR  272 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred             HHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence            9999999999999999999999999865543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1e-49  Score=362.42  Aligned_cols=260  Identities=26%  Similarity=0.457  Sum_probs=221.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++++.||+|+||+||+|.+..+++.||+|.+..  ........+.+|+..+.++. ||||+++++++.......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceEE
Confidence            4689999999999999999999999999999999975  24456677899999999996 99999999988766677899


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCC-----eEecCCCCCcEEEccCCceEEecccc
Q 017445          158 IALEYMDGGSLADILRMQ----KSIPEPILSSMFKKLLQGLSYLHGVRH-----LVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~-----iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+ +|     |+||||||+||+++.++.+||+|||.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999999653    349999999999999999999999 88     99999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      +..............||+.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+..... ...+..+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~~-~~~~~~~  240 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKF-RRIPYRY  240 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCC-CCCCTTS
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-HHHHHHHHhhccc-ccCCccc
Confidence            9776554333345679999999999999899999999999999999999999997643 3334444444433 3345678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ++++.+++.+||+.||.+|||+.++++|+|+.+..
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            99999999999999999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.3e-50  Score=392.08  Aligned_cols=259  Identities=25%  Similarity=0.410  Sum_probs=224.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...   .......+.+|+.++.++. ||||+++++++  .+.+.
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~--~~~~~  100 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFF--EDKGY  100 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEE--ECSSE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEE--EeCCE
Confidence            346899999999999999999999999999999998642   2345677889999998886 99999999987  45678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccC
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGL  232 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~  232 (371)
                      +|+||||+.+|+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999999999888899999999999999999999999 999999999999999   46789999999999766


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSP  310 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  310 (371)
                      .... .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ....+..+.......  +.+..+++
T Consensus       180 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          180 EASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             CCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             cccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCCCCCcccccCCH
Confidence            5442 2345679999999999976 69999999999999999999999997644 344555555554332  33457899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ++.+||++||+.||.+|||+.++|+||||+.+..
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            9999999999999999999999999999987755

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-49  Score=370.58  Aligned_cols=280  Identities=34%  Similarity=0.651  Sum_probs=211.9

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..+.+..++|++++.||+|+||.||+|.+..+|+.||||++... .......+..|+..+.+..+||||+++++++.  +
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~   92 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--R   92 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--C
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--e
Confidence            45566778999999999999999999999999999999999753 34455667778876666667999999999885  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEccCCceEEecc
Q 017445          153 SGQISIALEYMDGGSLADILRM-----QKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      .+..++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+ + ||+||||||+||+++.++.+||+||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            5689999999985 88888763     5679999999999999999999999 8 9999999999999999999999999


Q ss_pred             cccccCcccccccccccccCcccCCccc----cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC
Q 017445          227 GISAGLENSIAMCATFVGTVTYMSPERI----RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS  302 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  302 (371)
                      |++....... ......||+.|+|||++    .+..++.++||||||+++|+|++|..||.........+.++.....+.
T Consensus       171 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3aln_A          171 GISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ  249 (327)
T ss_dssp             SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred             CCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence            9998765442 22344799999999999    456789999999999999999999999976443222222222222221


Q ss_pred             ---CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcC
Q 017445          303 ---PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFD  358 (371)
Q Consensus       303 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~  358 (371)
                         .....+++++.+|+.+||+.||++|||+.++++||||....+...+....+..+++
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~  308 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD  308 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHHHHh
Confidence               12246899999999999999999999999999999999999999998888888773

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.7e-49  Score=370.75  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=211.8

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC----CCCCeeEeceeEEe
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP----CNEGLVEFHGAFYM  150 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----~h~~iv~l~~~~~~  150 (371)
                      ...+..++|++++.||+|+||+||+|.+..+++.||||++.. ..........|+.++..+.    .||||+++++++..
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            334556899999999999999999999999999999999974 3344455677888888776    59999999998854


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-----------
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-----------  217 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-----------  217 (371)
                        .+..++||||+ +++|.+++....  .+++..+..++.|++.||.|||+ +||+||||||+|||++.           
T Consensus       108 --~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          108 --YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             --TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             --CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchh
Confidence              55899999999 889999997654  59999999999999999999999 99999999999999975           


Q ss_pred             --------------CCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCC
Q 017445          218 --------------KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYA  283 (371)
Q Consensus       218 --------------~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~  283 (371)
                                    ++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                          789999999999765432   245679999999999999999999999999999999999999997


Q ss_pred             CCCCcHHHHHHHhhCCCCCC------------------------C--------------------CCCCCHHHHHHHHHh
Q 017445          284 ASEGPVNLMLQILEDPSPSP------------------------S--------------------RQNFSPEFCSFVDDC  319 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~------------------------~--------------------~~~~~~~~~~li~~~  319 (371)
                      .... ...+..+.....+.+                        .                    ....++.+.+||.+|
T Consensus       261 ~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          261 THEH-MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CSSH-HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCcH-HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            6442 222222211100000                        0                    011237788999999


Q ss_pred             cccCcCCCCCHHHHhcCcccc
Q 017445          320 LKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~  340 (371)
                      |+.||++|||+.++|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999995

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-50  Score=374.50  Aligned_cols=263  Identities=26%  Similarity=0.433  Sum_probs=216.5

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...     .......+.+|+.++.++. ||||+++++++  .+.
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~--~~~  100 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY--EDE  100 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE--ECS
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh--ccC
Confidence            346899999999999999999999999999999998642     2345567889999999996 99999999987  456


Q ss_pred             CeEEEEEeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 017445          154 GQISIALEYMDGGSLADILRM----------------------------------------QKSIPEPILSSMFKKLLQG  193 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~a  193 (371)
                      +..++||||++||+|.+++..                                        ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            689999999999999998842                                        1123678889999999999


Q ss_pred             HHHHHcCCCeEecCCCCCcEEEccCC--ceEEecccccccCcccc----cccccccccCcccCCccccC--CCCCCchhH
Q 017445          194 LSYLHGVRHLVHRDIKPANLLVNLKG--RPKITDFGISAGLENSI----AMCATFVGTVTYMSPERIRN--ESYSYPADI  265 (371)
Q Consensus       194 L~~LH~~~~iiH~Dlkp~NIl~~~~~--~~kl~Dfg~s~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv  265 (371)
                      |.|||+ +||+||||||+||+++.++  .+||+|||++.......    .......||+.|+|||++.+  ..++.++||
T Consensus       181 l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          181 LHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            999999 9999999999999998776  89999999997653321    12345679999999999965  678999999


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       266 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ||||+++|+|++|..||.... ......++........  ....+++++.+||.+||+.||.+||++.++++||||+.+.
T Consensus       260 wslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            999999999999999997654 3444555555544332  2235899999999999999999999999999999999887


Q ss_pred             ccc
Q 017445          344 HAK  346 (371)
Q Consensus       344 ~~~  346 (371)
                      .+-
T Consensus       339 ~~~  341 (345)
T 3hko_A          339 DKI  341 (345)
T ss_dssp             SCS
T ss_pred             Hhh
Confidence            543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.5e-49  Score=362.60  Aligned_cols=256  Identities=26%  Similarity=0.424  Sum_probs=208.3

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      ...+.+...+|++.+.||+|+||+||+|.+  +++.||||++...  .......+.+|+.++.++. ||||+++++++  
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~--  103 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAV--  103 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE--
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--
Confidence            345667788999999999999999999986  6789999998653  3455677899999999997 99999999987  


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEccCCceEEec
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNLKGRPKITD  225 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~~~~~kl~D  225 (371)
                      .+...+++||||+++|+|.+++...+.   +++..++.++.|++.||.|||+ +|  |+||||||+||+++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECC
Confidence            456679999999999999999986553   9999999999999999999999 99  99999999999999999999999


Q ss_pred             ccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          226 FGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       226 fg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.........+
T Consensus       183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~  261 (309)
T 3p86_A          183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKCKRLEIP  261 (309)
T ss_dssp             CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-HHHHHHHHHHSCCCCCCC
T ss_pred             CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCC
Confidence            9999866554444456789999999999999999999999999999999999999997644 334444443344445556


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..+++++.+|+.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            789999999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.8e-49  Score=358.85  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=224.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++...   .......+.+|+.++..+. ||||+++++++.  +.+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~   89 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--DNDF   89 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeec--cCCE
Confidence            346899999999999999999999999999999998652   3455677888999998885 999999999874  5668


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+......
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999999999888899999999999999999999999 99999999999999999999999999999876544


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ........||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ......+.....  ..+..+++.+.++
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l  245 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-KETYLRIKKNEY--SIPKHINPVAASL  245 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTTCC--CCCTTSCHHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhhccC--CCccccCHHHHHH
Confidence            4444556799999999999988899999999999999999999999976442 333334433332  2345789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +.+||+.||++|||+.++++||||.....
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHcccChhhCcCHHHHhhChheecCCc
Confidence            99999999999999999999999976543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.9e-49  Score=388.31  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=220.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-------------HHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-------------EKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .++|++++.||+|+||+||+|.+..+++.||+|++.....             .....+.+|+.++.++. ||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~  113 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFD  113 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeEEE
Confidence            4689999999999999999999999999999999865321             23466889999999986 999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---ceEE
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---RPKI  223 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~~kl  223 (371)
                      ++  .+...+||||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++   .+||
T Consensus       114 ~~--~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          114 VF--EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EE--ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EE--EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCCCccEEE
Confidence            87  4567899999999999999999888899999999999999999999999 9999999999999998876   6999


Q ss_pred             ecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC
Q 017445          224 TDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP  303 (371)
Q Consensus       224 ~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      +|||++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ....+..+..+.....
T Consensus       191 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          191 VDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN-DQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCC
T ss_pred             EECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCC
Confidence            9999998765542 3356679999999999874 58999999999999999999999997644 3445555555543322


Q ss_pred             --CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          304 --SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       304 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                        .+..+++++.+||++||+.||.+|||+.++|+||||+++...
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence              235789999999999999999999999999999999887653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.6e-50  Score=372.65  Aligned_cols=262  Identities=24%  Similarity=0.415  Sum_probs=213.6

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      +....++|++++.||+|+||+||+|.+..+|+.||+|++..  ........+.+|+.++.++. ||||+++++++.  +.
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~   96 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCK--KK   96 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--ET
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEee--cC
Confidence            33445799999999999999999999999999999999854  23445566789999999997 999999999875  46


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+....
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            6899999999999999988877889999999999999999999999 999999999999999999999999999998766


Q ss_pred             ccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---C-----------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---D-----------  298 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~-----------  298 (371)
                      ..........||+.|+|||++.+. .++.++||||||+++|+|++|..||...... .....+..   .           
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhHhhh
Confidence            554444567799999999999775 6899999999999999999999999775432 22222211   0           


Q ss_pred             -----CCCCC----------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          299 -----PSPSP----------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       299 -----~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                           ....+          ....+++++.+|+.+||+.||++|||+.++|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                 00000          013578999999999999999999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-49  Score=364.42  Aligned_cols=278  Identities=33%  Similarity=0.635  Sum_probs=217.5

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .|....++|++++.||+|+||+||+|.+..+|+.||||++... ..........|+..+.+..+||||+++++++.  +.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~   96 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TN   96 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cC
Confidence            4556677999999999999999999999999999999999753 33344455556655555556999999999875  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..+++||||+ ++.+..+... ...+++..++.++.|++.||.|||+ + ||+||||||+||+++.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            6899999999 5566666543 5679999999999999999999998 6 999999999999999999999999999976


Q ss_pred             CcccccccccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC-CCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-PSR  305 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  305 (371)
                      ..... ......||+.|+|||++.     +..++.++||||||+++|+|++|..||.........+..+.....+. +..
T Consensus       175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (318)
T 2dyl_A          175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH  253 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred             ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence            65432 224557999999999994     45688999999999999999999999987665556666665554432 333


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVF  357 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~  357 (371)
                      ..+++++.+|+.+||+.||.+||++.++++||||+++....+++.+|++.+.
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~  305 (318)
T 2dyl_A          254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM  305 (318)
T ss_dssp             SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhhccc
Confidence            5689999999999999999999999999999999999999999999999877

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-49  Score=388.17  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=217.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++++.||+|+||+||+|.+..++..||+|++....  ......+.+|+.++..+. ||||+++++++.  +.+.+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~~~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE--DKRNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEE--eCCEEE
Confidence            357999999999999999999999999999999997532  233566889999998886 999999999874  567899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~  234 (371)
                      +||||+++|+|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++..   +.+||+|||++.....
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            999999999999999888899999999999999999999999 999999999999999764   5599999999987665


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  312 (371)
                      .. .....+||+.|+|||++. ..++.++||||+||++|+|++|..||.... ....+..+.......  +.+..+++++
T Consensus       192 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          192 QK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-DQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             TB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             Cc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            42 335678999999999986 468999999999999999999999997644 344555555554332  3346789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+||++||+.||.+|||+.++|+||||+...
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            9999999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.8e-50  Score=372.64  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=214.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....        ......+.+|+.++.++. ||||+++++++  .
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~--~   99 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF--E   99 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE--E
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--e
Confidence            368999999999999999999999999999999987532        113345677999998885 99999999987  4


Q ss_pred             CCCeEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGG-SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +.+..++||||+.+| +|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            567899999999776 999999988899999999999999999999999 999999999999999999999999999998


Q ss_pred             cCcccccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ..... ....+.+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....       ...  .....+..++
T Consensus       179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~~~~~~  248 (335)
T 3dls_A          179 YLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHPPYLVS  248 (335)
T ss_dssp             ECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCCSSCCC
T ss_pred             ECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCCCcccC
Confidence            76554 23356779999999999988776 7899999999999999999999965221       111  1223345689


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +++.+|+.+||+.||++|||+.++++||||++..
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            9999999999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=362.00  Aligned_cols=265  Identities=31%  Similarity=0.472  Sum_probs=214.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ....+|.....||+|+||+||+|.+..+++.||+|.+..........+.+|+..+..+. ||||+++++++.  +.+..+
T Consensus        19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~~~~~   95 (295)
T 2clq_A           19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGSFS--ENGFIK   95 (295)
T ss_dssp             ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEE
T ss_pred             ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC-CCCEeeEeeEEE--eCCcEE
Confidence            33444555558999999999999999999999999997765556677889999998886 999999999885  456899


Q ss_pred             EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-CCceEEecccccccCc
Q 017445          158 IALEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-KGRPKITDFGISAGLE  233 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-~~~~kl~Dfg~s~~~~  233 (371)
                      +||||+++++|.+++....   .+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||.+....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            9999999999999997642   46789999999999999999999 99999999999999988 8999999999998765


Q ss_pred             ccccccccccccCcccCCccccCCC--CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ..........||+.|+|||++.+..  ++.++||||||+++|+|++|..||......................+..++++
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE  254 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence            5433345667999999999997643  88999999999999999999999976544433333332223333445678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +.+|+.+||+.||++||++.++++||||+.....+
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  289 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK  289 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence            99999999999999999999999999998776544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-48  Score=365.50  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=223.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.++..+. ||||+++++++.  +.+..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--~~~~~  116 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFE--DNDFV  116 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe--cCCeE
Confidence            46899999999999999999999999999999998642   3455677888999998886 999999999874  56689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999999999888889999999999999999999999 999999999999999999999999999998765444


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+......  .+..+++++.+|+
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~li  272 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKKNEYS--IPKHINPVAASLI  272 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCC--CCTTSCHHHHHHH
T ss_pred             ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHhcCCCC--CCccCCHHHHHHH
Confidence            44456679999999999999889999999999999999999999997644 23333444443322  3457899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ++||+.||++|||+.++++||||....
T Consensus       273 ~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHccCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999997653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=364.11  Aligned_cols=262  Identities=31%  Similarity=0.595  Sum_probs=217.6

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|.+....  ....+.+|+.++..+. ||||+++++++..  .+..|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD-SPHVVKYYGSYFK--NTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCC-CCCCccEEEEEEe--CCEEE
Confidence            34568999999999999999999999999999999997532  3456788999998886 9999999998854  56899


Q ss_pred             EEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||+++++|.+++. ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||.+.......
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999999986 45679999999999999999999999 999999999999999999999999999998766554


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC-CCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP-SPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  315 (371)
                      .......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ........... .....+..+++.+.+|
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-MRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence            444566799999999999998999999999999999999999999976443 23333333332 2233345679999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +.+||..||.+|||+.++++||||+......
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence            9999999999999999999999998776443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7e-49  Score=368.97  Aligned_cols=264  Identities=24%  Similarity=0.323  Sum_probs=212.9

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----  152 (371)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|++....  ......+.+|+.++..+. ||||+++++++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            3578999999999999999999999999999999986422  223456778999999987 999999999886543    


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          153 --SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       153 --~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                        .+.+|+||||+++ +|.+.+... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence              4579999999986 777777543 579999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCccc----ccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh--hCCCCC
Q 017445          230 AGLENS----IAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL--EDPSPS  302 (371)
Q Consensus       230 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~  302 (371)
                      ......    ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.  ....+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP  250 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence            765422    122345678999999999976 45899999999999999999999999875432 2222221  111111


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          303 PSRQN----------------------------FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       303 ~~~~~----------------------------~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      .....                            .++++.+||.+||+.||++|||+.++|+||||+....+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            11111                            267899999999999999999999999999998765544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.7e-49  Score=358.76  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=218.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++....      .....+.+|+.++.++. ||||+++++++.  +.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--~~   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE--NK   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CS
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec--CC
Confidence            3579999999999999999999999999999999865321      13567889999999987 999999999874  46


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC----ceEEeccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG----RPKITDFGIS  229 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~----~~kl~Dfg~s  229 (371)
                      ...++||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++    .+||+|||.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            6899999999999999999888889999999999999999999999 9999999999999998877    8999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQN  307 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~  307 (371)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.......  .....
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          160 HKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-KQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             EECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-hHHHHHHhHhcccCCcchhccc
Confidence            7665432 2245679999999999999999999999999999999999999997644 233333333332221  12256


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      +++.+.+|+.+||..||++|||+.++++||||+......
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            889999999999999999999999999999998776544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-49  Score=374.90  Aligned_cols=258  Identities=22%  Similarity=0.418  Sum_probs=208.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec------
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP------  151 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~------  151 (371)
                      ....+|++.+.||+|+||+||+|.+..+|+.||||++.....    ...+|+.++..+. ||||++++++|...      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCC-CTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcC-CCCccchhheeeecCccccc
Confidence            456789999999999999999999999999999999864321    1236888888885 99999999988642      


Q ss_pred             ------------------------------CCCeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q 017445          152 ------------------------------DSGQISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSYL  197 (371)
Q Consensus       152 ------------------------------~~~~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~L  197 (371)
                                                    +..++++||||+++ +|.+.+.    ....+++..++.++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                          23458999999985 8777664    357799999999999999999999


Q ss_pred             HcCCCeEecCCCCCcEEEc-cCCceEEecccccccCcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHH
Q 017445          198 HGVRHLVHRDIKPANLLVN-LKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFEC  275 (371)
Q Consensus       198 H~~~~iiH~Dlkp~NIl~~-~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el  275 (371)
                      |+ +||+||||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus       158 H~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          158 HS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HT-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HH-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99 9999999999999998 68999999999998665442 33556789999999998765 489999999999999999


Q ss_pred             hcCCCCCCCCCCcHHHHHHHhh---CCC----------------CC--------CCCCCCCHHHHHHHHHhcccCcCCCC
Q 017445          276 GTGEFPYAASEGPVNLMLQILE---DPS----------------PS--------PSRQNFSPEFCSFVDDCLKKDAEARP  328 (371)
Q Consensus       276 l~g~~pf~~~~~~~~~~~~~~~---~~~----------------~~--------~~~~~~~~~~~~li~~~l~~dp~~Rp  328 (371)
                      ++|+.||..... ...+..++.   .+.                +.        ..+..+++++.+|+.+||+.||.+||
T Consensus       236 l~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          236 ILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            999999987543 333333221   110                00        02345789999999999999999999


Q ss_pred             CHHHHhcCcccccccc
Q 017445          329 TADQLLSHPFITKYEH  344 (371)
Q Consensus       329 s~~~il~hp~~~~~~~  344 (371)
                      |+.|+++||||+.+..
T Consensus       315 t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          315 NPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CHHHHHTSGGGHHHHH
T ss_pred             CHHHHhcCHHHHHHHh
Confidence            9999999999987643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=365.17  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=215.6

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.++.++. ||||+++++++..  .+..
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~   82 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYK--DKRL   82 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEec--CCee
Confidence            345679999999999999999999999999999999997777777888999999998886 9999999998854  5689


Q ss_pred             EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          157 SIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999999999999986 5679999999999999999999999 99999999999999999999999999999765433


Q ss_pred             ccc--------------cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH----HHHHHhh
Q 017445          236 IAM--------------CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN----LMLQILE  297 (371)
Q Consensus       236 ~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~----~~~~~~~  297 (371)
                      ...              ..+..||+.|+|||++.+..++.++||||||+++|+|++|..||........    .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            221              1256799999999999999999999999999999999999999875332110    0111111


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .    ..+..+++++.+++.+||+.||++|||+.++++  |+..+
T Consensus       242 ~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          242 R----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             H----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             c----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            1    123568889999999999999999999999986  55433

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-49  Score=374.18  Aligned_cols=265  Identities=25%  Similarity=0.406  Sum_probs=218.6

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      .+...+|++.+.||+|+||+||+|.+.   .+++.||||+++...    ......+.+|+.++..+.+||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            344579999999999999999999984   589999999986421    2233456678888888867999999999875


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      .  ...++|||||+++++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus       130 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          130 T--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             E--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             e--CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            3  56899999999999999999888899999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccc-cccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCCCCCC---cHHHHHHHhhCCCCCC
Q 017445          230 AGLENSI-AMCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYAASEG---PVNLMLQILEDPSPSP  303 (371)
Q Consensus       230 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~  303 (371)
                      ....... ......+||+.|+|||++.+  ..++.++|||||||++|+|++|..||.....   .......+.....  .
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~  284 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--P  284 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--C
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--C
Confidence            7654332 23345679999999999975  3478999999999999999999999975432   2222333333332  2


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      .+..++..+.+||.+||..||.+||     ++.++++||||+...+..
T Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~  332 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD  332 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred             CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhH
Confidence            3457899999999999999999999     999999999999876544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-49  Score=364.41  Aligned_cols=269  Identities=31%  Similarity=0.588  Sum_probs=195.2

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ...+.+..++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+..+.++. ||||+++++++.. 
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-   84 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVV-   84 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCC-CTTBCCEEEEEES-
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeEEEEEee-
Confidence            3456777889999999999999999999998899999999986532 334556778888888775 9999999998854 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEE
Q 017445          152 DSGQISIALEYMDGGSLADILRM--------QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI  223 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl  223 (371)
                       .+..++||||+++++|.+++..        ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||
T Consensus        85 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           85 -KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             -SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEE
T ss_pred             -cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCCCEEE
Confidence             5579999999999999999863        4569999999999999999999999 99999999999999999999999


Q ss_pred             ecccccccCcccc-----cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh
Q 017445          224 TDFGISAGLENSI-----AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       224 ~Dfg~s~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  297 (371)
                      +|||.+.......     .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ......
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~  241 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQ  241 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHT
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhc
Confidence            9999987654321     12234579999999999965 5689999999999999999999999977554333 233322


Q ss_pred             CCCCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          298 DPSPS--------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       298 ~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ...+.        .....++.++.+++.+||+.||.+|||+.++++||||++...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence            22211        12356789999999999999999999999999999998876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-49  Score=368.68  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=210.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH-----HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-----KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++......     ....+.+|+.++..+. ||||+++++++  .+.+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~   85 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF--GHKS   85 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE--CCTT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEE--eeCC
Confidence            46899999999999999999999999999999999752221     1245778999999986 99999999987  4566


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..++||||+++ +|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            89999999986 899888654 368999999999999999999999 999999999999999999999999999998776


Q ss_pred             ccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCCCC-----
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSPS-----  304 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~-----  304 (371)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+..+..   .......     
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhcc
Confidence            554455667899999999999654 58899999999999999999999997654 3333333332   1111100     


Q ss_pred             ------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          305 ------------------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       305 ------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                        ...+++++.+||++||+.||++|||+.|+|+||||.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence                              1456789999999999999999999999999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-48  Score=354.36  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=211.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ++..++|++.+.||+|+||.||+|.+..+|+.||||++....   ......+.+|+..+..+. ||||+++++++.  +.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~   83 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIS--TP   83 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CS
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEe--cC
Confidence            445678999999999999999999999999999999986532   123456788999998886 999999999874  46


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +..|+||||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            6899999999999999999888889999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ... ......+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||.... .......+......  .+..++.++
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~--~~~~~~~~l  238 (276)
T 2h6d_A          163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGGVFY--IPEYLNRSV  238 (276)
T ss_dssp             C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred             CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCccc--CchhcCHHH
Confidence            432 2345679999999999987765 689999999999999999999997643 23333444333322  345689999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .+++.+||+.||++|||+.++++||||++.
T Consensus       239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            999999999999999999999999999754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-48  Score=358.27  Aligned_cols=261  Identities=24%  Similarity=0.405  Sum_probs=215.4

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++++.||+|+||+||+|.+..+++.||+|++..   ........+.+|+..+.++. ||||+++++++  .+.+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~--~~~~   84 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVD--EEDD   84 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEE--ECSS
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEee--eeCC
Confidence            345789999999999999999999999999999999854   23455677889999998886 99999999987  4567


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..|+||||++|++|.+++...+++++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            899999999999999999988899999999999999999999999 9999999999999999999999999999987654


Q ss_pred             ccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC---CCCCCCCH
Q 017445          235 SIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---PSRQNFSP  310 (371)
Q Consensus       235 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  310 (371)
                      ... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .....+.+....+.   .....+++
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-VSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-HHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhhccCCCcchhcccCCCH
Confidence            322 23445799999999999999999999999999999999999999976543 33334444443332   23467899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+.+++.+||..||.+||+..+.+.+.|..-..
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            999999999999999999766777777655443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.3e-49  Score=369.64  Aligned_cols=261  Identities=23%  Similarity=0.396  Sum_probs=221.1

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEE-----EcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAV-----HIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      ...+.+..++|++.+.||+|+||.||+|.     +..+++.||||+++. ........+.+|+.++.++.+||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            45677888999999999999999999998     556779999999976 344556778999999999988999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcCC-------------------------------------------------
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQKS-------------------------------------------------  177 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------------------------------------------  177 (371)
                      ++.. ....+++||||+++|+|.+++.....                                                 
T Consensus        94 ~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           94 ACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EECS-TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeec-CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            8753 34468999999999999999976433                                                 


Q ss_pred             -----------------CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc--cc
Q 017445          178 -----------------IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI--AM  238 (371)
Q Consensus       178 -----------------l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~  238 (371)
                                       +++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.......  ..
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                             8999999999999999999999 999999999999999999999999999998664332  22


Q ss_pred             cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          239 CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      .....||+.|+|||++.+..++.++||||||+++|+|++ |..||............+.. ......+..+++++.+++.
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTML  330 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Confidence            345568999999999998899999999999999999998 99999876655444444433 3344445678999999999


Q ss_pred             HhcccCcCCCCCHHHHhcC
Q 017445          318 DCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       318 ~~l~~dp~~Rps~~~il~h  336 (371)
                      +||..||.+|||+.++++|
T Consensus       331 ~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH
Confidence            9999999999999999876

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-48  Score=367.25  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=215.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC---CCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD---SGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~---~~~  155 (371)
                      ..+|++++.||+|+||+||+|.+..+++.||||++... .......+.+|+.++.++. ||||+++++++....   ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccccce
Confidence            35899999999999999999999999999999999753 3445577889999999997 999999999885432   247


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      .|+||||+.+ +|.+++.. +.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            8999999975 99999874 579999999999999999999999 99999999999999999999999999999766543


Q ss_pred             ccc---cccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh---hCCC--------
Q 017445          236 IAM---CATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL---EDPS--------  300 (371)
Q Consensus       236 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~--------  300 (371)
                      ...   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+.   ..+.        
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhh
Confidence            221   245589999999998754 45899999999999999999999999765432 2222221   1110        


Q ss_pred             -------------CCC-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          301 -------------PSP-----SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       301 -------------~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                   ...     ....+++++.+||.+||+.||++|||+.++|+||||+++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                         000     11457899999999999999999999999999999998743

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-49  Score=364.38  Aligned_cols=258  Identities=23%  Similarity=0.415  Sum_probs=214.6

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ....+|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++.++. ||||+++++++........
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceE
Confidence            45678999999999999999999999999999999997532 233566789999999997 9999999998876666689


Q ss_pred             EEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE----ccCCceEEeccccc
Q 017445          157 SIALEYMDGGSLADILRMQKS---IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGIS  229 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~----~~~~~~kl~Dfg~s  229 (371)
                      ++||||+++++|.+++.....   +++..++.++.|++.||.|||+ +||+||||||+||++    +.++.+||+|||++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999999975433   9999999999999999999999 999999999999999    77788999999999


Q ss_pred             ccCcccccccccccccCcccCCcccc--------CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc---HHHHHHHhhC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIR--------NESYSYPADIWSIGLALFECGTGEFPYAASEGP---VNLMLQILED  298 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~  298 (371)
                      ....... ...+..||+.|+|||++.        +..++.++|||||||++|+|++|..||......   ...+..++..
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8765543 234567999999999986        567899999999999999999999999754332   3344444433


Q ss_pred             CCCC-----------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          299 PSPS-----------------------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       299 ~~~~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      ....                       .....++..+.+|+++||+.||++|||++|+|+||=
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2211                       111233467889999999999999999999999984

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.6e-48  Score=366.81  Aligned_cols=257  Identities=23%  Similarity=0.396  Sum_probs=216.6

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEc-------CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHI-------PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      .+.+..++|++.+.||+|+||+||+|.+.       .++..||||+++.. .......+.+|+.++..+.+||||+++++
T Consensus        75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            45667789999999999999999999874       34568999999753 44556778999999999967999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCC
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKP  210 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp  210 (371)
                      ++  .+.+.+|+||||+++|+|.+++...+                .+++..+..++.|++.||.|||+ +||+||||||
T Consensus       155 ~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp  231 (370)
T 2psq_A          155 AC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA  231 (370)
T ss_dssp             EE--CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCG
T ss_pred             EE--ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccch
Confidence            87  45668999999999999999997643                47899999999999999999999 9999999999


Q ss_pred             CcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCC
Q 017445          211 ANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEG  287 (371)
Q Consensus       211 ~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~  287 (371)
                      +|||++.++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999986544322  2234457889999999999999999999999999999999 9999976442


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                       ... ...+........+..+++++.+++.+||+.||.+||++.+++++
T Consensus       312 -~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 -EEL-FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             -GGH-HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             233 33334444444556889999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-49  Score=365.77  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=214.4

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC-
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG-  154 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~-  154 (371)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...   .......+.+|+..+.++. ||||+++++++...... 
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEETTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCCCC
Confidence            456899999999999999999999999999999999753   3344567888998888885 99999999988654332 


Q ss_pred             -eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 -QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 -~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                       ..|+||||++|++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence             469999999999999999888899999999999999999999999 999999999999999999999999999997664


Q ss_pred             ccc---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCC
Q 017445          234 NSI---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNF  308 (371)
Q Consensus       234 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  308 (371)
                      ...   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ......+........  .....+
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCCCcccccCCC
Confidence            432   12234569999999999999999999999999999999999999997644 333444444443322  223568


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ++++.+|+.+||+.||.+||+..+++.|+|+...
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999999754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-48  Score=374.74  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=209.3

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-----PCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~-----~~h~~iv~l~~~~~~~  151 (371)
                      .....+|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.++..+     .+|+||+++++.+.. 
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-  170 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-  170 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence            3445689999999999999999999999999999999975 334445566777766544     258899999998854 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc--eEEeccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR--PKITDFG  227 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~--~kl~Dfg  227 (371)
                       ...+++||||+. ++|.+++....  .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||
T Consensus       171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence             568999999996 59999987654  49999999999999999999999 99999999999999999887  9999999


Q ss_pred             ccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC----
Q 017445          228 ISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS----  300 (371)
Q Consensus       228 ~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~----  300 (371)
                      ++......   ..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+..   .+.    
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred             cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHH
Confidence            99755432   24568999999999999999999999999999999999999999775432 22222211   000    


Q ss_pred             ---------------CC-----------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017445          301 ---------------PS-----------------------------------PSRQNFSPEFCSFVDDCLKKDAEARPTA  330 (371)
Q Consensus       301 ---------------~~-----------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~  330 (371)
                                     +.                                   ......++++.+||++||+.||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                           00                                   0012347889999999999999999999


Q ss_pred             HHHhcCcccccccc
Q 017445          331 DQLLSHPFITKYEH  344 (371)
Q Consensus       331 ~~il~hp~~~~~~~  344 (371)
                      .|+|+||||++...
T Consensus       404 ~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          404 GQALRHPWLRRRLP  417 (429)
T ss_dssp             HHHHTSTTTC----
T ss_pred             HHHhCChhhccCCC
Confidence            99999999987643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.8e-49  Score=370.90  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=197.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CCC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DSG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~~  154 (371)
                      ++|++++.||+|+||.||+|.+..+|+.||||++..  ........+.+|+.++..+. ||||+++++++...    +..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCC
Confidence            689999999999999999999999999999999865  34456677889999999987 99999999988532    225


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+|+|++ +++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            689999999 6799999874 679999999999999999999999 9999999999999999999999999999976544


Q ss_pred             cccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC----------
Q 017445          235 SIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS----------  300 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~----------  300 (371)
                      .   ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+. ...+..+..   .+.          
T Consensus       185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            3   245679999999999976 6799999999999999999999999976543 222222211   110          


Q ss_pred             ----------CCC------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          301 ----------PSP------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       301 ----------~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                ...      ....+++++.+||++||+.||++|||+.++|.||||..+..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                      000      013568899999999999999999999999999999987543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-49  Score=377.19  Aligned_cols=259  Identities=14%  Similarity=0.123  Sum_probs=196.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHH---HHHhCCCCCCeeEece-------
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIR---TLCEAPCNEGLVEFHG-------  146 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~~~~h~~iv~l~~-------  146 (371)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++....   ......+.+|+.   .+..  +||||++++.       
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~--~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG--ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC------------CBCCCCE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc--cChhhhhhceeEEeeeh
Confidence            346999999999999999999999999999999997632   334455667744   4444  5999888653       


Q ss_pred             eEEecCC---------------CeEEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHcCCCeE
Q 017445          147 AFYMPDS---------------GQISIALEYMDGGSLADILRMQ-KSIPEPIL------SSMFKKLLQGLSYLHGVRHLV  204 (371)
Q Consensus       147 ~~~~~~~---------------~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~------~~i~~qi~~aL~~LH~~~~ii  204 (371)
                      ++..+..               ..+||||||++ |+|.+++... ..+++..+      ..++.|++.||.|||+ +||+
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence            3322211               34899999998 7999999753 34555556      6788999999999999 9999


Q ss_pred             ecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCC
Q 017445          205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPY  282 (371)
Q Consensus       205 H~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf  282 (371)
                      ||||||+|||++.++.+||+|||++.......   ....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765432   24557799999999987  67999999999999999999999999


Q ss_pred             CCCCCcHHHHH------HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          283 AASEGPVNLML------QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       283 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      ...........      .........+....+++++.+||.+||+.||++|||+.++|+||||++..+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            76532111000      0011122223335789999999999999999999999999999999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-48  Score=363.07  Aligned_cols=259  Identities=30%  Similarity=0.432  Sum_probs=214.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....        ......+.+|+.++.++. ||||+++++++.. 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEES-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEcC-
Confidence            468999999999999999999999999999999986422        122345788999999986 9999999998742 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc---eEEecccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR---PKITDFGI  228 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~---~kl~Dfg~  228 (371)
                        ...|+||||+++++|.+++.....+++..++.++.|++.||.|||+ +||+||||||+||+++.++.   +||+|||+
T Consensus        87 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           87 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             --SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             --CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence              2489999999999999999888889999999999999999999999 99999999999999987654   99999999


Q ss_pred             cccCcccccccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--  303 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  303 (371)
                      +....... ......||+.|+|||++.   ...++.++||||||+++|+|++|..||............+........  
T Consensus       164 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (322)
T 2ycf_A          164 SKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  242 (322)
T ss_dssp             CEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred             ceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence            98765432 224567999999999973   567899999999999999999999999765544344444443332221  


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ....+++++.+|+.+||..||++||++.++++||||+....
T Consensus       243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence            12568999999999999999999999999999999987543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.2e-49  Score=368.13  Aligned_cols=271  Identities=26%  Similarity=0.426  Sum_probs=225.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHH-----------------HHHHHHHHHHHHhCCCCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-----------------RNQLLTEIRTLCEAPCNEG  140 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~~~~h~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+  +++.||||++.......                 ...+.+|+.++.++. |||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~  104 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY  104 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence            3457999999999999999999998  89999999986422111                 167889999999887 999


Q ss_pred             eeEeceeEEecCCCeEEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCc
Q 017445          141 LVEFHGAFYMPDSGQISIALEYMDGGSLADI------LRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPAN  212 (371)
Q Consensus       141 iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~------l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~N  212 (371)
                      |+++++++.  +.+..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+.+||+||||||+|
T Consensus       105 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          105 CLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             BCCCSEEEE--SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             cceEEEEEe--eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            999999875  45689999999999999998      655  56799999999999999999999964789999999999


Q ss_pred             EEEccCCceEEecccccccCcccccccccccccCcccCCccccCC-CCCC-chhHHHHHHHHHHHhcCCCCCCCCCCcHH
Q 017445          213 LLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-SYSY-PADIWSIGLALFECGTGEFPYAASEGPVN  290 (371)
Q Consensus       213 Il~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~il~ell~g~~pf~~~~~~~~  290 (371)
                      |+++.++.+||+|||.+......  ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||........
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999999876543  23456799999999999877 5666 99999999999999999999987665455


Q ss_pred             HHHHHhhCCCCCCCC-----------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHH
Q 017445          291 LMLQILEDPSPSPSR-----------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFV  353 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~  353 (371)
                      ....+.......+..                 ..+++++.+|+.+||+.||.+|||+.++++||||+....+.+  .++.
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~--~~~~  338 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL--REFS  338 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHH--HHHH
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHH--HHHH
Confidence            555555443333211                 568999999999999999999999999999999998775543  3555


Q ss_pred             HHhc
Q 017445          354 RSVF  357 (371)
Q Consensus       354 ~~~~  357 (371)
                      +.++
T Consensus       339 ~~~~  342 (348)
T 2pml_X          339 KELY  342 (348)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.4e-50  Score=379.43  Aligned_cols=255  Identities=15%  Similarity=0.137  Sum_probs=203.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCC--CCCCeeEece-----
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAP--CNEGLVEFHG-----  146 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~--~h~~iv~l~~-----  146 (371)
                      ....++|++.+.||+|+||+||+|.+..+|+.||||++..   ........+.+|+.++..+.  +||||+++++     
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            3445789999999999999999999999999999999973   23345677889996555443  5999999984     


Q ss_pred             --eEEecC----------CC-----eEEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHcCCC
Q 017445          147 --AFYMPD----------SG-----QISIALEYMDGGSLADILRMQKSIPE-------PILSSMFKKLLQGLSYLHGVRH  202 (371)
Q Consensus       147 --~~~~~~----------~~-----~~~lv~E~~~~g~L~~~l~~~~~l~~-------~~~~~i~~qi~~aL~~LH~~~~  202 (371)
                        ++..++          .+     ..||||||+ +|+|.+++...+.+++       ..++.++.|++.||.|||+ +|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~  226 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YG  226 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CC
Confidence              332111          01     388999999 5799999987655655       8888899999999999999 99


Q ss_pred             eEecCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccccCC-----------CCCCchhHHHHHHH
Q 017445          203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE-----------SYSYPADIWSIGLA  271 (371)
Q Consensus       203 iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~i  271 (371)
                      |+||||||+|||++.++.+||+|||++.....   ...+.+| +.|+|||++.+.           .++.++|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999999999999999999986443   2245567 999999999877           89999999999999


Q ss_pred             HHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          272 LFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       272 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +|+|++|+.||...... .....+.      .....+++++.+|+.+||+.||++|||+.++++||||+....
T Consensus       303 l~elltg~~Pf~~~~~~-~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          303 IYWIWCADLPITKDAAL-GGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHHSSCCC-------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HHHHHHCCCCCcccccc-cchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            99999999999754321 1111111      122578999999999999999999999999999999986543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-48  Score=369.23  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=203.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      .++|++++.||+|+||+||+|.+..+++.||||++..  ........+.+|+.++..+. ||||+++++++...+    .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccccc
Confidence            3689999999999999999999999999999999965  34455677889999998886 999999999885432    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            378999999975 8888885  469999999999999999999999 999999999999999999999999999998665


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC-----------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS-----------  302 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  302 (371)
                      .. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ...+..++......           
T Consensus       179 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          179 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            43 223456799999999999999999999999999999999999999976542 33333333211100           


Q ss_pred             --------CC---------------C------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          303 --------PS---------------R------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       303 --------~~---------------~------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                              +.               +      ...++++.+||++||+.||++|||++++|+||||+.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                    00               0      00146789999999999999999999999999998654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.6e-48  Score=356.59  Aligned_cols=266  Identities=26%  Similarity=0.417  Sum_probs=218.5

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCC-CCCeeEeceeEEe
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPC-NEGLVEFHGAFYM  150 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~-h~~iv~l~~~~~~  150 (371)
                      ....+..++|++++.||+|+||.||+|.+. +++.||+|++..  ........+.+|+.++.++.. ||||+++++++. 
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-   98 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-   98 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-
Confidence            345667789999999999999999999874 588999999864  344566778899999988874 799999999774 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       +....|+||| +.+++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++ ++.+||+|||++.
T Consensus        99 -~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~  174 (313)
T 3cek_A           99 -TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIAN  174 (313)
T ss_dssp             -CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             -cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE-CCeEEEeeccccc
Confidence             4568999999 5578999999988899999999999999999999999 9999999999999997 5899999999998


Q ss_pred             cCccccc--ccccccccCcccCCccccC-----------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh
Q 017445          231 GLENSIA--MCATFVGTVTYMSPERIRN-----------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  297 (371)
                      .......  ......||+.|+|||.+.+           ..++.++||||||+++|+|++|..||...............
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            7654322  2235579999999999875           46888999999999999999999999876655555566665


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                      .......+...+.++.+++.+||..||++|||+.++++||||+....+
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            555555566778999999999999999999999999999999866543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.9e-48  Score=372.64  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=208.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~~  155 (371)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++....    ....+|+.++..+. ||||++++++|....    ..+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcC-CCCccceeeEEeccCCCCccee
Confidence            457999999999999999999999999999999986422    12346888888886 999999999886422    234


Q ss_pred             EEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccccc
Q 017445          156 ISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISA  230 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~  230 (371)
                      +++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+++
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            7799999986 7776654    35679999999999999999999999 999999999999999965 678999999998


Q ss_pred             cCcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC-------
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP-------  299 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~-------  299 (371)
                      ...... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+.+++.   .+       
T Consensus       206 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          206 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             ECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHHH
T ss_pred             hcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence            765432 23456899999999999764 799999999999999999999999987543 223332221   10       


Q ss_pred             ----CC---CC----------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          300 ----SP---SP----------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       300 ----~~---~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                          ..   .+          ....+++++.+||.+||+.||.+||++.++++||||..+....
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence                00   00          1235689999999999999999999999999999998875543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-48  Score=357.40  Aligned_cols=257  Identities=22%  Similarity=0.402  Sum_probs=213.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEE----EcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAV----HIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .+..++|++++.||+|+||+||+|.    +..+++.||||++..........+.+|+.++.++. ||||+++++++...+
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            4556799999999999999999998    56789999999998777777788999999999997 999999999886555


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ...+++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            567999999999999999997654 49999999999999999999999 9999999999999999999999999999987


Q ss_pred             Cccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-----------H---HHHHH
Q 017445          232 LENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-----------V---NLMLQ  294 (371)
Q Consensus       232 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-----------~---~~~~~  294 (371)
                      ......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......           .   .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            654321   223345778899999999889999999999999999999999998642110           0   01223


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+........+..+++++.+|+.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            33344445556789999999999999999999999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.5e-48  Score=353.35  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=219.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.++.++. ||||+++++++.  +.+..+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILE--DSSSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEe--CCCeEE
Confidence            36899999999999999999999999999999998642  2334567889999999885 999999999874  466899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---CceEEecccccccCcc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GRPKITDFGISAGLEN  234 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~~kl~Dfg~s~~~~~  234 (371)
                      +||||+++++|.+++...+.+++..++.++.|++.||.|||+ +|++||||||+||+++.+   +.+||+|||.+.....
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            999999999999999888889999999999999999999999 999999999999999764   4799999999876654


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEF  312 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  312 (371)
                      .. ......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||.... .......+.......  +....+++++
T Consensus       177 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          177 NT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             CS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             CC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            32 22445689999999998764 8999999999999999999999997644 334444454444332  2235789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .+|+++||..||++|||+.++++||||+++..
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            99999999999999999999999999987754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=358.15  Aligned_cols=262  Identities=27%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe---------
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM---------  150 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~---------  150 (371)
                      .++|++++.||+|+||+||+|.+..+++.||+|++..........+.+|+.++.++. ||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccccccccc
Confidence            468999999999999999999999999999999998766677788899999999986 9999999987632         


Q ss_pred             ---cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc-cCCceEEecc
Q 017445          151 ---PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LKGRPKITDF  226 (371)
Q Consensus       151 ---~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~-~~~~~kl~Df  226 (371)
                         .+....|+||||++ |+|.+++. .+++++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence               23468999999997 59999986 4679999999999999999999999 9999999999999997 5679999999


Q ss_pred             cccccCcccc---cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCC--
Q 017445          227 GISAGLENSI---AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPS--  300 (371)
Q Consensus       227 g~s~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  300 (371)
                      |.+.......   .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+.....  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILESIPVV  244 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHSCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC
Confidence            9998764321   12244567999999999865 6789999999999999999999999976542 222222222110  


Q ss_pred             ----------------------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 ----------------------PS----PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 ----------------------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                            +.    .....++.++.+|+++||+.||++|||+.++++||||+.+..+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence                                  00    01246899999999999999999999999999999999876654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-48  Score=358.70  Aligned_cols=269  Identities=18%  Similarity=0.319  Sum_probs=200.3

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCc---EEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHR---IIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      .....+..++|++.+.||+|+||+||+|.+..++.   .||||+++..  .......+.+|+.++.++. ||||++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   93 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGV   93 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhce
Confidence            34556777899999999999999999999877765   8999998753  3445677899999999885 9999999998


Q ss_pred             EEecCCC----eEEEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc
Q 017445          148 FYMPDSG----QISIALEYMDGGSLADILRMQK------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL  217 (371)
Q Consensus       148 ~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~  217 (371)
                      +...+..    ..++||||+++|+|.+++....      .+++..++.++.|++.||.|||+ +||+||||||+||+++.
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE  172 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC
Confidence            8643321    2499999999999999986432      59999999999999999999999 99999999999999999


Q ss_pred             CCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHH
Q 017445          218 KGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQ  294 (371)
Q Consensus       218 ~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~  294 (371)
                      ++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~  251 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNY  251 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-HHHHHH
Confidence            99999999999976644321  1233457789999999999999999999999999999999 9999976543 333344


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC-------HHHHhcCccccccccc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPT-------ADQLLSHPFITKYEHA  345 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~il~hp~~~~~~~~  345 (371)
                      +... .....+..+++++.+|+.+||+.||.+|||       +++++.|||+......
T Consensus       252 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          252 LIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             HHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             HhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            4333 334445678999999999999999999999       8889999999876544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.2e-48  Score=357.61  Aligned_cols=275  Identities=26%  Similarity=0.415  Sum_probs=215.3

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEc-CCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCC--CCCCeeEeceeEEe---
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHI-PTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAP--CNEGLVEFHGAFYM---  150 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~--~h~~iv~l~~~~~~---  150 (371)
                      ..++|++.+.||+|+||+||+|.+. .+++.||+|++....  ......+.+|+.++..+.  .||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3468999999999999999999985 678999999986422  112234556666665542  59999999998753   


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      ......++||||++ |+|.+++....  .+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence            24457899999998 59999997643  49999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC-----
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS-----  300 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~-----  300 (371)
                      +....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+..++.   .+.     
T Consensus       167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCcccCc
Confidence            98765432 33556799999999999998999999999999999999999999976543 333333321   100     


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHHHhcChhh
Q 017445          301 -----------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ  361 (371)
Q Consensus       301 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
                                       .......++..+.+|+.+||+.||.+|||+.++++||||+........    +.+.++|.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~----~~~~~~~~~  318 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN----LDSHLPPSQ  318 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCCC-------------
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhhh----hccCCCCcc
Confidence                             011224688999999999999999999999999999999988765544    344445544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=362.05  Aligned_cols=259  Identities=23%  Similarity=0.400  Sum_probs=220.2

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCC-------CcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEe
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPT-------HRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEF  144 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l  144 (371)
                      ...+.+..++|++.+.||+|+||+||+|.+..+       +..||+|+++.. .......+.+|+.++.++.+||||+++
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            345677889999999999999999999997543       357999999753 445567789999999999779999999


Q ss_pred             ceeEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCC
Q 017445          145 HGAFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDI  208 (371)
Q Consensus       145 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dl  208 (371)
                      ++++  .+.+..++||||+++|+|.+++....                .+++..++.++.|++.||.|||+ +||+||||
T Consensus       141 ~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dl  217 (382)
T 3tt0_A          141 LGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDL  217 (382)
T ss_dssp             EEEE--CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             eeee--ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCC
Confidence            9987  45667999999999999999997653                49999999999999999999999 99999999


Q ss_pred             CCCcEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCC
Q 017445          209 KPANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAAS  285 (371)
Q Consensus       209 kp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~  285 (371)
                      ||+|||++.++.+||+|||++.......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998765432  22234467889999999999999999999999999999999 99999764


Q ss_pred             CCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          286 EGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .  ...+...+........+..+++++.+|+.+||+.||++|||+.+++++
T Consensus       298 ~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 P--VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             C--HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C--HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4  333444444444455567899999999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-47  Score=363.60  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=208.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC----
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG----  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~----  154 (371)
                      ++|.+.+.||+|+||+||+|.+..+|+.||||++..  ........+.+|+.++..+. ||||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcccce
Confidence            689999999999999999999999999999999975  23445677889999999987 99999999988543221    


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..|+||||+. ++|.+++.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            2499999997 58988873  459999999999999999999999 9999999999999999999999999999976544


Q ss_pred             cccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC-----------
Q 017445          235 SIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP-----------  299 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~-----------  299 (371)
                      .   .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+. ...+.++..   .+           
T Consensus       197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            3   245678999999999977 6799999999999999999999999976442 222222211   00           


Q ss_pred             ---------CCCC------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          300 ---------SPSP------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       300 ---------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                               ....      ....+++++.+||++||+.||++|||+.++|+||||+.+..+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence                     0000      123578999999999999999999999999999999877543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-47  Score=358.89  Aligned_cols=263  Identities=27%  Similarity=0.411  Sum_probs=213.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec---CCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP---DSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~---~~~~  155 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++... .......+.+|+.++.++. ||||+++++++...   ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCccce
Confidence            46899999999999999999999999999999999753 3445567889999999986 99999999976432   2367


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      .|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++......
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            999999997 599999875 579999999999999999999999 99999999999999999999999999999766432


Q ss_pred             cc----------ccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCC--
Q 017445          236 IA----------MCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPS--  300 (371)
Q Consensus       236 ~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~--  300 (371)
                      ..          .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........  +......+.  
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            11          1233578999999998754 67899999999999999999999999765422211  111111111  


Q ss_pred             -------------------CC------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 -------------------PS------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 -------------------~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                         ..      .....+++++.+|+++||+.||++|||+.++++||||+.+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                               00      01136789999999999999999999999999999999876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-47  Score=352.51  Aligned_cols=258  Identities=24%  Similarity=0.431  Sum_probs=208.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec---------
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP---------  151 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~---------  151 (371)
                      ++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.++.++. ||||+++++++...         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhhcc
Confidence            589999999999999999999999999999999965 3455677889999998886 99999999987542         


Q ss_pred             --CCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          152 --DSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       152 --~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                        .....|+||||+++++|.+++...+ .+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence              2457899999999999999997543 57889999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccc--------------cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHH
Q 017445          229 SAGLENSI--------------AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML  293 (371)
Q Consensus       229 s~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~  293 (371)
                      +.......              .......||+.|+|||++.+. .++.++||||||+++|+|++   ||...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            97654321              122455799999999999764 68999999999999999998   6643222223333


Q ss_pred             HHhhC--CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          294 QILED--PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       294 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .+...  ..+.......+..+.+++++||+.||.+|||+.++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            33322  2233344567888999999999999999999999999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=366.57  Aligned_cols=259  Identities=22%  Similarity=0.352  Sum_probs=215.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEE-----EcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAV-----HIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+..++|++.+.||+|+||+||+|.     +..+++.||||+++.. .......+.+|+.++.++. ||||+++++++. 
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~-  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSL-  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe-
Confidence            4566899999999999999999999     4557889999999653 4555667889999999986 999999999874 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC---c
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQK-------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG---R  220 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~---~  220 (371)
                       +....++||||+++|+|.+++...+       .+++..++.++.|++.||.|||+ +||+||||||+|||++.++   .
T Consensus       145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 -QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             -cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence             4567899999999999999997643       48999999999999999999999 9999999999999999655   5


Q ss_pred             eEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhh
Q 017445          221 PKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~  297 (371)
                      +||+|||++.......  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ....... +.
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-~~~~~~~-i~  300 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEF-VT  300 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHH-HH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH-HH
Confidence            9999999997543221  22244568999999999998899999999999999999998 999997644 2333333 33


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      .......+..++..+.+|+.+||+.||.+|||+.+|++|.++..
T Consensus       301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            33344445678999999999999999999999999999988753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=356.00  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=211.3

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCc---EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHR---IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .+...+|++.+.||+|+||+||+|.+..++.   .||||+++.. .......+.+|+.++.++. ||||+++++++  .+
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~  121 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVV--TR  121 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE--CG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE--Ee
Confidence            4556799999999999999999999886554   5999999763 4556677899999998886 99999999987  44


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .+..|+||||+++++|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            56799999999999999999654 579999999999999999999999 9999999999999999999999999999987


Q ss_pred             Ccccccc---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          232 LENSIAM---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       232 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...... +........+..
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~  278 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISS-VEEGYRLPAPMG  278 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHHHH-HHTTCCCCCCTT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-HHHHHH-HHcCCCCCCCCC
Confidence            6543221   223346778999999998889999999999999999999 9999976442 333333 334444455678


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++++.+|+.+||..||.+|||+.++++
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999999964

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=352.40  Aligned_cols=258  Identities=23%  Similarity=0.407  Sum_probs=215.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE----KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ......+.+|+.++..+. ||||+++++++...+....
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---CE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCeE
Confidence            57899999999999999999999999999999997532    234567889999998886 9999999999876667789


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          157 SIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      |+||||++++ |.+++..  ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            9999999875 7777765  4569999999999999999999999 9999999999999999999999999999976543


Q ss_pred             c--ccccccccccCcccCCccccCCC--CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          235 S--IAMCATFVGTVTYMSPERIRNES--YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       235 ~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .  ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||.... .......+.....  ..+..+++
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~~--~~~~~~~~  238 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSY--AIPGDCGP  238 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCC--CCCSSSCH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHHhcCCC--CCCCccCH
Confidence            2  12234567999999999997644  3779999999999999999999997643 3333444444433  23457899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .+.+|+.+||..||.+|||+.++++||||++...
T Consensus       239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            9999999999999999999999999999987654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-47  Score=364.32  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=206.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCC-----CeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-----GLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~-----~iv~l~~~~~~~  151 (371)
                      ....++|++.+.||+|+||+||+|.+..+++.||||+++. ..........|+.++..+..|+     +|+++++.+.. 
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-  127 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-  127 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence            3446799999999999999999999999999999999975 3334455667777776655455     59999998754 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHc-CCCeEecCCCCCcEEEc--cCCceEEecc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHG-VRHLVHRDIKPANLLVN--LKGRPKITDF  226 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~-~~~iiH~Dlkp~NIl~~--~~~~~kl~Df  226 (371)
                       .+.+||||||+++ +|.+++...  +.+++..+..++.|++.||.|||+ ..||+||||||+|||++  .++.+||+||
T Consensus       128 -~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          128 -RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             -TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             -CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence             5689999999965 999999765  469999999999999999999995 26899999999999995  4688999999


Q ss_pred             cccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhC--CCC---
Q 017445          227 GISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSP---  301 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~---  301 (371)
                      |++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+...  ..+   
T Consensus       206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE-VDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHH
T ss_pred             cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence            999876543   2456799999999999999999999999999999999999999986543 2333322211  000   


Q ss_pred             ---------------C-----------------CCCC---------------------C----CCHHHHHHHHHhcccCc
Q 017445          302 ---------------S-----------------PSRQ---------------------N----FSPEFCSFVDDCLKKDA  324 (371)
Q Consensus       302 ---------------~-----------------~~~~---------------------~----~~~~~~~li~~~l~~dp  324 (371)
                                     .                 +...                     .    .++++.+||++||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                           0                 0000                     0    01378999999999999


Q ss_pred             CCCCCHHHHhcCccccccc
Q 017445          325 EARPTADQLLSHPFITKYE  343 (371)
Q Consensus       325 ~~Rps~~~il~hp~~~~~~  343 (371)
                      ++|||+.|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.4e-48  Score=369.59  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=207.7

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC-------CCCCeeEeceeEEe
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP-------CNEGLVEFHGAFYM  150 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-------~h~~iv~l~~~~~~  150 (371)
                      ....+|++.+.||+|+||+||+|.+..+++.||||++.. .......+.+|+.++..+.       +|+||+++++.+..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            345789999999999999999999999999999999975 3345566788888887664       38899999998863


Q ss_pred             c--CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEccCC------
Q 017445          151 P--DSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNLKG------  219 (371)
Q Consensus       151 ~--~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~~~------  219 (371)
                      .  +...+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||+ + ||+||||||+|||++.++      
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhh
Confidence            2  455799999999 55777766544  469999999999999999999999 8 999999999999998775      


Q ss_pred             -------------------------------------------ceEEecccccccCcccccccccccccCcccCCccccC
Q 017445          220 -------------------------------------------RPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN  256 (371)
Q Consensus       220 -------------------------------------------~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~  256 (371)
                                                                 .+||+|||.+......   ....+||+.|+|||++.+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence                                                       7999999999776543   245679999999999999


Q ss_pred             CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-----HHHHHHH---hhCCCC---------------------------
Q 017445          257 ESYSYPADIWSIGLALFECGTGEFPYAASEGP-----VNLMLQI---LEDPSP---------------------------  301 (371)
Q Consensus       257 ~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-----~~~~~~~---~~~~~~---------------------------  301 (371)
                      ..++.++|||||||++|+|++|..||......     ...+..+   ......                           
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            99999999999999999999999999764421     1111111   111100                           


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          302 ----------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       302 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                                .......+.++.+||.+||+.||++|||+.++|+||||+.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                      0001223467889999999999999999999999999963

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8e-48  Score=367.47  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----CC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----SG  154 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~~  154 (371)
                      ...+|++.+.||+|+||+||+|.+..+++ ||+|++.....    ...+|+.++..+. ||||+++++++....    ..
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCce
Confidence            34579999999999999999999877776 88888754221    1235888888886 999999999986533    22


Q ss_pred             eEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc-cCCceEEeccccc
Q 017445          155 QISIALEYMDGGSLADILR----MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LKGRPKITDFGIS  229 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~-~~~~~kl~Dfg~s  229 (371)
                      .+++||||+++ ++.+.+.    ....+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            48899999987 4444332    35679999999999999999999999 9999999999999999 7899999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC------
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP------  299 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~------  299 (371)
                      ....... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.... ..+..++.   .+      
T Consensus       190 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          190 KILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             EECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             ccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            8764432 23566799999999999765 5899999999999999999999999875432 22222221   10      


Q ss_pred             ----------CCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          300 ----------SPS--------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       300 ----------~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                .+.        .....+++++.+||.+||+.||.+|||+.++++||||+.+....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence                      000        11235789999999999999999999999999999999876544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-47  Score=345.54  Aligned_cols=255  Identities=23%  Similarity=0.390  Sum_probs=214.1

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..|.+..++|++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+|+.++.++. ||||+++++++  .+.
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--~~~   77 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS-HPKLVQLYGVC--LEQ   77 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCC-CTTBCCEEEEE--CSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCC-CCCEeeEEEEE--ecC
Confidence            356677889999999999999999999976 56789999997532 23356889999999987 99999999987  456


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      +..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            6899999999999999999654 458999999999999999999999 99999999999999999999999999999766


Q ss_pred             cccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          233 ENSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       233 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .... .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||.... .......+ ........+..+++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  234 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDI-STGFRLYKPRLAST  234 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHH-HTTCCCCCCTTSCH
T ss_pred             cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHH-hcCccCCCCCcCCH
Confidence            4432 22244557888999999998899999999999999999999 999997644 23333333 33344445567899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ++.+++.+||+.||.+|||+.++++|
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          235 HVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=358.51  Aligned_cols=261  Identities=23%  Similarity=0.344  Sum_probs=218.5

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+     ..+++.||+|++... .......+.+|+.++.++..||||++++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            35677889999999999999999999997     346678999999753 334456788999999999669999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeE
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQK-----------------------SIPEPILSSMFKKLLQGLSYLHGVRHLV  204 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~LH~~~~ii  204 (371)
                      +.  ..+..++||||+++|+|.+++....                       .+++..++.++.|++.||.|||+ +||+
T Consensus       118 ~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iv  194 (344)
T 1rjb_A          118 CT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCV  194 (344)
T ss_dssp             EC--SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             Ee--eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcc
Confidence            74  4668999999999999999997543                       37999999999999999999999 9999


Q ss_pred             ecCCCCCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCC
Q 017445          205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFP  281 (371)
Q Consensus       205 H~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~p  281 (371)
                      ||||||+||+++.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999986644322  2234567889999999988889999999999999999998 9999


Q ss_pred             CCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          282 YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      |....... .....+........+..+++++.+|+.+||..||.+|||+.++++|..
T Consensus       275 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          275 YPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             STTCCCSH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCCcHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            98765443 334444555555556778999999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-47  Score=352.67  Aligned_cols=261  Identities=23%  Similarity=0.385  Sum_probs=221.0

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      ....+++..++|++.+.||+|+||+||+|.+     ..+++.||+|++... .......+.+|+.++.++.+||||++++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            3456788889999999999999999999985     457889999999753 3345677899999999996799999999


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecC
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRMQK------------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRD  207 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~D  207 (371)
                      +++  .+.+..++||||+++|+|.+++....                  .+++..++.++.|++.||.|||+ +||+|||
T Consensus        94 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~d  170 (313)
T 1t46_A           94 GAC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRD  170 (313)
T ss_dssp             EEE--CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             EEE--ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCC
Confidence            987  44668999999999999999997654                  48999999999999999999999 9999999


Q ss_pred             CCCCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCC
Q 017445          208 IKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAA  284 (371)
Q Consensus       208 lkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~  284 (371)
                      |||+||+++.++.+||+|||++........  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999987654422  2234557889999999988899999999999999999999 9999987


Q ss_pred             CCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          285 SEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ...... ....+........+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          251 MPVDSK-FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CCSSHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchhH-HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            654433 333334344444556789999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=369.97  Aligned_cols=261  Identities=23%  Similarity=0.363  Sum_probs=196.1

Q ss_pred             ceeE-eeeecccCCeEEEEEEEc--CCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           82 EMRI-FGAIGSGASSVVQRAVHI--PTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        82 ~~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .|++ .++||+|+||+||+|.+.  .+++.||||++....  ....+.+|+.++..+. ||||+++++++.......+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEE
Confidence            4555 347999999999999965  578999999997532  2235778999999997 999999999998777889999


Q ss_pred             EEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE----ccCCceEEec
Q 017445          159 ALEYMDGGSLADILRMQ---------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITD  225 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~----~~~~~~kl~D  225 (371)
                      ||||+.+ +|.+++...         ..+++..++.++.||+.||.|||+ +||+||||||+|||+    +.++.+||+|
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9999975 888887532         249999999999999999999999 999999999999999    6778999999


Q ss_pred             ccccccCcccc---cccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--------HHHHH
Q 017445          226 FGISAGLENSI---AMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGP--------VNLML  293 (371)
Q Consensus       226 fg~s~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--------~~~~~  293 (371)
                      ||++.......   ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......        ...+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            99998765432   22345679999999999977 45899999999999999999999999764421        12222


Q ss_pred             HH---hhCCCCCC---------------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          294 QI---LEDPSPSP---------------------------------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       294 ~~---~~~~~~~~---------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      .+   +..+....                                 .....++++.+||++||+.||.+|||+.|+|+||
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            22   22111110                                 0112367899999999999999999999999999


Q ss_pred             cccccccccc
Q 017445          338 FITKYEHAKV  347 (371)
Q Consensus       338 ~~~~~~~~~~  347 (371)
                      ||.....+..
T Consensus       336 ~f~~~~~~~~  345 (405)
T 3rgf_A          336 YFLEDPLPTS  345 (405)
T ss_dssp             GGTSSSCCCS
T ss_pred             hhccCCCCcc
Confidence            9988755443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-47  Score=364.23  Aligned_cols=256  Identities=22%  Similarity=0.372  Sum_probs=216.8

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+..+++.||||.++.. .......+.+|+.++.++. ||||+++++++  .+
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~--~~  183 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVC--TQ  183 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEE--CS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE--ec
Confidence            45677889999999999999999999999999999999998753 3344566889999998886 99999999987  44


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .+.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            56799999999999999999764 359999999999999999999999 9999999999999999999999999999976


Q ss_pred             Cccccccc--ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAMC--ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ........  ....+++.|+|||++.+..++.++||||||+++|||++ |..||.....  ......+......+.+..+
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  340 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRLPCPELC  340 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCCCCCCTTC
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCC
Confidence            54432111  12235778999999988889999999999999999998 9999976542  2333444444445556778


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++++.+|+.+||+.||++|||+.++++
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.7e-48  Score=362.12  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=199.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC---
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS---  153 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~---  153 (371)
                      ....++|++.+.||+|+||+||+|.+..+|+.||||++.... ........++..+..+. ||||+++++++.....   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCT
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccc
Confidence            344568999999999999999999999999999999985422 22234456666666665 9999999999865322   


Q ss_pred             --CeEEEEEeccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--cCCCeEecCCCCCcEEEcc-CCceEEe
Q 017445          154 --GQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYLH--GVRHLVHRDIKPANLLVNL-KGRPKIT  224 (371)
Q Consensus       154 --~~~~lv~E~~~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~iiH~Dlkp~NIl~~~-~~~~kl~  224 (371)
                        ..+++||||+++ +|.+.+    .....+++..+..++.|++.||.|||  + +||+||||||+|||++. ++.+||+
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEe
Confidence              248899999986 555443    34567999999999999999999999  8 99999999999999997 8999999


Q ss_pred             cccccccCcccccccccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC
Q 017445          225 DFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS  300 (371)
Q Consensus       225 Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~  300 (371)
                      |||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ...+..+..   .+.
T Consensus       175 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          175 DFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCPS  252 (360)
T ss_dssp             CCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCC
T ss_pred             eCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCCC
Confidence            999998766542 334567999999999996554 89999999999999999999999977543 223333221   000


Q ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          301 ---------------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       301 ---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                                                 ........++++.+||.+||+.||.+|||+.++|+||||+......
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                       0011223568999999999999999999999999999999886544

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-47  Score=356.36  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=208.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEE-cCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC-----CCCCeeEeceeEEec
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVH-IPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP-----CNEGLVEFHGAFYMP  151 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-----~h~~iv~l~~~~~~~  151 (371)
                      ...++|++.+.||+|+||+||+|.+ ..+++.||||+++.. ......+.+|+.++..+.     .|++++++++++.  
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~--   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE--   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE--
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc--
Confidence            4457999999999999999999998 568899999999753 334456677777765543     3556999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc------------
Q 017445          152 DSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL------------  217 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~------------  217 (371)
                      +.+..++||||+ +++|.+++...+  ++++..+..++.|++.||.|||+ +||+||||||+||+++.            
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            456899999999 789999997665  68999999999999999999999 99999999999999987            


Q ss_pred             -------CCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH
Q 017445          218 -------KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN  290 (371)
Q Consensus       218 -------~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~  290 (371)
                             ++.+||+|||.+......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   668999999998765432   2456799999999999999999999999999999999999999976543221


Q ss_pred             H--HHHHhhCCCC----------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017445          291 L--MLQILEDPSP----------------------------------------SPSRQNFSPEFCSFVDDCLKKDAEARP  328 (371)
Q Consensus       291 ~--~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp  328 (371)
                      .  +..... ..+                                        .......++++.+|+.+||+.||.+||
T Consensus       243 ~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          243 LAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            1  111111 110                                        001122356789999999999999999


Q ss_pred             CHHHHhcCcccccccc
Q 017445          329 TADQLLSHPFITKYEH  344 (371)
Q Consensus       329 s~~~il~hp~~~~~~~  344 (371)
                      |+.++++||||+..+.
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.1e-47  Score=342.69  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=212.5

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      +.+..++|++++.||+|+||+||+|.+. ++..||+|++.... .....+.+|+.++.++. ||||+++++++  .+...
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--~~~~~   77 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLS-HPKLVKFYGVC--SKEYP   77 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCC-CTTBCCEEEEE--CSSSS
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCC-CCCEeeEEEEE--ccCCc
Confidence            4566789999999999999999999765 56789999997532 23356889999999987 99999999977  55668


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.....
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999999999997654 59999999999999999999999 9999999999999999999999999999976544


Q ss_pred             ccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          235 SIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       235 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+ ........+..+++.+
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~l  234 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKV-SQGHRLYRPHLASDTI  234 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHH-HTTCCCCCCTTSCHHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-HHHHHHH-HcCCCCCCCCcChHHH
Confidence            322 2234456778999999998889999999999999999999 9999976443 3333333 3333444456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+++.+||+.||++|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.7e-47  Score=352.12  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=217.1

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+++..++|++.+.||+|+||.||+|.+.     .+++.||+|++... .......+.+|+.++..+. ||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEE
Confidence            356777889999999999999999999873     45689999999753 3455677889999998885 9999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHcCCCe
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQKS------------------------IPEPILSSMFKKLLQGLSYLHGVRHL  203 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~~LH~~~~i  203 (371)
                      +  .+.+..++||||+++++|.+++.....                        +++..++.++.|++.||.|||+ +||
T Consensus        95 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i  171 (314)
T 2ivs_A           95 C--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKL  171 (314)
T ss_dssp             E--CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             E--ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCC
Confidence            7  456689999999999999999976543                        8999999999999999999999 999


Q ss_pred             EecCCCCCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCC
Q 017445          204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEF  280 (371)
Q Consensus       204 iH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~  280 (371)
                      +||||||+||+++.++.+||+|||++........  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999976644322  2234457889999999998889999999999999999999 999


Q ss_pred             CCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          281 PYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       281 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ||..... .. +...+........+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       252 p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPGIPP-ER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTTCCG-GG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCH-HH-HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9976543 22 334444444445567899999999999999999999999999865

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.8e-47  Score=356.82  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=209.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC----
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS----  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~----  153 (371)
                      ..+|.+.+.||+|+||+||+|.+..+|+.||||++..  ........+.+|+.++..+. ||||+++++++...+.    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccccc
Confidence            3589999999999999999999999999999999965  23445677889999999887 9999999998854322    


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ...|+||||+. ++|.+++.  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            24699999997 59988774  459999999999999999999999 999999999999999999999999999997654


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---------------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---------------  297 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------  297 (371)
                      ..   .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+. ...+..+..               
T Consensus       178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHHHhh
Confidence            33   245678999999999976 6789999999999999999999999976542 222222211               


Q ss_pred             --------C------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          298 --------D------PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       298 --------~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                              .      .........+++++.+||.+||+.||++|||+.++++||||+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                    0      0011123467899999999999999999999999999999987754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-47  Score=355.76  Aligned_cols=257  Identities=22%  Similarity=0.388  Sum_probs=220.6

Q ss_pred             ecCcceeEeeeecccCCeEEEEEE----EcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAV----HIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      +..++|++++.||+|+||+||+|.    +..+++.||||++..........+.+|+.++.++. ||||+++++++..++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCC
Confidence            445799999999999999999998    56789999999998777777788999999999985 9999999999887777


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            889999999999999999976 4569999999999999999999999 99999999999999999999999999999866


Q ss_pred             ccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC-------------cHHHHHHHh
Q 017445          233 ENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG-------------PVNLMLQIL  296 (371)
Q Consensus       233 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~-------------~~~~~~~~~  296 (371)
                      .....   ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....             ........+
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            43321   22345688899999999988899999999999999999999999864321             112333444


Q ss_pred             hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ........+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5555555667899999999999999999999999999644

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3e-47  Score=355.94  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=186.2

Q ss_pred             cCcceeEee-eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CCCe
Q 017445           79 ASHEMRIFG-AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQ  155 (371)
Q Consensus        79 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~~~  155 (371)
                      ..++|.+.+ .||+|+||+||+|.+..+++.||||++....     ....|+..+.+...||||+++++++...  +...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            346788865 6999999999999999999999999996532     1233444444445699999999988542  2446


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEecccccc
Q 017445          156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISA  230 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~  230 (371)
                      +++||||+++|+|.+++...+  .+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||++.
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            899999999999999998653  69999999999999999999999 99999999999999976   4569999999997


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH---HHHHHh--hCCCCCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN---LMLQIL--EDPSPSPSR  305 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~---~~~~~~--~~~~~~~~~  305 (371)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|..||........   ....+.  ....+....
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (336)
T 3fhr_A          180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW  257 (336)
T ss_dssp             EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred             ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence            65533  22456789999999999888899999999999999999999999976443211   011111  112233334


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      ..+++++.+|+.+||+.||.+|||+.++++||||++..
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            67899999999999999999999999999999998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.7e-47  Score=358.62  Aligned_cols=261  Identities=21%  Similarity=0.292  Sum_probs=204.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-----------cHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-----------EKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      ....++|++.+.||+|+||+||+|.+.. |+.||||++...           .......+.+|+.++.++. ||||++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~   95 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLR   95 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcccee
Confidence            3445789999999999999999998754 899999998531           2233477899999999997 99999999


Q ss_pred             eeEEec---CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCce
Q 017445          146 GAFYMP---DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRP  221 (371)
Q Consensus       146 ~~~~~~---~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~  221 (371)
                      +++...   ....+|+||||++ |+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCE
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCCCE
Confidence            988652   3447899999998 5888887644 469999999999999999999999 999999999999999999999


Q ss_pred             EEecccccccCcccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---
Q 017445          222 KITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---  297 (371)
Q Consensus       222 kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---  297 (371)
                      ||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+..   
T Consensus       174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~  251 (362)
T 3pg1_A          174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-YNQLNKIVEVVG  251 (362)
T ss_dssp             EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHC
T ss_pred             EEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcC
Confidence            99999999755443 22345679999999999976 6789999999999999999999999976542 222222211   


Q ss_pred             --------------------CCCCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          298 --------------------DPSPS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       298 --------------------~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                                          .....       .....+++.+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                                10000       01235688999999999999999999999999999998774

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6e-47  Score=344.97  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=212.7

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+.+..++|++++.||+|+||+||+|.+. ++..||+|++.... .....+.+|+.++.++. ||||+++++++  .+.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--~~~   91 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLS-HEKLVQLYGVC--TKQ   91 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCC-CTTBCCEEEEE--CSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCC-CCCEeeEEEEE--ecC
Confidence            466777889999999999999999999865 67789999997532 22356889999999987 99999999977  456


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      +..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            689999999999999999976 4679999999999999999999999 99999999999999999999999999999766


Q ss_pred             ccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          233 ENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       233 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+ ........+..+++
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~-~~~~~~~~~~~~~~  248 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHI-AQGLRLYRPHLASE  248 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHH-HTTCCCCCCTTCCH
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-hhHHHHHH-hcccCCCCCCcCCH
Confidence            44322 2234457788999999998889999999999999999998 999997644 23333333 34444445567899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+.+++.+||+.||.+|||+.++++|
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-47  Score=355.06  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=214.3

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      .+.+..++|++.+.||+|+||+||+|.+.     .+++.||+|+++.. .......+.+|+.++.++. ||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE
Confidence            45667789999999999999999999987     45589999999753 3445677899999999986 99999999987


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeE
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQ------------------------KSIPEPILSSMFKKLLQGLSYLHGVRHLV  204 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~ii  204 (371)
                        .+.+..|+||||+++|+|.+++...                        ..+++..++.++.|++.||.|||+ +||+
T Consensus       120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iv  196 (343)
T 1luf_A          120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFV  196 (343)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCC
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCee
Confidence              4566899999999999999999763                        568999999999999999999999 9999


Q ss_pred             ecCCCCCcEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCC
Q 017445          205 HRDIKPANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFP  281 (371)
Q Consensus       205 H~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~p  281 (371)
                      ||||||+||+++.++.+||+|||++.......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999999999999999999997654332  22234568899999999998889999999999999999999 9999


Q ss_pred             CCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          282 YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      |.... .......+... .....+..+++++.+++++||+.||++|||+.++++
T Consensus       277 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMA-HEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSC-HHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCC-hHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            97644 33333444333 333445688999999999999999999999999974

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.2e-47  Score=345.23  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=203.8

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+..+   +..||+|.+.. ........+.+|+..+.++. ||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence            35677788999999999999999999998654   45799999875 33455677889999998886 999999999862


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                         .+..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+
T Consensus        87 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 ---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             ---cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCCCEEECcccc
Confidence               456899999999999999997654 69999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          229 SAGLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       229 s~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      +........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+... .....+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-~~~~~~i~~~-~~~~~~~  240 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG-ERLPMPP  240 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTT-CCCCCCT
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-HHHHHHHHcC-CCCCCCC
Confidence            987654322 1233457789999999998889999999999999999996 9999976543 3333343333 3334556


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+++++.+++.+||..||++|||+.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999998753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=352.10  Aligned_cols=263  Identities=20%  Similarity=0.288  Sum_probs=214.5

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec-
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP-  151 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~-  151 (371)
                      ...+.+..++|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+.++..+. ||||+++++++... 
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN-HPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEE
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEecc
Confidence            3456677789999999999999999999999999999999997766677788899999998886 99999999988643 


Q ss_pred             -CCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          152 -DSGQISIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       152 -~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                       .....++||||+++|+|.+++..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEec
Confidence             33478999999999999999875    4679999999999999999999999 99999999999999999999999999


Q ss_pred             cccccCcccccc---------cccccccCcccCCccccCCC---CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 017445          227 GISAGLENSIAM---------CATFVGTVTYMSPERIRNES---YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ  294 (371)
Q Consensus       227 g~s~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~  294 (371)
                      |.+.........         .....||+.|+|||++.+..   ++.++||||||+++|+|++|..||............
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            998765432111         12345799999999997654   689999999999999999999999531111111222


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      ........+....+++++.+++.+||+.||.+|||+.+++++-
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            2333334444567899999999999999999999999998763

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.8e-47  Score=351.46  Aligned_cols=260  Identities=23%  Similarity=0.393  Sum_probs=219.8

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEE-----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVH-----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+     ..+++.||||++... .......+.+|+.++.++.+||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            45667788999999999999999999985     457789999999753 344556788999999999779999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCC
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQKS----------------IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA  211 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~  211 (371)
                      +.. ..+.+++||||+++++|.+++.....                +++..++.++.|++.||.|||+ +||+||||||+
T Consensus       100 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~  177 (316)
T 2xir_A          100 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAAR  177 (316)
T ss_dssp             ECC-TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             Eec-CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccc
Confidence            753 34568999999999999999986543                8999999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCc
Q 017445          212 NLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGP  288 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~  288 (371)
                      ||+++.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999986644322  2234568899999999998899999999999999999998 99999876654


Q ss_pred             HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ......+... .....+..+++++.+++.+||..||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccC-ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444444433 3334456789999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-46  Score=351.59  Aligned_cols=258  Identities=23%  Similarity=0.385  Sum_probs=215.3

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEc-------CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHI-------PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+.       .+++.||+|+++.. .......+.+|+.++.++.+||||++++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            456777889999999999999999999975       46788999999753 3455677889999999996799999999


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCC
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK  209 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlk  209 (371)
                      +++  .+.+.+++||||+++|+|.+++....                .+++..++.++.|++.||.|||+ +||+|||||
T Consensus       108 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlk  184 (334)
T 2pvf_A          108 GAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLA  184 (334)
T ss_dssp             EEE--CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCS
T ss_pred             EEE--ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCc
Confidence            987  45668999999999999999997644                38999999999999999999999 999999999


Q ss_pred             CCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCC
Q 017445          210 PANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASE  286 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~  286 (371)
                      |+||+++.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999999976654321  2233457889999999988889999999999999999999 999997643


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                       .......+ ........+..++.++.+++.+||..||.+|||+.+++++
T Consensus       265 -~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 -VEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             -HHHHHHHH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             23333333 3333344456789999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.2e-47  Score=346.92  Aligned_cols=249  Identities=18%  Similarity=0.307  Sum_probs=208.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCC-------cEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTH-------RIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ++..++|++.+.||+|+||+||+|.+..++       ..||+|++..........+.+|+.++.++. ||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-HKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence            455679999999999999999999988777       479999997766666778899999999987 999999999874


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc--------
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR--------  220 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~--------  220 (371)
                        +.+..++||||+++++|.+++...+. +++..+..++.|++.||.|||+ +||+||||||+||+++.++.        
T Consensus        83 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           83 --CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             --CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             --eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccccce
Confidence              45678999999999999999986654 9999999999999999999999 99999999999999998887        


Q ss_pred             eEEecccccccCcccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC
Q 017445          221 PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP  299 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  299 (371)
                      +||+|||.+......    ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+........ ........
T Consensus       160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~  234 (289)
T 4fvq_A          160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR  234 (289)
T ss_dssp             EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT
T ss_pred             eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc
Confidence            999999998765443    34458999999999987 6799999999999999999995544433333222 22333332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          300 SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .  ..+...++++.+|+.+||+.||++|||+.++++|
T Consensus       235 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 H--QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             C--CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             C--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2  2234568899999999999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.5e-47  Score=353.34  Aligned_cols=258  Identities=23%  Similarity=0.335  Sum_probs=204.8

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ....+.+...+|++.+.||+|+||+||+|.+.  ++.||||++.... ........|+..+.++. ||||+++++++...
T Consensus        15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   90 (322)
T 3soc_A           15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMK-HENILQFIGAEKRG   90 (322)
T ss_dssp             CCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE
T ss_pred             CccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCC-CCCchhhcceeccC
Confidence            34456778889999999999999999999874  7899999997533 33344566888887776 99999999998754


Q ss_pred             C--CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC----------CeEecCCCCCcEEEccCC
Q 017445          152 D--SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR----------HLVHRDIKPANLLVNLKG  219 (371)
Q Consensus       152 ~--~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------~iiH~Dlkp~NIl~~~~~  219 (371)
                      .  ...+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+ .          ||+||||||+|||++.++
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC
Confidence            4  3458999999999999999975 569999999999999999999999 8          999999999999999999


Q ss_pred             ceEEecccccccCccccc--ccccccccCcccCCccccCC-----CCCCchhHHHHHHHHHHHhcCCCCCCCCCCc----
Q 017445          220 RPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNE-----SYSYPADIWSIGLALFECGTGEFPYAASEGP----  288 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~ell~g~~pf~~~~~~----  288 (371)
                      .+||+|||++........  ......||+.|+|||++.+.     .++.++|||||||++|+|++|+.||......    
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999976544322  22346799999999999763     4566889999999999999999999754321    


Q ss_pred             ----------HHHHHH-HhhCCCCCCCCC-----CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          289 ----------VNLMLQ-ILEDPSPSPSRQ-----NFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       289 ----------~~~~~~-~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                                ...+.. ............     ..++++.+|+.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                      111222 222222111111     12355999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.4e-47  Score=344.71  Aligned_cols=255  Identities=21%  Similarity=0.360  Sum_probs=218.9

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+++..++|++.+.||+|+||+||+|.+..++..||+|.+... ......+.+|+.++..+. ||||+++++++  .+.
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--~~~   81 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK-HPNLVQLLGVC--TRE   81 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCC-CTTBCCEEEEE--CSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--ccC
Confidence            45677788999999999999999999999999999999999753 334567889999999997 99999999977  456


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+..
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            6899999999999999999764  449999999999999999999999 9999999999999999999999999999987


Q ss_pred             Ccccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          232 LENSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....  ......+........+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRMERPEGCP  238 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCCCCCTTCC
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhccCCCCCCCCCC
Confidence            65432 22334457889999999998899999999999999999999 9999976542  22334444444455567899


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++.+|+++||..||.+|||+.++++
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999999964

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.7e-46  Score=339.19  Aligned_cols=250  Identities=15%  Similarity=0.279  Sum_probs=213.2

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+..++|++.+.||+|+||+||+|.+  +++.||+|++...  .......+.+|+.++.++. ||||+++++++...+.
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCC
Confidence            345667999999999999999999997  4789999999753  3455677889999988885 9999999998865555


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEccCCceEEeccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      ...++||||+++|+|.+++....  .+++..++.++.|++.||.|||+ +|  ++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccce
Confidence            78999999999999999998655  48999999999999999999999 89  999999999999999999999999987


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCC---chhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSY---PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .....     ....||+.|+|||.+.+..++.   ++||||||+++|+|++|..||.... .................+.
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~  234 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPP  234 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCT
T ss_pred             eeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCC
Confidence            54332     3456899999999998765554   7999999999999999999997654 3444455555555555667


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999999999999999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-46  Score=349.87  Aligned_cols=258  Identities=22%  Similarity=0.385  Sum_probs=218.1

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCc-----EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHR-----IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+..+++     .||+|.+... .......+.+|+.++..+.+||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3577888999999999999999999999877664     7999999753 344567788999999999669999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcE
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQ--------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL  213 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NI  213 (371)
                      +  .+.+..++||||+++|+|.+++...              ..+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus       119 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 C--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNV  195 (333)
T ss_dssp             E--CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGC
T ss_pred             E--ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceE
Confidence            7  4566899999999999999998642              358999999999999999999999 9999999999999


Q ss_pred             EEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHH
Q 017445          214 LVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVN  290 (371)
Q Consensus       214 l~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~  290 (371)
                      +++.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            999999999999999986544322  2234557889999999988889999999999999999998 9999987554333


Q ss_pred             HHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          291 LMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                       .............+..+++++.+++.+||+.||.+|||+.++++
T Consensus       276 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 -FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             -HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence             33444444444455678999999999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-46  Score=352.90  Aligned_cols=260  Identities=27%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCC-cEEEEEEeccccHHHHHHHHHHHHHHHhCC-----CCCCeeEeceeEEec
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTH-RIIALKKINIFEKEKRNQLLTEIRTLCEAP-----CNEGLVEFHGAFYMP  151 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-----~h~~iv~l~~~~~~~  151 (371)
                      ...++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ......+.+|+.++..+.     .+++++.+++++.  
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~--   92 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN--   92 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE--
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee--
Confidence            44679999999999999999999998777 78999999753 344556677887776654     2334888888774  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE--------------
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV--------------  215 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~--------------  215 (371)
                      ..+..+|||||+ +++|.+++...  ..+++..++.++.|++.||.|||+ +||+||||||+|||+              
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence            356899999999 56777777654  369999999999999999999999 999999999999999              


Q ss_pred             -----ccCCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH
Q 017445          216 -----NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN  290 (371)
Q Consensus       216 -----~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~  290 (371)
                           +.++.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                 66789999999999765433   2456799999999999999999999999999999999999999976543221


Q ss_pred             H--HHHHhhCCCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCcCCCC
Q 017445          291 L--MLQILEDPSPS----------------------------------------PSRQNFSPEFCSFVDDCLKKDAEARP  328 (371)
Q Consensus       291 ~--~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp  328 (371)
                      .  +.... ...+.                                        ......+.++.+||++||+.||++||
T Consensus       248 ~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 LVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            1  11111 11110                                        00112245788999999999999999


Q ss_pred             CHHHHhcCcccccccccc
Q 017445          329 TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       329 s~~~il~hp~~~~~~~~~  346 (371)
                      |+.++++||||+....+.
T Consensus       327 t~~e~l~hp~f~~~~~~~  344 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPEE  344 (355)
T ss_dssp             CHHHHTTSGGGGGCCHHH
T ss_pred             CHHHHhcChhhcCCChhh
Confidence            999999999999876543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.4e-47  Score=354.24  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=215.3

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------HHHHHHHHHHHHHHhCC-CCCCeeEeceeE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------EKRNQLLTEIRTLCEAP-CNEGLVEFHGAF  148 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~-~h~~iv~l~~~~  148 (371)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++.....      .....+.+|+.++.++. .||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34456789999999999999999999999999999999865221      12244567888888876 389999999987


Q ss_pred             EecCCCeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc-cCCceEEecc
Q 017445          149 YMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LKGRPKITDF  226 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~-~~~~~kl~Df  226 (371)
                      .  +.+..++|||++.+ ++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+||
T Consensus       118 ~--~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          118 E--RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             E--CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             e--cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            4  45689999999986 8999999888899999999999999999999999 9999999999999999 6799999999


Q ss_pred             cccccCcccccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          227 GISAGLENSIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       227 g~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      |++......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....       .......  ...
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~--~~~  263 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--FFR  263 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--CCS
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc--ccc
Confidence            999876543  2245679999999999976665 688999999999999999999996421       1222222  234


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ..+++++.+|+++||+.||++|||+.++++||||+....+.
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence            57899999999999999999999999999999999876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-46  Score=345.09  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=212.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEE----EcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAV----HIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      .+...+|++++.||+|+||.||+|.    +..+++.||+|++.... ......+.+|+.++..+. ||||+++++++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence            4456789999999999999999998    56789999999997532 234467889999999886 99999999998766


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccccc
Confidence            55779999999999999999954 4679999999999999999999999 999999999999999999999999999997


Q ss_pred             cCcccc---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC-------------CcHHHHHH
Q 017445          231 GLENSI---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASE-------------GPVNLMLQ  294 (371)
Q Consensus       231 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~-------------~~~~~~~~  294 (371)
                      ......   .......+|+.|+|||++.+..++.++||||||+++|+|++|..|+....             .....+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            765432   22345568889999999998889999999999999999999998864321             11122333


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+........+..+++++.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            44444555566789999999999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2e-46  Score=347.81  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=216.2

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEece
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHG  146 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~  146 (371)
                      ...+++..++|++.+.||+|+||+||+|.+.     .+++.||+|.+... .......+.+|+.++..+. ||||+++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~   95 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLG   95 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEE
Confidence            3456777889999999999999999999876     45788999999753 3445567889999998886 999999999


Q ss_pred             eEEecCCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc
Q 017445          147 AFYMPDSGQISIALEYMDGGSLADILRMQ----------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN  216 (371)
Q Consensus       147 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~  216 (371)
                      ++  .+....++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+ +||+||||||+||+++
T Consensus        96 ~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EE--CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEEC
T ss_pred             EE--ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEc
Confidence            87  4566899999999999999998642          457999999999999999999999 9999999999999999


Q ss_pred             cCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 017445          217 LKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLML  293 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~  293 (371)
                      .++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ......
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HHHHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-HHHHHH
Confidence            999999999999976544322  2234457889999999998889999999999999999999 899997643 233333


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+... .....+..+++.+.+++.+||+.||.+|||+.++++|
T Consensus       252 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          252 FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            33333 3334456789999999999999999999999999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-46  Score=340.01  Aligned_cols=250  Identities=25%  Similarity=0.457  Sum_probs=202.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH----HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK----EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ++...+|++.+.||+|+||+||+|.+  +++.||+|++.....    .....+.+|+.++..+. ||||+++++++  .+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~--~~   77 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVC--LK   77 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEE--CC
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEE--ec
Confidence            34567999999999999999999987  478999999865322    22456788999998887 99999999987  45


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC---eEecCCCCCcEEEcc--------CCce
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH---LVHRDIKPANLLVNL--------KGRP  221 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~---iiH~Dlkp~NIl~~~--------~~~~  221 (371)
                      .+..++||||+++++|.+++. .+.+++..++.++.|++.||.|||+ +|   |+||||||+||+++.        ++.+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCcce
Confidence            667999999999999999986 5689999999999999999999999 88   999999999999986        6789


Q ss_pred             EEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC
Q 017445          222 KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP  301 (371)
Q Consensus       222 kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  301 (371)
                      ||+|||.+........  ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..............
T Consensus       156 kl~Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~  232 (271)
T 3dtc_A          156 KITDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLA  232 (271)
T ss_dssp             EECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-HHHHHHHHHTSCCC
T ss_pred             EEccCCcccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHhhhcCCCC
Confidence            9999999976654322  34579999999999998889999999999999999999999997654 33444455555555


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ...+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            56667899999999999999999999999999865

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.1e-47  Score=351.69  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=205.4

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEE----EEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +..++|++.+.||+|+||+||+|.+..+++.+    |+|.+... .......+.+|+.++.++. ||||+++++++..  
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--   88 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES--
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec--
Confidence            45678999999999999999999988887654    77776542 2344567889999999997 9999999998853  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                       +..++|+||+.+|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence             348899999999999999976 4569999999999999999999999 9999999999999999999999999999976


Q ss_pred             Ccccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      .......  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....  ..+...+........+..+
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  244 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCCTTB
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHcCCCCCCCccC
Confidence            5433221  233456889999999999999999999999999999999 9999976543  2234444444445556778


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.++.+++.+||+.||.+||++.+++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.9e-46  Score=344.13  Aligned_cols=252  Identities=30%  Similarity=0.527  Sum_probs=202.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI---FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++..   ........+.+|+.++.++. ||||+++++++..  .+..
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~  107 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE--DNEL  107 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc--CCcE
Confidence            3589999999999999999999999999999999974   34556677889999999886 9999999998854  5689


Q ss_pred             EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          157 SIALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999999864    4569999999999999999999999 99999999999999999999999999999876


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH-HHHHHHhhCCCCCCCCCCCCHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV-NLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ...........|++.|+|||++.+..++.++||||||+++|+|++|..||....... .....+.....+......++++
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            654444455679999999999999999999999999999999999999997654333 3333444444444445678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+++.+||..||.+|||+.++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.2e-47  Score=358.67  Aligned_cols=262  Identities=25%  Similarity=0.397  Sum_probs=208.6

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC----------CCCCeeEece
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP----------CNEGLVEFHG  146 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----------~h~~iv~l~~  146 (371)
                      .+...+|++.+.||+|+||+||+|.+..+++.||||++.. .......+.+|+.++.++.          .||||+++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3456799999999999999999999999999999999975 3344556777887776654          2899999999


Q ss_pred             eEEecC--CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCC-CeEecCCCCCcEEEcc----
Q 017445          147 AFYMPD--SGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVR-HLVHRDIKPANLLVNL----  217 (371)
Q Consensus       147 ~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~-~iiH~Dlkp~NIl~~~----  217 (371)
                      ++...+  ...+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+ + ||+||||||+|||++.    
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCC
Confidence            886532  23789999999 88999999763  459999999999999999999999 8 9999999999999954    


Q ss_pred             --CCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC-----cHH
Q 017445          218 --KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG-----PVN  290 (371)
Q Consensus       218 --~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~-----~~~  290 (371)
                        .+.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              347999999999766543   2445799999999999999999999999999999999999999976432     111


Q ss_pred             HHHHHhh--CCCC--------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017445          291 LMLQILE--DPSP--------------------------------------SPSRQNFSPEFCSFVDDCLKKDAEARPTA  330 (371)
Q Consensus       291 ~~~~~~~--~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~  330 (371)
                      .+.++..  +..+                                      ...+..++.++.+||.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            2222211  0000                                      01112345788999999999999999999


Q ss_pred             HHHhcCcccccccc
Q 017445          331 DQLLSHPFITKYEH  344 (371)
Q Consensus       331 ~~il~hp~~~~~~~  344 (371)
                      .++|+||||+....
T Consensus       329 ~ell~hp~f~~~~~  342 (373)
T 1q8y_A          329 GGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHTCGGGTTCTT
T ss_pred             HHHhhChhhhcccC
Confidence            99999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.4e-46  Score=340.68  Aligned_cols=250  Identities=21%  Similarity=0.392  Sum_probs=210.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH----HH---HHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK----EK---RNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~---~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|++.....    ..   ...+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   93 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMH   93 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEET
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeec
Confidence            3556799999999999999999999999999999999864221    11   156889999999886 999999999873


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEccCCc-----e
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNLKGR-----P  221 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~~~~-----~  221 (371)
                        +.  .++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|  |+||||||+||+++.++.     +
T Consensus        94 --~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           94 --NP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --TT--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --CC--CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeE
Confidence              32  37999999999999888644 469999999999999999999999 99  999999999999988776     9


Q ss_pred             EEecccccccCcccccccccccccCcccCCccc--cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH-HHHHHhhC
Q 017445          222 KITDFGISAGLENSIAMCATFVGTVTYMSPERI--RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN-LMLQILED  298 (371)
Q Consensus       222 kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~  298 (371)
                      ||+|||++......   .....||+.|+|||++  ....++.++||||||+++|+|++|..||........ ........
T Consensus       169 kl~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          169 KVADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             EECCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             EeCCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            99999999755443   2456799999999999  445578999999999999999999999986554333 34444555


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ......+..+++++.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            5555666789999999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-46  Score=350.32  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=209.4

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEE--EEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRII--ALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++.+.||+|+||.||+|.+..++..+  |+|.+... .......+.+|+.++.++.+||||+++++++.  +.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee--eCC
Confidence            34578999999999999999999998888865  99988752 33455668899999999967999999999874  456


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          155 QISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      ..|+||||+++++|.+++...+                .+++..++.++.|++.||.|||+ +||+||||||+||+++.+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcCC
Confidence            8999999999999999997654                69999999999999999999999 999999999999999999


Q ss_pred             CceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhh
Q 017445          219 GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~  297 (371)
                      +.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.... ....... +.
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~-~~  255 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEK-LP  255 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHH-GG
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-HHHHHHH-hh
Confidence            99999999998754432 22234457889999999988889999999999999999998 999997644 2333333 33


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .......+..+++++.+|+.+||..||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            333444456789999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=348.70  Aligned_cols=259  Identities=21%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe--
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM--  150 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~--  150 (371)
                      .....+...+|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+..+.++.+||||+++++++..  
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            345567778999999999999999999999999999999999766667777889999999999889999999998853  


Q ss_pred             ----cCCCeEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEccCCce
Q 017445          151 ----PDSGQISIALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVNLKGRP  221 (371)
Q Consensus       151 ----~~~~~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~~~~~~  221 (371)
                          .....+++||||+. |+|.+++..   .+.+++..++.++.|++.||.|||+ +|  |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCE
Confidence                33446899999996 699998864   4679999999999999999999999 88  9999999999999999999


Q ss_pred             EEecccccccCcccccc------------cccccccCcccCCccc---cCCCCCCchhHHHHHHHHHHHhcCCCCCCCCC
Q 017445          222 KITDFGISAGLENSIAM------------CATFVGTVTYMSPERI---RNESYSYPADIWSIGLALFECGTGEFPYAASE  286 (371)
Q Consensus       222 kl~Dfg~s~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~  286 (371)
                      ||+|||++.........            .....||+.|+|||++   .+..++.++||||||+++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999876543211            1245699999999998   56678899999999999999999999996533


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      .     ..+.............+..+.+|+++||+.||.+|||+.++++|-+
T Consensus       258 ~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          258 K-----LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             H-----HHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2     2223333344445677889999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-46  Score=336.94  Aligned_cols=254  Identities=23%  Similarity=0.392  Sum_probs=212.7

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .|.+..++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++..+. ||||+++++++.  +.+
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~   76 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQA   76 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCC-CTTBCCEEEEEC--SSS
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCC-CCCEeeEEEEEc--cCC
Confidence            35567789999999999999999999975 677899999975322 3356889999999886 999999999874  456


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||.+....
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCCCEEEcccccccccc
Confidence            899999999999999999765 568999999999999999999999 999999999999999999999999999997664


Q ss_pred             ccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          234 NSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       234 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+ ........+..+++.
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~i-~~~~~~~~~~~~~~~  233 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDI-STGFRLYKPRLASTH  233 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHH-HTTCCCCCCTTSCHH
T ss_pred             cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-HHHHHHHH-hcCCcCCCCccCcHH
Confidence            432 22234557889999999998889999999999999999999 899997643 23333333 333334445678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.+++.+||+.||.+|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          234 VYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.6e-47  Score=345.86  Aligned_cols=253  Identities=20%  Similarity=0.247  Sum_probs=209.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .+..++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+|+..+..+.+|++++++++++.  +....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCcee
Confidence            345678999999999999999999999999999999986422  23456788999999978999999999774  56689


Q ss_pred             EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc-----eEEecccccc
Q 017445          157 SIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR-----PKITDFGISA  230 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~-----~kl~Dfg~s~  230 (371)
                      ++||||+ +++|.+++...+ ++++..+..++.|++.||.|||+ +||+||||||+||+++.++.     +||+|||++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999999 899999998654 59999999999999999999999 99999999999999987765     9999999998


Q ss_pred             cCccccc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC--cHHHHHHHhhC---
Q 017445          231 GLENSIA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG--PVNLMLQILED---  298 (371)
Q Consensus       231 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~~---  298 (371)
                      .......       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  .......+...   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            6654322       23456799999999999999999999999999999999999999987432  22222222221   


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          299 PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .........+++++.+++.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1111223468999999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-46  Score=356.76  Aligned_cols=253  Identities=24%  Similarity=0.427  Sum_probs=201.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEc---CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHI---PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .+...+|++.+.||+|+||+||+|.+.   .++..||||+++.. .......+.+|+.++.++. ||||+++++++  .+
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~--~~  117 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVV--TK  117 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE--CS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE--ee
Confidence            455678999999999999999999876   46778999999753 4455677899999998886 99999999987  45


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .+..++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            668999999999999999997654 69999999999999999999999 9999999999999999999999999999987


Q ss_pred             Cccccccc---ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          232 LENSIAMC---ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       232 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ........   ....+++.|+|||++.+..++.++||||||+++|||++ |..||..... .. +...+......+.+..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~~-~~~~i~~~~~~~~~~~  274 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QD-VIKAVDEGYRLPPPMD  274 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-HH-HHHHHHTTEECCCCTT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HH-HHHHHHcCCCCCCCcc
Confidence            65432211   22235778999999998899999999999999999998 9999976442 23 3333444434444567


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++..+.+++.+||+.||.+||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8999999999999999999999998875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.5e-46  Score=344.16  Aligned_cols=262  Identities=19%  Similarity=0.311  Sum_probs=207.1

Q ss_pred             CccccceecCcceeEeeeecccCCeEEEEEEEcC---CCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           71 HSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIP---THRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      .....+.+..++|.+.+.||+|+||+||+|.+..   +++.||+|.++..  .......+.+|+..+.++. ||||++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~  102 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLL  102 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCC
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeee
Confidence            3445667778899999999999999999998765   5568999998753  3455677889999999887 99999999


Q ss_pred             eeEEecCCC---eEEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc
Q 017445          146 GAFYMPDSG---QISIALEYMDGGSLADILRM------QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN  216 (371)
Q Consensus       146 ~~~~~~~~~---~~~lv~E~~~~g~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~  216 (371)
                      +++...+..   ..++||||+++++|.+++..      ...+++..++.++.|++.||.|||+ +||+||||||+||+++
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~  181 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEEC
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc
Confidence            988654332   46999999999999999842      3569999999999999999999999 9999999999999999


Q ss_pred             cCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHH
Q 017445          217 LKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLML  293 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~  293 (371)
                      .++.+||+|||++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .....
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~  260 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYD  260 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-HHHHH
Confidence            99999999999997664432  12233457889999999999999999999999999999999 8999976543 33333


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+... .....+..+++++.+++.+||..||.+|||+.+++.+
T Consensus       261 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          261 YLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33333 3344456789999999999999999999999999754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-47  Score=353.41  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=207.2

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcE----EEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRI----IALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +..++|++++.||+|+||+||+|.+..+++.    ||+|.+... .......+.+|+..+.++. ||||+++++++.   
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---   85 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP---   85 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC---
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc---
Confidence            4567899999999999999999999888876    677766432 1223345677888888886 999999999763   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ....++||||+++|+|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            45699999999999999999764 579999999999999999999999 9999999999999999999999999999987


Q ss_pred             Cccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          232 LENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       232 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  .....+........+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  242 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERLAQPQIC  242 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBCCCCTTB
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCCCCCcC
Confidence            644322  2244568889999999998899999999999999999999 99999765432  233333444444445678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.++.+++.+||..||.+|||+.++++|
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.6e-46  Score=360.70  Aligned_cols=250  Identities=26%  Similarity=0.421  Sum_probs=210.9

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+  +++.||||+++...  ....+.+|+.++.++. ||||+++++++.. +.
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~  259 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EK  259 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCC-CTTBCCEEEEEEC-TT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhcc-CCCEEEEEEEEEc-CC
Confidence            34567889999999999999999999987  47799999997533  4567889999999986 9999999998753 34


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +.+||||||+++|+|.+++...+.  +++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            479999999999999999986543  7999999999999999999999 9999999999999999999999999999875


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .....   ....+++.|+|||++.+..++.++||||||+++|||++ |..||...... ..... +........+..+++
T Consensus       339 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~-i~~~~~~~~p~~~~~  413 (450)
T 1k9a_A          339 ASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPR-VEKGYKMDAPDGCPP  413 (450)
T ss_dssp             CC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHH-HHTTCCCCCCTTCCH
T ss_pred             ccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HHcCCCCCCCCcCCH
Confidence            44321   23467889999999999999999999999999999998 99999765432 23333 333444455678999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+|+.+||..||.+|||+.++++
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-46  Score=344.16  Aligned_cols=250  Identities=27%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++...   .......+.+|+..+.++. ||||+++++++..  .+..
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~  109 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEI--DGQL  109 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEee--CCeE
Confidence            46899999999999999999999999999999999753   2334567889999998886 9999999998754  5689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||+++++|.+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999999999999988889999999999999999999999 999999999999999999999999999987665432


Q ss_pred             -cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCCCCCCHHHH
Q 017445          237 -AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSRQNFSPEFC  313 (371)
Q Consensus       237 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  313 (371)
                       .......|++.|+|||.+.+..++.++||||||+++|+|++|..||....  ...+...+....+  ......+++++.
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--HHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--HHHHHHHhccCCCCccccCCCCCHHHH
Confidence             22245579999999999999999999999999999999999999997643  2233333333322  234567899999


Q ss_pred             HHHHHhcccCcCCCC-CHHHHhc
Q 017445          314 SFVDDCLKKDAEARP-TADQLLS  335 (371)
Q Consensus       314 ~li~~~l~~dp~~Rp-s~~~il~  335 (371)
                      +++.+||+.||++|| +++++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7777763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.6e-47  Score=352.62  Aligned_cols=250  Identities=20%  Similarity=0.286  Sum_probs=206.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ...+|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+|+.++..+.+||||+++++++..  ....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEE
Confidence            3568999999999999999999999999999999986432  223577899999999679999999998754  568999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc-----eEEecccccccC
Q 017445          159 ALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR-----PKITDFGISAGL  232 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~-----~kl~Dfg~s~~~  232 (371)
                      ||||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ +||+||||||+|||++.++.     +||+|||++...
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99999 8999999976 4679999999999999999999999 99999999999999998887     999999999865


Q ss_pred             ccccc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhCCC---
Q 017445          233 ENSIA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPS---  300 (371)
Q Consensus       233 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~---  300 (371)
                      .....       ......||+.|+|||++.+..++.++||||||+++|+|++|..||......  ...+..+.....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            44322       124668999999999999999999999999999999999999999874322  222222222111   


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          301 PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       301 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .......+| ++.+++..||..||.+||++++|++
T Consensus       241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111123345 9999999999999999999988875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-46  Score=367.85  Aligned_cols=255  Identities=20%  Similarity=0.356  Sum_probs=218.7

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+..++..||||.++... .....+.+|+.++.++. ||||+++++++  .+.
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~--~~~  288 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK-HPNLVQLLGVC--TRE  288 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEE--CSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcC-CCCEeeEEEEE--ecC
Confidence            456788899999999999999999999999999999999997532 23567899999999996 99999999987  445


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..+||||||+++|+|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            6899999999999999999764  458999999999999999999999 9999999999999999999999999999987


Q ss_pred             Ccccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          232 LENSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......  .+...+........+..++
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCCCCTTCC
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCC
Confidence            64432 22234456789999999998889999999999999999999 99999765432  2334445555555567899


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++.+|+.+||+.||++|||+.++++
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-46  Score=348.81  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=211.1

Q ss_pred             eecCcceeEeeeecccCCeEEEEEE-----EcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAV-----HIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+..++|++.+.||+|+||+||+|.     +..+++.||||.+... .......+.+|+.++.++. ||||+++++++. 
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSL-  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc-
Confidence            4567899999999999999999998     5567889999999643 4455667889999999985 999999999874 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC---Cc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQK-------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK---GR  220 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~---~~  220 (371)
                       +....|+||||+++++|.+++....       .+++..++.++.|++.||.|||+ +||+||||||+||+++.+   ..
T Consensus       104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          104 -QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             -CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence             4567899999999999999998653       48999999999999999999999 999999999999999844   46


Q ss_pred             eEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhh
Q 017445          221 PKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILE  297 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~  297 (371)
                      +||+|||++.......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+ .
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~~-~  259 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFV-T  259 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHH-H
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-HHHHHHHH-h
Confidence            9999999987543322  12234568999999999988889999999999999999998 999997643 23333333 3


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .......+..+++.+.+++.+||+.||.+||++.++++|.|+...
T Consensus       260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            333334456789999999999999999999999999999987543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-46  Score=339.02  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=214.0

Q ss_pred             ceecCcceeEee-eecccCCeEEEEEEEc--CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           76 YRCASHEMRIFG-AIGSGASSVVQRAVHI--PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        76 ~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      +.+..++|.+.+ .||+|+||+||+|.+.  .++..||+|+++.. .......+.+|+.++..+. ||||+++++++.  
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--   80 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ--   80 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEec--
Confidence            445667888887 9999999999999854  56788999999763 4456677899999999996 999999999873  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       .+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        81 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           81 -AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCCCEEECccccee
Confidence             34699999999999999999643 569999999999999999999999 999999999999999999999999999997


Q ss_pred             cCccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          231 GLENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+ ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i-~~~~~~~~~~  236 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFI-EQGKRMECPP  236 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHH-HTTCCCCCCT
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHH-hcCCcCCCCC
Confidence            6643322   1233456899999999988889999999999999999998 9999976553 3333333 3333344456


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPF  338 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~  338 (371)
                      .+++++.+++.+||..||.+||++.++++|.+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            89999999999999999999999999997753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.1e-46  Score=339.85  Aligned_cols=254  Identities=21%  Similarity=0.356  Sum_probs=210.3

Q ss_pred             cceecCcceeEee-eecccCCeEEEEEE--EcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           75 TYRCASHEMRIFG-AIGSGASSVVQRAV--HIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        75 ~~~~~~~~~~~~~-~lg~G~~g~Vy~~~--~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ...+...+|.+.+ .||+|+||+||+|.  ...+++.||||+++...  ......+.+|+.++..+. ||||+++++++ 
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-   87 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC-   87 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-
Confidence            4455667899998 99999999999995  45678899999997532  234567889999999886 99999999987 


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                        +.+..++||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++
T Consensus        88 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           88 --EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             --ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             --CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence              245789999999999999999988889999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCcccccc---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          230 AGLENSIAM---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       230 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .. +...+........+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~-~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SE-VTAMLEKGERMGCP  242 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH-HHHHHHTTCCCCCC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-HH-HHHHHHcCCCCCCC
Confidence            766443221   123346789999999988889999999999999999999 9999976442 23 33333443344455


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..+++++.+++.+||+.||.+||++.++++
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            689999999999999999999999999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=341.37  Aligned_cols=246  Identities=28%  Similarity=0.509  Sum_probs=201.7

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      +..++|++.+.||+|+||+||+|.+  .++.||+|++..  ......+.+|+..+.++. ||||+++++++.    +..+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES--ESERKAFIVELRQLSRVN-HPNIVKLYGACL----NPVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS--TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT----TTTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC--hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----CCcE
Confidence            4567899999999999999999987  478899999864  234567889999999986 999999999763    3489


Q ss_pred             EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcC--CCeEecCCCCCcEEEccCCc-eEEeccccccc
Q 017445          158 IALEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGV--RHLVHRDIKPANLLVNLKGR-PKITDFGISAG  231 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~--~~iiH~Dlkp~NIl~~~~~~-~kl~Dfg~s~~  231 (371)
                      +||||+++++|.+++....   .+++..+..++.|++.||.|||+.  +||+||||||+||+++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998654   378999999999999999999984  47999999999999998886 79999999976


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      .....   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........................+++.
T Consensus       156 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (307)
T 2eva_A          156 IQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP  232 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHH
T ss_pred             ccccc---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHH
Confidence            54332   345699999999999999999999999999999999999999986554443333333344444455678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+++.+||+.||++|||+.++++
T Consensus       233 l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          233 IESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-46  Score=338.44  Aligned_cols=255  Identities=20%  Similarity=0.313  Sum_probs=209.3

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcC---CCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIP---THRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .+.+..++|++.+.||+|+||+||+|.+..   ++..||+|.+... .......+.+|+.++..+. ||||+++++++. 
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE-   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC-
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEEc-
Confidence            355677899999999999999999998654   3456999998763 4455677889999999886 999999999863 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                        .+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+
T Consensus        84 --~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           84 --EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             --CCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCCcEEeCccCCC
Confidence              33578999999999999999764 459999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          230 AGLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       230 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+... .....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~  238 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKG-DRLPKPDL  238 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHHT-CCCCCCTT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhcC-CCCCCCCC
Confidence            87654322 2234457889999999998889999999999999999998 99999764432 233333332 23334567


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +++.+.+++.+||..||++|||+.+++++
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            89999999999999999999999999865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=345.77  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEE----EEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRII----ALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      .+..++|++++.||+|+||+||+|.+..+++.+    |+|.+.. ........+.+|+.++.++. ||||+++++++.. 
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-   88 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-   88 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEES-
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEec-
Confidence            345679999999999999999999998888765    6666543 23345567889999998886 9999999998853 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                        ...++|+||+.+|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        89 --~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           89 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             --SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             --CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence              348899999999999999976 4569999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          231 GLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....  ..+...+........+..
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQPPI  243 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCCTT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCCcc
Confidence            7644322  2233457889999999999999999999999999999999 9999976543  223444445445555677


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.++.+++++||..||.+|||+.++++
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=343.17  Aligned_cols=254  Identities=23%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCC----cEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTH----RIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      .+..++|.+.+.||+|+||+||+|.+..++    ..||+|.+... .......+.+|+.++.++. ||||+++++++  .
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~  116 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVI--S  116 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE--C
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE--e
Confidence            456689999999999999999999876553    45999999753 3445667889999999886 99999999987  4


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +.+..+|||||+++++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            566899999999999999999764 579999999999999999999999 999999999999999999999999999998


Q ss_pred             cCcccccc---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          231 GLENSIAM---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       231 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+ ......+.+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~~-~~~~~~~~~~  273 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAI-NDGFRLPTPM  273 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHH-HTTCCCCCCT
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-HHHHHHHH-HCCCcCCCcc
Confidence            76543221   122346788999999999899999999999999999998 999997644 23333333 3333344456


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+++.+.+++.+||+.||++||++.+++++
T Consensus       274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.1e-46  Score=354.01  Aligned_cols=255  Identities=16%  Similarity=0.181  Sum_probs=200.0

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCC-----CcEEEEEEeccccHHHH-----------HHHHHHHHHHHhCCCCCCe
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPT-----HRIIALKKINIFEKEKR-----------NQLLTEIRTLCEAPCNEGL  141 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~~~~h~~i  141 (371)
                      ....+|++.+.||+|+||+||+|.+..+     ++.||||++........           .....|+..+..+. ||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence            4567999999999999999999998764     58899999875432111           11233444444454 9999


Q ss_pred             eEeceeEEecCC--CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc--
Q 017445          142 VEFHGAFYMPDS--GQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN--  216 (371)
Q Consensus       142 v~l~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~--  216 (371)
                      +++++++.....  ...||||||+ |++|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+|||++  
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESS
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecC
Confidence            999999865433  4689999999 99999999765 679999999999999999999999 9999999999999999  


Q ss_pred             cCCceEEecccccccCcccccc-------cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH
Q 017445          217 LKGRPKITDFGISAGLENSIAM-------CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV  289 (371)
Q Consensus       217 ~~~~~kl~Dfg~s~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~  289 (371)
                      .++.+||+|||++.........       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999766443211       134559999999999999999999999999999999999999998543332


Q ss_pred             HHHHHHh---hCCC-----CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          290 NLMLQIL---EDPS-----PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       290 ~~~~~~~---~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .......   ....     .......+++++.+++..||..||.+||++.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2221111   0000     00112568999999999999999999999998874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.3e-46  Score=338.41  Aligned_cols=254  Identities=23%  Similarity=0.443  Sum_probs=200.7

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ...++...+|++.+.||+|+||+||+|.+..   .||+|+++.  ........+.+|+.++.++. ||||++++++.   
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~---   89 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS---   89 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE---
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec---
Confidence            3557778899999999999999999998533   599999865  34555677889999998887 99999999954   


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCCCEEEccceecc
Confidence            34568999999999999999954 3569999999999999999999999 999999999999999999999999999997


Q ss_pred             cCccc--ccccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC---
Q 017445          231 GLENS--IAMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS---  302 (371)
Q Consensus       231 ~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  302 (371)
                      .....  ........||+.|+|||.+.   +..++.++||||||+++|+|++|..||....................   
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence            65432  12224457999999999986   56688899999999999999999999987665544444443333222   


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       303 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .....+++++.+|+.+||..||.+|||+.++++
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            233578999999999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-45  Score=335.85  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=212.1

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..+.+..++|++.+.||+|+||+||+|.+. ++..||+|.+.... .....+.+|+.++..+. ||||+++++++.   .
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~   79 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT---Q   79 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---S
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCC-CcCcceEEEEEc---C
Confidence            356777889999999999999999999864 56789999997532 23467889999999986 999999999763   3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+..
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            46899999999999999986433  69999999999999999999999 9999999999999999999999999999987


Q ss_pred             Cccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          232 LENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .... ..+........+..++
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~  236 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVI-QNLERGYRMVRPDNCP  236 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHH-HHHHTTCCCCCCTTCC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-HHHH-HHHhcccCCCCccccc
Confidence            654322 2234457889999999988889999999999999999999 9999976442 2333 3333334444556889


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++.+++.+||..||++|||+.++++
T Consensus       237 ~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          237 EELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-47  Score=348.43  Aligned_cols=254  Identities=25%  Similarity=0.447  Sum_probs=203.9

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------HHHHHHHHHHHHHHhCC---CCCCeeEecee
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------EKRNQLLTEIRTLCEAP---CNEGLVEFHGA  147 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~---~h~~iv~l~~~  147 (371)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++.....      .....+.+|+..+.++.   .||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3345689999999999999999999999999999999965321      12233556777777662   59999999997


Q ss_pred             EEecCCCeEEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc-cCCceEEec
Q 017445          148 FYMPDSGQISIALEY-MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN-LKGRPKITD  225 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~-~~~~~kl~D  225 (371)
                      +.  +.+..++|||+ +.+++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|
T Consensus       107 ~~--~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          107 FE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             C-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             Ee--cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeEEEEE
Confidence            74  45678999999 7899999999888889999999999999999999999 9999999999999999 789999999


Q ss_pred             ccccccCcccccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          226 FGISAGLENSIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       226 fg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ||.+.......  .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....       .+.....  ..
T Consensus       184 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~--~~  252 (312)
T 2iwi_A          184 FGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAEL--HF  252 (312)
T ss_dssp             CSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTCC--CC
T ss_pred             cchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhcc--CC
Confidence            99998765432  245679999999999976665 458999999999999999999996421       1222222  23


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +..++.++.+|+.+||+.||++|||+.++++||||+...+
T Consensus       253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            4578999999999999999999999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.3e-46  Score=340.91  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCCeeEeceeEEec--CCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-PCNEGLVEFHGAFYMP--DSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~-~~h~~iv~l~~~~~~~--~~~  154 (371)
                      ...++|++.+.||+|+||+||+|.+  +++.||||++...   .......|..++... .+||||+++++++...  ...
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            3457899999999999999999987  7889999998653   234445566665543 3599999999987542  345


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH--------GVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      .+++||||+++|+|.++++ ...+++..+..++.|++.||.|||        + +||+||||||+|||++.++.+||+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            6899999999999999995 467999999999999999999999        8 89999999999999999999999999


Q ss_pred             cccccCcccccc----cccccccCcccCCccccCC------CCCCchhHHHHHHHHHHHhcC----------CCCCCCCC
Q 017445          227 GISAGLENSIAM----CATFVGTVTYMSPERIRNE------SYSYPADIWSIGLALFECGTG----------EFPYAASE  286 (371)
Q Consensus       227 g~s~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~ell~g----------~~pf~~~~  286 (371)
                      |++.........    .....||+.|+|||++.+.      .++.++||||||+++|+|++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            998655433221    2345799999999999876      445789999999999999999          88886532


Q ss_pred             C---cHHHHHHHhhCC-CCCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          287 G---PVNLMLQILEDP-SPSPSR-----QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       287 ~---~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .   ............ .....+     ..+++++.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            1   222233332221 111111     224578999999999999999999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.7e-46  Score=338.75  Aligned_cols=249  Identities=22%  Similarity=0.400  Sum_probs=210.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe---------
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM---------  150 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~---------  150 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....    ..+.+|+.++.++. ||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCC-CCCEEEEeeeEeccccCccccc
Confidence            368999999999999999999999999999999997643    24567889998886 9999999998743         


Q ss_pred             -----cCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEE
Q 017445          151 -----PDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKI  223 (371)
Q Consensus       151 -----~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl  223 (371)
                           .....+++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEE
Confidence                 1234689999999999999999754  579999999999999999999999 99999999999999999999999


Q ss_pred             ecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC
Q 017445          224 TDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP  303 (371)
Q Consensus       224 ~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      +|||.+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+...   ...........    
T Consensus       164 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~----  235 (284)
T 2a19_B          164 GDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRDGI----  235 (284)
T ss_dssp             CCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTC----
T ss_pred             Ccchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhccc----
Confidence            9999987765542 234567999999999999999999999999999999999999888431   12222222221    


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .+..++.++.+++.+||..||.+|||+.++++|++..+-
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            235688999999999999999999999999999877544

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=361.71  Aligned_cols=261  Identities=21%  Similarity=0.306  Sum_probs=199.3

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ....+...+|.+.+.||+|+||+|+.. ...+++.||||++.....   ....+|+.++..+.+||||+++++++.  +.
T Consensus        17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~   90 (432)
T 3p23_A           17 SVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK--DR   90 (432)
T ss_dssp             -CEEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE--ET
T ss_pred             CcEEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe--cC
Confidence            345666778999999999999997643 456889999999864221   224578889988877999999999774  46


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---C--CceEEeccc
Q 017445          154 GQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---K--GRPKITDFG  227 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~--~~~kl~Dfg  227 (371)
                      ...||||||+. |+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.   +  ..+||+|||
T Consensus        91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            68999999996 59999997553 45666778999999999999999 99999999999999953   2  357899999


Q ss_pred             ccccCcccc---cccccccccCcccCCcccc---CCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCC
Q 017445          228 ISAGLENSI---AMCATFVGTVTYMSPERIR---NESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPS  300 (371)
Q Consensus       228 ~s~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  300 (371)
                      ++.......   ......+||+.|+|||++.   ...++.++|||||||++|+|++ |..||......  ..........
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~  246 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLGACS  246 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHHTTCCC
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHHhccCC
Confidence            998765432   2234567999999999997   4567889999999999999999 99999654322  2222222221


Q ss_pred             CC--CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          301 PS--PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       301 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ..  ......+..+.+||.+||+.||.+|||+.++++||||....+
T Consensus       247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            11  112234566899999999999999999999999999987654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5e-47  Score=351.99  Aligned_cols=254  Identities=26%  Similarity=0.320  Sum_probs=206.5

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++..........+.+|+.++..+. ||||+++++++  .+.+..++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~--~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLIGFC--DERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC-CTTBCCEEEEC--CCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEE--cCCCeEEE
Confidence            446788889999999999999985 568999999987765566677889999998886 99999999977  45668999


Q ss_pred             EEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          159 ALEYMDGGSLADILRMQK----SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999986443    58999999999999999999999 9999999999999999999999999999976433


Q ss_pred             cc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcH--HHH----HHHhhCCC------
Q 017445          235 SI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPV--NLM----LQILEDPS------  300 (371)
Q Consensus       235 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~--~~~----~~~~~~~~------  300 (371)
                      ..  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ...    ........      
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            21  22234568999999999988899999999999999999999999997543211  111    01111111      


Q ss_pred             --CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          301 --PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       301 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                        .......++..+.+++.+||+.||++|||+.+++++.
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence              1111223456789999999999999999999999765

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.3e-46  Score=360.31  Aligned_cols=254  Identities=25%  Similarity=0.414  Sum_probs=213.9

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...+.+..++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.++.++. ||||+++++++.   
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~---  253 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT---  253 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC---
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe---
Confidence            3457888899999999999999999999875 46789999997533 34567899999998886 999999999873   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ...+||||||+++|+|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            45689999999999999999743  368999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+. .....+.+..+
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~-~~~~~~~~~~~  410 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALE-RGYRMPRPENC  410 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHH-HTCCCCCCTTS
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCCCCCCCCCC
Confidence            7654322 1233456788999999998889999999999999999999 9999976542 33333333 33344455789


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++++.+|+.+||..||++|||+.+|+.
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=345.59  Aligned_cols=258  Identities=22%  Similarity=0.396  Sum_probs=213.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEE----EcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAV----HIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..+..++|++++.||+|+||.||+|.    +..+++.||+|++..........+.+|+.++.++. ||||+++++++...
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA  114 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence            34566789999999999999999998    46689999999998766667778999999999986 99999999988655


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +...+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            555789999999999999999865 459999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC----------c-H---HHHH
Q 017445          231 GLENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG----------P-V---NLML  293 (371)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~----------~-~---~~~~  293 (371)
                      .......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....          . .   ..+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            7654322   12334577889999999888899999999999999999999999864210          0 0   1122


Q ss_pred             HHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          294 QILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..+......+.+..+++++.+++++||..||++|||+.++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333344444456789999999999999999999999999974

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.7e-46  Score=343.68  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=211.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEE----cCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVH----IPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +..+.|++++.||+|+||+||++..    ..+++.||||+++.. .......+.+|+.++.++. ||||+++++++...+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCC
Confidence            3344559999999999999988753    457899999999763 3455677899999999997 999999999987766


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ...+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+...
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            6789999999999999999975 459999999999999999999999 99999999999999999999999999999876


Q ss_pred             ccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-------------HHHHHHHh
Q 017445          233 ENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-------------VNLMLQIL  296 (371)
Q Consensus       233 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-------------~~~~~~~~  296 (371)
                      .....   ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......             ...+...+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            54321   223456888999999999888999999999999999999999999653211             11223344


Q ss_pred             hCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ........+..+++++.+|+++||+.||.+|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            455555566789999999999999999999999999973

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=352.49  Aligned_cols=256  Identities=18%  Similarity=0.193  Sum_probs=200.4

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcC---CCcEEEEEEeccccHH-----------HHHHHHHHHHHHHhCCCCCCeeE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIP---THRIIALKKINIFEKE-----------KRNQLLTEIRTLCEAPCNEGLVE  143 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~~~~h~~iv~  143 (371)
                      +..++|++.+.||+|+||+||+|.+..   ++..+|+|++......           ....+.+|+..+..+. ||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence            445789999999999999999999987   7889999998653211           1123556777777775 999999


Q ss_pred             eceeEEec--CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC--
Q 017445          144 FHGAFYMP--DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG--  219 (371)
Q Consensus       144 l~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~--  219 (371)
                      +++++...  +....|+||||+ +++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence            99988652  356899999999 99999999877789999999999999999999999 9999999999999999887  


Q ss_pred             ceEEecccccccCccccc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH
Q 017445          220 RPKITDFGISAGLENSIA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM  292 (371)
Q Consensus       220 ~~kl~Dfg~s~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~  292 (371)
                      .+||+|||++........       ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999976643321       1245579999999999999999999999999999999999999996533222222


Q ss_pred             HHH---hhCCCCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          293 LQI---LEDPSPS-----PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       293 ~~~---~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ...   .....+.     .....+++++.+++.+||..||++|||+.++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            211   1111111     1123689999999999999999999999999753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=359.40  Aligned_cols=255  Identities=23%  Similarity=0.402  Sum_probs=210.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      ....+|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.++.++. ||||+++++++...+....
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCee
Confidence            45678999999999999999999999999999999997532 233566788999999987 9999999998876666689


Q ss_pred             EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE----ccCCceEEeccccc
Q 017445          157 SIALEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV----NLKGRPKITDFGIS  229 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~----~~~~~~kl~Dfg~s  229 (371)
                      ++||||+++|+|.+++....   .+++..++.++.|++.||.|||+ +||+||||||+||++    +.++.+||+|||++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999999997543   39999999999999999999999 999999999999999    77788999999999


Q ss_pred             ccCcccccccccccccCcccCCccccC--------CCCCCchhHHHHHHHHHHHhcCCCCCCCCC---CcHHHHHHHhhC
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRN--------ESYSYPADIWSIGLALFECGTGEFPYAASE---GPVNLMLQILED  298 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ell~g~~pf~~~~---~~~~~~~~~~~~  298 (371)
                      ....... ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||....   .....+..++.+
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            8765543 3345679999999999865        457789999999999999999999996532   234455555554


Q ss_pred             CCCCC-------------------C----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          299 PSPSP-------------------S----RQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       299 ~~~~~-------------------~----~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .....                   .    ...++..+.+++++||+.||++||++.++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            33211                   1    1223467889999999999999999998853

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.5e-46  Score=336.26  Aligned_cols=249  Identities=25%  Similarity=0.421  Sum_probs=202.9

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .+.+..++|++.+.||+|+||+||+|.+  +|+.||+|.++...  ..+.+.+|+.++.++. ||||+++++++. .+.+
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-~~~~   88 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR-HSNLVQLLGVIV-EEKG   88 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCC-CTTBCCEEEEEC-CC--
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCC-CCCEeeEEEEEE-cCCC
Confidence            4566778999999999999999999987  57899999997533  4566888999998886 999999999864 3345


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          155 QISIALEYMDGGSLADILRMQKS--IPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      ..++||||+++++|.+++...+.  +++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            78999999999999999976543  8999999999999999999999 99999999999999999999999999998765


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ....   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+ ........+..+++.
T Consensus       168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~  242 (278)
T 1byg_A          168 SSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRV-EKGYKMDAPDGCPPA  242 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHHHH-TTTCCCCCCTTCCHH
T ss_pred             cccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-hcCCCCCCcccCCHH
Confidence            4432   33467899999999998889999999999999999998 9999976542 3333333 333344455678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017445          312 FCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+++++||..||.+|||+.++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-45  Score=333.13  Aligned_cols=250  Identities=21%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCc---EEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHR---IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .|++.+.||+|+||+||+|.+..++.   .||+|.+.. ........+.+|+.++.++. ||||+++++++.. ..+..+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLP-PEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC-SSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEec-CCCCcE
Confidence            56677899999999999999766554   799999875 34455677889999999886 9999999998753 333458


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          158 IALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      +||||+.+++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            99999999999999976 4568999999999999999999999 999999999999999999999999999997654432


Q ss_pred             ----cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          237 ----AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       237 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                          .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+............+ ........+..+++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCCCCCCccchHHH
Confidence                12234568899999999999999999999999999999999665554444444444433 3334444567789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .+++.+||+.||.+|||+.++++
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5e-45  Score=334.72  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=205.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ..+|++.+.||+|+||+||+|.+..+   ...+|+|.+.. ........+.+|+.++.++. ||||+++++++. .+.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICL-RSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEC-CSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEE-cCCCc
Confidence            45789999999999999999986543   34689999875 34455677889999999886 999999999865 34557


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||.+.....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            8999999999999999975 3458999999999999999999999 9999999999999999999999999999986654


Q ss_pred             ccc----ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          235 SIA----MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       235 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ...    ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.... .......+... .....+..++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~  258 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQG-RRLLQPEYCP  258 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-TTTHHHHHHTT-CCCCCCTTCC
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhcC-CCCCCCccCC
Confidence            321    1234467889999999998899999999999999999999 556665543 33333333333 3334456789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.+.+++.+||..||.+|||+.++++
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-45  Score=356.33  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=193.2

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +.|.+.+.||+|+||+||.+ ...+|+.||||++...   ......+|+.++.++.+||||+++++.+  .+.+.+||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~--~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE--TTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE--ECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE--ecCCeEEEEE
Confidence            35566789999999999875 4668999999998652   2345678999998876799999999977  4567899999


Q ss_pred             eccCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-------------Cc
Q 017445          161 EYMDGGSLADILRMQKSIP-------EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-------------GR  220 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~-------~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-------------~~  220 (371)
                      ||+. |+|.+++.......       +..++.++.|++.||.|||+ +||+||||||+|||++.+             +.
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            9996 59999997654332       23456799999999999999 999999999999999754             48


Q ss_pred             eEEecccccccCccccc----ccccccccCcccCCccccC-------CCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCc
Q 017445          221 PKITDFGISAGLENSIA----MCATFVGTVTYMSPERIRN-------ESYSYPADIWSIGLALFECGT-GEFPYAASEGP  288 (371)
Q Consensus       221 ~kl~Dfg~s~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~  288 (371)
                      +||+|||++........    ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999987654322    1234579999999999965       568999999999999999999 99999765433


Q ss_pred             HHHHHHHhhCCCCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          289 VNLMLQILEDPSPSPS-----RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .   ..++........     ...+++++.+|+.+||+.||++|||+.++++||||...
T Consensus       247 ~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          247 E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            3   223332222111     12345789999999999999999999999999999654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.9e-45  Score=354.23  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...+.+..++|++.+.||+|+||+||+|.+.. +..||||+++... .....+.+|+.++.++. ||||+++++++.  +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~  250 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS--E  250 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCC-CCCEeeEEEEEc--C
Confidence            34677888999999999999999999999765 4579999997533 23457889999999996 999999999773  2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       +..||||||+++|+|.+++..  ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus       251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCCCEEECCCccce
Confidence             568999999999999999964  3569999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||..... ...... +......+.+..+
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~-i~~~~~~~~~~~~  406 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQ-VERGYRMPCPPEC  406 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHH-HHTTCCCCCCTTS
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HHcCCCCCCCCCC
Confidence            7654321 2233457789999999998899999999999999999999 9999976542 333333 3344444455689


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+.+|+.+||+.||++|||++++++
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.8e-47  Score=350.89  Aligned_cols=262  Identities=20%  Similarity=0.316  Sum_probs=206.6

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-EKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ......++|++.+.||+|+||+||+|. ..+++.||||++..... .....+.+|+.++..+. ||||+++++++.  +.
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--~~   99 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM--TP   99 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEEC--CS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEe--cC
Confidence            344556788899999999999999997 45689999999975322 22235788999888886 999999999874  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCC---CeEecCCCCCcEEEccCCceEEecc
Q 017445          154 GQISIALEYMDGGSLADILRMQK----SIPEPILSSMFKKLLQGLSYLHGVR---HLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      ...++||||+++|+|.+++....    .+++..+..++.|++.||.|||+ +   ||+||||||+||+++.++.+||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            67899999999999999997543    49999999999999999999999 8   9999999999999999999999999


Q ss_pred             cccccCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCC----CCCcHHHHHHHhhCCCC
Q 017445          227 GISAGLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA----SEGPVNLMLQILEDPSP  301 (371)
Q Consensus       227 g~s~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~----~~~~~~~~~~~~~~~~~  301 (371)
                      |++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..    ..... ...........
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~  257 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV-MLLDWVKGLLK  257 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS-BHHHHHTTTTS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch-hHHHHHHHHhh
Confidence            99986643322 23445699999999999888899999999999999999999999952    11111 11111111110


Q ss_pred             -------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          302 -------------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       302 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                                   .......+..+.+++.+||+.||.+|||+.++++|-.-...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence                         01111223679999999999999999999999988764433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4e-45  Score=335.87  Aligned_cols=235  Identities=23%  Similarity=0.382  Sum_probs=190.3

Q ss_pred             cceeEe-eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe--cCCCeEE
Q 017445           81 HEMRIF-GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM--PDSGQIS  157 (371)
Q Consensus        81 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~--~~~~~~~  157 (371)
                      .+|.+. +.||+|+||.||+|.+..+++.||+|++...     ....+|+..+.+..+||||+++++++..  .+...++
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            467777 7899999999999999999999999999642     3456788888677679999999998753  3356799


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEecccccccC
Q 017445          158 IALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISAGL  232 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~~~  232 (371)
                      +||||+++|+|.+++....  .+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            9999999999999998654  69999999999999999999999 99999999999999998   788999999988543


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh----CCCCC--CCCC
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE----DPSPS--PSRQ  306 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~~~--~~~~  306 (371)
                      .                      +..++.++|||||||++|+|++|..||....... .......    .....  ....
T Consensus       171 ~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  227 (299)
T 3m2w_A          171 T----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEWS  227 (299)
T ss_dssp             T----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHT
T ss_pred             c----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-hhHHHHHHHhhccccCCchhcc
Confidence            2                      2346779999999999999999999997643211 0000000    00000  0114


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      .+++++.+|+.+||+.||.+|||+.++++||||++...
T Consensus       228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            68999999999999999999999999999999977643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=340.89  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=190.2

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHH-hCCCCCCeeEeceeEEe---cC
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLC-EAPCNEGLVEFHGAFYM---PD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~~~~h~~iv~l~~~~~~---~~  152 (371)
                      .+..++|++.+.||+|+||+||+|.+  +++.||||++.....   ..+..|..+.. ....||||+++++.+..   .+
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            45567999999999999999999976  788999999975332   23333444332 23459999999986532   33


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC---------CeEecCCCCCcEEEccCCceEE
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR---------HLVHRDIKPANLLVNLKGRPKI  223 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------~iiH~Dlkp~NIl~~~~~~~kl  223 (371)
                      ...+++||||+++|+|.+++.. ...++..++.++.|++.||.|||+ .         ||+||||||+|||++.++.+||
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCCcEEE
Confidence            4468999999999999999975 456999999999999999999999 8         9999999999999999999999


Q ss_pred             ecccccccCccc--------ccccccccccCcccCCccccC-------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc
Q 017445          224 TDFGISAGLENS--------IAMCATFVGTVTYMSPERIRN-------ESYSYPADIWSIGLALFECGTGEFPYAASEGP  288 (371)
Q Consensus       224 ~Dfg~s~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~  288 (371)
                      +|||++......        ........||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            999999765432        112235579999999999977       45667899999999999999997776432210


Q ss_pred             ----------------HHHHHHHh-hCCCCCCCCCC------CCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          289 ----------------VNLMLQIL-EDPSPSPSRQN------FSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       289 ----------------~~~~~~~~-~~~~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                                      ........ ........+..      +++++.+||.+||+.||++|||+.+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence                            11111111 11111111122      345799999999999999999999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-44  Score=364.77  Aligned_cols=254  Identities=21%  Similarity=0.346  Sum_probs=208.5

Q ss_pred             cceecCcceeEe-eeecccCCeEEEEEEE--cCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           75 TYRCASHEMRIF-GAIGSGASSVVQRAVH--IPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        75 ~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      .+.+....+.+. +.||+|+||+||+|.+  ..+++.||||+++..  .......+.+|+.++.++. ||||+++++++.
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  440 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE  440 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            344455556554 4899999999999954  466789999999753  2344677999999999997 999999999773


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                         ....+|||||+++|+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus       441 ---~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~~~kL~DFGla  516 (635)
T 4fl3_A          441 ---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLS  516 (635)
T ss_dssp             ---SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred             ---cCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence               34589999999999999999988889999999999999999999999 99999999999999999999999999999


Q ss_pred             ccCccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          230 AGLENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       230 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ........   ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....  ..+...+........+
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~~~p  594 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCP  594 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCC
T ss_pred             cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCC
Confidence            86644321   1233456789999999999899999999999999999998 9999976543  2334444444445556


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..+++++.+|+..||..||++||++.+|++
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            789999999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=347.57  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ...|++.+.||+|+||+||+|.+..+   +..||+|.++. ........+.+|+.++.++. ||||+++++++. ...+.
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~-~~~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICL-RSEGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEEC-CCSSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEE-cCCCC
Confidence            45688899999999999999987543   34689999865 33456677899999998886 999999999764 33457


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          156 ISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            89999999999999999754 458999999999999999999999 9999999999999999999999999999976543


Q ss_pred             ccc----ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          235 SIA----MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       235 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ...    ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...... .....+... .....+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~~~-~~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQG-RRLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHHTT-CCCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHHcC-CCCCCCCCCC
Confidence            321    1233457889999999999999999999999999999999 77888664432 233333333 3334456789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      +.+.+++.+||..||++|||+.+++++
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.9e-45  Score=334.01  Aligned_cols=250  Identities=19%  Similarity=0.283  Sum_probs=198.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+|+.++..+. |++++..++.+. .+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~-~~~~i~~~~~~~-~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQ-GGVGIPTIRWCG-AEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHT-TSTTCCCEEEEE-EETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhc-CCCCCCeeeeec-CCCCceEEE
Confidence            368999999999999999999999999999999875422  2234677888888887 555554444443 345689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            9999 8899999974 4679999999999999999999999 999999999999999   78899999999999766543


Q ss_pred             cc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhC---CCCCC
Q 017445          236 IA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILED---PSPSP  303 (371)
Q Consensus       236 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~---~~~~~  303 (371)
                      ..       ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......  ...+..+...   .....
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            22       223567999999999999999999999999999999999999999764321  1122222111   11111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ....+++++.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            22567899999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=351.00  Aligned_cols=252  Identities=16%  Similarity=0.212  Sum_probs=199.6

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEE-----EEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC--CCCCeeEec
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRA-----VHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP--CNEGLVEFH  145 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~--~h~~iv~l~  145 (371)
                      ...+.+..++|++.+.||+|+||+||+|     .+..+++.||||+++.....   .+..|+..+..+.  .|+||++++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhh
Confidence            3466778899999999999999999999     46778999999999764433   3455555555543  389999999


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRM-----QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---  217 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---  217 (371)
                      +++.  ..+..||||||+++|+|.+++..     ...+++..++.++.|++.||+|||+ +||+||||||+|||++.   
T Consensus       134 ~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHL--FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEE--CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGT
T ss_pred             eeee--cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEeccccc
Confidence            9875  45579999999999999999973     4679999999999999999999999 99999999999999998   


Q ss_pred             --------CCceEEecccccccCc--ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCC
Q 017445          218 --------KGRPKITDFGISAGLE--NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG  287 (371)
Q Consensus       218 --------~~~~kl~Dfg~s~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~  287 (371)
                              ++.+||+|||+|....  .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    8999999999996543  222334567899999999999999999999999999999999999999965332


Q ss_pred             cHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          288 PVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      ....    ....   ......++.+.+++..||+.+|.+|++..+.+.+.
T Consensus       291 ~~~~----~~~~---~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          291 GECK----PEGL---FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             TEEE----ECSC---CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             Ccee----echh---ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            1100    0111   11113467899999999999999997655555443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.6e-45  Score=332.23  Aligned_cols=250  Identities=19%  Similarity=0.283  Sum_probs=201.8

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.....  ...+.+|+.++..+. |++++..++.+. .+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~-~~~~i~~~~~~~-~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ-GGVGIPTIRWCG-AEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHT-TSTTCCCEEEEE-EETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhh-cCCCCCcccccc-CCCCceEEE
Confidence            4689999999999999999999999999999999865322  235778899998888 555444444443 345689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||+ +++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||.+......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9999 8899999974 4579999999999999999999999 999999999999999   47899999999999766543


Q ss_pred             cc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhC---CCCCC
Q 017445          236 IA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILED---PSPSP  303 (371)
Q Consensus       236 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~---~~~~~  303 (371)
                      ..       ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......  ......+...   .....
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            22       124567999999999999999999999999999999999999999764321  1122222111   11111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ....+|+++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            23568999999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-45  Score=333.04  Aligned_cols=254  Identities=22%  Similarity=0.382  Sum_probs=204.1

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcC-CC--cEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIP-TH--RIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ..+..++|++.+.||+|+||+||+|.+.. ++  ..||+|+++..   .......+.+|+.++.++. ||||+++++++.
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   91 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL   91 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEc
Confidence            34556799999999999999999998643 33  36899998653   2345677889999999986 999999999875


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      .   ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+
T Consensus        92 ~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           92 T---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             S---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             c---CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCCCEEEccccc
Confidence            3   2488999999999999998754 569999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          229 SAGLENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       229 s~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      +........   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... .......+.........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERLPR  246 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTSCCCCCC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-HHHHHHHHHccCCCCCC
Confidence            977644322   1234457889999999988889999999999999999999 999997654 34455555555555556


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +..+++++.+++.+||..||.+|||+.++++
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            6789999999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=336.36  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=196.4

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCCeeEeceeEEecCC--Ce
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-PCNEGLVEFHGAFYMPDS--GQ  155 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~-~~h~~iv~l~~~~~~~~~--~~  155 (371)
                      ..++|++.+.||+|+||+||+|.+  +++.||||++....   ......|..++... .+||||+++++++.....  ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            346899999999999999999987  48899999986432   23344555555443 369999999998865432  68


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeEecCCCCCcEEEccCCceEEeccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR--------HLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                      +++||||+++|+|.++++. ..+++..++.++.|++.||.|||+ +        ||+||||||+||+++.++.+||+|||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             eEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence            9999999999999999975 579999999999999999999999 7        99999999999999999999999999


Q ss_pred             ccccCcccccc----cccccccCcccCCccccCCCCCCc------hhHHHHHHHHHHHhcC----------CCCCCCCCC
Q 017445          228 ISAGLENSIAM----CATFVGTVTYMSPERIRNESYSYP------ADIWSIGLALFECGTG----------EFPYAASEG  287 (371)
Q Consensus       228 ~s~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~il~ell~g----------~~pf~~~~~  287 (371)
                      ++.........    .....||+.|+|||++.+...+..      +|||||||++|||++|          ..||.....
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            99765443221    235579999999999988777665      9999999999999999          677754321


Q ss_pred             ---cHHHHHHHhh-CCCCCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          288 ---PVNLMLQILE-DPSPSPSR-----QNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       288 ---~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                         .......... .......+     ..+++++.+|+.+||+.||.+|||+.++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence               1222222222 21111111     2456779999999999999999999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=361.35  Aligned_cols=254  Identities=23%  Similarity=0.389  Sum_probs=208.2

Q ss_pred             ccceecCcceeEee-eecccCCeEEEEEEEc--CCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           74 KTYRCASHEMRIFG-AIGSGASSVVQRAVHI--PTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        74 ~~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ..+.+...++.+.+ .||+|+||+||+|.+.  .++..||||+++.. .......+.+|+.++.++. ||||+++++++.
T Consensus       328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~  406 (613)
T 2ozo_A          328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ  406 (613)
T ss_dssp             CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEec
Confidence            34556677788777 8999999999999875  45677999999763 3345677899999998886 999999999874


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      .   +.++|||||+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus       407 ~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          407 A---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             S---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             c---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence            2   4699999999999999999644 459999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCcccccc---cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCC
Q 017445          229 SAGLENSIAM---CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPS  304 (371)
Q Consensus       229 s~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      +.........   .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ ........
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i-~~~~~~~~  560 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFI-EQGKRMEC  560 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHH-HTTCCCCC
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHH-HcCCCCCC
Confidence            9876543221   123345689999999998899999999999999999998 9999987554 3333333 34444445


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      +..+++++.+|+.+||..||++||++.+++
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            568999999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=344.16  Aligned_cols=248  Identities=16%  Similarity=0.209  Sum_probs=201.8

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCC--------CcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeE-------
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPT--------HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE-------  143 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~-------  143 (371)
                      ..++|++.+.||+|+||+||+|.+..+        ++.||+|.+...     ..+.+|+.++.++. ||||++       
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~  113 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAA-KPLQVNKWKKLYS  113 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHC-CHHHHHHHHHHTT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhc-ccchhhhhhhhcc
Confidence            357999999999999999999998874        889999998753     35678888888886 888887       


Q ss_pred             --------eceeEEecCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcE
Q 017445          144 --------FHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANL  213 (371)
Q Consensus       144 --------l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NI  213 (371)
                              +++++.. +....|+||||+ +++|.+++...  ..+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus       114 ~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NI  190 (352)
T 2jii_A          114 TPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENI  190 (352)
T ss_dssp             CTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGE
T ss_pred             CCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHE
Confidence                    4555432 356899999999 89999999875  789999999999999999999999 9999999999999


Q ss_pred             EEccCC--ceEEecccccccCccccc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCC
Q 017445          214 LVNLKG--RPKITDFGISAGLENSIA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAA  284 (371)
Q Consensus       214 l~~~~~--~~kl~Dfg~s~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~  284 (371)
                      +++.++  .+||+|||++........       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  899999999977654322       12345799999999999998999999999999999999999999987


Q ss_pred             CCCcHHHHHHH----hhCCCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          285 SEGPVNLMLQI----LEDPSPSP----SRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       285 ~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .......+...    ........    ....+++++.+|+.+||..||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            54222222222    12221111    11357899999999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=356.02  Aligned_cols=261  Identities=24%  Similarity=0.377  Sum_probs=217.0

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...+.+..++|++.+.||+|+||+||+|.+.. +..||||+++... ...+.+.+|+.++.++. ||||+++++++.  +
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--~  333 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS--E  333 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCC-CCCEeeEEEEEe--e
Confidence            45678888999999999999999999999765 4579999997533 23457889999999997 999999999773  2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       +.+||||||+++|+|.+++..  ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence             568999999999999999964  3569999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ...... +........+..+
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-~~~~~~-i~~~~~~~~~~~~  489 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQ-VERGYRMPCPPEC  489 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-HHHHHH-HHTTCCCCCCTTC
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HHcCCCCCCCCCC
Confidence            7654321 2233457789999999988889999999999999999999 9999976542 233333 3344444455689


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC--cccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSH--PFITKY  342 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~h--p~~~~~  342 (371)
                      +.++.+||.+||+.||++|||+.+|++.  .+|...
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            9999999999999999999999999863  455433

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.6e-46  Score=369.36  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=208.7

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe----cCCCe
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM----PDSGQ  155 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~----~~~~~  155 (371)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++.. ........+.+|+.++.++. ||||+++++++..    ...+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCCCe
Confidence            588999999999999999999999999999999875 34556677899999999996 9999999997632    22567


Q ss_pred             EEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc---eEEeccccc
Q 017445          156 ISIALEYMDGGSLADILRMQK---SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR---PKITDFGIS  229 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~---~kl~Dfg~s  229 (371)
                      .++||||++||+|.+++....   .+++..++.++.|++.||.|||+ +||+||||||+||+++.++.   +||+|||.+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            899999999999999997644   59999999999999999999999 99999999999999997764   999999999


Q ss_pred             ccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH--------HHH-----h
Q 017445          230 AGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM--------LQI-----L  296 (371)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~--------~~~-----~  296 (371)
                      ....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....+....        ...     .
T Consensus       172 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          172 KELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            8765542 3355689999999999999999999999999999999999999997542211100        000     0


Q ss_pred             hCC--------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          297 EDP--------SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       297 ~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .+.        .+......+++.+.+|+.+||..||++|||+.++++||||..+
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            000        0111123356889999999999999999999999999999765

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-44  Score=351.10  Aligned_cols=250  Identities=21%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+..|+.++..+.+|+++..+..++  .+....+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~--~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG--VEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE--EETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE--eeCCEEEEE
Confidence            4689999999999999999999999999999998864322  234778899998888667777765544  346689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE---ccCCceEEecccccccCccc
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV---NLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~---~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||+ +++|.+++.. .+.+++..++.|+.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||++......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9999 8899999975 5679999999999999999999999 999999999999999   67899999999999876543


Q ss_pred             cc-------ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhhCC---CCCC
Q 017445          236 IA-------MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDP---SPSP  303 (371)
Q Consensus       236 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~---~~~~  303 (371)
                      ..       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ...+..+....   ....
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            22       123567999999999999999999999999999999999999999864432  22222222111   1111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ....++.++.+|+..||..||++||++.+|++
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22467899999999999999999999988763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-44  Score=330.57  Aligned_cols=266  Identities=26%  Similarity=0.406  Sum_probs=207.0

Q ss_pred             cccccccccccCCccCCCCCccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc----cHHHHHHHHH
Q 017445           52 NFNELGLQKCTSWLADESDHSEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF----EKEKRNQLLT  127 (371)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~  127 (371)
                      .|...++.+.+..+....            .|...+.||+|+||+||+|.+  +++.||+|++...    .......+.+
T Consensus        14 ~~~~~~l~~~~~~f~~~~------------~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~   79 (307)
T 2nru_A           14 SFSFYELKNVTNNFDERP------------ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQ   79 (307)
T ss_dssp             ECCHHHHHHHTTTTCCSB------------TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred             cccHHHHHHHHccccccc------------ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHH
Confidence            444455566665554332            233345899999999999986  6789999998642    2345667889


Q ss_pred             HHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCeE
Q 017445          128 EIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRM---QKSIPEPILSSMFKKLLQGLSYLHGVRHLV  204 (371)
Q Consensus       128 E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~ii  204 (371)
                      |+.++.++. ||||+++++++  .+.+..++||||+++++|.+++..   ..++++..++.++.|++.||.|||+ +||+
T Consensus        80 E~~~l~~l~-h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~  155 (307)
T 2nru_A           80 EIKVMAKCQ-HENLVELLGFS--SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-NHHI  155 (307)
T ss_dssp             HHHHHHHCC-CTTBCCEEEEE--CSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             HHHHHHhcC-CCCeEEEEEEE--ecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCee
Confidence            999999986 99999999987  455689999999999999999863   3469999999999999999999999 9999


Q ss_pred             ecCCCCCcEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCC
Q 017445          205 HRDIKPANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPY  282 (371)
Q Consensus       205 H~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf  282 (371)
                      ||||||+||+++.++.+||+|||++.......  .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||
T Consensus       156 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence            99999999999999999999999987654322  12234579999999999875 4889999999999999999999999


Q ss_pred             CCCCCcH--HHHHHHhhCC----------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          283 AASEGPV--NLMLQILEDP----------SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       283 ~~~~~~~--~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .......  ..+.......          ........++..+.+++.+||..||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7644321  1111111111          1111123345778999999999999999999999853

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-43  Score=357.27  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=211.8

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      ...+.+..++|++.+.||+|+||+||+|.+..+   +..||+|.+.. ........+.+|+.++.++. ||||+++++++
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  460 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVI  460 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence            345677889999999999999999999998654   46799999875 34455677899999999986 99999999987


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccc
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFG  227 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg  227 (371)
                      .   .+..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus       461 ~---~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          461 T---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             C---SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             e---cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCCCEEEEecC
Confidence            3   346899999999999999997554 69999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCcccccc-cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCC
Q 017445          228 ISAGLENSIAM-CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSR  305 (371)
Q Consensus       228 ~s~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.... .......+.... ....+
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-~~~~~~~i~~~~-~~~~~  614 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGE-RLPMP  614 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHHTC-CCCCC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCC-CCCCC
Confidence            99876543221 233457789999999988899999999999999999997 999997644 334444444433 33345


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ..+++.+.+|+.+||..||++|||+.++++
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.1e-44  Score=333.26  Aligned_cols=252  Identities=22%  Similarity=0.297  Sum_probs=201.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCCeeEeceeEEecCC--C
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-PCNEGLVEFHGAFYMPDS--G  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~-~~h~~iv~l~~~~~~~~~--~  154 (371)
                      ...++|++.+.||+|+||+||+|.+  +++.||||++...   ....+.+|..++... .+||||+++++++.....  .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            3457899999999999999999987  5889999999643   334567788887764 469999999998864332  2


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCeEecCCCCCcEEEccCCceEEecc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH--------GVRHLVHRDIKPANLLVNLKGRPKITDF  226 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~iiH~Dlkp~NIl~~~~~~~kl~Df  226 (371)
                      .+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||        + +||+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            79999999999999999975 57999999999999999999999        7 89999999999999999999999999


Q ss_pred             cccccCccccc----ccccccccCcccCCccccCCC------CCCchhHHHHHHHHHHHhcC----------CCCCCCCC
Q 017445          227 GISAGLENSIA----MCATFVGTVTYMSPERIRNES------YSYPADIWSIGLALFECGTG----------EFPYAASE  286 (371)
Q Consensus       227 g~s~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~ell~g----------~~pf~~~~  286 (371)
                      |++........    ......||+.|+|||++.+..      ++.++||||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976544321    224557999999999997653      33689999999999999999          78886542


Q ss_pred             C---cHHHHHHHh-hCCCCCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          287 G---PVNLMLQIL-EDPSPSPSR-----QNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       287 ~---~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .   ....+...+ ........+     ..+++.+.+|+.+||+.||++|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2   222333332 222222221     1334679999999999999999999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=333.15  Aligned_cols=255  Identities=21%  Similarity=0.349  Sum_probs=206.0

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEE
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFY  149 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~  149 (371)
                      ....+.+..++|++.+.||+|+||+||+|.+..   .+|+|+++...  ......+.+|+.++.++. ||||+++++++.
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   99 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACM   99 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEE
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEe
Confidence            345677778899999999999999999998754   49999986522  223345667888888776 999999999875


Q ss_pred             ecCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccc
Q 017445          150 MPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       150 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                        +....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ +|++||||||+||+++ ++.+||+|||+
T Consensus       100 --~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          100 --SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             --CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             --cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CCCEEEeecCC
Confidence              4557999999999999999997654 69999999999999999999999 9999999999999998 78999999999


Q ss_pred             cccCccc-----ccccccccccCcccCCccccC---------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHH
Q 017445          229 SAGLENS-----IAMCATFVGTVTYMSPERIRN---------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQ  294 (371)
Q Consensus       229 s~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~  294 (371)
                      +......     ........||+.|+|||++.+         ..++.++||||||+++|+|++|..||.... ......+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~  254 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-AEAIIWQ  254 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-HHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Confidence            8654321     112234568999999999864         347889999999999999999999997644 3344445


Q ss_pred             HhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +.....+......++.++.+++.+||..||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            55555555555578999999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-44  Score=345.03  Aligned_cols=252  Identities=15%  Similarity=0.153  Sum_probs=195.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCCee--------------
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK---EKRNQLLTEIRTLCEAPCNEGLV--------------  142 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~iv--------------  142 (371)
                      ...|+..+.||+|+||+||+|.+..+|+.||||++.....   ...+.+.+|+.++..+.++++..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3568889999999999999999999999999999874222   23466788888887776323211              


Q ss_pred             -Ee------ceeEEecC---CCeEEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEe
Q 017445          143 -EF------HGAFYMPD---SGQISIALEYMDGGSLADILRM-------QKSIPEPILSSMFKKLLQGLSYLHGVRHLVH  205 (371)
Q Consensus       143 -~l------~~~~~~~~---~~~~~lv~E~~~~g~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH  205 (371)
                       .+      ...+....   ...++++|+++ +++|.++++.       .+.+++..+..++.|++.||.|||+ +||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiH  234 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVH  234 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence             11      11111111   22467888876 5799998841       2347888999999999999999999 99999


Q ss_pred             cCCCCCcEEEccCCceEEecccccccCcccccccccccccCcccCCccc----------cCCCCCCchhHHHHHHHHHHH
Q 017445          206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI----------RNESYSYPADIWSIGLALFEC  275 (371)
Q Consensus       206 ~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~il~el  275 (371)
                      |||||+|||++.++.+||+|||++......   ..+.+| +.|+|||++          .+..++.++|||||||++|+|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999998766544   355678 999999999          555688899999999999999


Q ss_pred             hcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          276 GTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       276 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      ++|+.||...... .....++      .....+|+++.+|+.+||+.||++||++.++++||||+....
T Consensus       311 ltg~~Pf~~~~~~-~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          311 WCADLPNTDDAAL-GGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             HHSSCCCCTTGGG-SCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHCCCCCCCcchh-hhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            9999999764321 1111111      122468899999999999999999999999999999987654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-44  Score=335.50  Aligned_cols=248  Identities=20%  Similarity=0.246  Sum_probs=192.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--------HHHHHHHHHHHHHHHhCC--------CCCCe
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--------KEKRNQLLTEIRTLCEAP--------CNEGL  141 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~--------~h~~i  141 (371)
                      +..++|++.+.||+|+||+||+|.+  +|+.||||++....        ......+.+|+.++..+.        .||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3456899999999999999999987  78999999997532        122356777887776654        47777


Q ss_pred             eEeceeEEec----------------------------CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 017445          142 VEFHGAFYMP----------------------------DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQG  193 (371)
Q Consensus       142 v~l~~~~~~~----------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~a  193 (371)
                      +++.+++...                            +.+.+||||||+++|++.+.+. .+.+++..++.++.|++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-TTCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-hcCCCHHHHHHHHHHHHHH
Confidence            7776654321                            2568999999999997766664 3678999999999999999


Q ss_pred             HHHHH-cCCCeEecCCCCCcEEEccCC--------------------ceEEecccccccCcccccccccccccCcccCCc
Q 017445          194 LSYLH-GVRHLVHRDIKPANLLVNLKG--------------------RPKITDFGISAGLENSIAMCATFVGTVTYMSPE  252 (371)
Q Consensus       194 L~~LH-~~~~iiH~Dlkp~NIl~~~~~--------------------~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE  252 (371)
                      |.||| + +||+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+|||
T Consensus       174 L~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE  247 (336)
T 2vuw_A          174 LAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred             HHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence            99999 8 9999999999999999887                    8999999999866542     457999999999


Q ss_pred             cccCCCCCCchhHHHHHHH-HHHHhcCCCCCCCCCCcHHHHHHHhhCCC-CCC----CCCCCCHHHHHHHHHhcccCcCC
Q 017445          253 RIRNESYSYPADIWSIGLA-LFECGTGEFPYAASEGPVNLMLQILEDPS-PSP----SRQNFSPEFCSFVDDCLKKDAEA  326 (371)
Q Consensus       253 ~~~~~~~~~~~Dv~slG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~li~~~l~~dp~~  326 (371)
                      ++.+.. +.++||||++++ .+++++|..||............+..... ...    ....+++++.+||++||+.|   
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence            998776 889999998776 77788899999431110112223332211 111    12346789999999999976   


Q ss_pred             CCCHHHHh-cCcccc
Q 017445          327 RPTADQLL-SHPFIT  340 (371)
Q Consensus       327 Rps~~~il-~hp~~~  340 (371)
                        |+.|+| +||||+
T Consensus       324 --sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 --SATDLLCQHSLFK  336 (336)
T ss_dssp             --SHHHHHHHCGGGC
T ss_pred             --CHHHHHhcCCCcC
Confidence              999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-42  Score=351.82  Aligned_cols=245  Identities=20%  Similarity=0.252  Sum_probs=200.5

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcC-CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC-
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIP-THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG-  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~-  154 (371)
                      +...+|++.+.||+|+||+||+|.+.. +++.||||++.. ........+.+|+.++.++. ||||+++++++...+.. 
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCC
Confidence            445799999999999999999999876 789999999864 33455667889999998886 99999999988654321 


Q ss_pred             --eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          155 --QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       155 --~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                        ..||||||++|++|.+++..  .+++..+..++.||+.||.|||+ +||+||||||+|||++.+ .+||+|||++...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence              27999999999999998754  79999999999999999999999 999999999999999975 8999999999876


Q ss_pred             cccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ...    ....||+.|+|||++.+. ++.++|||||||++|+|++|..||......         ...........++.+
T Consensus       232 ~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          232 NSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSY  297 (681)
T ss_dssp             TCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHH
T ss_pred             ccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHHH
Confidence            543    456799999999999765 488999999999999999999888642110         000001111245789


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      .+||.+||+.||++||+..+.+.|+|+.-
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            99999999999999999999999988753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-41  Score=309.90  Aligned_cols=225  Identities=15%  Similarity=0.152  Sum_probs=183.6

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +...+|++.+.||+|+||+||+|.+..+++.||||++...   .......+.+|+..+.++. ||||+++++++..  .+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~  104 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHT--RA  104 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TT
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEE--CC
Confidence            4456899999999999999999999999999999999753   2445577889999998886 9999999998854  56


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..|+||||++|++|.+++.. + .....+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+++|.      
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g~~kl~~~~~------  175 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPAT------  175 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred             cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCCCEEEEeccc------
Confidence            89999999999999999953 3 4666788999999999999999 9999999999999999999999985543      


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhhCCCCC--CCCCCCCH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILEDPSPS--PSRQNFSP  310 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~  310 (371)
                                    ++       .++.++|||||||++|+|++|+.||.........  ..+........  .....+++
T Consensus       176 --------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T 3uqc_A          176 --------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF  234 (286)
T ss_dssp             --------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred             --------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence                          22       2688999999999999999999999865432100  00111111111  12357899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      ++.+++.+||+.||++| |+.++++.
T Consensus       235 ~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          235 QISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHHHcccCCccC-CHHHHHHH
Confidence            99999999999999999 99999863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.9e-36  Score=300.92  Aligned_cols=187  Identities=17%  Similarity=0.169  Sum_probs=138.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccc----------cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIF----------EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..+.|+.|.+..++..-.|+.+|+|++...          .....+++.+|+.+|.++..|+||+++++++  ++++.+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQSGW  318 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCEEE
Confidence            467888888888877778999999998542          1234567899999999998899999999977  6778999


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||||++|++|.++|...+++++.   .|+.||+.||+|||+ +|||||||||+|||++.+|.+||+|||+|+.......
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            999999999999999988888865   488999999999999 9999999999999999999999999999988776655


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCC
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFP  281 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~p  281 (371)
                      ...+.+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            56778999999999999764 67789999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=9.1e-29  Score=244.32  Aligned_cols=182  Identities=19%  Similarity=0.171  Sum_probs=142.9

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccc--------cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIF--------EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .+.||+|+||+||+|.  ..++.+++|+....        .....+++.+|+.++.++. ||||+++..++..  ....|
T Consensus       341 ~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~--~~~~~  415 (540)
T 3en9_A          341 EHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVD--LDNKR  415 (540)
T ss_dssp             -------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEE--TTTTE
T ss_pred             CCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEe--CCccE
Confidence            4589999999999994  46778999986431        1122456789999999996 9999955444443  34569


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||||++|++|.+++..        +..++.|++.||.|||+ +||+||||||+|||++.  .+||+|||+++.......
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            99999999999999864        56899999999999999 99999999999999998  999999999988765422


Q ss_pred             c-------cccccccCcccCCccccC--CCCCCchhHHHHHHHHHHHhcCCCCCC
Q 017445          238 M-------CATFVGTVTYMSPERIRN--ESYSYPADIWSIGLALFECGTGEFPYA  283 (371)
Q Consensus       238 ~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~ell~g~~pf~  283 (371)
                      .       ..+.+||+.|+|||++.+  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1       246789999999999976  567888999999999888887777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2e-26  Score=209.39  Aligned_cols=145  Identities=18%  Similarity=0.132  Sum_probs=115.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccH------------------HHHHHHHHHHHHHHhCCCCCCee
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK------------------EKRNQLLTEIRTLCEAPCNEGLV  142 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~~~~h~~iv  142 (371)
                      ..|.+.+.||+|+||.||+|.+ .+|+.||||.++....                  .....+.+|+.++.++. |++++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~  167 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVP  167 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSC
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcC
Confidence            3455669999999999999998 8899999999864221                  23566889999999987 44444


Q ss_pred             EeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceE
Q 017445          143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPK  222 (371)
Q Consensus       143 ~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~k  222 (371)
                         +++.   .+..|+||||++|++|.+ +.      ......++.|++.||.|||+ +||+||||||+|||++ ++.+|
T Consensus       168 ---~~~~---~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          168 ---KVYA---WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             ---CEEE---EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TTEEE
T ss_pred             ---eEEe---ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CCcEE
Confidence               4332   235699999999999988 42      12345799999999999999 9999999999999999 99999


Q ss_pred             EecccccccCcccccccccccccCcccCCcccc
Q 017445          223 ITDFGISAGLENSIAMCATFVGTVTYMSPERIR  255 (371)
Q Consensus       223 l~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~  255 (371)
                      |+|||+|..             +..+.|||.+.
T Consensus       233 l~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          233 IIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             ECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             EEECCCCeE-------------CCCCCHHHHHH
Confidence            999999852             34467888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=5e-22  Score=178.12  Aligned_cols=139  Identities=19%  Similarity=0.205  Sum_probs=106.3

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcE--EEEEEeccccH------------------------HHHHHHHHHHHHHHhC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRI--IALKKINIFEK------------------------EKRNQLLTEIRTLCEA  135 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~~  135 (371)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++....                        .....+.+|+..+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367888999999999999998788989  99998754211                        1123567888888776


Q ss_pred             CCCCC--eeEeceeEEecCCCeEEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-cCCCeEecC
Q 017445          136 PCNEG--LVEFHGAFYMPDSGQISIALEYMDG-G----SLADILRMQKSIPEPILSSMFKKLLQGLSYLH-GVRHLVHRD  207 (371)
Q Consensus       136 ~~h~~--iv~l~~~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~iiH~D  207 (371)
                      . |++  ++.+++.      ...+|||||+.+ |    +|.++...   .++..+..++.|++.||.||| + .||+|||
T Consensus       128 ~-~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~-~givHrD  196 (258)
T 1zth_A          128 K-EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE-AELVHAD  196 (258)
T ss_dssp             H-HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT-SCEECSS
T ss_pred             H-hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH-CCEEeCC
Confidence            5 443  3333331      246899999942 3    77776432   345678899999999999999 8 9999999


Q ss_pred             CCCCcEEEccCCceEEecccccccCc
Q 017445          208 IKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       208 lkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      |||+|||++.  .++|+|||+|....
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCHHHEEEcC--cEEEEECcccccCC
Confidence            9999999997  99999999986543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=4e-19  Score=166.21  Aligned_cols=138  Identities=17%  Similarity=0.223  Sum_probs=97.0

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-------H-------HHHH--------HHHHHHHHHHhCCCCC
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-------K-------EKRN--------QLLTEIRTLCEAPCNE  139 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~-------~~~~--------~~~~E~~~l~~~~~h~  139 (371)
                      -|++.+.||+|++|.||+|.+ .+|+.||||+++...       .       ....        ...+|...|.++. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            488999999999999999986 569999999875310       0       0001        1123444454442 21


Q ss_pred             Ce--eEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc
Q 017445          140 GL--VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL  217 (371)
Q Consensus       140 ~i--v~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~  217 (371)
                      ++  ...++.   .   ..+|||||++|++|.++..      ......++.|++.+|.+||+ .|||||||||.|||++.
T Consensus       174 gv~vp~p~~~---~---~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          174 GFPVPEPIAQ---S---RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             TCSCCCEEEE---E---TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEE
T ss_pred             CCCCCeeeec---c---CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeC
Confidence            11  222221   1   2369999999988876432      23456788999999999999 99999999999999988


Q ss_pred             CC----------ceEEecccccccCcc
Q 017445          218 KG----------RPKITDFGISAGLEN  234 (371)
Q Consensus       218 ~~----------~~kl~Dfg~s~~~~~  234 (371)
                      +|          .+.|+||+.+.....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             CCCcccccccccceEEEEeCCcccCCC
Confidence            76          389999998765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=4.4e-13  Score=119.74  Aligned_cols=141  Identities=13%  Similarity=0.089  Sum_probs=107.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ..|++...++.|+.+.||++..  .++.+++|............+.+|+..+..+..+..++++++++.  +.+..|+||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe--cCCceEEEE
Confidence            3577888899999999999974  367899999864221223357788888887765777888888664  456899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV----------------------------------------  200 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------------------------------------  200 (371)
                      ||++|.+|.+.+.     +......++.+++.+|..||+.                                        
T Consensus        90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9999999987531     2233457888999999999971                                        


Q ss_pred             ------------------CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 ------------------RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ------------------~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                                        ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              348999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=6.1e-12  Score=111.83  Aligned_cols=135  Identities=14%  Similarity=0.074  Sum_probs=93.8

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCC-CeeEeceeEEecCCCeEEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNE-GLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~-~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      .+.+....+.|..+.||++. ..+|+.+++|.....   ....+..|+..+..+..+. .++++++..  .+.+..++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~--~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec--cCCCCCEEEE
Confidence            34444344566679999996 456778999997643   2234567777776665442 256677755  3446789999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR---------------------------------------  201 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------  201 (371)
                      ||++|.+|.  ..   ..+   ...++.+++.+|..||+..                                       
T Consensus        95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998884  21   122   2356777888888888621                                       


Q ss_pred             ------------------CeEecCCCCCcEEEccCCceEEecccccc
Q 017445          202 ------------------HLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       202 ------------------~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                                        +++|+|++|.||+++.++.+.|+|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                              19999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=7.1e-11  Score=110.41  Aligned_cols=142  Identities=13%  Similarity=0.172  Sum_probs=101.8

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEec--ccc-HHHHHHHHHHHHHHHhCCC-CCCeeEeceeEEecC-CCeEEEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKIN--IFE-KEKRNQLLTEIRTLCEAPC-NEGLVEFHGAFYMPD-SGQISIAL  160 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~~~~-h~~iv~l~~~~~~~~-~~~~~lv~  160 (371)
                      ++.|+.|.++.||++..  .+..+++|+..  ... ......+.+|..++..+.. +..+++++..+...+ .+..|+||
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45799999999999975  34578899876  321 1223467778888776653 345777777553221 14689999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV----------------------------------------  200 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------------------------------------  200 (371)
                      ||++|..+.+..  ...++......++.+++.+|..||+.                                        
T Consensus       121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999998875421  23477888899999999999999972                                        


Q ss_pred             -----------------CCeEecCCCCCcEEEccCCc--eEEeccccccc
Q 017445          201 -----------------RHLVHRDIKPANLLVNLKGR--PKITDFGISAG  231 (371)
Q Consensus       201 -----------------~~iiH~Dlkp~NIl~~~~~~--~kl~Dfg~s~~  231 (371)
                                       ..++|+|++|.||+++.++.  +.|.||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             36999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=1.5e-10  Score=105.73  Aligned_cols=186  Identities=17%  Similarity=0.186  Sum_probs=119.2

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCC--eeEeceeEEecC-CCeEEEEEeccC
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG--LVEFHGAFYMPD-SGQISIALEYMD  164 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~--iv~l~~~~~~~~-~~~~~lv~E~~~  164 (371)
                      .++.|....||++.     ..+++|+...  ......+.+|...+..+..+..  +++++......+ -...|+||++++
T Consensus        27 ~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             EEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             ecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            68999999999863     3588998653  2345667888888876643332  334433221111 124589999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV--------------------------------------------  200 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------------------------------------------  200 (371)
                      |.+|.+...  ..++.+....++.+++..|..||+.                                            
T Consensus       100 G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          100 GVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             CEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             CeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            988876432  3467778888888888888888851                                            


Q ss_pred             -------------CCeEecCCCCCcEEEcc--CCceEEecccccccCcccccccccccccCcccCCcccc----CCC---
Q 017445          201 -------------RHLVHRDIKPANLLVNL--KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR----NES---  258 (371)
Q Consensus       201 -------------~~iiH~Dlkp~NIl~~~--~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~---  258 (371)
                                   ..++|+|++|.||+++.  .+.+.|+||+.+................ .-..|+...    ...   
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcCCCC
Confidence                         13799999999999998  4568899999876433221110000000 002222211    000   


Q ss_pred             -------CCCchhHHHHHHHHHHHhcCCCCCC
Q 017445          259 -------YSYPADIWSIGLALFECGTGEFPYA  283 (371)
Q Consensus       259 -------~~~~~Dv~slG~il~ell~g~~pf~  283 (371)
                             .....+.|+++.+++.+.+|..+|.
T Consensus       257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                   0122589999999999999988773

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.74  E-value=8.7e-08  Score=85.48  Aligned_cols=134  Identities=16%  Similarity=0.091  Sum_probs=93.8

Q ss_pred             eecccCCe-EEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           88 AIGSGASS-VVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        88 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      .+..|..| .||+......+..+++|.-..   .....+..|...+..+..+--+.++++.+  .+.+..|+|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~--~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFI--RTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEE--EECCeEEEEEEeeCCc
Confidence            44556555 699988766777899998754   23455677888877665554567777755  3456899999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------------
Q 017445          167 SLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV----------------------------------------------  200 (371)
Q Consensus       167 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------------------------------------------  200 (371)
                      ++.+.....    ......+..++...|.-||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765321    222334555666666666621                                              


Q ss_pred             -----------CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 -----------RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 -----------~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                                 ..++|+|+++.||+++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       027899999999999987777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.6e-07  Score=85.54  Aligned_cols=136  Identities=18%  Similarity=0.200  Sum_probs=91.7

Q ss_pred             eeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC-C-CeeEeceeEEecCCCeEEEEEeccC
Q 017445           87 GAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-E-GLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h-~-~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      +.++.|....||+.     +..+++|+..  .......+.+|...+..+..+ + .+.+.+.... ...+..|+||||++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccC
Confidence            36888999999988     4568899853  233456788899888877643 2 2455555443 34567889999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 017445          165 GGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV--------------------------------------------  200 (371)
Q Consensus       165 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------------------------------------------  200 (371)
                      |.+|.+..-  ..++......++.++...|..||+.                                            
T Consensus        97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            988876321  2234444455555555555555531                                            


Q ss_pred             ---------------CCeEecCCCCCcEEEcc---CCc-eEEecccccccC
Q 017445          201 ---------------RHLVHRDIKPANLLVNL---KGR-PKITDFGISAGL  232 (371)
Q Consensus       201 ---------------~~iiH~Dlkp~NIl~~~---~~~-~kl~Dfg~s~~~  232 (371)
                                     ..++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           24699999999999997   355 589999987543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.44  E-value=6.4e-07  Score=84.61  Aligned_cols=77  Identities=13%  Similarity=0.047  Sum_probs=46.1

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccH-------HHHHHHHHHHHHHHhCCCC-C-CeeEeceeEEecCCCeE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEK-------EKRNQLLTEIRTLCEAPCN-E-GLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~~~~h-~-~iv~l~~~~~~~~~~~~  156 (371)
                      .+.||.|..+.||++....+++.+++|.......       ....+...|...+..+..+ | .+++++.+  ..  ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~--~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--Ccc
Confidence            4579999999999997655678899998653211       1123456677776654322 2 34455442  22  245


Q ss_pred             EEEEeccCCC
Q 017445          157 SIALEYMDGG  166 (371)
Q Consensus       157 ~lv~E~~~~g  166 (371)
                      ++|||+++|.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.36  E-value=2.9e-07  Score=85.62  Aligned_cols=85  Identities=11%  Similarity=-0.003  Sum_probs=50.2

Q ss_pred             Eeeee-cccCCeEEEEEEEc---C---CCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCC--CCeeEeceeEEecC
Q 017445           85 IFGAI-GSGASSVVQRAVHI---P---THRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCN--EGLVEFHGAFYMPD  152 (371)
Q Consensus        85 ~~~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h--~~iv~l~~~~~~~~  152 (371)
                      ..+.| +.|....+|++...   .   +++.+++|......   ......+.+|...+..+..+  ..+.+++......+
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            44578 88999999988643   0   25678899865422   00113455666655544332  24556665432111


Q ss_pred             -CCeEEEEEeccCCCCHH
Q 017445          153 -SGQISIALEYMDGGSLA  169 (371)
Q Consensus       153 -~~~~~lv~E~~~~g~L~  169 (371)
                       .+..|+||||++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence             14578999999986643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.21  E-value=1.7e-05  Score=72.74  Aligned_cols=30  Identities=20%  Similarity=0.284  Sum_probs=27.3

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            679999999999999888899999999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.07  E-value=1.1e-05  Score=76.64  Aligned_cols=77  Identities=12%  Similarity=0.103  Sum_probs=46.1

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccccCcccccccccc-cccCcccCCccccCCC---CCCchhHHHHHHHHHHHh
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF-VGTVTYMSPERIRNES---YSYPADIWSIGLALFECG  276 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~ell  276 (371)
                      ..++|+|++|.||+++.++ +.|+||+.+............. .-...|++|+......   -....++.++...+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            6799999999999999776 9999999886543221111100 0113455555443111   112345557777777776


Q ss_pred             cC
Q 017445          277 TG  278 (371)
Q Consensus       277 ~g  278 (371)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.94  E-value=5e-05  Score=69.11  Aligned_cols=76  Identities=13%  Similarity=0.006  Sum_probs=54.1

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC--CCCeeEeceeEEecCCCeEEEEEecc
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC--NEGLVEFHGAFYMPDSGQISIALEYM  163 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--h~~iv~l~~~~~~~~~~~~~lv~E~~  163 (371)
                      .+.|+.|....+|+...  ++..+++|.....   ....+..|...+..+..  ...+++++...  ...+..++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~--~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIG--NSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE--ECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEe--ecCCceEEEEEec
Confidence            45799999999999974  4668889987542   24556777776655432  24567777654  3456899999999


Q ss_pred             CCCCH
Q 017445          164 DGGSL  168 (371)
Q Consensus       164 ~~g~L  168 (371)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.91  E-value=0.00013  Score=61.87  Aligned_cols=137  Identities=16%  Similarity=0.148  Sum_probs=91.3

Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccccccc
Q 017445          166 GSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVG  244 (371)
Q Consensus       166 g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~~~~g  244 (371)
                      -+|.++|.. ..+++++++|.++.|.+.+|.-+-..+.-..+=+.|..|++..+|.|-+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            489998864 568999999999999999988772101112333467899999999987764 1110            12


Q ss_pred             cCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhccc--
Q 017445          245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK--  322 (371)
Q Consensus       245 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--  322 (371)
                      ...+.|||... ...+.+.=|||||+++|..+--..|                    ...+..+|+.+.+||..|...  
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~~~~  158 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMANTVE  158 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTTCCC
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHhccc
Confidence            33456777653 3346788999999999998753322                    122356899999999999865  


Q ss_pred             -----------------------CcCCCCCHHHHhcC
Q 017445          323 -----------------------DAEARPTADQLLSH  336 (371)
Q Consensus       323 -----------------------dp~~Rps~~~il~h  336 (371)
                                             .+..|++.++|++.
T Consensus       159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             --------------------CCSCCCCCCSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCcCCHHHHHHH
Confidence                                   24688899998853

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.75  E-value=5.6e-05  Score=68.34  Aligned_cols=29  Identities=28%  Similarity=0.189  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          202 HLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       202 ~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5577889999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.72  E-value=0.00046  Score=61.79  Aligned_cols=80  Identities=13%  Similarity=0.034  Sum_probs=53.5

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC--CCeeEeceeEEecCCCeEEEE
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN--EGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h--~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +..-++.+|.|..+.||++. ..+|+.|.+|+...........+..|...|..+...  ..++++++..      .-++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEE
T ss_pred             CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEE
Confidence            44556789999999999997 567899999987543322234566787777665432  2244554421      23789


Q ss_pred             EeccCCCCH
Q 017445          160 LEYMDGGSL  168 (371)
Q Consensus       160 ~E~~~~g~L  168 (371)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.61  E-value=8.4e-05  Score=67.69  Aligned_cols=142  Identities=12%  Similarity=0.128  Sum_probs=73.6

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC----CCCeeEec-eeEEecCCCeEEEE
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC----NEGLVEFH-GAFYMPDSGQISIA  159 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~----h~~iv~l~-~~~~~~~~~~~~lv  159 (371)
                      -++.|+.|....+|++.. .+| .+++|......  ....+..|...+..+..    -|.++... |.......+..+++
T Consensus        26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEECC---EEEEEEEE-SSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            345788899899999974 334 68899886521  11223344444433221    23333211 11111123567899


Q ss_pred             EeccCCCCHH-----H---------HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHc--
Q 017445          160 LEYMDGGSLA-----D---------ILRMQ-KSI--------PEPILSSM---------------FKKLLQGLSYLHG--  199 (371)
Q Consensus       160 ~E~~~~g~L~-----~---------~l~~~-~~l--------~~~~~~~i---------------~~qi~~aL~~LH~--  199 (371)
                      |+|++|..+.     .         .++.. ..+        ........               ...+...+..+..  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            9999986531     1         11211 111        10100000               0113344555542  


Q ss_pred             ----CCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          200 ----VRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       200 ----~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                          ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                1369999999999999977666899999764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.55  E-value=0.00021  Score=65.22  Aligned_cols=137  Identities=12%  Similarity=0.079  Sum_probs=73.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCC-CCeeEecee---EEecCCCeEEEEEecc
Q 017445           88 AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGA---FYMPDSGQISIALEYM  163 (371)
Q Consensus        88 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h-~~iv~l~~~---~~~~~~~~~~lv~E~~  163 (371)
                      .|+ |....||++. ..+|+.+++|...... .....+..|...+..+..+ -.+++++..   ......+..+++|+++
T Consensus        33 ~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQ-DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEEC-CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEE-cCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            466 8888999885 3456679999986321 1123344455544433211 113333331   1111245678999999


Q ss_pred             CCCCHH-----HH---------HHh---cC------CCCHHHH----------------------HHHHHHHHHHHHHH-
Q 017445          164 DGGSLA-----DI---------LRM---QK------SIPEPIL----------------------SSMFKKLLQGLSYL-  197 (371)
Q Consensus       164 ~~g~L~-----~~---------l~~---~~------~l~~~~~----------------------~~i~~qi~~aL~~L-  197 (371)
                      +|.++.     .+         ++.   ..      .++....                      ...+.+++..+.-+ 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            885431     11         111   00      1111110                      01111222222222 


Q ss_pred             ---HcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          198 ---HGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       198 ---H~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                         .. ..++|+|+++.||+++ + .+.|+||+.+.
T Consensus       190 ~~~~~-~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFT-VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSC-CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCC-eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence               12 4589999999999999 4 89999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.46  E-value=0.00021  Score=66.78  Aligned_cols=137  Identities=17%  Similarity=0.194  Sum_probs=78.9

Q ss_pred             eeecccCCeEEEEEEEcC-------CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           87 GAIGSGASSVVQRAVHIP-------THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +.|..|....+|++....       +++.+++|+.... ........+|..++..+..+.-..++++.+  ++    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----ccE
Confidence            367778888999997532       3578999986431 112344557777776554443346666644  33    289


Q ss_pred             EeccCCCCHHH--------------H---HHhc-----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 017445          160 LEYMDGGSLAD--------------I---LRMQ-----KSIP--EPILSSMFKKLLQ-------------------GLSY  196 (371)
Q Consensus       160 ~E~~~~g~L~~--------------~---l~~~-----~~l~--~~~~~~i~~qi~~-------------------aL~~  196 (371)
                      |||++|.+|..              .   |+..     +...  +.++..+..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99999855431              1   1211     1112  3455555544322                   1233


Q ss_pred             H----Hc---CCCeEecCCCCCcEEEccC----CceEEecccccc
Q 017445          197 L----HG---VRHLVHRDIKPANLLVNLK----GRPKITDFGISA  230 (371)
Q Consensus       197 L----H~---~~~iiH~Dlkp~NIl~~~~----~~~kl~Dfg~s~  230 (371)
                      |    ..   ...++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3    22   1248999999999999876    789999999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00033  Score=66.62  Aligned_cols=75  Identities=15%  Similarity=0.070  Sum_probs=47.4

Q ss_pred             EeeeecccCCeEEEEEEEcC-------CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           85 IFGAIGSGASSVVQRAVHIP-------THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      -++.|+.|....||++....       ++..+++|+......  ...+..|...+..+..+.-.+++++.+  ++    .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIF--SG----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----C
Confidence            34578889999999997542       257899998843111  133446777666554343345666644  22    2


Q ss_pred             EEEeccCCCC
Q 017445          158 IALEYMDGGS  167 (371)
Q Consensus       158 lv~E~~~~g~  167 (371)
                      +|+||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998744

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.41  E-value=0.00099  Score=60.86  Aligned_cols=31  Identities=32%  Similarity=0.344  Sum_probs=26.9

Q ss_pred             CCeEecCCCCCcEEEccC----CceEEeccccccc
Q 017445          201 RHLVHRDIKPANLLVNLK----GRPKITDFGISAG  231 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~----~~~kl~Dfg~s~~  231 (371)
                      ..++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6799999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.14  E-value=0.0035  Score=57.48  Aligned_cols=31  Identities=29%  Similarity=0.285  Sum_probs=27.3

Q ss_pred             CCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.08  E-value=0.0032  Score=60.28  Aligned_cols=77  Identities=17%  Similarity=0.166  Sum_probs=46.7

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEeccC
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEYMD  164 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~~~  164 (371)
                      -++.|+.|....+|++.....+..+++|+....... .-...+|..++..+..+.-.+++++.+  + .+   +||||++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~-~G---~v~e~I~  184 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--T-NG---RIEEFMD  184 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--T-TE---EEEECCC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--C-Ce---EEEEeeC
Confidence            356788899999999986544578889987432111 001146777776665444446777655  2 22   4999998


Q ss_pred             CCCH
Q 017445          165 GGSL  168 (371)
Q Consensus       165 ~g~L  168 (371)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            8444

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.97  E-value=0.0012  Score=61.33  Aligned_cols=76  Identities=13%  Similarity=0.092  Sum_probs=40.3

Q ss_pred             eeeecccCCeEEEEEEEcC--------CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           86 FGAIGSGASSVVQRAVHIP--------THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++.|+.|....+|++....        .+..+++|+....... ......|...+..+..+.-.+++++..  .  +  +
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--G  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--C--c
Confidence            3478888889999997532        1367889987542211 111234555554443232244555433  1  2  5


Q ss_pred             EEEeccCCCCH
Q 017445          158 IALEYMDGGSL  168 (371)
Q Consensus       158 lv~E~~~~g~L  168 (371)
                      +||||++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999998543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.73  E-value=0.031  Score=52.76  Aligned_cols=76  Identities=17%  Similarity=0.106  Sum_probs=44.5

Q ss_pred             eeeecccCCeEEEEEEEcCC-------CcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           86 FGAIGSGASSVVQRAVHIPT-------HRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++.|..|....+|++.....       ++.+++++...... ......+|..++..+..+.-.+++++.+  .    -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P----EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCE
Confidence            45677788899999986421       57899998754221 1111234555554443333345555533  2    268


Q ss_pred             EEeccCCCCH
Q 017445          159 ALEYMDGGSL  168 (371)
Q Consensus       159 v~E~~~~g~L  168 (371)
                      ||||++|.+|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            8999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.99  E-value=0.048  Score=51.06  Aligned_cols=29  Identities=28%  Similarity=0.424  Sum_probs=24.7

Q ss_pred             eEecCCCCCcEEE------ccCCceEEeccccccc
Q 017445          203 LVHRDIKPANLLV------NLKGRPKITDFGISAG  231 (371)
Q Consensus       203 iiH~Dlkp~NIl~------~~~~~~kl~Dfg~s~~  231 (371)
                      ++|+|+.+.||++      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3457799999998854

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.80  E-value=1.3  Score=37.33  Aligned_cols=113  Identities=10%  Similarity=0.134  Sum_probs=77.8

Q ss_pred             CCCCeeEeceeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHcCCCeEecCCCCCcEEE
Q 017445          137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS-YLHGVRHLVHRDIKPANLLV  215 (371)
Q Consensus       137 ~h~~iv~l~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~iiH~Dlkp~NIl~  215 (371)
                      .||++..-    ...+.+.+.+.++.-+++.=+..+   ..++....++++.+|+.... ++++   -+|=-|+|+||++
T Consensus        48 ~~~~f~~~----I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCIVRD----IDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSSEEE----EEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGGEEE
T ss_pred             cCCCCCeE----EEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCceEEE
Confidence            37777222    224566788878766443333333   34788999999999998887 6665   5788899999999


Q ss_pred             ccCCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhH-HHHHHHHHHHhcCCCCC
Q 017445          216 NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI-WSIGLALFECGTGEFPY  282 (371)
Q Consensus       216 ~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-~slG~il~ell~g~~pf  282 (371)
                      +.++.+++.-.|+-..                 ++|..     .+ ..|. -.+=|++..++.++..|
T Consensus       118 ~~~~~p~i~hRGi~~~-----------------lpP~e-----~~-ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          118 NRALEPFFLHVGVKES-----------------LPPDE-----WD-DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CTTCCEEESCCEETTT-----------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eCCCcEEEEEcCCccc-----------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999997775322                 23321     12 2344 45788888999988777

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.31  E-value=0.6  Score=39.34  Aligned_cols=115  Identities=10%  Similarity=0.044  Sum_probs=78.7

Q ss_pred             CCCCeeEeceeEEecCCCeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE
Q 017445          137 CNEGLVEFHGAFYMPDSGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV  215 (371)
Q Consensus       137 ~h~~iv~l~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~  215 (371)
                      .||+++..-   ...+.+.+.+.++.-+. -++.. +   +.++....++++.+|+....++++   -+|=-|+|+||++
T Consensus        43 ~~~~Fl~~~---I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDAE---LTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCEE---EEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEE
T ss_pred             cCCcccceE---EEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEE
Confidence            388887652   22344577777776542 23332 2   347889999999999998877765   4788899999999


Q ss_pred             ccCCceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCC
Q 017445          216 NLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYA  283 (371)
Q Consensus       216 ~~~~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~  283 (371)
                      +.++.+++.--|+...+                 +|.     .++...=+-.+=|++..+++++..|.
T Consensus       113 ~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999977753222                 221     12222333457889999999988874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	371
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-74
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-68
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-67
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-66
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-64
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-63
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-62
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-60
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-60
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-59
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-57
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-57
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-56
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-53
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-51
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-50
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-46
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-44
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-42
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-41
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-39
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-34
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 9e-74
 Identities = 106/312 (33%), Positives = 161/312 (51%), Gaps = 47/312 (15%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G+G   VV +  H P+  ++A K I++  K   RNQ++ E++ L E   +  +V F+GA
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGA 72

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           FY    G+ISI +E+MDGGSL  +L+    IPE IL  +   +++GL+YL     ++HRD
Sbjct: 73  FY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWS 267
           +KP+N+LVN +G  K+ DFG+S  L +S+A   +FVGT +YMSPER++   YS  +DIWS
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWS 188

Query: 268 IGLALFECGTGEFPYAASE----------------------------------------- 286
           +GL+L E   G +P    +                                         
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 248

Query: 287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK 346
               L+  I+ +P P      FS EF  FV+ CL K+   R    QL+ H FI + +  +
Sbjct: 249 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308

Query: 347 VDLAAFVRSVFD 358
           VD A ++ S   
Sbjct: 309 VDFAGWLCSTIG 320

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 6e-68
 Identities = 83/272 (30%), Positives = 142/272 (52%), Gaps = 12/272 (4%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
            I G +G GA   V +A +  T  + A K I+   +E+    + EI  L     +  +V+
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVK 73

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
              AFY      + I +E+  GG++  ++  +++ + E  +  + K+ L  L+YLH    
Sbjct: 74  LLDAFY--YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NK 130

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES---- 258
           ++HRD+K  N+L  L G  K+ DFG+SA    +I    +F+GT  +M+PE +  E+    
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 259 -YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR-QNFSPEFCSFV 316
            Y Y AD+WS+G+ L E    E P+     P+ ++L+I +   P+ ++   +S  F  F+
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249

Query: 317 DDCLKKDAEARPTADQLLSHPFITKYEHAKVD 348
             CL+K+ +AR T  QLL HPF+T   +  + 
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  212 bits (541), Expect = 3e-67
 Identities = 74/285 (25%), Positives = 141/285 (49%), Gaps = 16/285 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G+   V  A  +    ++A+KK++       EK   ++ E+R L +   +   +++ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYR 81

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G +         + +EY  G +   +   +K + E  ++++    LQGL+YLH   +++H
Sbjct: 82  GCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIH 138

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES---YSYP 262
           RD+K  N+L++  G  K+ DFG +    + +A   +FVGT  +M+PE I       Y   
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D+WS+G+   E    + P       ++ +  I ++ SP+    ++S  F +FVD CL+K
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 323 DAEARPTADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQRMKDLA 367
             + RPT++ LL H F+ + E     +   ++   D ++ + +L 
Sbjct: 254 IPQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQRTKDAVRELDNLQ 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (537), Expect = 4e-67
 Identities = 68/256 (26%), Positives = 112/256 (43%), Gaps = 12/256 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V  A    +  I+ALK +    + +    +QL  E+        +  ++  +
Sbjct: 14  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 72

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
           G F+  D+ ++ + LEY   G++   L+      E   ++   +L   LSY H  + ++H
Sbjct: 73  GYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIH 129

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIKP NLL+   G  KI DFG S    +S     T  GT+ Y+ PE I    +    D+
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDL 187

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS+G+  +E   G+ P+ A         +I       P     +      +   LK +  
Sbjct: 188 WSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPS 244

Query: 326 ARPTADQLLSHPFITK 341
            RP   ++L HP+IT 
Sbjct: 245 QRPMLREVLEHPWITA 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 1e-66
 Identities = 67/266 (25%), Positives = 125/266 (46%), Gaps = 13/266 (4%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGL 141
            +   IG+G+    Q+       +I+  K+++     + ++  L++E+  L E   +  +
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNI 65

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADIL----RMQKSIPEPILSSMFKKLLQGLSYL 197
           V ++       +  + I +EY +GG LA ++    + ++ + E  +  +  +L   L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 198 H----GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPER 253
           H    G   ++HRD+KPAN+ ++ K   K+ DFG++  L +  +    FVGT  YMSPE+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
           +   SY+  +DIWS+G  L+E      P+ A      L  +I E          +S E  
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIP-YRYSDELN 243

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFI 339
             +   L      RP+ +++L +P I
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-66
 Identities = 77/260 (29%), Positives = 136/260 (52%), Gaps = 5/260 (1%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
             F  IG GAS  V  A+ + T + +A++++N+ ++ K+  ++ EI  + E   N  +V 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVN 81

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
           +  ++      ++ + +EY+ GGSL D++  +  + E  ++++ ++ LQ L +LH    +
Sbjct: 82  YLDSYL--VGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHS-NQV 137

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           +HRDIK  N+L+ + G  K+TDFG  A +    +  +T VGT  +M+PE +  ++Y    
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           DIWS+G+   E   GE PY        L L          + +  S  F  F++ CL  D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 324 AEARPTADQLLSHPFITKYE 343
            E R +A +LL H F+   +
Sbjct: 258 VEKRGSAKELLQHQFLKIAK 277

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 1e-65
 Identities = 61/257 (23%), Positives = 118/257 (45%), Gaps = 10/257 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G+   V + +   T   +A  ++      K +R +   E   L     +  +V F+ 
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYD 75

Query: 147 AFYMPDSGQ--ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH-GVRHL 203
           ++     G+  I +  E M  G+L   L+  K +   +L S  +++L+GL +LH     +
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135

Query: 204 VHRDIKPANLLVNLK-GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYP 262
           +HRD+K  N+ +    G  KI D G++     S A     +GT  +M+PE    + Y   
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEEK-YDES 192

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
            D+++ G+ + E  T E+PY+  +    +  ++     P+   +   PE    ++ C+++
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252

Query: 323 DAEARPTADQLLSHPFI 339
           + + R +   LL+H F 
Sbjct: 253 NKDERYSIKDLLNHAFF 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-64
 Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 8/257 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G GA   VQ AV+  T   +A+K +++    +    +  EI        +E +V+F+G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGH 71

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
               +     + LEY  GG L D +     +PEP     F +L+ G+ YLHG   + HRD
Sbjct: 72  RREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 128

Query: 208 IKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESY-SYPAD 264
           IKP NLL++ +   KI+DFG++      N   +     GT+ Y++PE ++   + + P D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDA 324
           +WS G+ L     GE P+              E  +     +       + +   L ++ 
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 248

Query: 325 EARPTADQLLSHPFITK 341
            AR T   +    +  K
Sbjct: 249 SARITIPDIKKDRWYNK 265

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 22/271 (8%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFE---------KEKRNQLLTEIRTLCEAPCNE 139
           +G G SSVV+R +H PT +  A+K I++           +E R   L E+  L +   + 
Sbjct: 11  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70

Query: 140 GLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG 199
            +++    +    +    +  + M  G L D L  + ++ E     + + LL+ +  LH 
Sbjct: 71  NIIQLKDTYE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 128

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIR---- 255
             ++VHRD+KP N+L++     K+TDFG S  L+          GT +Y++PE I     
Sbjct: 129 -LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMN 186

Query: 256 --NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPE 311
             +  Y    D+WS G+ ++    G  P+   +  + ++  I+       SP   ++S  
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQFGSPEWDDYSDT 245

Query: 312 FCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
               V   L    + R TA++ L+HPF  +Y
Sbjct: 246 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  200 bits (509), Expect = 6e-62
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 11/264 (4%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
            I   +G+GA  VV R     T    A K +    +  +  +  EI+T+     +  LV 
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVN 87

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
            H AF   D  ++ +  E+M GG L + +      + E       +++ +GL ++H   +
Sbjct: 88  LHDAFE--DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NN 144

Query: 203 LVHRDIKPANLLVNLK--GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
            VH D+KP N++   K     K+ DFG++A L+   ++     GT  + +PE    +   
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAPEVAEGKPVG 203

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDD 318
           Y  D+WS+G+  +   +G  P+   E     +  +          +    S +   F+  
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262

Query: 319 CLKKDAEARPTADQLLSHPFITKY 342
            L  D   R T  Q L HP++T  
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPG 286

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (494), Expect = 4e-60
 Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 12/259 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKE-KRNQLLTEIRTLCEAPCNEGLVEFHGA 147
           +G+GA S V  A    T +++A+K I     E K   +  EI  L +   +  +V     
Sbjct: 17  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDI 75

Query: 148 FYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
           +     G + + ++ + GG L D +  +    E   S +  ++L  + YLH    +VHRD
Sbjct: 76  YE--SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRD 132

Query: 208 IKPANLLVNL---KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPAD 264
           +KP NLL        +  I+DFG+S  +E+  ++ +T  GT  Y++PE +  + YS   D
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDDCLKK 322
            WSIG+  +    G  P+   E    L  QIL+      SP   + S     F+   ++K
Sbjct: 192 CWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250

Query: 323 DAEARPTADQLLSHPFITK 341
           D E R T +Q L HP+I  
Sbjct: 251 DPEKRFTCEQALQHPWIAG 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  195 bits (497), Expect = 4e-60
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 11/264 (4%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
            I   +GSGA  VV R V   T R+   K IN      +  +  EI  + +   +  L+ 
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLIN 90

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLAD-ILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
            H AF   D  ++ + LE++ GG L D I      + E  + +  ++  +GL ++H    
Sbjct: 91  LHDAFE--DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HS 147

Query: 203 LVHRDIKPANLLVNLK--GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
           +VH DIKP N++   K     KI DFG++  L     +  T   T  + +PE +  E   
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPVG 206

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDD 318
           +  D+W+IG+  +   +G  P+A  +  +  +  +          +  + SPE   F+ +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265

Query: 319 CLKKDAEARPTADQLLSHPFITKY 342
            L+K+   R T    L HP++   
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGD 289

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 60/263 (22%), Positives = 107/263 (40%), Gaps = 10/263 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+   V  A    T++  A+K +    +   +     + E R L  A  +  L    
Sbjct: 10  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F       +   +EY++GG L   ++          +    +++ GL +LH  + +V+
Sbjct: 70  CTFQ--TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVY 126

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+K  N+L++  G  KI DFG+        A   TF GT  Y++PE +  + Y++  D 
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 186

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS G+ L+E   G+ P+   +    L   I  D    P       E    +     ++ E
Sbjct: 187 WSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPE 243

Query: 326 ARPTA-DQLLSHPFITKYEHAKV 347
            R      +  HP   +    ++
Sbjct: 244 KRLGVRGDIRQHPLFREINWEEL 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-57
 Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 12/256 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G+ S V  A  + T R  A+K +    I ++ K   +  E   +     +   V+ +
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 74

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             F   D  ++   L Y   G L   +R   S  E        +++  L YLHG + ++H
Sbjct: 75  FTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIH 131

Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNESYSYPA 263
           RD+KP N+L+N     +ITDFG +     E+  A   +FVGT  Y+SPE +  +S    +
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191

Query: 264 DIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKD 323
           D+W++G  +++   G  P+ A      +  +I++     P    F P+    V+  L  D
Sbjct: 192 DLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLD 248

Query: 324 AEARPTADQLLSHPFI 339
           A  R   +++  +  +
Sbjct: 249 ATKRLGCEEMEGYGPL 264

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 8e-57
 Identities = 64/266 (24%), Positives = 118/266 (44%), Gaps = 19/266 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G +  V +  +  T    ALK +    K +R     E+     A     +V     +
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 74

Query: 149 YMPDSGQ--ISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
               +G+  + I +E +DGG L   +  R  ++  E   S + K + + + YLH   ++ 
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIA 133

Query: 205 HRDIKPANLLVNL---KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+KP NLL          K+TDFG +    +  ++  T   T  Y++PE +  E Y  
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-TPCYTPYYVAPEVLGPEKYDK 192

Query: 262 PADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPSPSRQNFSPEFCSFV 316
             D+WS+G+ ++    G  P+ ++ G      +   +++ +   P+P     S E    +
Sbjct: 193 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 252

Query: 317 DDCLKKDAEARPTADQLLSHPFITKY 342
            + LK +   R T  + ++HP+I + 
Sbjct: 253 RNLLKTEPTQRMTITEFMNHPWIMQS 278

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 5e-56
 Identities = 56/263 (21%), Positives = 114/263 (43%), Gaps = 12/263 (4%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
            I   +G G   +V R V   + +    K + + +   +  +  EI  L  A  +  ++ 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIA-RHRNILH 65

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRH 202
            H +F      ++ +  E++ G  + + +      + E  + S   ++ + L +LH   +
Sbjct: 66  LHESFE--SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HN 122

Query: 203 LVHRDIKPANLLVNLKGRP--KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
           + H DI+P N++   +     KI +FG +  L+              Y +PE  +++  S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR-LLFTAPEYYAPEVHQHDVVS 181

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFVDD 318
              D+WS+G  ++   +G  P+ A E    ++  I+         + +  S E   FVD 
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 319 CLKKDAEARPTADQLLSHPFITK 341
            L K+ ++R TA + L HP++ +
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQ 263

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 3e-54
 Identities = 63/259 (24%), Positives = 121/259 (46%), Gaps = 19/259 (7%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IGSG+   V +      H  +A+K +N+     ++      E+  L +   +  ++ F G
Sbjct: 16  IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMG 71

Query: 147 AFYMPDSGQISIALEYMDGGSLADILRMQKS-IPEPILSSMFKKLLQGLSYLHGVRHLVH 205
                 + Q++I  ++ +G SL   L + ++      L  + ++  QG+ YLH  + ++H
Sbjct: 72  YS---TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKSIIH 127

Query: 206 RDIKPANLLVNLKGRPKITDFGISA--GLENSIAMCATFVGTVTYMSPERIRNES---YS 260
           RD+K  N+ ++     KI DFG++      +         G++ +M+PE IR +    YS
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI---LEDPSPSPSRQNFSPEFCSFVD 317
           + +D+++ G+ L+E  TG+ PY+       ++  +      P  S  R N        + 
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247

Query: 318 DCLKKDAEARPTADQLLSH 336
           +CLKK  + RP   Q+L+ 
Sbjct: 248 ECLKKKRDERPLFPQILAS 266

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  178 bits (452), Expect = 2e-53
 Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 16/262 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIR--TLCEAPCNEGLVE 143
           IG G    V       T ++ A+K ++   I  K+     L E    +L        +V 
Sbjct: 12  IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
              AF+     ++S  L+ M+GG L   L       E  +     +++ GL ++H  R +
Sbjct: 72  MSYAFH--TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFV 128

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI-RNESYSYP 262
           V+RD+KPAN+L++  G  +I+D G++             VGT  YM+PE + +  +Y   
Sbjct: 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAYDSS 186

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           AD +S+G  LF+   G  P+   +      +  +          +FSPE  S ++  L++
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246

Query: 323 DAEARPT-----ADQLLSHPFI 339
           D   R       A ++   PF 
Sbjct: 247 DVNRRLGCLGRGAQEVKESPFF 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 4e-53
 Identities = 66/264 (25%), Positives = 115/264 (43%), Gaps = 24/264 (9%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEA-------PCNEGL 141
           +GSG    V   + +  +  +A+K +         +L    R   E            G+
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGS-LADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           +     F  PDS    + LE  +    L D +  + ++ E +  S F ++L+ + + H  
Sbjct: 72  IRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN- 128

Query: 201 RHLVHRDIKPANLLVNL-KGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             ++HRDIK  N+L++L +G  K+ DFG  A L+++  +   F GT  Y  PE IR   Y
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRY 186

Query: 260 -SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
               A +WS+G+ L++   G+ P+   E  +   +           RQ  S E    +  
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSECQHLIRW 237

Query: 319 CLKKDAEARPTADQLLSHPFITKY 342
           CL      RPT +++ +HP++   
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDV 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  172 bits (436), Expect = 5e-52
 Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 13/266 (4%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEG 140
            +   +G G  S V  A  +  HR +A+K +      +     +   E +       +  
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPA 68

Query: 141 LVEFHGAFY--MPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           +V  +       P      I +EY+DG +L DI+  +  +       +     Q L++ H
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIR 255
               ++HRD+KPAN++++     K+ DFGI+  +    NS+   A  +GT  Y+SPE+ R
Sbjct: 129 Q-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 256 NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFC 313
            +S    +D++S+G  L+E  TGE P+   + PV++  Q + +    PS   +  S +  
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 314 SFVDDCLKKDAEARPTADQLLSHPFI 339
           + V   L K+ E R      +    +
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-51
 Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 13/257 (5%)

Query: 82  EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGL 141
           E+++   IG G    V    +      +A+K I           L E   + +   +  L
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK--NDATAQAFLAEASVMTQL-RHSNL 62

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHG 199
           V+  G     + G + I  EYM  GSL D LR +    +    L      + + + YL G
Sbjct: 63  VQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 200 VRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY 259
             + VHRD+   N+LV+     K++DFG++    ++     T    V + +PE +R + +
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKF 177

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           S  +D+WS G+ L+E  +            +++ ++ +      +     P     + +C
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGCPPAVYEVMKNC 236

Query: 320 LKKDAEARPTADQLLSH 336
              DA  RP+  QL   
Sbjct: 237 WHLDAAMRPSFLQLREQ 253

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 18/267 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI------FEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSG  +VV++     T    A K I             R  +  E+  L E   +  ++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVI 76

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             H  +   +   + + LE + GG L D L  ++S+ E   +   K++L G+ YLH    
Sbjct: 77  TLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQ 133

Query: 203 LVHRDIKPANLLVNLKGRP----KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES 258
           + H D+KP N+++  +  P    KI DFG++  ++          GT  +++PE +  E 
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEFVAPEIVNYEP 192

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPEFCSFV 316
               AD+WSIG+  +   +G  P+   +     +  +             N S     F+
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 317 DDCLKKDAEARPTADQLLSHPFITKYE 343
              L KD + R T    L HP+I   +
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 61/266 (22%), Positives = 117/266 (43%), Gaps = 18/266 (6%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEG 140
           +I   +G+G+   V         R  A+K +    +   ++      E   L     +  
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPF 65

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
           ++   G F   D+ QI + ++Y++GG L  +LR  +  P P+      ++   L YLH  
Sbjct: 66  IIRMWGTFQ--DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS- 122

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
           + +++RD+KP N+L++  G  KITDFG +  + +   +  T  GT  Y++PE +  + Y+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYN 179

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
              D WS G+ ++E   G  P+      +    +IL      P    F+ +    +   +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLI 236

Query: 321 KKDAEAR-----PTADQLLSHPFITK 341
            +D   R        + + +HP+  +
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 4e-50
 Identities = 72/267 (26%), Positives = 112/267 (41%), Gaps = 15/267 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V       T R  A+K +    I  K++    +TE R L     +  L    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 71

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
             +      ++   +EY +GG L   L  ++   E        +++  L YLH  R +V+
Sbjct: 72  --YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVY 128

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RDIK  NL+++  G  KITDFG+     +  A   TF GT  Y++PE + +  Y    D 
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           W +G+ ++E   G  P+   +    L   IL +    P     SPE  S +   LKKD +
Sbjct: 189 WGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPK 245

Query: 326 ARP-----TADQLLSHPFITKYEHAKV 347
            R       A +++ H F        V
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDV 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 5e-50
 Identities = 52/261 (19%), Positives = 104/261 (39%), Gaps = 18/261 (6%)

Query: 89  IGSGASSVVQRAVHI--PTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           +GSG    V++  +      + +A+K +     +   +++LL E   + +   N  +V  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRM 73

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
            G           + +E  + G L   L+  + + +  +  +  ++  G+ YL    + V
Sbjct: 74  IGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE-ESNFV 129

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT---FVGTVTYMSPERIRNESYSY 261
           HRD+   N+L+  +   KI+DFG+S  L                V + +PE I    +S 
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 262 PADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
            +D+WS G+ ++E  + G+ PY        +   + +             E    ++ C 
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDLMNLCW 247

Query: 321 KKDAEARPTADQL---LSHPF 338
             D E RP    +   L + +
Sbjct: 248 TYDVENRPGFAAVELRLRNYY 268

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  167 bits (423), Expect = 1e-49
 Identities = 53/294 (18%), Positives = 116/294 (39%), Gaps = 45/294 (15%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           ++   +G G  S V  A++I  +  + +K +      K+ ++  EI+ L        ++ 
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIIT 94

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                  P S   ++  E+++      +    +++ +  +     ++L+ L Y H    +
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS-MGI 150

Query: 204 VHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPE-RIRNESYSY 261
           +HRD+KP N++++ + R  ++ D+G++             V +  +  PE  +  + Y Y
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDY 209

Query: 262 PADIWSIGLALFECGTGEFPYAASEGPVNLMLQI-------------------------- 295
             D+WS+G  L      + P+       + +++I                          
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 296 ---------LEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFIT 340
                     E    S ++   SPE   F+D  L+ D ++R TA + + HP+  
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-49
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 13/260 (5%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G    V    +   H  +A+K +        +  L E   + +   ++ LV  +   
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL-QHQRLVRLYAVV 77

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSIPEPI--LSSMFKKLLQGLSYLHGVRHLVHR 206
                  I I  EYM+ GSL D L+    I   I  L  M  ++ +G++++   R+ +HR
Sbjct: 78  ---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHR 133

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT-FVGTVTYMSPERIRNESYSYPADI 265
           D++ AN+LV+     KI DFG++  +E++           + + +PE I   +++  +D+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           WS G+ L E  T             ++  +           N   E    +  C K+  E
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VRPDNCPEELYQLMRLCWKERPE 252

Query: 326 ARPTADQLLS--HPFITKYE 343
            RPT D L S    F T  E
Sbjct: 253 DRPTFDYLRSVLEDFFTATE 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-48
 Identities = 57/279 (20%), Positives = 110/279 (39%), Gaps = 34/279 (12%)

Query: 89  IGSGASSVVQRAVHIPTHRI-----IALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +GSGA   V  A      +      +A+K +    +  +R  L++E++ + +   +E +V
Sbjct: 45  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS-----------------------IP 179
              GA     SG I +  EY   G L + LR ++                        + 
Sbjct: 105 NLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 180 EPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIA 237
              L     ++ +G+ +L   +  VHRD+   N+LV      KI DFG++  +  +++  
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221

Query: 238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE 297
           +       V +M+PE +    Y+  +D+WS G+ L+E  +                ++++
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281

Query: 298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
           +          + E    +  C   D+  RP+   L S 
Sbjct: 282 NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-48
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 13/268 (4%)

Query: 81  HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEG 140
             +R+   +G G    V       T R+ A+K +           L E + + +   +E 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKL-RHEK 73

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLH 198
           LV+ +          I I  EYM  GSL D L+ +  K +  P L  M  ++  G++Y+ 
Sbjct: 74  LVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT-FVGTVTYMSPERIRNE 257
              + VHRD++ AN+LV      K+ DFG++  +E++           + + +PE     
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD 317
            ++  +D+WS G+ L E  T             ++ Q+       P            + 
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPECPESLHDLMC 248

Query: 318 DCLKKDAEARPTADQLLS--HPFITKYE 343
            C +K+ E RPT + L +    + T  E
Sbjct: 249 QCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-48
 Identities = 59/286 (20%), Positives = 104/286 (36%), Gaps = 37/286 (12%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQ-----LLTEIRTLCEAPCNEGLVE 143
           +G G  + V +A    T++I+A+KKI +  + +         L EI+ L E   +  ++ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 64

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                       IS+  ++M+      I      +    + +     LQGL YLH    +
Sbjct: 65  LLD--AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWI 121

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-ESYSYP 262
           +HRD+KP NLL++  G  K+ DFG++    +        V T  Y +PE +     Y   
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ---------------- 306
            D+W++G  L E           +  ++ + +I E        Q                
Sbjct: 182 VDMWAVGCILAELLLRVPFLPG-DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 307 ----------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                         +    +      +  AR TA Q L   + +  
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (411), Expect = 5e-48
 Identities = 49/277 (17%), Positives = 94/277 (33%), Gaps = 23/277 (8%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           R+   IGSG+   +     I     +A+K   +  K K  QL  E +         G+  
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
                   +     + +E +            +      +  +  +++  + Y+H  ++ 
Sbjct: 68  IRWCGA--EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNF 124

Query: 204 VHRDIKPANLLVNLKG---RPKITDFGISAGLENS-------IAMCATFVGTVTYMSPER 253
           +HRD+KP N L+ L        I DFG++    ++               GT  Y S   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 254 IRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPSPSR---QNF 308
                 S   D+ S+G  L     G   +    +        +I E    +P     + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

Query: 309 SPEFCSFVDDCLKKDAEARPTAD---QLLSHPFITKY 342
             EF ++++ C     + +P      QL  + F  + 
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 6e-48
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 11/251 (4%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G+G   VV+          +A+K I        ++ + E + +     +E LV+ +G  
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 68

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
                  I I  EYM  G L + LR  +       L  M K + + + YL   +  +HRD
Sbjct: 69  T--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRD 125

Query: 208 IKPANLLVNLKGRPKITDFGISAGLENSIAMCAT-FVGTVTYMSPERIRNESYSYPADIW 266
           +   N LVN +G  K++DFG+S  + +     +      V +  PE +    +S  +DIW
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185

Query: 267 SIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           + G+ ++E  + G+ PY            I +           S +  + +  C  + A+
Sbjct: 186 AFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRLYRP-HLASEKVYTIMYSCWHEKAD 243

Query: 326 ARPTADQLLSH 336
            RPT   LLS+
Sbjct: 244 ERPTFKILLSN 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 58/263 (22%), Positives = 116/263 (44%), Gaps = 18/263 (6%)

Query: 89  IGSGASSVVQRAVHIPTHR--IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G G    V++ V+    +   +A+K +    EK    +++ E + + +   N  +V   
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLI 75

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLV 204
           G      +  + + +E   GG L   L   ++ IP   ++ +  ++  G+ YL   ++ V
Sbjct: 76  GVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFV 131

Query: 205 HRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNESYSY 261
           HRD+   N+L+  +   KI+DFG+S  L   ++     +     + + +PE I    +S 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 262 PADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCL 320
            +D+WS G+ ++E  + G+ PY   +GP  +M  I +            PE  + + DC 
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKRM-ECPPECPPELYALMSDCW 249

Query: 321 KKDAEARPTADQL---LSHPFIT 340
               E RP    +   +   + +
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYS 272

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-47
 Identities = 57/250 (22%), Positives = 101/250 (40%), Gaps = 9/250 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IGSG   +V           +A+K I           + E   + +   +  LV+ +G  
Sbjct: 13  IGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 69

Query: 149 YMPDSGQISIALEYMDGGSLADILRMQKSI-PEPILSSMFKKLLQGLSYLHGVRHLVHRD 207
              +   I +  E+M+ G L+D LR Q+ +     L  M   + +G++YL     ++HRD
Sbjct: 70  L--EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRD 126

Query: 208 IKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIRNESYSYPADIW 266
           +   N LV      K++DFG++  + ++           V + SPE      YS  +D+W
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186

Query: 267 SIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEA 326
           S G+ ++E  +       +     ++  I         R   S      ++ C K+  E 
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR-LASTHVYQIMNHCWKERPED 245

Query: 327 RPTADQLLSH 336
           RP   +LL  
Sbjct: 246 RPAFSRLLRQ 255

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-47
 Identities = 67/299 (22%), Positives = 122/299 (40%), Gaps = 37/299 (12%)

Query: 84  RIFGAIGSGASSVVQRAVHIPT-HRIIALKKINI--FEKEKRNQLLTEIRTL--CEAPCN 138
                IG GA   V +A  +    R +ALK++ +   E+      + E+  L   E   +
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 139 EGLVEFHGAFYMPDS---GQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGL 194
             +V       +  +    ++++  E++D      + ++ +  +P   +  M  +LL+GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 195 SYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERI 254
            +LH    +VHRD+KP N+LV   G+ K+ DFG+ A + +      + V T+ Y +PE +
Sbjct: 130 DFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAPEVL 187

Query: 255 RNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE----------------- 297
              SY+ P D+WS+G    E    +  +  S   V+ + +IL+                 
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 298 --------DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVD 348
                            +        +  CL  +   R +A   LSHP+    E  K +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-46
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 38/294 (12%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLV 142
                IG GA  +V  A        +A+KKI+ FE +    + L EI+ L     +E ++
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENII 69

Query: 143 EFHGAFYMPDSGQIS--IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV 200
             +     P   Q+     + ++ G  L  +L+ Q  +    +     ++L+GL Y+H  
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHS- 127

Query: 201 RHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPERIRNE 257
            +++HRD+KP+NLL+N     KI DFG++       +       +V T  Y +PE + N 
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 258 -SYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILEDPSPSPSR--------- 305
             Y+   DIWS+G  L E  +    +        +N +L IL  PS              
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247

Query: 306 -----------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                             N   +    +D  L  +   R   +Q L+HP++ +Y
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 4e-46
 Identities = 57/272 (20%), Positives = 112/272 (41%), Gaps = 29/272 (10%)

Query: 89  IGSGASSVVQRA-----VHIPTHRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLV 142
           +G+GA   V  A     +       +A+K +        R  L++E++ L     +  +V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS------------------IPEPILS 184
              GA      G   +  EY   G L + LR ++                   +    L 
Sbjct: 91  NLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN--SIAMCATF 242
           S   ++ +G+++L   ++ +HRD+   N+L+      KI DFG++  ++N  +  +    
Sbjct: 149 SFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 243 VGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS 302
              V +M+PE I N  Y++ +D+WS G+ L+E  +            +   +++++    
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267

Query: 303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLL 334
            S ++   E    +  C   D   RPT  Q++
Sbjct: 268 LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-46
 Identities = 63/301 (20%), Positives = 105/301 (34%), Gaps = 44/301 (14%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGL 141
                IG G    V +A H  T + +ALKK+ +   ++      L EI+ L     +E +
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENV 71

Query: 142 VEFHGAFYMPDS------GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLS 195
           V          S      G I +  ++ +      +  +        +  + + LL GL 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 196 YLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA----MCATFVGTVTYMSP 251
           Y+H    ++HRD+K AN+L+   G  K+ DFG++     +           V T+ Y  P
Sbjct: 132 YIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 252 ERIRNE-SYSYPADIWSIGLALFECGTGEFPYAAS--EGPVNLMLQILEDPSPSP----- 303
           E +  E  Y  P D+W  G  + E  T       +  +  + L+ Q+    +P       
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 304 ----------------------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
                                       P     +D  L  D   R  +D  L+H F   
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

Query: 342 Y 342
            
Sbjct: 311 D 311

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-45
 Identities = 62/289 (21%), Positives = 113/289 (39%), Gaps = 34/289 (11%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGL 141
                IG G    V +A +  TH I+ALK++ +   ++   +  L EI  L E   ++ +
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNI 63

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V  H   +     ++++  E+ D             +   I+ S   +LL+GL + H  R
Sbjct: 64  VRLHDVLH--SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SR 120

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YS 260
           +++HRD+KP NLL+N  G  K+ +FG++      +   +  V T+ Y  P+ +     YS
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQ-------------- 306
              D+WS G    E      P        + + +I          Q              
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 307 -------------NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                          +      + + LK +   R +A++ L HP+ + +
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 4e-45
 Identities = 54/263 (20%), Positives = 106/263 (40%), Gaps = 15/263 (5%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTH---RIIALKKIN---IFEKEKRNQLLTEIRTLCEAPC 137
           R+   +G G+  VV+R            +A+K +    + + E  +  + E+  +     
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 69

Query: 138 NEGLVEFHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSY 196
           +  L+  +G      +  + +  E    GSL D L + Q       LS    ++ +G+ Y
Sbjct: 70  HRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL---ENSIAMCATFVGTVTYMSPER 253
           L   +  +HRD+   NLL+  +   KI DFG+   L   ++   M         + +PE 
Sbjct: 127 LES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 254 IRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFC 313
           ++  ++S+ +D W  G+ L+E  T             ++ +I ++    P  ++   +  
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245

Query: 314 SFVDDCLKKDAEARPTADQLLSH 336
           + +  C     E RPT   L   
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRDF 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 8e-45
 Identities = 57/267 (21%), Positives = 99/267 (37%), Gaps = 24/267 (8%)

Query: 89  IGSGASSVVQRAVHIPT--HRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           IG G    V +A           A+K++     K+       E+  LC+   +  ++   
Sbjct: 18  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 77

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKK 189
           GA        + +A+EY   G+L D LR                   ++    L      
Sbjct: 78  GACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 190 LLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYM 249
           + +G+ YL   +  +HRD+   N+LV      KI DFG+S G E  +         V +M
Sbjct: 136 VARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRWM 193

Query: 250 SPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS 309
           + E +    Y+  +D+WS G+ L+E  +             L  ++ +         N  
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-EKPLNCD 252

Query: 310 PEFCSFVDDCLKKDAEARPTADQLLSH 336
            E    +  C ++    RP+  Q+L  
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVS 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  155 bits (392), Expect = 1e-44
 Identities = 61/259 (23%), Positives = 119/259 (45%), Gaps = 18/259 (6%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKIN---IFEKEKRNQLLTEIRTLCEAPCNEGLVEFH 145
           +G+G+   V    H  +    A+K ++   + + ++    L E R L +A     LV+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL-QAVNFPFLVKLE 107

Query: 146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
                 D+  + + +EY+ GG +   LR      EP       +++    YLH    L++
Sbjct: 108 F--SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIY 164

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADI 265
           RD+KP NLL++ +G  ++TDFG +   +       T  GT   ++PE I ++ Y+   D 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           W++G+ ++E   G  P+ A + P+ +  +I+      PS  +FS +    + + L+ D  
Sbjct: 222 WALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLT 278

Query: 326 -----ARPTADQLLSHPFI 339
                 +   + + +H + 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 47/250 (18%), Positives = 94/250 (37%), Gaps = 9/250 (3%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           +G G    V   V       +A+K +   +  +  + L E   + E   +  LV+  G  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVC 82

Query: 149 YMPDSGQISIALEYMDGGSLADIL--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHR 206
                    I  E+M  G+L D L    ++ +   +L  M  ++   + YL   ++ +HR
Sbjct: 83  T--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHR 139

Query: 207 DIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV-GTVTYMSPERIRNESYSYPADI 265
           D+   N LV      K+ DFG+S  +              + + +PE +    +S  +D+
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199

Query: 266 WSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAE 325
           W+ G+ L+E  T             +   + +D       +    +    +  C + +  
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKVYELMRACWQWNPS 258

Query: 326 ARPTADQLLS 335
            RP+  ++  
Sbjct: 259 DRPSFAEIHQ 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (386), Expect = 1e-44
 Identities = 64/287 (22%), Positives = 107/287 (37%), Gaps = 34/287 (11%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGL 141
                IG G   VV +A +       ALKKI +   ++   +  + EI  L E   +  +
Sbjct: 5   HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNI 62

Query: 142 VEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           V+ +   +     ++ +  E++D      +   +  +      S   +LL G++Y H  R
Sbjct: 63  VKLYDVIH--TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-R 119

Query: 202 HLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNES-YS 260
            ++HRD+KP NLL+N +G  KI DFG++      +      + T+ Y +P+ +     YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLM--------------------------LQ 294
              DIWS+G    E   G   +        LM                            
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 295 ILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK 341
           + E        +         +   LK D   R TA Q L H +  +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 2e-44
 Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 21/276 (7%)

Query: 84  RIFGAIGSGASSVVQRAVHI---PTHRIIALKKIN---IFEKEK-RNQLLTEIRTLCEAP 136
            +   +G+GA   V     I    T ++ A+K +    I +K K      TE + L    
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 137 CNEGLVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSY 196
            +  LV  H AF      ++ + L+Y++GG L   L  ++   E  +     +++  L +
Sbjct: 87  QSPFLVTLHYAFQ--TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 197 LHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL-ENSIAMCATFVGTVTYMSPERIR 255
           LH    +++RDIK  N+L++  G   +TDFG+S     +       F GT+ YM+P+ +R
Sbjct: 145 LHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 256 NESYSY--PADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED--PSPSPSRQNFSPE 311
                +    D WS+G+ ++E  TG  P+   +G  N   +I      S  P  Q  S  
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 312 FCSFVDDCLKKDAEARP-----TADQLLSHPFITKY 342
               +   L KD + R       AD++  H F  K 
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 57/258 (22%), Positives = 108/258 (41%), Gaps = 15/258 (5%)

Query: 89  IGSGASSVVQRAVHIPTHR---IIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IG+G    V         +    +A+K +   + +++R   L+E   + +   +  ++  
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHL 92

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            G      S  + I  E+M+ GSL   LR          L  M + +  G+ YL    + 
Sbjct: 93  EGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA-DMNY 149

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT-----FVGTVTYMSPERIRNES 258
           VHRD+   N+LVN     K++DFG+S  LE+  +             + + +PE I+   
Sbjct: 150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209

Query: 259 YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD 318
           ++  +D+WS G+ ++E  +            +++  I +D    P   +        + D
Sbjct: 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-PPPMDCPSALHQLMLD 268

Query: 319 CLKKDAEARPTADQLLSH 336
           C +KD   RP   Q+++ 
Sbjct: 269 CWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 7e-44
 Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 12/254 (4%)

Query: 89  IGSGASSVVQRAVHIPTHR---IIALKKI-NIFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IG G    V + +++        +A+K   N      R + L E  T+ +   +  +V+ 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKL 73

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            G         + I +E    G L   L   + S+    L     +L   L+YL   +  
Sbjct: 74  IGVI---TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRF 129

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT-FVGTVTYMSPERIRNESYSYP 262
           VHRDI   N+LV+     K+ DFG+S  +E+S    A+     + +M+PE I    ++  
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189

Query: 263 ADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKK 322
           +D+W  G+ ++E               +++ +I       P   N  P   S +  C   
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTLYSLMTKCWAY 248

Query: 323 DAEARPTADQLLSH 336
           D   RP   +L + 
Sbjct: 249 DPSRRPRFTELKAQ 262

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-44
 Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 42/296 (14%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF 148
           IG+G+  VV +A    +  ++A+KK+   ++ K      E++ + +   +  +V     F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL-DHCNIVRLRYFF 82

Query: 149 YMPDSGQ----ISIALEYMDGGSLADIL---RMQKSIPEPILSSMFKKLLQGLSYLHGVR 201
           Y     +    +++ L+Y+            R ++++P   +     +L + L+Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-F 141

Query: 202 HLVHRDIKPANLLVNLKGRP-KITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYS 260
            + HRDIKP NLL++      K+ DFG +  L       +                  Y+
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 201

Query: 261 YPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE----------------------- 297
              D+WS G  L E   G+  +      V+ +++I++                       
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260

Query: 298 ----DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDL 349
                P     R    PE  +     L+    AR T  +  +H F  +     V L
Sbjct: 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 8e-44
 Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 36/285 (12%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHG 146
           IG G   VV +A +  T  ++ALKKI +    +   +  + EI  L E   +  +V+   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLD 68

Query: 147 AFYMPDSGQISIALEYMDGGSLADI-LRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVH 205
              +    ++ +  E++       +       IP P++ S   +LLQGL++ H    ++H
Sbjct: 69  --VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLH 125

Query: 206 RDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESY-SYPAD 264
           RD+KP NLL+N +G  K+ DFG++      +      V T+ Y +PE +    Y S   D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185

Query: 265 IWSIGLALFECGTGEFPYAASEGPVNLMLQILE--------------------DPSPSPS 304
           IWS+G    E  T    +   +  ++ + +I                         P  +
Sbjct: 186 IWSLGCIFAEMVTRRALFPG-DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 305 RQNF-------SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           RQ+F         +  S +   L  D   R +A   L+HPF    
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 47/269 (17%), Positives = 93/269 (34%), Gaps = 22/269 (8%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVE 143
           ++   IG G+  V+    ++  ++ +A+K      +    QL  E RT        G+  
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPN 65

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHL 203
            +  ++  +     + ++ +       +    +      ++   K++L  +  +H  + L
Sbjct: 66  VY--YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSL 122

Query: 204 VHRDIKPANLLVNLK-----GRPKITDFGISAGLENSIA-------MCATFVGTVTYMSP 251
           V+RDIKP N L+            + DFG+     + +              GT  YMS 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 252 ERIRNESYSYPADIWSIGLALFECGTGE--FPYAASEGPVNLMLQILEDPSPSPSRQ--- 306
                   S   D+ ++G        G   +    +        +I E    +P R+   
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 307 NFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            F  EF  ++        +A P  D L  
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-43
 Identities = 64/257 (24%), Positives = 112/257 (43%), Gaps = 16/257 (6%)

Query: 89  IGSGASSVVQRAVHIPTHR----IIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLVE 143
           +GSGA   V + + IP        +A+K++      K   ++L E   +     N  +  
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCR 75

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADIL-RMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             G      +  + +  + M  G L D +   + +I    L +   ++ +G++YL   R 
Sbjct: 76  LLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRR 131

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMSPERIRNESYS 260
           LVHRD+   N+LV      KITDFG++  L  E            + +M+ E I +  Y+
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191

Query: 261 YPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           + +D+WS G+ ++E  T G  PY     P + +  ILE     P     + +    +  C
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 320 LKKDAEARPTADQLLSH 336
              DA++RP   +L+  
Sbjct: 250 WMIDADSRPKFRELIIE 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 32/275 (11%)

Query: 89  IGSGASSVVQRAVHIPTHR-------IIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEG 140
           +G GA   V  A  I   +        +A+K +     EK  + L++E+  +     ++ 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 141 LVEFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----------------IPEPILS 184
           ++   GA      G + + +EY   G+L + L+ ++                 +    L 
Sbjct: 81  IINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 185 SMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFV- 243
           S   ++ +G+ YL   +  +HRD+   N+LV      KI DFG++  + +      T   
Sbjct: 139 SCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 244 -GTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSP 301
              V +M+PE + +  Y++ +D+WS G+ L+E  T G  PY     PV  + ++L++   
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEGHR 255

Query: 302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
                N + E    + DC       RPT  QL+  
Sbjct: 256 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 8e-43
 Identities = 50/279 (17%), Positives = 93/279 (33%), Gaps = 37/279 (13%)

Query: 89  IGSGASSVVQRAVH-----IPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLV 142
           IG GA   V +A            ++A+K +      + +     E   + E      + 
Sbjct: 21  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS------------------------I 178
                        + +  EYM  G L + LR                            +
Sbjct: 81  LLG---VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137

Query: 179 PEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--I 236
                  + +++  G++YL   +  VHRD+   N LV      KI DFG+S  + ++   
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERKF-VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL 296
                    + +M PE I    Y+  +D+W+ G+ L+E  +             ++  + 
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 256

Query: 297 EDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS 335
            D +     +N   E  + +  C  K    RP+   +  
Sbjct: 257 -DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 58/272 (21%), Positives = 113/272 (41%), Gaps = 26/272 (9%)

Query: 89  IGSGASSVVQRAV-----HIPTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +G GA   V  A         T R +A+K +       +   L++E++ L     +  +V
Sbjct: 21  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----------------IPEPILSSM 186
              GA   P  G + + +E+   G+L+  LR +++                +    L   
Sbjct: 81  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 187 FKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVG 244
             ++ +G+ +L   R  +HRD+   N+L++ K   KI DFG++  +  +           
Sbjct: 140 SFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 198

Query: 245 TVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPS 304
            + +M+PE I +  Y+  +D+WS G+ L+E  +                + L++ +   +
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 258

Query: 305 RQNFSPEFCSFVDDCLKKDAEARPTADQLLSH 336
               +PE    + DC   +   RPT  +L+ H
Sbjct: 259 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-42
 Identities = 54/257 (21%), Positives = 107/257 (41%), Gaps = 13/257 (5%)

Query: 89  IGSGASSVVQRAVHIP---THRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLVEF 144
           IG G    V     +         A+K +N I +  + +Q LTE   + +   +  ++  
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSL 93

Query: 145 HGAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPI-LSSMFKKLLQGLSYLHGVRHL 203
            G     + G   + L YM  G L + +R +   P    L     ++ +G+ +L   +  
Sbjct: 94  LGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-SKKF 151

Query: 204 VHRDIKPANLLVNLKGRPKITDFGISAGLE----NSIAMCATFVGTVTYMSPERIRNESY 259
           VHRD+   N +++ K   K+ DFG++  +     +S+         V +M+ E ++ + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           +  +D+WS G+ L+E  T   P        ++ + +L+        +         +  C
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKC 270

Query: 320 LKKDAEARPTADQLLSH 336
               AE RP+  +L+S 
Sbjct: 271 WHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-41
 Identities = 55/256 (21%), Positives = 100/256 (39%), Gaps = 14/256 (5%)

Query: 89  IGSGASSVVQRAVHIPT----HRIIALKKINIFEKEK-RNQLLTEIRTLCEAPCNEGLVE 143
           IG+G    V + +   +       +A+K +     EK R   L E   + +   +  ++ 
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIR 73

Query: 144 FHGAFYMPDSGQISIALEYMDGGSLADI-LRMQKSIPEPILSSMFKKLLQGLSYLHGVRH 202
             G         + I  EYM+ G+L               L  M + +  G+ YL    +
Sbjct: 74  LEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MN 130

Query: 203 LVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATF---VGTVTYMSPERIRNESY 259
            VHRD+   N+LVN     K++DFG+S  LE+      T       + + +PE I    +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190

Query: 260 SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDC 319
           +  +D+WS G+ ++E  T             +M  I +     P+  +        +  C
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-PTPMDCPSAIYQLMMQC 249

Query: 320 LKKDAEARPTADQLLS 335
            +++   RP    ++S
Sbjct: 250 WQQERARRPKFADIVS 265

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 4e-41
 Identities = 60/305 (19%), Positives = 110/305 (36%), Gaps = 53/305 (17%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGL 141
           +    IGSGA  +V  A      R +A+KK++     +    +   E+  +     ++ +
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNI 78

Query: 142 VEFHGAFYMPDS----GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +     F    +      + + +E MD      I           +S +  ++L G+ +L
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHL 135

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           H     +HRD+KP+N++V      KI DFG+ A    +  M   +V T  Y +PE I   
Sbjct: 136 HSAGI-IHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILED------------------- 298
            Y    DIWS+G  + E    +  +      ++   +++E                    
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 299 ---------------------PSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHP 337
                                P+ S   +  + +    +   L  D   R + D  L HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312

Query: 338 FITKY 342
           +I  +
Sbjct: 313 YINVW 317

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 9e-41
 Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 44/295 (14%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGL 141
           R    +GSGA   V  AV   T   +A+KK+      +    +   E+R L     +E +
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENV 79

Query: 142 VEFHGAFYMPDSGQIS----IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
           +     F   ++        + + +M  G+    L   + + E  +  +  ++L+GL Y+
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN- 256
           H    ++HRD+KP NL VN     KI DFG++   ++ +     +V T  Y +PE I N 
Sbjct: 138 HA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNW 193

Query: 257 ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSR----------- 305
             Y+   DIWS+G  + E  TG+  +  S+  ++ + +I++     P+            
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSD-HLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 306 ------------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
                              N SP   + ++  L  DAE R TA + L+HP+    
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-39
 Identities = 52/266 (19%), Positives = 100/266 (37%), Gaps = 23/266 (8%)

Query: 89  IGSGASSVVQRAVH-----IPTHRIIALKKIN-IFEKEKRNQLLTEIRTLCEAPCNEGLV 142
           +G G+  +V   V            +A+K +N      +R + L E   + E      +V
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVV 86

Query: 143 EFHGAFYMPDSGQISIALEYMDGGSLADILRMQKS----------IPEPILSSMFKKLLQ 192
              G           + +E M  G L   LR  +                +  M  ++  
Sbjct: 87  RLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 193 GLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL--ENSIAMCATFVGTVTYMS 250
           G++YL+     VHRD+   N +V      KI DFG++  +   +        +  V +MS
Sbjct: 145 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 251 PERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP 310
           PE +++  ++  +D+WS G+ L+E  T             ++  ++E         N   
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL-DKPDNCPD 262

Query: 311 EFCSFVDDCLKKDAEARPTADQLLSH 336
                +  C + + + RP+  +++S 
Sbjct: 263 MLFELMRMCWQYNPKMRPSFLEIISS 288

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 69/293 (23%), Positives = 122/293 (41%), Gaps = 40/293 (13%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKIN--IFEKEKRNQLLTEIRTLCEAPCNEGL 141
           +    +GSGA   V  A    T   +A+KK++          +   E+R L     +E +
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENV 79

Query: 142 VEFHGAFYMPDS---GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH 198
           +     F    S         + ++ G  L +I++ QK + +  +  +  ++L+GL Y+H
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH 138

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRN-E 257
               ++HRD+KP+NL VN     KI DFG++   ++       +V T  Y +PE + N  
Sbjct: 139 S-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWM 194

Query: 258 SYSYPADIWSIGLALFECGTGEFPYAA--------------------------SEGPVNL 291
            Y+   DIWS+G  + E  TG   +                            SE   N 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 292 MLQILEDPSPSPSRQ--NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY 342
           +  + + P  + +      +P     ++  L  D++ R TA Q L+H +  +Y
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-38
 Identities = 57/285 (20%), Positives = 97/285 (34%), Gaps = 45/285 (15%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCN-EGLVEFHGA 147
           IG G    V R         +A+K  +     +      E           E ++ F  A
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 148 FYMPDSGQISIAL--EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLH------- 198
               +     + L  +Y + GSL D L  + ++    +  +      GL++LH       
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 199 GVRHLVHRDIKPANLLVNLKGRPKITDFGI----SAGLENSIAMCATFVGTVTYMSPERI 254
           G   + HRD+K  N+LV   G   I D G+     +  +         VGT  YM+PE +
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 255 RNE------SYSYPADIWSIGLALFECGTGEFPYAASEG-------------PVNLMLQI 295
            +            ADI+++GL  +E           E               V  M ++
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 296 LEDPSPSPSRQNF------SPEFCSFVDDCLKKDAEARPTADQLL 334
           + +    P+  N              + +C   +  AR TA ++ 
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  128 bits (321), Expect = 2e-34
 Identities = 68/318 (21%), Positives = 118/318 (37%), Gaps = 62/318 (19%)

Query: 84  RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTL----------C 133
            +   +G G  S V  A  +  +  +A+K +   +K        EI+ L           
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 134 EAPCNEGLVEF--HGAFYMPDSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKL 190
           ++     +++   H     P+   + +  E +    LA I + + + IP   +  + K+L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 191 LQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCAT---FVGTVT 247
           L GL Y+H    ++H DIKP N+L+ +   P+       A L N+          + T  
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 248 YMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEG-----PVNLMLQILEDPSPS 302
           Y SPE +    +   ADIWS    +FE  TG+F +   EG       + + QI+E     
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 303 PSR----------------------------------------QNFSPEFCSFVDDCLKK 322
           PS                                         ++ + E   F+   L+ 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 323 DAEARPTADQLLSHPFIT 340
           D   R  A  L++HP++ 
Sbjct: 315 DPRKRADAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.5 bits (190), Expect = 2e-17
 Identities = 30/197 (15%), Positives = 61/197 (30%), Gaps = 24/197 (12%)

Query: 89  IGSGASSVVQRAVHIPTHRIIALKKINI----FEKEKRNQLLTEIRTLCEAPCN-----E 139
           +G G  S V             +K   +    F+K K  +   ++     A  +      
Sbjct: 8   MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 140 GLVEFHGAFYMP--DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYL 197
            L +  G            ++ +E +D             +       +   +L+ ++  
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVAKF 119

Query: 198 HGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNE 257
           +  R +VH D+   N+LV+ +    I DF  S  +             V  +      + 
Sbjct: 120 YH-RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR-EILERDVRNII--TYFSR 174

Query: 258 SYSYPADIWSIGLALFE 274
           +Y    DI S    + +
Sbjct: 175 TYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	371
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.7
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.26
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.96
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.3
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.1
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.39

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-64  Score=464.34  Aligned_cols=276  Identities=38%  Similarity=0.673  Sum_probs=235.7

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      ++..++|++++.||+|+||+||+|.++.+|+.||+|+++.. ......++.+|+.++.++. |||||+++++|.  +.+.
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~   78 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY--SDGE   78 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEE--CSSE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCE
Confidence            35678999999999999999999999999999999999753 3445577899999998886 999999999885  4568


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc
Q 017445          156 ISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS  235 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~  235 (371)
                      +||||||++||+|.+++.+.+.+++..++.++.|++.||.|||+.+||+||||||+|||++.+|.+||+|||+|+.....
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999999999999988899999999999999999999997248999999999999999999999999999866543


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHH-----------------------
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLM-----------------------  292 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~-----------------------  292 (371)
                        ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+......                       
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              2356789999999999999999999999999999999999999997654332111                       


Q ss_pred             ------------------HHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccccHHHHHH
Q 017445          293 ------------------LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKVDLAAFVR  354 (371)
Q Consensus       293 ------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~~~~~~~~  354 (371)
                                        ........+......++.++.+||.+||+.||.+|||++|+|+||||++....++|++.|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~~~~~~  316 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC  316 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccccHHHHHH
Confidence                              11111222222234578999999999999999999999999999999999999999999998


Q ss_pred             Hhc
Q 017445          355 SVF  357 (371)
Q Consensus       355 ~~~  357 (371)
                      +.+
T Consensus       317 ~~~  319 (322)
T d1s9ja_         317 STI  319 (322)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-63  Score=448.97  Aligned_cols=260  Identities=26%  Similarity=0.426  Sum_probs=224.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++... ....+.+.+|+.++.++. ||||+++++++.  +.+.+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~--~~~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRR--EGNIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeec--cCceeEE
Confidence            358999999999999999999999999999999997533 234456889999998886 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccc--c
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENS--I  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~--~  236 (371)
                      ||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....  .
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999999888889999999999999999999999 99999999999999999999999999999876433  2


Q ss_pred             cccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                      ....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.........................+++++.+|
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            23456789999999999988775 57899999999999999999999876655555555555555555557789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +.+||+.||++|||++|+|+||||++.-
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            9999999999999999999999998643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-63  Score=449.30  Aligned_cols=256  Identities=30%  Similarity=0.567  Sum_probs=226.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      .+|++++.||+|+||+||+|.++.+|+.||||+++.......+.+.+|+.++.++. ||||++++++|..  .+.+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC-CCCEeeEeEEEEE--CCEEEEEE
Confidence            47899999999999999999999999999999997655555677899999999887 9999999998854  55899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMCA  240 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~~  240 (371)
                      |||+||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+..........
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            99999999998864 579999999999999999999999 9999999999999999999999999999988766555557


Q ss_pred             cccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh-hCCCCCCCCCCCCHHHHHHHHHh
Q 017445          241 TFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL-EDPSPSPSRQNFSPEFCSFVDDC  319 (371)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~  319 (371)
                      ..+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+. ...+..+. ........+..+++++++||.+|
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  253 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence            77899999999999999999999999999999999999999976543 33344443 33344445577999999999999


Q ss_pred             cccCcCCCCCHHHHhcCcccccc
Q 017445          320 LKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       320 l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      |+.||++|||+.|+|+||||+..
T Consensus       254 L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         254 LDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             TCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-62  Score=438.53  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=223.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .++|++++.||+|+||+||+|.++.+++.||+|++....   ......+.+|+.++.++. ||||+++++++.  +.+.+
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH--DATRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE--CSSEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEE--ECCEE
Confidence            468999999999999999999999999999999986422   233566889999998886 999999999884  56689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |||||||++|+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.......
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            9999999999999999988899999999999999999999999 999999999999999999999999999998765432


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                        ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+ ......++......  .+..+|+++.+||
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~~li  235 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISRVEFT--FPDFVTEGARDLI  235 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCCC--CCTTSCHHHHHHH
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC--CCccCCHHHHHHH
Confidence              345689999999999999999999999999999999999999997643 44455555554433  3457899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccc
Q 017445          317 DDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                      .+||+.||++|||++|+|+||||+.
T Consensus       236 ~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-62  Score=440.27  Aligned_cols=256  Identities=26%  Similarity=0.458  Sum_probs=211.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++..  .......+.+|+.++.++. ||||+++++++..+..+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            36899999999999999999999999999999998653  4455677889999998886 99999999998766667899


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eEecCCCCCcEEEccCCceEEecccc
Q 017445          158 IALEYMDGGSLADILRM----QKSIPEPILSSMFKKLLQGLSYLHGVRH-----LVHRDIKPANLLVNLKGRPKITDFGI  228 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~-----iiH~Dlkp~NIl~~~~~~~kl~Dfg~  228 (371)
                      ||||||+||+|.+++..    ...+++..++.++.|++.||.|||+ +|     |+||||||+|||++.++.+||+|||+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            99999999999999853    4679999999999999999999998 65     99999999999999999999999999


Q ss_pred             cccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          229 SAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       229 s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      |+..........+.+||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ......++.....+ ..+..+
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~i~~~~~~-~~~~~~  238 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFR-RIPYRY  238 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTCCC-CCCTTS
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCC-CCCccc
Confidence            9887765555567889999999999999999999999999999999999999997643 44555555555443 345679


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      |+++.+|+++||+.||++|||++|+|+|||+
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-62  Score=443.69  Aligned_cols=258  Identities=32%  Similarity=0.581  Sum_probs=226.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      +.|++++.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+.++.++. |||||++++++..  .+.+||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYY--ENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEee--CCeEEEEE
Confidence            46899999999999999999999999999999997755566677899999999987 9999999998854  56899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+||+|.+++.. .+++++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.........
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            99999999998764 4679999999999999999999999 999999999999999999999999999998766554455


Q ss_pred             ccccccCcccCCcccc-----CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC-CCCCCCCCHHHH
Q 017445          240 ATFVGTVTYMSPERIR-----NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP-SPSRQNFSPEFC  313 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  313 (371)
                      .+.+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||...+ ....+.++.....+ ...+..+|+++.
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            6788999999999983     4568999999999999999999999997654 44555666655433 344567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      +||++||+.||++|||+.|+|+||||+...
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999997543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-61  Score=431.85  Aligned_cols=253  Identities=24%  Similarity=0.462  Sum_probs=220.4

Q ss_pred             eeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec--CCCeEEE
Q 017445           83 MRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP--DSGQISI  158 (371)
Q Consensus        83 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~--~~~~~~l  158 (371)
                      |++.+.||+|+||+||+|.+..+++.||+|++..  ......+.+.+|+.++.++. |||||+++++|...  +...+||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEE
Confidence            4666789999999999999999999999999865  24555677899999999887 99999999998642  3456899


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC--eEecCCCCCcEEEc-cCCceEEecccccccCccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRH--LVHRDIKPANLLVN-LKGRPKITDFGISAGLENS  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~--iiH~Dlkp~NIl~~-~~~~~kl~Dfg~s~~~~~~  235 (371)
                      ||||+++|+|.+++...+.+++..+..++.||+.||+|||+ ++  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999999999999988899999999999999999999999 88  99999999999996 4789999999999765433


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSF  315 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  315 (371)
                        ...+.+||+.|+|||++.+ .++.++|||||||++|||++|+.||............+..+..+...+..+++++.+|
T Consensus       169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  245 (270)
T d1t4ha_         169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  245 (270)
T ss_dssp             --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence              2356789999999999876 5999999999999999999999999876655555556655555555566789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFIT  340 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~  340 (371)
                      |.+||+.||++|||++|+|+||||+
T Consensus       246 i~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         246 IEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-60  Score=443.19  Aligned_cols=261  Identities=27%  Similarity=0.413  Sum_probs=230.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++++.||+|+||+||+|+++.+|+.||||+++..   .......+.+|+.++.++. ||||++++++|.  +..
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~--~~~   78 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ--THD   78 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE--CSS
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeec--ccc
Confidence            4557899999999999999999999999999999999752   2234567889999998886 999999999884  567


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||++||+|.+++...+.++++.++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            899999999999999999999999999999999999999999999 9999999999999999999999999999987766


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ......+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+ .......+......  .+..+|+++.+
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~d  234 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR--FPRTLSPEAKS  234 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-HHHHHHHHhcCCCC--CCccCCHHHHH
Confidence            5555677899999999999999999999999999999999999999997654 34455555555443  34679999999


Q ss_pred             HHHHhcccCcCCCCC-----HHHHhcCccccccccc
Q 017445          315 FVDDCLKKDAEARPT-----ADQLLSHPFITKYEHA  345 (371)
Q Consensus       315 li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~  345 (371)
                      ||++||+.||++|++     +.++++||||....+.
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence            999999999999995     9999999999876543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-61  Score=437.25  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=225.7

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++...   ......+.+|+.++.++. ||||++++++|.  +.+.+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--~~~~~   83 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ--DDEKL   83 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEE--CSSEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEE--ECCEE
Confidence            468999999999999999999999999999999996422   234467889999999886 999999999884  56789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+......
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999999999988999999999999999999999999 999999999999999999999999999998765332


Q ss_pred             --cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          237 --AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       237 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                        ....+.+||+.|+|||++.+..++.++||||+||++|+|++|..||... +......++......  .+..+++++.+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~~  239 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYD--FPEKFFPKARD  239 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHTTCCC--CCTTCCHHHHH
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-CHHHHHHHHHcCCCC--CCccCCHHHHH
Confidence              2335678999999999999999999999999999999999999999764 345555666655443  34578999999


Q ss_pred             HHHHhcccCcCCCCCHHH------HhcCccccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQ------LLSHPFITKYEHAKV  347 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~------il~hp~~~~~~~~~~  347 (371)
                      ||++||+.||++|||++|      +++||||+.+.++++
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            999999999999999987      689999998877664

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-60  Score=438.52  Aligned_cols=257  Identities=27%  Similarity=0.486  Sum_probs=226.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ..|++++.||+|+||+||+|++..+|+.||||+++..   .....+.+.+|+.++.++. |||||++++++..  .+.+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEE--CCEEE
Confidence            3589999999999999999999999999999998753   3445567899999999886 9999999998854  56899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||||.+|+|..++...+++++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|......  
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            999999999998888878899999999999999999999999 99999999999999999999999999999866543  


Q ss_pred             ccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCS  314 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                        ...+||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+.. ....+.++.....+......+|+++.+
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence              45689999999999864   458999999999999999999999997644 455666777777666667789999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      ||.+||+.||++|||++++|+||||.+...+.
T Consensus       246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~  277 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence            99999999999999999999999998765443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-60  Score=436.59  Aligned_cols=259  Identities=28%  Similarity=0.420  Sum_probs=209.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      .+.|++.+.||+|+||+||+|.++.+|+.||||++.... ......+.+|+.++.++. ||||+++++++.  +.+.+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--~~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYE--SGGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEEE
Confidence            356999999999999999999999999999999997532 233456788999998886 999999999884  5678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc---cCCceEEecccccccCccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN---LKGRPKITDFGISAGLENS  235 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~---~~~~~kl~Dfg~s~~~~~~  235 (371)
                      |||||+||+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+||++.   .++.+||+|||+|+.....
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            99999999999999988899999999999999999999999 9999999999999995   4789999999999876544


Q ss_pred             ccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCCCCCCHHHH
Q 017445          236 IAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSRQNFSPEFC  313 (371)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  313 (371)
                       ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. .......+......  .+....+|+++.
T Consensus       164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-DAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCCCCCccccCCCHHHH
Confidence             23356789999999999999999999999999999999999999997644 34555566555433  334467999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          314 SFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       314 ~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +||.+||+.||++|||+.|+++||||++...
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  272 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTA  272 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence            9999999999999999999999999986544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.6e-60  Score=440.19  Aligned_cols=258  Identities=24%  Similarity=0.395  Sum_probs=227.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||||++........+.+.+|+.++.++. |||||+++++|.  +.+.+||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFE--DDNEMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEE--ETTEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEEEEE
Confidence            58999999999999999999999999999999998766667788899999999996 999999999885  466899999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc--CCceEEecccccccCccccc
Q 017445          161 EYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL--KGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       161 E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~--~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+||+|.+++. ..+++++..++.++.||+.||.|||+ +||+||||||+|||++.  ++.+||+|||+|+..... .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~  180 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  180 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-S
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheecccc-c
Confidence            9999999999985 44679999999999999999999999 99999999999999964  588999999999876654 3


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCCHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFSPEFCSF  315 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  315 (371)
                      ...+..||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +....+.++.......  .....+++++.+|
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            335678999999999999999999999999999999999999999764 3455566665554432  3335789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      |++||+.||++|||++|+|+||||+....
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            99999999999999999999999987654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-59  Score=431.62  Aligned_cols=257  Identities=24%  Similarity=0.443  Sum_probs=227.1

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      -++|++++.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.++..+. ||||+++++++.  +.+.+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~~~   79 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ--DAQQI   79 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE--CSSEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEe--eCCee
Confidence            36899999999999999999999999999999999642   2233567889999998886 999999999884  56799


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+||||++||+|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999999999999999999999999999999999999 99999999999999999999999999999876543 


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                        ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+. +......++......  .+..+++++.+++
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~~li  232 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNAELR--FPPFFNEDVKDLL  232 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHCCCC--CCTTSCHHHHHHH
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-CHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence              24678999999999999999999999999999999999999999764 345556666666543  3457899999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          317 DDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       317 ~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      .+||+.||.+|+     |++++++||||+++.+++
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~  267 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  267 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             HHHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence            999999999996     899999999999876544

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-59  Score=421.36  Aligned_cols=258  Identities=27%  Similarity=0.464  Sum_probs=225.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM  150 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~  150 (371)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...         ....+.+.+|+.++.++..||||+++++++. 
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-   80 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence            468999999999999999999999999999999986421         2234568899999999988999999999884 


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          151 PDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       151 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       +.+.+||||||++||+|.+++..++++++..++.++.||+.||+|||+ +||+||||||+||+++.++.+||+|||++.
T Consensus        81 -~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          81 -TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             -cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEccchhee
Confidence             567999999999999999999988999999999999999999999999 999999999999999999999999999998


Q ss_pred             cCcccccccccccccCcccCCccccC------CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--C
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRN------ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--S  302 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~  302 (371)
                      ...... .....+||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.. .......+......  .
T Consensus       159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCT
T ss_pred             EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-HHHHHHHHHhCCCCCCC
Confidence            776543 3356789999999999853      347889999999999999999999998654 44555566655443  3


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          303 PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       303 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      .....+|+++.+|+.+||+.||++|||++|||+||||+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            3345799999999999999999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-60  Score=434.82  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=226.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQIS  157 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~  157 (371)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..   .......+..|..++.+..+||||+++++++.  +.+.+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCcee
Confidence            5899999999999999999999999999999999642   22334567788887776556999999999884  566899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          158 IALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       158 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||||+++|+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+++.......
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            999999999999999988999999999999999999999999 9999999999999999999999999999987766555


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVD  317 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  317 (371)
                      .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+ ......++......  .+..+|+++.+||+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~--~p~~~s~~~~dli~  235 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPF--YPRWLEKEAKDLLV  235 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--CCTTSCHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC--CCccCCHHHHHHHH
Confidence            5667789999999999999999999999999999999999999997643 44555555555433  34578999999999


Q ss_pred             HhcccCcCCCCCHH-HHhcCcccccccc
Q 017445          318 DCLKKDAEARPTAD-QLLSHPFITKYEH  344 (371)
Q Consensus       318 ~~l~~dp~~Rps~~-~il~hp~~~~~~~  344 (371)
                      +||+.||++||++. ++++||||+++.+
T Consensus       236 ~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HhcccCCCCCcCHHHHHHhCchhccCCH
Confidence            99999999999995 8999999987643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-59  Score=436.62  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=225.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++.........+.+|+.++.++. |||||+++++|.  +.+.+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFE--DKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEE--CSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECCEEEEEE
Confidence            57999999999999999999999999999999998766666778889999998886 999999999884  567899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEc--cCCceEEecccccccCccccc
Q 017445          161 EYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVN--LKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       161 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~--~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      |||+||+|.+++... .++++..++.++.||+.||.|||+ +||+||||||+|||++  .++.+||+|||+|...... .
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~  183 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E  183 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceecCCC-C
Confidence            999999999987654 469999999999999999999999 9999999999999998  5689999999999877654 3


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC--CCCCCCCCHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP--SPSRQNFSPEFCSF  315 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  315 (371)
                      ...+..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+.++......  ......+|+++.+|
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            3356789999999999999999999999999999999999999997644 34555566555433  33446799999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          316 VDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       316 i~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      |.+||+.||.+|||+.|+|+||||+..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=426.43  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=223.0

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc------HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE------KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++...      ....+.+.+|+.++.++. |||||+++++|.  +.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~~   86 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--NKT   86 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE--CSS
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE--ECC
Confidence            57999999999999999999999999999999986421      123577899999999996 999999999884  567


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC----ceEEecccccc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG----RPKITDFGISA  230 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~----~~kl~Dfg~s~  230 (371)
                      .+|||||||+||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++    .+||+|||+|.
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEecchhhhh
Confidence            899999999999999999988899999999999999999999999 9999999999999998776    59999999998


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQNF  308 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~  308 (371)
                      ...... ...+..||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+ ....+.++........  ....+
T Consensus       166 ~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         166 KIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             ECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCCCchhcCCC
Confidence            765542 3356789999999999999999999999999999999999999997643 4445555555443322  23578


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccccc
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAK  346 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~  346 (371)
                      |+++.+||++||+.||++|||++|+|+||||+....++
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence            99999999999999999999999999999998765544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-59  Score=438.62  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=217.3

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHH---HHHHHhCCCCCCeeEeceeEEecC
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTE---IRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++....   ......+.+|   +.++..+ +|||||+++++|.  +
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~--~   78 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFH--T   78 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEE--C
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEE--E
Confidence            3568999999999999999999999999999999986421   1222334444   3444444 5999999999884  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          153 SGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      .+.+||||||++||+|.+++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+..
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            66899999999999999999988999999999999999999999999 99999999999999999999999999999876


Q ss_pred             cccccccccccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHH
Q 017445          233 ENSIAMCATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPE  311 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ...  .....+||+.|+|||++. +..|+.++|||||||++|+|++|+.||......................+..+|++
T Consensus       158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            553  235568999999999996 45689999999999999999999999976543322211112223333445679999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCcccccccccc
Q 017445          312 FCSFVDDCLKKDAEARPT-----ADQLLSHPFITKYEHAK  346 (371)
Q Consensus       312 ~~~li~~~l~~dp~~Rps-----~~~il~hp~~~~~~~~~  346 (371)
                      +.+||.+||+.||++|||     ++++++||||+...+..
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~  275 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  275 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence            999999999999999999     79999999999876543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-59  Score=435.09  Aligned_cols=257  Identities=23%  Similarity=0.403  Sum_probs=226.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE---KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~  156 (371)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++...   ......+.+|+.++..+. ||||+++++++.  +...+
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~  116 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK--DNSNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccc--ccccc
Confidence            368999999999999999999999999999999986422   233456889999998886 999999999884  56689


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ++||||+.||+|.+++...+.+++..++.++.||+.||.|||+ +|||||||||+|||++.+|++||+|||+|+..... 
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999999999988899999999999999999999999 99999999999999999999999999999877543 


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                        ..+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +......++.......  +..+++++.+||
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~~--p~~~s~~~~~li  269 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSGKVRF--PSHFSSDLKDLL  269 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCC--CTTCCHHHHHHH
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-CHHHHHHHHhcCCCCC--CccCCHHHHHHH
Confidence              24678999999999999999999999999999999999999999764 3455566666655433  457999999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCcccccccccc
Q 017445          317 DDCLKKDAEARP-----TADQLLSHPFITKYEHAK  346 (371)
Q Consensus       317 ~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~  346 (371)
                      ++||+.||.+|+     |++++++||||+...+.+
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~  304 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccCCCHHH
Confidence            999999999995     899999999998775443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-58  Score=422.32  Aligned_cols=256  Identities=21%  Similarity=0.376  Sum_probs=222.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+|+.++..+. ||||++++++|.  +.+.+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~--~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR-HRNILHLHESFE--SMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSC-CTTBCCEEEEEE--ETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCC-CCCCCeEEEEEE--ECCEEEEE
Confidence            468999999999999999999999999999999997643 33456789999998887 999999999885  46689999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC--CceEEecccccccCcccc
Q 017445          160 LEYMDGGSLADILRMQK-SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK--GRPKITDFGISAGLENSI  236 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~--~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||||+||+|.+++...+ .+++..++.++.||+.||+|||+ +||+||||||+|||++.+  +.+||+|||++...... 
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            99999999999997654 79999999999999999999999 999999999999999854  58999999999876543 


Q ss_pred             cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCC--CCCCCCHHHHH
Q 017445          237 AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSP--SRQNFSPEFCS  314 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  314 (371)
                      ....+..+|+.|+|||.+.+..++.++||||+||++|+|++|..||...+ ....+.++.......+  ....+|+++.+
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            23356779999999999999999999999999999999999999997644 4555666666544332  23578999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          315 FVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       315 li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ||++||+.||++|||++|+++||||++.
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            9999999999999999999999999754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=423.23  Aligned_cols=257  Identities=24%  Similarity=0.365  Sum_probs=213.1

Q ss_pred             CcceeEee-eecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEe--cCCCeE
Q 017445           80 SHEMRIFG-AIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYM--PDSGQI  156 (371)
Q Consensus        80 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~--~~~~~~  156 (371)
                      .++|++++ .||+|+||+||+|.+..+++.||||+++..     ..+.+|+.++.++.+|||||+++++|..  .....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35899875 599999999999999999999999999642     3456788888777779999999998853  334679


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEeccccccc
Q 017445          157 SIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISAG  231 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~~  231 (371)
                      |||||||+||+|.+++...  .++++..++.++.|++.||+|||+ +||+||||||+|||++.   ++.+||+|||+|+.
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeee
Confidence            9999999999999999764  469999999999999999999999 99999999999999986   46799999999987


Q ss_pred             CcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHH--HHH-HHhhCCCC--CCCCC
Q 017445          232 LENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVN--LML-QILEDPSP--SPSRQ  306 (371)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~--~~~~~  306 (371)
                      ..... ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....  .+. .+......  .....
T Consensus       164 ~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  242 (335)
T d2ozaa1         164 TTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  242 (335)
T ss_dssp             CCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred             ccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence            66543 33567899999999999999999999999999999999999999976543221  111 11112211  12223


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                      .+|+++.+||++||+.||++|||+.|+++||||.+..
T Consensus       243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            6899999999999999999999999999999997543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-57  Score=415.41  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=211.7

Q ss_pred             EeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHH-----HHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           85 IFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKE-----KRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        85 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++.||+|+||+||+|.++.+|+.||||+++.....     ....+.+|+.++.++. |||||++++++.  +.+.+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~--~~~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG--HKSNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEEC--CTTCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeec--cCCceeeh
Confidence            467999999999999999999999999998653221     1346889999999987 999999999884  56689999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccccc
Q 017445          160 LEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      |||+.++++..+......+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|..........
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            9999998887777667789999999999999999999999 999999999999999999999999999998877665555


Q ss_pred             ccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCCC------------
Q 017445          240 ATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSP------------  303 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~------------  303 (371)
                      .+.+||+.|+|||++.+ ..++.++||||+||++|||++|..||.+.. ..+.+.++..   .+....            
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-HHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            67789999999999865 458999999999999999999999997654 3333333322   111000            


Q ss_pred             -----------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          304 -----------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       304 -----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                 ....+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence                       01256789999999999999999999999999999986543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-57  Score=409.43  Aligned_cols=256  Identities=20%  Similarity=0.323  Sum_probs=221.3

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..|++..++|++.+.||+|+||+||+|.+..+++.||||+++... ...+++.+|+.++.++. |||||++++++.  +.
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--~~   85 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT--RE   85 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCC-CCCEecCCccEe--eC
Confidence            457788899999999999999999999999999999999997532 34567899999999996 999999999874  56


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +.++|||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCCcEEEccccceee
Confidence            6899999999999999999754  568999999999999999999999 9999999999999999999999999999987


Q ss_pred             Cccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          232 LENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+.+.+........+..+|+
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCCCCCCccchH
Confidence            654332 23344689999999999999999999999999999999997777655443 3444555565555666778999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ++.+|+.+||+.||++|||+++|++
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999965

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-57  Score=416.31  Aligned_cols=258  Identities=23%  Similarity=0.366  Sum_probs=219.2

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCc-----EEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHR-----IIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      .|++..++|++.+.||+|+||+||+|.+..+++     .||+|.+... .......+.+|+.++.++.+|||||++++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            466778899999999999999999999876543     6999998653 3445567889999999987799999999988


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEe
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQ-----------------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVH  205 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH  205 (371)
                        .+.+.+|||||||++|+|.++|...                       ..+++..+..++.|++.||+|||+ +||+|
T Consensus       111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiH  187 (325)
T d1rjba_         111 --TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVH  187 (325)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEE
T ss_pred             --eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence              4566899999999999999999754                       248999999999999999999999 99999


Q ss_pred             cCCCCCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCC
Q 017445          206 RDIKPANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPY  282 (371)
Q Consensus       206 ~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf  282 (371)
                      |||||+|||++.++.+||+|||+|+.......  ...+..||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999987654332  2345668999999999999999999999999999999998 89999


Q ss_pred             CCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          283 AASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+.... ..+.+++........+..+|+++.+||.+||+.||++|||++||++|
T Consensus       268 ~~~~~~-~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVD-ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCS-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            765543 34556666666666677899999999999999999999999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=403.34  Aligned_cols=254  Identities=24%  Similarity=0.426  Sum_probs=208.3

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      .|++..++|++.+.||+|+||+||+|+..   ..||||+++.  ......+.+.+|+.++.++. |||||++++++.   
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~---   74 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST---   74 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe---
Confidence            35677889999999999999999999743   3699999865  24456678899999999986 999999999753   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ...++|||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus        75 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          75 APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceee
Confidence            34689999999999999999754 569999999999999999999999 9999999999999999999999999999977


Q ss_pred             Ccccc--cccccccccCcccCCccccC---CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCC---CC
Q 017445          232 LENSI--AMCATFVGTVTYMSPERIRN---ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSP---SP  303 (371)
Q Consensus       232 ~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~  303 (371)
                      .....  ....+..||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+..........+......   ..
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence            65332  23355689999999999964   348899999999999999999999998765444433333333222   23


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          304 SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       304 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+..+|+++.+|+.+||..||++|||+.+|+++
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            456789999999999999999999999999876

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=408.08  Aligned_cols=259  Identities=26%  Similarity=0.444  Sum_probs=213.5

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE--KEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++++.||+|+||+||+|.+..+|+.||||+++...  .....++.+|+.++.++. ||||++++++|.  +.+.+|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~--~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH--TENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEE--ETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccc--cccceeE
Confidence            58999999999999999999999999999999996532  223567889999998876 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          159 ALEYMDGGSLADILR--MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       159 v~E~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||||+.+ ++.+++.  ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||.|+......
T Consensus        79 v~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          79 VFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             EEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9999976 5554443  24569999999999999999999999 999999999999999999999999999998776655


Q ss_pred             cccccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCCCC---------
Q 017445          237 AMCATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSPSP---------  303 (371)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~---------  303 (371)
                      .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.+. ...+.++..   .+....         
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCCCchhhccccccccc
Confidence            5566778999999999986655 57899999999999999999999986543 333333321   111000         


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          304 ---------------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       304 ---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                     ....+++++.+|+++||+.||++|||++|+|+||||+....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                           012567899999999999999999999999999999887654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=404.23  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=218.7

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      ..|++..++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+.++.++. |||||+++|++.   .
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~---~   79 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT---Q   79 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---S
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCC-CCCEeEEEeeec---c
Confidence            456778889999999999999999999964 57889999997532 34467899999999996 999999999763   3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          154 GQISIALEYMDGGSLADILRMQ--KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +.+||||||+++|+|.+++...  .++++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccceEE
Confidence            4679999999999999977533  359999999999999999999999 9999999999999999999999999999987


Q ss_pred             Ccccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          232 LENSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||+||..|+............+ ........+..+++
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~~~~~~~p~~~~~  237 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPE  237 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCH
T ss_pred             ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCcccChH
Confidence            65432 23345679999999999998889999999999999999999666554444444444444 44444555678999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc--Cccccc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLS--HPFITK  341 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~--hp~~~~  341 (371)
                      ++.+|+.+||+.||++|||+++|++  |+||+.
T Consensus       238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999998  788853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-57  Score=405.83  Aligned_cols=251  Identities=25%  Similarity=0.438  Sum_probs=212.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc------HHHHHHHHHHHHHHHhCC-CCCCeeEeceeEEecC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE------KEKRNQLLTEIRTLCEAP-CNEGLVEFHGAFYMPD  152 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~~~-~h~~iv~l~~~~~~~~  152 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++...      .....++.+|+.++.++. .||||+++++++.  +
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~   80 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--R   80 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--C
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--e
Confidence            358999999999999999999999999999999986421      112234668898888775 4999999999884  5


Q ss_pred             CCeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC-CceEEecccccc
Q 017445          153 SGQISIALEYMDG-GSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK-GRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~-~~~kl~Dfg~s~  230 (371)
                      .+..|+||||+.+ +++.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|.
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEECccccce
Confidence            6689999999976 6888999888899999999999999999999999 999999999999999855 799999999997


Q ss_pred             cCcccccccccccccCcccCCccccCCCC-CCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESY-SYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .....  ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+       .+.....  ..+..+|
T Consensus       160 ~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~--~~~~~~s  228 (273)
T d1xwsa_         160 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--FFRQRVS  228 (273)
T ss_dssp             ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--CCSSCCC
T ss_pred             ecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc--CCCCCCC
Confidence            65443  3356789999999999977664 677999999999999999999996521       2333332  2345789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                      +++.+||++||+.||++|||++|+|+||||++...
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            99999999999999999999999999999987643

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-56  Score=406.61  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=212.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCC-CcEEEEEEeccc--cHHHHHHHHHHHHHHHhC--CCCCCeeEeceeEEec---
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPT-HRIIALKKINIF--EKEKRNQLLTEIRTLCEA--PCNEGLVEFHGAFYMP---  151 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~--~~h~~iv~l~~~~~~~---  151 (371)
                      .++|++++.||+|+||+||+|++..+ ++.||||+++..  .........+|+.++..+  .+||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999765 678999998642  222233456677766554  2599999999988542   


Q ss_pred             CCCeEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      ....++++|||++++.+..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            3457899999999877665443 34569999999999999999999999 999999999999999999999999999987


Q ss_pred             cCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCC-------
Q 017445          231 GLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPS-------  300 (371)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~-------  300 (371)
                      ..... ....+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+ ....+.+++.   .+.       
T Consensus       165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhccccc
Confidence            66544 34467789999999999999999999999999999999999999997654 3333333321   110       


Q ss_pred             ---------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccc
Q 017445          301 ---------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHA  345 (371)
Q Consensus       301 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~  345 (371)
                                     .......+++++.+||++||+.||++|||+.|+|+||||+..+.-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence                           011234678999999999999999999999999999999987543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=400.49  Aligned_cols=257  Identities=23%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             eecCcceeEeee-ecccCCeEEEEEEEcC--CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           77 RCASHEMRIFGA-IGSGASSVVQRAVHIP--THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        77 ~~~~~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      -+..++|.+.+. ||+|+||+||+|.+..  ++..||||+++. ......+.+.+|+.++.++. |||||+++|++.   
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~---   79 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ---   79 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE---
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeec---
Confidence            355678888885 9999999999998754  456899999975 34556778999999999996 999999999874   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      .+.+||||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          80 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhhc
Confidence            2358999999999999999864 4579999999999999999999999 9999999999999999999999999999987


Q ss_pred             Ccccc---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          232 LENSI---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       232 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+.. ......+..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~~i~~-~~~~~~p~~  236 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQ-GKRMECPPE  236 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHT-TCCCCCCTT
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHc-CCCCCCCCc
Confidence            65432   22234568999999999998899999999999999999998 9999987553 344444443 334445678


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHH---hcCcccc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQL---LSHPFIT  340 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~i---l~hp~~~  340 (371)
                      +|+++.+|+.+||+.||++|||+.+|   |+|+|+.
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999888   5777774

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-55  Score=401.78  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=202.8

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCc---EEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHR---IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS  153 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~  153 (371)
                      +..++|++.+.||+|+||+||+|.++.+++   .||||.+.. ......+.+.+|+.++.++. |||||+++|++.  +.
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~--~~   99 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVT--KS   99 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--SS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEe--eC
Confidence            345689999999999999999999877664   589998865 34556678999999999986 999999999874  45


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccC
Q 017445          154 GQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGL  232 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~  232 (371)
                      +.+|+|||||++|+|.+++... +.+++..+..++.|++.||.|||+ +||+||||||+|||++.++++||+|||+|+..
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccceEc
Confidence            6899999999999999988764 469999999999999999999999 99999999999999999999999999999876


Q ss_pred             cccccc-----cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          233 ENSIAM-----CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       233 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ......     .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... .......+ ......+.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~~~~i-~~~~~~~~~~  256 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVINAI-EQDYRLPPPM  256 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHH-HTTCCCCCCT
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHHHHHH-HcCCCCCCCc
Confidence            543221     122457899999999999999999999999999999998 899997644 33444444 3444444567


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+++++.+|+.+||+.||++|||+.+|+++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            899999999999999999999999999764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=394.87  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ..++|++++.||+|+||+||+|.+. +++.||||+++.. ....+.+.+|+.++.++. ||||++++|++.  +.+.++|
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~--~~~~~~l   77 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLS-HPKLVQLYGVCL--EQAPICL   77 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCC-CTTBCCEEEEEC--SSSSCEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcC-CCCcccccceec--cCCceEE
Confidence            3568999999999999999999865 5678999999753 233467899999999997 999999999874  4567999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc
Q 017445          159 ALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA  237 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~  237 (371)
                      ||||+++|+|.+++... ..++++.+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            99999999999998654 568999999999999999999999 9999999999999999999999999999987654432


Q ss_pred             -ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 -MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                       ......||+.|+|||++.+..++.++|||||||++|||+|+..|+............+.. ......+..+++++.+|+
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHH
Confidence             223457899999999999999999999999999999999954444333444444444444 344445577899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017445          317 DDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+||+.||++|||+++|++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=397.41  Aligned_cols=247  Identities=22%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             eeecccCCeEEEEEEEc--CCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEec
Q 017445           87 GAIGSGASSVVQRAVHI--PTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALEY  162 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E~  162 (371)
                      +.||+|+||+||+|.+.  .+++.||||+++..  +....+.+.+|+.++.++. |||||+++|++.   .+..+|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~---~~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE---AESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE---SSSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEec---cCCEEEEEEc
Confidence            36999999999999764  45678999998642  3344567899999999886 999999999873   2357899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc---cc
Q 017445          163 MDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA---MC  239 (371)
Q Consensus       163 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~---~~  239 (371)
                      +++|+|.+++.....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.......   ..
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999999999988999999999999999999999999 9999999999999999999999999999986543322   22


Q ss_pred             ccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHH
Q 017445          240 ATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDD  318 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  318 (371)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.. ...... .+........+..+|+++.+|+.+
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~~~~~~-~i~~~~~~~~p~~~~~~~~~li~~  245 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTA-MLEKGERMGCPAGCPREMYDLMNL  245 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHH-HHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-HHHHHH-HHHcCCCCCCCcccCHHHHHHHHH
Confidence            34568999999999999999999999999999999998 899997644 233333 334444445567899999999999


Q ss_pred             hcccCcCCCCCHHHH---hcCcccc
Q 017445          319 CLKKDAEARPTADQL---LSHPFIT  340 (371)
Q Consensus       319 ~l~~dp~~Rps~~~i---l~hp~~~  340 (371)
                      ||+.||++|||+++|   |+|+|+.
T Consensus       246 cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         246 CWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            999999999999998   4666653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.6e-55  Score=396.45  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=211.2

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCC--C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDS--G  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~--~  154 (371)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++..   +......+.+|+.++..+. ||||+++++++...+.  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCCCc
Confidence            46799999999999999999999999999999999652   3455667899999998876 9999999999875443  3


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+||||||++|++|.+++...+++++..+..++.|++.||+|||+ +||+||||||+|||++.++.++|+|||.+.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            589999999999999999888999999999999999999999999 9999999999999999999999999999865433


Q ss_pred             cc---cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCC--CCCCCCC
Q 017445          235 SI---AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPS--PSRQNFS  309 (371)
Q Consensus       235 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  309 (371)
                      ..   ....+.+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+ ......+++......  .....+|
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-HHHHHHHHHhcCCCCCchhccCCC
Confidence            22   23356689999999999999999999999999999999999999997644 445555555554332  3446799


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLSHPFI  339 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~hp~~  339 (371)
                      +++.+||.+||+.||++||+..+.+.|+|.
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            999999999999999999954444456665

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-55  Score=400.04  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++++.||+|+||+||+|.++ +|+.||||+++..  ......++.+|+.++.++. ||||+++++.+.  +.+..++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~--~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH--TKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE--CSSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecc--cCCceeE
Confidence            58999999999999999999975 7899999999653  2333567889999998886 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      +||++.++.+..+....+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||.|.........
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99999887777777777889999999999999999999999 99999999999999999999999999999876655455


Q ss_pred             cccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CCCC-------------
Q 017445          239 CATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DPSP-------------  301 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~-------------  301 (371)
                      .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+ ..+.+.++..   ....             
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            5666799999999999654 57899999999999999999999997644 3333333221   1000             


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 017445          302 -----------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITK  341 (371)
Q Consensus       302 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~  341 (371)
                                 ......+++++.+||++||+.||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                       0112457889999999999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=393.23  Aligned_cols=260  Identities=24%  Similarity=0.415  Sum_probs=221.8

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISI  158 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~l  158 (371)
                      ++|++++.||+|+||+||+|.++.+++.||||+++..  ......++.+|+.++..+. ||||+++++++.  +....++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~--~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH--SDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE--CSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccc--cccceeE
Confidence            4899999999999999999999999999999998652  3345678899999998876 999999999885  4568999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccccc
Q 017445          159 ALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIAM  238 (371)
Q Consensus       159 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~~  238 (371)
                      |+|++.+++|..++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||.|.........
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99999999999999888899999999999999999999999 99999999999999999999999999999887665555


Q ss_pred             cccccccCcccCCccccCCC-CCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---CC---------------
Q 017445          239 CATFVGTVTYMSPERIRNES-YSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---DP---------------  299 (371)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~---------------  299 (371)
                      .....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+......++..   ..               
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            55667889999999987654 689999999999999999999998665554444443321   10               


Q ss_pred             ---------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          300 ---------SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       300 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                               ........+++.+.+|+++||+.||++|||++|+|+||||+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                     011122456889999999999999999999999999999987653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=400.48  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=211.2

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..|.+..++|++.+.||+|+||+||+|.+..     +++.||||+++. ........+.+|...+.++.+|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3566788899999999999999999999754     457899999875 3445566788899999888889999999997


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCC
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPA  211 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~  211 (371)
                      +. .+...+++|||||++|+|.+++...                ..+++..+..++.|++.||.|||+ +||+||||||+
T Consensus        86 ~~-~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~  163 (299)
T d1ywna1          86 CT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAAR  163 (299)
T ss_dssp             EC-STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred             ec-cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcc
Confidence            65 3455789999999999999999643                248899999999999999999999 99999999999


Q ss_pred             cEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcC-CCCCCCCCCc
Q 017445          212 NLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG-EFPYAASEGP  288 (371)
Q Consensus       212 NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g-~~pf~~~~~~  288 (371)
                      |||++.++.+||+|||+|+.......  ...+..||+.|+|||++.+..++.++|||||||++|||++| ..||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999976544322  23456799999999999999999999999999999999986 5678765544


Q ss_pred             HHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          289 VNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .. +.+.+........+..+++++.+|+.+||+.||++|||+.+|++|
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         244 EE-FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43 334444444445567899999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-54  Score=401.98  Aligned_cols=256  Identities=20%  Similarity=0.368  Sum_probs=215.1

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++...   ..++.+|+.++..+..||||++++++|.......+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            58999999999999999999999999999999997533   456788999999988899999999998766777899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccCccccccc
Q 017445          161 EYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGLENSIAMC  239 (371)
Q Consensus       161 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~~~~~~~~  239 (371)
                      ||+.+++|..+.   +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|...... ...
T Consensus       112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~  186 (328)
T d3bqca1         112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEY  186 (328)
T ss_dssp             ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCC
T ss_pred             eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC-Ccc
Confidence            999999998753   569999999999999999999999 9999999999999998765 6999999999876554 234


Q ss_pred             ccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---------------CC----
Q 017445          240 ATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---------------DP----  299 (371)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------~~----  299 (371)
                      ...++|+.|+|||.+.+. .++.++||||+||++|+|++|..||............+..               ..    
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            567899999999998765 4799999999999999999999999776543322221110               00    


Q ss_pred             ----------------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          300 ----------------SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       300 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                                      ........+++++.+||++||+.||++|||++|+|+||||+...+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                            011112346889999999999999999999999999999987654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-55  Score=389.02  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=214.0

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      .++|++++.||+|+||+||+|++ .+++.||||+++... ...+.+.+|+.++.++. ||||++++|++  .+.+.+++|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~--~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLS-HEKLVQLYGVC--TKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCC-CTTBCCEEEEE--CCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcC-CCceeeEEEEE--eeCCceEEE
Confidence            46889999999999999999997 477899999997633 23457899999999996 99999999987  456689999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc-
Q 017445          160 LEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA-  237 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~-  237 (371)
                      |||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........ 
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            999999999998654 4579999999999999999999999 9999999999999999999999999999976544322 


Q ss_pred             ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                      ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ......++.. ......+..+++++.+|+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~~-~~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQ-GLRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHHh-CCCCCCcccccHHHHHHH
Confidence            2234678999999999999999999999999999999998 899997655 3444444444 444556678999999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017445          317 DDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+||+.||++|||+++|++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=392.87  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=215.7

Q ss_pred             cccceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC
Q 017445           73 EKTYRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD  152 (371)
Q Consensus        73 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~  152 (371)
                      ...|++..++|++.+.||+|+||+||+|.+..+ +.||||+++... ...+.+.+|+.++.++. |||||+++|++.   
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~---   82 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS---   82 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcc-cCCEeEEEEEEe---
Confidence            445677889999999999999999999997655 579999997533 34467899999999987 999999999763   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          153 SGQISIALEYMDGGSLADILRM--QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       153 ~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .+..++||||+++|+|..++..  .+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCCcEEEcccchhh
Confidence            2357999999999999998853  3579999999999999999999999 999999999999999999999999999998


Q ss_pred             cCcccc-cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCC
Q 017445          231 GLENSI-AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFS  309 (371)
Q Consensus       231 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|..||.........+..+.. ....+.+..++
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~  240 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECP  240 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSC
T ss_pred             hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccC
Confidence            764432 2234467999999999999999999999999999999999977666555555545544443 33444567899


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc--Cccccccc
Q 017445          310 PEFCSFVDDCLKKDAEARPTADQLLS--HPFITKYE  343 (371)
Q Consensus       310 ~~~~~li~~~l~~dp~~Rps~~~il~--hp~~~~~~  343 (371)
                      +++.+|+.+||+.||++|||+++|+.  ++||+...
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            99999999999999999999999988  88987654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=387.34  Aligned_cols=254  Identities=21%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             eecCcceeEeeeecccCCeEEEEEEEcCCC----cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           77 RCASHEMRIFGAIGSGASSVVQRAVHIPTH----RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        77 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ++..++|++.+.||+|+||+||+|.+..++    ..||||+++. ........+.+|+.++.++. |||||+++|++.  
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~--   79 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS--   79 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEe--
Confidence            345678999999999999999999977654    5799999965 34455567899999999986 999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      +....++||||+.++++.+++... +.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEcccchhh
Confidence            456899999999999999987654 579999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCC
Q 017445          231 GLENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQN  307 (371)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......   ......||+.|+|||++.+..++.++|||||||++|||++|..|+......... ...+......+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~  237 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAINDGFRLPTPMD  237 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTCCCCCCTT
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-HHHHhccCCCCCchh
Confidence            7654322   123346899999999999999999999999999999999976666554444444 444455555556678


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          308 FSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       308 ~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      +++++.+|+.+||+.||++|||+.+|++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999999965

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-54  Score=400.30  Aligned_cols=256  Identities=28%  Similarity=0.426  Sum_probs=208.5

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC----C
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD----S  153 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~----~  153 (371)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++.  ......+.+.+|+.++..+. |||||+++++|...+    .
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccccc
Confidence            5689999999999999999999999999999999975  34455678899999999986 999999999986432    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          154 GQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       154 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..+||||||+ +.+|..+++ .+++++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||.|....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcccccccccccccceeccC
Confidence            3689999999 568887765 5689999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh--CC-----------
Q 017445          234 NSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE--DP-----------  299 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~-----------  299 (371)
                      ..   ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.. ..+.....  ..           
T Consensus       173 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         173 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             Cc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHhhhcc
Confidence            43   256789999999999876 45789999999999999999999999775422 22211111  00           


Q ss_pred             ----------------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          300 ----------------SPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       300 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                                      ........+++++.+||++||+.||++|||+.|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                            00112246789999999999999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=388.53  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=205.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCC---CcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPT---HRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      |++..++|++.+.||+|+||+||+|.+..+   +..||||.++. ........+.+|+.++.++. ||||++++|++.  
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--   78 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT--   78 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe--
Confidence            567788999999999999999999998654   45689999865 34555677899999999986 999999999873  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       .+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||+|+
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhhe
Confidence             3578999999999999998754 4569999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc-ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCC
Q 017445          231 GLENSIA-MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNF  308 (371)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.... ......++..+. ..+.+..+
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-~~~~~~~i~~~~-~~~~~~~~  234 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGE-RLPMPPNC  234 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTC-CCCCCTTC
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCC-CCCCCCCC
Confidence            7654322 2344568999999999999999999999999999999998 899997644 344555554443 34456789


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          309 SPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       309 ~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      |+++.+||.+||+.||++|||+.+|++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999865

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-55  Score=403.31  Aligned_cols=274  Identities=25%  Similarity=0.400  Sum_probs=224.1

Q ss_pred             cCcceeEeeeecccCCeEEEEEEE---cCCCcEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVH---IPTHRIIALKKINIF----EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      ..++|++++.||+|+||+||+|.+   ..+|+.||||+++..    +......+.+|+.++.++.+||||+++++++.  
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~--   99 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--   99 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec--
Confidence            447899999999999999999987   447899999998642    22334567889999999986799999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      +...++++|||+.+|+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            456899999999999999999988999999999999999999999999 9999999999999999999999999999986


Q ss_pred             Cccc-ccccccccccCcccCCccccCC--CCCCchhHHHHHHHHHHHhcCCCCCCCCCCc---HHHHHHHhhCCCCCCCC
Q 017445          232 LENS-IAMCATFVGTVTYMSPERIRNE--SYSYPADIWSIGLALFECGTGEFPYAASEGP---VNLMLQILEDPSPSPSR  305 (371)
Q Consensus       232 ~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~  305 (371)
                      .... .....+..|++.|+|||.+.+.  .++.++|||||||++|+|++|..||......   ............  ..+
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~  256 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYP  256 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCC
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCc
Confidence            6433 3334567899999999999654  4688999999999999999999999765422   122222233322  334


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccccccccHHHHHHHhcChhh
Q 017445          306 QNFSPEFCSFVDDCLKKDAEARP-----TADQLLSHPFITKYEHAKVDLAAFVRSVFDPMQ  361 (371)
Q Consensus       306 ~~~~~~~~~li~~~l~~dp~~Rp-----s~~~il~hp~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
                      ..+++++.+|+++||++||.+||     |++|+++||||+++.+.+.    +.+++-+|+.
T Consensus       257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l----~~~~~~~p~~  313 (322)
T d1vzoa_         257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL----AAKKVPAPFK  313 (322)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH----HTTCSCCSCC
T ss_pred             ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHH----HhCCCCcCCC
Confidence            57999999999999999999999     5899999999987654332    2344556654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-54  Score=400.08  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=209.4

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CCCeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DSGQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~~~~  156 (371)
                      .+|+.+++||+|+||+||+|+++.+|+.||||++.....    ...+|+.++.++. ||||++++++|...    +..++
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceEE
Confidence            378899999999999999999999999999999965321    2246889998886 99999999998643    34468


Q ss_pred             EEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCC-ceEEecccccccC
Q 017445          157 SIALEYMDGGSLADIL---RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKG-RPKITDFGISAGL  232 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~-~~kl~Dfg~s~~~  232 (371)
                      ||||||++++.+..+.   .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999999875433332   345679999999999999999999999 9999999999999999875 8999999999876


Q ss_pred             cccccccccccccCcccCCccccC-CCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhh---C----------
Q 017445          233 ENSIAMCATFVGTVTYMSPERIRN-ESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILE---D----------  298 (371)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~---~----------  298 (371)
                      ... ....+.+||+.|+|||.+.+ ..++.++||||+||++|||++|..||..... .+.+.++..   .          
T Consensus       174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhhhhc
Confidence            554 33456789999999998865 5689999999999999999999999976543 222222221   0          


Q ss_pred             ------CCC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccccccc
Q 017445          299 ------PSP--------SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEHAKV  347 (371)
Q Consensus       299 ------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~~~~  347 (371)
                            ..+        ......+++++.+||.+||+.||++|||+.|+|+||||+.+..+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  314 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  314 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCC
Confidence                  000        0112457899999999999999999999999999999998765443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=396.98  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=208.3

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecC---CCeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF-EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPD---SGQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~---~~~~  156 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++.. .....+.+.+|+.++.++. ||||+++++++....   ...+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccccceE
Confidence            4699999999999999999999999999999999753 3455677899999999986 999999999885432   2345


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSI  236 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~  236 (371)
                      |+++ |+.+|+|.+++.. +.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|.......
T Consensus        87 ~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          87 YLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            5555 5668999999974 579999999999999999999999 999999999999999999999999999997654432


Q ss_pred             c---ccccccccCcccCCcccc-CCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHH--hhCC-----------
Q 017445          237 A---MCATFVGTVTYMSPERIR-NESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQI--LEDP-----------  299 (371)
Q Consensus       237 ~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~-----------  299 (371)
                      .   .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.............  ....           
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            2   235567999999999984 4567899999999999999999999997654322111111  0000           


Q ss_pred             --------CCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          300 --------SPS-------PSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       300 --------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                              .+.       .....+++++.+|+.+||+.||++|||+.++|+||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                    000       012467889999999999999999999999999999986644

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=393.41  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=208.9

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec------
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIF--EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP------  151 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~------  151 (371)
                      .++|++++.||+|+||+||+|++..+|+.||||++...  ......++.+|+.++.++. ||||+++++.+...      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccccc
Confidence            47999999999999999999999999999999998642  2334566889999999996 99999999988542      


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEeccccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAG  231 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~  231 (371)
                      ..+.+|+||||+.++.+..+......+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCCcEEeeecceeee
Confidence            235689999999887777666666789999999999999999999999 9999999999999999999999999999976


Q ss_pred             Ccccc----cccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHH---HHhhCCCCCC
Q 017445          232 LENSI----AMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLML---QILEDPSPSP  303 (371)
Q Consensus       232 ~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~  303 (371)
                      .....    ....+.+||+.|+|||++.+. .+++++||||+||++|||++|+.||.+... .....   +.........
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCChhh
Confidence            65322    223446799999999998754 689999999999999999999999976442 22222   2222211111


Q ss_pred             CC---------------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 017445          304 SR---------------------------QNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKY  342 (371)
Q Consensus       304 ~~---------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~  342 (371)
                      ..                           ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00                           0125778899999999999999999999999999853

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=393.53  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=206.4

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCc----EEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHR----IIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      .++|++++.||+|+||+||+|.+..+|+    .||+|+++. ......+.+.+|+.++.++. |||||+++|++..   +
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~---~   83 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT---S   83 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES---S
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec---C
Confidence            4689999999999999999999988876    588888764 23345677999999999986 9999999998852   3


Q ss_pred             eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          155 QISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      ..++++||+.+|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+...
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            57889999999999998765 4579999999999999999999999 999999999999999999999999999998765


Q ss_pred             ccccc--cccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCH
Q 017445          234 NSIAM--CATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSP  310 (371)
Q Consensus       234 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      .....  .....||+.|+|||++.++.++.++|||||||++|||+| |..||..... .. +...+......+.+..+++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~-~~~~i~~~~~~~~p~~~~~  240 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SE-ISSILEKGERLPQPPICTI  240 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GG-HHHHHHHTCCCCCCTTBCH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HH-HHHHHHcCCCCCCCcccCH
Confidence            43222  234468999999999999999999999999999999998 8899976542 23 3334433344455578999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCc
Q 017445          311 EFCSFVDDCLKKDAEARPTADQLLSHP  337 (371)
Q Consensus       311 ~~~~li~~~l~~dp~~Rps~~~il~hp  337 (371)
                      ++.+|+.+||..||++|||+.+|+.|.
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            999999999999999999999999884

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-53  Score=385.17  Aligned_cols=257  Identities=23%  Similarity=0.390  Sum_probs=214.3

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEcCCC-------cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHIPTH-------RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      ..|.+..++|++.+.||+|+||.||+|++..++       ..||||+++. ........+.+|+..+.++.+|||||+++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            347788899999999999999999999876554       4799999976 33455677899999999987899999999


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCC
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRMQK----------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK  209 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlk  209 (371)
                      +++.  +.+.+++||||+++|+|.++|...+                .+++..+..++.|++.||+|||+ ++|+|||||
T Consensus        86 ~~~~--~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiK  162 (299)
T d1fgka_          86 GACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLA  162 (299)
T ss_dssp             EEEC--SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCS
T ss_pred             cccc--cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeec
Confidence            9884  4668999999999999999996442                48999999999999999999999 999999999


Q ss_pred             CCcEEEccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCC
Q 017445          210 PANLLVNLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASE  286 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~  286 (371)
                      |+|||++.++.+||+|||+++.......  ......+|+.|+|||.+.++.|+.++||||||+++|||++ |..||....
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            9999999999999999999987654432  2344579999999999999999999999999999999998 788886544


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                       .. .+...+........+..+++++.+||.+||+.||++|||+.||++
T Consensus       243 -~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         243 -VE-ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             -HH-HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HH-HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence             23 344444455555566789999999999999999999999999976

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=381.63  Aligned_cols=249  Identities=25%  Similarity=0.414  Sum_probs=203.7

Q ss_pred             ceecCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCe
Q 017445           76 YRCASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQ  155 (371)
Q Consensus        76 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~  155 (371)
                      |.+..++|++.+.||+|+||.||+|.+  +|+.||||+++..  ...+.+.+|+.++.++. ||||++++|++.. +.+.
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~   75 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGG   75 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--C
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEe-cCCc
Confidence            567778999999999999999999997  4678999999753  34467889999999885 9999999998753 3456


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCc
Q 017445          156 ISIALEYMDGGSLADILRMQK--SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLE  233 (371)
Q Consensus       156 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~  233 (371)
                      +|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCCCEeecccccceecC
Confidence            899999999999999996543  58999999999999999999999 999999999999999999999999999998654


Q ss_pred             ccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHH
Q 017445          234 NSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEF  312 (371)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (371)
                      ..   .....+|+.|+|||++.+..++.++||||||+++|||+| |++||... ...+....+.. ......+..+++++
T Consensus       155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~-~~~~~~~~~~~~~~  229 (262)
T d1byga_         155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK-GYKMDAPDGCPPAV  229 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTT-TCCCCCCTTCCHHH
T ss_pred             CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHc-CCCCCCCccCCHHH
Confidence            43   244568999999999998899999999999999999998 78888654 33444444443 34444567799999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017445          313 CSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       313 ~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+|+++||+.||++|||+.+++++
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=385.38  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=220.7

Q ss_pred             ccceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEecee
Q 017445           74 KTYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGA  147 (371)
Q Consensus        74 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~  147 (371)
                      ..|.+..++|++.+.||+|+||.||+|++.     .+++.||||+++. ........+.+|+.++.++.+|||||+++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            357788899999999999999999999853     5678999999976 3445666789999999999789999999998


Q ss_pred             EEecCCCeEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCC
Q 017445          148 FYMPDSGQISIALEYMDGGSLADILRMQK------------------SIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIK  209 (371)
Q Consensus       148 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlk  209 (371)
                      +  .+...++||||||++|+|.+++....                  .+++..+..++.||+.||+|||+ +|++|||||
T Consensus        96 ~--~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLK  172 (311)
T d1t46a_          96 C--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLA  172 (311)
T ss_dssp             E--CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCS
T ss_pred             E--eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccc
Confidence            7  45567999999999999999997543                  58999999999999999999999 999999999


Q ss_pred             CCcEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcC-CCCCCCCC
Q 017445          210 PANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTG-EFPYAASE  286 (371)
Q Consensus       210 p~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g-~~pf~~~~  286 (371)
                      |+||+++.++.+||+|||.++......  .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+||.. .
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-~  251 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-M  251 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-C
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-C
Confidence            999999999999999999998765432  223446799999999999999999999999999999999994 555544 3


Q ss_pred             CcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          287 GPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      .....+.+++........+..+++++.+||.+||+.||++|||+++|++
T Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4445555666666666666789999999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=388.54  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=210.1

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcCCCcE--EEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCC
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIPTHRI--IALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSG  154 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~  154 (371)
                      +..++|++.+.||+|+||+||+|.++.+|..  ||||+++. ......+.+.+|+.++.++.+|||||+++|++..  .+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~   84 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG   84 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CC
Confidence            5567999999999999999999999888764  67888754 3344566789999999998779999999998854  56


Q ss_pred             eEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccC
Q 017445          155 QISIALEYMDGGSLADILRMQ----------------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLK  218 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~  218 (371)
                      .++|||||+++|+|.+++...                ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.+
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence            899999999999999999643                568999999999999999999999 999999999999999999


Q ss_pred             CceEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCC-CCCCCCCCcHHHHHHHhh
Q 017445          219 GRPKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE-FPYAASEGPVNLMLQILE  297 (371)
Q Consensus       219 ~~~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~-~pf~~~~~~~~~~~~~~~  297 (371)
                      +.+||+|||+|....... ......||+.|+|||.+.+..++.++|||||||++|||++|. +||.. .........+..
T Consensus       164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~  241 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ  241 (309)
T ss_dssp             GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGG
T ss_pred             CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHh
Confidence            999999999997655432 224556999999999999999999999999999999999976 46654 344444444444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          298 DPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      + .....+..+++++.+||.+||+.||++|||+.+|++|
T Consensus       242 ~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 G-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             T-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3 3444557899999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=384.37  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=213.5

Q ss_pred             cceecCcceeEeeeecccCCeEEEEEEEc-----CCCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeE
Q 017445           75 TYRCASHEMRIFGAIGSGASSVVQRAVHI-----PTHRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAF  148 (371)
Q Consensus        75 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~  148 (371)
                      .+++..++|++.+.||+|+||+||+|+++     .+++.||||+++. .......++.+|+.++.++. ||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeee
Confidence            45667789999999999999999999875     3568899999975 34455677999999999886 99999999987


Q ss_pred             EecCCCeEEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCeE
Q 017445          149 YMPDSGQISIALEYMDGGSLADILRMQK------------------------SIPEPILSSMFKKLLQGLSYLHGVRHLV  204 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~~LH~~~~ii  204 (371)
                      .  +.+..+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||+ ++|+
T Consensus        86 ~--~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iv  162 (301)
T d1lufa_          86 A--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFV  162 (301)
T ss_dssp             C--SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCC
T ss_pred             c--cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeE
Confidence            4  4668999999999999999986432                        38899999999999999999999 9999


Q ss_pred             ecCCCCCcEEEccCCceEEecccccccCcccc--cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCC-CC
Q 017445          205 HRDIKPANLLVNLKGRPKITDFGISAGLENSI--AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE-FP  281 (371)
Q Consensus       205 H~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~-~p  281 (371)
                      ||||||+|||++.++.+||+|||+|+......  ....+..||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999997654332  2234567899999999999999999999999999999999986 56


Q ss_pred             CCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          282 YAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      |... ........+..+. ....+..+++++.+|+.+||+.||++|||+.+|++
T Consensus       243 ~~~~-~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         243 YYGM-AHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTS-CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC-CHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6553 4444455554443 44456789999999999999999999999999954

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=394.19  Aligned_cols=258  Identities=25%  Similarity=0.400  Sum_probs=209.6

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec---CCC
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP---DSG  154 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~---~~~  154 (371)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++.  .+.....++.+|+.++.++. ||||+++++++...   +..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccccC
Confidence            3679999999999999999999999999999999975  34455667899999999996 99999999988542   223


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      ..+++++|+.||+|.+++. .+++++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||.+.....
T Consensus        96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccccccccccchhcccCc
Confidence            4455667778999999986 4679999999999999999999999 9999999999999999999999999999976654


Q ss_pred             cccccccccccCcccCCccccCC-CCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCC--------------
Q 017445          235 SIAMCATFVGTVTYMSPERIRNE-SYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDP--------------  299 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------------  299 (371)
                      .   ..+..||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+. ......+....              
T Consensus       174 ~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         174 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             G---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             c---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChHHhhhccch
Confidence            3   3567799999999987665 468999999999999999999999976542 22222221110              


Q ss_pred             ---------CCCC------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCcccccccc
Q 017445          300 ---------SPSP------SRQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYEH  344 (371)
Q Consensus       300 ---------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~~  344 (371)
                               ....      ....+++++.+||++||+.||.+|||+.|+|+||||+++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                     0000      01357899999999999999999999999999999998754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=394.47  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=200.6

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec----CCC
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINI--FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP----DSG  154 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~----~~~  154 (371)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++.  .+.....++.+|+.++.++. ||||++++++|..+    +..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccccCc
Confidence            479999999999999999999999999999999974  34555667889999999886 99999999998643    346


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCcc
Q 017445          155 QISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLEN  234 (371)
Q Consensus       155 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~  234 (371)
                      .+|+||||+.+ ++.+.+  ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+|++|||.+.....
T Consensus        96 ~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             eeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccccccceeeechhhhhcccc
Confidence            89999999976 555554  3579999999999999999999999 9999999999999999999999999999876655


Q ss_pred             cccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHh------------------
Q 017445          235 SIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQIL------------------  296 (371)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~------------------  296 (371)
                      . ......++|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+. .....+++                  
T Consensus       172 ~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         172 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             c-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            4 333566799999999999999999999999999999999999999976542 22222211                  


Q ss_pred             ----hCCCCCCC------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCccccccc
Q 017445          297 ----EDPSPSPS------------------RQNFSPEFCSFVDDCLKKDAEARPTADQLLSHPFITKYE  343 (371)
Q Consensus       297 ----~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~il~hp~~~~~~  343 (371)
                          ........                  ....++++.+||++||+.||++|||++|+|+||||+.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                11110000                  011356789999999999999999999999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=377.87  Aligned_cols=251  Identities=23%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             ecCcceeEeeeecccCCeEEEEEEEcC-CC--cEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEec
Q 017445           78 CASHEMRIFGAIGSGASSVVQRAVHIP-TH--RIIALKKINIF---EKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMP  151 (371)
Q Consensus        78 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~  151 (371)
                      +..++|++++.||+|+||+||+|+... ++  ..||||+++..   .....+.+.+|+.++.++. ||||++++|++.  
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~--   81 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL--   81 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC--
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEe--
Confidence            445789999999999999999998643 33  46899998652   3344567899999999995 999999999874  


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          152 DSGQISIALEYMDGGSLADILRM-QKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       152 ~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                       ....++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++
T Consensus        82 -~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          82 -TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             -ecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhh
Confidence             2367899999999999987754 4569999999999999999999999 999999999999999999999999999998


Q ss_pred             cCccccc---ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhc-CCCCCCCCCCcHHHHHHHhhCCCCCCCCC
Q 017445          231 GLENSIA---MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGT-GEFPYAASEGPVNLMLQILEDPSPSPSRQ  306 (371)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .......   ......|++.|+|||.+.+..++.++||||||+++|||+| |..||.+.+ ......++.......+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~  238 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERLPRPE  238 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTSCCCCCCCT
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-HHHHHHHHHhCCCCCCCcc
Confidence            7644322   2234467889999999999999999999999999999998 899997644 4455566666666666678


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          307 NFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       307 ~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                      .+|+++.+|+.+||..||++|||+.+|+
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            8999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=381.43  Aligned_cols=263  Identities=21%  Similarity=0.341  Sum_probs=219.4

Q ss_pred             ccccceecCcceeEeeeecccCCeEEEEEEEcC-----CCcEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           72 SEKTYRCASHEMRIFGAIGSGASSVVQRAVHIP-----THRIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        72 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      ....|++..++|++.+.||+|+||+||+|.+..     +++.||||+++. ........+.+|+.++.++. ||||++++
T Consensus        11 ~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~   89 (308)
T d1p4oa_          11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLL   89 (308)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEE
T ss_pred             CccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeee
Confidence            344678888999999999999999999998752     357899999975 34455567899999999987 99999999


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEE
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRMQ----------KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLV  215 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~  215 (371)
                      |++.  .....++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus        90 ~~~~--~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          90 GVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMV  166 (308)
T ss_dssp             EEEC--SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEE
T ss_pred             eEEe--cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceee
Confidence            9874  456799999999999999998542          246889999999999999999999 999999999999999


Q ss_pred             ccCCceEEecccccccCccccc--ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCC-CCCCCCCCcHHHH
Q 017445          216 NLKGRPKITDFGISAGLENSIA--MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGE-FPYAASEGPVNLM  292 (371)
Q Consensus       216 ~~~~~~kl~Dfg~s~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~-~pf~~~~~~~~~~  292 (371)
                      +.++++||+|||+|+.......  ......||+.|+|||.+.+..++.++||||||+++|||+||. .||... ......
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~~~  245 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVL  245 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence            9999999999999986654322  224446899999999999999999999999999999999985 677553 334444


Q ss_pred             HHHhhCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------Ccccc
Q 017445          293 LQILEDPSPSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS------HPFIT  340 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~------hp~~~  340 (371)
                      ..+..+. ....+..+++.+.+++.+||+.||++|||+.+|++      +|+|+
T Consensus       246 ~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         246 RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence            4444443 34445789999999999999999999999999987      56654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-51  Score=373.24  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=205.0

Q ss_pred             eeeecccCCeEEEEEEEcCCC---cEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           86 FGAIGSGASSVVQRAVHIPTH---RIIALKKINI-FEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      .++||+|+||+||+|.+..++   ..||||+++. ........+.+|+.++.++. ||||++++|++.. ..+..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEE-TTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEe-cCCceEEEEE
Confidence            468999999999999986543   4699999975 45666788999999999986 9999999998753 3468999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEecccccccCccccc---
Q 017445          162 YMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITDFGISAGLENSIA---  237 (371)
Q Consensus       162 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~~~~~~~~---  237 (371)
                      ||++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......   
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999998744 357888999999999999999999 9999999999999999999999999999987654322   


Q ss_pred             -ccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHHHHHHhhCCCCCCCCCCCCHHHHHHH
Q 017445          238 -MCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNLMLQILEDPSPSPSRQNFSPEFCSFV  316 (371)
Q Consensus       238 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  316 (371)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|..||.......+....+..+. ....+..+++++.+|+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~~p~~~~~~l~~li  267 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVM  267 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCcccCcHHHHHHH
Confidence             12335689999999999999999999999999999999998888876554444444444443 3345578899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017445          317 DDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       317 ~~~l~~dp~~Rps~~~il~h  336 (371)
                      .+||+.||++|||+.||++|
T Consensus       268 ~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         268 LKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-50  Score=366.56  Aligned_cols=256  Identities=20%  Similarity=0.303  Sum_probs=201.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIAL  160 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~  160 (371)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++....  ...++..|+.++..+.+|++|+.+.+++.  +....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~--~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA--EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE--ETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEe--cCCEEEEEE
Confidence            46999999999999999999999999999999986532  22346789999999985666666665543  456899999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc---CCceEEecccccccCcccc
Q 017445          161 EYMDGGSLADILR-MQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL---KGRPKITDFGISAGLENSI  236 (371)
Q Consensus       161 E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~---~~~~kl~Dfg~s~~~~~~~  236 (371)
                      ||+. ++|.+.+. ..+.+++..+..++.|++.||+|||+ +||+||||||+|||++.   +..+||+|||+|+......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9995 56666554 45679999999999999999999999 99999999999999864   4579999999998765432


Q ss_pred             -------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCcHHH--HHHHhh---CCCCCCC
Q 017445          237 -------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGPVNL--MLQILE---DPSPSPS  304 (371)
Q Consensus       237 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~---~~~~~~~  304 (371)
                             ....+..||+.|+|||++.+..++.++|||||||++|||++|..||.........  ..+...   .......
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence                   1234567999999999999999999999999999999999999999764432211  111111   1111222


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCcccccc
Q 017445          305 RQNFSPEFCSFVDDCLKKDAEARPTAD---QLLSHPFITKY  342 (371)
Q Consensus       305 ~~~~~~~~~~li~~~l~~dp~~Rps~~---~il~hp~~~~~  342 (371)
                      ...+|+++.+|+..||..||++||++.   ++|+|+|....
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            457899999999999999999999986   55788876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=361.14  Aligned_cols=249  Identities=22%  Similarity=0.266  Sum_probs=190.9

Q ss_pred             cceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHH--HHHhCCCCCCeeEeceeEEecCC--CeE
Q 017445           81 HEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIR--TLCEAPCNEGLVEFHGAFYMPDS--GQI  156 (371)
Q Consensus        81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~~~~h~~iv~l~~~~~~~~~--~~~  156 (371)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++....   .....|.+  .+.++ +||||+++++++..++.  ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEE
Confidence            5788899999999999999986  688999999965322   23334444  44444 49999999999876543  368


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-------CCeEecCCCCCcEEEccCCceEEeccccc
Q 017445          157 SIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGV-------RHLVHRDIKPANLLVNLKGRPKITDFGIS  229 (371)
Q Consensus       157 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s  229 (371)
                      |+||||+++|+|.++++. .++++..+..++.|++.||.|||+.       +||+||||||+|||++.++.+||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999975 4699999999999999999999962       58999999999999999999999999999


Q ss_pred             ccCccccc----ccccccccCcccCCccccCCC------CCCchhHHHHHHHHHHHhcCCCCCCCCC-------------
Q 017445          230 AGLENSIA----MCATFVGTVTYMSPERIRNES------YSYPADIWSIGLALFECGTGEFPYAASE-------------  286 (371)
Q Consensus       230 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~ell~g~~pf~~~~-------------  286 (371)
                      ........    .....+||+.|+|||++.+..      ++.++|||||||++|||+||..||....             
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            86644321    234567999999999987643      5678999999999999999988774321             


Q ss_pred             CcHHHHHHHhh-CCCCCCCCC-----CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017445          287 GPVNLMLQILE-DPSPSPSRQ-----NFSPEFCSFVDDCLKKDAEARPTADQLLSH  336 (371)
Q Consensus       287 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~il~h  336 (371)
                      .......+... .......+.     ..+..+.+|+.+||+.||++|||+.||+++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11122222222 222111111     123458899999999999999999999763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-49  Score=360.74  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=204.3

Q ss_pred             CcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           80 SHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      ..+|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+|+..+..+.+|+|++.+++++.  +....++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEEE
Confidence            468999999999999999999999999999999986432  22345678888888887899999998774  46689999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEcc-----CCceEEecccccccCc
Q 017445          160 LEYMDGGSLADILRMQ-KSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNL-----KGRPKITDFGISAGLE  233 (371)
Q Consensus       160 ~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~-----~~~~kl~Dfg~s~~~~  233 (371)
                      |||+ +++|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.     ++.+||+|||+|+...
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9999 67999988764 469999999999999999999999 99999999999999974     5789999999998654


Q ss_pred             ccc-------cccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc--HHHHHHHhh---CCCC
Q 017445          234 NSI-------AMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP--VNLMLQILE---DPSP  301 (371)
Q Consensus       234 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~---~~~~  301 (371)
                      ...       ....+.+||+.|+|||++.+..++.++||||||+++|||++|..||.+....  .....++..   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            321       1234567999999999999999999999999999999999999999764432  222222211   1122


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017445          302 SPSRQNFSPEFCSFVDDCLKKDAEARPTADQLLS  335 (371)
Q Consensus       302 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il~  335 (371)
                      ......+|+++.+++..|+..+|++||+++.+.+
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2223568999999999999999999999877643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-47  Score=356.15  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=200.2

Q ss_pred             cCcceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCC----------CCCCeeEeceeE
Q 017445           79 ASHEMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAP----------CNEGLVEFHGAF  148 (371)
Q Consensus        79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----------~h~~iv~l~~~~  148 (371)
                      ...+|++++.||+|+||+||+|+++.+|+.||||+++... .......+|+.++..+.          .|+||+++++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            3457999999999999999999999999999999997532 33455667777665543          378999999988


Q ss_pred             EecCCCeEEEEEeccCCCCHHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCc-----
Q 017445          149 YMPDSGQISIALEYMDGGSLADI-L--RMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGR-----  220 (371)
Q Consensus       149 ~~~~~~~~~lv~E~~~~g~L~~~-l--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~-----  220 (371)
                      ........+++|+++..+..... .  .....+++..++.++.|++.||.|||+..||+||||||+|||++.++.     
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            76666677777777766543332 2  234578999999999999999999997578999999999999987653     


Q ss_pred             -eEEecccccccCcccccccccccccCcccCCccccCCCCCCchhHHHHHHHHHHHhcCCCCCCCCCCc-----HHHHHH
Q 017445          221 -PKITDFGISAGLENSIAMCATFVGTVTYMSPERIRNESYSYPADIWSIGLALFECGTGEFPYAASEGP-----VNLMLQ  294 (371)
Q Consensus       221 -~kl~Dfg~s~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell~g~~pf~~~~~~-----~~~~~~  294 (371)
                       ++++|||.|......   ....+||+.|+|||++.+..++.++|+||+||++++|++|+.||......     ...+.+
T Consensus       170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence             999999998765432   25677999999999999999999999999999999999999999764321     111111


Q ss_pred             ---HhhCC-------------------C------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017445          295 ---ILEDP-------------------S------------------PSPSRQNFSPEFCSFVDDCLKKDAEARPTADQLL  334 (371)
Q Consensus       295 ---~~~~~-------------------~------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~il  334 (371)
                         .+...                   .                  ........++++.+||.+||+.||.+|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence               11100                   0                  0000112357899999999999999999999999


Q ss_pred             cCccccccc
Q 017445          335 SHPFITKYE  343 (371)
Q Consensus       335 ~hp~~~~~~  343 (371)
                      +||||+...
T Consensus       327 ~Hp~f~~~~  335 (362)
T d1q8ya_         327 NHPWLKDTL  335 (362)
T ss_dssp             TCGGGTTCT
T ss_pred             cCcccCCCC
Confidence            999998553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.1e-26  Score=194.12  Aligned_cols=164  Identities=17%  Similarity=0.112  Sum_probs=119.2

Q ss_pred             eEeeeecccCCeEEEEEEEcCCCcEEEEEEecccc------------------HHHHHHHHHHHHHHHhCCCCCCeeEec
Q 017445           84 RIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFE------------------KEKRNQLLTEIRTLCEAPCNEGLVEFH  145 (371)
Q Consensus        84 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~~~~h~~iv~l~  145 (371)
                      .+.++||+|+||+||+|.+ .+|+.||||+++...                  .........|...+.++. |++++..+
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~~   80 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKVY   80 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCEE
T ss_pred             hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceEE
Confidence            4678999999999999987 468999999875310                  111233456777787776 88888877


Q ss_pred             eeEEecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCeEecCCCCCcEEEccCCceEEec
Q 017445          146 GAFYMPDSGQISIALEYMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHGVRHLVHRDIKPANLLVNLKGRPKITD  225 (371)
Q Consensus       146 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~iiH~Dlkp~NIl~~~~~~~kl~D  225 (371)
                      +..      ..+++|||+++..+.+       ++...+..++.|++.|+.|||+ +||+||||||+|||++++ .++|+|
T Consensus        81 ~~~------~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          81 AWE------GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EEE------TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-EEEECC
T ss_pred             Eec------CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-CEEEEE
Confidence            642      1379999999865432       5566677899999999999999 999999999999999965 489999


Q ss_pred             ccccccCcccccccccccccCcccCC--c---cccCCCCCCchhHHHHHHHH
Q 017445          226 FGISAGLENSIAMCATFVGTVTYMSP--E---RIRNESYSYPADIWSIGLAL  272 (371)
Q Consensus       226 fg~s~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~Dv~slG~il  272 (371)
                      ||.|.........        .|...  +   .+....|+.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9998766543221        11110  0   01235578899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.70  E-value=2.1e-08  Score=86.92  Aligned_cols=140  Identities=14%  Similarity=0.079  Sum_probs=88.1

Q ss_pred             ceeEeeeecccCCeEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEEEe
Q 017445           82 EMRIFGAIGSGASSVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIALE  161 (371)
Q Consensus        82 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv~E  161 (371)
                      .|+..+..+.++.+.||+..  .++..+++|+...........+.+|...+..+..+--+.+++...  .+.+..++||+
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~~~lv~~   90 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWSNLLMS   90 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE--ecCCceEEEEE
Confidence            45566665555567899885  355678889876533333334566776665554444456666544  34568899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 017445          162 YMDGGSLADILRMQKSIPEPILSSMFKKLLQGLSYLHG------------------------------------------  199 (371)
Q Consensus       162 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------------  199 (371)
                      +++|.++.+...     +......++.++...+..||+                                          
T Consensus        91 ~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             eccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            999988765431     111122233334444444441                                          


Q ss_pred             -----------C-----CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          200 -----------V-----RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       200 -----------~-----~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                                 .     ..++|+|+.|.||+++.++.+.|.||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                       0     127899999999999977667899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.26  E-value=1.6e-06  Score=79.53  Aligned_cols=79  Identities=11%  Similarity=0.047  Sum_probs=46.2

Q ss_pred             eeeecccCCeEEEEEEEcCCCcEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCC--CCeeEeceeEEecCCCeE
Q 017445           86 FGAIGSGASSVVQRAVHIPTHRIIALKKINIFE-------KEKRNQLLTEIRTLCEAPCN--EGLVEFHGAFYMPDSGQI  156 (371)
Q Consensus        86 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~~~~h--~~iv~l~~~~~~~~~~~~  156 (371)
                      .+.||.|....||++.+..+++.++||.....-       .....+...|...+..+..+  ..+++++.  ++++  ..
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~--~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE--MA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT--TT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCC--CC
Confidence            346899999999999877778899999764311       01122344566665544322  34555554  2233  45


Q ss_pred             EEEEeccCCCCH
Q 017445          157 SIALEYMDGGSL  168 (371)
Q Consensus       157 ~lv~E~~~~g~L  168 (371)
                      ++|||++++..+
T Consensus       107 ~lvmE~L~~~~~  118 (392)
T d2pula1         107 VTVMEDLSHLKI  118 (392)
T ss_dssp             EEEECCCTTSEE
T ss_pred             EEEEeccCCccc
Confidence            789999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.96  E-value=1.5e-05  Score=67.94  Aligned_cols=75  Identities=16%  Similarity=0.076  Sum_probs=45.3

Q ss_pred             eecccCC-eEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCCeeEeceeEEecCCCeEEEEEeccCC
Q 017445           88 AIGSGAS-SVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC-NEGLVEFHGAFYMPDSGQISIALEYMDG  165 (371)
Q Consensus        88 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-h~~iv~l~~~~~~~~~~~~~lv~E~~~~  165 (371)
                      .+..|.. +.||+.. ..++..+++|........   .+..|...+..+.. ...+.+++...  .+.+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEEeeec
Confidence            4455554 5789886 456777889987643222   23445544433221 22356666644  445678999999998


Q ss_pred             CCH
Q 017445          166 GSL  168 (371)
Q Consensus       166 g~L  168 (371)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.30  E-value=0.00033  Score=61.82  Aligned_cols=70  Identities=16%  Similarity=0.089  Sum_probs=40.2

Q ss_pred             eEEEEEEEcCCCcEEEEEEeccccHHHHHHHHHHHHHHHhCCC----CCCeeEeceeEEecCCCeEEEEEeccCCC
Q 017445           95 SVVQRAVHIPTHRIIALKKINIFEKEKRNQLLTEIRTLCEAPC----NEGLVEFHGAFYMPDSGQISIALEYMDGG  166 (371)
Q Consensus        95 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~----h~~iv~l~~~~~~~~~~~~~lv~E~~~~g  166 (371)
                      -.||++. ..+|+.|++|+.+.. .....++..|...+..+..    .+..+..-+-......+..+.++++++|.
T Consensus        36 N~vy~v~-~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQ-DEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEEC-CTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEE-cCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            5799997 567888999998652 1123445556655433321    12222222222223356788999999873

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.10  E-value=0.00061  Score=61.74  Aligned_cols=74  Identities=16%  Similarity=0.094  Sum_probs=47.1

Q ss_pred             eeecccCCeEEEEEEEcC-------CCcEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCCeeEeceeEEecCCCeEEEE
Q 017445           87 GAIGSGASSVVQRAVHIP-------THRIIALKKINIFEKEKRNQLLTEIRTLCEAPCNEGLVEFHGAFYMPDSGQISIA  159 (371)
Q Consensus        87 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~iv~l~~~~~~~~~~~~~lv  159 (371)
                      +.|+.|-.-.+|++....       .++.|.+++..... . .....+|..++..+..+.-.+++++++  ++    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~--~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEc--CC----ceE
Confidence            578889999999997543       34567777764211 1 223446777666655454456777755  32    578


Q ss_pred             EeccCCCCH
Q 017445          160 LEYMDGGSL  168 (371)
Q Consensus       160 ~E~~~~g~L  168 (371)
                      +||++|.+|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.39  E-value=0.013  Score=50.62  Aligned_cols=30  Identities=17%  Similarity=0.242  Sum_probs=26.9

Q ss_pred             CCeEecCCCCCcEEEccCCceEEecccccc
Q 017445          201 RHLVHRDIKPANLLVNLKGRPKITDFGISA  230 (371)
Q Consensus       201 ~~iiH~Dlkp~NIl~~~~~~~kl~Dfg~s~  230 (371)
                      .|+||+|+.++||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988878999999874